PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chlond, D; Bugaj-Nawrocka, A				Chlond, Dominik; Bugaj-Nawrocka, Agnieszka			Distribution Pattern and Climate Preferences of the Representatives of the Cosmopolitan Genus Sirthenea Spinola, 1840 (Heteroptera: Reduviidae: Peiratinae)	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; HEMIPTERA; SYSTEMATICS	The main goal of this study was to predict, through the use of GIS tool as ecological niche modelling, potentially suitable ecological niche and defining the conditions of such niche for the representatives of the cosmopolitan genus Sirthenea. Among all known genera of the subfamily Peiratinae, only Sirthenea occurs on almost all continents and zoogeographical regions. Our research was based on 521 unique occurrence localities and a set of environmental variables covering the whole world. Based on occurrence localities, as well as climatic variables, digital elevation model, terrestrial ecoregions and biomes, information about the ecological preferences is given. Potentially useful ecological niches were modelled using Maxent software, which allowed for the creation of a map of the potential distribution and for determining climatic preferences. An analysis of climatic preferences suggested that the representatives of the genus were linked mainly to the tropical and temperate climates. An analysis of ecoregions also showed that they preferred areas with tree vegetation like tropical and subtropical moist broadleaf forests biomes as well as temperate broadleaf and mixed forest biomes. Therefore, on the basis of the museum data on the species occurrence and ecological niche modelling method, we provided new and valuable information on the potentially suitable habitat and the possible range of distribution of the genus Sirthenea along with its climatic preferences.	[Chlond, Dominik; Bugaj-Nawrocka, Agnieszka] Univ Silesia, Dept Zool, Fac Biol & Environm Protect, Katowice, Poland	University of Silesia in Katowice	Chlond, D (corresponding author), Univ Silesia, Dept Zool, Fac Biol & Environm Protect, Katowice, Poland.	dominik.chlond@us.edu.pl	Bugaj-Nawrocka, Agnieszka/AAN-1809-2021; Chłond, Dominik/AHD-1065-2022	Bugaj-Nawrocka, Agnieszka/0000-0003-3484-3527; Chłond, Dominik/0000-0002-9530-3463	EU Synthesys Project [AT-TAF-2928, NL-TAF-3392, BE-TAF-5548, DE-TAF-516, SE-TAF-876]	EU Synthesys Project	DC received a grant from the EU Synthesys Projects: AT-TAF-2928; NL-TAF-3392; BE-TAF-5548; DE-TAF-516; SE-TAF-876 (http://www.synthesys.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Gutierrez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063708; Anderson RP, 2003, J BIOGEOGR, V30, P591, DOI 10.1046/j.1365-2699.2003.00867.x; Audinet-Serville, 1843, HIST NATURELLE INSEC; CAI W, 1990, Entomotaxonomia, V12, P85; Cai WZ, 2006, ZOOTAXA, P51; Cai WZ, 2004, ORIENT INSECTS, V38, P85, DOI 10.1080/00305316.2004.10417377; Chlond D, 2008, ORIENT INSECTS, V42, P385; Chlond D, 2015, ZOOL STUD, V54, DOI 10.1186/s40555-014-0092-5; Chlond D, 2014, ZOOL STUD, V53, DOI 10.1186/1810-522X-53-8; Chond D, 2008, POLISH TAXONOMICAL M, V15, P139; Coscaron M.C., 2002, ANN MUS R AFR CENT S, V290, P27; Coscaron Maria Del Carmem, 1995, Revista Brasileira de Entomologia, V39, P453; Coscaron MD, 2007, ZOOTAXA, P65, DOI 10.11646/zootaxa.1439.1.4; COSCARON MC, 1997, PHYSIS-BUENOS AIRES, V54, P49; Coscaron MC, 1983, REV SOC ENTOMOLOGICA, V42, P369; Coscaron MD, 1996, P ENTOMOL SOC WASH, V98, P500; COSCARON MDC, 1995, ENTOMOL SCAND, V26, P191; de Araujo CB, 2014, J BIOGEOGR, V41, P513, DOI 10.1111/jbi.12234; de Souza RA, 2014, ECOL MODEL, V291, P250, DOI 10.1016/j.ecolmodel.2014.07.007; Dicko AH, 2014, P NATL ACAD SCI USA, V111, P10149, DOI 10.1073/pnas.1407773111; Distant W.L, 1904, RHYNCHOTA, V2; Drake C. J., 1945, Boletin de Entomologia Venezolana, V4, P55; Dungan JL, 2002, ECOGRAPHY, V25, P626, DOI 10.1034/j.1600-0587.2002.250510.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elmore AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074819; Fabricius J. Ch., 1798, ENTOMOLOGIAE SYSTE S, P511; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gil-Santana Helcio R., 2003, Revista Brasileira de Zoologia, V20, P3, DOI 10.1590/S0101-81752003000100002; GRASS Development Team, GEOGR RES AN SUPP SY; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horvah G xEza, 1909, Annales Historico Naturales Musei Nationalis Hungarici, V7; Ibarra-Cerdena CN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003266; Jeannel R, 1916, B SOC ENTOM FRANCE P, P300; Kirkaldy GW, 1903, ENTOMOL, V36, P229; Lee CE, 1996, P ENTOMOL SOC WASH, V98, P407; Maldonado Capriles J, 1990, SPECIAL EIDTION; Martinez-Meyer Enrique, 2005, Biodiversity Informatics, V2, P42; Mayr GL., 1865, VERHANDLUNGEN KAISER, V15, P429; Mayr GL., 1865, VEHR ZOOL BOT GES WI, V14, P904; McDowell WG, 2014, FRESHWATER BIOL, V59, P847, DOI 10.1111/fwb.12308; Miller N. C. E., 1959, Bulletin of the British Museum (Natural History) Entomology, V8, P49; MILLER N. C. E., 1952, ANN AND MAG NAT HIST 12TH SER, V5, P539; Morrone J. J., 1996, Zoologische Mededelingen (Leiden), V70, P1; MURUGAN C, 1990, Journal of the Bombay Natural History Society, V87, P125; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pereira JM, 2013, MEM I OSWALDO CRUZ, V108, P335, DOI 10.1590/S0074-02762013000300012; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Proches S, 2012, BIOSCIENCE, V62, P260, DOI 10.1525/bio.2012.62.3.7; R Core Team, R LANG ENV STAT COMP; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Readio P.A., 1927, U KANSAS SCI B, V1927, P275; Reuter O.M., 1881, ACTA SOC SCI FENN, V12, P269; SAGA Development Team, SYST AUT GEOSC AN SA; Sandoval-Ruiz CA, 2008, J MED ENTOMOL, V45, P540, DOI 10.1603/0022-2585(2008)45[540:PGAEDO]2.0.CO;2; SCHOFTEDEN H., 1933, MEM MUS ROY HIST NAT BELGIQUE HORS SERIE, V4, P43; Serville J.G.A., 1831, ANN SCI NATURELLES, V23, P213, DOI [10.5962/bhl.part.7283, DOI 10.5962/BHL.PART.7283]; Spinola MM., 1840, ESSAI INSECTES HEMIP; Stal C., 1862, ENTOMOL ZEITSCHR, V23, P437; Stal C, 1865, OFVERSIGT KONGL VETE, V3, P1; Stal C., 1863, ANN SOC ENTOMOLOGIQU, V3, P25, DOI 10.1080/00379271.1863.11755426; Stal C., 1867, OFVERSIGT KONGLIGA V, V23, P235; Stal C., 1859, OFVERS KONGLIGA VETE, V16, P175; Stohlgren TJ, 2011, CURR ZOOL, V57, P642, DOI 10.1093/czoolo/57.5.642; SUCHETA, 1988, Uttar Pradesh Journal of Zoology, V8, P59; TAEUBER H. W., 1934, ZOOL ANZ, V106, P187; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Villiers A., 1968, Suomen Hyonteistieteellinen Aikakauskirja, V34, P159; VILLIERS A., 1964, REV FRANC ENTOMOL, V31, P182; Villiers A., 1959, B I FRANCAIS AFRIQUE, V21, P301; Villiers A., 1948, FAUNE EMPIRE FRANCAI; VILLIERS ANDRE, 1949, BULL MUS NATION HIST NAT [PARIS], V21, P707; Wieczorek K, 2014, AGR FOREST ENTOMOL, V16, P434, DOI 10.1111/afe.12073; Wiken E. B., 1986, ECOLOGICAL LAND CLAS, V19; WILLEMSE L, 1985, Zoologische Verhandelingen (Leiden), P1; Williams G, 2011, USE R, P3, DOI 10.1007/978-1-4419-9890-3; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zhang GY, 2011, SYST ENTOMOL, V36, P115, DOI 10.1111/j.1365-3113.2010.00551.x	80	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140801	10.1371/journal.pone.0140801	http://dx.doi.org/10.1371/journal.pone.0140801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495965	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200032
J	Godi, A; Bissett, SL; Miller, E; Beddows, S				Godi, Anna; Bissett, Sara L.; Miller, Elizabeth; Beddows, Simon			Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix (R) or Gardasil (R) Vaccine	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS HPV; MEMORY B-CELL; (HPV)-16/18 AS04-ADJUVANTED VACCINE; POPULATION-LEVEL IMPACT; ANTIBODY-RESPONSES; HPV-6/11/16/18 VACCINE; CERVICAL-CANCER; YOUNG-WOMEN; NEUTRALIZATION ASSAY; PARTICLE VACCINE	Background Human papillomavirus (HPV) vaccines confer protection against the oncogenic genotypes HPV16 and HPV18 through the generation of type-specific neutralizing antibodies raised against virus-like particles (VLP) representing these genotypes. The vaccines also confer a degree of cross-protection against HPV31 and HPV45, which are genetically-related to the vaccine types HPV16 and HPV18, respectively, although the mechanism is less certain. There are a number of humoral immune measures that have been examined in relation to the HPV vaccines, including VLP binding, pseudovirus neutralization and the enumeration of memory B cells. While the specificity of responses generated against the vaccine genotypes are fairly well studied, the relationship between these measures in relation to non-vaccine genotypes is less certain. Methods We carried out a comparative study of these immune measures against vaccine and non-vaccine genotypes using samples collected from 12-15 year old girls following immunization with three doses of either Cervarix (R) or Gardasil (R) HPV vaccine. Results The relationship between neutralizing and binding antibody titers and HPV-specific memory B cell levels for the vaccine genotypes, HPV16 and HPV18, were very good. The proportion of responders approached 100% for both vaccines while the magnitude of these responses induced by Cervarix (R) were generally higher than those following Gardasil (R) immunization. A similar pattern was found for the non-vaccine genotype HPV31, albeit at a lower magnitude compared to its genetically-related vaccine genotype, HPV16. However, both the enumeration of memory B cells and VLP binding responses against HPV45 were poorly related to its neutralizing antibody responses. Purified IgG derived from memory B cells demonstrated specificities similar to those found in the serum, including the capacity to neutralize HPV pseudoviruses. Conclusions These data suggest that pseudovirus neutralization should be used as the preferred humoral immune measure for studying HPV vaccine responses, particularly for non-vaccine genotypes.	[Godi, Anna; Bissett, Sara L.; Beddows, Simon] Publ Hlth England, Virus Reference Dept, London, England; [Miller, Elizabeth] Publ Hlth England, Natl Vaccine Evaluat Consortium, London, England	Public Health England; Public Health England	Beddows, S (corresponding author), Publ Hlth England, Virus Reference Dept, London, England.	simon.beddows@phe.gov.uk		Beddows, Simon/0000-0002-6879-6215	UK Medical Research Council [G0701217]; UK Department of Health Policy Research Programme [039/0031]; MRC [G0701217] Funding Source: UKRI; Medical Research Council [G0701217] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health Policy Research Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The laboratory work was supported by the UK Medical Research Council (grant number G0701217) while the vaccine research nurses were supported by a grant from the UK Department of Health Policy Research Programme (grant number 039/0031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BREITBURD F, 1995, J VIROL, V69, P3959, DOI 10.1128/JVI.69.6.3959-3963.1995; Brown D, 2014, VACCINE, V32, P5880, DOI 10.1016/j.vaccine.2014.08.004; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Culp TD, 2007, VIROLOGY, V361, P435, DOI 10.1016/j.virol.2006.12.002; Dauner JG, 2010, VACCINE, V28, P5407, DOI 10.1016/j.vaccine.2010.06.018; Day PM, 2010, CELL HOST MICROBE, V8, P260, DOI 10.1016/j.chom.2010.08.003; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Draper E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061825; Draper E, 2011, VACCINE, V29, P8585, DOI 10.1016/j.vaccine.2011.09.021; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Einstein MH, 2014, HUM VACC IMMUNOTHER, V10, P3455, DOI 10.4161/hv.36117; Einstein MH, 2011, HUM VACCINES, V7, P1359, DOI 10.4161/hv.7.12.18282; Einstein MH, 2011, HUM VACCINES, V7, P1343, DOI 10.4161/hv.7.12.18281; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Herrero R, 2015, LANCET ONCOL, V16, pE206, DOI 10.1016/S1470-2045(14)70481-4; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Kavanagh K, 2014, BRIT J CANCER, V110, P2804, DOI 10.1038/bjc.2014.198; Kemp TJ, 2008, VACCINE, V26, P3608, DOI 10.1016/j.vaccine.2008.04.074; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Krajden M, 2014, VACCINE, V32, P624, DOI 10.1016/j.vaccine.2013.09.007; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Lehtinen M, 2013, NAT REV CLIN ONCOL, V10, P400, DOI 10.1038/nrclinonc.2013.84; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Mesher D, 2013, VACCINE, V32, P26, DOI 10.1016/j.vaccine.2013.10.085; Petaja T, 2009, J ADOLESCENT HEALTH, V44, P33, DOI 10.1016/j.jadohealth.2008.10.002; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Safaeian M, 2013, CANCER PREV RES, V6, P1242, DOI 10.1158/1940-6207.CAPR-13-0203; Safaeian M, 2013, HUM VACC IMMUNOTHER, V9, P1399, DOI 10.4161/hv.24340; Schiller JT, 2012, NAT REV MICROBIOL, V10, P681, DOI 10.1038/nrmicro2872; Smith JF, 2007, HUM VACCINES, V3, P109, DOI 10.4161/hv.3.4.4058; Smolen KK, 2012, VACCINE, V30, P3572, DOI 10.1016/j.vaccine.2012.03.051; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; SUZICH JA, 1995, P NATL ACAD SCI USA, V92, P11553, DOI 10.1073/pnas.92.25.11553; Tabrizi SN, 2012, J INFECT DIS, V206, P1645, DOI 10.1093/infdis/jis590; Truck J, 2014, HUM VACC IMMUNOTHER, V10, P2490, DOI 10.4161/hv.29318; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Walsh PN, 2013, J IMMUNOL METHODS, V394, P84, DOI 10.1016/j.jim.2013.05.007; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	45	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140926	10.1371/journal.pone.0140926	http://dx.doi.org/10.1371/journal.pone.0140926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495976	Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200041
J	Huang, RL; Zheng, Z; Wang, QH; Zhao, XX; Deng, YW; Jiao, Y; Du, XD				Huang, Rong-lian; Zheng, Zhe; Wang, Qing-heng; Zhao, Xiao-xia; Deng, Yue-wen; Jiao, Yu; Du, Xiao-dong			Mantle Branch-Specific RNA Sequences of Moon Scallop Amusium pleuronectes to Identify Shell Color-Associated Genes	PLOS ONE			English	Article							OYSTER PINCTADA-FUCATA; PIGMENT EPITHELIAL-CELLS; PEARL OYSTER; MATRIX PROTEIN; NACRE DEPOSITION; BINDING-PROTEIN; EXPRESSION; SELECTION; CLONING; BIOMINERALIZATION	Amusium pleuronectes (Linnaeus) that secretes red-and white-colored valves in two branches of mantle tissues is an excellent model for shell color research. High-throughput transcriptome sequencing and profiling were applied in this project to reveal the detailed molecular mechanism of this phenotype differentiation. In this study, 50,796,780 and 54,361,178 clean reads were generated from the left branch (secreting red valve, RS) and right branch (secreting white valve, WS) using the Illumina Hiseq 2000 platform. De novo assembly generated 149,375 and 176,652 unigenes with an average length of 764 bp and 698 bp in RS and WS, respectively. Kyoto encyclopedia of genes and genomes (KEGG) metabolic pathway analysis indicated that the differentially expressed genes were involved in 228 signaling pathways, and 43 genes were significantly enriched (P<0.01). Nineteen of 20 differentially expressed vitellogenin genes showed significantly high expression in RS, which suggested that they probably played a crucial role in organic pigment assembly and transportation of the shell. Moreover, 687 crystal formation-related (or biomineralization-related) genes were detected in A. pleuronectes, among which 144 genes exhibited significant difference between the two branches. Those genes could be classified into shell matrix framework participants, crystal nucleation and growth-related elements, upstream regulation factors, Ca level regulators, and other classifications. We also identified putative SNP and SSR markers from these samples which provided the markers for genetic diversity analysis, genetic linkage, QTL analysis. These results provide insight into the complexity of shell color differentiation in A. pleuronectes so as valuable resources for further research.	[Huang, Rong-lian; Zheng, Zhe; Wang, Qing-heng; Deng, Yue-wen; Jiao, Yu; Du, Xiao-dong] Guangdong Ocean Univ, Fishery Coll, Zhanjiang, Peoples R China; [Huang, Rong-lian; Zheng, Zhe; Wang, Qing-heng; Deng, Yue-wen; Jiao, Yu; Du, Xiao-dong] Lab Marine Pearl Culture, Zhanjiang, Peoples R China; [Zhao, Xiao-xia] Environm Protect Agcy Zhanjiang, Environm Protect Monitoring Stn, Zhanjiang, Peoples R China	Guangdong Ocean University	Wang, QH (corresponding author), Guangdong Ocean Univ, Fishery Coll, Zhanjiang, Peoples R China.	wangqingheng_haida@163.com			National Natural Science Foundation [31372526, 31272635]; Project of Science and Technology of Zhanjiang [2014B101]; Project of Enhancing School with Innovation of Guangdong Ocean University [GDOU2014050207]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Project of Science and Technology of Zhanjiang; Project of Enhancing School with Innovation of Guangdong Ocean University	This work was supported by the National Natural Science Foundation, Award Number: 31372526, Recipient: Yuewen Deng; the National Natural Science Foundation, Award Number: 31272635, Recipient: Xiaodong Du; the Project of Science and Technology of Zhanjiang, Award Number: 2014B101, Recipient: Ronglian Huang; and the Project of Enhancing School with Innovation of Guangdong Ocean University, Award Number: GDOU2014050207, Recipient: Qingheng Wang.	Aguilera F, 2014, ACTA BIOMATERIALIA; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; ATKINSON WD, 1983, BIOL J LINN SOC, V20, P137, DOI 10.1111/j.1095-8312.1983.tb00358.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai Z, 2013, COMP ANAL TRANSCRIPT; Baldo L, 2011, GENOME BIOL EVOL, V3, P443, DOI 10.1093/gbe/evr047; Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x; Blay C, 2014, AQUACULT INT, V22, P937, DOI 10.1007/s10499-013-9719-5; Blow N, 2009, NATURE, V458, P239, DOI 10.1038/458239a; Brake J, 2004, AQUACULTURE, V229, P89, DOI 10.1016/S0044-8486(03)00325-9; Budd A, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0062-0; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; COMFORT A, 1949, BIOCHEM J, V45, P199, DOI 10.1042/bj0450199; COMFORT A, 1949, BIOCHEM J, V44, P111, DOI 10.1042/bj0440111; COMFORT A, 1951, BIOL REV, V26, P285, DOI 10.1111/j.1469-185X.1951.tb01358.x; Damek-Poprawa M, 2009, J BIOL CHEM, V284, P10877, DOI 10.1074/jbc.M808857200; de Vega S, 2007, J BIOL CHEM, V282, P30878, DOI 10.1074/jbc.M705847200; Elde AC, 2012, MAR DRUGS, V10, P1400, DOI 10.3390/md10061400; Falini G, 2004, TISSUE ENG, V10, P1, DOI 10.1089/107632704322791646; Gao RC, 2014, FOOD CHEM, V146, P423, DOI 10.1016/j.foodchem.2013.09.107; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green DW, 2013, MAR DRUGS, V11, P1203, DOI 10.3390/md11041203; HELLER J, 1992, BIOL J LINN SOC, V46, P247, DOI 10.1111/j.1095-8312.1992.tb00863.x; Huang XD, 2012, FISH SHELLFISH IMMUN, V33, P652, DOI 10.1016/j.fsi.2012.06.026; Isowa Y, 2012, J MOL EVOL, V75, P11, DOI 10.1007/s00239-012-9514-3; Ji LL, 2013, AQUAC RES, V44, P1300, DOI 10.1111/j.1365-2109.2012.03134.x; Jiao Y, 2012, BIOCHEM BIOPH RES CO, V425, P679, DOI 10.1016/j.bbrc.2012.07.099; Jones DB, 2014, AQUACULTURE, V434, P476, DOI 10.1016/j.aquaculture.2014.08.038; KANTHA SS, 1989, J FOOD BIOCHEM, V13, P429, DOI 10.1111/j.1745-4514.1989.tb00410.x; Killian CE, 2008, CHEM REV, V108, P4463, DOI 10.1021/cr0782630; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kimura T, 2003, NEUROSCI RES, V46, P105, DOI 10.1016/S0168-0102(03)00038-5; Klatt AR, 2011, INT J BIOCHEM CELL B, V43, P320, DOI 10.1016/j.biocel.2010.12.010; Ky CL, 2014, AQUACULTURE, V432, P154, DOI 10.1016/j.aquaculture.2014.05.002; Li N, 2010, FOOD CHEM, V118, P616, DOI 10.1016/j.foodchem.2009.05.043; Li S, 2004, COMP BIOCHEM PHYS B, V138, P235, DOI 10.1016/j.cbpc.2004.03.012; Li XL, 2014, GENE, V538, P258, DOI 10.1016/j.gene.2014.01.046; Mann S., 2001, CONCEPTS BIOINORGANI; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyashita T, 2008, BIOSCI BIOTECH BIOCH, V72, P37, DOI 10.1271/bbb.70302; MOORE KJ, 1990, GENETICS, V125, P421; MORTON B, 1980, J ZOOL, V190, P375, DOI 10.1111/j.1469-7998.1980.tb01434.x; Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217; NEWKIRK GF, 1980, J EXP MAR BIOL ECOL, V47, P89, DOI 10.1016/0022-0981(80)90140-9; NICHOLAS REH, 1949, BIOCHEM J, V45, P208, DOI 10.1042/bj0450208; Ordas A, 2011, FISH SHELLFISH IMMUN, V31, P716, DOI 10.1016/j.fsi.2010.08.022; Petersen JL, 2012, AQUACULTURE, V350, P200, DOI 10.1016/j.aquaculture.2012.03.039; Prasad M, 2010, CONNECT TISSUE RES, V51, P404, DOI 10.3109/03008200903329789; Reed WL, 1999, BIOL J LINN SOC, V67, P331, DOI 10.1006/bijl.1998.0305; Setiamarga DHE, 2013, ZOOL SCI, V30, P877, DOI 10.2108/zsj.30.877; Smolenaars MMW, 2005, J LIPID RES, V46, P412, DOI 10.1194/jlr.M400374-JLR200; Sokolova IM, 2000, J EXP MAR BIOL ECOL, V245, P1, DOI 10.1016/S0022-0981(99)00132-X; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Speiser DI, 2011, J EXP BIOL, V214, P422, DOI 10.1242/jeb.048108; Suzuki M, 2011, CHEMBIOCHEM, V12, P2478, DOI 10.1002/cbic.201100317; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tan YD, 2014, BIOINFORMATICS, V30, P2018, DOI 10.1093/bioinformatics/btu124; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; WAITE JH, 1983, MOLLUSCA, V1, P467; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063927; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; Weiss IM, 2001, BIOCHEM BIOPH RES CO, V285, P244, DOI 10.1006/bbrc.2001.5170; Xie LP, 2007, MAR BIOTECHNOL, V9, P613, DOI 10.1007/s10126-007-9015-3; Yan F, 2014, INT J MOL SCI, V15, P21215, DOI 10.3390/ijms151121215; Zayzafoon M, 2005, J BIOL CHEM, V280, P7049, DOI 10.1074/jbc.M412680200; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zheng HP, 2010, FOOD CHEM, V122, P1164, DOI 10.1016/j.foodchem.2010.03.109; Zou KS, 2014, GENE, V542, P8, DOI 10.1016/j.gene.2014.03.029	72	8	10	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141390	10.1371/journal.pone.0141390	http://dx.doi.org/10.1371/journal.pone.0141390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496197	gold, Green Published, Green Submitted			2022-12-27	WOS:000363309200106
J	Lipinska, AP; Ahmed, S; Peters, AF; Faugeron, S; Cock, JM; Coelho, SM				Lipinska, Agnieszka P.; Ahmed, Sophia; Peters, Akira F.; Faugeron, Sylvain; Cock, J. Mark; Coelho, Susana M.			Development of PCR-Based Markers to Determine the Sex of Kelps	PLOS ONE			English	Article							BROWN ALGA ECTOCARPUS; UNDARIA-PINNATIFIDA; MACROCYSTIS-PYRIFERA; FEMALE GAMETOPHYTES; SILICULOSUS PHAEOPHYCEAE; JAPONICA PHAEOPHYCEAE; SACCHARINA-JAPONICA; TRIAL CULTIVATION; GENOME SEQUENCE; YELLOW CATFISH	Sex discriminating genetic markers are commonly used to facilitate breeding programs in economically and ecologically important animal and plant species. However, despite their considerable economic and ecological value, the development of sex markers for kelp species has been very limited. In this study, we used the recently described sequence of the sex determining region (SDR) of the brown algal model Ectocarpus to develop novel DNA-based sex-markers for three commercially relevant kelps: Laminaria digitata, Undaria pinnatifida and Macrocystis pyrifera. Markers were designed within nine protein coding genes of Ectocarpus male and female (U/V) sex chromosomes and tested on gametophytes of the three kelp species. Seven primer pairs corresponding to three loci in the Ectocarpus SDR amplified sex-specific bands in the three kelp species, yielding at least one male and one female marker for each species. Our work has generated the first male sex-specific markers for L. digitata and U. pinnatifida, as well as the first sex markers developed for the genus Macrocystis. The markers and methodology presented here will not only facilitate seaweed breeding programs but also represent useful tools for population and demography studies and provide a means to investigate the evolution of sex determination across this largely understudied eukaryotic group.	[Lipinska, Agnieszka P.; Ahmed, Sophia; Cock, J. Mark; Coelho, Susana M.] Univ Paris 06, Sorbonne Univ, Integrat Biol Marine Models, Algal Genet Grp,Stn Biol Roscoff,UMR 8227,CS 9007, F-29688 Roscoff, France; [Lipinska, Agnieszka P.; Ahmed, Sophia; Cock, J. Mark; Coelho, Susana M.] CNRS, Integrat Biol Marine Models, Stn Biol Roscoff, Algal Genet Grp,UMR 8227,CS 90074, F-29688 Roscoff, France; [Peters, Akira F.] Bezhin Rosko, F-29250 Santec, France; [Faugeron, Sylvain] Univ Paris 06, Sorbonne Univ, Evolutionary Biol & Ecol Algae, Stn Biol Roscoff,UMI 3614,CS 90074, F-29688 Roscoff, France; [Faugeron, Sylvain] CNRS, Evolutionary Biol & Ecol Algae, Stn Biol Roscoff, CS 90074, F-29688 Roscoff, France; [Faugeron, Sylvain] Pontificia Univ Catolica Chile, Ctr Conservac Marina, Santiago, Chile; [Faugeron, Sylvain] Pontificia Univ Catolica Chile, Fac Ciencias Biol, CeBiB, Santiago, Chile	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Coelho, SM (corresponding author), Univ Paris 06, Sorbonne Univ, Integrat Biol Marine Models, Algal Genet Grp,Stn Biol Roscoff,UMR 8227,CS 9007, F-29688 Roscoff, France.	coelho@sb-roscoff.fr	Lipinska, Agnieszka/ABF-9845-2021; Coelho, Susana/ABH-8166-2020	Peters, Akira/0000-0001-5332-199X; Faugeron, Sylvain/0000-0001-7258-5229; Cock, J. Mark/0000-0002-2650-0383	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR12-JSV7-0008, ANR-10-BLAN-1727]; University Pierre and Marie Curie Emergence program; Interreg program France (Channel)-England (project MARINEXUS); Bezhin Rosko	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); University Pierre and Marie Curie Emergence program; Interreg program France (Channel)-England (project MARINEXUS); Bezhin Rosko	This work was supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche (Project SEXSEAWEED ANR12-JSV7-0008, project Bi-CYCLE ANR-10-BLAN-1727 and project IDEALG), the University Pierre and Marie Curie Emergence program, and the Interreg program France (Channel)-England (project MARINEXUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bezhin Rosko provided support in the form of salaries for authors [AFP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed S, 2014, CURR BIOL, V24, P1945, DOI 10.1016/j.cub.2014.07.042; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; Carney LT, 2010, J PHYCOL, V46, P987, DOI 10.1111/j.1529-8817.2010.00882.x; Cock JM, 2011, CURR BIOL, V21, pR573, DOI 10.1016/j.cub.2011.05.006; Cock JM, 2010, NEW PHYTOL, V188, P1, DOI 10.1111/j.1469-8137.2010.03454.x; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Coelho SM, 2011, PLANT SIGNAL BEHAV, V6, P1858, DOI 10.4161/psb.6.11.17737; Coelho SM, 2011, P NATL ACAD SCI USA, V108, P11518, DOI 10.1073/pnas.1102274108; Correa T, 2016, AQUAC RES, V47, P698, DOI 10.1111/are.12529; Critchley AT, 1993, JPN INT COOP AGENCY, P151; Dan C, 2013, INT J BIOL SCI, V9, P1043, DOI 10.7150/ijbs.7203; Danilova TV, 2006, EUPHYTICA, V151, P15, DOI 10.1007/s10681-005-9020-4; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; DRUEHL LD, 1989, MAR BIOL, V101, P451, DOI 10.1007/BF00541646; Duarte CM, 2009, BIOSCIENCE, V59, P967, DOI 10.1525/bio.2009.59.11.8; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Fang Z. X. (Fang T. H.), 1980, Acta Genetica Sinica, V7, P19; Graham MH, 2007, OCEANOGR MAR BIOL, V45, P39; Gschloessl B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-393; Gu JG, 2014, J APPL PHYCOL, V26, P635, DOI 10.1007/s10811-013-0089-1; Guillemin ML, 2012, J PHYCOL, V48, P365, DOI 10.1111/j.1529-8817.2012.01116.x; Guiry GM, 2015, ALGAEBASE; Gutierrez A, 2006, 18 INT SEAW S, P33, DOI DOI 10.1007/978-1-4020-5670.3-5; HASEGAWA Y, 1976, J FISH RES BOARD CAN, V33, P1002, DOI 10.1139/f76-127; Heesch S, 2010, NEW PHYTOL, V188, DOI 10.1111/j.1469-8137.2010.03273.x; Henry EC, 1987, PHYCOLOGIA, V387, P393; HORMAZA JI, 1994, THEOR APPL GENET, V89, P9, DOI 10.1007/BF00226975; Hughes AD, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-86; Ince AG, 2011, J AGR SCI-CAMBRIDGE, V149, P327, DOI 10.1017/S0021859610000948; Kawai H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02491; Kijjoa A., 2004, MAR DRUGS, V2, P73, DOI [DOI 10.3390/MD202073, https://doi.org/10.3390/md202073, 10.3390/md202073]; Kim S-K, 2011, HANDBOOK OF MARINE M; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kovacs B, 2000, GENETICA, V110, P267, DOI 10.1023/A:1012739318941; Lane CE, 2006, J PHYCOL, V42, P493, DOI 10.1111/j.1529-8817.2006.00204.x; Le Bail A, 2008, J PHYCOL, V44, P1269, DOI 10.1111/j.1529-8817.2008.00582.x; LEWIS RJ, 1993, J PHYCOL, V29, P363, DOI 10.1111/j.0022-3646.1993.00363.x; Li XJ, 2008, AQUACULTURE, V280, P76, DOI 10.1016/j.aquaculture.2008.05.005; Li XJ, 2007, J APPL PHYCOL, V19, P139, DOI 10.1007/s10811-006-9120-0; Liao LQ, 2009, EUPHYTICA, V169, P49, DOI 10.1007/s10681-009-9913-8; Lipinska A, 2015, MOL BIOL EVOL, DOI [10.1093/molbev/msv049, DOI 10.1093/M0LBEV/MSV049]; Lipinska AP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-909; Liu YS, 2009, J PHYCOL, V45, P894, DOI 10.1111/j.1529-8817.2009.00719.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048784; Luthringer R, 2014, PERSPECT PHYCOL, V1, P11, DOI DOI 10.1127/2198-011X/2014/0002; Luthringer R, 2015, MOL BIOL EVOL, V32, P2973, DOI 10.1093/molbev/msv173; Macchiavello J, 2010, J APPL PHYCOL, V22, P691, DOI 10.1007/s10811-010-9508-8; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; MARKHAM J W, 1972, Phycologia, V11, P147, DOI 10.2216/i0031-8884-11-2-147.1; Martinez EA, 1999, MOL ECOL, V8, P1533, DOI 10.1046/j.1365-294x.1999.00721.x; Morelissen B, 2013, J EXP MAR BIOL ECOL, V448, P197, DOI 10.1016/j.jembe.2013.07.009; Oppliger LV, 2007, J PHYCOL, V43, P1295, DOI 10.1111/j.1529-8817.2007.00408.x; Oppliger LV, 2011, J PHYCOL, V47, P5, DOI 10.1111/j.1529-8817.2010.00930.x; Parasnis AS, 2000, MOL BREEDING, V6, P337, DOI 10.1023/A:1009678807507; Peters AF, 2004, EUR J PHYCOL, V39, P235, DOI 10.1080/09670260410001683241; Peters AF, 2008, DEVELOPMENT, V135, P1503, DOI 10.1242/dev.016303; Reamon-Buttner SM, 2000, THEOR APPL GENET, V100, P432, DOI 10.1007/s001220050056; Sauvageau C, 1918, PARIS MEM ACAD SCI; Shan TF, 2013, PHYCOL RES, V61, P154, DOI 10.1111/pre.12014; Shan TF, 2010, PHYCOL RES, V58, P171, DOI 10.1111/j.1440-1835.2010.00575.x; Shan TF, 2009, PHYCOL RES, V57, P36, DOI 10.1111/j.1440-1835.2008.00519.x; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Smale DA, 2013, ECOL EVOL, V3, P4016, DOI 10.1002/ece3.774; Smit AJ, 2004, J APPL PHYCOL, V16, P245, DOI 10.1023/B:JAPH.0000047783.36600.ef; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Sterck L, 2012, NAT METHODS, V9, P1041, DOI 10.1038/nmeth.2242; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Oppliger LV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102518; Wang D, 2009, ANIM GENET, V40, P978, DOI 10.1111/j.1365-2052.2009.01941.x; Wang WJ, 2013, PLANTA, V237, P1123, DOI 10.1007/s00425-012-1831-7; Westermeier R, 2006, AQUAC RES, V37, P164, DOI 10.1111/j.1365-2109.2005.01414.x; Westermeier R, 2007, J APPL PHYCOL, V19, P215, DOI 10.1007/s10811-006-9126-7; Westermeier R, 2010, J APPL PHYCOL, V22, P357, DOI 10.1007/s10811-009-9466-1; Wu C-Y, 1996, CHIN J OCEANOL LIMN, V14, P205, DOI [10.1007/BfF02850381, DOI 10.1007/BF02850381]; Wynne MJ, 1985, INTRO ALGAE; YABU H, 1973, Bulletin of the Faculty of Fisheries Hokkaido University, V23, P171; YONESHIGUEVALENTIN Y, 1990, HYDROBIOLOGIA, V204, P461, DOI 10.1007/BF00040271; Zhang N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1371-1	82	25	27	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140535	10.1371/journal.pone.0140535	http://dx.doi.org/10.1371/journal.pone.0140535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496392	Green Submitted, gold, Green Published			2022-12-27	WOS:000363309200018
J	Brooks, SE; Bonney, SA; Lee, C; Publicover, A; Khan, G; Smits, EL; Sigurdardottir, D; Arno, M; Li, DM; Mills, KI; Pulford, K; Banham, AH; van Tendeloo, V; Mufti, GJ; Rammensee, HG; Elliott, TJ; Orchard, KH; Guinn, BA				Brooks, Suzanne E.; Bonney, Stephanie A.; Lee, Cindy; Publicover, Amy; Khan, Ghazala; Smits, Evelien L.; Sigurdardottir, Dagmar; Arno, Matthew; Li, Demin; Mills, Ken I.; Pulford, Karen; Banham, Alison H.; van Tendeloo, Viggo; Mufti, Ghulam J.; Rammensee, Hans-Georg; Elliott, Tim J.; Orchard, Kim H.; Guinn, Barbara-ann			Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; WT1 PEPTIDE VACCINATION; ACUTE MYELOID-LEUKEMIA; CANCER TESTIS ANTIGEN; MUC1-DERIVED PEPTIDES; HUMAN-MELANOMA; CTL EPITOPES; IN-SITU; PROTEIN; IDENTIFICATION	Immunotherapy treatments for cancer are becoming increasingly successful, however to further improve our understanding of the T-cell recognition involved in effective responses and to encourage moves towards the development of personalised treatments for leukaemia immunotherapy, precise antigenic targets in individual patients have been identified. Cellular arrays using peptide-MHC (pMHC) tetramers allow the simultaneous detection of different antigen specific T-cell populations naturally circulating in patients and normal donors. We have developed the pMHC array to detect CD8(+) T-cell populations in leukaemia patients that recognise epitopes within viral antigens (cytomegalovirus (CMV) and influenza (Flu)) and leukaemia antigens (including Per Arnt Sim domain 1 (PASD1), MelanA, Wilms' Tumour (WT1) and tyrosinase). We show that the pMHC array is at least as sensitive as flow cytometry and has the potential to rapidly identify more than 40 specific T-cell populations in a small sample of T-cells (0.8-1.4 x 10(6)). Fourteen of the twenty-six acute myeloid leukaemia (AML) patients analysed had T cells that recognised tumour antigen epitopes, and eight of these recognised PASD1 epitopes. Other tumour epitopes recognised were MelanA (n = 3), tyrosinase (n = 3) and WT1(126-134) (n = 1). One of the seven acute lymphocytic leukaemia (ALL) patients analysed had T cells that recognised the MUC1(950-958) epitope. In the future the pMHC array may be used provide point of care T-cell analyses, predict patient response to conventional therapy and direct personalised immunotherapy for patients.	[Brooks, Suzanne E.; Bonney, Stephanie A.; Lee, Cindy; Elliott, Tim J.; Guinn, Barbara-ann] Univ Southampton, Canc Sci Unit, Southampton, Hants, England; [Lee, Cindy; Publicover, Amy; Orchard, Kim H.] Univ Southampton, Dept Haematol, Southampton Univ Hosp Trust, Southampton, Hants, England; [Khan, Ghazala; Guinn, Barbara-ann] Univ Bedfordshire, Dept Life Sci, Luton, Beds, England; [Smits, Evelien L.; van Tendeloo, Viggo] Univ Antwerp, Lab Expt Haematol, Vaccine & Infect Dis Inst, B-2650 Antwerp, Belgium; [Sigurdardottir, Dagmar; Rammensee, Hans-Georg] Univ Tubingen, Dept Immunol, Inst Cell Biol, Tubingen, Germany; [Arno, Matthew] Kings Coll London, Kings Genom Ctr, Sch Biomed & Hlth Sci, London WC2R 2LS, England; [Li, Demin; Pulford, Karen; Banham, Alison H.] Univ Oxford, John Radcliffe Hosp, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford OX3 9DU, England; [Mills, Ken I.] Queens Univ Belfast, Blood Canc Res Grp, CCRCB, Belfast, Antrim, North Ireland; [Mufti, Ghulam J.; Guinn, Barbara-ann] Kings Coll London, Sch Med, Dept Haematol Med, London WC2R 2LS, England	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Bedfordshire; University of Antwerp; Eberhard Karls University of Tubingen; University of London; King's College London; University of Oxford; Queens University Belfast; University of London; King's College London	Guinn, BA (corresponding author), Univ Southampton, Canc Sci Unit, MP824,Somers Canc Sci Bldg, Southampton, Hants, England.	barbara.guinn@beds.ac.uk	Li, Demin/O-4065-2019; Guinn, Barbara/AAB-7403-2021; Smits, Evelien/A-3520-2014; Guinn, Barbara-Ann/AHC-8282-2022; Van Tendeloo, Viggo FI/A-1233-2010; Orchard, Kim H/A-3073-2016; Mills, Ken/A-8556-2012	Li, Demin/0000-0002-7118-3401; Guinn, Barbara/0000-0003-0639-4541; Smits, Evelien/0000-0001-9255-3435; Guinn, Barbara-Ann/0000-0003-0639-4541; Van Tendeloo, Viggo FI/0000-0003-3217-9917; Orchard, Kim H/0000-0003-2276-3925; Mills, Ken/0000-0002-6362-4481	Cancer Research U.K; European Group for Blood and Marrow Transplant fellow; Leukaemia and Lymphoma Research; Cork Cancer Research Centre; Wellcome Value in People award; British Society for Haematology; Wessex Cancer Trust; Research Foundation Flanders; Cancer Research UK [10702, 16997] Funding Source: researchfish; Leukaemia & Lymphoma NI [R2536CNR] Funding Source: researchfish	Cancer Research U.K(Cancer Research UK); European Group for Blood and Marrow Transplant fellow; Leukaemia and Lymphoma Research; Cork Cancer Research Centre; Wellcome Value in People award; British Society for Haematology; Wessex Cancer Trust; Research Foundation Flanders(FWO); Cancer Research UK(Cancer Research UK); Leukaemia & Lymphoma NI	This work was supported by Cancer Research U.K. (SEB, SAB)(http://www.cancerresearchuk.org/), a European Group for Blood and Marrow Transplant fellow (CL) (https://www.ebmt.org/Contents/Pages/Default.aspx), Leukaemia and Lymphoma Research (BG)(https:// leukaemialymphomaresearch.org.uk/), Cork Cancer Research Centre (BG)(http://www.ccrc.ie/), Wellcome Value in People award (BG) (http://www.wellcome.ac.uk/Funding/Public-engagement/Funding-schemes/People-Awards-and-Society-Awards/), British Society for Haematology (BG) (http://www.b-s-h.org.uk/), the Wessex Cancer Trust (BG) (http://wessexcancer.org. uk/), and Research Foundation Flanders (ELS) (http://www.fwo.be/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Tahar K, 2009, BRIT J HAEMATOL, V146, P396, DOI 10.1111/j.1365-2141.2009.07761.x; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363; Arnold D, 1997, EUR J BIOCHEM, V249, P171, DOI 10.1111/j.1432-1033.1997.t01-1-00171.x; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Benninger-Doring G, 1999, VIROLOGY, V264, P289, DOI 10.1006/viro.1999.9996; BHARDWAJ V, 1993, J IMMUNOL, V151, P5000; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; BODMER H, 1989, NATURE, V342, P443, DOI 10.1038/342443a0; Brossart P, 1999, BLOOD, V93, P4309, DOI 10.1182/blood.V93.12.4309.412k19_4309_4317; Carmon L, 2000, INT J CANCER, V85, P391; Celie PHN, 2009, J AM CHEM SOC, V131, P12298, DOI 10.1021/ja9037559; Chen DS, 2005, PLOS MED, V2, P1018, DOI 10.1371/journal.pmed.0020265; Cooper CDO, 2006, LEUKEMIA, V20, P2172, DOI 10.1038/sj.leu.2404424; Deviren G, 2007, J MOL RECOGNIT, V20, P32, DOI 10.1002/jmr.805; Dittmann J, 2005, CANCER IMMUNOL IMMUN, V54, P750, DOI 10.1007/s00262-004-0640-7; Gao LQ, 2000, BLOOD, V95, P2198, DOI 10.1182/blood.V95.7.2198.007k38_2198_2203; GNJATIC S, 1995, EUR J IMMUNOL, V25, P1638, DOI 10.1002/eji.1830250625; Greiner J, 2006, BLOOD, V108, P4109, DOI 10.1182/blood-2006-01-023127; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; Guinn B, 2005, BIOCHEM BIOPH RES CO, V335, P1293, DOI 10.1016/j.bbrc.2005.08.024; Guinn B, 2009, BLOOD, V113, P1203, DOI 10.1182/blood-2008-09-178848; Haanen JBAG, 2000, NAT MED, V6, P1056, DOI 10.1038/79573; Hadrup SR, 2009, METHODS MOL BIOL, V524, P383, DOI 10.1007/978-1-59745-450-6_28; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Hardwick Nicola, 2013, Cancer Immun, V13, P16; HILL AB, 1995, J EXP MED, V181, P2221, DOI 10.1084/jem.181.6.2221; Hoff A, 2010, CANCER IMMUNOL IMMUN, V59, P1379, DOI 10.1007/s00262-010-0867-4; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; J Apperley, 2012, ESH EBMT HDB HAEMOPO; KAST WM, 1994, J IMMUNOL, V152, P3904; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; King EV, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27254; Kwong GA, 2009, J AM CHEM SOC, V131, P9695, DOI 10.1021/ja9006707; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mathieu MG, 2007, CANCER IMMUNOL IMMUN, V56, P1885, DOI 10.1007/s00262-007-0331-2; MISKO IS, 1990, INT J CANCER, V46, P399, DOI 10.1002/ijc.2910460312; Molldrem J, 1996, BLOOD, V88, P2450, DOI 10.1182/blood.V88.7.2450.bloodjournal8872450; MUKHERJI B, 1995, P NATL ACAD SCI USA, V92, P8078, DOI 10.1073/pnas.92.17.8078; NAYERSINA R, 1993, J IMMUNOL, V150, P4659; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; Passoni L, 2002, BLOOD, V99, P2100, DOI 10.1182/blood.V99.6.2100; Rehermann B, 1996, J CLIN INVEST, V97, P1655, DOI 10.1172/JCI118592; Rezvani K, 2008, BLOOD, V111, P236, DOI 10.1182/blood-2007-08-108241; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Romero P, 1997, J IMMUNOL, V159, P2366; Rudolf D, 2008, THESIS U TUBINGEN; Schmitz M, 2000, CANCER RES, V60, P4845; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Skipper JCA, 1999, INT J CANCER, V82, P669, DOI 10.1002/(SICI)1097-0215(19990827)82:5<669::AID-IJC9>3.0.CO;2-#; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Smithgall M, 2001, AM SOC HEM M DEC 8 1; Soen Y, 2003, PLOS BIOL, V1, P429, DOI 10.1371/journal.pbio.0000065; Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605; Uttenthal B, 2014, BRIT J HAEMATOL, V164, P366, DOI 10.1111/bjh.12637; Valmori D, 1998, J IMMUNOL, V160, P1750; Verma B, 2010, CANCER IMMUNOL IMMUN, V59, P563, DOI 10.1007/s00262-009-0774-8; Vissers JLM, 1999, CANCER RES, V59, P5554; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; Walter S, 2005, EUR J IMMUNOL, V35, P2876, DOI 10.1002/eji.200526207; Weinschenk T, 2002, CANCER RES, V62, P5818; Whelan JA, 1999, J IMMUNOL, V163, P4342; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Zhang QJ, 1996, INT IMMUNOL, V8, P927, DOI 10.1093/intimm/8.6.927; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	67	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140483	10.1371/journal.pone.0140483	http://dx.doi.org/10.1371/journal.pone.0140483			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492414	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000363249300007
J	Furihata, S; Hirata, M; Matsumoto, H; Hayakawa, Y				Furihata, Shunsuke; Hirata, Makiko; Matsumoto, Hitoshi; Hayakawa, Yoichi			Bacteria Endosymbiont, Wolbachia, Promotes Parasitism of Parasitoid Wasp Asobara japonica	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; DROSOPHILA-MELANOGASTER; INDUCED PARTHENOGENESIS; FEMINIZING WOLBACHIA; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; HOST; HYMENOPTERA; INFECTION; INSECT	Wolbachia is the most widespread endosymbiotic bacterium that manipulates reproduction of its arthropod hosts to enhance its own spread throughout host populations. Infection with Wolbachia causes complete parthenogenetic reproduction in many Hymenoptera, producing only female offspring. The mechanism of such reproductive manipulation by Wolbachia has been extensively studied. However, the effects of Wolbachia symbiosis on behavioral traits of the hosts are scarcely investigated. The parasitoid wasp Asobara japonica is an ideal insect to investigate this because symbiotic and aposymbiotic strains are available: Wolbachia-infected Tokyo (TK) and noninfected Iriomote (IR) strains originally collected on the main island and southwest islands of Japan, respectively. We compared the oviposition behaviors of the two strains and found that TK strain females parasitized Drosophila melanogaster larvae more actively than the IR strain, especially during the first two days after eclosion. Removing Wolbachia from the TK strain wasps by treatment with tetracycline or rifampicin decreased their parasitism activity to the level of the IR strain. Morphological and behavioral analyses of both strain wasps showed that Wolbachia endosymbionts do not affect development of the host female reproductive tract and eggs, but do enhance host-searching ability of female wasps. These results suggest the possibility that Wolbachia endosymbionts may promote their diffusion and persistence in the host A. japonica population not only at least partly by parthenogenesis but also by enhancement of oviposition frequency of the host females.	[Furihata, Shunsuke; Hirata, Makiko; Matsumoto, Hitoshi; Hayakawa, Yoichi] Saga Univ, Dept Appl Biol Sci, Saga 840, Japan	Saga University	Hayakawa, Y (corresponding author), Saga Univ, Dept Appl Biol Sci, Saga 840, Japan.	hayakayo@cc.saga-u.ac.jp	Furihata, Shunsuke/O-8571-2019					Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; Carroll MJ, 2006, J CHEM ECOL, V32, P1911, DOI 10.1007/s10886-006-9117-9; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Furihata SX, 2013, ARCH INSECT BIOCHEM, V83, P86, DOI 10.1002/arch.21093; Furihata SX, 2009, PHYSIOL ENTOMOL, V34, P292, DOI 10.1111/j.1365-3032.2009.00676.x; Hayakawa Y, 1998, EUR J BIOCHEM, V253, P810, DOI 10.1046/j.1432-1327.1998.2530810.x; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Jiggins FM, 2000, PARASITOLOGY, V120, P439, DOI 10.1017/S0031182099005867; Kageyama D, 2002, HEREDITY, V88, P444, DOI 10.1038/sj.hdy.6800077; Kremer N, 2009, HEREDITY, V103, P248, DOI 10.1038/hdy.2009.63; Kremer N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S7; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Mitsui H, 2007, J NAT HIST, V41, P1731, DOI 10.1080/00222930701504797; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Negri I, 2006, P ROY SOC B-BIOL SCI, V273, P2409, DOI 10.1098/rspb.2006.3592; Oda Y, 2010, P NATL ACAD SCI USA, V107, P15862, DOI 10.1073/pnas.1003785107; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Pannebakker BA, 2004, GENOME, V47, P299, DOI [10.1139/G03-137, 10.1139/g03-137]; Pannebakker BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068608; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Reumer BM, 2012, HEREDITY, V108, P341, DOI 10.1038/hdy.2011.82; Reumer BM, 2010, MOL ECOL, V19, P1733, DOI 10.1111/j.1365-294X.2010.04599.x; Richards S, 1996, GENETICS, V142, P1215; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; STOUTHAMER R, 1994, HEREDITY, V73, P317, DOI 10.1038/hdy.1994.139; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tsuzuki S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5628; Tsuzuki S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00210; van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Weeks AR, 2001, P ROY SOC B-BIOL SCI, V268, P2245, DOI 10.1098/rspb.2001.1797; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Yager J, 2001, P NATL ACAD SCI USA, V98, P10445, DOI 10.1073/pnas.191107698	43	14	15	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140914	10.1371/journal.pone.0140914	http://dx.doi.org/10.1371/journal.pone.0140914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492411	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300016
J	Koning, IV; Groenenberg, IAL; Gotink, AW; Willemsen, SP; Gijtenbeek, M; Dudink, J; Go, ATJI; Reiss, IKM; Steegers, EAP; Steegers-Theunissen, RPM				Koning, Irene V.; Groenenberg, Irene A. L.; Gotink, Anniek W.; Willemsen, Sten P.; Gijtenbeek, Manon; Dudink, Jeroen; Go, Attie T. J. I.; Reiss, Irwin K. M.; Steegers, Eric A. P.; Steegers-Theunissen, Regine P. M.			Periconception Maternal Folate Status and Human Embryonic Cerebellum Growth Trajectories: The Rotterdam Predict Study	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTS; ONE-CARBON METABOLISM; POSTERIOR-FOSSA; 3-DIMENSIONAL ULTRASOUND; PREGNANCY; CHILD; NEURODEVELOPMENT; METHYLATION; HYPOTHESIS; DISORDERS	We aimed to investigate whether periconceptional maternal folate status affects human embryonic cerebellar size and growth trajectories. In a prospective periconceptional cohort participants filled out questionnaires and received weekly transvaginal 3D-ultrasounds between 7+0 and 12+6 weeks gestational age (GA). Viable non-malformed singleton pregnancies were selected for cerebellar measurements; transcerebellar diameter, (TCD), left and right cerebellar diameters (LCD, RCD). Linear mixed models were performed to estimate associations between questionnaire data on the timing of maternal folic acid supplement initiation and longitudinal cerebellar measurements as a function of crown-rump length (CRL) and GA. Maternal red blood cell folate concentrations were analysed before 8 weeks GA to validate the associations. A total of 263 serial high quality three-dimensional ultrasound scans of 135 pregnancies were studied. Preconceptional compared to postconceptional initiation of folic acid use was associated with slightly larger cerebellar diameters per millimetre increase of CRL (TCD: beta = 0.260mm, 95% CI = 0.023-0.491, p<0.05; LCD: beta = 0.171mm, 95% CI = 0.038-0.305, p<0.05; RCD: beta = 0.156mm, 95% CI = 0.032-0.280, p<0.05) and with proportional cerebellar growth (TCD/CRL: beta = 0.015mm/mm, 95% CI = 0.005-0.024, p<0.01; LCD/CRL: beta = 0.012mm/mm, 95% CI = 0.005-0.018, p<0.01; RCD/CRL: beta = 0.011mm/mm, 95% CI = 0.005-0.017, p<0.01). Cerebellar growth was significantly highest in the third quartile of maternal red blood cell folate levels (1538-1813 nmol/L). These first findings show that periconceptional maternal folate status is associated with human embryonic cerebellar development. Implications of these small but significant variations for fetal cerebellar growth trajectories and the child's neurodevelopmental outcome are yet unknown and warrant further investigation.	[Koning, Irene V.; Groenenberg, Irene A. L.; Gotink, Anniek W.; Willemsen, Sten P.; Gijtenbeek, Manon; Go, Attie T. J. I.; Steegers, Eric A. P.; Steegers-Theunissen, Regine P. M.] Erasmus Univ, Dept Obstet & Gynaecol, Med Ctr, Rotterdam, Netherlands; [Koning, Irene V.; Dudink, Jeroen; Reiss, Irwin K. M.] Sophia Childrens Univ Hosp, Dept Paediat, Subdiv Neonatol, Rotterdam, Netherlands; [Willemsen, Sten P.] Erasmus Univ, Dept Biostat, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Dudink, Jeroen] Sophia Childrens Univ Hosp, Dept Radiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital	Steegers-Theunissen, RPM (corresponding author), Erasmus Univ, Dept Obstet & Gynaecol, Med Ctr, Rotterdam, Netherlands.	r.steegers@erasmusmc.nl		Dudink, Jeroen/0000-0003-0446-3646	Department of Obstetrics and Gynaecology of the Erasmus MC University Medical Centre, Rotterdam, The Netherlands; Sophia Foundation for Medical Research (SSWO) [644]	Department of Obstetrics and Gynaecology of the Erasmus MC University Medical Centre, Rotterdam, The Netherlands; Sophia Foundation for Medical Research (SSWO)	This study was funded by the Department of Obstetrics and Gynaecology of the Erasmus MC University Medical Centre, Rotterdam, The Netherlands. IVK was supported by an additional grant from the Sophia Foundation for Medical Research (SSWO grant number 644, http://www.vriendensophia.nl/welkom.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertucci E, 2011, J ULTRAS MED, V30, P1403, DOI 10.7863/jum.2011.30.10.1403; Bouwland-Both MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081731; Chen ZT, 2005, INT J DEV NEUROSCI, V23, P465, DOI 10.1016/j.ijdevneu.2005.05.007; Cho KH, 2011, SURG RADIOL ANAT, V33, P523, DOI 10.1007/s00276-011-0796-8; Craciunescu CN, 2004, J NUTR, V134, P162, DOI 10.1093/jn/134.1.162; D'Angelo E, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00116; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Garel C, 2011, J CHILD NEUROL, V26, P1483, DOI 10.1177/0883073811420148; GREENBLATT JM, 1994, PROG NEURO-PSYCHOPH, V18, P647, DOI 10.1016/0278-5846(94)90074-4; Hodgetts VA, 2015, BJOG-INT J OBSTET GY, V122, P478, DOI 10.1111/1471-0528.13202; Julvez J, 2009, PAEDIATR PERINAT EP, V23, P199, DOI 10.1111/j.1365-3016.2009.01032.x; Leitner Y, 2004, J CHILD NEUROL, V19, P435, DOI 10.1177/088307380401900607; Lyall K, 2014, INT J EPIDEMIOL, V43, P443, DOI 10.1093/ije/dyt282; Martinasevic MK, 1999, DEV NEUROSCI-BASEL, V21, P29, DOI 10.1159/000017363; Paladini D, 2006, ULTRASOUND OBST GYN, V27, P482, DOI 10.1002/uog.2748; Roth C, 2011, JAMA-J AM MED ASSOC, V306, P1566, DOI 10.1001/jama.2011.1433; Rousian M, 2013, REPROD SCI, V20, P899, DOI 10.1177/1933719112468950; Scheier M, 2011, ULTRASOUND OBST GYN, V38, P625, DOI 10.1002/uog.9067; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Shane B, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013367; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Steegers-Theunissen RPM, 2013, HUM REPROD UPDATE, V19, P640, DOI 10.1093/humupd/dmt041; Steegers-Theunissen RPM, 2003, EUR J OBSTET GYN R B, V106, P115, DOI 10.1016/S0301-2115(02)00358-5; Steinlin M, 2008, CEREBELLUM, V7, P607, DOI 10.1007/s12311-008-0083-3; ten Donkelaar HJ, 2003, J NEUROL, V250, P1025, DOI 10.1007/s00415-003-0199-9; Twigt J, 2011, FOLATE HUMAN REPROD; Valera-Gran D, 2014, JAMA PEDIATR, V168, DOI 10.1001/jamapediatrics.2014.2611; van Mil NH, 2014, REPRODUCTION, V148, P581, DOI 10.1530/REP-14-0260; van Uitert EM, 2014, BJOG-INT J OBSTET GY, V121, P821, DOI 10.1111/1471-0528.12592; van Uitert EM, 2013, HUM REPROD, V28, P3188, DOI 10.1093/humrep/det375; van Uitert EM, 2012, MOL NUTR FOOD RES; Veena SR, 2010, J NUTR, V140, P1014, DOI 10.3945/jn.109.118075; Wang SSH, 2014, NEURON, V83, P518, DOI 10.1016/j.neuron.2014.07.016; Wehby GL, 2008, MATERN CHILD HLTH J, V12, P180, DOI 10.1007/s10995-007-0230-3; Wilson RD, 2007, J OBSTET GYNAECOL CA, V29, P1003, DOI 10.1016/S1701-2163(16)32685-8	35	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141089	10.1371/journal.pone.0141089	http://dx.doi.org/10.1371/journal.pone.0141089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491876	Green Submitted, Green Published, gold			2022-12-27	WOS:000363249300028
J	Mues, KE; Lammie, PJ; Klein, M; Kleinbaum, DG; Addiss, D; Fox, LM				Mues, Katherine E.; Lammie, Patrick J.; Klein, Mitchel; Kleinbaum, David G.; Addiss, David; Fox, LeAnne M.			Changes in Antibody Levels during and following an Episode of Acute Adenolymphangitis (ADL) among Lymphedema Patients in Leogane, Haiti	PLOS ONE			English	Article							ELIMINATE LYMPHATIC FILARIASIS; PAPUA-NEW-GUINEA; BANCROFTIAN FILARIASIS; ENDEMIC COMMUNITY; IMMUNE-RESPONSE; MASS TREATMENT; BRUGIA-MALAYI; INFECTION; AREA; FREQUENCY	Introduction Episodes of acute adenolymphangitis (ADL) are often the first clinical sign of lymphatic filariasis (LF). They are often accompanied by swelling of the affected limb, inflammation, fever, and general malaise and lead to the progression of lymphedema. Although ADL episodes have been studied for a century or more, questions still remain as to their etiology. We quantified antibody levels to pathogens that potentially contribute to ADL episodes during and after an episode among lymphedema patients in Leogane, Haiti. We estimated the proportion of ADL episodes hypothesized to be attributed to specific pathogens. Methods We measured antibody levels to specific pathogens during and following an ADL episode among 41 lymphedema patients enrolled in a cohort study in Leogane, Haiti. We calculated the absolute and relative changes in antibody levels between the ADL and convalescent time points. We calculated the proportion of episodes that demonstrated a two-fold increase in antibody level for several bacterial, fungal, and filarial pathogens. Results Our results showed the greatest proportion of two-fold changes in antibody levels for the carbohydrate antigen Streptococcus group A, followed by IgG2 responses to a soluble filarial antigen (BpG2), Streptococcal Pyrogenic Exotoxin B, and an antigen for the fungal pathogen Candida. When comparing the median antibody level during the ADL episode to the median antibody level at the convalescent time point, only the antigens for Pseudomonas species (P-value = 0.0351) and Streptolysin O (P-value = 0.0074) showed a significant result. Conclusion Although our results are limited by the lack of a control group and few antibody responses, they provide some evidence for infection with Streptococcus A as a potential contributing factor to ADL episodes. Our results add to the current evidence and illustrate the importance of determining the causal role of bacterial and fungal pathogens and immunological antifilarial response in ADL episodes.	[Mues, Katherine E.; Klein, Mitchel; Kleinbaum, David G.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Mues, Katherine E.; Klein, Mitchel; Kleinbaum, David G.] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA; [Lammie, Patrick J.; Fox, LeAnne M.] Ctr Dis Control & Prevent, Parasit Dis Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Addiss, David] Task Force Global Hlth, Decatur, GA USA	Emory University; Rollins School Public Health; Emory University; Centers for Disease Control & Prevention - USA	Mues, KE (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	Katie.mues@gmail.com			Office of Women's Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; WHO/UNDP/World Bank Special Programme for Research and Training in Tropical Diseases (Filariasis Operational Research Project) [950568]; Emory University, Laney Graduate School	Office of Women's Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; WHO/UNDP/World Bank Special Programme for Research and Training in Tropical Diseases (Filariasis Operational Research Project); Emory University, Laney Graduate School	This study was funded by grants from the Office of Women's Health (http://www.cdc.gov/women/), U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; and the WHO/UNDP/World Bank Special Programme for Research and Training in Tropical Diseases (Filariasis Operational Research Project No. 950568) (http://apps.who.int/tdr/index.html). KEM was supported in part by Emory University, Laney Graduate School. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addiss DG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000668; AYOUB EM, 1991, PEDIATR INFECT DIS J, V10, pS15, DOI 10.1097/00006454-199110001-00004; Babu BV, 2003, TROP MED INT HEALTH, V8, P1102, DOI 10.1046/j.1360-2276.2003.01146.x; Baird JB, 2002, AM J TROP MED HYG, V66, P163, DOI 10.4269/ajtmh.2002.66.163; Bockarie MJ, 2002, NEW ENGL J MED, V347, P1841, DOI 10.1056/NEJMoa021309; Dreyer G, 1999, T ROY SOC TROP MED H, V93, P413, DOI 10.1016/S0035-9203(99)90140-2; DREYER G, 1998, PATHOLOGY EMERGING I, V2, P317; Dreyer G., 2002, BASIC LYMPHOEDEMA MA; ESTAMBALE BBA, 1994, ANN TROP MED PARASIT, V88, P153, DOI 10.1080/00034983.1994.11812853; Esterre P, 2000, PARASITE, V7, P91, DOI 10.1051/parasite/2000072091; KAR SK, 1993, T ROY SOC TROP MED H, V87, P230, DOI 10.1016/0035-9203(93)90505-K; KIMURA E, 1985, B WORLD HEALTH ORGAN, V63, P869; KING CL, 2000, HUNTERS TROPICAL MED, P740; Krishnamoorthy K, 1999, Indian J Public Health, V43, P58; KUPPER LL, 1978, AM J EPIDEMIOL, V108, P447, DOI 10.1093/oxfordjournals.aje.a112643; KURNIAWAN A, 1993, J IMMUNOL, V150, P3941; Kurniawan-Atmadja A, 1998, PARASITE IMMUNOL, V20, P155; KWANLIM GE, 1990, J IMMUNOL, V145, P4298; Mand S, 2012, CLIN INFECT DIS, V55, P621, DOI 10.1093/cid/cis486; McPherson T, 2006, BRIT J DERMATOL, V154, P933, DOI 10.1111/j.1365-2133.2005.07081.x; MORE SJ, 1990, TROP MED PARASITOL, V41, P403; Nanda B, 2003, TROP MED INT HEALTH, V8, P56, DOI 10.1046/j.1365-3156.2003.00962.x; Nutman TB, 2011, TROPICAL INFECT DIS, P729; Olszewski WL, 1997, AM J TROP MED HYG, V57, P7, DOI 10.4269/ajtmh.1997.57.7; Osborne J, 1996, INFECT IMMUN, V64, P3461, DOI 10.1128/IAI.64.9.3461-3466.1996; OTTESEN EA, 1992, PARASITOLOGY, V104, pS71, DOI 10.1017/S0031182000075259; PANI SP, 1995, T ROY SOC TROP MED H, V89, P72, DOI 10.1016/0035-9203(95)90666-5; PANI SP, 1995, INDIAN J MED RES, V102, P114; Ramaiah KD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003319; RAO CK, 1982, INDIAN J MED RES, V75, P813; Rothman K.J., 1998, MODERN EPIDEMIOLOGY, Vsecond, P329; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P7; Shenoy R. K., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P301; Suma T. K., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P826; Tisch DJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001241; Vincent AL, 1998, J PARASITOL, V84, P557, DOI 10.2307/3284723; Wamae CN, 1995, E AFR MED J, V72, P492	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141047	10.1371/journal.pone.0141047	http://dx.doi.org/10.1371/journal.pone.0141047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492462	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300025
J	Do, VBD; Tsai, WC; Lin, YJ; Higa, S; Yagi, N; Chang, SL; Lo, LW; Chung, FP; Liao, JN; Huang, YC; Chan, CS; Huang, HK; Hu, YF; Tsao, HM; Chen, SA				Do, Van Buu Dan; Tsai, Wen-Chin; Lin, Yenn-Jiang; Higa, Satoshi; Yagi, Nobumori; Chang, Shih-Lin; Lo, Li-Wei; Chung, Fa-Po; Liao, Jo-Nan; Huang, Yen-Chang; Chan, Chao-Shun; Huang, Hung-Kai; Hu, Yu-Feng; Tsao, Hsuan-Ming; Chen, Shih-Ann			The Different Substrate Characteristics of Arrhythmogenic Triggers in Idiopathic Right Ventricular Outflow Tract Tachycardia and Arrhythmogenic Right Ventricular Dysplasia: New Insight from Noncontact Mapping	PLOS ONE			English	Article							CATHETER ABLATION; ELECTROPHYSIOLOGIC CHARACTERISTICS; CARDIOMYOPATHY/DYSPLASIA; DYSPLASIA/CARDIOMYOPATHY; VOLTAGE; ELECTROGRAMS; VALIDATION; MYOCARDIUM; DIAGNOSIS; CONTACT	Background The aim of this study was to investigate the different substrate characteristics of repetitive premature ventricular complexed (PVC) trigger sites by the non-contact mapping (NCM). Methods Thirty-five consecutive patients, including 14 with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC) and 21 with idiopathic right ventricular outflow tract tachycardia (RVOT VT), were enrolled for electrophysiological study and catheter ablation guided by the NCM. Substrate and electrogram (Eg) characteristics of the earliest activation (EA) and breakout (BO) sites of PVCs were investigated, and these were confirmed by successful PVC elimination. Results Overall 35 dominant focal PVCs were identified. PVCs arose from the focal origins with preferential conduction, breakout, and spread to the whole right ventricle. The conduction time and distance from EA to BO site were both longer in the ARVC than the RVOT group. The conduction velocity was similar between the 2 groups. The negative deflection of local unipolar Eg at the EA site (EA slope3,5,10ms values) was steeper in the RVOT, compared to ARVC patients. The PVCs of ARVC occurred in the diseased substrate in the ARVC patients. More radiofrequency applications were required to eliminate the triggers in ARVC patients. Conclusions/Interpretation The substrate characteristics of PVC trigger may help to differentiate between idiopathic RVOT VT and ARVC. The slowing and slurred QS unipolar electrograms and longer distance from EA to BO in RVOT endocardium suggest that the triggers of ARVC may originate from mid- or sub-epicardial myocardium. More extensive ablation to the trigger site was required in order to create deeper lesions for a successful outcome.	[Do, Van Buu Dan; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Chung, Fa-Po; Liao, Jo-Nan; Huang, Yen-Chang; Chan, Chao-Shun; Huang, Hung-Kai; Hu, Yu-Feng; Chen, Shih-Ann] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Tsai, Wen-Chin] Hualien Tzu Chi Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Fac Med, Taipei 112, Taiwan; [Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chen, Shih-Ann] Natl Yang Ming Univ, Cardiovasc Res Inst, Taipei 112, Taiwan; [Higa, Satoshi] Makiminato Cent Hosp, Div Cardiovasc Med, Cardiac Electrophysiol & Pacing Lab, Urasoe, Okinawa, Japan; [Yagi, Nobumori] Nakagami Hosp, Div Cardiovasc Med, Urasoe, Okinawa, Japan; [Tsao, Hsuan-Ming] Natl Yang Ming Univ Hosp, Cardiol, Ilan, Taiwan	Taipei Veterans General Hospital; Buddhist Tzu Chi General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, YJ (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan.	linyennjiang@gmail.com	Tsai, WEN-CHIN/AGY-3079-2022; Hu, Yu-Feng/V-1401-2019; Chang, Shih-Lin/AGT-1191-2022	Hu, Yu-Feng/0000-0001-5715-2070; HIGA, SATOSHI/0000-0002-5735-6249	Ministry of Science and Technology (MOST) [103-2314-B-010 -048 -MY3, 102-2314-B-010-056-MY2, 101-2314-B-075-056-MY3, 103-2911-I-008-001]; Taipei Veteran General Hospital, Taiwan [V103E7-003, V102E7-002, V102C-128]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Taipei Veteran General Hospital, Taiwan	This study was supported by grants of Ministry of Science and Technology (MOST) 103-2314-B-010 -048 -MY3, 102-2314-B-010-056-MY2, 101-2314-B-075-056-MY3, 103-2911-I-008-001, and grants V103E7-003, V102E7-002, V102C-128 from Taipei Veteran General Hospital, Taiwan.	ABBOUD S, 1984, COMPUT BIOMED RES, V17, P258, DOI 10.1016/S0010-4809(84)80017-8; Arruda M, 2009, J INTERV CARD ELECTR, V25, P129, DOI 10.1007/s10840-008-9317-z; Berruezo A, 2012, CIRC-ARRHYTHMIA ELEC, V5, P111, DOI 10.1161/CIRCEP.110.960740; Boulos M, 2005, AM J CARDIOL, V95, P935, DOI 10.1016/j.amjcard.2004.12.030; Burke AP, 1998, CIRCULATION, V97, P1571, DOI 10.1161/01.CIR.97.16.1571; BUXTON AE, 1983, CIRCULATION, V68, P917, DOI 10.1161/01.CIR.68.5.917; Callans DJ, 1999, CIRCULATION, V100, P1744, DOI 10.1161/01.CIR.100.16.1744; Chi PC, 2014, J CARDIOVASC ELECTR, V25, P1343, DOI 10.1111/jce.12495; Corrado D, 2005, CIRCULATION, V111, P3042, DOI 10.1161/CIRCULATIONAHA.104.486977; Corrado D, 1997, J AM COLL CARDIOL, V30, P1512, DOI 10.1016/S0735-1097(97)00332-X; Corrado D, 2008, J AM COLL CARDIOL, V51, P731, DOI 10.1016/j.jacc.2007.11.027; Flemming MA, 1999, AM J CARDIOL, V84, P1266, DOI 10.1016/S0002-9149(99)00546-9; Fontaine G, 1999, ANNU REV MED, V50, P17, DOI 10.1146/annurev.med.50.1.17; Garcia FC, 2009, CIRCULATION, V120, P366, DOI 10.1161/CIRCULATIONAHA.108.834903; Higa S, 2004, CIRCULATION, V109, P84, DOI 10.1161/01.CIR.0000109481.73788.2E; HOCH D H, 1992, Cardiology Clinics, V10, P151; Huang JL, 2006, J AM COLL CARDIOL, V48, P492, DOI 10.1016/j.jacc.2006.03.045; Kazmierczak J, 1998, HEART, V79, P388, DOI 10.1136/hrt.79.4.388; Kies P, 2006, HEART RHYTHM, V3, P225, DOI 10.1016/j.hrthm.2005.10.018; Kornowski R, 1998, CIRCULATION, V98, P1116, DOI 10.1161/01.CIR.98.11.1116; LERMAN BB, 1995, CIRCULATION, V92, P421, DOI 10.1161/01.CIR.92.3.421; Lin YJ, 2007, J CARDIOVASC ELECTR, V18, P1147, DOI 10.1111/j.1540-8167.2007.00924.x; Lin YJ, 2005, J CARDIOVASC ELECTR, V16, P173, DOI 10.1046/j.1540-8167.2005.40513.x; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; O'Donnell D, 2003, EUR HEART J, V24, P801, DOI 10.1016/S0195-668X(02)00654-1; Okumura Y, 2011, J INTERV CARD ELECTR, V30, P17, DOI 10.1007/s10840-010-9522-4; Philips B, 2013, CIRC-ARRHYTHMIA ELEC, V6, P160, DOI 10.1161/CIRCEP.112.975441; Philips B, 2012, CIRC-ARRHYTHMIA ELEC, V5, P499, DOI 10.1161/CIRCEP.111.968677; Schilling RJ, 1998, CIRCULATION, V98, P887, DOI 10.1161/01.CIR.98.9.887; Shokrollahi E, 2009, IEEE ENG MED BIO, P1901, DOI 10.1109/IEMBS.2009.5333029; Sivagangabalan G, 2008, CIRC-ARRHYTHMIA ELEC, V1, P363, DOI 10.1161/CIRCEP.108.799619; Tandri H, 2009, HEART RHYTHM, V6, P769, DOI 10.1016/j.hrthm.2009.02.031; Tsai CF, 1997, INT J CARDIOL, V62, P143, DOI 10.1016/S0167-5273(97)00198-8; Zhang FX, 2013, HEART RHYTHM, V10, P1895, DOI 10.1016/j.hrthm.2013.09.052	35	9	9	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140167	10.1371/journal.pone.0140167	http://dx.doi.org/10.1371/journal.pone.0140167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488594	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400045
J	Matos, LL; Suarez, ER; Theodoro, TR; Trufelli, DC; Melo, CM; Garcia, LF; Oliveira, OCG; Matos, MGL; Kanda, JL; Nader, HB; Martins, JRM; Pinhal, MAS				Matos, Leandro Luongo; Suarez, Eloah Rabello; Theodoro, Therese Rachell; Trufelli, Damila Cristina; Melo, Carina Mucciolo; Garcia, Larissa Ferraz; Grimaldi Oliveira, Olivia Capela; Luongo Matos, Maria Graciela; Kanda, Jossi Ledo; Nader, Helena Bonciani; Maciel Martins, Joao Roberto; Silva Pinhal, Maria Aparecida			The Profile of Heparanase Expression Distinguishes Differentiated Thyroid Carcinoma from Benign Neoplasms	PLOS ONE			English	Article							NEEDLE-ASPIRATION BIOPSY; SYNDECAN-1 EXPRESSION; SULFATE PROTEOGLYCAN; EXTRACELLULAR-MATRIX; MOLECULAR DIAGNOSIS; GENE-EXPRESSION; CANCER PATIENTS; CELLS; METASTASIS; PROTEIN	Introduction The search for a specific marker that could help to distinguish between differentiated thyroid carcinoma and benign lesions remains elusive in clinical practice. Heparanase (HPSE) is an endo-beta-glucoronidase implicated in the process of tumor invasion, and the heparanase-2 (HPSE2) modulates HPSE activity. The aim of this study was to evaluate the role of heparanases in the development and differential diagnosis of follicular pattern thyroid lesions. Methods HPSE and HPSE2 expression by qRT-PCR, immunohistochemistry evaluation, western blot analysis and HPSE enzymatic activity were evaluated. Results The expression of heparanases by qRT-PCR showed an increase of HPSE2 in thyroid carcinoma (P = 0.001). HPSE activity was found to be higher in the malignant neoplasms than in the benign tumors (P<0.0001). On Western blot analysis, HPSE2 isoforms were detected only in malignant tumors. The immunohistochemical assay allowed us to establish a distinct pattern for malignant and benign tumors. Carcinomas showed a typical combination of positive labeling for neoplastic cells and negative immunostaining in colloid, when compared to benign tumors (P<0.0001). The proposed diagnostic test presents sensitivity and negative predictive value of around 100%, showing itself to be an accurate test for distinguishing between malignant and benign lesions. Conclusions This study shows, for the first time, a distinct profile of HPSE expression in thyroid carcinoma suggesting its role in carcinogenesis.	[Matos, Leandro Luongo; Suarez, Eloah Rabello; Theodoro, Therese Rachell; Trufelli, Damila Cristina; Garcia, Larissa Ferraz; Silva Pinhal, Maria Aparecida] Fac Med ABC, Dept Biochem, Santo Andre, Brazil; [Matos, Leandro Luongo; Kanda, Jossi Ledo] Fac Med ABC, Head & Neck Surg Dept, Santo Andre, Brazil; [Matos, Leandro Luongo; Suarez, Eloah Rabello; Melo, Carina Mucciolo; Nader, Helena Bonciani; Maciel Martins, Joao Roberto; Silva Pinhal, Maria Aparecida] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil; [Maciel Martins, Joao Roberto] Univ Fed Sao Paulo, Lab Mol & Translat Endocrinol, Endocrinol & Metab Discipline, Sao Paulo, Brazil; [Grimaldi Oliveira, Olivia Capela] Pathos Med Diag, Dept Pathol, Sao Paulo, Brazil; [Luongo Matos, Maria Graciela] Univ Cidade Sao Paulo Unicid, Sao Paulo, Brazil	Faculdade de Medicina do ABC; Faculdade de Medicina do ABC; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Cidade de Sao Paulo	Matos, LL (corresponding author), Fac Med ABC, Dept Biochem, Santo Andre, Brazil.	lmatos@amcham.com.br; jrmacmartins@yahoo.com.br	Nader, Helena Bonciani/D-9253-2012; Matos, Leandro/B-8344-2008; Theodoro, Thérèse Rachell/U-1721-2017; Suarez, Eloah Rabello/T-7448-2019; Pinhal, Maria Aparecida Silva/J-1797-2012; Suarez, Eloah Rabello/GQP-2672-2022; Martins, João Roberto M/J-6042-2015; Martins, João Roberto/AAC-6063-2021; Suarez, Eloah R/C-9225-2012	Matos, Leandro/0000-0002-5068-8208; Suarez, Eloah Rabello/0000-0002-0521-1056; Pinhal, Maria Aparecida Silva/0000-0003-4001-1663; Martins, João Roberto M/0000-0002-0204-3552; Martins, João Roberto/0000-0002-0204-3552; NADER, HELENA/0000-0002-7569-2166	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico).	Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; Arvatz G, 2011, CANCER METAST REV, V30, P253, DOI 10.1007/s10555-011-9288-x; Behzad F, 2003, ANAL BIOCHEM, V320, P207, DOI 10.1016/S0003-2697(03)00358-0; Ben Arush MW, 2009, PEDIATR HEMAT ONCOL, V26, P157, DOI 10.1080/08880010902754917; Bologna-Molina R, 2010, ARCH MED RES, V41, P33, DOI 10.1016/j.arcmed.2009.11.004; Boucas RI, 2008, ANAL CHIM ACTA, V618, P218, DOI 10.1016/j.aca.2008.04.059; Brown LM, 2006, MOL CARCINOGEN, V45, P613, DOI 10.1002/mc.20193; Buchs AE, 2003, ENDOCRINE, V22, P81, DOI 10.1385/ENDO:22:2:81; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Conejo JR, 2000, INT J CANCER, V88, P12, DOI 10.1002/1097-0215(20001001)88:1<12::AID-IJC3>3.0.CO;2-T; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; de Moura JP, 2009, INT J GYNECOL CANCER, V19, P1494, DOI 10.1111/IGC.0b013e3181a834a2; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Eszlinger M, 2010, MOL CELL ENDOCRINOL, V322, P29, DOI 10.1016/j.mce.2010.01.010; Ferraz C, 2011, J CLIN ENDOCR METAB, V96, P2016, DOI 10.1210/jc.2010-2567; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Hodak SP, 2013, THYROID, V23, P131, DOI 10.1089/thy.2012.0320; Ito Y, 2003, HISTOPATHOLOGY, V43, P157, DOI 10.1046/j.1365-2559.2003.01656.x; Jiang P, 2002, J BIOL CHEM, V277, P8989, DOI 10.1074/jbc.M105682200; Kleeff J, 1998, J CLIN INVEST, V102, P1662, DOI 10.1172/JCI4105; Levy-Adam F, 2010, J BIOL CHEM, V285, P28010, DOI 10.1074/jbc.M110.116384; Linke M, 2002, J CELL SCI, V115, P4877, DOI 10.1242/jcs.00184; llan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI [10.1016/i.biocel.2006.06.004, DOI 10.1016/I.BIOCEL.2006.06.004]; Lu S, 2000, VIRCHOWS ARCH, V436, P595, DOI 10.1007/s004280000180; Marques RM, 2012, J LOW GENIT TRACT DI, V16, P256, DOI 10.1097/LGT.0b013e3182422c69; Matos LL, 2012, DIAGN PATHOL, V7, P97; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; McKenzie E, 2000, BIOCHEM BIOPH RES CO, V276, P1170, DOI 10.1006/bbrc.2000.3586; Mitselou A., 2007, Experimental Oncology, V29, P54; Myers MB, 2014, MOL CARCINOGEN, V53, P159, DOI 10.1002/mc.21953; Nadav L, 2002, J CELL SCI, V115, P2179; Peretti T, 2008, EUR J GASTROEN HEPAT, V20, P756, DOI 10.1097/MEG.0b013e3282fc2649; Rodrigues LMR, 2013, SPINE, V38, P1112, DOI 10.1097/BRS.0b013e3182894cf4; Saggiorato E, 2005, ENDOCR-RELAT CANCER, V12, P305, DOI 10.1677/erc.1.00944; Suarez ER, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-444; Theodoro TR, 2007, NEOPLASIA, V9, P504, DOI 10.1593/neo.07241; Thompson CA, 2013, J BIOL CHEM, V288, P10093, DOI 10.1074/jbc.C112.444562; Trindade ES, 2008, J CELL PHYSIOL, V217, P328, DOI 10.1002/jcp.21504; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Wang CCC, 2011, THYROID, V21, P243, DOI 10.1089/thy.2010.0243; Xu XL, 2003, CLIN CANCER RES, V9, P5968; Yamanaka K, 2007, ONCOLOGY-BASEL, V73, P389, DOI 10.1159/000136159; Yassa L, 2007, CANCER CYTOPATHOL, V111, P508, DOI 10.1002/cncr.23116; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zhang W, 2011, ANTICANCER RES, V31, P3423; Zhang XG, 2013, CANCER EPIDEMIOL, V37, P1010, DOI 10.1016/j.canep.2013.09.012	46	17	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141139	10.1371/journal.pone.0141139	http://dx.doi.org/10.1371/journal.pone.0141139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488476	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400107
J	Matsukura, M; Ozaki, K; Takahashi, A; Onouchi, Y; Morizono, T; Komai, H; Shigematsu, H; Kudo, T; Inoue, Y; Kimura, H; Hosaka, A; Shigematsu, K; Miyata, T; Watanabe, T; Tsunoda, T; Kubo, M; Tanaka, T				Matsukura, Mitsuru; Ozaki, Kouichi; Takahashi, Atsushi; Onouchi, Yoshihiro; Morizono, Takashi; Komai, Hiroyoshi; Shigematsu, Hiroshi; Kudo, Toshifumi; Inoue, Yoshinori; Kimura, Hideo; Hosaka, Akihiro; Shigematsu, Kunihiro; Miyata, Teturo; Watanabe, Toshiaki; Tsunoda, Tatsuhiko; Kubo, Michiaki; Tanaka, Toshihiro			Genome-Wide Association Study of Peripheral Arterial Disease in a Japanese Population	PLOS ONE			English	Article							ANKLE-BRACHIAL INDEX; II HISTONE DEACETYLASES; ETA-RECEPTOR; FUNCTIONAL DECLINE; GENETIC VARIANT; ISCHEMIC-STROKE; RISK-FACTORS; ENDOTHELIN-1; ATHEROSCLEROSIS; STRATIFICATION	Characteristics of peripheral arterial disease (PAD) are the occlusion or stenosis of multiple vessel sites caused mainly by atherosclerosis and chronic lower limb ischemia. To identify PAD susceptible loci, we conducted a genome-wide association study (GWAS) with 785 cases and 3,383 controls in a Japanese population using 431,666 single nucleotide polymorphisms (SNP). After staged analyses including a total of 3,164 cases and 20,134 controls, we identified 3 novel PAD susceptibility loci at IPO5/RAP2A, EDNRA and HDAC9 with genome wide significance (combined P = 6.8 x 10(-14), 5.3 x 10(-9) and 8.8 x 10(-8), respectively). Fine-mapping at the IPO5/RAP2A locus revealed that rs9584669 conferred risk of PAD. Luciferase assay showed that the risk allele at this locus reduced expression levels of IPO5. To our knowledge, these are the first genetic risk factors for PAD.	[Matsukura, Mitsuru; Ozaki, Kouichi; Onouchi, Yoshihiro; Tanaka, Toshihiro] RIKEN Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan; [Matsukura, Mitsuru; Shigematsu, Kunihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg, Tokyo, Japan; [Takahashi, Atsushi] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Morizono, Takashi; Tsunoda, Tatsuhiko] RIKEN Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Komai, Hiroyoshi] Kansai Med Univ, Dept Surg, Unit Peripheral Vasc Surg, Osaka, Japan; [Shigematsu, Hiroshi] Int Univ Hlth & Welf, Clin Res Ctr Med, Tokyo, Japan; [Kudo, Toshifumi] Tokyo Med & Dent Univ, Dept Profess Dev, Tokyo, Japan; [Inoue, Yoshinori] Tokyo Med & Dent Univ, Dept Esophageal & Gen Surg, Dept Vasc Surg, Tokyo, Japan; [Kimura, Hideo] Manaka Hosp, Dept Surg, Odawara, Kanagawa, Japan; [Hosaka, Akihiro] Tokyo Metropolitan Tama Med Ctr, Dept Surg, Tokyo, Japan; [Miyata, Teturo] Sanno Hosp, Tokyo, Japan; [Miyata, Teturo] Vasc Ctr, Sanno Med Ctr, Tokyo, Japan; [Watanabe, Toshiaki] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo, Japan; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Tanaka, Toshihiro] Tokyo Med & Dent Univ, Bioresource Res Ctr, Tokyo, Japan	RIKEN; University of Tokyo; RIKEN; RIKEN; Kansai Medical University; International University of Health & Welfare; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; RIKEN; Tokyo Medical & Dental University (TMDU)	Tanaka, T (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan.	ttana012@riken.jp	Kubo, Michiaki/N-7947-2015; Tanaka, Toshihiro/J-9310-2014; Tsunoda, Tatsuhiko/K-2061-2014	Tanaka, Toshihiro/0000-0001-6201-9784; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Komai, Hiroyoshi/0000-0002-2069-157X; Ozaki, Kouichi/0000-0003-0028-1570	Ministry of Education, Culture, Sports, Sciences and Technology from the Japanese Government; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation	Ministry of Education, Culture, Sports, Sciences and Technology from the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders; Naito Foundation(Naito Memorial Foundation)	The Ministry of Education, Culture, Sports, Sciences and Technology from the Japanese Government (https://www.jsps.go.jp/j-grantsinaid/). The Astellas Foundation for Research on Metabolic Disorders (http://www.astellas.com/jp/byoutai/assist/gist.html). The Naito Foundation (https://www.naito-f.or.jp/jp/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton M, 1998, P NATL ACAD SCI USA, V95, P14367, DOI 10.1073/pnas.95.24.14367; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Browatzki M, 2000, BASIC RES CARDIOL, V95, P98, DOI 10.1007/s003950050170; Callera GE, 2004, HYPERTENSION, V43, P872, DOI 10.1161/01.HYP.0000117296.30296.14; Carmelli D, 2000, AM J EPIDEMIOL, V151, P452; Chung KM, 2008, MOL CELLS, V26, P291; Deane R, 1997, MOL CELL BIOL, V17, P5087, DOI 10.1128/MCB.17.9.5087; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dichgans M, 2014, STROKE, V45, P24, DOI 10.1161/STROKEAHA.113.002707; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hafizi S, 1999, ATHEROSCLEROSIS, V146, P351, DOI 10.1016/S0021-9150(99)00178-1; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Iwasa S, 1999, ATHEROSCLEROSIS, V146, P93, DOI 10.1016/S0021-9150(99)00134-3; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Kaluza D, 2013, ARTERIOSCL THROM VAS, V33, P533, DOI 10.1161/ATVBAHA.112.300415; Kullo IJ, 2006, ATHEROSCLEROSIS, V187, P433, DOI 10.1016/j.atherosclerosis.2005.10.003; Leeper NJ, 2012, CIRCULATION, V125, P3220, DOI 10.1161/CIRCULATIONAHA.111.033878; Leman LJ, 2014, J MED CHEM, V57, P2169, DOI 10.1021/jm4005847; Long J, 2004, J VASC SURG, V39, P723, DOI 10.1016/j.jvs.2003.12.006; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Markus HS, 2013, STROKE, V44, P1220, DOI 10.1161/STROKEAHA.111.000217; McDermott MM, 2009, J AM COLL CARDIOL, V53, P1056, DOI 10.1016/j.jacc.2008.09.063; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; MCMILLEN MA, 1995, CRIT CARE MED, V23, P34, DOI 10.1097/00003246-199501000-00009; Murabito JM, 2006, AM J EPIDEMIOL, V164, P963, DOI 10.1093/aje/kwj295; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramzy D, 2006, CIRCULATION, V114, pI319, DOI 10.1161/CIRCULATIONAHA.105.001503; Rooke TW, 2011, CIRCULATION, V124, P2020, DOI 10.1161/CIR.0b013e31822e80c3; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Tepe G, 2002, INVEST RADIOL, V37, P349, DOI 10.1097/00004424-200206000-00007; Wahlgren CM, 2011, ARTERIOSCL THROM VAS, V31, P678, DOI 10.1161/ATVBAHA.110.210385; Wang CJ, 2009, BIOCHEM BIOPH RES CO, V389, P537, DOI 10.1016/j.bbrc.2009.09.023; Yanagisawa M, 1998, J HYPERTENS        S, V6, pS188; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yang ZH, 1999, CIRCULATION, V100, P5, DOI 10.1161/01.CIR.100.1.5; Yaseen NR, 1997, P NATL ACAD SCI USA, V94, P4451, DOI 10.1073/pnas.94.9.4451; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zouki C, 1999, BRIT J PHARMACOL, V127, P969, DOI 10.1038/sj.bjp.0702593	48	26	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139262	10.1371/journal.pone.0139262	http://dx.doi.org/10.1371/journal.pone.0139262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488411	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400025
J	Gu, H; Fang, YJ; Liu, DD; Chen, P; Mei, YA				Gu, Hua; Fang, Yan-Jia; Liu, Dong-Dong; Chen, Ping; Mei, Yan-Ai			cAMP/PKA Pathways and S56 Phosphorylation Are Involved in AA/PGE(2)-Induced Increases in rNa(V)1.4 Current	PLOS ONE			English	Article							CEREBELLAR GRANULE CELLS; MUSCLE SODIUM-CHANNEL; GATED NA+ CHANNELS; ARACHIDONIC-ACID; SKELETAL-MUSCLE; METABOLIC PATHWAYS; POTASSIUM CHANNEL; PROTEIN-KINASE; K+ CURRENT; ACTIVATION	Arachidonic acid (AA) and its metabolites are important second messengers for ion channel modulation. The effects of extracellular application of AA and its non-metabolized analogue on muscle rNa(V)1.4 Na+ current has been studied, but little is known about the effects of intracellular application of AA on this channel isoform. Here, we report that intracellular application of AA significantly augmented the rNaV1.4 current peak without modulating the steady-state activation and inactivation properties of the rNa(V)1.4 channel. These results differed from the effects of extracellular application of AA on rNa(V)1.4 current. The effects of intracellular AA were mimicked by prostaglandin E-2 but not eicosatetraynoic acid (ETYA), the non-metabolized analogue of AA, and were eliminated by treatment with cyclooxygenase inhibitors, flufenamic acid, or indomethacin. AA/PGE(2)-induced activation of rNa(V)1.4 channels was mimicked by a cAMP analogue (db-cAMP) and eliminated by a PKA inhibitor, PKAi. Furthermore, inhibition of EP2 and EP4 (PGE2 receptors) with AH6809 and AH23848 reduced the intracellular AA/PGE(2)-induced increase of rNaV1.4 current. Two mutated channels, rNa(V)1.4S56A and rNa(V)1.4T21A, were designed to investigate the role of predicted phosphorylation sites in the AA/PGE(2)-mediated regulation of rNa(V)1.4 currents. In rNa(V)1.4S56A, the effects of intracellular db-cAMP, AA, and PGE(2) were significantly reduced. The results of the present study suggest that intracellular AA augments rNa(V)1.4 current by PGE(2)/EP receptor-mediated activation of the cAMP/PKA pathway, and that the S56 residue on the channel protein is important for this process.	[Fang, Yan-Jia; Liu, Dong-Dong; Mei, Yan-Ai] Fudan Univ, Inst Brain Sci, Sch Life Sci, Shanghai 200433, Peoples R China; [Fang, Yan-Jia; Liu, Dong-Dong; Mei, Yan-Ai] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Gu, Hua; Chen, Ping] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Fudan University; Fudan University; Tongji University	Gu, H (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	gu_hua@mail.tongji.edu.cn; yamei@fudan.edu.cn			Nationa Natural Science Foundation of China [NSFC 30670472]; Shanghai Leading Academic Discipline Project [B111]	Nationa Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the Nationa Natural Science Foundation of China (grant number NSFC 30670472) to Yan-Ai Mei and the Shanghai Leading Academic Discipline Project (grant number B111).	Banasiak KJ, 2004, NEUROSCIENCE, V126, P31, DOI 10.1016/S0306-4522(03)00425-1; Barrett CF, 2001, AM J PHYSIOL-CELL PH, V280, pC1306, DOI 10.1152/ajpcell.2001.280.5.C1306; Basora N, 2003, J BIOL CHEM, V278, P31709, DOI 10.1074/jbc.M304437200; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen WH, 2001, J PHYSIOL-LONDON, V537, P497, DOI 10.1111/j.1469-7793.2001.00497.x; Ding YN, 2008, J CELL PHYSIOL, V215, P77, DOI 10.1002/jcp.21289; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; England S, 2009, BRIT J PHARMACOL, V158, P1413, DOI 10.1111/j.1476-5381.2009.00437.x; Fang YJ, 2011, BIOCHEM J, V438, P203, DOI 10.1042/BJ20110569; Ferroni S, 2003, J NEUROSCI RES, V72, P363, DOI 10.1002/jnr.10580; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Fulton AM, 2006, CANCER RES, V66, P9794, DOI 10.1158/0008-5472.CAN-06-2067; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Gu H, 2009, J CELL PHYSIOL, V219, P173, DOI 10.1002/jcp.21664; He YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076495; Holmqvist MH, 2001, J NEUROSCI, V21, P4154, DOI 10.1523/JNEUROSCI.21-12-04154.2001; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Jurkat-Rott K, 2010, PFLUG ARCH EUR J PHY, V460, P239, DOI 10.1007/s00424-010-0814-4; KATSUKI H, 1995, PROG NEUROBIOL, V46, P607, DOI 10.1016/0301-0082(95)00016-O; Lawrence JH, 1996, BIOPHYS J, V71, P1285, DOI 10.1016/S0006-3495(96)79329-3; Lee GY, 2002, BRAIN RES, V950, P95, DOI 10.1016/S0006-8993(02)03008-1; Lerche H, 1996, ANN NEUROL, V39, P599, DOI 10.1002/ana.410390509; Liu LW, 2003, P NATL ACAD SCI USA, V100, P295, DOI 10.1073/pnas.0136826100; Markworth JF, 2013, AM J PHYSIOL-CELL PH, V304, pC56, DOI 10.1152/ajpcell.00038.2012; Ogata N, 2002, JPN J PHARMACOL, V88, P365, DOI 10.1254/jjp.88.365; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; SCHAECHTER JD, 1993, J NEUROSCI, V13, P4361; Scheuer T, 2011, SEMIN CELL DEV BIOL, V22, P160, DOI 10.1016/j.semcdb.2010.10.002; Smith ES, 2007, NEUROSCIENCE, V145, P686, DOI 10.1016/j.neuroscience.2006.12.024; Smith RD, 1996, J NEUROSCI, V16, P1965; SOLIVEN B, 1995, AM J PHYSIOL-CELL PH, V269, pC341, DOI 10.1152/ajpcell.1995.269.2.C341; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; Visentin S, 1998, GLIA, V22, P1; Waxman SG, 2007, NAT NEUROSCI, V10, P405, DOI 10.1038/nn1857; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140; YANG J, 1990, J NEUROCHEM, V54, P954, DOI 10.1111/j.1471-4159.1990.tb02343.x	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140715	10.1371/journal.pone.0140715	http://dx.doi.org/10.1371/journal.pone.0140715			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485043	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100062
J	Haverkate, MR; Dautzenberg, MJD; Ossewaarde, TJM; van der Zee, A; den Hollander, JG; Troelstra, A; Bonten, MJM; Bootsma, MCJ				Haverkate, Manon R.; Dautzenberg, Mirjam J. D.; Ossewaarde, Tjaco J. M.; van der Zee, Anneke; den Hollander, Jan G.; Troelstra, Annet; Bonten, Marc J. M.; Bootsma, Martin C. J.			Within-Host and Population Transmission of bla(OXA-48) in K. pneumoniae and E. coli	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; TO-PATIENT TRANSMISSION; ESCHERICHIA-COLI; ENTEROBACTERIACEAE; SPREAD; CARBAPENEMASES; DISSEMINATION; EMERGENCE; DYNAMICS; GENE	During a large hospital outbreak of OXA-48 producing bacteria, most K. pneumoniae(OXA-48) isolates were phenotypically resistant to meropenem or imipenem, whereas most E. coli(OXA-48) isolates were phenotypically susceptible to these antibiotics. In the absence of molecular gene-detection E. coli(OXA-48) could remain undetected, facilitating cross-transmission and horizontal gene transfer of bla(OXA-48). Based on 868 longitudinal molecular microbiological screening results from patients carrying K. pneumoniae(OXA-48) (n = 24), E. coli(OXA-48) (n = 17), or both (n = 40) and mathematical modelling we determined mean durations of colonisation (278 and 225 days for K. pneumoniae(OXA-48) and E. coli(OXA-48), respectively), and horizontal gene transfer rates (0.0091/day from K. pneumoniae to E. coli and 0.0015/day vice versa). Based on these findings the maximum effect of horizontal gene transfer of bla(OXA-48) originating from E. coli(OXA-48) on the basic reproduction number (R-0) is 1.9%, and it is, therefore, unlikely that phenotypically susceptible E. coli(OXA-48) will contribute significantly to the spread of bla(OXA-48).	[Haverkate, Manon R.; Dautzenberg, Mirjam J. D.; Bonten, Marc J. M.; Bootsma, Martin C. J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Dautzenberg, Mirjam J. D.; Troelstra, Annet; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Dautzenberg, Mirjam J. D.; Ossewaarde, Tjaco J. M.; van der Zee, Anneke] Maasstad Ziekenhuis, Dept Med Microbiol, Rotterdam, Netherlands; [den Hollander, Jan G.] Maasstad Ziekenhuis, Dept Internal Med, Rotterdam, Netherlands; [Bootsma, Martin C. J.] Univ Utrecht, Dept Math, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maasstad Hospital; Maasstad Hospital; Utrecht University	Haverkate, MR (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	m.r.haverkate-2@umcutrecht.nl			Netherlands Organisation of Scientific Research (VICI NWO) [918.76.611]; Priority Medicines Antimicrobial Resistance [205100013]; European Community [282512]	Netherlands Organisation of Scientific Research (VICI NWO)(Netherlands Organization for Scientific Research (NWO)); Priority Medicines Antimicrobial Resistance; European Community(European Commission)	This work was supported by the Netherlands Organisation of Scientific Research (VICI NWO Grant 918.76.611 to M.J.M.B. and Priority Medicines Antimicrobial Resistance grant 205100013 to M.R.H. and M.C.J.B.) and by funding from the European Community (RGNOSIS Integrated project [FP7/2007-2013] under grant agreement no. 282512 to M.C.J.B. and M.J.M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonten MJM, 2010, STAT BIOL HEALTH, P395, DOI 10.1007/978-0-387-93835-6_22; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Cremet L, 2012, J ANTIMICROB CHEMOTH, V67, P1041, DOI 10.1093/jac/dkr547; Dautzenberg M J, 2014, Euro Surveill, V19; Diekmann O., 2012, MATH TOOLS UNDERSTAN; Doi Y, 2012, DIAGN MICR INFEC DIS, V74, P34, DOI 10.1016/j.diagmicrobio.2012.05.020; Doyle D, 2012, J CLIN MICROBIOL, V50, P3877, DOI 10.1128/JCM.02117-12; Glupczynski Y, 2012, INT J ANTIMICROB AG, V39, P168, DOI 10.1016/j.ijantimicag.2011.10.005; Harris AD, 2007, CLIN INFECT DIS, V45, P1347, DOI 10.1086/522657; Harris AD, 2007, AM J INFECT CONTROL, V35, P97, DOI 10.1016/j.ajic.2006.09.011; Hilty M, 2012, CLIN INFECT DIS, V55, P967, DOI 10.1093/cid/cis581; Kaase M, 2012, J CLIN MICROBIOL, V50, P3115, DOI 10.1128/JCM.00991-12; Kalpoe JS, 2011, J MED MICROBIOL, V60, P677, DOI 10.1099/jmm.0.028308-0; Maasstad Ziekenhuis Rotterdam, 2012, MAATSCH JAARV 2011; Mathers AJ, 2011, MBIO, V2, DOI 10.1128/mBio.00204-11; Mooij MJ, 2009, INFECT CONT HOSP EP, V30, P1015, DOI 10.1086/606039; Nijssen S, 2005, CLIN INFECT DIS, V41, P1, DOI 10.1086/430711; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Norrby SR, 2005, CLIN INFECT DIS, V41, P10, DOI 10.1086/430715; Philipsen K.R., 2010, NONLINEAR STOCHASTIC; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Potron A, 2011, CLIN MICROBIOL INFEC, V17, pE24, DOI 10.1111/j.1469-0691.2011.03669.x; Thomson KS, 2010, J CLIN MICROBIOL, V48, P1019, DOI 10.1128/JCM.00219-10	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140960	10.1371/journal.pone.0140960	http://dx.doi.org/10.1371/journal.pone.0140960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485437	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100098
J	Jardine, CG; Boerner, FU; Boyd, AD; Driedger, SM				Jardine, Cynthia G.; Boerner, Franziska U.; Boyd, Amanda D.; Driedger, S. Michelle			The More the Better? A Comparison of the Information Sources Used by the Public during Two Infectious Disease Outbreaks	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; HEALTH INFORMATION; RISK COMMUNICATION; SYNDROME SARS; COMPLEMENTARITY; SEEKING; INFLUENZA; ADULTS; MEDIA; MANAGEMENT	Recent infectious disease outbreaks have resulted in renewed recognition of the importance of risk communication planning and execution to public health control strategies. Key to these efforts is public access to information that is understandable, reliable and meets their needs for informed decision-making on protective health behaviours. Learning from the trends in sources used in previous outbreaks will enable improvements in information access in future outbreaks. Two separate random-digit dialled telephone surveys were conducted in Alberta, Canada, to explore information sources used by the public, together with their perceived usefulness and credibility, during the 2003 Severe Acute Respiratory Syndrome (SARS) epidemic (n = 1209) and 2009-2010 H1N1 pandemic (n = 1206). Traditional mass media were the most used information sources in both surveys. Although use of the Internet increased from 25% during SARS to 56% during H1N1, overall use of social media was not as high as anticipated. Friends and relatives were commonly used as an information source, but were not deemed very useful or credible. Conversely, doctors and health professionals were considered credible, but not consulted as frequently. The use of five or more information sources increased by almost 60% between the SARS and H1N1 surveys. There was a shift to older, more educated and more affluent respondents between the surveys, most likely caused by a decrease in the use of landlines amongst younger Canadians. It was concluded that people are increasingly using multiple sources of health risk information, presumably in a complementary manner. Subsequently, although using online media is important, this should be used to augment rather than replace more traditional information channels. Efforts should be made to improve knowledge transfer to health care professionals and doctors and provide them with opportunities to be more accessible as information sources. Finally, the future use of telephone surveys needs to account for the changing demographics of the respondents accessed through such surveys.	[Jardine, Cynthia G.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Boerner, Franziska U.] Karlsruhe Inst Technol, Inst Technol Assessment & Syst Anal, D-76021 Karlsruhe, Germany; [Boyd, Amanda D.] Washington State Univ, Edward R Murrow Coll Commun, Pullman, WA 99164 USA; [Driedger, S. Michelle] Univ Manitoba, Community Hlth Sci, Winnipeg, MB, Canada	University of Alberta; Helmholtz Association; Karlsruhe Institute of Technology; Washington State University; University of Manitoba	Jardine, CG (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	cindy.jardine@ualberta.ca		Driedger, S. Michelle/0000-0003-3769-5785	Alberta Innovates Health Solution or AIHS; Canadian Institutes for Health Research (CIHR) [MOP 210293]	Alberta Innovates Health Solution or AIHS; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for the SARS survey was provided by the former Alberta Heritage Foundation for Medical Research (AHFMR) (now Alberta Innovates Health Solution or AIHS) (http://www.aihealthsolutions.ca/) in the form of a 2002-2005 Population Health Investigator salary support and operating grant to CGJ. Funding for the H1N1 Survey was provided by the Canadian Institutes for Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html) for the research project "Examining Pandemic Communication Strategies of Public Health Agencies for H1N1: How Well did They Work?", CIHR Operating Grant, 2010-2012 (MOP 210293).	Anker M, 2000, WHO REPORT GLOBAL SU; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P485; Berry TR, 2007, HEALTH COMMUN, V21, P35, DOI 10.1080/10410230701283322; Blendon RJ, 2004, CLIN INFECT DIS, V38, P925, DOI 10.1086/382355; Carter C., 2014, GLOBAL NEWS     1016; Clark SJ, 2011, PREV MED, V53, P421, DOI 10.1016/j.ypmed.2011.09.013; Courage KH, 2014, SCI AM; Dutta-Bergman MJ, 2004, J BROADCAST ELECTRON, V48, P41, DOI 10.1207/s15506878jobem4801_3; Gesualdo F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-561; Gilmour H, 2010, HLTH REPORTS, V21, P1; Government of Alberta, 2010, PAND H1N1 2009 ALB E; Haeder S, 2010, RES METHODS, V19, P3; Health Canada, 2003, LEARN SARS REN PUBL; Hurst Gill, 2013, Br J Community Nurs, V18, P34; Jadad AR, 2000, CAN MED ASSOC J, V162, P362; Jehn M, 2011, J PUBLIC HEALTH MAN, V17, P431, DOI 10.1097/PHH.0b013e3182113921; Kim S, 2012, AM J INFECT CONTROL, V40, P211, DOI 10.1016/j.ajic.2011.03.028; Kittler AF, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.1.e8; Krimsky S., 2007, ENVIRON HAZARDS-UK, V7, P157, DOI [DOI 10.1016/J.ENVHAZ.2007.05.006, 10.1016/j.envhaz.2007.05.006]; Lam P-P, 2011, COMMUNICATIONS STRAT; Lewison G, 2008, HEALTH RISK SOC, V10, P241, DOI 10.1080/13698570802160962; Manafo E, 2012, J NUTR EDUC BEHAV, V44, P85, DOI 10.1016/j.jneb.2011.05.018; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Nhan C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-115; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011292; O'Malley P, 2009, B WORLD HEALTH ORGAN, V87, P614, DOI 10.2471/BLT.08.056689; Ovadia KL, 2005, J HOSP INFECT, V61, P75, DOI 10.1016/j.jhin.2004.12.018; Pandey Ambarish, 2010, Am J Prev Med, V38, pe1, DOI 10.1016/j.amepre.2009.11.007; Payne E., 2014, OTTAWA CITIZEN; PHAC, 2010, LESS LEARN REV PUBL; Public Health Agency of Canada (PHAC), 2003, CAN SARS; Reid Ipsos, 2014, IPSOS POLL CONDUCTED; Ringel JS, 2009, HEALTH AFFAIR, V28, pW743, DOI 10.1377/hlthaff.28.4.w743; Ritvo P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-271; Robertson-Lang L, 2011, CAN J AGING, V30, P631, DOI 10.1017/S071498081100050X; Ruppel EK, 2012, COMMUN MONOGR, V79, P385, DOI 10.1080/03637751.2012.697627; Statistics Canada, 2012, 2011 CENS PROF; Statistics Canada, 2011, DAIL RES TEL SERV SU; Statistics Canada, 2006, DAIL RES TEL SERV SU; Statistics Canada, 2010, INT US IND SEL CHAR; Statistics Canada, 2013, CAN INT US SURV 2012; Tian Y, 2008, PATIENT EDUC COUNS, V71, P340, DOI 10.1016/j.pec.2008.02.006; Tian Y, 2008, HEALTH COMMUN, V23, P184, DOI 10.1080/10410230801968260; Varia M, 2003, CAN MED ASSOC J, V169, P285; Vaughan E, 2009, AM J PUBLIC HEALTH, V99, pS324, DOI 10.2105/AJPH.2009.162537; World Health Organization, 2003, CAS DEF SURV SEV AC; World Health Organization, 2010, PAND H1N1 2009 UPD 1; World Health Organization (WHO), 2016, INT HLTH REG 2005	49	25	25	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140028	10.1371/journal.pone.0140028	http://dx.doi.org/10.1371/journal.pone.0140028			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7XI	26485302	Green Published, gold			2022-12-27	WOS:000363028100020
J	Ernst, M; Romero, JM; Buhk, JH; Cheng, B; Herrmann, J; Fiehler, J; Groth, M				Ernst, Marielle; Romero, Javier M.; Buhk, Jan-Hendrik; Cheng, Bastian; Herrmann, Jochen; Fiehler, Jens; Groth, Michael			Sensitivity of Hyperdense Basilar Artery Sign on Non-Enhanced Computed Tomography	PLOS ONE			English	Article							CT ANGIOGRAPHY; STATISTICAL-METHODS; OCCLUSION; AGREEMENT; DIAGNOSIS; THROMBUS; STROKE	Purpose The hyperdense basilar artery sign (HBAS) is an indicator of vessel occlusion on non contrast-enhanced computer tomography (NECT) in acute stroke patients. Since basilar artery occlusion (BAO) is associated with a high mortality and morbidity, its early detection is of great clinical value. We sought to analyze the influence of density measurement as well as a normalized ratio of Hounsfield unit/hematocrit (HU/Hct) ratio on the detection of BAO on NECT in patients with suspected BAO. Materials and Methods 102 patients with clinically suspected BAO were examined with NECT followed immediately by Multidetector computed tomography Angiography. Two observers independently analyzed the images regarding the presence or absence of HBAS on NECT and performed HU measurements in the basilar artery. Receiver operating characteristic curve analysis was performed to determine the optimal density threshold for BAO using attenuation measurements or HU/Hct ratio. Results Sensitivity of visual detection of the HBAS on NECT was relatively low 81% (95%-CI, 54-95%) while specificity was high 91% (95%-CI, 82-96%). The highest sensitivity was achieved by the combination of visual assessment and additional quantitative attenuation measurements applying a cut-off value of 46.5 HU with 94% sensitivity and 81% specificity for BAO. A HU/Hct ratio >1.32 revealed sensitivity of 88% (95%-CI, 60-98%) and specificity of 84% (95%-CI, 74-90%). Conclusion In patients with clinically suspected acute BAO the combination of visual assessment and additional attenuation measurement with a cut-off value of 46.5 HU is a reliable approach with high sensitivity in the detection of BAO on NECT.	[Ernst, Marielle; Buhk, Jan-Hendrik; Fiehler, Jens; Groth, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Ctr Radiol & Endoscopy, Hamburg, Germany; [Romero, Javier M.] Harvard Univ, Sch Med, Dept Radiol, Div Neuroradiol,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Cheng, Bastian] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Herrmann, Jochen; Groth, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Ctr Radiol & Endoscopy, Div Pediat Radiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Ernst, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Ctr Radiol & Endoscopy, Hamburg, Germany.	m.ernst@uke.de	Herrmann, Jochen/AFQ-5508-2022	Romero, Javier/0000-0001-5749-3000				Beyer SE, 2015, STROKE, V46, P1840, DOI 10.1161/STROKEAHA.115.008841; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brandt T, 1999, STROKE, V30, P606, DOI 10.1161/01.STR.30.3.606; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; Buyck PJ, 2013, AM J NEURORADIOL, V34, P1568, DOI 10.3174/ajnr.A3469; Connell L, 2012, NEURORADIOLOGY, V54, P321, DOI 10.1007/s00234-011-0887-6; Costa-Santos C, 2011, J CLIN EPIDEMIOL, V64, P264, DOI 10.1016/j.jclinepi.2009.11.010; Ernst M, 2014, NEURORADIOLOGY, V56, P1063, DOI 10.1007/s00234-014-1443-y; Esquevin A, 2013, AM J EMERG MED, V31, P494, DOI 10.1016/j.ajem.2012.09.024; Goldmakher GV, 2009, STROKE, V40, P134, DOI 10.1161/STROKEAHA.108.516690; Groth M, 2015, THORACIC PATHOLOGIES; KUCKEIN D, 1982, COMPUTERTOM SONOGRAP, V2, P120; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lev MH, 2001, J COMPUT ASSIST TOMO, V25, P520, DOI 10.1097/00004728-200107000-00003; Mair G, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140216; Schonewille WJ, 2009, LANCET NEUROL, V8, P724, DOI 10.1016/S1474-4422(09)70173-5; Vergouwen MDI, 2012, STROKE, V43, P3003, DOI 10.1161/STROKEAHA.112.666867; VONOFAKOS D, 1983, AM J NEURORADIOL, V4, P525; ZATZ LM, 1977, RADIOLOGY, V124, P91, DOI 10.1148/124.1.91	19	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0141096	10.1371/journal.pone.0141096	http://dx.doi.org/10.1371/journal.pone.0141096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479718	gold, Green Published, Green Submitted			2022-12-27	WOS:000363026600030
J	Wang, T; Li, R; Wen, LW; Fu, DQ; Zhu, BZ; Luo, YB; Zhu, HL				Wang, Tian; Li, Rui; Wen, Liwei; Fu, Daqi; Zhu, Benzhong; Luo, Yunbo; Zhu, Hongliang			Functional Analysis and RNA Sequencing Indicate the Regulatory Role of Argonaute1 in Tomato Compound Leaf Development	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS; AGO1; PROTEINS; MERISTEM; PLANTS; MORPHOGENESIS; POLARITY; SHOOTS; LEAVES	Regardless of whether a leaf is simple or compound, the mechanism underlying its development will give rise to a full comprehension of plant morphogenesis. The role of Argonaute1 (AGO1) in the development of simple leaves has been established, but its role in the development of compound leaves remains to be characterized. In this paper, a virus-induced gene silencing (VIGS) strategy was used to dramatically down-regulate the expression of AGO1 ortholog in tomatoes, a model plant for research into compound leaves. AGO1-silenced tomato compound leaves exhibited morphological defects of leaf adaxial-abaxial and trichome development. Analysis of global gene expression profiles indicated that the silencing of AGO1 in tomato compound leaf caused significant changes in the expression of several critical genes, including Auxin Response Factor 4 (ARF4) and Non-expressor of PR5 (NPR5), which were involved in adaxial-abaxial formation and IAA15 that was found to contribute to growth of trichomes as well as Gibberellic Acid Insensitive (GAI) which participated in hormone regulation. Collectively, these results shed light on the complicated mechanism by which AGO1 regulates compound leaf development.	[Wang, Tian; Li, Rui; Wen, Liwei; Fu, Daqi; Zhu, Benzhong; Luo, Yunbo; Zhu, Hongliang] China Agr Univ, Coll Food Sci & Nutr Engn, Dept Food Biotechnol, Beijing 100094, Peoples R China	China Agricultural University	Zhu, HL (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Dept Food Biotechnol, Beijing 100094, Peoples R China.	hlzhu@cau.edu.cn	Zhu, Hongliang/I-7035-2019	Zhu, Hongliang/0000-0002-1484-2212				Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bar M, 2015, CURR OPIN PLANT BIOL, V23, P61, DOI 10.1016/j.pbi.2014.10.007; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Blein T, 2010, CURR OPIN PLANT BIOL, V13, P75, DOI 10.1016/j.pbi.2009.09.017; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Burko Yogev, 2013, Methods Mol Biol, V959, P1, DOI 10.1007/978-1-62703-221-6_1; Deng W, 2012, NEW PHYTOL, V194, P379, DOI 10.1111/j.1469-8137.2012.04053.x; Efroni I, 2010, PLANT CELL, V22, P1019, DOI 10.1105/tpc.109.073601; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Fambrini M, 2013, PLANT CELL REP, V32, P899, DOI 10.1007/s00299-013-1426-1; Fernandez-Moreno J.-P., 2013, VIRUS INDUCED GENE S, V975, P183, DOI DOI 10.1007/978-1-62703-278-0_14; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Gan Y, 2007, PLANT PHYSIOL, V145, P1031, DOI 10.1104/pp.107.104794; Ha CM, 2007, PLANT CELL, V19, P1809, DOI 10.1105/tpc.107.051938; Hay A, 2009, CURR OPIN PLANT BIOL, V12, P593, DOI 10.1016/j.pbi.2009.06.006; Hendelman A, 2013, PLANTA, V237, P363, DOI 10.1007/s00425-012-1778-8; Hu GJ, 2014, PLANT SCI, V229, P86, DOI 10.1016/j.plantsci.2014.08.010; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jones L, 2006, PLANT PHYSIOL, V141, P598, DOI 10.1104/pp.105.076109; Jover-Gil S, 2012, PLANT CELL PHYSIOL, V53, P1322, DOI 10.1093/pcp/pcs077; Kidner CA, 2005, DEV BIOL, V280, P504, DOI 10.1016/j.ydbio.2005.01.031; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Langford M, 2013, MILLENNIUM DEVELOPMENT GOALS AND HUMAN RIGHTS: PAST, PRESENT AND FUTURE, P1, DOI 10.1007/978-1-62703-278-0_1; Lee BH, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.988071; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XF, 2015, J EXP BOT, V66, P919, DOI 10.1093/jxb/eru447; Maunoury N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028729; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Miyashima S, 2011, DEVELOPMENT, V138, P2303, DOI 10.1242/dev.060491; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Ochando I, 2006, PLANT PHYSIOL, V141, P607, DOI 10.1104/pp.106.077149; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Pulido A, 2010, J EXP BOT, V61, P1277, DOI 10.1093/jxb/erp397; Robertson D, 2004, ANNU REV PLANT BIOL, V55, P495, DOI 10.1146/annurev.arplant.55.031903.141803; Rodriguez RE, 2014, WIRES DEV BIOL, V3, P41, DOI 10.1002/wdev.115; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Shani E, 2009, PLANT CELL, V21, P3078, DOI 10.1105/tpc.109.068148; Shao CG, 2014, J EXP BOT, V65, P6293, DOI [10.1093/jxb/eru382, 10.1093/jxb/e]; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Yang KZ, 2014, J INTEGR PLANT BIOL, V56, P539, DOI 10.1111/jipb.12154; Yifhar T, 2012, PLANT CELL, V24, P3575, DOI 10.1105/tpc.112.100222	49	5	8	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140756	10.1371/journal.pone.0140756	http://dx.doi.org/10.1371/journal.pone.0140756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479258	Green Submitted, gold, Green Published			2022-12-27	WOS:000363026600018
J	Wolfram, S; Wielsch, N; Hupfer, Y; Monch, B; Lu-Walther, HW; Heintzmann, R; Werz, O; Svatos, A; Pohnert, G				Wolfram, Stefanie; Wielsch, Natalie; Hupfer, Yvonne; Moench, Bettina; Lu-Walther, Hui-Wen; Heintzmann, Rainer; Werz, Oliver; Svatos, Ales; Pohnert, Georg			A Metabolic Probe-Enabled Strategy Reveals Uptake and Protein Targets of Polyunsaturated Aldehydes in the Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							ATP SYNTHASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; SPINACH PHOSPHORIBULOKINASE; GROWTH-INHIBITION; CHEMICAL DEFENSE; NATURAL-PRODUCTS; CLICK CHEMISTRY; COPEPOD; OXYLIPINS; PLANKTON	Diatoms are unicellular algae of crucial importance as they belong to the main primary producers in aquatic ecosystems. Several diatom species produce polyunsaturated aldehydes (PUAs) that have been made responsible for chemically mediated interactions in the plankton. PUA-effects include chemical defense by reducing the reproductive success of grazing copepods, allelochemical activity by interfering with the growth of competing phytoplankton and cell to cell signaling. We applied a PUA-derived molecular probe, based on the biologically highly active 2,4-decadienal, with the aim to reveal protein targets of PUAs and affected metabolic pathways. By using fluorescence microscopy, we observed a substantial uptake of the PUA probe into cells of the diatom Phaeodactylum tricornutum in comparison to the uptake of a structurally closely related control probe based on a saturated aldehyde. The specific uptake motivated a chemoproteomic approach to generate a qualitative inventory of proteins covalently targeted by the alpha,beta,gamma,delta-unsaturated aldehyde structure element. Activity-based protein profiling revealed selective covalent modification of target proteins by the PUA probe. Analysis of the labeled proteins gave insights into putative affected molecular functions and biological processes such as photosynthesis including ATP generation and catalytic activity in the Calvin cycle or the pentose phosphate pathway. The mechanism of action of PUAs involves covalent reactions with proteins that may result in protein dysfunction and interference of involved pathways.	[Wolfram, Stefanie; Pohnert, Georg] Univ Jena, Inst Inorgan & Analyt Chem, Bioorgan Analyt, Jena, Germany; [Wielsch, Natalie; Hupfer, Yvonne; Svatos, Ales] Max Planck Inst Chem Ecol, Dept Mass Spectrometry Prote, Jena, Germany; [Moench, Bettina; Werz, Oliver] Univ Jena, Inst Pharm, Dept Pharmaceut & Med Chem, Jena, Germany; [Lu-Walther, Hui-Wen; Heintzmann, Rainer] Leibniz Inst Photon Technol eV, Dept Microscopy, Biomed Imaging, Jena, Germany; [Heintzmann, Rainer] Univ Jena, Inst Phys Chem, Abbe Ctr Photon, D-07743 Jena, Germany	Friedrich Schiller University of Jena; Max Planck Society; Friedrich Schiller University of Jena; Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena	Pohnert, G (corresponding author), Univ Jena, Inst Inorgan & Analyt Chem, Bioorgan Analyt, Jena, Germany.	Georg.Pohnert@uni-jena.de	Svatos, Ales/A-3305-2014; Pohnert, Georg/D-3721-2013; Heintzmann, Rainer/AAY-4849-2020	Svatos, Ales/0000-0003-1032-7288; Pohnert, Georg/0000-0003-2351-6336; Heintzmann, Rainer/0000-0002-4950-1936	Deutsche Forschungsgemeinschaft, German Research Foundation (DFG); Studienstiftung des deutschen Volkes	Deutsche Forschungsgemeinschaft, German Research Foundation (DFG)(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	Support was provided by the Deutsche Forschungsgemeinschaft, German Research Foundation (DFG) and Studienstiftung des deutschen Volkes.	Adolph S, 2004, J EXP BIOL, V207, P2935, DOI 10.1242/jeb.01105; Adolph S, 2003, TETRAHEDRON, V59, P3003, DOI 10.1016/S0040-4020(03)00382-X; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Balestra C, 2011, AQUAT MICROB ECOL, V63, P123, DOI 10.3354/ame01486; Baskin JM, 2007, QSAR COMB SCI, V26, P1211, DOI 10.1002/qsar.200740086; Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726; Bottcher T, 2010, ANGEW CHEM INT EDIT, V49, P2680, DOI 10.1002/anie.200905352; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brandes HK, 1996, J BIOL CHEM, V271, P6490, DOI 10.1074/jbc.271.11.6490; Buttino I, 2011, HYDROBIOLOGIA, V666, P257, DOI 10.1007/s10750-010-0536-9; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Carl Roth GmbH, KARLSR POL GEL EL PA; Carvalho VM, 2000, CHEM RES TOXICOL, V13, P397, DOI 10.1021/tx9901682; Casotti R, 2005, J PHYCOL, V41, P7, DOI 10.1111/j.1529-8817.2005.04052.x; Casotti R, 2001, ASLO AQ SCI 2001 M S; Cunningham CW, 2010, MOL PHARMACEUT, V7, P1301, DOI 10.1021/mp100089k; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; GAFF DF, 1971, J EXP BOT, V22, P756, DOI 10.1093/jxb/22.3.756; Gersch M, 2012, NAT PROD REP, V29, P659, DOI 10.1039/c2np20012k; Graciet E, 2004, J EXP BOT, V55, P1245, DOI 10.1093/jxb/erh107; Groth G, 1999, PHYSIOL PLANTARUM, V106, P142, DOI 10.1034/j.1399-3054.1999.106120.x; Gundermann K, 2013, BBA-BIOENERGETICS, V1827, P303, DOI 10.1016/j.bbabio.2012.10.017; Hansen E, 2004, TOXICOL SCI, V81, P190, DOI 10.1093/toxsci/kfh192; Haugland R.P., 2002, HDB FLUORESCENT PROB; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ianora A, 2011, MAR DRUGS, V9, P1625, DOI 10.3390/md9091625; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapaille M, 2010, BBA-BIOENERGETICS, V1797, P1533, DOI 10.1016/j.bbabio.2010.04.013; Lauritano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026850; Lauritano C, 2011, J EXP MAR BIOL ECOL, V404, P79, DOI 10.1016/j.jembe.2011.05.009; Lebreton S, 2003, J BIOL CHEM, V278, P12078, DOI 10.1074/jbc.M213096200; Liu XD, 2004, FEBS LETT, V569, P337, DOI 10.1016/j.febslet.2004.05.065; Loureiro APM, 2000, CHEM RES TOXICOL, V13, P601, DOI 10.1021/tx000004h; Loureiro APM, 2004, CHEM RES TOXICOL, V17, P641, DOI 10.1021/tx034225+; Maberly SC, 2010, J EXP BOT, V61, P735, DOI 10.1093/jxb/erp337; MAIER I, 1994, BOT ACTA, V107, P451, DOI 10.1111/j.1438-8677.1994.tb00820.x; Meynier A, 2004, INT DAIRY J, V14, P681, DOI 10.1016/j.idairyj.2004.01.003; Michels AK, 2005, PLANT PHYSIOL, V137, P911, DOI 10.1104/pp.104.055285; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; OKEEFE SF, 1991, J AGR FOOD CHEM, V39, P1022, DOI 10.1021/jf00006a003; Pohnert G, 2005, CHEMBIOCHEM, V6, P946, DOI 10.1002/cbic.200400348; Pohnert G, 2002, MAR ECOL PROG SER, V245, P33, DOI 10.3354/meps245033; PORTER MA, 1986, BIOCHEMISTRY-US, V25, P7314, DOI 10.1021/bi00371a011; Ribalet F, 2007, AQUAT TOXICOL, V85, P219, DOI 10.1016/j.aquatox.2007.09.006; Ribalet F, 2007, PHYTOCHEMISTRY, V68, P2059, DOI 10.1016/j.phytochem.2007.05.012; Romano G, 2003, J EXP BIOL, V206, P3487, DOI 10.1242/jeb.00580; Schwobel JAH, 2010, CHEM RES TOXICOL, V23, P1576, DOI 10.1021/tx100172x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sigolo CAO, 2007, CHEM RES TOXICOL, V20, P1099, DOI 10.1021/tx700111v; Spielmeyer A, 2011, CHEMBIOCHEM, V12, P2276, DOI 10.1002/cbic.201100416; Sprenger GA, 1995, ARCH MICROBIOL, V164, P324, DOI 10.1007/BF02529978; UniProt consortium, 2002, UN PROT RES CORNS; van Creveld SG, 2015, ISME J, V9, P385, DOI 10.1038/ismej.2014.136; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vardi A, 2008, CURR BIOL, V18, P895, DOI 10.1016/j.cub.2008.05.037; Veith T, 2007, BBA-BIOENERGETICS, V1767, P1428, DOI 10.1016/j.bbabio.2007.09.004; Vidoudez C, 2008, J PLANKTON RES, V30, P1305, DOI 10.1093/plankt/fbn085; Vidoudez C, 2011, MAR DRUGS, V9, P500, DOI 10.3390/md9040500; WITZ G, 1989, FREE RADICAL BIO MED, V7, P333, DOI 10.1016/0891-5849(89)90137-8; Wolfram S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112522; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zheng YT, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-109; Zhu XC, 2010, CHEM RES TOXICOL, V23, P467, DOI 10.1021/tx900379a	64	2	2	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140927	10.1371/journal.pone.0140927	http://dx.doi.org/10.1371/journal.pone.0140927			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496085	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200042
J	Sakai, K; Yamashita, T; Imamoto, Y; Shichida, Y				Sakai, Kazumi; Yamashita, Takahiro; Imamoto, Yasushi; Shichida, Yoshinori			Diversity of Active States in TMT Opsins	PLOS ONE			English	Article							VERTEBRATE; EXPRESSION; PIGMENT; LIGHT; ACID	Opn3/TMT opsins belong to one of the opsin groups with vertebrate visual and non-visual opsins, and are widely distributed in eyes, brains and other internal organs in various vertebrates and invertebrates. Vertebrate Opn3/TMT opsins are further classified into four groups on the basis of their amino acid identities. However, there is limited information about molecular properties of these groups, due to the difficulty in preparing the recombinant proteins. Here, we successfully expressed recombinant proteins of TMT1 and TMT2 opsins of medaka fish (Oryzias latipes) in cultured cells and characterized their molecular properties. Spectroscopic and biochemical studies demonstrated that TMT1 and TMT2 opsins functioned as blue light-sensitive Gi/Go-coupled receptors, but exhibited spectral properties and photo-convertibility of the active state different from each other. TMT1 opsin forms a visible light-absorbing active state containing all-trans-retinal, which can be photo-converted to 7-cis- and 9-cis-retinal states in addition to the original 11-cis-retinal state. In contrast, the active state of TMT2 opsin is a UV light-absorbing state having all-trans-retinal and does not photo-convert to any other state, including the original 11-cis-retinal state. Thus, TMT opsins are diversified so as to form a different type of active state, which may be responsible for their different functions.	[Sakai, Kazumi; Yamashita, Takahiro; Imamoto, Yasushi; Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto, Japan	Kyoto University	Shichida, Y (corresponding author), Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto, Japan.	shichida@rh.biophys.kyoto-u.ac.jp		Imamoto, Yasushi/0000-0002-0803-4163	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25251036, 15H00812, 25440167]; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Shimizu Foundation for Immunology and Neuroscience; Mochida Memorial Foundation; Grants-in-Aid for Scientific Research [25440167] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Shimizu Foundation for Immunology and Neuroscience; Mochida Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to YS (25251036), TY (15H00812 and 25440167) and grants from The Naito Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research and The Shimizu Foundation for Immunology and Neuroscience to TY (MEXT: http://www.jsps.go.jp/index.html, Naito Foundation: https://www.naito-f.or.jp/jp/index.php, Mochida Memorial Foundation: http://www.mochida.co.jp/zaidan/, The Shimizu Foundation for Immunology and Neuroscience: http://www.shimizu-immun-neurosci.or.jp/outline/index.html).	Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Emanuel AJ, 2015, NEURON, V85, P1043, DOI 10.1016/j.neuron.2015.02.011; Fischer RM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001585; FUKADA Y, 1994, J BIOL CHEM, V269, P5163; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P7988, DOI 10.1021/bi050219w; HUBBARD R, 1958, P NATL ACAD SCI USA, V44, P130, DOI 10.1073/pnas.44.2.130; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; KATADA T, 1994, METHOD ENZYMOL, V237, P131; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Koyanagi M, 2014, BBA-BIOENERGETICS, V1837, P710, DOI 10.1016/j.bbabio.2013.09.003; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; LEE E, 1994, METHOD ENZYMOL, V237, P146; Matsuyama T, 2012, BIOCHEMISTRY-US, V51, P5454, DOI 10.1021/bi3004999; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nissila J, 2012, J COMP PHYSIOL A, V198, P833, DOI 10.1007/s00359-012-0754-x; Ohuchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031534; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Sakai K, 2010, PHOTOCH PHOTOBIO SCI, V9, P1490, DOI 10.1039/c0pp00183j; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Sato K, 2011, BIOCHEMISTRY-US, V50, P10484, DOI 10.1021/bi201212z; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Takahashi Y, 2011, FEBS J, V278, P973, DOI 10.1111/j.1742-4658.2011.08019.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	30	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141238	10.1371/journal.pone.0141238	http://dx.doi.org/10.1371/journal.pone.0141238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491964	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300038
J	Tolotti, MT; Bach, P; Hazin, F; Travassos, P; Dagorn, L				Tolotti, Mariana Travassos; Bach, Pascal; Hazin, Fabio; Travassos, Paulo; Dagorn, Laurent			Vulnerability of the Oceanic Whitetip Shark to Pelagic Longline Fisheries	PLOS ONE			English	Article							POPULATIONS; COLLAPSE; CATCH	A combination of fisheries dependent and independent data was used to assess the vulnerability of the oceanic whitetip shark to pelagic longline fisheries. The Brazilian tuna longline fleet, operating in the equatorial and southwestern Atlantic, is used as a case study. Fisheries dependent data include information from logbooks (from 1999 to 2011) and on-board observers (2004 to 2010), totaling 65,277 pelagic longline sets. Fisheries independent data were obtained from 8 oceanic whitetip sharks tagged with pop-up satellite archival tags in the area where longline fleet operated. Deployment periods varied from 60 to 178 days between 2010 and 2012. Tagging and pop-up sites were relatively close to each other, although individuals tended to travel long distances before returning to the tagging area. Some degree of site fidelity was observed. High utilization hotspots of tagged sharks fell inside the area under strongest fishing pressure. Despite the small sample size, a positive correlation between tag recorded information and catch data was detected. All sharks exhibited a strong preference for the warm and shallow waters of the mixed layer, spending on average more than 70% of the time above the thermocline and 95% above 120 m. Results indicate that the removal of shallow hooks on longline gear might be an efficient mitigation measure to reduce the bycatch of this pelagic shark species. The work also highlights the potential of tagging experiments to provide essential information for the development of spatio-temporal management measures.	[Tolotti, Mariana Travassos; Bach, Pascal; Dagorn, Laurent] Univ Montpellier, CNRS, IFREMER, IRD,UMR MARBEC, Sete, France; [Tolotti, Mariana Travassos] Univ Fed Pernambuco, Dept Oceanog, Programa Posgrad Oceanog, Recife, PE, Brazil; [Hazin, Fabio; Travassos, Paulo] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidade Federal de Pernambuco; Universidade Federal Rural de Pernambuco (UFRPE)	Tolotti, MT (corresponding author), Univ Montpellier, CNRS, IFREMER, IRD,UMR MARBEC, Ave Jean Monnet CS 30171, Sete, France.	mariana.travassos@ird.fr	Travassos, Paulo/AAX-5734-2020; Fennell, Hannah/AAI-1408-2019; Bach, Pascal/E-9370-2013; Dagorn, Laurent/K-1002-2016	Bach, Pascal/0000-0003-0804-8466; Dagorn, Laurent/0000-0003-3896-8589; TRAVASSOS, PAULO/0000-0001-8667-5292; Hazin, Fabio/0000-0003-3755-5379	Commission of the European Communities; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao CAPES; France Filiere Peche	Commission of the European Communities(European Commission); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); France Filiere Peche	This study has been carried out with financial support from the Commission of the European Communities, specific RTD programme of Framework Programme 7, "Theme 2-Food, Agriculture, Fisheries and Biotechnology", through the research project MADE (Mitigating adverse ecological impacts of open ocean fisheries). It does not necessarily reflect its views and in no way anticipates the Commission's future policy in this area. The fishery data was made available by the Ministry of Fisheries and Aquaculture of Brazil. The authors acknowledge Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), Fundacao CAPES (www.capes.gov.br) and France Filiere Peche (www.francefilierepeche.fr) for providing a fellowship to M.T. Tolotti.	Alwang J, 2001, SOCIAL PROTECTION DI, P46; BACKUS RH, 1956, DEEP-SEA RES, V3, P178, DOI 10.1016/0146-6313(56)90002-8; Barsley W., 2013, FAO FISHERIES AQUACU, P43; Baum J, 2006, IUCN RED LIST THREAT; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bernal D, 2009, ECOPHYSIOLOGY SWIMMI, P436; Beverly S, 2009, FISH RES, V96, P281, DOI 10.1016/j.fishres.2008.12.010; Bonfil R, 2008, BIOL ECOLOGY OCEANIC, P128; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Cardenosa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110193; Clarke SC, 2013, CONSERV BIOL, V27, P197, DOI 10.1111/j.1523-1739.2012.01943.x; Compagno LJ V, 1984, FAO SPECIES CATALO 1, V4, P249; Compagno LJ V, 2005, SHARKS WORLD; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Hazin F.H.V., 1998, MAR FISH REV, V60, P1, DOI DOI 10.1007/S12562-019-01360-W; Hazin F.V., 1993, THESIS; Hazin HG, 2007, COLLECT VOL SCI PAP, V60, P2029; Holland M, 2012, RECENT DEV POP UP TA; Howey-Jordan LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056588; Lawrence Eleanor, 1995, HENDERSONS DICT BIOL; Metcalfe JD, 2001, WORKSH DAYL MEAS GEO, P331; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; Musyl MK, 2011, FISH B-NOAA, V109, P341; Nakano H., 1997, B NAT RES I FAR SEAS, V34, P43; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rice J., 2012, WCPFCSC82012SAWP06; Tolotti MT, 2015, GLOB ECOL CONSERV, V4, P1, DOI 10.1016/j.gecco.2015.05.003; Tolotti MT, 2013, FISH RES, V143, P136, DOI 10.1016/j.fishres.2013.01.014; Travassos P, 1999, ARCH FISH MAR RES, V47, P211; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; Venables WN., 2002, MODERN APPL STAT S 4; Watson JT, 2014, CONSERV BIOL, V28, P1012, DOI 10.1111/cobi.12268	33	14	14	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141396	10.1371/journal.pone.0141396	http://dx.doi.org/10.1371/journal.pone.0141396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492091	Green Published, gold			2022-12-27	WOS:000363249300049
J	de Oliveira, FA; Barreto, AS; Bomfim, LGS; Leite, TRS; dos Santos, PL; de Almeida, RP; da Silva, AM; Duthie, MS; Reed, SG; de Moura, TR; de Jesus, AR				de Oliveira, Fabricia Alvisi; Barreto, Aline Silva; Bomfim, Lays G. S.; Leite, Talita Rebeca S.; dos Santos, Priscila Lima; de Almeida, Roque Pacheco; da Silva, Angela Maria; Duthie, Malcolm S.; Reed, Steven G.; de Moura, Tatiana Rodrigues; de Jesus, Amelia Ribeiro			Soluble CD40 Ligand in Sera of Subjects Exposed to Leishmania infantum Infection Reduces the Parasite Load in Macrophages	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; EXPERIMENTAL VISCERAL LEISHMANIASIS; NITRIC-OXIDE PRODUCTION; CELL-MEDIATED-IMMUNITY; NF-KAPPA-B; CD40-CD40 LIGAND; DENDRITIC CELLS; HUMAN MONOCYTES; T-CELLS; DONOVANI INFECTIONS	Background While CD40L is typically a membrane glycoprotein expressed on activated T cells and platelets that binds and activates CD40 on the surface on antigen presenting cells, a soluble derivative (sCD40L) that appears to retain its biological activity after cleavage from cell membrane also exists. We recently reported that sCD40L is associated with clinical resolution of visceral leishmaniasis and protection against the disease. In the present study we investigated if this sCD40L is functional and exerts anti-parasitic effect in L. infantum-infected macrophages. Methodology/Principal Findings Macrophages from normal human donors were infected with L. infantum promastigotes and incubated with either sera from subjects exposed to L. infantum infection, monoclonal antibodies against human CD40L, or an isotype control antibody. We then evaluated infection by counting the number of infected cells and the number of parasites in each cell. We also measured a variety of immune modulatory cytokines in these macrophage culture supernatants by Luminex assay. The addition of sCD40L, either recombinant or from infected individuals' serum, decreased both the number of infected macrophages and number of intracellular parasites. Moreover, this treatment increased the production of IL-12, IL-23, IL27, IL-15, and IL1 beta such that negative correlations between the levels of these cytokines with both the infection ratio and number of intracellular parasites were observed. Conclusions/Significance sCD40L from sera of subjects exposed to L. infantum is functional and improves both the control of parasite and production of inflamatory cytokines of infected macrophages. Although the mechanisms involved in parasite killing are still unclear and require further exploration, these findings indicate a protective role of sCD40L in visceral leishmaniasis.	[de Oliveira, Fabricia Alvisi; Barreto, Aline Silva; Bomfim, Lays G. S.; Leite, Talita Rebeca S.; dos Santos, Priscila Lima; de Almeida, Roque Pacheco; da Silva, Angela Maria; de Moura, Tatiana Rodrigues; de Jesus, Amelia Ribeiro] Univ Fed Sergipe, Univ Hosp, Lab Biol Mol, Aracaju, Brazil; [de Almeida, Roque Pacheco; de Jesus, Amelia Ribeiro] Inst Invest Imunol, Sao Paulo, Brazil; [Duthie, Malcolm S.; Reed, Steven G.] IDRI, Seattle, WA USA	Universidade Federal de Sergipe	de Jesus, AR (corresponding author), Univ Fed Sergipe, Univ Hosp, Lab Biol Mol, Aracaju, Brazil.	ameliaribeirodejesus@gmail.com	, Tatiana/AAN-1194-2020; DE MOURA, TATIANA RODRIGUES/L-4556-2016; dos Santos, Priscila Lima/AAJ-7766-2021	, Tatiana/0000-0002-7442-4434; DE MOURA, TATIANA RODRIGUES/0000-0002-7442-4434; dos Santos, Priscila Lima/0000-0002-8863-5718; Duthie, Malcolm/0000-0002-8515-5516; Santos Bomfim, Lays Gisele/0000-0002-4773-6889	Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe (FAPITEC)/SE/FUNTEC/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [12/2009, 019.203.02712/2009-8]; CNPq [04/2011, 019.203.01157/2011-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant: Programa Nacional de Incentivo a Pesquisa em Parasitologia Basica [032/2010]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [552721/2011-5]; Edital/Chamada: Universal [483540/2011-0]	Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe (FAPITEC)/SE/FUNTEC/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant: Programa Nacional de Incentivo a Pesquisa em Parasitologia Basica(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Edital/Chamada: Universal	This work was supported by: Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe (FAPITEC)/SE/FUNTEC/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Grants: CNPq no 12/2009 Processo no 019.203.02712/2009-8 (ARJ); CNPq no 04/2011 Processo n. 019.203.01157/2011-9 (TRM). Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant: Programa Nacional de Incentivo a Pesquisa em Parasitologia Basica, Edital No 032/2010 (ARJ). Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grants: PROCAD/CASADINHO- no552721/2011-5 (RPA); Edital/Chamada: Universal 14/2011 Processo n. 483540/2011-0 (TRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade RM, 2005, J IMMUNOL, V175, P6014, DOI 10.4049/jimmunol.175.9.6014; Ansari NA, 2011, J IMMUNOL, V186, P3977, DOI 10.4049/jimmunol.1003588; Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515; Campbell KA, 1996, IMMUNITY, V4, P283, DOI 10.1016/S1074-7613(00)80436-7; CARVALHO EM, 1988, BRAZ J MED BIOL RES, V21, P85; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chen G, 2001, INFECT IMMUN, V69, P3255, DOI 10.1128/IAI.69.5.3255-3263.2001; D'Aversa TG, 2002, AM J PATHOL, V160, P559, DOI 10.1016/S0002-9440(10)64875-4; de Oliveira FA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-331; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; GHALIB HW, 1995, J IMMUNOL, V154, P4623; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Grewal IS, 1997, CURR OPIN IMMUNOL, V9, P491, DOI 10.1016/S0952-7915(97)80100-8; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Gurunathan S, 1998, J IMMUNOL, V161, P4563; Guzzo C, 2010, J BIOL CHEM, V285, P24404, DOI 10.1074/jbc.M110.112599; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Heinzel FP, 1998, CELL IMMUNOL, V184, P129, DOI 10.1006/cimm.1998.1267; HO JL, 1992, J INFECT DIS, V165, P1094, DOI 10.1093/infdis/165.6.1094; Indramohan M, 2012, INFECT IMMUN, V80, P4099, DOI 10.1128/IAI.00589-12; Jana M, 2001, J BIOL CHEM, V276, P44527, DOI 10.1074/jbc.M106771200; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; LIEW FY, 1990, IMMUNOLOGY, V71, P556; Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221; Liu JG, 2007, J EXP MED, V204, P141, DOI 10.1084/jem.20061440; Lorente L, 2011, CRIT CARE, V15, DOI 10.1186/cc10104; Ludewig B, 1996, EUR J IMMUNOL, V26, P3137, DOI 10.1002/eji.1830261246; Malik N, 1996, J IMMUNOL, V156, P3952; Mathur RK, 2006, TRENDS PARASITOL, V22, P117, DOI 10.1016/j.pt.2006.01.003; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; McDowell MA, 2002, INFECT IMMUN, V70, P3994, DOI 10.1128/IAI.70.8.3994-4001.2002; McMahon-Pratt D, 2004, IMMUNOL REV, V201, P206, DOI 10.1111/j.0105-2896.2004.00190.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murray HW, 2005, J IMMUNOL, V174, P4916, DOI 10.4049/jimmunol.174.8.4916; Murray HW, 2003, INFECT IMMUN, V71, P6453, DOI 10.1128/IAI.71.11.6453-6462.2003; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Reinhard K, 2011, EUR J IMMUNOL, V41, P1388, DOI 10.1002/eji.201041056; Ribbens C, 2000, IMMUNOLOGY, V99, P279, DOI 10.1046/j.1365-2567.2000.00948.x; Shimizu M, 2013, IMMUNOBIOLOGY, V218, P628, DOI 10.1016/j.imbio.2012.07.028; Sipsas NV, 2002, CLIN DIAGN LAB IMMUN, V9, P558, DOI 10.1128/CDLI.9.3.558-561.2002; Soong L, 1996, IMMUNITY, V4, P263, DOI 10.1016/S1074-7613(00)80434-3; Stager S, 2006, EUR J IMMUNOL, V36, P1764, DOI 10.1002/eji.200635937; Stout RD, 1996, IMMUNOL TODAY, V17, P487, DOI 10.1016/0167-5699(96)10060-I; Subauste CS, 2009, SEMIN IMMUNOL, V21, P273, DOI 10.1016/j.smim.2009.06.003; Suttles J, 2009, SEMIN IMMUNOL, V21, P257, DOI 10.1016/j.smim.2009.05.011; Tan ZY, 2009, INT J BIOCHEM CELL B, V41, P733, DOI 10.1016/j.biocel.2008.04.027; TIAN LC, 1995, EUR J IMMUNOL, V25, P306, DOI 10.1002/eji.1830250152; Tousoulis D, 2010, TRENDS CARDIOVAS MED, V20, P153, DOI 10.1016/j.tcm.2010.12.004; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Verma S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010107; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Wesa Amy, 2002, BMC Immunol, V3, P14, DOI 10.1186/1471-2172-3-14; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Yan JC, 2004, CLIN CHIM ACTA, V343, P155, DOI 10.1016/j.cccn.2004.01.012	58	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141265	10.1371/journal.pone.0141265	http://dx.doi.org/10.1371/journal.pone.0141265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488744	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400118
J	Gibson, JF; Shokralla, S; Curry, C; Baird, DJ; Monk, WA; King, I; Hajibabaei, M				Gibson, Joel F.; Shokralla, Shadi; Curry, Colin; Baird, Donald J.; Monk, Wendy A.; King, Ian; Hajibabaei, Mehrdad			Large-Scale Biomonitoring of Remote and Threatened Ecosystems via High-Throughput Sequencing	PLOS ONE			English	Article							WATER-QUALITY; DNA; BIODIVERSITY; MACROINVERTEBRATES; COMMUNITIES; INDICATORS; DIVERSITY; TAXONOMY; ARTHROPODS; PATTERNS	Biodiversity metrics are critical for assessment and monitoring of ecosystems threatened by anthropogenic stressors. Existing sorting and identification methods are too expensive and labour-intensive to be scaled up to meet management needs. Alternately, a high-throughput DNA sequencing approach could be used to determine biodiversity metrics from bulk environmental samples collected as part of a large-scale biomonitoring program. Here we show that both morphological and DNA sequence-based analyses are suitable for recovery of individual taxonomic richness, estimation of proportional abundance, and calculation of biodiversity metrics using a set of 24 benthic samples collected in the Peace-Athabasca Delta region of Canada. The high-throughput sequencing approach was able to recover all metrics with a higher degree of taxonomic resolution than morphological analysis. The reduced cost and increased capacity of DNA sequence-based approaches will finally allow environmental monitoring programs to operate at the geographical and temporal scale required by industrial and regulatory end-users.	[Gibson, Joel F.; Shokralla, Shadi; King, Ian; Hajibabaei, Mehrdad] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Gibson, Joel F.; Shokralla, Shadi; King, Ian; Hajibabaei, Mehrdad] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Gibson, Joel F.] Environm Canada, Canada Ctr Inland Waters, Burlington, ON L7R 4A6, Canada; [Curry, Colin; Baird, Donald J.] Univ New Brunswick, Environm Canada, Canadian Rivers Inst, Fredericton, NB, Canada; [Monk, Wendy A.] Univ New Brunswick, Canadian Rivers Inst, Fredericton, NB, Canada	University of Guelph; University of Guelph; Environment & Climate Change Canada; Canada Centre for Inland Waters (CCIW); Environment & Climate Change Canada; University of New Brunswick; University of New Brunswick	Hajibabaei, M (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	mhajibab@uoguelph.ca	Gibson, Joel F/A-7051-2013; King, Ian W/J-8625-2012	Gibson, Joel F/0000-0001-7786-0066; Monk, Wendy/0000-0001-9031-5433; King, Ian/0000-0002-8820-6956	Ontario Genomics Institute; Genome Canada; NSERC; Environment Canada	Ontario Genomics Institute; Genome Canada(Genome Canada); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR)	This work was supported by the Ontario Genomics Institute; Genome Canada, NSERC, Environment Canada.	Anas MUM, 2014, CAN J FISH AQUAT SCI, V71, P719, DOI 10.1139/cjfas-2013-0472; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Arce E, 2014, FRESHW SCI, V33, P1060, DOI 10.1086/678673; Astorga A, 2014, ECOL EVOL, V4, P2693, DOI 10.1002/ece3.1124; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Buss DF, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4132-8; Chang FH, 2014, ENVIRON MONIT ASSESS, V186, P2135, DOI 10.1007/s10661-013-3523-6; Curry CJ, 2012, FRESHWATER BIOL, V57, P628, DOI 10.1111/j.1365-2427.2011.02724.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Environment Canada Canadian Aquatic Biomonitoring Network, 2012, CAN AQ BIOM NETW LAB; Florencio M, 2014, INSECT CONSERV DIVER, V7, P4, DOI 10.1111/icad.12029; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibson J, 2014, P NATL ACAD SCI USA, V111, P8007, DOI 10.1073/pnas.1406468111; Gill BA, 2014, FRESHW SCI, V33, P288, DOI 10.1086/674526; Gonzalez LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029176; Gray C, 2014, J APPL ECOL, V51, P1444, DOI 10.1111/1365-2664.12300; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hajibabaei M, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-28; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Heino J, 2005, BIODIVERS CONSERV, V14, P415, DOI 10.1007/s10531-004-5064-z; Huang Q, 2015, ECOL INDIC, V48, P649, DOI 10.1016/j.ecolind.2014.09.014; Jackson JK, 2014, FRESHW SCI, V33, P312, DOI 10.1086/675225; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Lindenmayer DB, 2011, ECOSYSTEMS, V14, P47, DOI 10.1007/s10021-010-9394-6; Marchant R., 1989, Australian Society for Limnology Bulletin, P49; Monaghan KA, 2013, CAN J FISH AQUAT SCI, V70, P885, DOI 10.1139/cjfas-2012-0402; Narangarvuu DDD, 2014, J ASIA-PAC ENTOMOL, V17, P505, DOI 10.1016/j.aspen.2014.04.011; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Orlofske JM, 2014, FRESHW SCI, V33, P978, DOI 10.1086/676912; Orlofske JM, 2013, AQUAT ECOL, V47, P481, DOI 10.1007/s10452-013-9460-1; Pasari JR, 2013, P NATL ACAD SCI USA, V110, P10219, DOI 10.1073/pnas.1220333110; Pilgrim EM, 2011, J N AM BENTHOL SOC, V30, P217, DOI 10.1899/10-012.1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RCoreTeam, 2014, R LANG ENV STAT COMP; Schmidt-Kloiber A, 2015, ECOL INDIC, V53, P271, DOI 10.1016/j.ecolind.2015.02.007; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Semprucci F, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4493-7; Stein ED, 2014, FRESHW SCI, V33, P302, DOI 10.1086/674782; Sweeney BW, 2011, J N AM BENTHOL SOC, V30, P195, DOI 10.1899/10-016.1; Tonkin JD, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone, DOI 10.1371/J0URNAL.P0NE]; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	47	102	117	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0138432	10.1371/journal.pone.0138432	http://dx.doi.org/10.1371/journal.pone.0138432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488407	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400007
J	Papke, RL; Horenstein, NA; Stokes, C				Papke, Roger L.; Horenstein, Nicole A.; Stokes, Clare			Nicotinic Activity of Arecoline, the Psychoactive Element of "Betel Nuts", Suggests a Basis for Habitual Use and AntiInflammatory Activity	PLOS ONE			English	Article							POSITIVE ALLOSTERIC MODULATOR; ACETYLCHOLINE-RECEPTORS; IMMUNE-RESPONSES; PARTIAL AGONIST; SILENT AGONIST; SMOOTH-MUSCLE; M-3 RECEPTOR; ARECA; ACTIVATION; CYTISINE	Habitual chewing of "betel nut" preparations constitutes the fourth most common human self-administration of a psychoactive substance after alcohol, caffeine, and nicotine. The primary active ingredient in these preparations is arecoline, which comes from the areca nut, the key component of all such preparations. Arecoline is known to be a relatively nonselective muscarinic partial agonist, accounting for many of the overt peripheral and central nervous system effects, but not likely to account for the addictive properties of the drug. We report that arecoline has activity on select nicotinic acetylcholine receptor (nAChR) subtypes, including the two classes of nAChR most related to the addictive properties of nicotine: receptors containing alpha 4 and beta 2 subunits and those which also contain alpha 6 and beta 3 subunits. Arecoline is a partial agonist with about 6-10% efficacy for the alpha 4* and alpha 6* receptors expressed in Xenopus oocytes. Additionally, arecoline is a silent agonist of alpha 7 nAChR; while it does not activate a7 receptors when applied alone, it produces substantial activation when co-applied with the positive allosteric modulator PNU-120696. Some alpha 7 silent agonists are effective inhibitors of inflammation, which might account for anti-inflammatory effects of arecoline. Arecoline's activity on nAChR associated with addiction may account for the habitual use of areca nut preparations in spite of the well-documented risk to personal health associated with oral diseases and cancer. The common link between betel and tobacco suggests that partial agonist therapies with cytisine or the related compound varenicline may also be used to aid betel cessation attempts.	[Papke, Roger L.; Stokes, Clare] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Horenstein, Nicole A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Papke, RL (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, POB 100267, Gainesville, FL 32610 USA.	rlpapke@ufl.edu			NIH [GM57481]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM57481.	Akhtar S, 2013, CANCER CAUSE CONTROL, V24, P257, DOI 10.1007/s10552-012-0113-9; Brunzell DH, 2014, ANN NY ACAD SCI, V1327, P27, DOI 10.1111/nyas.12421; Campling BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079653; Cannon CE, 2013, NEUROPHARMACOLOGY, V64, P191, DOI 10.1016/j.neuropharm.2012.05.003; Chojnacka K, 2013, BIOORG MED CHEM LETT, V23, P4145, DOI 10.1016/j.bmcl.2013.05.039; Chu NS, 2002, ADDICT BIOL, V7, P111, DOI 10.1080/13556210120091473; CLARKE PBS, 1985, J NEUROSCI, V5, P1307; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Coppola M, 2012, NORD J PSYCHIAT, V66, P73, DOI 10.3109/08039488.2011.605172; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; Cox S, 2010, J ORAL PATHOL MED, V39, P465, DOI 10.1111/j.1600-0714.2009.00881.x; Croucher R, 2002, ADDICT BIOL, V7, P139, DOI 10.1080/13556210120091518; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; DEMISSIE S, 1995, J NEUROIMMUNOL, V59, P57, DOI 10.1016/0165-5728(95)00025-W; Etter JF, 2006, ARCH INTERN MED, V166, P1553, DOI 10.1001/archinte.166.15.1553; Franke Adrian A, 2014, Hawaii J Med Public Health, V73, P400; Freedman R, 2008, AM J PSYCHIAT, V165, P1040, DOI 10.1176/appi.ajp.2008.07071135; Freitas K, 2013, NEUROPHARMACOLOGY, V65, P156, DOI 10.1016/j.neuropharm.2012.08.022; Garg A, 2014, INDIAN J MED PAEDIAT, V35, P3, DOI 10.4103/0971-5851.133702; Ghelardini C, 2001, FARMACO, V56, P383, DOI 10.1016/S0014-827X(01)01091-6; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Hsu H J, 2001, Kaohsiung J Med Sci, V17, P175; Huang LW, 2012, TOXICOL APPL PHARM, V258, P199, DOI 10.1016/j.taap.2011.11.001; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Hwang GS, 2013, J PHYSIOL PHARMACOL, V64, P535; Javed F, 2010, SCAND J PUBLIC HEALT, V38, P838, DOI 10.1177/1403494810379291; Kao SY, 2015, CHIN J DENT RES, V18, P7, DOI 10.3290/j.cjdr.a33965,PubMed:25815378; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Lord GA, 2002, ADDICT BIOL, V7, P99, DOI 10.1080/13556210120091455; Martin LF, 2004, PSYCHOPHARMACOLOGY, V174, P54, DOI 10.1007/s00213-003-1750-1; Mineur YS, 2009, J PHARMACOL EXP THER, V329, P377, DOI 10.1124/jpet.108.149609; Okamoto H, 2002, BRIT J PHARMACOL, V135, P1765, DOI 10.1038/sj.bjp.0704642; PAPKE RL, 1994, MOL PHARMACOL, V45, P142; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Papke RL, 2015, NEUROPHARMACOLOGY, V91, P34, DOI 10.1016/j.neuropharm.2014.12.002; Papke RL, 2014, J PHARMACOL EXP THER, V350, P665, DOI 10.1124/jpet.114.215236; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; Papke RL, 2011, J PHARMACOL EXP THER, V337, P367, DOI 10.1124/jpet.110.177485; Papke RL, 2010, METHODS, V51, P121, DOI 10.1016/j.ymeth.2010.01.012; Papke RL, 2010, J PHARMACOL EXP THER, V333, P501, DOI 10.1124/jpet.109.164566; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039; Russo P, 2014, CURR PHARM DESIGN; SELVAN RS, 1991, IMMUNOPHARM IMMUNOT, V13, P281, DOI 10.3109/08923979109019706; SELVAN RS, 1993, IMMUNOPHARM IMMUNOT, V15, P291, DOI 10.3109/08923979309026000; Song H, 2015, ASIA-PAC J PUBLIC HE, V27, pNP47, DOI 10.1177/1010539513486921; Sullivan RJ, 2007, AM J PSYCHIAT, V164, P670, DOI 10.1176/appi.ajp.164.4.670; Thomsen MS, 2012, J NEUROIMMUNOL, V251, P65, DOI 10.1016/j.jneuroim.2012.07.006; Ullah M, 2015, J ORAL PATHOL MED, V44, P591, DOI 10.1111/jop.12276; van Maanen MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116227; Wallace TL, 2011, PHARMACOL BIOCHEM BE, V99, P130, DOI 10.1016/j.pbb.2011.03.022; Wen XM, 2006, CELL BIOL INT, V30, P1048, DOI 10.1016/j.cellbi.2006.09.015; WHO, 2004, BETEL QUID AND ARECA, P1; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams S, 2002, ADDICT BIOL, V7, P147, DOI 10.1080/135562101200100147; Xie DP, 2004, CHINESE J PHYSIOL, V47, P89; Zhou Y, 2003, J NEUROSCI, V23, P9004	60	53	53	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140907	10.1371/journal.pone.0140907	http://dx.doi.org/10.1371/journal.pone.0140907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488401	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400079
J	Huang, LX; Zheng, WB; Wu, CX; Wei, XQ; Wu, XG; Wang, YT; Zheng, HY				Huang, Lexing; Zheng, Wenbin; Wu, Chunxiao; Wei, Xiaoqin; Wu, Xianguang; Wang, Yanting; Zheng, Hongyi			Diffusion Tensor Imaging of the Auditory Neural Pathway for Clinical Outcome of Cochlear Implantation in Pediatric Congenital Sensorineural Hearing Loss Patients	PLOS ONE			English	Article							BRAIN; MRI; ANISOTROPY; REGIONS; ADULTS; WATER; CT	Although conventional structural MRI provides vital information in the evaluation of congenital sensorineural hearing loss (SNHL), it is relatively insensitive to white matter microstructure. Our objective was to evaluate possible changes in microstructure of the auditory pathway in children with congenital sensorineural hearing loss (SNHL), and the possible distinction between good and poor outcome of cochlear implantation (CI) patients by using diffusion tensor imaging (DTI). Twenty-four patients with congenital SNHL and 20 healthy controls underwent conventional MRI and DTI examination using a 1.5T MR scanner. The DTI metrics of fractional anisotropy (FA) and mean diffusivity (MD) of six regions of interest (ROIs) positioned along the auditory pathway-the trapezoid body, superior olivary nucleus, inferior colliculus, medial geniculate body, auditory radiation and white matter of Heschl's gyrus-was measured in all subjects. Among the 24 patients, 8 patients with a categorie of auditory performance (CAP) score over 6 were classified into the good outcome group, and 16 patients with a CAP score below 6 were classified into the poor outcome group. A significant decrease was observed in FA values while MD values remained unchanged at the six ROIs of SNHL patients compared with healthy controls. Compared to good outcome subjects, poor outcome subjects displayed decreased FA values at all of the ROIs. No changes were observed in MD values. Correlation analyses only revealed strong correlations between FA values and CAP scores, and strong correlations between CAP scores and age at implant were also found. No correlations of FA values with age at implant were observed. Our results show that preoperative DTI can be used to evaluate microstructural alterations in the auditory pathway that are not detectable by conventional MR imaging, and may play an important role in evaluating the outcome of CI. Early cochlear implantation might be more effectively to restore hearing in SNHL patients.	[Huang, Lexing; Zheng, Wenbin; Wu, Chunxiao; Wang, Yanting; Zheng, Hongyi] Shantou Univ, Coll Med, Dept Radiol, Affiliated Hosp 2, Shantou, Peoples R China; [Wei, Xiaoqin; Wu, Xianguang] Shantou Univ, Coll Med, Dept ENT, Affiliated Hosp 2, Shantou, Peoples R China	Shantou University; Shantou University	Zheng, WB (corresponding author), Shantou Univ, Coll Med, Dept Radiol, Affiliated Hosp 2, Shantou, Peoples R China.	hwenb@126.com			National Natural Science Foundation of China [81571627]; Natural Science Foundation of Guangdong Province, China [S2012010008974, 2014A030313481]; Shantou University Medical College Clinical Research Enhancement Initiative, Shantou China; Science and Technology Planning Project of Shantou City, China, Shantou China [201424260]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Shantou University Medical College Clinical Research Enhancement Initiative, Shantou China; Science and Technology Planning Project of Shantou City, China, Shantou China	This study was supported by the National Natural Science Foundation of China (grant no. 81571627), Natural Science Foundation of Guangdong Province, China (grant no. S2012010008974, 2014A030313481), and was sponsored by the Shantou University Medical College Clinical Research Enhancement Initiative (2014), Shantou China, Science and Technology Planning Project of Shantou City, China (grant no. 201424260), Shantou China. WZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Chang YM, 2004, NEUROREPORT, V15, P1699, DOI 10.1097/01.wnr.0000134584.10207.1a; Chang Y, 2012, CLIN EXP OTORHINOLAR, V5, pS37, DOI 10.3342/ceo.2012.5.S1.S37; Chen L, 2002, J COMPUT ASSIST TOMO, V26, P482, DOI 10.1097/00004728-200205000-00030; Emmorey K, 2003, P NATL ACAD SCI USA, V100, P10049, DOI 10.1073/pnas.1730169100; Hasan KM, 2005, J MAGN RESON IMAGING, V21, P735, DOI 10.1002/jmri.20296; Hong P, 2010, INT J PEDIATR OTORHI, V74, P658, DOI 10.1016/j.ijporl.2010.03.014; Jonas NE, 2012, INT J PEDIATR OTORHI, V76, P927, DOI 10.1016/j.ijporl.2012.02.070; Joshi VM, 2012, RADIOGRAPHICS, V32, P683, DOI 10.1148/rg.323115073; Lazard DS, 2013, HUM BRAIN MAPP, V34, P1208, DOI 10.1002/hbm.21504; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Licameli G, 2010, LARYNGOSCOPE, V120, P2358, DOI 10.1002/lary.21363; Lin Y, 2008, J MAGN RESON IMAGING, V28, P598, DOI 10.1002/jmri.21464; Lobel U, 2009, NEURORADIOLOGY, V51, P253, DOI 10.1007/s00234-008-0488-1; Moon IJ, 2012, AUDIOL NEURO-OTOL, V17, P373, DOI 10.1159/000341818; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Wu CM, 2009, AUDIOL NEURO-OTOL, V14, P248, DOI 10.1159/000191282; Zwolan TA, 2004, OTOL NEUROTOL, V25, P112, DOI 10.1097/00129492-200403000-00006	21	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140643	10.1371/journal.pone.0140643	http://dx.doi.org/10.1371/journal.pone.0140643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485661	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100056
J	Raghunathan, K; Ahsan, A; Ray, D; Nyati, MK; Veatch, SL				Raghunathan, Krishnan; Ahsan, Aarif; Ray, Dipankar; Nyati, Mukesh K.; Veatch, Sarah L.			Membrane Transition Temperature Determines Cisplatin Response	PLOS ONE			English	Article							ANTICANCER DRUG CISPLATIN; OVARIAN-CANCER; LIPID-RAFT; INDUCED APOPTOSIS; SIGNALING PATHWAYS; INDUCED ACTIVATION; CELL-LINES; RESISTANCE; ORGANIZATION; DEATH	Cisplatin is a classical chemotherapeutic agent used in treating several forms of cancer including head and neck. However, cells develop resistance to the drug in some patients through a range of mechanisms, some of which are poorly understood. Using isolated plasma membrane vesicles as a model system, we present evidence suggesting that cisplatin induced resistance may be due to certain changes in the bio-physical properties of plasma membranes. Giant plasma membrane vesicles (GPMVs) isolated from cortical cytoskeleton exhibit a miscibility transition between a single liquid phase at high temperature and two distinct coexisting liquid phases at low temperature. The temperature at which this transition occurs is hypothesized to reflect the magnitude of membrane heterogeneity at physiological temperature. We find that addition of cisplatin to vesicles isolated from cisplatin-sensitive cells result in a lowering of this miscibility transition temperature, whereas in cisplatin-resistant cells such treatment does not affect the transition temperature. To explore if this is a cause or consequence of cisplatin resistance, we tested if addition of cisplatin in combination with agents that modulate GPMV transition temperatures can affect cisplatin sensitivity. We found that cells become more sensitive to cisplatin when isopropanol, an agent that lowers GPMV transition temperature, was combined with cisplatin. Conversely, cells became resistant to cisplatin when added in combination with menthol that raises GPMV transition temperatures. These data suggest that changes in plasma membrane heterogeneity augments or suppresses signaling events initiated in the plasma membranes that can determine response to cisplatin. We postulate that desired perturbations of membrane heterogeneity could provide an effective therapeutic strategy to overcome cisplatin resistance for certain patients.	[Raghunathan, Krishnan; Veatch, Sarah L.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Ahsan, Aarif; Ray, Dipankar; Nyati, Mukesh K.] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nyati, MK (corresponding author), Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.	nyati@umich.edu; sveatch@umich.edu	Veatch, Sarah L/G-9512-2016; Raghunathan, Krishnan/S-4212-2019	Veatch, Sarah L/0000-0002-9317-2308; Raghunathan, Krishnan/0000-0003-2228-6313	National Insitute of Health [R01GM110052, R01CA131290, R01CA160981]; University of Michigan [P50CA097248]; University of Michigan; NATIONAL CANCER INSTITUTE [R01CA160981, R01CA131290, P50CA097248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110052] Funding Source: NIH RePORTER	National Insitute of Health; University of Michigan(University of Michigan System); University of Michigan(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was funded through a University of Michigan M-Cubed [http://mcubed.umich.edu/] grant in addition to grants from the National Insitute of Health, [http://www.nih.gov/] (R01GM110052 to Sarah L. Veatch, R01CA131290 to Mukesh K. Nyati, R01CA160981 to Dipankar Ray) and startup funds from the University of Michigan (SLV) and P50CA097248 (to PI: Wolf, Co-Investigator Project 4 to M.K. Nyati), and startup funds from the University of Michigan (SLV).	Ahsan A, 2010, CANCER RES, V70, P2862, DOI 10.1158/0008-5472.CAN-09-4294; Alsop RJ, 2014, BIOCH BIOPHYS ACTA; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Baritaki S, 2007, ADV CANCER RES, V98, P149, DOI 10.1016/S0065-230X(06)98005-1; Barnoud J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003873; Barry J, 2009, J AM CHEM SOC, V131, P4490, DOI 10.1021/ja809217u; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BELL DR, 1985, J CLIN ONCOL, V3, P311, DOI 10.1200/JCO.1985.3.3.311; Benderitter M, 2000, CYTOMETRY, V39, P151, DOI 10.1002/(SICI)1097-0320(20000201)39:2<151::AID-CYTO8>3.0.CO;2-I; Benderitter M, 2009, CELL MEMBRANE BIOSEN; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Brown DA, 1998, ANN REV CELL DEV BIO; Burger KNJ, 1999, BBA-BIOMEMBRANES, V1419, P43, DOI 10.1016/S0005-2736(99)00052-8; Castro BM, 2011, BIOPHYS J, V101, P1632, DOI 10.1016/j.bpj.2011.08.022; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Dimanche-Boitrel MT, 2005, DRUG RESIST UPDATE, V8, P5, DOI 10.1016/j.drup.2005.02.003; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Eliaz RE, 2004, CANCER RES, V64, P711, DOI 10.1158/0008-5472.CAN-03-0654; EVANS DL, 1993, CANCER RES, V53, P2133; Farrand L, 2013, J BIOL CHEM, V288, P23740, DOI 10.1074/jbc.M113.487686; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Gottesman MM, 2002, ANN REV MED; Gray E, PLOS ONE IN PRESS; Gray E, 2013, BIOPHYS J, V105, P2751, DOI 10.1016/j.bpj.2013.11.005; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Huang CR, 2010, ANTICANCER RES, V30, P2065; Huang ZH, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-5; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Jensen M, 2010, J BIOL INORG CHEM, V15, P213, DOI 10.1007/s00775-009-0586-5; Kabolizadeh P, 2007, BIOCHEM PHARMACOL, V73, P1270, DOI 10.1016/j.bcp.2006.12.016; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kawaiz K, 1990, SELECTION CELLULAR P, V265, P13137; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kuo MT, 2007, CANCER METAST REV, V26, P71, DOI 10.1007/s10555-007-9045-3; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Levental I, 2009, BIOCHEM J, V424, P163, DOI 10.1042/BJ20091283; Liang XJ, 2004, EXP CELL RES, V293, P283, DOI 10.1016/j.yexcr.2003.10.012; Liang XJ, 2002, INT J BIOCHEM CELL B, V34, P1248, DOI 10.1016/S1357-2725(02)00056-0; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Machta BB, 2011, BIOPHYS J, V100, P1668, DOI 10.1016/j.bpj.2011.02.029; Moiset G, 2014, J AM CHEM SOC, V136, P16167, DOI 10.1021/ja505476c; Mueller T, 2003, CANCER RES, V63, P513; Nierzwicki L, 2015, PHYS CHEM CHEM PHYS, V17, P1458, DOI 10.1039/c4cp04360j; Owen DM, 2012, BIOESSAYS, V34, P739, DOI 10.1002/bies.201200044; OZAWA S, 1989, CANCER RES, V49, P3823; Pandey BN, 1999, RADIAT PHYS CHEM, V54, P481, DOI 10.1016/S0969-806X(98)00297-7; PARASASSI T, 1995, FREE RADICAL BIO MED, V19, P511, DOI 10.1016/0891-5849(95)00038-Y; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Rebillard A, 2007, CANCER RES, V67, P7865, DOI 10.1158/0008-5472.CAN-07-0353; Schuldes H, 2001, EUR J CANCER, V37, P660, DOI 10.1016/S0959-8049(00)00450-0; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Speelmans G, 1996, BBA-BIOMEMBRANES, V1283, P60, DOI 10.1016/0005-2736(96)00080-6; TROGER V, 1992, EUR J CANCER, V28A, P82, DOI 10.1016/0959-8049(92)90391-E; Tsukamoto S, 2012, BIOCHEM J, V443, P525, DOI 10.1042/BJ20111837; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Yellepeddi VK, 2012, ANTICANCER RES, V32, P3651; Yoshida T, 2008, FEBS LETT, V582, P4125, DOI 10.1016/j.febslet.2008.11.010; Zhou Y, 2013, J BIOL CHEM, V288, P35660, DOI 10.1074/jbc.M113.519116; Zhou Y, 2012, J BIOL CHEM, V287, P16586, DOI 10.1074/jbc.M112.348490; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008811	70	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140925	10.1371/journal.pone.0140925	http://dx.doi.org/10.1371/journal.pone.0140925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484687	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100092
J	van Breukelen-van der Stoep, DF; van Zeben, D; Klop, B; van de Geijn, GJM; Janssen, HJW; Hazes, MJMW; Birnie, E; van der Meulen, N; De Vries, MA; Cabezas, MC				van Breukelen-van der Stoep, Deborah F.; van Zeben, Derkjen; Klop, Boudewijn; van de Geijn, Gert-Jan M.; Janssen, Hans J. W.; Hazes, Mieke J. M. W.; Birnie, Erwin; van der Meulen, Noelle; De Vries, Marijke A.; Cabezas, Manuel Castro			Association of Cardiovascular Risk Factors with Carotid Intima Media Thickness in Patients with Rheumatoid Arthritis with Low Disease Activity Compared to Controls: A Cross-Sectional Study	PLOS ONE			English	Article							SUBCLINICAL ATHEROSCLEROSIS; PREVALENCE; ARTERY; INFLAMMATION; DYSFUNCTION; MORTALITY; EVENTS; BURDEN; DEATH	Objectives Rheumatoid arthritis (RA) has been identified as an independent cardiovascular risk factor. The importance of risk factors such as hypertension and hyperlipidemia in the generation of atherosclerosis in RA patients is unclear. This study analyzed clinical parameters associated with carotid intima media thickness (cIMT) in patients with RA. Methods Subjects with RA and healthy controls without RA, both without known cardiovascular disease, were included. Participants underwent a standard physical examination and laboratory measurements including a lipid profile. cIMT was measured semi-automatically by ultrasound. Results In total 243 RA patients and 117 controls were included. The median RA disease duration was 7 years (IQR 2-14 years). The median DAS28 was 2.4 (IQR 1.6-3.2) and 114 (50.4%) of the RA patients were in remission. The presence of RA and cIMT were not associated (univariate analysis). Multivariable regression analysis showed that cIMT in RA patients was associated with age (B = 0.006, P<0.001) and systolic blood pressure (B = 0.003, P = 0.003). In controls, cIMT was associated with age (B = 0.006, P<0.001) and smoking (B = 0.097, P = 0.001). Conclusion cIMT values were similar between RA patients and controls. Hypertension was strongly associated with cIMT in RA patients. After adjustment, no association between cIMT and specific RA disease characteristics was found in this well treated RA cohort.	[van Breukelen-van der Stoep, Deborah F.; van Zeben, Derkjen] St Franciscus Gasthuis, Dept Rheumatol, Rotterdam, Netherlands; [Klop, Boudewijn; van der Meulen, Noelle; De Vries, Marijke A.; Cabezas, Manuel Castro] St Franciscus Gasthuis, Dept Internal Med, Rotterdam, Netherlands; [van de Geijn, Gert-Jan M.; Janssen, Hans J. W.] St Franciscus Gasthuis, Dept Clin Chem, Rotterdam, Netherlands; [Hazes, Mieke J. M. W.] Erasmus MC, Dept Rheumatol, Rotterdam, Netherlands; [Birnie, Erwin] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands; [Birnie, Erwin] St Franciscus Gasthuis, Stat & Educ, Rotterdam, Netherlands	Franciscus Gasthuis; Franciscus Gasthuis; Franciscus Gasthuis; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Franciscus Gasthuis	Cabezas, MC (corresponding author), St Franciscus Gasthuis, Dept Internal Med, Rotterdam, Netherlands.	m.castrocabezas@sfvg.nl			Sint Francicsus Research Fund; Stichting Coolsingel Rotterdam	Sint Francicsus Research Fund; Stichting Coolsingel Rotterdam	This study consists of data from two studies. One study, the FRANCIS study, received financial support from the Sint Francicsus Research Fund and the Stichting Coolsingel Rotterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari MC, 2012, SEMIN ARTHRITIS RHEU, V41, P669, DOI 10.1016/j.semarthrit.2011.08.003; Ambrosino P, 2015, THROMB HAEMOSTASIS, V113, P916, DOI 10.1160/TH14-11-0921; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arts EEA, 2015, ANN RHEUM DIS, V74, P998, DOI 10.1136/annrheumdis-2013-204531; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Barbarroja N, 2014, ARTERIOSCL THROM VAS, V34, P2706, DOI 10.1161/ATVBAHA.114.304475; BOTS ML, 1993, ARTERIOSCLER THROMB, V13, P64, DOI 10.1161/01.ATV.13.1.64; Bovenberg SA, 2012, EUR J CLIN INVEST, V42, P365, DOI 10.1111/j.1365-2362.2011.02591.x; Chung CP, 2012, SEMIN ARTHRITIS RHEU, V41, P535, DOI 10.1016/j.semarthrit.2011.07.004; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; del Rincon I, 2005, ARTHRITIS RHEUM-US, V52, P3413, DOI 10.1002/art.21397; del Rincon I, 2003, ARTHRITIS RHEUM, V48, P1833, DOI 10.1002/art.11078; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Gabriel SE, 2001, RHEUM DIS CLIN N AM, V27, P269, DOI 10.1016/S0889-857X(05)70201-5; Gonzalez A, 2008, ANN RHEUM DIS, V67, P64, DOI 10.1136/ard.2006.059980; Gonzalez-Juanatey C, 2003, MEDICINE, V82, P407, DOI 10.1097/01.md.0000101572.76273.60; Graf J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006242; Grover S, 2006, J RHEUMATOL, V33, P244; Hannawi S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2323; Im CH, 2015, RHEUMATOLOGY, V54, P808, DOI 10.1093/rheumatology/keu376; Kerekes G, 2012, NAT REV RHEUMATOL, V8, P224, DOI 10.1038/nrrheum.2012.16; Klop B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075573; Kumeda Y, 2002, ARTHRITIS RHEUM-US, V46, P1489, DOI 10.1002/art.10269; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Mahajan V, 2008, J Assoc Physicians India, V56, P587; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Meek IL, 2013, RHEUMATOLOGY, V52, P210, DOI 10.1093/rheumatology/kes194; Mitrovic J., 2015, INT J RHEUM DIS; Myasoedova E, 2010, CURR OPIN RHEUMATOL, V22, P342, DOI 10.1097/BOR.0b013e3283379b91; Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383; Panoulas VF, 2010, ATHEROSCLEROSIS, V209, P255, DOI 10.1016/j.atherosclerosis.2009.08.047; PRIOR P, 1984, BRIT J RHEUMATOL, V23, P92; Ristic GG, 2010, RHEUMATOLOGY, V49, P1076, DOI 10.1093/rheumatology/kep456; Rollefstad S, 2013, ANN RHEUM DIS, V72, P1968, DOI 10.1136/annrheumdis-2012-202789; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Solomon A, 2012, J RHEUMATOL, V39, P1798, DOI 10.3899/jrheum.120073; Stamatelopoulos KS, 2009, ARTERIOSCL THROM VAS, V29, P1702, DOI 10.1161/ATVBAHA.109.190108; Steen KSS, 2009, ANN RHEUM DIS, V68, P1509, DOI 10.1136/ard.2008.105023; van Breukelen-van der Stoep DF, 2013, ATHEROSCLEROSIS, V231, P163, DOI 10.1016/j.atherosclerosis.2013.09.006; van Halm VP, 2009, ANN RHEUM DIS, V68, P1395, DOI 10.1136/ard.2008.094151; van Sijl AM, 2011, SEMIN ARTHRITIS RHEU, V40, P389, DOI 10.1016/j.semarthrit.2010.06.006; van Zonneveld AJ, 2010, ANN RHEUM DIS, V69, P57, DOI 10.1136/ard.2009.119495; Vazquez-Del Mercado M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/342649; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Zhang YY, 2014, ARTERIOSCL THROM VAS, V34, P1341, DOI 10.1161/ATVBAHA.113.302075	47	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140844	10.1371/journal.pone.0140844	http://dx.doi.org/10.1371/journal.pone.0140844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485681	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100078
J	Broglie, JJ; Alston, B; Yang, C; Ma, L; Adcock, AF; Chen, W; Yang, LJ				Broglie, Jessica Jenkins; Alston, Brittny; Yang, Chang; Ma, Lun; Adcock, Audrey F.; Chen, Wei; Yang, Liju			Antiviral Activity of Gold/Copper Sulfide Core/Shell Nanoparticles against Human Norovirus Virus-Like Particles	PLOS ONE			English	Article							HIGH-PRESSURE INACTIVATION; MURINE NOROVIRUS; NORWALK VIRUS; FULLERENE DERIVATIVES; THERMAL INACTIVATION; SILVER NANOPARTICLES; FELINE CALICIVIRUS; ENTERIC VIRUSES; SURROGATES; MECHANISMS	Human norovirus is a leading cause of acute gastroenteritis worldwide in a plethora of residential and commercial settings, including restaurants, schools, and hospitals. Methods for easily detecting the virus and for treating and preventing infection are critical to stopping norovirus outbreaks, and inactivation via nanoparticles (NPs) is a more universal and attractive alternative to other physical and chemical approaches. Using norovirus GI.1 (Norwalk) virus-like particles (VLPs) as a model viral system, this study characterized the antiviral activity of Au/CuS core/shell nanoparticles (NPs) against GI.1 VLPs for the rapid inactivation of HuNoV. Inactivation of VLPs (GI.1) by Au/CuS NPs evaluated using an absorbance-based ELISA indicated that treatment with 0.083 mu M NPs for 10 min inactivated similar to 50% VLPs in a 0.37 mu g/ml VLP solution and 0.83 mu M NPs for 10 min completely inactivated the VLPs. Increasing nanoparticle concentration and/or VLP-NP contact time significantly increased the virucidal efficacy of Au/CuS NPs. Changes to the VLP particle morphology, size, and capsid protein were characterized using dynamic light scattering, transmission electron microscopy, and Western blot analysis. The strategy reported here provides the first reported proof-of-concept Au/CuS NPs-based virucide for rapidly inactivating human norovirus.	[Broglie, Jessica Jenkins; Alston, Brittny; Adcock, Audrey F.; Yang, Liju] N Carolina Cent Univ, BRITE, Dept Pharmaceut Sci, Durham, NC 27701 USA; [Yang, Chang; Ma, Lun; Chen, Wei] Univ Texas Arlington, Dept Phys, Arlington, TX 76019 USA	University of North Carolina; North Carolina Central University; University of Texas System; University of Texas Arlington	Yang, LJ (corresponding author), N Carolina Cent Univ, BRITE, Dept Pharmaceut Sci, Durham, NC 27701 USA.	lyang@nccu.edu			Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture (NIFA) [329 2011-68003-30395]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture (NIFA)	This study was supported by Agriculture and Food Research Initiative Competitive Grant no. 329 2011-68003-30395 from the USDA National Institute of Food and Agriculture (NIFA).	Addae E, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-11; Bae J, 2008, APPL ENVIRON MICROB, V74, P477, DOI 10.1128/AEM.02095-06; Bertrand I, 2012, J APPL MICROBIOL, V112, P1059, DOI 10.1111/j.1365-2672.2012.05267.x; Bozkurt H, 2014, J FOOD PROTECT, V77, P276, DOI 10.4315/0362-028X.JFP-13-289; Broglie JJ, 2014, J ANAL BIOANAL TECH, V5, P220; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Chang YN, 2012, MATERIALS, V5, P2850, DOI 10.3390/ma5122850; Citkowicz A, 2008, ANAL BIOCHEM, V376, P163, DOI 10.1016/j.ab.2008.02.011; Colvin RA, 2003, EUR J PHARMACOL, V479, P171, DOI 10.1016/j.ejphar.2003.08.067; Cromeans T, 2014, APPL ENVIRON MICROB, V80, P5743, DOI 10.1128/AEM.01532-14; Cuellar JL, 2010, J GEN VIROL, V91, P2449, DOI 10.1099/vir.0.021212-0; D'Souza DH, 2006, INT J FOOD MICROBIOL, V108, P84, DOI 10.1016/j.ijfoodmicro.2005.10.024; D'Souza DH, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P581; D'Souza DH, 2009, J FOOD PROTECT, V72, P2418, DOI 10.4315/0362-028X-72.11.2418; Duizer E, 2004, APPL ENVIRON MICROB, V70, P4538, DOI 10.1128/AEM.70.8.4538-4543.2004; El-Nahhal IM, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-14; England PH, 2014, PHE MONTHLY NAT 0710, P1; Escudero-Abarca BI, 2014, FOOD MICROBIOL, V41, P91, DOI 10.1016/j.fm.2014.01.009; Feng K, 2011, APPL ENVIRON MICROB, V77, P3507, DOI 10.1128/AEM.00081-11; Gajjar Priyanka, 2009, J Biol Eng, V3, P9, DOI 10.1186/1754-1611-3-9; Ganapathy R, 2013, IN VITRO TIME TEMPER; Girard M, 2010, J FOOD PROTECT, V73, P400, DOI 10.4315/0362-028X-73.2.400; Green KY, 2014, CLIN MICROBIOL INFEC, V20, P717, DOI 10.1111/1469-0691.12761; Grove SF, 2008, INNOV FOOD SCI EMERG, V9, P206, DOI 10.1016/j.ifset.2007.07.006; Hale A, 2000, J MED VIROL, V62, P99, DOI 10.1002/1096-9071(200009)62:1&lt;99::AID-JMV15&gt;3.0.CO;2-0; Hall AJ, 2011, MMWR, V60; Hardy ME, 1996, VIROLOGY, V217, P252, DOI 10.1006/viro.1996.0112; Herbst-Kralovetz M, 2010, EXPERT REV VACCINES, V9, P299, DOI [10.1586/erv.09.163, 10.1586/ERV.09.163]; Huang RZ, 2014, INT J FOOD MICROBIOL, V185, P1, DOI 10.1016/j.ijfoodmicro.2014.05.007; Ingle A, 2008, CURR NANOSCI, V4, P141, DOI 10.2174/157341308784340804; Ingle AP, 2014, APPL MICROBIOL BIOT, V98, P1001, DOI 10.1007/s00253-013-5422-8; Jensen AW, 1996, BIOORGAN MED CHEM, V4, P767, DOI 10.1016/0968-0896(96)00081-8; Kang S, 2008, LANGMUIR, V24, P6409, DOI 10.1021/la800951v; Kingsley DH, 2014, INT J FOOD MICROBIOL, V171, P94, DOI 10.1016/j.ijfoodmicro.2013.11.018; Kirking HL, 2010, CLIN INFECT DIS, V50, P1216, DOI 10.1086/651597; Koo HL, 2009, CLIN INFECT DIS, V49, P1069, DOI 10.1086/605558; Kornylo K, 2009, J TRAVEL MED, V16, P349, DOI 10.1111/j.1708-8305.2009.00344.x; Lakshmanan SB, 2012, J BIOMED NANOTECHNOL, V8, P883, DOI 10.1166/jbn.2012.1486; Lee JE, 2013, WATER RES, V47, P5607, DOI 10.1016/j.watres.2013.06.035; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Li XH, 2013, INT J FOOD MICROBIOL, V162, P37, DOI 10.1016/j.ijfoodmicro.2012.12.016; Liu PB, 2013, APPL ENVIRON MICROB, V79, P7875, DOI 10.1128/AEM.02576-13; Liu PB, 2009, FOOD ENVIRON VIROL, V1, P141, DOI 10.1007/s12560-009-9019-4; Lou FF, 2012, APPL ENVIRON MICROB, V78, P5320, DOI 10.1128/AEM.00532-12; Macinga DR, 2008, APPL ENVIRON MICROB, V74, P5047, DOI 10.1128/AEM.00487-08; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Manuel CS, 2015, APPL ENVIRON MICROB, V81, P4940, DOI 10.1128/AEM.00388-15; Mashino T, 1999, BIOORG MED CHEM LETT, V9, P2959, DOI 10.1016/S0960-894X(99)00515-6; Morter S, 2011, J HOSP INFECT, V77, P106, DOI 10.1016/j.jhin.2010.09.035; Narayan RJ, 2005, MAT SCI ENG B-SOLID, V123, P123, DOI 10.1016/j.mseb.2005.07.007; Park GW, 2014, J PHOTOCH PHOTOBIO B, V140, P315, DOI 10.1016/j.jphotobiol.2014.08.009; Park S, 2014, APPL ENVIRON MICROB, V80, P2343, DOI 10.1128/AEM.03427-13; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Pattenden LK, 2005, TRENDS BIOTECHNOL, V23, P523, DOI 10.1016/j.tibtech.2005.07.011; PRASAD BVV, 1994, J VIROL, V68, P5117, DOI 10.1128/JVI.68.8.5117-5125.1994; PUMPENS P, 2002, ARTIFICIAL DNA METHO, P249; Seo K, 2012, J FOOD PROTECT, V75, P533, DOI 10.4315/0362-028X.JFP-11-199; Shionoiri N, 2012, J BIOSCI BIOENG, V113, P580, DOI 10.1016/j.jbiosc.2011.12.006; Su XW, 2009, J FOOD PROTECT, V72, P2623, DOI 10.4315/0362-028X-72.12.2623; Tang YJJ, 2007, NANO LETT, V7, P754, DOI 10.1021/nl063020t; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Thornton SA, 2005, CLIN INFECT DIS, V40, P519, DOI 10.1086/427501; Tsao N, 2002, J ANTIMICROB CHEMOTH, V49, P641, DOI 10.1093/jac/49.4.641; Vimont A, 2015, APPL ENVIRON MICROB, V81, P2950, DOI 10.1128/AEM.03840-14; Wadl M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-30; Warnes SL, 2015, APPL ENVIRON MICROB, V81, P1085, DOI 10.1128/AEM.03280-14; Warnes SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075017; Wigginton KR, 2012, CURR OPIN VIROL, V2, P84, DOI 10.1016/j.coviro.2011.11.003; Yap J, 2012, SINGAP MED J, V53, P249; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	70	61	61	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0141050	10.1371/journal.pone.0141050	http://dx.doi.org/10.1371/journal.pone.0141050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474396	gold, Green Published, Green Submitted			2022-12-27	WOS:000363185500142
J	Liu, CE; Lu, Y; Yao, DS				Liu, Chai-e; Lu, Yan; Yao, De-Sheng			Feasibility and Safety of Video Endoscopic Inguinal Lymphadenectomy in Vulvar Cancer: A Systematic Review	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ABDOMINAL HYSTERECTOMY; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; NODE DISSECTION; SAPHENOUS-VEIN; RISK-FACTORS; COMPLICATIONS; LIPOSUCTION; VULVECTOMY	Objective To systematically review previous studies and to evaluate the feasibility and safety of video endoscopic inguinal lymphadenectomy (VEIL) in vulvar cancer. Methods We conducted a comprehensive review of studies published through September 2014 to retrieve all relevant articles. The PubMed, EMBASE, Web of Science, Cochrane Library, Wan Fang Data and Chinese National Knowledge Infrastructure databases were systematically searched for all relevant studies published in English or Chinese through September 2014. Data were abstracted independently by two reviewers, and any differences were resolved by consensus. Results A total of 9 studies containing 249 VEIL procedures involving 138 patients were reviewed. Of the 249 VEIL procedures, only 1 (0.4%) was converted to an open procedure for suturing because of injury to the femoral vein. The range of operative time was 62 to 110 minutes, and the range of estimated blood loss was 5.5 to 22 ml. The range of the number of harvested lymph nodes was 7.3 to 16. The length of hospital stay varied from 7 to 13.6 days across reports. The incidence of lymph node metastasis was 19.7% (27/138), and the recurrence rate was 4.3% (3/70) within 3 to 41 months of follow-up. One or more short-term complications were documented in 18 of 138 (13.0%) patients. Complications after VEIL were observed in 14 (10.13%) patients and in 15 (6.0%) of the VEIL cases, including major lymphocyst formation in 9 (3.6%), lymphorrhea in 2 (0.8%), inguinal wound infection without wound breakdown in 3 (1.2%) and lymphedema in 1 (0.4%). Conclusions VEIL appears to be a feasible procedure in the management of vulvar cancer. There may be potential benefits that result in lower morbidity compared to traditional methods, but this has yet to be objectively proven.	[Liu, Chai-e; Lu, Yan; Yao, De-Sheng] Guang Xi Med Univ, Dept Gynecol Oncol, Affiliated Tumor Hosp, Nanning, Peoples R China		Yao, DS (corresponding author), Guang Xi Med Univ, Dept Gynecol Oncol, Affiliated Tumor Hosp, Nanning, Peoples R China.	yaodesheng@gxmu.edu.cn			Guangxi Zhuang Autonomous Region, Health and Family Planning CommissioN [S201418-01]	Guangxi Zhuang Autonomous Region, Health and Family Planning CommissioN	This work was supported by a grant from the Guangxi Zhuang Autonomous Region, Health and Family Planning CommissioN. The grant numbers was [S201418-01]. The URLs is http://www.gxrkjsw.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiocchi G, 2014, CURR OPIN OBSTET GYN, V26, P9, DOI 10.1097/GCO.0000000000000033; Carramaschi F, 1999, INT J GYNECOL OBSTET, V65, P157, DOI 10.1016/S0020-7292(99)00016-8; Chen BL, 2014, CHIN J LAPAROSCOPIC, V3, P172; Chen Gaowen, 2014, Zhonghua Yi Xue Za Zhi, V94, P39; Cui Zeng-ying, 2013, Zhonghua Yi Xue Za Zhi, V93, P1653; de Hullu J A, 2005, Ned Tijdschr Geneeskd, V149, P336; Fotiou S. K., 1996, European Journal of Gynaecological Oncology, V17, P67; Gaarenstroom KN, 2003, INT J GYNECOL CANCER, V13, P522, DOI 10.1046/j.1525-1438.2003.13304.x; Garry R, 2004, BRIT MED J, V328, P129, DOI 10.1136/bmj.37984.623889.F6; Goel A, 2014, J UROLOGY, V191, pE394, DOI 10.1016/j.juro.2014.02.1245; Hassanzade M, 2013, GYNECOL ONCOL, V130, P237, DOI 10.1016/j.ygyno.2013.04.023; Hinten F, 2011, BRIT J CANCER, V105, P1279, DOI 10.1038/bjc.2011.407; Howick J, 2011, OXFORD CENT EVIDENCE; Huber D, 2012, GYNECOL SURG, V9, P175, DOI 10.1007/s10397-011-0704-6; Kluivers KB, 2007, J MINIM INVAS GYN, V14, P442, DOI 10.1016/j.jmig.2007.02.015; Levenback CF, 2008, J CLIN ONCOL, V26, P828, DOI 10.1200/JCO.2007.14.7124; Li FG, 2014, MODERN JOURNAL OF IN, V24, P2692; [刘青 Liu Qing], 2013, [中国内镜杂志, China Journal of Endoscopy], V19, P862; Lu Y, 2012, CHIN CLIN ONCOL, V3, P251; Malur S, 2001, GYNECOL ONCOL, V80, P239, DOI 10.1006/gyno.2000.6069; Mathevet P, TROCAR J GYNECOL SUR; Moore RG, 2008, GYNECOL ONCOL, V109, P65, DOI 10.1016/j.ygyno.2007.12.027; Naldini A, 2014, INT J SURG CASE REP, V5, P455, DOI 10.1016/j.ijscr.2014.05.011; Persson P, 2006, BJOG-INT J OBSTET GY, V113, P1023, DOI 10.1111/j.1471-0528.2006.01025.x; Raspagliesi F, 2000, ANN SURG ONCOL, V7, P738, DOI 10.1007/s10434-000-0738-x; Raspagliesi F, 2006, GYNECOL ONCOL, V102, P333, DOI 10.1016/j.ygyno.2005.12.027; Robison K, 2014, GYNECOL ONCOL, V133, P416, DOI 10.1016/j.ygyno.2014.03.010; Rouzier R, 2003, J AM COLL SURGEONS, V196, P442, DOI 10.1016/S1072-7515(02)01895-1; Schneider N, 2012, INT J GYNECOL OBSTET, V119, pS627; Senn B, 2010, INT J GYNECOL CANCER, V20, P646, DOI 10.1111/IGC.0b013e3181d92723; Shridharani SM, 2014, MED DEVICES-EVID RES, V7, P241, DOI 10.2147/MDER.S47322; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soliman AA, 2012, SCI WORLD J, DOI 10.1100/2012/341253; Sudhir R, 2012, INT J UROL, V19, P330; Sudhir R, 2012, INDIA J SURG ONCOL, V3, P257, DOI 10.1007/s13193-012-0164-0; Tabbal GN, 2013, PRS-GLOB OPEN, V1, DOI 10.1097/GOX.0000000000000007; Tang J, 2012, XINJIANG MED J, V12, P112; Thyavihally Y, 2013, J UROLOGY, V189, pE349, DOI 10.1016/j.juro.2013.02.418; Tobias-Machado Marcos, 2006, Archivos Espanoles de Urologia, V59, P849; Tobias-Machado M, 2011, J ENDOUROL, V25, P607, DOI 10.1089/end.2010.0269; Van der Zee AGJ, 2008, J CLIN ONCOL, V26, P884, DOI 10.1200/JCO.2007.14.0566; Vidaurreta J, 1999, GYNECOL ONCOL, V75, P366, DOI 10.1006/gyno.1999.5597; Wills A, 2013, GYNECOL ONCOL, V131, P467, DOI 10.1016/j.ygyno.2013.07.082; Woelber L, 2009, ANTICANCER RES, V29, P545; Wu Q, 2013, ASIAN PAC J CANCER P, V14, P7121, DOI 10.7314/APJCP.2013.14.12.7121; Xia HL, 2014, YIAYAO QIANYAN, V4, P210; Xu HC, 2011, J MINIM INVAS GYN, V18, P644, DOI 10.1016/j.jmig.2011.06.011; Zalewski K, 2013, INT J GYNECOL CANCER, V23, P1214; Zhang SH, 2000, CANCER-AM CANCER SOC, V89, P1520, DOI 10.1002/1097-0142(20001001)89:7<1520::AID-CNCR15>3.3.CO;2-E; Zhang XL, 2007, GYNECOL ONCOL, V105, P722, DOI 10.1016/j.ygyno.2007.02.011	50	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140873	10.1371/journal.pone.0140873	http://dx.doi.org/10.1371/journal.pone.0140873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496391	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200036
J	Gao, C; Liu, JM				Gao, Chao; Liu, Jiming			Uncovering Spatiotemporal Characteristics of Human Online Behaviors during Extreme Events	PLOS ONE			English	Article							EMERGENCE	In response to an extreme event, individuals on social media demonstrate interesting behaviors depending on their backgrounds. By making use of the large-scale datasets of posts and search queries collected from Twitter and GoogleTrends, we first identify the distinct categories of human collective online concerns and durations based on the distributions of solo tweets and new incremental tweets about events. Such a characterization enables us to gain a better understanding of dynamic changes in human behaviors corresponding to different types of events. Next, we observe the heterogeneity of individual responses to events through measuring the fraction of event-related tweets relative to the tweets released by an individual, and thus empirically confirm the heterogeneity assumption as adopted in the meta-population models for characterizing collective responses to events. Finally, based on the correlations of information entropy in different regions, we show that the observed distinct responses may be caused by their different speeds in information propagation. In addition, based on the detrended fluctuation analysis, we find that there exists a self-similar evolution process for the collective responses within a region. These findings have provided a detailed account for the nature of distinct human behaviors on social media in presence of extreme events.	[Gao, Chao] Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China; [Liu, Jiming] Hong Kong Baptist Univ, Dept Comp Sci, Kowloon Tong, Hong Kong, Peoples R China; [Gao, Chao] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun 130023, Peoples R China	Southwest University - China; Hong Kong Baptist University; Jilin University	Liu, JM (corresponding author), Hong Kong Baptist Univ, Dept Comp Sci, Kowloon Tong, Hong Kong, Peoples R China.	jiming@comp.hkbu.edu.hk						Abhik D, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P783; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Bollen J, 2011, ARTIF LIFE, V17, P237, DOI 10.1162/artl_a_00034; Boyle MP, 2004, JOURNALISM MASS COMM, V81, P155, DOI 10.1177/107769900408100111; Cai SM, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/68001; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Gao C., 2012, P 20 INT S METH INT, P125; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gong K, 2012, ACTA PHYS SIN-CH ED, V61, DOI 10.7498/aps.61.098901; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Hua T, 2013, COMPUTER, V46, P80, DOI 10.1109/MC.2013.442; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Kim M, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P753, DOI 10.1145/2567948.2579325; Kleinberg J, 2008, COMMUN ACM, V51, P66, DOI 10.1145/1400214.1400232; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Matsubara Y., 2012, P 18 ACM SIGKDD INT, P6, DOI 10.1145/2339530.2339537; Mendonca DJ, 2007, IEEE T SYST MAN CY A, V37, P547, DOI 10.1109/TSMCA.2007.897581; Middleton SE, 2014, IEEE INTELL SYST, V29, P9, DOI 10.1109/MIS.2013.126; Mills A., 2009, J INFORM PRIVACY SEC, V5, P3, DOI DOI 10.1080/15536548.2009.10855867; Myers Seth A., 2012, P 18 ACM SIGKDD INT, P33, DOI DOI 10.1145/2339530.2339540; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Radinsky Kira, 2012, P 21 INT C WORLD WID, P599, DOI [10.1145/2187836.2187918, DOI 10.1145/2187836.2187918]; Ribeiro B, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P653, DOI 10.1145/2566486.2567984; Rybski D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00560; Sakaki T, 2013, IEEE T KNOWL DATA EN, V25, P919, DOI 10.1109/TKDE.2012.29; Sano Y, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012805; Sasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061823; Shneiderman B, 2011, COMMUN ACM, V54, P34, DOI 10.1145/1995376.1995389; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Wei JC, 2009, J AM SOC INF SCI TEC, V60, P1741, DOI 10.1002/asi.21109; Weng L, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00335; Xu ZH, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P545, DOI 10.1145/2348283.2348358; Yang J., 2011, P 4 ACM INT C WEB SE, P177; Yin J, 2012, IEEE INTELL SYST, V27, P52, DOI 10.1109/MIS.2012.6; Zhao ZD, 2015, CHAOS, V25, DOI 10.1063/1.4922302; Zhao ZD, 2013, SCI REP-UK, V3, DOI 10.1038/srep03472; Zhao ZD, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/48004	42	4	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0138673	10.1371/journal.pone.0138673	http://dx.doi.org/10.1371/journal.pone.0138673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492043	gold, Green Published, Green Submitted			2022-12-27	WOS:000363249300003
J	Mat, S; Tan, PJ; Ng, CT; Fadzli, F; Rozalli, FI; Khoo, EM; Hill, KD; Tan, MP				Mat, Sumaiyah; Tan, Pey June; Ng, Chin Teck; Fadzli, Farhana; Rozalli, Faizatul I.; Khoo, Ee Ming; Hill, Keith D.; Tan, Maw Pin			Mild Joint Symptoms Are Associated with Lower Risk of Falls than Asymptomatic Individuals with Radiological Evidence of Osteoarthritis	PLOS ONE			English	Article							MUSCULOSKELETAL PAIN; OLDER-ADULTS; WOMEN; BALANCE; TRIALS; KNEE	Osteoarthritis (OA) exacerbates skeletal muscle functioning, leading to postural instability and increased falls risk. However, the link between impaired physical function, OA and falls have not been elucidated. We investigated the role of impaired physical function as a potential mediator in the association between OA and falls. This study included 389 participants [229 fallers (>= 2 falls or one injurious fall in the past 12 months), 160 non-fallers (no history of falls)], age (>= 65 years) from a randomized controlled trial, the Malaysian Falls Assessment and Intervention Trial (MyFAIT). Physical function was assessed using Timed Up and Go (TUG) and Functional Reach (FR) tests. Knee and hip OA were diagnosed using three methods: Clinical, Radiological and Self-report. OA symptom severity was assessed using the Western Ontario and McMaster Universities Arthritis Index (WOMAC). The total WOMAC score was categorized to asymptomatic, mild, moderate and severe symptoms. Individuals with radiological OA and 'mild' overall symptoms on the WOMAC score had reduced risk of falls compared to asymptomatic OA [OR: 0.402(0.172-0.940), p = 0.042]. Individuals with clinical OA and 'severe' overall symptoms had increased risk of falls compared to those with 'mild' OA [OR: 4.487(1.883-10.693), p = 0.005]. In individuals with radiological OA, mild symptoms appear protective of falls while those with clinical OA and severe symptoms have increased falls risk compared to those with mild symptoms. Both relationships between OA and falls were not mediated by physical limitations. Larger prospective studies are needed for further evaluation.	[Mat, Sumaiyah; Tan, Pey June; Ng, Chin Teck; Tan, Maw Pin] Univ Malaya, Fac Med, Ageing & Age Associated Disorders Res Grp, Kuala Lumpur, Malaysia; [Ng, Chin Teck] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore; [Fadzli, Farhana; Rozalli, Faizatul I.] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Khoo, Ee Ming] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Hill, Keith D.] Curtin Univ, Fac Hlth Sci, Sch Physiotherapy & Exercise Sci, Perth, WA 6845, Australia; [Tan, Maw Pin] Univ Malaya, Fac Med, Dept Med, Div Geriatr Med, Kuala Lumpur, Malaysia	Universiti Malaya; Singapore General Hospital; Universiti Malaya; Universiti Malaya; Curtin University; Universiti Malaya	Tan, MP (corresponding author), Univ Malaya, Fac Med, Ageing & Age Associated Disorders Res Grp, Kuala Lumpur, Malaysia.	mptan@ummc.edu.my	KHOO, EE MING/B-8785-2010; Hill, Keith D/L-6398-2017; FADZLI, FARHANA/B-8487-2010; Ng, Chin Teck/GRO-7239-2022; Fadzli, Farhana/AAB-5625-2022; Rozalli, Faizatul Izza/M-6349-2014; Tan, Maw Pin/G-6917-2011; Ng, Chin Teck/G-6276-2011; Tan, Pey June/W-7301-2019; Mat, Sumaiyah/O-5610-2017; Mat, Sumaiyah/AFY-9404-2022	KHOO, EE MING/0000-0003-3191-1264; Hill, Keith D/0000-0002-2191-0308; FADZLI, FARHANA/0000-0001-8276-5813; Ng, Chin Teck/0000-0002-6396-1701; Tan, Maw Pin/0000-0002-3400-8540; Ng, Chin Teck/0000-0002-6396-1701; Mat, Sumaiyah/0000-0003-4973-6986; 	University of Malaya Research Grant [UMRG-RP-010-2012C]; Ministry of Science, Technology and Innovation Science Fund [06-01-03-SF0834]; Ministry for Higher Education High Impact Research grant [UM.C/625/1/HIR-MOHE/ASH/02]	University of Malaya Research Grant; Ministry of Science, Technology and Innovation Science Fund(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Ministry for Higher Education High Impact Research grant	This work was supported by the University of Malaya Research Grant (grant number UMRG-RP010-2012C) and the Ministry of Science, Technology and Innovation Science Fund (grant number 06-01-03-SF0834), and a Ministry for Higher Education High Impact Research grant (grant number UM.C/625/1/HIR-MOHE/ASH/02). The funders of this study played no part in the design, data collection, data analysis or reporting of the study. They supplied funding for the salaries of SM and PJT, and for the purchase of equipment, consumables and transportation required for the conduct of the study.	Alencar MA, 2007, BRAZ J MED BIOL RES, V40, P277, DOI 10.1590/S0100-879X2006005000058; ARHP Research Committee, 2012, W ONT MCMASTER U OST; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Ng CT, 2013, AGE AGEING, V42, P561, DOI 10.1093/ageing/aft070; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Edwards MH, 2014, AGE AGEING, V43, P806, DOI 10.1093/ageing/afu068; Eggermont LHP, 2012, J AM GERIATR SOC, V60, P230, DOI 10.1111/j.1532-5415.2011.03829.x; Foley SJ, 2006, OSTEOARTHR CARTILAGE, V14, P533, DOI 10.1016/j.joca.2005.12.007; Ganasegeran K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/370273; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; Hill K, 1999, AUST NZ J PUBL HEAL, V23, P41, DOI 10.1111/j.1467-842X.1999.tb01203.x; Hinman RS, 2002, RHEUMATOLOGY, V41, P1388, DOI 10.1093/rheumatology/41.12.1388; Hootman JM, 2006, ARTHRITIS RHEUM-US, V54, P226, DOI 10.1002/art.21562; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Kraus VB, 2015, OSTEOARTHR CARTILAGE, V23, P1233, DOI 10.1016/j.joca.2015.03.036; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Leveille SG, 2009, JAMA-J AM MED ASSOC, V302, P2214, DOI 10.1001/jama.2009.1738; Mat S, 2015, AGE AGEING, V44, P16, DOI 10.1093/ageing/afu112; Muraki S, 2013, OSTEOPOROSIS INT, V24, P459, DOI 10.1007/s00198-012-1967-0; Nguyen USD, 2011, ARTHRITIS RHEUM-US, V63, pS314; Pandya NK, 2005, CLIN ORTHOP RELAT R, P150, DOI 10.1097/01.blo.0000150316.97009.f2; Tan PJ, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-78; Thomas JI, 2005, ARCH PHYS MED REHAB, V86, P1636, DOI 10.1016/j.apmr.2005.03.004; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Trivedi Madhukar H, 2004, Prim Care Companion J Clin Psychiatry, V6, P12; Veerapen K, 2007, J RHEUMATOL, V34, P207; WEINER DK, 1992, J AM GERIATR SOC, V40, P203, DOI 10.1111/j.1532-5415.1992.tb02068.x; Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]	31	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141368	10.1371/journal.pone.0141368	http://dx.doi.org/10.1371/journal.pone.0141368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491868	gold, Green Published, Green Submitted			2022-12-27	WOS:000363249300046
J	Bankapalli, LK; Mishra, RC; Singh, B; Raychaudhuri, S				Bankapalli, Leela Krishna; Mishra, Rahul Chandra; Singh, Balvinder; Raychaudhuri, Saumya			Identification of Critical Amino Acids Conferring Lethality in VopK, a Type III Effector Protein of Vibrio cholerae: Lessons from Yeast Model System	PLOS ONE			English	Article							BACTERIAL EFFECTOR; SACCHAROMYCES-CEREVISIAE; CATALYTIC TRIAD; WH2 DOMAINS; REVEALS; ACTIVATION; INHIBITION; EXPRESSION; KINASE; GENES	VopK, a type III effector protein, has been implicated in the pathogenesis of Vibrio cholerae strains belonging to diverse serogroups. Ectopic expression of this protein exhibits strong toxicity in yeast model system. In order to map critical residues in VopK, we scanned the primary sequence guided by available data on various toxins and effector proteins. Our in silico analysis of VopK indicated the presence of predicted MCF1-SHE (SHxxxE) serine peptidase domain at the C-terminus region of the protein. Substitution of each of the predicted catalytic triad residues namely Ser(314), His(353) and Glu(357) with alanine resulted in recombinant VopK proteins varying in lethality as evaluated in yeast model system. We observed that replacement of glutamate(357) to alanine causes complete loss in toxicity while substitutions of serine(314) and histidine(353) with alanine exhibited partial loss in toxicity without affecting the stability of variants. In addition, replacement of another conserved serine residue at position 354 (S-354) within predicted (SHE357)-H-314-E-353 did not affect toxicity of VopK. In essence, combined in silico and site directed mutagenesis, we have identified critical amino acids contributing to the lethal activity of VopK in yeast model system.	[Bankapalli, Leela Krishna; Mishra, Rahul Chandra; Singh, Balvinder; Raychaudhuri, Saumya] CSIR, Inst Microbial Technol, Div Mol Biol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raychaudhuri, S (corresponding author), CSIR, Inst Microbial Technol, Div Mol Biol, Chandigarh, India.	saumya@rocketmail.com	Raychaudhuri, Saumya/AFL-0368-2022	Bankapalli, Leelakrishna/0000-0002-3062-1778	supra institutional project [SIP-BSC0210E]; GENESIS-CSIR; Department of Biotechnology (DBT India); Council of Scientific and Industrial (CSIR-India) Research (project UNSEEN-CSIR);  [OLP-80]	supra institutional project; GENESIS-CSIR; Department of Biotechnology (DBT India)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial (CSIR-India) Research (project UNSEEN-CSIR); 	This work is supported by the grants from the institutional projects OLP-80, supra institutional project (SIP-BSC0210E) and GENESIS-CSIR. Leela Krishna Bankapalli and Rahul Chandra Mishra acknowledge the Department of Biotechnology (DBT India) and Council of Scientific and Industrial (CSIR-India) Research (project UNSEEN-CSIR) respectively for their fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwar S, 2015, CELL MICROBIOL; Alam A, 2011, INFECT IMMUN, V79, P1728, DOI 10.1128/IAI.01194-10; Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Belyi Y, 2012, J BIOL CHEM, V287, P26029, DOI 10.1074/jbc.M112.372672; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Calder T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104387; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Dean P, 2011, FEMS MICROBIOL REV, P1; Dongre M, 2011, J BIOL CHEM, V286, P15043, DOI 10.1074/jbc.M110.209346; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Gupta V, 2010, INT J BIOL MACROMOL, V46, P317, DOI 10.1016/j.ijbiomac.2010.01.011; Hakansson K, 2000, P NATL ACAD SCI USA, V97, P14097, DOI 10.1073/pnas.260376797; Irena A, 2014, CYTOTOXICITY VIBRIO; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Nimchuk ZL, 2007, MOL PLANT MICROBE IN, V20, P346, DOI 10.1094/MPMI-20-4-0346; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Parente JA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-292; Pernier J, 2013, NAT STRUCT MOL BIOL, V20, P1069, DOI 10.1038/nsmb.2639; Ruter C, 2014, FEMS MICROBIOL LETT, V351, P126, DOI 10.1111/1574-6968.12333; Salomon D, 2013, CELL HOST MICROBE, V14, P269, DOI 10.1016/j.chom.2013.07.008; Salomon D, 2012, MICROBIOL-SGM, V158, P2859, DOI 10.1099/mic.0.062513-0; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Shin OS, 2011, MBIO, V2, DOI 10.1128/mBio.00106-11; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Stirling FR, 2006, MICROBIOL-SGM, V152, P2273, DOI 10.1099/mic.0.28831-0; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Tam VC, 2010, MBIO, V1, DOI 10.1128/mBio.00289-10; Tripathi R, 2013, GENE, V525, P116, DOI 10.1016/j.gene.2013.04.071; Tripathi R, 2010, J MED MICROBIOL, V59, P17, DOI 10.1099/jmm.0.012336-0; Trosky JE, 2004, J BIOL CHEM, V279, P51953, DOI 10.1074/jbc.M407001200; Valdivia RH, 2004, EUKARYOT CELL, V3, P827, DOI 10.1128/EC.3.4.827-834.2004; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141038	10.1371/journal.pone.0141038	http://dx.doi.org/10.1371/journal.pone.0141038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488395	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400097
J	Li, M; Feng, JM				Li, Miao; Feng, Jianmeng			Biogeographical Interpretation of Elevational Patterns of Genus Diversity of Seed Plants in Nepal	PLOS ONE			English	Article							SPECIES RICHNESS PATTERNS; INCORPORATING SPATIAL AUTOCORRELATION; GEOMETRIC CONSTRAINTS; GLOBAL PATTERNS; GRADIENT; SCALE; DETERMINANTS; DENSITY; CLIMATE; ENERGY	This study tests if the biogeographical affinities of genera are relevant for explaining elevational plant diversity patterns in Nepal. We used simultaneous autoregressive (SAR) models to investigate the explanatory power of several predictors in explaining the diversity-elevation relationships shown in genera with different biogeographical affinities. Delta akaike information criterion (Delta AIC) was used for multi-model inferences and selections. Our results showed that both the total and tropical genus diversity peaked below the mid-point of the elevational gradient, whereas that of temperate genera had a nearly symmetrical, unimodal relationship with elevation. The proportion of temperate genera increased markedly with elevation, while that of tropical genera declined. Compared to tropical genera, temperate genera had wider elevational ranges and were observed at higher elevations. Water-related variables, rather than mid-domain effects (MDE), were the most significant predictors of elevational patterns of tropical genus diversity. The temperate genus diversity was influenced by energy availability, but only in quadratic terms of the models. Though climatic factors and mid-domain effects jointly explained most of the variation in the diversity of temperate genera with elevation, the former played stronger roles. Total genus diversity was most strongly influenced by climate and the floristic overlap of tropical and temperate floras, while the influences of mid-domain effects were relatively weak. The influences of water-related and energy-related variables may vary with biogeographical affinities. The elevational patterns may be most closely related to climatic factors, while MDE may somewhat modify the patterns. Caution is needed when investigating the causal factors underlying diversity patterns for large taxonomic groups composed of taxa of different biogeographical affinities. Right-skewed diversity-elevation patterns may be produced by the differential response of taxa with varying biogeographical affinities to climatic factors and MDE.	[Li, Miao; Feng, Jianmeng] Dali Univ, Dept Life Sci & Chem, Dali, Peoples R China	Dali University	Feng, JM (corresponding author), Dali Univ, Dept Life Sci & Chem, Dali, Peoples R China.	fjm@pku.org.cn			National Natural Scientific Foundation of China [31360143]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Scientific Foundation of China (No. 31360143).	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Acharya KP, 2011, J BIOGEOGR, V38, P1821, DOI 10.1111/j.1365-2699.2011.02511.x; [Anonymous], 2002, MODEL SELECTION MULT; Baniya CB, 2010, LICHENOLOGIST, V42, P83, DOI 10.1017/S0024282909008627; Beck J, 2008, J BIOGEOGR, V35, P1452, DOI 10.1111/j.1365-2699.2008.01886.x; Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; Bohner J, 2006, BOREAS, V35, P279, DOI 10.1080/03009480500456073; Bossio D.A., 2007, 122 IWMI, P45; Carpenter C, 2005, J BIOGEOGR, V32, P999, DOI 10.1111/j.1365-2699.2005.01249.x; Colwell RK, 2005, AM NAT, V166, pE149, DOI 10.1086/491689; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; Currie DJ, 2008, ECOL MONOGR, V78, P3, DOI 10.1890/06-1302.1; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Ding TS, 2005, GLOBAL ECOL BIOGEOGR, V14, P299, DOI 10.1111/j.1466-822x.2005.00159.x; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dobremez JF, 1976, NEPAL ECOLOGIE BIOGE, P1; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Guo QF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03007; Hagen T., 1969, DENCKSCHRIFT DESSCHW, V86, P1; Hawkins BA, 2005, AM NAT, V166, pE140, DOI 10.1086/491686; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Herzog SK, 2005, ECOGRAPHY, V28, P209, DOI 10.1111/j.0906-7590.2005.03935.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hua Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045601; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; Kessler M, 2011, GLOBAL ECOL BIOGEOGR, V20, P868, DOI 10.1111/j.1466-8238.2011.00653.x; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI [10.1111/j.1466-822X.2006.00223.x, 10.1111/j.1466-822x.2006.00223.x]; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kuhn I, 2007, DIVERS DISTRIB, V13, P66, DOI 10.1111/j.1472-4642.2006.00293.x; LATHAM RE, 1993, OIKOS, V67, P325, DOI 10.2307/3545479; Latham Roger Earl, 1993, P294; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Manandhar MS, 1999, EVOLUTION HIMALAYA, P13; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Messerli B, 1989, HIMALAYAN DILEMMA RE, P1; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Oommen MA, 2005, ECOLOGY, V86, P3039, DOI 10.1890/04-1837; Peng Hua, 1996, Acta Botanica Yunnanica, V18, P385; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Qian H, 1998, J BIOGEOGR, V25, P829, DOI 10.1046/j.1365-2699.1998.00247.x; Qian H, 2006, ANN BOT-LONDON, V98, P1073, DOI 10.1093/aob/mcl192; Qian H, 2009, ACTA OECOL, V35, P819, DOI 10.1016/j.actao.2009.08.009; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rowe R, 2009, ECOGRAPHY, V32, P411, DOI 10.1111/j.1600-0587.2008.05538.x; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Spehn EM, 2010, DATA MINING FOR GLOBAL TRENDS IN MOUNTAIN BIODIVERSITY, P1; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Wang YM, 2015, PALAEOGEOGR PALAEOCL, V417, P1, DOI 10.1016/j.palaeo.2014.10.028; Wang ZH, 2007, DIVERS DISTRIB, V13, P845, DOI 10.1111/j.1472-4642.2007.00335.x; Wang ZH, 2011, P ROY SOC B-BIOL SCI, V278, P2122, DOI 10.1098/rspb.2010.1897; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wilson E.O., 1975, P1; Wu C. Y., 1991, ACTA BOT YUNNANICA S, VIV, P1; Zhao SQ, 2006, GLOBAL ECOL BIOGEOGR, V15, P386, DOI 10.1111/j.1466-822x.2006.00236.x; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014; [No title captured]	70	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140992	10.1371/journal.pone.0140992	http://dx.doi.org/10.1371/journal.pone.0140992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488164	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400095
J	Neale, C; Johnston, P; Hughes, M; Scholey, A				Neale, Chris; Johnston, Patrick; Hughes, Matthew; Scholey, Andrew			Functional Activation during the Rapid Visual Information Processing Task in a Middle Aged Cohort: An fMRI Study	PLOS ONE			English	Article							SUSTAINED ATTENTION; PREFRONTAL CORTEX; WORKING-MEMORY; DEFAULT MODE; NICOTINE; PRECUNEUS; BRAIN; NETWORK; DISEASE; HUMANS	The Rapid Visual Information Processing (RVIP) task, a serial discrimination task where task performance believed to reflect sustained attention capabilities, is widely used in behavioural research and increasingly in neuroimaging studies. To date, functional neuroimaging research into the RVIP has been undertaken using block analyses, reflecting the sustained processing involved in the task, but not necessarily the transient processes associated with individual trial performance. Furthermore, this research has been limited to young cohorts. This study assessed the behavioural and functional magnetic resonance imaging (fMRI) outcomes of the RVIP task using both block and event-related analyses in a healthy middle aged cohort (mean age = 53.56 years, n = 16). The results show that the version of the RVIP used here is sensitive to changes in attentional demand processes with participants achieving a 43% accuracy hit rate in the experimental task compared with 96% accuracy in the control task. As shown by previous research, the block analysis revealed an increase in activation in a network of frontal, parietal, occipital and cerebellar regions. The event related analysis showed a similar network of activation, seemingly omitting regions involved in the processing of the task (as shown in the block analysis), such as occipital areas and the thalamus, providing an indication of a network of regions involved in correct trial performance. Frontal (superior and inferior frontal gryi), parietal (precuenus, inferior parietal lobe) and cerebellar regions were shown to be active in both the block and event-related analyses, suggesting their importance in sustained attention/vigilance. These networks and the differences between them are discussed in detail, as well as implications for future research in middle aged cohorts.	[Neale, Chris; Hughes, Matthew; Scholey, Andrew] Swinburne Univ, Ctr Human Psychopharmacol, Melbourne, Vic 3122, Australia; [Neale, Chris] Univ York, Stockholm Environm Inst, York YO10 5DD, N Yorkshire, England; [Johnston, Patrick] Univ York, Sch Psychol, York YO10 5DD, N Yorkshire, England; [Johnston, Patrick] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia	University of York - UK; University of York - UK; Queensland University of Technology (QUT)	Neale, C (corresponding author), Swinburne Univ, Ctr Human Psychopharmacol, Melbourne, Vic 3122, Australia.	chrisneale02@gmail.com	Neale, Christopher/O-3525-2018; Scholey, Andrew/GWV-0066-2022; Scholey, Andrew/C-5940-2015; Johnston, Patrick/P-3158-2014	Neale, Christopher/0000-0003-0478-3500; Scholey, Andrew/0000-0003-4484-5462; Johnston, Patrick/0000-0001-7703-1073; Hughes, Matthew/0000-0001-5057-5556	National Institute of Complementary Medicine (NICM) grant [1211024]	National Institute of Complementary Medicine (NICM) grant	This trial was sponsored by a National Institute of Complementary Medicine (NICM) grant (Grant number 1211024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2010, P NATL ACAD SCI USA, V107, P20110, DOI 10.1073/pnas.1011616107; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BAKAN P, 1959, BRIT J PSYCHOL, V50, P325, DOI 10.1111/j.2044-8295.1959.tb00711.x; Beaver JD, 2011, NEUROPSYCHOPHARMACOL, V36, P1792, DOI 10.1038/npp.2011.53; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Bray S, 2013, NEUROIMAGE, V82, P137, DOI 10.1016/j.neuroimage.2013.05.080; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Camfield DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082897; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Commodari E, 2008, AGING CLIN EXP RES, V20, P578; Cools R, 2002, BRAIN, V125, P584, DOI 10.1093/brain/awf052; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Esslinger C., 2012, HUMAN BRAIN MAPPING; Evans DE, 2009, ADDICT BIOL, V14, P32, DOI 10.1111/j.1369-1600.2008.00130.x; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fernandez-Corcuera P, 2012, J AFFECTIVE DISORDER; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hong LE, 2011, SCHIZOPHRENIA BULL, V37, P416, DOI 10.1093/schbul/sbp089; JONES GMM, 1992, PSYCHOPHARMACOLOGY, V108, P485, DOI 10.1007/BF02247426; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Karas G, 2007, NEURORADIOLOGY, V49, P967, DOI 10.1007/s00234-007-0269-2; Knott VJ, 2011, BIOL PSYCHOL, V88, P83, DOI 10.1016/j.biopsycho.2011.06.012; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lawrence NS, 2002, NEURON, V36, P539, DOI 10.1016/S0896-6273(02)01004-8; Lepski G, 2012, BRAZ J MED BIOL RES, V45, P763, DOI 10.1590/S0100-879X2012007500104; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mars RB, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00189; Mazaika PK, 2007, HUMAN BRAIN MAPPING; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; O'Reilly RC, 2010, TRENDS NEUROSCI, V33, P355, DOI 10.1016/j.tins.2010.05.002; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Phillis J. W., 2005, Critical Reviews in Neurobiology, V17, P161; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Samanez-Larkin GR, 2008, SOC COGN AFFECT NEUR, V3, P290, DOI 10.1093/scan/nsn029; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Sarter M, 2000, NEUROSCIENCE, V95, P933; Sreenivas S, 2012, NEUROSCI LETT, V506, P229, DOI 10.1016/j.neulet.2011.11.012; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; van Schouwenburg MR, 2012, J NEUROSCI, V32, P5631, DOI 10.1523/JNEUROSCI.6428-11.2012; WESNES K, 1984, PSYCHOPHARMACOLOGY, V82, P147, DOI 10.1007/BF00427761; WESNES K, 1983, NEUROPSYCHOBIOLOGY, V9, P223, DOI 10.1159/000117969	52	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0138994	10.1371/journal.pone.0138994	http://dx.doi.org/10.1371/journal.pone.0138994			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488289	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400015
J	Basheer, L; Schultz, K; Fichman, M; Kerem, Z				Basheer, Loai; Schultz, Keren; Fichman, Merav; Kerem, Zohar			Use of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by Stilbenes	PLOS ONE			English	Article							ACTIVITY-RELATIONSHIPS QSARS; DRUG-INTERACTION; STRUCTURAL BASIS; RESVERATROL; METABOLISM; RAT; ENZYMES; CYP3A4; PHARMACOKINETICS; BIOAVAILABILITY	CYP3A4 is recognized as the main enzyme involved in the metabolism of drugs and xenobiotics in the human body and its inhibition may lead to undesirable consequences. Stilbenes, including resveratrol, belong to a group of dietary health-promoting compounds that also act as inhibitors of CYP3A4. The aim of this study was to examine the use of computer modeling of enzyme-ligand interactions to analyze and predict the inhibition of structurally related compounds. To this end, an aldehyde group was attached to resveratrol and the interactions of CYP3A4 with resveratrol, its aldehyde analogue (RA) and a known synthetic inhibitor were studied and compared in two biological models. Specifically, the metabolism of testosterone was examined in a human intestine cell line (Caco-2/TC7) and in rat liver microsomes (RLM). The results demonstrated a weak inhibitory effect of RA on CYP3A4, as compared to resveratrol itself, in both biological models. Human CYP3A4 was more susceptible to inhibition than the commonly used model isozyme from rat. Modeling of the binding site of CYP3A4 revealed a combination of three types of interactions: hydrophobic interactions, electrostatic interactions and hydrogen bonds. A docking simulation revealed that the RA lacked an important binding feature, as compared to resveratrol, and that that difference may be responsible for its lower level of affinity for CYP3A4. Software analysis of binding affinity may serve as a predictive tool for designing new therapeutic compounds in terms of inhibition of CYP3A4 and help to reveal the biochemical nature of the interactions of dietary compounds, herbal compounds and drugs whose metabolism is mediated by this enzyme.	[Basheer, Loai; Schultz, Keren; Fichman, Merav; Kerem, Zohar] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Kerem, Z (corresponding author), Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	Zohar.kerem@mail.huji.ac.il			Nutrigenomics and Functional Foods Research Center at The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem	Nutrigenomics and Functional Foods Research Center at The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem	This research was partially funded by the Nutrigenomics and Functional Foods Research Center at The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem.	Amri A, 2012, J CONTROL RELEASE, V158, P182, DOI 10.1016/j.jconrel.2011.09.083; Andreadi C, 2014, AUTOPHAGY, V10, P524, DOI 10.4161/auto.27593; Awortwe C, 2014, J PHARM PHARM SCI, V17, P1, DOI 10.18433/J30K63; Balimane PV, 2000, J PHARMACOL TOXICOL, V44, P301, DOI 10.1016/S1056-8719(00)00113-1; Basheer L, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/854015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARO I, 1995, INT J PHARMACEUT, V116, P147, DOI 10.1016/0378-5173(94)00280-I; CARRIERE V, 1994, FEBS LETT, V355, P247, DOI 10.1016/0014-5793(94)01199-0; Caruso F, 2004, J AGR FOOD CHEM, V52, P7279, DOI 10.1021/jf048794e; Chan WK, 2000, LIFE SCI, V67, P3103, DOI 10.1016/S0024-3205(00)00888-2; Choi MH, 2005, DRUG METAB DISPOS, V33, P714, DOI 10.1124/dmd.104.003327; Chow HHS, 2010, CANCER PREV RES, V3, P1168, DOI 10.1158/1940-6207.CAPR-09-0155; Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd ed., P247, DOI DOI 10.1007/0-387-27447-2_7; Cousein E, 2007, PROG NEURO-PSYCHOPH, V31, P878, DOI 10.1016/j.pnpbp.2007.01.028; de Montellano PRO, 2008, DRUG METAB REV, V40, P405, DOI [10.1080/03602530802186439, 10.1080/03602530802186439 ]; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Detampel P, 2012, DRUG METAB REV, V44, P253, DOI 10.3109/03602532.2012.700715; Didziapetris R, 2010, J COMPUT AID MOL DES, V24, P891, DOI 10.1007/s10822-010-9381-1; Eagling VA, 1998, BRIT J CLIN PHARMACO, V45, P107, DOI 10.1046/j.1365-2125.1998.00679.x; Ekins S, 2001, DRUG METAB DISPOS, V29, P936; Ekins S, 2003, TRENDS PHARMACOL SCI, V24, P161, DOI 10.1016/S0165-6147(03)00049-X; Ekins S, 1999, J PHARMACOL EXP THER, V291, P424; Ekins S, 1999, J PHARMACOL EXP THER, V290, P429; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Ferguson CS, 2011, TRENDS PHARMACOL SCI, V32, P708, DOI 10.1016/j.tips.2011.08.005; Galetin A, 2010, DRUG METAB PHARMACOK, V25, P28, DOI 10.2133/dmpk.25.28; Gonzalez A, 2002, J EXP ZOOL, V293, P500, DOI 10.1002/jez.90005; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Handa K, 2013, DRUG METAB PHARMACOK, V28, P345, DOI 10.2133/dmpk.DMPK-12-RG-133; Hayes AW., 2007, PRINCIPLES METHODS T, V5th, DOI DOI 10.1093/nar/gkw124; Hong SP, 2008, CARDIOVASC THER, V26, P269, DOI 10.1111/j.1755-5922.2008.00060.x; Hu M, 1999, PHARM RES, V16; Huang XF, 2008, CHEM BIODIVERS, V5, P636, DOI 10.1002/cbdv.200890059; Ibrahim RB, 2000, LIFE SCI, V66, P1293, DOI 10.1016/S0024-3205(00)00436-7; Karlsson FH, 2013, DRUG METAB DISPOS, V41, P2033, DOI 10.1124/dmd.113.051664; Kubinyi H., 2005, RAPPORTI ISTISAN, V20, P171; Laurence C, 2009, J MED CHEM, V52, P4073, DOI 10.1021/jm801331y; Lewis DFV, 2007, J ENZYM INHIB MED CH, V22, P1, DOI 10.1080/14756360600952183; Lewis DFV, 2006, J ENZYM INHIB MED CH, V21, P127, DOI 10.1080/14756360500532747; Liang W-t, 2012, PHARM TODAY, V1, P009; Liu YJ, 2011, IEEE SYS MAN CYBERN, P2011, DOI 10.1109/ICSMC.2011.6083967; Marier JF, 2002, J PHARMACOL EXP THER, V302, P369, DOI 10.1124/jpet.102.033340; Morra G, 2010, CURR MED CHEM, V17, P25, DOI 10.2174/092986710789957797; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Paine MF, 2006, DRUG METAB DISPOS, V34, P880, DOI 10.1124/dmd.105.008672; Patrick G.L., 2013, INTRO MED CHEM, V5th; Pfrunder A, 2003, J PHARM PHARMACOL, V55, P59, DOI 10.1111/j.2042-7158.2003.tb02434.x; Piver B, 2001, TOXICOL LETT, V125, P83, DOI 10.1016/S0378-4274(01)00418-0; Poulos TL, 2014, CHEM REV, V114, P3919, DOI 10.1021/cr400415k; Regev-Shoshani G, 2004, BIOCHEM BIOPH RES CO, V323, P668, DOI 10.1016/j.bbrc.2004.08.141; Regev-Shoshani G, 2003, BIOCHEM J, V374, P157, DOI 10.1042/BJ20030141; Rhodes G., 2010, CRYSTALLOGRAPHY MADE; Rodeiro I, 2013, PHYTOTHER RES, V27, P745, DOI 10.1002/ptr.4782; Roy K, 2009, EXPERT OPIN DRUG MET, V5, P1245, DOI 10.1517/17425250903158940; Stiborova M, 2006, GEN PHYSIOL BIOPHYS, V25, P245; Topletz AR, 2013, DRUG METAB DISPOS, V41, P1651, DOI 10.1124/dmd.113.051094; Vaclavikova R, 2003, N-S ARCH PHARMACOL, V368, P200, DOI 10.1007/s00210-003-0781-9; Vuppugalla R, 2012, XENOBIOTICA, V42, P1058, DOI 10.3109/00498254.2012.684104; Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x; Wanwimolruk S, 2014, EXCLI J, V13, P347; Wegiel LA, 2013, J PHARM SCI-US, V102, P171, DOI 10.1002/jps.23358; Yasui-Furukori N, 2001, DRUG METAB DISPOS, V29, P1263; Yuki H, 2012, BIOORGAN MED CHEM, V20, P775, DOI 10.1016/j.bmc.2011.12.004; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483	66	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141061	10.1371/journal.pone.0141061	http://dx.doi.org/10.1371/journal.pone.0141061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485399	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100109
J	Lai, CT; Chang, QL; Tian, GH; Wang, JW; Yin, HX; Liu, W				Lai, Chuntao; Chang, Qinglin; Tian, Guohong; Wang, Jiawei; Yin, Hongxia; Liu, Wu			Lesion Activity on Brain MRI in a Chinese Population with Unilateral Optic Neuritis	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROMES; DEFINITE MULTIPLE-SCLEROSIS; FOLLOW-UP; TREATMENT TRIAL; DIAGNOSTIC-CRITERIA; RISK; GUIDELINES; EXPERIENCE; CONVERSION; CENTERS	Longitudinal studies have shown that brain white matter lesions are strong predictors of the conversion of unilateral optic neuritis to multiple sclerosis (MS) in Caucasian populations. Consequently brain MRI criteria have been developed to improve the prediction of the development of clinically definite multiple sclerosis (CDMS). In Asian populations, optic neuritis may be the first sign of classical or optic-spinal MS. These signs add to the uncertainty regarding brain MRI changes with respect to the course of unilateral optic neuritis. The aim of this study was to examine the association between brain lesion activity and conversion to CDMS in Chinese patients with unilateral optic neuritis. A small prospective cohort study of 40 consecutive Chinese patients who presented with unilateral optic neuritis was conducted. Brain lesion activity was recorded as the incidence of Gd-enhanced lesions and new T2 lesions. Brain lesions on MRI that were characteristic of MS were defined according to the 2010 revisions of the McDonald criteria. The primary endpoint was the development of CDMS. We found that nineteen patients (48%) had brain lesions that were characteristic of MS on the initial scan. One of these patients (3%) had Gd-enhanced brain lesions. A significantly lower percentage of the patients (10%, p<0.001) presented with new T2 brain lesions on the second scan. During a median of 5 years of follow-up, seven patients (18%) developed CDMS. There was no significant difference in the conversion rate to CDMS between patients with and without brain lesions that were characteristic of MS (4/19 and 3/21, respectively; Fisher exact test, one-sided, p = 0.44). We conclude that brain lesions characteristic of MS are common in Chinese patients with unilateral optic neuritis; however, these patients exhibit low lesion activity. The predictive value of brain lesion activity for CDMS requires investigation in additional patients.	[Lai, Chuntao; Tian, Guohong; Wang, Jiawei] Capital Med Univ, Beijing Tongren Hosp, Dept Neurol, Beijing, Peoples R China; [Chang, Qinglin; Yin, Hongxia] Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China; [Liu, Wu] Capital Med Univ, Beijing Tongren Hosp, Ophthalmol Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Lai, CT (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Neurol, Beijing, Peoples R China.	chuntaolai@yahoo.com	Yin, Hong/AAC-5784-2020; Tian, Guohong/AAF-2756-2020	Liu, Wu/0000-0001-7967-6924				Bakshi R, 2001, ARCH NEUROL-CHICAGO, V58, P742, DOI 10.1001/archneur.58.5.742; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; BECK RW, 1993, ARCH NEUROL-CHICAGO, V50, P841, DOI 10.1001/archneur.1993.00540080050013; Brodsky M, 1997, NEUROLOGY, V49, P1404; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Chong HT, 2009, MULT SCLER J, V15, P887, DOI 10.1177/1352458509104587; Collongues N, 2011, ARCH NEUROL-CHICAGO, V68, P918, DOI 10.1001/archneurol.2011.127; Du Y, 2011, J CLIN NEUROSCI, V18, P902, DOI 10.1016/j.jocn.2010.11.011; Korteweg T, 2006, LANCET NEUROL, V5, P221, DOI 10.1016/S1474-4422(06)70353-2; Lai CT, 2011, J NEUROL SCI, V305, P38, DOI 10.1016/j.jns.2011.03.021; Lim SA, 2009, ANN ACAD MED SINGAP, V38, P821; Lin YC, 2006, JPN J OPHTHALMOL, V50, P170, DOI 10.1007/s10384-005-0281-1; Nakashima I, 1999, TOHOKU J EXP MED, V188, P89, DOI 10.1620/tjem.188.89; O'Riordan JI, 1998, BRAIN, V121, P495, DOI 10.1093/brain/121.3.495; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rovira A, 2009, ARCH NEUROL-CHICAGO, V66, P587, DOI 10.1001/archneurol.2009.49; RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117; Simon JH, 2006, AM J NEURORADIOL, V27, P455; Swanton JK, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.073247; Swanton JK, 2006, J NEUROL NEUROSUR PS, V77, P1070, DOI 10.1136/jnnp.2006.090910; Swanton JK, 2010, MULT SCLER, V16, P156, DOI 10.1177/1352458509353650; Swanton JK, 2007, LANCET NEUROL, V6, P677, DOI 10.1016/S1474-4422(07)70176-X; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Wakakura M, 1999, JPN J OPHTHALMOL, V43, P127, DOI 10.1016/S0021-5155(98)00072-0; WEINSHENKER BG, 1991, BRAIN, V114, P1045, DOI 10.1093/brain/114.2.1045; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729	27	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141005	10.1371/journal.pone.0141005	http://dx.doi.org/10.1371/journal.pone.0141005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485719	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100101
J	Cheng, QJ; Chang, SS; Guo, YQ; Yip, PSF				Cheng, Qijin; Chang, Shu-Sen; Guo, Yingqi; Yip, Paul S. F.			Information Accessibility of the Charcoal Burning Suicide Method in Mainland China	PLOS ONE			English	Article							MEDIA GUIDELINES; HONG-KONG; RATES; PREVENTION; TAIWAN; TRENDS; IMPACT	Background There has been a marked rise in suicide by charcoal burning (CB) in some East Asian countries but little is known about its incidence in mainland China. We examined media-reported CB suicides and the availability of online information about the method in mainland China. Methods We extracted and analyzed data for i) the characteristics and trends of fatal and nonfatal CB suicides reported by mainland Chinese newspapers (1998-2014); ii) trends and geographic variations in online searches using keywords relating to CB suicide (2011-2014); and iii) the content of Internet search results. Results 109 CB suicide attempts (89 fatal and 20 nonfatal) were reported by newspapers in 13 out of the 31 provinces or provincial-level-municipalities in mainland China. There were increasing trends in the incidence of reported CB suicides and in online searches using CB-related keywords. The province-level search intensities were correlated with CB suicide rates (Spearman's correlation coefficient = 0.43 [95% confidence interval: 0.08-0.68]). Two-thirds of the web links retrieved using the search engine contained detailed information about the CB suicide method, of which 15% showed pro-suicide attitudes, and the majority (86%) did not encourage people to seek help. Limitations The incidence of CB suicide was based on newspaper reports and likely to be underestimated. Conclusions Mental health and suicide prevention professionals in mainland China should be alert to the increased use of this highly lethal suicide method. Better surveillance and intervention strategies need to be developed and implemented.	[Cheng, Qijin; Yip, Paul S. F.] Univ Hong Kong, HKJC Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Chang, Shu-Sen] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Behav & Community Sci, Taipei 10764, Taiwan; [Chang, Shu-Sen] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Guo, Yingqi; Yip, Paul S. F.] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; National Taiwan University; National Taiwan University; University of Hong Kong	Yip, PSF (corresponding author), Univ Hong Kong, HKJC Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.	sfpyip@hku.hk	Chang, Shu-Sen/AAH-6733-2021; Chang, Shu-Sen/B-3518-2012	Chang, Shu-Sen/0000-0001-5012-1132; Chang, Shu-Sen/0000-0001-5012-1132; Cheng, Qijin/0000-0002-6223-5345; Guo, Yingqi/0000-0002-3682-2917	University of Hong Kong Small Project [201309176175]; Fogarty International Center of US NIH [D43 TW009101]; Chiang Ching-kuo Foundation, Taiwan [RG014-P-12]; Strategic Public Policy Research Funding, Hong Kong [HKU 7003-SPPR-12]; FOGARTY INTERNATIONAL CENTER [D43TW009101] Funding Source: NIH RePORTER	University of Hong Kong Small Project(University of Hong Kong); Fogarty International Center of US NIH; Chiang Ching-kuo Foundation, Taiwan; Strategic Public Policy Research Funding, Hong Kong; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	QC's work was supported by The University of Hong Kong Small Project Funding (201309176175) and grant D43 TW009101 from the Fogarty International Center of US NIH. SSC was supported by the Chiang Ching-kuo Foundation, Taiwan (Grant number RG014-P-12). PSFY's work was supported by Strategic Public Policy Research Funding, Hong Kong (HKU 7003-SPPR-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CHINA DAILY; Biddle L, 2008, BRIT MED J, V336, P800, DOI 10.1136/bmj.39525.442674.AD; Biddle L, 2012, J AFFECT DISORDERS, V136, P702, DOI 10.1016/j.jad.2011.10.004; Bohanna I, 2012, CRISIS, V33, P190, DOI 10.1027/0227-5910/a000137; Chan KPM, 2005, BRIT J PSYCHIAT, V186, P67, DOI 10.1192/bjp.186.1.67; Chang SS, 2015, SOC PSYCH PSYCH EPID, V50, P1451, DOI 10.1007/s00127-015-1057-7; Chang SS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001622; Chang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000212; Chen X., 2004, ZHEJIANG SOC SCI, V6, P71; Chen YY, 2013, J PUBLIC HEALTH-UK, V35, P223, DOI 10.1093/pubmed/fds095; Chen YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055000, 10.1371/journal.pone.0059263]; Cheng QJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108724; Cheng QJ, 2014, CRISIS, V35, P74, DOI 10.1027/0227-5910/a000241; Cheng QJ, 2012, LANCET, V379, pE53, DOI 10.1016/S0140-6736(12)60856-3; Cheng QJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d2113; Cheng QJ, 2011, J CLIN PSYCHIAT, V72, P313, DOI 10.4088/JCP.09m05440blu; China Internet Network Information Center, 2014, 33 CHIN INT NETW INF; China Internet Network Information Center, 2014, STAT REP INT DEV CHI; Facebook Help Center, SUIC PREV; Florentine JB, 2010, SOC SCI MED, V70, P1626, DOI 10.1016/j.socscimed.2010.01.029; Fu KW, 2011, J EPIDEMIOL COMMUN H, V65, P928, DOI 10.1136/jech.2009.105650; Hagihara A, 2014, SOC PSYCH PSYCH EPID, V49, P221, DOI 10.1007/s00127-013-0741-8; Hagihara A, 2012, EUR ARCH PSY CLIN N, V262, P39, DOI 10.1007/s00406-011-0212-8; Incitez China, 2014, CHIN SEARCH ENG MARK; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Ji NJ, 2014, J KOREAN MED SCI, V29, P1174, DOI 10.3346/jkms.2014.29.8.1174; Lee DTS, 2002, ARCH GEN PSYCHIAT, V59, P293, DOI 10.1001/archpsyc.59.3.293; Li F, 2015, FORENSIC SCI INT, V253, P112, DOI 10.1016/j.forsciint.2015.06.007; Milian M, 2011, GOOGLE REFER SUICIDA; National Bureau of Statistics of the Peoples Republic of China, 2010, 2010 POP CENS PEOPL; Niederkrotenthaler T, 2012, J EPIDEMIOL COMMUN H, V66, P1037, DOI 10.1136/jech-2011-200707; Thomas K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-314; Tian L., 2009, J FORENSIC MED, V25, P306; Tsai CW, 2011, J AFFECT DISORDERS, V131, P402, DOI 10.1016/j.jad.2010.12.013; Twitter Help Center, DEAL SELF HARM SUIC; Wang CW, 2014, SOC PSYCH PSYCH EPID, V49, P929, DOI 10.1007/s00127-013-0789-5; World Health Organization, 2014, PREV SUIC PREV SUIC; Xinhua News Agency, 2014, LIV ONL SUIC RAIS CO; Yip PSF, 2013, J AFFECT DISORDERS, V148, P98, DOI 10.1016/j.jad.2012.11.056; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2; Zeng D., 2008, J FORENSIC MED, V24, P392	41	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140686	10.1371/journal.pone.0140686	http://dx.doi.org/10.1371/journal.pone.0140686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0DF	26474297	gold, Green Published			2022-12-27	WOS:000363185500081
J	Mustafa, RA; Wiercioch, W; Santesso, N; Cheung, A; Prediger, B; Baldeh, T; Carrasco-Labra, A; Brignardello-Petersen, R; Neumann, I; Bossuyt, P; Garg, AX; Lelgemann, M; Buhler, D; Brozek, J; Schunemann, HJ				Mustafa, Reem A.; Wiercioch, Wojtek; Santesso, Nancy; Cheung, Adrienne; Prediger, Barbara; Baldeh, Tejan; Carrasco-Labra, Alonso; Brignardello-Petersen, Romina; Neumann, Ignacio; Bossuyt, Patrick; Garg, Amit X.; Lelgemann, Monika; Buehler, Diedrich; Brozek, Jan; Schuenemann, Holger J.			Decision-Making about Healthcare Related Tests and Diagnostic Strategies: User Testing of GRADE Evidence Tables	PLOS ONE			English	Article							REVIEWS	Objective To develop guidance on what information to include and how to present it in tables summarizing the evidence from systematic reviews of test accuracy following the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Methods To design and refine the evidence tables, we used an iterative process based on the analysis of data from four rounds of discussions, feedback and user testing. During the final round, we conducted one-on-one user testing with target end users. We presented a number of alternative formats of evidence tables to participants and obtained information about users' understanding and preferences. Results More than 150 users participated in initial discussions and provided their formal and informal feedback. 20 users completed one-on-one user testing interviews. Almost all participants preferred summarizing the results of systematic reviews of test accuracy in tabular format rather than plain text. Users generally preferred less complex tables but found presenting sensitivity and specificity estimates only as too simplistic. Users found the presentation of test accuracy for several values of prevalence initially confusing but modifying table layout and adding sample clinical scenarios for each prevalence reduced this confusion. Providing information about clinical consequences of testing result was viewed as not feasible for authors of systematic reviews. Conclusion We present the current formats for tables presenting test accuracy following the GRADE approach. These tables can be developed using GRADEpro guidelines development tool (www.guidelinedevelopment.org or www.gradepro.org) and are being further developed into electronic interactive tables that will suit the needs of different end users. The formatting of these tables, and how they influence result interpretation and decision-making will be further evaluated in a randomized trial.	[Mustafa, Reem A.; Wiercioch, Wojtek; Santesso, Nancy; Baldeh, Tejan; Carrasco-Labra, Alonso; Neumann, Ignacio; Garg, Amit X.; Brozek, Jan; Schuenemann, Holger J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Mustafa, Reem A.] Univ Missouri, Dept Internal Med, Kansas City, MO USA; [Mustafa, Reem A.] Univ Missouri, Dept Biomed & Hlth Informat, Kansas City, MO USA; [Cheung, Adrienne] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Prediger, Barbara] Univ Freiburg, Ctr Med Biometry & Med Informat, D-79106 Freiburg, Germany; [Carrasco-Labra, Alonso; Brignardello-Petersen, Romina] Univ Chile, Fac Dent, Evidence Based Dent Unit, Santiago, Chile; [Brignardello-Petersen, Romina] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Neumann, Ignacio] Pontificia Univ Catolica Chile, Dept Internal Med, Santiago, Chile; [Bossuyt, Patrick] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Garg, Amit X.] Western Univ, Dept Med, London, ON, Canada; [Lelgemann, Monika] Kranken Kassen eV, Spitzenverbandes Bund, Med Dienst, D-45133 Essen, Germany; [Buehler, Diedrich] Abt Med GKV, D-10117 Berlin, Germany; [Brozek, Jan; Schuenemann, Holger J.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of British Columbia; University of Freiburg; Universidad de Chile; University of Toronto; Pontificia Universidad Catolica de Chile; University of Amsterdam; Academic Medical Center Amsterdam; Western University (University of Western Ontario); McMaster University	Schunemann, HJ (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	schuneh@mcmaster.ca	Garg, Amit X/G-3295-2011; Neumann, Ignacio/ABB-5013-2020; Bossuyt, Patrick M/AAR-1183-2021; Carrasco-Labra, Alonso/ABF-9555-2020; Wiercioch, Wojtek/AAQ-8087-2020; Bossuyt, Patrick M./B-4557-2016	Bossuyt, Patrick M/0000-0003-4427-0128; Carrasco-Labra, Alonso/0000-0003-3546-3526; Wiercioch, Wojtek/0000-0001-6576-1650; Bossuyt, Patrick M./0000-0003-4427-0128; Prediger, Barbara/0000-0002-2012-7549; Schunemann, Holger/0000-0003-3211-8479; Baldeh, Tejan/0000-0001-9194-3319	German Insurance Fund agency; Methods Innovation Fund from the Cochrane Collaboration	German Insurance Fund agency; Methods Innovation Fund from the Cochrane Collaboration	This work was partially funded by the German Insurance Fund agency as part of a larger project about decision-making for healthcare related tests and diagnostic strategies. It was also partially funded by a Methods Innovation Fund from the Cochrane Collaboration. The views presented here are those of the authors and should not be attributed to the funding agency or its staff.	[Anonymous], 2011, AUT REAL TIM NUCL AC; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Glenton C, 2010, MED DECIS MAKING, V30, P566, DOI 10.1177/0272989X10375853; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P158, DOI 10.1016/j.jclinepi.2012.01.012; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P173, DOI 10.1016/j.jclinepi.2012.08.001; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Mustafa RAW, DECISION MAKING HEAL; Rosenbaum SE, 2010, J CLIN EPIDEMIOL, V63, P620, DOI 10.1016/j.jclinepi.2009.12.014; Rosenbaum SE, 2010, J CLIN EPIDEMIOL, V63, P607, DOI 10.1016/j.jclinepi.2009.12.013; Schunemann Holger J, 2008, Evid Based Med, V13, P162, DOI 10.1136/ebm.13.6.162-a; Tiselius HG, 2012, GUIDELINES UROLITHIA; Vandvik PO, 2012, J CLIN EPIDEMIOL, V65, P748, DOI 10.1016/j.jclinepi.2011.11.013; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM	13	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0134553	10.1371/journal.pone.0134553	http://dx.doi.org/10.1371/journal.pone.0134553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474310	gold, Green Published, Green Submitted			2022-12-27	WOS:000363185500001
J	Tsu, BV; Saier, MH				Tsu, Brian V.; Saier, Milton H., Jr.			The LysE Superfamily of Transport Proteins Involved in Cell Physiology and Pathogenesis	PLOS ONE			English	Article							WEB-BASED PROGRAM; ESCHERICHIA-COLI; PHYLOGENETIC CHARACTERIZATION; TRANSMEMBRANE TOPOLOGY; RESISTANCE; PREDICTION; FAMILY; AMPHIPATHICITY; HOMEOSTASIS; HYDROPATHY	The LysE superfamily consists of transmembrane transport proteins that catalyze export of amino acids, lipids and heavy metal ions. Statistical means were used to show that it includes newly identified families including transporters specific for (1) tellurium, (2) iron/lead, (3) manganese, (4) calcium, (5) nickel/cobalt, (6) amino acids, and (7) peptidoglycolipids as well as (8) one family of transmembrane electron carriers. Internal repeats and conserved motifs were identified, and multiple alignments, phylogenetic trees and average hydropathy, amphipathicity and similarity plots provided evidence that all members of the superfamily derived from a single common 3-TMS precursor peptide via intragenic duplication. Their common origin implies that they share common structural, mechanistic and functional attributes. The transporters of this superfamily play important roles in ionic homeostasis, cell envelope assembly, and protection from excessive cytoplasmic heavy metal/metabolite concentrations. They thus influence the physiology and pathogenesis of numerous microbes, being potential targets of drug action.	[Tsu, Brian V.; Saier, Milton H., Jr.] Univ Calif San Diego, Div Biol Sci, Dept Mol Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Saier, MH (corresponding author), Univ Calif San Diego, Div Biol Sci, Dept Mol Biol, La Jolla, CA 92093 USA.	msaier@ucsd.edu		Saier, Milton/0000-0001-5530-0017; Tsu, Brian/0000-0003-0268-8323	National Institutes of Health [GM077402]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (http://grants.nih.gov/grants/oer.htm), Grant #: GM077402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahane S, 2003, J BIOCHEM, V133, P173, DOI 10.1093/jb/mvg021; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BRENNER S, 1987, NATURE, V329, P496; Burian J, 1998, FOLIA MICROBIOL, V43, P589, DOI 10.1007/BF02816374; Chen JS, 2011, J MOL MICROB BIOTECH, V21, P83, DOI 10.1159/000334611; Crupper SS, 1999, J BACTERIOL, V181, P4071, DOI 10.1128/JB.181.13.4071-4075.1999; Debut AJ, 2006, J MOL MICROB BIOTECH, V11, P1, DOI 10.1159/000092814; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Denoncin K, 2013, ANTIOXID REDOX SIGN, V19, P63, DOI 10.1089/ars.2012.4864; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; DOOLITTLE RF, 1981, SCIENCE, V214, P149, DOI 10.1126/science.7280687; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Haier B, 2001, FUNKTIONELLE ANAL LY, P83; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaur G, 2014, J BACTERIOL, V196, P2587, DOI 10.1128/JB.01717-14; Kimball RA, 2003, J MOL MICROB BIOTECH, V5, P133, DOI 10.1159/000070263; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KUAN J, 1993, CRIT REV BIOCHEM MOL, V28, P209, DOI 10.3109/10409239309086795; Kunji ERS, 2010, CURR OPIN STRUC BIOL, V20, P440, DOI 10.1016/j.sbi.2010.06.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee A, 2014, MICROBIOL-SGM, V160, P1679, DOI 10.1099/mic.0.077776-0; Marrero J, 2007, MICROB ECOL, V53, P123, DOI 10.1007/s00248-006-9152-7; McDermottt PF, 2008, ANTIMICROB AGENTS CH, V52, P382, DOI 10.1128/AAC.00930-07; Page Roderic D M, 2002, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0602s01; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Reddy BL, 2013, BBA-BIOMEMBRANES, V1828, P2654, DOI 10.1016/j.bbamem.2013.07.004; Reddy VS, 2012, FEBS J, V279, P2036, DOI 10.1111/j.1742-4658.2012.08590.x; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Sonden B, 2005, MOL MICROBIOL, V58, P426, DOI 10.1111/j.1365-2958.2005.04847.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vastermark A, 2014, PROTEINS, V82, P2797, DOI 10.1002/prot.24643; Vrljic M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P327; Waters LS, 2011, J BACTERIOL, V193, P5887, DOI 10.1128/JB.05872-11; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Yen MR, 2010, METHODS MOL BIOL, V637, P47, DOI 10.1007/978-1-60761-700-6_3; Yen MR, 2009, J MOL MICROB BIOTECH, V17, P163, DOI 10.1159/000239667; Zakataeva NP, 1999, FEBS LETT, V452, P228, DOI 10.1016/S0014-5793(99)00625-0; Zhai YF, 2002, J MOL MICROB BIOTECH, V4, P375; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P501; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P285	46	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0137184	10.1371/journal.pone.0137184	http://dx.doi.org/10.1371/journal.pone.0137184			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474485	Green Published, gold			2022-12-27	WOS:000363185500003
J	Gunewardena, SS; Yoo, B; Peng, L; Lu, H; Zhong, XB; Klaassen, CD; Cui, JY				Gunewardena, Sumedha S.; Yoo, Byunggil; Peng, Lai; Lu, Hong; Zhong, Xiaobo; Klaassen, Curtis D.; Cui, Julia Yue			Deciphering the Developmental Dynamics of the Mouse Liver Transcriptome	PLOS ONE			English	Article							MESSENGER-RNA ABUNDANCE; ALTERNATIVE TRANSCRIPTS; DRUG-METABOLISM; GENE-EXPRESSION; BILE-ACIDS; ONTOGENY; SEQ; CHILDREN; QUANTIFICATION; PHARMACOLOGY	During development, liver undergoes a rapid transition from a hematopoietic organ to a major organ for drug metabolism and nutrient homeostasis. However, little is known on a transcriptome level of the genes and RNA-splicing variants that are differentially regulated with age, and which up-stream regulators orchestrate age-specific biological functions in liver. We used RNA-Seq to interrogate the developmental dynamics of the liver transcriptome in mice at 12 ages from late embryonic stage (2-days before birth) to maturity (60-days after birth). Among 21,889 unique NCBI RefSeq-annotated genes, 9,641 were significantly expressed in at least one age, 7,289 were differently regulated with age, and 859 had multiple (> = 2) RNA splicing-variants. Factor analysis showed that the dynamics of hepatic genes fall into six distinct groups based on their temporal expression. The average expression of cytokines, ion channels, kinases, phosphatases, transcription regulators and translation regulators decreased with age, whereas the average expression of peptidases, enzymes and transmembrane receptors increased with age. The average expression of growth factors peak between Day-3 and Day-10, and decrease thereafter. We identified critical biological functions, upstream regulators, and putative transcription modules that seem to govern age-specific gene expression. We also observed differential ontogenic expression of known splicing variants of certain genes, and 1,455 novel splicing isoform candidates. In conclusion, the hepatic ontogeny of the transcriptome ontogeny has unveiled critical networks and up-stream regulators that orchestrate age-specific biological functions in liver, and suggest that age contributes to the complexity of the alternative splicing landscape of the hepatic transcriptome.	[Gunewardena, Sumedha S.] Univ Kansas, Med Ctr, Dept Biostat, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Yoo, Byunggil] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Peng, Lai; Zhong, Xiaobo] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Lu, Hong] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Klaassen, Curtis D.; Cui, Julia Yue] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital; University of Connecticut; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Washington; University of Washington Seattle	Gunewardena, SS (corresponding author), Univ Kansas, Med Ctr, Dept Biostat, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA.	sgunewardena@kumc.edu; juliacui@uw.edu			National Institute of Environmental Health Sciences (NIEHS) [ES-019487]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Environmental Health Sciences (NIEHS: http://www.niehs.nih.gov/) [grant number ES-019487; CDK XZ HL].	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; BANNISTER P, 1986, BMJ-BRIT MED J, V293, P1191, DOI 10.1136/bmj.293.6556.1191; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Cash WJ, 2010, QJM-INT J MED, V103, P9, DOI 10.1093/qjmed/hcp152; Collier JD, 2002, GUT, V50, P1; Cordeiro A, 2013, J ENDOCRINOL, V216, pR47, DOI 10.1530/JOE-12-0542; Csanaky IL, 2011, HEPATOLOGY, V53, P272, DOI 10.1002/hep.23984; Cui JY, 2012, TOXICOL SCI, V127, P592, DOI 10.1093/toxsci/kfs107; Davidson E, 2005, P NATL ACAD SCI USA, V102, P4935, DOI 10.1073/pnas.0502024102; Davidson EH, 2006, REGULATORY GENOME GE, Vxi; DURBIN J, 1971, BIOMETRIKA, V58, P1; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Ginsberg G, 2004, TOXICOL APPL PHARM, V198, P164, DOI 10.1016/j.taap.2003.10.010; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hata S, 2007, DEV GROWTH DIFFER, V49, P163, DOI 10.1111/j.1440-169x.2007.00910.x; Hines RN, 2002, J PHARMACOL EXP THER, V300, P355, DOI 10.1124/jpet.300.2.355; Hines RN, 2008, PHARMACOL THERAPEUT, V118, P250, DOI 10.1016/j.pharmthera.2008.02.005; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Isaksson OGP, 2001, HORM RES, V55, P18, DOI 10.1159/000063468; Kaakkola S, 2000, DRUGS, V59, P1233, DOI 10.2165/00003495-200059060-00004; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KOPIN IJ, 1994, J NEURAL TRANSM-SUPP, P57; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-33; Leeder JS, 2005, J PHARMACOL EXP THER, V314, P626, DOI 10.1124/jpet.105.086504; Levy P, 2010, METAB SYNDR RELAT D, V8, pS9, DOI 10.1089/met.2010.0087; Li JJ, 2011, P NATL ACAD SCI USA, V108, P19867, DOI 10.1073/pnas.1113972108; Li TT, 2009, GENOMICS, V93, P235, DOI 10.1016/j.ygeno.2008.10.006; Lu H, 2012, EPIGENETICS-US, V7, P914, DOI 10.4161/epi.21113; Maes M, 1997, Pediatr Transplant, V1, P171; Mak HC, 2011, NAT BIOTECHNOL, V29, P45, DOI 10.1038/nbt0111-45b; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; MARIE S, 1989, BIOCHIM BIOPHYS ACTA, V1009, P221, DOI 10.1016/0167-4781(89)90106-1; McLin Valerie A, 2006, Clin Liver Dis, V10, P1, DOI 10.1016/j.cld.2005.10.002; Miceli V, 2011, OMICS, V15, P313, DOI 10.1089/omi.2010.0108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullany LK, 2008, CELL CYCLE, V7, P2215, DOI 10.4161/cc.7.14.6274; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Naspitz CK, 2010, PEDIATR ALLERGY IMMU, V21, P249, DOI 10.1111/j.1399-3038.2010.01044.x; NATHANSON MH, 1991, HEPATOLOGY, V14, P551, DOI 10.1002/hep.1840140324; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pellanda H, 2012, INT J BIOCHEM CELL B, V44, P385, DOI 10.1016/j.biocel.2011.11.014; Peng L, 2012, DRUG METAB DISPOS, V40, P1198, DOI 10.1124/dmd.112.045088; PETERS T, 1987, CLIN CHEM, V33, P1317; Prawitt J, 2011, CURR DIABETES REP, V11, P160, DOI 10.1007/s11892-011-0187-x; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sasaki K, 2000, ARCH HISTOL CYTOL, V63, P137, DOI 10.1679/aohc.63.137; Sharov AA, 2005, GENOME RES, V15, P748, DOI 10.1101/gr.3269805; SHIRKEY HC, 1970, SOUTHERN MED J, V63, P1361; Sjogren K, 2001, DIABETES, V50, P1539, DOI 10.2337/diabetes.50.7.1539; STEWART SM, 1988, PEDIATRICS, V82, P167; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; Suzuki T, 2012, J DIABETES COMPLICAT, V26, P34, DOI 10.1016/j.jdiacomp.2011.11.008; TATA F, 1985, HUM GENET, V69, P345, DOI 10.1007/BF00291654; Tauer Carol, 2003, Bioeth Exam, V7, P1; Torres-Padilla ME, 2001, MECH DEVELOP, V109, P183, DOI 10.1016/S0925-4773(01)00521-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vyhlidal CA, 2006, DRUG METAB DISPOS, V34, P131, DOI 10.1124/dmd.105.005967; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wei CY, 2012, HUM MOL GENET, V21, pR58, DOI 10.1093/hmg/dds341; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114	71	23	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141220	10.1371/journal.pone.0141220	http://dx.doi.org/10.1371/journal.pone.0141220			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496202	Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200079
J	Xie, LJ; Man, E; Cheung, PT; Cheung, YF				Xie, Lijian; Man, Elim; Cheung, Pik-to; Cheung, Yiu-fai			Myocardial Integrated Backscatter in Obese Adolescents: Associations with Measures of Adiposity and Left Ventricular Deformation	PLOS ONE			English	Article							CORONARY PERIVASCULAR FIBROSIS; DISEASE RISK-FACTORS; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; CHILDREN; ECHOCARDIOGRAPHY; PATHOPHYSIOLOGY; DYSFUNCTION; MARKERS; STRAIN	Background Myocardial fibrosis has been proposed to play an important pathogenetic role in left ventricular (LV) dysfunction in obesity. This study tested the hypothesis that calibrated integrated backscatter (cIB) as a marker of myocardial fibrosis is altered in obese adolescents and explored its associations with adiposity, LV myocardial deformation, and metabolic parameters. Methods/Principal Findings Fifty-two obese adolescents and 38 non-obese controls were studied with conventional and speckle tracking echocardiography. The average cIB of ventricular septum and LV posterior wall was measured. In obese subjects, insulin resistance as estimated by homeostasis model assessment (HOMA-IR) and glucose tolerance were determined. Compared with controls, obese subjects had significantly greater cIB of ventricular septum (-16.8 +/- 7.8 dB vs -23.2 +/- 7.8 dB, p<0.001), LV posterior wall (-20.5 +/- 5.6 dBvs -25.0 +/- 5.1 dB, p<0.001) and their average (-18.7 +/- 5.7 dB vs -24.1 +/- 5.0 dB, p<0.001). For myocardial deformation, obese subjects had significantly reduced LV longitudinal systolic strain rate (SR) (p = 0.045) and early diastolic SR (p = 0.015), and LV circumferential systolic strain (p = 0.008), but greater LV longitudinal late diastolic SR (p<0.001), and radial early (p = 0.037) and late (p = 0.002) diastolic SR than controls. For the entire cohort, myocardial cIB correlated positively with body mass index (r = 0.45, p<0.001) and waist circumference (r = 0.45, p<0.001), but negatively with LV circumferential systolic strain (r = -0.23, p = 0.03) and systolic SR (r = -0.25, p = 0.016). Among obese subjects, cIB tended to correlate with HOMA-IR (r = 0.26, p = 0.07). Conclusion Obese adolescents already exhibit evidence of increased myocardial fibrosis, which is associated with measures of adiposity and impaired LV circumferential myocardial deformation.	[Xie, Lijian] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai 200030, Peoples R China; [Xie, Lijian; Man, Elim; Cheung, Pik-to; Cheung, Yiu-fai] Univ Hong Kong, Dept Paediat & Adolescent Med, Queen Mary Hosp, Hong Kong, Peoples R China	Shanghai Jiao Tong University; University of Hong Kong	Cheung, YF (corresponding author), Univ Hong Kong, Dept Paediat & Adolescent Med, Queen Mary Hosp, Hong Kong, Peoples R China.	xfcheung@hku.hk	Cheung, Yiu Fai/C-4240-2009	Cheung, Yiu Fai/0000-0002-7279-4992				Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Aurigemma GP, 2013, CIRC-CARDIOVASC IMAG, V6, P142, DOI 10.1161/CIRCIMAGING.111.964627; Barbosa JAA, 2013, EUR HEART J-CARD IMG, V14, P882, DOI 10.1093/ehjci/jes294; Caprio S, 2008, DIABETES CARE, V31, P2211, DOI 10.2337/dc08-9024; Cavalera M, 2014, TRANSL RES, V164, P323, DOI 10.1016/j.trsl.2014.05.001; Cheung YF, 2014, KOREAN CIRC J, V44, P59, DOI 10.4070/kcj.2014.44.2.59; Cheung YF, 2010, HEART, V96, P1137, DOI 10.1136/hrt.2010.194118; Chirinos JA, 2010, HYPERTENSION, V56, P91, DOI 10.1161/HYPERTENSIONAHA.110.150250; Chirinos JA, 2009, HYPERTENSION, V54, P558, DOI 10.1161/HYPERTENSIONAHA.109.131870; Cittadini A, 1999, CIRCULATION, V100, P2177, DOI 10.1161/01.CIR.100.21.2177; Dai ZH, 2012, J CARDIOL, V60, P416, DOI 10.1016/j.jjcc.2012.06.009; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Di Salvo G, 2008, J AM SOC ECHOCARDIOG, V21, P151, DOI 10.1016/j.echo.2007.05.028; Fesinmeyer MD, 2013, OBESITY, V21, P835, DOI 10.1002/oby.20268; Forsey J, 2013, ECHOCARDIOGR-J CARD, V30, P447, DOI 10.1111/echo.12131; Hayden MR, 2011, CARDIORENAL MED, V1, P75, DOI 10.1159/000327022; Jellis C, 2011, CIRC-CARDIOVASC IMAG, V4, P693, DOI 10.1161/CIRCIMAGING.111.963587; Katzmarzyk PT, 2004, PEDIATRICS, V114, P198; Kosmala W, 2008, INT J OBESITY, V32, P763, DOI 10.1038/sj.ijo.0803794; Kosmala W, 2013, HEART, V99, P320, DOI 10.1136/heartjnl-2012-303329; Kosmala W, 2012, EUR HEART J-CARD IMG, V13, P459, DOI 10.1093/ejechocard/jer291; Labombarda F, 2013, EUR HEART J-CARD IMG, V14, P668, DOI 10.1093/ehjci/jes238; Leonardi B, 2010, PEDIATR CARDIOL, V31, P766, DOI 10.1007/s00246-010-9694-9; Leopoldo AS, 2010, CAN J CARDIOL, V26, P423, DOI 10.1016/S0828-282X(10)70440-2; Martinez-Martinez E, 2014, J HYPERTENS, V32, P1104, DOI 10.1097/HJH.0000000000000149; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ng ACT, 2012, CIRC-CARDIOVASC IMAG, V5, P51, DOI 10.1161/CIRCIMAGING.111.965608; Perez J E, 1994, Am J Card Imaging, V8, P106; Peterson LR, 2004, J AM COLL CARDIOL, V43, P1399, DOI 10.1016/j.jacc.2003.10.062; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Quilliot D, 2005, INT J OBESITY, V29, P1321, DOI 10.1038/sj.ijo.0803022; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Shah AM, 2012, CIRCULATION, V125, pE244, DOI 10.1161/CIRCULATIONAHA.111.086348; Shah RV, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000279; Taniguchi K, 2000, CLIN CARDIOL, V23, P608, DOI 10.1002/clc.4960230812; TRIVEDI P, 1991, PEDIATR RES, V30, P276, DOI 10.1203/00006450-199109000-00016; Vogel M, 2002, CIRCULATION, V105, P1693, DOI 10.1161/01.CIR.0000013773.67850.BA; Yu W, 2013, EUR HEART J-CARD IMG, V14, P175, DOI 10.1093/ehjci/jes143; Zaman AKMT, 2004, J MOL CELL CARDIOL, V37, P525, DOI 10.1016/j.yjmcc.2004.05.006	41	4	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141149	10.1371/journal.pone.0141149	http://dx.doi.org/10.1371/journal.pone.0141149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492195	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300032
J	Bandau, F; Decker, VHG; Gundale, MJ; Albrectsen, BR				Bandau, Franziska; Decker, Vicki Huizu Guo; Gundale, Michael J.; Albrectsen, Benedicte Riber			Genotypic Tannin Levels in Populus tremula Impact the Way Nitrogen Enrichment Affects Growth and Allocation Responses for Some Traits and Not for Others	PLOS ONE			English	Article							NUTRIENT AVAILABILITY; SECONDARY CHEMISTRY; ECOSYSTEM GENETICS; FOLIAR CHEMISTRY; CLONAL VARIATION; ASPEN; COMMUNITY; DEFENSE; DEPOSITION; RESISTANCE	Plant intraspecific variability has been proposed as a key mechanism by which plants adapt to environmental change. In boreal forests where nitrogen availability is strongly limited, nitrogen addition happens indirectly through atmospheric N deposition and directly through industrial forest fertilization. These anthropogenic inputs of N have numerous environmental consequences, including shifts in plant species composition and reductions in plant species diversity. However, we know less about how genetic differences within plant populations determine how species respond to eutrophication in boreal forests. According to plant defense theories, nitrogen addition will cause plants to shift carbon allocation more towards growth and less to chemical defense, potentially enhancing vulnerability to antagonists. Aspens are keystone species in boreal forests that produce condensed tannins to serve as chemical defense. We conducted an experiment using ten Populus tremula genotypes from the Swedish Aspen Collection that express extreme levels of baseline investment into foliar condensed tannins. We investigated whether investment into growth and phenolic defense compounds in young plants varied in response to two nitrogen addition levels, corresponding to atmospheric N deposition and industrial forest fertilization. Nitrogen addition generally caused growth to increase, and tannin levels to decrease; however, individualistic responses among genotypes were found for height growth, biomass of specific tissues, root: shoot ratios, and tissue lignin and N concentrations. A genotype's baseline ability to produce and store condensed tannins also influenced plant responses to N, although this effect was relatively minor. High-tannin genotypes tended to grow less biomass under low nitrogen levels and more at the highest fertilization level. Thus, the ability in aspen to produce foliar tannins is likely associated with a steeper reaction norm of growth responses, which suggests a higher plasticity to nitrogen addition, and potentially an advantage when adapting to higher concentrations of soil nitrogen.	[Bandau, Franziska; Decker, Vicki Huizu Guo; Albrectsen, Benedicte Riber] Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, SE-90183 Umea, Sweden; [Gundale, Michael J.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden; [Albrectsen, Benedicte Riber] Univ Copenhagen, Dept Plant & Environm Sci, DK-1871 Frederiksberg C, Denmark	Umea University; Swedish University of Agricultural Sciences; University of Copenhagen	Albrectsen, BR (corresponding author), Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, SE-90183 Umea, Sweden.	benedicte.albrectsen@plantphys.umu.se	Gundale, Michael J/O-1265-2013	Gundale, Michael J/0000-0003-2447-609X; Albrectsen, Benedicte Riber/0000-0002-9337-4540	Centre for Environmental Research in Umea [CMF0922352]; Royal Swedish Academy of Agriculture and Forestry KSLA [H120196-GBN]	Centre for Environmental Research in Umea; Royal Swedish Academy of Agriculture and Forestry KSLA	The authors received funding from The Centre for Environmental Research in Umea (Grant number: CMF0922352; http://cere.se/en/about-cere.html) and The Royal Swedish Academy of Agriculture and Forestry KSLA (Grant number: H120196-GBN; http://www.ksla.se/en/).	Abreu IN, 2011, J CHEM ECOL, V37, P857, DOI 10.1007/s10886-011-9991-7; Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Albrectsen BR, 2010, ECOGRAPHY, V33, P483, DOI 10.1111/j.1600-0587.2009.05982.x; Albrectsen BR, 2010, FUNGAL DIVERS, V41, P17, DOI 10.1007/s13225-009-0011-y; Bailey JK, 2002, ECOLOGY, V83, P1701, DOI 10.1890/0012-9658(2002)083[1701:IAFAAE]2.0.CO;2; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Bergqvist G, 2014, SILVA FENN, V48, DOI 10.14214/sf.1077; Bernhardsson C, 2013, ECOL LETT, V16, P791, DOI 10.1111/ele.12114; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; BRYANT JP, 1987, OECOLOGIA, V73, P513, DOI 10.1007/BF00379408; Bylesjoe M, 2008, BMC PLANT BIOL, P8, DOI [10.1188/14/1-2229-8-82, DOI 10.1188/14/1-2229-8-82]; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Donaldson JR, 2006, NEW PHYTOL, V169, P561, DOI 10.1111/j.1469-8137.2005.01613.x; Edenius L, 2011, J APPL ECOL, V48, P301, DOI 10.1111/j.1365-2664.2010.01923.x; Forkner RE, 2004, FOREST ECOL MANAG, V199, P21, DOI 10.1016/j.foreco.2004.03.044; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Glynn C, 2003, OIKOS, V101, P385, DOI 10.1034/j.1600-0706.2003.12089.x; Glynn C, 2007, NEW PHYTOL, V176, P623, DOI 10.1111/j.1469-8137.2007.02203.x; Gundale MJ, 2011, GLOBAL CHANGE BIOL, V17, P2743, DOI 10.1111/j.1365-2486.2011.02407.x; Haikio E, 2009, J CHEM ECOL, V35, P664, DOI 10.1007/s10886-009-9644-2; Harding SA, 2009, J EXP BOT, V60, P3443, DOI 10.1093/jxb/erp180; Hemming JDC, 1999, J CHEM ECOL, V25, P1687, DOI 10.1023/A:1020805420160; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hjalten J, 2004, ACTA THERIOL, V49, P53, DOI 10.1007/BF03192508; Holeski LM, 2012, OECOLOGIA, V170, P695, DOI 10.1007/s00442-012-2344-6; Holeski LM, 2009, BIOCHEM SYST ECOL, V37, P139, DOI 10.1016/j.bse.2009.02.003; Hwang SY, 1997, OECOLOGIA, V111, P99, DOI 10.1007/s004420050213; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; Jones CG, 1999, OIKOS, V86, P27, DOI 10.2307/3546567; Keefover-Ring K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107189; Kouki Jari, 2004, Journal for Nature Conservation (Jena), V12, P41, DOI 10.1016/j.jnc.2003.08.002; Kumordzi BB, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00339.1; Lindroth RL, 2013, FOREST ECOL MANAG, V299, P14, DOI 10.1016/j.foreco.2012.11.018; Lindroth RL, 2001, OECOLOGIA, V126, P371, DOI 10.1007/s004420000521; Lindroth RL, 1996, BIOCHEM SYST ECOL, V24, P357, DOI 10.1016/0305-1978(96)00043-9; Lucas RW, 2011, FOREST ECOL MANAG, V262, P95, DOI 10.1016/j.foreco.2011.03.018; Luquez V, 2008, TREE GENET GENOMES, V4, P279, DOI 10.1007/s11295-007-0108-y; Madritch MD, 2009, OECOLOGIA, V160, P119, DOI 10.1007/s00442-009-1283-3; Mansfield JL, 1999, AM J BOT, V86, P1154, DOI 10.2307/2656979; McKown AD, 2014, NEW PHYTOL, V201, P1263, DOI 10.1111/nph.12601; Mitton JB, 1996, BIOSCIENCE, V46, P25, DOI 10.2307/1312652; Nordin A, 2005, AMBIO, V34, P20, DOI 10.1639/0044-7447(2005)034[0020:NDATBO]2.0.CO;2; Osier TL, 2004, OECOLOGIA, V139, P55, DOI 10.1007/s00442-003-1481-3; Osier TL, 2001, J CHEM ECOL, V27, P1289, DOI 10.1023/A:1010352307301; Osier TL, 2006, OECOLOGIA, V148, P293, DOI 10.1007/s00442-006-0373-8; PORTER LJ, 1985, PHYTOCHEMISTRY, V25, P223, DOI 10.1016/S0031-9422(00)94533-3; Randriamanana TR, 2014, TREE PHYSIOL, V34, P471, DOI 10.1093/treephys/tpu034; Robinson KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037679; ROWLAND AP, 1994, COMMUN SOIL SCI PLAN, V25, P269, DOI 10.1080/00103629409369035; Schweitzer JA, 2004, ECOL LETT, V7, P127, DOI 10.1111/j.1461-0248.2003.00562.x; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Stevens MT, 2005, OECOLOGIA, V145, P298, DOI 10.1007/s00442-005-0128-y; Sundqvist MK, 2012, FUNCT ECOL, V26, P1090, DOI 10.1111/j.1365-2435.2012.02034.x; Tamm C., 1991, NITROGEN TERRESTRIAL, DOI DOI 10.2307/2260680; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877	58	16	16	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140971	10.1371/journal.pone.0140971	http://dx.doi.org/10.1371/journal.pone.0140971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488414	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400088
J	Cho, S; Park, H; Jarboe, EA; Peterson, CM; Bae, YH; Janat-Amsbury, MM				Cho, Sungpil; Park, Hongsuk; Jarboe, Elke A.; Peterson, C. Matthew; Bae, You Han; Janat-Amsbury, Margit M.			Design and Characterization of Bioengineered Cancer-Like Stem Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; OVARIAN-CANCER; RAS; EXPRESSION; TRANSFORMATION; DIFFERENTIATION; IDENTIFICATION; SUPPRESSION; INDUCTION; ONCOGENE	Cancer stem cells (CSCs) are a small subset of cancer cells responsible for maintenance and progression of several types of cancer. Isolation, propagation, and the differentiation of CSCs in the proper stem niches expose the intrinsic difficulties for further studies. Here we show that induced cancer like stem cells (iCLSCs) can be generated by in vitro oncogenic manipulation of mouse embryonic stem cells (mESCs) with well-defined oncogenic elements; SV40 LTg and HrasV12 by using a mouse stem virus long terminal repeat (MSCV-LTR)-based retroviral system. The reprogrammed mESCs using both oncogenes were characterized through their oncogenic gene expression, the enhancement of proliferation, and unhampered maintenance of stem properties in vitro and in vivo. In addition, these transformed cells resulted in the formation of malignant, immature ovarian teratomas in vivo. To successfully further expand these properties to other organs and species, more research needs to be done to fully understand the role of a tumor-favorable microenvironment. Our current study has provided a novel approach to generate induced cancer like stem cells through in vitro oncogenic reprogramming and successfully initiated organ-specific malignant tumor formation in an orthotopic small animal cancer model.	[Cho, Sungpil; Peterson, C. Matthew; Janat-Amsbury, Margit M.] Dept Obstet & Gynecol, Div Gynecol Oncol, Salt Lake City, UT 84132 USA; [Park, Hongsuk] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Jarboe, Elke A.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Bae, You Han] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Janat-Amsbury, MM (corresponding author), Dept Obstet & Gynecol, Div Gynecol Oncol, Salt Lake City, UT 84132 USA.	margit.janat-amsbury@hsc.utah.edu						Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Arauchi A, 2015, TISSUE ENG PART C-ME, V21, P23, DOI [10.1089/ten.tec.2014.0040, 10.1089/ten.TEC.2014.0040]; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; BOS JL, 1989, CANCER RES, V49, P4682; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Cho S, 2013, ANTICANCER RES, V33, P1317; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Ferrandina G, 2008, INT J GYNECOL CANCER, V18, P506, DOI 10.1111/j.1525-1438.2007.01056.x; Fujimori H, 2012, J BIOL CHEM, V287, P36777, DOI 10.1074/jbc.M112.372557; GREZ M, 1990, P NATL ACAD SCI USA, V87, P9202, DOI 10.1073/pnas.87.23.9202; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HIRAKAWA T, 1988, P NATL ACAD SCI USA, V85, P1519, DOI 10.1073/pnas.85.5.1519; Joneson T, 1999, MOL CELL BIOL, V19, P5892; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; MCCARTHY SA, 1994, P NATL ACAD SCI USA, V91, P3979, DOI 10.1073/pnas.91.9.3979; MICHALOVITZ D, 1987, J VIROL, V61, P2648, DOI 10.1128/JVI.61.8.2648-2654.1987; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Perez-Caro M, 2009, EMBO J, V28, P8, DOI 10.1038/emboj.2008.253; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Scaffidi P, 2011, NAT CELL BIOL, V13, P1051, DOI 10.1038/ncb2308; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yan T, 2014, J CANCER, V5, P572, DOI 10.7150/jca.8865	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141172	10.1371/journal.pone.0141172	http://dx.doi.org/10.1371/journal.pone.0141172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488294	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400114
J	Clendenen, TV; Ge, WZ; Koenig, KL; Axelsson, T; Liu, ML; Afanasyeva, Y; Andersson, A; Arslan, AA; Chen, Y; Hallmans, G; Lenner, P; Kirchhoff, T; Lundin, E; Shore, RE; Sund, M; Zeleniuch-Jacquotte, A				Clendenen, Tess V.; Ge, Wenzhen; Koenig, Karen L.; Axelsson, Tomas; Liu, Mengling; Afanasyeva, Yelena; Andersson, Anne; Arslan, Alan A.; Chen, Yu; Hallmans, Goran; Lenner, Per; Kirchhoff, Tomas; Lundin, Eva; Shore, Roy E.; Sund, Malin; Zeleniuch-Jacquotte, Anne			Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study	PLOS ONE			English	Article							D-BINDING PROTEIN; PLASMA 25-HYDROXYVITAMIN D; D-RECEPTOR POLYMORPHISMS; D PATHWAY; VARIANTS; SERUM; DETERMINANTS; 25(OH)D; WOMEN	Genetic polymorphisms in vitamin D metabolism and signaling genes have been inconsistently associated with risk of breast cancer, though few studies have examined SNPs in vitamin D-related genes other than the vitamin D receptor (VDR) gene and particularly have not examined the association with the retinoid X receptor alpha (RXRA) gene which may be a key vitamin D pathway gene. We conducted a nested case-control study of 734 cases and 1435 individually matched controls from a population-based prospective cohort study, the Northern Sweden Mammary Screening Cohort. Tag and functional SNPs were genotyped for the VDR, cytochrome p450 24A1 (CYP24A1), and RXRA genes. We also genotyped specific SNPs in four other genes related to vitamin D metabolism and signaling (GC/VDBP, CYP2R1, DHCR7, and CYP27B1). SNPs in the CYP2R1, DHCR7, and VDBP gene regions that were associated with circulating 25(OH) D concentration in GWAS were also associated with plasma 25(OH) D in our study (p-trend < 0.005). After taking into account the false discovery rate, these SNPs were not significantly associated with breast cancer risk, nor were any of the other SNPs or haplotypes in VDR, RXRA, and CYP24A1. We observed no statistically significant associations between polymorphisms or haplotypes in key vitamin D-related genes and risk of breast cancer. These results, combined with the observation in this cohort and most other prospective studies of no association of circulating 25(OH) D with breast cancer risk, do not support an association between vitamin D and breast cancer risk.	[Clendenen, Tess V.; Ge, Wenzhen; Koenig, Karen L.; Liu, Mengling; Afanasyeva, Yelena; Arslan, Alan A.; Chen, Yu; Kirchhoff, Tomas; Shore, Roy E.; Zeleniuch-Jacquotte, Anne] NYU, Sch Med, Dept Populat Hlth, New York, NY 10010 USA; [Koenig, Karen L.; Arslan, Alan A.; Chen, Yu; Zeleniuch-Jacquotte, Anne] NYU, Inst Canc, Sch Med, New York, NY USA; [Axelsson, Tomas] Uppsala Univ, Sci Life Lab, Dept Mol Med, Uppsala, Sweden; [Andersson, Anne; Lenner, Per] Umea Univ Hosp, Dept Oncol, S-90185 Umea, Sweden; [Arslan, Alan A.] NYU, Sch Med, Dept Obstet & Gynecol, New York, NY USA; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med Nutr Res, Umea, Sweden; [Lundin, Eva] Umea Univ, Dept Med Biosci Pathol, Umea, Sweden; [Shore, Roy E.] Radiat Effects Res Fdn, Minami Ku, Hiroshima, Japan; [Sund, Malin] Umea Univ Hosp, Dept Surg, S-90185 Umea, Sweden	New York University; New York University; Uppsala University; Umea University; New York University; Umea University; Umea University; Radiation Effects Research Foundation - Japan; Umea University	Clendenen, TV (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 10010 USA.	tess.clendenen@nyumc.org	Ge, Wenzhen/J-4689-2019	Chen, Yu/0000-0002-1519-4894; Kirchhoff, Tomas/0000-0002-9055-2364; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Shore, Roy/0000-0002-6842-2248; Arslan, Alan/0000-0002-7775-8085; Liu, Mengling/0000-0001-9758-8522	National Cancer Institute [R01 CA098661, UM1CA182934, P30 CA016087]; National Institute of Environmental Health Sciences Center [ES000260]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA098661, UM1CA182934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Cancer Institute grants (R01 CA098661 [AZJ], UM1CA182934 [AZJ] and P30 CA016087) and the National Institute of Environmental Health Sciences Center grant (ES000260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, CANCER EPIDEM BIOMAR, V17, P1339, DOI 10.1158/1055-9965.EPI-08-0162; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Anderson LN, 2011, CANCER EPIDEM BIOMAR, V20, P1708, DOI 10.1158/1055-9965.EPI-11-0300; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIKLE DD, 1985, J CLIN ENDOCR METAB, V61, P969, DOI 10.1210/jcem-61-5-969; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; BISHOP JE, 1994, J BONE MINER RES, V9, P1277; Dorjgochoo T, 2011, CANCER EPIDEM BIOMAR, V20, P2313, DOI 10.1158/1055-9965.EPI-11-0704; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fu L, 2009, CLIN BIOCHEM, V42, P1174, DOI 10.1016/j.clinbiochem.2009.03.008; Fuhrman BJ, 2013, ANTICANCER RES, V33, P543; Gnagnarella P, 2014, CARCINOGENESIS, V35, P1913, DOI 10.1093/carcin/bgu150; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Kemmis CM, 2006, J NUTR, V136, P887, DOI 10.1093/jn/136.4.887; Kim Y, 2014, BRIT J CANCER, V110, P2772, DOI 10.1038/bjc.2014.175; Kuhn T, 2013, INT J CANCER, V133, P1689, DOI 10.1002/ijc.28172; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; McCullough ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1642; Mondul AM, 2015, CANCER EPIDEM BIOMAR, V24, P627, DOI 10.1158/1055-9965.EPI-14-1127; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Reimers LL, 2015, CANCER CAUSE CONTROL, V26, P187, DOI 10.1007/s10552-014-0497-9; Scarmo S, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3390; Segersten U, 2005, BREAST CANCER RES, V7, pR980, DOI 10.1186/bcr1332; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; Tang CB, 2009, BREAST CANCER RES TR, V117, P391, DOI 10.1007/s10549-008-0262-4; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Visvanathan K, 2015, CANCER RES, V75; Wang D, 2013, TUMOR BIOL, V34, P3509, DOI 10.1007/s13277-013-0929-2; Wang J, 2013, TUMOR BIOL, V34, P3823, DOI 10.1007/s13277-013-0967-9; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Welsh J, 2012, ARCH BIOCHEM BIOPHYS, V523, P107, DOI 10.1016/j.abb.2011.10.019; Yao S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3162; Zhu JG, 2013, P NATL ACAD SCI USA, V110, P15650, DOI 10.1073/pnas.1315006110	34	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140478	10.1371/journal.pone.0140478	http://dx.doi.org/10.1371/journal.pone.0140478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488576	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400054
J	Xu, GP; Wu, LF; Li, JJ; Gao, Q; Liu, ZD; Kang, QH; Hou, YJ; Zhang, LC; Hu, XM; Li, J; Zhang, J				Xu, Gui-Ping; Wu, Li-Fang; Li, Jing-Jing; Gao, Qi; Liu, Zhi-Dong; Kang, Qiong-Hua; Hou, Yi-Jun; Zhang, Luo-Chuan; Hu, Xiao-Mei; Li, Jie; Zhang, Juan			Performance Assessment of Internal Quality Control (IQC) Products in Blood Transfusion Compatibility Testing in China	PLOS ONE			English	Article							MEDICINE; ERRORS; SAFETY	Internal quality control (IQC) is a critical component of laboratory quality management, and IQC products can determine the reliability of testing results. In China, given the fact that most blood transfusion compatibility laboratories do not employ IQC products or do so minimally, there is a lack of uniform and standardized IQC methods. To explore the reliability of IQC products and methods, we studied 697 results from IQC samples in our laboratory from 2012 to 2014. The results showed that the sensitivity and specificity of the IQCs in anti-B testing were 100% and 99.7%, respectively. The sensitivity and specificity of the IQCs in forward blood typing, anti-A testing, irregular antibody screening, and cross-matching were all 100%. The reliability analysis indicated that 97% of anti-B testing results were at a 99% confidence level, and 99.9% of forward blood typing, anti-A testing, irregular antibody screening, and cross-matching results were at a 99% confidence level. Therefore, our IQC products and methods are highly sensitive, specific, and reliable. Our study paves the way for the establishment of a uniform and standardized IQC method for pre-transfusion compatibility testing in China and other parts of the world.	[Xu, Gui-Ping; Li, Jing-Jing; Gao, Qi; Liu, Zhi-Dong; Kang, Qiong-Hua; Hou, Yi-Jun; Zhang, Luo-Chuan; Hu, Xiao-Mei; Li, Jie; Zhang, Juan] Chongqing Med Univ, Hosp 2, Transfus Dept, Chongqing, Peoples R China; [Wu, Li-Fang] Chongqing Med Univ, Hosp 2, Dept Lab Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Zhang, J (corresponding author), Chongqing Med Univ, Hosp 2, Transfus Dept, Chongqing, Peoples R China.	juanmcq@163.com	Wu, Lifang/R-3630-2016	Wu, Lifang/0000-0003-3334-2923	National Natural Science Foundation of China [81101318]; Science and Technology Project of Chongqing Municipal Education Commission [KJ1400202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Chongqing Municipal Education Commission	This work was supported by the National Natural Science Foundation of China (81101318), the Science and Technology Project of Chongqing Municipal Education Commission (KJ1400202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Blood Banks, 2011, TECHNICAL MANUAL; Chang C, 2014, TRANSFUSION MED, V24, P33, DOI 10.1111/tme.12073; Chaudhary Rajendra, 2010, Asian J Transfus Sci, V4, P28, DOI 10.4103/0973-6247.59388; Chinese Ministry of Health, 2006, REG CLIN LAB MED I; Ditomasso J, 2012, TRANSFUS APHER SCI, V46, P329, DOI 10.1016/j.transci.2012.03.024; Downes KA, 2012, ARCH PATHOL LAB MED, V136, P294, DOI 10.5858/2011-0127-CPR.1; Dzik WH, 2007, BRIT J HAEMATOL, V136, P181, DOI 10.1111/j.1365-2141.2006.06373.x; Dzik WH, 2003, TRANSFUSION, V43; Ellis H, 2007, BRIT J HOSP MED, V68, P447, DOI 10.12968/hmed.2007.68.8.24500; Evanovitch D, 2012, TRANSFUS APHER SCI, V46, P281, DOI 10.1016/j.transci.2012.03.017; Fan FY, 2014, J CLIN TRANSFUS LAB, V16, P47; Fastman BR, 2011, MT SINAI J MED, V78, P854, DOI 10.1002/msj.20296; Ferreira Ângela Melgaço, 2012, Rev. Bras. Hematol. Hemoter., V34, P21, DOI 10.5581/1516-8484.20120009; Franchini M, 2010, CLIN CHEM LAB MED, V48, P1075, DOI 10.1515/CCLM.2010.178; Goodnough LT, 2003, LANCET, V361, P161, DOI 10.1016/S0140-6736(03)12195-2; Guyard A, 2008, TRANSFUS CLIN BIOL, V15, P383, DOI 10.1016/j.tracli.2008.10.001; Janatpour KA, 2008, AM J CLIN PATHOL, V129, P276, DOI 10.1309/VXY1ULAFUY6E6JT3; Knowles SM, 2002, TRANSFUSION MED, V12, P11, DOI 10.1046/j.1365-3148.2002.00353.x; Landsteiner K, 1927, J EXP MED, V46, P213, DOI 10.1084/jem.46.2.213; Landsteiner K, 1941, J EXP MED, V74, P309, DOI 10.1084/jem.74.4.309; Landsteiner K., 1900, ZBL BAKT, V27, P357; Linden JV, 2000, TRANSFUSION, V40, P1207, DOI 10.1046/j.1537-2995.2000.40101207.x; Lindsey Terianne, 2005, J Am Acad Nurse Pract, V17, P277, DOI 10.1111/j.1745-7599.2005.0046.x; Marconi M, 2000, CURR OPIN HEMATOL, V7, P382, DOI 10.1097/00062752-200011000-00010; Milkins C, 2013, TRANSFUSION MED, V23, P3, DOI 10.1111/j.1365-3148.2012.01199.x; Milkins C, 2007, TRANSFUS APHER SCI, V36, P129, DOI 10.1016/j.transci.2006.12.006; Salama OS, 2014, BLOOD TRANSFUS-ITALY, V12, P187, DOI 10.2450/2014.0120-13; Serious Hazards of Transfusion Steering Group, 2014, SER HAZ TRANSF ANN R; South SF, 2012, TRANSFUSION, V52, p81S, DOI 10.1111/j.1537-2995.2012.03816.x; Stainsby D, 2005, BRIT J HAEMATOL, V131, P8, DOI 10.1111/j.1365-2141.2005.05702.x; Tocci LJ, 2009, J VET EMERG CRIT CAR, V19, P66, DOI 10.1111/j.1476-4431.2009.00387.x; 于洋, 2009, [中国输血杂志, Chinese Journal of Blood Transfusion], V22, P790	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141145	10.1371/journal.pone.0141145	http://dx.doi.org/10.1371/journal.pone.0141145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488582	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400108
J	Galgano, A; Barinov, A; Vasseur, F; de Villartay, JP; Rocha, B				Galgano, Alessia; Barinov, Aleksandr; Vasseur, Florence; de Villartay, Jean-Pierre; Rocha, Benedita			CD8 Memory Cells Develop Unique DNA Repair Mechanisms Favoring Productive Division	PLOS ONE			English	Article							DAMAGE RESPONSE; GENOMIC INSTABILITY; IONIZING-RADIATION; STRAND BREAKS; T-CELLS; LYMPHOCYTES; ACTIVATION; EXPRESSION; GENES; 53BP1	Immune responses are efficient because the rare antigen-specific naive cells are able to proliferate extensively and accumulate upon antigen stimulation. Moreover, differentiation into memory cells actually increases T cell accumulation, indicating improved productive division in secondary immune responses. These properties raise an important paradox: how T cells may survive the DNA lesions necessarily induced during their extensive division without undergoing transformation. We here present the first data addressing the DNA damage responses (DDRs) of CD8 T cells in vivo during exponential expansion in primary and secondary responses in mice. We show that during exponential division CD8 T cells engage unique DDRs, which are not present in other exponentially dividing cells, in T lymphocytes after UV or X irradiation or in non-metastatic tumor cells. While in other cell types a single DDR pathway is affected, all DDR pathways and cell cycle checkpoints are affected in dividing CD8 T cells. All DDR pathways collapse in secondary responses in the absence of CD4 help. CD8 T cells are driven to compulsive suicidal divisions preventing the propagation of DNA lesions. In contrast, in the presence of CD4 help all the DDR pathways are up regulated, resembling those present in metastatic tumors. However, this up regulation is present only during the expansion phase; i.e., their dependence on antigen stimulation prevents CD8 transformation. These results explain how CD8 T cells maintain genome integrity in spite of their extensive division, and highlight the fundamental role of DDRs in the efficiency of CD8 immune responses.	[Galgano, Alessia; Barinov, Aleksandr; Vasseur, Florence; Rocha, Benedita] Univ Paris 05, Sorbonne Paris Cite, Med Fac Paris Descartes, INSERM,U1020,CNRS,UMR 8253, Paris, France; [de Villartay, Jean-Pierre] Hop Necker Enfants Malad, INSERM, Inst Imagine, UMR 1163, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rocha, B (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Med Fac Paris Descartes, INSERM,U1020,CNRS,UMR 8253, Paris, France.	benedita.rocha@pasteur.fr	de Villartay, jean pierre/H-9353-2017	de Villartay, jean pierre/0000-0001-5987-0463; BARINOV, Aleksandr/0000-0003-2530-5081	European Research Council (ERC)	European Research Council (ERC)(European Research Council (ERC))	The European Research Council supported this work (Grant No. ERC-2008-AdG; http://erc.europa.eu/development-and-differentiation-cd8-t-lymphocytes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bee L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069061; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Cha HJ, 2013, TUMOR BIOL, V34, P3293, DOI 10.1007/s13277-013-1038-y; Cheung AMY, 2002, CANCER RES, V62, P6194; de Miranda NFCC, 2011, ANN NY ACAD SCI, V1246, P50, DOI 10.1111/j.1749-6632.2011.06322.x; Deriano L, 2005, BLOOD, V105, P4776, DOI 10.1182/blood-2004-07-2888; Dhariwala FA, 2012, MOL CELL BIOCHEM, V363, P43, DOI 10.1007/s11010-011-1156-z; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Gillert E, 1999, ONCOGENE, V18, P4663, DOI 10.1038/sj.onc.1202842; Gourzones-Dmitriev C, 2013, CELL CYCLE, V12, P2760, DOI 10.4161/cc.25951; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Houtgraaf JH, 2006, CARDIOVASC REVASCULA, V7, P165, DOI 10.1016/j.carrev.2006.02.002; Huang YL, 2014, CELL REP, V7, P1849, DOI 10.1016/j.celrep.2014.04.029; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; JAMES SJ, 1991, MUTAT RES, V249, P255, DOI 10.1016/0027-5107(91)90152-E; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; Mayer C, 2002, DNA REPAIR, V1, P237, DOI 10.1016/S1568-7864(01)00019-2; McKay BC, 2014, ANTIOXID REDOX SIGN, V20, P640, DOI 10.1089/ars.2013.5523; Mognato M, 2005, MUTAT RES-FUND MOL M, V578, P417, DOI 10.1016/j.mrfmmm.2005.06.011; Morales JC, 2006, P NATL ACAD SCI USA, V103, P3310, DOI 10.1073/pnas.0511259103; Oberle C, 2010, CURR GENOMICS, V11, P184, DOI 10.2174/138920210791110979; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; ROCHA B, 1995, J EXP MED, V181, P993, DOI 10.1084/jem.181.3.993; Rybanska-Spaeder I, 2013, MOL CANCER RES, V11, P1223, DOI 10.1158/1541-7786.MCR-13-0252-T; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarasin A, 2008, MUTAT RES-REV MUTAT, V659, P49, DOI 10.1016/j.mrrev.2007.12.002; Seo J, 2012, NUCLEIC ACIDS RES, V40, P5965, DOI 10.1093/nar/gks287; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Zhang JR, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-11	35	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140849	10.1371/journal.pone.0140849	http://dx.doi.org/10.1371/journal.pone.0140849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485718	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100079
J	Graindorge, D; Martineau, S; Machon, C; Arnoux, P; Guitton, J; Francesconi, S; Frochot, C; Sage, E; Girard, PM				Graindorge, Dany; Martineau, Sylvain; Machon, Christelle; Arnoux, Philippe; Guitton, Jerome; Francesconi, Stefania; Frochot, Celine; Sage, Evelyne; Girard, Pierre-Marie			Singlet Oxygen-Mediated Oxidation during UVA Radiation Alters the Dynamic of Genomic DNA Replication	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE; MOLECULAR-OXYGEN; NUCLEOTIDE POOL; CELL-CYCLE; INHIBITION; STRESS; PROGRESSION; ACTIVATION; INITIATION; EXPRESSION	UVA radiation (320-400 nm) is a major environmental agent that can exert its deleterious action on living organisms through absorption of the UVA photons by endogenous or exogenous photosensitizers. This leads to the production of reactive oxygen species (ROS), such as singlet oxygen (O-1(2)) and hydrogen peroxide (H2O2), which in turn can modify reversibly or irreversibly biomolecules, such as lipids, proteins and nucleic acids. We have previously reported that UVA-induced ROS strongly inhibit DNA replication in a dose-dependent manner, but independently of the cell cycle checkpoints activation. Here, we report that the production of O-1(2) by UVA radiation leads to a transient inhibition of replication fork velocity, a transient decrease in the dNTP pool, a quickly reversible GSH-dependent oxidation of the RRM1 subunit of ribonucleotide reductase and sustained inhibition of origin firing. The time of recovery post irradiation for each of these events can last from few minutes (reduction of oxidized RRM1) to several hours (replication fork velocity and origin firing). The quenching of O-1(2) by sodium azide prevents the delay of DNA replication, the decrease in the dNTP pool and the oxidation of RRM1, while inhibition of Chk1 does not prevent the inhibition of origin firing. Although the molecular mechanism remains elusive, our data demonstrate that the dynamic of replication is altered by UVA photosensitization of vitamins via the production of singlet oxygen.	[Graindorge, Dany; Martineau, Sylvain; Francesconi, Stefania; Sage, Evelyne; Girard, Pierre-Marie] CNRS, UMR 3348, Stress Genotox & Canc, F-91405 Orsay, France; [Graindorge, Dany; Martineau, Sylvain; Francesconi, Stefania; Sage, Evelyne; Girard, Pierre-Marie] PSL Res Univ, Inst Curie, Orsay, France; [Machon, Christelle; Guitton, Jerome] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Lab Biochim Toxicol, Pierre Benite, France; [Machon, Christelle] Univ Lyon 1, Lab Chim Analyt, ISPBL, Fac Pharm, F-69365 Lyon, France; [Arnoux, Philippe; Frochot, Celine] Univ Lorraine, LRGP, Nancy, France; [Arnoux, Philippe; Frochot, Celine] CNRS, UMR7274, Nancy, France; [Guitton, Jerome] Univ Lyon 1, ISPBL, Fac Pharm, Lab Toxicol, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Girard, PM (corresponding author), CNRS, UMR 3348, Stress Genotox & Canc, F-91405 Orsay, France.	pierre-marie.girard@curie.fr	Francesconi, Stefania/J-7910-2016	francesconi, stefania/0000-0002-9665-349X; Guitton, Jerome/0000-0001-6180-5708; ARNOUX, Philippe/0000-0002-6834-9597; Machon, Christelle/0000-0002-4494-8034; girard, pierre-marie/0000-0001-9703-4407	French National Center for Scientific Research (CNRS); Curie Institute; La Region Ile de France (DIM SEnT program); La Ligue Nationale Contre le Cancer	French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Curie Institute; La Region Ile de France (DIM SEnT program)(Region Ile-de-France); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the French National Center for Scientific Research (CNRS) and Curie Institute. DG was the recipient of a doctoral fellowship from La Region Ile de France (DIM SEnT program) and La Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Artin E, 2009, BIOCHEMISTRY-US, V48, P11622, DOI 10.1021/bi901590q; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Avval FZ, 2009, BIOCHEM BIOPH RES CO, V379, P775, DOI 10.1016/j.bbrc.2008.12.128; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Baumler W, 2012, PHOTOCH PHOTOBIO SCI, V11, P107, DOI 10.1039/c1pp05142c; Baier J, 2006, BIOPHYS J, V91, P1452, DOI 10.1529/biophysj.106.082388; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Boos D, 2012, CURR OPIN CELL BIOL, V24, P423, DOI 10.1016/j.ceb.2012.01.011; Boulton S, 2011, FREE RADICAL RES, V45, P115, DOI 10.3109/10715762.2010.517751; Bracchitta G, 2013, PHOTOCH PHOTOBIO SCI, V12, P911, DOI 10.1039/c3pp25326k; Casas-Delucchi CS, 2011, NUCLEUS-PHILA, V2, P370, DOI 10.4161/nucl.2.5.17861; Chabosseau P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1363; Chiarelli-Neto O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113266; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Douglas ME, 2012, CURR BIOL, V22, pR81, DOI 10.1016/j.cub.2011.12.028; Elkeeb D, 2012, CUTAN OCUL TOXICOL, V31, P263, DOI 10.3109/15569527.2012.656293; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; Fernandez-Vidal A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5285; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x; Fotouhi A, 2013, MUTAT RES-FUND MOL M, V751, P8, DOI 10.1016/j.mrfmmm.2013.10.001; Fotouhi A, 2011, MUTAT RES-FUND MOL M, V715, P13, DOI 10.1016/j.mrfmmm.2011.07.005; Ge XQ, 2010, J CELL BIOL, V191, P1285, DOI 10.1083/jcb.201007074; Girard PM, 2011, J PHYS CONF SER, V261, DOI 10.1088/1742-6596/261/1/012002; Girard PM, 2008, DNA REPAIR, V7, P1500, DOI 10.1016/j.dnarep.2008.05.004; Girard PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075751; Girotti AW, 2004, ANTIOXID REDOX SIGN, V6, P301, DOI 10.1089/152308604322899369; GOULD JW, 1995, J AM ACAD DERMATOL, V33, P551, DOI 10.1016/0190-9622(95)91271-1; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Guarino E, 2014, SEMIN CELL DEV BIOL, V30, P97, DOI 10.1016/j.semcdb.2014.03.030; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; HUSCHTSCHA LI, 1983, J CELL SCI, V63, P77; Kamada Katsuhiko, 2012, Subcell Biochem, V62, P135, DOI 10.1007/978-94-007-4572-8_8; Kamath-Loeb AS, 2014, J BIOL CHEM, V289, P21663, DOI 10.1074/jbc.M114.570242; Knak A, 2014, PHOTOCH PHOTOBIO SCI, V13, P820, DOI 10.1039/c3pp50413a; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; KREK W, 1995, METHOD ENZYMOL, V254, P114; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Li MY, 2001, PHOTOCHEM PHOTOBIOL, V74, P760, DOI 10.1562/0031-8655(2001)074<0760:QOSMOO>2.0.CO;2; Machon C, 2014, ANAL BIOANAL CHEM, V406, P2925, DOI 10.1007/s00216-014-7711-1; MacNeill Stuart, 2012, Subcell Biochem, V62, P1, DOI 10.1007/978-94-007-4572-8_1; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Magdalou I, 2014, SEMIN CELL DEV BIOL, V30, P154, DOI 10.1016/j.semcdb.2014.04.035; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; MERKEL PB, 1972, J AM CHEM SOC, V94, P7244, DOI 10.1021/ja00776a003; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Nakanishi M, 2010, CHROMOSOME RES, V18, P103, DOI 10.1007/s10577-009-9086-2; Niida H, 2010, CANCER SCI, V101, P2505, DOI 10.1111/j.1349-7006.2010.01719.x; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Noda T, 2001, FASEB J, V15, P2131, DOI 10.1096/fj.01-0131com; Odsbu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007617; PARKER JG, 1984, J PHOTOCHEM, V25, P545, DOI 10.1016/0047-2670(84)87054-9; Pattison DI, 2012, PHOTOCH PHOTOBIO SCI, V11, P38, DOI 10.1039/c1pp05164d; Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Redmond RW, 1999, PHOTOCHEM PHOTOBIOL, V70, P391, DOI 10.1562/0031-8655(1999)070<0391:ACOSOY>2.3.CO;2; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Ridley AJ, 2009, INT J RADIAT BIOL, V85, P177, DOI 10.1080/09553000902740150; Runger TM, 2012, PHOTOCH PHOTOBIO SCI, V11, P207, DOI 10.1039/c1pp05232b; Sage E, 2012, PHOTOCH PHOTOBIO SCI, V11, P74, DOI 10.1039/c1pp05219e; Scholz M, 2015, PHOTOCH PHOTOBIO SCI, V14, P700, DOI 10.1039/c4pp00339j; Schwob Etienne, 2009, V521, P673, DOI 10.1007/978-1-60327-817-5_36; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Sengupta Rajib, 2014, World J Biol Chem, V5, P68, DOI 10.4331/wjbc.v5.i1.68; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Tabancay AP, 2006, CURR TOP DEV BIOL, V76, P129, DOI 10.1016/S0070-2153(06)76005-7; Thu YM, 2013, TRENDS BIOCHEM SCI, V38, P184, DOI 10.1016/j.tibs.2012.12.003; Tognetti S, 2015, CHROMOSOMA, V124, P13, DOI 10.1007/s00412-014-0489-2; Tyrrell RM, 2012, PHOTOCH PHOTOBIO SCI, V11, P135, DOI 10.1039/c1pp05222e; TYRRELL RM, 1989, PHOTOCHEM PHOTOBIOL, V49, P407, DOI 10.1111/j.1751-1097.1989.tb09187.x; Wang J, 2009, BIOCHEMISTRY-US, V48, P11612, DOI 10.1021/bi901588z; Wondrak GT, 2006, PHOTOCH PHOTOBIO SCI, V5, P215, DOI 10.1039/b504573h; Yamada M, 2014, CELL CYCLE, V13, P1859, DOI 10.4161/cc.29251; Zegerman P, 2015, CHROMOSOMA, V124, P309, DOI 10.1007/s00412-014-0500-y	84	23	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140645	10.1371/journal.pone.0140645	http://dx.doi.org/10.1371/journal.pone.0140645			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485711	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100057
J	Nimishakavi, S; Raymond, WW; Gruenert, DC; Caughey, GH				Nimishakavi, Shilpa; Raymond, Wilfred W.; Gruenert, Dieter C.; Caughey, George H.			Divergent Inhibitor Susceptibility among Airway Lumen-Accessible Tryptic Proteases	PLOS ONE			English	Article							TRYPSIN-LIKE PROTEASE; MAST-CELL TRYPTASE; BRONCHIAL EPITHELIAL-CELLS; SODIUM-CHANNEL FUNCTION; NAFAMOSTAT MESILATE; SERINE-PROTEASE; BLOOD-PRESSURE; IN-VIVO; PROSTASIN; MATRIPTASE	Tryptic serine proteases of bronchial epithelium regulate ion flux, barrier integrity, and allergic inflammation. Inhibition of some of these proteases is a strategy to improve mucociliary function in cystic fibrosis and asthmatic inflammation. Several inhibitors have been tested in pre-clinical animal models and humans. We hypothesized that these inhibitors inactivate a variety of airway protease targets, potentially with bystander effects. To establish relative potencies and modes of action, we compared inactivation of human prostasin, matriptase, airway trypsin-like protease (HAT), and beta-tryptase by nafamostat, camostat, bis(5-amidino-2-benzimidazolyl)methane (BABIM), aprotinin, and benzamidine. Nafamostat achieved complete, nearly stoichiometric and very slowly reversible inhibition of matriptase and tryptase, but inhibited prostasin less potently and was weakest versus HAT. The IC50 of nafamostat's leaving group, 6-amidino-2-naphthol, was > 10(4)-fold higher than that of nafamostat itself, consistent with suicide rather than product inhibition as mechanisms of prolonged inactivation. Stoichiometric release of 6-amidino-2-naphthol allowed highly sensitive fluorometric estimation of active-site concentration in preparations of matriptase and tryptase. Camostat inactivated all enzymes but was less potent overall and weakest towards matriptase, which, however was strongly inhibited by BABIM. Aprotinin exhibited nearly stoichiometric inhibition of prostasin and matriptase, but was much weaker towards HAT and was completely ineffective versus tryptase. Benzamidine was universally weak. Thus, each inhibitor profile was distinct. Nafamostat, camostat and aprotinin markedly reduced tryptic activity on the apical surface of cystic fibrosis airway epithelial monolayers, suggesting prostasin as the major source of such activity and supporting strategies targeting prostasin for inactivation.	[Nimishakavi, Shilpa; Raymond, Wilfred W.; Gruenert, Dieter C.; Caughey, George H.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Nimishakavi, Shilpa; Raymond, Wilfred W.; Caughey, George H.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Gruenert, Dieter C.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA USA; [Gruenert, Dieter C.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Gruenert, Dieter C.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Gruenert, Dieter C.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Gruenert, Dieter C.] Univ Vermont, Coll Med, Dept Pediat, Burlington, VT USA; [Caughey, George H.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Vermont; University of California System; University of California San Francisco	Caughey, GH (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	George.Caughey@ucsf.edu			United States National Institutes of Health [HL024136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by United States National Institutes of Health grant HL024136 (GHC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger P, 1999, CLIN EXP ALLERGY, V29, P804; Berling R, 1996, J GASTROENTEROL, V31, P702, DOI 10.1007/BF02347620; Bridges RJ, 2001, AM J PHYSIOL-LUNG C, V281, pL16, DOI 10.1152/ajplung.2001.281.1.L16; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Cairns JA, 1996, J IMMUNOL, V156, P275; CAUGHEY GH, 1993, J PHARMACOL EXP THER, V264, P676; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen CL, 2006, J ALLERGY CLIN IMMUN, V118, P105, DOI 10.1016/j.jaci.2006.02.047; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; CLARK JM, 1995, AM J RESP CRIT CARE, V152, P2076, DOI 10.1164/ajrccm.152.6.8520778; Coote K, 2009, J PHARMACOL EXP THER, V329, P764, DOI 10.1124/jpet.108.148155; Coote KJ, 2008, BRIT J PHARMACOL, V155, P1025, DOI 10.1038/bjp.2008.363; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Gong YF, 2014, P NATL ACAD SCI USA, V111, pE3766, DOI 10.1073/pnas.1406741111; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Isozaki Y, 2006, SCAND J GASTROENTERO, V41, P944, DOI 10.1080/00365520500529470; Katz BA, 1998, NATURE, V391, P608, DOI 10.1038/35422; Li P, 2007, J MED CHEM, V50, P5976, DOI 10.1021/jm0704898; Maekawa A, 2009, J HYPERTENS, V27, P181, DOI 10.1097/HJH.0b013e328317a762; Mori S, 2003, J PHARMACOL SCI, V92, P420; Morinaga J, 2013, AM J PHYSIOL-RENAL, V305, pF173, DOI 10.1152/ajprenal.00586.2012; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Netzel-Arnett S, 2012, INFLAMM BOWEL DIS, V18, P1303, DOI 10.1002/ibd.21930; Nimishakavi S, 2012, AM J PHYSIOL-LUNG C, V303, pL97, DOI 10.1152/ajplung.00303.2011; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Ramjee MK, 2000, THROMB RES, V98, P559, DOI 10.1016/S0049-3848(00)00206-1; Raymond WW, 2005, ARCH BIOCHEM BIOPHYS, V435, P311, DOI 10.1016/j.abb.2004.12.025; Rickert KW, 2008, J BIOL CHEM, V283, P34864, DOI 10.1074/jbc.M805262200; Rowe SM, 2013, CHEST, V144, P200, DOI 10.1378/chest.12-2431; Spraggon G, 2009, PROTEIN SCI, V18, P1081, DOI 10.1002/pro.118; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Takahashi M, 2001, HISTOCHEM CELL BIOL, V115, P181; Tong ZY, 2004, AM J PHYSIOL-LUNG C, V287, pL928, DOI 10.1152/ajplung.00160.2004; Ui H, 2006, EUR J PHARMACOL, V530, P172, DOI 10.1016/j.ejphar.2005.11.021; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Verghese GM, 2004, AM J RESP CELL MOL, V30, P519, DOI 10.1165/rcmb.2003-0251OC; Yamaoka K, 1998, J BIOL CHEM, V273, P11895, DOI 10.1074/jbc.273.19.11895; Yasuoka S, 1997, AM J RESP CELL MOL, V16, P300, DOI 10.1165/ajrcmb.16.3.9070615	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141169	10.1371/journal.pone.0141169	http://dx.doi.org/10.1371/journal.pone.0141169			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485396	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100120
J	Zhou, QY; Zheng, YR				Zhou, Qingyuan; Zheng, Yuanrun			Comparative De Novo Transcriptome Analysis of Fertilized Ovules in Xanthoceras sorbifolium Uncovered a Pool of Genes Expressed Specifically or Preferentially in the Selfed Ovule That Are Potentially Involved in Late-Acting Self-Incompatibility	PLOS ONE			English	Article							LOCUS RECEPTOR KINASE; PROTEIN-KINASE; MAP KINASE; S-LOCUS; SIGNAL-TRANSDUCTION; GENOME ANNOTATION; BREEDING SYSTEM; ABSCISIC-ACID; POLLEN; BRASSICA	Xanthoceras sorbifolium, a tree species endemic to northern China, has high oil content in its seeds and is recognized as an important biodiesel crop. The plant is characterized by late-acting self-incompatibility (LSI). LSI was found to occur in many angiosperm species and plays an important role in reducing inbreeding and its harmful effects, as do gametophytic self-incompatibility (GSI) and sporophytic self-incompatibility (SSI). Molecular mechanisms of conventional GSI and SSI have been well characterized in several families, but no effort has been made to identify the genes involved in the LSI process. The present studies indicated that there were no significant differences in structural and histological features between the self-and cross-pollinated ovules during the early stages of ovule development until 5 days after pollination (DAP). This suggests that 5 DAP is likely to be a turning point for the development of the selfed ovules. Comparative de novo transcriptome analysis of the selfed and crossed ovules at 5 DAP identified 274 genes expressed specifically or preferentially in the selfed ovules. These genes contained a significant proportion of genes predicted to function in the biosynthesis of secondary metabolites, consistent with our histological observations in the fertilized ovules. The genes encoding signal transduction-related components, such as protein kinases and protein phosphatases, are over-represented in the selfed ovules. X. sorbifolium selfed ovules also specifically or preferentially express many unique transcription factor (TF) genes that could potentially be involved in the novel mechanisms of LSI. We also identified 42 genes significantly up-regulated in the crossed ovules compared to the selfed ovules. The expression of all 16 genes selected from the RNA-seq data was validated using PCR in the selfed and crossed ovules. This study represents the first genome-wide identification of genes expressed in the fertilized ovules of an LSI species. The availability of a pool of specifically or preferentially expressed genes from selfed ovules for X. sorbifolium will be a valuable resource for future genetic analyses of candidate genes involved in the LSI response.	[Zhou, Qingyuan; Zheng, Yuanrun] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Zhou, QY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	qyzhou@ibcas.ac.cn			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China.	Allen A. M., 2008, P73, DOI 10.1007/978-3-540-68486-2_4; Anil VS, 2001, J PLANT PHYSIOL, V158, P1237, DOI 10.1078/0176-1617-00550; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Bittencourt NS, 2005, INT J PLANT SCI, V166, P493, DOI 10.1086/428758; Bittencourt NS, 2003, ANN BOT-LONDON, V91, P827, DOI 10.1093/aob/mcg088; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; COPE FW, 1962, HEREDITY, V17, P157, DOI 10.1038/hdy.1962.14; de Graaf BHJ, 2006, NATURE, V444, P490, DOI 10.1038/nature05311; deNettancourt D, 1997, SEX PLANT REPROD, V10, P185, DOI 10.1007/s004970050087; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Elleman CJ, 1999, SEX PLANT REPROD, V12, P194, DOI 10.1007/s004970050192; Feng CP, 2004, PLANT SCI, V167, P1099, DOI 10.1016/j.plantsci.2004.06.014; Finatto T, 2011, AUST J BOT, V59, P53, DOI 10.1071/BT10152; Ford CS, 2012, SEX PLANT REPROD, V25, P169, DOI 10.1007/s00497-012-0188-1; Gandolphi G, 2010, ACTA BOT BRAS, V24, P840, DOI 10.1590/S0102-33062010000300026; Gibbs PE, 1999, ANN BOT-LONDON, V84, P449, DOI 10.1006/anbo.1999.0933; Gibbs PE, 2014, NEW PHYTOL, V203, P717, DOI 10.1111/nph.12874; Giranton JL, 2000, P NATL ACAD SCI USA, V97, P3759, DOI 10.1073/pnas.070025097; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; Gonzalez A, 2009, DEV BIOL, V325, P412, DOI 10.1016/j.ydbio.2008.10.005; Huber SC, 2007, BIOCHEM SOC T, V35, P28, DOI 10.1042/BST0350028; Ito M, 2005, J PLANT RES, V118, P61, DOI 10.1007/s10265-005-0192-8; Iyer MK, 2011, NAT BIOTECHNOL, V29, P599, DOI 10.1038/nbt.1915; Kakita M, 2007, PLANT CELL, V19, P3961, DOI 10.1105/tpc.106.049999; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; Knox RB, 1983, POLLEN BIOLOGY AND I; Kunz C, 1996, SEX PLANT REPROD, V9, P25, DOI 10.1007/BF00230363; LaDoux T, 2006, INT J PLANT SCI, V167, P463, DOI 10.1086/500985; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; Lee TS, 2008, EVOL BIOINFORM, V4, P7; Lipow SR, 2000, GENETICS, V154, P893; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Luu DT, 2000, NATURE, V407, P649, DOI 10.1038/35036623; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morse AM, 2009, NEW PHYTOL, V183, P1001, DOI 10.1111/j.1469-8137.2009.02900.x; Murase K, 2004, SCIENCE, V303, P1516, DOI 10.1126/science.1093586; Nelson D. R., 2008, Tropical Plant Biology, V1, P216, DOI 10.1007/s12042-008-9022-1; Nelson David R., 2009, Human Genomics, V4, P59; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Nettancourt, 2001, INCOMPATIBILITY INCO; ONeill SD, 1997, ANNU REV PLANT PHYS, V48, P547, DOI 10.1146/annurev.arplant.48.1.547; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; PIMIENTA E, 1983, ANN BOT, V71, P469; Pound LM, 2003, AUST J BOT, V51, P189, DOI 10.1071/BT02082; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Rudd JJ, 1996, PLANT CELL, V8, P713, DOI 10.1105/tpc.8.4.713; Rudd JJ, 2003, FEBS LETT, V547, P223, DOI 10.1016/S0014-5793(03)00710-5; Sage TL, 2006, AM J BOT, V93, P254, DOI 10.3732/ajb.93.2.254; Sage TL, 1999, AM J BOT, V86, P855, DOI 10.2307/2656706; SAGE TL, 1995, SEX PLANT REPROD, V8, P257; Sage TL., 1994, GENETIC CONTROL SELF; SAGE TL, 2003, ANN BOT, V91, P1, DOI DOI 10.1093/AOB/MCG085; Sassa H, 2010, SEX PLANT REPROD, V23, P39, DOI 10.1007/s00497-009-0111-6; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Sears ER, 1937, GENETICS, V22, P130; SEAVEY SR, 1986, BOT REV, V52, P195, DOI 10.1007/BF02861001; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Vaughton G, 2010, ANN BOT-LONDON, V106, P547, DOI 10.1093/aob/mcq149; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; Wang Y, 2003, PLANT MOL BIOL, V53, P565, DOI 10.1023/B:PLAN.0000019068.00034.09; Watanabe M., 2008, P151, DOI 10.1007/978-3-540-68486-2_7; Wheeler MJ, 2010, J EXP BOT, V61, P2015, DOI 10.1093/jxb/erp383; Wheeler MJ, 2009, NATURE, V459, P992, DOI 10.1038/nature08027; Yang T, 2002, P NATL ACAD SCI USA, V99, P4097, DOI 10.1073/pnas.052564899; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321; Zhou QY, 2012, PLANT SYST EVOL, V298, P457, DOI 10.1007/s00606-011-0558-4	76	21	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140507	10.1371/journal.pone.0140507	http://dx.doi.org/10.1371/journal.pone.0140507			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485030	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100040
J	Di Stefano, A; Scata, M; La Corte, A; Lio, P; Catania, E; Guardo, E; Pagano, S				Di Stefano, Alessandro; Scata, Marialisa; La Corte, Aurelio; Lio, Pietro; Catania, Emanuele; Guardo, Ermanno; Pagano, Salvatore			Quantifying the Role of Homophily in Human Cooperation Using Multiplex Evolutionary Game Theory	PLOS ONE			English	Article							PRISONERS-DILEMMA; BEHAVIOR; NETWORKS; EMERGENCE; DYNAMICS	Nature shows as human beings live and grow inside social structures. This assumption allows us to explain and explore how it may shape most of our behaviours and choices, and why we are not just blindly driven by instincts: our decisions are based on more complex cognitive reasons, based on our connectedness on different spaces. Thus, human cooperation emerges from this complex nature of social network. Our paper, focusing on the evolutionary dynamics, is intended to explore how and why it happens, and what kind of impact is caused by homophily among people. We investigate the evolution of human cooperation using evolutionary game theory on multiplex. Multiplexity, as an extra dimension of analysis, allows us to unveil the hidden dynamics and observe non-trivial patterns within a population across network layers. More importantly, we find a striking role of homophily, as the higher the homophily between individuals, the quicker is the convergence towards cooperation in the social dilemma. The simulation results, conducted both macroscopically and microscopically across the network layers in the multiplex, show quantitatively the role of homophily in human cooperation.	[Di Stefano, Alessandro; Scata, Marialisa; La Corte, Aurelio; Catania, Emanuele; Guardo, Ermanno; Pagano, Salvatore] Univ Catania, DIEEI, Catania, Italy; [Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England	University of Catania; University of Cambridge	Di Stefano, A (corresponding author), Univ Catania, DIEEI, Catania, Italy.	alessandro.distefano@dieei.unict.it	P. Lió, Pietro Lio/AAV-3358-2021; La Corte, Aurelio/H-4519-2017; SCATÀ, Marialisa/AAM-4892-2020	P. Lió, Pietro Lio/0000-0002-0540-5053; La Corte, Aurelio/0000-0003-0370-7717; SCATÀ, Marialisa/0000-0002-4785-0067; DI STEFANO, Alessandro/0000-0003-4905-3309	Italian Ministry of University and Research (MIUR-"Programma Operativo Nazionale Ricerca AMP; Competitivita") [PON04a2 E, PON04a2 C]	Italian Ministry of University and Research (MIUR-"Programma Operativo Nazionale Ricerca AMP; Competitivita")	This work was supported by the following Research Grants: Italian Ministry of University and Research (MIUR-"Programma Operativo Nazionale Ricerca & Competitivita 2007-2013" within the projects "PON04a2 E" and "PON04a2 C") (www.ponrec.it/en/).	Anagnostopoulos A., 2014, ARXIV14112893; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bashan A, 2013, NAT PHYS, V9, P667, DOI 10.1038/NPHYS2727; Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804; Bianconi G, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012804; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Bonacich P, 2001, SOC NETWORKS, V23, P191, DOI 10.1016/S0378-8733(01)00038-7; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Cardillo A, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052825; Centola D, 2007, J CONFLICT RESOLUT, V51, P905, DOI 10.1177/0022002707307632; Centola DM, 2013, RATION SOC, V25, P3, DOI 10.1177/1043463112473734; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Cozzo E, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050801; Dickison M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066109; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Easley D, 2010, NETWORKS CROWDS MARK; Estrada E, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042819; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Fu F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00845; Gao J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.092002; Gomez-Gardenes J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00620; Gonzalez-Bailon S, 2013, AM BEHAV SCI, V57, P943, DOI 10.1177/0002764213479371; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; HANNAN MT, 1977, AM J SOCIOL, V82, P929, DOI 10.1086/226424; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Huang KK, 2015, CHAOS SOLITON FRACT, V80, P90, DOI 10.1016/j.chaos.2015.06.016; Huang KK, 2015, APPL MATH COMPUT, V266, P501, DOI 10.1016/j.amc.2015.05.065; Huang KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120317; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Marwell G., 1993, CRITICAL MASS COLLEC; Matamalas JT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13511; Maynard Smith J., 1982, pi; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Meng XK, 2015, PHYS LETT A, V379, P767, DOI 10.1016/j.physleta.2014.12.051; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pennisi E, 2005, SCIENCE, V309, P93, DOI 10.1126/science.309.5731.93; Pennisi E, 2009, SCIENCE, V325, P1196, DOI 10.1126/science.325_1196; Perc M, 2013, CHAOS SOLITON FRACT, V56, P1, DOI 10.1016/j.chaos.2013.06.002; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Podolny JM, 1996, AM J SOCIOL, V102, P659, DOI 10.1086/230994; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Porter M.E, 1980, COMPETITIVE STRATEGY; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos MD, 2014, SCI REP-UK, V4, DOI 10.1038/srep04436; Sanz J, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041005; Steglich C, 2010, SOCIOL METHODOL, V40, P329, DOI 10.1111/j.1467-9531.2010.01225.x; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tsvetkova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087275; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Wang Z, 2015, PHYS LIFE REV, V15, P1, DOI 10.1016/j.plrev.2015.07.006; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Wasserman S, 1994, SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilson DS, 1997, AM NAT, V149, P336, DOI 10.1086/285993; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002	71	21	22	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140646	10.1371/journal.pone.0140646	http://dx.doi.org/10.1371/journal.pone.0140646			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU1VG	26496351	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200026
J	Meier, SM; Muqaku, B; Ullmann, R; Bileck, A; Kreutz, D; Mader, JC; Knasmuller, S; Gerner, C				Meier, Samuel M.; Muqaku, Besnik; Ullmann, Ronald; Bileck, Andrea; Kreutz, Dominique; Mader, Johanna C.; Knasmueller, Siegfried; Gerner, Christopher			Proteomic and Metabolomic Analyses Reveal Contrasting Anti-Inflammatory Effects of an Extract of Mucor Racemosus Secondary Metabolites Compared to Dexamethasone	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; CHRONIC INFLAMMATION; PROTEIN; CANCER	Classical drug assays are often confined to single molecules and targeting single pathways. However, it is also desirable to investigate the effects of complex mixtures on complex systems such as living cells including the natural multitude of signalling pathways. Evidence based on herbal medicine has motivated us to investigate potential beneficial health effects of Mucor racemosus (M rac) extracts. Secondary metabolites of M rac were collected using a good-manufacturing process (GMP) approved production line and a validated manufacturing process, in order to obtain a stable product termed SyCircue (National Drug Code USA: 10424-102). Toxicological studies confirmed that this product does not contain mycotoxins and is non-genotoxic. Potential effects on inflammatory processes were investigated by treating stimulated cells with M rac extracts and the effects were compared to the standard anti-inflammatory drug dexamethasone on the levels of the proteome and metabolome. Using 2D-PAGE, slight anti-inflammatory effects were observed in primary white blood mononuclear cells, which were more pronounced in primary human umbilical vein endothelial cells (HUVECs). Proteome profiling based on nLC-MS/MS analysis of tryptic digests revealed inhibitory effects of M rac extracts on pro-inflammatory cytoplasmic mediators and secreted cytokines and chemokines in these endothelial cells. This finding was confirmed using targeted proteomics, here treatment of stimulated cells with M rac extracts down-regulated the secretion of IL-6, IL-8, CXCL5 and GROA significantly. Finally, the modulating effects of M rac on HUVECs were also confirmed on the level of the metabolome. Several metabolites displayed significant concentration changes upon treatment of inflammatory activated HUVECs with the M rac extract, including spermine and lysophosphatidylcholine acyl C18: 0 and sphingomyelin C26: 1, while the bulk of measured metabolites remained unaffected. Interestingly, the effects of M rac treatment on lipids were orthogonal to the effect of dexamethasone underlining differences in the overall mode of action.	[Meier, Samuel M.; Muqaku, Besnik; Bileck, Andrea; Kreutz, Dominique; Mader, Johanna C.; Gerner, Christopher] Univ Vienna, Dept Analyt Chem, A-1090 Vienna, Austria; [Ullmann, Ronald] Syntrion GmbH, D-75365 Calw, Germany; [Knasmueller, Siegfried] Med Univ Vienna, Inst Canc Res, A-1090 Vienna, Austria	University of Vienna; Medical University of Vienna	Gerner, C (corresponding author), Univ Vienna, Dept Analyt Chem, Wahringer Str 38, A-1090 Vienna, Austria.	christopher.gerner@univie.ac.at	Meier-Menches, Samuel/L-8203-2018	Meier-Menches, Samuel/0000-0002-8930-4574; Gerner, Christopher/0000-0003-4964-0642; Kreutz, Dominique/0000-0003-0938-4015; Bileck, Andrea/0000-0002-7053-8856	Syntrion GmbH; Dr. Warkentin GmbH, Stephanskirchen; Marien Apotheke, Prien	Syntrion GmbH; Dr. Warkentin GmbH, Stephanskirchen; Marien Apotheke, Prien	Syntrion GmbH funded consumables and provided the extract of M rac. Syntrion GmbH had no role in study design, data collection and analysis and the decision to publish. R.U. is grateful to Dr. Ben Warkentin and Rie Warkentin, Dr. Warkentin GmbH, Stephanskirchen as well as Dr. Herbert Reuther, Marien Apotheke, Prien for co-funding this project.	Aiyar N, 2007, MOL CELL BIOCHEM, V295, P113, DOI 10.1007/s11010-006-9280-x; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Arya P, 2002, CHEM BIOL, V9, P145, DOI 10.1016/S1074-5521(02)00105-9; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Bileck A, 2014, J PROTEOME RES, V13, P5989, DOI 10.1021/pr5008625; BL E., 2014, ADV DRUG DELIVERY RE, V69-70, P190; Chen GT, 2013, BIOTECHNOL LETT, V35, P439, DOI 10.1007/s10529-012-1098-x; Das S, 2015, CURRTOP MED CHEM; Demain AL, 1999, APPL MICROBIOL BIOT, V52, P455, DOI 10.1007/s002530051546; Filer A, 2006, CURR OPIN PHARMACOL, V6, P393, DOI 10.1016/j.coph.2006.03.007; Garcia-Faroldi G, 2009, CURR OPIN CLIN NUTR, V12, P59, DOI 10.1097/MCO.0b013e328314b9ac; Gerner C, 2002, MOL CELL PROTEOMICS, V1, P528, DOI 10.1074/mcp.M200026-MCP200; Haudek-Prinz VJ, 2012, J PROTEOMICS, V76, P150, DOI 10.1016/j.jprot.2012.07.012; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; KAUR N, 1989, INDIAN J BIOCHEM BIO, V26, P371; Koal T, 2010, CURR MOL MED, V10, P216, DOI 10.2174/156652410790963312; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Muqaku B, 2015, ANAL BIOANAL CHEM, V407, P6525, DOI 10.1007/s00216-015-8817-9; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Slany A, 2013, ELECTROPHORESIS, V34, P3315, DOI 10.1002/elps.201300326; Smeekens SP, 2015, CYTOKINE, V71, P215, DOI 10.1016/j.cyto.2014.10.013; Sugimura K, 2012, CIRC J, V76, P485, DOI 10.1253/circj.CJ-11-1217; Tajdini F, 2010, INT J BIOL MACROMOL, V47, P180, DOI 10.1016/j.ijbiomac.2010.05.002; Toledo TR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/767061; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Zhu S, 2009, MOL MED, V15, P275, DOI 10.2119/molmed.2009.00062	27	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140367	10.1371/journal.pone.0140367	http://dx.doi.org/10.1371/journal.pone.0140367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496078	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200015
J	Mosedale, JR; Wilson, RJ; Maclean, IMD				Mosedale, Jonathan R.; Wilson, Robert J.; Maclean, Ilya M. D.			Climate Change and Crop Exposure to Adverse Weather: Changes to Frost Risk and Grapevine Flowering Conditions	PLOS ONE			English	Article							VITIS-VINIFERA L.; PHENOLOGICAL MODEL; WINE; DAMAGE; CLASSIFICATION; TEMPERATURES; VITICULTURE; GENERATOR; VERAISON; BUDBURST	The cultivation of grapevines in the UK and many other cool climate regions is expected to benefit from the higher growing season temperatures predicted under future climate scenarios. Yet the effects of climate change on the risk of adverse weather conditions or events at key stages of crop development are not always captured by aggregated measures of seasonal or yearly climates, or by downscaling techniques that assume climate variability will remain unchanged under future scenarios. Using fine resolution projections of future climate scenarios for south-west England and grapevine phenology models we explore how risks to cool-climate vineyard harvests vary under future climate conditions. Results indicate that the risk of adverse conditions during flowering declines under all future climate scenarios. In contrast, the risk of late spring frosts increases under many future climate projections due to advancement in the timing of budbreak. Estimates of frost risk, however, were highly sensitive to the choice of phenology model, and future frost exposure declined when budbreak was calculated using models that included a winter chill requirement for dormancy break. The lack of robust phenological models is a major source of uncertainty concerning the impacts of future climate change on the development of cool-climate viticulture in historically marginal climatic regions.	[Mosedale, Jonathan R.; Maclean, Ilya M. D.] Univ Exeter, Coll Life & Environm Sci, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Wilson, Robert J.] Coll Life & Environm Sci, Exeter, Devon, England	University of Exeter; University of Exeter	Mosedale, JR (corresponding author), Univ Exeter, Coll Life & Environm Sci, Environm & Sustainabil Inst, Penryn Campus, Penryn, Cornwall, England.	J.Mosedale@exeter.ac.uk	Wilson, Robert J/I-8726-2014	Wilson, Robert J/0000-0003-4477-7068; Maclean, Ilya/0000-0001-8030-9136	European Social Fund [09099NC05, 11200NC05]; Natural Environment Research Council knowledge exchange grant [NE/M021599/1]; Natural Environment Research Council [NE/M021599/1, NE/L00268X/1] Funding Source: researchfish; NERC [NE/L00268X/1, NE/M021599/1] Funding Source: UKRI	European Social Fund(European Social Fund (ESF)); Natural Environment Research Council knowledge exchange grant; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Research funded by European Social Fund (project numbers 09099NC05 and 11200NC05) and a Natural Environment Research Council (www.nerc.ac.uk) knowledge exchange grant (NE/M021599/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerine M. A., 1944, HILGARDIA, V15, P493; [Anonymous], 2013, CONTRIBUTION WORKING, P1535; Belliveau S, 2006, GLOBAL ENVIRON CHANG, V16, P364, DOI 10.1016/j.gloenvcha.2006.03.003; Bindi M, 2001, EUR J AGRON, V14, P145, DOI 10.1016/S1161-0301(00)00093-9; Bock A, 2011, CLIM RES, V50, P69, DOI 10.3354/cr01048; Caffarra A, 2011, AUST J GRAPE WINE R, V17, P52, DOI 10.1111/j.1755-0238.2010.00118.x; Caffarra A, 2010, INT J BIOMETEOROL, V54, P255, DOI 10.1007/s00484-009-0277-5; CANNELL MGR, 1986, J APPL ECOL, V23, P177, DOI 10.2307/2403090; Challinor AJ, 2013, AGR FOREST METEOROL, V170, P2, DOI 10.1016/j.agrformet.2012.09.007; Chloupek O, 2004, FIELD CROP RES, V85, P167, DOI 10.1016/S0378-4290(03)00162-X; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Chuine I, 2003, TASK VEG SC, V39, P217; Cola G, 2014, AGR FOREST METEOROL, V184, P117, DOI 10.1016/j.agrformet.2013.09.008; Cuccia C, 2014, J INT SCI VIGNE VIN, V48, P169; de Cortazar-Atauri IG, 2009, INT J BIOMETEOROL, V53, P317, DOI 10.1007/s00484-009-0217-4; DEBLIJ HJ, 1983, J GEOGR, V82, P112, DOI 10.1080/00221348308980792; DEFRA, 2012, UK CLIM CHANG RISK A, P464; Duchene E, 2005, AGRON SUSTAIN DEV, V25, P93, DOI 10.1051/agro:2004057; DUE G, 1993, AGR FOREST METEOROL, V65, P91, DOI 10.1016/0168-1923(93)90039-K; Ebadi A., 1995, Australian Journal of Grape and Wine Research, V1, P11, DOI 10.1111/j.1755-0238.1995.tb00072.x; Eccel E, 2009, INT J BIOMETEOROL, V53, P273, DOI 10.1007/s00484-009-0213-8; Fila G, 2014, AGR FOREST METEOROL, V195, P192, DOI 10.1016/j.agrformet.2014.05.011; Food Standards A, UK VIN REG; Friend A. P., 2005, THESIS LINCOLN U NZ; Frigg R, 2013, PHILOS SCI, V80, P886, DOI 10.1086/673892; Gladstones J.S., 1992, VITICULTURE ENV; Glenn DM, 2013, HORTICUL RE, V41, P47, DOI 10.1002/9781118707418.ch02; Hannah L, 2013, P NATL ACAD SCI USA, V110, P6907, DOI 10.1073/pnas.1210127110; Harris CNP, 2014, METEOROL APPL, V21, P129, DOI 10.1002/met.1335; Holland T, 2014, REG ENVIRON CHANGE, V14, P1109, DOI 10.1007/s10113-013-0555-y; Hope-Ross P, 2006, BUSINESS TRADE STAT; IPCC, 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; Jenkins GJ, 2009, PROGRAMME UKCI CLIMA; Johns TC, 1997, CLIM DYNAM, V13, P103, DOI 10.1007/s003820050155; JOHNSON DE, 1981, AM J ENOL VITICULT, V32, P144; Jones G. V., 2012, GEOGRAPHY WINE REGIO, P109, DOI [10.1007/978-94-007-0464-0_7, DOI 10.1007/978-94-007-0464-0_7]; Jones GV, 2000, AM J ENOL VITICULT, V51, P249; Jones GV, 2005, CLIMATIC CHANGE, V73, P319, DOI 10.1007/s10584-005-4704-2; Jones P, 2010, UK CLIMATE PROJECTIO; Keller M, 2010, AUST J GRAPE WINE R, V16, P56, DOI 10.1111/j.1755-0238.2009.00077.x; Kenny G. J., 1992, Journal of Wine Research, V3, P163, DOI 10.1080/09571269208717931; Kilsby CG, 2007, ENVIRON MODELL SOFTW, V22, P1705, DOI 10.1016/j.envsoft.2007.02.005; Lavee S., 1997, Australian Journal of Grape and Wine Research, V3, P31, DOI 10.1111/j.1755-0238.1997.tb00114.x; Madelin M, 2005, METEOROL APPL, V12, P51, DOI 10.1017/S1350482705001568; Matthews RB, 2013, GLOB FOOD SECUR-AGR, V2, P24, DOI 10.1016/j.gfs.2012.11.009; McGregor JL, 1998, WORKSH GEN MONS SYST; MCINTYRE GN, 1982, AM J ENOL VITICULT, V33, P80; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Molitor D, 2014, AUST J GRAPE WINE R, V20, P160, DOI 10.1111/ajgw.12059; Molitor D, 2014, AM J ENOL VITICULT, V65, P72, DOI 10.5344/ajev.2013.13066; Moriondo M, 2006, CLIMATE RES, V30, P149, DOI 10.3354/cr030149; Moriondo M, 2013, CLIMATIC CHANGE, V119, P825, DOI 10.1007/s10584-013-0739-y; Murphy J.M, 2009, UK CLIMATE PROJECTIO; Nakicenovic N., 2000, SPECIAL REPORT EMISS; New M, 2007, PHILOS T R SOC A, V365, P2117, DOI 10.1098/rsta.2007.2080; Parker AK, 2011, AUST J GRAPE WINE R, V17, P206, DOI 10.1111/j.1755-0238.2011.00140.x; Parker A, 2013, AGR FOREST METEOROL, V180, P249, DOI 10.1016/j.agrformet.2013.06.005; Perry M, 2005, INT J CLIMATOL, V25, P1023, DOI 10.1002/joc.1160; Perry M, 2005, INT J CLIMATOL, V25, P1041, DOI 10.1002/joc.1161; Perry M, 2006, CLIM RES; Petrie PR, 2008, AUST J GRAPE WINE R, V14, P33, DOI 10.1111/j.1755-0238.2008.00005.x; Poling EB, 2008, HORTSCIENCE, V43, P1652, DOI 10.21273/HORTSCI.43.6.1652; Rodrigo J, 2000, SCI HORTIC-AMSTERDAM, V85, P155, DOI 10.1016/S0304-4238(99)00150-8; Sadras VO, 2013, AGR FOREST METEOROL, V173, P107, DOI 10.1016/j.agrformet.2012.10.003; Semenov MA, 1997, CLIMATIC CHANGE, V35, P397, DOI 10.1023/A:1005342632279; Semenov MA, 2009, J R SOC INTERFACE, V6, P343, DOI 10.1098/rsif.2008.0285; Sexton DMH, 2012, CLIM DYNAM, V38, P2543, DOI 10.1007/s00382-011-1209-8; Smart R., 2014, ENCOURAGING DEV WINE; Stott PA, 2014, B AM METEOROL SOC, V95, pS1; Team RDC, 2014, R LANG ENV STAT COMP; Vasconcelos MC, 2009, AM J ENOL VITICULT, V60, P411; White JW, 2011, FIELD CROP RES, V124, P357, DOI 10.1016/j.fcr.2011.07.001; WILLIAMS DW, 1985, AM J ENOL VITICULT, V36, P283; Winkler AJ, 1974, GEN VITICULTURE	74	59	62	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141218	10.1371/journal.pone.0141218	http://dx.doi.org/10.1371/journal.pone.0141218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496127	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200078
J	Pi, J; Cai, HH; Jin, H; Yang, F; Jiang, JH; Wu, AG; Zhu, HY; Liu, JX; Su, XH; Yang, PH; Cai, JY				Pi, Jiang; Cai, Huaihong; Jin, Hua; Yang, Fen; Jiang, Jinhuan; Wu, Anguo; Zhu, Haiyan; Liu, Jianxin; Su, Xiaohui; Yang, Peihui; Cai, Jiye			Qualitative and Quantitative Analysis of ROS-Mediated Oridonin-Induced Oesophageal Cancer KYSE-150 Cell Apoptosis by Atomic Force Microscopy	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; INHIBITION; ACTIVATION; AUTOPHAGY; ACTIN; MEMBRANES; ADHESION; RECEPTOR; SURFACE; DEATH	High levels of intracellular reactive oxygen species (ROS) in cells is recognized as one of the major causes of cancer cell apoptosis and has been developed into a promising therapeutic strategy for cancer therapy. However, whether apoptosis associated biophysical properties of cancer cells are related to intracellular ROS functions is still unclear. Here, for the first time, we determined the changes of biophysical properties associated with the ROS-mediated oesophageal cancer KYSE-150 cell apoptosis using high resolution atomic force microscopy (AFM). Oridonin was proved to induce ROS-mediated KYSE-150 cell apoptosis in a dose dependent manner, which could be reversed by N-acetylcysteine (NAC) pretreatment. Based on AFM imaging, the morphological damage and ultrastructural changes of KYSE-150 cells were found to be closely associated with ROS-mediated oridonin-induced KYSE-150 cell apoptosis. The changes of cell stiffness determined by AFM force measurement also demonstrated ROS-dependent changes in oridonin induced KYSE-150 cell apoptosis. Our findings not only provided new insights into the anticancer effects of oridonin, but also highlighted the use of AFM as a qualitative and quantitative nanotool to detect ROS-mediated cancer cell apoptosis based on cell biophysical properties, providing novel information of the roles of ROS in cancer cell apoptosis at nanoscale.	[Pi, Jiang; Jin, Hua; Yang, Fen; Jiang, Jinhuan; Wu, Anguo; Su, Xiaohui; Yang, Peihui] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Cai, Huaihong; Zhu, Haiyan; Liu, Jianxin] Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China; [Liu, Jianxin] Hunan Univ Med, Dept Pharmacol, Huaihua, Peoples R China	Macau University of Science & Technology; Jinan University		tjycai@jnu.edu.cn	Pi, Jiang/AAJ-7366-2021; zhu, xueqiong/U-1320-2019; Anguo, Wu/GRF-4136-2022; Liu, Jianxin/HDN-1293-2022	Pi, Jiang/0000-0003-4418-1248; Liu, Jianxin/0000-0002-5077-4990; Cai, Jiye/0000-0002-4791-3320; Wu, An-Guo/0000-0002-9850-7576	Macao Science and Technology Development Fund [028/2014/A1]	Macao Science and Technology Development Fund	This work was supported by the Macao Science and Technology Development Fund (No. 028/2014/A1), http://www.fdct.gov.mo/.	Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Aresvik DM, 2010, ANTICANCER RES, V30, P3879; Bai HH, 2014, SCANNING, V36, P622, DOI 10.1002/sca.21170; CHAPMAN EH, 1981, J CLIN PATHOL, V34, P1083, DOI 10.1136/jcp.34.10.1083; Chaurio RA, 2009, MOLECULES, V14, P4892, DOI 10.3390/molecules14124892; Chen JH, 2007, CHIN J CLIN ONCOL, V4, P16, DOI DOI 10.1007/S11805-007-0016-9; Costa A, 2014, SEMIN CANCER BIOL, V25, P23, DOI 10.1016/j.semcancer.2013.12.007; Costa L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101687; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Demchenko A. P., 2012, Experimental Oncology, V34, P263; Fang YQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07074; Gao FH, 2012, INT J MOL MED, V29, P649, DOI 10.3892/ijmm.2012.895; Girasole M, 2007, BBA-BIOMEMBRANES, V1768, P1268, DOI 10.1016/j.bbamem.2007.01.014; Gonzalez C, 2002, RESP PHYSIOL NEUROBI, V132, P17, DOI 10.1016/S1569-9048(02)00047-2; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hossain K, 2003, FREE RADICAL BIO MED, V34, P598, DOI 10.1016/S0891-5849(02)01359-X; Huang J, 2008, J PHARMACOL SCI, V107, P370, DOI 10.1254/jphs.08044FP; Ikezoe T, 2003, INT J ONCOL, V23, P1187; Ivanova D, 2013, ADV CLIN EXP MED, V22, P899; Jin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091611; Jin H, 2011, SCANNING, V33, P413, DOI 10.1002/sca.20265; Jin H, 2011, J CELL BIOCHEM, V112, P169, DOI 10.1002/jcb.22912; Kim KS, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-49; Laurent VM, 2005, BIOPHYS J, V89, P667, DOI 10.1529/biophysj.104.052316; Lekka M, 2009, NAT NANOTECHNOL, V4, P72, DOI 10.1038/nnano.2009.004; Leporatti S, 2006, FEBS LETT, V580, P450, DOI 10.1016/j.febslet.2005.12.037; Li CY, 2011, INT J BIOCHEM CELL B, V43, P701, DOI 10.1016/j.biocel.2011.01.020; Lim SC, 2011, CARCINOGENESIS, V32, P723, DOI 10.1093/carcin/bgr038; Liu JB, 2014, J INT MED RES, V42, P984, DOI 10.1177/0300060513507389; Pi J, 2014, NANOSCALE, V6, P12229, DOI 10.1039/c4nr04195j; Pi J, 2014, MICRON, V65, P1, DOI 10.1016/j.micron.2014.03.012; Pi J, 2013, APPL MICROBIOL BIOT, V97, P1051, DOI 10.1007/s00253-012-4359-7; Radmacher M, 2002, METHOD CELL BIOL, V68, P67; Radotic K, 2012, BIOPHYS J, V103, P386, DOI 10.1016/j.bpj.2012.06.046; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Song MY, 2011, ANTIOXID REDOX SIGN, V15, P1549, DOI 10.1089/ars.2010.3648; Szarama KB, 2012, DEVELOPMENT, V139, P2187, DOI 10.1242/dev.073734; Tsang WP, 2003, LIFE SCI, V73, P2047, DOI 10.1016/S0024-3205(03)00566-6; Xu L, 2013, FEBS LETT, V587, P3815, DOI 10.1016/j.febslet.2013.10.007; Yang F, 2013, BIOORG MED CHEM LETT, V23, P5544, DOI 10.1016/j.bmcl.2013.08.055; Ye LH, 2012, ANAT REC, V295, P417, DOI 10.1002/ar.21528; Zeng R, 2012, ACTA PHARMACOL SIN, V33, P91, DOI 10.1038/aps.2011.143; Zhang L, 2014, BIOSENS BIOELECTRON, V56, P271, DOI 10.1016/j.bios.2014.01.024; Zhang YH, 2011, ACTA PHARMACOL SIN, V32, P1266, DOI 10.1038/aps.2011.92	46	21	22	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140935	10.1371/journal.pone.0140935	http://dx.doi.org/10.1371/journal.pone.0140935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496199	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200043
J	Zhang, J; Fan, DH; Jian, ZX; Chen, GG; Lai, PBS				Zhang, Jian; Fan, Dahua; Jian, Zhixiang; Chen, George G.; Lai, Paul B. S.			Cancer Specific Long Noncoding RNAs Show Differential Expression Patterns and Competing Endogenous RNA Potential in Hepatocellular Carcinoma	PLOS ONE			English	Article							INTERACTION NETWORKS; SIGNALING PATHWAY; HEPATOMA-CELLS; LIVER-CANCER; PROMOTES; TARGET; CERNA; IDENTIFICATION; PROLIFERATION; ASSOCIATIONS	Long noncoding RNAs (lncRNAs) regulate gene expression by acting with microRNAs (miRNAs). However, the roles of cancer specific lncRNA and its related competitive endogenous RNAs (ceRNA) network in hepatocellular cell carcinoma (HCC) are not fully understood. The lncRNA profiles in 372 HCC patients, including 372 tumor and 48 adjacent non-tumor liver tissues, from The Cancer Genome Atlas (TCGA) and NCBI GEO omnibus (GSE65485) were analyzed. Cancer specific lncRNAs (or HCC related lncRNAs) were identified and correlated with clinical features. Based on bioinformatics generated from miRcode, starBase, and miRTarBase, we constructed an lncRNA-miRNA-mRNA network (ceRNA network) in HCC. We found 177 cancer specific lncRNAs in HCC (fold change >= 1.5, P < 0.01), 41 of them were also discriminatively expressed with gender, race, tumor grade, AJCC tumor stage, and AJCC TNM staging system. Six lncRNAs (CECR7, LINC00346, MAPKAPK5-AS1, LOC338651, FLJ90757, and LOC283663) were found to be significantly associated with overall survival (OS, log-rank P < 0.05). Collectively, our results showed the lncRNA expression patterns and a complex ceRNA network in HCC, and identified a complex cancer specific ceRNA network, which includes 14 lncRNAs and 17 miRNAs in HCC.	[Zhang, Jian; Chen, George G.; Lai, Paul B. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; [Zhang, Jian] Sun Yat Sen Univ, Div Gastrointestinal Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Jian] Sun Yat Sen Univ, Gastr Canc Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Fan, Dahua] Shenzhen Univ, Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China; [Jian, Zhixiang] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Sun Yat Sen University; Sun Yat Sen University; Shenzhen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Chen, GG (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China.	paullai@surgery.cuhk.edu.hk	ZHANG, Jian/ABB-7267-2020; Lai, Paul BS/K-8556-2015; Chen, George Gong/I-2757-2016; zhang, jian/E-7203-2010	ZHANG, Jian/0000-0001-8870-515X; Lai, Paul BS/0000-0002-9469-6728; zhang, jian/0000-0001-8870-515X	Specialized Research Fund for the Doctoral Program of Higher Education; Research Grants Council Earmarked Research Grants Joint Research Scheme [M-CUHK406/13]; National Natural Science Foundation of China [81472339]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research Grants Council Earmarked Research Grants Joint Research Scheme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Specialized Research Fund for the Doctoral Program of Higher Education and Research Grants Council Earmarked Research Grants Joint Research Scheme (No. M-CUHK406/13) and the National Natural Science Foundation of China (No. ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bak RO, 2014, WIRES RNA, V5, P317, DOI 10.1002/wrna.1213; Bridgland L, 2003, HUM GENET, V112, P57, DOI 10.1007/s00439-002-0827-y; Crea F, 2014, ONCOTARGET, V5, P764, DOI 10.18632/oncotarget.1769; Cui M, 2015, CANCER RES, V75, P846, DOI 10.1158/0008-5472.CAN-14-1192; Cui M, 2015, NEOPLASIA, V17, P79, DOI 10.1016/j.neo.2014.11.004; Du YM, 2012, J BIOL CHEM, V287, P26302, DOI 10.1074/jbc.M112.342113; Fachel AA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-140; Gao YZ, 2015, TUMOR BIOL, V36, P7409, DOI 10.1007/s13277-015-3408-0; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hu Y, 2014, ONCOTARGET, V5, P2230, DOI 10.18632/oncotarget.1895; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Li JG, 2014, GUT, V63, P1700, DOI 10.1136/gutjnl-2013-305806; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Quagliata L, 2014, HEPATOLOGY, V59, P911, DOI 10.1002/hep.26740; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106282; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tsang FHC, 2015, LIVER INT, V35, P1597, DOI 10.1111/liv.12746; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; Wang F, 2015, ONCOTARGET, V6, P7899, DOI 10.18632/oncotarget.3219; Wang P, 2015, NUCLEIC ACIDS RES, V43, P3478, DOI 10.1093/nar/gkv233; Weiler S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0286-9; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128628; Zhao YD, 2008, CANCER INFORM, V6, P9; Zhu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101707	34	103	108	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141042	10.1371/journal.pone.0141042	http://dx.doi.org/10.1371/journal.pone.0141042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492393	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300024
J	Fernandez-Delgado, L; Vega-Rioja, A; Ventura, I; Chamorro, C; Aroca, R; Prados, M; Bobadilla, P; Rodriguez, D; Palacios, R; Monteseirin, J				Fernandez-Delgado, Lourdes; Vega-Rioja, Antonio; Ventura, Inmaculada; Chamorro, Cristina; Aroca, Rocio; Prados, Manuel; Bobadilla, Pedro; Rodriguez, David; Palacios, Ricardo; Monteseirin, Javier			Allergens Induce the Release of Lactoferrin by Neutrophils from Asthmatic Patients	PLOS ONE			English	Article							CUTANEOUS INFLAMMATION; AIRWAY INFLAMMATION; MEDIATOR RELEASE; MURINE MODEL; MAST-CELLS; ACTIVATION; EXPRESSION; GALECTIN-3; IGE; MIGRATION	Background Despite the evidence that Lactoferrin (Lf) is involved in allergic asthma processes, it is unknown whether neutrophils can be one of the main cellular sources of this key inflammatory mediator directly in response of an IgE mediated stimulus. The present study was undertaken to analyze this question. Methods Neutrophils from healthy subjects (n = 34) and neutrophils from allergic asthmatic patients (n = 102) were challenged in vitro with specific allergens to which the patients were sensitized, PAF, or agonist mAbs against IgE-receptors, and the levels of Lf were measured in the culture supernatant. The levels of serum IgE together with the severity of symptoms were also analyzed. Results Lf was released into the culture supernatant of neutrophils from allergic asthmatic patients in response to allergens and PAF. This response was highly allergen-specific, and did not happen in neutrophils from healthy donors. Allergen effect was mimicked by Abs against Fc epsilon RI and galectin-3 but not by Fc epsilon RII. The levels of released Lf correlated well with the levels of serum specific IgE and severity of asthma symptoms. These observations represent a novel view of neutrophils as an important source of Lf in allergic asthma. Importantly, the levels of released Lf by neutrophils could therefore be used to evaluate disease severity in allergic asthmatic patients.	[Fernandez-Delgado, Lourdes; Vega-Rioja, Antonio; Ventura, Inmaculada; Chamorro, Cristina; Aroca, Rocio; Prados, Manuel; Monteseirin, Javier] Hosp Univ Virgen Macarena, Unidad Gest Clin Alergia Intercentros, Seville, Spain; [Monteseirin, Javier] Univ Seville, Fac Med, Dept Med, Seville, Spain; [Bobadilla, Pedro] Hosp Infanta Elena, Serv Alergia, Badajoz, Spain; [Rodriguez, David; Palacios, Ricardo] Labs Diater, Madrid, Spain	Hospital Universitario Virgen Macarena; University of Sevilla	Monteseirin, J (corresponding author), Hosp Univ Virgen Macarena, Unidad Gest Clin Alergia Intercentros, Seville, Spain.	fmonteseirin@us.es		Vega Rioja, Antonio/0000-0003-4698-9697	FIS-Thematic Networks; Co-Operative Research Centres RIRAAF [RD07-0064]; Fundacion Alergol, Spain	FIS-Thematic Networks; Co-Operative Research Centres RIRAAF; Fundacion Alergol, Spain	This work was supported by the FIS-Thematic Networks and Co-Operative Research Centres RIRAAF (RD07-0064) and Fundacion Alergol, Spain. Javier Monteseirin is under the Programa de Intensificacion de la Actividad Investigadora del Sistema Nacional de Salud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaniz L, 2013, FASEB J, V27, P2902, DOI 10.1096/fj.12-223867; Aroca R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094558; Bournazou I, 2010, IMMUNOL CELL BIOL, V88, P220, DOI 10.1038/icb.2009.86; Chen HY, 2006, J IMMUNOL, V177, P4991, DOI 10.4049/jimmunol.177.8.4991; Ciepiela O, 2013, ADV EXP MED BIOL, V756, P73, DOI 10.1007/978-94-007-4549-0_10; De la Rosa G, 2008, J IMMUNOL, V180, P6868, DOI 10.4049/jimmunol.180.10.6868; Elrod KC, 1997, AM J RESP CRIT CARE, V156, P375, DOI 10.1164/ajrccm.156.2.9607012; FAHY JV, 1993, AM REV RESPIR DIS, V147, P1132, DOI 10.1164/ajrccm/147.5.1132; GAHR M, 1991, J LEUKOCYTE BIOL, V49, P427, DOI 10.1002/jlb.49.5.427; Gao P, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-136; Gounni AS, 2001, FASEB J, V15, P940, DOI 10.1096/fj.00-0378com; Griffiths CEM, 2001, BRIT J DERMATOL, V144, P715, DOI 10.1046/j.1365-2133.2001.04125.x; He SH, 2003, BIOCHEM PHARMACOL, V65, P1007, DOI 10.1016/S0006-2952(02)01651-9; Hoskins A, 2013, AM J RESP CRIT CARE, V187, P34, DOI 10.1164/rccm.201204-0786OC; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Kimber I, 2002, BIOCHEM CELL BIOL, V80, P103, DOI 10.1139/o01-227; Konishi M, 2006, HEPATOL RES, V36, P27, DOI 10.1016/j.hepres.2006.06.005; Kowalski ML, 1999, ALLERGY, V54, P804, DOI 10.1034/j.1398-9995.1999.00897.x; Kruzel ML, 2006, IMMUNOLOGY, V119, P159, DOI 10.1111/j.1365-2567.2006.02417.x; Legrand D, 2012, BIOCHEM CELL BIOL, V90, P252, DOI [10.1139/O11-056, 10.1139/o11-056]; Legrand D, 2010, BIOMETALS, V23, P365, DOI 10.1007/s10534-010-9297-1; MENEELY GR, 1962, AM REV RESPIR DIS, V85, P762; Monteseirin J, 2005, CLIN EXP ALLERGY, V35, P1204, DOI 10.1111/j.1365-2222.2005.02320.x; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Monteseirin J, 2007, J IMMUNOL, V179, P2634, DOI 10.4049/jimmunol.179.4.2634; National Heart Lung and Blood Institute National High Blood Pressure Education Program Working Group, 2005, NIH PUBL; Pejler G, 1996, BIOCHEM J, V320, P897, DOI 10.1042/bj3200897; PRUZANSKY JJ, 1983, J IMMUNOL, V131, P1949; Ruas LP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004519; Saegusa J, 2009, AM J PATHOL, V174, P922, DOI 10.2353/ajpath.2009.080500; SATO K, 1992, J ALLERGY CLIN IMMUN, V90, P21, DOI 10.1016/S0091-6749(06)80007-2; Sedgwick JB, 2003, AM J RESP CELL MOL, V29, P702, DOI 10.1165/rcmb.2002-0257OC; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Sorimachi K, 1997, BIOCHEM MOL BIOL INT, V43, P79; VANDEGRAAF EA, 1991, LUNG, V169, P275, DOI 10.1007/BF02714163; Vega A, 2007, J CELL SCI, V120, P2328, DOI 10.1242/jcs.000331; Vega A, 2006, J LEUKOCYTE BIOL, V80, P152, DOI 10.1189/jlb.0705411; Ventura I, 2014, ALLERGY, V69, P898, DOI 10.1111/all.12414; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Zuberi RI, 2004, AM J PATHOL, V165, P2045, DOI 10.1016/S0002-9440(10)63255-5; Zweiman B, 2000, CLIN EXP ALLERGY, V30, P856	41	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141278	10.1371/journal.pone.0141278	http://dx.doi.org/10.1371/journal.pone.0141278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488881	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400119
J	Iura, A; McNerny, EG; Zhang, YS; Kamiya, N; Tantillo, M; Lynch, M; Kohn, DH; Mishina, Y				Iura, Ayaka; McNerny, Erin Gatenby; Zhang, Yanshuai; Kamiya, Nobuhiro; Tantillo, Margaret; Lynch, Michelle; Kohn, David H.; Mishina, Yuji			Mechanical Loading Synergistically Increases Trabecular Bone Volume and Improves Mechanical Properties in the Mouse when BMP Signaling Is Specifically Ablated in Osteoblasts	PLOS ONE			English	Article							LONG-DURATION SPACEFLIGHT; IA RECEPTOR BMPRIA; CORTICAL BONE; FAS LIGAND; EXERCISE; MICE; EXPRESSION; POROSITY; MASS; MICROSTRUCTURE	Bone homeostasis is affected by several factors, particularly mechanical loading and growth factor signaling pathways. There is overwhelming evidence to validate the importance of these signaling pathways, however, whether these signals work synergistically or independently to contribute to proper bone maintenance is poorly understood. Weight-bearing exercise increases mechanical load on the skeletal system and can improves bone quality. We previously reported that conditional knockout (cKO) of Bmpr1a, which encodes one of the type 1 receptors for Bone Morphogenetic Proteins (BMPs), in an osteoblast-specific manner increased trabecular bone mass by suppressing osteoclastogenesis. The cKO bones also showed increased cortical porosity, which is expected to impair bone mechanical properties. Here, we evaluated the impact of weight-bearing exercise on the cKO bone phenotype to understand interactions between mechanical loading and BMP signaling through BMPR1A. Male mice with disruption of Bmpr1a induced at 9 weeks of age, exercised 5 days per week on a motor-driven treadmill from 11 to 16 weeks of age. Trabecular bone volume in cKO tibia was further increased by exercise, whereas exercise did not affect the trabecular bone in the control genotype group. This finding was supported by decreased levels of osteoclasts in the cKO tibiae. The cortical porosity in the cKO bones showed a marginally significant decrease with exercise and approached normal levels. Exercise increased ductility and toughness in the cKO bones. Taken together, reduction in BMPR1A signaling may sensitize osteoblasts for mechanical loading to improve bone mechanical properties.	[Iura, Ayaka; McNerny, Erin Gatenby; Zhang, Yanshuai; Kamiya, Nobuhiro; Tantillo, Margaret; Lynch, Michelle; Kohn, David H.; Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Mishina, Y (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	mishina@umich.edu	Kohn, David/AAJ-4131-2020	Saito, Ayaka/0000-0002-9916-0463; McNerny, Erin/0000-0002-1825-9657	National Institutes of Health [R01AR056657, R01DE020843, S10RR026475]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study is supported by the National Institutes of Health (R01AR056657 to DK, R01DE020843 to YM, S10RR026475 to the School of Dentistry microCT Core), URL: http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrecht G, 2011, J BONE MINER RES, V26, P2399, DOI 10.1002/jbmr.482; Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; Banse X, 2002, ACTA ORTHOP SCAND, V73, P2; Bikle DD, 1999, J BONE MINER METAB, V17, P233, DOI 10.1007/s007740050090; CASSELLA JP, 1994, BONE, V15, P329, DOI 10.1016/8756-3282(94)90296-8; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Cuenca-Lopez MD, 2010, J TISSUE ENG REGEN M, V4, P543, DOI 10.1002/term.271; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dong XN, 2004, J BIOMECH, V37, P1281, DOI [10.1016/j.jbiomech.2003.12.011, 10.1016/j.biomech.2003.12.011]; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kamiya N, 2011, BIOFACTORS, V37, P75, DOI 10.1002/biof.139; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Kamiya N, 2008, J BONE MINER RES, V23, P2007, DOI 10.1359/JBMR.080809; Kohn DH, 2009, CELLS TISSUES ORGANS, V189, P33, DOI 10.1159/000151452; Kopf J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-37; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lang TF, 2006, J BONE MINER RES, V21, P1224, DOI 10.1359/JBMR.060509; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCALDEN RW, 1993, J BONE JOINT SURG AM, V75A, P1193, DOI 10.2106/00004623-199308000-00009; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Patsch JM, 2013, J BONE MINER RES, V28, P313, DOI 10.1002/jbmr.1763; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Rui YF, 2011, J ORTHOP RES, V29, P390, DOI 10.1002/jor.21218; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Simpson AHRW, 2006, J BONE JOINT SURG BR, V88B, P701, DOI 10.1302/0301-620X.88B6; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wallace JM, 2007, BONE, V40, P1120, DOI 10.1016/j.bone.2006.12.002; Wallace JM, 2010, ANN BIOMED ENG, V38, P1607, DOI 10.1007/s10439-009-9881-0; Wallace JM, 2009, CALCIFIED TISSUE INT, V84, P297, DOI 10.1007/s00223-009-9228-8; Wang H, 2012, OSTEOPOROSIS INT, V23, P2169, DOI 10.1007/s00198-011-1839-z; Wess TJ, 2005, ADV PROTEIN CHEM, V70, P341, DOI 10.1016/S0065-3233(05)70010-3; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Yeni YN, 1997, BONE, V21, P453, DOI 10.1016/S8756-3282(97)00173-7; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	41	22	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141345	10.1371/journal.pone.0141345	http://dx.doi.org/10.1371/journal.pone.0141345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489086	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400121
J	Kokkinopoulou, M; Spiecker, L; Messerschmidt, C; Barbeck, M; Ghanaati, S; Landfester, K; Markl, J				Kokkinopoulou, Maria; Spiecker, Lisa; Messerschmidt, Claudia; Barbeck, Mike; Ghanaati, Shahram; Landfester, Katharina; Markl, Juergen			On the Ultrastructure and Function of Rhogocytes from the Pond Snail Lymnaea stagnalis	PLOS ONE			English	Article							KEYHOLE LIMPET HEMOCYANIN; ELECTRON-MICROSCOPY; PORE CELLS; CONNECTIVE-TISSUE; SLIT DIAPHRAGM; IN-VIVO; MERCENARIA-MERCENARIA; MEGA-HEMOCYANIN; BROWN CELLS; GASTROPOD	Rhogocytes, also termed "pore cells", occur as solitary or clustered cells in the connective tissue of gastropod molluscs. Rhogocytes possess an enveloping lamina of extracellular matrix and enigmatic extracellular lacunae bridged by cytoplasmic bars that form 20 nm diaphragmatic slits likely to act as a molecular sieve. Recent papers highlight the embryogenesis and ultrastructure of these cells, and their role in heavy metal detoxification. Rhogocytes are the site of hemocyanin or hemoglobin biosynthesis in gastropods. Based on electron microscopy, we recently proposed a possible pathway of hemoglobin exocytosis through the slit apparatus, and provided molecular evidence of a common phylogenetic origin of molluscan rhogocytes, insect nephrocytes and vertebrate podocytes. However, the previously proposed secretion mode of the respiratory proteins into the hemolymph is still rather hypothetical, and the possible role of rhogocytes in detoxification requires additional data. Although our previous study on rhogocytes of the red-blooded (hemoglobin-containing) freshwater snail Biomphalaria glabrata provided much new information, a disadvantage was that the hemoglobin molecules were not unequivocally defined in the electron microscope. This made it difficult to trace the exocytosis pathway of this protein. Therefore, we have now performed a similar study on the rhogocytes of the blue-blooded (hemocyanin-containing) freshwater snail Lymnaea stagnalis. The intracellular hemocyanin could be identified in the electron microscope, either as individual molecules or as pseudo-crystalline arrays. Based on 3D-electron microscopy, and supplemented by in situ hybridization, immunocytochemistry and stress response experiments, we provide here additional details on the structure and hemocyanin biosynthesis of rhogocytes, and on their response in animals under cadmium and starvation stress. Moreover, we present an advanced model on the release of synthesized hemocyanin molecules through the slit apparatus into the hemolymph, and the uptake of much smaller particles such as cadmium ions from the hemolymph through the slit apparatus into the cytoplasm.	[Kokkinopoulou, Maria; Spiecker, Lisa; Markl, Juergen] Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany; [Messerschmidt, Claudia; Landfester, Katharina] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Barbeck, Mike; Ghanaati, Shahram] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, D-55101 Mainz, Germany	Johannes Gutenberg University of Mainz; Max Planck Society; Johannes Gutenberg University of Mainz	Markl, J (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany.	markl@uni-mainz.de	Landfester, Katharina/F-9449-2011; Barbeck, Mike/U-4340-2018	Landfester, Katharina/0000-0001-9591-4638; Barbeck, Mike/0000-0002-3001-1347; Spiecker, Lisa/0000-0003-1801-4630; Ghanaati, Shahram/0000-0002-7897-0854	Max Planck Graduate Center (MPGC) of the Johannes Gutenberg University, Mainz, Germany; Electron Microscopy Center Mainz (EMZM) of the Johannes Gutenberg University	Max Planck Graduate Center (MPGC) of the Johannes Gutenberg University, Mainz, Germany; Electron Microscopy Center Mainz (EMZM) of the Johannes Gutenberg University	This work was funded by the Max Planck Graduate Center (MPGC) of the Johannes Gutenberg University, Mainz, Germany (MK: grant; JM: consumables, instruments) and the Electron Microscopy Center Mainz (EMZM) of the Johannes Gutenberg University (JM: instruments). The funders (www.uni-mainz.de) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Allah AT, 2002, J MOLLUS STUD, V69, P35; Albrecht T, 2001, CELL TISSUE RES, V304, P455, DOI 10.1007/s004410100368; BANI G, 1990, Z MIKROSK ANAT FORSC, V104, P856; Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8; BOER HH, 1976, CELL TISSUE RES, V170, P221; CAVALIER A, 2009, HDB CRYOPREPARATION; Dallinger R, 1997, NATURE, V388, P237, DOI 10.1038/40785; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; De Carlo S, 2011, MICRON, V42, P117, DOI 10.1016/j.micron.2010.06.003; FIORONI P, 1984, ZOOL ANZ, V212, P193; FOURNIE J, 1982, MALACOLOGIA, V22, P265; Gatsogiannis C, 2015, STRUCTURE, V23, P93, DOI 10.1016/j.str.2014.10.013; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; GEBAUER W, 1994, ZOOL-ANAL COMPLEX SY, V98, P51; Ghanaati S, 2011, ACTA BIOMATER, V7, P4018, DOI 10.1016/j.actbio.2011.07.003; Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006; Ghanaati S, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035005; Giamberini L, 1996, BIOL CELL, V86, P59, DOI 10.1016/0248-4900(96)89525-6; Gomot A, 1998, ECOTOX ENVIRON SAFE, V41, P288, DOI 10.1006/eesa.1998.1711; Gust M, 2013, AQUAT TOXICOL, V126, P393, DOI 10.1016/j.aquatox.2012.09.001; HALL RL, 1975, COMP BIOCHEM PHYS B, V52, P211; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; Handke B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067208; HARRIS JR, 1992, MICRON MICROSC ACTA, V23, P287, DOI 10.1016/0739-6260(92)90031-8; Haszprunar G, 1996, J MOLLUS STUD, V62, P185, DOI 10.1093/mollus/62.2.185; JONES GW, 1979, CELL TISSUE RES, V204, P253; Kokkinopoulou M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101078; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LESSARD JL, 1988, CELL MOTIL CYTOSKEL, V10, P349, DOI 10.1002/cm.970100302; Lieb B, 2004, J MOL EVOL, V59, P536, DOI 10.1007/s00239-004-2646-3; Lieb B, 2000, J BIOL CHEM, V275, P5675, DOI 10.1074/jbc.275.8.5675; Lieb B, 2001, P NATL ACAD SCI USA, V98, P4546, DOI 10.1073/pnas.071049998; Lieb B, 2006, P NATL ACAD SCI USA, V103, P12011, DOI 10.1073/pnas.0601861103; Lieb B, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-14; Manubens A, 2010, CELL TISSUE RES, V342, P423, DOI 10.1007/s00441-010-1057-6; Marigomez I, 2002, MICROSC RES TECHNIQ, V56, P358, DOI 10.1002/jemt.10040; MARIGOMEZ JA, 1990, HISTOCHEMISTRY, V94, P191, DOI 10.1007/BF02440187; MARKL J, 1992, J COMP PHYSIOL B, V162, P665, DOI 10.1007/BF00301616; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; Martin AM, 2011, INVERTEBR BIOL, V130, P302, DOI 10.1111/j.1744-7410.2011.00249.x; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Meister G., 1977, Zoologische Jb (Anat), V97, P54; Nott JA, 1993, J MAR BIOL ASSOC UK, V13, P396; Prince JS, 2006, J MOLLUS STUD, V72, P349, DOI 10.1093/mollus/eyl017; Pyatt A. J., 2002, Invertebrate Neuroscience, V4, P135; RIVEST BR, 1992, BIOL BULL, V182, P305, DOI 10.2307/1542251; RUPPERT EE, 1994, AM ZOOL, V34, P542; Russo J, 2007, ENVIRON POLLUT, V146, P420, DOI 10.1016/j.envpol.2006.06.032; Sairi F, 2015, MAR BIOTECHNOL, V17, P168, DOI 10.1007/s10126-014-9605-9; Schaffeld M, 2004, METHOD CELL BIOL, V78, P627; SKELDING JM, 1975, CELL TISSUE RES, V156, P381; SMINIA T, 1972, Z ZELLFORSCH MIK ANA, V130, P497, DOI 10.1007/BF00307004; SMINIA T, 1972, Z ZELLFORSCH MIK ANA, V135, P563, DOI 10.1007/BF00583437; SMINIA T, 1973, Z ZELLFORSCH MIK ANA, V145, P443, DOI 10.1007/BF00307166; SMINIA T, 1977, CELL TISSUE RES, V183, P299; Stewart H, 2014, INVERTEBR BIOL, V133, P47, DOI 10.1111/ivb.12041; Streit K, 2005, DIFFERENTIATION, V73, P341, DOI 10.1111/j.1432-0436.2005.00035.x; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VONBALOGH K, 1988, WATER RES, V22, P1205, DOI 10.1016/0043-1354(88)90106-6; Wartiovaara J, 2004, J CLIN INVEST, V114, P1475, DOI 10.1172/JCI200422562; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; WOOD EJ, 1981, COMP BIOCHEM PHYS B, V69, P877, DOI 10.1016/0305-0491(81)90398-9; Zaroogian G, 2002, ECOTOX ENVIRON SAFE, V53, P285, DOI 10.1006/eesa.2002.2218; ZAROOGIAN G, 1995, COMP BIOCHEM PHYS C, V111, P109, DOI 10.1016/0742-8413(95)00014-X; Zhang QF, 2013, STRUCTURE, V21, P604, DOI 10.1016/j.str.2013.02.018; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	68	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141195	10.1371/journal.pone.0141195	http://dx.doi.org/10.1371/journal.pone.0141195			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488403	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400115
J	Benson, EA; Skaar, TC; Liu, YL; Nephew, KP; Matei, D				Benson, Eric A.; Skaar, Todd C.; Liu, Yunlong; Nephew, Kenneth P.; Matei, Daniela			Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; BLOOD; PATHOGENESIS; CARCINOMA	Objective Plasma miRNAs represent potential minimally invasive biomarkers to monitor and predict outcomes from chemotherapy. The primary goal of the current study-consisting of patients with recurrent, platinum-resistant ovarian cancer-was to identify the changes in circulating miRNA concentrations associated with decitabine followed by carboplatin chemotherapy treatment. A secondary goal was to associate clinical response with changes in circulating miRNA concentration. Methods We measured miRNA concentrations in plasma samples from 14 patients with platinum-resistant, recurrent ovarian cancer enrolled in a phase II clinical trial that were treated with a low dose of the hypomethylating agent (HMA) decitabine for 5 days followed by carboplatin on day 8. The primary endpoint was to determine chemotherapy-associated changes in plasma miRNA concentrations. The secondary endpoint was to correlate miRNA changes with clinical response as measured by progression free survival (PFS). Results Seventy-eight miRNA plasma concentrations were measured at baseline (before treatment) and at the end of the first cycle of treatment (day 29). Of these, 10 miRNAs (miR-193a-5p, miR-375, miR-339-3p, miR-340-5p, miR-532-3p, miR-133a-3p, miR-25-3p, miR-10a-5p, miR-616-5p, and miR-148b-5p) displayed fold changes in concentration ranging from -2.9 to 4 (p < 0.05), in recurrent platinum resistant ovarian cancer patients, that were associated with response to decitabine followed by carboplatin chemotherapy. Furthermore, lower concentrations of miR-148b-5p after this chemotherapy regimen were associated (P < 0.05) with the PFS. Conclusions This is the first report demonstrating altered circulating miRNA concentrations following a combination platinum plus HMA chemotherapy regiment. In addition, circulating miR-148b-5p concentrations were associated with PFS and may represent a novel biomarker of therapeutic response, with this chemotherapy regimen, in women with recurrent, drug-resistant ovarian cancer.	[Benson, Eric A.; Skaar, Todd C.; Matei, Daniela] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Benson, Eric A.; Skaar, Todd C.] Indiana Univ Sch Med, Div Clin Pharmacol, Indianapolis, IN 46202 USA; [Benson, Eric A.; Matei, Daniela] Indiana Univ Sch Med, VA Roudebush Hosp, Indianapolis, IN 46202 USA; [Liu, Yunlong] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Liu, Yunlong] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Nephew, Kenneth P.] Indiana Univ Sch Med, Dept Cellular Physiol, Indianapolis, IN 46202 USA; [Nephew, Kenneth P.] Indiana Univ Sch Med, Dept Integrat Physiol, Indianapolis, IN 46202 USA; [Nephew, Kenneth P.; Matei, Daniela] Indiana Univ Sch Med, Dept Obstet & Gynecol, Med Sci Program, Indianapolis, IN 46202 USA; [Nephew, Kenneth P.; Matei, Daniela] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Matei, Daniela] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Benson, EA (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA.	eabenson@iu.edu	Skaar, Todd/ABD-7827-2021	Matei, Daniela/0000-0003-2169-5035; Benson, Eric/0000-0002-3111-9464	National Cancer Institute [CA133877-01, NCI-CA182832]; National Institute of General Medical Sciences [5T32GM008425-19]; Indiana University Simon Cancer Center Cancer Center [P30 CA082709-15]; NATIONAL CANCER INSTITUTE [P30CA082709, R21CA133877, R01CA182832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088076, T32GM008425] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Indiana University Simon Cancer Center Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partly funded by the National Cancer Institute Award CA133877-01 (DM), NCI-CA182832 (DM & KPN), National Institute of General Medical Sciences 5T32GM008425-19 (EAB), and the Indiana University Simon Cancer Center Cancer Center Support Grant P30 CA082709-15 supporting the Bioinformatics core. The authors thank Eisai Co., Ltd. (Tokyo, Japan) for providing decitabine, Mrs. Amber Allen, Carol Kulesavage, Nancy Menning, and Jessica Roy for coordination of clinical trial activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benson EA, 2013, DRUG METAB DISPOS, V41, P1778, DOI 10.1124/dmd.113.052357; Chang H, 2012, MOL MED REP, V5, P1277, DOI 10.3892/mmr.2012.794; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Eitan R, 2009, GYNECOL ONCOL, V114, P253, DOI 10.1016/j.ygyno.2009.04.024; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frederick PJ, 2013, BIOTECH HISTOCHEM, V88, P403, DOI 10.3109/10520295.2013.788736; Gezer U, 2014, ONCOL LETT, V8, P845, DOI 10.3892/ol.2014.2188; Gu YY, 2015, ONCOTARGET, V6, P2397, DOI 10.18632/oncotarget.2963; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kjersem JB, 2014, MOL ONCOL, V8, P59, DOI 10.1016/j.molonc.2013.09.001; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909; Mezzanzanica D, 2010, INT J BIOCHEM CELL B, V42, P1262, DOI 10.1016/j.biocel.2009.12.017; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Muller V, 2014, BREAST CANCER RES TR, V147, P61, DOI 10.1007/s10549-014-3079-3; Nakano H, 2013, INT J ONCOL, V42, P1875, DOI 10.3892/ijo.2013.1896; Plumb JA, 2000, CANCER RES, V60, P6039; Schorge JO, 2010, GYNECOL ONCOL, V119, P7, DOI 10.1016/j.ygyno.2010.06.003; Triozzi PL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-241; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Wen Z, 2015, MOL MED REPORTS; Xiang Y, 2014, ONCOGENE, V33, P378, DOI 10.1038/onc.2012.575; Zhao HM, 2015, TUMOUR BIOL; Zhao S, 2015, MOL MED REPORTS; Zhao YN, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-14; Zheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077853; Zhou X, 2012, ONCOL REP, V27, P447, DOI 10.3892/or.2011.1482	29	45	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141279	10.1371/journal.pone.0141279	http://dx.doi.org/10.1371/journal.pone.0141279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485143	Green Published, gold			2022-12-27	WOS:000363028100129
J	Gao, ZQ; Li, Y; Wu, GX; Li, GQ; Sun, HF; Deng, SZ; Shen, YC; Chen, GQ; Zhang, RH; Meng, CX; Zhang, XW				Gao, Zhengquan; Li, Yan; Wu, Guanxun; Li, Guoqiang; Sun, Haifeng; Deng, Suzhen; Shen, Yicheng; Chen, Guoqiang; Zhang, Ruihao; Meng, Chunxiao; Zhang, Xiaowen			Transcriptome Analysis in Haematococcus pluvialis: Astaxanthin Induction by Salicylic Acid (SA) and Jasmonic Acid (JA)	PLOS ONE			English	Article							CAROTENOID ACCUMULATION; FACTOR FAMILY; EXPRESSION; STRESS; GENES; ANNOTATION; IDENTIFICATION; GROWTH	Haematococcus pluvialis is an astaxanthin-rich microalga that can increase its astaxanthin production by salicylic acid (SA) or jasmonic acid (JA) induction. The genetic transcriptome details of astaxanthin biosynthesis were analyzed by exposing the algal cells to 25 mg/L of SA and JA for 1, 6 and 24 hours, plus to the control (no stress). Based on the RNA-seq analysis, 56,077 unigenes (51.7%) were identified with functions in response to the hormone stress. The top five identified subcategories were cell, cellular process, intracellular, catalytic activity and cytoplasm, which possessed 5600 (similar to 9.99%), 5302 (similar to 9.45%), 5242 (similar to 9.35%), 4407 (similar to 7.86%) and 4195 (similar to 7.48%) unigenes, respectively. Furthermore, 59 unigenes were identified and assigned to 26 putative transcription factors (TFs), including 12 plant-specific TFs. They were likely associated with astaxanthin biosynthesis in Haematococcus upon SA and JA stress. In comparison, the up-regulation of differential expressed genes occurred much earlier, with higher transcript levels in the JA treatment (about 6 h later) than in the SA treatment (beyond 24 h). These results provide valuable information for directing metabolic engineering efforts to improve astaxanthin biosynthesis in H. pluvialis.	[Gao, Zhengquan; Wu, Guanxun; Li, Guoqiang; Sun, Haifeng; Deng, Suzhen; Shen, Yicheng; Chen, Guoqiang; Zhang, Ruihao; Meng, Chunxiao] Shandong Univ Technol, Sch Life Sci, Zibo 255049, Peoples R China; [Zhang, Xiaowen] Chinese Acad Fishery Sci, Yellow Sea Fishery Res Inst, Qingdao 266071, Peoples R China; [Li, Yan] James Cook Univ, Coll Marine & Environm Sci, Douglas 4811, Australia; [Li, Yan] Univ Queensland, Sch Food & Agr Sci, St Lucia, Qld 4072, Australia	Shandong University of Technology; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; James Cook University; University of Queensland	Meng, CX (corresponding author), Shandong Univ Technol, Sch Life Sci, Zibo 255049, Peoples R China.	mengchunxiao@126.com; zhangxw@ysfri.ac.cn		Li, Yan/0000-0002-9742-0081	National Natural Science Foundation of China [41106124, 31170279]; Hi-Tech Research and Developmemt Program (863) of China [2014AA022003]; National Natural Science Foundation of Shandong province [ZR2011DM006, ZR2011CQ010]; James Cook University Miscellaneous Research Fund [JCU20732]; Supporting Program of Young Teachers in Shandong University of Technology [4072-110045, 4072-114021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Developmemt Program (863) of China; National Natural Science Foundation of Shandong province; James Cook University Miscellaneous Research Fund; Supporting Program of Young Teachers in Shandong University of Technology	This research was supported by the National Natural Science Foundation of China (41106124, 31170279), the Hi-Tech Research and Developmemt Program (863) of China (2014AA022003), and the National Natural Science Foundation of Shandong province (ZR2011DM006, ZR2011CQ010). The authors are also sincerely grateful for the partial financial support provided by the James Cook University Miscellaneous Research Fund 2013 (JCU20732) and the Supporting Program of Young Teachers in Shandong University of Technology (4072-110045, 4072-114021).	Aoyagi LN, 2014, PLANT SCI, V229, P32, DOI 10.1016/j.plantsci.2014.08.005; BOROWITZKA MA, 1991, J APPL PHYCOL, V3, P295, DOI 10.1007/BF02392882; BOUSSIBA S, 1991, PLANT CELL PHYSIOL, V32, P1077, DOI 10.1093/oxfordjournals.pcp.a078171; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Collen J, 2006, J EXP BOT, V57, P3869, DOI 10.1093/jxb/erl171; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; Galpaz N, 2013, ARCH BIOCHEM BIOPHYS, V539, P117, DOI 10.1016/j.abb.2013.08.006; Gao ZQ, 2015, J APPL PHYCOL, V27, P1853, DOI 10.1007/s10811-014-0491-3; Gao ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042243; Gao ZQ, 2012, ENZYME MICROB TECH, V51, P225, DOI 10.1016/j.enzmictec.2012.07.001; Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Gwak Y, 2014, J EXP BOT, V65, P4317, DOI 10.1093/jxb/eru206; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim S, 2013, GENES GENOM, V35, P215, DOI 10.1007/s13258-013-0085-5; Lemoine Y, 2010, PHOTOSYNTH RES, V106, P155, DOI 10.1007/s11120-010-9583-3; Li HL, 2012, GENE, V503, P248, DOI 10.1016/j.gene.2012.04.069; Li JB, 2014, PHYSIOL MOL PLANT P, V87, P25, DOI 10.1016/j.pmpp.2014.05.004; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nowicka B, 2009, J PLANT PHYSIOL, V166, P1045, DOI 10.1016/j.jplph.2008.12.010; Ohmiya A, 2013, SCI HORTIC-AMSTERDAM, V163, P10, DOI 10.1016/j.scienta.2013.06.018; Raman V, 2011, ACTA PHYSIOL PLANT, V33, P1043, DOI 10.1007/s11738-010-0623-6; Riano-Pachon DM, 2008, GENETICS, V179, P31, DOI 10.1534/genetics.107.086090; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Sandmann G, 2009, ARCH BIOCHEM BIOPHYS, V483, P169, DOI 10.1016/j.abb.2008.10.004; Steinbrenner J, 2003, PLANT MOL BIOL, V52, P343, DOI 10.1023/A:1023948929665; Steinbrenner J, 2006, APPL ENVIRON MICROB, V72, P7477, DOI 10.1128/AEM.01461-06; Sun Z, 1998, P NATL ACAD SCI USA, V95, P11482, DOI 10.1073/pnas.95.19.11482; Vidhyavathi R, 2008, J EXP BOT, V59, P1409, DOI 10.1093/jxb/ern048; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Yang SH, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-118; Zheng MG, 2013, GENE, V523, P117, DOI 10.1016/j.gene.2013.04.005; Zhu Q, 2010, GENE, V457, P1, DOI 10.1016/j.gene.2010.02.011; Zhu ZG, 2013, J PLANT PHYSIOL, V170, P923, DOI 10.1016/j.jplph.2013.01.017	38	29	32	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140609	10.1371/journal.pone.0140609	http://dx.doi.org/10.1371/journal.pone.0140609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484871	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000363028100050
J	Katakura, M; Hashimoto, M; Inoue, T; Al Mamun, A; Tanabe, Y; Arita, M; Shido, O				Katakura, Masanori; Hashimoto, Michio; Inoue, Takayuki; Al Mamun, Abdullah; Tanabe, Yoko; Arita, Makoto; Shido, Osamu			Chronic Arachidonic Acid Administration Decreases Docosahexaenoic Acid- and Eicosapentaenoic Acid-Derived Metabolites in Kidneys of Aged Rats	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; RENAL ISCHEMIA-REPERFUSION; LIPID MEDIATORS; MESANGIAL CELLS; PROTECTIN D1; AGING KIDNEY; INJURY; CYCLOOXYGENASE-2; INFLAMMATION; EXPRESSION	Arachidonic acid (ARA) metabolites produced by cyclo-oxygenase and lipoxygenase are important mediators maintaining physiological renal function. However, the effects of exogenous ARA on kidney function in vivo remain unknown. This study examined the effects of long-term oral ARA administration on normal renal function as well as inflammation and oxidative stress in aged rats. In addition, we measured levels of renal eicosanoids and docosanoids using liquid chromatography-tandem mass spectrometry. Control or ARA oil (240 mg/kg body weight/day) was orally administered to 21-month-old Wistar rats for 13 weeks. Levels of plasma creatinine, blood urea nitrogen, inflammatory and anti-inflammatory cytokines, reactive oxygen species, and lipid peroxidation were not significantly different between the two groups. The ARA concentration in the plasma, kidney, and liver increased in the ARA-administered group. In addition, levels of free-form ARA, prostaglandin E2, and 12- and 15-hydroxyeicosatetraenoic acid increased in the ARA-administered group, whereas renal concentration of docosahexaenoic acid and eicosapentaenoic acid decreased in the ARA-administered group. Levels of docosahexaenoic acid-derived protectin D1, eicosapentaenoic acid-derived 5-, and 18-hydroxyeicosapentaenoic acids, and resolvin E2 and E3 decreased in the ARA-administered group. Our results indicate that long-term ARA administration led to no serious adverse reactions under normal conditions and to a decrease in anti-inflammatory docosahexaenoic acid-and eicosapentaenoic acid-derived metabolites in the kidneys of aged rats. These results indicate that there is a possibility of ARA administration having a reducing anti-inflammatory effect on the kidney.	[Katakura, Masanori; Hashimoto, Michio; Inoue, Takayuki; Al Mamun, Abdullah; Tanabe, Yoko; Shido, Osamu] Shimane Univ, Fac Med, Dept Environm Physiol, Izumo, Shimane, Japan; [Arita, Makoto] RIKEN Ctr Integrat Med Sci, Lab Metabol, Yokohama, Kanagawa, Japan	Shimane University; RIKEN	Hashimoto, M (corresponding author), Shimane Univ, Fac Med, Dept Environm Physiol, Izumo, Shimane, Japan.	michio1@med.shimane-u.ac.jp		Katakura, Masanori/0000-0002-2237-9651; Arita, Makoto/0000-0001-9902-0463	Health and Labour Sciences Research Grant of Japan [H22-Shokuhin-Ippan-002];  [23500955];  [26350120];  [21790226];  [24790234]; Grants-in-Aid for Scientific Research [15H04648, 26350120] Funding Source: KAKEN	Health and Labour Sciences Research Grant of Japan; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Health and Labour Sciences Research Grant of Japan (#H22-Shokuhin-Ippan-002) and a Grant-in-Aid for Scientific Research (C) (#23500955 to MH and #26350120 to MK) and by a Grant-in-Aid for Young Scientists (B) (#21790226 and #24790234 to MK).	ANTONIPILLAI I, 1989, ENDOCRINOLOGY, V125, P2028, DOI 10.1210/endo-125-4-2028; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Chok Mohammed Koussai, 2009, Inflammation & Allergy Drug Targets, V8, P252; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; El-Sherbeni AA, 2013, AAPS J, V15, P112, DOI 10.1208/s12248-012-9425-7; Feitoza CQ, 2010, INFLAMM RES, V59, P167, DOI 10.1007/s00011-009-0083-x; Ferreri NR, 1999, AM J PHYSIOL-RENAL, V277, pF360, DOI 10.1152/ajprenal.1999.277.3.F360; FISCHER DB, 1992, KIDNEY INT, V41, P1155, DOI 10.1038/ki.1992.176; Goto S, 1999, J Anesth, V13, P90, DOI 10.1007/s005400050032; Hao CM, 2007, KIDNEY INT, V71, P1105, DOI 10.1038/sj.ki.5002192; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Harirforoosh S, 2009, EXPERT OPIN DRUG SAF, V8, P669, DOI 10.1517/14740330903311023; Hashimoto M, 1999, J NUTR, V129, P70, DOI 10.1093/jn/129.1.70; Hashimoto M, 2005, J NUTR, V135, P549, DOI 10.1093/jn/135.3.549; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; HENRICH WL, 1992, AM J PHYSIOL, V263, pF665, DOI 10.1152/ajprenal.1992.263.4.F665; Hong S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00013; Huang SM, 1999, KIDNEY INT, V55, P1740, DOI 10.1046/j.1523-1755.1999.00440.x; Inoue T, 2014, PROSTAG LEUKOTR ESS, V91, P119, DOI 10.1016/j.plefa.2014.07.015; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Juman S, 2013, NUTRIENTS, V5, P1949, DOI 10.3390/nu5061949; Kambe T, 1999, FEBS LETT, V453, P81, DOI 10.1016/S0014-5793(99)00702-4; Katakura M, 2014, MOLECULES, V19, P3247, DOI 10.3390/molecules19033247; Katakura M, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-18; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; Kvirkvelia N, 2013, AM J PHYSIOL-RENAL, V304, pF463, DOI 10.1152/ajprenal.00575.2012; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mate SM, 2010, MOL CELL BIOCHEM, V345, P259, DOI 10.1007/s11010-010-0580-9; Matsuyama M, 2008, MOL MED REP, V1, P493; Mei CL, 2009, SEMIN NEPHROL, V29, P555, DOI 10.1016/j.semnephrol.2009.07.002; Musu M, 2011, EUR REV MED PHARMACO, V15, P1461; Nasrallah R, 2005, AM J PHYSIOL-RENAL, V289, pF235, DOI 10.1152/ajprenal.00454.2004; NASSAR GM, 1995, MINER ELECTROL METAB, V21, P262; Nolin Thomas D, 2010, Handb Exp Pharmacol, P111, DOI 10.1007/978-3-642-00663-0_5; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489; Vlassara H, 2009, KIDNEY INT, V76, pS3, DOI 10.1038/ki.2009.401; Wang XH, 2014, INT J MOL SCI, V15, P15358, DOI 10.3390/ijms150915358; Yoshizawa K, 2013, ONCOL LETT, V5, P1112, DOI 10.3892/ol.2013.1162; Zhou L, 2002, J NUTR, V132, P2626, DOI 10.1093/jn/132.9.2626; Zhou XJ, 2008, KIDNEY INT, V74, P710, DOI 10.1038/ki.2008.319	42	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140884	10.1371/journal.pone.0140884	http://dx.doi.org/10.1371/journal.pone.0140884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485038	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100084
J	Ricketts, CJ; Linehan, WM				Ricketts, Christopher J.; Linehan, W. Marston			Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC)	PLOS ONE			English	Article							ESCAPES X-INACTIVATION; GENE-EXPRESSION; JARID1C	Renal cell carcinoma (RCC) is diagnosed in >200,000 individuals worldwide each year, accounting for similar to 2% of all cancers, but the spread of this disease amongst genders is distinctly uneven. In the U.S. the male:female incidence ratio is approximately 2:1. A potential hypothesis is mutation spectra may differ between tumors dependent upon the gender of the patient, such as mutations of X chromosome encoded genes being more prevalent in male-derived tumors. Combined analysis of three recent large-scale clear cell renal cell carcinoma (CCRCC) mutation sequencing projects identified a significantly increased mutation frequency of PBRM1 and the X chromosome encoded KDM5C in tumors from male patients and BAP1 in tumors from female patients. Mutation of BAP1 had previously been significantly associated with poorer overall survival; however, when stratified by gender, mutation of BAP1 only significantly affected overall survival in female patients. Mutation of chromatin remodeling genes alters gene regulation, but the overall effect of these alterations may also be modified by the presence of other gender specific factors. Thus, the combination of gender and mutation of a specific gene, such as BAP1, may have implications not only for prognosis but also for understanding the role of chromatin remodeling gene mutations in kidney cancer progression.	[Ricketts, Christopher J.; Linehan, W. Marston] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Linehan, WM (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	WML@nih.gov	Ricketts, Christopher/AAV-9580-2020		Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research;  [ZIA BC011028]; NATIONAL CANCER INSTITUTE [ZIABC011028, ZIABC011038, ZIDBC011089] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. Funding was provided by a grant (ZIA BC011028) awarded to Dr. W. Marston Linehan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Howlader N, 2013, SEER CANC STAT REV 1; Kwekel JC, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-14; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Xu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002553	14	46	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140257	10.1371/journal.pone.0140257	http://dx.doi.org/10.1371/journal.pone.0140257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484545	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100025
J	Sackner-Bernstein, J; Kanter, D; Kaul, S				Sackner-Bernstein, Jonathan; Kanter, David; Kaul, Sanjay			Dietary Intervention for Overweight and Obese Adults: Comparison of Low-Carbohydrate and Low-Fat Diets. A Meta-Analysis	PLOS ONE			English	Article							WEIGHT-LOSS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; RANDOMIZED-TRIAL; PATTERN; PROTEIN; PREVENTION; GUIDELINES; PROGRAMS; ORNISH	Background Reduced calorie, low fat diet is currently recommended diet for overweight and obese adults. Prior data suggest that low carbohydrate diets may also be a viable option for those who are overweight and obese. Purpose Compare the effects of low carbohydrate versus low fats diet on weight and atherosclerotic cardiovascular disease risk in overweight and obese patients. Data Sources Systematic literature review via PubMed (1966-2014). Study Selection Randomized controlled trials with >= 8 weeks follow up, comparing low carbohydrate (<= 120gm carbohydrates/day) and low fat diet (<= 30% energy from fat/day). Data Extraction Data were extracted and prepared for analysis using double data entry. Prior to identification of candidate publications, the outcomes of change in weight and metabolic factors were selected as defined by Cochrane Collaboration. Assessment of the effects of diets on predicted risk of atherosclerotic cardiovascular disease risk was added during the data collection phase. Data Synthesis 1797 patients were included from 17 trials with <1 year follow up in 12. Compared with low fat diet, low carbohydrate was associated with significantly greater reduction in weight (Delta= -2.0 kg, 95% CI: -3.1, -0.9) and significantly lower predicted risk of atherosclerotic cardiovascular disease events (p<0.03). Frequentist and Bayesian results were concordant. The probability of greater weight loss associated with low carbohydrate was >99% while the reduction in predicted risk favoring low carbohydrate was >98%. Limitations Lack of patient-level data and heterogeneity in dropout rates and outcomes reported. Conclusions This trial-level meta-analysis of randomized controlled trials comparing LoCHO diets with LoFAT diets in strictly adherent populations demonstrates that each diet was associated with significant weight loss and reduction in predicted risk of ASCVD events. However, LoCHO diet was associated with modest but significantly greater improvements in weight loss and predicted ASCVD risk in studies from 8 weeks to 24 months in duration. These results suggest that future evaluations of dietary guidelines should consider low carbohydrate diets as effective and safe intervention for weight management in the overweight and obese, although long-term effects require further investigation.	[Sackner-Bernstein, Jonathan] ExVivos LLC, Hastings On Hudson, NY 10706 USA; [Kanter, David] Georgetown Univ, Ctr Law, Washington, DC USA; [Kaul, Sanjay] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	Georgetown University; Cedars Sinai Medical Center	Sackner-Bernstein, J (corresponding author), ExVivos LLC, Hastings On Hudson, NY 10706 USA.	jsb@exvivos.com			Atkins Nutritionals	Atkins Nutritionals	The study was supported by Atkins Nutritionals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jonathan Sackner-Bernstein owns and may receive compensation from ExVivos, LLC. ExVivos, LLC provided payment to authors (DK and SK) for their role as contractors to ExVivos, LLC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of each author is articulated in the 'author contributions' section.	[Anonymous], 2014, OBESITY, V22, pS41, DOI 10.1002/oby.20660; de Luis DA, 2012, DIABETES-METAB RES, V28, P663, DOI 10.1002/dmrr.2323; Bradley U, 2009, DIABETES, V58, P2741, DOI 10.2337/db09-0098; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Brehm BJ, 2005, J CLIN ENDOCR METAB, V90, P1475, DOI 10.1210/jc.2004-1540; Brinkworth GD, 2009, AM J CLIN NUTR, V90, P23, DOI 10.3945/ajcn.2008.27326; Bueno NB, 2013, BRIT J NUTR, V110, P1178, DOI 10.1017/S0007114513000548; CDER, 2013, MET PUBL M SILV SPRI, P115; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281; Diamond GA, 2004, J AM COLL CARDIOL, V43, P1929, DOI 10.1016/j.jacc.2004.01.035; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Flechtner-Mors M, 2010, DIABETES-METAB RES, V26, P393, DOI 10.1002/dmrr.1097; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Goff David C Jr, 2014, J Am Coll Cardiol, V63, P2935, DOI 10.1016/j.jacc.2013.11.005; Harcombe Z, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000196; Howard BV, 2010, AM J CLIN NUTR, V91, P860, DOI 10.3945/ajcn.2009.28034; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Hu T, 2012, AM J EPIDEMIOL, V176, pS44, DOI 10.1093/aje/kws264; IOM Food and Nutrition Board, 2005, DIET REF INT EN CARB; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Karmali KN, 2014, J AM COLL CARDIOL, V64, P959, DOI 10.1016/j.jacc.2014.06.1186; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Lean MEJ, 1997, EUR J CLIN NUTR, V51, P243, DOI 10.1038/sj.ejcn.1600391; Lim SS, 2010, NUTR METAB CARDIOVAS, V20, P599, DOI 10.1016/j.numecd.2009.05.003; Meckling KA, 2004, J CLIN ENDOCR METAB, V89, P2717, DOI 10.1210/jc.2003-031606; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; Pirozzo S, 2002, COCHRANE DB SYST REV; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Ruth MR, 2013, METABOLISM, V62, P1779, DOI 10.1016/j.metabol.2013.07.006; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Santos FL, 2012, OBES REV, V13, P1048, DOI 10.1111/j.1467-789X.2012.01021.x; Saraswat A, 2012, COCHRANE DB SYST REV, P1; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Truby H, 2006, BMJ-BRIT MED J, V332, P1309, DOI 10.1136/bmj.38833.411204.80; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Volek JS, 2009, LIPIDS, V44, P297, DOI 10.1007/s11745-008-3274-2; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006	44	122	122	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139817	10.1371/journal.pone.0139817	http://dx.doi.org/10.1371/journal.pone.0139817			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485706	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100013
J	Velasco, V; Buyukcangaz, E; Sherwood, JS; Stepan, RM; Koslofsky, RJ; Logue, CM				Velasco, Valeria; Buyukcangaz, Esra; Sherwood, Julie S.; Stepan, Ryan M.; Koslofsky, Ryan J.; Logue, Catherine M.			Characterization of Staphylococcus aureus from Humans and a Comparison with Isolates of Animal Origin, in North Dakota, United States	PLOS ONE			English	Article							METHICILLIN-RESISTANT; MRSA; PREVALENCE; IDENTIFICATION; INFECTIONS; STRAINS	Different clones of methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) Staphylococcus aureus have been found in humans as well as in animals and retail meat. However, more information about the genetic characteristics and similarities between strains is needed. The aim of this study was to identify and characterize Staphylococcus aureus from humans, and to compare their characteristics with isolates of animal origin. A total of 550 nasal swabs were taken from healthy humans, and S. aureus was isolated and identified. Positive S. aureus isolates were subjected to molecular typing and susceptibility testing. In addition, 108 MRSA isolates recovered from clinical patients in the state of North Dakota and 133 S. aureus isolates from animals and meat previously analyzed were included. The nasal carriage of S. aureus in healthy people was 7.6% and, in general, clones were genetically diverse. None of the S. aureus strains obtained from healthy people were mecA-or PVL-positive. A total of 105 (97.2%) MRSA isolates from clinical cases harbored the mecA gene and 11 (10.2%) isolated from blood stream infections harbored the PVL gene. The most common resistance profile among S. aureus from healthy people was penicillin, and from clinical cases were erythromycin-penicillin-ciprofloxacin. The rate of multidrug resistance (MDR) was 70% in humans. Most of the S. aureus harboring mecA and PVL genes were identified as ST5 and ST8, and exhibited MDR. However, S. aureus isolates of animal origin used for comparison exhibited a lower rate of MDR. The most common resistance profiles in isolates of animal origin were penicillin-tetracycline and penicillin-tetracycline-erythromycin, in animals and raw meat, respectively. The ST5 was also found in animals and meat, with ST9 and ST398 being the major clones. The genetic similarity between clones from humans and meat suggests the risk of spread of S. aureus in the food chain.	[Velasco, Valeria; Sherwood, Julie S.; Stepan, Ryan M.; Koslofsky, Ryan J.] N Dakota State Univ, Dept Vet & Microbiol Sci, Fargo, ND 58105 USA; [Velasco, Valeria] Univ Concepcion, Dept Anim Sci, Chillan, Chile; [Buyukcangaz, Esra] Uludag Univ, Dept Microbiol, Coll Vet Med, Bursa, Turkey; [Logue, Catherine M.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA	North Dakota State University Fargo; Universidad de Concepcion; Uludag University; Iowa State University	Logue, CM (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	cmlogue@iastate.edu	Buyukcangaz, Esra/AAL-2323-2020	Buyukcangaz, Esra/0000-0003-4337-577X; Logue, Catherine/0000-0002-6098-2662	Dean's Office, College of Agriculture, Food Systems and Natural Resources College, North Dakota State University; Dean's Office, College of Veterinary Medicine, Iowa State University, Ames, Iowa; Commission of Scientific Research Projects, Uludag University [YDP (V)-2009/4]	Dean's Office, College of Agriculture, Food Systems and Natural Resources College, North Dakota State University; Dean's Office, College of Veterinary Medicine, Iowa State University, Ames, Iowa; Commission of Scientific Research Projects, Uludag University(Uludag University)	This work was supported by the Dean's Office, College of Agriculture, Food Systems and Natural Resources College, North Dakota State University (Valeria Velasco), the Dean's Office, College of Veterinary Medicine, Iowa State University, Ames, Iowa; and the Commission of Scientific Research Projects, Uludag University (Project YDP (V)-2009/4) (Esra Buyukcangaz). The sponsors had no role in the study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Arora S, 2014, J LAB PHYS, V2, P79; Aydin A, 2011, FOODBORNE PATHOG DIS, V8, P63, DOI 10.1089/fpd.2010.0613; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Buyukcangaz E, 2013, FOODBORNE PATHOG DIS, V10, P608, DOI 10.1089/fpd.2012.1427; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Ebert MD, 2009, EMERG RADIOL, V16, P159, DOI 10.1007/s10140-008-0706-5; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; HARTMAN B, 1981, ANTIMICROB AGENTS CH, V19, P726, DOI 10.1128/AAC.19.5.726; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kishore S, 2014, J CLIN DIAGN RES, V8, pDC12, DOI 10.7860/JCDR/2014/7751.4338; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krziwanek K, 2009, EMERG INFECT DIS, V15, P766, DOI 10.3201/eid1505.080326; Kumar P, 2011, BIOL MED PARIS, V3, P182; Laurent F, 2012, EMERG INFECT DIS, V18, P1465, DOI 10.3201/eid1809.111920; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Mainous AG, 2006, ANN FAM MED, V4, P132, DOI 10.1370/afm.526; Makgotlho PE, 2009, FEMS IMMUNOL MED MIC, V57, P104, DOI 10.1111/j.1574-695X.2009.00585.x; McCarthy AJ, 2012, VET DERMATOL, V23, P267, DOI 10.1111/j.1365-3164.2012.01072.x; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Moxnes JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070499; Nadarajah J, 2006, J MED MICROBIOL, V55, P1675, DOI 10.1099/jmm.0.46700-0; Nimmo GR, 2013, J INFECTION, V67, P439, DOI 10.1016/j.jinf.2013.07.020; O'Brien AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030092; Persoons D, 2009, EMERG INFECT DIS, V15, P452, DOI 10.3201/eid1503.080696; Petersen A, 2013, CLIN MICROBIOL INFEC, V19, pE16, DOI 10.1111/1469-0691.12036; Pu SH, 2009, APPL ENVIRON MICROB, V75, P265, DOI 10.1128/AEM.01110-08; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; Stegger M, 2011, CLIN MICROBIOL INFEC, V18, P385; Stenhem M, 2010, EMERG INFECT DIS, V16, P189, DOI 10.3201/eid1602.081655; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Swartz MN, 1997, NEW ENGL J MED, V337, P491, DOI 10.1056/NEJM199708143370709; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; Van De Griend P, 2009, EMERG INFECT DIS, V15, P1582, DOI 10.3201/eid1510.080877; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507	47	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140497	10.1371/journal.pone.0140497	http://dx.doi.org/10.1371/journal.pone.0140497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484768	gold, Green Submitted, Green Published			2022-12-27	WOS:000363028100038
J	Xu, XP; Liu, XY; He, P; Johnston, AM; Zhao, SC; Qiu, SJ; Zhou, W				Xu, Xinpeng; Liu, Xiaoyan; He, Ping; Johnston, Adrian M.; Zhao, Shicheng; Qiu, Shaojun; Zhou, Wei			Yield Gap, Indigenous Nutrient Supply and Nutrient Use Efficiency for Maize in China	PLOS ONE			English	Article							NITROGEN-USE EFFICIENCY; FERTILIZER RECOMMENDATION; MANAGEMENT; WHEAT; SOIL; SYSTEM; BALANCE; REQUIREMENTS; PERFORMANCE; INCREASE	Great achievements have been attained in agricultural production of China, while there are still many difficulties and challenges ahead that call for put more efforts to overcome to guarantee food security and protect environment simultaneously. Analyzing yield gap and nutrient use efficiency will help develop and inform agricultural policies and strategies to increase grain yield. On-farm datasets from 2001 to 2012 with 1,971 field experiments for maize (Zea mays L.) were collected in four maize agro-ecological regions of China, and the optimal management (OPT), farmers' practice (FP), a series of nutrient omission treatments were used to analyze yield gap, nutrient use efficiency and indigenous nutrient supply by adopting meta-analysis and ANOVA analysis. Across all sites, the average yield gap between OPT and FP was 0.7 t ha(-1), the yield response to nitrogen (N), phosphorus (P), and potassium (K) were 1.8, 1.0, and 1.2 t ha(-1), respectively. The soil indigenous nutrient supply of N, P, and K averaged 139.9, 33.7, and 127.5 kg ha(-1), respectively. As compared to FP, the average recovery efficiency (RE) of N, P, and K with OPT increased by percentage point of 12.2, 5.5, and 6.5, respectively. This study indicated that there would be considerable potential to further improve yield and nutrient use efficiency in China, and will help develop and inform agricultural policies and strategies, while some management measures such as soil, plant and nutrient are necessary and integrate with advanced knowledge and technologies.	[Xu, Xinpeng; Liu, Xiaoyan; He, Ping; Zhao, Shicheng; Qiu, Shaojun; Zhou, Wei] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Plant Nutr & Fertilizer, Minist Agr, Beijing 100081, Peoples R China; [Xu, Xinpeng] Beijing Acad Agr & Forestry Sci, Inst Plant Nutrient & Resources, Beijing 100097, Peoples R China; [He, Ping] CAAS, IPNI Joint Lab Plant Nutr Innovat Res, IPNI China Program, Beijing 100081, Peoples R China; [Johnston, Adrian M.] IPNI, Saskatoon, SK S7N4L8, Canada	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Beijing Academy of Agriculture & Forestry; Chinese Academy of Agricultural Sciences	He, P (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Plant Nutr & Fertilizer, Minist Agr, Beijing 100081, Peoples R China.	phe@ipni.net; zhouwei02@caas.cn	He, Ping/HGD-5389-2022; Qiu, Shaojun/AGO-2672-2022	Xu, Xinpeng/0000-0001-9856-2762	National Basic Research Program of China [2013CB127405]; National Natural Science Foundation of China [31272243]; International Plant Nutrition Institute (IPNI); CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research [IARRP-2015-27]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Plant Nutrition Institute (IPNI); CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research	This research was supported by the National Basic Research Program of China (973 Program) (2013CB127405), National Natural Science Foundation of China (No. 31272243), International Plant Nutrition Institute (IPNI), and CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research (IARRP-2015-27).	[Anonymous], 2007, FERTIL BEST MANAGE P; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Chen XP, 2010, SOIL SCI SOC AM J, V74, P1367, DOI 10.2136/sssaj2009.0227; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chuan LM, 2013, FIELD CROP RES, V140, P1, DOI 10.1016/j.fcr.2012.09.020; Cui ZL, 2008, NUTR CYCL AGROECOSYS, V81, P37, DOI 10.1007/s10705-007-9149-8; Cui ZL, 2008, FIELD CROP RES, V105, P48, DOI 10.1016/j.fcr.2007.07.008; Cui ZL, 2010, AMBIO, V39, P376, DOI 10.1007/s13280-010-0076-6; Dobermann A, 2004, SCOPE SER, V65, P261; Dobermann A, 2005, SCI CHINA SER C, V48, P745, DOI 10.1360/062005-268; Dobermann A, 2003, AGRON J, V95, P924, DOI 10.2134/agronj2003.0924; Dobermann A, 2003, AGRON J, V95, P913, DOI 10.2134/agronj2003.0913; Dobermann A., 2004, INCREASING PRODUCTIV, p[76, 410]; Gao Q, 2012, AGRON J, V104, P165, DOI 10.2134/agronj2011.0215; Giller KE, 2004, SCOPE SER, V65, P35; He P, 2013, J PLANT NUTR, V36, P1258, DOI 10.1080/01904167.2013.784982; He P, 2009, AGRON J, V101, P1489, DOI 10.2134/agronj2009.0099; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Khurana HS, 2007, AGRON J, V99, P1436, DOI 10.2134/agronj2006.0283; Ladha JK, 2005, ADV AGRON, V87, P86, DOI DOI 10.1016/S0065-2113(05)87003-8; Le C, 2010, ENVIRON MANAGE, V45, P662, DOI 10.1007/s00267-010-9440-3; Li ShuTian, 2011, Scientia Agricultura Sinica, V44, P4207; Liu MQ, 2006, NUTR CYCL AGROECOSYS, V74, P245, DOI 10.1007/s10705-006-9002-5; Liu XY, 2011, AGRON J, V103, P1452, DOI 10.2134/agronj2010.0476; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Ma QA, 2010, NUTR CYCL AGROECOSYS, V88, P315, DOI 10.1007/s10705-010-9356-6; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Pampolino MF, 2012, COMPUT ELECTRON AGR, V88, P103, DOI 10.1016/j.compag.2012.07.007; Sileshi G, 2010, FIELD CROP RES, V116, P1, DOI 10.1016/j.fcr.2009.11.014; van Ittersum MK, 2013, FIELD CROP RES, V143, P4, DOI 10.1016/j.fcr.2012.09.009; van Wart J, 2013, FIELD CROP RES, V143, P34, DOI 10.1016/j.fcr.2012.11.018; Witt C., 2002, Better Crops International, V16, P20; Wortmann CS, 2009, AGRON J, V101, P546, DOI 10.2134/agronj2008.0103x; Xu XP, 2014, FIELD CROP RES, V163, P10, DOI 10.1016/j.fcr.2014.04.014; Xu XP, 2014, FIELD CROP RES, V157, P27, DOI 10.1016/j.fcr.2013.12.013; Xu XP, 2013, FIELD CROP RES, V150, P115, DOI 10.1016/j.fcr.2013.06.006; Yengoh GT, 2014, AMBIO, V43, P175, DOI 10.1007/s13280-013-0428-0; Zhao RF, 2006, AGRON J, V98, P938, DOI 10.2134/agronj2005.0157	39	21	24	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140767	10.1371/journal.pone.0140767	http://dx.doi.org/10.1371/journal.pone.0140767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484543	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100069
J	Wollstadt, P; Meyer, U; Wibral, M				Wollstadt, Patricia; Meyer, Ulrich; Wibral, Michael			A Graph Algorithmic Approach to Separate Direct from Indirect Neural Interactions	PLOS ONE			English	Article							COMPLEX BRAIN NETWORKS; GRANGER CAUSALITY; INFORMATION-FLOW; EVOKED-RESPONSES; TIME-SERIES; MEG; EEG	Network graphs have become a popular tool to represent complex systems composed of many interacting subunits; especially in neuroscience, network graphs are increasingly used to represent and analyze functional interactions between multiple neural sources. Interactions are often reconstructed using pairwise bivariate analyses, overlooking the multivariate nature of interactions: it is neglected that investigating the effect of one source on a target necessitates to take all other sources as potential nuisance variables into account; also combinations of sources may act jointly on a given target. Bivariate analyses produce networks that may contain spurious interactions, which reduce the interpretability of the network and its graph metrics. A truly multivariate reconstruction, however, is computationally intractable because of the combinatorial explosion in the number of potential interactions. Thus, we have to resort to approximative methods to handle the intractability of multivariate interaction reconstruction, and thereby enable the use of networks in neuroscience. Here, we suggest such an approximative approach in the form of an algorithm that extends fast bivariate interaction reconstruction by identifying potentially spurious interactions post-hoc: the algorithm uses interaction delays reconstructed for directed bivariate interactions to tag potentially spurious edges on the basis of their timing signatures in the context of the surrounding network. Such tagged interactions may then be pruned, which produces a statistically conservative network approximation that is guaranteed to contain non-spurious interactions only. We describe the algorithm and present a reference implementation in MATLAB to test the algorithm's performance on simulated networks as well as networks derived from magnetoencephalographic data. We discuss the algorithm in relation to other approximative multivariate methods and highlight suitable application scenarios. Our approach is a tractable and data-efficient way of reconstructing approximative networks of multivariate interactions. It is preferable if available data are limited or if fully multivariate approaches are computationally infeasible.	[Wollstadt, Patricia; Wibral, Michael] Goethe Univ Frankfurt, Brain Imaging Ctr, MEG Unit, D-60054 Frankfurt, Germany; [Meyer, Ulrich] Goethe Univ Frankfurt, Inst Comp Sci, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Wollstadt, P (corresponding author), Goethe Univ Frankfurt, Brain Imaging Ctr, MEG Unit, D-60054 Frankfurt, Germany.	patricia.wollstadt@stud.uni-frankfurt.de	Wibral, Michael/H-5255-2019	Wibral, Michael/0000-0001-8010-5862; Wollstadt, Patricia/0000-0002-7105-5207	LOEWE "Neuronale Koordination Forschungsschwerpunkt Frankfurt (NeFF)" - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the Land Hessen (LOEWE)	LOEWE "Neuronale Koordination Forschungsschwerpunkt Frankfurt (NeFF)" - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the Land Hessen (LOEWE)	MW and PW received financial support from the grant LOEWE "Neuronale Koordination Forschungsschwerpunkt Frankfurt (NeFF)" awarded by the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the Land Hessen (LOEWE), https://wissenschaft.hessen.de/loewe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2004, EUR PHYS J B, V38, P147, DOI 10.1140/epjb/e2004-00110-5; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Batagelj V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036113; Beer, 2010, ARXIV10042515, DOI DOI 10.HTTPS://ARXIV.0RG/ABS/1004.2515; Bertschinger N, 2014, ENTROPY-SWITZ, V16, P2161, DOI 10.3390/e16042161; Blinowska KJ, 2011, MED BIOL ENG COMPUT, V49, P521, DOI 10.1007/s11517-011-0739-x; Blinowska KJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.050902; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B, 2004, COMBINATORICA, V24, P5, DOI 10.1007/s00493-004-0002-2; Bollobas B, 2001, RANDOM STRUCT ALGOR, V18, P279, DOI 10.1002/rsa.1009; Borner K, 2007, ANNU REV INFORM SCI, V41, P537, DOI 10.1002/aris.2007.1440410119; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen YH, 2004, PHYS LETT A, V324, P26, DOI 10.1016/j.physleta.2004.02.032; CHERNIAK C, 1995, TRENDS NEUROSCI, V18, P522, DOI 10.1016/0166-2236(95)98373-7; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Cormen Thomas H., 2009, INTRO ALGORITHMS; Das A, 2008, ACM S THEORY COMPUT, P45; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; Diestel Reinhard, 2010, GRAPH THEORY; Faes L, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051112; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garey M. R., 1979, Computers and intractability. A guide to the theory of NP-completeness; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Griffith V, 2014, EMERGENCE COMPLEX CO, V9, P159, DOI 10.1007/978-3-642-53734-9_6; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Grutzner C, 2010, J NEUROSCI, V30, P8342, DOI 10.1523/JNEUROSCI.5434-09.2010; Harder M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012130; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kiebel SJ, 2006, NEUROIMAGE, V30, P1273, DOI 10.1016/j.neuroimage.2005.12.055; Kotter R, 2000, PHILOS T ROY SOC B, V355, P127, DOI 10.1098/rstb.2000.0553; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kulesa A, 2015, NAT METHODS, V12, P477, DOI 10.1038/nmeth.3414; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Lizier J., 2012, 252012 M PLANCK I MA; Marinazzo D, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/303601; Mooney CM, 1951, CAN J PSYCHOLOGY, V5, P129, DOI 10.1037/h0083540; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2012, NEUROIMAGE, V62, P881, DOI 10.1016/j.neuroimage.2011.08.085; Stam CJ, 2014, INT J PSYCHOPHYSIOL, V92, P129, DOI 10.1016/j.ijpsycho.2014.04.001; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stramaglia S, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/105003; Tewarie P, 2015, NEUROIMAGE, V104, P177, DOI 10.1016/j.neuroimage.2014.10.015; Vakorin VA, 2009, J NEUROSCI METH, V184, P152, DOI 10.1016/j.jneumeth.2009.07.014; Wasserman S, 1994, SOCIAL NETWORK ANALY, V8; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WELCH WJ, 1982, J STAT COMPUT SIM, V15, P17, DOI 10.1080/00949658208810560; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wibral M, 2012, IEEE ENG MED BIO, P3676, DOI 10.1109/EMBC.2012.6346764; Williams P.L., 2011, ARXIV11021507; Wollstadt P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102833	61	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140530	10.1371/journal.pone.0140530	http://dx.doi.org/10.1371/journal.pone.0140530			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479713	Green Published, gold			2022-12-27	WOS:000363026600012
J	Ma, L; Bai, YN; Pu, HQ; Gou, FX; Dai, M; Wang, H; He, J; Zheng, TZ; Cheng, N				Ma, Li; Bai, Yana; Pu, Hongquan; Gou, Faxiang; Dai, Min; Wang, Hui; He, Jie; Zheng, Tongzhang; Cheng, Ning			Histone Methylation in Nickel-Smelting Industrial Workers	PLOS ONE			English	Article							CELLS; CARCINOGENESIS; EXPRESSION; CHROMIUM; CANCER; CHINA; ACETYLATION; DEMETHYLASE; EXPOSURE; HYPOXIA	Background Nickel is an essential trace metal naturally found in the environment. It is also common in occupational settings, where it associates with various levels of both occupational and nonoccupational exposure In vitro studies have shown that nickel exposure can lead to intracellular accumulation of Ni2+, which has been associated with global decreases in DNA methylation, increases in chromatin condensation, reductions in H3K9me2, and elevated levels of H3K4me3. Histone modifications play an important role in modulating chromatin structure and gene expression. For example, tri-methylation of histone H3k4 has been found to be associated with transcriptional activation, and tri-methylation of H3k27 has been found to be associated with transcriptional repression. Aberrant histone modifications have been found to be associated with various human diseases, including cancer. The purpose of this work was to identify biomarkers for populations with occupational nickel exposure and to examine the relationship between histone methylation and nickel exposure. This may provide a scientific indicator of early health impairment and facilitate exploration of the molecular mechanism underlying cancer pathogenesis. Methods One hundred and forty subjects with occupational exposure to Ni and 140 referents were recruited. H3K4 and H3K27 trimethylation levels were measured in subjects' blood cells. Results H3K4me3 levels were found to be higher in nickel smelting workers (47.24 +/- 20.85) than in office workers (22.65 +/- 8.81; P = 0.000), while the opposite was found for levels of H3K27me3(nickel smelting workers, 13.88 +/- 4.23; office workers, 20.67 +/- 5.96; P = 0.000). H3K4me3 was positively (r = 0.267, P = 0.001) and H3K27 was negatively (r = -0.684, P = 0.000) associated with age and length of service in smelting workers. Conclusion This study indicated that occupational exposure to Ni is associated with alterations in levels of histone modification.	[Ma, Li; Bai, Yana; Gou, Faxiang; Wang, Hui; Cheng, Ning] Lanzhou Univ, Sch Publ Hlth, Lanzhou, Gansu, Peoples R China; [Pu, Hongquan] Jinchuan Grp CO LTD, Workers Hosp Jinchuan Co, Jinchang, Gansu, Peoples R China; [Cheng, Ning] Lanzhou Univ, Coll Basic Med, Lanzhou, Gansu, Peoples R China; [Dai, Min; He, Jie] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Zheng, Tongzhang] Yale Univ, Sch Publ Hlth, New Haven, CT USA	Lanzhou University; Lanzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Yale University	Bai, YN (corresponding author), Lanzhou Univ, Sch Publ Hlth, Lanzhou, Gansu, Peoples R China.	baiyana@lzu.edu.cn; chengn@lzu.edu.cn	DAI, M/GPS-8291-2022		U.S. National Institutes of Health [D43TW 008323, D43TW 007864-01]; project of science and technology in Jinchuan company; FOGARTY INTERNATIONAL CENTER [D43TW008323, D43TW007864] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); project of science and technology in Jinchuan company; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Fogarty training grants D43TW 008323 and D43TW 007864-01 from the U.S. National Institutes of Health and The project of science and technology in Jinchuan company (2012-13).	Arita A, 2012, ENVIRON HEALTH PERSP, V120, P198, DOI 10.1289/ehp.1104140; Bai YN, 2014, BIOMED ENVIRON SCI, V27, P208, DOI 10.3967/bes2014.042; Barrow TM, 2014, BIOCHEM BIOPH RES CO, V455, P70, DOI 10.1016/j.bbrc.2014.08.002; Cempel M, 2006, POL J ENVIRON STUD, V15, P375; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chervona Y, 2012, METALLOMICS, V4, P619, DOI 10.1039/c2mt20033c; Davis J.R., 2000, ASM SPECIALTY HDB NI; DOLL R, 1977, BRIT J IND MED, V34, P102; DOLL R, 1990, SCAND J WORK ENV HEA, V16, P1; Govindarajan B, 2002, MOL MED, V8, P1; John MS, 2011, ANTIOXIDANTS REDOX S, V14, P241; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Katz AJ, 2001, MOL CELL BIOCHEM, V222, P61, DOI 10.1023/A:1017959222379; Ke QD, 2006, CARCINOGENESIS, V27, P1481, DOI 10.1093/carcin/bgl004; Kowara R, 2004, MOL CELL BIOCHEM, V255, P195, DOI 10.1023/B:MCBI.0000007275.22785.91; LEE YW, 1995, MOL CELL BIOL, V15, P2547; Ma L, 2014, BIOMED ENVIRON SCI, V27, P567, DOI 10.3967/bes2014.088; Sawan C, 2010, ADV GENET, V70, P57, DOI [10.1016/S0065-2660(10)70003-1, 10.1016/B978-0-12-380866-0.60003-4]; Sewack GF, 2001, MOL CELL BIOL, V21, P1404, DOI 10.1128/MCB.21.4.1404-1415.2001; She J, 2013, CHEST, V143, P1117, DOI 10.1378/chest.11-2948; Sun H, 2009, TOXICOL APPL PHARM, V237, P258, DOI 10.1016/j.taap.2009.04.008; Suu H, 2013, GENE S, V4, P583, DOI [10.3390/genes4040583, DOI 10.3390/GENES4040583]; Ushijima T, 2014, BIOCH BIOPHYS RES CO; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Yan Y, 2003, TOXICOL APPL PHARM, V190, P272, DOI 10.1016/S0041-008X(03)00169-8; Yang Lin-qing, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P622; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942; Zhou X, 2009, TOXICOL APPL PHARM, V236, P78, DOI 10.1016/j.taap.2009.01.009	30	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140339	10.1371/journal.pone.0140339	http://dx.doi.org/10.1371/journal.pone.0140339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474320	Green Published, gold, Green Submitted			2022-12-27	WOS:000363185500041
J	Oliver, JAC; Forman, OP; Pettitt, L; Mellersh, CS				Oliver, James A. C.; Forman, Oliver P.; Pettitt, Louise; Mellersh, Cathryn S.			Two Independent Mutations in ADAMTS17 Are Associated with Primary Open Angle Glaucoma in the Basset Hound and Basset Fauve de Bretagne Breeds of Dog	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; SITE MUTATION; GENE; IDENTIFICATION; POAG	Purpose Mutations in ADAMTS10 (CFA20) have previously been associated with primary open angle glaucoma (POAG) in the Beagle and Norwegian Elkhound. The closely related gene, ADAMTS17, has also been associated with several different ocular phenotypes in multiple breeds of dog, including primary lens luxation and POAG. We investigated ADAMTS17 as a candidate gene for POAG in the Basset Hound and Basset Fauve de Bretagne dog breeds. Methods We performed ADAMTS17 exon resequencing in three Basset Hounds and three Basset Fauve de Bretagne dogs with POAG. Identified variants were genotyped in additional sample cohorts of both breeds and dogs of other breeds to confirm their association with disease. Results All affected Basset Hounds were homozygous for a 19 bp deletion in exon 2 that alters the reading frame and is predicted to lead to a truncated protein. Fifty clinically unaffected Basset Hounds were genotyped for this mutation and all were either heterozygous or homozygous for the wild type allele. Genotyping of 223 Basset Hounds recruited for a different study revealed a mutation frequency of 0.081 and predicted frequency of affected dogs in the population to be 0.007. Based on the entire genotyping dataset the association statistic for the POAG-associated deletion was p = 1.26 x 10(-10). All affected Basset Fauve de Bretagne dogs were homozygous for a missense mutation in exon 11 causing a glycine to serine amino acid substitution (G519S) in the disintegrin-like domain of ADAMTS17 which is predicted to alter protein function. Unaffected Basset Fauve de Bretagne dogs were either heterozygous for the mutation (5/24) or homozygous for the wild type allele (19/24). Based on the entire genotyping dataset the association statistic for the POAG-associated deletion was p = 2.80 x 10(-7). Genotyping of 85 dogs of unrelated breeds and 90 dogs of related breeds for this variant was negative. Conclusion This report documents strong associations between two independent ADAMTS17 mutations and POAG in two different dog breeds.	[Oliver, James A. C.; Forman, Oliver P.; Pettitt, Louise; Mellersh, Cathryn S.] Anim Hlth Trust, Ctr Prevent Med, Dept Canine Genet Res, Newmarket, Suffolk, England	Animal Health Trust	Oliver, JAC (corresponding author), Anim Hlth Trust, Ctr Prevent Med, Dept Canine Genet Res, Newmarket, Suffolk, England.	James.Oliver@aht.org.uk		Oliver, James/0000-0002-2540-2183				Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Ahonen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111941; Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; ALEXANDER JP, 1991, INVEST OPHTH VIS SCI, V32, P172; Apte SS, 2015, MATRIX BIOL; Apte SS, 2015, MATRIX BIOL; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Baird PN, 2005, HUM GENET, V117, P249, DOI 10.1007/s00439-005-1296-x; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Chandra A, 2012, INVEST OPHTH VIS SCI, V53, P4889, DOI 10.1167/iovs.12-9874; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Farias FHG, 2010, INVEST OPHTH VIS SCI, V51, P4716, DOI 10.1167/iovs.09-5142; Forman O, 2015, 8 INT C ADV CAN FEL; GELATT KN, 1976, T AM ACAD OPHTHALMOL, V81, pO636; Gould D, 2011, VET OPHTHALMOL, V14, P378, DOI 10.1111/j.1463-5224.2011.00892.x; Greene VB, 2010, OPHTHALMIC GENET, V31, P47, DOI 10.3109/13816810903567604; Grimm DG, 2015, HUM MUTAT, V36, P513, DOI 10.1002/humu.22768; Kato K, 2009, GRAEF ARCH CLIN EXP, V247, P1435, DOI 10.1007/s00417-009-1053-2; Keller KE, 2009, INVEST OPHTH VIS SCI, V50, P5769, DOI 10.1167/iovs.09-3673; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Khan AO, 2012, OPHTHALMIC GENET, V33, P235, DOI 10.3109/13816810.2012.666708; Kuchtey J, 2013, INVEST OPHTH VIS SCI, V54, P1881, DOI 10.1167/iovs.12-10796; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Li J, 2014, MOL VIS, V20, P1017; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Palko JR, 2013, INVEST OPHTH VIS SCI, V54, P2685, DOI 10.1167/iovs.12-10621; Peng XQ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S5-S8; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Racette L, 2003, SURV OPHTHALMOL, V48, P295, DOI 10.1016/S0039-6257(03)00028-6; Radner FPW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003536; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Shah MH, 2014, MOL VIS, V20, P790; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Takamoto M, 2014, JPN J OPHTHALMOL, V58, P1, DOI 10.1007/s10384-013-0286-0; TEIKARI JM, 1987, ACTA OPHTHALMOL, V65, P715; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640	42	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140436	10.1371/journal.pone.0140436	http://dx.doi.org/10.1371/journal.pone.0140436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474315	Green Published, Green Submitted, gold			2022-12-27	WOS:000363185500051
J	Kim, HS; Tian, L; Jung, M; Choi, SK; Sun, Y; Kim, H; Moon, WK				Kim, Hoe Suk; Tian, Lianji; Jung, Minji; Choi, Sul Ki; Sun, Yujin; Kim, Hyeonjin; Moon, Woo Kyung			Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells	PLOS ONE			English	Article							MALIGNANT-TRANSFORMATION; PHOSPHOLIPID-METABOLISM; CLINICAL-EVIDENCE; DRUG-RESISTANCE; ROLES; DEATH; MACROAUTOPHAGY; PATHWAY; OVEREXPRESSION; PHOSPHOCHOLINE	Choline kinase-alpha (Chk-alpha) and autophagy have gained much attention, as they relate to the drug-resistance of breast cancer. Here, we explored the potential connection between Chk-alpha and autophagy in the mechanisms driving to tamoxifen (TAM) resistance, in estrogen receptor positive (ER+) breast cancer cells (BCCs). Human BCC lines (MCF-7 and TAM-resistant MCF-7 (MCF-7/TAM) cells) were used. Chk-alpha expression and activity was suppressed by the transduction of shRNA (shChk-alpha) with lentivirus and treatment with CK37, a Chk-alpha inhibitor. MCF-7/TAM cells had higher Chk-alpha expression and phosphocholine levels than MCF-7 cells. A specific downregulation of Chk-alpha by the transduction of shChk-alpha exhibited a significant decrease in phosphocholine levels in MCF-7 and MCF-7/TAM cells. The autophagy-related protein, cleaved microtubule-associated protein light chain 3 (LC3) and autophagosome-like structures were significantly increased in shChk-alpha-transduced or CK37-treated MCF-7 and MCF-7/TAM cells. The downregulation of Chk-alpha attenuated the phosphorylation of AKT, ERK1/2, and mTOR in both MCF-7 and MCF-7/TAM cells. In MCF-7 cells, the downregulation of Chk-alpha resulted in an induction of autophagy, a decreased proliferation ability and an activation of caspase-3. In MCF-7/TAM cells, despite a significant decrease in proliferation ability and an increase in the percentage of cells in the G0/G1 phase of the cell cycle, the downregulation of Chk-alpha did not induced caspase-dependent cell death and further enhanced autophagy and G0/G1 phase arrest. An autophagy inhibitor, methyladenine (3-MA) induced death and attenuated the level of elevated LC3 in MCF7/TAM cells. Elucidating the interplay between choline metabolism and autophagy will provide unique opportunities to identify new therapeutic targets and develop novel treatment strategies that preferentially target TAM-resistance.	[Tian, Lianji; Jung, Minji; Choi, Sul Ki; Kim, Hyeonjin; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Kim, Hoe Suk; Sun, Yujin; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Moon, WK (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 103 Daehak Ro, Seoul 110799, South Korea.	moonwk@snu.ac.kr	Kim, Hyeonjin/M-3761-2019		National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2015R1A2A1A05001860, 2012R1A2A1A01010846]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2015R1A2A1A05001860, 2012R1A2A1A01010846).	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Al-Saffar NMS, 2010, CANCER RES, V70, P5507, DOI 10.1158/0008-5472.CAN-09-4476; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Bursch W, 2000, J CELL SCI, V113, P1189; Carroll RG, 2013, CANCER CELL, V23, P425, DOI 10.1016/j.ccr.2013.04.001; Cheng Y, 2011, CANCER RES, V71, P2654, DOI 10.1158/0008-5472.CAN-10-2889; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Esclatine A, 2009, CURR TOP MICROBIOL, V335, P33, DOI 10.1007/978-3-642-00302-8_2; Furuta S, 2004, ONCOGENE, V23, P3898, DOI 10.1038/sj.onc.1207539; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hu YL, 2012, CANCER RES, V72, P4294, DOI 10.1158/0008-5472.CAN-12-1076; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mori N, 2007, CANCER RES, V67, P11284, DOI 10.1158/0008-5472.CAN-07-2728; Nakagami K, 1999, JPN J CANCER RES, V90, P1212, DOI 10.1111/j.1349-7006.1999.tb00698.x; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Ramirez de Molina A, 2005, CANCER RES, V65, P5647, DOI 10.1158/0008-5472.CAN-04-4416; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489; Ramirez de Molina A, 2002, ONCOGENE, V21, P937, DOI 10.1038/sj.onc.1205144; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Shah T, 2010, NMR BIOMED, V23, P633, DOI 10.1002/nbm.1510; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Thomas S, 2012, CANCER LETT, V325, P63, DOI 10.1016/j.canlet.2012.05.030; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Wu YT, 2009, AUTOPHAGY, V5, P824, DOI 10.4161/auto.9099; Yalcin A, 2010, ONCOGENE, V29, P139, DOI 10.1038/onc.2009.317; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047	47	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141110	10.1371/journal.pone.0141110	http://dx.doi.org/10.1371/journal.pone.0141110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496360	gold, Green Published, Green Submitted			2022-12-27	WOS:000363309200062
J	Muller-Germann, I; Vogel, B; Vogel, H; Pauling, A; Frohlich-Nowoisky, J; Poschl, U; Despres, VR				Mueller-Germann, Isabell; Vogel, Bernhard; Vogel, Heike; Pauling, Andreas; Froehlich-Nowoisky, Janine; Poeschl, Ulrich; Despres, Viviane R.			Quantitative DNA Analyses for Airborne Birch Pollen	PLOS ONE			English	Article							NUMERICAL WEATHER PREDICTION; BET V 1; RIBOSOMAL DNA; ALLERGENIC POLLEN; COPY NUMBER; MODEL; DISPERSION; AIR; QUANTIFICATION; GENE	Birch trees produce large amounts of highly allergenic pollen grains that are distributed by wind and impact human health by causing seasonal hay fever, pollen-related asthma, and other allergic diseases. Traditionally, pollen forecasts are based on conventional microscopic counting techniques that are labor-intensive and limited in the reliable identification of species. Molecular biological techniques provide an alternative approach that is less labor-intensive and enables identification of any species by its genetic fingerprint. A particularly promising method is quantitative Real-Time polymerase chain reaction (qPCR), which can be used to determine the number of DNA copies and thus pollen grains in air filter samples. During the birch pollination season in 2010 in Mainz, Germany, we collected air filter samples of fine (<3 mu m) and coarse air particulate matter. These were analyzed by qPCR using two different primer pairs: one for a single-copy gene (BP8) and the other for a multi-copy gene (ITS). The BP8 gene was better suitable for reliable qPCR results, and the qPCR results obtained for coarse particulate matter were well correlated with the birch pollen forecasting results of the regional air quality model COSMO-ART. As expected due to the size of birch pollen grains (similar to 23 mu m), the concentration of DNA in fine particulate matter was lower than in the coarse particle fraction. For the ITS region the factor was 64, while for the single-copy gene BP8 only 51. The possible presence of so-called sub-pollen particles in the fine particle fraction is, however, interesting even in low concentrations. These particles are known to be highly allergenic, reach deep into airways and cause often severe health problems. In conclusion, the results of this exploratory study open up the possibility of predicting and quantifying the pollen concentration in the atmosphere more precisely in the future.	[Mueller-Germann, Isabell; Froehlich-Nowoisky, Janine; Poeschl, Ulrich] Max Planck Inst Chem, Dept Biochem, D-55128 Mainz, Germany; [Mueller-Germann, Isabell; Froehlich-Nowoisky, Janine; Poeschl, Ulrich] Max Planck Inst Chem, Multiphase Chem Dept, D-55128 Mainz, Germany; [Mueller-Germann, Isabell] Johannes Gutenberg Univ Mainz, Geosci, D-55122 Mainz, Germany; [Vogel, Bernhard; Vogel, Heike] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Eggenstein Leopoldshafen, Germany; [Pauling, Andreas] Zurich Airport, MeteoSchweiz, Zurich, Switzerland; [Despres, Viviane R.] Johannes Gutenberg Univ Mainz, Dept Gen Bot, D-55122 Mainz, Germany	Max Planck Society; Max Planck Society; Johannes Gutenberg University of Mainz; Helmholtz Association; Karlsruhe Institute of Technology; Federal Office of Meteorology & Climatology (MeteoSwiss); Johannes Gutenberg University of Mainz	Despres, VR (corresponding author), Johannes Gutenberg Univ Mainz, Dept Gen Bot, D-55122 Mainz, Germany.	despres@uni-mainz.de	Vogel, Bernhard/A-9558-2013; Pöschl, Ulrich/A-6263-2010; Froehlich, Janine/D-6227-2015	Vogel, Bernhard/0000-0002-8894-0165; Pöschl, Ulrich/0000-0003-1412-3557; Froehlich, Janine/0000-0002-1278-0054				Baldauf M, 2011, MON WEATHER REV, V139, P3887, DOI 10.1175/MWR-D-10-05013.1; Bugaj TZ, 2005, HAUFIGKEIT ORALEN AL; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buters JTM, 2010, ALLERGY, V65, P850, DOI 10.1111/j.1398-9995.2009.02286.x; Buters JTM, 2008, INT ARCH ALLERGY IMM, V145, P122, DOI 10.1159/000108137; Buters JTM, 2012, ATMOS ENVIRON, V55, P496, DOI 10.1016/j.atmosenv.2012.01.054; Cecchi L., 2013, ALLERGENIC POLLEN, P1; Clot B., 2001, AEROBIOLOGIA, V17, P25, DOI [DOI 10.1023/A:1007652220568, 10.1023/A:1007652220568]; Comtois P., 1999, Aerobiologia, V15, P19, DOI 10.1023/A:1007501017470; D'Amato G., 1992, Aerobiologia, V8, P447, DOI 10.1007/BF02272914; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Dahl A, 2013, ALLERGENIC POLLEN RE, P29, DOI DOI 10.1007/978-94-007-4881-1_3; De Weger L.A., 2013, ALLERGENIC POLLEN RE; Despres VR, 2007, BIOGEOSCIENCES, V4, P1127, DOI 10.5194/bg-4-1127-2007; Emberlin J, 2002, INT J BIOMETEOROL, V46, P159, DOI 10.1007/s00484-002-0139-x; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; FOUNTAIN DW, 1992, INT ARCH ALLERGY IMM, V98, P370, DOI 10.1159/000236213; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Helbig Nora, 2004, Aerobiologia, V20, P3, DOI 10.1023/B:AERO.0000022984.51588.30; HIRST JM, 1952, ANN APPL BIOL, V39, P257, DOI 10.1111/j.1744-7348.1952.tb00904.x; HOWLAND DE, 1995, NEW PHYTOL, V130, P117, DOI 10.1111/j.1469-8137.1995.tb01821.x; Huffman J. A., 2013, ATMOS CHEM PHYS DISC, V13, P1767, DOI DOI 10.5194/ACPD-13-1767-2013; INGLE J, 1975, PLANT PHYSIOL, V55, P496, DOI 10.1104/pp.55.3.496; Jarosz N, 2004, ATMOS ENVIRON, V38, P5555, DOI 10.1016/j.atmosenv.2004.06.027; Katelaris CH, 2004, ANN ALLERG ASTHMA IM, V93, P131, DOI 10.1016/S1081-1206(10)61464-0; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Longhi S, 2009, ANN ALLERG ASTHMA IM, V103, P508, DOI 10.1016/S1081-1206(10)60268-2; Mucke W, 2008, BIOAEROSOLE GESUNDHE; Mumy KL, 2004, J MICROBIOL METH, V57, P259, DOI 10.1016/j.mimet.2004.01.013; Navarro E, 2003, PLANT SOIL, V254, P207, DOI 10.1023/A:1024978409187; Pasken R, 2005, ATMOS ENVIRON, V39, P7689, DOI 10.1016/j.atmosenv.2005.04.043; Pauling A, 2012, INT J BIOMETEOROL, V56, P949, DOI 10.1007/s00484-011-0505-7; Pfaffl MW, 2004, A Z QUANTITATIVE PCR; Pummer BG, 2013, J RAMAN SPECTROSC, V44, P1654, DOI 10.1002/jrs.4395; PUUPPONENPIMIA R, 1993, PLANT MOL BIOL, V23, P423, DOI 10.1007/BF00029018; R Core Team, 2016, R FDN STAT COMP; Riediker M., 2000, AEROBIOLOGIA, V16, P251, DOI DOI 10.1023/A:1007651106231; Rittenour WR, 2012, J IMMUNOL METHODS, V383, P47, DOI 10.1016/j.jim.2012.01.012; ROGERS SO, 1987, PLANT MOL BIOL, V9, P509, DOI 10.1007/BF00015882; Rozen S, 2003, METHOD MOL BIOL, P365; Sanchez-Ochoa A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008180; Schenk MF, 2009, BMC PLANT BIOL, P9; SCHLOTTERER C, 1994, MOL BIOL EVOL, V11, P513; Schueler S, 2006, ENVIRON MODEL ASSESS, V11, P179, DOI 10.1007/s10666-006-9044-8; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Siljamo P, 2007, NATO-CHAL M, V17, P331; Sofiev M, 2006, INT J BIOMETEOROL, V50, P392, DOI 10.1007/s00484-006-0027-x; Sofiev M, 2004, NATO-CHAL M, V16, P417; Sofiev M, 2013, INT J BIOMETEOROL, V57, P45, DOI 10.1007/s00484-012-0532-z; SOLOMON PA, 1983, AEROSOL SCI TECH, V2, P455, DOI 10.1080/02786828308958649; Spellerberg Ian F., 2006, Arboriculture & Urban Forestry, V32, P133; Steiner AL, 2015, GEOPHYS RES LETT, V42, P3596, DOI 10.1002/2015GL064060; Straka H., 1975, POLLEN SPORENKUNDE G; Taylor PE, 2004, CURR ALLERGY ASTHM R, V4, P409, DOI 10.1007/s11882-004-0092-3; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vogel B, 2009, ATMOS CHEM PHYS, V9, P8661, DOI 10.5194/acp-9-8661-2009; Vogel H, 2008, INT J BIOMETEOROL, V52, P805, DOI 10.1007/s00484-008-0174-3; Walklate PJ, 2004, P ROY SOC B-BIOL SCI, V271, P441, DOI 10.1098/rspb.2003.2578; Weber RW, 2004, CURR ALLERGY ASTHM R, V4, P401, DOI 10.1007/s11882-004-0091-4; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Williams JH, 2014, AM J BOT, V101, P559, DOI 10.3732/ajb.1300423; Yli-Panula E, 2009, INT J ENV RES PUB HE, V6, P1706, DOI 10.3390/ijerph6061706; Zink K, 2013, GEOSCI MODEL DEV, V6, P1961, DOI 10.5194/gmd-6-1961-2013; Zink K, 2012, INT J BIOMETEOROL, V56, P669, DOI 10.1007/s00484-011-0468-8	66	14	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140949	10.1371/journal.pone.0140949	http://dx.doi.org/10.1371/journal.pone.0140949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492534	Green Published, Green Submitted, gold			2022-12-27	WOS:000363249300018
J	Briceno, F; Linnane, AJ; Quiroz, JC; Gardner, C; Pecl, GT				Briceno, Felipe; Linnane, Adrian Joseph; Quiroz, Juan Carlos; Gardner, Caleb; Pecl, Gretta Tatyana			Predation Risk within Fishing Gear and Implications for South Australian Rock Lobster Fisheries	PLOS ONE			English	Article							JASUS-EDWARDSII; SPINY LOBSTER; MAORI OCTOPUS; SIZE; SELECTION; BYCATCH; REEF	Depredation of southern rock lobster (Jasus edwardsii) within fishing gear by the Maori octopus (Pinnoctopus cordiformis) has economic and ecological impacts on valuable fisheries in South Australia. In addition, depredation rates can be highly variable resulting in uncertainties for the fishery. We examined how in-pot lobster predation was influenced by factors such as lobster size and sex, season, fishing zone, and catch rate. Using mixed modelling techniques, we found that in-pot predation risk increased with lobster size and was higher for male lobsters. In addition, the effect of catch rate of lobsters on predation risk by octopus differed among fishing zones. There was both a seasonal and a spatial component to octopus predation, with an increased risk within discrete fishing grounds in South Australia at certain times of the year. Information about predation within lobster gear can assist fishery management decision-making, potentially leading to significant reduction in economic losses to the fishery.	[Briceno, Felipe; Quiroz, Juan Carlos; Gardner, Caleb; Pecl, Gretta Tatyana] Univ Tasmania, IMAS, Hobart, Tas, Australia; [Linnane, Adrian Joseph] South Australian Res & Dev Inst Aquat Sci, Adelaide, SA, Australia	University of Tasmania	Briceno, F (corresponding author), Univ Tasmania, IMAS, Hobart, Tas, Australia.	fbricenoj@gmail.com	Pecl, Gretta/D-7267-2011; Gardner, Caleb/I-7086-2013	Pecl, Gretta/0000-0003-0192-4339; Gardner, Caleb/0000-0003-0324-4337	Fisheries Research and Development Corporation (FRDC) [2011/039]; IMAS; Holsworth Wildlife Research Endowment [P00221678]; Bookend Lynchpin Ocean scholarship; ARC Future Fellowship	Fisheries Research and Development Corporation (FRDC)(Fisheries R&D Corp); IMAS; Holsworth Wildlife Research Endowment; Bookend Lynchpin Ocean scholarship; ARC Future Fellowship(Australian Research Council)	The research was funded by the Fisheries Research and Development Corporation (FRDC), Project 2011/039 (www.frdc.com.au). FB acknowledges the Becas Chile scholarship program (CONICYT Chile), as well as financial support from IMAS, the Holsworth Wildlife Research Endowment (P00221678) and the Bookend Lynchpin Ocean scholarship. GTP was supported by an ARC Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES, 2014, AUSTR FISH STAT 2013, P3298; [Anonymous], 1900, J MAR BIOL ASSOC UK; Barnett A, 2013, MAR ECOL PROG SER, V494, P241, DOI 10.3354/meps10577; Bax NJ, 1998, ICES J MAR SCI, V55, P997, DOI 10.1006/jmsc.1998.0350; Berger DK, 2001, MAR FRESHWATER RES, V52, P1049, DOI 10.1071/MF01076; Bouwma PE, 2009, NEW ZEAL J MAR FRESH, V43, P3, DOI 10.1080/00288330909509977; Boyle P. R., 2005, CEPHALOPODS ECOLOGY; Boyle Peter R., 1997, P125; BOYLE PR, 1986, J MAR BIOL ASSOC UK, V66, P855, DOI 10.1017/S0025315400048487; Briceno F, 2015, FISH OCEANOGR, DOI [10.1111/fog.12115, DOI 10.1111/F0G.12115]; Brock D, 2003, RD030063 SARDI AQ SC; Brock DJ, 2006, FISH RES, V80, P129, DOI 10.1016/j.fishres.2006.05.006; Brock DJ, 2004, FISH B-NOAA, V102, P430; Buscaino G, 2011, MAR ECOL PROG SER, V423, P143, DOI 10.3354/meps08957; Butler MJ, 2009, MAR ECOL PROG SER, V386, P115, DOI 10.3354/meps08071; EGGLESTON DB, 1992, ECOLOGY, V73, P992, DOI 10.2307/1940175; Frusher SD, 2001, CAN J FISH AQUAT SCI, V58, P2482, DOI 10.1139/cjfas-58-12-2482; Gardner C, 2000, 14 TASM AQ FISH I; Groeneveld JC, 2006, FISH RES, V79, P90, DOI 10.1016/j.fishres.2005.12.016; Hamer DJ, 2012, MAR MAMMAL SCI, V28, pE345, DOI 10.1111/j.1748-7692.2011.00544.x; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Herrnkind WF, 2001, MAR FRESHWATER RES, V52, P1113, DOI 10.1071/MF01044; Hobday D, 2001, MAR FRESHWATER RES, V52, P1495, DOI 10.1071/MF01050; Holling C. S., 1959, Canadian Entomologist, V91, P385; Hunsicker ME, 2011, ECOL LETT, V14, P1288, DOI 10.1111/j.1461-0248.2011.01696.x; Hunter CM, 2005, NZ J MAR FRESHW RES; Joll L, 1977, 29 DEP FISH WILDL W; KARNOFSKY EB, 1989, CAN J FISH AQUAT SCI, V46, P1625, DOI 10.1139/f89-207; LEWIS RK, 1981, AUST J MAR FRESH RES, V32, P843; Linnane A, 2014, F20130004601 S AUSTR; Linnane A, 2014, F20070003208 S AUSTR; Linnane A, 2014, F20070002768 S AUSTR; Linnane AJ, 2008, J MAR BIOL ASSOC UK, V88, P583, DOI 10.1017/S0025315408001021; Linnane A, 2009, NEW ZEAL J MAR FRESH, V43, P475, DOI 10.1080/00288330909510016; MACDIARMID AB, 1991, MAR ECOL PROG SER, V70, P129, DOI 10.3354/meps070129; McGarvey R, 1999, MAR FRESHWATER RES, V50, P333, DOI 10.1071/MF97172; McGarvey R, 2014, 200971420 AUSTR SEAF; Mills DJ, 2008, MAR ECOL PROG SER, V364, P1, DOI 10.3354/meps07527; Norman Mark, 2000, P1; O'Shea S, 1999, MARINE FAUNA NZ OCTO; O'Sullivan S, 2003, FISH RES, V64, P55, DOI 10.1016/S0165-7836(03)00100-0; Peterson MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088906; R Core Team, 2021, R LANGUAGE ENV STAT; REES WJ, 1954, J MAR BIOL ASSOC UK, V33, P515, DOI 10.1017/S0025315400008511; Ritchie LD, 1972, 81 NZ MAR DEP; Robin JP, 2014, ADV MARINE BIOL; Smith CD, 2003, MAR BIOL, V143, P1127, DOI 10.1007/s00227-003-1144-2; Tixier P, 2015, ICES J MAR SCI, V72, P1610, DOI 10.1093/icesjms/fsu137; Trussell GC, 2006, ECOLOGY, V87, P2979, DOI 10.1890/0012-9658(2006)87[2979:TFOBER]2.0.CO;2; Tyrrell MC, 2011, FISH RES, V108, P1, DOI 10.1016/j.fishres.2010.12.025; Uhlmann SS, 2015, FISH FISH, V16, P183, DOI 10.1111/faf.12049; Ziegler PE, 2004, MAR BIOL, V145, P179, DOI 10.1007/s00227-004-1298-6	52	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139816	10.1371/journal.pone.0139816	http://dx.doi.org/10.1371/journal.pone.0139816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489035	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400039
J	Carrillo-Briceno, JD; Maxwell, E; Aguilera, OA; Sanchez, R; Sanchez-Villagra, MR				Carrillo-Briceno, Jorge D.; Maxwell, Erin; Aguilera, Orangel A.; Sanchez, Rodolfo; Sanchez-Villagra, Marcelo R.			Sawfishes and Other Elasmobranch Assemblages from the Mio-Pliocene of the South Caribbean (Urumaco Sequence, Northwestern Venezuela)	PLOS ONE			English	Article							TOOTHED WHITE SHARKS; SENSORY SYSTEMS; UPPER MIOCENE; FALCON STATE; NEOGENE; CHONDRICHTHYES; SILURIFORMES; DIVERSITY; CATFISHES; ROSTRUM	The Urumaco stratigraphic sequence, western Venezuela, preserves a variety of paleoenvironments that include terrestrial, riverine, lacustrine and marine facies. A wide range of fossil vertebrates associated with these facies supports the hypothesis of an estuary in that geographic area connected with a hydrographic system that flowed from western Amazonia up to the Proto-Caribbean Sea during the Miocene. Here the elasmobranch assemblages of the middle Miocene to middle Pliocene section of the Urumaco sequence (Socorro, Urumaco and Codore formations) are described. Based on new findings, we document at least 21 taxa of the Lamniformes, Carcharhiniformes, Myliobatiformes and Rajiformes, and describe a new carcharhiniform species (+Carcharhinus caquetius sp. nov.). Moreover, the Urumaco Formation has a high number of well-preserved fossil Pristis rostra, for which we provide a detailed taxonomic revision, and referral in the context of the global Miocene record of Pristis as well as extant species. Using the habitat preference of the living representatives, we hypothesize that the fossil chondrichthyan assemblages from the Urumaco sequence are evidence for marine shallow waters and estuarine habitats.	[Carrillo-Briceno, Jorge D.; Sanchez-Villagra, Marcelo R.] Univ Zurich, Paleontol Inst & Museum, Zurich, Switzerland; [Maxwell, Erin] Staatliches Museum Nat Kunde, Stuttgart, Germany; [Aguilera, Orangel A.] Univ Fed Fluminense, Inst Biol, Rio De Janeiro, Brazil; [Sanchez, Rodolfo] Museo Paleontol Urumaco, Urumaco, Estado Falcon, Venezuela	University of Zurich; Universidade Federal Fluminense	Sanchez-Villagra, MR (corresponding author), Univ Zurich, Paleontol Inst & Museum, Zurich, Switzerland.	m.sanchez@pim.uzh.ch	Aguilera, Orangel/D-5055-2013	Sanchez-Villagra, Marcelo Ricardo/0000-0001-7587-3648; Carrillo Briceno, Jorge Domingo/0000-0002-8652-7692; Aguilera, Orangel/0000-0003-4418-8351	Swiss National Fund SNF [31003A-149605]	Swiss National Fund SNF(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Fund SNF 31003A-149605 to MRSV (www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2004, CARIBB J SCI, V40, P368; Aguilera O, 2004, J PALEONTOL, V78, P1202, DOI 10.1666/0022-3360(2004)078<1202:GGPSFT>2.0.CO;2; Aguilera O.A., 2004, TESOROS PALEONTOLOGI; Aguilera OA, 2010, PECES FOSILES CARIBE; Aguilera O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076202; Aguilera Orangel, 2012, Swiss Journal of Palaeontology, V131, P265, DOI 10.1007/s13358-012-0043-x; Aguilera OA, 2008, PALAEONTOL Z, V82, P204, DOI 10.1007/BF02988410; Aguilera Orangel A., 2010, P129; Aguilera Socorro Orangel Antonio, 2011, Swiss Journal of Palaeontology, V130, P217, DOI 10.1007/s13358-011-0020-9; Ameghino F., 1901, ANALES SOC CIENTIFIC, V51, P65; Ameghino F., 1901, ANALES SOC CIENTIFIC, V51, P65; [Anonymous], 1833, RECHERCHES POISSONS; ANTUNES M.T., 2006, CAINOZOIC RES, V4, P41; Baughman J. L., 1943, COPEIA, V1943, P43, DOI 10.2307/1437880; Berg L. S., 1937, Bull Acad Leningrad Biol, V1937, P1277; Bleeker P., 1851, NATUURKUNDIG TIJDSCH, V2, P415; Bleeker P., 1859, ACT SOC REG SCI IND, V6, P1; Bonaparte C.L., 1838, NOUVELLES ANN SCI NA, V2, P195; Bor Taco, 2012, Palaeontos, V21, P1; BUDKER PAUL, 1935, BULL MUS NATION HIST NAT [PARIS], V7, P107; CAFFETTA H., 1970, PALAEOVERTEBRATA MEM, V1970, P1, DOI DOI 10.18563/PV.3.EXT.1-139; Cappetta H., 1980, Palaeovertebrata (Montpellier), V10, P29; Cappetta H, 2012, HDB PALAEOICHTHYOLOG, V3E; Carpenter KE, 2002, FAO SPECIES IDENTIFI, V5, P1; Carrillo-Briceno JD, 2015, J S AM EARTH SCI, V60, P56, DOI 10.1016/j.jsames.2015.02.001; Carrillo-Briceno JD, 2014, J S AM EARTH SCI, V51, P76, DOI 10.1016/j.jsames.2014.01.001; Casier E., 1949, I ROYAL SCI NATURELL, V25, P1; CASIER E, 1958, MEMOIRES SUISSES PAL, V74, P1, DOI DOI 10.1111/J.1463-6395.2011.00502.X; Cicimurri DJ, 2007, J PALEONTOL, V81, P597, DOI 10.1666/05086.1; Coates AG, 2013, B MAR SCI, V89, P801, DOI 10.5343/bms.2012.1076; Compagno L.J.V., 1973, Zoological J Linn Soc, V53, P15; Compagno L.J.V., 1984, FAO SPECIES CATALOGU, V4; Compagno L.J.V., 2005, SHARKS WORLD; Compagno Leonard J.V., 2005, P503; COMPAGNO LJV, 1977, AM ZOOL, V17, P303; Compagno LJV., 1984, FAO FISH SYNOP, P20; Cuvier G., 1829, REGNE ANIMAL DISTRIB; Cuvier G J L r., 1816, POISSONS MOLLUSQUESE; de Blainville HM., 1816, B SOC PHILOMATIQUE P, V8, P121; de Carvalho M.R., 2003, CHECK LIST FRESHWATE, P17; DEBLAINVILLE HMD, 1816, B SCI SOC PHILOMATIQ, V8, P105; deGamero MLD, 1996, PALAEOGEOGR PALAEOCL, V123, P385, DOI 10.1016/0031-0182(96)00115-0; Delfortrie E., 1871, ACTES SOC LINNEENNE, V28, P213; Diaz de Gamero M.L., 1989, GEOS, V29, P25; Diaz de Gamero M.L., 1989, 7 CONGRESO GEOL OGIC, V1, P419; Donovan Stephen K., 2001, Bulletin of the Mizunami Fossil Museum, V28, P211; DumERIL A. H. A., 1865, HIST NATURELLE POISS, V1; Euphrasen B. A., 1790, KONGLIGA VETENSKAPS, V11, P217; Faria VV, 2013, ZOOL J LINN SOC-LOND, V167, P136, DOI 10.1111/j.1096-3642.2012.00872.x; Garman S., 1913, Memoirs of the Museum of Comparative Zoology at Harvard College Cambridge, V36; Garman S., 1906, BULL MUS COMP ZOOL, V46, P203; Gilbert R., 1976, P US NATL MUS, V14, P1, DOI [10.5479/si.00963801.119-3539.1, DOI 10.5479/SI.00963801.119-3539.1]; Gill TN., 1872, SMITHSONIAN MISCELLA, V247, P1, DOI DOI 10.5962/BHL.TITLE.18974; Gillette D.D., 1984, Journal of Vertebrate Paleontology, V4, P172; Glikman LS., 1964, SHARKS PALEOGENE THE; Hambalek N., 1994, BOLET N SOC VENEZOLA, V191, P7; Hasse J.C.F., 1879, NATURLICHE SYSTEM EL; Herman J., 1997, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V67, P107; Hoffmann L., 1912, ZOOLOGISCHE JB ABTEI, V33, P237; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Hovestadt D.C., 2013, Palaeontos, V24, P1; Iturralde-Vinent M., 1996, Journal of the Geological Society of Jamaica, V31, P7; Iturralde-Vinent M, 1998, REV SOC MEXICANA PAL, V8, P135; Johnson KG, 2009, PALAIOS, V24, P59, DOI 10.2110/palo.2008.p08-004r; Jordan D. S., 1923, Bulletin of the Southern California Academy of Sciences, V22, P27; Jordan D.S., 1896, B US NAT MUS, V47, P1, DOI [10.5962/bhl.title.39714, DOI 10.5962/BHL.TITLE.46755]; Jordan DS, 1888, P ACAD NAT SCI PHILA, V39, P387; Kirkland James I., 2002, Revista Mexicana de Ciencias Geologicas, V19, P16; Kruckow T., 1990, Courier Forschungsinstitut Senckenberg, V119, P1; Latham J. F., 1794, T LINN SOC LOND, V2, P273, DOI [10.1111/j.1096-3642.1794.tb00259.x, DOI 10.1111/J.1096-3642.1794.TB00259.X]; Laurito C., 2004, BRENESIA, V62, P57; Laurito C. A, 1999, SELACEOS FOSILES LOC; Le Sueur CA, 1818, J ACAD NATURAL SCI P, V1, P222; Leriche M., 1938, Mem Soc Pal Suisse Bale, V61, P1; Linck H. F., 1790, MAGAZIN NEUESTE PHYS, V6, P28; Linnaeus C, 1758, SYSTEMA NATURAE; Lundberg John G., 2003, Neotrop. ichthyol., V1, P97, DOI 10.1590/S1679-62252003000200004; Lundberg JG, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P281; MILLER WA, 1974, COPEIA, P311; Mitchill S. L., 1815, T LIT PHILOS SOC NEW, V1, P355; Muller George Friedrich, 1760, KONIGLICH PREUSSISCH; Muller J., 1839, SYSTEMATISCHE BESCHR; Musick JA, 2004, CRC MAR BIOL SER, P33; Nardo J. D., 1827, OKENS ISIS, V20, P472; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nieves-Rivera AM, 2003, CARIBB J SCI, V39, P223; NISHDA K, 1990, Memoirs of the Faculty of Fisheries Hokkaido University, V37, P1; Perez MHS, 2007, P ACAD NAT SCI PHILA, V156, P157, DOI 10.1635/0097-3157(2007)156[157:FCOTFD]2.0.CO;2; Pietschmann V., 1913, JB NASSAUISCHEN VERE, V66, P170; Pimiento C, 2015, PALEOBIOLOGY, V41, P479, DOI 10.1017/pab.2015.16; Pimiento C, 2013, J PALEONTOL, V87, P755, DOI 10.1666/12-117; Pimiento C, 2013, J S AM EARTH SCI, V42, P159, DOI 10.1016/j.jsames.2012.11.005; Pimiento C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010552; Poey F, 1868, REPERTORIO FISICO NA, V2, P279; Portell RW, 2008, CARIBB J SCI, V44, P279; Purdy RW, 2001, SM C PALEOB, V90, P71; Purdy RW, 1996, J VERTEBR PALEONTOL, V16, P165, DOI 10.1080/02724634.1996.10011294; Puron F., 1822, J ACAD NATURAL SCI P, V2, P343; Quiroz L.I, 2010, URUMACO VENEZUELAN P, P153; Rafinesque C.S., 1810, CARATTERI ALCUNI NUO; Ranzani C., 1839, NOVI COMMENTARII ACA, V4, P65; REIF WE, 1982, EVOL BIOL, V15, P287; Reinecke Thomas, 2011, Palaeontos, V20, P1; Rey O, 1990, THESIS U CENTRAL VEN; Rey O, 1994, B SOC VENEZOLANA GEO, V19, P50; Robillard M, 2006, CYBIUM, V30, P23; Rod E, 1981, GEOS, V26, P54; Sanchez-Villagra MR, 2006, J SYST PALAEONTOL, V4, P213, DOI 10.1017/S1477201906001829; Sanchez-Villagra MR., 2010, URUMACO VENEZUELAN P; Scheyer TM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2940; SCHULTZ LEONARD P., 1949, PROC U S NATION MUS, V99, P1; Simpfendorfer CA, 2008, J FISH BIOL, V72, P711, DOI 10.1111/j.1095-8649.2007.01764.x; Smith CJ, 2010, J FORAMIN RES, V40, P266, DOI 10.2113/gsjfr.40.3.266; Underwood C. J., 2004, CAINOZOIC RES, V3, P157; Valenciennes A., 1839, SYSTEMATISCHE BESCHR, P39; Voigt M., 2011, FIELD GUIDE SHARKS G; White E. I., 1941, Annals & Magazine of Natural History Series 11, V7, P395; Whitley G. P., 1929, Australian Zoologist, V5, P353; Whitley G. P., 1943, Proceedings of the Linnean Society of New South Wales, V68, P114; Whitty JM, 2014, AQUAT CONSERV, V24, P791, DOI 10.1002/aqc.2398; Wiley TR, 2008, ZOOTAXA, P51, DOI 10.11646/zootaxa.1810.1.3; Wood R.C., 1976, Breviora, VNo. 435, P1; Wueringer BE, 2011, BRAIN BEHAV EVOLUT, V78, P139, DOI 10.1159/000329515; Wueringer BE, 2011, BRAIN BEHAV EVOLUT, V78, P150, DOI 10.1159/000329518; Wueringer BE, 2009, REV FISH BIOL FISHER, V19, P445, DOI 10.1007/s11160-009-9112-7; Zbyszewski G., 1947, Boletim da Sociadade Geologica de Portugal, V6, P237	126	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139230	10.1371/journal.pone.0139230	http://dx.doi.org/10.1371/journal.pone.0139230			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488163	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000363248400023
J	Rubenstein, DI; Sundaresan, SR; Fischhoff, IR; Tantipathananandh, C; Berger-Wolf, TY				Rubenstein, Daniel I.; Sundaresan, Siva R.; Fischhoff, Ilya R.; Tantipathananandh, Chayant; Berger-Wolf, Tanya Y.			Similar but Different: Dynamic Social Network Analysis Highlights Fundamental Differences between the Fission-Fusion Societies of Two Equid Species, the Onager and Grevy's Zebra	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ORGANIZATION; EVOLUTION	Understanding why animal societies take on the form that they do has benefited from insights gained by applying social network analysis to patterns of individual associations. Such analyses typically aggregate data over long time periods even though most selective forces that shape sociality have strong temporal elements. By explicitly incorporating the temporal signal in social interaction data we re-examine the network dynamics of the social systems of the evolutionarily closely-related Grevy's zebras and wild asses that show broadly similar social organizations. By identifying dynamic communities, previously hidden differences emerge: Grevy's zebras show more modularity than wild asses and in wild asses most communities consist of solitary individuals; and in Grevy's zebras, lactating females show a greater propensity to switch communities than non-lactating females and males. Both patterns were missed by static network analyses and in general, adding a temporal dimension provides insights into differences associated with the size and persistence of communities as well as the frequency and synchrony of their formation. Dynamic network analysis provides insights into the functional significance of these social differences and highlights the way dynamic community analysis can be applied to other species.	[Rubenstein, Daniel I.] Princeton Univ, Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Sundaresan, Siva R.] Jackson Hole Conservat Alliance, Jackson, WY USA; [Fischhoff, Ilya R.] Univ Corp Atmospheric Res, Washington, DC USA; [Rubenstein, Daniel I.; Sundaresan, Siva R.; Fischhoff, Ilya R.] Mpala Res Ctr, Nanyuki, Kenya; [Tantipathananandh, Chayant] Google Inc, Mountain View, CA USA; [Berger-Wolf, Tanya Y.] Univ Illinois, Comp Sci, Chicago, IL USA	Princeton University; National Center Atmospheric Research (NCAR) - USA; Google Incorporated; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Berger-Wolf, TY (corresponding author), Univ Illinois, Comp Sci, Chicago, IL USA.	tanyabw@uic.edu			Princeton University; McMaster; Smithsonian Institution; Denver Zoological Foundation; Wildlife Conservation Society; University of Illinois at Chicago; Microsoft award [14936]; NSF [IBN-0309233, CNS-025214, IOB-9874523, IIS-0705822, IIS-0747369, OCI-1152895, CNS-1248080]; Div Of Information & Intelligent Systems [0747369] Funding Source: National Science Foundation	Princeton University(Princeton University); McMaster; Smithsonian Institution(Smithsonian Institution); Denver Zoological Foundation; Wildlife Conservation Society; University of Illinois at Chicago; Microsoft award(Microsoft); NSF(National Science Foundation (NSF)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was in part supported by Princeton University (IRF, SRS), McMaster (IRF), Smithsonian Institution (IRF), Denver Zoological Foundation (SRS), Wildlife Conservation Society (SRS), University of Illinois at Chicago (CT), Microsoft award 14936 (TYB), and the following NSF grants: IBN-0309233 (DIR, SRS), CNS-025214 (DIR), IOB-9874523 (DIR), IIS-0705822 (TYB, DIR), IIS-0747369 (TYB), OCI-1152895 (TYB, DIR, CT), CNS-1248080 (TYB, DIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal CC, 2005, SIAM PROC S, P56; [Anonymous], 1908, BIOMETRIKA, V6, P302, DOI 10.1093/biomet/6.2-3.302; [Anonymous], 1908, BIOMETRIKA, V6, P1; [Anonymous], 2005, P 3 INT WORKSH LINK, DOI [http://doi.acm.org/10.1145/1134271.1134280, DOI 10.1145/1134271.1134280]; [Anonymous], SDM; Archie EA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1261; Backstrom L., 2006, P SIGKDD, P44, DOI DOI 10.1145/1150402.1150412; Berger-Wolf T, 2010, LINK MINING: MODELS, ALGORITHMS, AND APPLICATIONS, P307, DOI 10.1007/978-1-4419-6515-8_12; Berger-Wolf TY, 2006, P 12 ACM SIGKDD INT, P523, DOI [10.1145/1150402.1150462, DOI 10.1145/1150402.1150462]; Bhadra A, 2009, ECOL COMPLEX, V6, P48, DOI 10.1016/j.ecocom.2008.10.004; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Blonder B, 2012, METHODS ECOL EVOL, V3, P958, DOI 10.1111/j.2041-210X.2012.00236.x; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Breiger RL, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P19; Caceres R.S., 2013, TEMPORAL NETWORKS, P65, DOI [10.1007/978-3-642-36461-7_4, http://dx.doi.org/10.1007/978-3-642-36461-7-4, DOI 10.1007/978-3-642-36461-7_4]; Carley KM, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P133; Cormen T.H., 2001, INTRO ALGORITHMS; Crofoot MC, 2011, AM J PRIMATOL, V73, P821, DOI 10.1002/ajp.20959; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Du N, 2010, LECT NOTES ARTIF INT, V6321, P393; Escalera S, 2010, INT C MULT INT WORKS, P52, DOI [http://doi.acm.org/10.1145/1891903.1891967, DOI 10.1145/1891903.1891967]; Falkowski T, 2009, THESIS U MAGDEBURG; Falkowski T, 2006, 2006 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE, (WI 2006 MAIN CONFERENCE PROCEEDINGS), P52, DOI 10.1109/WI.2006.118; Farine DR, 2015, ANIMAL BEHAV ONLINE; FELD SL, 1981, AM J SOCIOL, V86, P1015, DOI 10.1086/227352; Fortunato S., 2012, COMPUT COMPLEX THEOR, P490, DOI [10.1007/978-1-4614-1800-9_33, DOI 10.1007/978-1-4614-1800-9_33]; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freeman LC, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P39; Ghani S, 2013, IEEE T VIS COMPUT GR, V19, P2032, DOI 10.1109/TVCG.2013.223; GILLESPIE JH, 1974, GENETICS, V76, P601; Govaert G., 2013, COCLUSTERING; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Habiba Tantipathananandh C, 2013, SIAM WORKSH NETW SCI; Hinde, 1983, PRIMATE SOCIAL RELAT; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Huffman MA, 2008, CURR DIR PSYCHOL SCI, V17, P410, DOI 10.1111/j.1467-8721.2008.00616.x; Iriberri A, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1459352.1459356; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Jacoby DMP, 2012, METHODS ECOL EVOL, V3, P574, DOI 10.1111/j.2041-210X.2012.00187.x; Kempe D, 2002, J COMPUT SYST SCI, V64, P820, DOI 10.1006/jcss.2002.1829; Kleinberg J.M., 2003, ADV NEURAL INFORM PR, V15, P463; Krause J, 2015, ANIMAL SOCIAL NETWORKS, P1; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Kumar R, 2005, WORLD WIDE WEB, V8, P159, DOI 10.1007/s11280-004-4872-4; Leskovec J., 2010, P 19 INT C WORLD WID; Lin Y.R., 2008, P 17 INT C WORLD WID, P685, DOI [10.1145/1367497.1367590, DOI 10.1145/1367497.1367590]; Macker JP, 2012, IEEE MILIT COMMUN C; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Nguyen NP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091431; Nicosia V., 2013, TEMPORAL NETWORKS, P15, DOI DOI 10.1007/978-3-642-36461-7_2; Nunez CMV, 2015, BEHAV ECOL, V26, P138, DOI 10.1093/beheco/aru163; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Rozenshtein Polina, 2014, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2014. Proceedings: LNCS 8725, P678, DOI 10.1007/978-3-662-44851-9_43; Rubenstein D.I., 1982, P91; Rubenstein DI, 2015, ANIMAL SOCIAL NETWORKS, P184; Rubenstein DI, 2009, REPRODUCTIVE SKEW IN VERTEBRATES: PROXIMATE AND ULTIMATE CAUSES, P196, DOI 10.1017/CBO9780511641954.010; Rubenstein DI., 1986, ECOLOGICAL ASPECTS S; Saramaki J, 2013, UNDERSTING COMPLE; Scott JP, 2000, SOCIAL NEWTWORK ANAL; Shen ZQ, 2006, IEEE T VIS COMPUT GR, V12, P1427, DOI 10.1109/TVCG.2006.107; Spiliopoulou M., 2006, P 12 ACM SIGKDD INT, P706, DOI [10.1145/1150402.1150491, DOI 10.1145/1150402.1150491]; Sun JM, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P687; Sundaresan SR, 2007, OECOLOGIA, V151, P140, DOI 10.1007/s00442-006-0553-6; Tang J., 2012, P 5 ACM INT C WEB SE, P743, DOI [http://doi.acm.org/10.1145/2124295.2124382, DOI 10.1145/2124295.2124382, 10.1145/2124295.2124382]; Tantipathananandh C., 2011, Proceedings of the 2011 IEEE 11th International Conference on Data Mining (ICDM 2011), P1236, DOI 10.1109/ICDM.2011.67; Tantipathananandh C, 2013, TEHSIS U ILLINOIS CH; Tantipathananandh C, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P827; Tantipathananandh C, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P717; Tong, 2008, P 14 ACM SIGKDD INT, P686, DOI DOI 10.1145/1401890.1401973; Toyoda M., 2003, P 14 ACM C HYP HYP, P28, DOI [DOI 10.1145/900051.900059, 10.1145/900051.900059]; Wasserman S, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P197; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; West DB, 1999, INTRO GRAPH THEORY; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020	79	24	24	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0138645	10.1371/journal.pone.0138645	http://dx.doi.org/10.1371/journal.pone.0138645			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488598	Green Published, gold			2022-12-27	WOS:000363248400009
J	Schulze, K; Weismueller, TJ; Bubenheim, M; Huebener, P; Zenouzi, R; Lenzen, H; Rupp, C; Gotthardt, D; de Leuw, P; Teufel, A; Zimmer, V; Reiter, FP; Rust, C; Tharun, L; Quaas, A; Weidemann, SA; Lammert, F; Sarrazin, C; Manns, MP; Lohse, AW; Schramm, C				Schulze, Kornelius; Weismueller, Tobias J.; Bubenheim, Michael; Huebener, Peter; Zenouzi, Roman; Lenzen, Henrike; Rupp, Christian; Gotthardt, Daniel; de Leuw, Philipp; Teufel, Andreas; Zimmer, Vincent; Reiter, Florian P.; Rust, Christian; Tharun, Lars; Quaas, Alexander; Weidemann, Soern A.; Lammert, Frank; Sarrazin, Christoph; Manns, Michael P.; Lohse, Ansgar W.; Schramm, Christoph		German PSC Study Grp	Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis	PLOS ONE			English	Article							AUTOIMMUNE HEPATITIS; SCORING SYSTEM; DIAGNOSIS; MANAGEMENT; PATHOGENESIS; OVERLAP	Background & Aims Current guidelines recommend immunosuppressive treatment (IT) in patients with primary sclerosing cholangitis (PSC) and elevated aminotransferase levels more than five times the upper limit of normal and elevated serum IgG-levels above twice the upper limit of normal. Since there is no evidence to support this recommendation, we aimed to assess the criteria that guided clinicians in clinical practice to initiate IT in patients with previously diagnosed PSC. Methods This is a retrospective analysis of 196 PSC patients from seven German hepatology centers, of whom 36 patients had received IT solely for their liver disease during the course of PSC. Analyses were carried out using methods for competing risks. Results A simplified autoimmune hepatitis (AIH) score > 5 (HR of 36, p<0.0001) and a modified histological activity index (mHAI) greater than 3/18 points (HR 3.6, p = 0.0274) were associated with the initiation of IT during the course of PSC. Of note, PSC patients who subsequently received IT differed already at the time of PSC diagnosis from those patients, who did not receive IT during follow-up: they presented with increased levels of IgG (p = 0.004) and more frequently had clinical signs of cirrhosis (p = 0.0002). Conclusions This is the first study which investigates the parameters associated with IT in patients with PSC in clinical practice. A simplified AIH score > 5 and a mHAI score > 3, suggesting concomitant features of AIH, influenced the decision to introduce IT during the course of PSC. In German clinical practice, the cutoffs used to guide IT may be lower than recommended by current guidelines.	[Schulze, Kornelius; Huebener, Peter; Zenouzi, Roman; Lohse, Ansgar W.; Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Weismueller, Tobias J.] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Weismueller, Tobias J.; Lenzen, Henrike; Manns, Michael P.] Hannover Med Sch, Clin Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Bubenheim, Michael] Univ Rouen, Hosp Charles Nicolle, Dept Biostat, Rouen, France; [Rupp, Christian; Gotthardt, Daniel] Univ Med Ctr Heidelberg, Dept Med 4, Heidelberg, Germany; [de Leuw, Philipp; Sarrazin, Christoph] Univ Med Ctr Frankfurt, Dept Med 1, Frankfurt, Germany; [Teufel, Andreas] Univ Med Ctr Mainz, Dept Med 1, Mainz, Germany; [Teufel, Andreas] Univ Hosp Regensburg, Dept Med, Regensburg, Germany; [Zimmer, Vincent; Lammert, Frank] Univ Saarland, Med Ctr Homburg, Dept Med 2, Homburg, Germany; [Reiter, Florian P.; Rust, Christian] Univ Munich, Liver Ctr Munich, Dept Med 2, Munich, Germany; [Tharun, Lars; Quaas, Alexander] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany; [Quaas, Alexander; Weidemann, Soern A.] Univ Med Ctr Cologne, Dept Pathol, Cologne, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; Hannover Medical School; CHU de Rouen; Universite de Rouen Normandie; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; University of Regensburg; Saarland University; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne	Schramm, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany.	cschramm@uke.de	Teufel, Andreas/ABD-8000-2021; Zimmer, Vincent/A-9601-2008; Rupp, Christian/E-7652-2019; Weismüller, Tobias J./I-1879-2019; Huebener, Peter/AAF-2593-2020	Zimmer, Vincent/0000-0002-6298-4717; Rupp, Christian/0000-0003-2808-9230; Weismüller, Tobias J./0000-0001-9736-1483; Schramm, Christoph/0000-0002-4264-1928; Huebener, Peter/0000-0001-7558-7625	YAEL Foundation; Deutsche Forschungsgemeinschaft [SFB841]	YAEL Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the YAEL Foundation and by the Deutsche Forschungsgemeinschaft (SFB841).	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Boberg KM, 2011, J HEPATOL, V54, P374, DOI 10.1016/j.jhep.2010.09.002; Boberg KM, 1996, HEPATOLOGY, V23, P1369, DOI 10.1053/jhep.1996.v23.pm0008675153; Chandok Natasha, 2010, Gastroenterol Hepatol (N Y), V6, P108; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; Czaja AJ, 1996, DIGEST DIS SCI, V41, P305, DOI 10.1007/BF02093820; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; Floreani A, 2005, AM J GASTROENTEROL, V100, P1516, DOI 10.1111/j.1572-0241.2005.41841.x; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Katt J, 2013, HEPATOLOGY, V58, P1084, DOI 10.1002/hep.26447; Kaya M, 2000, J HEPATOL, V33, P537, DOI 10.1034/j.1600-0641.2000.033004537.x; Liaskou E, 2014, GASTROENTEROLOGY, V147, P221, DOI 10.1053/j.gastro.2014.04.003; Luth S, 2008, J CLIN GASTROENTEROL, V42, P926, DOI 10.1097/MCG.0b013e318154af74; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584	18	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140525	10.1371/journal.pone.0140525	http://dx.doi.org/10.1371/journal.pone.0140525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489083	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400058
J	Vega-Zelaya, L; Pastor, J; de Sola, RG; Ortega, GJ				Vega-Zelaya, Lorena; Pastor, Jesus; de Sola, Rafael G.; Ortega, Guillermo J.			Disrupted Ipsilateral Network Connectivity in Temporal Lobe Epilepsy	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; NEURAL NETWORKS; SYNCHRONIZATION; BRAIN; EEG; PATTERNS; CLUSTERS; SEIZURES; SIGNALS; MEG	Objective The current practice under which patients with refractory epilepsy are surgically treated is based mainly on the identification of specific cortical areas, mainly the epileptogenic zone, which is believed to be responsible for generation of seizures. A better understanding of the whole epileptic network and its components and properties is required before more effective and less invasive therapies can be developed. The aim of the present study was to partially characterize the evolution of the functional network during the preictal-ictal transition in partial seizures in patients with temporal lobe epilepsy (TLE). Methods Scalp and foramen ovale (FOE) recordings from twenty-two TLE patients were analyzed under the complex network perspective. The density of links, average path length, average clustering coefficient, and modularity were calculated during the preictal and the ictal stages. Both linear-Pearson correlation-and non-linear-phase synchronization-measures were used as proxies of functional connectivity between the electrode locations areas. The transition from one stage to the other was evaluated in the whole network and in the mesial sub-networks. The results were compared with a voltage-dependent measure, namely, the spectral entropy. Results Changes in the global functional network during the transition from the preictal to the ictal stage show, in the linear case, that in sixteen cases (72.7%) the density of the links increased during the seizure, with a decrease in the average path length in fifteen cases (68.1%). There was also a preictal and ictal imbalance in functional connectivity during both stages (77.2% to 86.3%). The SE dropped during the seizure in 95.4% of the cases, but did not show any tendency towards lateralization. When using the nonlinear measure of functional connectivity, the phase synchronization, similar results were obtained. Conclusions In TLE patients, the transition to the ictal stage is accompanied by increasing global synchronization and a more ordered spectral content of the signals, indicated by lower spectral entropy. The interictal connectivity imbalance (lower ipsilateral connectivity) is sustained during the seizure, irrespective of any appreciable imbalance in the spectral entropy of the mesial recordings.	[Vega-Zelaya, Lorena; Pastor, Jesus] Hosp Univ Princesa, Clin Neurophysiol, Madrid, Spain; [de Sola, Rafael G.; Ortega, Guillermo J.] Hosp Univ Princesa, Neurosurg, Madrid, Spain; [Vega-Zelaya, Lorena; Pastor, Jesus; de Sola, Rafael G.; Ortega, Guillermo J.] Hosp Univ Princesa, Inst Invest Sanitaria, Madrid, Spain		Ortega, GJ (corresponding author), Hosp Univ Princesa, Neurosurg, Madrid, Spain.	gjortega.hlpr@salud.madrid.org	Pastor, Jesus/AAH-9238-2020; Vega-Zelaya, Lorena/AAV-5670-2021	Pastor, Jesus/0000-0001-6870-8409; G. Sola, Rafael/0000-0002-0063-9301	Ministerio de Sanidad [FIS PI12/02839]; FEDER (Fonds Europeen de Developpement Economique et Regional); CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP 11420100100261]	Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); FEDER (Fonds Europeen de Developpement Economique et Regional); CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was financed by the Ministerio de Sanidad FIS PI12/02839 and was partially supported by FEDER (Fonds Europeen de Developpement Economique et Regional) and PIP 11420100100261 CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas).	Afra P, 2008, EPILEPSIA, V49, P677, DOI 10.1111/j.1528-1167.2007.01420.x; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bartolomei F, 2001, CLIN NEUROPHYSIOL, V112, P1746, DOI 10.1016/S1388-2457(01)00591-0; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Bialonski S, 2013, CHAOS, V23, DOI 10.1063/1.4821915; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Burns SP, 2014, P NATL ACAD SCI USA, V111, pE5321, DOI 10.1073/pnas.1401752111; Chang BS, 2011, NIEDERMEYERS ELECTRO; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Engel JJ, SURG TREATMENT EPILE; Focke NK, 2008, NEUROIMAGE, V40, P728, DOI 10.1016/j.neuroimage.2007.12.031; Frei MG, 2010, EPILEPSY BEHAV, V19, P4, DOI 10.1016/j.yebeh.2010.06.009; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hassan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105041; Kramer MA, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061916; Kramer MA, 2010, J NEUROSCI, V30, P10076, DOI 10.1523/JNEUROSCI.6309-09.2010; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lee SA, 2000, EPILEPSIA, V41, P297, DOI 10.1111/j.1528-1157.2000.tb00159.x; Mormann F, 2003, EPILEPSY RES, V53, P173, DOI 10.1016/S0920-1211(03)00002-0; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Ortega GJ, 2011, CLIN NEUROPHYSIOL, V122, P1106, DOI 10.1016/j.clinph.2010.11.001; Palmigiano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041799; Pastor J, 2005, REV NEUROLOGIA, V41, P709, DOI 10.33588/rn.4112.2005477; Pastor J, 2008, EPILEPSIA, V49, P464, DOI 10.1111/j.1528-1167.2007.01314.x; Pastor J, 2014, J NEUROSCI METH, V223, P69, DOI 10.1016/j.jneumeth.2013.11.027; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Roopun AK, 2009, EPILEPSY BEHAV, V14, P39, DOI 10.1016/j.yebeh.2008.09.008; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sola RG, 2005, REV NEUROLOGIA, V41, P4; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; SPERLING MR, 1994, CLIN NEUROSCI, V2, P17; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Terry JR, 2012, EPILEPSIA, V53, pe166, DOI 10.1111/j.1528-1167.2012.03560.x; van Diessen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114606; van Diessen E, 2013, EPILEPSIA, V54, P1855, DOI 10.1111/epi.12350; Vega LC, 2014, FRONT NEUROL, V5, P171; Vega-Zelaya L, 2014, CLIN NEUROPHYSIOL, V125, P2349, DOI 10.1016/j.clinph.2014.03.027; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Wendling F, 2009, J NEUROSCI METH, V183, P9, DOI 10.1016/j.jneumeth.2009.04.021; Wieser HG, 2001, CLIN NEUROPHYSIOL, V112, P2053, DOI 10.1016/S1388-2457(01)00639-3	51	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140859	10.1371/journal.pone.0140859	http://dx.doi.org/10.1371/journal.pone.0140859			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489091	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400076
J	Yang, CW; Tzeng, NS; Yin, YJ; Li, CH; Chen, HA; Chiu, SH; Ho, SY; Huang, HL				Yang, CW; Tzeng, NS; Yin, YJ; Li, CH; Chen, HA; Chiu, SH; Ho, SY; Huang, HL			Angiotensin Receptor Blockers Decrease the Risk of Major Adverse Cardiovascular Events in Patients with End-Stage Renal Disease on Maintenance Dialysis: A Nationwide Matched-Cohort Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INSURANCE RESEARCH DATABASE; ACUTE MYOCARDIAL-INFARCTION; LONG-TERM HEMODIALYSIS; HEALTH INSURANCE; SYSTEM BLOCKADE; BLOOD-PRESSURE; TAIWAN; MORTALITY; ATHEROGENESIS	Background Major adverse cardiovascular events (MACE) cause the leading cause of morbidity and mortality in patients with end-stage renal disease (ESRD) on maintenance Hemodialysis (HD) or peritoneal dialysis (PD). Many randomized-controlled trials (RCTs) have proved that angiotensin receptor blockers (ARBs) can reduce the risk of MACE in the people with normal or impaired kidney function without dialysis. This study seeks to clarify whether ARBs therapy could also attenuate this risk in patients with ESRD on maintenance dialysis. Materials and Methods The National Health Research Institute provided a database of one million random subjects for the study. A random sample was taken of 1800 patients >= 18 years y/o with ESRD on dialysis without a history of MACE and use of ARBs within 6-months prior to enrollment. Cox proportional hazard regression analysis was used to identify the risk factors and compute the hazard ratios accompanying 95% confidence intervals. Results In these 1800 patients, 1061 had never used ARBs, while 224 had used them for 1-90 days, and 515 had used them for more than 90 days. We found that ARBs significantly decrease the incidences of acute myocardial infarctions (AMI), coronary artery diseases (CAD) requiring coronary stent or percutaneous transluminal coronary angioplasty (PTCA), peripheral artery disease (PAD) requiring percutaneous transluminal angioplasty (PTA), and acute stroke. Cumulative prescription days of ARBs beyond 365-760 days or more were found to be negatively correlated with incidence of MACEs. For patients with dual comorbidity (i.e., mellitus and hyperlipidemia), 91-365 cumulative prescription days might also attenuate the risk. Conclusions For patients on maintenance dialysis, the use of ARBs could significantly attenuate the risk of major cardiovascular events: AMI, acute stroke, and PAD requiring PTA.	Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Med, Div Nephrol, Hsinchu, Taiwan; Natl Def Med Ctr, Sch Med, Triserv Gen Hosp, Dept Psychiat, Taipei, Taiwan; Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan; [Ho, SY] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Surg, Div Neurosurg, Hsinchu, Taiwan; [Ho, SY] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University	Ho, SY (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	syho@mail.nctu.edu.tw; hlhuang@mail.nctu.edu.tw	Ho, Shinn-Ying/AAE-9394-2022; Tzeng, Nian-Sheng/AAU-4945-2021; Ho, Shinn-Ying/AFD-8402-2022	Ho, Shinn-Ying/0000-0002-1901-8353; Ho, Shinn-Ying/0000-0002-1901-8353; LI, CHIEN-HSUN/0000-0001-7671-9618; YANG, CHUNG-WEI/0000-0002-8613-3597	National Science Council of Taiwan [MOST-104-2627-M-009-009-, MOST-104-2221-E-009-183-]; "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C. [103W962]; UST-UCSD International Center of Excellence in Advanced Bioengineering - Taiwan National Science Council I-RiCE Program [MOST-103-2911-I-009-101-]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan); UST-UCSD International Center of Excellence in Advanced Bioengineering - Taiwan National Science Council I-RiCE Program	This work was supported by National Science Council of Taiwan under the contract number MOST-104-2627-M-009-009-, MOST-104-2221-E-009-183-, and "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C., for the project 103W962. This work was also supported in part by the UST-UCSD International Center of Excellence in Advanced Bioengineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: MOST-103-2911-I-009-101-.	Bejan-Angoulvant T, 2012, NEPHROL DIAL TRANSPL, V27, P2886, DOI 10.1093/ndt/gfs008; Berl T, 2004, J AM SOC NEPHROL, V15, pS71, DOI 10.1097/01.ASN.0000093235.09769.9C; Carson P, 2001, CLIN CARDIOL, V24, P183, DOI 10.1002/clc.4960240303; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; EBERHARDT RT, 1993, J CLIN PHARMACOL, V33, P1023, DOI 10.1002/j.1552-4604.1993.tb01939.x; Fink HA, 2012, ANN INTERN MED, V156, P570, DOI [10.7326/0003-4819-156-8-201204170-00008, 10.7326/0003-4819-156-8-201204170-00004]; Hernandez-Hernandez R, 2002, J HUM HYPERTENS, V16, pS93, DOI 10.1038/sj.jhh.1001352; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Iseki K, 2013, NEPHROL DIAL TRANSPL, V28, P1579, DOI 10.1093/ndt/gfs590; Ku E, 2015, KIDNEY INT, V87, P1055, DOI 10.1038/ki.2014.376; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Nickenig G, 2002, CIRCULATION, V105, P393, DOI 10.1161/hc0302.102618; Rahman M, 2000, AM J KIDNEY DIS, V35, P257, DOI 10.1016/S0272-6386(00)70335-0; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sharma S, 2013, EUR HEART J, V34, P354, DOI 10.1093/eurheartj/ehs300; Strawn WB, 2000, CIRCULATION, V101, P1586, DOI 10.1161/01.CIR.101.13.1586; System USRD, 2014, 2014 ANN DAT REP OV; Tai DJ, 2010, CLIN J AM SOC NEPHRO, V5, P623, DOI 10.2215/CJN.07831109; Tang CH, 2013, EUR J HEART FAIL, V15, P1194, DOI 10.1093/eurjhf/hft082; Thambyrajah J, 2000, HEART, V83, P205, DOI 10.1136/heart.83.2.205; vanGuldener C, 1997, NEPHROL DIAL TRANSPL, V12, P14; Venkata C, 1998, Am J Ther, V5, P101; Wang SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105218; Warnholtz A, 1999, CIRCULATION, V99, P2027, DOI 10.1161/01.CIR.99.15.2027; Wassmann S, 2006, J HYPERTENS, V24, pS15, DOI 10.1097/01.hjh.0000220402.53869.72; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Werner C, 2008, CLIN RES CARDIOL, V97, P418, DOI 10.1007/s00392-008-0668-3; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140633	10.1371/journal.pone.0140633	http://dx.doi.org/10.1371/journal.pone.0140633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488749	gold, Green Submitted, Green Published			2022-12-27	WOS:000363248400064
J	Huang, HM; Chang, DST; Wu, PC				Huang, Hsiu-Mei; Chang, Dolly Shuo-Teh; Wu, Pei-Chang			The Association between Near Work Activities and Myopia in Children-A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							AUSTRALIAN SCHOOL-CHILDREN; OUTDOOR ACTIVITY; RISK-FACTORS; REFRACTIVE ERROR; INCIDENT MYOPIA; VISUAL ACTIVITY; NEAR-WORK; SINGAPOREAN CHILDREN; CHINESE-AMERICAN; PARENTAL HISTORY	Myopia has a multifactorial etiology, although environmental factors are predominant in determining its current patterns. Currently, associations between near work activities and myopia have not been consistently observed. Therefore, we performed a systematic review to quantify the effect of near work activities on myopia in children. Relevant articles published between 1989 and 2014 were identified in MEDLINE, Embase, and the Cochrane Library, and the citation lists were reviewed. Twelve cohort studies and 15 cross-sectional studies were included (25,025 children aged between 6 and 18 years). The I-2 statistic was used to assess heterogeneity. Study-level data were pooled using a random-effects model or a fixed-effects model (when less than 5 studies were included). We found that more time spent on near work activities was associated with higher odds of myopia (odds ratio [OR] = 1.14; 95% confidence interval [CI] = 1.08-1.20) and that the odds of myopia increased by 2% (OR: 1.02; 95% CI = 1.01-1.03) for every one diopter-hour (hr) more of near work per week. Therefore, the development of a strategy to reduce the impact of near work on myopia would be important for preventing myopia in children.	[Huang, Hsiu-Mei; Wu, Pei-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Huang, Hsiu-Mei; Wu, Pei-Chang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chang, Dolly Shuo-Teh] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA	Chang Gung Memorial Hospital; Chang Gung University; Johns Hopkins University; Johns Hopkins Medicine	Wu, PC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Ophthalmol, Kaohsiung, Taiwan.	wpc@adm.cgmh.org.tw			Bureau of Health Promotion, Department of Health, Taiwan [PARPG8B0051, PARPG8B0141]	Bureau of Health Promotion, Department of Health, Taiwan	PCW received grants from the Bureau of Health Promotion, Department of Health, Taiwan (PARPG8B0051; PARPG8B0141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun C I, 1996, Ophthalmic Epidemiol, V3, P13, DOI 10.3109/09286589609071597; Chen HB, 2001, ADOLESCENCE, V36, P305; Deng L, 2010, OPTOMETRY VISION SCI, V87, P406, DOI 10.1097/OPX.0b013e3181da8a85; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; Fulk George W, 2002, Optometry, V73, P470; GOSS DA, 1990, OPTOMETRY VISION SCI, V67, P631, DOI 10.1097/00006324-199008000-00014; GOSS DA, 1987, OPHTHAL PHYSL OPT, V7, P195, DOI 10.1111/j.1475-1313.1987.tb01020.x; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; GWIAZDA J, 1993, INVEST OPHTH VIS SCI, V34, P690; Hepsen IF, 2001, VISION RES, V41, P2511, DOI 10.1016/S0042-6989(01)00135-3; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P3858, DOI 10.1167/iovs.07-1451; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; JENSEN H, 1995, ACTA OPHTHALMOL SCAN, V73, P389; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2012, INVEST OPHTH VIS SCI, V53, P7169, DOI 10.1167/iovs.11-8336; Jones-Jordan LA, 2011, INVEST OPHTH VIS SCI, V52, P1841, DOI 10.1167/iovs.09-4997; Khader Y. S., 2006, Eastern Mediterranean Health Journal, V12, P434; Liang CL, 2004, INVEST OPHTH VIS SCI, V45, P3446, DOI 10.1167/iovs.03-1058; Lin LLK, 1996, OPTOMETRY VISION SCI, V73, P495, DOI 10.1097/00006324-199607000-00007; Lin Z, 2014, OPTOMETRY VISION SCI, V91, P376, DOI 10.1097/OPX.0000000000000219; Loman J, 2002, OPHTHALMOLOGY, V109, P1032, DOI 10.1016/S0161-6420(02)01012-6; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; Lu B, 2009, ARCH OPHTHALMOL-CHIC, V127, P769, DOI 10.1001/archophthalmol.2009.105; Mavracanas TA, 2000, ACTA OPHTHALMOL SCAN, V78, P656, DOI 10.1034/j.1600-0420.2000.078006656.x; Minckler D, 1999, OPHTHALMOLOGY, V106, P11, DOI 10.1016/S0161-6420(99)90569-9; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2013, OPHTHAL PHYSL OPT, V33, P329, DOI 10.1111/opo.12040; Morgan IG, OPHTHALMIC PHYSL OPT, V33, P329, DOI 10.1111/opo.12040; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pararajasegaram R, 1999, AM J OPHTHALMOL, V128, P359; PARSSINEN O, 1989, BRIT J OPHTHALMOL, V73, P547, DOI 10.1136/bjo.73.7.547; PARSSINEN O, 1993, INVEST OPHTH VIS SCI, V34, P2794; Pruett R C, 1998, Curr Opin Ophthalmol, V9, P16, DOI 10.1097/00055735-199806000-00004; Qin DB, 2012, NEW DIR CHILD ADOLES, V135, P35, DOI 10.1002/cd.20003; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw A, 2013, ANXIETY STRESS COPIN, V26, P187, DOI 10.1080/10615806.2012.668536; Saw SM, 2000, OPTOMETRY VISION SCI, V77, P549, DOI 10.1097/00006324-200010000-00009; Saw SM, 2006, INVEST OPHTH VIS SCI, V47, P1839, DOI 10.1167/iovs.05-1081; Saw SM, 2006, BRIT J OPHTHALMOL, V90, P525, DOI 10.1136/bjo.2005.087999; Saw SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P620, DOI 10.1001/archopht.120.5.620; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Saw SM, 2001, BRIT J OPHTHALMOL, V85, P855, DOI 10.1136/bjo.85.7.855; Saw SM, 2001, J PEDIAT OPHTH STRAB, V38, P149; Scheiman M, 2014, OPHTHAL PHYSL OPT, V34, P353, DOI 10.1111/opo.12111; Seang-Mei S, 2005, OPHTHAL PHYSL OPT, V25, P381; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Shih YF, 1999, J OCUL PHARMACOL TH, V15, P85, DOI 10.1089/jop.1999.15.85; Tan DTH, 2005, OPHTHALMOLOGY, V112, P84, DOI 10.1016/j.ophtha.2004.06.038; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Wu PC, 2010, OPHTHAL EPIDEMIOL, V17, P338, DOI 10.3109/09286586.2010.508347; Yi Jun-Hui, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P32; Yingyong Penpimol, 2010, Journal of the Medical Association of Thailand, V93, P1288; ZADNIK K, 1994, JAMA-J AM MED ASSOC, V271, P1323, DOI 10.1001/jama.271.17.1323; Zhang MZ, 2010, INVEST OPHTH VIS SCI, V51, P4969, DOI 10.1167/iovs.10-5424	59	211	225	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140419	10.1371/journal.pone.0140419	http://dx.doi.org/10.1371/journal.pone.0140419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485393	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100032
J	Leidgens, V; Seliger, C; Jachnik, B; Welz, T; Leukel, P; Vollmann-Zwerenz, A; Bogdahn, U; Kreutz, M; Grauer, OM; Hau, P				Leidgens, Verena; Seliger, Corinna; Jachnik, Birgit; Welz, Tobias; Leukel, Petra; Vollmann-Zwerenz, Arabel; Bogdahn, Ulrich; Kreutz, Marina; Grauer, Oliver M.; Hau, Peter			Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; KAPPA-B ACTIVATION; CYCLOOXYGENASE-2 INHIBITORS; CANCER PREVENTION; INDUCED APOPTOSIS; BREAST-CANCER; TUMOR-GROWTH; STAT3; COX-2; EXPRESSION	Background Non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with anti-tumorigenic effects in different tumor entities. For glioma, research has generally focused on diclofenac; however data on other NSAIDs, such as ibuprofen, is limited. Therefore, we performed a comprehensive investigation of the cellular, molecular, and metabolic effects of ibuprofen and diclofenac on human glioblastoma cells. Methods Glioma cell lines were treated with ibuprofen or diclofenac to investigate functional effects on proliferation and cell motility. Cell cycle, extracellular lactate levels, lactate dehydrogenase-A (LDH-A) expression and activity, as well as inhibition of the Signal Transducer and Activator of Transcription 3 (STAT-3) signaling pathway, were determined. Specific effects of diclofenac and ibuprofen on STAT-3 were investigated by comparing their effects with those of the specific STAT-3 inhibitor STATTIC. Results Ibuprofen treatment led to a stronger inhibition of cell growth and migration than treatment with diclofenac. Proliferation was affected by cell cycle arrest at different checkpoints by both agents. In addition, diclofenac, but not ibuprofen, decreased lactate levels in all concentrations used. Both decreased STAT-3 phosphorylation; however, diclofenac led to decreased c-myc expression and subsequent reduction in LDH-A activity, whereas treatment with ibuprofen in higher doses induced c-myc expression and less LDH-A alteration. Conclusions This study indicates that both ibuprofen and diclofenac strongly inhibit glioma cells, but the subsequent metabolic responses of both agents are distinct. We postulate that ibuprofen may inhibit tumor cells also by COX- and lactate-independent mechanisms after long-term treatment in physiological dosages, whereas diclofenac mainly acts by inhibition of STAT-3 signaling and downstream modulation of glycolysis.	[Leidgens, Verena; Seliger, Corinna; Jachnik, Birgit; Leukel, Petra; Vollmann-Zwerenz, Arabel; Bogdahn, Ulrich; Grauer, Oliver M.; Hau, Peter] Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany; [Leidgens, Verena; Seliger, Corinna; Jachnik, Birgit; Leukel, Petra; Vollmann-Zwerenz, Arabel; Bogdahn, Ulrich; Grauer, Oliver M.; Hau, Peter] Univ Hosp Regensburg, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany; [Welz, Tobias] Univ Hosp Regensburg, Dept Neurol, Mol Cell Biol Lab, Regensburg, Germany; [Kreutz, Marina] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany; [Kreutz, Marina] Regensburg Ctr Intervent Immunol RCI, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Hau, P (corresponding author), Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany.	Peter.Hau@ukr.de		Hau, Peter/0000-0003-3894-5053	Wilhelm Sander-Stiftung, GER	Wilhelm Sander-Stiftung, GER	This work was supported by Wilhelm Sander-Stiftung, GER (http://www.wilhelm-sanderstiftung.de), to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2009, BRIT J CANCER, V100, P551, DOI 10.1038/sj.bjc.6604880; Andrews J, 2002, CANCER CHEMOTH PHARM, V50, P277, DOI 10.1007/s00280-002-0485-8; Arslan F, 2007, BRIT J CANCER, V96, P1560, DOI 10.1038/sj.bjc.6603766; Augoff K, 2015, CANCER LETT, V358, P1, DOI 10.1016/j.canlet.2014.12.035; Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106; Buettner R, 2002, CLIN CANCER RES, V8, P945; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Chirasani SR, 2013, INT J CANCER, V132, P843, DOI 10.1002/ijc.27712; Choi JS, 2005, J PHARM PHARMACOL, V57, P1185, DOI 10.1211/jpp.57.9.0013; Clond MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061819; Demaria M, 2012, CELL DEATH DIFFER, V19, P1390, DOI 10.1038/cdd.2012.20; Emoto A, 2002, AM J PHYSIOL-CELL PH, V282, pC1064, DOI 10.1152/ajpcell.00179.2001; FARRELL CL, 1988, J NEUROSURG, V68, P925, DOI 10.3171/jns.1988.68.6.0925; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Fosslien E, 2000, CRIT REV CL LAB SCI, V37, P431, DOI 10.1080/10408360091174286; Fredriksson L, 2011, HEPATOLOGY, V53, P2027, DOI 10.1002/hep.24314; Giuliano F, 1999, BRIT J PHARMACOL, V126, P1824, DOI 10.1038/sj.bjp.0702518; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gottfried E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066987; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris RE, 1996, EPIDEMIOLOGY, V7, P203, DOI 10.1097/00001648-199603000-00017; Harris RE, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-27; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Inoue T, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-1; Janssen A, 2006, EUR J PHARMACOL, V540, P24, DOI 10.1016/j.ejphar.2006.04.030; Joe Andrew K, 2003, J Exp Ther Oncol, V3, P83, DOI 10.1046/j.1359-4117.2003.01076.x; Johnsen JI, 2004, CANCER RES, V64, P7210, DOI 10.1158/0008-5472.CAN-04-1795; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Lau L, 2007, ONCOGENE, V26, P1920, DOI 10.1038/sj.onc.1209981; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; Leitner L, 2011, J CELL SCI, V124, P4318, DOI 10.1242/jcs.092791; Lin MT, 2001, J BIOL CHEM, V276, P48997, DOI 10.1074/jbc.M107829200; Liu LYD, 2014, CANCER INFORM, V13, P21, DOI 10.4137/CIN.S12493; Marx J, 2001, SCIENCE, V291, P581, DOI 10.1126/science.291.5504.581; Meredith D, 2008, XENOBIOTICA, V38, P1072, DOI [10.1080/00498250802010868, 10.1080/00498250802010868 ]; Miranda-Goncalves V, 2013, NEURO-ONCOLOGY, V15, P172, DOI 10.1093/neuonc/nos298; Neuhoff S, 2005, EUR J PHARM SCI, V25, P211, DOI 10.1016/j.ejps.2005.02.009; Palayoor ST, 1999, ONCOGENE, V18, P7389, DOI 10.1038/sj.onc.1203160; Pan YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054565; Parra-Bonilla G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075984; Roller A, 1999, BIOCHEM BIOPH RES CO, V259, P600, DOI 10.1006/bbrc.1999.0825; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Seliger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078935; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Sivak-Sears NR, 2004, AM J EPIDEMIOL, V159, P1131, DOI 10.1093/aje/kwh153; Song XQ, 2002, J NATL CANCER I, V94, P585; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Taketo MM, 1998, JNCI-J NATL CANCER I, V90, P1609, DOI 10.1093/jnci/90.21.1609; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Tegeder I, 2001, FASEB J, V15, P2057, DOI 10.1096/fj.01-0390rev; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Valle BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061836; Van Lieshout EMM, 1998, BBA-GEN SUBJECTS, V1381, P305, DOI 10.1016/S0304-4165(98)00042-7; Wake MS, 2015, FEBS J, V282, P2600, DOI 10.1111/febs.13285; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Wittmann T, 2001, J CELL SCI, V114, P3795; Yamasaki F, 2011, NEURO-ONCOLOGY, V13, P791, DOI 10.1093/neuonc/nor038	62	45	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140613	10.1371/journal.pone.0140613	http://dx.doi.org/10.1371/journal.pone.0140613			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485029	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100051
J	Tirupula, KC; Zhang, DM; Osbourne, A; Chatterjee, A; Desnoyer, R; Willard, B; Karnik, SS				Tirupula, Kalyan C.; Zhang, Dongmei; Osbourne, Appledene; Chatterjee, Arunachal; Desnoyer, Russ; Willard, Belinda; Karnik, Sadashiva S.			MAS C-Terminal Tail Interacting Proteins Identified by Mass Spectrometry- Based Proteomic Approach	PLOS ONE			English	Article							ANGIOTENSIN-(1-7) RECEPTOR MAS; GENETIC DELETION; PDZ DOMAINS; ENDOTHELIAL DYSFUNCTION; STATISTICAL-MODEL; EXPRESSION; COMPLEX; TRANSFORMATION; DEFICIENCY; ACTIVATION	Propagation of signals from G protein-coupled receptors (GPCRs) in cells is primarily mediated by protein-protein interactions. MAS is a GPCR that was initially discovered as an oncogene and is now known to play an important role in cardiovascular physiology. Current literature suggests that MAS interacts with common heterotrimeric G-proteins, but MAS interaction with proteins which might mediate G protein-independent or atypical signaling is unknown. In this study we hypothesized that MAS C-terminal tail (Ct) is a major determinant of receptor-scaffold protein interactions mediating MAS signaling. Mass-spectrometry based proteomic analysis was used to comprehensively identify the proteins that interact with MAS Ct comprising the PDZ-binding motif (PDZ-BM). We identified both PDZ and non-PDZ proteins from human embryonic kidney cell line, mouse atrial cardiomyocyte cell line and human heart tissue to interact specifically with MAS Ct. For the first time our study provides a panel of PDZ and other proteins that potentially interact with MAS with high significance. A 'cardiac-specific finger print' of MAS interacting PDZ proteins was identified which includes DLG1, MAGI1 and SNTA. Cell based experiments with wild-type and mutant MAS lacking the PDZ-BM validated MAS interaction with PDZ proteins DLG1 and TJP2. Bioinformatics analysis suggested well-known multi-protein scaffold complexes involved in nitric oxide signaling (NOS), cell-cell signaling of neuromuscular junctions, synapses and epithelial cells. Majority of these protein hits were predicted to be part of disease categories comprising cancers and malignant tumors. We propose a 'MAS-signalosome' model to stimulate further research in understanding the molecular mechanism of MAS function. Identifying hierarchy of interactions of 'signalosome' components with MAS will be a necessary step in future to fully understand the physiological and pathological functions of this enigmatic receptor.	[Tirupula, Kalyan C.; Chatterjee, Arunachal; Desnoyer, Russ; Karnik, Sadashiva S.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Zhang, Dongmei; Willard, Belinda] Cleveland Clin, Lerner Res Inst, Prote Lab, Cleveland, OH 44195 USA; [Osbourne, Appledene; Karnik, Sadashiva S.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Karnik, SS (corresponding author), Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019; Chatterjee, Arunachal/AAW-9807-2021	Karnik, Sadashiva/0000-0003-0746-2753; 	National Institutes of Health [HL57470, HL115964]; NIH [1S10RR031537-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057470, R01HL115964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grants HL57470 and HL115964 to SSK and NIH shared instrument grant 1S10RR031537-01 to BW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenina N, 2008, EXP PHYSIOL, V93, P528, DOI 10.1113/expphysiol.2007.040345; Belotti E, 2013, MOL CELL PROTEOMICS, V12, P2587, DOI 10.1074/mcp.O112.021022; Bernardi S, 2012, J RENIN-ANGIO-ALDO S, V13, P202, DOI 10.1177/1470320311426023; Bian WH, 2013, BIOCHEM J, V453, P345, DOI 10.1042/BJ20121885; Bikkavilli RK, 2006, BIOCHEM PHARMACOL, V71, P319, DOI 10.1016/j.bcp.2005.10.050; Bohl J, 2007, J BIOL CHEM, V282, P9392, DOI 10.1074/jbc.M610002200; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Botelho-Santos Giancarla Aparecida, 2012, Ther Adv Cardiovasc Dis, V6, P201, DOI 10.1177/1753944712461164; Bredt DS, 2003, J CELL SCI, V116, P9, DOI 10.1242/jcs.00183; Caruana G, 2002, INT J DEV BIOL, V46, P511; Castro CH, 2006, LIFE SCI, V80, P264, DOI 10.1016/j.lfs.2006.09.007; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Constantin B, 2014, BBA-BIOMEMBRANES, V1838, P635, DOI 10.1016/j.bbamem.2013.08.023; da Costa Goncalves AC, 2007, AM J PHYSIOL-HEART C, V293, pH2588, DOI 10.1152/ajpheart.00173.2007; El Far O, 2002, BIOCHEM J, V365, P329, DOI 10.1042/BJ20020481; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Facciuto F, 2012, FEBS J, V279, P3538, DOI 10.1111/j.1742-4658.2012.08699.x; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fraga-Silva RA, 2008, MOL MED, V14, P28, DOI 10.2119/2007-00073.Fraga-Silva; Franklin JL, 2005, EXP CELL RES, V303, P457, DOI 10.1016/j.yexcr.2004.10.007; Gava E, 2012, REGUL PEPTIDES, V175, P30, DOI 10.1016/j.regpep.2012.01.001; Gokce E, 2011, J AM SOC MASS SPECTR, V22, P2199, DOI 10.1007/s13361-011-0237-2; Santos SHS, 2008, DIABETES, V57, P340, DOI 10.2337/db07-0953; Hering H, 2002, FEBS LETT, V521, P185, DOI 10.1016/S0014-5793(02)02831-4; Heringer-Walther S, 2012, EUR J PHARMACOL, V689, P147, DOI 10.1016/j.ejphar.2012.05.025; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lin FT, 2008, BBA-MOL CELL BIOL L, V1781, P558, DOI 10.1016/j.bbalip.2008.04.013; Lin WZ, 2009, INT J CANCER, V125, P1316, DOI 10.1002/ijc.24440; Luck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025376; Lyssand JS, 2010, P NATL ACAD SCI USA, V107, P21854, DOI 10.1073/pnas.1010819107; Mahon MJ, 2012, CURR DRUG TARGETS, V13, P116; Mario EG, 2012, PEPTIDES, V33, P174, DOI 10.1016/j.peptides.2011.11.014; Medlin MD, 2010, ARTERIOSCL THROM VAS, V30, P1779, DOI 10.1161/ATVBAHA.110.209395; Miura T, 2010, AM J PHYSIOL-HEART C, V298, pH1115, DOI 10.1152/ajpheart.00879.2009; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Peiro C, 2007, J HYPERTENS, V25, P2421, DOI 10.1097/HJH.0b013e3282f0143c; Pinheiro SVB, 2009, KIDNEY INT, V75, P1184, DOI 10.1038/ki.2009.61; Rabelo LA, 2008, J AM SOC HYPERTENS, V2, P418, DOI 10.1016/j.jash.2008.05.003; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Rybak JN, 2004, PROTEOMICS, V4, P2296, DOI 10.1002/pmic.200300780; Sakarya O, 2010, MOL BIOL EVOL, V27, P1058, DOI 10.1093/molbev/msp311; Santos RAS, 2006, HYPERTENSION, V47, P996, DOI 10.1161/01.HYP.0000215289.51180.5c; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Singh Anurag, 2010, J Mol Signal, V5, P11, DOI 10.1186/1750-2187-5-11; Subbaiah VK, 2011, BIOCHEM J, V439, P195, DOI 10.1042/BJ20110903; Tirupula KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103520; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Walther T, 1998, J BIOL CHEM, V273, P11867, DOI 10.1074/jbc.273.19.11867; Wawrzak D, 2009, ADV ENZYME REGUL, V49, P98, DOI 10.1016/j.advenzreg.2009.01.002; Whitehead IP, 2001, ONCOGENE, V20, P1547, DOI 10.1038/sj.onc.1204188; Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764; Yang-Boja E, 2000, ANAL BIOCHEM, V285, P205, DOI 10.1006/abio.2000.4734; Yao R, 2004, ONCOGENE, V23, P6023, DOI 10.1038/sj.onc.1207817; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; Zhang T, 2012, AM J PHYSIOL-HEART C, V302, pH299, DOI 10.1152/ajpheart.00723.2011; Zohn IE, 1998, MOL CELL BIOL, V18, P1225, DOI 10.1128/MCB.18.3.1225	62	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140872	10.1371/journal.pone.0140872	http://dx.doi.org/10.1371/journal.pone.0140872			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484771	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100082
J	Benso, B; Rosalen, PL; Alencar, SM; Murata, RM				Benso, Bruna; Rosalen, Pedro Luiz; Alencar, Severino Matias; Murata, Ramiro Mendonca			Malva sylvestris Inhibits Inflammatory Response in Oral Human Cells. An In Vitro Infection Model	PLOS ONE			English	Article							PERIODONTAL-DISEASE; NATURAL-PRODUCTS; PORPHYROMONAS-GINGIVALIS; PLANT-EXTRACTS; ACTINOMYCETEMCOMITANS; GROWTH; L.	The aim of this study was to investigate the in vitro anti-inflammatory activity of Malva sylvestris extract (MSE) and fractions in a co-culture model of cells infected by Aggregatibacter actinomycetemcomitans. In addition, we evaluated the phytochemical content in the extract and fractions of M. sylvestris and demonstrated that polyphenols were the most frequent group in all samples studied. An in vitro dual-chamber model to mimic the periodontal structure was developed using a monolayer of epithelial keratinocytes (OBA-9) and a subepithelial layer of fibroblasts (HGF-1). The invasive periodontopathogen A. actinomycetemcomitans (D7S-1) was applied to migrate through the cell layers and induce the synthesis of immune factors and cytokines in the host cells. In an attempt to analyze the antimicrobial properties of MSE and fractions, a susceptibility test was carried out. The extract (MIC 175 mu g/mL, MBC 500 mu g/mL) and chloroform fraction (MIC 150 mu g/mL, MBC 250 mu g/mL) were found to have inhibitory activity. The extract and all fractions were assessed using a cytotoxicity test and results showed that concentrations under 100 mu g/mL did not significantly reduce cell viability compared to the control group (p > 0.05, viability > 90%). In order to analyze the inflammatory response, transcriptional factors and cytokines were quantified in the supernatant released from the cells. The chloroform fraction was the most effective in reducing the bacterial colonization (p < 0.05) and controlling inflammatory mediators, and promoted the down-regulation of genes including IL-1beta, IL-6, IL-10, CD14, PTGS, MMP-1 and FOS as well as the reduction of the IL-1beta, IL-6, IL-8 and GM-CSF protein levels (p < 0.05). Malva sylvestris and its chloroform fraction minimized the A. actinomycetemcomitans infection and inflammation processes in oral human cells by a putative pathway that involves important cytokines and receptors. Therefore, this natural product may be considered as a successful dual anti-inflammatory-antimicrobial candidate.	[Benso, Bruna; Rosalen, Pedro Luiz] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Sao Paulo, Brazil; [Alencar, Severino Matias] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Agrifood Ind Food & Nutr, Sao Paulo, Brazil; [Murata, Ramiro Mendonca] Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA 90089 USA; [Murata, Ramiro Mendonca] Univ So Calif, Herman Ostrow Sch Dent, Div Biomed Sci, Los Angeles, CA USA	Universidade Estadual de Campinas; Universidade de Sao Paulo; University of Southern California; University of Southern California	Murata, RM (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA 90089 USA.	ramiro.murata@usc.edu	Benso, Bruna/L-1010-2015; Rosalen, Pedro Luiz/I-3718-2012; Murata, Ramiro M/P-9052-2014; Alencar, Severino Matias/B-7743-2012	Benso, Bruna/0000-0002-4425-5174; Rosalen, Pedro Luiz/0000-0003-0812-4027; Murata, Ramiro M/0000-0002-8478-6981; Alencar, Severino Matias/0000-0002-6637-7973	National Center for Complementary and Integrative Health of the National Institutes of Health [R00AT006507]; Sao Paulo Research Foundation [FAPESP - 2011/23980-5]; Brazilian Federal Agency for the Support and Evaluation of Graduate Education [CAPES - 2317/2014-01]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R00AT006507] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health of the National Institutes of Health; Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Federal Agency for the Support and Evaluation of Graduate Education; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Research reported in this publication was supported by: National Center for Complementary and Integrative Health of the National Institutes of Health under award number R00AT006507, Sao Paulo Research Foundation (FAPESP - 2011/23980-5), and Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES - 2317/2014-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros L, 2010, FOOD CHEM TOXICOL, V48, P1466, DOI 10.1016/j.fct.2010.03.012; Chen C, 2010, J BACTERIOL, V192, P2643, DOI 10.1128/JB.00157-10; *CLIN LAB STAND I, 2009, M100S19 CLIN LAB STA; Cogo LL, 2010, BRAZ J MICROBIOL, V41, P304, DOI 10.1590/S1517-83822010000200007; Cragg GM, 2014, J NAT PROD, V77, P703, DOI 10.1021/np5000796; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Cutillo F, 2006, PHYTOCHEMISTRY, V67, P481, DOI 10.1016/j.phytochem.2005.11.023; da Cunha MG, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-23; Darveau RP, 1997, PERIODONTOL 2000, V14, P12, DOI 10.1111/j.1600-0757.1997.tb00190.x; DellaGreca M, 2009, NAT PROD COMMUN, V4, P893; El Ghaoui WBJ, 2008, PHYTOTHER RES, V22, P1599, DOI 10.1002/ptr.2530; Folin O, 1912, J BIOL CHEM, V12, P239; Freires IA, 2015, MOLECULES, V20, P7329, DOI 10.3390/molecules20047329; Freires ID, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099086; Gasparetto JC, 2012, J PHARM PHARMACOL, V64, P172, DOI 10.1111/j.2042-7158.2011.01383.x; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Irwin CR, 1998, J ORAL PATHOL MED, V27, P255; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; Johansson A., 2011, TOXINS, V3, P2459; Kang JH, 2014, J DENT RES, V93, P1116, DOI 10.1177/0022034514552677; Koeberle A, 2014, DRUG DISCOV TODAY, V19, P1871, DOI 10.1016/j.drudis.2014.08.006; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Magro Ana, 2006, Revista Iberoamericana de Micologia, V23, P176; Negrato CA, 2013, J APPL ORAL SCI, V21, P1, DOI 10.1590/1678-7757201302106; Offenbacher S, 2007, J PERIODONTOL, V78, P1911, DOI 10.1902/jop.2007.060465; Pasetto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115323; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Prudente AS, 2013, FOOD CHEM TOXICOL, V58, P324, DOI 10.1016/j.fct.2013.04.042; Quave CL, 2008, J ETHNOPHARMACOL, V118, P418, DOI 10.1016/j.jep.2008.05.005; Rautemaa R, 2007, CLIN MICROBIOL INFEC, V13, P1041, DOI 10.1111/j.1469-0691.2007.01802.x; Reynier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024828; Scapoli Luca, 2012, Dent Res J (Isfahan), V9, pS197, DOI 10.4103/1735-3327.109754; SEIBERG M, 2006, Patent No. 1811955; SEIBERG M, 2006, Patent No. 2006047470; SIEBERG M, 2006, Patent No. 2006088616; SLOTS J, 1980, INFECT IMMUN, V29, P1013; SOCRANSKY SS, 1977, J PERIODONTOL, V48, P497, DOI 10.1902/jop.1977.48.9.497; Stathopoulou PG, 2010, J CLIN PERIODONTOL, V37, P24, DOI 10.1111/j.1600-051X.2009.01505.x; Susin C, 2014, PERIODONTOL 2000, V65, P27, DOI 10.1111/prd.12019; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202; Wang PL, 2002, CRIT REV ORAL BIOL M, V13, P132, DOI 10.1177/154411130201300204; Zhao LX, 2013, J PERIODONTOL, V84, P1847, DOI 10.1902/jop.2013.120548	44	28	30	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140331	10.1371/journal.pone.0140331	http://dx.doi.org/10.1371/journal.pone.0140331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479870	Green Published, gold, Green Submitted			2022-12-27	WOS:000363026600005
J	Guo, XB; Li, YX; Ding, XH; He, MG; Wang, XQ; Zhang, HP				Guo, Xiaobo; Li, Yixi; Ding, Xiaohu; He, Mingguang; Wang, Xueqin; Zhang, Heping			Association Tests of Multiple Phenotypes: ATeMP	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; REFRACTIVE ERROR; TRAITS; LOCI; LINKAGE	Joint analysis of multiple phenotypes has gained growing attention in genome-wide association studies (GWASs), especially for the analysis of multiple intermediate phenotypes which measure the same underlying complex human disorder. One of the multivariate methods, MultiPhen (O' Reilly et al. 2012), employs the proportional odds model to regress a genotype on multiple phenotypes, hence ignoring the phenotypic distributions. Despite the flexibilities of MultiPhen, the properties and performance of MultiPhen are not well understood, especially when the phenotypic distributions are non-normal. In fact, it is well known in the statistical literature that the estimation is attenuated when the explanatory variables contain measurement errors. In this study, we first established an equivalence relationship between MultiPhen and the generalized Kendall tau association test, shedding light on why MultiPhen can perform well for joint association analysis of multiple phenotypes. Through the equivalence, we show that MultiPhen may lose power when the phenotypes are non-normal. To maintain the power, we propose two solutions (ATeMP-rn and ATeMP-or) to improve MultiPhen, and demonstrate their effectiveness through extensive simulation studies and a real case study from the Guangzhou Twin Eye Study.	[Guo, Xiaobo; Wang, Xueqin; Zhang, Heping] Sun Yat Sen Univ, Sch Math & Computat Sci, Dept Stat Sci, Guangzhou 510275, GD, Peoples R China; [Guo, Xiaobo; Wang, Xueqin] SYSU, CMU Shunde Int Joint Res Inst, Shunde 528300, GD, Peoples R China; [Zhang, Heping] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA; [Guo, Xiaobo; Wang, Xueqin; Zhang, Heping] Sun Yat Sen Univ, Southern China Res Ctr Stat Sci, Guangzhou 510275, GD, Peoples R China; [Wang, Xueqin] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510080, GD, Peoples R China; [Ding, Xiaohu; He, Mingguang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510080, GD, Peoples R China; [Li, Yixi] Peking Univ, HSBC Business Sch, Shenzhen 518055, GD, Peoples R China	Sun Yat Sen University; Yale University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Peking University	Zhang, HP (corresponding author), Sun Yat Sen Univ, Sch Math & Computat Sci, Dept Stat Sci, Guangzhou 510275, GD, Peoples R China.	heping.zhang@yale.edu	He, Mingguang/AAY-5239-2020; Zhang, He/GXN-0028-2022	He, Mingguang/0000-0002-6912-2810; 	U.S. National Institute on Drug Abuse [R01 DA016750]; 1000-plan scholarship from the Chinese Government; International Collaborative Research Fund from NSFC [11328103]; NSFC [11401600, 11271383]; Fundamental Research Funds for the Central Universities [15lgpy07]; Chinese Government; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016750] Funding Source: NIH RePORTER	U.S. National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); 1000-plan scholarship from the Chinese Government; International Collaborative Research Fund from NSFC; NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese Government; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Zhang's research is partially supported by the U.S. National Institute on Drug Abuse (R01 DA016750), a 1000-plan scholarship from the Chinese Government, and the International Collaborative Research Fund from NSFC (11328103). Guo's research is supported by the NSFC (11401600), and the Fundamental Research Funds for the Central Universities (15lgpy07). Wang's research is partially supported by the free application projects from the SYSU-CMU Shunde International Joint Research Institute, NSFC (11271383) and Chinese Government, and the International Collaborative Research Fund from NSFC (11328103).	AMOS CI, 1993, GENET EPIDEMIOL, V10, P671, DOI 10.1002/gepi.1370100657; Aschard H, 2014, AM J HUM GENET, V94, P662, DOI 10.1016/j.ajhg.2014.03.016; Cheng CY, 2013, AM J HUM GENET, V93, P264, DOI 10.1016/j.ajhg.2013.06.016; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; Galesloot TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095923; Guo XB, 2013, GENET EPIDEMIOL, V37, P122, DOI 10.1002/gepi.21688; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hollander M., 2013, NONPARAMETRIC STAT M, VVolume 751; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; LAVERY JR, 1988, OPHTHAL PHYSL OPT, V8, P394, DOI 10.1111/j.1475-1313.1988.tb01175.x; Li C, 2012, BIOMETRIKA; Li Q, 2015, HUM GENET, V134, P131, DOI 10.1007/s00439-014-1500-y; Medland S, 2010, EUR J HUM GENET, V18, P233, DOI 10.1038/ejhg.2009.133; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Schifano ED, 2013, AM J HUM GENET, V92, P744, DOI 10.1016/j.ajhg.2013.04.004; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Suo C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-151; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Wang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106918; Wei CS, 2014, GENET EPIDEMIOL, V38, P699, DOI 10.1002/gepi.21864; Zhang HP, 2010, J AM STAT ASSOC, V105, P473, DOI 10.1198/jasa.2009.ap08387; Zhang HP, 2006, GENETICS, V172, P693, DOI 10.1534/genetics.105.049122; Zheng YF, 2013, TWIN RES HUM GENET, V16, P73, DOI 10.1017/thg.2012.120; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]; Zhu WS, 2009, J KOREAN STAT SOC, V38, P1, DOI 10.1016/j.jkss.2008.10.006	29	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140348	10.1371/journal.pone.0140348	http://dx.doi.org/10.1371/journal.pone.0140348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479245	gold, Green Submitted, Green Published			2022-12-27	WOS:000363026600009
J	Ahmad, AF; Abbas, Z; Obaiys, SJ; Ibrahim, N; Hashim, M; Khaleel, H				Ahmad, Ahmad F.; Abbas, Zulkifly; Obaiys, Suzan J.; Ibrahim, Norazowa; Hashim, Mansor; Khaleel, Haider			Theoretical and Numerical Approaches for Determining the Reflection and Transmission Coefficients of OPEFB-PCL Composites at X-Band Frequencies	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; NATURAL FIBERS	Bio-composites of oil palm empty fruit bunch (OPEFB) fibres and polycaprolactones (PCL) with a thickness of 1 mm were prepared and characterized. The composites produced from these materials are low in density, inexpensive, environmentally friendly, and possess good dielectric characteristics. The magnitudes of the reflection and transmission coefficients of OPEFB fibre-reinforced PCL composites with different percentages of filler were measured using a rectangular waveguide in conjunction with a microwave vector network analyzer (VNA) in the X-band frequency range. In contrast to the effective medium theory, which states that polymer-based composites with a high dielectric constant can be obtained by doping a filler with a high dielectric constant into a host material with a low dielectric constant, this paper demonstrates that the use of a low filler percentage (12.2% OPEFB) and a high matrix percentage (87.8% PCL) provides excellent results for the dielectric constant and loss factor, whereas 63.8% filler material with 36.2% host material results in lower values for both the dielectric constant and loss factor. The open-ended probe technique (OEC), connected with the Agilent vector network analyzer (VNA), is used to determine the dielectric properties of the materials under investigation. The comparative approach indicates that the mean relative error of FEM is smaller than that of NRW in terms of the corresponding S-21 magnitude. The present calculation of the matrix/filler percentages endorses the exact amounts of substrate utilized in various physics applications.	[Ahmad, Ahmad F.; Abbas, Zulkifly] Univ Putra Malaysia, Inst Math Res, Serdang 43400, Selangor Darul, Malaysia; [Abbas, Zulkifly; Obaiys, Suzan J.; Hashim, Mansor] Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang 43400, Selangor Darul, Malaysia; [Ibrahim, Norazowa] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor Darul, Malaysia; [Khaleel, Haider] Sonoma State Univ, Dept Engn Sci, Rohnert Pk, CA 94928 USA	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; California State University System; Sonoma State University	Ahmad, AF (corresponding author), Univ Putra Malaysia, Inst Math Res, Serdang 43400, Selangor Darul, Malaysia.	ahmad_al67@yahoo.com; suzan_ye@yahoo.com	OBAIYS, SUZAN J./AAK-1117-2021; AHMAD, AHMAD/AAW-3699-2021; ahmad, ahmad/GVT-1790-2022; Ahmad, Ahmad Fahad/M-1094-2019	OBAIYS, SUZAN J./0000-0003-4523-2385; 				AL-Oqla FM, SYNTHETIC METALS, V206, P42; Andersons J, 2006, POLYM COMPOSITE, V27, P221, DOI 10.1002/pc.20184; Coccioli R, 1999, IEEE T MICROW THEORY, V47, P1106, DOI 10.1109/22.775443; Dang ZM, 2005, CERAM INT, V31, P349, DOI 10.1016/j.ceramint.2004.05.008; Deshpande MD, 1995, APPL FEM ESTIMATE CO; Fahma F, 2010, CELLULOSE, V17, P977, DOI 10.1007/s10570-010-9436-4; Fratticcioli E, 2004, IEEE T INSTRUM MEAS, V53, P1071, DOI 10.1109/TIM.2004.830753; George J., 1997, COMPOSITE INTERFACES, V5, P201; Hasar UC, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/5/055706; Herrera-Franco PJ, 2004, COMPOS PART A-APPL S, V35, P339, DOI 10.1016/j.compositesa.2003.09.012; Khalid M, 2008, MATER DESIGN, V29, P173, DOI 10.1016/j.matdes.2006.11.002; Mohanty JR, 2013, POLYM COMPOSITE, V34, P959, DOI 10.1002/pc.22502; NICOLSON AM, 1970, IEEE T INSTRUM MEAS, VIM19, P377, DOI 10.1109/TIM.1970.4313932; Phang SW, 2005, THIN SOLID FILMS, V477, P125, DOI 10.1016/j.tsf.2004.08.120; Pozar D. M., 2009, MICROWAVE ENG; Rozman HD, 2005, NATURAL FIBERS, BIOPOLYMERS, AND BIOCOMPOSITES, P407; Singh D, 2009, INT J THEO APPL SCI, V1, P34; Soleimani H, 2009, SOLID STATE SCI TECH, V17, P32; The Comsol Multi physics, 2006, QUICK START QUICK RE; WEIR WB, 1974, P IEEE, V62, P33, DOI 10.1109/PROC.1974.9382; Wollerdorfer M, 1998, IND CROP PROD, V8, P105, DOI 10.1016/S0926-6690(97)10015-2; Yao F, 2008, POLYM DEGRAD STABIL, V93, P90, DOI 10.1016/j.polymdegradstab.2007.10.012; Zak AK, 2011, CERAM INT, V37, P1653, DOI 10.1016/j.ceramint.2011.01.037	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140505	10.1371/journal.pone.0140505	http://dx.doi.org/10.1371/journal.pone.0140505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474301	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000363185500061
J	Cheng, RH; Leung, RKK; Chen, Y; Pan, YD; Tong, Y; Li, ZF; Ning, LW; Ling, XFB; He, JK				Cheng, Ronghai; Leung, Ross Ka-Kit; Chen, Yao; Pan, Yidan; Tong, Yin; Li, Zhoufang; Ning, Luwen; Ling, Xuefeng B.; He, Jiankui			Virtual Pharmacist: A Platform for Pharmacogenomics	PLOS ONE			English	Article							GENOME	We present Virtual Pharmacist, a web-based platform that takes common types of high-throughput data, namely microarray SNP genotyping data, FASTQ and Variant Call Format (VCF) files as inputs, and reports potential drug responses in terms of efficacy, dosage and toxicity at one glance. Batch submission facilitates multivariate analysis or data mining of targeted groups. Individual analysis consists of a report that is readily comprehensible to patients and practioners who have basic knowledge in pharmacology, a table that summarizes variants and potential affected drug response according to the US Food and Drug Administration pharmacogenomic biomarker labeled drug list and PharmGKB, and visualization of a gene-drug-target network. Group analysis provides the distribution of the variants and potential affected drug response of a target group, a sample-gene variant count table, and a sample-drug count table. Our analysis of genomes from the 1000 Genome Project underlines the potentially differential drug responses among different human populations. Even within the same population, the findings from Watson's genome highlight the importance of personalized medicine. Virtual Pharmacist can be accessed freely at http://www.sustc-genome.org.cn/vp or installed as a local web server. The codes and documentation are available at the GitHub repository (https://github.com/VirtualPharmacist/vp). Administrators can download the source codes to customize access settings for further development.	[Cheng, Ronghai; Chen, Yao; Pan, Yidan; Tong, Yin; Li, Zhoufang; Ning, Luwen; He, Jiankui] South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China; [Leung, Ross Ka-Kit] Chinese Univ Hong Kong, Div Genom & Bioinformat, Hong Kong, Hong Kong, Peoples R China; [Ling, Xuefeng B.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA	Southern University of Science & Technology; Chinese University of Hong Kong; Stanford University	He, JK (corresponding author), South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China.	hejk@sustc.edu.cn	ZHOUFANG, LI/GWN-1360-2022; Chen, Yao/S-4358-2019	Chen, Yao/0000-0003-2708-8674; Ling, Bruce/0000-0002-5386-3884	National Natural Science Foundation of China [31200688, 81470136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China (Grant No. 31200688 and 81470136).	Aleman A, 2014, NUCLEIC ACIDS RES; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Capriotti E, 2012, BRIEF BIOINFORM, V13, P495, DOI 10.1093/bib/bbr070; Dalton R, 2006, NATURE, V443, P258, DOI 10.1038/443258a; Dondorp WJ, 2013, EUR J HUM GENET, V21, pS6, DOI 10.1038/ejhg.2013.73; Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Juan LR, 2014, NUCLEIC ACIDS RES, V42, pW192, DOI 10.1093/nar/gku361; Kaplun A, 2015, PHARMACOGENOMICS J; Karczewski KJ, 2012, PAC S BIOCOMPUT; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu CC, 2014, NUCLEIC ACIDS RES, V42, pW137, DOI 10.1093/nar/gku412; Mardis ER, 2010, GENOME MED, V2, DOI 10.1186/gm205; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Sana ME, 2011, BIOINFORMATICS, V27, P9, DOI 10.1093/bioinformatics/btq603; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shetty AC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-471; Sulakhe D, 2014, NUCLEIC ACIDS RES, V42, pW473, DOI 10.1093/nar/gku517; Wang K, 2012, J MED GENETICS; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96	28	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141105	10.1371/journal.pone.0141105	http://dx.doi.org/10.1371/journal.pone.0141105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496198	Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200061
J	De Smet, B; Fournier, J; De Troch, M; Vincx, M; Vanaverbeke, J				De Smet, Bart; Fournier, Jerome; De Troch, Marleen; Vincx, Magda; Vanaverbeke, Jan			Integrating Ecosystem Engineering and Food Web Ecology: Testing the Effect of Biogenic Reefs on the Food Web of a Soft-Bottom Intertidal Area	PLOS ONE			English	Article							LANICE-CONCHILEGA PALLAS; STABLE-ISOTOPE RATIOS; BENTHIC ASSEMBLAGES; COMMUNITY STRUCTURE; CARBON; BIODIVERSITY; DELTA-N-15; ENRICHMENT; MEIOFAUNA; SEDIMENT	The potential of ecosystem engineers to modify the structure and dynamics of food webs has recently been hypothesised from a conceptual point of view. Empirical data on the integration of ecosystem engineers and food webs is however largely lacking. This paper investigates the hypothesised link based on a field sampling approach of intertidal biogenic aggregations created by the ecosystem engineer Lanice conchilega (Polychaeta, Terebellidae). The aggregations are known to have a considerable impact on the physical and biogeochemical characteristics of their environment and subsequently on the abundance and biomass of primary food sources and the macrofaunal (i.e. the macro-, hyper- and epibenthos) community. Therefore, we hypothesise that L. conchilega aggregations affect the structure, stability and isotopic niche of the consumer assemblage of a soft-bottom intertidal food web. Primary food sources and the bentho-pelagic consumer assemblage of a L. conchilega aggregation and a control area were sampled on two soft-bottom intertidal areas along the French coast and analysed for their stable isotopes. Despite the structural impacts of the ecosystem engineer on the associated macrofaunal community, the presence of L. conchilega aggregations only has a minor effect on the food web structure of soft-bottom intertidal areas. The isotopic niche width of the consumer communities of the L. conchilega aggregations and control areas are highly similar, implying that consumer taxa do not shift their diet when feeding in a L. conchilega aggregation. Besides, species packing and hence trophic redundancy were not affected, pointing to an unaltered stability of the food web in the presence of L. conchilega.	[De Smet, Bart; De Troch, Marleen; Vincx, Magda; Vanaverbeke, Jan] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Fournier, Jerome] Museum Natl Hist Nat, CNRS, BOREA, UMR 7208, Paris 05, France; [Fournier, Jerome] Museum Natl Hist Nat, Stn Marine Dinard, USM 404, Dinard, France	Ghent University; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN)	De Smet, B (corresponding author), Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium.	badsmet.desmet@ugent.be	De Troch, Marleen/AAB-9809-2019	De Troch, Marleen/0000-0002-6800-0299	Special Research Fund (BOF), Ghent University, Belgium [GOA 01GA1911W]	Special Research Fund (BOF), Ghent University, Belgium(Ghent University)	BDS received funding from the Special Research Fund (BOF;GOA 01GA1911W), Ghent University, Belgium, http://www.ugent.be/en/research/funding/phd/bof/doc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arditi R, 2005, ECOL COMPLEX, V2, P249, DOI 10.1016/j.ecocom.2005.04.003; Baeta A, 2009, MAR BIOL, V156, P2107, DOI 10.1007/s00227-009-1241-y; Batschelet E, 1981, CIRCULAR STAT BIOL; Bergamino L, 2011, ESTUAR COAST SHELF S, V91, P536, DOI 10.1016/j.ecss.2010.12.007; Botto F, 2005, IMPACT BURROWING CRA; Braeckman U, 2011, MAR ECOL PROG SER, V422, P179, DOI 10.3354/meps08910; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Brind'Amour A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084198; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; CAREY DA, 1983, CAN J FISH AQUAT SCI, V40, P301, DOI 10.1139/f83-291; Clarke KR, 2006, PRIMER V6 USER MANUA; Coull BC, 1999, AUST J ECOL, V24, P327, DOI 10.1046/j.1442-9993.1999.00979.x; De Smet B, 2015, ESTUAR COAST SHELF S, V152, P44, DOI 10.1016/j.ecss.2014.11.002; De Smet B, 2013, MAR BIOL, V160, P751, DOI 10.1007/s00227-012-2130-3; Dubois SF, 2014, FOOD WEBS, V1, P1, DOI [DOI 10.1016/j.fooweb.2014.07.001, DOI 10.1016/J.FOOWEB.2014.07.001]; ECKMAN JE, 1985, J MAR RES, V43, P419, DOI 10.1357/002224085788438685; Evrard V, 2010, MAR ECOL PROG SER, V416, P1, DOI 10.3354/meps08770; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; FORSTER S, 1995, MAR BIOL, V123, P335, DOI 10.1007/BF00353625; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; GALLAGHER ED, 1983, ECOLOGY, V64, P1200, DOI 10.2307/1937829; GEARING JN, 1984, GEOCHIM COSMOCHIM AC, V48, P1089, DOI 10.1016/0016-7037(84)90199-6; Godet L, 2008, AMBIO, V37, P347, DOI 10.1579/07-A-317.1; Godet L, 2009, MAR POLLUT BULL, V58, P589, DOI 10.1016/j.marpolbul.2008.11.001; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Grall J, 2006, J EXP MAR BIOL ECOL, V338, P1, DOI 10.1016/j.jembe.2006.06.013; Heymans JJ, 1996, ESTUAR COAST SHELF S, V43, P485, DOI 10.1006/ecss.1996.0083; Iken K, 2010, DEEP-SEA RES PT II, V57, P71, DOI 10.1016/j.dsr2.2009.08.007; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; JANSSEN GM, 1980, NETH J SEA RES, V14, P339, DOI 10.1016/0077-7579(80)90007-1; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Lorrain A, 2003, ANAL CHIM ACTA, V491, P125, DOI 10.1016/S0003-2670(03)00815-8; Maria TF, 2012, ESTUAR COAST SHELF S, V97, P114, DOI 10.1016/j.ecss.2011.11.030; Mees Jan, 1997, Oceanography and Marine Biology an Annual Review, V35, P221; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Norkko A., 2015, BIOL INVASIONS, P1; Olff H, 2009, PHILOS T R SOC B, V364, P1755, DOI 10.1098/rstb.2008.0222; Passarelli C, 2012, MAR ECOL PROG SER, V465, P85, DOI 10.3354/meps09915; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rabaut M, 2013, J SEA RES, V84, P70, DOI 10.1016/j.seares.2012.07.008; Rabaut M, 2007, ESTUAR COAST SHELF S, V75, P525, DOI 10.1016/j.ecss.2007.05.041; Rabaut M, 2009, HELGOLAND MAR RES, V63, P37, DOI 10.1007/s10152-008-0137-4; Reise K, 2009, HELGOLAND MAR RES, V63, P1, DOI 10.1007/s10152-009-0147-x; Rigolet C, 2015, FUNCT ECOL; Rigolet C, 2014, MAR ECOL PROG SER, V500, P25, DOI 10.3354/meps10685; Rigolet C, 2014, J SEA RES, V85, P413, DOI 10.1016/j.seares.2013.07.013; Sanders D, 2014, OIKOS, V123, P513, DOI 10.1111/j.1600-0706.2013.01011.x; Van Hoey G, 2008, MAR BIOL, V154, P1009, DOI 10.1007/s00227-008-0992-1; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; WOODIN SA, 1978, ECOLOGY, V59, P274, DOI 10.2307/1936373; Zuhlke R, 2001, J SEA RES, V46, P261, DOI 10.1016/S1385-1101(01)00091-0; Zuhlke Ruth, 1998, Senckenbergiana Maritima, V29, P131	57	5	7	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140857	10.1371/journal.pone.0140857	http://dx.doi.org/10.1371/journal.pone.0140857			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496349	Green Published, gold			2022-12-27	WOS:000363309200035
J	Boisnard, S; Li, YFZ; Arnaise, S; Sequeira, G; Raffoux, X; Enache-Angoulvant, A; Bolotin-Fukuhara, M; Fairhead, C				Boisnard, Stephanie; Li, Youfang Zhou; Arnaise, Sylvie; Sequeira, Gregory; Raffoux, Xavier; Enache-Angoulvant, Adela; Bolotin-Fukuhara, Monique; Fairhead, Cecile			Efficient Mating-Type Switching in Candida glabrata Induces Cell Death	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE HO; SITE-DIRECTED MUTAGENESIS; COMPARATIVE GENOMICS; DONOR PREFERENCE; SEXUAL CYCLE; DNA-SEQUENCE; SP-NOV.; YEAST; LOCUS; GENE	Candida glabrata is an apparently asexual haploid yeast that is phylogenetically closer to Saccharomyces cerevisiae than to Candida albicans. Its genome contains three MAT-like cassettes, MAT, which encodes either MATa or MATalpha information in different strains, and the additional loci, HML and HMR. The genome also contains an HO gene homolog, but this yeast has never been shown to switch mating-types spontaneously, as S. cerevisiae does. We have recently sequenced the genomes of the five species that, together with C. glabrata, make up the Nakaseomyces clade. All contain MAT-like cassettes and an HO gene homolog. In this work, we express the HO gene of all Nakaseomyces and of S. cerevisiae in C. glabrata. All can induce mating-type switching, but, despite the larger phylogenetic distance, the most efficient endonuclease is the one from S. cerevisiae. Efficient matingtype switching in C. glabrata is accompanied by a high cell mortality, and sometimes results in conversion of the additional cassette HML. Mortality probably results from the cutting of the HO recognition sites that are present, in HML and possibly HMR, contrary to what happens naturally in S. cerevisiae. This has implications in the life-cycle of C. glabrata, as we show that efficient MAT switching is lethal for most cells, induces chromosomal rearrangements in survivors, and that the endogenous HO is probably rarely active indeed.	[Boisnard, Stephanie; Li, Youfang Zhou; Arnaise, Sylvie; Sequeira, Gregory; Enache-Angoulvant, Adela; Bolotin-Fukuhara, Monique; Fairhead, Cecile] Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR8621, F-91405 Orsay, France; [Boisnard, Stephanie; Li, Youfang Zhou; Raffoux, Xavier; Bolotin-Fukuhara, Monique; Fairhead, Cecile] Univ Paris 11, CNRS, INRA, Genet Quantitat & Evolut Moulon,AgroParisTech,UF, F-91405 Orsay, France; [Enache-Angoulvant, Adela] Hop Bicetre, APHP, Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Boisnard, S (corresponding author), Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR8621, F-91405 Orsay, France.	stephanie.boisnard@u-psud.fr		Bolotin-Fukuhara, Monique/0000-0002-5285-5006; Zhou Li, Youfang/0000-0002-0390-8925; Fairhead, Cecile/0000-0002-0456-0377; XAVIER, RAFFOUX/0000-0003-0518-0904	CNRS; University Paris-Sud	CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud	This study was supported by CNRS and University Paris-Sud.	Alcoba-Florez J, 2005, J CLIN MICROBIOL, V43, P4107, DOI 10.1128/JCM.43.8.4107-4111.2005; Bakhrat A, 2004, GENETICS, V166, P721, DOI 10.1534/genetics.166.2.721; Barsoum E, 2010, GENE DEV, V24, P33, DOI 10.1101/gad.557310; Brisse S, 2009, EUKARYOT CELL, V8, P287, DOI 10.1128/EC.00215-08; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CONNOLLY B, 1988, MOL CELL BIOL, V8, P2342, DOI 10.1128/MCB.8.6.2342; Cormack BP, 1999, GENETICS, V151, P979; Correia A, 2006, INT J SYST EVOL MICR, V56, P313, DOI 10.1099/ijs.0.64076-0; Cosma MP, 2004, EMBO REP, V5, P953, DOI 10.1038/sj.embor.7400251; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Edskes HK, 2013, EUKARYOT CELL, V12, P551, DOI 10.1128/EC.00015-13; Fidel PL, 1996, J INFECT DIS, V173, P425, DOI 10.1093/infdis/173.2.425; Gabaldon T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-623; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; HABER JE, 1980, CELL, V20, P519, DOI 10.1016/0092-8674(80)90638-8; HAGEN DC, 1993, MOL CELL BIOL, V13, P6866, DOI 10.1128/MCB.13.11.6866; HARASHIMA S, 1989, MOL CELL BIOL, V9, P4523, DOI 10.1128/MCB.9.10.4523; Hickman MA, 2013, NATURE, V494, P55, DOI 10.1038/nature11865; Hickman MA, 2011, EUKARYOT CELL, V10, P1183, DOI 10.1128/EC.05123-11; HICKS J, 1979, NATURE, V282, P478, DOI 10.1038/282478a0; HICKS JB, 1977, GENETICS, V85, P395; Houston P, 2004, GENETICS, V166, P1187, DOI 10.1534/genetics.166.3.1187; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; KEELING PJ, 1995, NATURE, V375, P283, DOI 10.1038/375283a0; KLAR AJS, 1982, CELL, V28, P551, DOI 10.1016/0092-8674(82)90210-0; KLAR AJS, 1980, COLD SPRING HARB SYM, V45, P983, DOI 10.1101/SQB.1981.045.01.114; Klar AJS, 2007, ANNU REV GENET, V41, P213, DOI 10.1146/annurev.genet.39.073103.094316; Klar AJS, 2010, GENETICS, V186, P443, DOI 10.1534/genetics.110.122531; Koufopanou V, 2005, MOL BIOL EVOL, V22, P1535, DOI 10.1093/molbev/msi149; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; Lin CY, 2007, J CLIN MICROBIOL, V45, P2452, DOI 10.1128/JCM.00699-07; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; Mathias JR, 2004, NUCLEIC ACIDS RES, V32, P6469, DOI 10.1093/nar/gkh985; MCGILL C, 1989, CELL, V57, P459, DOI 10.1016/0092-8674(89)90921-5; MEHRA RK, 1992, GENE, V113, P119, DOI 10.1016/0378-1119(92)90678-I; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Muller Heloise, 2007, P247; Muller H, 2008, EUKARYOT CELL, V7, P848, DOI 10.1128/EC.00456-07; Murphy HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010461; Naumov G I, 1971, Nauchnye Doki Vyss Shkoly Biol Nauki, V9, P92; Ni M, 2011, ANNU REV GENET, V45, P405, DOI 10.1146/annurev-genet-110410-132536; NICKOLOFF JA, 1990, MOL CELL BIOL, V10, P1174, DOI 10.1128/MCB.10.3.1174; NICKOLOFF JA, 1986, P NATL ACAD SCI USA, V83, P7831, DOI 10.1073/pnas.83.20.7831; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Okuda Y, 2003, YEAST, V20, P563, DOI 10.1002/yea.984; OSHIMA Y, 1971, GENETICS, V67, P327; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rajaei N, 2014, P NATL ACAD SCI USA, V111, P15491, DOI 10.1073/pnas.1406027111; Roach KC, 2014, ADV GENET, V85, P255, DOI 10.1016/B978-0-12-800271-1.00005-6; SPRAGUE GF, 1981, NATURE, V289, P250, DOI 10.1038/289250a0; Srikantha T, 2003, EUKARYOT CELL, V2, P328, DOI 10.1128/EC.2.2.328-340.2003; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; STRATHERN JN, 1980, P NATL ACAD SCI-BIOL, V77, P2839, DOI 10.1073/pnas.77.5.2839; STRATHERN JN, 1979, CELL, V17, P371, DOI 10.1016/0092-8674(79)90163-6; TATCHELL K, 1981, CELL, V27, P25, DOI 10.1016/0092-8674(81)90357-3; THIERRY A, 1990, YEAST, V6, P521, DOI 10.1002/yea.320060609; Tolstorukov I I, 1973, Nauchnye Doki Vyss Shkoly Biol Nauki, V117, P111; WEILER KS, 1992, GENETICS, V132, P929; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wong S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r10; Wu XH, 1997, GENETICS, V147, P399; Wu XH, 1996, MOL CELL BIOL, V16, P657; Zordan RE, 2013, G3-GENES GENOM GENET, V3, P1675, DOI 10.1534/g3.113.006908	69	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140990	10.1371/journal.pone.0140990	http://dx.doi.org/10.1371/journal.pone.0140990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491872	Green Published, Green Submitted, gold			2022-12-27	WOS:000363249300019
J	Trojan, J; Mineur, L; Tomasek, J; Rouleau, E; Fabian, P; de Maglio, G; Garcia-Alfonso, P; Aprile, G; Taylor, A; Kafatos, G; Downey, G; Terwey, JH; van Krieken, JH				Trojan, Joerg; Mineur, Laurent; Tomasek, Jiri; Rouleau, Etienne; Fabian, Pavel; de Maglio, Giovanna; Garcia-Alfonso, Pilar; Aprile, Giuseppe; Taylor, Aliki; Kafatos, George; Downey, Gerald; Terwey, Jan-Henrik; van Krieken, J. Han			Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review	PLOS ONE			English	Review							PHASE-III TRIAL; CETUXIMAB PLUS IRINOTECAN; CLINICAL-PRACTICE; 1ST-LINE TREATMENT; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; GUIDELINES; MUTATIONS; CHEMOTHERAPY	Background From 2008-2013, the European indication for panitumumab required that patients' tumor KRAS exon 2 mutation status was known prior to starting treatment. To evaluate physician awareness of panitumumab prescribing information and how physicians prescribe panitumumab in patients with metastatic colorectal cancer (mCRC), two European multi-country, cross-sectional, observational studies were initiated in 2012: a physician survey and a medical records review. The first two out of three planned rounds for each study are reported. Methods The primary objective in the physician survey was to estimate the prevalence of KRAS testing, and in the medical records review, it was to evaluate the effect of test results on patterns of panitumumab use. The medical records review study also included a pathologists' survey. Results In the physician survey, nearly all oncologists (299/301) were aware of the correct panitumumab indication and the need to test patients' tumor KRAS status before treatment with panitumumab. Nearly all oncologists (283/301) had in the past 6 months of clinical practice administered panitumumab correctly to mCRC patients with wild-type KRAS status. In the medical records review, 97.5% of participating oncologists (77/79) conducted a KRAS test for all of their patients prior to prescribing panitumumab. Four patients (1.3%) did not have tumor KRAS mutation status tested prior to starting panitumumab treatment. Approximately one-quarter of patients (85/306) were treated with panitumumab and concurrent oxaliplatincontaining chemotherapy; of these, 83/85 had confirmed wild-type KRAS status prior to starting panitumumab treatment. All 56 referred laboratories that participated used a Conformite Europeenne-marked or otherwise validated KRAS detection method, and nearly all (55/56) participated in a quality assurance scheme. Conclusions There was a high level of knowledge amongst oncologists around panitumumab prescribing information and the need to test and confirm patients' tumors as being wild-type KRAS prior to treatment with panitumumab, with or without concurrent oxaliplatin-containing therapy.	[Trojan, Joerg] Univ Hosp, Frankfurt, Germany; [Mineur, Laurent] Inst St Catherine, Avignon, France; [Tomasek, Jiri; Fabian, Pavel] Masaryk Mem Canc Inst, Brno, Czech Republic; [Rouleau, Etienne] Inst Curie, Paris, France; [de Maglio, Giovanna; Aprile, Giuseppe] Univ & Gen Hosp, Udine, Italy; [Garcia-Alfonso, Pilar] Hosp Gen Gregorio Maranon, Madrid, Spain; [Taylor, Aliki; Kafatos, George; Downey, Gerald] Amgen Ltd, Uxbridge, Middx, England; [Terwey, Jan-Henrik] Amgen Europe GmbH, Zug, Switzerland; [van Krieken, J. Han] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Masaryk Memorial Cancer Institute; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Udine; University Hospital of Udine; General University Gregorio Maranon Hospital; Amgen; Amgen Limited; Amgen; AMGEN Europe; Radboud University Nijmegen	Trojan, J (corresponding author), Univ Hosp, Frankfurt, Germany.	trojan@em.uni-frankfurt.de	van Krieken, Joannes H J M/D-4138-2009; taylor, aliki/AAM-1702-2021	van Krieken, Joannes H J M/0000-0001-6544-1040; taylor, aliki/0000-0002-4863-9810; van Krieken, Joannes/0000-0002-8105-0450; Kafatos, George/0000-0001-7871-9216	Amgen	Amgen(Amgen)	These studies were funded by Amgen. Amgen was also involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. They also provided funding for medical writing assistance and for the journal publication fee.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Ciardiello F, 2011, TARGET ONCOL, V6, P133, DOI 10.1007/s11523-011-0181-x; Cox SL, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/294730; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Davis KJ, 2015, INT J CHRONIC OBSTR, V10, P39, DOI 10.2147/COPD.S70162; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Freeman DJ, 2008, CLIN COLORECTAL CANC, V7, P184, DOI 10.3816/CCC.2008.n.024; Goldberg SL, 2013, CURR MED RES OPIN, V29, P1075, DOI 10.1185/03007995.2013.812034; Harris JN, 2013, CANCER MED-US, V2, P881, DOI 10.1002/cam4.135; Jimeno A, 2009, J CLIN ONCOL, V27, P1130, DOI 10.1200/JCO.2008.19.8168; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lledo A, 2007, EUR J NEUROL, V14, P644, DOI 10.1111/j.1468-1331.2007.01801.x; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Smith DC, 2011, J CLIN ONCOL, V29; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; The National Comprehensive Cancer Network. Distress Management, 2009, CLIN PRACT GUID ONC; Van Cutsem E, 2010, ANN ONCOL, V21, pv93, DOI 10.1093/annonc/mdq222; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Webster J, 2013, CANCER EPIDEM BIOMAR, V22, P91, DOI 10.1158/1055-9965.EPI-12-0545; Wilke H, 2008, J CLIN ONCOL, V26, P5335, DOI 10.1200/JCO.2008.16.3758; Witjes JA, 2013, BJU INT, V112, P742, DOI 10.1111/bju.12012	30	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140717	10.1371/journal.pone.0140717	http://dx.doi.org/10.1371/journal.pone.0140717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491871	Green Published, Green Submitted, gold			2022-12-27	WOS:000363249300010
J	Huan, XJ; Lu, HY; Wang, C; Tang, XG; Zuo, XX; Ge, Y; He, KY				Huan, Xiujia; Lu, Houyuan; Wang, Can; Tang, Xiangan; Zuo, Xinxin; Ge, Yong; He, Keyang			Bulliform Phytolith Research in Wild and Domesticated Rice Paddy Soil in South China	PLOS ONE			English	Article							ARCHAEOLOGICAL SITES; CULTIVATED RICE; SILICA BODY; JAPONICA; ORIGINS; INDICA; RECORD; CELLS	Bulliform phytoliths play an important role in researching rice origins as they can be used to distinguish between wild and domesticated rice. Rice bulliform phytoliths are characterized by numerous small shallow fish-scale decorations on the lateral side. Previous studies have shown that domesticated rice has a larger number of these decorations than wild rice and that the number of decorations >= 9 is a useful feature for identifying domesticated rice. However, this standard was established based on limited samples of modern rice plants. In this study, we analyzed soil samples from both wild and domesticated rice paddies. Results showed that, in wild rice soil samples, the proportion of bulliform phytoliths with >= 9 decorations was 17.46% +/- 8.29%, while in domesticated rice soil samples, the corresponding proportion was 63.70% +/- 9.22%. This suggests that the proportion of phytoliths with >= 9 decorations can be adopted as a criterion for discriminating between wild and domesticated rice in prehistoric soil. This indicator will be of significance in improving the application of fish-scale decorations to research into rice origins and the rice domestication process.	[Huan, Xiujia; Lu, Houyuan; Wang, Can; Zuo, Xinxin; Ge, Yong; He, Keyang] Chinese Acad Sci, Inst Geol & Geophys, Beijing, Peoples R China; [Huan, Xiujia; Wang, Can; Ge, Yong; He, Keyang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lu, Houyuan] Chinese Acad Sci, Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Tang, Xiangan] Jiangxi Acad Agr Sci, Soil & Fertilizer & Environm & Resources Res Inst, Nanchang, Jiangxi, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Huan, XJ (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Beijing, Peoples R China.	huanxiujia@mail.iggcas.ac.cn; houyuanlu@mail.iggcas.ac.cn	Lu, houyuan/AAD-3100-2019; Liu, Kam-Biu/B-4966-2012; WANG, CAN/GWV-0969-2022; He, Keyang/ABC-9289-2020; Lu, houyuan/L-8661-2019; Zuo, Xinxin/F-7064-2010	Lu, houyuan/0000-0001-5721-6679; Liu, Kam-Biu/0000-0002-0038-2198; He, Keyang/0000-0002-6014-823X; Zuo, Xinxin/0000-0002-1693-0275	National Natural Science Foundation of China [41230104, 41461043]; National Science and Technology Major Project of China [2015CB953801]; Chinese Academy of Sciences [XDA05130604]; National Key Technology R&D Program of China [2013BAK08B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Technology R&D Program of China(National Key Technology R&D Program)	This study was supported by the National Natural Science Foundation of China (Grant No. 41230104), the National Science and Technology Major Project of China (Grant No. 2015CB953801), the "Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences (Grant No. XDA05130604), the National Key Technology R&D Program of China (Grant No. 2013BAK08B02) and National Natural Science Foundation of China (Grant No. 41461043).	Alvarez JM, 2008, BRAZILIAN ARCH BIOL; Archaeologists T, 2007, SCIENCE, V29, P1830; Callaway E, 2014, NATURE, V514, pS58, DOI 10.1038/514S58a; Chauhan D.K., 2011, INT J INNOVATIONS BI, V1, P22; Chen B., 1995, CHINESE SCI BULL, V40, P339; Dalla Vecchia F, 1998, PLANT GROWTH REGUL, V24, P219; Dong YC, 2006, CROPS THEIR WILD REL; ELLIS R P, 1976, Bothalia, V12, P65; Fujiwara H, 1993, MASCA RES PAPERS SCI, V10, P147; Fujiwara H, 1976, ARCHAEOLOGY NATURAL, V9, P15; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Gu HB, 2009, J HUMAN ARCHAEOLOGY, P268; Gu YS, 2013, QUATERN INT, V287, P141, DOI 10.1016/j.quaint.2012.02.013; Higham C, 1998, ANTIQUITY, V72, P867, DOI 10.1017/S0003598X00087500; [郇秀佳 Huan Xiujia], 2014, [第四纪研究, Quaternary Sciences], V34, P106; JANE W-N, 1991, Taiwania, V36, P85; Jiang, 2007, ARCHAEOLOGY, P19; Jiang LP, 2006, ANTIQUITY, V80, P355, DOI 10.1017/S0003598X00093674; Jin GY, 2007, CHINESE SCI BULL, V52, P3376, DOI 10.1007/s11434-007-0449-9; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li XQ, 2007, CHINESE SCI BULL, V52, P1372, DOI 10.1007/s11434-007-0186-0; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Lu H, 1996, ARCHAEOLOGY, P82; Lu HouYuan, 1997, Estado actual de los estudios de fitolitos en suelas y plantas. Primer encuentro Europeo sobre el estudio de fitolitos., P159; Lu HY, 2002, BOREAS, V31, P378, DOI 10.1080/030094802320942581; Lu L., 2009, RELICS S, P72; Ma Xue-Long, 2007, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V27, P1531; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; PEARSALL DM, 1995, ECON BOT, V49, P183, DOI 10.1007/BF02862923; Peng Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-15; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Qu Bo, 2010, Xibei Zhiwu Xuebao, V30, P1595; SATO YI, 1990, JPN J BREED, V40, P495; Saxena A, 2006, CURR SCI INDIA, V90, P1547; Smithson F, 1958, SILICIFICATION BULLI; Tewari Rakesh, 2008, PRAGDHARA, V18, P347, DOI DOI 10.1016/J.JAS.2016.04.018; Wang CaiLin, 1997, Jiangsu Journal of Agricultural Sciences, V13, P129; [王灿 Wang Can], 2012, [第四纪研究, Quaternary Sciences], V32, P269; Wang CL, 1996, BREEDING SCI, V46, P61; Wang X, 1998, CHINESE SCI BULL, P2354; Wang Y., 1993, STUDY PHYTOLITH ITS; Wang Y., 2005, BIOL TEACHING, V30, P7; Zhang JP, 2010, BOREAS, V39, P592, DOI 10.1111/j.1502-3885.2010.00145.x; Zhang M, 1998, AGR ARCHAEOLOGY, P172; Zhang WenXu, 1998, Acta Agronomica Sinica, V24, P416; Zhang WenXu, 1998, Journal of China Agricultural University, V3, P21; Zhao ZJ, 1998, ECON BOT, V52, P134, DOI 10.1007/BF02861201; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524; Zheng Y, 2000, RICE SCI, V8, P9; Zheng YF, 2007, CHINESE SCI BULL, V52, P1654, DOI 10.1007/s11434-007-0258-1; Zheng YunFei, 1999, Chinese Journal of Rice Science, V13, P25; Zheng YunFei, 2004, Chinese Journal of Rice Science, V18, P119; Zou JiangShi, 1998, Scientia Agricultura Sinica, V31, P75; 龚子同, 2007, [科学通报, Chinese Science Bulletin], V52, P562	55	46	60	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141255	10.1371/journal.pone.0141255	http://dx.doi.org/10.1371/journal.pone.0141255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488583	gold, Green Submitted, Green Published			2022-12-27	WOS:000363248400117
J	Moreno-Opo, R; Afonso, I; Jimenez, J; Fernandez-Olalla, M; Canut, J; Garcia-Ferre, D; Pique, J; Garcia, F; Roig, J; Munoz-Igualada, J; Gonzalez, LM; Lopez-Bao, JV				Moreno-Opo, Ruben; Afonso, Ivan; Jimenez, Jose; Fernandez-Olalla, Mariana; Canut, Jordi; Garcia-Ferre, Diego; Pique, Josep; Garcia, Francisco; Roig, Job; Munoz-Igualada, Jaime; Mariano Gonzalez, Luis; Vicente Lopez-Bao, Jose			Is It Necessary Managing Carnivores to Reverse the Decline of Endangered Prey Species? Insights from a Removal Experiment of Mesocarnivores to Benefit Demographic Parameters of the Pyrenean Capercaillie	PLOS ONE			English	Article							FOX VULPES-VULPES; BREEDING SUCCESS; RED FOX; TETRAO-UROGALLUS; POPULATION-DYNAMICS; GROUSE POPULATIONS; PREDATOR ABUNDANCE; TROPHIC CASCADES; BLACK GROUSE; HOME RANGES	Mesopredator control has long been used to alleviate the effect of elevated predation pressure on vulnerable, threatened or valuable species. However, the convenience of using mesopredator controls is technically questionable and scientifically-sound research is therefore required to evaluate the impact of predation on prey case by case. In this study we evaluated the effect of the alteration of terrestrial mesopredator dynamics on the demographic parameters of a relict capercaillie Tetrao urogallus aquitanicus population currently in decline for which the impact of predation has not previously been assessed. We used a six-year mesocarnivore removal experiment (2008-2013) together with seven-years of previous demographic information on capercaillies (1999-2007) within a before-after control-impact (BACI) design to evaluate the effect of mesocarnivore removal on capercaillie demographic parameters and on spatial behaviour of the most frequent predatory mesocarnivores of the capercaillie (Martes spp. and red fox Vulpes vulpes). Using a dynamic site-occupancy approach, the reduction of mesocarnivore population levels as a result of removal was clear for marten species, mainly during key months for capercaillie reproduction, but not for the red fox. Our results show that the breeding success of capercaillies was enhanced in areas where carnivores were removed and was inversely related to the occupation level of the studied mesocarnivores, although being only significant for Martes spp. Moreover, capercaillie predation rates were lower and adult survival seemingly higher in treatment during the removal phase. Cost-effective, long-term management interventions to ensure the recovery of this threatened capercaillie population are discussed in the light of the results. At our study area, the decision for implementing predation management should be included within a broader long-term conservation perspective. In this regard, a more feasible and sustainable management intervention in ecological and economic terms may be to balance the impact of mesocarnivores on capercaillies through the recovery of apex predators.	[Moreno-Opo, Ruben; Garcia, Francisco; Munoz-Igualada, Jaime; Mariano Gonzalez, Luis] Minist Agr Food & Environm, Madrid, Spain; [Moreno-Opo, Ruben; Pique, Josep; Munoz-Igualada, Jaime] TRAGSATEC, Madrid, Spain; [Afonso, Ivan] MUSIA, La Plana, Lleida, Spain; [Afonso, Ivan; Canut, Jordi; Roig, Job] Assoc Conservat Capercaillie ACU, Buseu, Baix Pallars, Spain; [Jimenez, Jose] Inst Res Game Resources CSIC, Ciudad Real, Spain; [Fernandez-Olalla, Mariana] Univ Politecn Madrid, ETSI Montes, Madrid, Spain; [Canut, Jordi] Alt Pirineu Nat Pk, Llavorsi, Spain; [Garcia-Ferre, Diego] Generalitat Catalunya, Dept Agr Ramaderia Pesca Alimentacio & Medi Ambie, Barcelona, Spain; [Vicente Lopez-Bao, Jose] Univ Oviedo, Res Unit Biodivers, Mieres, Spain; [Vicente Lopez-Bao, Jose] Swedish Univ Agr Sci, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Politecnica de Madrid; University of Oviedo; Swedish University of Agricultural Sciences	Moreno-Opo, R (corresponding author), Minist Agr Food & Environm, Madrid, Spain.	at_sgb4@magrama.es	Jimenez, Jose/I-9840-2019; VICENTE, LIERN/B-6112-2008	Jimenez, Jose/0000-0003-0607-6973; VICENTE, LIERN/0000-0001-5883-9640; Lopez-Bao, Jose Vicente/0000-0001-9213-998X	Generalitat de Catalunya; European Union; Spanish Ministry of Economy and Competitiveness	Generalitat de Catalunya(Generalitat de Catalunya); European Union(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	The present work was commissioned by the Spanish Ministry of Environment, and the GALLIPYR-POCTEFA 2007 cofunded by the Generalitat de Catalunya and the European Union, who provided support in the form of salaries for authors [RM-O, IA, JP, JM-I], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. JVLB received a postdoctoral grant "Juan de la Cierva" from the Spanish Ministry of Economy and Competitiveness."	Ameztegui A, 2010, GLOBAL ECOL BIOGEOGR, V19, P632, DOI 10.1111/j.1466-8238.2010.00550.x; Baines D, 2004, J APPL ECOL, V41, P59, DOI 10.1111/j.1365-2664.2004.00875.x; Baines D, 2013, WILDLIFE BIOL, V19, P490, DOI 10.2981/13-030; Baker PJ, 2006, EUR J WILDLIFE RES, V52, P99, DOI 10.1007/s10344-005-0018-y; Barea-Azcon JM, 2007, BIODIVERS CONSERV, V16, P1213, DOI 10.1007/s10531-006-9114-x; Beaufort F, 1965, MAMMALIA, V29, P589; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Bodey TW, 2011, BIOL INVASIONS, V13, P2817, DOI 10.1007/s10530-011-9965-2; Bosch M, 2000, J APPL ECOL, V37, P369, DOI 10.1046/j.1365-2664.2000.00501.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canut J, 1996, ALAUDA, V64, P193; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Clavero M, 2013, BIODIVERS CONSERV, V22, P1691, DOI 10.1007/s10531-013-0506-4; Cote IM, 1997, CONSERV BIOL, V11, P395, DOI 10.1046/j.1523-1739.1997.95410.x; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Olivier D, 2007, CONSERV GENET, V8, P513, DOI 10.1007/s10592-006-9165-2; Elmhagen B, 2010, J ANIM ECOL, V79, P785, DOI 10.1111/j.1365-2656.2010.01678.x; Elmhagen B, 2007, ECOL LETT, V10, P197, DOI 10.1111/j.1461-0248.2006.01010.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Evans KL, 2004, IBIS, V146, P1, DOI 10.1111/j.1474-919X.2004.00231.x; Fernandez-Olalla M, 2012, BIOL CONSERV, V148, P79, DOI 10.1016/j.biocon.2012.01.047; Fletcher K, 2013, WILDLIFE BIOL, V19, P248, DOI 10.2981/12-009; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fox J., 2018, R COMPANION APPL REG, VThird; Fryxell J.M., 2014, WILDLIFE ECOLOGY CON, VThird Edition; Gelman A., 2013, CHAPMAN HALL CRC TEX, DOI [10.1201/b16018, DOI 10.1201/B16018]; Gervasi V, 2012, J ANIM ECOL, V81, P443, DOI 10.1111/j.1365-2656.2011.01928.x; Gortazar C, 2000, MAMMALIA, V64, P411, DOI 10.1515/mamm.2000.64.4.411; Harding EK, 2001, CONSERV BIOL, V15, P1114, DOI 10.1046/j.1523-1739.2001.0150041114.x; Heleno R, 2010, ECOL APPL, V20, P1191, DOI 10.1890/09-1384.1; Kauhala K, 2000, ECOGRAPHY, V23, P161, DOI 10.1111/j.1600-0587.2000.tb00271.x; Kauhala K, 2002, ORNIS FENNICA, V79, P14; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Klein JP., 2003, SURVIVAL ANAL TECHNI; Kurki S, 1997, OIKOS, V79, P301, DOI 10.2307/3546014; LaPoint SD, 2015, ANIM CONSERV, V18, P50, DOI 10.1111/acv.12138; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; MARCSTROM V, 1988, J ANIM ECOL, V57, P859, DOI 10.2307/5097; Marks CA, 2009, WILDLIFE RES, V36, P647, DOI 10.1071/WR08109; Marsh DM, 2008, CONSERV BIOL, V22, P647, DOI 10.1111/j.1523-1739.2008.00927.x; McKenzie D. I., 2006, OCCUPANCY ESTIMATION; MENONI E, 1991, Gibier Faune Sauvage, V8, P251; Mittelbach GG, 2012, COMMUNITY ECOLOGY, P1; Moss R, 2001, J ANIM ECOL, V70, P47, DOI 10.1046/j.1365-2656.2001.00473.x; Munoz-Igualada J, 2008, J WILDLIFE MANAGE, V72, P830, DOI 10.2193/2007-198; Newsome TM, 2015, RESTOR ECOL, V23, P201, DOI 10.1111/rec.12186; Newsome TM, 2015, J ANIM ECOL, V84, P49, DOI 10.1111/1365-2656.12258; O'Mahony DT, 2014, ACTA THERIOL, V59, P251, DOI 10.1007/s13364-013-0167-4; Overskaug K., 2000, Lutra, V43, P215; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Pasanen-Mortensen M, 2013, GLOBAL ECOL BIOGEOGR, V22, P868, DOI 10.1111/geb.12051; Pekkola M, 2014, EUR J WILDLIFE RES, V60, P477, DOI 10.1007/s10344-014-0809-0; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Prowse TAA, 2015, J APPL ECOL, V52, P455, DOI 10.1111/1365-2664.12378; Prugh LR, 2015, OIKOS; R Development Core Team, 2014, R LANG ENV STAT COMP; Rajala P., 1974, Riistatieteellisia Julk, V35, P1; Reynolds JC, 1996, MAMMAL REV, V26, P127, DOI 10.1111/j.1365-2907.1996.tb00150.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ripple WJ, 2014, J ANIM ECOL, V83, P223, DOI 10.1111/1365-2656.12123; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Ritchie EG, 2012, TRENDS ECOL EVOL, V27, P265, DOI 10.1016/j.tree.2012.01.001; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Robles L, 2006, SITUACION ACTUAL; Rogers L.L., 1988, P76; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Ruiz-Gonzalez A, 2008, EUR J WILDLIFE RES, V54, P253, DOI 10.1007/s10344-007-0138-7; Rushton SP, 2006, J WILDLIFE MANAGE, V70, P1102, DOI 10.2193/0022-541X(2006)70[1102:EOCFPA]2.0.CO;2; Salafsky N., 2001, ADAPTIVE MANAGEMENT; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Sanz-Aguilar A, 2009, BIOL CONSERV, V142, P424, DOI 10.1016/j.biocon.2008.11.004; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; SLAGSVOLD T, 1979, ORNIS SCAND, V10, P37, DOI 10.2307/3676342; Smedshaug CA, 1999, WILDLIFE BIOL, V5, P157, DOI 10.2981/wlb.1999.020; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; STORAAS T, 1987, J WILDLIFE MANAGE, V51, P167, DOI 10.2307/3801649; STORCH I, 1995, J WILDLIFE MANAGE, V59, P392, DOI 10.2307/3808953; Storch I., 2007, GROUSE STATUS SURVEY; Summers RW, 2009, WILDLIFE BIOL, V15, P319, DOI 10.2981/08-036; Summers RW, 2004, J APPL ECOL, V41, P513, DOI 10.1111/j.0021-8901.2004.00891.x; Sunde P, 1999, ECOGRAPHY, V22, P521, DOI 10.1111/j.1600-0587.1999.tb01281.x; Tapper SC, 1996, J APPL ECOL, V33, P965, DOI 10.2307/2404678; TERBORGH J, 2013, TROPHIC CASCADES PRE; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; TRAVAINI A, 1993, ACTA THERIOL, V38, P427, DOI 10.4098/AT.arch.93-33; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Vicente-Serrano SM, 2004, ENVIRON MANAGE, V34, P802, DOI 10.1007/s00267-003-0022-5; Viota Maria, 2012, Open Journal of Ecology, V2, P115; Wallach AD, 2015, TRENDS ECOL EVOL, V30, P146, DOI 10.1016/j.tree.2015.01.003; Wegge P, 2007, ANN ZOOL FENN, V44, P141; Wilson DE, 2009, HDB MAMMALS WORLD, V1; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Woodroffe R, 2015, SCIENCE, V348, P1312, DOI 10.1126/science.aaa8465; Zalewski A, 2012, ACTA THERIOL, V57, P371, DOI 10.1007/s13364-012-0086-9; Zuur A.F, 2012, ZERO INFLATED MODELS	99	18	18	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139837	10.1371/journal.pone.0139837	http://dx.doi.org/10.1371/journal.pone.0139837			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489094	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400040
J	Sarkar, A; Desai, UR				Sarkar, Aurijit; Desai, Umesh R.			A Simple Method for Discovering Druggable, Specific Glycosaminoglycan-Protein Systems. Elucidation of Key Principles from Heparin/Heparan Sulfate-Binding Proteins	PLOS ONE			English	Article							HEPARIN-BINDING; CRYSTAL-STRUCTURE; ANTITHROMBIN-III; PENTASACCHARIDE BINDING; COMPLEX REVEALS; ACID RESIDUES; THROMBIN; SITES; IDENTIFICATION; ACTIVATION	Glycosaminoglycans (GAGs) affect human physiology and pathology by modulating more than 500 proteins. GAG-protein interactions are generally assumed to be ionic and nonspecific, but specific interactions do exist. Here, we present a simple method to identify the GAG-binding site (GBS) on proteins that in turn helps predict high specific GAG-protein systems. Contrary to contemporary thinking, we found that the electrostatic potential at basic arginine and lysine residues neither identifies the GBS consistently, nor its specificity. GBSs are better identified by considering the potential at neutral hydrogen bond donors such as asparagine or glutamine sidechains. Our studies also reveal that an unusual constellation of ionic and non-ionic residues in the binding site leads to specificity. Nature engineers the local environment of Asn45 of antithrombin, Gln255 of 3-O-sulfotransferase 3, Gln163 and Asn167 of 3-O-sulfotransferase 1 and Asn27 of basic fibroblast growth factor in the respective GBSs to induce specificity. Such residues are distinct from other uncharged residues on the same protein structure in possessing a significantly higher electrostatic potential, resultant from the local topology. In contrast, uncharged residues on nonspecific GBSs such as thrombin and serum albumin possess a diffuse spread of electrostatic potential. Our findings also contradict the paradigm that GAG-binding sites are simply a collection of contiguous Arg/Lys residues. Our work demonstrates the basis for discovering specifically interacting and druggable GAG-protein systems based on the structure of protein alone, without requiring access to any structure-function relationship data.	[Desai, Umesh R.] Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Desai, UR (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Med Coll Virginia Campus, Richmond, VA 23284 USA.	urdesai@vcu.edu	Sarkar, Aurijit/AAW-3417-2020; Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597; Sarkar, Aurijit/0000-0003-3735-6345	NIH [HL107152, HL090586, HL125639]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090586, P01HL107152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH through grants HL107152, HL090586, and HL125639 to URD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino M, 2014, GLYCOBIOLOGY, V24, P840, DOI 10.1093/glycob/cwu045; Agostino M, 2013, J MOL GRAPH MODEL, V40, P80, DOI 10.1016/j.jmgm.2013.01.001; Arocas V, 2001, J BIOL CHEM, V276, P43809, DOI 10.1074/jbc.M105294200; ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Boothello RS, 2015, ACS CHEM BIOL, V10, P1485, DOI 10.1021/acschembio.5b00071; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Desai U, 2000, J BIOL CHEM, V275, P18976, DOI 10.1074/jbc.M001340200; Desai UR, 2004, MED RES REV, V24, P151, DOI 10.1002/med.10058; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; Desai UR, 2014, GLYCOBIOLOGY, V0, P1; Edavettal SC, 2004, J BIOL CHEM, V279, P25789, DOI 10.1074/jbc.M401089200; Forster M, 2006, BIOCHEM SOC T, V34, P431, DOI 10.1042/BST0340431; GAN ZR, 1994, J BIOL CHEM, V269, P1301; Gandhi NS, 2008, BIOCHEMISTRY-US, V47, P4851, DOI 10.1021/bi702455e; Gandhi NS, 2012, BBA-PROTEINS PROTEOM, V1824, P1374, DOI 10.1016/j.bbapap.2012.07.002; Gandhi NS, 2009, GLYCOBIOLOGY, V19, P1103, DOI 10.1093/glycob/cwp101; GILSON MK, 1985, J MOL BIOL, V184, P503, DOI 10.1016/0022-2836(85)90297-9; Grant JA, 2001, J COMPUT CHEM, V22, P608, DOI 10.1002/jcc.1032; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Hattori T, 2001, ANAL BIOCHEM, V295, P158, DOI 10.1006/abio.2001.5129; He XH, 1997, BIOCHEMISTRY-US, V36, P8969, DOI 10.1021/bi9704717; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kridel SJ, 1996, J BIOL CHEM, V271, P20935, DOI 10.1074/jbc.271.34.20935; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Liu CH, 2014, J BIOL CHEM, V289, P13407, DOI 10.1074/jbc.M113.530535; MACCARANA M, 1994, J BIOL CHEM, V269, P3903; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MASCOTTI DP, 1995, BIOCHEMISTRY-US, V34, P2908, DOI 10.1021/bi00009a022; Meagher JL, 1996, J BIOL CHEM, V271, P29353, DOI 10.1074/jbc.271.46.29353; Moon AF, 2004, J BIOL CHEM, V279, P45185, DOI 10.1074/jbc.M405013200; Moon AF, 2012, P NATL ACAD SCI USA, V109, P5265, DOI 10.1073/pnas.1117923109; Mosier PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048632; Mottarella SE, 2014, J CHEM INF MODEL, V54, P2068, DOI 10.1021/ci500115j; Mulloy B, 2008, MOL SIMULAT, V34, P481, DOI 10.1080/08927020701784754; Munoz-Garcia JC, 2015, J AM CHEM SOC, V137, P4100, DOI 10.1021/ja511529x; Munoz-Garcia JC, 2014, GLYCOBIOLOGY, V24, P1004, DOI 10.1093/glycob/cwu071; OLSON ST, 1991, J BIOL CHEM, V266, P6342; OLSON ST, 1991, J BIOL CHEM, V266, P6353; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; Raghuraman A, 2006, J MED CHEM, V49, P3553, DOI 10.1021/jm060092o; Raghuraman A, 2010, ACS MED CHEM LETT, V1, P281, DOI 10.1021/ml100048y; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Ren PY, 2012, Q REV BIOPHYS, V45, P427, DOI 10.1017/S003358351200011X; Rogers CJ, 2011, P NATL ACAD SCI USA, V108, P9747, DOI 10.1073/pnas.1102962108; Samsonov SA, 2014, J CHEM INF MODEL; Samsonov SA, 2014, J CHEM INF MODEL, V54, P582, DOI 10.1021/ci4006047; Sapay N, 2011, GLYCOBIOLOGY, V21, P1181, DOI 10.1093/glycob/cwr052; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P12369, DOI 10.1021/bi020406j; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SOBEL M, 1992, J BIOL CHEM, V267, P8857; SPILLMANN D, 1994, CURR OPIN STRUC BIOL, V4, P677, DOI 10.1016/S0959-440X(94)90165-1; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Torrent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042692; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yamada Shuhei, 2011, Commun Integr Biol, V4, P150, DOI 10.4161/cib.4.2.14547	60	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141127	10.1371/journal.pone.0141127	http://dx.doi.org/10.1371/journal.pone.0141127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488293	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400105
J	Soszynska-Jozwiak, M; Michalak, P; Moss, WN; Kierzek, R; Kierzek, E				Soszynska-Jozwiak, Marta; Michalak, Paula; Moss, Walter N.; Kierzek, Ryszard; Kierzek, Elzbieta			A Conserved Secondary Structural Element in the Coding Region of the Influenza A Virus Nucleoprotein (NP) mRNA Is Important for the Regulation of Viral Proliferation	PLOS ONE			English	Article							STRUCTURE PREDICTION; SPLICE SITES; INHIBITION; IDENTIFICATION; REPLICATION; CONSTRAINTS; DUPLEXES; MODEL; MICE	Influenza A virus is a threat to humans due to seasonal epidemics and infrequent, but dangerous, pandemics that lead to widespread infection and death. Eight segments of RNA constitute the genome of this virus and they encode greater than eight proteins via alternative splicing of coding (+)RNAs generated from the genomic (-)RNA template strand. RNA is essential in its life cycle. A bioinformatics analysis of segment 5, which encodes nucleoprotein, revealed a conserved structural motif in the (+)RNA. The secondary structure proposed by energy minimization and comparative analysis agrees with structure predicted based on experimental data using a 121 nucleotide in vitro RNA construct comprising an influenza A virus consensus sequence and also an entire segment 5 (+)RNA (strain A/VietNam/1203/2004 (H5N1)). The conserved motif consists of three hairpins with one being especially thermodynamically stable. The biological importance of this conserved secondary structure is supported in experiments using antisense oligonucleotides in cell line, which found that disruption of this motif led to inhibition of viral fitness. These results suggest that this conserved motif in the segment 5 (+)RNA might be a candidate for oligonucleotide-based antiviral therapy.	[Soszynska-Jozwiak, Marta; Michalak, Paula; Kierzek, Ryszard; Kierzek, Elzbieta] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland; [Moss, Walter N.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Howard Hughes Medical Institute; Yale University	Kierzek, E (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	elzbieta.kierzek@ibch.poznan.pl	Moss, Walter/H-8096-2019	Moss, Walter/0000-0001-6419-5570; Kierzek, Ryszard/0000-0002-7644-0016; Kierzek, Elzbieta/0000-0002-5563-003X	National Science Center [UMO-2013/08/M/NZ1/01062, UMO-2013/08/A/ST5/00295]; American Cancer Society [126117-PF-14-139-01-MPC]; National Institutes of Health [K99GM112877-01, R03TW008739]; Polish Ministry of Science and Higher Education under the KNOW program; FOGARTY INTERNATIONAL CENTER [R03TW008739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM112877] Funding Source: NIH RePORTER	National Science Center(National Science Centre, Poland); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education under the KNOW program(Ministry of Science and Higher Education, Poland); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Center grants: UMO-2013/08/M/NZ1/01062 to EK and UMO-2013/08/A/ST5/00295 to RK, American Cancer Society grant 126117-PF-14-139-01-MPC and National Institutes of Health grant K99GM112877-01 to WNM, and by NIH grant R03TW008739 to EK. This publication was also supported by the Polish Ministry of Science and Higher Education, under the KNOW program.	Bae SH, 2001, P NATL ACAD SCI USA, V98, P10602, DOI 10.1073/pnas.191268798; Baker SF, 2013, J VIROL, V87, P8591, DOI 10.1128/JVI.01081-13; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Chiang C, 2008, J VIROL, V82, P10873, DOI 10.1128/JVI.00506-08; Dela-Moss LI, 2012, PLOS ONE, V7, DOI [10.1071/journal.pone.0038323, DOI 10.1371/J0URNAL.P0NE.0038323]; Dela-Moss Lumbini I, 2014, BMC Res Notes, V7, P22, DOI 10.1186/1756-0500-7-22; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Franco-Paredes C, 2009, ARCH MED RES, V40, P669, DOI 10.1016/j.arcmed.2009.10.004; Fratczak A, 2011, BIOCHEMISTRY-US, V50, P7647, DOI 10.1021/bi200463p; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Ge Q, 2006, ANTIMICROB AGENTS CH, V50, P3724, DOI 10.1128/AAC.00644-06; Giannecchini S, 2011, ANTIVIR RES, V92, P64, DOI 10.1016/j.antiviral.2011.06.013; Gruber AR, 2007, NUCLEIC ACIDS RES, V35, pW335, DOI 10.1093/nar/gkm222; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; Gultyaev AP, 2014, RNA BIOL, V11, P942, DOI 10.4161/rna.29730; Gultyaev AP, 2010, INT REV IMMUNOL, V29, P533, DOI 10.3109/08830185.2010.507828; Gultyaev AP, 2010, RNA BIOL, V7, P125, DOI 10.4161/rna.7.2.11287; Jiang T, 2014, BIOCHEMISTRY-US, V53, P5236, DOI 10.1021/bi500611j; Kierzek E, 2006, BIOCHEMISTRY-US, V45, P581, DOI 10.1021/bi051409+; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4472, DOI 10.1093/nar/gkg633; Kierzek E, 2007, INT P DIV MED BOL IT, P25; Kierzek E, 2008, NUCLEIC ACIDS RES, V36, P1770, DOI 10.1093/nar/gkm1085; Kierzek E, 2009, BIOCHEMISTRY-US, V48, P11344, DOI 10.1021/bi901264v; Kierzek E, 2009, J MOL BIOL, V390, P428, DOI 10.1016/j.jmb.2009.04.048; Kumar B, 2012, MOL BIOTECHNOL, V51, P27, DOI 10.1007/s12033-011-9437-z; Li WY, 2011, ARCH VIROL, V156, P1979, DOI 10.1007/s00705-011-1087-8; Martelli F, 2015, J BIOTECHNOL, V210, P85, DOI 10.1016/j.jbiotec.2015.06.391; Martinez-Sobrido L, 2010, J VIROL, V84, P2157, DOI 10.1128/JVI.01433-09; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2010, BMC BIOINFORMATICS, P11; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mizuta T, 1999, NAT BIOTECHNOL, V17, P583, DOI 10.1038/9893; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pasternak A, NUCL ACIDS RES; Pasternak A, 2008, BIOCHEMISTRY-US, V47, P1249, DOI 10.1021/bi701758z; Priore SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070615; Priore SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035989; Shapshak P, 2011, MOL DIAGN THER, V15, P63, DOI 10.2165/11590660-000000000-00000; Van Kerkhove MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000275; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wu YH, 2008, BIOCHEM BIOPH RES CO, V365, P369, DOI 10.1016/j.bbrc.2007.10.196; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; York A, 2013, RNA BIOL, V10, P1274, DOI 10.4161/rna.25356; Zhang T, 2011, INT IMMUNOPHARMACOL, V11, P2057, DOI 10.1016/j.intimp.2011.08.019; Zhang T, 2011, VACCINE, V29, P1558, DOI 10.1016/j.vaccine.2010.12.088	50	14	15	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141132	10.1371/journal.pone.0141132	http://dx.doi.org/10.1371/journal.pone.0141132			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488402	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400106
J	Zhai, YX; Liu, K; Zhang, L; Gao, H; Chen, Z; Du, SY; Zhang, LL; Guo, Y				Zhai, Yanxue; Liu, Kun; Zhang, Lin; Gao, Han; Chen, Zhuo; Du, Siyi; Zhang, Lili; Guo, Yu			The Relationship between Post-Traumatic Symptoms, Parenting Style, and Resilience among Adolescents in Liaoning, China: A Cross-Sectional Study	PLOS ONE			English	Article							STRESS-DISORDER; PTSD SYMPTOMS; IMPACT	Background In China, a growing number of adolescents have experienced traumatic events that have resulted in PTSD (post-traumatic stress disorder). Post-traumatic symptoms are common psychological problems in adolescents who have experienced traumatic events. However, existing studies tend to focus on the factors influencing PTSD, such as the response styles and social support, and studies on the relationships between parenting style, resilience and post-traumatic symptoms are still rare. Objectives To analyze the relationships between parenting style, resilience and post-traumatic symptoms among adolescents in China. Methods A cross-sectional survey was conducted from June to December 2013 in the Liaoning Province, China. N = 5765 adolescents (aged 12 to 18 years old) were ultimately chosen to participate. The Chinese version of the Essen Trauma Inventory for Kids and Juveniles (ETI-KJ), a modified version of the Parental Authority Questionnaire, and the Chinese Resilience Scale were used to estimate the post-traumatic symptoms, parenting style, and resilience, respectively. Pearson's correlations, multiple linear regression analyses and structural equation modeling (SEM) were applied to analyze the data. Results Of the adolescents, 39.76% (N = 2292) had been exposed to traumatic events during their lives. The prevalence of probable PTSD at the time of the interview (one-month-prevalence) was 12.65%. Parenting style and resilience were significantly associated with post-traumatic symptoms. According to the SEM, parenting style had a significant direct effect on resilience (0.70, P<0.01) and post-traumatic symptoms (-0.15, P<0.05), and resilience had a significant direct effect on the post-traumatic symptoms (-0.43, P<0.01). Furthermore, parenting style had a significant indirect effect (-0.43x0.70 = -0.30. P<0.01) on the post-traumatic symptoms through resilience. The SEM significantly explained 49% of the variance in resilience and 30% of the variance in post-traumatic symptoms. Conclusions Parenting style and resilience have significant effects on adolescents' post-traumatic symptoms. Schools and social-related departments could share knowledge on the impact of parenting style with parents enabling them to improve their own parenting style and their children's resilience and ability to respond effectively to traumatic events.	[Zhai, Yanxue; Liu, Kun; Zhang, Lin; Gao, Han; Du, Siyi; Zhang, Lili; Guo, Yu] Liaoning Med Univ, Coll Nursing, Jinzhou, Liaoning, Peoples R China; [Chen, Zhuo] Liaoning Med Univ, Coll Basic Med Sci, Jinzhou, Liaoning, Peoples R China	Jinzhou Medical University; Jinzhou Medical University	Liu, K (corresponding author), Liaoning Med Univ, Coll Nursing, Jinzhou, Liaoning, Peoples R China.	yuandxue717@163.com	zhai, yanxue/GZG-4029-2022		Ministry of Education in China Project of Humanities and Social Sciences [13YJAZH052]	Ministry of Education in China Project of Humanities and Social Sciences	This work was supported by Ministry of Education in China Project of Humanities and Social Sciences (NO. 13YJAZH052).	Acierno R, 2000, J TRAUMA STRESS, V13, P381, DOI 10.1023/A:1007772905696; Ahmad S, 2010, J TRAUMA STRESS, V23, P408, DOI 10.1002/jts.20535; Alim TN, 2008, AM J PSYCHIAT, V165, P1566, DOI 10.1176/appi.ajp.2008.07121939; Ang RP, 2006, AM J ORTHOPSYCHIAT, V76, P503, DOI 10.1037/0002-9432.76.4.503; Baumrind D., 1991, J EARLY ADOLESC, V11, P56, DOI [DOI 10.1177/0272431691111004, 10.1177/0272431691111004]; BURI JR, 1991, J PERS ASSESS, V57, P110, DOI 10.1207/s15327752jpa5701_13; Chen SH, 2006, NAT HAZARDS, V37, P225, DOI 10.1007/s11069-005-4671-y; Cheng YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096644; Chorpita BF, 1998, PSYCHOL BULL, V124, P3, DOI 10.1037/0033-2909.124.1.3; [杜思怡 Du Siyi], 2014, [中国全科医学, Chinese General Practice], V17, P2213; Dwairy M, 2006, J ADOLESCENCE, V29, P103, DOI 10.1016/j.adolescence.2005.03.002; Frias-Armenta M, 1998, J ABNORM CHILD PSYCH, V26, P129, DOI 10.1023/A:1022621922331; Howgego IM, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-21; [胡月琴 HU YueQin], 2008, [心理学报, Acta Psychologica Sinica], V40, P902; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Khamis V, 2005, CHILD ABUSE NEGLECT, V29, P81, DOI 10.1016/j.chiabu.2004.06.013; Lee JS, 2014, J AFFECT DISORDERS, V162, P128, DOI 10.1016/j.jad.2014.02.031; Lin Z, 2004, J SHANGHAI NORMAL U, V33, P107; Long E, 2015, SOC PSYCH PSYCH EPID, V50, P1569, DOI 10.1007/s00127-015-1065-7; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mengzhu Y, THESIS SHANGHAI NORM; Perkonigg A, 2005, AM J PSYCHIAT, V162, P1320, DOI 10.1176/appi.ajp.162.7.1320; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Ruifang J, 2011, THESIS HUAZHONG U SC; Tagay S., 2007, PSYCHOTHER PSYCHOSOM, V1, P75, DOI [10.1055/s-2006-934318, DOI 10.1055/S-2006-934318]; Trinkner R, 2012, J ADOLESCENCE, V35, P119, DOI 10.1016/j.adolescence.2011.05.003; Yanjie Y, 2011, CHNESE J PUBLIC HLTH, V27; Zakeri H, 2010, PROCD SOC BEHV, V5, P1067, DOI 10.1016/j.sbspro.2010.07.236; Zhang YM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-235; Zhongjie L, 2004, J ENV HYGIENE, V31, P239	30	13	13	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141102	10.1371/journal.pone.0141102	http://dx.doi.org/10.1371/journal.pone.0141102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26489079	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400103
J	Banerjee, S; Versaw, WK; Garcia, LR				Banerjee, Swayoma; Versaw, Wayne K.; Garcia, L. Rene			Imaging Cellular Inorganic Phosphate in Caenorhabditis elegans Using a Genetically Encoded FRET-Based Biosensor	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; YELLOW FLUORESCENT PROTEIN; CONFOCAL MICROSCOPY; ACID-PHOSPHATASE; RATIOMETRIC FRET; LIVING CELLS; C-ELEGANS; GENE; INDICATORS; CALMODULIN	Inorganic phosphate (Pi) has central roles in metabolism, cell signaling and energy conversion. The distribution of Pi to each cell and cellular compartment of an animal must be tightly coordinated with its dietary supply and with the varied metabolic demands of individual cells. An analytical method for monitoring Pi dynamics with spatial and temporal resolution is therefore needed to gain a comprehensive understanding of mechanisms governing the transport and recycling of this essential nutrient. Here we demonstrate the utility of a genetically encoded FRET-based Pi sensor to assess cellular Pi levels in the nematode Caenorhabditis elegans. The sensor was expressed in different cells and tissues of the animal, including head neurons, tail neurons, pharyngeal muscle, and the intestine. Cytosolic Pi concentrations were monitored using ratiometric imaging. Injection of phosphate buffer into intestinal cells confirmed that the sensor was responsive to changes in Pi concentration in vivo. Live Pi imaging revealed cell-specific and developmental stage-specific differences in cytosolic Pi concentrations. In addition, cellular Pi levels were perturbed by food deprivation and by exposure to the respiratory inhibitor cyanide. These results suggest that Pi concentration is a sensitive indicator of metabolic status. Moreover, we propose that live Pi imaging in C. elegans is a powerful approach to discern mechanisms that govern Pi distribution in individual cells and throughout an animal.	[Banerjee, Swayoma; Versaw, Wayne K.; Garcia, L. Rene] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Garcia, L. Rene] Howard Hughes Med Inst, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Howard Hughes Medical Institute	Garcia, LR (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rgarcia@mail.bio.tamu.edu			Howard Hughes Medical Institute; National Science Foundation [IOS-0956486]; NIH Office of Research Infrastructure Programs [P40 OD010440]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Howard Hughes Medical Institute (SB and LRG) and by the National Science Foundation (grant no. IOS-0956486 to WKV). We also thank the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), for providing strains. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; Anderson P, 1995, METHOD CELL BIOL, V48, P31; BABU P, 1981, MUTAT RES, V82, P269, DOI 10.1016/0027-5107(81)90156-1; BEH CT, 1991, DEV BIOL, V147, P133, DOI 10.1016/S0012-1606(05)80013-2; Berndt T, 2009, PHYSIOLOGY, V24, P17, DOI 10.1152/physiol.00034.2008; Biber J, 2013, ANNU REV PHYSIOL, V75, P535, DOI 10.1146/annurev-physiol-030212-183748; DECUYPER C, 1982, COMP BIOCHEM PHYS A, V73, P283, DOI 10.1016/0300-9629(82)90071-8; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Frommer WB, 2009, CHEM SOC REV, V38, P2833, DOI 10.1039/b907749a; Fukushige T, 2005, DEV BIOL, V279, P446, DOI 10.1016/j.ydbio.2004.12.012; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gu H, 2006, FEBS LETT, V580, P5885, DOI 10.1016/j.febslet.2006.09.048; HODGKIN J, 1979, GENETICS, V91, P67; Hum JM, 2012, INT J MOL SCI, V13, P14385, DOI 10.3390/ijms131114385; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kormish JD, 2005, DEV BIOL, V287, P35, DOI 10.1016/j.ydbio.2005.08.027; LeBoeuf B, 2007, PLOS GENETICS, V3; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Mukherjee P, 2015, PLANT PHYSIOL, V167, P628, DOI 10.1104/pp.114.254003; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Okumoto S, 2012, ANNU REV PLANT BIOL, V63, P663, DOI 10.1146/annurev-arplant-042110-103745; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Roszik J, 2009, CYTOM PART A, V75A, P761, DOI 10.1002/cyto.a.20747; SCHNABEL H, 1990, SCIENCE, V250, P686, DOI 10.1126/science.250.4981.686; SULSTON JE, 1974, GENETICS, V77, P95; Tadross MR, 2009, J MICROSC-OXFORD, V233, P192, DOI 10.1111/j.1365-2818.2008.03109.x; Van Heyningen W E, 1935, Biochem J, V29, P2036; Vanfleteren JR, 1996, J EXP ZOOL, V274, P93, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;93::AID-JEZ2&gt;3.0.CO;2-8; Vidal G, 1997, ARCH BIOCHEM BIOPHYS, V337, P317, DOI 10.1006/abbi.1996.9775; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Zaborin A, 2009, P NATL ACAD SCI USA, V106, P6327, DOI 10.1073/pnas.0813199106; Zakrzewska J, 2005, ANN NY ACAD SCI, V1048, P482, DOI 10.1196/annals.1342.073	44	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141128	10.1371/journal.pone.0141128	http://dx.doi.org/10.1371/journal.pone.0141128			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484766	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100115
J	Bouchon, C; Nazzi, T; Gervain, J				Bouchon, Camillia; Nazzi, Thierry; Gervain, Judit			Hemispheric Asymmetries in Repetition Enhancement and Suppression Effects in the Newborn Brain	PLOS ONE			English	Article							ACTIVATION; MECHANISMS; MEMORY; REPRESENTATION; RECOGNITION; SENSITIVITY; ACQUISITION; ADAPTATION; IMPLICIT; DESIGNS	Background The repeated presentation of stimuli typically attenuates neural responses (repetition suppression) or, less commonly, increases them (repetition enhancement) when stimuli are highly complex, degraded or presented under noisy conditions. In adult functional neuroimaging research, these repetition effects are considered as neural correlates of habituation. The development and respective functional significance of these effects in infancy remain largely unknown. Objective This study investigates repetition effects in newborns using functional near-infrared spectroscopy, and specifically the role of stimulus complexity in evoking a repetition enhancement vs. a repetition suppression response, following up on Gervain et al. (2008). In that study, abstract rule-learning was found at birth in cortical areas specific to speech processing, as evidenced by a left-lateralized repetition enhancement of the hemodynamic response to highly variable speech sequences conforming to a repetition-based ABB artificial grammar, but not to a random ABC grammar. Methods Here, the same paradigm was used to investigate how simpler stimuli (12 different sequences per condition as opposed to 140), and simpler presentation conditions (blocked rather than interleaved) would influence repetition effects at birth. Results Results revealed that the two grammars elicited different dynamics in the two hemispheres. In left fronto-temporal areas, we reproduce the early perceptual discrimination of the two grammars, with ABB giving rise to a greater response at the beginning of the experiment than ABC. In addition, the ABC grammar evoked a repetition enhancement effect over time, whereas a stable response was found for the ABB grammar. Right fronto-temporal areas showed neither initial discrimination, nor change over time to either pattern. Conclusion Taken together with Gervain et al. (2008), this is the first evidence that manipulating methodological factors influences the presence or absence of neural repetition enhancement effects in newborns and stimulus variability appears a particularly important factor. Further, this temporal modulation is restricted to the left hemisphere, confirming its specialization for learning linguistic regularities from birth.	[Bouchon, Camillia; Nazzi, Thierry; Gervain, Judit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bouchon, Camillia; Nazzi, Thierry; Gervain, Judit] CNRS, Lab Psychol Percept, UMR 8242, Paris, France; [Bouchon, Camillia] Univ Pompeu Fabra, Ctr Brain & Cognit, Barcelona, Spain	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Pompeu Fabra University; University of Barcelona	Bouchon, C (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	camillia.bouchon@upf.edu		Nazzi, Thierry/0000-0002-4378-3661; Gervain, Judit/0000-0002-2125-6369	Agence Nationale de la Recherche Project [ANR-10-JCJC-1901-02]; Programme 'Emergence(s)' of the City of Paris; HFSP Young Investigator Grant [RGY0073/2014]; Labex EFL [ANR-10-LABX-0083]	Agence Nationale de la Recherche Project(French National Research Agency (ANR)); Programme 'Emergence(s)' of the City of Paris; HFSP Young Investigator Grant; Labex EFL	This study was supported by the Agence Nationale de la Recherche Project nr. ANR-10-JCJC-1901-02, the Programme 'Emergence(s)' of the City of Paris, an HFSP Young Investigator Grant (nr. RGY0073/2014) to JG, as well as by the Labex EFL (ANR-10-LABX-0083) to CB, JG and TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2000, MED RAD DIA IMG, P369; Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; Baldeweg T, 2006, TRENDS COGN SCI, V10, P93, DOI 10.1016/j.tics.2006.01.010; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Benavides-Varela S, 2012, P NATL ACAD SCI USA, V109, P17908, DOI 10.1073/pnas.1205413109; Benavides-Varela S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027497; Benjamini Y, 2001, ANN STAT, V29, P1165; BIJELJACBABIC R, 1993, DEV PSYCHOL, V29, P711, DOI 10.1037/0012-1649.29.4.711; Bortfeld H, 2007, NEUROIMAGE, V34, P407, DOI 10.1016/j.neuroimage.2006.08.010; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; Chee MWL, 2003, HUM BRAIN MAPP, V18, P186, DOI 10.1002/hbm.10092; Cohen L, 2004, NEUROIMAGE, V23, P1256, DOI 10.1016/j.neuroimage.2004.07.052; Dehaene-Lambertz G, 2006, HUM BRAIN MAPP, V27, P360, DOI 10.1002/hbm.20250; Dehaene-Lambertz G, 2006, P NATL ACAD SCI USA, V103, P14240, DOI 10.1073/pnas.0606302103; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Dutoit T, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P1393, DOI 10.1109/ICSLP.1996.607874; Endress AD, 2007, COGNITION, V105, P247, DOI 10.1016/j.cognition.2006.09.010; Endress AD, 2009, TRENDS COGN SCI, V13, P348, DOI 10.1016/j.tics.2009.05.005; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gervain J, 2012, J COGNITIVE NEUROSCI, V24, P564, DOI 10.1162/jocn_a_00157; Gervain J, 2011, DEV COGN NEUROS-NETH, V1, P22, DOI 10.1016/j.dcn.2010.07.004; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Haenschel C, 2000, P NATL ACAD SCI USA, V97, P7645, DOI 10.1073/pnas.120162397; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Homae F, 2007, NEUROSCI RES, V59, P29, DOI 10.1016/j.neures.2007.05.005; James TW, 2006, HUM BRAIN MAPP, V27, P37, DOI 10.1002/hbm.20165; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kisilevsky BS, 2009, INFANT BEHAV DEV, V32, P59, DOI 10.1016/j.infbeh.2008.10.002; Kisilevsky BS, 2003, PSYCHOL SCI, V14, P220, DOI 10.1111/1467-9280.02435; Kourtzi Z, 2005, NEUROIMAGE, V28, P440, DOI 10.1016/j.neuroimage.2005.06.017; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; May P, 1999, J COMPUT NEUROSCI, V6, P99, DOI 10.1023/A:1008896417606; Meek J, 2002, DEVELOPMENTAL SCI, V5, P371, DOI 10.1111/1467-7687.00376; Meek JH, 1998, PEDIATR RES, V43, P840, DOI 10.1203/00006450-199806000-00019; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Minagawa-Kawai Y, 2011, DEV COGN NEUROS-NETH, V1, P217, DOI 10.1016/j.dcn.2011.03.005; Moon C, 2013, ACTA PAEDIATR, V102, P156, DOI 10.1111/apa.12098; Naatanen R, 2002, NEUROSCI LETT, V318, P49, DOI 10.1016/S0304-3940(01)02438-7; Naatanen R., 1984, HUMAN ACTION PERSONA, V54, P29; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nakano T, 2009, CEREB CORTEX, V19, P455, DOI 10.1093/cercor/bhn096; Nazzi T, 1998, J EXP PSYCHOL HUMAN, V24, P756, DOI 10.1037/0096-1523.24.3.756; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Obrig Hellmuth, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00013; Okada E, 1995, PHYS MED BIOL, V40, P2093, DOI 10.1088/0031-9155/40/12/007; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Quaresima V, 2012, BRAIN LANG, V121, P79, DOI 10.1016/j.bandl.2011.03.009; Segaert K, 2013, NEUROPSYCHOLOGIA, V51, P59, DOI 10.1016/j.neuropsychologia.2012.11.006; Shi RS, 1999, COGNITION, V72, pB11, DOI 10.1016/S0010-0277(99)00047-5; Southgate V, 2014, NEUROIMAGE, V85, P294, DOI 10.1016/j.neuroimage.2013.08.043; Turk-Browne NB, 2007, CEREB CORTEX, V17, P425, DOI 10.1093/cercor/bhj159; Turk-Browne NB, 2006, NEURON, V49, P917, DOI 10.1016/j.neuron.2006.01.030; Turk-Browne NB, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.016.2008; Vuilleumier P, 2005, J COGNITIVE NEUROSCI, V17, P1245, DOI 10.1162/0898929055002409; Wagner JB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00168; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	64	22	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140160	10.1371/journal.pone.0140160	http://dx.doi.org/10.1371/journal.pone.0140160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7XI	26485434	gold, Green Submitted, Green Published			2022-12-27	WOS:000363028100021
J	Fang, H; Ren, D; Wang, YJ				Fang, Hui; Ren, Dong; Wang, Yongjie			Familial Clarification of Saucrosmylidae stat. nov and New Saucrosmylids from Daohugou, China (Insecta, Neuroptera)	PLOS ONE			English	Article							MIDDLE JURASSIC AGE; INNER-MONGOLIA; NORTHEASTERN CHINA; GENUS; BED; IGNIMBRITE; OSMYLIDAE; NINGCHENG	Backgound Saucrosmylids are characterized by the typically large body size, complicated venation and diverse wing markings, which were only discovered in Middle Jurassic of Daohugou, Ningcheng county, Inner Mongolia, China. Principal Findings Saucrosmylinae Ren, 2003, originally included as a subfamily in the Osmylidae, was transferred and elevated to family rank based on the definitive synapomorphic character. The updated definition of Saucrosmylidae stat. nov. was outlined in detail: presence of nygma and trichosors; diverse markings on membrane; complicated cross-veins; distal fusion of Sc and R1; expanded space between R1 and Rs having 2-7 rows of cells that should be a synapomorphic character of the family; proximal MP fork. And the previous misuses of Saucrosmylidae are also clarified. Furthermore, a new genus with a new species and an indeterminate species of Saucrosmylidae are described as Ulrikezza aspoeckae gen. et sp. nov. and Ulrikezza sp. from the Middle Jurassic of Daohugou, Inner Mongolia, China. A key to genera of Saucrosmylidae is provided. Conclusions/Significance The intriguing group represents a particular lineage of Neuroptera in the Mesozoic Era. The familial status of Saucrosmylidae was firstly advanced that clarified the former incorrect citation and use of the family name. As an extinct clade, many species of the saucrosmylids were erected just based on a single fore-or hindwing, and it should be realized that providing more stable characters is necessary when describing new lacewing taxa just based on an isolated hindwing. It is vital for the systematics of Saucrosmylidae.	[Fang, Hui; Ren, Dong; Wang, Yongjie] Capital Normal Univ, Coll Life Sci, Key Lab Insect Evolut & Environm Change, Beijing, Peoples R China	Capital Normal University	Wang, YJ (corresponding author), Capital Normal Univ, Coll Life Sci, Key Lab Insect Evolut & Environm Change, Beijing, Peoples R China.	wangyjosmy@gmail.com	Wang, Yongjie/H-3328-2019		National Basic Research Program of China (973 Program) [2012CB821906]; National Science Foundation of China [31230065, 31301905, 41372013, 41272006]; China Postdoctoral Science Foundation [2012T50113]; Research Fund for the Doctoral Program of Higher Education of China [20131108120005]; Beijing Natural Science Foundation [5132008]; Great Wall Scholar and KEY project of the Beijing Municipal Commission of Education [KZ201310028033]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13081]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Great Wall Scholar and KEY project of the Beijing Municipal Commission of Education; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research is supported by the National Basic Research Program of China (973 Program) (2012CB821906), National Science Foundation of China (31230065, 31301905), National Science Foundation of China (41372013, 41272006), China Postdoctoral Science Foundation (2012T50113), Research Fund for the Doctoral Program of Higher Education of China (20131108120005), Beijing Natural Science Foundation (5132008), Great Wall Scholar and KEY project of the Beijing Municipal Commission of Education (KZ201310028033), Program for Changjiang Scholars and Innovative Research Team in University (IRT13081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[陈文 Chen Wen], 2004, [地质通报, Geological Bulletin of China], V23, P1165; Grimaldi David, 2005, pi; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020792; He HY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022787; LAMBKIN K J, 1988, Memoirs of the Queensland Museum, V25, P445; Liu Q, 2014, ALCHERINGA, V38, P301, DOI 10.1080/03115518.2014.886849; Liu Q, 2013, ZOOTAXA, V 3736, P387, DOI 10.11646/zootaxa.3736.4.6; [柳永清 Liu Yanxue], 2004, [地质通报, Geological Bulletin of China], V23, P1180; Liu YQ, 2006, CHINESE SCI BULL, V51, P2634, DOI 10.1007/s11434-006-2165-2; MAKARKIN VN, 1990, DEUT ENTOMOL Z, V37, P101; NEW TR, 1983, AUST J ZOOL, V31, P393, DOI 10.1071/ZO9830393; Ponomarenko AG, 2010, ANN ZOOL, V60, P169, DOI 10.3161/000345410X516812; Rasnitsyn AP, 2004, PALAEONTOLOGY, V47, P1507, DOI 10.1111/j.0031-0239.2004.00416.x; Ren D, 2003, J NEW YORK ENTOMOL S, V111, P1, DOI 10.1664/0028-7199(2003)111[0001:NOFNFT]2.0.CO;2; Ren D., 2010, SILENT STORIES INSEC; Ren D, 2008, J KANSAS ENTOMOL SOC, V81, P161, DOI 10.2317/JKES-0804.15.1; [任东 Ren Dong], 2002, [地质通报, Geological Bulletin of China], V21, P584; Ren Dong, 2002, Entomologia Sinica, V9, P53; Shen Yan-bin, 2003, Journal of Stratigraphy, V27, P311; Wang XL, 2005, CHINESE SCI BULL, V50, P2369, DOI 10.1360/982005-581; Wang YJ, 2010, THESIS CHINESE AGR U; Wang YJ, 2010, P NATL ACAD SCI USA, V107, P16212, DOI 10.1073/pnas.1006460107; Yang Q, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-126; Yang Q, 2013, PALAEONTOLOGY, V56, P49, DOI 10.1111/j.1475-4983.2012.01157.x; Yang Q, 2012, SCI WORLD J, DOI 10.1100/2012/862021; Yang W., 2004, S NAT PETR CONT GEOD	26	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141048	10.1371/journal.pone.0141048	http://dx.doi.org/10.1371/journal.pone.0141048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485027	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100106
J	Lu, QB; Feng, XM; Tong, N; Sun, HJ; Ding, L; Wang, YJ; Wang, X; Zhou, YB				Lu, Qing-Bo; Feng, Xue-Mei; Tong, Ning; Sun, Hai-Jian; Ding, Lei; Wang, Yu-Jiao; Wang, Xuan; Zhou, Ye-Bo			Neuronal and Endothelial Nitric Oxide Synthases in the Paraventricular Nucleus Modulate Sympathetic Overdrive in Insulin-Resistant Rats	PLOS ONE			English	Article							AFFERENT REFLEX; NERVOUS-SYSTEM; BLOOD-PRESSURE; ACTIVATION; HYPERTENSION; TETRAHYDROBIOPTERIN; HYPERINSULINEMIA; CONTRIBUTE; RECEPTORS; ESTROGEN	A central mechanism participates in sympathetic overdrive during insulin resistance (IR). Nitric oxide synthase (NOS) and nitric oxide (NO) modulate sympathetic nerve activity (SNA) in the paraventricular nucleus (PVN), which influences the autonomic regulation of cardiovascular responses. The aim of this study was to explore whether the NO system in the PVN is involved in the modulation of SNA in fructose-induced IR rats. Control rats received ordinary drinking water, whereas IR rats received 12.5% fructose-containing drinking water for 12 wks to induce IR. Basal SNA was assessed based on the changes in renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) in response to chemicals administered to the PVN. We found an increased plasma norepinephrine level but significantly reduced NO content and neuronal NOS (nNOS) and endothelial NOS (eNOS) protein expression levels in the PVN of IR rats compared to Control rats. No difference in inducible NOS (iNOS) protein expression was observed between the two groups. In anesthetized rats, the microinjection of sodium nitroprusside (SNP), an NO donor, or N omega-nitro-L-arginine methyl ester (L-NAME), a non-selective inhibitor of NOS, into the PVN significantly decreased and increased basal SNA, respectively, in both normal and IR rats, but these responses to SNP and L-NAME in IR rats were smaller than those in normal rats. The administration of selective inhibitors of nNOS or eNOS, but not iNOS, to the PVN significantly increased basal SNA in both groups, but these responses were also smaller in IR rats. Moreover, IR rats exhibited reduced nNOS and eNOS activity in the PVN. In conclusion, these data indicate that the decreased protein expression and activity levels of nNOS and eNOS in the PVN lead to a reduction in the NO content in the PVN, thereby contributing to a subsequent enhancement in sympathoexcitation during IR.	[Lu, Qing-Bo; Sun, Hai-Jian; Ding, Lei; Zhou, Ye-Bo] Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing 210029, Jiangsu, Peoples R China; [Feng, Xue-Mei] Luyi Peoples Hosp, Clin Lab, Zhoukou 466000, Peoples R China; [Tong, Ning] Heze Municipal Hosp, Dept Neurol, Heze 274000, Peoples R China; [Wang, Yu-Jiao; Wang, Xuan] Nanjing Med Univ, Clin Med Coll 4, Dept Pediat, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhou, YB (corresponding author), Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing 210029, Jiangsu, Peoples R China.	zhouyebo666@njmu.edu.cn		Zhou, Yebo/0000-0001-9465-1338	National Natural Science Foundation of China [81470539, 81000106]; National Natural Science Foundation of the Education Department of Jiangsu Province of China [BK20141434]; College Students' Innovative and Entrepreneurial Training Project of Jiangsu Province [201410312006Z]; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of the Education Department of Jiangsu Province of China; College Students' Innovative and Entrepreneurial Training Project of Jiangsu Province; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine	This work was supported by the funds from the National Natural Science Foundation of China [grant no. 81470539: http://isisn.nsfc.gov.cn/egrantweb/proposal/projectInfo/pubPrjList (Y-bZ) and 81000106: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list (Y-bZ)], the National Natural Science Foundation of the Education Department of Jiangsu Province of China [grant no. BK20141434: [This grant had no online announcements, and relevant documents have been laid in the other section of attach files (Page 82, Line 12) as further proof) (Y-bZ)] and the College Students' Innovative and Entrepreneurial Training Project of Jiangsu Province [grant no. 201410312006Z: http://www.ec.js.edu.cn/art/2014/6/18/art_4266_151258.html (Y-bZ)]. The authors gratefully acknowledge the generous support of the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerena J, 1995, Hypertens Res, V18, P99, DOI 10.1291/hypres.18.99; ANDERSON EA, 1991, J CLIN INVEST, V87, P2246, DOI 10.1172/JCI115260; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busnardo C, 2013, EXP PHYSIOL, V98, P1411, DOI 10.1113/expphysiol.2013.073619; Catena C, 2003, AM J HYPERTENS, V16, P973, DOI 10.1016/S0895-7061(03)01002-1; Coote JH, 1998, CLIN EXP PHARMACOL P, V25, P461, DOI 10.1111/j.1440-1681.1998.tb02235.x; Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; Cozzolino D, 2014, J CLIN ENDOCR METAB, V99, P3199, DOI 10.1210/jc.2013-4211; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Ding L, 2015, ACTA PHYSL OXF; Dong H, 2014, J INVASIVE CARDIOL, V26, P322; Gingerich S, 2006, HYPERTENSION, V48, P1130, DOI 10.1161/01.HYP.0000248754.67128.ff; Grassi G, 1998, J HYPERTENS, V16, P1979, DOI 10.1097/00004872-199816121-00019; Grassi G, 2006, HYPERTENS RES, V29, P839, DOI 10.1291/hypres.29.839; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 2004, ENDOCRIN METAB CLIN, V33, P267, DOI 10.1016/j.ecl.2004.03.001; Huang BS, 2014, J PHYSIOL-LONDON, V592, P3273, DOI 10.1113/jphysiol.2014.276584; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; IYER SN, 1994, LIFE SCI, V55, pPL139, DOI 10.1016/0024-3205(94)00750-0; Iyngkaran P, 2013, DIABETES METAB, V39, P290, DOI 10.1016/j.diabet.2013.05.002; Julius S, 2000, HYPERTENSION, V35, P807, DOI 10.1161/01.HYP.35.3.807; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Krukoff TL, 1998, CLIN EXP PHARMACOL P, V25, P474, DOI 10.1111/j.1440-1681.1998.tb02238.x; Landsberg L, 1996, Hypertens Res, V19 Suppl 1, pS51, DOI 10.1291/hypres.19.SupplementI_S51; Martins-Pinge MC, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00490; Patel KP, 2001, EXP BIOL MED, V226, P814, DOI 10.1177/153537020122600902; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Riethmuller C, 1999, J BIOL CHEM, V274, P16047, DOI 10.1074/jbc.274.23.16047; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Sharma NM, 2013, AM J PHYSIOL-HEART C, V305, pH843, DOI 10.1152/ajpheart.00170.2013; Sharma NM, 2011, CARDIOVASC RES, V92, P348, DOI 10.1093/cvr/cvr217; Straznicky NE, 2014, J CLIN ENDOCR METAB, V99, pE1701, DOI 10.1210/jc.2014-1976; Sun HJ, 2014, ACTA PHYSIOL, V212, P267, DOI 10.1111/apha.12405; Takahashi T, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/590541; Tashiro Y, 2015, CLIN EXP NEPHROL, V19, P343, DOI 10.1007/s10157-014-0998-6; TOGASHI H, 1992, J PHARMACOL EXP THER, V262, P343; Xiong XQ, 2012, HYPERTENSION, V60, P1280, DOI 10.1161/HYPERTENSIONAHA.112.198002; Xue BJ, 2009, AM J PHYSIOL-HEART C, V297, pH1638, DOI 10.1152/ajpheart.00502.2009; Yamaguchi N, 2010, NEUROSCIENCE, V170, P773, DOI 10.1016/j.neuroscience.2010.07.051; Yamaguchi N, 2009, AUTON NEUROSCI-BASIC, V148, P83, DOI 10.1016/j.autneu.2009.02.009; Yang WW, 2000, NEUROPHARMACOLOGY, V39, P2075, DOI 10.1016/S0028-3908(00)00054-X; Zhang F, 2014, ACTA PHYSIOL, V212, P17, DOI 10.1111/apha.12342; Zhang K, 1997, AM J PHYSIOL-REG I, V273, pR864, DOI 10.1152/ajpregu.1997.273.3.R864; Zhang L, 2012, J APPL PHYSIOL, V113, P47, DOI 10.1152/japplphysiol.01228.2011; Zheng H, 2006, AM J PHYSIOL-REG I, V290, pR992, DOI 10.1152/ajpregu.00363.2005; Zheng H, 2011, AM J PHYSIOL-HEART C, V301, pH2402, DOI 10.1152/ajpheart.00330.2011; Zheng H, 2011, HYPERTENSION, V58, P966, DOI 10.1161/HYPERTENSIONAHA.111.176222; Zhou YB, 2014, HYPERTENSION, V63, P330, DOI 10.1161/HYPERTENSIONAHA.113.01681	48	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140762	10.1371/journal.pone.0140762	http://dx.doi.org/10.1371/journal.pone.0140762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485682	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100067
J	Niculescu, LS; Simionescu, N; Sanda, GM; Carnuta, MG; Stancu, CS; Popescu, AC; Popescu, MR; Vlad, A; Dimulescu, DR; Simionescu, M; Sima, AV				Niculescu, Loredan S.; Simionescu, Natalia; Sanda, Gabriela M.; Carnuta, Mihaela G.; Stancu, Camelia S.; Popescu, Andreea C.; Popescu, Mihaela R.; Vlad, Adelina; Dimulescu, Doina R.; Simionescu, Maya; Sima, Anca V.			MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; MICRORNAS; BIOMARKERS; ATHEROSCLEROSIS; CELLS; METABOLISM; EXPRESSION; PLASMA	Small non-coding microRNAs (miRNAs) are implicated in gene regulation, including those involved in coronary artery disease (CAD). Our aim was to identify whether specific serum miRNAs present in the circulating lipoproteins (Lp) are associated with stable or vulnerable CAD patients. A cardiovascular disease-focused screening array was used to assess miRNAs distribution in sera collected from 95 CAD patients: 30 with stable angina (SA), 39 with unstable angina (UA), 26 at one month after myocardial infarction (MI) and 16 healthy control subjects. We found that miR-486, miR-92a and miR-122 presented the highest expression in CAD sera. These miRNA together with miR-125a, miR-146a and miR-33a were further individually analyzed by TaqMan assays. The results were consistent with PCR-array screening data that all of these miRNAs were significantly increased in CAD patients compared to controls. Using a binary logistic regression model, we established that miR-486 and miR-92a in association with some high-density lipoprotein (HDL) components can designate vulnerable CAD patients. Further, all classes of Lp were isolated from sera by density gradient ultracentrifugation. Analysis of the selected miRNAs in each Lp class showed that they were associated mainly with HDL, miR-486 and miR-92a having the highest levels. In UA and MI patients, miR-486 prevailed in HDL2, while miR-92a prevailed in HDL3, and their levels discriminate between stable and vulnerable CAD patients. We identified two circulating miRNAs that in association with some lipid metabolism biomarkers can be used as an additional tool to designate vulnerable CAD patients.	[Niculescu, Loredan S.; Simionescu, Natalia; Sanda, Gabriela M.; Carnuta, Mihaela G.; Stancu, Camelia S.; Simionescu, Maya; Sima, Anca V.] Romanian Acad, Inst Cellular Biol & Pathol Nicolae Simionescu, Lipid Dept, Bucharest, Romania; [Simionescu, Natalia] Petru Poni Inst Macromol Chem, Ctr Adv Res Bionanoconjugates & Biopolymers, Iasi, Romania; [Popescu, Andreea C.; Popescu, Mihaela R.; Vlad, Adelina; Dimulescu, Doina R.] Elias Univ Emergency Hosp, Cardiol Clin, Bucharest, Romania	Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology; Romanian Academy of Sciences; Petru Poni Institute of Macromolecular Chemistry	Sima, AV (corresponding author), Romanian Acad, Inst Cellular Biol & Pathol Nicolae Simionescu, Lipid Dept, Bucharest, Romania.	anca.sima@icbp.ro	Popescu, Mihaela Roxana/AAD-6433-2019; Sima, Anca Volumnia/C-3904-2011; Turtoi, Mihaela/AAP-2061-2021; Sanda, Gabriela Maria/C-2561-2011; Simionescu, Natalia/N-6574-2015; Stancu, Camelia Sorina/C-3882-2011; Niculescu, Loredan Stefan/F-2591-2010; Simionescu, Maya/C-4794-2011; Vlad, Adelina/C-6288-2012	Popescu, Mihaela Roxana/0000-0002-4539-5259; Turtoi, Mihaela/0000-0001-6418-3406; Simionescu, Natalia/0000-0001-5581-4624; Niculescu, Loredan Stefan/0000-0002-1394-9085; Simionescu, Maya/0000-0003-2077-0400; Sima, Anca V./0000-0003-1932-8965; Sanda, Gabriela Maria/0000-0001-5368-4264; Stancu, Camelia Sorina/0000-0002-2988-9961; Vlad, Adelina/0000-0002-2282-6802	Romanian Academy; Romanian Ministry of National Education [PN-II-PT-PCCA-2011-3.1-0184, PCCA-127/2012]; European Social Fund [POSDRU/159/1.5/S/133391]	Romanian Academy(Romanian Academy of Sciences); Romanian Ministry of National Education(Ministry of Education and Research - Romania); European Social Fund(European Social Fund (ESF))	This work was supported by the Romanian Academy, the Romanian Ministry of National Education PN-II-PT-PCCA-2011-3.1-0184 project (grant number PCCA-127/2012, http://uefiscdi.gov.ro), and cofinanced (GMS) by the European Social Fund through Sectorial Operational Program Human Resources Development 2007-2013 (project number POSDRU/159/1.5/S/133391, http://biounibuc.wix.com/unibuc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bidzhekov K, 2012, THROMB HAEMOSTASIS, V107, P619, DOI 10.1160/TH11-09-0607; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Guo M, 2010, IMMUNOL CELL BIOL, V88, P555, DOI 10.1038/icb.2010.16; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Haraguchi Y, 2014, ATHEROSCLEROSIS, V234, P288, DOI 10.1016/j.atherosclerosis.2014.03.009; Jaguszewski M, 2014, EUR HEART J, V35, P999, DOI 10.1093/eurheartj/eht392; Kaudewitz D, 2013, THROMB HAEMOSTASIS, V110, P609, DOI 10.1160/TH13-05-0368; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kypreos KE, 2005, J BIOL CHEM, V280, P6276, DOI 10.1074/jbc.M413458200; Lai CTM, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-73; Loyer X, 2014, CIRC RES, V114, P434, DOI 10.1161/CIRCRESAHA.114.302213; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Madrigal-Matute J, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0322-z; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Oerlemans MIFJ, 2012, EMBO MOL MED, V4, P1176, DOI 10.1002/emmm.201201749; Ono K, 2015, INT HEART J, V56, P365, DOI 10.1536/ihj.15-019; Ono K, 2011, FEBS J, V278, P1619, DOI 10.1111/j.1742-4658.2011.08090.x; Rayner KJ, 2014, CIRC RES, V114, P183, DOI 10.1161/CIRCRESAHA.114.300645; Rayner KJ, 2012, THROMB HAEMOSTASIS, V107, P642, DOI 10.1160/TH11-10-0694; Ren JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080738; Rozenberg O, 2005, ATHEROSCLEROSIS, V181, P9, DOI 10.1016/j.atherosclerosis.2004.12.030; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sima AV, 2010, J CELL MOL MED, V14, P2790, DOI 10.1111/j.1582-4934.2009.00933.x; Simionescu N, 2014, MOL BIOL REP, V41, P5765, DOI 10.1007/s11033-014-3449-2; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; van Empel VPM, 2012, CURR HYPERTENS REP, V14, P498, DOI 10.1007/s11906-012-0310-7; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wagner J, 2013, ARTERIOSCL THROM VAS, V33, P1392, DOI 10.1161/ATVBAHA.112.300741; Zampetaki A, 2012, THROMB HAEMOSTASIS, V108, P592, DOI 10.1160/TH12-02-0097; Zampetaki A, 2012, CARDIOVASC RES, V93, P555, DOI 10.1093/cvr/cvr266	37	104	108	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140958	10.1371/journal.pone.0140958	http://dx.doi.org/10.1371/journal.pone.0140958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485305	Green Submitted, gold, Green Published			2022-12-27	WOS:000363028100097
J	Reglinski, K; Keil, M; Altendorf, S; Waithe, D; Eggeling, C; Schliebs, W; Erdmann, R				Reglinski, Katharina; Keil, Marina; Altendorf, Sabrina; Waithe, Dominic; Eggeling, Christian; Schliebs, Wolfgang; Erdmann, Ralf			Peroxisomal Import Reduces the Proapoptotic Activity of Deubiquitinating Enzyme USP2	PLOS ONE			English	Article							MATRIX PROTEIN-DEGRADATION; RECEPTOR PEX5P; CELL-DEATH; UBIQUITIN; PTS1; IDENTIFICATION; RECOGNITION; EXPRESSION; CANCER; SIGNAL	The human deubiquitinating enzyme ubiquitin-specific protease 2 (USP2) regulates multiple cellular pathways, including cell proliferation and apoptosis. As a result of alternative splicing four USP2 isoenzymes are expressed in human cells of which all contain a weak peroxisome targeting signal of type 1 (PTS1) at their C-termini. Here, we systematically analyzed apoptotic effects induced by overexpression and intracellular localization for each isoform. All isoforms exhibit proapoptotic activity and are post-translationally imported into the matrix of peroxisomes in a PEX5-dependent manner. However, a significant fraction of the USP2 pool resides in the cytosol due to a weaker PTS1 and thus low affinity to the PTS receptor PEX5. Blocking of peroxisomal import did not interfere with the proapoptotic activity of USP2, suggesting that the enzyme performs its critical function outside of this compartment. Instead, increase of the efficiency of USP2 import into peroxisomes either by optimization of its peroxisomal targeting signal or by overexpression of the PTS1 receptor did result in a reduction of the apoptotic rate of transfected cells. Our studies suggest that peroxisomal import of USP2 provides additional control over the proapoptotic activity of cytosolic USP2 by spatial separation of the deubiquitinating enzymes from their interaction partners in the cytosol and nucleus.	[Reglinski, Katharina; Keil, Marina; Altendorf, Sabrina; Schliebs, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Abt Syst Biochem, D-44780 Bochum, Germany; [Waithe, Dominic; Eggeling, Christian] Univ Oxford, Weatherall Inst Mol Med, Wolfson Imaging Ctr, Oxford OX3 9DS, England	Ruhr University Bochum; University of Oxford	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Abt Syst Biochem, D-44780 Bochum, Germany.	ralf.erdmann@rub.de		Waithe, Dominic/0000-0003-2685-4226; Schliebs, Wolfgang/0000-0003-2762-3403; Reglinski, Katharina/0000-0001-8994-067X	Studienstiftung des Deutschen Volkes; Deutsche Forschungsgemeinschaft [1905]; MRC [MC_UU_12010/9, MR/K01577X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L00433X/1] Funding Source: researchfish; Medical Research Council [MC_UU_12010/9, MR/K01577X/1] Funding Source: researchfish	Studienstiftung des Deutschen Volkes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	KR was supported by a fellowship from the Studienstiftung des Deutschen Volkes. This work was supported by the Deutsche Forschungsgemeinschaft (Research Unit 1905 (PerTrans), grants to RE and CE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Bellu AR, 2002, J BIOL CHEM, V277, P42875, DOI 10.1074/jbc.M205437200; Benassi B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.289; Benassi B, 2012, CANCER DISCOV, V2, P236, DOI 10.1158/2159-8290.CD-11-0219; Bharti P, 2011, J CELL SCI, V124, P1759, DOI 10.1242/jcs.079368; Bhattacharya S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/435197; Burkhart SE, 2013, GENETICS, V193, P125, DOI 10.1534/genetics.112.146100; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; ECKER DJ, 1987, J BIOL CHEM, V262, P3524; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Fodor K, 2015, TRAFFIC, V16, P85, DOI 10.1111/tra.12238; Fodor K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001309; Gewies A, 2003, CANCER RES, V63, P682; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Grou CP, 2012, J BIOL CHEM, V287, P12815, DOI 10.1074/jbc.M112.340158; He X, 2013, J MOL CELL BIOL, V5, P39, DOI 10.1093/jmcb/mjs024; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; IMANAKA T, 1987, J CELL BIOL, V105, P2915, DOI 10.1083/jcb.105.6.2915; Jung S, 2010, J BIOL CHEM, V285, P6739, DOI 10.1074/jbc.M109.058552; Kataya ARA, 2015, J PLANT PHYSIOL, V179, P12, DOI 10.1016/j.jplph.2015.03.002; Kataya ARA, 2010, PLANT SIGNAL BEHAV, V5, P171, DOI 10.4161/psb.5.2.10527; Kim J, 2012, CELL CYCLE, V11, P1123, DOI 10.4161/cc.11.6.19550; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Lingard MJ, 2009, P NATL ACAD SCI USA, V106, P4561, DOI 10.1073/pnas.0811329106; Liu Z, 2013, ONCOGENE, V32, P1660, DOI 10.1038/onc.2012.188; Luo B, 2008, J MOL BIOL, V380, P31, DOI 10.1016/j.jmb.2008.04.064; Mahul-Mellier AL, 2012, CELL DEATH DIFFER, V19, P891, DOI 10.1038/cdd.2011.185; Mahul-Mellier AL, 2012, BIOCHIM BIOPHYS ACTA, V1823, P1323; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Molusky MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047970; Neuhaus A, 2014, J BIOL CHEM, V289, P437, DOI 10.1074/jbc.M113.499707; Oh KH, 2011, CELL DEATH DIFFER, V18, P1326, DOI 10.1038/cdd.2011.3; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Otera H, 2012, TRAFFIC, V13, P1364, DOI 10.1111/j.1600-0854.2012.01391.x; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Schluter A, 2010, NUCLEIC ACIDS RES, V38, pD800, DOI 10.1093/nar/gkp935; Selvendiran K, 2010, MOL CANCER RES, V8, P1188, DOI 10.1158/1541-7786.MCR-10-0201; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shi Y, 2011, J BIOL CHEM, V286, P38960, DOI 10.1074/jbc.M111.231498; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Terlecky SR, 2001, EXP CELL RES, V263, P98, DOI 10.1006/excr.2000.5111; WALTON PA, 1994, J CELL BIOL, V125, P1037, DOI 10.1083/jcb.125.5.1037; WENDLAND M, 1993, J CELL BIOL, V120, P675, DOI 10.1083/jcb.120.3.675; Will GK, 1999, MOL CELL BIOL, V19, P2265; Williams C, 2013, BIOCHEM BIOPH RES CO, V438, P395, DOI 10.1016/j.bbrc.2013.07.086; Williams C, 2012, BBA-MOL CELL RES, V1823, P1133, DOI 10.1016/j.bbamcr.2012.04.006; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	55	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140685	10.1371/journal.pone.0140685	http://dx.doi.org/10.1371/journal.pone.0140685			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484888	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100061
J	Bui, TV; Blizzard, CL; Luong, KN; Truong, NLV; Tran, BQ; Otahal, P; Srikanth, V; Nelson, MR; Au, TB; Ha, ST; Phung, HN; Tran, MH; Callisaya, M; Gall, S				Tan Van Bui; Blizzard, Christopher Leigh; Khue Ngoc Luong; Ngoc Le Van Truong; Bao Quoc Tran; Otahal, Petr; Srikanth, Velandai; Nelson, Mark Raymond; Thuy Bich Au; Son Thai Ha; Hai Ngoc Phung; Mai Hoang Tran; Callisaya, Michele; Gall, Seana			Physical Activity in Vietnam: Estimates and Measurement Issues	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; FOOD-CONSUMPTION; RISK-FACTORS; INACTIVITY; PATTERNS; HEALTH; RELIABILITY; PREVALENCE; WORLDWIDE; VALIDITY	Introduction Our aims were to provide the first national estimates of physical activity (PA) for Vietnam, and to investigate issues affecting their accuracy. Methods Measurements were made using the Global Physical Activity Questionnaire (GPAQ) on a nationally-representative sample of 14706 participants (46.5% males, response 64.1%) aged 25-64 years selected by multi-stage stratified cluster sampling. Results Approximately 20% of Vietnamese people had no measureable PA during a typical week, but 72.9%(men) and 69.1% (women) met WHO recommendations for PA by adults for their age. On average, 52.0 (men) and 28.0 (women) Metabolic Equivalent Task (MET)-hours/week (largely from work activities) were reported. Work and total PA were higher in rural areas and varied by season. Less than 2% of respondents provided incomplete information, but an additional one-in-six provided unrealistically high values of PA. Those responsible for reporting errors included persons from rural areas and all those with unstable work patterns. Box-Cox transformation (with an appropriate constant added) was the most successful method of reducing the influence of large values, but energy-scaled values were most strongly associated with pathophysiological outcomes. Conclusions Around seven-in-ten Vietnamese people aged 25-64 years met WHO recommendations for total PA, which was mainly from work activities and higher in rural areas. Nearly all respondents were able to report their activity using the GPAQ, but with some exaggerated values and seasonal variation in reporting. Data transformation provided plausible summary values, but energy-scaling fared best in association analyses.	[Tan Van Bui; Blizzard, Christopher Leigh; Otahal, Petr; Srikanth, Velandai; Nelson, Mark Raymond; Thuy Bich Au; Hai Ngoc Phung; Mai Hoang Tran; Callisaya, Michele; Gall, Seana] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Tan Van Bui] Can Tho Univ Med & Pharm, Can Tho, Vietnam; [Khue Ngoc Luong; Ngoc Le Van Truong; Bao Quoc Tran; Son Thai Ha] Minist Hlth Socialist Republ Vietnam, Med Serv Adm, Hanoi, Vietnam; [Srikanth, Velandai; Callisaya, Michele] Monash Univ, Southern Clin Sch, Dept Med, Monash Med Ctr, Melbourne, Vic 3004, Australia	University of Tasmania; Menzies Institute for Medical Research; Can Tho University of Medicine & Pharmacy (CTUMP); Monash University	Blizzard, CL (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	Leigh.Blizzard@utas.edu.au	Callisaya, Michele/I-2333-2013; Gall, Seana/B-6585-2013; Bui, Tan/G-4138-2014	Callisaya, Michele/0000-0003-2122-1622; Gall, Seana/0000-0002-5138-2526; Srikanth, Velandai/0000-0002-8442-8981; Bui, Tan/0000-0001-6357-7307; Otahal, Petr/0000-0003-4042-1769; Phung, Hai/0000-0003-1533-8074	Atlantic Philanthropies Inc., USA [G0015338]; Tasmania Graduate Research Scholarship; National Health and Medical Research Council [1034482, 1061457]; National Heart Foundation of Australia [100089, PH11H6047]	Atlantic Philanthropies Inc., USA; Tasmania Graduate Research Scholarship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was supported by funding from the Atlantic Philanthropies Inc., USA (grant number G0015338). TVB was supported by a Tasmania Graduate Research Scholarship. CLB (1034482) and VS (1061457) were supported by fellowships awarded by the National Health and Medical Research Council. VS (100089) and SG (PH11H6047) were supported by fellowships awarded by the National Heart Foundation of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2006, MED SCI SPORT EXER, V38, P1584, DOI 10.1249/01.mss.0000229457.73333.9a; [Anonymous], 2008, GLOB PHYS ACT QUEST; Thuy AB, 2012, ASIA-PAC J PUBLIC HE, V24, P308, DOI 10.1177/1010539510379394; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Du HD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-826; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Guthold R, 2011, AM J PREV MED, V41, P52, DOI 10.1016/j.amepre.2011.03.008; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; International Physical Activity Questionnaire, 2005, INT PHYS ACT QUEST; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Monda KL, 2007, SOC SCI MED, V64, P858, DOI 10.1016/j.socscimed.2006.10.019; Ng N, 2009, GLOBAL HEALTH ACTION, V2, P44, DOI 10.3402/gha.v2i0.1985; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Nguyen PH, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-126; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pham LH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-291; Sebastiao E, 2012, PUBLIC HEALTH, V126, P967, DOI 10.1016/j.puhe.2012.07.004; Bui TV, 2015, NICOTINE TOB RES, V17, P831, DOI 10.1093/ntr/ntu202; Thang NM, 2004, EUR J CLIN NUTR, V58, P145, DOI 10.1038/sj.ejcn.1601761; Thuy AB, 2010, J PHYS ACT HEALTH, V7, P410, DOI 10.1123/jpah.7.3.410; Trinh OTH, 2009, J PHYS ACT HEALTH, V6, pS46, DOI 10.1123/jpah.6.s1.s46; Trinh OTH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-204; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization, 2008, WHO STEPS SURV MAN W	28	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140941	10.1371/journal.pone.0140941	http://dx.doi.org/10.1371/journal.pone.0140941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485044	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100095
J	Xu, C; Tang, PJ; Ding, C; Li, C; Chen, J; Xu, ZL; Mao, Y; Wu, MY; Zhao, J				Xu, Chun; Tang, Peijun; Ding, Cheng; Li, Chang; Chen, Jun; Xu, Zhenlei; Mao, Yi; Wu, Meiying; Zhao, Jun			Vitamin D Receptor Gene FOKI Polymorphism Contributes to Increasing the Risk of HIV-Negative Tuberculosis: Evidence from a Meta-Analysis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SUSCEPTIBILITY; ASSOCIATION; VARIANTS; INFECTION; VDR	Background Vitamin D receptor (VDR) gene FokI polymorphism have been studied in relation to tuberculosis (TB) in many populations and provided inconsistent results. In this study, we carried out a meta-analysis to derive a more reliable assessment on FokI polymorphism and the risk of HIV-negative TB. Methods The Embase, PubMed, and Cochrane Library databases were used to undertake a comprehensive systematic literature review of all current published VDR gene FOKI association studies aimed at the risk of TB up to June 30, 2015. Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were used to measure the strength of the models. Results A total of 14 studies (1,668 cases and 1,893 controls) were retrieved in the meta-analysis. The pooled OR was 1.60 (95% = 1.28-1.97, P < 0.001; I-2 = 29.5%, and P = 0.141 for heterogeneity) in the best genetic model (recessive model: ff vs. fF + FF). In the subgroup analysis by ethnicities, a significantly increased risk was found in the Asian group (OR = 1.82, 95% CI = 1.42-2.33, P < 0.001; I-2 = 31.0%, and P = 0.150 for heterogeneity) in the recessive model. Similarly, significant associations were also found in the polymerase chain reaction-restriction fragment length polymorphism group, high-quality studies, and the population based or hospital based groups. Moderate heterogeneity was found in this study. Conclusion Our results suggested that VDR FokI polymorphism contributes to increasing the risk of TB in HIV-negative individuals, especially in the Asian region. Further studies on this topic in other races are expected to be conducted in future.	[Xu, Chun; Ding, Cheng; Li, Chang; Chen, Jun; Xu, Zhenlei; Mao, Yi; Zhao, Jun] Soochow Univ, Hosp Affiliated 1, Dept Cardiothorac Surg, Suzhou, Jiangsu, Peoples R China; [Tang, Peijun; Wu, Meiying] Soochow Univ, Affiliated Infect Hosp, Dept TB, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Wu, MY (corresponding author), Soochow Univ, Affiliated Infect Hosp, Dept TB, Suzhou, Jiangsu, Peoples R China.	wu_my@126.com; zhaojia0327@126.com			Special Project of Key Clinical Disease Diagnosis and Treatment Technology in Suzhou [LCZX201314]; Preventive Medicine Scientific Research in Jiangsu Province [Y2013023]	Special Project of Key Clinical Disease Diagnosis and Treatment Technology in Suzhou; Preventive Medicine Scientific Research in Jiangsu Province	This research was supported by Special Project of Key Clinical Disease Diagnosis and Treatment Technology in Suzhou (Grant No: LCZX201314) and Preventive Medicine Scientific Research in Jiangsu Province (Grant No: Y2013023).	Alagarasu K, 2009, J CLIN IMMUNOL, V29, P196, DOI 10.1007/s10875-008-9234-z; Ansari A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004778; Babb C, 2007, TUBERCULOSIS, V87, P295, DOI 10.1016/j.tube.2007.03.001; Banoei MM, 2010, INT J INFECT DIS, V14, pE84, DOI 10.1016/j.ijid.2009.05.001; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bornman L, 2004, J INFECT DIS, V190, P1631, DOI 10.1086/424462; Chen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083843; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Facchini L, 2015, J CHEMOTHERAPY, V27, P128, DOI 10.1179/1973947815Y.0000000043; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Garcia-Laorden MI, 2006, MOL IMMUNOL, V43, P2143, DOI 10.1016/j.molimm.2006.01.008; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu W, 2004, INT J TUBERC LUNG D, V8, P428; Lombard Z, 2006, HUM IMMUNOL, V67, P643, DOI 10.1016/j.humimm.2006.04.008; Manolagas S, 1994, SEMINARS NEPHROLOGY; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Pfeffer PE, 2012, THORAX, V67, P1018, DOI 10.1136/thoraxjnl-2012-202139; Raghavan S, 2012, TUBERCULOSIS, V92, P18, DOI 10.1016/j.tube.2011.08.004; Rashedi J, 2014, ADV PHARM BULL, V4, P607, DOI 10.5681/apb.2014.089; Remus N, 2004, J INFECT DIS, V190, P580, DOI 10.1086/422534; Roth DE, 2004, J INFECT DIS, V190, P920, DOI 10.1086/423212; Salimi S, 2015, BIOMED REP, V3, P189, DOI 10.3892/br.2014.402; Sato S, 2012, RESPIR INVESTIG, V50, P40, DOI 10.1016/j.resinv.2012.05.002; Selvaraj P, 2008, J CLIN IMMUNOL, V28, P306, DOI 10.1007/s10875-007-9152-5; Selvaraj P, 2009, J CLIN IMMUNOL, V29, P470, DOI 10.1007/s10875-009-9277-9; Selvaraj P, 2006, JAIDS-J ACQ IMM DEF, V43, P497, DOI 10.1097/01.qai.0000233312.36226.76; Sinaga BYM, 2014, ACTA MED INDONES, V46, P275; Singh A, 2011, INT J TUBERC LUNG D, V15, P1468, DOI 10.5588/ijtld.11.0089; Soborg C, 2007, MOL IMMUNOL, V44, P2213, DOI 10.1016/j.molimm.2006.11.002; Sun YP, 2015, GENET MOL RES, V14, P6156, DOI 10.4238/2015.June.9.1; Swaminathan S, 2000, INT J TUBERC LUNG D, V4, P839; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; WHO, 2014, GLOB TUB REP 2014 WH; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Wu F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484535; Ye XR, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-282; Zhang HQ, 2010, ARCH MED RES, V41, P46, DOI 10.1016/j.arcmed.2009.12.004	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140634	10.1371/journal.pone.0140634	http://dx.doi.org/10.1371/journal.pone.0140634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485279	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100053
J	Zozus, MN; Pieper, C; Johnson, CM; Johnson, TR; Franklin, A; Smith, J; Zhang, JJ				Zozus, Meredith N.; Pieper, Carl; Johnson, Constance M.; Johnson, Todd R.; Franklin, Amy; Smith, Jack; Zhang, Jiajie			Factors Affecting Accuracy of Data Abstracted from Medical Records	PLOS ONE			English	Article							EMERGENCY-MEDICINE; MEASUREMENT ERROR; QUALITY; RELIABILITY; INFORMATION; REVIEWS; IMPACT	Objective Medical record abstraction (MRA) is often cited as a significant source of error in research data, yet MRA methodology has rarely been the subject of investigation. Lack of a common framework has hindered application of the extant literature in practice, and, until now, there were no evidence-based guidelines for ensuring data quality in MRA. We aimed to identify the factors affecting the accuracy of data abstracted from medical records and to generate a framework for data quality assurance and control in MRA. Methods Candidate factors were identified from published reports of MRA. Content validity of the top candidate factors was assessed via a four-round two-group Delphi process with expert abstractors with experience in clinical research, registries, and quality improvement. The resulting coded factors were categorized into a control theory-based framework of MRA. Coverage of the framework was evaluated using the recent published literature. Results Analysis of the identified articles yielded 292 unique factors that affect the accuracy of abstracted data. Delphi processes overall refuted three of the top factors identified from the literature based on importance and five based on reliability (six total factors refuted). Four new factors were identified by the Delphi. The generated framework demonstrated comprehensive coverage. Significant underreporting of MRA methodology in recent studies was discovered. Conclusion The framework generated from this research provides a guide for planning data quality assurance and control for studies using MRA. The large number and variability of factors indicate that while prospective quality assurance likely increases the accuracy of abstracted data, monitoring the accuracy during the abstraction process is also required. Recent studies reporting research results based on MRA rarely reported data quality assurance or control measures, and even less frequently reported data quality metrics with research results. Given the demonstrated variability, these methods and measures should be reported with research results.	[Zozus, Meredith N.] Duke Translat Med Inst, Durham, NC 27705 USA; [Pieper, Carl] Duke Univ, Sch Med, Durham, NC USA; [Johnson, Constance M.] Duke Univ, Sch Nursing, Durham, NC USA; [Johnson, Todd R.; Franklin, Amy; Smith, Jack; Zhang, Jiajie] Univ Texas Houston, Sch Biomed Informat, Houston, TX USA	Duke University; Duke University; Duke University; University of Texas System; University of Texas Health Science Center Houston	Zozus, MN (corresponding author), Duke Translat Med Inst, Durham, NC 27705 USA.	meredith.nahm@dm.duke.edu		Pieper, Carl/0000-0003-4809-1725; Johnson, Todd/0000-0002-6189-463X; Franklin, Amy/0000-0003-2227-7978	National Center for Research Resources (NCRR); National Library of Medicine (NLM) [5K99LM011128];  [UL1RR024128];  [UL1RR024148]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148, UL1RR024128] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K99LM011128] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Library of Medicine (NLM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The project received support from Grants UL1RR024128 and UL1RR024148 to Duke University and the University of Texas Health Science Center Houston, respectively, from the National Center for Research Resources (NCRR), and from Grant 5K99LM011128 from the National Library of Medicine (NLM). Both NCRR and NLM are components of the National Institutes of Health (NIH). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of the NIH.	Badcock D, 2005, ANN EMERG MED, V45, P444, DOI 10.1016/j.annemergmed.2004.11.011; Bean K P, 1994, Top Health Inf Manage, V15, P13; Cassidy LD, 2002, AM J MANAG CARE, V8, P787; Eder C, 2005, APPL NURS RES, V18, P50, DOI 10.1016/j.apnr.2004.04.005; Engel L, 2009, EVAL HEALTH PROF, V32, P281, DOI 10.1177/0163278709338561; FEINSTEIN AR, 1969, ARCH INTERN MED, V123, P571, DOI 10.1001/archinte.123.5.571; Flood M, 2009, MIDWIFERY, V25, P701, DOI 10.1016/j.midw.2007.12.003; FREEDMAN LS, 1990, AM J EPIDEMIOL, V132, P1185, DOI 10.1093/oxfordjournals.aje.a115762; Gibbs D, 1996, BRIT MED J, V313, P798; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Hemmila MR, 2007, SURGERY, V142, P439, DOI 10.1016/j.surg.2007.07.002; Institute of Medicine, 1977, REL MED HOSP DISCH R; Institute of Medicine, 1977, REL HOSP DISCH ABSTR; JASPERSE DM, 1989, CONTROL CLIN TRIALS, V10, P282, DOI 10.1016/0197-2456(89)90068-8; Linstone HA, 2002, DELPHI METHOD TECHNI; Lowenstein SR, 2005, ANN EMERG MED, V45, P452, DOI 10.1016/j.annemergmed.2005.01.032; Meads S, 1982, Top Health Rec Manage, V2, P23; Nahm M., 2012, CLIN RES INFORM, P175, DOI DOI 10.1007/978-1-84882-448-5_10; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; Pan L, 2005, J CLIN EPIDEMIOL, V58, P918, DOI 10.1016/j.jclinepi.2005.02.004; Perkins DO, 2000, BIOL PSYCHIAT, V47, P762, DOI 10.1016/S0006-3223(00)00837-4; Reisch LM, 2003, AM J EPIDEMIOL, V157, P546, DOI 10.1093/aje/kwg016; Rostami R, 2009, CLIN TRIALS, V6, P141, DOI 10.1177/1740774509102590; Simmons Barbara, 2002, SCI Nurs, V19, P22; Thoburn KK, 2007, CANCER-AM CANCER SOC, V109, P1607, DOI 10.1002/cncr.22566; vonKoss Krowchuk H, 1995, J Nurs Meas, V3, P3; Worster A, 2005, ANN EMERG MED, V45, P448, DOI 10.1016/j.annemergmed.2004.11.021	27	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0138649	10.1371/journal.pone.0138649	http://dx.doi.org/10.1371/journal.pone.0138649			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7XI	26484762	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100005
J	Mathur, MR; Watt, RG; Millett, CJ; Parmar, P; Tsakos, G				Mathur, Manu Raj; Watt, Richard G.; Millett, Christopher J.; Parmar, Priyanka; Tsakos, Georgios			Determinants of Socioeconomic Inequalities in Traumatic Dental Injuries among Urban Indian Adolescents	PLOS ONE			English	Article							SOCIAL NETWORKS; HEALTH; SCHOOLCHILDREN; POPULATION; MULTILEVEL; MORTALITY; PREVALENCE; AREA	Objectives To assess socioeconomic inequalities in traumatic dental injuries (TDIs) in adolescents in New Delhi and examine the role of material, psychosocial and behavioural factors in explaining these inequalities. Methods We conducted a cross sectional study of 1386 adolescents aged between 12-15 years residing in three diverse areas of New Delhi. A non-invasive clinical examination was used to estimate the prevalence of TDIs, and an interviewer-administered questionnaire was used to gather relevant behavioural and socio-demographic data. Multiple logistic regression models were used to assess the association between area based socioeconomic position and TDIs. Results The overall prevalence of TDIs was 10.9%. Social inequalities in the prevalence of TDIs were observed across the adolescent population according to their area of residence. Socio-economic group differences in the prevalence of TDIs remained statistically significant after adjusting for demographic factors, material resources, social capital, social support and health affecting behaviours (OR 3.36, 95% CI 1.75-6.46 and OR 3.99, 95% CI 1.86-8.56 for adolescents from resettlement areas and urban slums respectively in comparison to middle class adolescents). Different psychosocial, material and socio-demographic variables did not attenuate the estimates for the relationship between area socioeconomic position and TDIs. Conclusion Area of residence was a strong predictor of TDIs in adolescents with a higher prevalence in more deprived areas. Social inequalities in TDIs were not explained by psychosocial and behavioural variables. Health promoting policies aimed at improving the physical environment in which adolescents reside might be instrumental in reducing the prevalence of TDIs and associated inequalities.	[Mathur, Manu Raj; Parmar, Priyanka] Publ Hlth Fdn India, Dept Dent Publ Hlth, Gurgaon, Haryana, India; [Watt, Richard G.; Tsakos, Georgios] UCL, Dept Epidemiol & Publ Hlth, London, England; [Millett, Christopher J.] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England	Public Health Foundation of India; University of London; University College London; Imperial College London	Mathur, MR (corresponding author), Publ Hlth Fdn India, Dept Dent Publ Hlth, Gurgaon, Haryana, India.	manu.mathur@phfi.org	Choudhary, Priyanka/ABD-7169-2021	Tsakos, Georgios/0000-0002-5086-235X; Watt, Richard/0000-0001-6229-8584; Mathur, Manu/0000-0001-5518-1935; Choudhary, Priyanka/0000-0002-2420-4118; Millett, Christopher/0000-0002-0793-9884	Wellcome Trust Capacity Strengthening Award; NIHR Research Professorship award; consortium of UK universities	Wellcome Trust Capacity Strengthening Award; NIHR Research Professorship award; consortium of UK universities	This work was supported by a Wellcome Trust Capacity Strengthening Award to the Public Health Foundation of India and a consortium of UK universities. CM is funded by a NIHR Research Professorship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bajjali TT, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-101; [Anonymous], 2010, FAIR SOC HLTH LIV ST; Bendo CB, 2012, INT J ENV RES PUB HE, V9, P4278, DOI 10.3390/ijerph9124278; Bendo CB, 2009, DENT TRAUMATOL, V25, P420, DOI 10.1111/j.1600-9657.2009.00803.x; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Carvalho ML, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-203; Coleman JS, 1990, FDN SOCIAL THEORY SO, V69, P993; Correa-faria P., 2015, INFLUENCE CLIN SOCIO, V29, P1; Cortes MIS, 2001, DENT TRAUMATOL, V17, P22, DOI 10.1034/j.1600-9657.2001.170105.x; Gage Julia C, 2005, J Adolesc Health, V37, P517, DOI 10.1016/j.jadohealth.2004.12.012; George L. K., 1986, ELDER ABUSE CONFLICT, P67; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Hamilton FA, 1997, BRIT DENT J, V182, P91, DOI 10.1038/sj.bdj.4809313; HENDERSON S, 1980, PSYCHOL MED, V10, P723, DOI 10.1017/S003329170005501X; Jung SH, 2011, COMMUNITY DENT ORAL, V39, P221, DOI 10.1111/j.1600-0528.2010.00595.x; Kahn RL., 1980, LIFE SPAN DEV BEHAV, P253, DOI DOI 10.1038/NATURE12518; Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I, 1996, J EPIDEMIOL COMMUN H, V50, P245, DOI 10.1136/jech.50.3.245; Kundu A, 1999, 4 MOST CIT WORDS PRO; MACINTYRE S, 1993, J SOC POLICY, V22, P213, DOI 10.1017/S0047279400019310; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Marcenes W, 2001, DENT TRAUMATOL, V17, P17, DOI 10.1034/j.1600-9657.2001.170104.x; Masiga M A, 2004, East Afr Med J, V81, P577; Mathur MR, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006391; Mitchell R, 2000, HEALTH PLACE, V6, P67, DOI 10.1016/S1353-8292(00)00004-6; OBrien M, 1994, MOD BAS CONSTR AN MO; ORTHGOMER K, 1987, J CHRON DIS, V40, P949, DOI 10.1016/0021-9681(87)90145-7; Pattussi MP, 2008, INJURY, V39, P561, DOI 10.1016/j.injury.2007.11.013; Pattussi MP, 2006, AM J PUBLIC HEALTH, V96, P1462, DOI 10.2105/AJPH.2005.066159; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Roberts C, 2009, INT J PUBLIC HEALTH, V54, P140, DOI 10.1007/s00038-009-5405-9; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; SEIDMAN E, 1995, AM J COMMUN PSYCHOL, V23, P355, DOI 10.1007/BF02506949; Singh N., 2004, IF I WERE RAIN CELEB; Thelen DS, 2010, DENT TRAUMATOL, V26, P284, DOI 10.1111/j.1600-9657.2010.00918.x; UN-HABITAT, 2012, SOLID WASTE MANAGEME; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organisation, 2002, AD FRIENDL HLTH SERV	43	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140860	10.1371/journal.pone.0140860	http://dx.doi.org/10.1371/journal.pone.0140860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7WW	26479873	Green Published, gold			2022-12-27	WOS:000363026600022
J	Tooth, L; Mishra, GD				Tooth, Leigh; Mishra, Gita D.			Does Further Education in Adulthood Improve Physical and Mental Health among Australian Women? A Longitudinal Study	PLOS ONE			English	Article							LIFE-COURSE; OLDER-ADULTS; DEPRESSION; INEQUALITIES; TRAJECTORIES; SELECTION; ANXIETY; MIDLIFE; COHORT; EXPLANATIONS	Objective We analyzed whether further education in young adult and mid-life [adult educational mobility] influences physical functioning and depressive symptoms in women. Methods 14247 women born 1973-78 (younger cohort) and 13715 women born 1946-51 (mid-aged cohort) from the Australian Longitudinal Study on Women's Health were followed for 14-16 years. Measures were the Short-Form 36 Health Survey physical functioning subscale (SF-36 PF) and Centre for Epidemiologic Studies 10-item Depression Scale (CESD-10). Linear mixed modelling, accounting for time varying covariates, assessed the influence of further education on physical functioning and depressive symptoms over time. Sensitivity analysis to assess the impact of missing data was conducted using multiple imputation. Results Compared to younger women with a pre-existing high level of education, women gaining further education (up to age 39 years) from low levels had lower SF-36 PF scores (poorer physical functioning) (fully adjusted beta estimates (95% CIs) -1.52 (-2.59, -0.44)) while those gaining further education from middle to high levels showed equivalent SF-36 PF scores (-0.08 (-0.61, 0.44)). A similar pattern was shown for CESD-10 scores (0.78 (0.29, 1.25); -0.02 (-0.26, 0.21), respectively) where higher scores represented more depressive symptoms. For mid-age women, further education from a middle to high level resulted in equivalent SF-36 PF scores (-0.61 (-1.93,0.71)) but higher CESD-10 scores (0.49 (0.11, 0.86)), compared to highly educated women. Conclusion Women who delay further education until they are aged between their 40s and 60s can improve or maintain their physical functioning but may have missed the critical time to minimise depressive symptomatology. Public health policy should focus on encouraging women to upgrade their educational qualifications earlier in life in order to potentially offset the negative associations between their initial lower socio-economic position class of origin and their mental health.	[Tooth, Leigh; Mishra, Gita D.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia	University of Queensland	Tooth, L (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.	l.tooth@uq.edu.au	Tooth, Leigh/F-2769-2010	Tooth, Leigh/0000-0002-1569-934X	Australian Government Department of Health; Australian Research Council Future Fellowship [FT120100812]	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Australian Research Council Future Fellowship(Australian Research Council)	The Australian Longitudinal Study on Women's Health, including A/Professor Tooth's salary, is funded by the Australian Government Department of Health. Professor Gita Mishra is funded by an Australian Research Council Future Fellowship (FT120100812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Armstrong T, 2000, PHYS ACTIVITY PATTER; Australian Bureau of Statistics, 1997, NAT HLTH SURV SF 36; Beebe-Dimmer J, 2004, AM J EPIDEMIOL, V159, P481, DOI 10.1093/aje/kwh057; Bell A, 2014, SOC SCI MED, V120, P21, DOI 10.1016/j.socscimed.2014.09.008; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Butterworth P, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-44; Chandola T, 2011, INT J EPIDEMIOL, V40, P1499, DOI 10.1093/ije/dyr087; Chazelle E, 2011, J AFFECT DISORDERS, V134, P304, DOI 10.1016/j.jad.2011.05.049; Claussen B, 2005, SOC SCI MED, V61, P2513, DOI 10.1016/j.socscimed.2005.04.045; Cohen J.E., 1988, STAT POWER ANAL BEHA; Commonwealth Department of Health and Aged Care, 2001, COMM DEP HLTH AG CAR, V14; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Houle JN, 2011, SOC SCI RES, V40, P757, DOI 10.1016/j.ssresearch.2010.11.008; Johansson G, 2007, SOC SCI MED, V65, P685, DOI 10.1016/j.socscimed.2007.04.001; Johnson-Lawrence V, 2013, ANN EPIDEMIOL, V23, P167, DOI 10.1016/j.annepidem.2013.02.004; Jokela M, 2010, EPIDEMIOLOGY, V21, P284, DOI 10.1097/EDE.0b013e3181d61f53; Ki M, 2011, J EPIDEMIOL COMMUN H, V65, P1132, DOI 10.1136/jech.2009.107995; Koster A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-244; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lynch SM, 2006, J HEALTH SOC BEHAV, V47, P324, DOI 10.1177/002214650604700402; Miech R, 2007, ANN EPIDEMIOL, V17, P289, DOI 10.1016/j.annepidem.2006.07.015; Mishra GD, 2014, QUAL LIFE RES, V23, P1515, DOI 10.1007/s11136-013-0586-3; National Health and Medical Research Council Commonwealth of Australia, 2001, AUSTR ALC GUID HLTH; Nicholson A, 2008, J AFFECT DISORDERS, V105, P125, DOI 10.1016/j.jad.2007.04.026; Peeters G, 2013, B WORLD HEALTH ORGAN, V91, P661, DOI 10.2471/BLT.13.123075; Plewis I, 2014, RES SOC STRAT MOBIL, V36, P1, DOI 10.1016/j.rssm.2013.10.001; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; Ross CE, 2006, SOC SCI MED, V63, P1400, DOI 10.1016/j.socscimed.2006.03.013; Rubin DB., 2004, MULTIPLE IMPUTATION; SAS/Stat, 2011, SAS STAT US GUID VER; Singh-Manoux A, 2004, INT J EPIDEMIOL, V33, P1072, DOI 10.1093/ije/dyh224; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Stansfeld SA, 2011, SOC PSYCH PSYCH EPID, V46, P549, DOI 10.1007/s00127-010-0221-3; Turrell G, 2000, J EPIDEMIOL COMMUN H, V54, P207, DOI 10.1136/jech.54.3.207; Ware J.E., 2000, SF 36 HLTH SURVEY MA; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454	38	2	2	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140334	10.1371/journal.pone.0140334	http://dx.doi.org/10.1371/journal.pone.0140334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7WW	26480313	Green Published, Green Submitted, gold			2022-12-27	WOS:000363026600007
J	Brown, VR; Adney, DR; Olea-Popelka, F; Bowen, RA				Brown, Vienna R.; Adney, Danielle R.; Olea-Popelka, Francisco; Bowen, Richard A.			Prior Inoculation with Type B Strains of Francisella tularensis Provides Partial Protection against Virulent Type A Strains in Cottontail Rabbits	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; TULAREMIA; CLADES	Francisella tularensis is a highly virulent bacterium that is capable of causing severe disease (tularemia) in a wide range of species. This organism is characterized into two distinct subspecies: tularensis (type A) and holarctica (type B) which vary in several crucial ways, with some type A strains having been found to be considerably more virulent in humans and laboratory animals. Cottontail rabbits have been widely implicated as a reservoir species for this subspecies; however, experimental inoculation in our laboratory revealed type A organisms to be highly virulent, resulting in 100% mortality following challenge with 50-100 organisms. Inoculation of cottontail rabbits with the same number of organisms from type B strains of bacteria was found to be rarely lethal and to result in a robust humoral immune response. The objective of this study was to characterize the protection afforded by a prior challenge with type B strains against a later inoculation with a type A strain in North American cottontail rabbits (Sylvilagus spp). Previous infection with a type B strain of organism was found to lengthen survival time and in some cases prevent death following inoculation with a type A2 strain of F. tularensis. In contrast, inoculation of a type A1b strain was uniformly lethal in cottontail rabbits irrespective of a prior type B inoculation. These findings provide important insight about the role cottontail rabbits may play in environmental maintenance and transmission of this organism.	[Brown, Vienna R.; Adney, Danielle R.; Bowen, Richard A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Olea-Popelka, Francisco] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Bowen, RA (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	rbowen@colostate.edu			United States Department of Agriculture [11-7100-0331-CA]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was funded through cooperative agreement 11-7100-0331-CA from the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimana C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00034; BAKER CN, 1985, J CLIN MICROBIOL, V22, P212, DOI 10.1128/JCM.22.2.212-215.1985; BELL J F, 1975, Journal of Wildlife Diseases, V11, P421; Brown VR, 2015, J WILDLIFE DIS, V51, P564, DOI 10.7589/2015-02-030; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Foley JE, 2010, VET MICROBIOL, V140, P332, DOI 10.1016/j.vetmic.2009.07.017; Johansson A, 2000, J CLIN MICROBIOL, V38, P4180, DOI 10.1128/JCM.38.11.4180-4185.2000; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; LONG GW, 1993, J CLIN MICROBIOL, V31, P152, DOI 10.1128/JCM.31.1.152-154.1993; Molins CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010205; Nakazawa Y, 2010, AM J TROP MED HYG, V82, P912, DOI 10.4269/ajtmh.2010.09-0354; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Petersen JM, 2010, FUTURE MICROBIOL, V5, P649, DOI 10.2217/FMB.10.17; Reed DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024654; Reese SM, 2011, J MED ENTOMOL, V48, P884, DOI 10.1603/ME11005; Reese SM, 2010, AM J TROP MED HYG, V83, P645, DOI 10.4269/ajtmh.2010.10-0127; Rossow H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108864; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Tarnvik A., 2007, WHO GUIDELINES TULAR; Telford SR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00150	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140723	10.1371/journal.pone.0140723	http://dx.doi.org/10.1371/journal.pone.0140723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474413	Green Submitted, Green Published, gold			2022-12-27	WOS:000363185500092
J	Vajravelu, BN; Hong, KU; Al-Maqtari, T; Cao, PX; Keith, MCL; Wysoczynski, M; Zhao, J; Moore, JB; Bolli, R				Vajravelu, Bathri N.; Hong, Kyung U.; Al-Maqtari, Tareq; Cao, Pengxiao; Keith, Matthew C. L.; Wysoczynski, Marcin; Zhao, John; Moore, Joseph B.; Bolli, Roberto			C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; SIDE POPULATION CELLS; STEM-CELLS; MAST-CELLS; KINASE DOMAIN; MURINE MODEL; PI 3-KINASE; RECEPTOR; SURVIVAL; ACTIVATION	A recent phase I clinical trial (SCIPIO) has shown that autologous c-kit+ cardiac progenitor cells (CPCs) improve cardiac function and quality of life when transplanted into patients with ischemic heart disease. Although c-kit is widely used as a marker of resident CPCs, its role in the regulation of the cellular characteristics of CPCs remains unknown. We hypothesized that c-kit plays a role in the survival, growth, and migration of CPCs. To test this hypothesis, human CPCs were grown under stress conditions in the presence or absence of SCF, and the effects of SCF-mediated activation of c-kit on CPC survival/growth and migration were measured. SCF treatment led to a significant increase in cell survival and a reduction in cell death under serum depletion conditions. In addition, SCF significantly promoted CPC migration in vitro. Furthermore, the pro-survival and pro-migratory effects of SCF were augmented by c-kit overexpression and abrogated by c-kit inhibition with imatinib. Mechanistically, c-kit activation in CPCs led to activation of the PI3K and the MAPK pathways. With the use of specific inhibitors, we confirmed that the SCF/c-kit-dependent survival and chemotaxis of CPCs are dependent on both pathways. Taken together, our findings suggest that c-kit promotes the survival/growth and migration of human CPCs cultured ex vivo via the activation of PI3K and MAPK pathways. These results imply that the efficiency of CPC homing to the injury site as well as their survival after transplantation may be improved by modulating the activity of c-kit.	[Vajravelu, Bathri N.; Hong, Kyung U.; Al-Maqtari, Tareq; Cao, Pengxiao; Keith, Matthew C. L.; Wysoczynski, Marcin; Zhao, John; Moore, Joseph B.; Bolli, Roberto] Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40202 USA	University of Louisville	Bolli, R (corresponding author), Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40202 USA.	rbolli@louisville.edu	Vajravelu, Bathri/K-5504-2019; Al-Maqtari, Tareq/AAO-7951-2021; Hong, Kyung Uk/G-7145-2011	Hong, Kyung Uk/0000-0001-6700-9470	National Institutes of Health [P01 HL078825, P20 GM103492, UM1 HL113530]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL113530, P01HL078825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The following National Institutes of Health grants, awarded to RB, supported the authors' work: P01 HL078825, P20 GM103492, and UM1 HL113530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bone-Larson CL, 2000, AM J PATHOL, V157, P1177, DOI 10.1016/S0002-9440(10)64633-0; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; Cosgun KN, 2014, CELL STEM CELL, V15, P227, DOI 10.1016/j.stem.2014.06.001; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fazel SS, 2008, FASEB J, V22, P930, DOI 10.1096/fj.07-8636com; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gommerman JL, 2000, BLOOD, V96, P3734, DOI 10.1182/blood.V96.12.3734.h8003734_3734_3742; He JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027719; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725; Hong Kyung U, 2014, Curr Treat Options Cardiovasc Med, V16, P324, DOI 10.1007/s11936-014-0324-3; Hong KU, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0346-0; Hoyer PE, 2005, MOL CELL ENDOCRINOL, V234, P1, DOI 10.1016/j.mce.2004.09.012; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kimura Y, 2004, P NATL ACAD SCI USA, V101, P6015, DOI 10.1073/pnas.0305363101; Kimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026918; Lennartsson J, 2003, EXP CELL RES, V288, P110, DOI 10.1016/S0014-4827(03)00206-4; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; LEV S, 1992, P NATL ACAD SCI USA, V89, P678, DOI 10.1073/pnas.89.2.678; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Longley BJ, 2001, LEUKEMIA RES, V25, P571, DOI 10.1016/S0145-2126(01)00028-5; Lutz M, 2008, CARDIOVASC RES, V77, P143, DOI 10.1093/cvr/cvm027; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; Matsui J, 2004, J BIOL CHEM, V279, P18600, DOI 10.1074/jbc.M311643200; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; McDaniel AS, 2008, BLOOD, V112, P4646, DOI 10.1182/blood-2008-04-155085; MEKORI YA, 1995, INT ARCH ALLERGY IMM, V107, P136, DOI 10.1159/000236955; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Orth JM, 1997, BIOL REPROD, V57, P676, DOI 10.1095/biolreprod57.3.676; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Pesce M, 1997, MECH DEVELOP, V68, P37, DOI 10.1016/S0925-4773(97)00120-2; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; ROTTAPEL R, 1991, MOL CELL BIOL, V11, P3043, DOI 10.1128/MCB.11.6.3043; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; Sanada F, 2014, CIRC RES, V114, P41, DOI 10.1161/CIRCRESAHA.114.302500; Schachinger V, 2008, CIRCULATION, V118, P1425, DOI 10.1161/CIRCULATIONAHA.108.777102; SERVE H, 1994, J BIOL CHEM, V269, P6026; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Simpson K, 2003, LAB INVEST, V83, P199, DOI 10.1097/01.LAB.0000057002.16935.84; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Thommes K, 1999, BIOCHEM J, V341, P211, DOI 10.1042/0264-6021:3410211; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; Todd JR, 2014, ONCOGENE, V33, P236, DOI 10.1038/onc.2012.562; Trieselmann NZ, 2003, CELL MOL LIFE SCI, V60, P759, DOI 10.1007/s00018-003-2349-8; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Wang CH, 2006, CIRC RES, V99, P617, DOI 10.1161/01.RES.0000243210.79654.fd; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; WILSON I, 1986, J MED CHEM, V29, P1381, DOI 10.1021/jm00158a010; Yaniz-Galende E, 2012, CIRC RES, V111, P1434, DOI 10.1161/CIRCRESAHA.111.263830; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; YEE NS, 1994, J EXP MED, V179, P1777, DOI 10.1084/jem.179.6.1777; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	72	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140798	10.1371/journal.pone.0140798	http://dx.doi.org/10.1371/journal.pone.0140798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474484	Green Published, Green Submitted, gold			2022-12-27	WOS:000363185500113
J	Clement, AM; Nysjo, J; Strand, R; Ahlberg, PE				Clement, Alice M.; Nysjo, Johan; Strand, Robin; Ahlberg, Per E.			Brain - Endocast Relationship in the Australian Lungfish, Neoceratodus forsteri, Elucidated from Tomographic Data (Sarcopterygii: Dipnoi)	PLOS ONE			English	Article							CRANIAL ENDOCAST; COELACANTH; INTERRELATIONSHIPS; OSTEICHTHYES; TETRAPOD; ANATOMY	Although the brains of the three extant lungfish genera have been previously described, the spatial relationship between the brain and the neurocranium has never before been fully described nor quantified. Through the application of virtual microtomography (mu CT) and 3D rendering software, we describe aspects of the gross anatomy of the brain and labyrinth region in the Australian lungfish, Neoceratodus forsteri and compare this to previous accounts. Unexpected characters in this specimen include short olfactory peduncles connecting the olfactory bulbs to the telencephalon, and an oblong telencephalon. Furthermore, we illustrate the endocast (the mould of the internal space of the neurocranial cavity) of Neoceratodus, also describing and quantifying the brain-endocast relationship in a lungfish for the first time. Overall, the brain of the Australian lungfish closely matches the size and shape of the endocast cavity housing it, filling more than four fifths of the total volume. The forebrain and labyrinth regions of the brain correspond very well to the endocast morphology, while the midbrain and hindbrain do not fit so closely. Our results cast light on the gross neural and endocast anatomy in lungfishes, and are likely to have particular significance for palaeoneurologists studying fossil taxa.	[Clement, Alice M.; Ahlberg, Per E.] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, S-75236 Uppsala, Sweden; [Clement, Alice M.] Museum Victoria, Dept Sci, Melbourne, Vic 3001, Australia; [Nysjo, Johan; Strand, Robin] Uppsala Univ, Ctr Image Anal, Dept Informat Technol, S-75105 Uppsala, Sweden	Uppsala University; Museum Victoria; Uppsala University	Clement, AM (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	alice.clement@ebc.uu.se	Clement, Alice/ABH-2642-2020	Clement, Alice/0000-0003-0380-7347; Ahlberg, Per/0000-0001-9054-2900	Knut and Alice Wallenberg Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	The work was supported by Knut and Alice Wallenberg Foundation (awarded to PEA), https://www.wallenberg.com/kaw/en/foundation/knut-andalicewallenberg-foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Anthony J., 1958, ANATOMIE LATIMERIA C; Aspert N, 2002, IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOL I AND II, PROCEEDINGS, P705, DOI 10.1109/ICME.2002.1035879; BEMIS WE, 1986, J MORPHOL, P249; Bemis WE, 1986, J MORPHOLOGY S, V1, P3; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bing R., 1905, Denkschriften Ges Jena, Viv, P513; Challands TJ, 2015, PAP PALAEONTOL, V1, DOI 10.1002/spp2.1016; Clement AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113898; Clement AM, 2012, PALAEONTOLOGY, V55, P51, DOI 10.1111/j.1475-4983.2011.01118.x; Cloutier R, 1996, INTERRELATIONSHIPS F, P445, DOI DOI 10.1016/B978-012670950-6/50018-7; Coates MI, 1999, PHILOS T R SOC B, V354, P435, DOI 10.1098/rstb.1999.0396; Collin SP, 2007, FISH PHYSIOL, V26, P121, DOI 10.1016/S1546-5098(07)26003-0; Edinger T., 1921, SENCKENBERGIANA, V3, P121, DOI DOI 10.1002/AJMG.A.30539; Fitzinger L. J., 1837, ARCH NATURGESCH, V2, P232; Friedman M, 2007, ZOOL J LINN SOC-LOND, V151, P115, DOI 10.1111/j.1096-3642.2007.00320.x; Fulliquet G., 1886, RECHERCHES CERVEAU P; Giles S, 2014, J PALEONTOL, V88, P636, DOI 10.1666/13-094; Griel A., 1913, DENKSCHR MED NATURW, V4, P935; Hamel MH, 2008, J VERTEBR PALEONTOL, V28, P989, DOI 10.1671/0272-4634-28.4.989; Heckel J, 1851, SITZ AKAD WISS WIEN, V6, P685; Heinicke Matthew P., 2009, P348; Holmgren N., 1925, Acta Zoologica Stockholm, V6, P59; Huxley TH., 1876, PHILOS T, V2, pe541, DOI [10.1111/j.1096-3642.1876.tb02541.x, DOI 10.1111/J.1096-3642.1876.TB02541.X]; Jorgensen JM, 2010, BIOL LUNGFISHES, V1, P489; Joss JMP, 2006, GEN COMP ENDOCR, V148, P285, DOI 10.1016/j.ygcen.2005.10.010; Kardong K., 2006, VERTEBRATES COMP ANA; Kemp A, 1999, J ZOOL, V248, P97, DOI 10.1017/S0952836999005117; Krefft G., 1870, P ZOOL SOC LOND, V1870, P221; KRUSKA DCT, 1988, BRAIN BEHAV EVOLUT, V32, P353, DOI 10.1159/000116562; Liang D, 2013, MOL BIOL EVOL, V30, P1803, DOI 10.1093/molbev/mst072; Long JA, 2010, ANN REV EARTH PLANET, V38, P665; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Macrini TE, 2009, J VERTEBR PALEONTOL, V29, P1199, DOI 10.1671/039.029.0413; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; Miles R.S., 1975, Colloques Internationaux du Centre National de la Recherche Scientifique, P133; MILES RS, 1977, ZOOL J LINN SOC-LOND, V61, P1, DOI 10.1111/j.1096-3642.1977.tb01031.x; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; NIEUWENHUYS R, 1982, AM ZOOL, V22, P287; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Northcutt R. Glenn, 2011, P393; NORTHCUTT RG, 1986, J MORPHOL, P277; Owen R., 1839, P LINN SOC LONDON, V1, P27; Platt C, 2004, J COMP NEUROL, V471, P277, DOI 10.1002/cne.20038; Retzius G, 1881, GEHORORGAN WIRBELTIE; ROSEN D E, 1981, Bulletin of the American Museum of Natural History, V167, P159; Rudebeck Birger, 1945, ACTA ZOOL [STOCKHOLM], V26, P9; Sakellariou A, 2004, PHYSICA A, V339, P152, DOI 10.1016/j.physa.2004.03.055; Schroeder W., 2006, VISUALIZATION TOOLKI, V4th; Sedgwick A., 1828, T GEOLOGICAL SOC LON, V2, P125, DOI [10.1144/transgslb.3.1.125, DOI 10.1144/TRANSGSLB.3.1.125]; Stensio E., 1963, SKRIFTER UTGITT NORS, V13, P1; Takezaki N, 2004, MOL BIOL EVOL, V21, P1512, DOI 10.1093/molbev/msh150; Ward SR, 2005, J BIOMECH, V38, P2317, DOI 10.1016/j.jbiomech.2004.10.001; Zardoya R, 1996, P NATL ACAD SCI USA, V93, P5449, DOI 10.1073/pnas.93.11.5449; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	57	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141277	10.1371/journal.pone.0141277	http://dx.doi.org/10.1371/journal.pone.0141277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492190	Green Published, Green Submitted, gold			2022-12-27	WOS:000363249300041
J	Yoon, YE; Choi, KH; Kim, SY; Cho, YI; Lee, KS; Kim, KH; Yang, SC; Han, WK				Yoon, Young Eun; Choi, Kyung Hwa; Kim, Sook Young; Cho, Young In; Lee, Kwang Suk; Kim, Kwang Hyun; Yang, Seung Choul; Han, Woong Kyu			Renoprotective Mechanism of Remote Ischemic Preconditioning Based on Transcriptomic Analysis in a Porcine Renal Ischemia Reperfusion Injury Model	PLOS ONE			English	Article							GLOMERULAR MESANGIAL CELLS; ACTIVATED PROTEIN-KINASE; CHRONIC KIDNEY-DISEASE; ISCHEMIA/REPERFUSION INJURY; GENE-EXPRESSION; IN-VITRO; FACTOR-H; COMPLEMENT; TOLERANCE; SECRETION	Ischemic preconditioning (IPC) is a well-known phenomenon in which tissues are exposed to a brief period of ischemia prior to a longer ischemic event. This technique produces tissue tolerance to ischemia reperfusion injury (IRI). Currently, IPC's mechanism of action is poorly understood. Using a porcine single kidney model, we performed remote IPC with renal IRI and evaluated the IPC mechanism of action. Following left nephrectomy, 15 female Yorkshire pigs were divided into three groups: no IPC and 90 minutes of warm ischemia (control), remote IPC immediately followed by 90 minutes of warm ischemia (rIPCe), and remote IPC with 90 minutes of warm ischemia performed 24 hours later (rIPCl). Differential gene expression analysis was performed using a porcine-specific microarray. The microarray analysis of porcine renal tissues identified 1,053 differentially expressed probes in preconditioned pigs. Among these, 179 genes had altered expression in both the rIPCe and rIPCl groups. The genes were largely related to oxidation reduction, apoptosis, and inflammatory response. In the rIPCl group, an additional 848 genes had altered expression levels. These genes were primarily related to immune response and inflammation, including those coding for cytokines and cytokine receptors and those that play roles in the complement system and coagulation cascade. In the complement system, the membrane attack complex was determined to be sublytic, because it colocalized with phosphorylated extracellular signal-regulated kinase. Furthermore, alpha 2 macroglobulin, tissue plasminogen activator, uterine plasmin trypsin inhibitor, and arginase-1 mRNA levels were elevated in the rIPCl group. These findings indicate that remote IPC produces renoprotective effects through multiple mechanisms, and these effects develop over a long timeframe rather than immediately following IPC.	[Yoon, Young Eun; Kim, Sook Young; Cho, Young In; Lee, Kwang Suk; Han, Woong Kyu] Yonsei Univ, Coll Med, Dept Urol, Urol Sci Inst, Seoul, South Korea; [Choi, Kyung Hwa; Yang, Seung Choul] CHA Univ, CHA Bundang Med Ctr, Dept Urol, Songnam, South Korea; [Cho, Young In] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea; [Kim, Kwang Hyun] Ewha Womans Univ, Mokdong Hosp, Dept Urol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Ewha Womans University	Han, WK (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Urol Sci Inst, Seoul, South Korea.	hanwk@yuhs.ac		Yoon, Young Eun/0000-0001-8059-6649; Han, Woong Kyu/0000-0002-2527-4046; Lee, Kwang Suk/0000-0002-7961-8393	National Research Foundation of Korea (NRF) - Korea government (MEST) [NRF-2012R1A1A1042968]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant (NRF-2012R1A1A1042968) funded by the Korea government (MEST).	Ates E, 2002, TRANSPLANTATION, V74, P1247, DOI 10.1097/01.TP.0000032752.61372.36; Basile DP, 2005, AM J PHYSIOL-RENAL, V288, pF953, DOI 10.1152/ajprenal.00329.2004; Boffa MB, 1999, BIOCHEMISTRY-US, V38, P6547, DOI 10.1021/bi990229v; Bonomo JA, 2014, NEPHROL DIAL TRANSPL, V29, P1409, DOI 10.1093/ndt/gfu036; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Castellano G, 2010, AM J PATHOL, V176, P1648, DOI 10.2353/ajpath.2010.090276; Chadban SJ, 1997, LAB INVEST, V76, P619; Das M, 2008, IUBMB LIFE, V60, P199, DOI 10.1002/iub.31; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Farrar CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00341; Gardner DS, 2014, AM J PHYSIOL-RENAL, V306, pF873, DOI 10.1152/ajprenal.00576.2013; Gassanov N, 2014, J AM SOC NEPHROL, V25, P216, DOI 10.1681/ASN.2013070708; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gross GJ, 2011, CARDIOVASC DRUG THER, V25, P517, DOI 10.1007/s10557-011-6321-9; Haji Mohd, 2014, J SURG RES, V186, P207, DOI DOI 10.1016/J.JSS.2013.09.006; Hanto DW, 2010, AM J TRANSPLANT, V10, P2421, DOI 10.1111/j.1600-6143.2010.03289.x; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hernandez DJ, 2008, J ENDOUROL, V22, P2531, DOI 10.1089/end.2008.0145; Hu X, 2013, PERFUSION-UK, V28, P546, DOI 10.1177/0267659113487766; Huang JW, 2013, BJU INT, V112, P74, DOI 10.1111/bju.12004; Ishida T, 1997, SHOCK, V8, P86, DOI 10.1097/00024382-199708000-00003; Kitamura M, 1996, J IMMUNOL, V156, P2964; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Kosieradzki M, 2003, SURGERY, V133, P81, DOI 10.1067/msy.2003.93; Kraus S, 2001, CLIN EXP IMMUNOL, V123, P366, DOI 10.1046/j.1365-2249.2001.01477.x; Lazaris AM, 2009, J SURG RES, V154, P267, DOI 10.1016/j.jss.2008.06.037; Li FZ, 2005, ACTA PHARMACOL SIN, V26, P851, DOI 10.1111/j.1745-7254.2005.00109.x; Lin Qing, 2013, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V29, P137; Liu BL, 1999, AM J PHYSIOL-RENAL, V277, pF186, DOI 10.1152/ajprenal.1999.277.2.F186; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Niculescu F, 1999, ATHEROSCLEROSIS, V142, P47, DOI 10.1016/S0021-9150(98)00185-3; Nie J, 2011, J SURG RES, V168, P281, DOI 10.1016/j.jss.2009.10.020; Orvieto MA, 2007, UROLOGY, V69, P984, DOI 10.1016/j.urology.2007.01.100; PASSWELL J, 1988, J CLIN INVEST, V82, P1676, DOI 10.1172/JCI113780; Renner B, 2011, KIDNEY INT, V80, P166, DOI 10.1038/ki.2011.115; Roelofs JJTH, 2006, J AM SOC NEPHROL, V17, P131, DOI 10.1681/ASN.2005010089; Salehipour M, 2007, UROL INT, V79, P328, DOI 10.1159/000109718; Serafin A, 2004, HISTOL HISTOPATHOL, V19, P281, DOI 10.14670/HH-19.281; Simon C, 2012, EUR J CARDIO-THORAC, V41, P933, DOI 10.1093/ejcts/ezr049; Sinuani I, 2006, AM J PHYSIOL-RENAL, V291, pF384, DOI 10.1152/ajprenal.00418.2005; Soendergaard P, 2012, TRANSPL INT, V25, P1002, DOI 10.1111/j.1432-2277.2012.01522.x; Song D, 1998, NEPHRON, V78, P15, DOI 10.1159/000044876; Stockand JD, 1998, PHYSIOL REV, V78, P723, DOI 10.1152/physrev.1998.78.3.723; Surendra H, 2013, J MOL CELL CARDIOL, V60, P142, DOI 10.1016/j.yjmcc.2013.04.010; Takeshita M, 2010, TRANSPL P, V42, P3406, DOI 10.1016/j.transproceed.2010.06.038; Tanhehco EJ, 2000, IMMUNOPHARMACOLOGY, V49, P391, DOI 10.1016/S0162-3109(00)00258-7; TAVERA C, 1992, BIOCHEM BIOPH RES CO, V182, P1082, DOI 10.1016/0006-291X(92)91842-E; Thompson JW, 2013, NEUROTHERAPEUTICS, V10, P789, DOI 10.1007/s13311-013-0202-9; Tortelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079610; Treska Vladislav, 2006, Exp Clin Transplant, V4, P439; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296; Wever KE, 2011, NEPHROL DIAL TRANSPL, V26, P3108, DOI 10.1093/ndt/gfr103; WU K, 1981, J BIOL CHEM, V256, P409; Xu YK, 2011, J IMMUNOL, V186, P3666, DOI 10.4049/jimmunol.1001934; Yoon YE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124130	58	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141099	10.1371/journal.pone.0141099	http://dx.doi.org/10.1371/journal.pone.0141099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489007	gold, Green Published			2022-12-27	WOS:000363248400102
J	Chung, CL; Huang, SY; Huang, YC; Tzean, SS; Ann, PJ; Tsai, JN; Yang, CC; Lee, HH; Huang, TW; Huang, HY; Chang, TT; Lee, HL; Liou, RF				Chung, Chia-Lin; Huang, Shun-Yuan; Huang, Yu-Ching; Tzean, Shean-Shong; Ann, Pao-Jen; Tsai, Jyh-Nong; Yang, Chin-Cheng; Lee, Hsin-Han; Huang, Tzu-Wei; Huang, Hsin-Yu; Chang, Tun-Tschu; Lee, Hui-Lin; Liou, Ruey-Fen			The Genetic Structure of Phellinus noxius and Dissemination Pattern of Brown Root Rot Disease in Taiwan	PLOS ONE			English	Article							POPULATION-GENETICS; SPORE DISPERSAL; FOREST; BASIDIOSPORES; DISTANCE; PACKAGE; NUMBER; WEIRII; TREES; FRUIT	Since the 1990s, brown root rot caused by Phellinus noxius (Corner) Cunningham has become a major tree disease in Taiwan. This fungal pathogen can infect more than 200 hardwood and softwood tree species, causing gradual to fast decline of the trees. For effective control, we must determine how the pathogen is disseminated and how the new infection center of brown root rot is established. We performed Illumina sequencing and de novo assembly of a single basidiospore isolate Daxi42 and obtained a draft genome of similar to 40 Mb. By comparing the 12,217 simple sequence repeat (SSR) regions in Daxi42 with the low-coverage Illumina sequencing data for four additional P. noxius isolates, we identified 154 SSR regions with potential polymorphisms. A set of 13 polymorphic SSR markers were then developed and used to analyze 329 P. noxius isolates collected from 73 tree species from urban/agricultural areas in 14 cities/counties all around Taiwan from 1989 to 2012. The results revealed a high proportion (similar to 98%) of distinct multilocus genotypes (MLGs) and that none of the 329 isolates were genome-wide homozygous, which supports a possible predominant outcrossing reproductive mode in P. noxius. The diverse MLGs exist as discrete patches, so brown root rot was most likely caused by multiple clones rather than a single predominant strain. The isolates collected from diseased trees near each other tend to have similar genotype(s), which indicates that P. noxius may spread to adjacent trees via root-to-root contact. Analyses based on Bayesian clustering, F-ST statistics, analysis of molecular variance, and isolation by distance all suggest a low degree of population differentiation and little to no barrier to gene flow throughout the P. noxius population in Taiwan. We discuss the involvement of basidiospore dispersal in disease dissemination.	[Chung, Chia-Lin; Huang, Shun-Yuan; Huang, Yu-Ching; Tzean, Shean-Shong; Lee, Hsin-Han; Huang, Tzu-Wei; Huang, Hsin-Yu; Liou, Ruey-Fen] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10617, Taiwan; [Chung, Chia-Lin; Yang, Chin-Cheng; Liou, Ruey-Fen] Natl Taiwan Univ, Master Program Plant Med, Taipei 10617, Taiwan; [Ann, Pao-Jen; Tsai, Jyh-Nong] Agr Res Inst Taiwan, Plant Pathol Div, Taichung 41362, Taiwan; [Chang, Tun-Tschu] Taiwan Forestry Res Inst, Div Forest Protect, Taipei 10066, Taiwan; [Lee, Hui-Lin] Taitung Dist Agr Res & Extens Stn, Dept Crop Environm, Taitung 95055, Taiwan	National Taiwan University; National Taiwan University; Agricultural Research Institute of Taiwan	Liou, RF (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	rfliou@ntu.edu.tw		LIOU, RUEY-FEN/0000-0001-7799-9287; Lee, Hsin-Han/0000-0003-3904-8004; CHUNG, CHIA-LIN/0000-0002-1612-0109	Aim for the Top University Project of the National Taiwan University [100R3505, 101R3505]	Aim for the Top University Project of the National Taiwan University	The work was supported by 2011-2012 "Aim for the Top University Project of the National Taiwan University", 100R3505 and 101R3505, http://top100.ntu.edu.tw/index.htm, to the Department of Plant Pathology and Microbiology (RFL, CLC, SST).	Abajian C., 1994, SPUTNIK; Ann PJ, 1999, PLANT DIS, V83, P746, DOI 10.1094/PDIS.1999.83.8.746; Ann PJ, 2002, PLANT DIS, V86, P820, DOI 10.1094/PDIS.2002.86.8.820; Ann PJ, 1992, PLANT PATHOL B, V1, P19; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Bolland L., 1984, Australian Forestry, V47, P2; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Brurberg MB, 2011, FUNGAL BIOL-UK, V115, P335, DOI 10.1016/j.funbio.2011.01.003; Cai GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082408; Chang T. T., 1992, Plant Pathology Bulletin, V1, P90; CHANG TT, 1995, EUR J FOREST PATHOL, V25, P185; Chang TT, 1996, PHYTOPATHOLOGY, V86, P272, DOI 10.1094/Phyto-86-272; CHANG TT, 1995, PLANT DIS, V79, P962, DOI 10.1094/PD-79-0962; Cunningham GH, 1965, POLYPORACEAE NZ; Doyle J. J., 1987, PHYTOCHEM B, P11; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Duong TA, 2015, PLANT PATHOL, V64, P235, DOI 10.1111/ppa.12231; Edman M, 2004, ECOGRAPHY, V27, P103, DOI 10.1111/j.0906-7590.2004.03671.x; Edman M, 2003, MYCOLOGIA, V95, P553, DOI 10.2307/3761898; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Galante TE, 2011, MYCOLOGIA, V103, P1175, DOI 10.3852/10-388; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hallenberg N, 2001, NORD J BOT, V21, P431, DOI 10.1111/j.1756-1051.2001.tb00793.x; Hansen EM, 2000, ANNU REV PHYTOPATHOL, V38, P515, DOI 10.1146/annurev.phyto.38.1.515; Hattori T, 1996, EUR J FOREST PATHOL, V26, P69; Hayden MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-80; Hedrick PW, 2013, J HERED, V104, P298, DOI 10.1093/jhered/ess139; Heinzelmann R, 2012, FUNGAL BIOL-UK, V116, P985, DOI 10.1016/j.funbio.2012.07.002; Ivors K, 2006, MOL ECOL, V15, P1493, DOI 10.1111/j.1365-294X.2006.02864.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kallio T, 1970, AERIAL DISTRIBUTION; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Kauserud Havard, 2012, Fungal Biology Reviews, V26, P84, DOI 10.1016/j.fbr.2012.08.001; Kauserud H, 2008, FUNGAL ECOL, V1, P19, DOI 10.1016/j.funeco.2007.12.001; Labbe J, 2011, CURR GENET, V57, P75, DOI 10.1007/s00294-010-0328-9; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; MALLETT KI, 1995, MYCOLOGIA, V87, P597, DOI 10.2307/3760804; MANTEL N, 1967, CANCER RES, V27, P209; Mascheretti S, 2009, MOL ECOL, V18, P4577, DOI 10.1111/j.1365-294X.2009.04379.x; Maurice S, 2014, MYCOLOGIA, V106, P889, DOI [10.3852/12-344, 10.3852/13-344]; NANDRIS D, 1987, EUR J FOREST PATHOL, V17, P271; NEI M, 1978, GENETICS, V89, P583; NELSON EE, 1976, FOREST SCI, V22, P407; Norden B, 2000, NORD J BOT, V20, P215, DOI 10.1111/j.1756-1051.2000.tb01572.x; Perrier X., 2006, DARWIN SOFTWARE; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rizzo DM, 1995, MYCOLOGIA, V87, P805, DOI 10.2307/3760857; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Sahashi N, 2010, MYCOL PROG, V9, P425, DOI 10.1007/s11557-009-0652-y; Sawada K, 1942, DESCRIPT CATAL FORMO, V7, P97; Sawada K, 1928, DESCRIPT CATAL FORMO, V4; Siju Senan, 2014, Notulae Scientia Biologicae, V6, P1; Srivilai P., 2013, African Journal of Microbiology Research, V7, P2885; Team RDCR, 2011, LANG ENV STAT COMP; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Travadon R, 2012, NEW PHYTOL, V193, P959, DOI 10.1111/j.1469-8137.2011.04015.x; Tsai J. N., 2007, Plant Pathology Bulletin, V16, P193; Tsai JN, 2008, THESIS NATL CHUNG HS; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/281912; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wu M.L., 2009, Q J CHINESE FORESTRY, V42, P239; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	66	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139445	10.1371/journal.pone.0139445	http://dx.doi.org/10.1371/journal.pone.0139445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485142	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100008
J	Kao, HC; Lin, CJ; Lee, YH; Chen, SH				Kao, Huei Chu; Lin, Chiuhsiang Joe; Lee, Yung Hui; Chen, Su Huang			The Effects of Direction of Exertion, Path, and Load Placement in Nursing Cart Pushing and Pulling Tasks: An Electromyographical Study	PLOS ONE			English	Article							LOW-BACK-PAIN; RISK-FACTORS; MUSCULOSKELETAL DISORDERS; HANDLE HEIGHT; WORK; DESIGN; SYMPTOMS; EXPOSURE; STRAINS; FORCES	The purpose of this study was to explore the effects of direction of exertion (DOE) (pushing, pulling), path (walking in a straight line, turning left, walking uphill), and load placement (LP) (the 18 blocks were indicated by X, Y and Z axis; there were 3 levels on the X axis, 2 levels on the Y axis, and 3 levels on the Z axis) on muscle activity and ratings of perceived exertion in nursing cart pushing and pulling tasks. Ten participants who were female students and not experienced nurses were recruited to participate in the experiment. Each participant performed 108 experimental trials in the study, consisting of 2 directions of exertion (push and pull), 3 paths, and 18 load placements (indicated by X, Y and Z axes). A 23kg load was placed into one load placement. The dependent variables were electromyographic (EMG) data of four muscles collected bilaterally as follows: Left (L) and right (R) trapezius (TR), flexor digitorum superficialis (FDS), extensor digitorum (ED), and erector spinae (ES) and subjective ratings of perceived exertion (RPE). Split-split-plot ANOVA was conducted to analyze significant differences between DOE, path, and LP in the EMG and RPE data. Pulling cart tasks produced a significantly higher activation of the muscles (RTR:54.4%, LTR:50.3%, LFDS:57.0%, LED:63.4%, RES:40.7%, LES:36.7%) than pushing cart tasks (RTR:42.4%, LTR:35.1%, LFDS:32.3%, LED:55.1%, RES:33.3%, LES:32.1%). A significantly greater perceived exertion was found in pulling cart tasks than pushing cart tasks. Significantly higher activation of all muscles and perceived exertion were observed for walking uphill than walking in a straight line and turning left. Significantly lower muscle activity of all muscles and subject ratings were observed for the central position on the X axis, the bottom position on the Y axis, and the posterior position on the Z axis. These findings suggest that nursing staff should adopt forward pushing when moving a nursing cart, instead of backward pulling, and that uphill paths should be avoided in the design of work environments. In terms of distribution of the load in a nursing cart, heavier materials should be positioned at bottom of the cabinet, centered on the horizontal plane and close to the handle, to reduce the physical load of the nursing staff.	[Kao, Huei Chu] Natl Taiwan Univ Sci & Technol, Grad Inst Management, Taipei, Taiwan; [Lin, Chiuhsiang Joe; Lee, Yung Hui; Chen, Su Huang] Natl Taiwan Univ Sci & Technol, Dept Ind Management, Taipei, Taiwan	National Taiwan University of Science & Technology; National Taiwan University of Science & Technology	Chen, SH (corresponding author), Natl Taiwan Univ Sci & Technol, Grad Inst Management, Taipei, Taiwan.	ryanchen11@gmail.com						Al-Eisawi KW, 1999, APPL ERGON, V30, P235, DOI 10.1016/S0003-6870(98)00019-2; Al-Eisawi KW, 1999, ERGONOMICS, V42, P1099, DOI 10.1080/001401399185162; Ando S, 2000, OCCUP ENVIRON MED, V57, P211, DOI 10.1136/oem.57.3.211; Authier, 1992, INT J IND ERGONOM, V9, P1, DOI 10.1016/0169-8141(92)90072-8; Bennett AI, 2011, WORK, V38, P291, DOI 10.3233/WOR-2011-1132; Borg G., 1998, BORGS PERCEIVED EXER; Burdorf A, 1999, SCAND J WORK ENV HEA, V25, P25; Bureau of Labor Statistics, 2014, OCC OUTL HDB; CHAFFIN DB, 1987, AM IND HYG ASSOC J, V48, P989, DOI 10.1202/0002-8894(1987)048<0989:MMHATB>2.0.CO;2; Chen SH, 2014, WORK IN PRESS; Ciriello VM, 2007, APPL ERGON, V38, P1, DOI 10.1016/j.apergo.2006.02.001; de Looze MP, 2000, ERGONOMICS, V43, P377, DOI 10.1080/001401300184477; Engels JA, 1996, OCCUP ENVIRON MED, V53, P636, DOI 10.1136/oem.53.9.636; Garcin M, 1996, EUR J APPL PHYSIOL O, V72, P478, DOI 10.1007/BF00242278; GARG A, 1992, OCCUP MED, V7, P593; Glitsch U, 2007, INT J IND ERGONOM, V37, P845, DOI 10.1016/j.ergon.2007.07.004; Hislop HJ, 2007, MUSCLE TESTING; Hoozemans M, 2004, ERGONOMICS, V47, P1, DOI 10.1080/00140130310001593577; Hoozemans MJM, 2014, OCCUP ENVIRON MED, V71, P788, DOI 10.1136/oemed-2013-101837; Hoozemans MJM, 1998, ERGONOMICS, V41, P757, DOI 10.1080/001401398186621; Jung MC, 2005, INT J IND ERGONOM, V35, P79, DOI 10.1016/j.ergon.2004.08.006; KANT IJ, 1992, INT ARCH OCC ENV HEA, V63, P423, DOI 10.1007/BF00386939; Kingma I, 2003, INT J IND ERGONOM, V31, P73, DOI 10.1016/S0169-8141(02)00176-2; KLEIN BP, 1984, J OCCUP ENVIRON MED, V26, P443, DOI 10.1097/00043764-198406000-00017; Kuijer PPFM, 2007, INT J IND ERGONOM, V37, P855, DOI 10.1016/j.ergon.2007.07.011; Kuiper JI, 1999, INT J IND ERGONOM, V24, P389, DOI 10.1016/S0169-8141(99)00006-2; KUMAR S, 1995, INT J IND ERGONOM, V15, P427, DOI 10.1016/0169-8141(94)00062-8; Lagerstrom M, 1995, INT ARCH OCC ENV HEA, V68, P27; LARESE F, 1994, ERGONOMICS, V37, P1205, DOI 10.1080/00140139408964898; LEE KS, 1991, APPL ERGON, V22, P117, DOI 10.1016/0003-6870(91)90310-E; LEE KS, 1992, IIE TRANS, V24, P139, DOI 10.1080/07408179208964254; Lee KS, 1982, SCI ENG, V43; Lin CL, 2010, APPL ERGON, V41, P313, DOI 10.1016/j.apergo.2009.08.005; Macfarlane GJ, 2000, BRIT MED J, V321, P676, DOI 10.1136/bmj.321.7262.676; METZLER F, 1985, ERGONOMICS, V28, P21, DOI 10.1080/00140138508963107; Moore Christopher, 2013, Occupational Ergonomics, V11, P75, DOI 10.3233/OER-130208; National Institute for Occupational Safety and Health, 1981, DHHS PUBL NIOSH, P81; Nijenhuis AWT, 1987, 30561A BGD; Perotto AO., 2011, ANATOMICAL GUIDE ELE; Resnick ML, 1996, HUM FACTORS, V38, P114, DOI 10.1518/001872096778940778; Roffey DM, 2010, SPINE J, V10, P544, DOI 10.1016/j.spinee.2010.03.025; SMEDLEY J, 1995, OCCUP ENVIRON MED, V52, P160, DOI 10.1136/oem.52.3.160; SNOOK SH, 1978, ERGONOMICS, V21, P963, DOI 10.1080/00140137808931804; Theado EW, 2007, INT J IND ERGONOM, V37, P825, DOI 10.1016/j.ergon.2007.07.012; Trinkoff AM, 2001, J OCCUP ENVIRON MED, V43, P355, DOI 10.1097/00043764-200104000-00012; Turpin-Legendre E, 2012, WORK, V41, P5516, DOI 10.3233/WOR-2012-0867-5516; van der Beek AJ, 1999, INT J IND ERGONOM, V24, P417, DOI 10.1016/S0169-8141(99)00008-6; WATERS TR, 1993, ERGONOMICS, V36, P749, DOI 10.1080/00140139308967940	48	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140792	10.1371/journal.pone.0140792	http://dx.doi.org/10.1371/journal.pone.0140792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485039	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100073
J	Ferguson, PE; Sales, CM; Hodges, DC; Sales, EW				Ferguson, Philip E.; Sales, Catherine M.; Hodges, Dalton C.; Sales, Elizabeth W.			Effects of a Multidisciplinary Approach to Improve Volume of Diagnostic Material in CT-Guided Lung Biopsies	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; CANCER; ADEQUACY; EGFR; CLASSIFICATION; EPIDEMIOLOGY; PNEUMOTHORAX; SPECIMENS; RISK	Background Recent publications have emphasized the importance of a multidisciplinary strategy for maximum conservation and utilization of lung biopsy material for advanced testing, which may determine therapy. This paper quantifies the effect of a multidisciplinary strategy implemented to optimize and increase tissue volume in CT-guided transthoracic needle core lung biopsies. The strategy was three-pronged: (1) once there was confidence diagnostic tissue had been obtained and if safe for the patient, additional biopsy passes were performed to further increase volume of biopsy material, (2) biopsy material was placed in multiple cassettes for processing, and (3) all tissue ribbons were conserved when cutting blocks in the histology laboratory. This study quantifies the effects of strategies #1 and #2. Design This retrospective analysis comparing CT-guided lung biopsies from 2007 and 2012 (before and after multidisciplinary approach implementation) was performed at a single institution. Patient medical records were reviewed and main variables analyzed include biopsy sample size, radiologist, number of blocks submitted, diagnosis, and complications. The biopsy sample size measured was considered to be directly proportional to tissue volume in the block. Results Biopsy sample size increased 2.5 fold with the average total biopsy sample size increasing from 1.0 cm (0.9-1.1 cm) in 2007 to 2.5 cm (2.3-2.8 cm) in 2012 (P<0.0001). The improvement was statistically significant for each individual radiologist. During the same time, the rate of pneumothorax requiring chest tube placement decreased from 15% to 7% (P = 0.065). No other major complications were identified. The proportion of tumor within the biopsy material was similar at 28% (23%-33%) and 35% (30%-40%) for 2007 and 2012, respectively. The number of cases with at least two blocks available for testing increased from 10.7% to 96.4% (P<0.0001). Conclusions The effect of this multidisciplinary strategy to CT-guided lung biopsies was effective in significantly increasing tissue volume and number of blocks available for advanced diagnostic testing.	[Ferguson, Philip E.; Sales, Elizabeth W.] St Bernards Med Ctr, Dept Pathol, Jonesboro, AR 72401 USA; [Ferguson, Philip E.; Sales, Elizabeth W.] Doctors Anat Pathol Serv, Jonesboro, AR USA; [Ferguson, Philip E.] PathMD, Jonesboro, AR USA; [Sales, Catherine M.] Tulane Univ, Dept Publ Hlth, New Orleans, LA 70118 USA; [Hodges, Dalton C.] Arkansas State Univ, Dept Sci & Math, Jonesboro, AR USA	Tulane University; Arkansas State University	Ferguson, PE (corresponding author), St Bernards Med Ctr, Dept Pathol, Jonesboro, AR 72401 USA.	peferguson@pathmd.com			PathMD	PathMD	The authors have no support or funding to report. PathMD, LLC is an educational services company wholly owned and operated by Dr. Philip Ferguson, M.D. (PEF). PathMD provides online educational resources at no charge for pathologists and pathology residents preparing for board certification. PathMD provided support in the form of salaries for author PEF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Specific roles of this author are articulated in the "author contributions" section.	Beasley MB, 2011, J ONCOL PRACT, V7, P202, DOI 10.1200/JOP.2010.000166; Boskovic T, 2014, J THORAC DIS, V6, pS99, DOI 10.3978/j.issn.2072-1439.2013.12.08; Cooper WA, 2011, PATHOLOGY, V43, P103, DOI 10.1097/PAT.0b013e328342629d; Dacic S, 2010, MODERN PATHOL, V23, P159, DOI 10.1038/modpathol.2009.154; Ferretti GR, 2013, LUNG CANCER, V82, P69, DOI 10.1016/j.lungcan.2013.07.010; Ghanaati H, 2008, IRAN J RADIOL, V5, P39; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Howlader N., 2017, SEER CANC STAT REV 1; Lindeman NI, 2013, ARCH PATHOL LAB MED, V137, P828, DOI [10.5858/arpa.2012-0720-OA, 10.1097/JTO.0b013e318290868f]; Rekhtman N, 2015, ARCH PATHOL LAB MED, V139, P907, DOI 10.5858/arpa.2014-0392-OA; Schneider F, 2015, AM J CLIN PATHOL, V143, P193, DOI 10.1309/AJCPMY8UI7WSFSYY; Shah PL, 2006, J THORAC ONCOL, V1, P324, DOI 10.1097/01243894-200605000-00010; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Solomon SB, 2010, AM J ROENTGENOL, V194, P266, DOI 10.2214/AJR.09.2858; Travis W, 2004, WHO CLASSIFICATION T; Travis WD, 2011, EUR RESPIR J, V38, P239, DOI 10.1183/09031936.00026711; Travis WD, 2011, SEMIN RESP CRIT CARE, V32, P22, DOI 10.1055/s-0031-1272866; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; U.S. Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; Wallace MJ, 2002, RADIOLOGY, V225, P823, DOI 10.1148/radiol.2253011465; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003; Yeow KM, 2004, CHEST, V126, P748, DOI 10.1378/chest.126.3.748; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	24	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140998	10.1371/journal.pone.0140998	http://dx.doi.org/10.1371/journal.pone.0140998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479367	gold, Green Published, Green Submitted			2022-12-27	WOS:000363026600028
J	Guma, M; Wang, Y; Viollet, B; Ru, LB				Guma, Monica; Wang, Yun; Viollet, Benoit; Ru Liu-Bryan			AMPK Activation by A-769662 Controls IL-6 Expression in Inflammatory Arthritis	PLOS ONE			English	Article							NF-KAPPA-B; INSULIN-RESISTANCE; TNF; INHIBITION; RELEVANCE; CANCER; CELLS	Objective AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase critically involved in the regulation of cellular energy homeostasis. It is a central regulator of both lipid and glucose metabolism. Many studies have suggested that AMPK activation exert significant anti-inflammatory and immunosuppressive effects. In this study, we assessed whether targeted activation of AMPK inhibits inflammatory arthritis in vivo. Methods We tested the effect of A-769662, a specific AMPK agonist (60mg/kg/bid) in mouse models of antigen-induced arthritis (AIA) and passive K/BxN serum-induced arthritis. The passive K/BxN serum-induced arthritis model was also applied to AMPK alpha 1-deficient mice. Joints were harvested and subjected to histological analysis. IL-6 expression was measured in both joint tissues and sera by ELISA. The effect of A-769662 on bone marrow derived macrophage (BMDM) response to stimulation with TLR2 and TLR4 agonists was tested in vitro. Results AMPK activation by A-769662 reduced inflammatory infiltration and joint damage in both mouse models. IL-6 expression in serum and arthritic joints was significantly decreased in A-769662-treated mice. AMPK alpha 1 deficient mice mildly elicited an increase of clinical arthritis. IL-6 expression at both mRNA and protein levels, phosphorylation of p65 NF-kappa B and MAPK phosphorylation were inhibited by A-769662 in BMDMs stimulated with either TLR2 or TLR4 agonists. Conclusions AMPK activation by specific AMPK agonist A-769662 suppressed inflammatory arthritis in mice as well as IL-6 expression in serum and arthritic joints. These data suggest that targeted activation of AMPK has a potential to be an effective therapeutic strategy for IL-6 dependent inflammatory arthritis.	[Guma, Monica; Wang, Yun; Ru Liu-Bryan] Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA; [Viollet, Benoit] INSERM, Inst Cochin, U1016, Paris, France; [Viollet, Benoit] CNRS, UMR8104, Paris, France; [Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Ru Liu-Bryan] VA San Diego Healthcare Syst, La Jolla, CA USA	University of California System; University of California San Diego; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Guma, M (corresponding author), Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA.	mguma@ucsd.edu; ruliu@ucsd.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; guma, monica/0000-0003-1951-9411; wang, yun/0000-0002-4346-0096	National Institutes of Health [K08AR064834, T32AR06419, AR106796]; Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR064834, T32AR064194] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health [K08AR064834 (MG); T32AR06419 (YW); AR106796 (RLB)] and Arthritis Foundation [http://www.arthritis.org (RLB)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai AP, 2010, J PHARMACOL EXP THER, V333, P717, DOI 10.1124/jpet.109.164954; Benziane B, 2009, AM J PHYSIOL-CELL PH, V297, pC1554, DOI 10.1152/ajpcell.00010.2009; Christianson CA, 2012, METHODS MOL BIOL, V851, P249, DOI 10.1007/978-1-61779-561-9_19; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Ding CH, 2009, EXPERT OPIN INV DRUG, V18, P1457, DOI 10.1517/13543780903203789; Ferraz-Amaro I, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/710928; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Geyer M, 2010, CURR OPIN RHEUMATOL, V22, P246, DOI 10.1097/BOR.0b013e3283373fa0; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Green CJ, 2011, BIOCHEM J, V435, P463, DOI 10.1042/BJ20101517; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Hammaker D, 2003, ANN RHEUM DIS, V62, P86; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kang KY, 2013, INT IMMUNOPHARMACOL, V16, P85, DOI 10.1016/j.intimp.2013.03.020; Kim YD, 2012, DIABETOLOGIA, V55, P1482, DOI 10.1007/s00125-012-2494-4; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Muller-Ladner Ulf, 2002, Curr Rheumatol Rep, V4, P201, DOI 10.1007/s11926-002-0066-1; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Prasad R, 2006, J NEUROSCI RES, V84, P614, DOI 10.1002/jnr.20953; Richards PJ, 1999, RHEUMATOLOGY, V38, P818, DOI 10.1093/rheumatology/38.9.818; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Salt IP, 2012, EXPERT OPIN INV DRUG, V21, P1155, DOI 10.1517/13543784.2012.696609; Sethi G, 2009, ADV EXP MED BIOL, V647, P37, DOI 10.1007/978-0-387-89520-8_3; Simmonds RE, 2008, RHEUMATOLOGY, V47, P584, DOI 10.1093/rheumatology/kem298; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Treebak JT, 2009, AM J PHYSIOL-CELL PH, V297, pC1041, DOI 10.1152/ajpcell.00051.2009; Vincent EE, 2014, ONCOGENE; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yusof MYM, 2013, DRUGS, V73, P341, DOI 10.1007/s40265-013-0018-2; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	37	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140452	10.1371/journal.pone.0140452	http://dx.doi.org/10.1371/journal.pone.0140452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474486	Green Published, Green Submitted, gold			2022-12-27	WOS:000363185500053
J	Anzai, T; Fukunaga, I; Hatakeyama, K; Fujimoto, A; Kobayashi, K; Nishikawa, A; Aoki, T; Noda, T; Minowa, O; Ikeda, K; Kamiya, K				Anzai, Takashi; Fukunaga, Ichiro; Hatakeyama, Kaori; Fujimoto, Ayumi; Kobayashi, Kazuma; Nishikawa, Atena; Aoki, Toru; Noda, Tetsuo; Minowa, Osamu; Ikeda, Katsuhisa; Kamiya, Kazusaku			Deformation of the Outer Hair Cells and the Accumulation of Caveolin-2 in Connexin 26 Deficient Mice	PLOS ONE			English	Article							CELLULAR DEGENERATION; POSTNATAL-DEVELOPMENT; HEARING-LOSS; EXPRESSION; ORGAN; VARIABILITY; PROGRESSION; MUTATIONS; ABLATION; CORTI	Background Mutations in GJB2, which encodes connexin 26 (Cx26), a cochlear gap junction protein, represent a major cause of pre-lingual, non-syndromic deafness. The degeneration of the organ of Corti observed in Cx26 mutant-associated deafness is thought to be a secondary pathology of hearing loss. Here we focused on abnormal development of the organ of Corti followed by degeneration including outer hair cell (OHC) loss. Methods We investigated the crucial factors involved in late-onset degeneration and loss of OHC by ultrastructural observation, immunohistochemistry and protein analysis in our Cx26-deficient mice (Cx26(f/f)P0Cre). Results In ultrastructural observations of Cx26(f/f)P0Cre mice, OHCs changed shape irregularly, and several folds or notches were observed in the plasma membrane. Furthermore, the mutant OHCs had a flat surface compared with the characteristic wavy surface structure of OHCs of normal mice. Protein analysis revealed an increased protein level of caveolin-2 (CAV2) in Cx26(f/f)P0Cre mouse cochlea. In immunohistochemistry, a remarkable accumulation of CAV2 was observed in Cx26(f/f)P0Cre mice. In particular, this accumulation of CAV2 was mainly observed around OHCs, and furthermore this accumulation was observed around the shrunken site of OHCs with an abnormal hourglass-like shape. Conclusions The deformation of OHCs and the accumulation of CAV2 in the organ of Corti may play a crucial role in the progression of, or secondary OHC loss in, GJB2-associated deafness. Investigation of these molecular pathways, including those involving CAV2, may contribute to the elucidation of a new pathogenic mechanism of GJB2-associated deafness and identify effective targets for new therapies.	[Anzai, Takashi; Fukunaga, Ichiro; Hatakeyama, Kaori; Fujimoto, Ayumi; Kobayashi, Kazuma; Nishikawa, Atena; Aoki, Toru; Ikeda, Katsuhisa; Kamiya, Kazusaku] Juntendo Univ, Fac Med, Dept Otorhinolaryngol, Tokyo 1138421, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 1358550, Japan; [Noda, Tetsuo; Minowa, Osamu] RIKEN BioResource Ctr, Team Adv Dev & Evaluat Human Dis Models, Tsukuba, Ibaraki 3050074, Japan	Juntendo University; Japanese Foundation for Cancer Research; RIKEN	Kamiya, K (corresponding author), Juntendo Univ, Fac Med, Dept Otorhinolaryngol, Tokyo 1138421, Japan.	kkamiya@juntendo.ac.jp	Minowa, Osamu/AAM-1238-2020; Anzai, Toshihisa/J-2179-2015; Noda, Tetsuo/B-1667-2016; Kamiya, Kazusaku/Y-3376-2019	Anzai, Toshihisa/0000-0003-3319-4967; 	JSPS KAKENHI [25462653]; Ministry of Health, Labor and Welfare of Japan [25293351]; MEXT-support program for the Strategic Research Foundation at Private Universities; Research on Intractable Diseases from Japan Agency for Medical Research and development, AMED; Takeda science foundation; Grants-in-Aid for Scientific Research [15K20229] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); MEXT-support program for the Strategic Research Foundation at Private Universities; Research on Intractable Diseases from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Takeda science foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI grant number 25462653 (to K Kamiya) and grant number 25293351 (to KI), Ministry of Health, Labor and Welfare of Japan (to K Kamiya), MEXT-support program for the Strategic Research Foundation at Private Universities, 2011-2015 (to KI), the Research on Intractable Diseases from Japan Agency for Medical Research and development, AMED (to K Kamiya) and Takeda science foundation (to K Kamiya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaut J, 2015, NEUROSCIENCE, V285, P215, DOI 10.1016/j.neuroscience.2014.10.035; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Birkenhager R, 2010, AM J MED GENET A, V152A, P1798, DOI 10.1002/ajmg.a.33464; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Chan DK, 2010, GENET MED, V12, P174, DOI 10.1097/GIM.0b013e3181d0d42b; Chen J, 2014, BIOCHEM BIOPH RES CO, V448, P28, DOI 10.1016/j.bbrc.2014.04.016; Chen S, 2014, BIOCHEM BIOPH RES CO, V445, P71, DOI 10.1016/j.bbrc.2014.01.154; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Dallos P, 1997, J NEUROSCI, V17, P2212; Edge ASB, 2008, CURR OPIN NEUROBIOL, V18, P377, DOI 10.1016/j.conb.2008.10.001; Frolenkov GI, 2000, J NEUROSCI, V20, P5940, DOI 10.1523/JNEUROSCI.20-16-05940.2000; Gassmann MG, 2000, EXP CELL RES, V258, P23, DOI 10.1006/excr.2000.4904; Iizuka T, 2015, HUM MOL GENET, V24, P3651, DOI 10.1093/hmg/ddv109; Inoshita A, 2008, NEUROSCIENCE, V156, P1039, DOI 10.1016/j.neuroscience.2008.08.027; Inoshita A, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-1; Iwatsubo K, 2003, EXPERT OPIN THER TAR, V7, P441, DOI 10.1517/eott.7.3.441.22433; Jun AI, 2000, LARYNGOSCOPE, V110, P269, DOI 10.1097/00005537-200002010-00016; Kalinec F, 2000, J BIOL CHEM, V275, P28000; Kamiya K, 2014, J CLIN INVEST, V124, P1598, DOI 10.1172/JCI67621; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kudo T, 2003, HUM MOL GENET, V12, P995, DOI 10.1093/hmg/ddg116; Lee JA, 2015, ONCOTARGET, V6, P1942, DOI 10.18632/oncotarget.3039; Mason JA, 1998, PEDIATRICS, V101, P221, DOI 10.1542/peds.101.2.221; Minekawa A, 2009, NEUROSCIENCE, V164, P1312, DOI 10.1016/j.neuroscience.2009.08.043; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Petersen MB, 2006, CLIN GENET, V69, P371, DOI 10.1111/j.1399-0004.2006.00613.x; Rhim JH, 2010, MOL MED, V16, P527, DOI 10.2119/molmed.2010.00046; Sowa G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/809259; Sun Y, 2009, J COMP NEUROL, V516, P569, DOI 10.1002/cne.22117; Teranishi M, 2013, FREE RADICAL RES, V47, P498, DOI 10.3109/10715762.2013.793319; Volonte D, 2009, AGING-US, V1, P831, DOI 10.18632/aging.100079; Wang YF, 2009, BIOCHEM BIOPH RES CO, V385, P33, DOI 10.1016/j.bbrc.2009.05.023; Xie LK, 2010, AM J PHYSIOL-CELL PH, V298, pC693, DOI 10.1152/ajpcell.00401.2009; Zelenskaya A, 2005, BIOPHYS J, V88, P2982, DOI 10.1529/biophysj.104.052225; Zhang M, 2003, J BIOL CHEM, V278, P35644, DOI 10.1074/jbc.M301668200	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141258	10.1371/journal.pone.0141258	http://dx.doi.org/10.1371/journal.pone.0141258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492081	Green Published, Green Submitted, gold			2022-12-27	WOS:000363249300040
J	Bruce, A; Evans, R; Mezan, R; Shi, L; Moses, BS; Martin, KH; Gibson, LF; Yang, Y				Bruce, Allison; Evans, Rebecca; Mezan, Ryan; Shi, Lin; Moses, Blake S.; Martin, Karen H.; Gibson, Laura F.; Yang, Yong			Three-Dimensional Microfluidic Tri-Culture Model of the Bone Marrow Microenvironment for Study of Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; DRUG-RESISTANCE; CANCER CELLS; HEMATOPOIETIC MICROENVIRONMENT; EXTRACELLULAR-MATRIX; INTERSTITIAL FLOW; PROSTATE-CANCER; TUMOR-CELLS; 3D; COLLAGEN	Acute lymphoblastic leukemia (ALL) initiates and progresses in the bone marrow, and as such, the marrow microenvironment is a critical regulatory component in development of this cancer. However, ALL studies were conducted mainly on flat plastic substrates, which do not recapitulate the characteristics of marrow microenvironments. To study ALL in a model of in vivo relevance, we have engineered a 3-D microfluidic cell culture platform. Biologically relevant populations of primary human bone marrow stromal cells, osteoblasts and human leukemic cells representative of an aggressive phenotype were encapsulated in 3-D collagen matrix as the minimal constituents and cultured in a microfluidic platform. The matrix stiffness and fluidic shear stress were controlled in a physiological range. The 3-D microfluidic as well as 3-D static models demonstrated coordinated cell-cell interactions between these cell types compared to the compaction of the 2-D static model. Tumor cell viability in response to an antimetabolite chemotherapeutic agent, cytarabine in tumor cells alone and tri-culture models for 2-D static, 3-D static and 3-D microfluidic models were compared. The present study showed decreased chemotherapeutic drug sensitivity of leukemic cells in 3-D tri-culture models from the 2-D models. The results indicate that the bone marrow microenvironment plays a protective role in tumor cell survival during drug treatment. The engineered 3-D microfluidic tri-culture model enables systematic investigation of effects of cell-cell and cell-matrix interactions on cancer progression and therapeutic intervention in a controllable manner, thus improving our limited comprehension of the role of microenvironmental signals in cancer biology.	[Bruce, Allison; Mezan, Ryan; Shi, Lin; Yang, Yong] W Virginia Univ, Dept Chem Engn, Morgantown, WV 26506 USA; [Evans, Rebecca; Moses, Blake S.; Gibson, Laura F.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Alexander B Osborn Hematopoiet Malignancy & Trans, Morgantown, WV 26506 USA; [Martin, Karen H.] W Virginia Univ, Dept Neurobiol & Anat, Morgantown, WV 26506 USA; [Gibson, Laura F.] W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University	Gibson, LF (corresponding author), W Virginia Univ, Mary Babb Randolph Canc Ctr, Alexander B Osborn Hematopoiet Malignancy & Trans, Morgantown, WV 26506 USA.	lgibson@hsc.wvu.edu; yong.yang@mail.wvu.edu		Gibson, Laura/0000-0002-7291-9046; Martin, Karen/0000-0001-8916-4092; Moses, Blake/0000-0001-8045-3066	NIGMS NIH HHS [U54 GM104942, P30 GM103488] Funding Source: Medline; Div Of Chem, Bioeng, Env, & Transp Sys [1227766] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488, U54GM104942] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Aljitawi OS, 2014, LEUKEMIA LYMPHOMA, V55, P378, DOI 10.3109/10428194.2013.793323; Ayala F, 2009, LEUKEMIA, V23, P2233, DOI 10.1038/leu.2009.175; Bergfeld SA, 2014, MOL CANCER THER, V13, P962, DOI 10.1158/1535-7163.MCT-13-0400; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Buchanan CF, 2014, TISSUE ENG PART C-ME, V20, P64, DOI [10.1089/ten.tec.2012.0731, 10.1089/ten.TEC.2012.0731]; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; CLAVEL C, 1989, INT J CANCER, V44, P548, DOI 10.1002/ijc.2910440329; Dafni H, 2002, CANCER RES, V62, P6731; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ellis WJ, 2003, UROLOGY, V61, P277, DOI 10.1016/S0090-4295(02)02291-4; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Gao BT, 2014, BIOMATERIALS, V35, P2181, DOI 10.1016/j.biomaterials.2013.11.060; Haessler U, 2012, INTEGR BIOL-UK, V4, P401, DOI 10.1039/c1ib00128k; HAMILTON R, 1991, ANAT REC, V231, P218, DOI 10.1002/ar.1092310210; Herrmann D, 2014, CARCINOGENESIS, V35, P1671, DOI 10.1093/carcin/bgu108; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Howe GA, 2012, CELL ADHES MIGR, V6, P71, DOI 10.4161/cam.20077; Hsieh YT, 2013, BLOOD, V121, P1814, DOI 10.1182/blood-2012-01-406272; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Ibbetson SJ, 2013, AM J PATHOL, V183, P930, DOI 10.1016/j.ajpath.2013.05.014; IMAMURA T, 1995, PANCREAS, V11, P357, DOI 10.1097/00006676-199511000-00007; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Janouskova H, 2012, CANCER RES, V72, P3463, DOI 10.1158/0008-5472.CAN-11-4199; Jiglaire CJ, 2014, EXP CELL RES, V321, P99, DOI 10.1016/j.yexcr.2013.12.010; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kihara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082382; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; KLEIN G, 1995, EXPERIENTIA, V51, P914, DOI 10.1007/BF01921741; Lam CRI, 2014, MOL PHARMACEUT, V11, P2016, DOI 10.1021/mp500059q; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Ling Y, 2007, LAB CHIP, V7, P756, DOI 10.1039/b615486g; Liu J, 2012, NAT MATER, V11, P734, DOI [10.1038/nmat3361, 10.1038/NMAT3361]; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; MAYANI H, 1992, EUR J HAEMATOL, V49, P225; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Nair RR, 2010, BIOCHEM PHARMACOL, V80, P602, DOI 10.1016/j.bcp.2010.04.003; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Pizzimenti S., 2014, J PEDIAT ONCOL, V2, P40, DOI [10.14205/2309-3021.2014.02.01.5, DOI 10.14205/2309-3021.2014.02.01.5]; Polacheck WJ, 2011, P NATL ACAD SCI USA, V108, P11115, DOI 10.1073/pnas.1103581108; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Rhodes NP, 2004, J MATER SCI-MATER M, V15, P391, DOI 10.1023/B:JMSM.0000021108.74004.7e; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; Santini MT, 2000, CRIT REV ONCOL HEMAT, V36, P75, DOI 10.1016/S1040-8428(00)00078-0; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Shieh AC, 2011, CANCER RES, V71, P790, DOI 10.1158/0008-5472.CAN-10-1513; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Szot CS, 2011, BIOMATERIALS, V32, P7905, DOI 10.1016/j.biomaterials.2011.07.001; Talukdar S, 2012, ADV FUNCT MATER, V22, P4778, DOI 10.1002/adfm.201200375; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Windus LCE, 2012, EXP CELL RES, V318, P2507, DOI 10.1016/j.yexcr.2012.07.013; Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang Y, 2004, POLYMER, V45, P1959, DOI 10.1016/j.polymer.2004.01.015; Yang Y, 2012, ACS NANO, V6, P8591, DOI 10.1021/nn301713d; Yang Y, 2011, LAB CHIP, V11, P1638, DOI 10.1039/c0lc00736f; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Zustiak S, 2014, BIOTECHNOL BIOENG, V111, P396, DOI 10.1002/bit.25097	68	57	57	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140506	10.1371/journal.pone.0140506	http://dx.doi.org/10.1371/journal.pone.0140506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488876	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400056
J	Fisher, G; Brown, AW; Brown, MMB; Alcorn, A; Noles, C; Winwood, L; Resuehr, H; George, B; Jeansonne, MM; Allison, DB				Fisher, Gordon; Brown, Andrew W.; Brown, Michelle M. Bohan; Alcorn, Amy; Noles, Corey; Winwood, Leah; Resuehr, Holly; George, Brandon; Jeansonne, Madeline M.; Allison, David B.			High Intensity Interval- vs Moderate Intensity-Training for Improving Cardiometabolic Health in Overweight or Obese Males: A Randomized Controlled Trial	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; BODY-MASS INDEX; INSULIN SENSITIVITY; SPRINT INTERVAL; CARDIORESPIRATORY FITNESS; BLOOD-PRESSURE; RISK-FACTORS; LOW-VOLUME; FAT LOSS; EXERCISE	Purpose To compare the effects of six weeks of high intensity interval training (HIIT) vs continuous moderate intensity training (MIT) for improving body composition, insulin sensitivity (SI), blood pressure, blood lipids, and cardiovascular fitness in a cohort of sedentary overweight or obese young men. We hypothesized that HIIT would result in similar improvements in body composition, cardiovascular fitness, blood lipids, and SI as compared to the MIT group, despite requiring only one hour of activity per week compared to five hours per week for the MIT group. Methods 28 sedentary overweight or obese men (age, 20 +/- 1.5 years, body mass index 29.5 +/- 3.3 kg/m(2)) participated in a six week exercise treatment. Participants were randomly assigned to HIIT or MIT and evaluated at baseline and post-training. DXA was used to assess body composition, graded treadmill exercise test to measure cardiovascular fitness, oral glucose tolerance tomeasure SI, nuclear magnetic resonance spectroscopy to assess lipoprotein particles, and automatic auscultation tomeasure blood pressure. Results A greater improvement in VO2peak was observed in MIT compared to HIIT (11.1% vs 2.83%, P = 0.0185) in the complete-case analysis. No differences were seen in the intention to treat analysis, and no other group differences were observed. Both exercise conditions were associated with temporal improvements in% body fat, total cholesterol, medium VLDL, medium HDL, triglycerides, SI, and VO2peak (P < 0.05). Conclusion Participation in HIIT or MIT exercise training displayed: 1) improved SI, 2) reduced blood lipids, 3) decreased % body fat, and 4) improved cardiovascular fitness. While both exercise groups led to similar improvements for most cardiometabolic risk factors assessed, MIT led to a greater improvement in overall cardiovascular fitness. Overall, these observations suggest that a relatively short duration of either HIIT or MIT training may improve cardiometabolic risk factors in previously sedentary overweight or obese young men, with no clear advantage between these two specific regimes	[Fisher, Gordon; Noles, Corey; Winwood, Leah] Univ Alabama Birmingham, Dept Human Studies, Birmingham, AL USA; [Fisher, Gordon; Brown, Andrew W.; Alcorn, Amy; Resuehr, Holly; George, Brandon; Jeansonne, Madeline M.; Allison, David B.] Univ Alabama Birmingham, Nutr & Obes Res Ctr, Birmingham, AL USA; [Brown, Andrew W.; Alcorn, Amy; George, Brandon; Jeansonne, Madeline M.; Allison, David B.] Univ Alabama Birmingham, Off Energet, Birmingham, AL USA; [Fisher, Gordon; Brown, Michelle M. Bohan; Resuehr, Holly; Allison, David B.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL USA; [Brown, Michelle M. Bohan] Clemson Univ, Dept Food Nutr & Packaging Sci, Clemson, SC USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Clemson University	Fisher, G (corresponding author), Univ Alabama Birmingham, Dept Human Studies, Birmingham, AL USA.	grdnfs@uab.edu	Brown, Andrew W/N-1826-2013	Brown, Andrew W/0000-0002-1758-8205; Fisher, Gordon/0000-0002-9191-3774	Coca-Cola Foundation; NIH [P30DK056336, UL1RR025777, T32DK062710]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001417] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, T32DK062710, P30DK079626] Funding Source: NIH RePORTER	Coca-Cola Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Drs. Fisher, Allison, Brown, and Bohan-Brown report receiving grant support from the Coca-Cola Foundation through their institution. Supported in part by an unrestricted gift from the Coca-Cola Foundation (http://www.coca-colacompany.com/our-company/the-coca-cola-foundation) and by NIH grants P30DK056336, UL1RR025777, and T32DK062710. The content is solely the responsibility of the authors and does not necessarily reflect that of the NIH or any other organization. The funding agencies for this study did not provide any input towards the study design, data collection, analysis, decision to publish, or the preparation of the manuscript.	Aamot IL, 2016, PHYSIOTHER RES INT, V21, P54, DOI 10.1002/pri.1619; Aronis KN, 2014, METABOLISM, V63, P1, DOI 10.1016/j.metabol.2013.08.002; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; Bajpeyi S, 2009, J APPL PHYSIOL, V106, P1079, DOI 10.1152/japplphysiol.91262.2008; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Chan-Dewar F, 2015, PRIM CARE DIABETES, V9, P446, DOI 10.1016/j.pcd.2015.01.013; Ciolac EG, 2010, HYPERTENS RES, V33, P836, DOI 10.1038/hr.2010.72; Cromwell William C, 2004, Curr Atheroscler Rep, V6, P381, DOI 10.1007/s11883-004-0050-5; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Gillen JB, 2013, OBESITY, V21, P2249, DOI 10.1002/oby.20379; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hazell TJ, 2014, APPL PHYSIOL NUTR ME, V39, P944, DOI 10.1139/apnm-2013-0503; Hazell TJ, 2010, EUR J APPL PHYSIOL, V110, P153, DOI 10.1007/s00421-010-1474-y; Houmard JA, 2004, J APPL PHYSIOL, V96, P101, DOI 10.1152/japplphysiol.00707.2003; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Kaminsky LA, 2013, CIRCULATION, V127, P652, DOI 10.1161/CIR.0b013e31827ee100; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kokkinos P, 2010, CIRCULATION, V122, P1637, DOI 10.1161/CIRCULATIONAHA.110.948349; Lamarche B, 1996, ATHEROSCLEROSIS, V119, P235, DOI 10.1016/0021-9150(95)05653-X; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Musa DI, 2009, J STRENGTH COND RES, V23, P587, DOI 10.1519/JSC.0b013e318198fd28; Nybo L, 2010, MED SCI SPORT EXER, V42, P1951, DOI 10.1249/MSS.0b013e3181d99203; RICHTER EA, 1989, J APPL PHYSIOL, V66, P876; Rondon MUP, 2002, J AM COLL CARDIOL, V39, P676, DOI 10.1016/S0735-1097(01)01789-2; Rye KA, 2012, BBA-MOL CELL BIOL L, V1821, P473, DOI 10.1016/j.bbalip.2011.10.012; Sloth M, 2013, SCAND J MED SCI SPOR, V23, pE341, DOI 10.1111/sms.12092; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; van Lenthe FJ, 1998, AM J EPIDEMIOL, V147, P686, DOI 10.1093/oxfordjournals.aje.a009510; WALLBERGHENRIKSSON H, 1984, J APPL PHYSIOL, V57, P1045, DOI 10.1152/jappl.1984.57.4.1045; Wallman K, 2009, RES SPORTS MED, V17, P156, DOI 10.1080/15438620903120215; Warburton DER, 2005, AM J CARDIOL, V95, P1080, DOI 10.1016/j.amjcard.2004.12.063; Webber LS, 1995, AM J MED SCI, V310, pS53, DOI 10.1097/00000441-199512000-00010; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002	41	118	121	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0138853	10.1371/journal.pone.0138853	http://dx.doi.org/10.1371/journal.pone.0138853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489022	Green Submitted, gold, Green Published			2022-12-27	WOS:000363248400012
J	Koch, P; Stranzinger, J; Nienhaus, A; Kozak, A				Koch, Peter; Stranzinger, Johanna; Nienhaus, Albert; Kozak, Agnessa			Musculoskeletal Symptoms and Risk of Burnout in Child Care Workers - A Cross-Sectional Study	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; ROAD TRAFFIC NOISE; OCCUPATIONAL STRESS; JOB-STRESS; PAIN; HEALTH; QUESTIONNAIRE; TEACHERS; EXPOSURE; NECK	Objectives German child care workers' job satisfaction is influenced by the consequences of unfavourable underlying conditions. Child care workers tend to suffer from psychosocial stress, as they feel that their work is undervalued. The objective of the present study is to investigate how the psychosocial factors of the effort-reward imbalance (ERI) model influence musculoskeletal symptoms (MS) and the risk of burnout. To our knowledge this is the first study investigating the association between the factors of the ERI model and MS in child care workers. Methods and Findings Data from 199 child care workers were examined in a cross-sectional study. Psychosocial factors were recorded with the ERI questionnaire. MS was recorded with the Nordic Questionnaire and risk of burnout with the Personal Burnout scale of the Copenhagen Burnout Inventory. Multivariate analysis was performed using linear and logistic regression models. The response rate was 57%. In most of the sample (65%), an effort-reward imbalance was observed. 56% of the child care workers were at risk of burnout and 58% reported MS. Factors associated with risk of burnout were subjective noise exposure (OR: 4.4, 95% CI: 1.55-12.29) and overcommitment (OR: 3.4; 95% CI: 1.46-7.75). There were statistically significant associations between MS and overcommitment (low back pain-OR: 2.2, 95% CI: 1.04-4.51), low control (overall MS OR: 3.8; 95% CI: 1.68-3.37) and risk of burnout (overall MS OR: 2.3, 95% CI: 1.01-5.28). For ERI no statistically significant associations were found with reference to risk of burnout or MS. Conclusion Overcommitment in child care workers is related to MS and risk of burnout. There is also evidence that low control is associated with MS and subjective noise exposure with risk of burnout. Effort-reward imbalance is not related to either outcome. This occupational health risk assessment identifies changeable working factors in different types of facilities.	[Koch, Peter; Nienhaus, Albert; Kozak, Agnessa] Univ Med Ctr Hamburg Eppendorf, Ctr Excellence Epidemiol & Hlth Serv Res Healthca, D-20246 Hamburg, Germany; [Stranzinger, Johanna; Nienhaus, Albert] Inst Statutory Accid Insurance & Prevent Hlth & W, Hlth Protect Div FBG, D-22089 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Koch, P (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Excellence Epidemiol & Hlth Serv Res Healthca, Martinistr 52, D-20246 Hamburg, Germany.	p.koch@uke.de						[Anonymous], 1992, CAR LIV STUD WAG WOR; ARCHES J, 1991, SOC WORK, V36, P202; Armon G, 2010, J OCCUP HEALTH PSYCH, V15, P399, DOI 10.1037/a0020726; Bernard C, 2011, J OCCUP HEALTH, V53, P297, DOI 10.1539/joh.10-0031-OA; Bertolino B., 1999, RESIDENTIAL YOUTH CA; Bodin T, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-38; Bonzini M, 2015, INT ARCH OCC ENV HEA, V88, P607, DOI 10.1007/s00420-014-0982-1; Bosma H, 1998, AM J PUBLIC HEALTH, V88, P68, DOI 10.2105/AJPH.88.1.68; Chou LP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004185; de Jonge J, 2000, SOC SCI MED, V50, P1317, DOI 10.1016/S0277-9536(99)00388-3; de Kluizenaar Y, 2009, J ACOUST SOC AM, V126, P626, DOI 10.1121/1.3158834; Dragano N., 2003, J PUBLIC HEALTH-UK, V11, P196, DOI [10.1007/BF02956410, DOI 10.1007/BF02956410]; Ehlen A, 2014, STRESSBELASTUNGEN BU; Eysel-Gosepath K, 2010, HNO, V58, P1013, DOI 10.1007/s00106-010-2121-y; Frank H, 1998, ARBEIT GESUNDHEIT MI; Frieling E, 2001, BELASTUNGS BEANSPRUC; Gan WQ, 2011, OCCUP ENVIRON MED, V68, P183, DOI 10.1136/oem.2010.055269; Grant KA, 1995, APPL ERGON, V26, P405, DOI 10.1016/0003-6870(95)00057-7; Gratz RR, 1996, EARLY CHILD RES Q, V11, P243, DOI 10.1016/S0885-2006(96)90008-3; Hebert S, 2009, INT J HYG ENVIR HEAL, V212, P37, DOI 10.1016/j.ijheh.2007.11.005; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Joksimovic L, 2002, INT J BEHAV MED, V9, P122, DOI 10.1207/S15327558IJBM0902_04; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Koch P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-37; Kozak A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089362; Kraatz S, 2013, INT ARCH OCC ENV HEA, V86, P375, DOI 10.1007/s00420-013-0848-y; Krause N, 2010, SCAND J WORK ENV HEA, V36, P42, DOI 10.5271/sjweh.2881; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Kushnir T, 1992, INT C CHILD DAY CAR; Lang J, 2012, SOC SCI MED, V75, P1163, DOI 10.1016/j.socscimed.2012.04.015; Lapointe J, 2013, WORK, V44, P133, DOI 10.3233/WOR-2012-1357; Lau Bjorn, 2008, J Occup Med Toxicol, V3, P9, DOI 10.1186/1745-6673-3-9; Manlove EE, 1993, EARLY CHILD RES Q, V8, P499, DOI [10.1016/S0885-2006(05)80082-1, DOI 10.1016/S0885-2006(05)80082-1]; Melamed S, 2009, STRESS HEALTH, V25, P313, DOI 10.1002/smi.1265; Neitzel RL, 2014, NOISE HEALTH, V16, P270, DOI 10.4103/1463-1741.140503; Nuebling M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-538; Paulsen R, 2004, CFA DAGA 04 30 JAHR, V1, p[573, 573]; Picard M, 2001, AUDIOLOGY, V40, P221; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; PRUMPER J, 1995, Z ARB ORGAN, V39, P125; Rudow B., 2004, BILDUNG WISSENSCHAFT, V6, P6; Rugulies R, 2008, OCCUP ENVIRON MED, V65, P525, DOI 10.1136/oem.2007.035188; Santana AMC, 2012, WORK, V41, P3709, DOI 10.3233/WOR-2012-0674-3709; Schaufeli W.B., 2003, HDB WORK HLTH PSYCHO, V2, P282, DOI DOI 10.1002/0470013400.CH19; Scheuch K., 2007, ARBEIT GESUNDHEIT ZU, P42; Schreyer I., 2014, AQUA ARBEITSPLATZ QU; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Sjodin F, 2012, NOISE HEALTH, V14, P166, DOI 10.4103/1463-1741.99892; Slesina W., FEBA FRAGEBOGEN SUBJ; Snow K., 1994, J CHILD YOUTH CARE, V9, P11; TRUCHONGAGNON C, 1988, NOISE CONTROL ENG, V30, P57, DOI 10.3397/1.2827703; Tsutsumi A, 2001, SCAND J WORK ENV HEA, V27, P146, DOI 10.5271/sjweh.602; Tsutsumi A, 2001, WORK STRESS, V15, P86, DOI 10.1080/02678370118173; Venetjoki N, 2006, ERGONOMICS, V49, P1068, DOI 10.1080/00140130600679142; Viernickel S., 2013, STEGE STRUKTURQUALIT; von dem Knesebeck O, 2005, GESUNDHEITSWESEN, V67, P674, DOI 10.1055/s-2005-858607; Wang Y, 2015, INT ARCH OCC ENV HEA, V88, P589, DOI 10.1007/s00420-014-0987-9; Weyers S, 2006, SCAND J CARING SCI, V20, P26, DOI 10.1111/j.1471-6712.2006.00376.x; Whitebook M, 1989, WHO CARES CHILD CARE; Whitebook M, 1980, CHILDREN TODAY, V10, P2	62	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140980	10.1371/journal.pone.0140980	http://dx.doi.org/10.1371/journal.pone.0140980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488770	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400091
J	Reverter-Gil, O; Berning, B; Souto, J				Reverter-Gil, Oscar; Berning, Bjoern; Souto, Javier			Diversity and Systematics of Schizomavella Species (Bryozoa: Bitectiporidae) from the Bathyal NE Atlantic	PLOS ONE			English	Article							BIODIVERSITY; POLYZOA; BISCAY; BAY	Eight NE Atlantic and Mediterranean species, which were originally assigned to the genus Schizoporella (Family Schizoporellidae) when introduced, are redescribed and stabilized by typification. Seven of these species are transferred to the bitectiporid genus Schizomavella: S. fischeri, S. glebula, S. neptuni, S. obsoleta, S. richardi, S. triaviculata, and S. triaviculata var. paucimandibulata, which is here raised to species rank. The eighth species, Schizoporella fayalensis, is transferred to the lanceoporid genus Stephanotheca. Schizomavella obsoleta and S. glebula are considered junior subjective synonyms of S. fischeri and S. richardi, respectively. Two new species are described: Schizomavella rectangularis n. sp. from the Strait of Gibraltar, and Schizomavella phterocopa n. sp. from the Great Meteor Bank. A new subgenus, Calvetomavella n. subgen. is established as a result of a phylogenetic analysis based on morphological characters; it includes S. neptuni, S. triaviculata, S. paucimandibulata and S. phterocopa n. sp., together with Schizomavella discoidea and Schizomavella noronhai. The rest of the species remain in the nominotypical subgenus Schizomavella.	[Reverter-Gil, Oscar; Souto, Javier] Univ Santiago de Compostela, Fac Biol, Dept Zool & Antropol Fis, Santiago De Compostela 15782, Spain; [Berning, Bjoern] Oberosterreich Landesmuseum, Geowissensch Sammlungen, A-4060 Leonding, Austria; [Souto, Javier] Univ Vienna, Geozentrum, Fak Geowissensch Geog & Astron, Inst Palaontol, A-1090 Vienna, Austria	Universidade de Santiago de Compostela; University of Vienna	Souto, J (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Zool & Antropol Fis, Santiago De Compostela 15782, Spain.	javier.souto-derungs@univie.ac.at	Javier, Souto/D-2588-2014	Reverter-Gil, Oscar/0000-0003-1950-0155; Berning, Bjorn/0000-0002-0068-9739; Souto Derungs, Javier/0000-0003-0791-2590	project "Fauna Iberica: Briozoos II (Familia Cribrilinidae - Familia Watersiporidae)" [CGL2010-22267-C07-02]; Ministerio de Economia y Competitividad (Spanish Government); FEDER; SYNTHESYS Project - European Community; Austrian Science Fund (FWF) [M1444-B25]	project "Fauna Iberica: Briozoos II (Familia Cribrilinidae - Familia Watersiporidae)"; Ministerio de Economia y Competitividad (Spanish Government); FEDER(European Commission); SYNTHESYS Project - European Community; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The work by ORG and JS was partially supported by the project "Fauna Iberica: Briozoos II (Familia Cribrilinidae - Familia Watersiporidae)" (CGL2010-22267-C07-02), co-financed by the Ministerio de Economia y Competitividad (Spanish Government) and FEDER. BB acknowledges support from the SYNTHESYS Project (http://www.synthesys.info/), which is financed by the European Community Research Infrastructure Action under the FP7 "Capacities" Program, and which allowed studying type and comparative material at the MNHN (FR-TAF-1902) and the NHMUK (GB-TAF-3347). JS thanks the Austrian Science Fund (FWF, Lise Meitner Program, grant M1444-B25) for financial support (https://www.fwf.ac.at/).	Avila SP, 2015, PALAEOGEOGR PALAEOCL, V430, P57, DOI 10.1016/j.palaeo.2015.04.015; Berning B, DIVERSITY SYST UNPUB; Berning B, 2008, VIRGINIA MUSEUM NATU, V15, P1; Berning B, 2012, ZOOTAXA, P36, DOI 10.11646/zootaxa.3236.1.2; Bock P., WORLD LIST BRYOZOA; Calvet L, 1907, BRYOZOAIRES EXPEDITI, V8, P355; Calvet L. Louis, 1906, Bulletin du Museum Paris, V12; CALVET LOUIS, 1931, RESULTATS CAMPAGNES SCI ALBERT IER PRINCE DE MONACO FASC, V83, P1; Calvet Louis, 1906, Bulletin du Museum Paris, V12; Canu F, 1917, B US NATL MUS, V96, P1; COOK PL, 1965, CAH BIOL MAR, V6, P435; d'Hondt J.-L., 1973, Bulletin Mus Natn Hist Nat Paris (Zool), VNo. 92, P365; d'Hondt J.-L., 1975, B MUSEUM NATL HIST N, V299, P553; De Blauwe H., 2009, MOSDIERTJES ZUIDELIJ; de la Cuadra CML, 2001, J NAT HIST, V35, P1717, DOI 10.1080/002229301317092414; dHondt J.-L., 2009, MEM SOC LINN BORDEAU, V11, P1; dHondt J-L, 1986, B MUSEUM NATL HIST N, V8, P697; dHondt J-L, 1973, B MUS NATL HIST NAT, V179, P1209; DHONDT JL, 1974, CAH BIOL MAR, V15, P27; Gordon D.P., 1984, New Zealand Oceanographic Institute Memoir, P1; Gordon DP, 2008, ZOOL J LINN SOC-LOND, V153, P115, DOI 10.1111/j.1096-3642.2008.00386.x; Gordon DP, 1997, MEMOIR MUS NATL HIST, V176, P9; Harmelin J.-G., 1979, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V25-26, P171; Harmelin Jean-Georges, 1992, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V14, P23; Harmelin JG, 1997, MAR ECOL PROG SER, V153, P139, DOI 10.3354/meps153139; Harmer S.F., 1957, SIBOGA EXPEDITIE D, V28d, P641, DOI DOI 10.1080/00222939300770771; Hayward P.J., 1999, SYNOPSES BRIT FAUNA, V14; HAYWARD PJ, 1978, J MAR BIOL ASSOC UK, V58, P143, DOI 10.1017/S0025315400024462; Hayward PJ, 2002, B AM MUS NAT HIST, P1; HAYWARD PJ, 1995, J ZOOL, V235, P661, DOI 10.1111/j.1469-7998.1995.tb01776.x; HAYWARD PJ, 1979, CAH BIOL MAR, V20, P59; Huelsenbeck J. P., 2000, MRBAYES BAYESIAN INF; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jullien J., 1882, EXTR B SOC ZOOL FRAN, V7, P1, DOI [10.5962/bhl.title.4721, DOI 10.5962/BHL.TITLE.4721]; Jullien J., 1883, B SOC ZOOLOGIQUE FRA, V7, P497, DOI DOI 10.5962/BHL.TITLE.4721; Jullien JL, 1903, RESULTATS CAMPAGNES, V23, P1; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Meireles RP, 2013, SEDIMENTOLOGY, V60, P1769, DOI 10.1111/sed.12055; Neave SA, NOMENCLATOR ZOOLOGIC, V1-10; O'Dea A, 2008, PALAEONTOLOGY, V51, P847, DOI 10.1111/j.1475-4983.2008.00790.x; Ostrovsky A. N., 2008, VIRGINIA MUSEUM NATU, V15, P195; Ostrovsky AN, 2013, EVOLUTION OF SEXUAL REPRODUCTION IN MARINE INVERTEBRATES: EXAMPLE OF GYMNOLAEMATE BRYOZOANS, DOI 10.1007/978-94-007-7146-8; Reverter Gil O, 2001, NOVA ACTA CIENT COMP, V1, P1; Reverter-Gil O, J NAT HIST IN PRESS; Reverter-Gil Oscar, 2014, NACC Bioloxia, V21, P1; Reverter-Gil O, 2012, ZOOTAXA, P1; ReverterGil O, 1997, CAH BIOL MAR, V38, P1; ReverterGil O, 1995, CAH BIOL MAR, V36, P259; Rosso A., 2009, Biologia Marina Mediterranea, V16, P44; Rosso A, 2012, BIOL MAR MEDITERR, V17, P589; Ryland JS, 1880, B MUS NATL HIST NAT, V17, P207; Souto J., 2013, LECT NOTES EARTH SYS, V143, P357, DOI DOI 10.1007/978-3-642-16411-8_24; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Tilbrook Kevin J., 2006, P1; Vieira LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095296; Wisshak M, 2015, MAR BIODIVERS, V45, P87, DOI 10.1007/s12526-014-0231-6; Zabala M., 1988, Treballs del Museu de Zoologia, P1; Zabala Mikel., 1993, Scientia Marina, V57, P65	58	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139084	10.1371/journal.pone.0139084	http://dx.doi.org/10.1371/journal.pone.0139084			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488874	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400020
J	Feng, Y; Zhu, H; Zhang, X; Wang, XX; Xu, FQ; Tang, HR; Ye, CH; Liu, ML				Feng, Yue; Zhu, Hang; Zhang, Xu; Wang, Xuxia; Xu, Fuqiang; Tang, Huiru; Ye, Chaohui; Liu, Maili			NMR Based Cerebrum Metabonomic Analysis Reveals Simultaneous Interconnected Changes during Chick Embryo Incubation	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; HUMAN FETAL BRAIN; FREE AMINO-ACIDS; IN-VIVO; RAT-BRAIN; NEUROCHEMICAL PROFILE; H-1-NMR SPECTROSCOPY; H-1; METABOLITE	To find out if content changes of the major functional cerebrum metabolites are interconnected and formed a network during the brain development, we obtained high-resolution magic-angle-spinning (HR-MAS) H-1 NMR spectra of cerebrum tissues of chick embryo aged from incubation day 10 to 20, and postnatal day 1, and analyzed the data with principal component analysis (PCA). Within the examined time window, 26 biological important molecules were identified and 12 of them changed their relative concentration significantly in a time-dependent manner. These metabolites are generally belonged to three categories, neurotransmitters, nutrition sources, and neuronal or glial markers. The relative concentration changes of the metabolites were interconnected among/between the categories, and, more interestingly, associated with the number and size of Nissl-positive neurons. These results provided valuable biochemical and neurochemical information to understand the development of the embryonic brain.	[Feng, Yue; Zhu, Hang; Zhang, Xu; Wang, Xuxia; Xu, Fuqiang; Tang, Huiru; Ye, Chaohui; Liu, Maili] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan Ctr Magnet Resonance, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan 430071, Peoples R China; [Feng, Yue] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; University System of Maryland; University of Maryland Baltimore	Liu, ML (corresponding author), Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan Ctr Magnet Resonance, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan 430071, Peoples R China.	ml.liu@wipm.ac.cn	Liu, Maili/A-8543-2011; Tang, Huiru/F-9849-2011; xu, fuqiang/AAI-1571-2019	Liu, Maili/0000-0002-9359-915X; Tang, Huiru/0000-0002-7139-2756; xu, fu qiang/0000-0002-4382-9797	Chinese Natural Science Foundation [21120102038, 21221064]	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by a research grant fron the Chinese Natural Science Foundation (#21120102038, #21221064).	ANDREW ER, 1959, NATURE, V183, P1802, DOI 10.1038/1831802a0; Bain MM, 2007, J MAGN RESON IMAGING, V26, P198, DOI 10.1002/jmri.20963; Bates T E, 1989, NMR Biomed, V2, P225, DOI 10.1002/nbm.1940020509; Benitez-Diaz P, 2003, DEV NEUROSCI-BASEL, V25, P366, DOI 10.1159/000073514; Benson J D, 1994, Endocr Regul, V28, P9; Bluml S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085829; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; BURRI R, 1990, NEUROCHEM RES, V15, P1009, DOI 10.1007/BF00965747; Cheng LL, 1997, P NATL ACAD SCI USA, V94, P6408, DOI 10.1073/pnas.94.12.6408; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Feng Y, 2009, J MAGN RESON, V26, P27; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Florian CL, 1996, NEUROCHEM RES, V21, P1065, DOI 10.1007/BF02532417; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Granata F, 2000, BBA-MOL CELL BIOL L, V1483, P334, DOI 10.1016/S1388-1981(99)00186-9; Heerschap A, 2003, CHILD NERV SYST, V19, P418, DOI 10.1007/s00381-003-0774-5; Hidalgo A, 2000, DEVELOPMENT, V127, P393; HUPPI PS, 1991, PEDIATR RES, V30, P574; Inder TE, 2000, MENT RETARD DEV D R, V6, P59, DOI 10.1002/(SICI)1098-2779(2000)6:1<59::AID-MRDD8>3.0.CO;2-E; Jean-Xavier C, 2006, J NEUROPHYSIOL, V96, P2274, DOI 10.1152/jn.00328.2006; Kadota T, 2001, AM J NEURORADIOL, V22, P128; Kato T, 1997, BRAIN DEV-JPN, V19, P131, DOI 10.1016/S0387-7604(96)00496-2; Kim HW, 2006, ADV EXP MED BIOL, V583, P69; Kok RD, 2002, MAGNET RESON MED, V48, P611, DOI 10.1002/mrm.10264; Kok RD, 2001, AM J OBSTET GYNECOL, V185, P1011, DOI 10.1067/mob.2001.117677; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Lee JY, 2003, J NEUROSCI RES, V73, P156, DOI 10.1002/jnr.10647; LEVI G, 1971, BRAIN RES, V26, P131, DOI 10.1016/0006-8993(71)90548-8; Lindon JC, 1999, ANNU REP NMR SPECTRO, V38, P1, DOI 10.1016/S0066-4103(08)60035-6; Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W; Liu HL, 2008, EXP NEUROL, V212, P377, DOI 10.1016/j.expneurol.2008.04.013; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; MOLLA R, 1986, J HIRNFORSCH, V27, P625; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Sabatier J, 2001, REV NEUROL-FRANCE, V157, P858; Sato M, 2009, AMINO ACIDS, V36, P303, DOI 10.1007/s00726-008-0068-z; Scarabino T, 1999, EUR J RADIOL, V30, P142, DOI 10.1016/S0720-048X(99)00055-8; SPOERRI PE, 1988, SYNAPSE, V2, P11, DOI 10.1002/syn.890020104; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; Terpstra M, 2004, MAGN RESON MED, V51, P225, DOI 10.1002/mrm.10715; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; Tomiyasu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082746; VANDERKNAAP MS, 1990, RADIOLOGY, V176, P509, DOI 10.1148/radiology.176.2.2164237; Wang YL, 2003, ANAL BIOCHEM, V323, P26, DOI 10.1016/j.ab.2003.07.026; Xu H, 2006, HEARING RES, V220, P95, DOI 10.1016/j.heares.2006.07.005; Yao FS, 1999, NMR BIOMED, V12, P463, DOI 10.1002/(SICI)1099-1492(199911)12:7<463::AID-NBM586>3.0.CO;2-S; Yoshida M, 2004, J NEUROBIOL, V60, P166, DOI 10.1002/neu.20003; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang LL, 2006, J NEUROPHYSIOL, V95, P2404, DOI 10.1152/jn.00578.2005	56	2	2	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139948	10.1371/journal.pone.0139948	http://dx.doi.org/10.1371/journal.pone.0139948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485040	Green Submitted, gold, Green Published			2022-12-27	WOS:000363028100018
J	Mori, Y; Inoue, Y; Tanaka, S; Doda, S; Yamanaka, S; Fukuchi, H; Terada, Y				Mori, Yusuke; Inoue, Yoko; Tanaka, Sayori; Doda, Satoka; Yamanaka, Shota; Fukuchi, Hiroki; Terada, Yasuhiko			Cep169, a Novel Microtubule Plus-End-Tracking Centrosomal Protein, Binds to CDK5RAP2 and Regulates Microtubule Stability	PLOS ONE			English	Article							RING COMPLEX; CELLS; TIPS; INHIBITION; ATTACHMENT; NUCLEATION; DYNAMICS; MOTIF; EB1	The centrosomal protein, CDK5RAP2, is a microcephaly protein that regulates centrosomal maturation by recruitment of a.-tubulin ring complex (gamma-TuRC) onto centrosomes. In this report, we identified a novel human centrosomal protein, Cep169, as a binding partner of CDK5RAP2, a member of microtubule plus-end-tracking proteins (+TIPs). Cep169 interacts directly with CDK5RAP2 through CM1, an evolutionarily conserved domain, and colocalizes at the pericentriolar matrix (PCM) around centrioles with CDK5RAP2. In addition, Cep169 interacts with EB1 through SxIP-motif responsible for EB1 binding, and colocalizes with CDK5RAP2 at the microtubule plus-end. EB1-binding-deficient Cep169 abolishes EB1 interaction and microtubule plus-end attachment, indicating Cep169 as a novel member of +TIPs. We further show that ectopic expression of either Cep169 or CDK5RAP2 induces microtubule bundling and acetylation in U2OS cells, and depletion of Cep169 induces microtubule depolymerization in HeLa cells, although Cep169 is not required for assembly of.-tubulin onto centrosome by CDK5RAP2. These results show that Cep169 targets microtubule tips and regulates stability of microtubules with CDK5RAP2.	[Mori, Yusuke; Inoue, Yoko; Tanaka, Sayori; Doda, Satoka; Yamanaka, Shota; Fukuchi, Hiroki; Terada, Yasuhiko] Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Tokyo 1698555, Japan	Waseda University	Terada, Y (corresponding author), Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	yterada@waseda.jp		Terada, Yasuhiko/0000-0003-4784-5273	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Grant-in-Aid for Scientific Research on Priority Areas. Grants-in-Aid for Scientific Research is a competitive research sponsored by Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Society for the Promotion of Science (JSPS) to promote research across a wide variety of fields, ranging from the humanities and social sciences to the natural sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Fong KW, 2009, MOL BIOL CELL, V20, P3660, DOI 10.1091/mbc.E09-01-0009; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Terada Y, 2003, J CELL BIOL, V162, P757, DOI 10.1083/jcb.200305048; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	26	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140968	10.1371/journal.pone.0140968	http://dx.doi.org/10.1371/journal.pone.0140968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485573	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100099
J	Steenhuis, LA; Nauta, MH; Bocking, CLH; Pijnenborg, GHM				Steenhuis, Laura A.; Nauta, Maaike H.; Bocking, Claudi L. H.; Pijnenborg, Gerdina H. M.			Treating Depressive Symptoms in Psychosis: A Network Meta-Analysis on the Effects of Non-Verbal Therapies	PLOS ONE			English	Article							COGNITIVE-BEHAVIOR THERAPY; GROUP MUSIC-THERAPY; YOGA THERAPY; EXERCISE THERAPY; CONTROLLED-TRIAL; SCHIZOPHRENIA; INCONSISTENCY; RECOGNITION; MANAGEMENT; ANXIETY	Aims The aim of this study was to examine whether non-verbal therapies are effective in treating depressive symptoms in psychotic disorders. Material and Methods A systematic literature search was performed in PubMed, Psychinfo, Picarta, Embase and ISI Web of Science, up to January 2015. Randomized controlled trials (RCTs) comparing a non-verbal intervention to a control condition in patients with psychotic disorders, whilst measuring depressive symptoms as a primary or secondary outcome, were included. The quality of studies was assessed using the 'Clinical Trials Assessment Measure for psychological treatments' (CTAM) scale. Cohen's d was calculated as a measure of effect size. Using a Network Meta-analysis, both direct and indirect evidence was investigated. Results 10 RCTs were included, of which three were of high quality according to the CTAM. The direct evidence demonstrated a significant effect on the reduction in depressive symptoms relative to treatment as usual (TAU), in favor of overall non-verbal therapy (ES: -0.66, 95% C.I. = -0.88, -0.44) and music therapy (ES: -0.59, 95% C.I. = -0.85, -0.33). Combining both direct and indirect evidence, yoga therapy (ES: -0.79, 95% C.I. = -1.24, -0.35) had a significant effect on depressive symptoms, and occupational therapy (ES: 1.81, 95% C.I. = 0.81, 2.81) was less effective, relative to TAU. Exercise therapy did not show a significant effect on depressive symptoms in comparison to TAU (ES: -0.02 95% C.I. = -0.67, 0.62). Due to inconsistency of study evidence, the indirect effects should be interpreted cautiously. Conclusions Non-verbal therapies appear to be effective in reducing depressive symptomatology in psychotic disorders, in particular music therapy and yoga therapy.	[Steenhuis, Laura A.; Nauta, Maaike H.; Bocking, Claudi L. H.; Pijnenborg, Gerdina H. M.] Univ Groningen, Fac Behav & Social Sci, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Bocking, Claudi L. H.] Univ Utrecht, Dept Clin & Hlth Psychol, Fac Social Sci, Utrecht, Netherlands; [Pijnenborg, Gerdina H. M.] GGZ Drenthe, Fac Social Sci, Assen, Netherlands	University of Groningen; Utrecht University	Steenhuis, LA (corresponding author), Univ Groningen, Fac Behav & Social Sci, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	l.a.steenhuis@rug.nl		Nauta, Maaike H./0000-0001-7694-1382; Steenhuis, Laura/0000-0002-1256-3754	Netherlands Organisation for Scientific Research, NWO grant [43212807]	Netherlands Organisation for Scientific Research, NWO grant	This study was financially supported by The Netherlands Organisation for Scientific Research, NWO grant number 43212807	ADDINGTON D, 1990, SCHIZOPHR RES, V3, P247, DOI 10.1016/0920-9964(90)90005-R; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; [Anonymous], 2013, DSM 5; [Anonymous], 2010, DEPR TREATM MAN DEPR; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; Behere RV, 2011, ACTA PSYCHIAT SCAND, V123, P147, DOI 10.1111/j.1600-0447.2010.01605.x; BIGGS JT, 1978, BRIT J PSYCHIAT, V132, P381, DOI 10.1192/bjp.132.4.381; Birchwood M, 2000, BRIT J PSYCHIAT, V177, P516, DOI 10.1192/bjp.177.6.516; Bruscia KE, 1998, DEFINING MUSIC THERA, V2nd; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Clara IP, 2001, J PSYCHOPATHOL BEHAV, V23, P61, DOI 10.1023/A:1011095624717; CLARK FA, 1991, AM J OCCUP THER, V45, P300, DOI 10.5014/ajot.45.4.300; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001; Duraiswamy G, 2007, ACTA PSYCHIAT SCAND, V116, P226, DOI 10.1111/j.1600-0447.2007.01032.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Grocke D, 2014, ACTA PSYCHIAT SCAND, V130, P144, DOI 10.1111/acps.12224; Harrison I, 2008, PSYCHOL MED, V38, P79, DOI 10.1017/S0033291707000797; Harvey SB, 2008, BRIT J PSYCHIAT, V192, P178, DOI 10.1192/bjp.bp.107.037192; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Lako IM, 2012, J AFFECT DISORDERS, V140, P38, DOI 10.1016/j.jad.2011.10.014; Lin J, 2013, IMPACTS AEROBIC EXER; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Lu SF, 2013, COMPLEMENT THER MED, V21, P682, DOI 10.1016/j.ctim.2013.09.002; Manjunath RB, 2013, INDIAN J PSYCHIAT, V55, pS374, DOI 10.4103/0019-5545.116314; Maratos AS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004517.pub2; Marzolini S., 2009, MENT HEALTH PHYS ACT, V2, P29, DOI DOI 10.1016/J.MHPA.2008.11.001; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morgan K, 2011, ACTA PSYCHIAT SCAND, V124, P363, DOI 10.1111/j.1600-0447.2011.01739.x; Mossler K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004025.pub3; NICE, 2009, SCHIZ COR INT TREATM; Oosthuizen P, 2006, WORLD PSYCHIATRY, V5, P172; Orwin R.G., 1994, HDB RES SYNTHESIS; Pelizza L, 2012, J PSYCHOPATHOL, V18, P145; Perkins DO, 2006, SCHIZOPHR RES, V83, P53, DOI 10.1016/j.schres.2005.10.016; Pilkington K, 2005, J AFFECT DISORDERS, V89, P13, DOI 10.1016/j.jad.2005.08.013; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Sayers SL, 1996, PSYCHOL ASSESSMENT, V8, P269, DOI 10.1037/1040-3590.8.3.269; Scheewe TW, 2013, ACTA PSYCHIAT SCAND, V127, P464, DOI 10.1111/acps.12029; Silverman MJ, 2003, J MUSIC THER, V40, P27, DOI 10.1093/jmt/40.1.27; Siris S. G., 1995, P128; Siris SG, 2001, SCHIZOPHR RES, V47, P185, DOI 10.1016/S0920-9964(00)00135-3; Tarrier N, 2004, BEHAV RES THER, V42, P1377, DOI 10.1016/j.brat.2004.06.020; Telles S, 1997, Indian J Med Sci, V51, P123; Tkachuk GA, 1999, PROF PSYCHOL-RES PR, V30, P275, DOI 10.1037/0735-7028.30.3.275; Townsend E, 1996, OCCUP THER J RES, V16, P179, DOI 10.1177/153944929601600303; Turkington D, 2008, SCHIZOPHR RES, V98, P1, DOI 10.1016/j.schres.2007.09.026; Ulrich G, 2007, ACTA PSYCHIAT SCAND, V116, P362, DOI 10.1111/j.1600-0447.2007.01073.x; Upthegrove R, 2010, ACTA PSYCHIAT SCAND, V122, P211, DOI 10.1111/j.1600-0447.2009.01506.x; Viechtbauer W., 2010, METAFOR METAANALYSIS; Visceglia E, 2011, J ALTERN COMPLEM MED, V17, P601, DOI 10.1089/acm.2010.0075; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wen S, 2005, J CLIN REHABIL, V9, P195; Wheeler B, 1978, READINGS MUSIC THERA, P51; Whitehead C, 2003, PSYCHOL MED, V33, P589, DOI 10.1017/S0033291703007645; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114	61	4	4	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140637	10.1371/journal.pone.0140637	http://dx.doi.org/10.1371/journal.pone.0140637			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7XI	26485401	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100054
J	Wang, JY; Li, YS; Chen, JD; Liang, WM; Yang, TC; Lee, YC; Wang, CW				Wang, Jong-Yi; Li, Yi-Shan; Chen, Jen-De; Liang, Wen-Miin; Yang, Tung-Chuan; Lee, Young-Chang; Wang, Chia-Woei			Investigating the Relationships among Stressors, Stress Level, and Mental Symptoms for Infertile Patients: A Structural Equation Modeling Approach	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; PERCEIVED SOCIAL SUPPORT; SELF-ESTEEM; WOMEN; COUPLES; DEPRESSION; DISTRESS; FERTILITY; HUSBANDS; ANXIETY	Objective Patients with infertility are a high risk group in depression and anxiety. However, an existing theoretically and empirically validated model of stressors, stress, and mental symptoms specific for infertile patients is still a void. This study aimed to determine the related factors and their relational structures that affect the level of depressive and anxiety symptoms among infertile patients. Methods A cross-sectional sample of 400 infertility outpatients seeking reproduction treatments in three teaching hospitals across Taiwan participated in the structured questionnaire survey in 2011. The hypothesized model comprising 10 latent variables was tested by Structural Equation Modeling using AMOS 17. Results Goodness-of-fit indexes, including chi(2)/DF = 1.871, PGFI = 0.746, PNFI = 0.764, and others, confirmed the modified model fit the data well. Marital stressor, importance of children, guilt- and-blame, and social stressor showed a direct effect on perceived stress. Instead of being a factor of stress, social support was directly and positively related to self-esteem. Perceived stress and self-esteem were the two major mediators for the relationships between stressors and mental symptoms. Increase in social support and self-esteem led to decrease in mental symptoms among the infertile patients. Conclusions The relational structures were identified and named as the Stressors Stress Symptoms Model, clinically applied to predict anxiety and depression from various stressors. Assessing sources and level of infertility-related stress and implementing culturally-sensitive counseling with an emphasis on positive personal value may assist in preventing the severity of depression and anxiety.	[Wang, Jong-Yi] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Li, Yi-Shan] Chungyo Dept Store, Dept Business, Taichung, Taiwan; [Chen, Jen-De] Natl Changhua Univ Educ, Off President, Changhua 500, Taiwan; [Liang, Wen-Miin] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Yang, Tung-Chuan] China Med Univ Hosp, Dept Obstet & Gynecol, Reprod Med Ctr, Taichung, Taiwan; [Lee, Young-Chang] Yuans Gen Hosp, Reprod Med Ctr, Kaohsiung, Taiwan; [Wang, Chia-Woei] Taipei Med Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan	China Medical University Taiwan; National Changhua University of Education; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; Taipei Medical University Hospital	Wang, CW (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	cwwang@ms4.hinet.net			Taiwan National Science Council [NSC100-2410-H-039-003-SS2, NSC102-2410-H-039-006-SS2]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by Taiwan National Science Council (http://www.most.gov.tw/mp.aspx?mp=7) Grant No. NSC100-2410-H-039-003-SS2 and NSC102-2410-H-039-006-SS2 (JYW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY A, 1992, J MARRIAGE FAM, V54, P408, DOI 10.2307/353072; ALTMAIER EM, 1995, J COUNS PSYCHOL, V42, P304, DOI 10.1037/0022-0167.42.3.304; BARRERA M, 1981, AM J COMMUN PSYCHOL, V9, P435, DOI 10.1007/BF00918174; Benyamini Y, 2004, COGNITIVE THER RES, V28, P577, DOI 10.1023/B:COTR.0000045566.97966.22; Boivin J, 2005, FERTIL STERIL, V83, P1745, DOI 10.1016/j.fertnstert.2004.12.039; Bollen K.A., 1993, TESTING STRUCTURAL E, DOI DOI 10.1093/SF/73.3.1161; Chang SN, 2008, J CLIN NURS, V17, P531, DOI 10.1111/j.1365-2702.2006.01801.x; COHEN S, 1988, CLAR SYMP, P31; Crowley SL, 1997, J PERS ASSESS, V68, P508, DOI 10.1207/s15327752jpa6803_4; Department of Statistics Ministry of the Interior, 2015, FERT RAT CHILDB AG W; Derogatis L. R., 1993, HDB STRESS THEORETIC; Donkor ES, 2007, SOC SCI MED, V65, P1683, DOI 10.1016/j.socscimed.2007.06.003; Drosdzol A, 2009, J PSYCHOSOM OBST GYN, V30, P11, DOI 10.1080/01674820902830276; Faramarzi M, 2008, EUR J OBSTET GYN R B, V141, P49, DOI 10.1016/j.ejogrb.2008.07.012; Ghorbani N, 2008, INT J PSYCHOL, V43, P958, DOI 10.1080/00207590701295264; Greil AL, 1988, GENDER SOC, V2, P172, DOI 10.1177/089124388002002004; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; HILL R, 1958, SOC CASEWORK-JCSW, V39, P139, DOI 10.1177/1044389458039002-318; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang CY, 2015, SPINAL CORD, V53, P413, DOI 10.1038/sc.2014.158; Hung JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097041; Joreskog K.G., 1996, LISREL 8 USERS REFER; Klemetti R, 2010, ACTA OBSTET GYN SCAN, V89, P677, DOI 10.3109/00016341003623746; Kline R.B., 2011, PRINCIPLES PRACTICE; Klonoff-Cohen H, 2001, FERTIL STERIL, V76, P675, DOI 10.1016/S0015-0282(01)02008-8; Lee JS, 2013, STRESS HEALTH, V29, P75, DOI 10.1002/smi.2428; Lee TY, 2000, ARCH ANDROLOGY, V45, P143; Lee TY, 2001, HUM REPROD, V16, P1762, DOI 10.1093/humrep/16.8.1762; Leventhal H., 1980, COMMON SENSE REPRESE; Lin JL, 2012, J NURS RES, V20, P310, DOI 10.1097/jnr.0b013e3182748f26; MAHLSTEDT PP, 1987, J IN VITRO FERTIL EM, V4, P232, DOI 10.1007/BF01533762; Martins MV, 2014, HUM REPROD, V29, P83, DOI 10.1093/humrep/det403; Martins MV, 2011, HUM REPROD, V26, P2113, DOI 10.1093/humrep/der157; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; Masoumi SZ, 2013, IRAN J PUBLIC HEALTH, V42, P458; Matsubayashi H, 2004, GEN HOSP PSYCHIAT, V26, P398, DOI 10.1016/j.genhosppsych.2004.05.002; Mattox J. H., 1985, J OBSTET GYNECOLOGIC, P63; McQuillan J, 2012, J MARRIAGE FAM, V74, P1166, DOI 10.1111/j.1741-3737.2012.01015.x; Moura-Ramos M, 2012, PSYCHOL HEALTH, V27, P533, DOI 10.1080/08870446.2011.598231; Nachtigall RD, 2006, FERTIL STERIL, V85, P871, DOI 10.1016/j.fertnstert.2005.08.066; Newton CR, 1999, FERTIL STERIL, V72, P54, DOI 10.1016/S0015-0282(99)00164-8; Norizan A, 2010, J INTELL DISABIL RES, V54, P992, DOI 10.1111/j.1365-2788.2010.01324.x; Peterson BD, 2008, HUM REPROD, V23, P1128, DOI 10.1093/humrep/den067; Peterson BD, 2014, HUM REPROD, V29, P76, DOI 10.1093/humrep/det412; Powell DH, 1983, UNDERSTANDING HUMAN; Rockliff HE, 2014, HUM REPROD UPDATE, V20, P594, DOI 10.1093/humupd/dmu010; Slade P, 2007, HUM REPROD, V22, P2309, DOI 10.1093/humrep/dem115; Smeenk JMJ, 2001, HUM REPROD, V16, P1420, DOI 10.1093/humrep/16.7.1420; Steuber KR, 2015, HUM REPROD, V30, P1635, DOI 10.1093/humrep/dev093; THIERING P, 1993, J PSYCHOSOM RES, V37, P481, DOI 10.1016/0022-3999(93)90004-Y; Volgsten H, 2010, FERTIL STERIL, V93, P1088, DOI 10.1016/j.fertnstert.2008.11.008; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Welbourne JL, 2013, COMPUT HUM BEHAV, V29, P129, DOI 10.1016/j.chb.2012.07.024; Williams KE, 2007, HUM REPROD UPDATE, V13, P607, DOI 10.1093/humupd/dmm019; Yamada T, 2013, 36 STANF U WH SHOR A; Yoldemir T, 2012, CURR OPIN OBSTET GYN, V24, P119, DOI 10.1097/GCO.0b013e32835213f1; Yu YJ, 2014, PSYCHIAT RES, V215, P401, DOI 10.1016/j.psychres.2013.10.032; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140581	10.1371/journal.pone.0140581	http://dx.doi.org/10.1371/journal.pone.0140581			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7XI	26484531	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100047
J	Wang, Y; Li, JT; He, LS; Yang, B; Gao, ZM; Cao, HL; Batang, Z; Al-Suwailem, A; Qian, PY				Wang, Yong; Li, Jiang Tao; He, Li Sheng; Yang, Bo; Gao, Zhao Ming; Cao, Hui Luo; Batang, Zenon; Al-Suwailem, Abdulaziz; Qian, Pei-Yuan			Zonation of Microbial Communities by a Hydrothermal Mound in the Atlantis II Deep (the Red Sea)	PLOS ONE			English	Article							ANAEROBIC OXIDATION; GUAYMAS BASIN; METHANE; SEDIMENTS; DEPOSITS; DESIGN; BRINES; WATER	In deep-sea geothermal rift zones, the dispersal of hydrothermal fluids of moderately-high temperatures typically forms subseafloor mounds. Major mineral components of the crust covering the mound are barite and metal sulfides. As a result of the continental rifting along the Red Sea, metalliferous sediments accumulate on the seafloor of the Atlantis II Deep. In the present study, a barite crust was identified in a sediment core from the Atlantis II Deep, indicating the formation of a hydrothermal mound at the sampling site. Here, we examined how such a dense barite crust could affect the local environment and the distribution of microbial inhabitants. Our results demonstrate distinctive features of mineral components and microbial communities in the sediment layers separated by the barite crust. Within the mound, archaea accounted for 65% of the community. In contrast, the sediments above the barite boundary were overwhelmed by bacteria. The composition of microbial communities under the mound was similar to that in the sediments of the nearby Discovery Deep and marine cold seeps. This work reveals the zonation of microbial communities after the formation of the hydrothermal mound in the subsurface sediments of the rift basin.	[Wang, Yong; He, Li Sheng; Gao, Zhao Ming] Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, San Ya, Peoples R China; [Wang, Yong; Yang, Bo; Cao, Hui Luo; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Jiang Tao] Tongji Univ, State Key Lab Marine Geol, Shanghai 200092, Peoples R China; [Batang, Zenon; Al-Suwailem, Abdulaziz] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia	Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Hong Kong University of Science & Technology; Tongji University; King Abdullah University of Science & Technology	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	Batang, Zenon/W-1963-2019	wang, yong/0000-0003-3595-3867; Qian, Pei-Yuan/0000-0003-4074-9078; Li, Jiangtao/0000-0001-9225-6748	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB06010102, XDB06010103, XDB06010201]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; National Natural Science Foundation of China [41476104, 31460001]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB06010102, XDB06010103 and XDB06010201) and an award from the King Abdullah University of Science and Technology (SA-C0040/UK-C0016). This work was also supported the National Natural Science Foundation of China (No. 41476104 and 31460001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT JC, 1988, MAR GEOL, V81, P227, DOI 10.1016/0025-3227(88)90029-1; Biddle JF, 2012, ISME J, V6, P1018, DOI 10.1038/ismej.2011.164; BLANC G, 1995, GEOLOGY, V23, P543, DOI 10.1130/0091-7613(1995)023<0543:NSITHB>2.3.CO;2; Borin Sara, 2008, Saline Syst, V4, P10, DOI 10.1186/1746-1448-4-10; Bougouffa S, 2013, APPL ENVIRON MICROB, V79, P3425, DOI 10.1128/AEM.00254-13; Brewer PG, 1969, HOT BRINES RECENT HE, P174; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; COCHERIE A, 1994, MAR GEOL, V118, P291, DOI 10.1016/0025-3227(94)90089-2; CORLISS JB, 1978, EARTH PLANET SC LETT, V40, P12, DOI 10.1016/0012-821X(78)90070-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Galley A.G., 2007, SPECIAL PUBLICATION, V5, P141, DOI 10.1016/0169-1368(95)00022-4; Griffith EM, 2012, SEDIMENTOLOGY, V59, P1817, DOI 10.1111/j.1365-3091.2012.01327.x; Gurvich E., 2006, METALLIFEROUS SEDIME; Hartmann M, 1998, MAR GEOL, V144, P311, DOI 10.1016/S0025-3227(97)00055-8; Horton T, 2012, HYDROTHERMAL CARBONA; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Lejzerowicz F, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0283; Mahmood Q, 2009, J HAZARD MATER, V165, P558, DOI 10.1016/j.jhazmat.2008.10.021; MILLER AR, 1966, GEOCHIM COSMOCHIM AC, V30, P341, DOI 10.1016/0016-7037(66)90007-X; Nicol GW, 2005, ENVIRON MICROBIOL, V7, P337, DOI 10.1111/j.1462-2920.2005.00698.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; RAMBOZ C, 1988, CAN MINERAL, V26, P765; Ruff SE, 2015, P NATL ACAD SCI USA, V112, P4015, DOI 10.1073/pnas.1421865112; Schneider D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066662; Siam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042872; Sval'nov V. N., 1984, Oceanology, V24, P716; SWALLOW JC, 1965, NATURE, V205, P165, DOI 10.1038/205165a0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Tivey MK, 2007, OCEANOGRAPHY, V20, P50, DOI 10.5670/oceanog.2007.80; Wang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01748; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029149; Wang Y, 2011, ISME J, V5, P1652, DOI 10.1038/ismej.2011.42; Winckler G, 2000, GEOCHIM COSMOCHIM AC, V64, P1567, DOI 10.1016/S0016-7037(99)00441-X; Wu YR, 2009, J ENVIRON SCI-CHINA, V21, P1446, DOI 10.1016/S1001-0742(08)62438-9; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	39	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140766	10.1371/journal.pone.0140766	http://dx.doi.org/10.1371/journal.pone.0140766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485717	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100068
J	Fan, SJ; Jiang, LY; Wu, JJ; Dong, LD; Cheng, Q; Xu, PF; Zhang, SZ				Fan, Sujie; Jiang, Liangyu; Wu, Junjiang; Dong, Lidong; Cheng, Qun; Xu, Pengfei; Zhang, Shuzhen			A Novel Pathogenesis-Related Class 10 Protein Gly m 4l, Increases Resistance upon Phytophthora sojae Infection in Soybean (Glycine max [L.] Merr.)	PLOS ONE			English	Article							BET V 1; GLY M 4; BARCELONA ASTHMA OUTBREAKS; BIRCH POLLEN ALLERGEN; APPLE MALUS-DOMESTICA; MOLECULAR-CLONING; JASMONIC ACID; YELLOW LUPINE; VITIS-PSEUDORETICULATA; PLASMOPARA-VITICOLA	Phytophthora root and stem rot of soybean, caused by Phytophthora sojae (P. sojae), is a destructive disease in many soybean planting regions worldwide. In a previous study, an expressed sequence tag (EST) homolog of the major allergen Pru ar 1 in apricot (Prunus armeniaca) was identified up-regulated in the highly resistant soybean 'Suinong 10' infected with P. sojae. Here, the full length of the EST was isolated using rapid amplification of cDNA ends (RACE). It showed the highest homolgy of 53.46% with Gly m 4 after comparison with the eight soybean allergen families reported and was named Gly m 4-like (Gly m 4l, GenBank accession no. HQ913577.1). The cDNA full length of Gly m 4l was 707 bp containing a 474 bp open reading frame encoding a polypeptide of 157 amino acids. Sequence analysis suggests that Gly m 4l contains a conserved 'P-loop' (phosphate-binding loop) motif at residues 47-55 aa and a Bet v 1 domain at residues 87-120 aa. The transcript abundance of Gly m 4l was significantly induced by P. sojae, salicylic acid (SA), NaCl, and also responded to methyl jasmonic acid (MeJA) and ethylene (ET). The recombinant Gly m 4l protein showed RNase activity and displayed directly antimicrobial activity that inhibited hyphal growth and reduced zoospore release in P. sojae. Further analyses showed that the RNase activity of the recombinant protein to degrading tRNA was significantly affected in the presence of zeatin. Over-expression of Gly m 4l in susceptible 'Dongnong 50' soybean showed enhanced resistance to P. sojae. These results indicated that Gly m 4l protein played an important role in the defense of soybean against P. sojae infection.	[Fan, Sujie; Jiang, Liangyu; Dong, Lidong; Cheng, Qun; Xu, Pengfei; Zhang, Shuzhen] Northeast Agr Univ, Soybean Res Inst, Chinese Educ Minist, Key Lab Soybean Biol, Harbin 150030, Heilongjiang, Peoples R China; [Wu, Junjiang] Heilongjiang Acad Agr Sci, Collaborat Innovat Ctr Grain Prod Capac Improveme, Soybean Res Inst, Harbin 150086, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Heilongjiang Academy of Agricultural Sciences	Xu, PF (corresponding author), Northeast Agr Univ, Soybean Res Inst, Chinese Educ Minist, Key Lab Soybean Biol, Harbin 150030, Heilongjiang, Peoples R China.	xupengfei@neau.edu.cn; zhangshuzhen@neau.edu.cn			Heilongjiang Province outstanding youth fund [JC201308]; NSFC [31071439, 31171577, 31101167]; Natural Science Foundation of Heilongjiang Province [C2015010]; Specialized Research Fund for the Doctoral Program of Higher Education [20112325120005]; Science and Technology Innovation Project in Harbin [2012RFQXN011, 2012RFXXN019]; Research Fund for Young Teachers through NEAU [2012 RCB 08]	Heilongjiang Province outstanding youth fund; NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Innovation Project in Harbin; Research Fund for Young Teachers through NEAU	The research was supported through funding from the Heilongjiang Province outstanding youth fund (JC201308), NSFC Projects (31071439, 31171577, 31101167), Natural Science Foundation of Heilongjiang Province (C2015010), the Specialized Research Fund for the Doctoral Program of Higher Education (20112325120005), the Science and Technology Innovation Project in Harbin (2012RFQXN011, 2012RFXXN019), and the Research Fund for Young Teachers through NEAU (2012 RCB 08).	Agarwal GK, 2002, PROTEOMICS, V2, P947, DOI 10.1002/1615-9861(200208)2:8<947::AID-PROT947>3.0.CO;2-J; Agarwal P, 2014, MOL BIOL REP, V41, P599, DOI 10.1007/s11033-013-2897-4; Bahramnejad B, 2010, PLANT CELL REP, V29, P1235, DOI 10.1007/s00299-010-0909-6; Bantignies B, 2000, PLANT MOL BIOL, V42, P871, DOI 10.1023/A:1006475303115; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Berkner H, 2009, BIOSCIENCE REP, V29, P183, DOI 10.1042/BSR20080117; Biesiadka J, 2002, J MOL BIOL, V319, P1223, DOI 10.1016/S0022-2836(02)00385-6; Borsics T, 2002, J EXP BOT, V53, P1831, DOI 10.1093/jxb/erf039; Breiteneder H, 2000, J ALLERGY CLIN IMMUN, V106, P27, DOI 10.1067/mai.2000.106929; Chacon O, 2010, GENE, V452, P54, DOI 10.1016/j.gene.2009.11.011; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Codina R, 1999, INT ARCH ALLERGY IMM, V119, P69, DOI 10.1159/000024178; Codina R, 1997, CLIN EXP ALLERGY, V27, P424, DOI 10.1046/j.1365-2222.1997.d01-514.x; Colditz F, 2007, PLANTA, V226, P57, DOI 10.1007/s00425-006-0466-y; CROWELL DN, 1992, PLANT MOL BIOL, V18, P459, DOI 10.1007/BF00040662; Enkerli K, 1997, CAN J BOT, V75, P1493, DOI 10.1139/b97-864; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114; Fujimoto Y, 1998, EUR J BIOCHEM, V258, P794, DOI 10.1046/j.1432-1327.1998.2580794.x; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gao ZS, 2005, THEOR APPL GENET, V111, P171, DOI 10.1007/s00122-005-2018-4; Geng T, 2015, J AGR FOOD CHEM, V63, P4947, DOI 10.1021/acs.jafc.5b00792; Hadjiivanova C, 2001, BULG J PLANT PHYSL, V27, P101; Hashimoto M, 2004, PLANT CELL PHYSIOL, V45, P550, DOI 10.1093/pcp/pch063; He MY, 2013, PROTOPLASMA, V250, P129, DOI 10.1007/s00709-012-0384-8; HoffmannSommergruber K, 1997, GENE, V197, P91, DOI 10.1016/S0378-1119(97)00246-1; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Holzhauser T, 2009, J ALLERGY CLIN IMMUN, V123, P452, DOI 10.1016/j.jaci.2008.09.034; Ito K, 2015, CHEM IMMUNOL ALLERGY, V101, P145, DOI 10.1159/000375468; Jellouli N, 2008, J PLANT PHYSIOL, V165, P471, DOI 10.1016/j.jplph.2007.02.009; Julka S, 2012, ANAL CHEM, V84, P10019, DOI 10.1021/ac3024685; Jwa NS, 2001, BIOCHEM BIOPH RES CO, V286, P973, DOI 10.1006/bbrc.2001.5507; Kim SG, 2011, MOL CELLS, V31, P25, DOI 10.1007/s10059-011-0004-z; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Kim ST, 2008, PLANT CELL REP, V27, P593, DOI 10.1007/s00299-007-0485-6; Kim YJ, 2014, PLANT CELL TISS ORG, V118, P531, DOI 10.1007/s11240-014-0505-5; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Koistinen KM, 2005, PHYTOCHEMISTRY, V66, P2524, DOI 10.1016/j.phytochem.2005.09.007; Lee OR, 2012, MOL BIOL REP, V39, P2365, DOI 10.1007/s11033-011-0987-8; Liu JJ, 2003, PHYSIOL PLANTARUM, V119, P544, DOI 10.1046/j.1399-3054.2003.00200.x; Liu XJ, 2006, J PLANT PHYSIOL, V163, P546, DOI 10.1016/j.jplph.2005.04.031; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Maillot P, 2009, PLANT PHYSIOL BIOCH, V47, P743, DOI 10.1016/j.plaphy.2009.03.016; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; Peters S, 2011, TRANSGENIC RES, V20, P547, DOI 10.1007/s11248-010-9435-0; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Poupard P, 2001, AUST J PLANT PHYSIOL, V28, P57; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Rakwal R, 1999, ELECTROPHORESIS, V20, P3472, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3472::AID-ELPS3472>3.0.CO;2-0; Rakwal R, 2001, PLANT SCI, V161, P469, DOI 10.1016/S0168-9452(01)00433-2; Rihs HP, 1999, J ALLERGY CLIN IMMUN, V104, P1293, DOI 10.1016/S0091-6749(99)70027-8; Robert N, 2001, EUR J PLANT PATHOL, V107, P249, DOI 10.1023/A:1011241001383; Samanani N, 2004, PLANT J, V40, P302, DOI 10.1111/j.1365-313X.2004.02210.x; Sampson HA, 2015, SOY REACTIVITY MAY B; Scheurer S, 1997, MOL IMMUNOL, V34, P619, DOI 10.1016/S0161-5890(97)00072-2; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Sikorski MM, 1999, PLANT SCI, V149, P125, DOI 10.1016/S0168-9452(99)00148-X; SOMSSICH IE, 1986, P NATL ACAD SCI USA, V83, P2427, DOI 10.1073/pnas.83.8.2427; Utriainen M, 1998, PLANT CELL ENVIRON, V21, P821, DOI 10.1046/j.1365-3040.1998.00326.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VANEKKREBITZ M, 1995, BIOCHEM BIOPH RES CO, V214, P538, DOI 10.1006/bbrc.1995.2320; Walter MH, 1996, EUR J BIOCHEM, V239, P281, DOI 10.1111/j.1432-1033.1996.0281u.x; WALTER MH, 1990, MOL GEN GENET, V222, P353, DOI 10.1007/BF00633840; Wang HX, 2001, INT J BIOCHEM CELL B, V33, P483, DOI 10.1016/S1357-2725(01)00038-3; Wang L, 2014, INT J MOL SCI, V15, P19162, DOI 10.3390/ijms151019162; WARD EWB, 1979, PHYTOPATHOLOGY, V69, P951, DOI 10.1094/Phyto-69-951; Wen J, 1997, MOL PHYLOGENET EVOL, V8, P317, DOI 10.1006/mpev.1997.0447; Wisniewski M, 2004, TREE PHYSIOL, V24, P339, DOI 10.1093/treephys/24.3.339; Wood NT, 2000, PLANT J, V24, P335, DOI 10.1046/j.1365-313x.2000.00881.x; Xu PF, 2012, J INTEGR AGR, V11, P368, DOI 10.1016/S2095-3119(12)60021-5; Xu PF, 2014, MOL BIOL REP, V41, P4899, DOI 10.1007/s11033-014-3356-6; Xu TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095102; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang SZ, 2010, PLANT DIS, V94, P87, DOI 10.1094/PDIS-94-1-0087; Zubini P, 2009, PLANT PHYSIOL, V150, P1235, DOI 10.1104/pp.109.139543	82	18	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140364	10.1371/journal.pone.0140364	http://dx.doi.org/10.1371/journal.pone.0140364			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474489	gold, Green Submitted, Green Published			2022-12-27	WOS:000363185500043
J	Martincic, R; Mravljak, J; Svajger, U; Perdih, A; Anderluh, M; Novic, M				Martincic, Rok; Mravljak, Janez; Svajger, Urban; Perdih, Andrej; Anderluh, Marko; Novic, Marjana			In Silico Discovery of Novel Potent Antioxidants on the Basis of Pulvinic Acid and Coumarine Derivatives and Their Experimental Evaluation	PLOS ONE			English	Article							CENTER-DOT ASSAY; SCAVENGING ACTIVITY; PROOXIDANT ACTIVITIES; PHENOLIC-COMPOUNDS; VALIDATION; CAPACITY; QSAR; CURCUMIN; PHARMACOPHORE; POLYPHENOLS	A pigment from the edible mushroom Xerocomus badius norbadione A, which is a natural derivative of pulvinic acid, was found to possess antioxidant properties. Since the pulvinic acid represents a novel antioxidant scaffold, several other derivatives were recently synthetized and evaluated experimentally, along with some structurally related coumarine derivatives. The obtained data formed the basis for the construction of several quantitative structure-activity and pharmacophore models, which were employed in the virtual screening experiments of compound libraries and for the prediction of their antioxidant activity, with the goal of discovering novel compounds possessing antioxidant properties. A final prioritization list of 21 novel compounds alongside 8 established antioxidant compounds was created for their experimental evaluation, consisting of the DPPH assay, 2-deoxyribose assay, beta-carotene bleaching assay and the cellular antioxidant activity assay. Ten novel compounds from the tetronic acid and barbituric acid chemical classes displayed promising antioxidant activity in at least one of the used assays, that is comparable to or even better than some standard antioxidants. Compounds 5, 7 and 9 displayed good activity in all the assays, and were furthermore effective preventers of oxidative stress in human peripheral blood mononuclear cells, which are promising features for the potential therapeutic use of such compounds.	[Martincic, Rok; Novic, Marjana] Natl Inst Chem Slovenia, Lab Chemometr, Ljubljana 1000, Slovenia; [Mravljak, Janez; Anderluh, Marko] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia; [Svajger, Urban] Blood Transfus Ctr Slovenia, Ljubljana 1000, Slovenia; [Perdih, Andrej] Natl Inst Chem Slovenia, Lab Biocomp & Bioinformat, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana; National Institute of Chemistry - Slovenia	Martincic, R (corresponding author), Natl Inst Chem Slovenia, Lab Chemometr, Hajdrihova 19, Ljubljana 1000, Slovenia.	rok.martincic@ki.si	Mravljak, Janez/ABC-8040-2020; Anderluh, Marko/B-7170-2008; Perdih, Andrej/T-7029-2018; Švajger, Urban/AAQ-1756-2020; Mravljak, Janez/GRX-7308-2022; Švajger, Urban/ABD-8035-2021	Mravljak, Janez/0000-0003-4591-3455; Anderluh, Marko/0000-0003-1768-8246; Perdih, Andrej/0000-0002-6645-9231; Švajger, Urban/0000-0002-1908-4254	Slovenian Research Agency (ARRS) through the ARRS Research Program [P1-0017, P1-0012]; PhD grant for Rok Martincic	Slovenian Research Agency (ARRS) through the ARRS Research Program; PhD grant for Rok Martincic	The study was funded by the Slovenian Research Agency (ARRS) (url: https://www.arrs.gov.si/en/novo.asp) through the ARRS Research Program Grants P1-0017, P1-0012, and a PhD grant for Rok Martincic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas F, 2006, Z NATURFORSCH C, V61, P625; Anuj Malik, 2011, Journal of Chemical and Pharmaceutical Research, V3, P659; Ao GZ, 2014, INT J MOL SCI, V15, P3970, DOI 10.3390/ijms15033970; ARUOMA OI, 1994, METHOD ENZYMOL, V233, P57; Biljali Sefedin, 2012, Folia Med (Plovdiv), V54, P42; Bortolomeazzi R, 2007, FOOD CHEM, V100, P1481, DOI 10.1016/j.foodchem.2005.11.039; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Burda S, 2001, J AGR FOOD CHEM, V49, P2774, DOI 10.1021/jf001413m; Burits M, 2000, PHYTOTHER RES, V14, P323, DOI 10.1002/1099-1573(200008)14:5&lt;323::AID-PTR621&gt;3.0.CO;2-Q; Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021; Chaillou LL, 2006, J AGR FOOD CHEM, V54, P8397, DOI 10.1021/jf061729f; Chen Z, 2013, FOOD CHEM, V138, P414, DOI 10.1016/j.foodchem.2012.11.001; Cheng ZH, 2006, J AGR FOOD CHEM, V54, P7429, DOI 10.1021/jf0611668; Cheng ZY, 2003, ANAL CHIM ACTA, V478, P129, DOI 10.1016/S0003-2670(02)01435-6; Dawidowicz A, 2010, EUR FOOD RES TECHNOL, V231, P835, DOI 10.1007/s00217-010-1333-4; Dror O, 2009, J CHEM INF MODEL, V49, P2333, DOI 10.1021/ci900263d; El Bakkali M, 2011, INT J MED CHEM, V2011, DOI 10.1155/2011/592879; Frankel EN, 2000, J SCI FOOD AGR, V80, P1925, DOI 10.1002/1097-0010(200010)80:13&lt;1925::AID-JSFA714&gt;3.0.CO;2-4; Genaro-Mattos TC, 2009, BBA-GEN SUBJECTS, V1790, P1636, DOI 10.1016/j.bbagen.2009.09.003; Gu BB, 2013, MOLECULES, V18, P7486, DOI 10.3390/molecules18077486; Habrant D, 2009, J MED CHEM, V52, P2454, DOI 10.1021/jm801500h; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b; HALLIWELL B, 1995, FREE RADICAL BIO MED, V18, P125, DOI 10.1016/0891-5849(95)91457-3; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hoffman R.D., 2006, PHARMACOPHORES PHARM; Hossain SU, 2007, BIOORG MED CHEM LETT, V17, P1149, DOI 10.1016/j.bmcl.2006.12.040; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Jaworska J, 2005, ATLA-ALTERN LAB ANIM, V33, P445, DOI 10.1177/026119290503300508; Jayaprakasha GK, 2004, BIOORGAN MED CHEM, V12, P5141, DOI 10.1016/j.bmc.2004.07.028; Jing P, 2012, MOLECULES, V17, P12910, DOI 10.3390/molecules171112910; Kerns EH, 2008, DRUG-LIKE PROPERTIES: CONCEPTS, STRUCTURE DESIGN AND METHODS, P1; Khanduja KL, 2003, INDIAN J BIOCHEM BIO, V40, P416; Kim JK, 2002, B KOREAN CHEM SOC, V23, P661; Kirchmair J, 2008, J COMPUT AID MOL DES, V22, P213, DOI 10.1007/s10822-007-9163-6; Langer T, 2008, PRACTICE OF MEDICINAL CHEMISTRY, 3RD EDITION, P210, DOI 10.1016/B978-0-12-374194-3.00010-X; Le Roux A, 2012, LETT DRUG DES DISCOV, V9, P48, DOI 10.2174/157018012798192900; Le Roux A, 2011, J CHEM INF MODEL, V51, P3050, DOI 10.1021/ci200205d; Li XC, 2011, FUNCT FOODS HEALTH D, V1, P232; LIN JK, 1994, CARCINOGENESIS, V15, P1717, DOI 10.1093/carcin/15.8.1717; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lu Y., 2014, Pharmacology and Pharmacy, V5, P395, DOI 10.4236/pp.2014.54047; Lu YR, 2000, FOOD CHEM, V68, P81, DOI 10.1016/S0308-8146(99)00167-3; Macrides TA, 1997, BIOCHEM MOL BIOL INT, V42, P1249; Martincic R, 2015, ANAL CHIM ACTA, V868, P23, DOI 10.1016/j.aca.2015.01.050; Meunier S, 2005, CHEMBIOCHEM, V6, P1234, DOI 10.1002/cbic.200400421; Meunier S, 2004, CHEMBIOCHEM, V5, P832, DOI 10.1002/cbic.200300787; Mishra K, 2012, FOOD CHEM, V130, P1036, DOI 10.1016/j.foodchem.2011.07.127; Mitra Indrani, 2013, Sci Pharm, V81, P57, DOI 10.3797/scipharm.1208-01; Mogana R, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/734824; Mogana R, 2013, ISRN Biotechnol, V2013, P986361, DOI 10.5402/2013/986361; Ndhlala AR, 2010, MOLECULES, V15, P6905, DOI 10.3390/molecules15106905; OECD, 2007, GUID DOC VAL QUANT S; Otajagic S., 2012, B CHEM TECHNOL BOSNI, V38, P35; Prieto MA, 2012, J AGR FOOD CHEM, V60, P8983, DOI 10.1021/jf302218g; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Queiroz AN, 2009, EUR J MED CHEM, V44, P1644, DOI 10.1016/j.ejmech.2008.09.023; Radice M., 2011, THESIS U FERRARA; Rebelo MM, 2009, REV BRAS FARMACOGN, V19, P230, DOI 10.1590/S0102-695X2009000200009; Roy K, 2012, J CHEM INF MODEL, V52, P396, DOI 10.1021/ci200520g; Rufino MSM, 2009, FOOD CHEM, V114, P693, DOI 10.1016/j.foodchem.2008.09.098; Sabudak T, 2013, PHYTOCHEMISTRY, V96, P305, DOI [10.1016/j.phytochem.2013.08.014, 1]; Sewell JC, 2006, ANESTH ANALG, V102, P764, DOI 10.1213/01.ane.0000195421.46107.d0; Shen M, 2004, J MED CHEM, V47, P2356, DOI 10.1021/jm030584q; Siatka T, 2010, MOLECULES, V15, P9450, DOI 10.3390/molecules15129450; Skedelj V, 2013, EUR J MED CHEM, V67, P208, DOI 10.1016/j.ejmech.2013.06.017; Song W, 2010, J AGR FOOD CHEM, V58, P6621, DOI 10.1021/jf9035832; Sykes MJ, 2006, J CHEM INF MODEL, V46, P2661, DOI 10.1021/ci600221h; Szelag M, 2015, OPEN CHEM, V13, P17, DOI 10.1515/chem-2015-0001; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Triballeau N, 2005, J MED CHEM, V48, P2534, DOI 10.1021/jm049092j; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; van Reyk DM, 2001, FREE RADICAL BIO MED, V30, P82, DOI 10.1016/S0891-5849(00)00449-4; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wang X., 2011, ASIAN J PHARM BIOL R, V1, P186; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166; Wu CR, 2007, FOOD CHEM, V104, P1464, DOI 10.1016/j.foodchem.2007.02.023; Zhu LC, 2009, CHEM BIODIVERS, V6, P1716, DOI 10.1002/cbdv.200800248	80	8	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140602	10.1371/journal.pone.0140602	http://dx.doi.org/10.1371/journal.pone.0140602			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474393	Green Published, gold, Green Submitted			2022-12-27	WOS:000363185500072
J	Moriwaki, Y; Takada, K; Nagasaki, T; Kubo, N; Ishii, T; Kose, K; Kageyama, T; Tsuji, S; Kawashima, K; Misawa, H				Moriwaki, Yasuhiro; Takada, Kiyoko; Nagasaki, Toshinori; Kubo, Natsuki; Ishii, Tomohiro; Kose, Kazuaki; Kageyama, Taihei; Tsuji, Shoutaro; Kawashima, Koichiro; Misawa, Hidemi			IL-22/STAT3-Induced Increases in SLURP1 Expression within Psoriatic Lesions Exerts Antimicrobial Effects against Staphylococcus aureus	PLOS ONE			English	Article							SKIN INFLAMMATION; IL-22; DIFFERENTIATION; KERATINOCYTES; PEPTIDES; PROTEIN; MELEDA; CELLS; CYTOKINES; VULGARIS	Background SLURP1 is the causal gene for Mal de Meleda (MDM), an autosomal recessive skin disorder characterized by diffuse palmoplantar keratoderma and transgressive keratosis. Moreover, although SLURP1 likely serves as an important proliferation/differentiation factor in keratinocytes, the possible relation between SLURP1 and other skin diseases, such as psoriasis and atopic dermatitis, has not been studied, and the pathophysiological control of SLURP1 expression in keratinocytes is largely unknown. Objectives Our aim was to examine the involvement of SLURP1 in the pathophysiology of psoriasis using an imiquimod (IMQ)-induced psoriasis model mice and normal human epidermal keratinocytes (NHEKs). Results SLURP1 expression was up-regulated in the skin of IMQ-induced psoriasis model mice. In NHEKs stimulated with the inflammatory cytokines IL-17, IL-22 and TNF-alpha, which are reportedly expressed in psoriatic lesions, SLURP1 mRNA expression was significantly up-regulated by IL-22 but not the other two cytokines. The stimulatory effect of IL-22 was completely suppressed in NHEKs treated with a STAT3 inhibitor or transfected with siRNA targeting STAT3. Because IL-22 induces production of antimicrobial proteins in epithelial cells, the antibacterial activity of SLURP1 was assessed against Staphylococcus aureus (S. aureus), which is known to be associated with disease severity in psoriasis. SLURP1 significantly suppressed the growth of S. aureus. Conclusions These results indicate SLURP1 participates in pathophysiology of psoriasis by regulating keratinocyte proliferation and differentiation, and by suppressing the growth of S. aureus.	[Moriwaki, Yasuhiro; Takada, Kiyoko; Nagasaki, Toshinori; Kubo, Natsuki; Ishii, Tomohiro; Kose, Kazuaki; Misawa, Hidemi] Keio Univ, Dept Pharmacol, Fac Pharm, Minato Ku, Tokyo 1058512, Japan; [Kageyama, Taihei; Tsuji, Shoutaro] Kanagawa Canc Ctr, Res Inst, Mol Diagnost Project, Yokohama, Kanagawa 2410815, Japan; [Kawashima, Koichiro] Kitasato Univ, Sch Pharm, Dept Mol Pharmacol, Minato Ku, Tokyo, Japan	Keio University; Kanagawa Prefectural Cancer Center; Kitasato University	Moriwaki, Y (corresponding author), Keio Univ, Dept Pharmacol, Fac Pharm, Minato Ku, Tokyo 1058512, Japan.	moriwaki-ys@pha.keio.ac.jp; misawa-hd@pha.keio.ac.jp		Ishii, Tomohiro/0000-0003-3092-1401; Moriwaki, Yasuhiro/0000-0001-9533-0421	JSPS KAKENHI [15K21370, 23111006, 26460692]; MEXT KAKENHI [25293020, 24590120]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1411004]; Smoking Research Foundation; Naito Foundation; Hoansha Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; Naito Foundation(Naito Memorial Foundation); Hoansha Foundation(Hoansha Foundation)	This work was supported in part by JSPS KAKENHI Grant Numbers 15K21370 (Y.M.), 23111006 (H.M.) and 26460692 (S.T.); MEXT KAKENHI Grant Numbers 25293020 (H.M.) and 24590120 (K.K.); MEXT-Supported Program (Grant Number S1411004) for the Strategic Research Foundation at Private Universities 2014-2016 (H.M.); the Smoking Research Foundation (K.K. and H.M.); The Naito Foundation (H.M.); and the Hoansha Foundation (H.M.).	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Adeyo O, 2014, J INVEST DERMATOL, V134, P1589, DOI 10.1038/jid.2014.19; Arredondo J, 2002, J CELL BIOL, V159, P325, DOI 10.1083/jcb.200206096; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Balci DD, 2009, EUR J DERMATOL, V19, P238, DOI 10.1684/ejd.2009.0663; Barker JN, 2007, LANCET, V370, P263; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Chernyavsky AI, 2012, WOUND REPAIR REGEN, V20, P103, DOI 10.1111/j.1524-475X.2011.00753.x; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fischer J, 2001, HUM MOL GENET, V10, P875, DOI 10.1093/hmg/10.8.875; Fujii T, 2014, J NEUROIMMUNOL, V267, P43, DOI 10.1016/j.jneuroim.2013.12.003; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1420, DOI 10.1016/j.jaci.2011.01.054; Kormeili T, 2004, BRIT J DERMATOL, V151, P3, DOI 10.1111/j.1365-2133.2004.06009.x; Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu HJ, 2006, EUR J DERMATOL, V16, P205; MARPLES RR, 1973, ARCH DERMATOL, V107, P568, DOI 10.1001/archderm.107.4.568; Mastrangeli R, 2003, EUR J DERMATOL, V13, P560; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Niebuhr M, 2010, J ALLERGY CLIN IMMUN, V126, P1176, DOI 10.1016/j.jaci.2010.07.041; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Rajesh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032633; Sakabe J, 2014, ACTA DERM-VENEREOL, V94, P512, DOI 10.2340/00015555-1775; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Tjiu JW, 2011, BRIT J DERMATOL, V164, P47, DOI 10.1111/j.1365-2133.2010.10059.x; Tomi NS, 2005, J AM ACAD DERMATOL, V53, P67, DOI 10.1016/j.jaad.2005.02.034; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; ZASLOFF M, 1988, P NATL ACAD SCI USA, V85, P910, DOI 10.1073/pnas.85.3.910	34	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140750	10.1371/journal.pone.0140750	http://dx.doi.org/10.1371/journal.pone.0140750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474319	gold, Green Submitted, Green Published			2022-12-27	WOS:000363185500101
J	Wada, A; Takagi, Y; Kono, M; Morikawa, T				Wada, Atsushi; Takagi, Yuri; Kono, Mari; Morikawa, Takashi			Accuracy of a New Platelet Count System (PLT-F) Depends on the Staining Property of Its Reagents	PLOS ONE			English	Article							FLOW REFERENCE METHOD; PERFORMANCE EVALUATION; AUTOMATED HEMATOLOGY; ANALYZERS; CHAPERONE	Background Platelet count is essential for the diagnosis and management of hemostasis abnormalities. Although existing platelet count methods installed in common hematology analyzers can correctly count platelets in normal blood samples, they tend to miscount platelets in some abnormal samples. The newly developed PLT-F channel in the XN-Series hematology analyzer (Sysmex) has been reported to be a reliable platelet count system, even in abnormal samples. However, how the PLT-F platelet counting system achieves such accuracy has not been described in scientific articles. Methods Isolated platelets, erythrocytes, and fragmented erythrocytes were examined using an automated hematology analyzer. The samples were labeled by combining PLT-F reagents and anti-CD62p, CD63, Grp75, Calreticulin, CD41, or CD61 antibody, and analyzed using confocal laser scanning microscopy or flow cytometry. Results The PLT-F system correctly discriminated platelets in erythrocytes. Its reagents strongly stained some intraplatelet organelles labeled with anti-Grp75, but only faintly stained the plasma membrane of both platelets and erythrocytes. Microscopic observation and flow cytometric examination revealed that all of these strongly stained cells were also labeled with platelet-specific anti-CD41 and anti-CD61 antibodies. Conclusions This study revealed that the staining property of the PLT-F reagents, by which platelets and fragmented erythrocytes are clearly distinguished, contributes to the platelet-counting accuracy of the PLT-F system.	[Wada, Atsushi; Takagi, Yuri; Kono, Mari; Morikawa, Takashi] Sysmex Corp, Sci Affairs, Sci Res Div, Nishi Ku, Kobe, Hyogo 6512241, Japan	Sysmex Corporation	Wada, A (corresponding author), Sysmex Corp, Sci Affairs, Sci Res Div, Nishi Ku, 1-3-2 Murotani, Kobe, Hyogo 6512241, Japan.	wada.atsushi@sysmex.co.jp						[Anonymous], 2010, VET CLIN PATH, V39, P395, DOI 10.1111/j.1939-165X.2010.00240.x; Araki J, 2012, TISSUE ENG PART C-ME, V18, P176, DOI [10.1089/ten.tec.2011.0308, 10.1089/ten.TEC.2011.0308]; Briggs C, 2012, J CLIN PATHOL, V65, P1024, DOI 10.1136/jclinpath-2012-200930; Cid J, 2010, TRANSFUSION, V50, P795, DOI 10.1111/j.1537-2995.2009.02504.x; Dadu T, 2013, INDIAN J PATHOL MICR, V56, P114, DOI 10.4103/0377-4929.118701; Daugirdas JT, 2012, KIDNEY INT, V82, P147, DOI 10.1038/ki.2012.130; DICKERHOFF R, 1995, CLIN LAB HAEMATOL, V17, P163; Diquattro M, 2009, INT J LAB HEMATOL, V31, P199, DOI 10.1111/j.1751-553X.2007.01025.x; Flachbartova Z, 2013, ACTA VIROL, V57, P2, DOI 10.4149/av_2013_01_3; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Harrison P, 2001, AM J CLIN PATHOL, V115, P448; Heijnen HFG, 1998, BLOOD, V91, P2313, DOI 10.1182/blood.V91.7.2313.2313_2313_2325; Hong KH, 2009, INT J LAB HEMATOL, V31, P298, DOI 10.1111/j.1751-553X.2008.01032.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kashiwagi H, 2013, INT J HEMATOL, V98, P24, DOI 10.1007/s12185-013-1370-4; Kono M, 2009, CLIN CHIM ACTA, V404, P105, DOI 10.1016/j.cca.2009.03.017; Kuwana M, 2014, WORLD J GASTROENTERO, V20, P714, DOI 10.3748/wjg.v20.i3.714; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Ortel Thomas L, 2009, Hematology Am Soc Hematol Educ Program, P225, DOI 10.1182/asheducation-2009.1.225; RAPPAPORT ES, 1988, SOUTH MED J, V81, P365, DOI 10.1097/00007611-198803000-00018; Sandhaus LM, 2002, AM J CLIN PATHOL, V118, P235; Schoorl M, 2013, AM J CLIN PATHOL, V140, P495, DOI 10.1309/AJCPUAGGB4URL5XO; Sehgal K, 2010, CYTOM PART B-CLIN CY, V78B, P279, DOI 10.1002/cyto.b.20515; Seo JY, 2015, INT J LAB HEMATOL, V37, P155, DOI 10.1111/ijlh.12254; Sola-Visner M, 2012, HEMATOL-AM SOC HEMAT, P506, DOI 10.1182/asheducation-2012.1.506; Tanaka Y, 2014, J CLIN LAB ANAL, V28, P341, DOI 10.1002/jcla.21691; Trabuio E, 2009, BLOOD TRANSFUS-ITALY, V7, P43, DOI 10.2450/2008.0039-08; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839	28	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141311	10.1371/journal.pone.0141311	http://dx.doi.org/10.1371/journal.pone.0141311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496387	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200090
J	Zhang, H; Ma, TW				Zhang, Hui; Ma, Tianwei			Roles of the Excitation in Harvesting Energy from Vibrations	PLOS ONE			English	Article							LEVITATION	The study investigated the role of excitation in energy harvesting applications. While the energy ultimately comes from the excitation, it was shown that the excitation may not always behave as a source. When the device characteristics do not perfectly match the excitation, the excitation alternately behaves as a source and a sink. The extent to which the excitation behaves as a sink determines the energy harvesting efficiency. Such contradictory roles were shown to be dictated by a generalized phase defined as the instantaneous phase angle between the velocity of the device and the excitation. An inductive prototype device with a diamagnetically levitated seismic mass was proposed to take advantage of the well established phase changing mechanism of vibro-impact to achieve a broader device bandwidth. Results suggest that the vibro-impact can generate an instantaneous, significant phase shift in response velocity that switches the role of the excitation. If introduced properly outside the resonance zone it could dramatically increase the energy harvesting efficiency.	[Zhang, Hui; Ma, Tianwei] Univ Hawaii Manoa, Dept Civil & Environm Engn, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Ma, TW (corresponding author), Univ Hawaii Manoa, Dept Civil & Environm Engn, Honolulu, HI 96822 USA.	tianwei@hawaii.edu	Zhang, Hui/Q-7220-2016	Zhang, Hui/0000-0002-7522-8267; Ma, Tianwei/0000-0002-1826-8844	National Science Foundation [CMMI 0758632]; Hawaii Department of Transportation [2008-2R]	National Science Foundation(National Science Foundation (NSF)); Hawaii Department of Transportation	The research was supported by National Science Foundation (Grant #: CMMI 0758632) and Hawaii Department of Transportation (Grant #: 2008-2R), which are greatly acknowledged.	Ahmadabadi ZN, 2014, J SOUND VIB, V333, P4444, DOI 10.1016/j.jsv.2014.04.033; Amirtharajah R, 1998, IEEE J SOLID-ST CIRC, V33, P687, DOI 10.1109/4.668982; Arrieta AF, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3487780; Babitsky VI., 1999, MECCANICA, V34, P299, DOI [10.1023/A:1004678130702, DOI 10.1023/A:1004678130702]; Challa VR, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/2/025005; Dagdeviren C, 2014, P NATL ACAD SCI USA, V111, P1927, DOI 10.1073/pnas.1317233111; Daqaq MF, 2010, J SOUND VIB, V329, P3621, DOI 10.1016/j.jsv.2010.04.002; Dunne PA, 2007, J MAGN MAGN MATER, V316, P273, DOI 10.1016/j.jmmm.2007.02.128; Elvin NG, 2006, SMART MATER STRUCT, V15, P977, DOI 10.1088/0964-1726/15/4/011; Geim AK, 1999, NATURE, V400, P323, DOI 10.1038/22444; Green PL, 2012, J SOUND VIB, V331, P4504, DOI 10.1016/j.jsv.2012.04.035; Gu L, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/4/045004; Guyomar D, 2005, IEEE T ULTRASON FERR, V52, P584, DOI 10.1109/TUFFC.2005.1428041; Halvorsen E, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042129; Harne RL, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/2/023001; Harne RL, 2012, J ACOUST SOC AM, V132, P162, DOI 10.1121/1.4725765; Hwang GT, 2014, ADV MATER, V26, P4880, DOI 10.1002/adma.201400562; Liang JR, 2012, IEEE T IND ELECTRON, V59, P1950, DOI 10.1109/TIE.2011.2167116; Liu L, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3583675; Ma T, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4879846; Ma T, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694272; Ma TW, 2011, P I MECH ENG I-J SYS, V225, P467, DOI 10.1177/2041304110394563; Ma TW, 2012, MECH SYST SIGNAL PR, V28, P323, DOI 10.1016/j.ymssp.2012.01.017; McFarland DM, 2005, INT J NONLIN MECH, V40, P891, DOI 10.1016/j.ijnonlinmec.2004.11.001; Moss S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3521265; Nguyen SD, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4775687; Roundy S, 2004, SMART MATER STRUCT, V13, P1131, DOI 10.1088/0964-1726/13/5/018; SHAW SW, 1983, J SOUND VIB, V90, P129, DOI 10.1016/0022-460X(83)90407-8; Stephen NG, 2006, J SOUND VIB, V293, P409, DOI 10.1016/j.jsv.2005.10.003; Sumali H, 2007, J MICROMECH MICROENG, V17, P2231, DOI 10.1088/0960-1317/17/11/009; Vakakis A.F., 2008, NONLINEAR TARGETED E, V156; Zhao S, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/1/015002	32	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141299	10.1371/journal.pone.0141299	http://dx.doi.org/10.1371/journal.pone.0141299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496183	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200088
J	Garcia, J; Parker, C; Parker, RG; Wilson, PA; Philbin, MM; Hirsch, JS				Garcia, Jonathan; Parker, Caroline; Parker, Richard G.; Wilson, Patrick A.; Philbin, Morgan M.; Hirsch, Jennifer S.			"You're Really Gonna Kick Us All Out?" Sustaining Safe Spaces for Community-Based HIV Prevention and Control among Black Men Who Have Sex with Men	PLOS ONE			English	Article							AFRICAN-AMERICAN MEN; PUBLIC-HEALTH; COMBINATION PREVENTION; RISK BEHAVIORS; POLICY; YOUTH; IMPLEMENTATION; OPPORTUNITIES; EMPOWERMENT; DISPARITIES	Black men who have sex with men (BMSM) experience among the highest rates of HIV infection in the United States. We conducted a community-based ethnography in New York City to identify the structural and environmental factors that influence BMSMs vulnerability to HIV and their engagement with HIV prevention services. Methods included participant observation at community-based organizations (CBOs) in New York City, in-depth interviews with 31 BMSM, and 17 key informant interviews. Our conceptual framework shows how creating and sustaining safe spaces could be a critical environmental approach to reduce vulnerability to HIV among BMSM. Participant observation, in-depth and key informant interviews revealed that fear and mistrust characterized men's relation to social and public institutions, such as churches, schools, and the police. This fear and mistrust created HIV vulnerability among the BMSM in our sample by challenging engagement with services. Our findings suggest that to be successful, HIV prevention efforts must address these structural and environmental vulnerabilities. Among the CBOs that we studied, "safe spaces" emerged as an important tool for addressing these environmental vulnerabilities. CBOs used safe spaces to provide social support, to address stigma, to prepare men for the work-force, and to foster a sense of community among BMSM. In addition, safe spaces were used for HIV and STI testing and treatment campaigns. Our ethnographic findings suggest that safe spaces represent a promising but so far under-utilized part of HIV prevention infrastructure. Safe spaces seem integral to high impact comprehensive HIV prevention efforts, and may be considered more appropriately as part of HIV capacity-building rather than being nested within program-specific funding structures.	[Garcia, Jonathan] Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Parker, Caroline; Parker, Richard G.; Wilson, Patrick A.; Hirsch, Jennifer S.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA; [Philbin, Morgan M.] New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA	Oregon State University; Columbia University; New York State Psychiatry Institute	Garcia, J (corresponding author), Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA.	jonathan.garcia@oregonstate.edu	/AAF-4450-2021; /AET-2949-2022; Garcia, Jonathan/N-2151-2016	Garcia, Jonathan/0000-0001-5457-5107; Parker, Caroline/0000-0002-0817-2494	National Institute of Mental Health [R01 MH098723]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD058486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520, T32MH019139, R01MH098723] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant from the National Institute of Mental Health (R01 MH098723, PIs: PC and JSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton P, 2015, AM J PUBLIC HLTH; Aidala A, 2005, AIDS BEHAV, V9, P251, DOI 10.1007/s10461-005-9000-7; [Anonymous], 2014, HUFFINGTON POST; [Anonymous], 2014, COMMUNICATION; Aral SO, 2012, SEX TRANSM INFECT, V88, P157, DOI 10.1136/sextrans-2011-050389; Arnold EA, 2014, CULTURE HLTH SEXUALI, P1; Baum F, 2002, HEALTH PROMOT INT, V17, P351, DOI 10.1093/heapro/17.4.351; Bowleg L, 2013, AIDS BEHAV, V17, P407, DOI 10.1007/s10461-012-0179-0; Brunson RK, 2015, JUSTICE Q, V32, P1006, DOI 10.1080/07418825.2013.868505; Calabrese SK, 2014, AIDS BEHAV, V18, P226, DOI 10.1007/s10461-013-0675-x; CDC, 2011, HIGH IMP HIV PREV CD, P12; Centers for Disease Control and Prevention, 2012, EST HIV INC US 2007; Corliss HL, 2011, AM J PUBLIC HEALTH, V101, P1683, DOI 10.2105/AJPH.2011.300155; Dupper DR, 2002, URBAN EDUC, V37, P350, DOI 10.1177/00485902037003003; Durkin E, NY DAILY NEWS; Fischer B, 1998, GEOFORUM, V29, P187, DOI 10.1016/S0016-7185(98)00006-2; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grossman CI, 2013, AM PSYCHOL, V68, P237, DOI 10.1037/a0032711; Hampton T, 2011, JAMA-J AM MED ASSOC, V306, P2551, DOI 10.1001/jama.2011.1805; Hanhardt C.B, 2013, SAFE SPACE GAY NEIGH; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Kegeles SM, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0216-2; Keuroghlian AS, 2014, AM J ORTHOPSYCHIAT, V84, P66, DOI 10.1037/h0098852; Kippax S, 2013, AM J PUBLIC HEALTH, V103, P1367, DOI 10.2105/AJPH.2013.301301; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; Miller RL, 2012, AM J COMMUN PSYCHOL, V49, P199, DOI 10.1007/s10464-011-9459-5; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Montgomery Catherine M, 2011, J Int AIDS Soc, V14 Suppl 2, pS4, DOI 10.1186/1758-2652-14-S2-S4; National Coalition of Anti-Violence Programs, 2015, LESB GAY BIS TRANSG; Nguyen VK, 2011, AIDS, V25, P291, DOI 10.1097/QAD.0b013e3283402c3e; NYCDOHMH, 2012, HIV SURV ANN REP 201; Office of National AIDS Policy, 2010, NATL HIV AIDS STRAT; Parker R, 2014, GAPW B, V1, P16; Parker RG, 1996, AIDS, V10, pS27; Saleh LD, 2011, AIDS EDUC PREV, V23, P521, DOI 10.1521/aeap.2011.23.6.521; Schuck A, 2013, J ETHN CRIM JUSTICE, V11, P219, DOI 10.1080/15377938.2012.762635; Schwab-Stone M, 1999, J AM ACAD CHILD PSY, V38, P359, DOI 10.1097/00004583-199904000-00007; Solorio MR, 2008, J ADOLESCENT HEALTH, V42, P401, DOI 10.1016/j.jadohealth.2007.09.023; Stokes JP, 1998, AIDS EDUC PREV, V10, P278; Stokols D, 1996, AM J HEALTH PROMOT, V10, P282, DOI 10.4278/0890-1171-10.4.282; UNAIDS, 2010, COMB HIV PREV TAIL C; Voelker R, 2011, JAMA-J AM MED ASSOC, V306, P1642, DOI 10.1001/jama.2011.1478; Weinberg J., 2013, HUFFINGTON POST; Wilson PA, 1996, URBAN STUD, V33, P617, DOI 10.1080/00420989650011753; Zorrilla CD, 2012, P R HEALTH SCI J, V31, P170	45	40	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141326	10.1371/journal.pone.0141326	http://dx.doi.org/10.1371/journal.pone.0141326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZU	26492412	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300043
J	Tomkowicz, B; Walsh, E; Cotty, A; Verona, R; Sabins, N; Kaplan, F; Santulli-Marotto, S; Chin, CN; Mooney, J; Lingham, RB; Naso, M; McCabe, T				Tomkowicz, Brian; Walsh, Eileen; Cotty, Adam; Verona, Raluca; Sabins, Nina; Kaplan, Fred; Santulli-Marotto, Sandy; Chin, Chen-Ni; Mooney, Jill; Lingham, Russell B.; Naso, Michael; McCabe, Timothy			TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway	PLOS ONE			English	Article							T-CELL EXHAUSTION; CHRONIC VIRAL-INFECTION; LYMPHOCYTE-ACTIVATION; CANCER-IMMUNOTHERAPY; NEGATIVE REGULATION; ANTITUMOR IMMUNITY; RECEPTOR TIM-3; PD-1; CD4(+); TRANSCRIPTION	TIM-3 (T cell immunoglobulin and mucin-domain containing protein 3) is a member of the TIM family of proteins that is preferentially expressed on Th-1 polarized CD4(+) and CD8(+) T cells. Recent studies indicate that TIM-3 serves as a negative regulator of T cell function (i.e. T cell dependent immune responses, proliferation, tolerance, and exhaustion). Despite having no recognizable inhibitory signaling motifs, the intracellular tail of TIM-3 is apparently indispensable for function. Specifically, the conserved residues Y265/Y272 and surrounding amino acids appear to be critical for function. Mechanistically, several studies suggest that TIM-3 can associate with interleukin inducible T cell kinase (ITK), the Src kinases Fyn and Lck, and the p85 phosphatidylinositol 3-kinase (PI3K) adaptor protein to positively or negatively regulate IL-2 production via NF-kappa B/NFAT signaling pathways. To begin to address this discrepancy, we examined the effect of TIM-3 in two model systems. First, we generated several Jurkat T cell lines stably expressing human TIM-3 or murine CD28-ECD/human TIM-3 intracellular tail chimeras and examined the effects that TIM-3 exerts on T cell Receptor (TCR)-mediated activation, cytokine secretion, promoter activity, and protein kinase association. In this model, our results demonstrate that TIM-3 inhibits several TCR-mediated phenotypes: i) NF-kB/NFAT activation, ii) CD69 expression, and iii) suppression of IL-2 secretion. To confirm our Jurkat cell observations we developed a primary human CD8(+) cell system that expresses endogenous levels of TIM-3. Upon TCR ligation, we observed the loss of NFAT reporter activity and IL-2 secretion, and identified the association of Src kinase Lck, and PLC-gamma with TIM-3. Taken together, our results support the conclusion that TIM-3 is a negative regulator of TCR-function by attenuating activation signals mediated by CD3/CD28 co-stimulation.	[Tomkowicz, Brian; Walsh, Eileen; Cotty, Adam; Verona, Raluca; Sabins, Nina; Kaplan, Fred; Santulli-Marotto, Sandy; Chin, Chen-Ni; Mooney, Jill; Lingham, Russell B.; Naso, Michael; McCabe, Timothy] Janssen BioTherapeut, Spring House, PA 19477 USA		Tomkowicz, B (corresponding author), Janssen BioTherapeut, 1400 McKean Rd, Spring House, PA 19477 USA.	btomkowi@its.jnj.com; tmccabe1@its.jnj.com		Cotty, Adam/0000-0001-9795-7156	Janssen Pharmaceuticals	Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Janssen Pharmaceuticals provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Anderson DE, 2007, EXPERT OPIN THER TAR, V11, P1005, DOI 10.1517/14728222.11.8.1005; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Cho JL, 2012, J IMMUNOL, V189, P2879, DOI 10.4049/jimmunol.1102483; Clayton KL, 2014, J IMMUNOL, V192, P782, DOI 10.4049/jimmunol.1302663; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fourcade J, 2014, CANCER RES, V74, P1045, DOI 10.1158/0008-5472.CAN-13-2908; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Lee MJ, 2012, IMMUNOBIOLOGY, V217, P986, DOI 10.1016/j.imbio.2012.01.012; Leitner J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003253; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Li J, 2015, CANCER RES, V75, P508, DOI 10.1158/0008-5472.CAN-14-1215; Lisowska K, 2003, FOLIA HISTOCHEM CYTO, V41, P233; Lu LH, 2007, J BIOCHEM, V141, P157, DOI 10.1093/jb/mvm019; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1189/jlb.1006610; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Ngiow SF, 2011, CANCER RES, V71, P6567, DOI 10.1158/0008-5472.CAN-11-1487; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Nirschl CJ, 2013, CLIN CANCER RES, V19, P4917, DOI 10.1158/1078-0432.CCR-12-1972; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Sakuishi K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23849; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Su EW, 2011, GLYCOBIOLOGY, V21, P1258, DOI 10.1093/glycob/cwq214; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	49	47	53	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140694	10.1371/journal.pone.0140694	http://dx.doi.org/10.1371/journal.pone.0140694			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492563	Green Published, Green Submitted, gold			2022-12-27	WOS:000363249300009
J	Graf, D; Wesslowski, J; Ma, H; Scheerer, P; Krauss, N; Oberpichler, I; Zhang, F; Lamparter, T				Graf, Dominik; Wesslowski, Janine; Ma, Hongju; Scheerer, Patrick; Krauss, Norbert; Oberpichler, Inga; Zhang, Fan; Lamparter, Tilman			Key Amino Acids in the Bacterial (6-4) Photolyase PhrB from Agrobacterium fabrum	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DNA; PHOTOREDUCTION	Photolyases can repair pyrimidine dimers on the DNA that are formed during UV irradiation. PhrB from Agrobacterium fabrum represents a new group of prokaryotic (6-4) photolyases which contain an iron-sulfur cluster and a DMRL chromophore. We performed site-directed mutagenesis in order to assess the role of particular amino acid residues in photorepair and photoreduction, during which the FAD chromophore converts from the oxidized to the enzymatically active, reduced form. Our study showed that Trp342 and Trp390 serve as electron transmitters. In the H366A mutant repair activity was lost, which points to a significant role of His366 in the protonation of the lesion, as discussed for the homolog in eukaryotic (6-4) photolyases. Mutants on cysteines that coordinate the Fe-S cluster of PhrB were either insoluble or not expressed. The same result was found for proteins with a truncated C-terminus, in which one of the Fe-S binding cysteines was mutated and for expression in minimal medium with limited Fe concentrations. We therefore assume that the Fe-S cluster is required for protein stability. We further mutated conserved tyrosines that are located between the DNA lesion and the Fe-S cluster. Mutagenesis results showed that Tyr424 was essential for lesion binding and repair, and Tyr430 was required for efficient repair. The results point to an important function of highly conserved tyrosines in prokaryotic (6-4) photolyases.	[Graf, Dominik; Wesslowski, Janine; Ma, Hongju; Oberpichler, Inga; Zhang, Fan; Lamparter, Tilman] Karlsruhe Inst Technol, Inst Bot, D-76131 Karlsruhe, Germany; [Scheerer, Patrick] Charite, Inst Med Phys & Biophys CC2, AG Prot Xray Crystallog & Signal Transduct, D-10117 Berlin, Germany; [Krauss, Norbert] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	Helmholtz Association; Karlsruhe Institute of Technology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; Queen Mary University London	Zhang, F (corresponding author), Karlsruhe Inst Technol, Inst Bot, Kaiserstr 2, D-76131 Karlsruhe, Germany.	fanzhangscu@hotmail.com; tilman.lamparter@kit.edu	; Lamparter, Tilman/E-4421-2013	Krauss, Norbert/0000-0002-7128-4632; Lamparter, Tilman/0000-0003-4327-9737; Scheerer, Patrick/0000-0001-5028-2075	Deutsche Forschungsgemeinschaft (DFG) [799/8-1, SFB 740-B6, SFB 1078-B6]; China Scholarship Council; Karlsruhe House of Young Scientists; DFG Cluster of Excellence "Unifying Concepts in Catalysis" Research Field [D3/E3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council); Karlsruhe House of Young Scientists; DFG Cluster of Excellence "Unifying Concepts in Catalysis" Research Field(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant 799/8-1 (to T.L.) and SFB 740-B6 and SFB 1078-B6 (to P.S.); grants from the China Scholarship Council (to F.Z.); Karlsruhe House of Young Scientists (to F.Z.); and DFG Cluster of Excellence "Unifying Concepts in Catalysis" Research Field D3/E3 (to P.S.).	Bauer TO, 2014, HYPERFINE INTERACT, V226, P445, DOI 10.1007/s10751-013-0969-4; Brettel K, 2010, CURR OPIN STRUC BIOL, V20, P693, DOI 10.1016/j.sbi.2010.07.003; Geisselbrecht Y, 2012, EMBO REP, V13, P223, DOI 10.1038/embor.2012.2; HARRIMAN A, 1987, J PHYS CHEM-US, V91, P6102, DOI 10.1021/j100308a011; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Kiontke S, 2011, EMBO J, V30, P4437, DOI 10.1038/emboj.2011.313; Kneuttinger AC, 2014, PHOTOCHEM PHOTOBIOL, V90, P1, DOI 10.1111/php.12197; Lamparter T, 2014, ENCY INORGANIC BIOIN; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Liu ZY, 2013, P NATL ACAD SCI USA, V110, P12966, DOI 10.1073/pnas.1311073110; Mack M, 2006, APPL MICROBIOL BIOT, V71, P265, DOI 10.1007/s00253-006-0421-7; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Oberpichler I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026775; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Scheerer P, 2015, J BIOL CHEM, V290, P11504, DOI 10.1074/jbc.M115.637868; Zhang F, 2013, P NATL ACAD SCI USA, V110, P7217, DOI 10.1073/pnas.1302377110	16	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140955	10.1371/journal.pone.0140955	http://dx.doi.org/10.1371/journal.pone.0140955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489006	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400084
J	Leng, PF; Ji, Q; Tao, YF; Ibrahim, R; Pan, GT; Xu, ML; Lubberstedt, T				Leng, Pengfei; Ji, Qing; Tao, Yongfu; Ibrahim, Rania; Pan, Guangtang; Xu, Mingliang; Luebberstedt, Thomas			Characterization of Sugarcane Mosaic Virus Scmv1 and Scmv2 Resistance Regions by Regional Association Analysis in Maize	PLOS ONE			English	Article							ZEA-MAYS L.; MULTILOCUS GENOTYPE DATA; INBRED LINES; POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; CONFERRING RESISTANCE; POTYVIRUS RESISTANCE; GENETIC-STRUCTURE; AFLP MARKERS; POLYMORPHISMS	Sugarcane Mosaic Virus (SCMV) causes one of the most severe virus diseases in maize worldwide, resulting in reduced grain and forage yield in susceptible cultivars. In this study, two association panels consisting of 94 inbred lines each, from China and the U.S., were characterized for resistance to two isolates: SCMV-Seehausen and SCMV-BJ. The population structure of both association panels was analyzed using 3072 single nucleotide polymorphism (SNP) markers. The Chinese and the U. S. panel were both subdivided into two sub-populations, the latter comprised of Stiff Stalk Synthetic (SS) lines and Non Stiff Stalk Synthetic (NSS). The relative kinships were calculated using informative 2947 SNPs with minor allele frequency >= 5% and missing data <= 20% for the Chinese panel and 2841 SNPs with the same characteristics were used for the U. S. panel. The Scmv1 region was genotyped using 7 single sequence repeat (SSR) and sequence-tagged site (STS) markers, and 12 SSR markers were used for the Scmv2 region in the U. S. panel, while 5 of them were used for the Chinese panel. For all traits, a MLM (Mix Linear Model) controlling both population structure and relative kinship (Q + K) was used for association analysis. Three markers Trx-1, STS-11, and STS-12 located in the Scmv1 region were strongly associated (P = 0.001) with SCMV resistance, and explained more than 16.0%, 10.6%, and 19.7% of phenotypic variation, respectively. 207FG003 located in the Scmv2 region was significantly associated (P = 0.001) with SCMV resistance, and explained around 18.5% of phenotypic variation.	[Leng, Pengfei; Tao, Yongfu; Xu, Mingliang] China Agr Univ, Natl Maize Improvement Ctr, Beijing 100094, Peoples R China; [Leng, Pengfei; Ji, Qing; Ibrahim, Rania; Luebberstedt, Thomas] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Pan, Guangtang] Sichuan Agr Univ, Maize Res Inst, Chengdu 611130, Sichuan, Peoples R China	China Agricultural University; Iowa State University; Sichuan Agricultural University	Leng, PF (corresponding author), China Agr Univ, Natl Maize Improvement Ctr, Beijing 100094, Peoples R China.	pfleng@163.com; thomasl@iastate.edu	Tao, Yongfu/AAM-5494-2020	Tao, Yongfu/0000-0001-9096-7407; Lubberstedt, Thomas/0000-0002-0526-0798	R.F. Baker Center for Plant Breeding at Iowa State University; iAGRI project of USAID	R.F. Baker Center for Plant Breeding at Iowa State University; iAGRI project of USAID(United States Agency for International Development (USAID))	The R.F. Baker Center for Plant Breeding at Iowa State University is highly appreciated for financial assistance for this work. The authors would also like to thank the iAGRI project of USAID for funding.	Andersen JR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-2; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Borras-Hidalgo O, 2006, MOL PLANT MICROBE IN, V19, P399, DOI 10.1094/MPMI-19-0399; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brenner EA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-27; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Chen X, 2004, ZUO WU XUE BAO, V31, P983; Chen YS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-12; Cotton S, 2009, J VIROL, V83, P10460, DOI 10.1128/JVI.00819-09; Dussle CM, 2000, PLANT BREEDING, V119, P299, DOI 10.1046/j.1439-0523.2000.00509.x; Dussle CM, 2003, THEOR APPL GENET, V106, P485, DOI 10.1007/s00122-002-1107-x; Dussle CM, 2002, THEOR APPL GENET, V105, P1190, DOI 10.1007/s00122-002-0964-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Fuchs E, 1995, J PLANT DIS PROTECT, V102, P44; Garces-Claver A, 2007, THEOR APPL GENET, V115, P907, DOI 10.1007/s00122-007-0617-y; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; gvardsen C, 2007, PROGR BOT, V69, P61; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Ingvardsen CR, 2010, THEOR APPL GENET, V120, P1621, DOI 10.1007/s00122-010-1281-1; Jones M, 2011, THEOR APPL GENET, V123, P729, DOI 10.1007/s00122-011-1622-8; Krill AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009958; Kuntze L, 1997, PLANT BREEDING, V116, P499, DOI 10.1111/j.1439-0523.1997.tb01038.x; Kuntze L, 1995, AGRONOMIE, V15, P463, DOI 10.1051/agro:19950714; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu KJ, 2003, GENETICS, V165, P2117; Lubberstedt T, 2006, PLANT BREEDING, V125, P352, DOI 10.1111/j.1439-0523.2006.01244.x; MCMULLEN MD, 1989, MOL PLANT MICROBE IN, V2, P309, DOI 10.1094/MPMI-2-309; MCMULLEN MD, 1994, MOL PLANT MICROBE IN, V7, P708, DOI 10.1094/MPMI-7-0708; Melchinger AE, 1998, THEOR APPL GENET, V96, P1151, DOI 10.1007/s001220050851; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Napier RM, 2002, PLANT MOL BIOL, V49, P339, DOI 10.1023/A:1015259130955; Noctor G, 2002, J EXP BOT, V53, P1283, DOI 10.1093/jexbot/53.372.1283; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Pritchard JK, 2000, GENETICS, V155, P945; Quint M, 2003, THEOR APPL GENET, V106, P1171, DOI 10.1007/s00122-002-1105-z; ROANE CW, 1989, PHYTOPATHOLOGY, V79, P1364, DOI 10.1094/Phyto-79-1364; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Ryabov EV, 1999, P NATL ACAD SCI USA, V96, P1212, DOI 10.1073/pnas.96.4.1212; SCOTT GE, 1971, CROP SCI, V11, P801, DOI 10.2135/cropsci1971.0011183X001100060008x; SCOTT GE, 1981, PHYTOPATHOLOGY, V71, P937, DOI 10.1094/Phyto-71-937; SHUKLA DD, 1989, PHYTOPATHOLOGY, V79, P223, DOI 10.1094/Phyto-79-223; Steffens B, 2001, PLANT J, V27, P591, DOI 10.1046/j.1365-313X.2001.01103.x; Sun LJ, 2010, MOL PLANT MICROBE IN, V23, P1470, DOI 10.1094/MPMI-01-10-0029; Takemoto T, 1998, FREE RADICAL BIO MED, V24, P556, DOI 10.1016/S0891-5849(97)00287-6; Tao YF, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-162; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tromas A, 2010, TRENDS PLANT SCI, V15, P436, DOI 10.1016/j.tplants.2010.05.001; Uzarowska A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-15; Wang RH, 2008, THEOR APPL GENET, V117, P1141, DOI 10.1007/s00122-008-0852-x; Wang ZhenHua, 2003, Acta Agronomica Sinica, V29, P391; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Wei TY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000962; Weijers D, 2004, CURR OPIN PLANT BIOL, V7, P687, DOI 10.1016/j.pbi.2004.09.006; WINGATE VPM, 1988, PLANT PHYSIOL, V87, P206, DOI 10.1104/pp.87.1.206; Wu JY, 2007, EUPHYTICA, V156, P355, DOI 10.1007/s10681-007-9384-8; Wu Jian-Yu, 2002, Acta Genetica Sinica, V29, P1095; Xia XC, 1999, PHYTOPATHOLOGY, V89, P660, DOI 10.1094/PHYTO.1999.89.8.660; Xie CX, 2008, MOL BREEDING, V21, P407, DOI 10.1007/s11032-007-9140-8; Xing Y, 2006, GENOME, V49, P1274, DOI 10.1139/G06-070; Xu ML, 1999, MOL GEN GENET, V261, P574, DOI 10.1007/s004380051003; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yuan L, 2003, MAYDICA, V48, P55; Zhang SH, 2003, MAYDICA, V48, P307; Zhang Y, 2013, J GENET GENOMICS, V40, P23, DOI 10.1016/j.jgg.2012.11.003; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	71	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140617	10.1371/journal.pone.0140617	http://dx.doi.org/10.1371/journal.pone.0140617			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488483	gold, Green Submitted, Green Published			2022-12-27	WOS:000363248400062
J	Lopez-Piriz, R; Sola-Linares, E; Rodriguez-Portugal, M; Malpica, B; Diaz-Gumes, I; Enciso, S; Esteban-Tejeda, L; Cabal, B; Granizo, JJ; Moya, JS; Torrecillas, R				Lopez-Piriz, Roberto; Sola-Linares, Eva; Rodriguez-Portugal, Mercedes; Malpica, Beatriz; Diaz-Guemes, Idoia; Enciso, Silvia; Esteban-Tejeda, Leticia; Cabal, Belen; Jose Granizo, Juan; Serafin Moya, Jose; Torrecillas, Ramon			Evaluation in a Dog Model of Three Antimicrobial Glassy Coatings: Prevention of Bone Loss around Implants and Microbial Assessments	PLOS ONE			English	Article							PERI-IMPLANTITIS; DENTAL IMPLANTS; IN-VIVO; BIOCIDE; NANOPARTICLES; OXIDE; PERIODONTOLOGY; INFECTION; BREAKDOWN; LESIONS	Objectives The aim of the present study is to evaluate, in a ligature-induced peri-implantitis model, the efficacy of three antimicrobial glassy coatings in the prevention of biofilm formation, intrasulcular bacterial growth and the resulting peri-implant bone loss. Methods Mandibular premolars were bilaterally extracted from five beagle dogs. Four dental implants were inserted on each hemiarch. Eight weeks after, one control zirconia abutment and three with different bactericidal coatings (G1n-Ag, ZnO35, G3) were connected. After a plaque control period, bacterial accumulation was allowed and biofilm formation on abutments was observed by Scanning Electron Microscopy (SEM). Peri-implantitis was induced by cotton ligatures. Microbial samples and peri-implant crestal bone levels of all implant sites were obtained before, during and after the breakdown period. Results During experimental induce peri-implantitis: colony forming units counts from intrasulcular microbial samples at implants with G1n-Ag coated abutment remained close to the basal inoculum; G3 and ZnO35 coatings showed similar low counts; and anaerobic bacterias counts at control abutments exhibited a logarithmic increase by more than 2. Bone loss during passive breakdown period was no statistically significant. Additional bone loss occurred during ligature-induce breakdown: 0.71 (SD 0.48) at G3 coating, 0.57 (SD 0.36) at ZnO35 coating, 0.74 (SD 0.47) at G1n-Ag coating, and 1.29 (SD 0.45) at control abutments; and statistically significant differences (p<0.001) were found. The lowest bone loss at the end of the experiment was exhibited by implants dressing G3 coated abutments (mean 2.1; SD 0.42). Significance Antimicrobial glassy coatings could be a useful tool to ward off, diminish or delay peri-implantitis progression.	[Lopez-Piriz, Roberto; Cabal, Belen; Serafin Moya, Jose; Torrecillas, Ramon] Univ Oviedo, Nanomat & Nanotechnol Res Ctr CINN CSIC, San Martin Rey Aurelio, Asturias, Spain; [Sola-Linares, Eva] Adv Surg Ctr Inst ICOA, Madrid, Spain; [Diaz-Guemes, Idoia; Enciso, Silvia] Minimally Invas Surg Ctr CCMIJU, Caceres, Spain; [Esteban-Tejeda, Leticia] Univ Dublin Trinity Coll, Sch Chem, Dublin 2, Ireland; [Jose Granizo, Juan] Infanta Mercedes Hosp, Prevent Med Unit, Parla, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion en Nanomateriales y Nanotecnologia (CINN); University of Oviedo; Trinity College Dublin	Lopez-Piriz, R (corresponding author), Univ Oviedo, Nanomat & Nanotechnol Res Ctr CINN CSIC, San Martin Rey Aurelio, Asturias, Spain.	lopezpiriz@gmail.com	Cabal, Belén/G-2694-2019; López-Píriz, Roberto/W-8146-2019; Torrecillas, Ramón/G-7851-2011	Cabal, Belén/0000-0002-4102-3810; López-Píriz, Roberto/0000-0003-2431-6950; Torrecillas, Ramón/0000-0003-3856-0217; Diaz-Guemes, Idoia/0000-0001-6047-2489; Enciso, Silvia/0000-0001-5004-6734	Spanish Ministry of Science and Innovation (MICINN); Spanish National Research Council (CSIC) [MAT2012-38645, 201360E012]; JAE-Doc program (CSIC)	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Research Council (CSIC); JAE-Doc program (CSIC)	This work was supported by the Spanish Ministry of Science and Innovation (MICINN) and The Spanish National Research Council (CSIC) under the projects MAT2012-38645 and 201360E012 respectively. B. Cabal acknowledges financial support from JAE-Doc program (CSIC, cofounded by FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11; Berglundh T, 1992, Clin Oral Implants Res, V3, P1, DOI 10.1034/j.1600-0501.1992.030101.x; Berglundh T, 2011, J CLIN PERIODONTOL, V38, P188, DOI 10.1111/j.1600-051X.2010.01672.x; Cabal B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05440; Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089; ERICSSON I, 1975, SCAND J DENT RES, V83, P189; Esteban-Tejeda L, 2013, MATER LETT, V111, P59, DOI 10.1016/j.matlet.2013.08.049; Esteban-Tejeda L, 2015, J NONCRYSTALLINE SOL; Esteban-Tejeda L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132709; Esteban-Tejeda L, 2010, ADV ENG MATER, V12, pB292, DOI 10.1002/adem.200980077; Gotfredsen K, 2002, J CLIN PERIODONTOL, V29, P144, DOI 10.1034/j.1600-051x.2002.290209.x; Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Lang N P, 1993, Clin Oral Implants Res, V4, P2, DOI 10.1034/j.1600-0501.1993.040101.x; Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x; Lindhe J, 2008, J CLIN PERIODONTOL, V35, P282, DOI 10.1111/j.1600-051X.2008.01283.x; Lopez-Esteban S, 2014, J MECH BEHAV BIOMED, V34, P302, DOI 10.1016/j.jmbbm.2014.02.019; Lopez-Piriz R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052861; Lopez-Piriz R, 2012, MED ORAL PATOL ORAL, V17, pE893, DOI 10.4317/medoral.17999; MARINELLO CP, 1995, J CLIN PERIODONTOL, V22, P475, DOI 10.1111/j.1600-051X.1995.tb00180.x; Martinez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086926; Memarzadeh K, 2015, J BIOMED MATER RES A, V103, P981, DOI 10.1002/jbm.a.35241; Miranda M, 2012, J MATER SCI-MATER M, V23, P1655, DOI 10.1007/s10856-012-4642-2; Miranda M, 2010, INT J MATER RES, V101, P122, DOI 10.3139/146.110256; Moya JS, 2012, MATER LETT, V70, P113, DOI 10.1016/j.matlet.2011.11.104; Moya JS, 2011, ADV ENG MATER, V13, pB256, DOI 10.1002/adem.201080133; Pjetursson BE, 2007, CLIN ORAL IMPLAN RES, V18, P73, DOI 10.1111/j.1600-0501.2007.01467.x; Renvert S, 2012, J CLIN PERIODONTOL, V39, P1191, DOI 10.1111/jcpe.12017; Roos J, 1997, INT J ORAL MAX IMPL, V12, P504; Sun FJ, 2013, FUTURE MICROBIOL, V8, P877, DOI 10.2217/fmb.13.58; Tomsia AP, 2013, INT J ORAL MAX IMPL, V28, pE535, DOI 10.11607/jomi.te34; Wang B, 2013, METALLOMICS, V5, P793, DOI 10.1039/c3mt00093a; Weinberg MA, 1999, J CLIN PERIODONTOL, V26, P335, DOI 10.1034/j.1600-051X.1999.260601.x	34	15	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140374	10.1371/journal.pone.0140374	http://dx.doi.org/10.1371/journal.pone.0140374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489088	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400049
J	Nam, BH; Park, JW; Jeong, SH; Lee, SS; Yu, A; Kim, BH; Kim, WR				Nam, Byung-Ho; Park, Joong-Won; Jeong, Sook-Hyang; Lee, Sang Soo; Yu, Ami; Kim, Bo Hyun; Kim, W. Ray			Korean Version of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma (K-MESIAH)	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; VALIDATION; PROGNOSIS	Background and Aim A model to estimate survival in ambulatory hepatocellular carcinoma patients (MESIAH) is useful for estimating patient prognosis but needs improvement for Korean patients, most of whom have a hepatitis B virus. We aimed to modify the MESIAH for better prognostication through enhancing calibration for Korean patient population (K-MESIAH). Methods Utilizing a cohort of 1,969 hepatocellular carcinoma (HCC) patients from the National Cancer Center of Korea between 2004 and 2009, a survival prediction model was developed using the Cox proportional hazards model. The model's performance was evaluated using C-statistical and. 2-statistical analyses. External validation was performed using an independent cohort of 328 patients from the Seoul National University Bundang Hospital. Results To develop the K-MESIAH, etiology was added to the original risk factors (age, Model for Endstage Liver Disease, albumin, size of the largest nodule, number of tumor nodules, vascular invasion, metastasis, and alpha fetoprotein) in the MESIAH. From the internal validation study, the C-statistics and. 2-statistics for one-, three-, and five-years of survival were 0.83 (95% Confidence Interval: 0.82 - 0.85), 49.07; 0.81 (95% Confidence Interval: 0.79 -0.82), 28.95; and 0.80 (95% Confidence Interval: 0.79 - 0.81), 20.93, respectively. The K-MESIAH also showed a high prediction ability for the external validation cohort. Conclusions A survival prediction model for Korean HCC patients was developed and validated to have a high level of performance. This K-MESIAH may be more useful in clinical practice and personalized care in a hepatitis B virus endemic area.	[Nam, Byung-Ho] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang, South Korea; [Park, Joong-Won; Kim, Bo Hyun] Natl Canc Ctr, Ctr Liver Canc, Goyang, South Korea; [Jeong, Sook-Hyang; Lee, Sang Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Songnam, South Korea; [Yu, Ami] Natl Canc Ctr, Biometr Res Branch, Goyang, South Korea; [Kim, W. Ray] Stanford Univ, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Seoul National University (SNU); National Cancer Center - Korea (NCC); Stanford University	Park, JW (corresponding author), Natl Canc Ctr, Ctr Liver Canc, Goyang, South Korea.	jwpark@ncc.re.kr	Lee, Sang Soo/P-7617-2019; Lee, Sang Soo/X-9628-2019	Lee, Sang Soo/0000-0003-1029-3436; Kim, W. Ray/0000-0002-3030-860X	National Cancer Center, Korea [1410030-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK092336] Funding Source: NIH RePORTER	National Cancer Center, Korea; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a grant from the National Cancer Center, Korea (#1410030-1).	Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cantarini MC, 2006, AM J GASTROENTEROL, V101, P91, DOI 10.1111/j.1572-0241.2006.00364.x; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kim BH, 2014, LIVER INT, V34, pE317, DOI 10.1111/liv.12519; Kim YI, 2014, LIVER INT; Korean Liver Cancer Study Group and National Cancer Center Korea, 2009, Korean J Hepatol, V15, P391, DOI 10.3350/kjhep.2009.15.3.391; Kwak HW, 2014, J GASTROEN HEPATOL, V29, P820, DOI 10.1111/jgh.12470; Kwak HW, 2013, J GASTROENTEROL HEPA; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Nam B-H, 2000, THESIS BOSTON U; Park KW, 2008, J GASTROEN HEPATOL, V23, P467, DOI 10.1111/j.1440-1746.2007.05112.x; Pons Fernando, 2005, HPB (Oxford), V7, P35, DOI 10.1080/13651820410024058; Ueno S, 2002, HEPATOL RES, V24, P395, DOI 10.1016/S1386-6346(02)00144-4; Umesh A, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.27_suppl.31; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yang JD, 2012, HEPATOLOGY, V56, P614, DOI 10.1002/hep.25680	21	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0138374	10.1371/journal.pone.0138374	http://dx.doi.org/10.1371/journal.pone.0138374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488298	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400006
J	Spoorenberg, SLW; Wynia, K; Fokkens, AS; Slotman, K; Kremer, HPH; Reijneveld, SA				Spoorenberg, Sophie L. W.; Wynia, Klaske; Fokkens, Andrea S.; Slotman, Karin; Kremer, Hubertus P. H.; Reijneveld, Sijmen A.			Experiences of Community-Living Older Adults Receiving Integrated Care Based on the Chronic Care Model: A Qualitative Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; CHRONIC ILLNESS CARE; HEALTH-CARE; PERCEIVED CONTROL; OF-LIFE; MANAGEMENT; PEOPLE; MULTIMORBIDITY; INDEPENDENCE; FRAIL	Background Integrated care models aim to solve the problem of fragmented and poorly coordinated care in current healthcare systems. These models aim to be patient-centered by providing continuous and coordinated care and by considering the needs and preferences of patients. The objective of this study was to evaluate the opinions and experiences of community-living older adults with regard to integrated care and support, along with the extent to which it meets their health and social needs. Methods Semi-structured interviews were conducted with 23 older adults receiving integrated care and support through "Embrace," an integrated care model for community-living older adults that is based on the Chronic Care Model and a population health management model. Embrace is currently fully operational in the northern region of the Netherlands. Data analysis was based on the grounded theory approach. Results Responses of participants concerned two focus areas: 1) Experiences with aging, with the themes "Struggling with health," "Increasing dependency," "Decreasing social interaction," "Loss of control," and "Fears;" and 2) Experiences with Embrace, with the themes "Relationship with the case manager," "Interactions," and "Feeling in control, safe, and secure". The prospect of becoming dependent and losing control was a key concept in the lives of the older adults interviewed. Embrace reinforced the participants' ability to stay in control, even if they were dependent on others. Furthermore, participants felt safe and secure, in contrast to the fears of increasing dependency within the standard care system. Conclusion The results indicate that integrated care and support provided through Embrace met the health and social needs of older adults, who were coping with the consequences of aging.	[Spoorenberg, Sophie L. W.; Wynia, Klaske; Slotman, Karin; Reijneveld, Sijmen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands; [Fokkens, Andrea S.] Univ Groningen, Univ Med Ctr Groningen, Dept Appl Res Care, Groningen, Netherlands; [Wynia, Klaske; Kremer, Hubertus P. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Spoorenberg, SLW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands.	s.l.w.spoorenberg@umcg.nl		Fokkens, Andrea/0000-0003-4110-7659; Reijneveld, Sijmen/0000-0002-1206-7523	Netherlands Organisation for Health Research and Development (ZonMw) [314010201]; Dutch Healthcare Authority (NZa) [300-1021]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Healthcare Authority (NZa)	The Embrace study was funded by the Netherlands Organisation for Health Research and Development (ZonMw: grant number 314010201; http://www.zonmw.nl). The healthcare professionals involved were funded by the Dutch Healthcare Authority (NZa: file number 300-1021; http://www.nza.nl). Financial sponsors played no role in any contribution of these authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres L, 2008, SAGE ENCY QUALITATIV, P810, DOI [DOI 10.4135/9781412963909.N420, 10.4135/9781412963909]; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Basch E, 2012, JAMA-J AM MED ASSOC, V307, P1636, DOI 10.1001/jama.2012.466; Bastiaens H, 2007, PATIENT EDUC COUNS, V68, P33, DOI 10.1016/j.pec.2007.03.025; Bell S, 2015, J APPL GERONTOL, V34, pNP1, DOI 10.1177/0733464812469292; Bostrom M., 2013, HEALTH-LONDON, V5, P56, DOI [https://doi.org/10.4236/health.2013.56A2009, DOI 10.4236/HEALTH.2013.56A2009]; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Bradley SM, 2011, AM FAM PHYSICIAN, V84, P405; Callaghan L, 2014, AGEING SOC, V34, P1427, DOI 10.1017/S0144686X13000184; Chang PJ, 2014, HEALTH PSYCHOL, V33, P516, DOI 10.1037/hea0000051; Chipperfield JG, 2004, J AGING HEALTH, V16, P116, DOI 10.1177/0898264303260447; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Cramm JM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-28; de Stampa M, 2013, GERONTOLOGIST, V53, P313, DOI 10.1093/geront/gns081; Ellefsen B, 2002, SCAND J CARING SCI, V16, P157, DOI 10.1046/j.1471-6712.2002.00073.x; Glaser B.G., 1968, DISCOV GROUNDED THEO; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Greenfield G, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0619-9; Gustafsson M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-496; Haak Maria, 2007, Scand J Occup Ther, V14, P16, DOI 10.1080/11038120601024929; Hacihasanoglu R, 2012, ARCH GERONTOL GERIAT, V54, P61, DOI 10.1016/j.archger.2011.03.011; Hillcoat-Nalletamby S, 2014, J GERONTOL B-PSYCHOL, V69, P419, DOI 10.1093/geronb/gbu008; Iliffe S, 2007, BRIT J GEN PRACT, V57, P277; Kodner Dennis L, 2002, Int J Integr Care, V2, pe12; Kumar A, 2014, AGE AGEING, V43, P76, DOI 10.1093/ageing/aft154; Lachman ME, 2006, CURR DIR PSYCHOL SCI, V15, P282, DOI 10.1111/j.1467-8721.2006.00453.x; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; Macdonald M, 2014, J PATIENT S IN PRESS; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Nolte E, 2008, CARING PEOPLE CHRONI, P222; Nolte E., 2008, CARING PEOPLE CHRONI, P64; Nolte E, 2012, HEALTH ECON POLICY L, V7, P125, DOI 10.1017/S1744133111000338; Nuevo R, 2009, AGING MENT HEALTH, V13, P135, DOI 10.1080/13607860802591088; Nuno R, 2012, HEALTH POLICY, V105, P55, DOI 10.1016/j.healthpol.2011.10.006; O'Cathain A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-215; OECD, 2011, HLTH REF M CHALL AG, DOI [http://dx.doi.org/10.1787/9789264122314-en, DOI 10.1787/9789264122314-EN]; Panagioti M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-356; Patton M. Q., 1990, QUALITATIVE EVALUATI; Perez-Jara J, 2010, REV CLIN GERONTOL, V20, P277, DOI 10.1017/S0959259810000237; Peters LL, 2013, J PSYCHOSOM RES, V74, P518, DOI 10.1016/j.jpsychores.2013.02.003; Petersson P, 2011, INT J OLDER PEOPLE N, V6, P25, DOI 10.1111/j.1748-3743.2010.00211.x; Plath D, 2008, BRIT J SOC WORK, V38, P1353, DOI 10.1093/bjsw/bcm045; Puts MTE, 2007, QUAL LIFE RES, V16, P263, DOI 10.1007/s11136-006-9121-0; Quine S, 2007, HEALTH SOC CARE COMM, V15, P212, DOI 10.1111/j.1365-2524.2006.00675.x; Resnik L, 2009, DISABIL HEALTH J, V2, P77, DOI 10.1016/j.dhjo.2008.12.002; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; Sandberg M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-14; Singh D, 2006, IMPROVING CARE PEOPL; Spoorenberg SLW, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-62; Stein KV, 2013, INT J INTEGR CARE, V13; Steverink Nardi, 2005, Eur J Ageing, V2, P235, DOI 10.1007/s10433-005-0012-y; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van Kempen JAL, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653606; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Vrijhoef HJM, 2009, HEALTH EXPECT, V12, P417, DOI 10.1111/j.1369-7625.2009.00557.x; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wagner EH, 2005, J ALTERN COMPLEM MED, V11, pS7, DOI 10.1089/acm.2005.11.s-7; Walker KO, 2013, INT J INTEGR CARE, V13; Walters BH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-114; Weicht B, 2010, SOCIOL REV, V58, P205; Wodskou PM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-471; Wolinsky FD, 2003, J GERONTOL B-PSYCHOL, V58, pS212, DOI 10.1093/geronb/58.4.S212; World Health Organization, 2002, ACT AG A POL FRAM; World Health Organization (WHO), 2013, ROADMAP STRENGTHENIN	65	44	44	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0137803	10.1371/journal.pone.0137803	http://dx.doi.org/10.1371/journal.pone.0137803			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26489096	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400004
J	Yang, L; Zhu, J; Huang, H; Yang, QC; Cai, J; Wang, QH; Zhu, JY; Shao, MT; Xiao, JZ; Cao, J; Gu, XD; Zhang, SS; Wang, YY				Yang, Lei; Zhu, Jia; Huang, Hua; Yang, Qichang; Cai, Jing; Wang, Qiuhong; Zhu, Junya; Shao, Mengting; Xiao, Jinzhang; Cao, Jie; Gu, Xiaodan; Zhang, Shusen; Wang, Yingying			PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion	PLOS ONE			English	Article							PROTEIN-KINASE; CYCLIN Y; CELL; IDENTIFICATION; DIFFERENTIATION; SUPPRESSOR; EXPRESSION; GENE	PFTK1, also known as PFTAIRE1, CDK14, is a novel member of Cdc2-related serine/threonine protein kinases. Recent studies show that PFTK1 is highly expressed in several malignant tumors such as hepatocellular carcinoma, esophageal cancer, breast cancer, and involved in regulation of cell cycle, tumors proliferation, migration, and invasion that further influence the prognosis of tumors. However, the expression and physiological significance of PFTK1 in gastric cancer remain unclear. In this study, we analyzed the expression and clinical significance of PFTK1 by Western blot in 8 paired fresh gastric cancer tissues, non-tumorous gastric mucosal tissues and immunohistochemistry on 161 paraffinembedded slices. High PFTK1 expression was correlated with the tumor grade, lymph node invasion as well as Ki-67. Through Cell Counting Kit (CCK)-8 assay, flow cytometry, colony formation, wound healing and transwell assays, the vitro studies demonstrated that PFTK1 overexpression promoted proliferation, migration and invasion of gastric cancer cells, while PFTK1 knockdown led to the opposite results. Our findings for the first time supported that PFTK1 might play an important role in the regulation of gastric cancer proliferation, migration and would provide a novel promising therapeutic strategy against human gastric cancer.	[Yang, Lei; Zhu, Jia; Cai, Jing; Wang, Qiuhong; Xiao, Jinzhang] Nantong Tumor Hosp, Dept Oncol, Nantong, Jiangsu, Peoples R China; [Zhu, Junya; Shao, Mengting; Gu, Xiaodan; Zhang, Shusen; Wang, Yingying] Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Dept Pathogen Biol, Nantong, Jiangsu, Peoples R China; [Huang, Hua] Nantong Univ, Affiliated Hosp, Dept Pathol, Nantong, Jiangsu, Peoples R China; [Yang, Qichang; Cao, Jie] Nantong First Peoples Hosp, Dept Pathol, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University	Wang, YY (corresponding author), Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Dept Pathogen Biol, Nantong, Jiangsu, Peoples R China.	wyy0418@ntu.edu.cn	wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; wang, yi/GVT-8516-2022		Natural Science Foundation of China [81302285, 81402015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of China (No. 81302285, No. 81402015).	Bani-Hani KE, 2005, CLIN CANCER RES, V11, P1447, DOI 10.1158/1078-0432.CCR-04-1730; Besset V, 1998, MOL REPROD DEV, V50, P18, DOI 10.1002/(SICI)1098-2795(199805)50:1&lt;18::AID-MRD3&gt;3.0.CO;2-#; Cao Y, 2011, NAT REV CANCER, V11, P749, DOI 10.1038/nrc3138; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji YH, 2010, NEUROCHEM RES, V35, P219, DOI 10.1007/s11064-009-0045-2; Jiang M, 2009, FEBS LETT, V583, P2171, DOI 10.1016/j.febslet.2009.06.010; Kaldis P, 2009, DEV CELL, V17, P749, DOI 10.1016/j.devcel.2009.12.001; Katoh M, 2005, ONCOL REP, V14, P1583; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lazzaro MA, 1997, GENOMICS, V42, P536, DOI 10.1006/geno.1997.4760; Leung WKC, 2011, ONCOGENE, V30, P4464, DOI 10.1038/onc.2011.161; Leung WKC, 2011, MOL CELL BIOCHEM, V350, P201, DOI 10.1007/s11010-010-0699-8; Liu YH, 2012, MOL BIOL CELL, V23, P4506, DOI 10.1091/mbc.E12-05-0362; Mayanagi T, 2011, CELL ADHES MIGR, V5, P150, DOI 10.4161/cam.5.2.14398; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Miyagaki H, 2012, BRIT J CANCER, V106, P947, DOI 10.1038/bjc.2012.35; Pang EYT, 2007, HEPATOLOGY, V46, P436, DOI 10.1002/hep.21691; Shu F, 2007, P NATL ACAD SCI USA, V104, P9248, DOI 10.1073/pnas.0703327104; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun TT, 2014, BIOCHEM BIOPH RES CO, V449, P163, DOI 10.1016/j.bbrc.2014.05.002; Wang J, 2012, SURG ONCOL, V21, P119, DOI 10.1016/j.suronc.2010.12.004; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Xu YG, 2009, ONCOL RES, V18, P359, DOI 10.3727/096504010X12644422320582; Yang HJ, 2015, J MOL NEUROSCI, V55, P977, DOI 10.1007/s12031-014-0454-9; Yang T, 2001, GENE, V267, P165, DOI 10.1016/S0378-1119(01)00391-2; Zhang DM, 2012, NEUROCHEM INT, V61, P1021, DOI 10.1016/j.neuint.2012.07.019	28	48	52	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140451	10.1371/journal.pone.0140451	http://dx.doi.org/10.1371/journal.pone.0140451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488471	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400053
J	Acikgoz, E; Guven, U; Duzagac, F; Uslu, R; Kara, M; Soner, BC; Oktem, G				Acikgoz, Eda; Guven, Ummu; Duzagac, Fahriye; Uslu, Ruchan; Kara, Mikail; Soner, Burak Cem; Oktem, Gulperi			Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells	PLOS ONE			English	Article							ANTICANCER DRUGS; UNIQUE MECHANISM; ET-743; ECTEINASCIDIN-743; IDENTIFICATION; CARCINOMA; LINES	Trabectedin (Yondelis, ET-743) is a marine-derived tetrahydroisoquinoline alkaloid. It is originally derived from the Caribbean marine tunicate Ecteinascidia turbinata and currently produced synthetically. Trabectedin is active against a variety of tumor cell lines growing in culture. The present study focused on the effect of trabectedin in cell proliferation, cell cycle progression, apoptosis and spheroid formation in prostate cancer stem cells (CSCs). Cluster of differentiation (CD) 133(+high)/CD44(+high) prostate CSCs were isolated from the DU145 and PC-3 human prostate cancer cell line through flow cytometry. We studied the growth-inhibitory effects of trabectedin and its molecular mechanisms on human prostate CSCs and non-CSCs. DU-145 and PC-3 CSCs were treated with 0.1, 1, 10 and 100 nM trabectedin for 24, 48 and 72 h and the growth inhibition rates were examined using the sphere-forming assay. Annexin-V assay and immunofluorescence analyses were performed for the detection of the cell death. Concentration-dependent effects of trabectedin on the cell cycle were also evaluated. The cells were exposed to the different doses of trabectedin for 24, 48 and 72 h to evaluate the effect of trabectedin on the number and diameter of spheroids. According to the results, trabectedin induced cytotoxicity and apoptosis at the IC50 dose, resulting in a significant increase expression of caspase-3, caspase-8, caspase-9, p53 and decrease expression of bcl-2 in dose-dependentmanner. Cell cycle analyses revealed that trabectedin induces dose-dependent G2/M-phase cell cycle arrest, particularly at high-dose treatments. Three-dimensional culture studies showed that trabectedin reduced the number and diameter of spheroids of DU145 and PC3 CSCs. Furthermore, we have found that trabectedin disrupted cell-cell interactions via E-cadherin in prostasphere of DU-145 and PC-3 CSCs. Our results showed that trabectedin inhibits cellular proliferation and accelerates apoptotic events in prostate CSCs; and may be a potential effective therapeutic agent against prostate cancer.	[Acikgoz, Eda; Oktem, Gulperi] Ege Univ, Fac Med, Dept Histol & Embryol, Izmir, Turkey; [Guven, Ummu; Duzagac, Fahriye] Ege Univ, Dept Stem Cell, Hlth Sci Inst, Izmir, Turkey; [Uslu, Ruchan] Ege Univ, Dept Med Oncol, Fac Med, Izmir, Turkey; [Kara, Mikail] Yuzuncu Yil Univ, Fac Med, Dept Histol & Embryol, Van, Turkey; [Soner, Burak Cem] Necmettin Erbakan Univ, Meram Fac Med, Dept Med Pharmacol, Konya, Turkey	Ege University; Ege University; Ege University; Yuzuncu Yil University; Necmettin Erbakan University	Oktem, G (corresponding author), Ege Univ, Fac Med, Dept Histol & Embryol, Izmir, Turkey.	gulperi.oktem@ege.edu.tr	Acikgoz, eda/W-2171-2017; Guven, Ummu/AAY-1196-2020; Uslu, Ruchan/CAA-9946-2022; Soner, Burak Cem/AAB-7965-2020; Uslu, Ruchan/C-6855-2008	Guven, Ummu/0000-0002-5427-263X; Soner, Burak Cem/0000-0002-3712-3210; Uslu, Ruchan/0000-0002-9584-6134; Acikgoz, Eda/0000-0002-6772-3081				Atmaca H, 2013, TOXICOL LETT, V221, P128, DOI 10.1016/j.toxlet.2013.06.213; Bae KM, 2011, AM J CANCER RES, V1, P71; Carter NJ, 2010, DRUGS, V70, P355, DOI 10.2165/11202860-000000000-00000; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cuevas C, 2009, NAT PROD REP, V26, P322, DOI 10.1039/b808331m; D'Incalci M, 2010, MOL CANCER THER, V9, P2157, DOI 10.1158/1535-7163.MCT-10-0263; Enmon RM, 2002, BIOTECHNOL BIOENG, V80, P580, DOI 10.1002/bit.10394; Erba E, 2001, EUR J CANCER, V37, P97, DOI 10.1016/S0959-8049(00)00357-9; Gajate C, 2002, J BIOL CHEM, V277, P41580, DOI 10.1074/jbc.M204644200; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Larzabal L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079798; Li YQ, 2012, CANCER RES, V72, P576, DOI 10.1158/0008-5472.CAN-11-3070; Iglesias JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077281; Martinez-Serra J, 2011, EUR J PHARMACOL, V658, P57, DOI 10.1016/j.ejphar.2011.02.035; Minuzzo M, 2005, MOL PHARMACOL, V68, P1496, DOI 10.1124/mol.105.013615; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Preusser M, 2012, CANCER-AM CANCER SOC, V118, P5038, DOI 10.1002/cncr.27460; Sessa C, 2005, J CLIN ONCOL, V23, P1867, DOI 10.1200/JCO.2005.09.032; Shimazui T, 2004, ONCOL REP, V11, P357; SHIMOYAMA Y, 1992, CANCER RES, V52, P5770; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Singh SK, 2003, CANCER RES, V63, P5821; Sobel RE, 2005, J UROLOGY, V173, P360, DOI 10.1097/01.ju.0000149989.01263.dc; Tolomeo M., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P387, DOI 10.2174/1568011024606361; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Williams K, 2013, EXP BIOL MED, V238, P324, DOI 10.1177/1535370213480714	26	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141090	10.1371/journal.pone.0141090	http://dx.doi.org/10.1371/journal.pone.0141090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485709	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100112
J	Chuang, ML; Lee, CY; Chen, YF; Huang, SF; Lin, IF				Chuang, Ming-Lung; Lee, Chai-Yuan; Chen, Yi-Fang; Huang, Shih-Feng; Lin, I-Feng			Revisiting Unplanned Endotracheal Extubation and Disease Severity in Intensive Care Units	PLOS ONE			English	Article							DELIBERATE SELF-EXTUBATION; RISK-FACTORS; PROSPECTIVE MULTICENTER; MECHANICAL VENTILATION; REINTUBATION; ICU; SEDATION; OUTCOMES; SUPPORT	Most reports regarding unplanned extubation (UE) are case-control studies with matching age and disease severity. To avoid diminishing differences in matched factors, this study with only matching duration of mechanical ventilation aimed to re-examine the risk factors and the factors governing outcomes of UE in intensive care units (ICUs). This case-control study was conducted on 1,775 subjects intubated for mechanical ventilation. Thirty-seven (2.1%) subjects with UE were identified, and 156 non-UE subjects were randomly selected as the control group. Demographic data, acute Physiological and Chronic Health Evaluation II (APACHE II) scores, and outcomes of UE were compared between the two groups. Logistic regression analysis was used to identify the risk factors of UE. Milder disease, younger age, and higher Glasgow Coma Scale (GCS) scores with more frequently being physically restrained (all p<0.05) were related to UE. Logistic regression revealed that APACHE II score (odds ratio (OR) 0.91, p<0.01), respiratory infection (OR 0.24, p<0.01), physical restraint (OR 5.36, p<0.001), and certain specific diseases (OR 3.79-5.62, p<0.05) were related to UE. The UE patients had a lower ICU mortality rate (p<0.01) and a trend of lower in-hospital mortality rate (p = 0.08). Cox regression analysis revealed that in-hospital mortality was associated with APACHE II score, age, shock, and oxygen used, all of which were co-linear, but not UE. The results showed that milder disease with higher GCS scores thereby requiring a higher use of physical restraints were related to UE. Disease severity but not UE was associated with in-hospital mortality.	[Chuang, Ming-Lung; Huang, Shih-Feng] Chung Shan Med Univ Hosp, Div Pulm Med, Taichung 40201, Taiwan; [Chuang, Ming-Lung; Huang, Shih-Feng] Chung Shan Med Univ Hosp, Dept Crit Care Med, Taichung 40201, Taiwan; [Chuang, Ming-Lung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lee, Chai-Yuan] Chung Shan Med Univ, Dept Nursing, Taichung, Taiwan; [Chen, Yi-Fang] Chung Shan Med Univ Hosp, Div Resp Care, Taichung 40201, Taiwan; [Lin, I-Feng] Natl Yang Ming Univ, Inst & Dept Publ Hlth, Taipei 112, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Yang Ming Chiao Tung University	Chuang, ML (corresponding author), Chung Shan Med Univ Hosp, Dept Crit Care Med, Taichung 40201, Taiwan.	yuan1007@ms36.hinet.net; csha884@csh.org.tw			Chung Shan Medical University Hospital, Taichung, Taiwan	Chung Shan Medical University Hospital, Taichung, Taiwan	The work was supported by Chung Shan Medical University Hospital, Taichung, Taiwan.	Atkins PM, 1997, CHEST, V112, P1317, DOI 10.1378/chest.112.5.1317; Baker DP, 2006, HEALTH SERV RES, V41, P1576, DOI 10.1111/j.1475-6773.2006.00566.x; Betbese AJ, 1998, CRIT CARE MED, V26, P1180, DOI 10.1097/00003246-199807000-00016; Boulain T, 1998, AM J RESP CRIT CARE, V157, P1131, DOI 10.1164/ajrccm.157.4.9702083; Bouza C, 2007, HEART LUNG, V36, P270, DOI 10.1016/j.hrtlng.2006.10.002; Chang LC, 2011, APPL NURS RES, V24, P188, DOI 10.1016/j.apnr.2009.09.002; Chang LY, 2008, AM J CRIT CARE, V17, P408; Chevron V, 1998, CRIT CARE MED, V26, P1049, DOI 10.1097/00003246-199806000-00026; Curry K, 2008, AM J CRIT CARE, V17, P45; de Groot RI, 2011, CRIT CARE, V15, DOI 10.1186/cc9964; de Lassence A, 2002, ANESTHESIOLOGY, V97, P148, DOI 10.1097/00000542-200207000-00021; Epstein SK, 2000, AM J RESP CRIT CARE, V161, P1912, DOI 10.1164/ajrccm.161.6.9908068; Greenberg RS, 2001, MED EPIDEMIOLOGY, P127; Krinsley JS, 2005, CHEST, V128, P560, DOI 10.1378/chest.128.2.560; da Silva PSL, 2012, ANESTH ANALG, V114, P1003, DOI 10.1213/ANE.0b013e31824b0296; Mehta S, 2012, AM J RESP CRIT CARE, V186, P699, DOI 10.1164/rccm.201208-1387ED; Moons P, 2004, INTENS CARE MED, V30, P1348, DOI 10.1007/s00134-004-2228-2; PANDEY CK, 2002, J INDIAN MED ASSOC, V100, P14; Penuelas O, 2011, CRIT CARE, V15, DOI 10.1186/cc10049; Phoa L. L., 2002, SMJ Singapore Medical Journal, V43, P504; Razek T, 2000, J TRAUMA, V48, P466, DOI 10.1097/00005373-200003000-00015; Rosner B, 2011, FUNDAMENTALS BIOSTAT, P204; TINDOL GA, 1994, CHEST, V105, P1804, DOI 10.1378/chest.105.6.1804; Tominaga GT, 1995, AM J SURG, V170, P589; Tung A, 2001, J CLIN ANESTH, V13, P24, DOI 10.1016/S0952-8180(00)00237-3; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; WHELAN J, 1994, CHEST, V105, P1808, DOI 10.1378/chest.105.6.1808; Yeh SH, 2004, INT J NURS STUD, V41, P255, DOI 10.1016/S0020-7489(03)00136-6	28	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139864	10.1371/journal.pone.0139864	http://dx.doi.org/10.1371/journal.pone.0139864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484674	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100015
J	Kaczmarska, I; Ehrman, JM				Kaczmarska, Irena; Ehrman, James M.			Auxosporulation in Paralia guyana MacGillivary (Bacillariophyta) and Possible New Insights into the Habit of the Earliest Diatoms	PLOS ONE			English	Article							LIFE-CYCLE; PHYLOGENETIC ANALYSIS; RESTING SPORES; CELL-WALLS; EVOLUTION; MARINE; FRUSTULE; TAXONOMY; FOSSIL; BIOSTRATIGRAPHY	Background Diatoms are one of the most ecologically important aquatic micro-eukaryotes. As a group unambiguously recognized as diatoms, they seem to have appeared relatively recently with a limited record of putative remains from oldest sediments. In contrast, molecular clock estimates for the earliest possible emergence of diatoms suggest a considerably older date. Depending on the analysis, Paralia and Leptocylindrus have been recovered within the basal molecular divergences of diatoms. Thus these genera may be in the position to inform on characters that the earliest diatoms possessed. Findings Here we present auxospore development and structure of initial and post-auxospore cells in a representative of the ancient non-polar centric genus Paralia. Their initial frustules showed unusual, but not unprecedented, spore-like morphology. Similarly, initial frustules of Leptocylindrus have been long considered resting spores and a unique peculiarity of this genus. However, even though spore-like in appearance, initial cells of Paralia readily resumed mitotic divisions. In addition, Paralia post-auxospore cells underwent several rounds of mitoses in a multi-step process of building a typical, "perfect" vegetative valve. This degree of heteromorphy immediately post-auxosporulation is thus far unknown among the diatoms. Implications A spore-related origin of diatoms has already been considered, most recently in the form of the "multiplate diploid cyst" hypothesis. Our discovery that the initial cells in some of the most ancient diatom lineages are structurally spore-like is consistent with that hypothesis because the earliest diatoms may be expected to look somewhat similar to their ancestors. We speculate that because the earliest diatoms may have appeared less diatom-like and more spore-like, they could have gone unrecognized as such in the Triassic/Jurassic sediments. If correct, diatoms may indeed be much older than the fossil record indicates, and possibly more in line with some molecular clock predictions.	[Kaczmarska, Irena] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [Ehrman, James M.] Mt Allison Univ, Digital Microscopy Facil, Sackville, NB E0A 3C0, Canada	Mount Allison University; Mount Allison University	Kaczmarska, I (corresponding author), Mt Allison Univ, Dept Biol, 63B York St, Sackville, NB E0A 3C0, Canada.	iehrman@mta.ca			National Science and Engineering Research Council of Canada Discovery Grant; Marjorie Young Bell Faculty Fund (Mount Allison University)	National Science and Engineering Research Council of Canada Discovery Grant; Marjorie Young Bell Faculty Fund (Mount Allison University)	The work was supported by National Science and Engineering Research Council of Canada Discovery Grant to IK (http://www.nserccrsng.gc.ca/) - no funding numbers were given from this agency. The work was also supported by Marjorie Young Bell Faculty Fund (Mount Allison University) to IK (http://www.mta.ca/Community/Governance_and_admin/VP_Academic_and_Research/Funding_opportunities/Marjorie_Young_Bell_Faculty_Fund/Marjorie_Young_Bell_Faculty_Fund/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson AJ, 2007, MOL PHYLOGENET EVOL, V45, P193, DOI 10.1016/j.ympev.2007.03.024; Alverson AJ, 2006, J PHYCOL, V42, P655, DOI 10.1111/j.1529-8817.2006.00228.x; Ashworth MP, 2012, PHYCOLOGIA, V51, P684, DOI 10.2216/12-004.1; Ban F, 2011, DIATOM, V27, P46; Beraldi-Campesi H, 2014, CRETACEOUS RES, V50, P89, DOI 10.1016/j.cretres.2014.03.025; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012759; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; Chang KH, 2008, ACTA GEOL SIN-ENGL, V82, P1179; Choi HG, 2008, NOVA HEDWIGIA, P7; CLEVE-EULER ASTRID, 1951, K SVENSKA VETENSKAPSAKAD HANDL, V2, P1; CRAWFORD R M, 1974, British Phycological Journal, V9, P9; Crawford RM, 2007, DIATOM RES, V22, P17; Crawford R.M., 1988, ALGAE AQUATIC ENV, P413; CRAWFORD R. M., 1975, NOVA HEDWIGIA BEIH, V53, P37; CRAWFORD R. M., 1982, P 7 S REC FOSS DIAT, P21; CRAWFORD RM, 1979, J PHYCOL, V15, P200, DOI 10.1111/j.0022-3646.1979.00200.x; DAVIS CO, 1980, J PHYCOL, V16, P296; Dorrell RG, 2011, EUKARYOT CELL, V10, P856, DOI 10.1128/EC.00326-10; DREBES G, 1966, HELGOLAND WISS MEER, V13, P101, DOI 10.1007/BF01612659; Drebes G., 1977, BOTANICAL MONOGRAPHS, P250; Drebes G, 1969, GESCHLECHTLICHE FORT; Ehara M, 2000, CURR GENET, V37, P29; EHRMAN J. M., 2012, CURRENT ADV ALGAL TA, P253; FRENCH FW, 1985, J PHYCOL, V21, P477; Gersonde R., 1990, P OC DRILL PROGR SCI, V113, P403; Gleser S.I., 1992, DIATOMS USSR FOSSIL, V2, P125; GRAHAM L. E., 2009, ALGAE; Green J.C., 1989, CHROMOPHYTE ALGAE PR, P305; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hajos M., 1975, Initial Rep Deep Sea Drilling Project, V29, P913; Hajos M., 1976, Initial Rep Deep Sea Drilling Project, V35, P817, DOI 10.2973/dsdp.proc.35.29chap1.1976; Hanna GD., 1927, OCCASIONAL PAPERS CA, V12, P5; Hargraves P.E., 1990, NOVA HEDWIGIA S, V100, P47; Hargraves P.E., 1983, SURVIVAL STRATEGIES, P49; Harwood D.M., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P403; HARWOOD D. M., 2007, PALEONTOL SOC PAP, V13, P33, DOI DOI 10.1017/S1089332600001455; Hustedt F, 1927, LR KRYPTOGRAMEN FLOR, VVII; IDEI M, 1992, BOT MAG TOKYO, V105, P649, DOI 10.1007/BF02489438; Idei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041890; JEWSON DH, 1992, PHILOS T ROY SOC B, V336, P191, DOI 10.1098/rstb.1992.0056; JEWSON DH, 1992, J PHYCOL, V28, P856, DOI 10.1111/j.0022-3646.1992.00856.x; Kaczmarska I, 2005, HARMFUL ALGAE, V4, P1, DOI 10.1016/j.hal.2003.07.001; KACZMARSKA I, 1976, Fragmenta Floristica et Geobotanica, V22, P235; Kaczmarska I., 2001, P 16 INT DIAT S, P153; Kaczmarska I, 1983, BACILLARIA, V6, P157; Kaczmarska I, 2007, PHYCOLOGIA, V46, P726, DOI 10.2216/07-04.1; Kaczmarska I, 2013, DIATOM RES, V28, P263, DOI 10.1080/0269249X.2013.791344; Kobayashi A, 2001, P 16 INT DIAT S U AT, P197; Kooistra WHCF, 1996, MOL PHYLOGENET EVOL, V6, P391, DOI 10.1006/mpev.1996.0088; MacGillivary ML, 2015, J BIOL RES-THESSALON, V22, DOI 10.1186/s40709-015-0024-5; MacGillivary ML, 2012, BOTANY, V90, P205, DOI 10.1139/B11-101; Macgillivary ML, 2011, DIATOM RES, V26, P321, DOI 10.1080/0269249X.2011.639145; Makarova IV, 2002, DIATOMS USSR FOSSIL, VII; Mann DG, 2013, J EUKARYOT MICROBIOL, V60, P414, DOI 10.1111/jeu.12047; Mann DG, 2013, PHYCOLOGIA, V52, P204, DOI 10.2216/12-077.1; MANN DG, 1989, PLANT SYST EVOL, V163, P43, DOI 10.1007/BF00936152; Mather L, 2014, EUR J PROTISTOL, V50, P1, DOI 10.1016/j.ejop.2013.06.002; Medlin LK, 2004, PHYCOLOGIA, V43, P245, DOI 10.2216/i0031-8884-43-3-245.1; Medlin LK, 2014, J BIODIVERS BIOPROSP, Vl, P129, DOI DOI 10.4172/2376-0214.1000129; Mills KE, 2006, BOT MAR, V49, P417, DOI 10.1515/BOT.2006.053; Mock T, 2012, ADV BOT RES GENOMIC, V64, P251; Nagai S, 1995, PHYCOLOGIA, V34, P533, DOI 10.2216/i0031-8884-34-6-533.1; Nanjappa D, 2013, J PHYCOL, V49, P917, DOI 10.1111/jpy.12102; Nikolaev AV, 2001, EARLY CRETACEOUS DIA; Nikolaev V. A., 2001, P 16 INT DIAT S ATH, P127; Oreshkina TV, 2013, STRATIGR GEO CORREL+, V21, P222, DOI 10.1134/S0869593813020056; Rampen SW, 2009, J PHYCOL, V45, P444, DOI 10.1111/j.1529-8817.2009.00657.x; Renzaglia KS, 2000, PHILOS T R SOC B, V355, P769, DOI 10.1098/rstb.2000.0615; Riisberg I, 2009, PROTIST, V160, P191, DOI 10.1016/j.protis.2008.11.004; Rothpletz A, 1896, DTSCH GEOL GES Z, V48, P854; Rothpletz A, 1900, DTSCH GEOLOGISCHE GE, V52, P152; Rott E, 2009, FOTTEA, V9, P299, DOI 10.5507/fot.2009.029; Round F.E., 1990, DIATOMS; ROUND FE, 1981, PROC R SOC SER B-BIO, V211, P237, DOI 10.1098/rspb.1981.0004; ROUND FE, 1982, ANN BOT-LONDON, V49, P447, DOI 10.1093/oxfordjournals.aob.a086269; Sabbe K, 2004, EUR J PHYCOL, V39, P327, DOI 10.1080/0967026042000236445; Sato S, 2008, PHYCOLOGIA, V47, P371, DOI 10.2216/PH08-02.1; Schmid A. M.-M., 2000, ORIGIN EARLY EVOLUTI, P13; SCHMID AMM, 1994, PROTOPLASMA, V181, P43, DOI 10.1007/BF01666388; Schmid AMM, 2001, EUR J PHYCOL, V36, P307, DOI 10.1080/09670260110001735468; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Sims PA, 2007, DIATOM RES, V22, P197; Sorhannus U, 2004, CLADISTICS, V20, P487, DOI 10.1111/j.1096-0031.2004.00034.x; Sorhannus U, 2007, MAR MICROPALEONTOL, V65, P1, DOI 10.1016/j.marmicro.2007.05.002; Suto I, 2004, THESIS U TSUKUBA; Suto I, 2009, MICROPALEONTOLOGY, V55, P259; Theriot EC, 2011, CELL ORIG LIFE EXTRE, V19, P119, DOI 10.1007/978-94-007-1327-7_5; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Theriot EC, 2009, EUR J PHYCOL, V44, P277, DOI 10.1080/09670260902749159; Tiffany Mary A., 2010, Polish Botanical Journal, V55, P27; Toyoda K, 2005, EUR J PHYCOL, V40, P269, DOI 10.1080/09670260500150511; von Stosch H. A., 1982, BACILLARIA, V5, P127; von Stosch H.A, 1965, PHYCOLOGIA, V5, P21, DOI DOI 10.2216/I0031-8884-5-1-21.1; VONSTOSCH HA, 1973, HELGOL WISS MEERESUN, V25, P384; Webster J, 2010, INTRO FUNGI; Williams PH, 2008, APIDOLOGIE, V39, P46, DOI 10.1051/apido:2007052; Witkowski J, 2011, CRETACEOUS RES, V32, P277, DOI 10.1016/j.cretres.2010.12.009; Zalat AA, 2013, MICROPALEONTOLOGY, V59, P305	98	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141150	10.1371/journal.pone.0141150	http://dx.doi.org/10.1371/journal.pone.0141150			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485144	gold, Green Submitted, Green Published			2022-12-27	WOS:000363028100118
J	Zhang, L; Zou, X; Zhang, D; Li, XL; Zhao, PZ; Ling, L				Zhang, Lei; Zou, Xia; Zhang, Di; Li, Xiaoling; Zhao, Peizhen; Ling, Li			Investigation of Repeat Client Drop-Out and Re-Enrolment Cycles in Fourteen Methadone Maintenance Treatment Clinics in Guangdong, China	PLOS ONE			English	Article							INJECTING DRUG-USERS; YUNNAN PROVINCE; HEALTH-STATUS; HEROIN; HIV; MISCONCEPTIONS; EMPLOYMENT; BEHAVIORS; GUANGZHOU; PATTERNS	Objective Client adherence is vital for effective methadone maintenance treatment (MMT). This study explores the pattern and associated factors of client adherence, drop-out and re-enrolment in the Chinese MMT programme over the period of 2006-2013. Methods This retrospective study was conducted in 14 MMT clinics in Guangdong Province, China. We employed Kaplan-Meier survival analysis to estimate the rates of drop-out and re-enrolment of MMT clients and multivariate Cox regression to identify associated factors. Results Among 1,512 study participants, 79% have experienced 'drop-out' during the 7-year study period. However, 82% 'dropped-out' clients resumed treatment at a later time. Low education level (junior high or below versus otherwise, HR = 1.21, 1.05-1.40), low methadone dosage in the first treatment episode (<50 ml versus >= 50 ml, HR = 1.84, 1.64-2.06) and higher proportion of positive urine test (>= 50% versus <50%, HR = 3.72, 3.30-4.20) during the first treatment episode were strong predictors of subsequent drop-outs of the participants. Among the 'dropped-out' clients, being female (HR = 1.40, 1.23-1.60), being married (HR = 1.19, 1.09-1.30), and having a higher proportion of positive urine tests in the first treatment episode (>= 50% versus <50%, HR = 1.35, 1.20-1.51) had greater likelihood of subsequent re-enrolment in MMT. Clients receiving lower methadone dosage (first treatment episode <50 ml versus >= 50 ml, HR = 1.12, 1.03-1.23; the last intake before drop-out <50 ml versus >= 50 ml, HR = 1.16, 1.04-1.30) were also more likely to re-enrol. Conclusion Persistent cycling in-and-out of clients in MMT programmes is common. Insufficient dosage and higher proportion of positive urine samples in the first treatment episode are the key determinants for subsequent client drop-out and re-enrolment. Interventions should target clients in their early stage of treatment to improve retention in the long term.	[Zhang, Lei; Zou, Xia; Zhang, Di; Li, Xiaoling; Zhao, Peizhen; Ling, Li] Sun Yat Sen Univ, Sun Yat Sen Ctr Migrant Hlth Policy, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Lei] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Zou, Xia; Zhang, Di; Li, Xiaoling; Zhao, Peizhen; Ling, Li] Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Di] Sun Yat Sen Univ, Off Med Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; University of New South Wales Sydney; Kirby Institute; Sun Yat Sen University; Sun Yat Sen University	Ling, L (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Ctr Migrant Hlth Policy, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	lingli@mail.sysu.edu.cn	Zhang, Lei/D-4039-2011; Zou, Xia/U-2205-2019	Zhang, Lei/0000-0003-2343-084X; 	National Natural Science Foundation of China [30972552, 71173245, 81473065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant 30972552, grant 71173245, grant 81473065). Grants received by LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell J, 2006, DRUG ALCOHOL DEPEN, V81, P55, DOI 10.1016/j.drugalcdep.2005.05.010; Beynon CM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-205; Bohang W, 2013, INFORM TIMES; Che YH, 2011, AM J DRUG ALCOHOL AB, V37, P148, DOI 10.3109/00952990.2010.535578; Chou YC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-190; Cohen JE, 2008, PLOS MED, V5, P1682, DOI 10.1371/journal.pmed.0050234; Deering DE, 2004, DRUG ALCOHOL REV, V23, P273, DOI 10.1080/09595230412331289428; Deren S, 2001, J SUBST ABUSE TREAT, V20, P185, DOI 10.1016/S0740-5472(00)00153-7; Dobler-Mikola A, 2005, J SUBST ABUSE TREAT, V29, P259, DOI 10.1016/j.jsat.2005.08.002; Ellul Rita Darmanin, 2009, Int J Adolesc Med Health, V21, P591; Fareed A, 2011, J ADDICT DIS, V30, P27, DOI 10.1080/10550887.2010.531672; Fareed A, 2010, AM J DRUG ALCOHOL AB, V36, P332, DOI 10.3109/00952990.2010.505991; GEARING FR, 1974, AM J EPIDEMIOL, V100, P101, DOI 10.1093/oxfordjournals.aje.a112012; Gu J, 2012, ADDICTION, V107, P1641, DOI 10.1111/j.1360-0443.2012.03859.x; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Lau JTF, 2008, SEX TRANSM DIS, V35, P325, DOI 10.1097/OLQ.0b013e3181614364; Leavitt S. B., 2003, ATF FORUM; Lin CQ, 2011, SUBST USE MISUSE, V46, P1190, DOI 10.3109/10826084.2011.561905; Marsch LA, 1998, ADDICTION, V93, P515, DOI 10.1046/j.1360-0443.1998.9345157.x; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Narcotics Control Bureau of the Ministry of Public Security, 2014, ANN REP DRUG CONTR C; National Health and Family Planning Commission of the People's Republic of China, 2013, BACKGR AIDS CONTR CH; Nava F, 2006, J ADDICT DIS, V25, P9, DOI 10.1300/J069v25n02_02; Noori R, 2012, SUBST USE MISUSE, V47, P767, DOI 10.3109/10826084.2010.517726; Office of Canada's Drug Strategy Health Canada, 2002, LIT REV METH MAINT T; Pang L, 2007, AIDS, V21, pS103, DOI 10.1097/01.aids.0000304704.71917.64; Philbin MM, 2010, AIDS CARE, V22, P623, DOI 10.1080/09540120903311490; Qadir F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1150; Richardson L, 2012, J SUBST ABUSE TREAT, V43, P276, DOI 10.1016/j.jsat.2011.12.008; RUTHERFORD MJ, 1994, J SUBST ABUSE TREAT, V11, P415, DOI 10.1016/0740-5472(94)90094-9; Shi J, 2007, J ADDICT MED, V1, P186, DOI 10.1097/ADM.0b013e318156cc19; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Svensson B, 2012, NORD STUD ALCOHOL DR, V29, P173, DOI 10.2478/v10199-012-0012-0; Termorshuizen F, 2005, DRUG ALCOHOL DEPEN, V79, P231, DOI 10.1016/j.drugalcdep.2005.01.013; WANG P, 2009, CHIN J DRUGS ABUSE P, V15, P77; Wu F, 2012, J PUBLIC HLTH OXF; Wu ZY, 2007, AIDS, V21, pS115, DOI 10.1097/01.aids.0000304706.79541.ef; Xu HF, 2012, ADDICT BEHAV, V37, P657, DOI 10.1016/j.addbeh.2012.01.020; YANG M, 2012, PRACTICAL PREVENTIVE, V19, P1582; Yang M, 2012, PRACTICAL PREVENTIVE, V19, P1589; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076931; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068906; Zhao Y, 2013, B WORLD HEALTH ORGAN, V91, P93, DOI 10.2471/BLT.12.108944; Zhu WX, 2009, DRUG ALCOHOL REV, V28, P641, DOI 10.1111/j.1465-3362.2009.00068.x	46	22	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139942	10.1371/journal.pone.0139942	http://dx.doi.org/10.1371/journal.pone.0139942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7XI	26484772	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100016
J	Lackey, L; McArthur, E; Laederach, A				Lackey, Lela; McArthur, Evonne; Laederach, Alain			Increased Transcript Complexity in Genes Associated with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLYCATION END-PRODUCTS; RNA SECONDARY STRUCTURES; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CYSTIC-FIBROSIS; LUNG-DISEASE; GLUCOCORTICOID-RECEPTOR; EMERGING GENETICS; INDUCED EMPHYSEMA	Genome-wide association studies aim to correlate genotype with phenotype. Many common diseases including Type II diabetes, Alzheimer's, Parkinson's and Chronic Obstructive Pulmonary Disease (COPD) are complex genetic traits with hundreds of different loci that are associated with varied disease risk. Identifying common features in the genes associated with each disease remains a challenge. Furthermore, the role of post-transcriptional regulation, and in particular alternative splicing, is still poorly understood in most multigenic diseases. We therefore compiled comprehensive lists of genes associated with Type II diabetes, Alzheimer's, Parkinson's and COPD in an attempt to identify common features of their corresponding mRNA transcripts within each gene set. The SERPINA1 gene is a well-recognized genetic risk factor of COPD and it produces 11 transcript variants, which is exceptional for a human gene. This led us to hypothesize that other genes associated with COPD, and complex disorders in general, are highly transcriptionally diverse. We found that COPD-associated genes have a statistically significant enrichment in transcript complexity stemming from a disproportionately high level of alternative splicing, however, Type II Diabetes, Alzheimer's and Parkinson's disease genes were not significantly enriched. We also identified a subset of transcriptionally complex COPD-associated genes (similar to 40%) that are differentially expressed between mild, moderate and severe COPD. Although the genes associated with other lung diseases are not extensively documented, we found preliminary data that idiopathic pulmonary disease genes, but not cystic fibrosis modulators, are also more transcriptionally complex. Interestingly, complex COPD transcripts are more often the product of alternative acceptor site usage. To verify the biological importance of these alternative transcripts, we used RNA-sequencing analyses to determine that COPD-associated genes are frequently expressed in lung and liver tissues and are regulated in a tissue-specific manner. Additionally, many complex COPD-associated genes are spliced differently between COPD and non-COPD patients. Our analysis therefore suggests that post-transcriptional regulation, particularly alternative splicing, is an important feature specific to COPD disease etiology that warrants further investigation.	[Lackey, Lela; McArthur, Evonne; Laederach, Alain] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Laederach, A (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	alain@unc.edu		Lackey, Lela/0000-0003-2163-4005; McArthur, Evonne/0000-0003-4566-4321	National Institutes of Health/National Heart Lung and Blood Institute [RO1 HL111527-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111527] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101237] Funding Source: NIH RePORTER	National Institutes of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health/National Heart Lung and Blood Institute: RO1 HL111527-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Arif E, 2008, CLIN CHIM ACTA, V397, P46, DOI 10.1016/j.cca.2008.07.010; Artigas MS, 2011, AM J RESP CRIT CARE, V184, P786, DOI 10.1164/rccm.201102-0192OC; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Berndt A, 2012, EMBO MOL MED, V4, P1144, DOI 10.1002/emmm.201100627; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; Bosse Y, 2012, INT J CHRONIC OBSTR, V7, P607, DOI 10.2147/COPD.S35294; Bosse Y, 2009, PHARMACOGENOMICS, V10, P655, DOI 10.2217/PGS.09.10; Brebner JA, 2013, EXPERT REV RESP MED, V7, P213, DOI [10.1586/ERS.13.20, 10.1586/ers.13.20]; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; Castaldi PJ, 2015, HUM MOL GENET, V24, P1200, DOI 10.1093/hmg/ddu525; Chang CQ, 2014, EUR J HUM GENET, V22, P402, DOI 10.1038/ejhg.2013.161; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chen L, 2014, MOL BIOL EVOL, V31, P1402, DOI 10.1093/molbev/msu083; Chen W, 2015, ANN AM THORAC SOC, V12, P340, DOI 10.1513/AnnalsATS.201408-380OC; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Corvol H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-88; Corvol H, 2014, J MED GENET, V51, P646, DOI 10.1136/jmedgenet-2014-102525; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; D'Anna C, 2015, LIFE SCI, V126, P10, DOI 10.1016/j.lfs.2015.01.017; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; de Jong K, 2015, J ALLERGY CLIN IMMUN, V136, P1664, DOI 10.1016/j.jaci.2015.03.042; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; DUMUR V, 1990, LANCET, V335, P1340, DOI 10.1016/0140-6736(90)91216-W; Elbein SC, 2012, AM J HUM GENET, V91, P466, DOI 10.1016/j.ajhg.2012.08.002; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; Foissac S, 2007, NUCLEIC ACIDS RES, V35, pW297, DOI 10.1093/nar/gkm311; Gao CX, 2012, J BIOL CHEM, V287, P16699, DOI 10.1074/jbc.M111.315333; Gebauer F, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012245; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghouse R, 2014, DIS MODEL MECH, V7, P411, DOI 10.1242/dmm.014092; Gooptu B, 2009, EUR RESPIR J, V34, P475, DOI 10.1183/09031936.00096508; Guo WA, 2012, INTENS CARE MED, V38, P1588, DOI 10.1007/s00134-012-2624-y; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hambly N, 2015, RESPIROLOGY, V20, P1010, DOI 10.1111/resp.12569; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hancox RJ, 2009, HUM GENET, V126, P559, DOI 10.1007/s00439-009-0704-z; Hao LL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-316; He JQ, 2008, EUR RESPIR J, V32, P25, DOI 10.1183/09031936.00040307; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hindorff LA, CATALOG PUBLISHED GE; Homma S, 2006, INT J MOL MED, V18, P933; Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Jin ZG, 2015, MOL BIOL CELL, V26, P1160, DOI 10.1091/mbc.E14-08-1276; Jourquin J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S20; Kamio K, 2012, BIOCHEM BIOPH RES CO, V424, P112, DOI 10.1016/j.bbrc.2012.06.081; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim S, 2015, J HUM GENET, V60, P139, DOI 10.1038/jhg.2014.118; Kim WJ, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/206937; Knowles MR, 2006, CURR OPIN PULM MED, V12, P416, DOI 10.1097/01.mcp.0000245707.59138.40; Konrad FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121725; Kropski JA, 2015, EUR RESPIR J, V45, P1717, DOI 10.1183/09031936.00163814; Lajoie M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-231; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JH, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0113-2; Lee YL, 2006, J LAB CLIN MED, V147, P228, DOI 10.1016/j.lab.2005.12.008; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lin WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116229; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Lu ZX, 2012, WIRES RNA, V3, P581, DOI 10.1002/wrna.120; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Marciniak SJ, 2014, CLIN CHEST MED, V35, P29, DOI 10.1016/j.ccm.2013.10.008; Matamala N, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0585-y; Mathers C, 2008, GLOB BURD DIS 2004 U, pvii; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Miniati M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-37; Murray J. F., 2010, MURRAY NADELS TXB RE; Nakamura Hidetoshi, 2011, Allergology International, V60, P253, DOI 10.2332/allergolint.11-RAI-0326; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Obeidat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019382; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Petrie JR, 2011, BIOCHEM PHARMACOL, V81, P471, DOI 10.1016/j.bcp.2010.11.010; Pillai SG, 2010, AM J RESP CRIT CARE, V182, P1498, DOI 10.1164/rccm.201002-0151OC; Puschmann A, 2013, PARKINSONISM RELAT D, V19, P407, DOI 10.1016/j.parkreldis.2013.01.020; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Research MPIfHaL, 2014, SNP4DISEASE; Rider CF, 2011, J PHARMACOL EXP THER, V338, P860, DOI 10.1124/jpet.111.181016; Ridge PG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/254954; Ringman John M, 2013, Continuum (Minneap Minn), V19, P358, DOI 10.1212/01.CON.0000429179.21977.a1; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Schafer SA, 2011, DIABETES RES CLIN PR, V93, pS9, DOI 10.1016/S0168-8227(11)70008-0; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sessa L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086903; Sharma S, 2009, EUR RESPIR J, V33, P1287, DOI 10.1183/09031936.00113008; Shepard PJ, 2008, RNA, V14, P1463, DOI 10.1261/rna.1069408; Shetty SK, 2012, AM J RESP CELL MOL, V47, P474, DOI 10.1165/rcmb.2011-0390OC; Silverman EK, 2002, AM J HUM GENET, V70, P1229, DOI 10.1086/340316; Simm A, 2004, ANN NY ACAD SCI, V1019, P228, DOI 10.1196/annals.1297.038; Singh D, 2011, THORAX, V66, P489, DOI 10.1136/thx.2010.153767; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Smith DJ, 2011, EUR RESPIR J, V37, P516, DOI 10.1183/09031936.00029310; Spagnolo P, 2014, LANCET RESP MED, V2, P416, DOI 10.1016/S2213-2600(14)70047-5; Stoller JK, 1993, ALPHA 1 ANTITRYPSIN; Tanzi RE, 2013, J ALZHEIMERS DIS, V33, pS5, DOI 10.3233/JAD-2012-129044; Thun GA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003585; Tosto G, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0381-0; Tsui LC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009472; Xie JG, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0209-3; Yamada M, 2011, J HUM GENET, V56, P857, DOI 10.1038/jhg.2011.118; Yoon HK, 2014, COPD, V11, P652, DOI 10.3109/15412555.2014.898045; Zanini A, 2014, RESPIRATION, V87, P234, DOI 10.1159/000356749; Zhang F, 2011, RESPIRATION, V82, P358, DOI 10.1159/000328762; Zhang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-90	112	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140885	10.1371/journal.pone.0140885	http://dx.doi.org/10.1371/journal.pone.0140885			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480348	Green Published, Green Submitted, gold			2022-12-27	WOS:000363026600024
J	Mohrbeck, I; Raupach, MJ; Arbizu, PM; Knebelsberger, T; Laakmann, S				Mohrbeck, Inga; Raupach, Michael J.; Arbizu, Pedro Martinez; Knebelsberger, Thomas; Laakmann, Silke			High-Throughput Sequencing-The Key to Rapid Biodiversity Assessment of Marine Metazoa?	PLOS ONE			English	Article							18S RIBOSOMAL-RNA; OCEAN DEEP-SEA; SMALL-SUBUNIT; SPECIES IDENTIFICATION; MICROBIAL DIVERSITY; CONCERTED EVOLUTION; MITOCHONDRIAL-DNA; RDNA; GENE; EXPANSION	The applications of traditional morphological and molecular methods for species identification are greatly restricted by processing speed and on a regional or greater scale are generally considered unfeasible. In this context, high-throughput sequencing, or metagenetics, has been proposed as an efficient tool to document biodiversity. Here we evaluated the effectiveness of 454 pyrosequencing in marine metazoan community analysis using the 18S rDNA: V1-V2 region. Multiplex pyrosequencing of the V1-V2 region was used to analyze two pooled samples of DNA, one comprising 118 and the other 37 morphologically identified species, and one natural sample taken directly from a North Sea zooplankton community. A DNA reference library comprising all species represented in the pooled samples was created by Sanger sequencing, and this was then used to determine the optimal similarity threshold for species delineation. The optimal threshold was found at 99% species similarity, with 85% identification success. Pyrosequencing was able to identify between fewer species: 67% and 78% of the species in the two pooled samples. Also, a large number of sequences for three species that were not included in the pooled samples were amplified by pyrosequencing, suggesting preferential amplification of some genotypes and the sensitivity of this approach to even low levels of contamination. Conversely, metagenetic analysis of the natural zooplankton sample identified many more species (particularly gelatinous zooplankton and meroplankton) than morphological analysis of a formalin-fixed sample from the same sampling site, suggesting an increased level of taxonomic resolution with pyrosequencing. The study demonstrated that, based on the V1-V2 region, 454 sequencing does not provide accurate species differentiation and reliable taxonomic classification, as it is required in most biodiversity monitoring. The analysis of artificially prepared samples indicated that species detection in pyrosequencing datasets is complicated by potential PCR-based biases and that the V1-V2 marker is poorly resolved for some taxa.	[Mohrbeck, Inga; Raupach, Michael J.; Arbizu, Pedro Martinez; Knebelsberger, Thomas; Laakmann, Silke] Senckenberg Meer, Dept German Ctr Marine Biodivers Res, Wilhelmshaven, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN)	Mohrbeck, I (corresponding author), Senckenberg Meer, Dept German Ctr Marine Biodivers Res, Wilhelmshaven, Germany.	imohrbeck@senckenberg.de	Raupach, Michael J./AAF-7566-2020	Raupach, Michael J./0000-0001-8299-6697; Laakmann, Silke/0000-0003-3273-7907	Federal Ministry for Education and Research; State of Lower Saxony [03F0499A, 03F0664A]	Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); State of Lower Saxony(European Commission)	This work was funded by the Federal Ministry for Education and Research (www.bmbf.de) and the State of Lower Saxony (grant no. 03F0499A, 03F0664A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Benita Y, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng101; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bik HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038550; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Brokeland W, 2008, ZOOL J LINN SOC-LOND, V152, P655, DOI 10.1111/j.1096-3642.2008.00362.x; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Carranza S, 1996, MOL BIOL EVOL, V13, P824, DOI 10.1093/oxfordjournals.molbev.a025643; Cepeda GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035861; Chen HN, 2013, BIOFOULING, V29, P133, DOI 10.1080/08927014.2012.753061; Crease TJ, 1998, MOL BIOL EVOL, V15, P1430, DOI 10.1093/oxfordjournals.molbev.a025871; CREASE TJ, 1991, MOL BIOL EVOL, V8, P620; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Edwards Robert A, 2006, BMC Genomics, V7, P57; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca VG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks002; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; Greve W, 2001, SENCK MARIT, V31, P263, DOI 10.1007/BF03043035; Hajibabaei M, 2012, TRENDS GENET, V28, P535, DOI 10.1016/j.tig.2012.08.001; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hancock JM, 2000, MOL PHYLOGENET EVOL, V14, P366, DOI 10.1006/mpev.1999.0709; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647; HOEH WR, 1991, SCIENCE, V251, P1488, DOI 10.1126/science.1672472; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Hwang UW, 2000, ZOOL SCI, V17, P111, DOI 10.2108/zsj.17.111; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keller I, 2008, EVOLUTION, V62, P833, DOI 10.1111/j.1558-5646.2008.00320.x; Kemppainen P, 2009, J EVOLUTION BIOL, V22, P2000, DOI 10.1111/j.1420-9101.2009.01810.x; Ko HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053451; Krieger J, 2004, J APPL ICHTHYOL, V20, P433, DOI 10.1111/j.1439-0426.2004.00610.x; Krieger J, 2006, J HERED, V97, P218, DOI 10.1093/jhered/esj035; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Laakmann S, 2012, MOL PHYLOGENET EVOL, V65, P535, DOI 10.1016/j.ympev.2012.07.007; Lecroq B, 2011, P NATL ACAD SCI USA, V108, P13177, DOI 10.1073/pnas.1018426108; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Luddington IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045664; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046180; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035887; Machida RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010278; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; McTaggart SJ, 2005, MOL BIOL EVOL, V22, P1309, DOI 10.1093/molbev/msi119; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Mohrbeck I, 2010, SYST PARASITOL, V77, P131, DOI 10.1007/s11230-010-9260-0; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; Pereira Filipe, 2008, Recent Pat DNA Gene Seq, V2, P187, DOI 10.2174/187221508786241738; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pfenninger M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-100; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Radulovici Adriana E., 2010, Diversity, V2, P450; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Raupach MJ, 2006, ANTARCT SCI, V18, P191, DOI 10.1017/S0954102006000228; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santos SR, 2003, J EUKARYOT MICROBIOL, V50, P417, DOI 10.1111/j.1550-7408.2003.tb00264.x; Schaechter M, 2004, DESK ENCY MICROBIOLO; Shinoda N, 2009, NUCLEOS NUCLEOT NUCL, V28, P324, DOI 10.1080/15257770902963400; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Stoeckle M, 2003, BIOSCIENCE, V53, P796, DOI 10.1641/0006-3568(2003)053[0796:TDATBC]2.0.CO;2; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1816, DOI 10.1111/j.1365-294X.2011.05317.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tsaousis AD, 2005, MOL BIOL EVOL, V22, P925, DOI 10.1093/molbev/msi084; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; White KN, 2011, J CRUSTACEAN BIOL, V31, P710, DOI 10.1651/11-3489.1; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; Wu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131498; Xie Q, 2009, MOL PHYLOGENET EVOL, V50, P310, DOI 10.1016/j.ympev.2008.10.025; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zhan AB, 2013, METHODS ECOL EVOL, V4, P558, DOI 10.1111/2041-210X.12037; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	110	41	43	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140342	10.1371/journal.pone.0140342	http://dx.doi.org/10.1371/journal.pone.0140342			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479071	gold, Green Published, Green Submitted			2022-12-27	WOS:000363026600008
J	Nomura, R; Liang, YZ; Okada, T				Nomura, Ryota; Liang, Yingzong; Okada, Takeshi			Interactions among Collective Spectators Facilitate Eyeblink Synchronization	PLOS ONE			English	Article							SELF-ADAPTIVE SYSTEMS	Whereas the entrainment of movements and aspirations among audience members has been known as a basis of collective excitement in the theater, the role of the entrainment of cognitive processes among audience members is still unclear. In the current study, temporal patterns of the audience's attention were observed using eyeblink responses. To determine the effect of interactions among audience members on cognitive entrainment, as well as its direction (attractive or repulsive), the eyeblink synchronization of the following two groups were compared: (1) the experimental condition, where the audience members (seven frequent viewers and seven first-time viewers) viewed live performances in situ, and (2) the control condition, where the audience members (15 frequent viewers and 15 first-time viewers) viewed videotaped performances in individual experimental settings (results reported in previous study.) The results of this study demonstrated that the mean values of a measure of asynchrony (i.e., D-interval) were much lower for the experimental condition than for the control condition. Frequent viewers had a moderate attractive effect that increased as the story progressed, while a strong attractive effect was observed throughout the story for first-time viewers. The attractive effect of interactions among a group of spectators was discussed from the viewpoint of cognitive and somatic entrainment in live performances.	[Nomura, Ryota; Okada, Takeshi] Univ Tokyo, Dept Educ, Bunkyo Ward, Tokyo, Japan; [Liang, Yingzong] Univ Tokyo, Grad Sch Engn, Bunkyo Ward, Tokyo, Japan	University of Tokyo; University of Tokyo	Nomura, R (corresponding author), Univ Tokyo, Dept Educ, Bunkyo Ward, 7-3-1 Hongo, Tokyo, Japan.	nomuraryota@gmail.com			Japan Society for the Promotion of Science [2408089, 24243062]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Support was provided by the Japan Society for the Promotion of Science, Grant-in-Aid for Japan Society for the Promotion of Science Fellows #2408089 to RN [https://kaken.nii.ac.jp/d/p/12J08089.en.html] and the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research(A) #24243062 to TO [https://kaken.nii.ac.jp/d/p/ 24243062.en.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brun Y, 2009, LECT NOTES COMPUT SC, V5525, P48, DOI 10.1007/978-3-642-02161-9_3; HOLLAND MK, 1975, PERCEPT MOTOR SKILL, V41, P403, DOI 10.2466/pms.1975.41.2.403; Latif N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105036; Louzada VHP, 2013, SCI REP, P3; Macias-Escriva FD, 2013, EXPERT SYST APPL, V40, P7267, DOI 10.1016/j.eswa.2013.07.033; Nakano T, 2009, P ROY SOC B-BIOL SCI, V276, P3635, DOI 10.1098/rspb.2009.0828; Nomura R., 2014, COGN STUD, V21, P226, DOI 10.11225/jcss.21.226; Nomura R., 2008, JAPANESE PSYCHOL REV, V51, P500; Nomura R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00447; Oh J, 2012, HUM MOVEMENT SCI, V31, P1353, DOI 10.1016/j.humov.2012.06.003; Oh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034871; Strogatz S.H., 2014, NONLINEAR DYNAMICS C; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; von Scheve C., 2014, COLLECTIVE EMOTIONS; Wang RQ, 2006, BIOINFORMATICS, V22, P1775, DOI 10.1093/bioinformatics/btl182; WYER RS, 1992, PSYCHOL REV, V99, P663, DOI 10.1037/0033-295X.99.4.663	16	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140774	10.1371/journal.pone.0140774	http://dx.doi.org/10.1371/journal.pone.0140774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479405	Green Submitted, Green Published, gold			2022-12-27	WOS:000363026600019
J	Scheuplein, F; Lamont, DJ; Poynter, ME; Boyson, JE; Serreze, D; Lundblad, LKA; Mashal, R; Schaub, R				Scheuplein, Felix; Lamont, Deanna J.; Poynter, Matthew E.; Boyson, Jonathan E.; Serreze, David; Lundblad, Lennart K. A.; Mashal, Robert; Schaub, Robert			Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo	PLOS ONE			English	Article							KILLER T-CELLS; PULMONARY INFLAMMATION; MICE	Invariant Natural Killer T (iNKT) cells are a T cell subset expressing an invariant T Cell Receptor (TCR) that recognizes glycolipid antigens rather than peptides. The cells have both innate-like rapid cytokine release, and adaptive-like thymic positive selection. iNKT cell activation has been implicated in the pathogenesis of allergic asthma and inflammatory diseases, while reduced iNKT cell activation promotes infectious disease, cancer and certain autoimmune diseases such as Type 1 diabetes (T1D). Therapeutic means to reduce or deplete iNKT cells could treat inflammatory diseases, while approaches to promote their activation may have potential in certain infectious diseases, cancer or autoimmunity. Thus, we developed invariant TCR-specific monoclonal antibodies to better understand the role of iNKT cells in disease. We report here the first monoclonal antibodies specific for the mouse invariant TCR that by modifying the Fc construct can specifically deplete or activate iNKT cells in vivo in otherwise fully immuno-competent animals. We have used both the depleting and activating version of the antibody in the NOD model of T1D. As demonstrated previously using genetically iNKT cell deficient NOD mice, and in studies of glycolipid antigen activated iNKT cells in standard NOD mice, we found that antibody mediated depletion or activation of iNKT cells respectively accelerated and retarded T1D onset. In BALB/c mice, ovalbumin (OVA) mediated airway hyper-reactivity (AHR) was abrogated with iNKT cell depletion prior to OVA sensitization, confirming studies in knockout mice. Depletion of iNKT cells after sensitization had no effect on AHR in the conducting airways but did reduce AHR in the lung periphery. This result raises caution in the interpretation of studies that use animals that are genetically iNKT cell deficient from birth. These activating and depleting antibodies provide a novel tool to assess the therapeutic potential of iNKT cell manipulation.	[Scheuplein, Felix; Mashal, Robert; Schaub, Robert] NKT Therapeut Inc, Waltham, MA 02451 USA; [Lamont, Deanna J.; Serreze, David] Jackson Lab, Bar Harbor, ME 04609 USA; [Poynter, Matthew E.; Boyson, Jonathan E.; Lundblad, Lennart K. A.] Univ Vermont, Dept Med, Burlington, VT USA	Jackson Laboratory; University of Vermont	Schaub, R (corresponding author), NKT Therapeut Inc, Waltham, MA 02451 USA.	rschaub@nktrx.com		Lundblad, Lennart/0000-0002-1749-8242; Poynter, Matthew/0000-0002-7578-4570	NKT Therapeutics Inc.; NIH/NIAID grant [1R21AI112804-01, P30 RR 031158]; University of Vermont College of Medicine; NKT Therapeutics Inc; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046266, R01DK095735] Funding Source: NIH RePORTER	NKT Therapeutics Inc.; NIH/NIAID grant; University of Vermont College of Medicine; NKT Therapeutics Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by NKT Therapeutics Inc., NIH/NIAID grant 1R21AI112804-01, P30 RR 031158 and the University of Vermont College of Medicine internal grant program. NKT Therapeutics Inc provided support in the form of salaries for authors Felix Scheuplein, Robert Mashal and Robert Schaub but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Bate JHT, 2008, RESP PHYSIOL NEUROBI, V163, P54, DOI 10.1016/j.resp.2008.03.012; Bedel R, 2012, NAT IMMUNOL, V13, P705, DOI 10.1038/ni.2347; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Chen YG, 2012, GENES IMMUN, V13, P164, DOI 10.1038/gene.2011.68; Chen YG, 2005, J IMMUNOL, V174, P1196, DOI 10.4049/jimmunol.174.3.1196; Driver JP, 2010, DIABETES, V59, P423, DOI 10.2337/db09-1116; Farrow CE, 2012, J APPL PHYSIOL, V113, P958, DOI 10.1152/japplphysiol.01618.2011; Field JJ, 2011, CLIN IMMUNOL, V140, P177, DOI 10.1016/j.clim.2011.03.002; Hamid Q, 1997, J ALLERGY CLIN IMMUN, V100, P44, DOI 10.1016/S0091-6749(97)70193-3; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Kaminsky DA, 2004, J APPL PHYSIOL, V97, P1849, DOI 10.1152/japplphysiol.00300.2004; Li S, 2014, AM J PHYSIOL-LUNG C, V306, pL196, DOI 10.1152/ajplung.00055.2013; Lundblad LKA, 2007, AM J RESP CRIT CARE, V175, P768, DOI 10.1164/rccm.200610-1410OC; Lundblad LKA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-27; Lundblad LKA, 2002, J APPL PHYSIOL, V93, P1198, DOI 10.1152/japplphysiol.00080.2002; Matangkasombut P, 2008, J ALLERGY CLIN IMMUN, V121, P1287, DOI 10.1016/j.jaci.2008.02.006; Matangkasombut P, 2009, J ALLERGY CLIN IMMUN, V123, P1181, DOI 10.1016/j.jaci.2009.02.013; Renukaradhya GJ, 2008, BLOOD, V111, P5637, DOI 10.1182/blood-2007-05-092866; Riesenfeld Erik, 2012, J Allergy Ther, V1, P1; Scheuplein F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076692; Scheuplein F, 2010, J AUTOIMMUN, V34, P145, DOI 10.1016/j.jaut.2009.08.012; SCHUESSLER TF, 1995, IEEE T BIO-MED ENG, V42, P860, DOI 10.1109/10.412653; Shi FD, 2001, P NATL ACAD SCI USA, V98, P6777, DOI 10.1073/pnas.121169698; STEURER W, 1995, J IMMUNOL, V155, P1165; Van Kaer L, 2011, CELL TISSUE RES, V343, P43, DOI 10.1007/s00441-010-1023-3; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Yamasaki K, 2011, CLIN IMMUNOL, V138, P255, DOI 10.1016/j.clim.2010.11.014	30	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140729	10.1371/journal.pone.0140729	http://dx.doi.org/10.1371/journal.pone.0140729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474487	Green Submitted, Green Published, gold			2022-12-27	WOS:000363185500093
J	Khan, MD; Abdulateif, H; Ismail, IM; Sabir, S; Khan, MZ				Khan, Mohammad Danish; Abdulateif, Huda; Ismail, Iqbal M.; Sabir, Suhail; Khan, Mohammad Zain			Bioelectricity Generation and Bioremediation of an Azo-Dye in a Microbial Fuel Cell Coupled Activated Sludge Process	PLOS ONE			English	Article							ELECTRICITY-GENERATION; BACTERIAL COMMUNITIES; DECOLORIZATION; DEGRADATION; BIODEGRADATION; PERFORMANCE; ACETATE; DIVERSITY; SYSTEM	Simultaneous bioelectricity generation and dye degradation was achieved in the present study by using a combined anaerobic-aerobic process. The anaerobic system was a typical single chambered microbial fuel cell (SMFC) which utilizes acid navy blue r (ANB) dye along with glucose as growth substrate to generate electricity. Four different concentrations of ANB (50, 100, 200 and 400 ppm) were tested in the SMFC and the degradation products were further treated in an activated sludge post treatment process. The dye decolorization followed pseudo first order kinetics while the negative values of the thermodynamic parameter Delta G (change in Gibbs free energy) shows that the reaction proceeds with a net decrease in the free energy of the system. The coulombic efficiency (CE) and power density (PD) attained peak values at 10.36% and 2,236 mW/m(2) respectively for 200 ppm of ANB. A further increase in ANB concentrations results in lowering of cell potential (and PD) values owing to microbial inhibition at higher concentrations of toxic substrates. Cyclic voltammetry studies revealed a perfect redox reaction was taking place in the SMFC. The pH, temperature and conductivity remain 7.5-8.0, 27(+/- 2 degrees C and 10.6-18.2 mS/cm throughout the operation. The biodegradation pathway was studied by the gas chromatography coupled with mass spectroscopy technique, suggested the preferential cleavage of the azo bond as the initial step resulting in to aromatic amines. Thus, a combined anaerobic-aerobic process using SMFC coupled with activated sludge process can be a viable option for effective degradation of complex dye substrates along with energy (bioelectricity) recovery.	[Khan, Mohammad Danish; Sabir, Suhail; Khan, Mohammad Zain] Aligarh Muslim Univ, Dept Chem, Environm Res Lab, Aligarh 202002, Uttar Pradesh, India; [Abdulateif, Huda; Ismail, Iqbal M.; Khan, Mohammad Zain] King Abdulaziz Univ, Ctr Excellence Environm Studies, Jeddah 21413, Saudi Arabia	Aligarh Muslim University; King Abdulaziz University	Khan, MZ (corresponding author), Aligarh Muslim Univ, Dept Chem, Environm Res Lab, Aligarh 202002, Uttar Pradesh, India.	dr_mzain.fa@amu.ac.in	Ismail, Iqbal/J-2319-2016; Khan, Mohammad/AAQ-2099-2020	Khan, Mohammad/0000-0003-2009-0990; Khan, Mohammad/0000-0002-0898-4046	Department of Science & Technology, Government of India [SB/FT/CS-037/2012]; King Abdul Aziz University	Department of Science & Technology, Government of India(Department of Science & Technology (India)); King Abdul Aziz University	Department of Science & Technology, Government of India is duly acknowledged for the financial support to this project (SB/FT/CS-037/2012). King Abdul Aziz University will be acknowledged for providing a travel grant to MZK for visiting Center of Excellence in Environmental Studies, Kingdom of Saudi Arabia.	Bakhshian S, 2011, BIORESOURCE TECHNOL, V102, P6761, DOI 10.1016/j.biortech.2011.03.060; Bilgi S, 2005, DYES PIGMENTS, V66, P69, DOI 10.1016/j.dyepig.2004.08.007; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Bureau NEP, 2002, STANDARD METHODS EXA; Chae KJ, 2009, BIORESOURCE TECHNOL, V100, P3518, DOI 10.1016/j.biortech.2009.02.065; Cummings DE, 2003, MICROB ECOL, V46, P257, DOI [10.1007/s00248-002-0005-8, 10.1007/s00248-005-8002-3]; Cusick RD, 2010, INT J HYDROGEN ENERG, V35, P8855, DOI 10.1016/j.ijhydene.2010.06.077; Dewan A, 2010, J POWER SOURCES, V195, P90, DOI 10.1016/j.jpowsour.2009.07.001; ElMekawy A, 2014, J POWER SOURCES, V262, P183, DOI 10.1016/j.jpowsour.2014.03.111; Georgiou D, 2004, BIOCHEM ENG J, V19, P75, DOI 10.1016/j.bej.2003.11.003; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Hsueh CC, 2007, J HAZARD MATER, V141, P842, DOI 10.1016/j.jhazmat.2006.07.056; Isik M, 2007, ENZYME MICROB TECH, V40, P934, DOI 10.1016/j.enzmictec.2006.07.032; Jung S, 2007, APPL MICROBIOL BIOT, V77, P393, DOI 10.1007/s00253-007-1162-y; Khan MZ, 2015, NEW J CHEM, V39, P5597, DOI 10.1039/c5nj00541h; Khan MZ, 2014, RSC ADV, V4, P46851, DOI 10.1039/c4ra06716a; Kondo R, 2004, GEOMICROBIOL J, V21, P145, DOI 10.1080/01490450490275307; Kook L, 2016, J CLEAN PROD, V112, P4406, DOI 10.1016/j.jclepro.2015.06.116; Koupaie EH, 2012, INT BIODETER BIODEGR, V71, P43, DOI 10.1016/j.ibiod.2012.04.002; Liu H, 2005, ENVIRON SCI TECHNOL, V39, P658, DOI 10.1021/es048927c; Logan B.E., 2008, MICROBIAL FUEL CELLS; Logan BE, 2005, WATER RES, V39, P942, DOI 10.1016/j.watres.2004.11.019; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2006, TRENDS MICROBIOL, V14, P512, DOI 10.1016/j.tim.2006.10.003; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Luo HP, 2015, FRONT ENV SCI ENG, V9, P522, DOI 10.1007/s11783-014-0633-5; Mendez-Paz D, 2005, ENZYME MICROB TECH, V36, P264, DOI 10.1016/j.enzmictec.2004.08.039; Mitrovic J, 2012, J SERB CHEM SOC, V77, P465, DOI 10.2298/JSC110216187M; Murali V, 2013, BIORESOURCE TECHNOL, V143, P104, DOI 10.1016/j.biortech.2013.05.122; Nevin KP, 2008, ENVIRON MICROBIOL, V10, P2505, DOI 10.1111/j.1462-2920.2008.01675.x; Pandey A, 2007, INT BIODETER BIODEGR, V59, P73, DOI 10.1016/j.ibiod.2006.08.006; Pant D, 2010, BIORESOURCE TECHNOL, V101, P1533, DOI 10.1016/j.biortech.2009.10.017; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Rabaey K, 2004, APPL ENVIRON MICROB, V70, P5373, DOI 10.1128/AEM.70.9.5373-5382.2004; RazoFlores E, 1997, ENVIRON SCI TECHNOL, V31, P2098, DOI 10.1021/es960933o; Ringeisen BR, 2007, J POWER SOURCES, V165, P591, DOI 10.1016/j.jpowsour.2006.10.026; Rivera I, 2015, J APPL ELECTROCHEM, V45, P1223, DOI 10.1007/s10800-015-0864-6; Rozsenberszki T, 2015, WASTE BIOMASS VALORI, V6, P465, DOI 10.1007/s12649-015-9379-y; Sevda S, 2013, CHEM ENG J, V228, P1, DOI 10.1016/j.cej.2013.05.014; Speece R. E., 1996, ANAEROBIC BIOTECHNOL, P1; Svobodova K, 2007, PROCESS BIOCHEM, V42, P1279, DOI 10.1016/j.procbio.2007.06.002; Tao HC, 2012, BIORESOURCE TECHNOL, V111, P92, DOI 10.1016/j.biortech.2012.02.029; Wang J, 2012, INT BIODETER BIODEGR, V67, P73, DOI 10.1016/j.ibiod.2011.12.003; Wang Z, 2011, BIORESOURCE TECHNOL, V102, P6304, DOI 10.1016/j.biortech.2011.02.027; Wu C, 2012, APPL ENERG, V98, P594, DOI 10.1016/j.apenergy.2012.02.058; Yu L, 2011, APPL MICROBIOL BIOT, V90, P1119, DOI 10.1007/s00253-011-3109-6; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhang BG, 2009, BIORESOURCE TECHNOL, V100, P5687, DOI 10.1016/j.biortech.2009.06.045; Zhang F, 2009, ELECTROCHEM COMMUN, V11, P2177, DOI 10.1016/j.elecom.2009.09.024; Zollinger H., 1991, COLOR CHEM SYNTHESES	51	78	78	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0138448	10.1371/journal.pone.0138448	http://dx.doi.org/10.1371/journal.pone.0138448			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496083	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200006
J	Liu, Z; Qiu, FF; Li, J; Zhu, ZZ; Yang, WZ; Zhou, XT; An, JH; Huang, FR; Wang, QS; Reinach, PS; Li, W; Chen, WS; Liu, ZG				Liu, Zhen; Qiu, Fangfang; Li, Jing; Zhu, Zhenzhen; Yang, Wenzhao; Zhou, Xiangtian; An, Jianhong; Huang, Furong; Wang, Qiongsi; Reinach, Peter S.; Li, Wei; Chen, Wensheng; Liu, Zuguo			Adenomatous Polyposis Coli Mutation Leads to Myopia Development in Mice	PLOS ONE			English	Article							FORM-DEPRIVATION MYOPIA; OPTICAL COHERENCE TOMOGRAPHY; RETINAL-PIGMENT EPITHELIUM; AXIAL LENGTH; PATHOLOGICAL COMPLICATIONS; TYROSINE-HYDROXYLASE; DOPAMINE SYNTHESIS; REFRACTIVE ERROR; OCULAR GROWTH; BRIEF PERIODS	Myopia incidence in China is rapidly becoming a very serious sight compromising problem in a large segment of the general population. Therefore, delineating the underlying mechanisms leading to myopia will markedly lessen the likelihood of other sight compromising complications. In this regard, there is some evidence that patients afflicted with familial adenomatous polyposis (FAP), havean adenomatous polyposis coli (APC) mutation and a higher incidence of myopia. To clarify this possible association, we determined whether the changes in pertinent biometric and biochemical parameters underlying postnatal refractive error development in APC(Min) mice are relevant for gaining insight into the pathogenesis of this disease in humans. The refraction and biometrics in APC(Min) mice and age-matched wild-type (WT) littermates between postnatal days P28 and P84 were examined with eccentric infrared photorefraction (EIR) and customized optical coherence tomography (OCT). Compared with WT littermates, the APC(Min) mutated mice developed myopia (average -4.64 D) on P84 which was associated with increased vitreous chamber depth (VCD). Furthermore, retinal and scleral changes appear in these mice along with: 1) axial length shortening; 2) increased retinal cell proliferation; 3) and decreased tyrosine hydroxylase (TH) expression, the rate-limiting enzyme of DA synthesis. Scleral collagen fibril diameters became heterogeneous and irregularly organized in the APC(Min) mice. Western blot analysis showed that scleral alpha-1 type I collagen (col1a1) expression also decreased whereas MMP2 and MMP9 mRNA expression was invariant. These results indicate that defective APC gene function promotes refractive error development. By characterizing in APC(Min) mice ocular developmental changes, this approach provides novel insight into underlying pathophysiological mechanisms contributing to human myopia development.	[Liu, Zhen; Qiu, Fangfang; Li, Jing; Zhu, Zhenzhen; Yang, Wenzhao; Li, Wei; Chen, Wensheng; Liu, Zuguo] Xiamen Univ, Inst Eye, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Peoples R China; [Zhou, Xiangtian; An, Jianhong; Huang, Furong; Wang, Qiongsi; Reinach, Peter S.] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Zhou, Xiangtian; An, Jianhong; Huang, Furong; Wang, Qiongsi; Reinach, Peter S.] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Zhou, Xiangtian; An, Jianhong; Huang, Furong; Wang, Qiongsi; Reinach, Peter S.] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China	Xiamen University; Wenzhou Medical University; Wenzhou Medical University	Liu, ZG (corresponding author), Xiamen Univ, Coll Med, 4th Floor,Chengyi Bldg,Xiang An Campus, Xiamen, Fujian, Peoples R China.	zuguoliu@xmu.edu.cn	Qiu, Fangfang/GLT-3181-2022; zhou, xt/GWZ-9212-2022; Li, Wei/P-8985-2015; Reinach, Peter/AAI-3582-2021; Qiu, Fangfang/GLT-3151-2022	Qiu, Fangfang/0000-0002-3584-0275; Li, Wei/0000-0001-7458-2590; Qiu, Fangfang/0000-0002-3584-0275	National Basic Research Program of China (Project 973) [2011CB504606]	National Basic Research Program of China (Project 973)(National Basic Research Program of China)	The authors received support from National Basic Research Program of China (Project 973) Grant 2011CB504606. The funders had no role in study design, data collection and analysis, decision on publish, and preparation of the manuscript.	Arumugam B, 2012, INVEST OPHTH VIS SCI, V53, P5827, DOI 10.1167/iovs.12-9943; Chakravarti S, 2003, INVEST OPHTH VIS SCI, V44, P2422, DOI 10.1167/iovs.02-0783; Chen JC, 2006, VISION RES, V46, P1221, DOI 10.1016/j.visres.2005.06.030; Cheng CY, 2013, AM J HUM GENET, V93, P264, DOI 10.1016/j.ajhg.2013.06.016; Cheng SCK, 2010, OPHTHAL PHYSL OPT, V30, P776, DOI 10.1111/j.1475-1313.2010.00788.x; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Dong F, 2011, MOL VIS, V17, P2824; Feldkaemper M, 2013, EXP EYE RES, V114, P106, DOI 10.1016/j.exer.2013.02.007; Feldkaemper MP, 2002, VISUAL NEUROSCI, V19, P755, DOI 10.1017/S0952523802196064; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Fischer AJ, 2000, DEV BIOL, V220, P197, DOI 10.1006/dbio.2000.9640; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; GELLER SF, 1995, INVEST OPHTH VIS SCI, V36, P737; Gentle A, 2003, J BIOL CHEM, V278, P16587, DOI 10.1074/jbc.M300970200; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; Inoue T, 2006, STEM CELLS, V24, P95, DOI 10.1634/stemcells.2005-0124; IUVONE PM, 1989, VISUAL NEUROSCI, V2, P465, DOI 10.1017/S0952523800012360; Jonas JB, 2013, INVEST OPHTH VIS SCI, V54, P1295, DOI 10.1167/iovs.12-11352; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Lam DSC, 2007, INVEST OPHTH VIS SCI, V48, P376, DOI 10.1167/iovs.06-0426; Lim MCC, 2005, INVEST OPHTH VIS SCI, V46, P974, DOI 10.1167/iovs.04-0828; Liou GI, 2004, MOL VIS, V10, P383; Luchtenborg M, 2004, CARCINOGENESIS, V25, P1219, DOI 10.1093/carcin/bgh117; Ma MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091086; Mallen EAH, 2005, OPHTHAL PHYSL OPT, V25, P302, DOI 10.1111/j.1475-1313.2005.00306.x; Marcus DM, 1997, ARCH OPHTHALMOL-CHIC, V115, P645, DOI 10.1001/archopht.1997.01100150647013; McBrien NA, 1997, INVEST OPHTH VIS SCI, V38, P321; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; McBrien NA, 2001, VISUAL NEUROSCI, V18, P571, DOI 10.1017/S0952523801184075; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; McCarthy CS, 2007, EXP EYE RES, V84, P100, DOI 10.1016/j.exer.2006.09.018; Meng WH, 2011, OPHTHALMOLOGICA, V225, P127, DOI 10.1159/000317072; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; NEGISHI K, 1991, CELL MOL NEUROBIOL, V11, P639, DOI 10.1007/BF00741451; Onouchi T, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-21; Pardue MT, 2008, INVEST OPHTH VIS SCI, V49, P706, DOI 10.1167/iovs.07-0643; Pizzarello L, 2004, ARCH OPHTHALMOL-CHIC, V122, P615, DOI 10.1001/archopht.122.4.615; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Ruhswurm I, 1998, AM J OPHTHALMOL, V125, P680, DOI 10.1016/S0002-9394(98)00005-1; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Schaeffel F, 2004, OPTOMETRY VISION SCI, V81, P99, DOI 10.1097/00006324-200402000-00008; Schippert R, 2007, INVEST OPHTH VIS SCI, V48, P11, DOI 10.1167/iovs.06-0851; Seko Y, 1998, OPHTHALMIC RES, V30, P361, DOI 10.1159/000055496; Smith EL, 2002, INVEST OPHTH VIS SCI, V43, P291; Song AP, 2014, INT J OPHTHALMOL-CHI, V7, P122, DOI 10.3980/j.issn.2222-3959.2014.01.23; STONE RA, 1989, P NATL ACAD SCI USA, V86, P704, DOI 10.1073/pnas.86.2.704; TEAKLE EM, 1993, VISION RES, V33, P2383, DOI 10.1016/0042-6989(93)90117-F; Tkatchenko AV, 2006, P NATL ACAD SCI USA, V103, P4681, DOI 10.1073/pnas.0600589103; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wu SY, 1999, INVEST OPHTH VIS SCI, V40, P2179; Xie RZ, 2009, OPTOMETRY VISION SCI, V86, P503, DOI 10.1097/OPX.0b013e31819f9bc5; You SJ, 2006, INT J EXP PATHOL, V87, P227, DOI 10.1111/j.1365-2613.2006.00477.x; Zhang N, 2013, INVEST OPHTH VIS SCI, V54, P8275, DOI 10.1167/iovs.13-12544; Zhou XT, 2008, VISION RES, V48, P1137, DOI 10.1016/j.visres.2008.01.030; Zhou XT, 2010, INVEST OPHTH VIS SCI, V51, P4362, DOI 10.1167/iovs.09-3998; Zhou XT, 2008, INVEST OPHTH VIS SCI, V49, P5208, DOI 10.1167/iovs.07-1545	59	4	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141144	10.1371/journal.pone.0141144	http://dx.doi.org/10.1371/journal.pone.0141144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495845	Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200067
J	Weng, SF; Wang, LH; Rong, Y; Liu, YW; Wang, X; Guan, HY; Chen, WH				Weng, Shaofan; Wang, Lihua; Rong, Yi; Liu, Yuewei; Wang, Xin; Guan, Hongyu; Chen, Weihong			Effects of the Interactions between Dust Exposure and Genetic Polymorphisms in Nalp3, Caspase-1, and IL-1 beta on the Risk of Silicosis: A Case-Control Study	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PULMONARY INFLAMMATION; OCCUPATIONAL-EXPOSURE; FIBROSIS; INTERLEUKIN-1-BETA; SUSCEPTIBILITY; ASSOCIATION; ACTIVATION; ASBESTOS; MINERS	Objectives To evaluate the effects of the interactions between polymorphisms in Nalp3, caspase-1, and interleukin(IL)-1 beta genes and occupational dust exposure on the risk of silicosis. Methods We conducted a population-based case-control study in a large iron mine in China. Between January 2006 and December 2009, we identified 179 patients with silicosis to evaluate as cases and 201 individuals without silicosis to evaluate as controls. We estimated cumulative dust exposure (CDE) for all subjects and we genotyped polymorphisms in Nalp3, caspase-1, and IL-1 beta genes. We estimated odds ratios(ORs), 95% confidence intervals(95% CIs), and p-values using logistic regression models adjusted for selected confounders. Results After adjusting for age, smoking status, and CDE, subjects with the CT genotype of Ex4-849C>T in Nalp3 and the GA genotype of Ex2+37G>A in caspase-1 had increased risks of silicosis (adjusted ORs[95% CIs] = 2.40 [1.12-5.12] and 3.62 [1.63-8.02], respectively). Among subjects younger than 70 years old, those with the CC genotype of IVS8-7652A>C inNalp3 had a lower risk of silicosis than those with other genotypes (adjusted OR[95% CI] = 0.24 [0.06-0.88]). Among subjects aged 70 years and older, those with the CT genotype of Ex4-849C>T in Nalp3 and those with the GA genotype of Ex2+37G>A in caspase-1 had a higher risk of silicosis than those with other genotypes (adjusted ORs [95% CI] = 2.52[1.04-6.12] and 5.19[1.88-14.35], respectively). Among subjects with CDE greater than 120 mg/m(3)xyear and among smokers, those with the GA genotype of Ex2+37G> A in caspase-1 had a higher risk of silicosis than those with other genotypes ( adjusted ORs[95% CIs] = 26.37[3.35-207.39] and 3.47[1.40-8.64], respectively). Conclusions Genetic polymorphisms in Nalp3 and caspase-1 may be associated with individual susceptibility to silicosis, especially when the polymorphisms interact with age, CDE, or smoking status.	[Weng, Shaofan; Wang, Lihua; Rong, Yi; Liu, Yuewei; Wang, Xin; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Hubei, Peoples R China; [Weng, Shaofan] Shenzhen Prevent & Treatment Ctr Occupat Dis, Shenzhen, Guangdong, Peoples R China; [Wang, Lihua] Shenzhen Baoan Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China; [Guan, Hongyu] Wuhan Iron & Steel Corp, Daye Iron Mine Hosp, Huangshi, Hubei, Peoples R China	Huazhong University of Science & Technology; China Baowu Steel Group	Chen, WH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Hubei, Peoples R China.	wchen@mails.tjmu.edu.cn	Liu, Yuewei/J-5147-2019; Chen, Weihong/D-2177-2011	Liu, Yuewei/0000-0001-5970-4262; Chen, Weihong/0000-0001-8689-7311	National Natural Scientific Foundation of China [81372967, 30972451]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by grants from the National Natural Scientific Foundation of China (81372967, 30972451); funder: ational Natural Science Foundation of China http://www.nsfc.gov.cn/; author: WC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archana P M, 2012, J Indian Soc Periodontol, V16, P174, DOI [10.4103/0972-124x.99258, 10.4103/0972-124X.99258]; CALLIS AH, 1986, CHEST, V89, pS169, DOI 10.1378/chest.89.3_Supplement.169S; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chen W, 2001, OCCUP ENVIRON MED, V58, P31, DOI 10.1136/oem.58.1.31; Chen WG, 2012, J NANOMATER, V2012, DOI 10.1155/2012/612420; Cisneros-Lira J, 2003, AM J PHYSIOL-LUNG C, V285, pL949, DOI 10.1152/ajplung.00074.2003; Corbett EL, 2002, AM J RESP CRIT CARE, V165, P690, DOI 10.1164/ajrccm.165.5.2010050; Dehghan A, 2009, CIRC-CARDIOVASC GENE, V2, P125, DOI 10.1161/CIRCGENETICS.108.825224; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dungan LS, 2011, CYTOKINE, V56, P126, DOI 10.1016/j.cyto.2011.07.007; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Fang GF, 2011, BIOMED ENVIRON SCI, V24, P678, DOI 10.3967/0895-3988.2011.06.013; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; GRISHINA TI, 1990, VESTN AKAD MED NAUK+, P58; Guo J, 2014, ARCH TOXICOL; Guo JL, 2013, ARCH TOXICOL, V87, P1963, DOI 10.1007/s00204-013-1063-z; Helmig S, 2012, INT J MOL MED, V30, P401, DOI 10.3892/ijmm.2012.996; Hessel PA, 2003, SCAND J WORK ENV HEA, V29, P329, DOI 10.5271/sjweh.739; Hoffman HM, 2010, CURR ALLERGY ASTHM R, V10, P229, DOI 10.1007/s11882-010-0109-z; Ji XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047949; Jindal SK, 2013, CURR OPIN PULM MED, V19, P163, DOI 10.1097/MCP.0b013e32835bb19e; Kauppinen T, 2000, OCCUP ENVIRON MED, V57, P10, DOI 10.1136/oem.57.1.10; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Levy H, 2009, PEDIATR PULM, V44, P580, DOI 10.1002/ppul.21026; Luotola K, 2011, J INTERN MED, V269, P322, DOI 10.1111/j.1365-2796.2010.02294.x; Maciejewska A, 2008, INT J OCCUP MED ENV, V21, P1, DOI 10.2478/v10001-008-0010-3; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Ministry of Health of the People's Republic of China, 2009, CHIN ANN HLTH STAT R; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Pontillo A, 2012, JAIDS-J ACQ IMM DEF, V59, P121, DOI 10.1097/QAI.0b013e3182392ebe; Provoost S, 2011, J IMMUNOL, V187, P3331, DOI 10.4049/jimmunol.1004062; Santos C, 2010, REV PORT PNEUMOL, V16, P99; Srivastava KD, 2002, AM J RESP CRIT CARE, V165, P527, DOI 10.1164/ajrccm.165.4.2106009; Steenland K, 2014, CA-CANCER J CLIN, V64, P63, DOI 10.3322/caac.21214; VELAN GM, 1993, PATHOLOGY, V25, P282, DOI 10.3109/00313029309066590; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Wang YW, 2012, BIOMED ENVIRON SCI, V25, P517, DOI 10.3967/0895-3988.2012.05.004; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wu F, 2008, AM J IND MED, V51, P843, DOI 10.1002/ajim.20616; Xing JC, 2014, J OCCUP HEALTH, V56, P301, DOI 10.1539/joh.13-0149-OA; Yucesoy B, 2001, AM J IND MED, V39, P286, DOI 10.1002/1097-0274(200103)39:3<286::AID-AJIM1016>3.0.CO;2-7; Yucesoy B, 2001, TOXICOL APPL PHARM, V172, P75, DOI 10.1006/taap.2001.9124; ZHANG Y, 1993, J IMMUNOL, V150, P4188	45	14	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140952	10.1371/journal.pone.0140952	http://dx.doi.org/10.1371/journal.pone.0140952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496436	Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200045
J	Yang, LP; Cui, H; Yin, XB; Dou, HL; Zhao, L; Chen, NN; Zhang, JL; Zhang, HR; Li, GL; Ma, ZZ				Yang, Liping; Cui, Hui; Yin, Xiaobei; Dou, Hongliang; Zhao, Lin; Chen, Ningning; Zhang, Jinlu; Zhang, Huirong; Li, Genlin; Ma, Zhizhong			Dependable and Efficient Clinical Molecular Diagnosis of Chinese RP Patient with Targeted Exon Sequencing	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; RETINAL DYSTROPHIES; RHODOPSIN GENE; MUTATIONS; FAMILIES; IDENTIFICATION	Retinitis pigmentosa (RP) is the most common inherited retinal disease. It is a clinically and genetically heterogeneous disorder, which is why it is particularly challenging to diagnose. The aim of this study was to establish a targeted next-generation sequencing (NGS) approach for the comprehensive, rapid, and cost-effective clinical molecular diagnosis of RP. A specific hereditary eye disease enrichment panel (HEDEP) based on exome capture technology was used to collect the protein coding regions of 371 targeted hereditary eye disease genes, followed by high-throughput sequencing on the Illumina HiSeq2000 platform. From a cohort of 34 Chinese RP families, 13 families were successfully diagnosed; thus, the method achieves a diagnostic rate of approximately 40%. Of 16 pathogenic mutations identified, 11 were novel. Our study demonstrates that targeted capture sequencing offers a rapid and effective method for the molecular diagnosis of RP, which helps to provide a more accurate clinical diagnosis and paves the way for genetic counseling, family planning, and future gene-targeted treatment.	[Yang, Liping; Dou, Hongliang; Zhao, Lin; Chen, Ningning; Zhang, Jinlu; Zhang, Huirong; Ma, Zhizhong] Peking Univ, Key Lab Vis Loss & Restorat, Hosp 3, Dept Ophthalmol,Minist Educ, Beijing 100871, Peoples R China; [Cui, Hui; Yin, Xiaobei; Li, Genlin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China	Peking University; Capital Medical University	Li, GL (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	ligenglin@263.net; mazzpuh3@163.com			National Natural Science Foundation of China [81170877, 81470666]; clinical Key Project of Peking University Third Hospital [BYSY2014004]; Seeding Grant for Medicine and Life Sciences of Peking University [2014-MB-20]; Peking University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); clinical Key Project of Peking University Third Hospital; Seeding Grant for Medicine and Life Sciences of Peking University; Peking University(Peking University)	This study was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/ grant number: 81170877 & 81470666 LY); The clinical Key Project of Peking University Third Hospital (BYSY2014004 LY); The Seeding Grant for Medicine and Life Sciences of Peking University (2014-MB-20 LY); and a Peking University grant for translational research (ZM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco-Kelly F, 2012, MOL VIS, V18, P1478; Bujakowska KM, 2014, INVEST OPHTH VIS SCI, V55, P8488, DOI 10.1167/iovs.14-15169; CHEN X, 2014, PLOS ONE, V0009; Clark GR, 2010, OPHTHALMOLOGY, V117, P2169, DOI 10.1016/j.ophtha.2010.02.029; Dai HJ, 2008, MOL VIS, V14, P2067; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; Frio TR, 2008, J CLIN INVEST, V118, P1519, DOI 10.1172/JCI34211; Fu Q, 2013, INVEST OPHTH VIS SCI, V54, P4158, DOI 10.1167/iovs.13-11672; Gonzalez-del Pozo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027894; Guo HK, 2010, J HUM GENET, V55, P571, DOI 10.1038/jhg.2010.68; Haim Marianne, 2002, Acta Ophthalmol Scand Suppl, P1; Katagiri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108721; KEEN TJ, 1991, GENOMICS, V11, P199, DOI 10.1016/0888-7543(91)90119-Y; Kim C, 2012, MOL VIS, V18, P2398; Kohl S, 1997, J MED GENET, V34, P620, DOI 10.1136/jmg.34.8.620; MACKE JP, 1993, AM J HUM GENET, V53, P80; Mokarzel-Falcon LL, 2008, PROTEINS, V70, P1133, DOI 10.1002/prot.21873; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Nishimura DY, 2010, AM J HUM GENET, V86, P686, DOI 10.1016/j.ajhg.2010.03.005; Shanks ME, 2013, EUR J HUM GENET, V21, P274, DOI 10.1038/ejhg.2012.172; Wang J, 2014, INVEST OPHTH VIS SCI, V55, P6213, DOI 10.1167/iovs.14-14936; Wang X, 2013, J MED GENET, V50, P674, DOI 10.1136/jmedgenet-2013-101558; Xu L, 2006, EUR J OPHTHALMOL, V16, P865; Xu Y, 2014, HUM GENET, V133, P1255, DOI 10.1007/s00439-014-1460-2; Yang L.X., 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1186/S13568-014-0054-7; Yang LP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004030	28	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140684	10.1371/journal.pone.0140684	http://dx.doi.org/10.1371/journal.pone.0140684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496393	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200027
J	Yuan, JW; Sun, CJ; Dou, TC; Yi, GQ; Qu, LJ; Qu, L; Wang, KH; Yang, N				Yuan, Jingwei; Sun, Congjiao; Dou, Taocun; Yi, Guoqiang; Qu, LuJiang; Qu, Liang; Wang, Kehua; Yang, Ning			Identification of Promising Mutants Associated with Egg Production Traits Revealed by Genome-Wide Association Study	PLOS ONE			English	Article							GENETIC-PARAMETERS; QUALITY TRAITS; BODY-WEIGHT; LOCI; HERITABILITY; CALCIUM; MODEL	Egg number (EN), egg laying rate (LR) and age at first egg (AFE) are important production traits related to egg production in poultry industry. To better understand the knowledge of genetic architecture of dynamic EN during the whole laying cycle and provide the precise positions of associated variants for EN, LR and AFE, laying records from 21 to 72 weeks of age were collected individually for 1,534 F-2 hens produced by reciprocal crosses between White Leghorn and Dongxiang Blue-shelled chicken, and their genotypes were assayed by chicken 600 K Affymetrix high density genotyping arrays. Subsequently, pedigree and SNP-based genetic parameters were estimated and a genome-wide association study (GWAS) was conducted on EN, LR and AFE. The heritability estimates were similar between pedigree and SNP-based estimates varying from 0.17 to 0.36. In the GWA analysis, we identified nine genome-wide significant loci associated with EN of the laying periods from 21 to 26 weeks, 27 to 36 weeks and 37 to 72 weeks. Analysis of GTF2A1 and CLSPN suggested that they influenced the function of ovary and uterus, and may be considered as relevant candidates. The identified SNP rs314448799 for accumulative EN from 21 to 40 weeks on chromosome 5 created phenotypic differences of 6.86 eggs between two homozygous genotypes, which could be potentially applied to the molecular breeding for EN selection. Moreover, our finding showed that LR was a moderate polygenic trait. The suggestive significant region on chromosome 16 for AFE suggested the relationship between sex maturity and immune in the current population. The present study comprehensively evaluates the role of genetic variants in the development of egg laying. The findings will be helpful to investigation of causative genes function and future marker-assisted selection and genomic selection in chickens.	[Yuan, Jingwei; Sun, Congjiao; Yi, Guoqiang; Qu, LuJiang; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China; [Yuan, Jingwei; Sun, Congjiao; Yi, Guoqiang; Qu, LuJiang; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, MOA Key Lab Anim Genet & Breeding, Beijing 100193, Peoples R China; [Dou, Taocun; Qu, Liang; Wang, Kehua] Jiangsu Inst Poultry Sci, Yangzhou 225125, Jiangsu, Peoples R China	China Agricultural University; China Agricultural University	Yang, N (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China.	nyang@cau.edu.cn		Yang, Ning/0000-0001-5772-3320	National High Technology Development Plan of China [2013AA102501]; National Scientific Supporting Projects of China [2011BAD28B03]; China Agriculture Research Systems [CARS-41]; Program for Changjiang Scholars and Innovative Research in University [IRT1191]	National High Technology Development Plan of China; National Scientific Supporting Projects of China; China Agriculture Research Systems; Program for Changjiang Scholars and Innovative Research in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The work was supported in parts by the National High Technology Development Plan of China (2013AA102501), National Scientific Supporting Projects of China (2011BAD28B03), China Agriculture Research Systems (CARS-41), and Program for Changjiang Scholars and Innovative Research in University (IRT1191).	Abasht B, 2007, ANIM GENET, V38, P491, DOI 10.1111/j.1365-2052.2007.01642.x; Abasht B, 2006, POULTRY SCI, V85, P2079, DOI 10.1093/ps/85.12.2079; Abasht B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S2-S2; Anang A, 2000, J ANIM BREED GENET, V117, P407, DOI 10.1046/j.1439-0388.2000.00258.x; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benevolo M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-132; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; ENGSTROM G, 1992, GENET SEL EVOL, V24, P265, DOI 10.1051/gse:19920305; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2011, GENET EPIDEMIOL, V35, P154, DOI 10.1002/gepi.20563; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Guan F, 2001, LIVESTOCK POULTRY IN, V7, P22; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YW, 2009, ONCOL REP, V22, P853, DOI 10.3892/or_00000509; Johnson PA, 2015, POULTRY SCI, V94, P816, DOI 10.3382/ps/peu083; Kang B, 2009, POULTRY SCI, V88, P1975, DOI 10.3382/ps.2008-00519; Klimentidis Yann C., 2013, Frontiers in Genetics, V4, P174, DOI 10.3389/fgene.2013.00174; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Kupittayanant S, 2009, ANIM REPROD SCI, V115, P215, DOI 10.1016/j.anireprosci.2008.10.020; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; LEVORSE JM, 1991, J REPROD FERTIL, V92, P159, DOI 10.1530/jrf.0.0920159; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Madsen P, 2008, USERS GUIDE DMU PACK; Niknafs S, 2012, TROP ANIM HEALTH PRO, V44, P1437, DOI 10.1007/s11250-012-0084-6; Onagbesan O, 2009, ANIM REPROD SCI, V111, P121, DOI 10.1016/j.anireprosci.2008.09.017; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rebhan M., 1997, GENECARDS ENCY GENES; Sasaki O, 2004, ANIM GENET, V35, P188, DOI 10.1111/j.1365-2052.2004.01133.x; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Sun YF, 2014, G3-GENES GENOM GENET, V4, P1167, DOI 10.1534/g3.114.011338; Sun YF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-458; Team RC, 2012, R LANG ENV STAT COMP; Tiezzi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114919; Tuiskula-Haavisto M, 2002, POULTRY SCI, V81, P919, DOI 10.1093/ps/81.7.919; Veerkamp RF, 2011, J DAIRY SCI, V94, P4189, DOI 10.3168/jds.2011-4223; Venturini GC, 2013, POULTRY SCI, V92, P2283, DOI 10.3382/ps.2013-03123; Walker BA, 2011, P NATL ACAD SCI USA, V108, P8396, DOI 10.1073/pnas.1019496108; Wolc A, 2014, J ANIM BREED GENET, V131, P173, DOI 10.1111/jbg.12086; Wolc A, 2013, POULTRY SCI, V92, P1486, DOI 10.3382/ps.2012-02882; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yuan JW, 2015, POULTRY SCI, V94, P1470, DOI 10.3382/ps/pev122; Zhang H, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-26; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	55	27	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140615	10.1371/journal.pone.0140615	http://dx.doi.org/10.1371/journal.pone.0140615			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496084	Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200024
J	De Santis, C; Taylor, JF; Martinez-Rubio, L; Boltana, S; Tocher, DR				De Santis, Christian; Taylor, John F.; Martinez-Rubio, Laura; Boltana, Sebastian; Tocher, Douglas R.			Influence of Development and Dietary Phospholipid Content and Composition on Intestinal Transcriptome of Atlantic Salmon (Salmo salar)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; CARPIO L. LARVAE; CYPRINUS-CARPIO; COMMON CARP; GROWTH-PERFORMANCE; SPARUS-AURATA; FISH; LECITHIN; SURVIVAL; ACID	The inclusion of intact phospholipids in the diet is essential during larval development and can improve culture performance of many fish species. The effects of supplementation of dietary phospholipid from marine (krill) or plant (soy lecithin) sources were investigated in Atlantic salmon, Salmo salar. First feeding fry were fed diets containing either krill oil or soybean lecithin supplying phospholipid at 2.6%, 3.2%, 3.6% and 4.2% of diet. Fish were sampled at similar to 2.5 g (similar to 1,990 degrees day post fertilization, dpf) and similar to 10 g (2,850 degrees dpf). By comparison of the intestinal transcriptome in specifically chosen contrasts, it was determined that by 2,850 degrees dpf fish possessed a profile that resembled that of mature and differentiated intestinal cell types with a number of changes specific to glycerophospholipid metabolism. It was previously shown that intact phospholipids and particularly phosphatidylcholine are essential during larval development and that this requirement is associated with the inability of enterocytes in young fry to endogenously synthesize sufficient phospholipid for the efficient export of dietary lipid. In the immature phase (similar to 1,990 degrees dpf), the dietary phospholipid content as well as its class composition impacted on several biochemical and morphological parameters including growth, but these differences were not associated with differences in intestinal transcriptomes. The results of this study have made an important contribution to our understanding of the mechanisms associated with lipid transport and phospholipid biosynthesis in early life stages of fish.	[De Santis, Christian; Taylor, John F.; Martinez-Rubio, Laura; Boltana, Sebastian; Tocher, Douglas R.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland	University of Stirling	De Santis, C (corresponding author), Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland.	Christian.desantis@stir.ac.uk	Boltana, Sebastian/AAC-8944-2019; Tocher, Douglas R/C-5652-2011	Boltana, Sebastian/0000-0002-5195-0490; Tocher, Douglas R/0000-0002-8603-9410; Taylor, John/0000-0003-4370-7922	European Commission, Advanced Research Initiatives for Nutrition & Aquaculture (ARRAINA) [288925]	European Commission, Advanced Research Initiatives for Nutrition & Aquaculture (ARRAINA)	The work was supported by European Commission FP7 Integrated Project No. 288925, Advanced Research Initiatives for Nutrition & Aquaculture (ARRAINA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asp L, 2005, ARTERIOSCL THROM VAS, V25, P566, DOI 10.1161/01.ATV.0000154135.21689.47; Azarm HM, 2013, AQUAC RES, V44, P634, DOI 10.1111/j.1365-2109.2011.03068.x; Bicskei B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-884; Cahu C, 2003, AQUACULTURE, V227, P245, DOI 10.1016/S0044-8486(03)00507-6; Cahu CL, 2003, BRIT J NUTR, V90, P21, DOI 10.1079/BJN2003880; Carmona-Antonanzas G, 2015, BBA-MOL CELL BIOL L, V1851, P1428, DOI 10.1016/j.bbalip.2015.08.006; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Coutteau P, 1997, AQUACULTURE, V155, P149, DOI 10.1016/S0044-8486(97)00125-7; Dapra F, 2011, AQUACULTURE, V319, P377, DOI 10.1016/j.aquaculture.2011.07.016; Fontagne S, 1998, AQUACULTURE, V161, P213, DOI 10.1016/S0044-8486(97)00271-8; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GEURDEN I, 1995, AQUACULTURE, V131, P303, DOI 10.1016/0044-8486(94)00344-N; Geurden I, 1999, AQUACULTURE, V171, P93, DOI 10.1016/S0044-8486(98)00423-2; Geurden I, 1998, AQUACULTURE, V161, P225, DOI 10.1016/S0044-8486(97)00272-X; Geurden I, 1998, FISH PHYSIOL BIOCHEM, V19, P217, DOI 10.1023/A:1007723515204; Grosell M, 2011, FISH PHYSIOL, V30, P1; Hernandez MPG, 2001, ANAT EMBRYOL, V204, P39, DOI 10.1007/s004290100173; Kalogeris TJ, 1997, J NUTR, V127, pS537, DOI 10.1093/jn/127.3.537S; Kenari AA, 2011, AQUAC RES, V42, P655, DOI 10.1111/j.1365-2109.2010.02587.x; Liu J, 2002, FISHERIES SCI, V68, P1165, DOI 10.1046/j.1444-2906.2002.00551.x; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Martinez-Rubio L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040266; Morais S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-410; Morais S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-448; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Olsen RE, 1999, FISH PHYSIOL BIOCHEM, V21, P35, DOI 10.1023/A:1007726615889; Palacios LE, 2005, J AM OIL CHEM SOC, V82, P571, DOI 10.1007/s11746-005-1111-4; POSTON HA, 1990, PROG FISH CULT, V52, P226, DOI 10.1577/1548-8640(1990)052&lt;0226:EOBSOG&gt;2.3.CO;2; R Core Team, 2013, LANG ENV STAT COMP; Rinchard J, 2007, AQUACULTURE, V264, P363, DOI 10.1016/j.aquaculture.2006.11.024; Sahlmann C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124179; Salhi M, 1999, AQUACULTURE, V179, P253, DOI 10.1016/S0044-8486(99)00194-5; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tacchi L, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-363; Tacchi L, 2011, PHYSIOL GENOMICS, V43, P1241, DOI 10.1152/physiolgenomics.00086.2011; Taylor JF, 2015, AQUACULTURE, V448, P262, DOI 10.1016/j.aquaculture.2015.06.012; Tocher DR, 2008, AQUACULTURE, V280, P21, DOI 10.1016/j.aquaculture.2008.04.034; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	43	23	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140964	10.1371/journal.pone.0140964	http://dx.doi.org/10.1371/journal.pone.0140964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488165	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400086
J	Mamalis, A; Koo, E; Isseroff, RR; Murphy, W; Jagdeo, J				Mamalis, Andrew; Koo, Eugene; Isseroff, R. Rivkah; Murphy, William; Jagdeo, Jared			Resveratrol Prevents High Fluence Red Light-Emitting Diode Reactive Oxygen Species-Mediated Photoinhibition of Human Skin Fibroblast Migration	PLOS ONE			English	Article							IN-VITRO; ANTIOXIDANT FUNCTION; KELOID FIBROBLASTS; PROLIFERATION; INHIBITION; EXPRESSION; BETA	Background Skin fibrosis is a significant medical problem that leads to a functional, aesthetic, and psychosocial impact on quality-of-life. Light-emitting diode-generated 633-nm red light (LED-RL) is part of the visible light spectrum that is not known to cause DNA damage and is considered a safe, non-invasive, inexpensive, and portable potential alternative to ultraviolet phototherapy that may change the treatment paradigm of fibrotic skin disease. Objective The goal of our study was to investigate the how reactive oxygen species (ROS) free radicals generated by high fluence LED-RL inhibit the migration of skin fibroblasts, the main cell type involved in skin fibrosis. Fibroblast migration speed is increased in skin fibrosis, and we studied cellular migration speed of cultured human skin fibroblasts as a surrogate measure of high fluence LED-RL effect on fibroblast function. To ascertain the inhibitory role of LED-RL generated ROS on migration speed, we hypothesized that resveratrol, a potent antioxidant, could prevent the photoinhibitory effects of high fluence LED-RL on fibroblast migration speed. Methods High fluence LED-RL generated ROS were measured by flow cytometry analysis using dihydrorhodamine (DHR). For purposes of comparison, we assessed the effects of ROS generated by hydrogen peroxide (H2O2) on fibroblast migration speed and the ability of resveratrol, a well known antioxidant, to prevent LED-RL and H2O2 generated ROS-associated changes in fibroblast migration speed. To determine whether resveratrol could prevent the high fluence LED-RL ROS-mediated photoinhibition of human skin fibroblast migration, treated cells were incubated with resveratrol at concentrations of 0.0001% and 0.001% for 24 hours, irradiated with high fluences LED-RL of 480, 640, and 800 J/cm(2). Results High fluence LED-RL increases intracellular fibroblast ROS and decreases fibroblast migration speed. LED-RL at 480, 640 and 800 J/cm(2) increased ROS levels to 132.8%, 151.0%, and 158.4% relative to matched controls, respectively. These LED-RL associated increases in ROS were prevented by pretreating cells with 0.0001% or 0.001% resveratrol. Next, we quantified the effect of hydrogen peroxide (H2O2)-associated ROS on fibroblast migration speed, and found that while H2O2-associated ROS significantly decreased relative fibroblast migration speed, pretreatment with 0.0001% or 0.001% resveratrol significantly prevented the decreases in migration speed. Furthermore, we found that LED-RL at 480, 640 and 800 J/cm(2) decreased fibroblast migration speed to 83.0%, 74.4%, and 68.6% relative to matched controls, respectively. We hypothesized that these decreases in fibroblast migration speed were due to associated increases in ROS generation. Pretreatment with 0.0001% and 0.001% resveratrol prevented the LED-RL associated decreases in migration speed. Conclusion High fluence LED-RL increases ROS and is associated with decreased fibroblast migration speed. We provide mechanistic support that the decreased migration speed associated with high fluence LED-RL is mediated by ROS, by demonstrating that resveratrol prevents high fluence LED-RL associated migration speed change. These data lend support to an increasing scientific body of evidence that high fluence LED-RL has anti-fibrotic properties. We hypothesize that our findings may result in a greater understanding of the fundamental mechanisms underlying visible light interaction with skin and we anticipate clinicians and other researchers may utilize these pathways for patient benefit.	[Mamalis, Andrew; Koo, Eugene; Isseroff, R. Rivkah; Murphy, William; Jagdeo, Jared] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA; [Mamalis, Andrew; Koo, Eugene; Isseroff, R. Rivkah; Jagdeo, Jared] Sacramento VA Med Ctr, Dermatol Serv, Mather, CA USA; [Murphy, William] Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA; [Jagdeo, Jared] Suny Downstate Med Ctr, Dept Dermatol, Brooklyn, NY 11203 USA	University of California System; University of California Davis; University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Jagdeo, J (corresponding author), Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA.	jrjagdeo@gmail.com	Isseroff, Roslyn Rivkah/AAD-8478-2021	Isseroff, Roslyn Rivkah/0000-0001-7813-0858; Mamalis, Andrew/0000-0002-9578-0884	National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000002, TL1 TR000133, KL2 TR000134]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000134, UL1TR000002, TL1TR000133] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded using Institutional Startup Funds from Dr. Jared Jagdeo and by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR000002 and linked awards TL1 TR000133 and KL2 TR000134.	Ashcroft KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075600; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Bhat KPL, 2001, ANTIOXID REDOX SIGN, V3, P1041, DOI 10.1089/152308601317203567; Bock O, 2006, ARCH DERMATOL RES, V297, P433, DOI 10.1007/s00403-006-0651-7; Chen J, 2002, J INVEST DERMATOL, V119, P1261, DOI 10.1046/j.1523-1747.2002.19611.x; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; He W, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/684242; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Ikeda K, 2013, WOUND REPAIR REGEN, V21, P616, DOI 10.1111/wrr.12062; Jagdeo J, 2011, J DRUGS DERMATOL, V10, P753; Jagdeo J, 2010, J DRUGS DERMATOL, V9, P1523; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Kim KH, 2011, J INVEST DERMATOL, V131, P195, DOI 10.1038/jid.2010.250; Lev-Tov H, 2013, DERMATOL SURG, V39, P1167, DOI 10.1111/dsu.12212; Lev-Tov H, 2013, DERMATOL SURG, V39, P422, DOI 10.1111/dsu.12087; Mamalis AD, 2014, J EUR ACAD DERMATOL, V28, P689, DOI 10.1111/jdv.12253; Mamalis A, 2015, LASER SURG MED, V47, P210, DOI 10.1002/lsm.22293; Mamalis A, 2015, DERMATOL SURG, V41, P35, DOI 10.1097/01.DSS.0000452650.06765.51; Mamalis A, 2013, J DRUGS DERMATOL, V12, P780; Marrot L, 2008, J AM ACAD DERMATOL, V58, pS139, DOI 10.1016/j.jaad.2007.12.007; Suenaga F, 2008, FEBS LETT, V582, P586, DOI 10.1016/j.febslet.2008.01.024; Uitto Jouni, 2008, J Drugs Dermatol, V7, ps12; Wu CS, 2012, BRIT J DERMATOL, V167, P532, DOI 10.1111/j.1365-2133.2012.11023.x	24	8	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140628	10.1371/journal.pone.0140628	http://dx.doi.org/10.1371/journal.pone.0140628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488596	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400063
J	Mehari, A; Afreen, S; Ngwa, J; Setse, R; Thomas, AN; Poddar, V; Davis, W; Polk, OD; Hassan, S; Thomas, AV				Mehari, Alem; Afreen, Samina; Ngwa, Julius; Setse, Rosanna; Thomas, Alicia N.; Poddar, Vishal; Davis, Wayne; Polk, Octavius D.; Hassan, Sheik; Thomas, Alvin V.			Obesity and Pulmonary Function in African Americans	PLOS ONE			English	Article							BODY-MASS INDEX; EXPIRATORY FLOW LIMITATION; X-RAY ABSORPTIOMETRY; LUNG-VOLUMES; GAS-EXCHANGE; RESPIRATORY-FUNCTION; FAT DISTRIBUTION; MORBIDLY OBESE; CLOSING VOLUME; WEIGHT-LOSS	Background Obesity prevalence in United States (US) adults exceeds 30% with highest prevalence being among blacks. Obesity is known to have significant effects on respiratory function and obese patients commonly report respiratory complaints requiring pulmonary function tests (PFTs). However, there is no large study showing the relationship between body mass index (BMI) and PFTs in healthy African Americans (AA). Objective To determine the effect of BMI on PFTs in AA patients who did not have evidence of underlying diseases of the respiratory system. Methods We reviewed PFTs of 339 individuals sent for lung function testing who had normal spirometry and lung diffusion capacity for carbon monoxide (DLCO) with wide range of BMI. Results Functional residual capacity (FRC) and expiratory reserve volume (ERV) decreased exponentially with increasing BMI, such that morbid obesity resulted in patients breathing near their residual volume (RV). However, the effects on the extremes of lung volumes, at total lung capacity (TLC) and residual volume (RV) were modest. There was a significant linear inverse relationship between BMI and DLCO, but the group means values remained within the normal ranges even for morbidly obese patients. Conclusions We showed that BMI has significant effects on lung function in AA adults and the greatest effects were on FRC and ERV, which occurred at BMI values <30 kg/m(2). These physiological effects of weight gain should be considered when interpreting PFTs and their effects on respiratory symptoms even in the absence of disease and may also exaggerate existing lung diseases.	[Mehari, Alem; Thomas, Alicia N.; Poddar, Vishal; Davis, Wayne; Polk, Octavius D.; Hassan, Sheik; Thomas, Alvin V.] Howard Univ, Div Pulm Dis, Washington, DC 20059 USA; [Afreen, Samina; Ngwa, Julius; Setse, Rosanna] Howard Univ, Dept Internal Med, Washington, DC 20059 USA	Howard University; Howard University	Mehari, A (corresponding author), Howard Univ, Div Pulm Dis, Washington, DC 20059 USA.	alem.mehari@howard.edu		Afreen, Samina/0000-0002-5267-0810				Abell JE, 2008, AM J PUBLIC HEALTH, V98, P63, DOI 10.2105/AJPH.2006.093781; Abell JE, 2007, PUBLIC HEALTH REP, V122, P507, DOI 10.1177/003335490712200412; Aloia JF, 1999, OSTEOPOROSIS INT, V10, P114, DOI 10.1007/s001980050204; Aloia JF, 1996, J CLIN ENDOCR METAB, V81, P2363, DOI 10.1210/jc.81.6.2363; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; Beuther DA, 2006, AM J RESP CRIT CARE, V174, P112, DOI 10.1164/rccm.200602-231PP; Biring MS, 1999, AM J MED SCI, V318, P293, DOI 10.1097/00000441-199911000-00002; COLLINS LC, 1995, CHEST, V107, P1298, DOI 10.1378/chest.107.5.1298; CRAPO RO, 1982, B EUR PHYSIOPATH RES, V18, P419; DEMEDTS M, 1980, CLIN RES PROC, V16, P271; Evans EM, 2006, INT J OBESITY, V30, P837, DOI 10.1038/sj.ijo.0803208; Faintuch Joel, 2004, Rev. Hosp. Clin., V59, P181, DOI 10.1590/S0041-87812004000400005; FAREBROTHER MJ, 1974, BMJ-BRIT MED J, V3, P391, DOI 10.1136/bmj.3.5927.391; Ferretti A, 2001, CHEST, V119, P1401, DOI 10.1378/chest.119.5.1401; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Guenette JA, 2010, CURR OPIN CLIN NUTR, V13, P618, DOI 10.1097/MCO.0b013e32833e3453; HAKALA K, 1995, INT J OBESITY, V19, P343; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HEDENSTIERNA G, 1976, ACTA ANAESTH SCAND, V20, P334, DOI 10.1111/j.1399-6576.1976.tb05047.x; HOLLEY HS, 1967, J CLIN INVEST, V46, P475, DOI 10.1172/JCI105549; HUREWITZ AN, 1985, J APPL PHYSIOL, V59, P774, DOI 10.1152/jappl.1985.59.3.774; Jones RL, 2006, CHEST, V130, P827, DOI 10.1378/chest.130.3.827; Lazarus R, 1997, CHEST, V111, P891, DOI 10.1378/chest.111.4.891; Littleton SW, 2012, RESPIROLOGY, V17, P43, DOI 10.1111/j.1440-1843.2011.02096.x; Mahadev S, 2013, PULM PHARMACOL THER, V26, P438, DOI 10.1016/j.pupt.2012.05.004; Milic-Emili J, 2007, EUR J APPL PHYSIOL, V99, P567, DOI 10.1007/s00421-006-0389-0; Ogden C.L, 2013, PREVALENCE OBESITY A; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Pankow W, 1998, J APPL PHYSIOL, V85, P1236, DOI 10.1152/jappl.1998.85.4.1236; Parameswaran Krishnan, 2006, Can Respir J, V13, P203; Pelosi P, 1998, ANESTH ANALG, V87, P654, DOI 10.1097/00000539-199809000-00031; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; RAY CS, 1983, AM REV RESPIR DIS, V128, P501, DOI 10.1164/arrd.1983.128.3.501; RUBINSTEIN I, 1990, ANN INTERN MED, V112, P828, DOI 10.7326/0003-4819-112-11-828; Sahebjami H, 1996, CHEST, V110, P1425, DOI 10.1378/chest.110.6.1425; SAMPSON MG, 1983, J APPL PHYSIOL, V55, P1269, DOI 10.1152/jappl.1983.55.4.1269; Schachter LM, 2001, THORAX, V56, P4, DOI 10.1136/thorax.56.1.4; Sebastian JC, 2013, BEST PRACT RES CL EN, V27, P157, DOI 10.1016/j.beem.2013.04.014; SHARP JT, 1964, J CLIN INVEST, V43, P728, DOI 10.1172/JCI104957; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; Sutherland TJT, 2008, EUR RESPIR J, V32, P85, DOI 10.1183/09031936.00112407; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Watson RA, 2010, J APPL PHYSIOL, V108, P1605, DOI 10.1152/japplphysiol.01267.2009; Watson RA, 2005, J APPL PHYSIOL, V98, P512, DOI 10.1152/japplphysiol.00430.2004; Watson RA, 1985, J APPL PHYSIOL, V2005, P512; YAP JCH, 1995, J APPL PHYSIOL, V79, P1199, DOI 10.1152/jappl.1995.79.4.1199; Zavorsky GS, 2008, OBES REV, V9, P326, DOI 10.1111/j.1467-789X.2008.00471.x	51	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140610	10.1371/journal.pone.0140610	http://dx.doi.org/10.1371/journal.pone.0140610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488406	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400061
J	Enanoria, WTA; Worden, L; Liu, FC; Gao, DZ; Ackley, S; Scott, J; Deiner, M; Mwebaze, E; Ip, W; Lietman, TM; Porco, TC				Enanoria, Wayne T. A.; Worden, Lee; Liu, Fengchen; Gao, Daozhou; Ackley, Sarah; Scott, James; Deiner, Michael; Mwebaze, Ernest; Ip, Wui; Lietman, Thomas M.; Porco, Travis C.			Evaluating Subcriticality during the Ebola Epidemic in West Africa	PLOS ONE			English	Article							TRANSMISSION; INFERENCE; LIBERIA	The 2014-2015 Ebola outbreak is the largest and most widespread to date. In order to estimate ongoing transmission in the affected countries, we estimated the weekly average number of secondary cases caused by one individual infected with Ebola throughout the infectious period for each affected West African country using a stochastic hidden Markov model fitted to case data from the World Health Organization. If the average number of infections caused by one Ebola infection is less than 1.0, the epidemic is subcritical and cannot sustain itself. The epidemics in Liberia and Sierra Leone have approached subcriticality at some point during the epidemic; the epidemic in Guinea is ongoing with no evidence that it is subcritical. Response efforts to control the epidemic should continue in order to eliminate Ebola cases in West Africa.	[Enanoria, Wayne T. A.; Lietman, Thomas M.; Porco, Travis C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Worden, Lee; Liu, Fengchen; Gao, Daozhou; Ackley, Sarah; Scott, James; Ip, Wui; Lietman, Thomas M.; Porco, Travis C.] Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA; [Scott, James] Colby Coll, Math & Stat, Waterville, ME 04901 USA; [Deiner, Michael; Lietman, Thomas M.; Porco, Travis C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Mwebaze, Ernest] Makerere Univ, Kampala, Uganda	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Colby College; University of California System; University of California San Francisco; Makerere University	Porco, TC (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	travis.porco@ucsf.edu	Gao, Daozhou/J-3157-2014	Gao, Daozhou/0000-0003-3991-569X; Worden, Lee/0000-0001-9799-0183	Models of Infectious Disease Agent Study (MIDAS) grant from the National Institute of General Medical Sciences at the National Institutes of Health to the University of California, San Francisco [U01GM087728]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087728, R25GM102149] Funding Source: NIH RePORTER	Models of Infectious Disease Agent Study (MIDAS) grant from the National Institute of General Medical Sciences at the National Institutes of Health to the University of California, San Francisco; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by a Models of Infectious Disease Agent Study (MIDAS) grant from the National Institute of General Medical Sciences at the National Institutes of Health to the University of California, San Francisco (Award Number U01GM087728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; [Anonymous], 2014, LANCET, V384, P637, DOI 10.1016/S0140-6736(14)61377-5; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bailey, 1990, ELEMENTS STOCHASTIC; Blumberg S, 2014, AM J EPIDEMIOL, V179, P1375, DOI 10.1093/aje/kwu068; Camacho Anton, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.406ae55e83ec0b5193e30856b9235ed2; Chowell G, 2015, PLOS CURR OUTBREAKS, DOI [10.1371/currents.outbreaks. 8b55f4bad99ac5c5db3663e916803261, DOI 10.1371/CURRENTS.OUTBREAKS.8B55F4BAD99AC5C5DB3663E916803261]; Chowell G, 2014, PLOS CURR, P6, DOI [10.1371/currents.outbreaks.b4690859d91684da963dc40e00f3da81, DOI 10.1371/CURRENTS.OUTBREAKS.B4690859D91684DA963DC40E00F3DA81]; Chowell G, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0196-0; Chretien JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094130, 10.1371/currents.outbreaks.3408774290b1a0f2dd7cae877c8b8ff6]; Drake JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002056; Enserink M, 2015, SCIENCE, V347, P219, DOI 10.1126/science.347.6219.219; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Halloran ME, 2001, EPIDEMIOLOGICAL METH; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Kitagawa G, 1998, J AM STAT ASSOC, V93, P1203, DOI 10.2307/2669862; Majumder Maimuna S, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c; Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6; Nyenswah T, 2014, MMWR-MORBID MORTAL W, V63, P1082; Nyenswah TG, 2014, MMWR-MORBID MORTAL W, V63, P1072; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Scarpino SV, 2015, CLIN INFECT DIS, V60, P1079, DOI 10.1093/cid/ciu1131; Sharma A, 2014, MMWR-MORBID MORTAL W, V63, P1; Towers Sherry, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.9e4c4294ec8ce1adad283172b16bc908; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Weitz JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08751; World Health Organization, EB RESP ROADM; World Health Organization, 2014, CAS DEF REC EB MARB; World Health Organization Global Health Observatory, 2014, EB DAT STAT; Yamin D, 2015, ANN INTERN MED, V162, P11, DOI 10.7326/M14-2255; Yang W, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003583	33	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140651	10.1371/journal.pone.0140651	http://dx.doi.org/10.1371/journal.pone.0140651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484544	Green Published, gold			2022-12-27	WOS:000363028100058
J	Klangthong, K; Promsthaporn, S; Leepitakrat, S; Schuster, AL; McCardle, PW; Kosoy, M; Takhampunya, R				Klangthong, Kewalin; Promsthaporn, Sommai; Leepitakrat, Surachai; Schuster, Anthony L.; McCardle, Patrick W.; Kosoy, Michael; Takhampunya, Ratree			The Distribution and Diversity of Bartonella Species in Rodents and Their Ectoparasites across Thailand	PLOS ONE			English	Article							MOLECULAR-DETECTION; MAMMALIAN HOSTS; SPP.; PREVALENCE; INFECTIONS; DNA; DIFFERENTIATION; IDENTIFICATION; PATHOGENICITY; PERSISTENCE	Our study highlights the surveillance of Bartonella species among rodents and their associated ectoparasites (ticks, fleas, lice, and mites) in several regions across Thailand. A total of 619 rodents and 554 pooled ectoparasites (287 mite pools, 62 flea pools, 35 louse pools, and 170 tick pools) were collected from 8 provinces within 4 regions of Thailand. Bandicota indica (279), Rattus rattus (163), and R. exulans (96) were the most prevalent species of rats collected in this study. Real-time PCR assay targeting Bartonella-specific ssrA gene was used for screening and each positive sample was confirmed by PCR using nuoG gene. The prevalence of Bartonella DNA in rodent (around 17%) was recorded in all regions. The highest prevalence of Bartonella species was found in B. savilei and R. rattus with the rate of 35.7% (5/14) and 32.5%(53/163), respectively. High prevalence of Bartonella-positive rodent was also found in B. indica (15.1%, 42/279), and R. norvegicus (12.5%, 5/40). In contrast, the prevalence of Bartonella species in ectoparasites collected from the rats varied significantly according to types of ectoparasites. A high prevalence of Bartonella DNA was found in louse pools (Polyplax spp. and Hoplopleura spp., 57.1%) and flea pools (Xenopsylla cheopis, 25.8%), while a low prevalence was found in pools of mites (Leptotrombidium spp. and Ascoschoengastia spp., 1.7%) and ticks (Haemaphysalis spp., 3.5%). Prevalence of Bartonella DNA in ectoparasites collected from Bartonella-positive rodents (19.4%) was significantly higher comparing to ectoparasites from Bartonella-negative rodents (8.7%). The phylogenetic analysis of 41 gltA sequences of 16 Bartonella isolates from rodent blood and 25 Bartonella-positive ectoparasites revealed a wide range of diversity among Bartonella species with a majority of sequences (61.0%) belonging to Bartonella elizabethae complex (11 rodents, 1 mite pool, and 5 louse pools), while the remaining sequences were identical to B. phoceensis (17.1%, 1 mite pool, 5 louse pools, and 1 tick pool), B. coopersplainensis (19.5%, 5 rodents, 1 louse pool, and 2 tick pools), and one previously unidentified Bartonella species (2.4%, 1 louse pool).	[Klangthong, Kewalin; Promsthaporn, Sommai; Leepitakrat, Surachai; Schuster, Anthony L.; McCardle, Patrick W.; Takhampunya, Ratree] Armed Forces Res Inst Med Sci, US Army Med Directorate, Dept Entomol, Bangkok 10400, Thailand; [Kosoy, Michael] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Centers for Disease Control & Prevention - USA	Takhampunya, R (corresponding author), Armed Forces Res Inst Med Sci, US Army Med Directorate, Dept Entomol, Bangkok 10400, Thailand.	RatreeT.fsn@afrims.org	Takhampunya, Ratree/ABA-4601-2021; Takhampunya, Ratree/ABA-5039-2021	Takhampunya, Ratree/0000-0001-5136-3547	Department of Defense Global Emerging Infections Surveillance and Response System (GEIS)	Department of Defense Global Emerging Infections Surveillance and Response System (GEIS)	This work has been supported by the Department of Defense Global Emerging Infections Surveillance and Response System (GEIS, https://www.afhsc.mil/Home/Divisions/GEIS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2014, INT J ANTIMICROB AG, V44, P16, DOI 10.1016/j.ijantimicag.2014.04.006; Assarasakorn S, 2012, RES VET SCI, V93, P1213, DOI 10.1016/j.rvsc.2012.03.015; Bai Y, 2009, AM J TROP MED HYG, V81, P811, DOI 10.4269/ajtmh.2009.09-0294; Billeter SA, 2011, J MED ENTOMOL, V48, P1257, DOI 10.1603/ME10240; Castle KT, 2004, AM J TROP MED HYG, V70, P429, DOI 10.4269/ajtmh.2004.70.429; Centers for Disease Control and Prevention (U.S.), 2003, PICT KEYS ARTHR REPT; Chomel BB, 2009, ANN NY ACAD SCI, V1166, P120, DOI 10.1111/j.1749-6632.2009.04523.x; Colborn JM, 2010, J CLIN MICROBIOL, V48, P4630, DOI 10.1128/JCM.00470-10; Cotte V, 2008, EMERG INFECT DIS, V14, P1074, DOI 10.3201/eid1407.071110; Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9; Diaz MH, 2012, J CLIN MICROBIOL, V50, P1645, DOI 10.1128/JCM.06621-11; DURDEN LA, 1988, J PARASITOL, V74, P900, DOI 10.2307/3282280; DURDEN LA, 1994, B AM MUS NAT HIST, P1; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11; Hsieh JW, 2010, ZOONOSES PUBLIC HLTH, V57, P439, DOI 10.1111/j.1863-2378.2009.01234.x; Jacomo V, 2002, CLIN DIAGN LAB IMMUN, V9, P8, DOI 10.1128/CDLI.9.1.8-18.2002; Jiyipong T, 2012, APPL ENVIRON MICROB, V78, P8463, DOI 10.1128/AEM.02008-12; Kabeya H, 2010, VECTOR-BORNE ZOONOT, V10, P429, DOI 10.1089/vbz.2009.0124; Korhonen EM, 2015, EPIDEMIOL INFECT, V143, P578, DOI 10.1017/S0950268814001411; Kosoy MY, 2010, BIOL BULL+, V37, P716, DOI 10.1134/S1062359010070071; Kosoy M, 2008, J CLIN MICROBIOL, V46, P772, DOI 10.1128/JCM.02120-07; Kosoy M, 2010, AM J TROP MED HYG, V82, P1140, DOI 10.4269/ajtmh.2010.09-0778; Kosoy MY, 1998, J WILDLIFE DIS, V34, P305, DOI 10.7589/0090-3558-34.2.305; Liu XY, 2014, PLOS NEGLECT TROP D, V8, P1; MacKinnon K., 1978, ORYX, V14, P262; Minnick MF, 2009, FUTURE MICROBIOL, V4, P743, DOI [10.2217/fmb.09.41, 10.2217/FMB.09.41]; Mogollon-Pasapera E, 2009, INT J INFECT DIS, V13, P3, DOI 10.1016/j.ijid.2008.04.002; Nadchatram M, 1974, PICTORIAL KEY SUBFAM; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995; Parola P, 2003, ANN NY ACAD SCI, V990, P173, DOI 10.1111/j.1749-6632.2003.tb07359.x; Pulliainen AT, 2012, FEMS MICROBIOL REV, V36, P563, DOI 10.1111/j.1574-6976.2012.00324.x; Seki N, 2007, AM J TROP MED HYG, V77, P562, DOI 10.4269/ajtmh.2007.77.562; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TANSKUL PL, 1989, J MED ENTOMOL, V26, P573, DOI 10.1093/jmedent/26.6.573; Tsai YL, 2011, COMP IMMUNOL MICROB, V34, P299, DOI 10.1016/j.cimid.2011.04.005; Tsai YL, 2010, AM J TROP MED HYG, V83, P917, DOI 10.4269/ajtmh.2010.10-0083; Watt G, 2014, EMERG INFECT DIS, V20, P473, DOI 10.3201/eid2003.131059	38	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140856	10.1371/journal.pone.0140856	http://dx.doi.org/10.1371/journal.pone.0140856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484537	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100080
J	Mascaro, O; Morin, O				Mascaro, Olivier; Morin, Olivier			Epistemology for Beginners: Two-to Five-Year-Old Children's Representation of Falsity	PLOS ONE			English	Article							YOUNG-CHILDREN; ELECTROPHYSIOLOGICAL EVIDENCE; TRUST; BELIEF; PRESCHOOLERS; INFANTS; TESTIMONY; MIND; PERFORMANCE; KNOWLEDGE	This paper investigates the ontogeny of human's naive concept of truth. Surprisingly, children find it hard to treat assertions as false before their fifth birthday. Yet, we show in six studies (N = 140) that human's concept of falsity develops early. Two-year-olds use truth-functional negation to exclude one term in an alternative (Study 1). Three-year-olds can evaluate discrepancies between the content of a representation and what it aims at representing (Study 2). They use this knowledge to treat beliefs and assertions as false (Study 3). Four-year-olds recognise the involutive nature of falsity ascriptions: they properly infer 'p' from 'It is not true that "It is not true that "p""' (Study 4), an inference that rests on second-order representations of representations. Controls confirm that children do not merely equate being mistaken with failing to achieve one's goal (Studies 5 and 6). These results demonstrate remarkable capacities to evaluate representations, and indicate that in the absence of formal training, young children develop the building blocks of a theory of truth and falsity-a naive epistemology. We suggest that children's difficulties in discarding false assertions need not reflect any conceptual lacuna, and may originate from their being trustful.	[Mascaro, Olivier; Morin, Olivier] Jean Nicod Inst, Paris, France; [Mascaro, Olivier] Cent European Univ, Cognit Dev Ctr, Budapest, Hungary; [Mascaro, Olivier] Univ Lyon 1, CNRS, Lab Language Cerveau & Cognit, L2C2,UMR5304, F-69365 Lyon, France; [Morin, Olivier] Cent European Univ, Social Mind Ctr, Budapest, Hungary	Central European University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Central European University	Mascaro, O (corresponding author), Jean Nicod Inst, Paris, France.	olivier.mascaro@gmail.com	Mascaro, Olivier/O-4306-2017	Mascaro, Olivier/0000-0002-1120-5955	Direction Generale de l'Armement; Agence nationale de la recherche [NR-14-ACHN-0020]; European Research Council [ERC-2013-SyG]; Constructing Social Minds: Communication, Coordination and Cultural Transmission, ERC [609819]; Centre for the Study of the Mind in Nature from the University of Oslo	Direction Generale de l'Armement; Agence nationale de la recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Constructing Social Minds: Communication, Coordination and Cultural Transmission, ERC; Centre for the Study of the Mind in Nature from the University of Oslo	This research was supported by a Phd grant from the Direction Generale de l'Armement (http://www.defense.gouv.fr/dga), by a grant from the Agence nationale de la recherche (http://www.agence-nationale-recherche.fr, grant number: ANR-14-ACHN-0020, PRAGmatics and Trust in Commnication in eArly Life), and by a grant from the European Research Council (http://erc.europa.eu, grant number: ERC-2013-SyG, Constructing Social Minds: Communication, Coordination and Cultural Transmission, ERC, grant agreement no [609819]). Data collection was also supported by the Centre for the Study of the Mind in Nature from the University of Oslo (http://www.hf.uio.no/csmn/english/).	Austin K, 2014, DEV PSYCHOL, V50, P2061, DOI 10.1037/a0037179; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Begus K, 2012, DEVELOPMENTAL SCI, V15, P611, DOI 10.1111/j.1467-7687.2012.01160.x; Behne T, 2005, DEVELOPMENTAL SCI, V8, P492, DOI 10.1111/j.1467-7687.2005.00440.x; Birch SAJ, 2008, COGNITION, V107, P1018, DOI 10.1016/j.cognition.2007.12.008; Birch SAJ, 2007, PSYCHOL SCI, V18, P382, DOI 10.1111/j.1467-9280.2007.01909.x; Bowler DM, 2005, J COGN DEV, V6, P259, DOI 10.1207/s15327647jcd0602_5; Burgess AJ, 2011, TRUTH; Butterfill SA, 2013, MIND LANG, V28, P606, DOI 10.1111/mila.12036; Call J, 1999, CHILD DEV, V70, P381, DOI 10.1111/1467-8624.00028; Carruthers P, 2013, MIND LANG, V28, P141, DOI 10.1111/mila.12014; Cheney D. L., 1990, MONKEYS SEE WORLD IN; CHOI S, 1988, J CHILD LANG, V15, P517, DOI 10.1017/S030500090001254X; Clement F, 2013, COGNITION EMOTION, V27, P539, DOI 10.1080/02699931.2012.724012; Clement F, 2010, REV PHILOS PSYCHOL, V1, P531, DOI 10.1007/s13164-010-0022-3; COADY CAJ, 1973, AM PHILOS QUART, V10, P149; Corriveau K, 2009, DEVELOPMENTAL SCI, V12, P188, DOI 10.1111/j.1467-7687.2008.00763.x; Corriveau KH, 2009, BRIT J DEV PSYCHOL, V27, P331, DOI 10.1348/026151008X310229; Cosmides L., 2000, METAREPRESENTATIONS, P53; Couillard NL, 1999, BRIT J DEV PSYCHOL, V17, P515, DOI 10.1348/026151099165447; Csibra G, 2006, TRENDS COGN SCI, V10, P4, DOI 10.1016/j.tics.2005.11.011; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; de Villiers JG, 2002, COGNITIVE DEV, V17, P1037, DOI 10.1016/S0885-2014(02)00073-4; DENNETT DC, 1978, BEHAV BRAIN SCI, V1, P568, DOI 10.1017/S0140525X00076664; Doebel S, 2013, DEV PSYCHOL, V49, P462, DOI 10.1037/a0031595; Dunn J., 1988, BEGINNINGS SOCIAL UN; Friedrich M, 2011, J COGNITIVE NEUROSCI, V23, P3228, DOI 10.1162/jocn_a_00002; Frith C, 2005, CURR BIOL, V15, pR644, DOI 10.1016/j.cub.2005.08.041; Fusaro M, 2008, DEVELOPMENTAL SCI, V11, P771, DOI 10.1111/j.1467-7687.2008.00728.x; Fusaro M, 2013, DEV PSYCHOL, V49, P514, DOI 10.1037/a0030580; Gliga T, 2009, PSYCHOL SCI, V20, P347, DOI 10.1111/j.1467-9280.2009.02295.x; Gouzoules H, 1996, INT J PRIMATOL, V17, P549, DOI 10.1007/BF02735191; GROVER DL, 1975, PHILOS STUD, V27, P73, DOI 10.1007/BF01209340; Happe F, 2002, MIND LANG, V17, P24, DOI 10.1111/1468-0017.00187; HARRIS P. L., 2012, TRUSTING WHAT YOURE; Harris PL, 2006, CHILD DEV, V77, P505, DOI 10.1111/j.1467-8624.2006.00886.x; Helming KA, 2014, TRENDS COGN SCI, V18, P167, DOI 10.1016/j.tics.2014.01.005; Herrmann E, 2006, DEVELOPMENTAL SCI, V9, P518, DOI 10.1111/j.1467-7687.2006.00519.x; Heyes C, 2014, DEVELOPMENTAL SCI, V17, P647, DOI 10.1111/desc.12148; Heyman GD, 2013, COGNITIVE SCI, V37, P646, DOI 10.1111/cogs.12020; Hill A, 2012, J COMP PSYCHOL, V126, P243, DOI 10.1037/a0024449; Hoicka E, 2012, BRIT J DEV PSYCHOL, V30, P586, DOI 10.1111/j.2044-835X.2011.02075.x; Horwich P., 1994, THEORIES OF TRUTH; HUMMER P, 1993, J CHILD LANG, V20, P607, DOI 10.1017/S0305000900008503; Jaswal VK, 2010, PSYCHOL SCI, V21, P1541, DOI 10.1177/0956797610383438; JOU JW, 1988, J EXP CHILD PSYCHOL, V45, P457, DOI 10.1016/0022-0965(88)90042-2; Jouie M., 1995, THESIS U HONG KONG; Junge C, 2012, NEUROPSYCHOLOGIA, V50, P3702, DOI 10.1016/j.neuropsychologia.2012.10.012; KIM KJ, 1985, DEV PSYCHOL, V21, P462, DOI 10.1037/0012-1649.21.3.462; Koenig MA, 2005, CHILD DEV, V76, P1261, DOI 10.1111/j.1467-8624.2005.00849.x; Koenig MA, 2004, PSYCHOL SCI, V15, P694, DOI 10.1111/j.0956-7976.2004.00742.x; Koenig MA, 2003, COGNITION, V87, P179, DOI 10.1016/S0010-0277(03)00002-7; Koenig MA, 2010, DEV PSYCHOL, V46, P815, DOI 10.1037/a0019664; Landrum AR, 2013, DEVELOPMENTAL SCI, V16, P622, DOI 10.1111/desc.12059; Lane JD, 2013, CHILD DEV, V84, P1253, DOI 10.1111/cdev.12029; Lee K, 1999, J CHILD LANG, V26, P1, DOI 10.1017/S0305000998003626; Leekam S, 2008, BRIT J DEV PSYCHOL, V26, P485, DOI 10.1348/026151007X260154; Leslie AM, 2004, TRENDS COGN SCI, V8, P528, DOI 10.1016/j.tics.2004.10.001; Low J, 2010, CHILD DEV, V81, P597, DOI 10.1111/j.1467-8624.2009.01418.x; Lyon TD, 2013, J COGN DEV, V14, P437, DOI 10.1080/15248372.2012.673187; Mascaro O, 2011, TERRAIN, V57, P20; Mascaro O, 2014, TRUST SKEPTICISM CHI, P69, DOI DOI 10.4324/9781315849362; Mascaro O, 2009, COGNITION, V112, P367, DOI 10.1016/j.cognition.2009.05.012; Miller SA, 2009, PSYCHOL BULL, V135, P749, DOI 10.1037/a0016854; Mills CM, 2013, DEV PSYCHOL, V49, P404, DOI 10.1037/a0029500; Mitchell P, 1994, CHILDRENS EARLY UNDE, P19; Mody S, 2014, INT C INF STUD JUL 3; Moravcsik, 1978, UNIVERSALS HUMAN LAN, V4, P127; Muller U, 2005, COGNITIVE DEV, V20, P173, DOI 10.1016/j.cogdev.2004.12.004; Nurmsoo E, 2010, REV PHILOS PSYCHOL, V1, P551, DOI 10.1007/s13164-010-0043-y; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Palmquist CM, 2012, PSYCHOL SCI, V23, P230, DOI 10.1177/0956797611427043; Palmquist CM, 2012, COGNITIVE DEV, V27, P54, DOI 10.1016/j.cogdev.2011.07.002; Parise E, 2012, PSYCHOL SCI, V23, P728, DOI 10.1177/0956797612438734; Pasquini ES, 2007, DEV PSYCHOL, V43, P1216, DOI 10.1037/0012-1649.43.5.1216; PEA RD, 1982, J CHILD LANG, V9, P597, DOI 10.1017/S0305000900004931; PEA RD, 1980, ANN NY ACAD SCI, V345, P27, DOI 10.1111/j.1749-6632.1980.tb51115.x; Perner J, 2003, CHILD DEV, V74, P179, DOI 10.1111/1467-8624.t01-1-00529; PERNER J, 1989, CHILD DEV, V60, P689, DOI 10.2307/1130734; Perner J, 1991, UNDERSTANDING REPRES; Perner J, 2005, WHY LANGUAGE MATTERS, P220, DOI DOI 10.1093/ACPROF:OSO/9780195159912.003.0011; Perner J, 2012, TRENDS COGN SCI, V16, P519, DOI 10.1016/j.tics.2012.08.004; Piaget J., 1947, PSYCHOL INTELLIGENCE; PYLYSHYN ZW, 1978, BEHAV BRAIN SCI, V1, P592, DOI 10.1017/S0140525X00076895; Quine W, 1992, THE PURSUIT OF TRUTH; Quine W.V.O., 1978, WEB BELIEF, V2; Rakoczy H, 2008, DEV PSYCHOL, V44, P875, DOI 10.1037/0012-1649.44.3.875; Rakoczy H, 2012, BRIT J DEV PSYCHOL, V30, P59, DOI 10.1111/j.2044-835X.2011.02061.x; Rakoczy H, 2009, COGNITION, V113, P205, DOI 10.1016/j.cognition.2009.07.013; Ramsey F., 1927, ARISTOTELIAN SOC S, V7, P153, DOI DOI 10.1093/ARISTOTELIANSUPP/7.1.153; Reid T., 1764, INQUIRY HUMAN MIND; RIGGS KJ, 1995, J EXP CHILD PSYCHOL, V60, P229, DOI 10.1006/jecp.1995.1039; Sabbagh MA, 2006, CHILD DEV, V77, P1034, DOI 10.1111/j.1467-8624.2006.00917.x; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Shafto P, 2012, DEVELOPMENTAL SCI, V15, P436, DOI 10.1111/j.1467-7687.2012.01135.x; Southgate V, 2010, DEVELOPMENTAL SCI, V13, P907, DOI 10.1111/j.1467-7687.2009.00946.x; Sperber D, 2000, METAREPRESENTATIONS; Sperber D, 2010, MIND LANG, V25, P359, DOI 10.1111/j.1468-0017.2010.01394.x; Suddendorf T, 2001, PSYCHOL BULL, V127, P629, DOI 10.1037//0033-2909.127.5.629; Szabo E, 2015, NIJM LECT OR THOUGHT; Tardif TV, 2004, J CHILD LANG, V31, P779, DOI 10.1017/S0305000904006580; Tarski A., 1943, PHILOS PHENOMEN RES, V4, P341, DOI [10.2307/2102968, DOI 10.2307/2102968]; Vanderbilt KE, 2014, DEVELOPMENTAL SCI, V17, P443, DOI 10.1111/desc.12134; Vanderbilt KE, 2011, CHILD DEV, V82, P1372, DOI 10.1111/j.1467-8624.2011.01629.x; Watson JS, 2001, J COMP PSYCHOL, V115, P219, DOI 10.1037//0735-7036.115.3.219; Wellman H.M., 1992, CHILDS THEORY MIND; WELLMAN HM, 1988, COGNITION, V30, P239, DOI 10.1016/0010-0277(88)90021-2; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zhou P, 2013, J EAST ASIAN LINGUIS, V1, P1	111	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140658	10.1371/journal.pone.0140658	http://dx.doi.org/10.1371/journal.pone.0140658			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7XI	26484675	Green Published, gold			2022-12-27	WOS:000363028100059
J	Raz, A; Tanasescu, AM; Zhao, AM; Serrano, A; Alston, T; Sol, A; Bachrach, G; Fischetti, VA				Raz, Assaf; Tanasescu, Ana-Maria; Zhao, Anna M.; Serrano, Anna; Alston, Tricia; Sol, Asaf; Bachrach, Gilad; Fischetti, Vincent A.			Streptococcus pyogenes Sortase Mutants Are Highly Susceptible to Killing by Host Factors Due to Aberrant Envelope Physiology	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; FIBRONECTIN-BINDING PROTEIN; GRAM-POSITIVE BACTERIA; GROUP-A STREPTOCOCCI; SURFACE-PROTEINS; CELL-WALL; ANTIMICROBIAL PEPTIDES; LISTERIA-MONOCYTOGENES; EPITHELIAL-CELLS; SUBSTRATE-SPECIFICITY	Cell wall anchored virulence factors are critical for infection and colonization of the host by Gram-positive bacteria. Such proteins have an N-terminal leader sequence and a C-terminal sorting signal, composed of an LPXTG motif, a hydrophobic stretch, and a few positively charged amino acids. The sorting signal halts translocation across the membrane, allowing sortase to cleave the LPXTG motif, leading to surface anchoring. Deletion of sortase prevents the anchoring of virulence factors to the wall; the effects on bacterial physiology however, have not been thoroughly characterized. Here we show that deletion of Streptococcus pyogenes sortase A leads to accumulation of sorting intermediates, particularly at the septum, altering cellular morphology and physiology, and compromising membrane integrity. Such cells are highly sensitive to cathelicidin, and are rapidly killed in blood and plasma. These phenomena are not a loss-of-function effect caused by the absence of anchored surface proteins, but specifically result from the accumulation of sorting intermediates. Reduction in the level of sorting intermediates leads to a return of the sortase mutant to normal morphology, while expression of M protein with an altered LPXTG motif in wild type cells leads to toxicity in the host environment, similar to that observed in the sortase mutant. These unanticipated effects suggest that inhibition of sortase by small-molecule inhibitors could similarly lead to the rapid elimination of pathogens from an infected host, making such inhibitors much better anti-bacterial agents than previously believed.	[Raz, Assaf; Tanasescu, Ana-Maria; Zhao, Anna M.; Serrano, Anna; Alston, Tricia; Fischetti, Vincent A.] Rockefeller Univ, Bacterial Pathogenesis & Immunol, New York, NY 10065 USA; [Sol, Asaf; Bachrach, Gilad] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, IL-91120 Jerusalem, Israel	Rockefeller University; Hebrew University of Jerusalem	Raz, A (corresponding author), Rockefeller Univ, Bacterial Pathogenesis & Immunol, 1230 York Ave Box 172, New York, NY 10065 USA.	araz@rockefeller.edu		Bachrach, Gilad/0000-0003-1350-2280; Sol, Asaf/0000-0002-8731-2490	U.S. Public Health Service Grant [AI11822]	U.S. Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by U.S. Public Health Service Grant AI11822 (to V.A.F.).	Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Bolken TC, 2001, INFECT IMMUN, V69, P75, DOI 10.1128/IAI.69.1.75-80.2001; Bormann NE, 1997, GENE, V200, P125, DOI 10.1016/S0378-1119(97)00392-2; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; CLEARY PP, 1975, INFECT IMMUN, V12, P109, DOI 10.1128/IAI.12.1.109-118.1975; COLE RM, 1962, SCIENCE, V135, P722, DOI 10.1126/science.135.3505.722; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; HAHN JJ, 1963, J EXP MED, V118, P659, DOI 10.1084/jem.118.5.659; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HANSKI E, 1992, P NATL ACAD SCI USA, V89, P6172, DOI 10.1073/pnas.89.13.6172; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Johansson L, 2008, INFECT IMMUN, V76, P3399, DOI 10.1128/IAI.01392-07; JONES KF, 1985, J EXP MED, V161, P623, DOI 10.1084/jem.161.3.623; Jonsson IM, 2002, J INFECT DIS, V185, P1417, DOI 10.1086/340503; Jonsson IM, 2003, MICROBES INFECT, V5, P775, DOI 10.1016/S1286-4579(03)00143-6; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Le Breton Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09838; Lee SF, 2003, INFECT IMMUN, V71, P676, DOI 10.1128/IAI.71.2.676-681.2003; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Mariscotti JF, 2012, INT MICROBIOL, V15, P43, DOI 10.2436/20.1501.01.157; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Navarre WW, 1998, J BIOL CHEM, V273, P29135, DOI 10.1074/jbc.273.44.29135; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; NORGREN M, 1989, INFECT IMMUN, V57, P3846, DOI 10.1128/IAI.57.12.3846-3850.1989; Oh KB, 2010, BIOCHEM BIOPH RES CO, V396, P440, DOI 10.1016/j.bbrc.2010.04.113; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Paterson GK, 2006, MICROBES INFECT, V8, P145, DOI 10.1016/j.micinf.2005.06.009; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; PEREZCASAL J, 1992, RES MICROBIOL, V143, P549, DOI 10.1016/0923-2508(92)90112-2; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Port GC, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00725-15; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Raz A, 2012, MOL MICROBIOL, V84, P631, DOI 10.1111/j.1365-2958.2012.08047.x; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; ROTHBARD S, 1948, J EXP MED, V87, P521, DOI 10.1084/jem.87.6.521; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Sol A, 2013, INFECT IMMUN, V81, P3577, DOI 10.1128/IAI.01288-12; SPANIER JG, 1984, SCIENCE, V225, P935, DOI 10.1126/science.6089334; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; SWANSON J, 1969, J EXP MED, V130, P1063, DOI 10.1084/jem.130.5.1063; TALAY SR, 1992, INFECT IMMUN, V60, P3837, DOI 10.1128/IAI.60.9.3837-3844.1992; TonThat H, 1997, J BIOL CHEM, V272, P22285, DOI 10.1074/jbc.272.35.22285; Wang CJ, 2009, ARCH MICROBIOL, V191, P23, DOI 10.1007/s00203-008-0425-z; Weiss WJ, 2004, J ANTIMICROB CHEMOTH, V53, P480, DOI 10.1093/jac/dkh078; Wu CG, 2014, MOL MICROBIOL, V94, P1227, DOI 10.1111/mmi.12780; Yamaguchi M, 2013, CELL MICROBIOL, V15, P503, DOI 10.1111/cmi.12083; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang J, 2014, P NATL ACAD SCI USA, V111, P13517, DOI 10.1073/pnas.1408601111	77	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140784	10.1371/journal.pone.0140784	http://dx.doi.org/10.1371/journal.pone.0140784			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484774	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100071
J	Viljakainen, HT; Ben-Shlomo, Y; Kinra, S; Ebrahim, S; Kuper, H; Radhakrishna, KV; Kulkarni, B; Tobias, JH				Viljakainen, Heli T.; Ben-Shlomo, Yoav; Kinra, Sanjay; Ebrahim, Shah; Kuper, Hannah; Radhakrishna, K. V.; Kulkarni, Bharati; Tobias, Jon H.			Urban-Rural Differences in Bone Mineral Density: A Cross Sectional Analysis Based on the Hyderabad Indian Migration Study	PLOS ONE			English	Article							HIP FRACTURE; METABOLIC SYNDROME; ASSOCIATION; RISK; MASS; MEN; CHILDREN; INSULIN; RATES; LIFE	Background Fracture risk is rising in countries undergoing rapid rural to urban migration, but whether this reflects an adverse effect of urbanization on intrinsic bone strength, as reflected by bone mineral density (BMD), is currently unknown. Methods Lumbar spine (LS) and total hip (TH) BMD, and total body fat and lean mass, were obtained from DXA scans performed in the Hyderabad arm of the Indian Migration Study (54% male, mean age 49 years). Sib-pair comparisons were performed between rural-urban migrants (RUM) and rural non-migrated (RNM) siblings (N = 185 sib-pairs). Results In analyses adjusted for height, gender, age and occupation, rural to urban migration was associated with higher lumbar and hip BMD and greater predicted hip strength; Delta LS BMD 0.030 (0.005, 0.055) g/cm(2), Delta TH BMD 0.044 (0.024; 0.064) g/cm(2), Delta cross-sectional moment of inertia 0.162 (0.036, 0.289) cm(4). These differences were largely attenuated after adjusting for body composition, insulin levels and current lifestyle factors ie. years of smoking, alcohol consumption and moderate to vigorous physical activity. Further analyses suggested that differences in lean mass, and to a lesser extent fat mass, largely explained the BMD differences which we observed. Conclusions Rural to urban migration as an adult is associated with higher BMD and greater predicted hip strength, reflecting associated alterations in body composition. It remains to be seen how differences in BMD between migration groups will translate into fracture risk in becoming years.	[Viljakainen, Heli T.; Tobias, Jon H.] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England; [Viljakainen, Heli T.] Univ Helsinki, Childrens Hosp, Cent Hosp, Helsinki, Finland; [Viljakainen, Heli T.] Univ Helsinki, Helsinki, Finland; [Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Kinra, Sanjay; Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1, England; [Ebrahim, Shah] Publ Hlth Fdn India, South Asia Network Chron Disease, New Delhi, India; [Kuper, Hannah] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Radhakrishna, K. V.; Kulkarni, Bharati] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India	University of Bristol; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Tobias, JH (corresponding author), Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England.	Jon.Tobias@bristol.ac.uk	Kulkarni, Bharati/ABB-3188-2020; Kulkarni, Bharati/C-9036-2011; Ben-Shlomo, Yoav/ABD-2004-2021; Tobias, Jon/E-2832-2014	Kulkarni, Bharati/0000-0003-0636-318X; Kulkarni, Bharati/0000-0003-0636-318X; Ben-Shlomo, Yoav/0000-0001-6648-3007; Tobias, Jon/0000-0002-7475-3932	Wellcome Trust [WT083707MA]; Academy of Finland; Foundation for Pediatric Research	Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland); Foundation for Pediatric Research	This study was funded by a grant from the Wellcome Trust [WT083707MA], Academy of Finland, and Foundation for Pediatric Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P585, DOI 10.1007/s00198-008-0711-2; Bansal D, 2010, PUBLIC HEALTH NUTR, V13, P1982, DOI 10.1017/S1368980010001254; Beck TJ, 2002, BMD STRUCTURAL  1029, P1; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Clark EM, 2006, J CLIN ENDOCR METAB, V91, P2534, DOI 10.1210/jc.2006-0332; de Liefde II, 2005, OSTEOPOROSIS INT, V16, P1713, DOI 10.1007/s00198-005-1909-1; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Gjesdal CG, 2008, MATURITAS, V59, P191, DOI 10.1016/j.maturitas.2007.11.002; Hagino H, 2009, OSTEOPOROSIS INT, V20, P695, DOI 10.1007/s00198-008-0761-5; Hernandez JL, 2010, MENOPAUSE, V17, P955, DOI 10.1097/gme.0b013e3181e39a15; Hwang DK, 2010, OSTEOPOROSIS INT, V21, P425, DOI 10.1007/s00198-009-0990-2; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kannus P, 2006, J BONE MINER RES, V21, P1836, DOI 10.1359/JBMR.060815; Kaptoge S, 2008, J BONE MINER RES, V23, P1892, DOI [10.1359/jbmr.080802, 10.1359/JBMR.080802]; Kim HY, 2010, CALCIFIED TISSUE INT, V86, P350, DOI 10.1007/s00223-010-9347-2; Kinra S, 2014, INT J EPIDEMIOL, V43, P1417, DOI 10.1093/ije/dyt128; Kinra S, 2011, AM J EPIDEMIOL, V174, P154, DOI 10.1093/aje/kwr053; Lawlor DA, 2012, J CLIN ENDOCR METAB, V97, P2068, DOI 10.1210/jc.2011-2721; Leslie WD, 2009, JAMA-J AM MED ASSOC, V302, P883, DOI 10.1001/jama.2009.1231; Lofman O, 2002, OSTEOPOROSIS INT, V13, P18; Matsuzaki M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132239; Otto A, 2010, EXP CELL RES, V316, P3059, DOI 10.1016/j.yexcr.2010.04.009; Pongchaiyakul C, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-5; Rowe SM, 2005, J KOREAN MED SCI, V20, P655, DOI 10.3346/jkms.2005.20.4.655; Sayers A, 2012, J BONE MINER RES, V27, P610, DOI 10.1002/jbmr.1467; Sogaard AJ, 2007, OSTEOPOROSIS INT, V18, P1063, DOI 10.1007/s00198-007-0353-9; Sullivan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024898; Szulc P, 2010, J BONE MINER RES, V25, P1446, DOI 10.1002/jbmr.13; Tobias JH, 2007, J BONE MINER RES, V22, P101, DOI 10.1359/JBMR.060913; von Muhlen D, 2007, OSTEOPOROSIS INT, V18, P1337, DOI 10.1007/s00198-007-0385-1; Xia WB, 2012, J BONE MINER RES, V27, P125, DOI 10.1002/jbmr.519	31	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140787	10.1371/journal.pone.0140787	http://dx.doi.org/10.1371/journal.pone.0140787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484878	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000363028100072
J	Goto, H; Ishihara, Y; Kikuchi, T; Izawa, A; Ozeki, N; Okabe, E; Kamiya, Y; Ozawa, Y; Mizutani, H; Yamamoto, G; Mogi, M; Nakata, K; Maeda, H; Noguchi, T; Mitani, A				Goto, Hisashi; Ishihara, Yuichi; Kikuchi, Takeshi; Izawa, Ario; Ozeki, Nobuaki; Okabe, Eijiro; Kamiya, Yosuke; Ozawa, Yusuke; Mizutani, Hiroki; Yamamoto, Genta; Mogi, Makio; Nakata, Kazuhiko; Maeda, Hatsuhiko; Noguchi, Toshihide; Mitani, Akio			Interleukin-1 Receptor Antagonist Has a Novel Function in the Regulation of Matrix Metalloproteinase-13 Expression	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; DEFICIENT MICE; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; RHEUMATOID-ARTHRITIS; LAMININ-5; MIGRATION; PERIODONTITIS; IL-1-BETA; IL-1RA	Interleukin-1 receptor antagonist (IL-1Ra) is an IL-1 family member, which binds to IL-1 receptors but does not induce any intracellular signaling. We addressed whether IL-1Ra has a novel function in regulation of the extracellular matrix or adhesion molecules. Polymerase chain reaction array analysis demonstrated a similar to 5-fold increase in matrix metalloproteinase 13 (MMP-13) mRNA expression of IL-1Ra siRNA-transfected Ca9-22 human oral squamous epithelial carcinoma cells compared with the control. In fact, MMP-13 mRNA and protein expression as well as its activity in IL-1Ra siRNA-transfected Ca9-22 cell lines were significantly higher than those in the control. IL-1Ra siRNA treatment resulted in strong elevation of MMP-13 expression, whereas addition of rhIL-1Ra (40 ng/ml) suppressed MMP-13 expression, suggesting that IL-1Ra had a specific effect on MMP-13 induction. IL-1Ra siRNA could potently suppress IL-1 alpha. No significant difference was found between the MMP-13 mRNA expression of IL-1Ra siRNA-transfected cells and those treated with antiI-L-1 alpha or anti-IL-1 beta antibodies. These results suggested that continuous supply of IL-1 had no effect on the induction of MMP-13 by IL-1Ra siRNA. Histopathological investigation of MMP-13 in periodontal tissue showed specific localization in the junctional epithelial cells of IL-1Ra knockout (KO) mice. Furthermore, infection with Aggregatibacter actinomycetemcomitans to establish an experimental periodontitis model resulted in predominant localization of MMP-13 along apical junctional epithelial cells. Laminin-5, which is degraded by MMP-13, was found in the internal basal lamina of wild-type mice, whereas the internal basal lamina of IL-1Ra KO mice did not show obvious laminin-5 localization. In particular, laminin-5 localization almost disappeared in the internal basal lamina of IL-1Ra KO mice infected with A. actinomycetemcomitans, suggesting that the suppression of IL-1Ra resulted in strong induction of MMP-13 that degraded laminin-5. In conclusion, IL-1Ra is associated with MMP-13 expression and has a novel function in such regulation without interference of the IL-1 signaling cascade.	[Goto, Hisashi; Kikuchi, Takeshi; Izawa, Ario; Okabe, Eijiro; Kamiya, Yosuke; Ozawa, Yusuke; Mizutani, Hiroki; Yamamoto, Genta; Noguchi, Toshihide; Mitani, Akio] Aichi Gakuin Univ, Dept Periodontol, Sch Dent, Chikusa Ku, Nagoya, Aichi 464, Japan; [Ishihara, Yuichi] Matsumoto Dent Univ, Dept Operat Dent Endodontol & Periodontol, Sch Dent, Nagano, Japan; [Ozeki, Nobuaki; Nakata, Kazuhiko] Aichi Gakuin Univ, Dept Endodont, Sch Dent, Chikusa Ku, Nagoya, Aichi 464, Japan; [Mogi, Makio] Aichi Gakuin Univ, Dept Med Biochem, Sch Pharm, Chikusa Ku, Nagoya, Aichi 464, Japan; [Maeda, Hatsuhiko] Aichi Gakuin Univ, Dept Pathol, Sch Dent, Chikusa Ku, Nagoya, Aichi 464, Japan	Aichi Gakuin University; Matsumoto Dental University; Aichi Gakuin University; Aichi Gakuin University; Aichi Gakuin University	Kikuchi, T (corresponding author), Aichi Gakuin Univ, Dept Periodontol, Sch Dent, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	tkikuchi@dpc.aichi-gakuin.ac.jp		Kikuchi, Takeshi/0000-0003-0310-5302	Japan Society for the Promotion of Science KAKENHI [24593137, 15K11402]; Grants-in-Aid for Scientific Research [15K11402, 26463149] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI (grant number: 24593137, 15K11402), http:/www.jsps.go.jp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Assirelli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096925; Atsuta I, 2005, BIOMATERIALS, V26, P6280, DOI 10.1016/j.biomaterials.2005.03.046; BRENNAN FM, 1989, LANCET, V2, P244; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Horikoshi M, 1974, Nihon Koku Geka Gakkai Zasshi, V20, P100; Hormia M, 1998, J DENT RES, V77, P1479, DOI 10.1177/00220345980770070201; Ilgenli T, 2006, ORAL DIS, V12, P573, DOI 10.1111/j.1601-0825.2006.01244.x; Ishihara Y, 1997, J PERIODONTAL RES, V32, P524, DOI 10.1111/j.1600-0765.1997.tb00568.x; Izawa A, 2014, INFECT IMMUN, V82, P1904, DOI 10.1128/IAI.01618-13; Kinumatsu T, 2009, J PERIODONTAL RES, V44, P13, DOI 10.1111/j.1600-0765.2007.01036.x; Kothapalli R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012494; Kriebel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078226; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; MARSH CB, 1994, AM J PHYSIOL, V267, pL39, DOI 10.1152/ajplung.1994.267.1.L39; Mizutani H, 2013, J PERIODONTAL RES, V48, P748, DOI 10.1111/jre.12065; Oksanen J, 2001, J DENT RES, V80, P2093, DOI 10.1177/00220345010800121401; Pirila E, 2003, BIOCHEM BIOPH RES CO, V303, P1012, DOI 10.1016/S0006-291X(03)00452-2; Rawlinson A, 2000, J CLIN PERIODONTOL, V27, P738, DOI 10.1034/j.1600-051x.2000.027010738.x; Somm E, 2005, DIABETES, V54, P3503, DOI 10.2337/diabetes.54.12.3503; Toker H, 2008, J CLIN PERIODONTOL, V35, P507, DOI 10.1111/j.1600-051X.2008.01213.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Zijnge V, 2012, FRONT ORAL BIOL, V15, P1, DOI 10.1159/000329667	25	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140942	10.1371/journal.pone.0140942	http://dx.doi.org/10.1371/journal.pone.0140942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474296	Green Published, gold			2022-12-27	WOS:000363185500131
J	Sommer, G; Gianinazzi, ME; Kuonen, R; Bohlius, J; l'Allemand, D; Hauschild, M; Mullis, PE; Kuehni, CE				Sommer, Grit; Gianinazzi, Micol E.; Kuonen, Rahel; Bohlius, Julia; l'Allemand, Dagmar; Hauschild, Michael; Mullis, Primus-Eugen; Kuehni, Claudia E.		Swiss Soc Paediat Endocrinology	Health-Related Quality of Life of Young Adults Treated with Recombinant Human Growth Hormone during Childhood	PLOS ONE			English	Article							IDIOPATHIC SHORT STATURE; ONSET CRANIOPHARYNGIOMA; DEFICIENT PATIENTS; CANCER SURVIVORS; GH REPLACEMENT; THERAPY; DISCONTINUATION; ADOLESCENTS; TRANSITION; STANDARDS	Background Since recombinant human growth hormone (rhGH) became available in 1985, the spectrum of indications has broadened and the number of treated patients increased. However, long-term health-related quality of life (HRQoL) after childhood rhGH treatment has rarely been documented. We assessed HRQoL and its determinants in young adults treated with rhGH during childhood. Methodology/Principal Findings For this study, we retrospectively identified former rhGH patients in 11 centers of paediatric endocrinology, including university hospitals and private practices. We sent a questionnaire to all patients treated with rhGH for any diagnosis, who were older than 18 years, and who resided in Switzerland at time of the survey. Three hundred participants (58% of 514 eligible) returned the questionnaire. Mean age was 23 years; 56% were women; 43% had isolated growth hormone deficiency, or idiopathic short stature; 43% had associated diseases or syndromes, and 14% had growth hormone deficiency after childhood cancer. Swiss siblings of childhood cancer survivors and the German norm population served as comparison groups. HRQoL was assessed using the Short Form-36. We found that the Physical Component Summary of healthy patients with isolated growth hormone deficiency or idiopathic short stature resembled that of the control group (53.8 vs. 54.9). Patients with associated diseases or syndromes scored slightly lower (52.5), and former cancer patients scored lowest (42.6). The Mental Component Summary was similar for all groups. Lower Physical Component Summary was associated with lower educational level (coeff. -1.9). Final height was not associated with HRQoL. Conclusions/Significance In conclusion, HRQoL after treatment with rhGH in childhood depended mainly on the underlying indication for rhGH treatment. Patients with isolated growth hormone deficiency/idiopathic short stature or patients with associated diseases or syndromes had HRQoL comparable to peers. Patients with growth hormone deficiency after childhood cancer were at high risk for lower HRQoL. This reflects the general impaired health of this vulnerable group, which needs long-term follow-up.	[Sommer, Grit; Gianinazzi, Micol E.; Kuonen, Rahel; Bohlius, Julia; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [l'Allemand, Dagmar] Ostschweizer Sauglings & Kinderspital, Div Paediat Endocrinol & Diabetol, Clin Adolescent Med, CH-9007 St Gallen, Switzerland; [Hauschild, Michael] Univ Hosp, Dept Paediat, Div Paediat Endocrinol Diabetol & Obes, Lausanne, Switzerland; [Mullis, Primus-Eugen] Univ Childrens Hosp Bern, Div Paediat Endocrinol Diabetol & Metab, Inselspital, Bern, Switzerland	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern	Kuehni, CE (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	claudia.kuehni@ispm.unibe.ch	Hauschild, Michael/AAZ-6990-2021	Hauschild, Michael/0000-0002-1940-8730; Bohlius, Julia/0000-0003-1955-1585; Kuehni, Claudia E./0000-0001-8957-2002	Swiss Cancer League [KLS-02586-02-2010, KLS-2948-02-2012]; 7th framework program of the European Union [HEALTH-F2-2009-223497]; Pfizer AG [WI172069]; Novo Nordisk Pharma AG; Sandoz Pharmaceuticals AG	Swiss Cancer League; 7th framework program of the European Union(European Commission); Pfizer AG; Novo Nordisk Pharma AG(Novo Nordisk); Sandoz Pharmaceuticals AG	This study was supported by the Swiss Cancer League (http://www.krebsliga.ch; KLS-02586-02-2010; KLS-2948-02-2012), the 7th framework program of the European Union (http://ec.europa.eu/research/fp7/index_en.cfm; Grant Agreement Number HEALTH-F2-2009-223497 (SAGhE)), Pfizer AG (www.pfizer.com; WI172069), Novo Nordisk Pharma AG (http://www.novonordisk.com), and Sandoz Pharmaceuticals AG (http://www.sandoz.com). All funding was granted to PEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson E, 2010, J CLIN ENDOCR METAB, V95, P1355, DOI 10.1210/jc.2009-1754; Armstrong GT, 2010, EUR J PAEDIATR NEURO, V14, P298, DOI 10.1016/j.ejpn.2009.12.006; Attanasio AF, 2005, J CLIN ENDOCR METAB, V90, P4525, DOI 10.1210/jc.2005-0439; Bannink EMN, 2006, J PEDIATR-US, V148, P95, DOI 10.1016/j.jpeds.2005.08.043; Bowling A, 1999, J PUBLIC HEALTH MED, V21, P255, DOI 10.1093/pubmed/21.3.255; Brutt AL, 2009, HORM RES, V72, P65, DOI 10.1159/000232158; Bullinger M, 2009, HORM RES, V72, P74, DOI 10.1159/000232159; Carel JC, 2005, J CLIN ENDOCR METAB, V90, P1992, DOI 10.1210/jc.2004-1395; Christensen TL, 2007, CLIN ENDOCRINOL, V67, P407, DOI 10.1111/j.1365-2265.2007.02901.x; Coste J, 2012, J CLIN ENDOCR METAB, V97, P3231, DOI 10.1210/jc.2012-1543; Ellert U, 1999, Gesundheitswesen, V61 Spec No, pS184; Furnee CA, 2008, EUR J PUBLIC HEALTH, V18, P417, DOI 10.1093/eurpub/ckn028; Hazem A, 2012, EUR J ENDOCRINOL, V166, P13, DOI 10.1530/EJE-11-0558; Hoybye C, 2015, BEST PRACT RES CL EN, V29, P115, DOI 10.1016/j.beem.2014.09.006; Kendall-Taylor P, 2005, EUR J ENDOCRINOL, V152, P557, DOI 10.1530/eje.1.01877; Kuehni CE, 2012, INT J EPIDEMIOL, V41, P1553, DOI 10.1093/ije/dyr142; Kuehni CE, 2012, CANCER-AM CANCER SOC, V118, P1439, DOI 10.1002/cncr.26418; Lagrou K, 2001, J Pediatr Endocrinol Metab, V14 Suppl 5, P1249; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Rekers-Mombarg LTM, 1998, ACTA PAEDIATR, V87, P865, DOI 10.1080/080352598750013653; ROBINSON LD, 1991, BIOMETRICS, V47, P342; Rueegg CS, 2013, J CANCER SURVIV, V7, P511, DOI 10.1007/s11764-013-0288-4; Sandberg DE, 1998, J CLIN ENDOCR METAB, V83, P1134, DOI 10.1210/jc.83.4.1134; Sommer R, 2015, EUR J PEDIATR, V174, P875, DOI 10.1007/s00431-014-2480-6; Stabler B, 2001, HORM RES, V56, P55, DOI 10.1159/000048136; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Stouthart PJHM, 2003, PSYCHONEUROENDOCRINO, V28, P612, DOI 10.1016/S0306-4530(02)00045-8; STRACK F, 1990, BRIT J SOC PSYCHOL, V29, P303, DOI 10.1111/j.2044-8309.1990.tb00912.x; Taback SP, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-49; Vahl N, 2000, J CLIN ENDOCR METAB, V85, P1874, DOI 10.1210/jc.85.5.1874; Visser-van Balen H, 2008, HORM RES, V69, P172, DOI 10.1159/000112591; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wengenroth L, 2014, PEDIATR BLOOD CANCER, V61, P538, DOI 10.1002/pbc.24821; Wiren L, 2001, J CLIN ENDOCR METAB, V86, P3494, DOI 10.1210/jc.86.8.3494; Wit JM, 2007, HORM RES, V68, pVII; Yuen KCJ, 2013, EUR J ENDOCRINOL, V169, P511, DOI 10.1530/EJE-13-0280	37	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140944	10.1371/journal.pone.0140944	http://dx.doi.org/10.1371/journal.pone.0140944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0DF	26474398	Green Published, Green Submitted, gold			2022-12-27	WOS:000363185500132
J	Kenyon, CR; Tsoumanis, A; Schwartz, IS				Kenyon, Chris R.; Tsoumanis, Achilleas; Schwartz, Ilan Steven			HIV Prevalence Correlates with High-Risk Sexual Behavior in Ethiopia's Regions	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; NORTHWEST ETHIOPIA; SEROLOGICAL SURVEY; URBAN; SEROPREVALENCE; PREVENTION; UNIVERSITY; SYPHILIS; WOMEN	Background HIV prevalence varies between 0.9 and 6.5% in Ethiopia's eleven regions. Little has been published examining the reasons for this variation. Methods We evaluated the relationship between HIV prevalence by region and a range of risk factors in the 2005 and 2011 Ethiopian Demographic Health Surveys. Pearson's correlation was used to assess the relationship between HIV prevalence and each variable. Results There was a strong association between HIV prevalence and three markers of sexual risk: mean lifetime number of partners (men: r = 0.87; P < 0.001; women: r = 0.60; P = 0.05); reporting sex with a non-married, non-cohabiting partner (men: r = 0.92; P < 0.001, women r = 0.93; P < 0.001); and premarital sex. Condom usage and HIV testing were positively associated with HIV prevalence, while the prevalence of circumcision, polygamy, age at sexual debut and male migration were not associated with HIV prevalence. Conclusion Variation in sexual behavior may contribute to the large variations in HIV prevalence by region in Ethiopia. Population-level interventions to reduce risky sexual behavior in high HIV incidence regions should be considered.	[Kenyon, Chris R.; Tsoumanis, Achilleas] Inst Trop Med, HIV STI Unit, B-2000 Antwerp, Belgium; [Kenyon, Chris R.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Schwartz, Ilan Steven] Univ Manitoba, Dept Med Microbiol, Fac Hlth Sci, Coll Med, Winnipeg, MB, Canada; [Schwartz, Ilan Steven] Univ Antwerp, Fac Hlth Sci, Dept Epidemiol & Social Med, Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Cape Town; University of Manitoba; University of Antwerp	Kenyon, CR (corresponding author), Inst Trop Med, HIV STI Unit, B-2000 Antwerp, Belgium.	ckenyon@itg.be	Schwartz, Ilan S./J-5666-2019	Schwartz, Ilan S./0000-0002-7522-0281				Abebe Y, 2003, AIDS, V17, P1835, DOI 10.1097/00002030-200308150-00013; Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; Aral SO, 1996, J INFECT DIS, V174, pS127, DOI 10.1093/infdis/174.Supplement_2.S127; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Beauclair R, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-11; Berhan Y, 2015, AIDS RES TREAT, V2015, DOI 10.1155/2015/580961; Bolland MJ, 2013, NEW ENGL J MED, V368, P82, DOI 10.1056/NEJMc1210464; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Endris M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0848-5; Fenton KA, 2005, LANCET, V365, P1246, DOI 10.1016/S0140-6736(05)74813-3; Fontanet AL, 1998, AIDS, V12, P315, DOI 10.1097/00002030-199803000-00010; HAILU K, 1989, J MED VIROL, V28, P21, DOI 10.1002/jmv.1890280106; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; HUI CH, 1989, J CROSS CULT PSYCHOL, V20, P296, DOI 10.1177/0022022189203004; [ICF International Central Statistical Agency [Ethiopia]], 2011, ETHIOPIA DEMOGRAPHIC; Kenyon C, 2013, INT J STD AIDS, V24, P211, DOI 10.1177/0956462412472455; Kenyon C, 2014, INTERDISCIPLINARY PE; Kenyon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064080; Kenyon CR, 2015, J SEX RES, V52, P878, DOI 10.1080/00224499.2014.963832; Kenyon CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106230; Kirby D, 2008, SEX TRANSM INFECT, V84, pII35, DOI 10.1136/sti.2008.029892; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; KLOOS H, 2000, NE AFRICAN STUDIES, V7, P13, DOI DOI 10.1353/NAS.2004.0006; Low-Beer Daniel, 2003, Afr J AIDS Res, V2, P9, DOI 10.2989/16085906.2003.9626555; Mishra V, 2009, LEVELS AND SPREAD OF; Morris M, 2008, SEXUALLY TRANSMITTED, pxxv; Morris M, 2013, AIDS BEHAV; [ORC Macro Central Statistical Agency [Ethiopia]], 2005, ETHIOPIA DEMOGRAPHIC; ROSE G, 1990, BRIT MED J, V301, P1031, DOI 10.1136/bmj.301.6759.1031; Rose G, 1993, THE STRATEGY OF PREV, Vxii; Shisana O, 2014, SOUTH AFRICAN NATION; Smith J, 2015, J GERONTOL B PSYCHOL; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111; TSEGA E, 1988, ETHIOPIAN MED J, V26, P179	35	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140835	10.1371/journal.pone.0140835	http://dx.doi.org/10.1371/journal.pone.0140835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496073	Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200033
J	Lavoie, PM; Stritzke, A; Ting, J; Jabr, M; Jain, A; Kwan, E; Chakkarapani, E; Brooks, P; Brant, R; McNamara, PJ; Holsti, L				Lavoie, Pascal M.; Stritzke, Amelie; Ting, Joseph; Jabr, Mohammad; Jain, Amish; Kwan, Eddie; Chakkarapani, Ela; Brooks, Paul; Brant, Rollin; McNamara, Patrick J.; Holsti, Liisa			A Randomized Controlled Trial of the Use of Oral Glucose with or without Gentle Facilitated Tucking of Infants during Neonatal Echocardiography	PLOS ONE			English	Article							PRETERM INFANTS; PROCEDURAL PAIN; BEHAVIORAL INDICATORS; SUCROSE; CARE; MANAGEMENT; BORN; STRESS; BRAIN	Objective To compare the effect of oral glucose given with or without facilitated tucking (FT), versus placebo (water) to facilitate image acquisition during a targeted neonatal echocardiography (TNE). Design Factorial, double blind, randomized controlled trial. Setting Tertiary neonatal intensive care unit (NICU). Patients Infants born between 26 and 42 weeks of gestation (GA). Interventions One of four treatment groups: oral water (placebo), oral glucose (25%), facilitated tucking with oral water or facilitated tucking with oral glucose, during a single, structured TNE. All infants received a soother. Main Outcome Measure Change in Behavioral Indicators of Infant Pain (BIIP) scores. Results 104 preterm infants were randomized (mean +/- SD GA: 33.4 +/- 3.5 weeks). BIIP scores remained low during the echocardiography scan (median, [IQ range]: 0, [0 to 1]). There were no differences in the level of agitation of infants amongst the treatment groups, with estimated reductions in mean BIIP relative to control of 0.27 (95% CI - 0.40 to 0.94) with use of oral glucose and.04 (-0.63 to 0.70) with facilitated tucking. There were also no differences between treatment groups in the quality and duration of the echocardiography scans. Conclusions In stable infants in the NICU, a TNE can be performed with minimal disruption in a majority of cases, simply by providing a soother. The use of 25% glucose water in this context did not provide further benefit in reducing agitation and improving image acquisition.	[Lavoie, Pascal M.; Stritzke, Amelie; Ting, Joseph; Jabr, Mohammad; Chakkarapani, Ela; Brooks, Paul] Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC, Canada; [Lavoie, Pascal M.; Stritzke, Amelie; Ting, Joseph; Jabr, Mohammad] Univ British Columbia, Dept Pediat, Div Neonatol, Vancouver, BC V6T 1W5, Canada; [Lavoie, Pascal M.; Ting, Joseph; Brant, Rollin; Holsti, Liisa] Child & Family Res Inst, Vancouver, BC, Canada; [Jain, Amish; McNamara, Patrick J.] Univ Toronto, Dept Pediat, Div Neonatol, Toronto, ON M5S 1A1, Canada; [Kwan, Eddie] Childrens & Womens Hlth Ctr British Columbia, Dept Pharm, Vancouver, BC, Canada; [Brooks, Paul] Univ British Columbia, Dept Pediat, Div Cardiol, Vancouver, BC V6T 1W5, Canada; [Brant, Rollin] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Holsti, Liisa] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC V5Z 1M9, Canada	BC Women's Hospital & Health Centre; University of British Columbia; Child & Family Research Institute; University of Toronto; BC Women's Hospital & Health Centre; University of British Columbia; University of British Columbia; University of British Columbia	Lavoie, PM (corresponding author), Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC, Canada.	plavoie@cw.bc.ca; liisa.holsti@ubc.ca	Jain, Amish/P-5856-2015; MCNAMARA, PATRICK J/M-6244-2018; Stritzke, Amelie/V-7953-2019	Brant, Rollin/0000-0002-8026-2451; Chakkarapani, Elavazhagan/0000-0003-3380-047X; Holsti, Liisa/0000-0003-0315-0330; Ting, Joseph Y/0000-0002-5246-8823; Lavoie, Pascal/0000-0002-2205-0362; McNamara, Patrick/0000-0001-7648-8872; Jain, Amish/0000-0002-1413-2966	Alva Foundation; Faculty of Medicine, University of British Columbia; CFRI; Michael Smith Foundation for Health Research (MSFHR); Canadian Institutes of Health Research Canada Research Chair	Alva Foundation; Faculty of Medicine, University of British Columbia; CFRI; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research Canada Research Chair(Canada Research ChairsCanadian Institutes of Health Research (CIHR))	This trial was funded by the Alva Foundation and by an unrestrictive grant from the Faculty of Medicine, University of British Columbia (to LH). PML is supported by Clinician-Scientist Awards from the CFRI and the Michael Smith Foundation for Health Research (MSFHR). LH is supported by a Canadian Institutes of Health Research Canada Research Chair. The funders had no role in the study design, data analysis and publication.	American Academy of Pediatrics, 2007, Adv Neonatal Care, V7, P151; [Anonymous], 2014, R LANG ENV STAT COMP; Asmerom Y, 2013, J PEDIATR-US, V163, P29, DOI 10.1016/j.jpeds.2012.12.088; Axelin A, 2006, EARLY HUM DEV, V82, P241, DOI 10.1016/j.earlhumdev.2005.09.012; Axelin A, 2009, CLIN J PAIN, V25, P138, DOI 10.1097/AJP.0b013e318181ad81; BLASS EM, 1989, ANN NY ACAD SCI, V575, P292, DOI 10.1111/j.1749-6632.1989.tb53251.x; Brummelte S, 2012, ANN NEUROL, V71, P385, DOI 10.1002/ana.22267; Doesburg SM, 2013, PAIN, V154, P1946, DOI 10.1016/j.pain.2013.04.009; Evans N, 2011, SEMIN FETAL NEONAT M, V16, P61, DOI 10.1016/j.siny.2010.06.005; Fabrizi L, 2011, CURR BIOL, V21, P1552, DOI 10.1016/j.cub.2011.08.010; Fitzgerald M, 1999, P NATL ACAD SCI USA, V96, P7719, DOI 10.1073/pnas.96.14.7719; Grunau RE, 2009, PAIN, V143, P138, DOI 10.1016/j.pain.2009.02.014; Holsti L, 2007, PAIN, V132, P264, DOI 10.1016/j.pain.2007.01.033; Holsti L, 2008, CLIN J PAIN, V24, P83, DOI 10.1097/AJP.0b013e318158c5e5; Holsti L, 2007, EARLY HUM DEV, V83, P341, DOI 10.1016/j.earlhumdev.2006.08.005; Holsti L, 2006, CLIN J PAIN, V22, P757, DOI 10.1097/01.ajp.0000210921.10912.47; Holsti L, 2010, PEDIATRICS, V125, P1042, DOI 10.1542/peds.2009-2445; Kluckow M, 2007, J PEDIATR-US, V150, P125, DOI 10.1016/j.jpeds.2006.10.056; Lavoie PM, 2015, ARCH DIS CHILD-FETAL, V100, pF374, DOI 10.1136/archdischild-2015-308191; Lefrak L, 2006, PEDIATRICS, V118, pS197, DOI 10.1542/peds.2006-0913R; McNamara PJ, 2010, SEMIN FETAL NEONATAL; Mertens L, 2011, J AM SOC ECHOCARDIOG, V24, P1057, DOI 10.1016/j.echo.2011.07.014; Noori S, 2014, J PERINATOL, V34, P847, DOI 10.1038/jp.2014.127; Obeidat H, 2009, J PERINAT NEONAT NUR, V23, P372, DOI 10.1097/JPN.0b013e3181bdcf77; Slater R, 2010, LANCET, V376, P1225, DOI 10.1016/S0140-6736(10)61303-7; Stevens B, 2002, CLIN PERINATOL, V29, P459, DOI 10.1016/S0095-5108(02)00016-7; Taddio A, 2009, PAIN, V144, P43, DOI 10.1016/j.pain.2009.02.012; Taddio A, 2009, PEDIATRICS, V123, pe425, DOI 10.1542/peds.2008-3028; Vinall J, 2012, PAIN, V153, P1374, DOI 10.1016/j.pain.2012.02.007; Ward-Larson Charlotte, 2004, MCN Am J Matern Child Nurs, V29, P151, DOI 10.1097/00005721-200405000-00004	31	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141015	10.1371/journal.pone.0141015	http://dx.doi.org/10.1371/journal.pone.0141015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496361	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200053
J	Somanchi, SS; McCulley, KJ; Somanchi, A; Chan, LL; Lee, DA				Somanchi, Srinivas S.; McCulley, Kelsey J.; Somanchi, Anitha; Chan, Leo L.; Lee, Dean A.			A Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image Cytometry	PLOS ONE			English	Article							NK CELL; FLOW-CYTOMETRY; RELEASE-ASSAY; TUMOR-CELLS; EFFECTOR-CELLS; LYMPHOID-CELLS; IN-VITRO; T-CELLS; TARGET; ACTIVATION	Natural killer (NK) cells belong to the innate arm of the immune system and though activated NK cells can modulate immune responses through the secretion of cytokines, their primary effector function is through target cell lysis. Accordingly, cytotoxicity assays are central to studying NK cell function. The (51)Chromium release assay, is the "gold standard" for cytotoxicity assay, however, due to concerns over toxicity associated with the use and disposal of radioactive compounds there is a significant interest in non-radioactive methods. We have previously used the calcein release assay as a non-radioactive alternative for studying NK cell cytotoxicity. In this study, we show that the calcein release assay varies in its dynamic range for different tumor targets, and that the entrapped calcein could remain unreleased within apoptotic bodies of lysed tumor targets or incompletely released resulting in underestimation of percent specific lysis. To overcome these limitations, we developed a novel cytotoxicity assay using the Cellometer Vision Image Cytometer and compared this method to standard calcein release assay for measuring NK cell cytotoxicity. Using tumor lines K562, 721.221, and Jurkat, we demonstrate here that image cytometry shows significantly higher percent specific lysis of the target cells compared to the standard calcein release assay within the same experimental setup. Image cytometry is able to accurately analyze live target cells by excluding dimmer cells and smaller apoptotic bodies from viable target cell counts. The image cytometry-based cytotoxicity assay is a simple, direct and sensitive method and is an appealing option for routine cytotoxicity assay.	[Somanchi, Srinivas S.; Somanchi, Anitha; Lee, Dean A.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA; [McCulley, Kelsey J.; Chan, Leo L.] Nexcelom Biosci LLC, Dept Technol R&D, Lawrence, MA 01843 USA; [Somanchi, Anitha; Lee, Dean A.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Somanchi, SS (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA.	sssomanchi@mdanderson.org	Lee, Dean Anthony/AAK-8443-2021	Lee, Dean Anthony/0000-0001-6693-5392; Somanchi, Anitha/0000-0002-3068-447X	Cancer Prevention and Research Institute of Texas (CPRIT) [RP110553]; St. Baldrick's Foundation [139143]; Translational Research Program Award from the Leukemia & Lymphoma Society [TRP-6149-14]	Cancer Prevention and Research Institute of Texas (CPRIT); St. Baldrick's Foundation; Translational Research Program Award from the Leukemia & Lymphoma Society	This research was funded in part by grant RP110553 from the Cancer Prevention and Research Institute of Texas (CPRIT), Scholar Award 139143 from the St. Baldrick's Foundation, and Translational Research Program Award TRP-6149-14 from the Leukemia & Lymphoma Society.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Bhat R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000326; Binyamin L, 2008, J IMMUNOL, V180, P6392, DOI 10.4049/jimmunol.180.9.6392; BRUNNER KT, 1968, IMMUNOLOGY, V14, P181; Carbone E, 1997, J EXP MED, V185, P2053, DOI 10.1084/jem.185.12.2053; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chan LL, 2012, J FLUORESC, V22, P1301, DOI 10.1007/s10895-012-1072-y; Chan LL, 2011, CYTOM PART A, V79A, P507, DOI 10.1002/cyto.a.21071; Cho D, 2010, CLIN CANCER RES, V16, P3901, DOI 10.1158/1078-0432.CCR-10-0735; Choi PJ, 2013, P NATL ACAD SCI USA, V110, P6488, DOI 10.1073/pnas.1221312110; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Denman CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030264; Devevre E, 2006, J IMMUNOL METHODS, V311, P31, DOI 10.1016/j.jim.2006.01.011; Erskine CL, 2012, JOVE-J VIS EXP, DOI 10.3791/3683; Fehniger TA, 2000, J CLIN INVEST, V106, P117, DOI 10.1172/JCI6218; FLIEGER D, 1995, J IMMUNOL METHODS, V180, P1, DOI 10.1016/0022-1759(94)00293-6; Forslund E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00300; Guldevall K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015453; Hallett WHD, 2008, J IMMUNOL, V180, P163, DOI 10.4049/jimmunol.180.1.163; Jang YY, 2012, ANN CLIN LAB SCI, V42, P42; Jedema I, 2004, BLOOD, V103, P2677, DOI 10.1182/blood-2003-06-2070; Karimi MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089357; Kim GG, 2007, J IMMUNOL METHODS, V325, P51, DOI 10.1016/j.jim.2007.05.013; KOLBER MA, 1988, J IMMUNOL METHODS, V108, P255, DOI 10.1016/0022-1759(88)90427-9; Konjevic G, 2001, BREAST CANCER RES TR, V66, P255, DOI 10.1023/A:1010602822483; Konjevic G, 1997, J IMMUNOL METHODS, V200, P199, DOI 10.1016/S0022-1759(96)00194-9; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Kurago ZB, 1998, J IMMUNOL, V160, P1573; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Lundqvist A, 2006, CANCER RES, V66, P7317, DOI 10.1158/0008-5472.CAN-06-0680; Lundqvist A, 2010, J IMMUNOL, V184, P1139, DOI 10.4049/jimmunol.0902856; Nagao F, 1996, IMMUNOL INVEST, V25, P507, DOI 10.3109/08820139609055739; Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001; Park KH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210726; Pietra G, 2012, CANCER RES, V72, P1407, DOI 10.1158/0008-5472.CAN-11-2544; RADOSEVIC K, 1990, J IMMUNOL METHODS, V135, P81, DOI 10.1016/0022-1759(90)90259-X; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Somanchi Srinivas S, 2011, J Vis Exp, DOI 10.3791/2540; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; VAINIO T, 1964, NATURE, V204, P453, DOI 10.1038/204453a0; Valiathan R, 2012, SCAND J IMMUNOL, V75, P455, DOI 10.1111/j.1365-3083.2011.02667.x; Vanherberghen B, 2013, BLOOD, V121, P1326, DOI 10.1182/blood-2012-06-439851; Wennerberg E, 2013, INT J CANCER, V133, P1643, DOI 10.1002/ijc.28163; WIERDA WG, 1989, J IMMUNOL METHODS, V122, P15, DOI 10.1016/0022-1759(89)90329-3; Zaritskaya L, 2009, J IMMUNOTHER, V32, P186, DOI 10.1097/CJI.0b013e318197b1b2	46	53	54	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141074	10.1371/journal.pone.0141074	http://dx.doi.org/10.1371/journal.pone.0141074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492577	Green Published, Green Submitted, gold			2022-12-27	WOS:000363249300027
J	Bruzzone, S; Magnone, M; Mannino, E; Sociali, G; Sturla, L; Fresia, C; Booz, V; Emionite, L; De Flora, A; Zocchi, E				Bruzzone, Santina; Magnone, Mirko; Mannino, Elena; Sociali, Giovanna; Sturla, Laura; Fresia, Chiara; Booz, Valeria; Emionite, Laura; De Flora, Antonio; Zocchi, Elena			Abscisic Acid Stimulates Glucagon-Like Peptide-1 Secretion from L-Cells and Its Oral Administration Increases Plasma Glucagon-Like Peptide-1 Levels in Rats	PLOS ONE			English	Article							CYCLIC ADP-RIBOSE; C-LIKE PROTEIN-2; HUMAN GRANULOCYTES; 2ND-MESSENGER; HYPERGLYCEMIA; MECHANISMS; RESPONSES; LANCL2; MODEL; GLP-1	In recent years, Abscisic Acid (ABA) has been demonstrated to be involved in the regulation of glucose homeostasis in mammals as an endogenous hormone, by stimulating both insulin release and peripheral glucose uptake. In addition, ABA is released by glucose-or GLP1- stimulated beta-pancreatic cells. Here we investigated whether ABA can stimulate GLP-1 release. The human enteroendocrine L cell line hNCI-H716 was used to explore whether ABA stimulates in vitro GLP-1 secretion and/or transcription. ABA induced GLP-1 release in hNCI-H716 cells, through a cAMP/PKA-dependent mechanism. ABA also enhanced GLP-1 transcription. In addition, oral administration of ABA significantly increased plasma GLP-1 and insulin levels in rats. In conclusion, ABA can stimulate GLP-1 release: this result and the previous observation that GLP-1 stimulates ABA release from beta-cells, suggest a positive feed-back mechanism between ABA and GLP-1, regulating glucose homeostasis. Type 2 diabetes treatments targeting the GLP-1 axis by either inhibiting its rapid clearance by dipeptidyl-peptidase IV or using GLP-1 mimetics are currently used. Moreover, the development of treatments aimed at stimulating GLP-1 release from L cells has been considered as an alternative approach. Accordingly, our finding that ABA increases GLP-1 release in vitro and in vivo may suggest ABA and/or ABA analogs as potential anti-diabetic treatments.	[Bruzzone, Santina; Magnone, Mirko; Mannino, Elena; Sociali, Giovanna; Sturla, Laura; Fresia, Chiara; Booz, Valeria; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Biochem Sect, Dept Expt Med DIMES, Genoa, Italy; [Bruzzone, Santina; Magnone, Mirko; Mannino, Elena; Sociali, Giovanna; Sturla, Laura; Fresia, Chiara; Booz, Valeria; De Flora, Antonio; Zocchi, Elena] Univ Genoa, CEBR, Genoa, Italy; [Emionite, Laura] IRCCS AOU San Martino IST Ist Nazl Ric Canc, Anim Facil, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST	Bruzzone, S (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med DIMES, Genoa, Italy.	santina.bruzzone@unige.it	Bruzzone, Santina/A-4264-2015; Emionite, Laura/AAB-3120-2020	Bruzzone, Santina/0000-0003-2034-3716; Emionite, Laura/0000-0002-5199-6384; FRESIA, CHIARA MARTA/0000-0002-9177-4655	Italian Ministry of Education, University and Scientific Research [2010MCLBCZ, RBFR1299K0_002]; University of Genova; Fondazione CARIGE; Compagnia di S. Paolo [2012-ID-ROL316]	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Genova; Fondazione CARIGE(Fondazione Carige); Compagnia di S. Paolo(Compagnia di San Paolo)	This work was supported in part by the Italian Ministry of Education, University and Scientific Research (grants #2010MCLBCZ to EZ and FIRB 2012 #RBFR1299K0_002 to CF), by the University of Genova (PRA2011 to SB), by the Fondazione CARIGE, by the Compagnia di S. Paolo (grant #2012-ID-ROL316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassaganya-Riera J, 2011, J BIOL CHEM, V286, P2504, DOI 10.1074/jbc.M110.160077; Bruzzone S, 2015, EP 2511272 B1, Patent No. 2511272B1; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bruzzone S, 2012, BIOCHEM BIOPH RES CO, V422, P70, DOI 10.1016/j.bbrc.2012.04.107; Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140; Bruzzone S, 2012, J CELL PHYSIOL, V227, P2502, DOI 10.1002/jcp.22987; Ezcurra M, 2013, CURR OPIN PHARMACOL, V13, P922, DOI 10.1016/j.coph.2013.08.013; Forest T, 2014, ENDOCRINOLOGY, V155, P783, DOI 10.1210/en.2013-1781; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Guri AJ, 2010, J NUTR BIOCHEM, V21, P1178, DOI 10.1016/j.jnutbio.2009.10.003; Guri AJ, 2010, CLIN NUTR, V29, P646, DOI 10.1016/j.clnu.2010.02.003; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hong JH, 2013, PLANT CELL REP, V32, P971, DOI 10.1007/s00299-013-1439-9; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Lu PY, 2014, CURR DRUG TARGETS, V15, P565, DOI 10.2174/1389450115666140313123714; Lu PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034643; Magnone M, 2009, J BIOL CHEM, V284, P17808, DOI 10.1074/jbc.M809546200; Moreschi I, 2006, J BIOL CHEM, V281, P31419, DOI 10.1074/jbc.M606625200; Reimann F, 2004, DIABETOLOGIA, V47, P1592, DOI 10.1007/s00125-004-1498-0; Reimer RA, 2001, ENDOCRINOLOGY, V142, P4522, DOI 10.1210/en.142.10.4522; Saha JK, 2005, EXP BIOL MED, V230, P777, DOI 10.1177/153537020523001012; Sandoval DA, 2015, PHYSIOL REV, V95, P513, DOI 10.1152/physrev.00013.2014; Sturla L, 2011, BIOCHEM BIOPH RES CO, V415, P390, DOI 10.1016/j.bbrc.2011.10.079; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; Tolhurst G, 2011, ENDOCRINOLOGY, V152, P405, DOI 10.1210/en.2010-0956; Tossi V, 2012, TRENDS PLANT SCI, V17, P510, DOI 10.1016/j.tplants.2012.05.007; Velasquez DA, 2010, VITAM HORM, V84, P303, DOI [10.1016/B978-0-12-381517-0.00011-4, 10.1016/S0083-6729(10)84007-5]; Vigliarolo T, 2015, J BIOL CHEM, V290, P13042, DOI 10.1074/jbc.M114.629501; Zeng M, 2014, MOL BIOL CELL, V25, P3954, DOI 10.1091/mbc.E14-01-0004	32	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140588	10.1371/journal.pone.0140588	http://dx.doi.org/10.1371/journal.pone.0140588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488296	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400060
J	Calzolari, M; Pautasso, A; Montarsi, F; Albieri, A; Bellini, R; Bonilauri, P; Defilippo, F; Lelli, D; Moreno, A; Chiari, M; Tamba, M; Zanoni, M; Varisco, G; Bertolini, S; Modesto, P; Radaelli, MC; Iulini, B; Prearo, M; Ravagnan, S; Cazzin, S; Mulatti, P; Monne, I; Bonfanti, L; Marangon, S; Goffredo, M; Savini, G; Martini, S; Mosca, A; Farioli, M; Brenzoni, LG; Palei, M; Russo, F; Natalini, S; Angelini, P; Casalone, C; Dottori, M; Capelli, G				Calzolari, Mattia; Pautasso, Alessandra; Montarsi, Fabrizio; Albieri, Alessandro; Bellini, Romeo; Bonilauri, Paolo; Defilippo, Francesco; Lelli, Davide; Moreno, Ana; Chiari, Mario; Tamba, Marco; Zanoni, Mariagrazia; Varisco, Giorgio; Bertolini, Silvia; Modesto, Paola; Radaelli, Maria Cristina; Iulini, Barbara; Prearo, Marino; Ravagnan, Silvia; Cazzin, Stefania; Mulatti, Paolo; Monne, Isabella; Bonfanti, Lebana; Marangon, Stefano; Goffredo, Maria; Savini, Giovanni; Martini, Simone; Mosca, Andrea; Farioli, Marco; Brenzoni, Laura Gemma; Palei, Manlio; Russo, Francesca; Natalini, Silvano; Angelini, Paola; Casalone, Cristina; Dottori, Michele; Capelli, Gioia			West Nile Virus Surveillance in 2013 via Mosquito Screening in Northern Italy and the Influence of Weather on Virus Circulation	PLOS ONE			English	Article							REGION; TIME; EPIDEMIOLOGY; SPACE; FEVER; BLOOD; CULEX; ASSAY	West Nile virus (WNV) is a recently re-emerged health problem in Europe. In Italy, an increasing number of outbreaks of West Nile disease, with occurrences of human cases, have been reported since 2008. This is particularly true in northern Italy, where entomological surveillance systems have been implemented at a regional level. The aim of this study was to use, for the first time, all the entomological data collected in the five regions undergoing surveillance for WNV in northern Italy to characterize the viral circulation (at a spatial and temporal scale), identify potential mosquito vectors, and specify relationships between virus circulation and meteorological conditions. In 2013, 286 sites covering the entire Pianura Padana area were monitored. A total of 757,461 mosquitoes were sampled. Of these, 562,079 were tested by real-time PCR in 9,268 pools, of which 180 (1.9%) were positive for WNV. The largest part of the detected WNV sequences belonged to lineage II, demonstrating that, unlike those in the past, the 2013 outbreak was mainly sustained by this WNV lineage. This surveillance also detected the Usutu virus, a WNV-related flavivirus, in 241 (2.6%) pools. The WNV surveillance systems precisely identified the area affected by the virus and detected the viral circulation approximately two weeks before the occurrence of onset of human cases. Ninety percent of the sampled mosquitoes were Culex pipiens, and 178/180 WNV-positive pools were composed of only this species, suggesting this mosquito is the main WNV vector in northern Italy. A significantly higher abundance of the vector was recorded in the WNV circulation area, which was characterized by warmer and less rainy conditions and greater evapotranspiration compared to the rest of the Pianura Padana, suggesting that areas exposed to these conditions are more suitable for WNV circulation. This observation highlights warmer and less rainy conditions as factors able to enhance WNV circulation and cause virus spillover outside the sylvatic cycle.	[Calzolari, Mattia; Bonilauri, Paolo; Defilippo, Francesco; Lelli, Davide; Moreno, Ana; Chiari, Mario; Tamba, Marco; Zanoni, Mariagrazia; Varisco, Giorgio; Dottori, Michele] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Pautasso, Alessandra; Bertolini, Silvia; Modesto, Paola; Radaelli, Maria Cristina; Iulini, Barbara; Prearo, Marino; Casalone, Cristina] Ist Zooprofilatt Piemonte Liguria & Valle Aosta, Turin, Italy; [Montarsi, Fabrizio; Ravagnan, Silvia; Cazzin, Stefania; Mulatti, Paolo; Monne, Isabella; Bonfanti, Lebana; Marangon, Stefano] Ist Zooprofilatt Sperimentale Venezie, Leganro, PD, Italy; [Albieri, Alessandro; Bellini, Romeo] Ctr Agr Ambiente G Nicoli, Crevalcore, BO, Italy; [Goffredo, Maria; Savini, Giovanni] Ist Zooprofilatt Spermentale Abruzzo & Molis, Teramo, Italy; [Martini, Simone] Entostudio Snc, Brugine, PD, Italy; [Mosca, Andrea] Ist Piante Legno & Ambiente SpA, Turin, Italy; [Farioli, Marco; Brenzoni, Laura Gemma] Reg Lombardia, Milan, Italy; [Palei, Manlio] Reg Friuli Venezia Giulia, Trieste, Italy; [Russo, Francesca] Reg Veneto, Venice, Italy; [Natalini, Silvano; Angelini, Paola] Reg Emilia Romagna, Bologna, Italy	IZS Lombardia e Emilia; IZS Piemonte Liguria e Valle D'aosta; IZS delle Venezie	Calzolari, M (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy.	mattia.calzolari@izsler.it	Prearo, Marino/AAF-3369-2021; Mulatti, Paolo/AFS-0719-2022; Savini, Giovanni/D-8416-2016; dottori, michele/AAB-3815-2019; Calzolari, Mattia/AAB-9487-2019; Lelli, Davide DL/K-5178-2016; Casalone, Cristina/J-6763-2018; Moreno, Ana/Q-2173-2019; Vita, Serafina/D-9445-2016; Mulatti, Paolo/V-7274-2019; Monne, Isabella/K-7652-2016; Modesto, Paola/AAW-3642-2020; Savini, Giovanni/AAT-7897-2020; Tamba, Marco/J-5495-2016; Lelli, Davide/AAB-6996-2019; Goffredo, Maria/D-9542-2016; Pautasso, Alessandra/J-7180-2018	Savini, Giovanni/0000-0001-7933-7367; Calzolari, Mattia/0000-0001-7489-2556; Casalone, Cristina/0000-0001-5271-832X; Moreno, Ana/0000-0002-8497-9708; Vita, Serafina/0000-0002-8045-1236; Mulatti, Paolo/0000-0001-8188-997X; Monne, Isabella/0000-0002-6564-4689; Savini, Giovanni/0000-0001-7933-7367; Tamba, Marco/0000-0002-5878-4595; Lelli, Davide/0000-0002-5775-6058; Varisco, Giorgio/0000-0001-7415-5644; MOSCA, Andrea/0000-0003-2180-0405; Bonilauri, Paolo/0000-0002-2625-7993; Goffredo, Maria/0000-0002-6831-4167; defilippo, francesco/0000-0002-1898-0997; Dottori, Michele/0000-0002-9975-0367; Marangon, Stefano/0000-0002-3158-4243; Ravagnan, Silvia/0000-0002-7146-6452; Pautasso, Alessandra/0000-0002-3135-5379	Regione Emilia-Romagna; CAA [COMM07001]; Regione Veneto; Regione Friuli Venezia Giulia; Entostudio snc	Regione Emilia-Romagna(Regione Emilia Romagna); CAA; Regione Veneto(Regione Veneto); Regione Friuli Venezia Giulia(Regione Friuli Venezia Giulia); Entostudio snc	The Regione Emilia-Romagna (www.regione.emilia-romagna.it) had partially funded this work to IZSLER (www.izsler.it) and CAA (www.caa.it) by the Regional project on insect borne diseases (COMM07001). The Regione Veneto (http://www.regione.veneto.it) and the Regione Friuli Venezia Giulia (http://www.regione.fvg.it) had partially funded this work to IZSVe by the Regional projects on surveillance of vector-borne diseases. No other external funding was utilized for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Entostudio snc provided support in the form of a salary for author MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Angelini P, 2010, EURO SURVEILL, V15; Angenvoort J, 2013, VET MICROBIOL, V167, P168, DOI 10.1016/j.vetmic.2013.08.013; Tran A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-26; Autorino GL, 2002, EMERG INFECT DIS, V8, P1372, DOI 10.3201/eid0812.020234; Balenghien T, 2008, VECTOR-BORNE ZOONOT, V8, P589, DOI 10.1089/vbz.2007.0266; Barzon L, 2013, INT J ENV RES PUB HE, V10, P4669, DOI 10.3390/ijerph10104669; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bellini R, 2014, EURO SURVEILL, V19; Bellini R., 2002, 68 ANN M AM MOSQ CON; Busani L, 2011, EPIDEMIOL INFECT, V139, P818, DOI 10.1017/S0950268810001871; Calzolari M, 2012, PLOS ONE, V7; Calzolari M, 2013, VET ITAL, V49, P315; Calzolari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063978; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; Calzolari M, 2010, VECTOR-BORNE ZOONOT, V10, P875, DOI 10.1089/vbz.2009.0176; Capelli G, 2013, VET ITAL, V49, P263; Cavrini F, 2009, EUROSURVEILLANCE, V14, P17; Centers for Disease Control and Prevention, 2013, W NIL VIR US GUID SU; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 EM V; European Centre for Disease Prevention and Control, 2009, EXPERT CONSULTATION; Gaibani P, 2012, VECTOR-BORNE ZOONOT, V12, P431, DOI 10.1089/vbz.2011.0813; Gaibani P, 2010, J CLIN MICROBIOL, V48, P3338, DOI 10.1128/JCM.02501-09; Hartemink N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020817; Higgs Stephen, 2005, P167; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Macini P, 2008, EURO SURVEILL, V13; Marcantonio M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121158; Mulatti P, 2015, EPIDEMIOL INFECT, V143, P202, DOI 10.1017/S0950268814000442; Mulatti P, 2013, ZOONOSES PUBLIC HLTH, V60, P375, DOI 10.1111/zph.12013; NCOOA, GLOB LAND ON KIL BAS; Pautasso A, 2013, TRANSBOUND EMERG DIS, V60, P154, DOI 10.1111/tbed.12123; Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561; Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398; Pecorari M, 2009, EUROSURVEILLANCE, V14, P15; Pierro A, 2013, CLIN MICROBIOL INFEC, V19, pE451, DOI 10.1111/1469-0691.12241; Rizzo C, 2009, EURO SURVEILL, V14; Rogers DJ, 2000, ADV PARASIT, V47, P129, DOI 10.1016/S0065-308X(00)47008-9; Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211; Savage HM, 2004, J AM MOSQUITO CONTR, V20, P208; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Schaffner F, MOSQUITOES EUROPE ID; Severini Francesco, 2009, Fragmenta Entomologica, V41, P213; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008	48	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140915	10.1371/journal.pone.0140915	http://dx.doi.org/10.1371/journal.pone.0140915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488475	Green Published, gold			2022-12-27	WOS:000363248400080
J	Mehravari, AS; Tanner, D; Wampler, EK; Valentine, GD; Osterhout, L				Mehravari, Alison S.; Tanner, Darren; Wampler, Emma K.; Valentine, Geoffrey D.; Osterhout, Lee			Effects of Grammaticality and Morphological Complexity on the P600 Event-Related Potential Component	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; MEMORY INTERFERENCE; WORKING-MEMORY; N400 COMPONENT; TIME-COURSE; BRAIN; AGREEMENT; COMPREHENSION; ACTIVATION; GENDER	We investigated interactions between morphological complexity and grammaticality on electrophysiological markers of grammatical processing during reading. Our goal was to determine whether morphological complexity and stimulus grammaticality have independent or additive effects on the P600 event-related potential component. Participants read sentences that were either well-formed or grammatically ill-formed, in which the critical word was either morphologically simple or complex. Results revealed no effects of complexity for well-formed stimuli, but the P600 amplitude was significantly larger for morphologically complex ungrammatical stimuli than for morphologically simple ungrammatical stimuli. These findings suggest that some previous work may have inadequately characterized factors related to reanalysis during morphosyntactic processing. Our results show that morphological complexity by itself does not elicit P600 effects. However, in ungrammatical circumstances, overt morphology provides a more robust and reliable cue to morphosyntactic relationships than null affixation.	[Mehravari, Alison S.; Osterhout, Lee] Univ Washington, Program Neurosci, Seattle, WA 98195 USA; [Tanner, Darren] Univ Illinois, Neurosci Program, Beckman Inst Adv Sci & Technol, Dept Linguist, Champaign, IL 61801 USA; [Wampler, Emma K.; Valentine, Geoffrey D.; Osterhout, Lee] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; University of Washington Seattle	Tanner, D (corresponding author), Univ Illinois, Neurosci Program, Beckman Inst Adv Sci & Technol, Dept Linguist, Champaign, IL 61801 USA.	dstanner@gmail.com		Tanner, Darren/0000-0003-0805-0494	National Institutes of Health [F31 DC013700, T32 DC005361]; National Science Foundation [BCS-1349110, BCS-1431324, BCS-1261501]; Division Of Behavioral and Cognitive Sci [1431324] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC005361, F31DC013700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors received no funding specifically designated for this work. Portions of this research were conducted while ASM was supported by National Institutes of Health (http://www.nih.gov/) grant F31 DC013700 and National Institutes of Health grant T32 DC005361, while DT was supported by National Science Foundation (http://www.nsf.gov/) grant BCS-1349110 and National Science Foundation grant BCS-1431324, and while LO was supported by National Science Foundation grant BCS-1261501. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2003, LANG COGNITIVE PROC, V18, P405, DOI 10.1080/01690960244000054; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Baayen R. H., 1995, THE CELEX LEXICAL DA; Brothers T, 2015, COGNITION, V136, P135, DOI 10.1016/j.cognition.2014.10.017; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Davies M., 2008, THE CORPUS OF CONTEM; De Swart H, 1998, NAT LANG LINGUIST TH, V16, P347, DOI 10.1023/A:1005916004600; Dell GS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0394; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; DeLong KA, 2014, NEUROPSYCHOLOGIA, V61, P150, DOI 10.1016/j.neuropsychologia.2014.06.016; Dikker S, 2010, PSYCHOL SCI, V21, P629, DOI 10.1177/0956797610367751; Dikker S, 2009, COGNITION, V110, P293, DOI 10.1016/j.cognition.2008.09.008; Dillon B, 2013, J MEM LANG, V69, P85, DOI 10.1016/j.jml.2013.04.003; Farmer TA, 2006, P NATL ACAD SCI USA, V103, P12203, DOI 10.1073/pnas.0602173103; Federmeier KD, 2007, BRAIN RES, V1146, P75, DOI 10.1016/j.brainres.2006.06.101; Federmeier KD, 2007, PSYCHOPHYSIOLOGY, V44, P491, DOI 10.1111/j.1469-8986.2007.00531.x; Federmeier KD, 1999, J MEM LANG, V41, P469, DOI 10.1006/jmla.1999.2660; Fine AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077661; Friederici AD, 1996, J EXP PSYCHOL LEARN, V22, P1219, DOI 10.1037//0278-7393.22.5.1219; Garnsey SM, 1997, J MEM LANG, V37, P58, DOI 10.1006/jmla.1997.2512; Gordon PC, 2001, J EXP PSYCHOL LEARN, V27, P1411, DOI 10.1037/0278-7393.27.6.1411; Guajardo LF, 2014, NEUROIMAGE, V91, P262, DOI 10.1016/j.neuroimage.2013.09.077; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Kaan E, 2002, J PSYCHOLINGUIST RES, V31, P165, DOI 10.1023/A:1014978917769; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lavric A, 2007, J COGNITIVE NEUROSCI, V19, P866, DOI 10.1162/jocn.2007.19.5.866; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Lew-Williams C, 2007, PSYCHOL SCI, V18, P193, DOI 10.1111/j.1467-9280.2007.01871.x; Lewis RL, 2006, TRENDS COGN SCI, V10, P447, DOI 10.1016/j.tics.2006.08.007; Lewis RL, 2005, COGNITIVE SCI, V29, P375, DOI 10.1207/s15516709cog0000_25; Luke SG, 2015, LANG COGN NEUROSCI, V30, P735, DOI 10.1080/23273798.2015.1009918; Luke SG, 2012, MEM COGNITION, V40, P628, DOI [10.3758/s13421-011-0170-4, 10.3758/s13421-011-0175-z]; Marcinek BT, 2014, POSTER PRESENTED AT; McElree B, 2006, PSYCHOL LEARN MOTIV, V46, P155, DOI 10.1016/S0079-7421(06)46005-9; McKinnon R, 2003, NEUROREPORT, V14, P883, DOI 10.1097/00001756-200305060-00022; Molinaro N, 2011, CORTEX, V47, P908, DOI 10.1016/j.cortex.2011.02.019; Morgan-Short K, 2012, J COGNITIVE NEUROSCI, V24, P933, DOI 10.1162/jocn_a_00119; Morris J, 2007, PSYCHOPHYSIOLOGY, V44, P506, DOI 10.1111/j.1469-8986.2007.00538.x; Morris J, 2012, BRAIN LANG, V123, P81, DOI 10.1016/j.bandl.2012.07.001; Morris J, 2008, LANG COGNITIVE PROC, V23, P1021, DOI 10.1080/01690960802299386; Munte TF, 1999, COGNITIVE BRAIN RES, V7, P241, DOI 10.1016/S0926-6410(98)00028-7; Nevins A, 2007, BRAIN RES, V1164, P81, DOI 10.1016/j.brainres.2007.05.058; Nieuwland MS, 2013, BRAIN LANG, V126, P151, DOI 10.1016/j.bandl.2013.04.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterhout L, 2004, ON-LINE STUDY OF SENTENCE COMPREHENSION, P271; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; OSTERHOUT L, 1993, LANG COGNITIVE PROC, V8, P413, DOI 10.1080/01690969308407584; Osterhout L, 1999, LANG COGNITIVE PROC, V14, P283, DOI 10.1080/016909699386310; OSTERHOUT L, 1994, J EXP PSYCHOL LEARN, V20, P786, DOI 10.1037/0278-7393.20.4.786; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Osterhout L, 2006, LANG LEARN, V56, P199, DOI 10.1111/j.1467-9922.2006.00361.x; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; Prevost P., 2000, SECOND LANG RES, V16, P103, DOI DOI 10.1191/026765800677556046; Rodriguez-Fornells A, 2002, J COGNITIVE NEUROSCI, V14, P443, DOI 10.1162/089892902317361958; Rommers J, 2013, J COGNITIVE NEUROSCI, V25, P762, DOI 10.1162/jocn_a_00337; Royle P, 2012, NEUROPSYCHOLOGIA, V50, P3542, DOI 10.1016/j.neuropsychologia.2012.09.007; Solomyak O, 2010, J COGNITIVE NEUROSCI, V22, P2042, DOI 10.1162/jocn.2009.21296; Steinhauer K, 2012, BRAIN LANG, V120, P135, DOI 10.1016/j.bandl.2011.07.001; Tanner D, PSYCHON BULL REV IN; Tanner D, 2015, CORTEX, V66, P149, DOI 10.1016/j.cortex.2014.04.007; Tanner D, 2014, J MEM LANG, V76, P195, DOI 10.1016/j.jml.2014.07.003; Tanner D, 2014, BILING-LANG COGN, V17, P277, DOI 10.1017/S1366728913000370; Tanner D, 2014, NEUROPSYCHOLOGIA, V56, P289, DOI 10.1016/j.neuropsychologia.2014.02.002; Tanner D, 2013, BILING-LANG COGN, V16, P367, DOI 10.1017/S1366728912000302; Thornhill DE, 2012, INT J PSYCHOPHYSIOL, V83, P382, DOI 10.1016/j.ijpsycho.2011.12.007; TRUESWELL JC, 1993, J EXP PSYCHOL LEARN, V19, P528, DOI 10.1037/0278-7393.19.3.528; Trueswell JC, 1998, J MEM LANG, V39, P102, DOI 10.1006/jmla.1998.2565; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; Van Dyke JA, 2007, J EXP PSYCHOL LEARN, V33, P407, DOI 10.1037/0278-7393.33.2.407; Van Dyke JA, 2014, COGNITION, V131, P373, DOI 10.1016/j.cognition.2014.01.007; Van Dyke JA, 2012, LANG LINGUIST COMPAS, V6, P193, DOI 10.1002/lnc3.330; Van Dyke JA, 2011, J MEM LANG, V65, P247, DOI 10.1016/j.jml.2011.05.002; Wagers MW, 2009, J MEM LANG, V61, P206, DOI 10.1016/j.jml.2009.04.002; White EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052318; Wicha NYY, 2004, J COGNITIVE NEUROSCI, V16, P1272, DOI 10.1162/0898929041920487; Wlotko EW, 2012, NEUROIMAGE, V62, P356, DOI 10.1016/j.neuroimage.2012.04.054	79	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140850	10.1371/journal.pone.0140850	http://dx.doi.org/10.1371/journal.pone.0140850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488893	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400074
J	Shi, Q; Zhou, W; Chen, C; Zhang, BY; Xiao, K; Zhang, XC; Shen, XJ; Li, Q; Deng, LQ; Dong, JH; Lin, WQ; Huang, P; Jiang, WJ; Lv, J; Han, J; Dong, XP				Shi, Qi; Zhou, Wei; Chen, Cao; Zhang, Bao-Yun; Xiao, Kang; Zhang, Xiu-Chun; Shen, Xiao-Jing; Li, Qing; Deng, Li-Quan; Dong, Jian-Hua; Lin, Wen-Qing; Huang, Pu; Jiang, Wei-Jia; Lv, Jie; Han, Jun; Dong, Xiao-Ping			The Features of Genetic Prion Diseases Based on Chinese Surveillance Program	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; FATAL FAMILIAL INSOMNIA; EARLY-ONSET DEMENTIA; PRNP GENE; DIAGNOSTIC-CRITERIA; E200K MUTATION; PATIENT; CJD; NETWORK; REGIONS	Objective To identify the features of Chinese genetic prion diseases. Methods Suspected Creutzfeldt-Jakob disease (CJD) cases that were reported under CJD surveillance were diagnosed and subtyped using the diagnostic criteria issued by the WHO. The general information concerning the patient, their clinical, MRI and EEG data, and the results of CSF 14-3-3 and PRNP sequencing were carefully collected from the database of the national CJD surveillance program and analyzed using the SPSS 11.5 statistical software program. Results Since 2006, 69 patients were diagnosed with genetic prion diseases and as having 15 different mutations. The median age of the 69 patients at disease onset was 53.5 years, varying from 19 to 80 years. The majority of patients displaying clinical symptoms were in the 50-59 years of age. FFI, T188K gCJD and E200K were the three most common subtypes. The disease appeared in the family histories of 43.48% of the patients. The clinical manifestations varied considerably among the various diseases. Patients who carried mutations in the N-terminus displayed a younger age of onset, were CSF 14-3-3 negative, had a family history of the condition, and experienced a longer duration of the condition. The clinical courses of T188K were significantly shorter than those of FFI and E200K gCJD, while the symptoms in the FFI group appeared at a younger age and for a longer duration. Moreover, the time intervals between the initial neurologist visit to the final diagnosis were similar among patients with FFI, T188K gCJD, E200K gCJD and other diseases. Conclusion The features of Chinese genetic prion diseases are different from those seen in Europe and other Asian countries.	[Shi, Qi; Zhou, Wei; Chen, Cao; Zhang, Bao-Yun; Xiao, Kang; Han, Jun; Dong, Xiao-Ping] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Shi, Qi; Chen, Cao; Xiao, Kang; Han, Jun; Dong, Xiao-Ping] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xiu-Chun] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Shen, Xiao-Jing] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Li, Qing] An Hui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Deng, Li-Quan] Jilin Prov Ctr Dis Control & Prevent, Dept Infect Dis Control & Prevent, Changchun, Peoples R China; [Dong, Jian-Hua] Shaanxi Prov Ctr Dis Control & Prevent, Xian, Peoples R China; [Lin, Wen-Qing] Guangdong Prov Ctr Dis Control & Prevent, Inst Infect Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Huang, Pu] Shanghai Municipal Ctr Dis Control & Prevent, Deptartment Acute Communicable Dis Control & Prev, Shanghai, Peoples R China; [Jiang, Wei-Jia] GuiZhou Prov Ctr Dis Control & Prevent, Inst Infect Dis Prevent & Control, Guiyang, GuiZhou, Peoples R China; [Lv, Jie] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Dong, Xiao-Ping] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Tianjin Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Microbiology, CAS	Dong, XP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	dongxp238@sina.com	Chen, Cao/CAF-1246-2022	Chen, Cao/0000-0002-5193-9283	Chinese National Natural Science Foundation [81301429, 81572048]; China Mega-Project for Infectious Disease [2012ZX10004215]; SKLID Development Grant [2012SKLID102, 2015 SKLID503]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Mega-Project for Infectious Disease; SKLID Development Grant	This work was supported by Chinese National Natural Science Foundation Grants (81301429,81572048), China Mega-Project for Infectious Disease (2012ZX10004215) and SKLID Development Grant (2012SKLID102, 2015 SKLID503).	Alperovitch A, 2001, REV NEUROL-FRANCE, V157, P633; Begue C, 2011, NEUROEPIDEMIOLOGY, V37, P193, DOI 10.1159/000331907; Brandel JP, 2013, TRANSFUS CLIN BIOL, V20, P395, DOI 10.1016/j.tracli.2013.02.029; Cannella M, 2007, J NEUROL NEUROSUR PS, V78, P1411, DOI 10.1136/jnnp.2007.121137; D'Alessandro M, 1998, LANCET, V352, P1989, DOI 10.1016/S0140-6736(05)61335-9; Doi Y, 2007, J EPIDEMIOL, V17, P133, DOI 10.2188/jea.17.133; Finckh U, 2000, ANN NY ACAD SCI, V920, P100; Gao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024231; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; Head MW, 2012, NEUROPATH APPL NEURO, V38, P296, DOI 10.1111/j.1365-2990.2012.01265.x; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Higuma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060003; Imran M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-559; Jansen C, 2011, ACTA NEUROPATHOL, V121, P59, DOI 10.1007/s00401-010-0656-3; Jeong BH, 2014, J KOREAN MED SCI, V29, P623, DOI 10.3346/jkms.2014.29.5.623; Klug GM, 2013, COMMUN DIS INTELL, V37, pE115; Kovacs GG, 2011, ACTA NEUROPATHOL, V121, P39, DOI 10.1007/s00401-010-0713-y; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mitrova E, 2002, ACTA VIROL, V46, P31; Newey CR, 2013, J NEUROIMAGING, V23, P58, DOI 10.1111/j.1552-6569.2012.00763.x; Nozaki I, 2010, BRAIN, V133, P3043, DOI 10.1093/brain/awq216; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qi S, 2012, BIOMED ENVIRON SCI, V25, P471, DOI 10.3967/0895-3988.2012.04.013; Roeber S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002147; Safer J, 1998, PROG BRAIN RES, V117, P421; Shi Q, 2015, PRION, V9, P304, DOI 10.1080/19336896.2015.1075115; Shi Q, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-216; Shi Q, 2012, NEUROPATHOLOGY, V32, P51, DOI 10.1111/j.1440-1789.2011.01237.x; Shi Q, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-360; Shi XH, 2010, INFECT GENET EVOL, V10, P292, DOI 10.1016/j.meegid.2010.01.007; SPUDICH S, 1995, MOL MED, V1, P607, DOI 10.1007/BF03401601; Wang XF, 2007, J NEUROL NEUROSUR PS, V78, P201, DOI 10.1136/jnnp.2006.09433; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204; Xie WL, 2013, INT J MOL MED, V31, P81, DOI 10.3892/ijmm.2012.1194; Ye Jing, 2008, J Med Case Rep, V2, P331, DOI 10.1186/1752-1947-2-331; Zerr I, 2002, APMIS, V110, P88, DOI 10.1034/j.1600-0463.2002.100111.x; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191; Zhang J, 2004, BIOMED ENVIRON SCI, V17, P65	40	39	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139552	10.1371/journal.pone.0139552	http://dx.doi.org/10.1371/journal.pone.0139552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488179	gold, Green Submitted, Green Published			2022-12-27	WOS:000363248400032
J	Stockhammer, PW; Massy, K; Knipper, C; Friedrich, R; Kromer, B; Lindauer, S; Radosavljevic, J; Wittenborn, F; Krause, J				Stockhammer, Philipp W.; Massy, Ken; Knipper, Corina; Friedrich, Ronny; Kromer, Bernd; Lindauer, Susanne; Radosavljevic, Jelena; Wittenborn, Fabian; Krause, Johannes			Rewriting the Central European Early Bronze Age Chronology: Evidence from Large-Scale Radiocarbon Dating	PLOS ONE			English	Article							ISOTOPE ANALYSIS; FRESH-WATER; COLLAGEN	The transition from the Neolithic to the Early Bronze Age in Central Europe has often been considered as a supra-regional uniform process, which led to the growing mastery of the new bronze technology. Since the 1920s, archaeologists have divided the Early Bronze Age into two chronological phases (Bronze A1 and A2), which were also seen as stages of technical progress. On the basis of the early radiocarbon dates from the cemetery of Singen, southern Germany, the beginning of the Early Bronze Age in Central Europe was originally dated around 2300/2200 BC and the transition to more complex casting techniques (i.e., Bronze A2) around 2000 BC. On the basis of 140 newly radiocarbon dated human remains from Final Neolithic, Early and Middle Bronze Age cemeteries south of Augsburg (Bavaria) and a re-dating of ten graves from the cemetery of Singen, we propose a significantly different dating range, which forces us to re-think the traditional relative and absolute chronologies as well as the narrative of technical development. We are now able to date the beginning of the Early Bronze Age to around 2150 BC and its end to around 1700 BC. Moreover, there is no transition between Bronze (Bz) A1 and Bronze (Bz) A2, but a complete overlap between the type objects of the two phases from 1900-1700 BC. We thus present a revised chronology of the assumed diagnostic type objects of the Early Bronze Age and recommend a radiocarbon-based view on the development of the material culture. Finally, we propose that the traditional phases Bz A1 and Bz A2 do not represent a chronological sequence, but regionally different social phenomena connected to the willingness of local actors to appropriate the new bronze technology.	[Stockhammer, Philipp W.; Radosavljevic, Jelena] Heidelberg Univ, Cluster Excellence Asia & Europe Global Context, Heidelberg, Germany; [Stockhammer, Philipp W.; Radosavljevic, Jelena] Heidelberg Univ, Inst Prehist & Early Hist & Near Eastern Archaeol, Heidelberg, Germany; [Massy, Ken] Univ Munich, Munich, Germany; [Massy, Ken; Wittenborn, Fabian] Heidelberg Acad Sci, Heidelberg, Germany; [Knipper, Corina; Friedrich, Ronny; Kromer, Bernd; Lindauer, Susanne] Curt Engelhorn Ctr Archaeometry gGmbH, Mannheim, Germany; [Krause, Johannes] Max Planck Inst Sci Human Hist, Jena, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Munich	Stockhammer, PW (corresponding author), Heidelberg Univ, Cluster Excellence Asia & Europe Global Context, Heidelberg, Germany.	philipp.stockhammer@uni-heidelberg.de	Krause, Johannes/AFP-2642-2022; Friedrich, Ronny/AAE-3588-2019	Krause, Johannes/0000-0001-9144-3920; Friedrich, Ronny/0000-0001-5199-1957; Lindauer, Susanne/0000-0001-5363-2755	Heidelberg Academy of Sciences (Germany); German Research Foundation via the Cluster of Excellence "Asia and Europe in a Global Context" at Heidelberg University (Germany)	Heidelberg Academy of Sciences (Germany); German Research Foundation via the Cluster of Excellence "Asia and Europe in a Global Context" at Heidelberg University (Germany)	The research (including all scientific analyses) was mostly funded by the Heidelberg Academy of Sciences (Germany) in the framework of the WIN-Kolleg Program "Times of Upheaval: Changes of Society and Landscape at the Beginning of the Bronze Age". The research of Stockhammer was also funded by the German Research Foundation via the Cluster of Excellence "Asia and Europe in a Global Context" at Heidelberg University (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asam T, 2005, DOCUMENTA ARCHAEOBIO, V2, P97; Asam Tanja, 2006, Anthropologischer Anzeiger, V64, P1; Ascough PL, 2012, J ARCHAEOL SCI, V39, P2261, DOI 10.1016/j.jas.2012.02.012; Ascough PL, 2004, RADIOCARBON, V46, P611, DOI 10.1017/S0033822200035657; Bartelheim M, 1998, UNIVARSITATSFORSCHUN, V46; Becker B., 1989, JAHRESSCHR MITTELDTS, V72, P299; Becker B, 1989, GERMANIA, V67, P421; Bogaard A, 2007, J ARCHAEOL SCI, V34, P335, DOI 10.1016/j.jas.2006.04.009; BUCK CE, 1991, ANTIQUITY, V65, P808, DOI 10.1017/S0003598X00080534; Childe V.G., 1925, DAWN EUROPEAN CIVILI; Christlein R, 1964, BAYERISCHE VORGESCHI, V27, P25; David W, 1997, 7 TREFF ARCH ARB OST, P108; David-Elbiali M, 2000, CAHIERS ARCHEOLOGIE, V80; Ernee M., 2009, GERMANIA ANZEIGER RO, V87, P355; Fuller BT, 2012, J ANAL ATOM SPECTROM, V27, P807, DOI 10.1039/c2ja10366d; Gerloff S., 1993, PRAHISTORISCHE Z, V68, P58, DOI 10.1515/prhz.1993.68.1.58; Geyh MA, 2000, RADIOCARBON, V42, P99, DOI 10.1017/S0033822200053078; Heyd V, 2000, SPATKUPFERZEIT SUDDE; Innerhofer F, 2000, UNIVARSITATSFORSCHUN, V71; Kanstrup M, 2011, RAPID COMMUN MASS SP, V25, P2879, DOI 10.1002/rcm.5176; Kienlin T, 2010, BAR INT SER, V2184; Kienlin TL, 2008, UNIVARSITATSFORSCHUN, V162; Koch J. K., 2012, BERLIN STUDIES ANCIE, V5, P225; Krause R, 2003, STUDIEN KUPFER FRUHB; Krause R, 1988, THEISS STUTTGART, V32; KROMER B, 1992, RADIOCARBON AFTER FOUR DECADES, P184; Kromer B., 1988, FORSCHUNGEN BERICHTE, P250; Kromer B, 2013, NUCL INSTRUM METH B, V294, P11, DOI 10.1016/j.nimb.2012.01.015; Kupke K, 2010, THESIS U LEIPZIG; Lechterbeck J, 2014, ENVIRON ARCHAEOL, V19, P95, DOI 10.1179/1749631413Y.0000000010; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Lorenz L, 2010, UNIVARSITATSFORSCHUN, V188; Mandera H.-E., 1953, JAHRESSCHR HALLE, V37, P177; Milner N, 2004, ANTIQUITY, V78, P9, DOI 10.1017/S0003598X00092887; Moslein S, 1998, BER BAYER BODENDENKM, V38, P37; Muller J., 2009, GERMANIA, V87, P25; Muller J, 2001, BERICHT ROMISCH GERM, V80, P25; Muller J., 1999, AKTUELLE PROBLEME ER, P113; Pare C., 2000, METALS MAKE WORLD GO, P1; Paul D, 2007, RAPID COMMUN MASS SP, V21, P3006, DOI 10.1002/rcm.3185; Pleinerova I., 1967, PAMATKY ARCHEOL, V58, P1; Pospieszny L, 2015, J ARCHAEOL SCI, V53, P264, DOI 10.1016/j.jas.2014.10.012; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Randsborg K, 1996, ACTA ARCHAEOL, V67, P199; Randsborg K, 1996, ACTA ARCHAEOLOGICA K, V67, P73; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Reinecke P., 1924, GERMANIA ANZEIGER RO, V8, P43; Reinecke P, 1902, MITTHEILUNGEN ANTHR, V32, P104; Risch R, 2013, TAG LAND VORG HALL 1, V11- 2, P696; Ruckdeschel W, 1978, ANTIQUITAS, VII; Schwenzer S., 2002, PRAHISTORISCHE Z, V77, P76; Shishlina N, 2012, RADIOCARBON, V54, P749, DOI 10.1017/S0033822200047408; Strahm C, 2001, HEMMENHOFENER SKRIPT, V2, P177; Strahm Ch, 2009, UNIVARSITATSFORSCHUN, V172, P343; Suter PJ, 2003, ARCHAOLOGISCHES KORR, V33, P325; Vogt I, 2004, UBERGANG FRUHEN MITT; Von Brunn W. A., 1959, SCHRIFTEN SEKTION VO, V7; Von Troja an die Saale Gerloff S., 2010, TAGUNGEN LANDESMUSEU, V5-2, P603; Zich B., 1996, VORGESCHICHTLICHE FO, V20	59	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139705	10.1371/journal.pone.0139705	http://dx.doi.org/10.1371/journal.pone.0139705			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CU0ZM	26488413	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400034
J	Thomas, NR; Poole, DJ; Herbers, JM				Thomas, Nicole R.; Poole, Daniel J.; Herbers, Joan M.			Gender in Science and Engineering Faculties: Demographic Inertia Revisited	PLOS ONE			English	Article							WOMEN; REPRESENTATION	The under-representation of women on faculties of science and engineering is ascribed in part to demographic inertia, which is the lag between retirement of current faculty and future hires. The assumption of demographic inertia implies that, given enough time, gender parity will be achieved. We examine that assumption via a semi-Markov model to predict the future faculty, with simulations that predict the convergence demographic state. Our model shows that existing practices that produce gender gaps in recruitment, retention, and career progression preclude eventual gender parity. Further, we examine sensitivity of the convergence state to current gender gaps to show that all sources of disparity across the entire faculty career must be erased to produce parity: we cannot blame demographic inertia.	[Thomas, Nicole R.; Herbers, Joan M.] Ohio State Univ, Comprehens Equ Ohio State, Columbus, OH 43210 USA; [Poole, Daniel J.] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Herbers, JM (corresponding author), Ohio State Univ, Comprehens Equ Ohio State, Columbus, OH 43210 USA.	herbers.4@osu.edu			National Science Foundation [0811123]	National Science Foundation(National Science Foundation (NSF))	National Science Foundation nsf.gov grant# 0811123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2013, BIOSCIENCE, V63, P43, DOI 10.1525/bio.2013.63.1.9; Baldwin R., 2008, CHANGE, V40, P46, DOI DOI 10.3200/CHNG.40.5.46-55; Baldwin RG, 2005, REV HIGH EDUC, V29, P97, DOI 10.1353/rhe.2005.0055; Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Chang D. A., 2006, LIBERAL EDUC, V92, P28; Gardner S. K., 2013, J HIGHER ED MANAGEME, V28, P148; Ginther D. K., 2006, NBER WORKING PAPER S; Goulden, 2013, BABIES MATTER GENDER; Hargens LL, 2002, J HIGH EDUC, V73, P494, DOI 10.1353/jhe.2002.0037; Hill C., 2010, WOMEN SCI TECHNOLOGY, DOI [10.1002/sce.21007, DOI 10.1002/SCE.21007]; Kaminski D, 2012, SCIENCE, V335, P864, DOI 10.1126/science.1214844; Leboy P, 2008, SCIENTIST, V22, P67; Marschke R, 2007, J HIGH EDUC-UK, V78, P1, DOI 10.1353/jhe.2007.0003; Morrison E, 2011, REV HIGH EDUC, V34, P525, DOI 10.1353/rhe.2011.0017; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; National Academy of Sciences (NAS), 2007, BIAS BARR FULF POT W; National Science Foundation DoSRS, 2003, GEND DIFF CAR AC SCI; Natl Res Council, 2010, GENDER DIFFERENCES AT CRITICAL TRANSITIONS IN THE CAREERS OF SCIENCE, ENGINEERING, AND MATHEMATICS FACULTY, P1; Neumann A., 2009, PROFESSING LEARN CRE; Shaw AK, 2012, P ROY SOC B-BIOL SCI, V279, P3736, DOI 10.1098/rspb.2012.0822; Sullivan KA, 2010, GENDER SCI TECHNOLOG, V2, P206; Terosky AL, 2010, CHANGE, V42, P44, DOI DOI 10.1080/00091383.2010.523408; Trower CA, 2012, SUCCESS ON THE TENURE TRACK: FIVE KEYS TO FACULTY JOB SATISFACTION, P1; Valian, 1999, WHY SO SLOW; Williams WM, 2015, P NATL ACAD SCI USA, V112, P5360, DOI 10.1073/pnas.1418878112; Wolf-Wendel L., 2012, ACAD MOTHERHOOD; Xu YHJ, 2008, RES HIGH EDUC, V49, P40, DOI 10.1007/s11162-007-9062-7	28	18	18	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139767	10.1371/journal.pone.0139767	http://dx.doi.org/10.1371/journal.pone.0139767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488899	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400038
J	Adriaanse, MPM; van der Sande, LJTM; van den Neucker, AM; Menheere, PPCA; Dompeling, E; Buurman, WA; Vreugdenhil, ACE				Adriaanse, Marlou P. M.; van der Sande, Linda J. T. M.; van den Neucker, Anita M.; Menheere, Paul P. C. A.; Dompeling, Edward; Buurman, Wim A.; Vreugdenhil, Anita C. E.			Evidence for a Cystic Fibrosis Enteropathy	PLOS ONE			English	Article							INTESTINE BACTERIAL OVERGROWTH; ACID-BINDING PROTEIN; SERUM I-FABP; CELIAC-DISEASE; PANCREATIC INSUFFICIENCY; PULMONARY EXACERBATIONS; FECAL CALPROTECTIN; ENTEROCYTE DAMAGE; INFLAMMATION; GROWTH	Background Previous studies have suggested the existence of enteropathy in cystic fibrosis (CF), which may contribute to intestinal function impairment, a poor nutritional status and decline in lung function. This study evaluated enterocyte damage and intestinal inflammation in CF and studied its associations with nutritional status, CF-related morbidities such as impaired lung function and diabetes, and medication use. Methods Sixty-eight CF patients and 107 controls were studied. Levels of serum intestinal-fatty acid binding protein (I-FABP), a specific marker for enterocyte damage, were retrospectively determined. The faecal intestinal inflammation marker calprotectin was prospectively studied. Nutritional status, lung function (FEV1), exocrine pancreatic insufficiency (EPI), CF-related diabetes (CFRD) and use of proton pump inhibitors (PPI) were obtained from the medical charts. Results Serum I-FABP levels were elevated in CF patients as compared with controls (p<0.001), and correlated negatively with FEV1 predicted value in children (r-.734, p<0.05). Faecal calprotectin level was elevated in 93% of CF patients, and correlated negatively with FEV1 predicted value in adults (r-.484, p<0.05). No correlation was found between calprotectin levels in faeces and sputum. Faecal calprotectin level was significantly associated with the presence of CFRD, EPI, and PPI use. Conclusion This study demonstrated enterocyte damage and intestinal inflammation in CF patients, and provides evidence for an inverse correlation between enteropathy and lung function. The presented associations of enteropathy with important CF-related morbidities further emphasize the clinical relevance.	[Adriaanse, Marlou P. M.; van der Sande, Linda J. T. M.; van den Neucker, Anita M.; Vreugdenhil, Anita C. E.] Maastricht Univ, Med Ctr, Dept Paediat Gastroenterol, NL-6200 MD Maastricht, Netherlands; [Adriaanse, Marlou P. M.; van der Sande, Linda J. T. M.; van den Neucker, Anita M.; Vreugdenhil, Anita C. E.] Maastricht Univ, Med Ctr, Nutr & Toxicol Res Inst Maastricht NUTRIM, NL-6200 MD Maastricht, Netherlands; [Buurman, Wim A.] Maastricht Univ, Med Ctr, Dept Gen Surg, NL-6200 MD Maastricht, Netherlands; [Dompeling, Edward] Maastricht Univ, Med Ctr, Dept Paediat Pulmonol, Sch Publ Hlth & Primary Care CAPHRI, NL-6200 MD Maastricht, Netherlands; [Menheere, Paul P. C. A.] Maastricht Univ, Med Ctr, Dept Immunodiagnost, Cent Diagnost Lab, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University	Vreugdenhil, ACE (corresponding author), Maastricht Univ, Med Ctr, Dept Paediat Gastroenterol, NL-6200 MD Maastricht, Netherlands.	a.vreugdenhil@mumc.nl						Adriaanse MPM, 2013, ALIMENT PHARM THER, V37, P482, DOI 10.1111/apt.12194; BalfourLynn IM, 1996, J ROY SOC MED, V89, P8; Bensalem N, 2005, MOL CELL PROTEOMICS, V4, P1591, DOI 10.1074/mcp.M500019-MCP200; Borowitz D, 2002, J PEDIATR GASTR NUTR, V35, P246, DOI 10.1097/00005176-200209000-00004; BRIARS GL, 1995, ARCH DIS CHILD, V73, P74, DOI 10.1136/adc.73.1.74; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Bruzzese E, 2007, CLIN NUTR, V26, P322, DOI 10.1016/j.clnu.2007.01.004; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; CROFT NM, 1995, LANCET, V346, P1265; De Boeck K, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1764; De Lisle RC, 2011, J PEDIATR GASTR NUTR, V53, P371, DOI 10.1097/MPG.0b013e318219c397; De Lisle RC, 2009, J CLIN INVEST, V119, P2535, DOI 10.1172/JCI40598; Derikx JPM, 2009, J CLIN GASTROENTEROL, V43, P727, DOI 10.1097/MCG.0b013e31819194b0; Dominguez JA, 2011, SHOCK, V36, P381, DOI 10.1097/SHK.0b013e31822793c4; Gelfond D, 2013, DIGEST DIS SCI, V58, P2275, DOI 10.1007/s10620-012-2209-1; GOSDEN CM, 1984, LANCET, V2, P541; Goss CH, 2013, AM J RESP CRIT CARE, V187, P915, DOI 10.1164/rccm.201301-0184UP; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Hendriks HJE, 2001, J PEDIATR GASTR NUTR, V33, P260, DOI 10.1097/00005176-200109000-00006; Hoffmanova I, 2015, PHYSIOL RES, V64, P537, DOI 10.33549/physiolres.932916; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Kerem E, 2014, EUR RESPIR J, V43, P125, DOI 10.1183/09031936.00166412; Klingberg E, 2012, SCAND J GASTROENTERO, V47, P435, DOI 10.3109/00365521.2011.648953; Levy E, 2009, HISTOCHEM CELL BIOL, V132, P351, DOI 10.1007/s00418-009-0608-y; Lisowska A, 2010, SCAND J CLIN LAB INV, V70, P322, DOI 10.3109/00365513.2010.486869; Lisowska A, 2009, ACTA BIOCHIM POL, V56, P631; Lloyd-Still J D, 1999, Curr Gastroenterol Rep, V1, P231, DOI 10.1007/s11894-999-0040-4; LLOYDSTILL JD, 1990, J PEDIATR GASTR NUTR, V11, P434, DOI 10.1097/00005176-199011000-00002; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Morison S, 1997, ARCH DIS CHILD, V77, P497, DOI 10.1136/adc.77.6.497; Norkina O, 2004, INFECT IMMUN, V72, P6040, DOI 10.1128/IAI.72.10.6040-6049.2004; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Pencharz PB, 2000, CLIN NUTR, V19, P387, DOI 10.1054/clnu.1999.0079; Pezzilli R, 2007, J GASTROENTEROL, V42, P754, DOI 10.1007/s00535-007-2086-0; Poullis A, 2003, EUR J GASTROEN HEPAT, V15, P573, DOI 10.1097/01.meg.0000059108.41030.23; Raia V, 2000, PEDIATR RES, V47, P344, DOI 10.1203/00006450-200003000-00010; Rumman N, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-133; Rutten EPA, 2014, CHEST, V145, P245, DOI 10.1378/chest.13-0584; Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016; Sbarbati A, 1998, PEDIATR RES, V43, P234, DOI 10.1203/00006450-199802000-00013; Scaparrotta A, 2012, J PEDIATR ENDOCR MET, V25, P393, DOI 10.1515/jpem-2012-0012; Schellekens DHSM, 2014, J CLIN GASTROENTEROL, V48, P253, DOI 10.1097/MCG.0b013e3182a87e3e; Sharma R, 2001, THORAX, V56, P746, DOI 10.1136/thorax.56.10.746; Sinaasappel M, 2002, J Cyst Fibros, V1, P51, DOI 10.1016/S1569-1993(02)00032-2; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; SMYTH RL, 1994, LANCET, V343, P85, DOI 10.1016/S0140-6736(94)90817-6; Smyth RL, 2000, ARCH DIS CHILD, V82, P394, DOI 10.1136/adc.82.5.394; Steinkamp G, 2002, THORAX, V57, P596, DOI 10.1136/thorax.57.7.596; Sun XS, 2014, AM J PATHOL, V184, P1309, DOI 10.1016/j.ajpath.2014.01.035; vanElburg RM, 1996, PEDIATR RES, V39, P985, DOI 10.1203/00006450-199606000-00010; Verdam FJ, 2011, J CLIN ENDOCR METAB, V96, pE379, DOI 10.1210/jc.2010-1333; Vreugdenhil AC, 2011, SCAND J GASTROENTERO, V46, P1435, DOI 10.3109/00365521.2011.627447; Walkowiak J, 2005, J PEDIATR GASTR NUTR, V40, P107, DOI 10.1097/00005176-200502000-00001; Walkowiak J, 2010, ACTA BIOCHIM POL, V57, P115; Weiss B, 2010, PEDIATR PULM, V45, P536, DOI 10.1002/ppul.21138; Werlin SL, 2010, J PEDIATR GASTR NUTR, V51, P304, DOI 10.1097/MPG.0b013e3181d1b013; Yu H, 2000, INFECT IMMUN, V68, P2142, DOI 10.1128/IAI.68.4.2142-2147.2000; Yui S, 2003, BIOL PHARM BULL, V26, P753	60	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0138062	10.1371/journal.pone.0138062	http://dx.doi.org/10.1371/journal.pone.0138062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484665	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100004
J	Reichhardt, C; Jacobson, AN; Maher, MC; Uang, J; McCrate, OA; Eckart, M; Cegelski, L				Reichhardt, Courtney; Jacobson, Amy N.; Maher, Marie C.; Uang, Jeremy; McCrate, Oscar A.; Eckart, Michael; Cegelski, Lynette			Congo Red Interactions with Curli-Producing E. coli and Native Curli Amyloid Fibers	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN; SECRETION; BIOGENESIS; BINDING; FIBRIL; CSGA	Microorganisms produce functional amyloids that can be examined and manipulated in vivo and in vitro. Escherichia coli assemble extracellular adhesive amyloid fibers termed curli that mediate adhesion and promote biofilm formation. We have characterized the dye binding properties of the hallmark amyloid dye, Congo red, with curliated E. coli and with isolated curli fibers. Congo red binds to curliated whole cells, does not inhibit growth, and can be used to comparatively quantify whole-cell curliation. Using Surface Plasmon Resonance, we measured the binding and dissociation kinetics of Congo red to curli. Furthermore, we determined that the binding of Congo red to curli is pH-dependent and that histidine residues in the CsgA protein do not influence Congo red binding. Our results on E. coli strain MC4100, the most commonly employed strain for studies of E. coli amyloid biogenesis, provide a starting point from which to compare the influence of Congo red binding in other E. coli strains and amyloid-producing organisms.	[Reichhardt, Courtney; Jacobson, Amy N.; Maher, Marie C.; Uang, Jeremy; McCrate, Oscar A.; Cegelski, Lynette] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Eckart, Michael] Stanford Univ, Prot & Nucle Acid Facil, Stanford, CA 94305 USA	Stanford University; Stanford University	Cegelski, L (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	cegelski@stanford.edu		Reichhardt, Courtney/0000-0002-1022-5110; Jacobson, Amy/0000-0001-6518-5446	National Institutes of Health [DP20D007488]; NSF [1453247]; Althouse Family Stanford Graduate Fellowship; Abbott Laboratories Stanford Graduate Fellowship; Div Of Molecular and Cellular Bioscience [1453247] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Althouse Family Stanford Graduate Fellowship; Abbott Laboratories Stanford Graduate Fellowship(Abbott Laboratories); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors gratefully acknowledge support from the National Institutes of Health Director's New Innovator Award (DP20D007488 to L.C.) and the NSF CAREER Award (Grant Number 1453247 to L.C.), the Althouse Family Stanford Graduate Fellowship (C.R.), and the Abbott Laboratories Stanford Graduate Fellowship (M.C.M.).	Alteri CJ, 2007, P NATL ACAD SCI USA, V104, P5145, DOI 10.1073/pnas.0602304104; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; BONAR L, 1969, P SOC EXP BIOL MED, V131, P1373; Capstick DS, 2011, P NATL ACAD SCI USA, V108, P9821, DOI 10.1073/pnas.1018715108; Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cherny I, 2005, J MOL BIOL, V352, P245, DOI 10.1016/j.jmb.2005.07.028; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Eisert R, 2006, ANAL BIOCHEM, V353, P144, DOI 10.1016/j.ab.2006.03.015; Garofalo CK, 2007, INFECT IMMUN, V75, P52, DOI 10.1128/IAI.01123-06; Gophna U, 2001, INFECT IMMUN, V69, P2659, DOI 10.1128/IAI.69.4.2659-2665.2001; Goyal P, 2014, NATURE, V516, P250, DOI 10.1038/nature13768; Inouye H, 2000, AMYLOID, V7, P179, DOI 10.3109/13506120009146832; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Lembre P, 2014, BIOFOULING, V30, P415, DOI 10.1080/08927014.2014.880112; Lembre P, 2013, PROTEIN PEPTIDE LETT, V20, P942, DOI 10.2174/0929866511320080012; Lim JY, 2014, BIOCHEM BIOPH RES CO, V443, P345, DOI 10.1016/j.bbrc.2013.11.026; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; McCrate OA, 2013, CHEM COMMUN, V49, P4193, DOI 10.1039/c2cc37792f; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Reinke AA, 2011, CHEM BIOL DRUG DES, V77, P399, DOI 10.1111/j.1747-0285.2011.01110.x; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Schutz AK, 2011, ANGEW CHEM INT EDIT, V50, P5956, DOI 10.1002/anie.201008276; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Wu C, 2012, BIOPHYS J, V103, P464, DOI 10.1016/j.bpj.2012.06.049	37	49	50	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140388	10.1371/journal.pone.0140388	http://dx.doi.org/10.1371/journal.pone.0140388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485271	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100031
J	Cai, LH; Wu, HL; Li, DF; Zhou, K; Zou, FH				Cai, Lihua; Wu, Honglong; Li, Dongfang; Zhou, Ke; Zou, Fuhao			Type 2 Diabetes Biomarkers of Human Gut Microbiota Selected via Iterative Sure Independent Screening Method	PLOS ONE			English	Article							VARIABLE SELECTION; REGRESSION; REGULARIZATION; METAGENOME; OBESITY	Type 2 diabetes, which is a complex metabolic disease influenced by genetic and environment, has become a worldwide problem. Previous published results focused on genetic components through genome-wide association studies that just interpret this disease to some extent. Recently, two research groups published metagenome-wide association studies (MGWAS) result that found meta-biomarkers related with type 2 diabetes. However, One key problem of analyzing genomic data is that how to deal with the ultra-high dimensionality of features. From a statistical viewpoint it is challenging to filter true factors in high dimensional data. Various methods and techniques have been proposed on this issue, which can only achieve limited prediction performance and poor interpretability. New statistical procedure with higher performance and clear interpretability is appealing in analyzing high dimensional data. To address this problem, we apply an excellent statistical variable selection procedure called iterative sure independence screening to gene profiles that obtained from metagenome sequencing, and 48/24 meta-markers were selected in Chinese/European cohorts as predictors with 0.97/0.99 accuracy in AUC (area under the curve), which showed a better performance than other model selection methods, respectively. These results demonstrate the power and utility of data mining technologies within the large-scale and ultra-high dimensional genomic-related dataset for diagnostic and predictive markers identifying.	[Cai, Lihua; Wu, Honglong; Li, Dongfang; Zhou, Ke; Zou, Fuhao] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China; [Cai, Lihua] Guangdong Ocean Univ, Sch Informat Sci, Zhanjiang, Guangdong, Peoples R China; [Wu, Honglong; Li, Dongfang] BGI Shenzhen, BGI Tianjin, Binhia Genom Inst, Tianjin, Peoples R China	Huazhong University of Science & Technology; Guangdong Ocean University; Beijing Genomics Institute (BGI)	Zhou, K (corresponding author), Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China.	k.zhou@hust.edu.cn		Li, Dongfang/0000-0002-6587-2892				Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Das UN, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-35; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fan JQ, 2010, STAT SINICA, V20, P101; Fan JQ, 2009, J MACH LEARN RES, V10, P2013; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Liu J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P547; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Strittmatter WJ, 2001, BIOCHEM SOC SYMP, V67, P101; Sun H, 2012, BIOINFORMATICS, V28, P1368, DOI 10.1093/bioinformatics/bts145; Tibshirani R, 2005, J R STAT SOC B, V67, P91, DOI 10.1111/j.1467-9868.2005.00490.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Z., 2014, REGULARIZATION OPTIM, P131; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	24	20	23	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140827	10.1371/journal.pone.0140827	http://dx.doi.org/10.1371/journal.pone.0140827			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479726	Green Submitted, Green Published, gold			2022-12-27	WOS:000363026600021
J	Salinas-Almaguer, S; Angulo-Sherman, A; Sierra-Valdez, FJ; Mercado-Uribe, H				Salinas-Almaguer, Samuel; Angulo-Sherman, Abril; Javier Sierra-Valdez, Francisco; Mercado-Uribe, Hilda			Sterilization by Cooling in Isochoric Conditions: The Case of Escherichia coli	PLOS ONE			English	Article							HIGH HYDROSTATIC-PRESSURE; STATIONARY-PHASE CELLS; MEMBRANE DAMAGE; WATER; INACTIVATION; PRESERVATION; INTEGRITY; PROTEIN; DEATH	High hydrostatic pressure (HHP) affects the structure, metabolism and survival of microorganisms including bacteria. For this reason HHP is a promising treatment in the food industry. The aim of this work is to evaluate the effect of high pressure, under isochoric cooling conditions, on Escherichia coli, where such high pressure develops due to the fact water cannot expand. We combine survival curves obtained by spectrophotometry and images of atomic force microscopy in this study. Our results show that cooling at -20 and -30 degrees C leads to a partial destruction of a Escherichia coli population. However, cooling at -15 degrees C causes a total extermination of bacteria. This intriguing result is explained by the phase diagram of water. In the first case, the simultaneous formation of ice III and ice Ih crystals provides a safe environment for bacteria. In the second case (-15 degrees C) Escherichia coli remains in a metastable and amorphous free-of-crystals liquid subjected to high pressure. Our work is the first experimental study carried out to inactivate Escherichia coli under isochoric cooling conditions. Unlike HHP, which is based on the application of an external load to augment the pressure, this technique only requires cooling. The method could be used for annihilation of other Escherichia coli strains and perhaps other micro-organisms.	[Salinas-Almaguer, Samuel; Angulo-Sherman, Abril; Javier Sierra-Valdez, Francisco; Mercado-Uribe, Hilda] CINVESTAV Monterrey, Apodaca, Nuevo Leon, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Mercado-Uribe, H (corresponding author), CINVESTAV Monterrey, Apodaca, Nuevo Leon, Mexico.	hmercado@cinvestav.mx		Sierra-Valdez, Francisco J/0000-0002-7803-9701	Consejo Nacional de Ciencia y Tecnologia [154202]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research work was supported by Consejo Nacional de Ciencia y Tecnologia (Grant 154202), HMU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2013, HIGH PRESSURE RES, V33, P278, DOI 10.1080/08957959.2013.769533; Angulo-Sherman A, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022406; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Black SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073995; Byrne RT, 2014, J BACTERIOL, V196, P3534, DOI 10.1128/JB.01589-14; Casadei MA, 2002, APPL ENVIRON MICROB, V68, P5965, DOI 10.1128/AEM.68.12.5965-5972.2002; Chaplin M., 2000, WATER STRUCTURE SCI; Chua B, 2014, BIOMED MICRODEVICES, V16, P355, DOI 10.1007/s10544-014-9838-4; GROSS M, 1993, EUR J BIOCHEM, V218, P463, DOI 10.1111/j.1432-1033.1993.tb18397.x; Hong YC, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3418371; Hsu H, 2014, FOOD MICROBIOL, V40, P25, DOI 10.1016/j.fm.2013.11.019; Kaletunc G, 2004, APPL ENVIRON MICROB, V70, P1116, DOI 10.1128/AEM.70.2.1116-1122.2004; KALICHEVSKY MT, 1995, TRENDS FOOD SCI TECH, V6, P253, DOI 10.1016/S0924-2244(00)89109-8; Kim HS, 2013, SEP PURIF TECHNOL, V120, P423, DOI 10.1016/j.seppur.2013.09.041; Klotz B, 2010, INT J FOOD MICROBIOL, V137, P214, DOI 10.1016/j.ijfoodmicro.2009.11.020; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; LeBail A, 2002, INT J REFRIG, V25, P504, DOI 10.1016/S0140-7007(01)00030-5; MACKEY BM, 2008, HIGHPR MICR, P53; Manas P, 2005, J APPL MICROBIOL, V98, P1387, DOI 10.1111/j.1365-2672.2005.02561.x; Manas P, 2004, APPL ENVIRON MICROB, V70, P1545, DOI 10.1128/AEM.70.3.1545-1554.2004; Moussa M, 2007, APPL ENVIRON MICROB, V73, P6508, DOI 10.1128/AEM.01212-07; Niven GW, 1999, MICROBIOL-SGM, V145, P419, DOI 10.1099/13500872-145-2-419; Ohshima S, 2013, HIGH PRESSURE RES, V33, P308, DOI 10.1080/08957959.2013.773429; Pagan R, 2000, APPL ENVIRON MICROB, V66, P2829, DOI 10.1128/AEM.66.7.2829-2834.2000; Pena-Eguiluz R, 2010, EUR PHYS J-APPL PHYS, V49, DOI 10.1051/epjap/2009197; Preciado JA, 2010, CRYOBIOLOGY, V60, P23, DOI 10.1016/j.cryobiol.2009.06.010; Prieto-Calvo M, 2014, MOLECULES, V19, P21310, DOI 10.3390/molecules191221310; Rubinsky B, 2005, CRYOBIOLOGY, V50, P121, DOI 10.1016/j.cryobiol.2004.12.002; Suppes GJ, 2003, CRYOBIOLOGY, V47, P93, DOI 10.1016/S0011-2240(03)00072-5; Szobota SA, 2006, CRYOBIOLOGY, V53, P139, DOI 10.1016/j.cryobiol.2006.04.001; Takahashi T, 2000, TRANSPL P, V32, P1634, DOI 10.1016/S0041-1345(00)01440-8; Velegol SB, 2002, LANGMUIR, V18, P5256, DOI 10.1021/la011818g; WELCH TJ, 1993, J BACTERIOL, V175, P7170, DOI 10.1128/JB.175.22.7170-7177.1993; Zhao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062388	34	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140882	10.1371/journal.pone.0140882	http://dx.doi.org/10.1371/journal.pone.0140882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480032	Green Published, gold, Green Submitted			2022-12-27	WOS:000363026600023
J	Plog, S; Klymiuk, N; Binder, S; Van Hook, MJ; Thoreson, WB; Gruber, AD; Mundhenk, L				Plog, Stephanie; Klymiuk, Nikolai; Binder, Stefanie; Van Hook, Matthew J.; Thoreson, Wallace B.; Gruber, Achim D.; Mundhenk, Lars			Naturally Occurring Deletion Mutants of the Pig-Specific, Intestinal Crypt Epithelial Cell Protein CLCA4b without Apparent Phenotype	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CHANNELS; MESSENGER-RNA DECAY; CYSTIC-FIBROSIS; CHLORIDE CURRENTS; APICAL MEMBRANE; BASIC DEFECT; CALCIUM; FAMILY; MCLCA3; GENE	The human CLCA4 (chloride channel regulator, calcium-activated) modulates the intestinal phenotype of cystic fibrosis (CF) patients via an as yet unknown pathway. With the generation of new porcine CF models, species-specific differences between human modifiers of CF and their porcine orthologs are considered critical for the translation of experimental data. Specifically, the porcine ortholog to the human CF modulator gene CLCA4 has recently been shown to be duplicated into two separate genes, CLCA4a and CLCA4b. Here, we characterize the duplication product, CLCA4b, in terms of its genomic structure, tissue and cellular expression patterns as well as its in vitro electrophysiological properties. The CLCA4b gene is a pig-specific duplication product of the CLCA4 ancestor and its protein is exclusively expressed in small and large intestinal crypt epithelial cells, a niche specifically occupied by no other porcine CLCA family member. Surprisingly, a unique deleterious mutation of the CLCA4b gene is spread among modern and ancient breeds in the pig population, but this mutation did not result in an apparent phenotype in homozygously affected animals. Electrophysiologically, neither the products of the wild type nor of the mutated CLCA4b genes were able to evoke a calcium-activated anion conductance, a consensus feature of other CLCA proteins. The apparently pig-specific duplication of the CLCA4 gene with unique expression of the CLCA4b protein variant in intestinal crypt epithelial cells where the porcine CFTR is also present raises the question of whether it may modulate the porcine CF phenotype. Moreover, the naturally occurring null variant of CLCA4b will be valuable for the understanding of CLCA protein function and their relevance in modulating the CF phenotype.	[Plog, Stephanie; Binder, Stefanie; Gruber, Achim D.; Mundhenk, Lars] Free Univ Berlin, Fac Vet Med, Dept Vet Pathol, Berlin, Germany; [Klymiuk, Nikolai] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Oberschleissheim, Germany; [Van Hook, Matthew J.; Thoreson, Wallace B.] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA	Free University of Berlin; University of Munich; University of Nebraska System; University of Nebraska Medical Center	Mundhenk, L (corresponding author), Free Univ Berlin, Fac Vet Med, Dept Vet Pathol, Berlin, Germany.	lars.mundhenk@fu-berlin.de	Thoreson, Wallace B./F-6172-2010; Klymiuk, Nikolai/AAB-8345-2022; Gruber, Achim D./ABA-4514-2021	Thoreson, Wallace B./0000-0001-7104-042X; Klymiuk, Nikolai/0000-0003-3532-1659; 	German Research Foundation [DFG MU 3015/1-1]; U.S. National Institutes of Health [EY10542, F32EY23864]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY010542, R55EY010542, F32EY023864, R29EY010542] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Financial support by the German Research Foundation (DFG MU 3015/1-1), U.S. National Institutes of Health (EY10542, WBT; F32EY23864, MJH), and a Senior Scientific Investigator Award from Research to Prevent Blindness (WBT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnel M, 1999, FEBS LETT, V455, P295, DOI 10.1016/S0014-5793(99)00891-1; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; Anton F, 2005, J HISTOCHEM CYTOCHEM, V53, P1011, DOI 10.1369/jhc.4A6599.2005; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Bothe MK, 2008, J HISTOCHEM CYTOCHEM, V56, P495, DOI 10.1369/jhc.2008.950592; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Ching JCH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083130; Dietert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102606; Evans SR, 2004, J BIOL CHEM, V279, P41792, DOI 10.1074/jbc.M408354200; Fuller CM, 2000, NEWS PHYSIOL SCI, V15, P165; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; GRAY MA, 1994, AM J PHYSIOL, V266, pC213, DOI 10.1152/ajpcell.1994.266.1.C213; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gruber AD, 1999, BBA-GENE STRUCT EXPR, V1444, P418, DOI 10.1016/S0167-4781(99)00008-1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamann M, 2009, J PHYSIOL-LONDON, V587, P2255, DOI 10.1113/jphysiol.2009.170159; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Klymiuk N, 2012, J MOL MED, V90, P597, DOI 10.1007/s00109-011-0839-y; Kolbe EW, 2013, EUR J HUM GENET, V21, P691, DOI 10.1038/ejhg.2012.234; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Meyerholz DK, 2010, AM J RESP CRIT CARE, V182, P1251, DOI 10.1164/rccm.201004-0643OC; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Plog S, 2012, CELL TISSUE RES, V350, P445, DOI 10.1007/s00441-012-1482-9; Plog S, 2012, J HISTOCHEM CYTOCHEM, V60, P45, DOI 10.1369/0022155411426455; Plog S, 2010, J HISTOCHEM CYTOCHEM, V58, P785, DOI 10.1369/jhc.2010.955377; Plog S, 2009, J HISTOCHEM CYTOCHEM, V57, P1169, DOI 10.1369/jhc.2009.954594; RIORDAN JR, 1989, SCIENCE, V245, P1066; Ritzka M, 2004, HUM GENET, V115, P483, DOI 10.1007/s00439-004-1190-y; RODMAN DM, 1991, MED HYPOTHESES, V36, P253, DOI 10.1016/0306-9877(91)90144-N; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Salvatore F, 2002, AM J MED GENET, V111, P88, DOI 10.1002/ajmg.10461; Scholte Bob J, 2004, J Cyst Fibros, V3 Suppl 2, P183, DOI 10.1016/j.jcf.2004.05.039; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; van der Doef HPJ, 2010, J PEDIATR GASTR NUTR, V50, P347, DOI 10.1097/MPG.0b013e3181afce6c; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Wuensch A, 2014, TRANSPLANTATION, V97, P138, DOI 10.1097/TP.0b013e3182a95cbc; Young FD, 2007, GASTROENTEROLOGY, V133, P1928, DOI 10.1053/j.gastro.2007.10.007; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083943; Zetoune AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-83	44	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140050	10.1371/journal.pone.0140050	http://dx.doi.org/10.1371/journal.pone.0140050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474299	Green Published, gold, Green Submitted			2022-12-27	WOS:000363185500021
J	Zatulovskaia, YA; Ilyechova, EY; Puchkova, LV				Zatulovskaia, Yulia A.; Ilyechova, Ekaterina Y.; Puchkova, Ludmila V.			The Features of Copper Metabolism in the Rat Liver during Development	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; SUPEROXIDE-DISMUTASE; WILSONS-DISEASE; CERULOPLASMIN-GENE; MITOCHONDRIAL MATRIX; MILK CERULOPLASMIN; HEPATIC COPPER; GUINEA-PIG; CHAPERONE; PROTEIN	Strong interest in copper homeostasis is due to the fact that copper is simultaneously a catalytic co-factor of the vital enzymes, a participant in signaling, and a toxic agent provoking oxidative stress. In mammals, during development copper metabolism is conformed to two types. In embryonic type copper metabolism (ETCM), newborns accumulate copper to high level in the liver because its excretion via bile is blocked; and serum copper concentration is low because ceruloplasmin (the main copper-containing protein of plasma) gene expression is repressed. In the late weaning, the ETCM switches to the adult type coppermetabolism (ATCM), which is manifested by the unlocking of copper excretion and the induction of ceruloplasmin gene activity. The considerable progress has been made in the understanding of the molecular basis of copper metabolic turnover in the ATCM, but many aspects of the copper homeostasis in the ETCM remain unclear. The aim of this study was to investigate the copper metabolism during transition from the ETCM (up to 12-days-old) to the ATCM in the rats. It was shown that in the liver, copper was accumulated in the nuclei during the first 5 days of life, and then it was re-located to the mitochondria. In parallel with the mitochondria, copper bulk bound with cytosolic metallothionein was increased. All compartments of the liver cells rapidly lost most of their copper on the 13th day of life. In newborns, serum copper concentration was low, and its major fraction was associated with holo-Cp, however, a small portion of copper was bound to extracellular metallothionein and a substance that was slowly eluted during gel-filtration. In adults, serum copper concentration increased by about a factor of 3, while metallothionein-bound copper level decreased by a factor of 2. During development, the expression level of Cp, Sod1, Cox4i1, Atp7b, Ctr1, Ctr2, Cox17, and Ccs genes was significantly increased, and metallothionein was decreased. Atp7a gene's activity was fully repressed. The copper routes in newborns are discussed.	[Zatulovskaia, Yulia A.; Ilyechova, Ekaterina Y.; Puchkova, Ludmila V.] Peter Great St Petersburg Polytech Univ, Dept Biophys, Inst Phys Nanotechnol & Telecommun, St Petersburg, Russia; [Ilyechova, Ekaterina Y.; Puchkova, Ludmila V.] Russian Acad Med Sci, Inst Expt Med, Dept Mol Genet, St Petersburg P-22, Russia; [Ilyechova, Ekaterina Y.; Puchkova, Ludmila V.] ITMO Univ, Lab Trace Element Metab, St Petersburg, Russia	Peter the Great St. Petersburg Polytechnic University; Institute of Experimental Medicine; Russian Academy of Medical Sciences; ITMO University	Ilyechova, EY (corresponding author), Peter Great St Petersburg Polytech Univ, Dept Biophys, Inst Phys Nanotechnol & Telecommun, St Petersburg, Russia.	ilichevaey@gmail.com			Russian Foundation for Basic Research (RU) [N15-04-06770]	Russian Foundation for Basic Research (RU)	Support was provided by the Russian Foundation for Basic Research (RU) N15-04-06770.	Adam V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011441; Airede AKI, 1997, E AFR MED J, V74, P221; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; BINGLE CD, 1991, BIOCHEM J, V276, P771, DOI 10.1042/bj2760771; Bogaard HJ, 2012, AM J RESP CELL MOL, V46, P582, DOI 10.1165/rcmb.2011-0296OC; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Bruckmann G, 1939, BIOCHEM J, V33, P1845; Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Cerveza PJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P451, DOI 10.1006/abbi.1999.1572; Chen HJ, 2004, BLOOD, V103, P3933, DOI 10.1182/blood-2003-09-3139; Chu YL, 2012, BIOMETALS, V25, P373, DOI 10.1007/s10534-011-9509-3; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; CZAJA MJ, 1987, J CLIN INVEST, V80, P1200, DOI 10.1172/JCI113180; De Bie P, 2005, J HERED, V96, P803, DOI 10.1093/jhered/esi110; Dodani SC, 2011, J AM CHEM SOC, V133, P8606, DOI 10.1021/ja2004158; Fieten H, 2012, MAMM GENOME, V23, P62, DOI 10.1007/s00335-011-9378-7; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gerard C, 2010, BIOMATERIALS, V31, P824, DOI 10.1016/j.biomaterials.2009.10.009; GOLDFISCHER S, 1980, AM J PATHOL, V99, P715; GOLDFISCHER S, 1968, AM J PATHOL, V53, P883; Gray LW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038327; GREGORIA.G, 1970, J BIOL CHEM, V245, P5833; Gulec S, 2014, ANNU REV NUTR, V34, P95, DOI 10.1146/annurev-nutr-071812-161215; Gupta A, 2009, FUTURE MED CHEM, V1, P1125, DOI 10.4155/FMC.09.84; Gyulikhandanova NE, 2004, B EXP BIOL MED+, V137, P485, DOI 10.1023/B:BEBM.0000038160.60211.6f; Han H, 2009, BIOL TRACE ELEM RES, V129, P130, DOI 10.1007/s12011-008-8293-6; Healy J, 2007, J NEURAL TRANSM, V114, P777, DOI 10.1007/s00702-007-0687-7; Hiromura M, 2000, BIOCHEM BIOPH RES CO, V275, P394, DOI 10.1006/bbrc.2000.3328; Hurley L S, 1980, Ciba Found Symp, V79, P227; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Kang YJ, 2006, EXP BIOL MED, V231, P1459, DOI 10.1177/153537020623100903; KATAOKA M, 1984, EXP CELL RES, V155, P232, DOI 10.1016/0014-4827(84)90784-5; Kawamata H, 2010, ANTIOXID REDOX SIGN, V13, P1375, DOI 10.1089/ars.2010.3212; Kenney GE, 2012, ACS CHEM BIOL, V7, pA, DOI 10.1021/cb2003913; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Kim H, 2009, AM J PHYSIOL-GASTR L, V296, pG356, DOI 10.1152/ajpgi.90632.2008; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Kodama H, 2012, CURR DRUG METAB, V13, P237, DOI 10.2174/138920012799320455; Kozlowski H, 2014, CURR MED CHEM, V21, P3721, DOI 10.2174/0929867321666140716093838; Lenartowicz M, 2010, J EXP ZOOL PART A, V313A, P209, DOI 10.1002/jez.586; Levy AR, 2014, J PHYS CHEM B, V118, P5832, DOI 10.1021/jp412589b; Liang ZD, 2012, MOL PHARMACOL, V81, P455, DOI 10.1124/mol.111.076422; loannoni R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036338, DOI 10.1371/J0URNAL.P0NE.0036338]; Lutsenko S, 1998, P NATL ACAD SCI USA, V95, P6004, DOI 10.1073/pnas.95.11.6004; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Lynes MA, 2006, EXP BIOL MED, V231, P1548, DOI 10.1177/153537020623100915; Mufti AR, 2007, ARCH BIOCHEM BIOPHYS, V463, P168, DOI 10.1016/j.abb.2007.01.033; Nakazato K, J TOXICOL SCI; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Opazo CM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00143; OWEN JA, 1961, CLIN CHIM ACTA, V6, P441, DOI 10.1016/0009-8981(61)90074-2; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Platonova N A, 2004, Ontogenez, V35, P171; Platonova NA, 2005, BIOPHYS CHEM, V115, P247, DOI 10.1016/j.bpc.2004.12.014; PLATONOVA NA, 2005, IZV AKAD NAUK BIOL+, V2, P141; Platonova N, 2007, J TRACE ELEM MED BIO, V21, P184, DOI 10.1016/j.jtemb.2007.04.003; Pope CR, 2013, P NATL ACAD SCI USA, V110, P20491, DOI 10.1073/pnas.1309820110; Prudovsky I., 2013, ANGIOL OPEN ACCESS, V1, DOI [10.4172/2329-9495.1000101, DOI 10.4172/2329-9495.1000101]; Puchkova L. V., 1994, Biokhimiya, V59, P296; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rezk NA, 2015, GENE; Richter OMH, 2003, REV PHYSIOL BIOCH P, V147, P47, DOI 10.1007/s10254-003-0006-0; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; SRAI SKS, 1986, HEPATOLOGY, V6, P427, DOI 10.1002/hep.1840060318; Summer KH, 2011, J TRACE ELEM MED BIO, V25, P36, DOI 10.1016/j.jtemb.2010.12.002; Suter A, 2001, DEVELOPMENT, V128, P4899; Takahashi Y, 2002, MOL CELL BIOL, V22, P7614, DOI 10.1128/MCB.22.21.7614-7621.2002; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P386, DOI 10.1016/S0753-3322(03)00012-X; Tariba B, 2015, CANCER CHEMOTH PHARM, V75, P813, DOI 10.1007/s00280-015-2702-2; Thirumoorthy N, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-54; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Vasak M, 2011, J BIOL INORG CHEM, V16, P1067, DOI 10.1007/s00775-011-0799-2; Vest KE, 2013, J BIOL CHEM, V288, P23884, DOI 10.1074/jbc.M113.470674; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P379, DOI 10.1016/S0091-679X(06)80019-1; Vonk WIM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092408; Vonk WIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029183; Wee NKY, 2013, INT J BIOCHEM CELL B, V45, P960, DOI 10.1016/j.biocel.2013.01.018; Wissler JH, 2004, ANN NY ACAD SCI, V1022, P163, DOI 10.1196/annals.1318.027; Wissler JH, 2008, ANN NY ACAD SCI, V1137, P316, DOI 10.1196/annals.1448.047; Zatulovskiy EA, 2012, J INORG BIOCHEM, V116, P88, DOI 10.1016/j.jinorgbio.2012.07.003; Zhang SP, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-100; Zischka H, 2011, J CLIN INVEST, V121, P1508, DOI 10.1172/JCI45401	86	26	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140797	10.1371/journal.pone.0140797	http://dx.doi.org/10.1371/journal.pone.0140797			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474410	Green Published, Green Submitted, gold			2022-12-27	WOS:000363185500112
J	Dienes, L; Kiss, HJ; Perenyi, K; Nagy, ZZ; Acosta, MC; Gallar, J; Kovacs, I				Dienes, Lorant; Kiss, Huba J.; Perenyi, Kristof; Nagy, Zoltan Z.; Carmen Acosta, M.; Gallar, Juana; Kovacs, Illes			Corneal Sensitivity and Dry Eye Symptoms in Patients with Keratoconus	PLOS ONE			English	Article							VIVO CONFOCAL MICROSCOPY; IN-VIVO; OCULAR SURFACE; COLD THERMORECEPTORS; NERVE INJURY; STIMULATION; INNERVATION; SENSATION; CONJUNCTIVAL; PROGRESSION	Purpose To investigate corneal sensitivity to selective mechanical, chemical, and thermal stimulation and to evaluate their relation to dry eye symptoms in patients with keratoconus. Methods Corneal sensitivity to mechanical, chemical, and thermal thresholds were determined using a gas esthesiometer in 19 patients with keratoconus (KC group) and in 20 age-matched healthy subjects (control group). Tear film dynamics was assessed by Schirmer I test and by the non-invasive tear film breakup time (NI-BUT). All eyes were examined with a rotating Scheimpflug camera to assess keratoconus severity. Results KC patients had significatly decreased tear secretion and significantly higher ocular surface disease index (OSDI) scores compared to controls (5.3 +/- 2.2 vs. 13.2 +/- 2.0 mm and 26.8 +/- 15.8 vs. 8.1 +/- 2.3; p<0.001). There was no significant difference in NI-BUT between the two groups (KC: 9.8 +/- 4.8 vs. control: 10.7 +/- 3.8; p>0.05). The mean threshold for selective mechanical (KC: 139.2 +/- 25.8 vs. control: 109.1 +/- 24.0 ml/min), chemical (KC: 39.4 +/- 3.9 vs. control: 35.2 +/- 1.9% CO2), heat (KC: 0.91 +/- 0.32 vs. control: 0.54 +/- 0.26 Delta degrees C) and cold (KC: 1.28 +/- 0.27 vs. control: 0.98 +/- 0.25 Delta degrees C) stimulation in the KC patients were significantly higher than in the control subjects (p<0.001, for all parameters). No correlation was found between age and mechanical, chemical, heat or cold thresholds in the patients with KC (p>0.05), whereas in the control subjects both mechanical (r = 0.52, p = 0.02), chemical (r = 0.47, p = 0.04), heat (r = 0.26, p = 0.04) and cold threshold (r = 0.40, p = 0.03) increased with age. In the KC group, neither corneal thickness nor tear flow, NI-BUT or OSDI correlated significantly with mechanical, chemical, heat or cold thresholds (p>0.05 for all variables). Conclusions Corneal sensitivity to different types of stimuli is decreased in patients with keratoconus independently of age and disease severity. The reduction of the sensory input from corneal nerves may contribute to the onset of unpleasant sensations in these patients and might lead to the impaired tear film dynamics.	[Dienes, Lorant; Kiss, Huba J.; Perenyi, Kristof; Nagy, Zoltan Z.; Kovacs, Illes] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary; [Carmen Acosta, M.; Gallar, Juana] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Alacant, Spain	Semmelweis University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Kovacs, I (corresponding author), Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary.	kovacs.illes@med.semmelweis-univ.hu	Acosta, M.Carmen/K-1313-2014; Nagy, Zoltan Zsolt/T-6180-2017; Gallar, Juana/B-4563-2011	Gallar, Juana/0000-0002-3559-3649; Acosta, M. Carmen/0000-0002-1759-068X	Hungarian Scientific Research Fund [OTKA NN106649]; Ministerio de Economia y Competitividad, Spain [SAF2014-54518-C3-1-R]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Ministerio de Economia y Competitividad, Spain	This work was supported by the Hungarian Scientific Research Fund OTKA NN106649 research grant (IK, LD) and SAF2014-54518-C3-1-R from Ministerio de Economia y Competitividad, Spain (JG, MCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MC, 2004, INVEST OPHTH VIS SCI, V45, P2333, DOI 10.1167/iovs.03-1366; Acosta MC, 2001, INVEST OPHTH VIS SCI, V42, P2063; Acosta MC, 2001, J PHYSIOL-LONDON, V534, P511, DOI 10.1111/j.1469-7793.2001.t01-1-00511.x; Al-Aqaba MA, 2011, AM J OPHTHALMOL, V152, P364, DOI 10.1016/j.ajo.2011.03.006; Belmonte C, 1999, INVEST OPHTH VIS SCI, V40, P513; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Belmonte C, 1997, PROG RETIN EYE RES, V16, P117, DOI 10.1016/S1350-9462(96)00027-4; Belmonte C, 2011, INVEST OPHTH VIS SCI, V52, P3888, DOI 10.1167/iovs.09-5119; Benitez-del-Castillo JM, 2007, INVEST OPHTH VIS SCI, V48, P173, DOI 10.1167/iovs.06-0127; Bitirgen G, 2015, INT J OPHTHALMOL-CHI, V8, P534, DOI 10.3980/j.issn.2222-3959.2015.03.17; Bourcier T, 2005, INVEST OPHTH VIS SCI, V46, P2341, DOI 10.1167/iovs.04-1426; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Brookes NH, 2003, EXP EYE RES, V77, P515, DOI 10.1016/S0014-4835(03)00148-9; Carracedo G, 2014, CURR EYE RES, V11, P1; CHEN XJ, 1995, EUR J NEUROSCI, V7, P1154, DOI 10.1111/j.1460-9568.1995.tb01105.x; Cho KJ, 2013, CORNEA, V32, P205, DOI 10.1097/ICO.0b013e3182632c07; CONSTANTINOU J, 1994, NEUROREPORT, V5, P2281, DOI 10.1097/00001756-199411000-00019; De Paiva CS, 2004, AM J OPHTHALMOL, V137, P109, DOI 10.1016/S0002-9394(03)00897-3; Dogru M, 2003, OPHTHALMOLOGY, V110, P1110, DOI 10.1016/S0161-6420(03)00261-6; Edwards M, 2001, CLIN EXP OPHTHALMOL, V29, P345, DOI 10.1046/j.1442-9071.2001.d01-16.x; Fujishima H, 1996, BRIT J OPHTHALMOL, V80, P29, DOI 10.1136/bjo.80.1.29; HAMA T, 1991, NEUROSCIENCE, V40, P445, DOI 10.1016/0306-4522(91)90132-8; Hollingsworth JG, 2005, CORNEA, V24, P397, DOI 10.1097/01.ico.0000151548.46231.27; Klein MA, 1997, GLIA, V19, P227, DOI 10.1002/(SICI)1098-1136(199703)19:3<227::AID-GLIA5>3.0.CO;2-W; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Macri A, 2000, ARCH OPHTHALMOL-CHIC, V118, P1632, DOI 10.1001/archopht.118.12.1632; Mannion Luisa Simo, 2007, Eye Contact Lens, V33, P106, DOI 10.1097/01.icl.0000235270.45379.9c; MARFURT CF, 1989, INVEST OPHTH VIS SCI, V30, P461; Mazzotta C, 2008, AM J OPHTHALMOL, V146, P527, DOI 10.1016/j.ajo.2008.05.042; MILLODOT M, 1983, ACTA OPHTHALMOL, V61, P908; Mocan MC, 2008, CURR EYE RES, V33, P933, DOI 10.1080/02713680802439219; Niederer RL, 2008, INVEST OPHTH VIS SCI, V49, P2964, DOI 10.1167/iovs.07-0968; NILSSON J, 1985, NATURE, V315, P61, DOI 10.1038/315061a0; Parra A, 2014, PAIN, V155, P1481, DOI 10.1016/j.pain.2014.04.025; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Patel DV, 2009, EYE, V23, P586, DOI 10.1038/eye.2008.52; Patel DV, 2006, INVEST OPHTH VIS SCI, V47, P1348, DOI 10.1167/iovs.05-1217; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; REYNOLDS ML, 1995, J COMP NEUROL, V358, P487, DOI 10.1002/cne.903580403; Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006; ROTSHENKER S, 1992, J NEUROIMMUNOL, V39, P75, DOI 10.1016/0165-5728(92)90176-L; Ruddle JB, 2003, CLIN EXP OPHTHALMOL, V31, P363, DOI 10.1046/j.1442-9071.2003.00673.x; Sawatzky DA, 2002, AM J PHYSIOL-LUNG C, V282, pL1279, DOI 10.1152/ajplung.00279.2001; Simo Mannion Luisa, 2005, Cont Lens Anterior Eye, V28, P185; Situ P, 2008, INVEST OPHTH VIS SCI, V49, P2971, DOI 10.1167/iovs.08-1734; Spadea L, 2013, SCI WORLD J, DOI 10.1155/2013/683090; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; Stern ME, 2004, EXP EYE RES, V78, P409, DOI 10.1016/j.exer.2003.09.003; Stoll G, 1999, BRAIN PATHOL, V9, P313; TENG CC, 1963, AM J OPHTHALMOL, V55, P18, DOI 10.1016/0002-9394(63)91645-3; Ucakhan Omur O, 2006, Eye Contact Lens, V32, P183; Yang JL, 2011, NEUROL RES, V33, P75, DOI 10.1179/016164110X12714125204353; ZABALA M, 1988, CLAO Journal, V14, P210; Zemova E, 2014, CURR EYE RES, V39, P1, DOI 10.3109/02713683.2013.798667	54	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141621	10.1371/journal.pone.0141621	http://dx.doi.org/10.1371/journal.pone.0141621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495846	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200112
J	Koufariotis, LT; Chen, YPP; Chamberlain, A; Jagt, CV; Hayes, BJ				Koufariotis, Lambros T.; Chen, Yi-Ping Phoebe; Chamberlain, Amanda; Jagt, Christy Vander; Hayes, Ben J.			A catalogue of novel bovine long noncoding RNA across 18 tissues	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; IDENTIFICATION; TRANSCRIPTS; CELL; EVOLUTION; METASTASIS; VARIANTS; LINCRNAS	Long non-coding RNA (lncRNA) have been implicated in diverse biological roles including gene regulation and genomic imprinting. Identifying lncRNA in bovine across many differing tissue would contribute to the current repertoire of bovine lncRNA, and help further improve our understanding of the evolutionary importance and constraints of these transcripts. Additionally, it could aid in identifying sites in the genome outside of protein coding genes where mutations could contribute to variation in complex traits. This is particularly important in bovine as genomic predictions are increasingly used in genetic improvement for milk and meat production. Our aim was to identify and annotate novel long non coding RNA transcripts in the bovine genome captured from RNA Sequencing (RNA-Seq) data across 18 tissues, sampled in triplicate from a single cow. To address the main challenge in identifying lncRNA, namely distinguishing lncRNA transcripts from unannotated genes and protein coding genes, a lncRNA identification pipeline with a number of filtering steps was developed. A total of 9,778 transcripts passed the filtering pipeline. The bovine lncRNA catalogue includes MALAT1 and HOTAIR, both of which have been well described in human and mouse genomes. We attempted to validate the lncRNA in libraries from three additional cows. 726 (87.47%) liver and 1,668 (55.27%) blood class 3 lncRNA were validated with stranded liver and blood libraries respectively. Additionally, this study identified a large number of novel unknown transcripts in the bovine genome with high protein coding potential, illustrating a clear need for better annotations of protein coding genes.	[Koufariotis, Lambros T.; Chen, Yi-Ping Phoebe; Hayes, Ben J.] La Trobe Univ Bundoora, Coll Sci Hlth & Engn, Melbourne, Vic, Australia; [Koufariotis, Lambros T.; Chamberlain, Amanda; Jagt, Christy Vander; Hayes, Ben J.] AgriBio Bundoora, Dept Environm & Primary Ind, Melbourne, Vic, Australia; [Koufariotis, Lambros T.; Chamberlain, Amanda; Jagt, Christy Vander; Hayes, Ben J.] Dairy Futures Cooperat Res Ctr, Melbourne, Vic, Australia	La Trobe University	Koufariotis, LT (corresponding author), La Trobe Univ Bundoora, Coll Sci Hlth & Engn, Melbourne, Vic, Australia.	rkoufariotis@students.latrobe.edu.au	Hayes, Ben J/L-3308-2016; Chen, Yi-Ping Phoebe/B-8844-2008	Hayes, Ben J/0000-0002-5606-3970; Chen, Yi-Ping Phoebe/0000-0002-4122-3767	Dairy Futures CRC; Australian federally funded Dairy Futures CRC	Dairy Futures CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian federally funded Dairy Futures CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	We would like to thank the Australian federally funded Dairy Futures CRC (www.dairyfuturescrc.com.au/) for their support and funding for this project for LTK. Dairy Futures CRC provides a scholarship for the author LTK with the author BJH being the supervisor of student LTK. All other authors except YPPC are also affiliated with the funder. The funder provided support in the form of a scholarship for author LTK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Anders S, 2014, PYTHON FRAMEWORK WOR; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Andersson L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0622-4; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Billerey C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-499; Bioinformatics UG, TWOBITTOFA UTILITY; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cao WJ, 2013, WORLD J GASTROENTERO, V19, P3658, DOI 10.3748/wjg.v19.i23.3658; Chamberlain A, 2014, P 10 WORLD C GEN APP; Chen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028318; Chwalisz Marina, 2014, BMC Res Notes, V7, P378, DOI 10.1186/1756-0500-7-378; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Groen JN, 2014, INT J BIOCHEM CELL B, V54, P350, DOI 10.1016/j.biocel.2014.05.008; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Huang W, 2012, ANIM GENET, V43, P674, DOI 10.1111/j.1365-2052.2012.02325.x; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Ilott NE, 2013, METHODS, V63, P50, DOI 10.1016/j.ymeth.2013.03.019; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kaikkonen MU, 2011, CARDIOVASC RES, V90, P430, DOI 10.1093/cvr/cvr097; Kapranov P, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-149; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Koufariotis L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-436; Lahens NF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r86; Li AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124003; Li XL, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/870597; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marques AC, 2014, CURR OPIN GENET DEV, V27, P48, DOI 10.1016/j.gde.2014.03.009; Nam JW, 2012, GENOME RES, V22, P2529, DOI 10.1101/gr.140475.112; NCBI, 2011, NCBI IGENOMES ANN 20; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Qu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042638; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Rearick D, 2011, NUCLEIC ACIDS RES, V39, P2357, DOI 10.1093/nar/gkq1080; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Washietl S, 2014, GENOME RES, V24, P616, DOI 10.1101/gr.165035.113; Weikard R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-789; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Zhou XL, 2014, ACTA BIOCH BIOPH SIN, V46, P1011, DOI 10.1093/abbs/gmu104	54	62	65	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141225	10.1371/journal.pone.0141225	http://dx.doi.org/10.1371/journal.pone.0141225			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496443	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200081
J	Wong, KT; Yoon, Y; Jang, M				Wong, Kien Tiek; Yoon, Yeomin; Jang, Min			Enhanced Recyclable Magnetized Palm Shell Waste-Based Powdered Activated Carbon for the Removal of Ibuprofen: Insights for Kinetics and Mechanisms	PLOS ONE			English	Article							AQUEOUS-SOLUTION; ENDOCRINE DISRUPTORS; PHARMACEUTICAL COMPOUNDS; WATER CONTAMINANTS; METHYLENE-BLUE; DRINKING-WATER; ADSORPTION; SURFACE; REGENERATION; TEMPERATURE	A novel preparation method of magnetized palm shell waste-based powdered activated carbon (MPPAC, avg. size 112 mu m) was developed. The prepared MPPAC was assessed by several physicochemical analyses, and batch tests were performed for ibuprofen (IBP) removal. Field emission scanning electron microscopy (FESEM) and N-2 gas isotherms revealed that magnetite and maghemite were homogeneous and deposited mostly on the surface of PPAC without a significant clogging effect on the micropores. Isotherm results showed that 3.8% Fe (w/w) impregnated PPAC [MPPAC-Fe(3.8%)] had about 2.2-fold higher maximum sorption capacity (157.3 mg g(-1)) and a 2.5-fold higher sorption density (0.23 mg m(-2)) than pristine PPAC. Both Fourier-transform infrared spectroscopy (FTIR) and isotherm data indicated that the high sorption capacity and density of IBP by MPPAC was primarily attributable to donor-acceptor complexes with the C = O group and dispersive pi-pi interactions with the carbon surface. Based on kinetic and repeated adsorption tests, pore diffusion was the rate-limiting step, and MPPAC-Fe(3.8%) had about 1.9 similar to 2.8- and 9.1 similar to 15.8-fold higher rate constants than MPPAC-Fe(8.6%) and palm shell-waste granular activated carbon (PGAC, avg. size 621 mu m), respectively. MPPAC showed almost eight fold greater re-adsorption capacity than PPAC due to a thermal catalytic effect of magnetite/maghemite.	[Wong, Kien Tiek; Jang, Min] Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia; [Yoon, Yeomin] Univ S Carolina, Dept Civil & Environm Engn, Columbia, SC 29208 USA; [Jang, Min] Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, Kuala Lumpur, Malaysia	Universiti Malaya; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Universiti Malaya	Jang, M (corresponding author), Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia.	minjang@um.edu.my	Yoon, Yeomin/C-3331-2012; Jang, Min/M-6690-2018	Jang, Min/0000-0002-5900-0991; Jang, Min/0000-0003-2700-7256	Malaysian Government Ministry of Higher Education [D000062-16001]	Malaysian Government Ministry of Higher Education	This work was supported by the Malaysian Government Ministry of Higher Education through the High Impact Research Grant (D000062-16001).	Attia TMS, 2013, CHEMOSPHERE, V93, P2076, DOI 10.1016/j.chemosphere.2013.07.046; Bastami TR, 2012, CHEM ENG J, V210, P510, DOI 10.1016/j.cej.2012.08.011; Behera SK, 2012, INT J ENVIRON SCI TE, V9, P85, DOI 10.1007/s13762-011-0020-8; Benotti MJ, 2009, ENVIRON SCI TECHNOL, V43, P597, DOI 10.1021/es801845a; Briceno S, 2014, J MAGN MAGN MATER, V360, P67, DOI 10.1016/j.jmmm.2014.01.073; Bui TX, 2009, J HAZARD MATER, V168, P602, DOI 10.1016/j.jhazmat.2009.02.072; Caliskan E, 2012, J ENVIRON MANAGE, V102, P134, DOI 10.1016/j.jenvman.2012.02.016; Cansado IPP, 2012, FUEL PROCESS TECHNOL, V103, P64, DOI 10.1016/j.fuproc.2011.10.015; Ciriaco L, 2009, ELECTROCHIM ACTA, V54, P1464, DOI 10.1016/j.electacta.2008.09.022; Cwiertny DM, 2014, ENVIRON SCI TECHNOL, DOI [10.1021/es503727b, DOI 10.1021/ES503727B]; Dubey SP, 2010, CHEM ENG J, V165, P537, DOI 10.1016/j.cej.2010.09.068; Guedidi H, 2014, ARABIAN J CHEM; Guedidi H, 2013, CARBON, V54, P432, DOI 10.1016/j.carbon.2012.11.059; Guo J, 2007, CARBON, V45, P330, DOI 10.1016/j.carbon.2006.09.016; HURLE KB, 1972, WEED RES, V12, P1, DOI 10.1111/j.1365-3180.1972.tb01181.x; Jermann D, 2009, J MEMBRANE SCI, V329, P75, DOI 10.1016/j.memsci.2008.12.016; Jones OAH, 2007, ENVIRON SCI TECHNOL, V41, P5085, DOI 10.1021/es0628248; Jurado A, 2012, SCI TOTAL ENVIRON, V440, P82, DOI 10.1016/j.scitotenv.2012.08.029; Kang KL, 2014, J MOL CATAL A; Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0; Khalil HPSA, 2013, J BIOBASED MATER BIO, V7, P1; Kim SD, 2007, WATER RES, V41, P1013, DOI 10.1016/j.watres.2006.06.034; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kyzas GZ, 2013, CHEM ENG J, V234, P491, DOI 10.1016/j.cej.2013.06.024; Lee Y, 2013, ENVIRON SCI TECHNOL, V47, P5872, DOI 10.1021/es400781r; Li QM, 2015, J CLEAN PROD, V86, P424, DOI 10.1016/j.jclepro.2014.08.008; Liu GF, 2009, J HAZARD MATER, V164, P1275, DOI 10.1016/j.jhazmat.2008.09.038; Liu Y, 2011, J HAZARD MATER, V186, P1314, DOI 10.1016/j.jhazmat.2010.12.007; Mao HY, 2015, J IND ENG CHEM, V21, P516, DOI 10.1016/j.jiec.2014.03.014; Mendez-Arriaga F, 2008, WATER RES, V42, P4243, DOI 10.1016/j.watres.2008.05.033; Mestre AS, 2009, BIORESOURCE TECHNOL, V100, P1720, DOI 10.1016/j.biortech.2008.09.039; Montes-Moran MA, 1998, J PHYS CHEM B, V102, P5595, DOI 10.1021/jp972656t; Omri A, 2013, J IND ENG CHEM, V19, P2092, DOI 10.1016/j.jiec.2013.03.025; Snyder SA, 2003, ENVIRON ENG SCI, V20, P449, DOI 10.1089/109287503768335931; Snyder SA, 2006, OZONE-SCI ENG, V28, P445, DOI 10.1080/01919510601039726; Snyder SA, 2014, J AM WATER WORKS ASS, V106, P38, DOI 10.5942/jawwa.2014.106.0126; Stackelberg PE, 2004, SCI TOTAL ENVIRON, V329, P99, DOI 10.1016/j.scitotenv.2004.03.015; Toledo IB, 2005, ENVIRON SCI TECHNOL, V39, P6246, DOI 10.1021/es0481169; Weng CH, 2006, COLLOID SURFACE A, V274, P154, DOI 10.1016/j.colsurfa.2005.08.044; Westerhoff P, 2005, ENVIRON SCI TECHNOL, V39, P6649, DOI 10.1021/es0484799; Wu RC, 2004, APPL CATAL B-ENVIRON, V48, P49, DOI 10.1016/j.apcatb.2003.09.006; Yoon Y, 2010, SCI TOTAL ENVIRON, V408, P636, DOI 10.1016/j.scitotenv.2009.10.049; Yu Y, 2004, CHEMOSPHERE, V54, P425, DOI 10.1016/S0045-6535(03)00654-4; Zhang GS, 2007, CHEMOSPHERE, V68, P1058, DOI 10.1016/j.chemosphere.2007.01.081	44	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141013	10.1371/journal.pone.0141013	http://dx.doi.org/10.1371/journal.pone.0141013			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496196	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200052
J	Stevenson, PR; Link, A; Gonzalez-Caro, S; Torres-Jimenez, MF				Stevenson, Pablo R.; Link, Andres; Gonzalez-Caro, Sebastian; Fernanda Torres-Jimenez, Maria			Frugivory in Canopy Plants in a Western Amazonian Forest: Dispersal Systems, Phylogenetic Ensembles and Keystone Plants	PLOS ONE			English	Article							TINIGUA-NATIONAL-PARK; SEED DISPERSAL; RAIN-FOREST; WOOLLY MONKEYS; COEVOLUTIONARY NETWORKS; DAMAGE TOLERANCE; FRUIT CHOICE; RESOURCE USE; SIZE; PATTERNS	Frugivory is a widespread mutualistic interaction in which frugivores obtain nutritional resources while favoring plant recruitment through their seed dispersal services. Nonetheless, how these complex interactions are organized in diverse communities, such as tropical forests, is not fully understood. In this study we evaluated the existence of plant-frugivore sub-assemblages and their phylogenetic organization in an undisturbed western Amazonian forest in Colombia. We also explored for potential keystone plants, based on network analyses and an estimate of the amount of fruit going from plants to frugivores. We carried out diurnal observations on 73 canopy plant species during a period of two years. During focal tree sampling, we recorded frugivore identity, the duration of each individual visit, and feeding rates. We did not find support for the existence of sub assemblages, such as specialized vs. generalized dispersal systems. Visitation rates on the vast majority of canopy species were associated with the relative abundance of frugivores, in which ateline monkeys ( i.e. Lagothrix and Ateles) played the most important roles. All fruiting plants were visited by a variety of frugivores and the phylogenetic assemblage was random in more than 67% of the cases. In cases of aggregation, the plant species were consumed by only primates or only birds, and filters were associated with fruit protection and likely chemical content. Plants suggested as keystone species based on the amount of pulp going from plants to frugivores differ from those suggested based on network approaches. Our results suggest that in tropical forests most tree-frugivore interactions are generalized, and abundance should be taken into account when assessing the most important plants for frugivores.	[Stevenson, Pablo R.; Link, Andres; Gonzalez-Caro, Sebastian; Fernanda Torres-Jimenez, Maria] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Link, Andres] Univ Los Andes, Fac Adm, Bogota, Colombia; [Gonzalez-Caro, Sebastian] Medellin Bot Garden, Ecosyst Serv, Medellin, Colombia; [Gonzalez-Caro, Sebastian] Medellin Bot Garden, Climate Change Lab, Medellin, Colombia; [Fernanda Torres-Jimenez, Maria] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); University of Edinburgh	Stevenson, PR (corresponding author), Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia.	psetevens@uniandes.edu.co	Torres Jimenez, Maria Fernanda/ABF-2304-2020; Gonzalez-Caro, Sebastian/T-3532-2019	Torres Jimenez, Maria Fernanda/0000-0002-7177-4164; Link, Andres/0000-0003-3125-249X	Banco de La Republica; Primate Conservation Inc.; La Fundacion para la Promocion de la Investigacion y la Tecnologia (Banco de la Republica); Margot Marsh Foundation; Lincoln Park Zoo; IdeaWild; Universidad de Los Andes	Banco de La Republica; Primate Conservation Inc.; La Fundacion para la Promocion de la Investigacion y la Tecnologia (Banco de la Republica); Margot Marsh Foundation; Lincoln Park Zoo; IdeaWild; Universidad de Los Andes	PRS received funds from Banco de La Republica (http://www.banrepcultural.org/fpit/inicio) and Primate Conservation Inc. (http://www.primate.org). Financial support also came from the following institutions: La Fundacion para la Promocion de la Investigacion y la Tecnologia (Banco de la Republica), Margot Marsh Foundation, Lincoln Park Zoo, Primate Conservation Inc., IdeaWild, and Universidad de Los Andes.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Alvarez-Rebolledo M, 1995, CENSOS AVES CT UNPUB; Baraloto C, 2007, AM J BOT, V94, P901, DOI 10.3732/ajb.94.6.901; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bohning-Gaese Katrin, 1995, Ecotropica, V1, P41; Bollen A, 2004, OECOLOGIA, V139, P604, DOI 10.1007/s00442-004-1544-0; Campbell CJ, 2005, INT J PRIMATOL, V26, P1039, DOI 10.1007/s10764-005-6457-1; Chapman Colin A., 1995, Evolutionary Anthropology, V4, P74, DOI 10.1002/evan.1360040303; Chapman Colin A., 2002, P275, DOI 10.1079/9780851995250.0275; Clark CJ, 2001, BIOTROPICA, V33, P606, DOI 10.1111/j.1744-7429.2001.tb00219.x; Correa DF, 2015, GLOBAL ECOL BIOGEOGR, V24, P203, DOI 10.1111/geb.12248; Dalling JW, 1999, OIKOS, V85, P257, DOI 10.2307/3546491; Dalling JW, 1997, J TROP ECOL, V13, P481, DOI 10.1017/S026646740001066X; Dattilo W, 2013, OIKOS, V122, P1643, DOI 10.1111/j.1600-0706.2013.00562.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Dew JL, 2005, INT J PRIMATOL, V26, P1107, DOI 10.1007/s10764-005-6461-5; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Dormann C.F., 2008, R NEWS, V8, P8; Dormann Carsten F., 2011, Network Biology, V1, P1; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Ferenc J, 2009, ECOL MODEL, V220, P2899, DOI 10.1016/j.ecolmodel.2008.12.003; FISCHER KE, 1993, OIKOS, V66, P472, DOI 10.2307/3544942; FLEMING TH, 1981, BIOTROPICA, V13, P45, DOI 10.2307/2388069; Fleming TH, 2011, ACTA OECOL, V37, P521, DOI 10.1016/j.actao.2011.01.016; FOSTER SA, 1985, ECOLOGY, V66, P773, DOI 10.2307/1940538; French AR, 2005, BIOTROPICA, V37, P96, DOI 10.1111/j.1744-7429.2005.04051.x; Fuentes M, 1995, OIKOS, V74, P324, DOI 10.2307/3545663; GAUTIERHION A, 1985, OECOLOGIA, V65, P324, DOI 10.1007/BF00378906; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; Hanya G, 2011, ECOGRAPHY, V34, P1009, DOI 10.1111/j.1600-0587.2010.06775.x; Hawes JE, 2014, J TROP ECOL, V30, P381, DOI 10.1017/S0266467414000261; Heindl Martin, 1999, Ecotropica, V5, P167; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; Herrera CM, 2002, OIKOS, V97, P426, DOI 10.1034/j.1600-0706.2002.970312.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HOWE HF, 1993, VEGETATIO, V108, P3; HOWE HF, 1977, ECOLOGY, V58, P539, DOI 10.2307/1939003; Jansen PA, 2012, P NATL ACAD SCI USA, V109, P12610, DOI 10.1073/pnas.1205184109; JANSON CH, 1983, SCIENCE, V219, P187, DOI 10.1126/science.219.4581.187; Jordan F, 2006, OIKOS, V112, P535, DOI 10.1111/j.0030-1299.2006.13724.x; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Kalko EKV, 1996, J BIOGEOGR, V23, P565, DOI 10.1111/j.1365-2699.1996.tb00018.x; Kidson R, 2000, OECOLOGIA, V125, P11, DOI 10.1007/PL00008882; Lambert JE, 1998, AM J PRIMATOL, V45, P9, DOI 10.1002/(SICI)1098-2345(1998)45:1<9::AID-AJP3>3.3.CO;2-A; Larson DL, 1996, OIKOS, V76, P113, DOI 10.2307/3545753; Link A, 2004, REV CHIL HIST NAT, V77, P319; Link A, 2006, J TROP ECOL, V22, P235, DOI 10.1017/S0266467405003081; Lord JM, 2004, AUSTRAL ECOL, V29, P430, DOI 10.1111/j.1442-9993.2004.01382.x; Gonzalez AMM, 2010, ECOL COMPLEX, V7, P36, DOI 10.1016/j.ecocom.2009.03.008; McKey D., 1975, COEVOLUTION ANIMALS, P158; Nunez-Iturri G, 2007, BIOTROPICA, V39, P348, DOI 10.1111/j.1744-7429.2007.00276.x; Peres CA, 2000, J TROP ECOL, V16, P287, DOI 10.1017/S0266467400001413; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Peres Carlos A., 2002, P407, DOI 10.1079/9780851995250.0407; Poulsen JR, 2002, ECOLOGY, V83, P228, DOI 10.1890/0012-9658(2002)083[0228:DRUBPA]2.0.CO;2; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Ratiarison S, 2005, J TROP ECOL, V21, P501, DOI 10.1017/S0266467405002518; Mello MAR, 2011, OECOLOGIA, V167, P131, DOI 10.1007/s00442-011-1984-2; Schleuning M, 2011, ECOLOGY, V92, P26, DOI 10.1890/09-1842.1; SCHUPP EW, 1993, VEGETATIO, V108, P15; Sewall BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068657; Smith AD, 2014, OECOLOGIA, V174, P931, DOI 10.1007/s00442-013-2834-1; SNOW DW, 1971, IBIS, V113, P194, DOI 10.1111/j.1474-919X.1971.tb05144.x; Stevenson P, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P37, DOI 10.1007/1-4020-3833-X_3; Stevenson P. R., 2007, Seed dispersal: theory and its application in a changing world, P340, DOI 10.1079/9781845931650.0340; Stevenson PR, 2008, BIOTROPICA, V40, P559, DOI 10.1111/j.1744-7429.2008.00417.x; Stevenson PR, 2014, DEV PRIMATOL-PROG PR, V39, P207, DOI 10.1007/978-1-4939-0697-0_12; Stevenson PR, 2011, BIOTROPICA, V43, P512, DOI 10.1111/j.1744-7429.2010.00708.x; Stevenson PR, 2000, BIOTROPICA, V32, P533, DOI 10.1111/j.1744-7429.2000.tb00499.x; Stevenson PR, 2001, BIOL J LINN SOC, V72, P161, DOI 10.1006/bijl.2000.0497; Stevenson PR, 2005, OIKOS, V110, P435, DOI 10.1111/j.0030-1299.2005.12898.x; Stevenson PR, 2004, INT J PRIMATOL, V25, P367, DOI 10.1023/B:IJOP.0000019157.35464.a0; Stevenson PR, 2002, INT J PRIMATOL, V23, P1187, DOI 10.1023/A:1021118618936; Stevenson PR, 2000, GUIA FRUTOS BOSQUES; STEVENSON PR, 2002, THESIS STATE U NEW Y; Swamy V, 2010, J ECOL, V98, P1096, DOI 10.1111/j.1365-2745.2010.01686.x; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Terborgh J., 1986, CONSERVATION BIOL SC, P330; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Tobler MW, 2002, BIOTROPICA, V34, P468, DOI 10.1111/j.1744-7429.2002.tb00563.x; VAN ROOSMALEN M. G. M., 1985, FRUITS GUIANAN FLORA; Vasas V, 2006, ECOL MODEL, V196, P365, DOI 10.1016/j.ecolmodel.2006.02.024; Venables W., 2013, MODERN APPL STAT S P, DOI DOI 10.1007/978-0-387-21706-2; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2001, ECOL LETT, V4, P491, DOI 10.1046/j.1461-0248.2001.00252.x; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; WRIGHT DH, 1989, AM NAT, V134, P664, DOI 10.1086/285003; Wright PC, 2011, AM J PRIMATOL, V73, P585, DOI 10.1002/ajp.20936; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yu DW, 2001, BIOL J LINN SOC, V72, P529, DOI [10.1006/bijl.2000.0514, 10.1111/j.1095-8312.2001.tb01336.x]	103	20	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140751	10.1371/journal.pone.0140751	http://dx.doi.org/10.1371/journal.pone.0140751			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492037	gold, Green Published, Green Submitted			2022-12-27	WOS:000363249300012
J	Chu, SY; Yu, HP; Chen, Y; Chen, Q; Wang, B; Zhang, J				Chu, Shuyuan; Yu, Hongping; Chen, Yan; Chen, Qian; Wang, Bin; Zhang, Jun			Periconceptional and Gestational Exposure to Antibiotics and Childhood Asthma	PLOS ONE			English	Article							COLLABORATIVE PERINATAL PROJECT; EARLY-LIFE; PREGNANCY; RISK; CHILDREN; FETAL; COLONIZATION; DISEASE; BIRTH; GUT	Background Previous studies suggest that maternal antibiotics exposure during pregnancy may increase the risk of childhood asthma, but the results were inconsistent. Furthermore, most studies did not examine periconception period as an exposure window. We aim to assess the associations between maternal exposure to specific antibiotics before and during pregnancy and the risk of asthma in early childhood. Methods Data from the Collaborative Perinatal Project were used. Maternal exposure to antibiotics before and during pregnancy was recorded at each prenatal visit. A total of 39,907 singleton children were followed up to 7 years of age. Multilevel multiple logistic regression models were used to control for potential confounders and account for multiple pregnancies per woman. Results Maternal use of penicillin or chloramphenicol was associated with an increased risk of asthma in the offspring (adjusted odds ratio = 1.21, 95% confidence interval 1.08-1.36 for penicillin; 1.72 [1.14-2.59] for chloramphenicol). The risk was significantly increased if penicillin or chloramphenicol was used in the 1st trimester (1.09 [1.04-1.13] for penicillin and 1.23 [1.01-1.51] for chloramphenicol). Conclusion Maternal exposure to certain antibiotics is associated with childhood asthma by 7 years of age. Early pregnancy may be a sensitive window.	[Chu, Shuyuan; Chen, Yan; Chen, Qian; Wang, Bin; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai 200092, Peoples R China; [Chu, Shuyuan; Yu, Hongping; Zhang, Jun] Guilin Med Univ, Sch Publ Hlth, Guilin 541004, Peoples R China; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Collaborat Innovat Ctr Syst Biomed, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Guilin Medical University; Shanghai Jiao Tong University	Yu, HP (corresponding author), Guilin Med Univ, Sch Publ Hlth, Guilin 541004, Peoples R China.	yhp268@163.com; junjimzhang@gmail.com		Wang, Bin/0000-0002-4869-1352	National Natural Science Foundation of China [81530086, 81273091]; Ministry of Science and Technology of China [2014DFG31460]; Shanghai Municipality Science and Technology Commission [14XD1403300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipality Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by grants from the National Natural Science Foundation of China (81530086 and 81273091), the Ministry of Science and Technology of China (2014DFG31460) and Shanghai Municipality Science and Technology Commission (14XD1403300).	[Anonymous], 2009, POCKET GUIDE ASTHMA; Benn CS, 2002, J ALLERGY CLIN IMMUN, V110, P72, DOI 10.1067/mai.2002.125833; Bloomfield FH, 2011, J NEURODEV DISORD, V3, P348, DOI 10.1007/s11689-011-9096-1; CHEN TC, 1990, ARCH NEUROL-CHICAGO, V47, P1227, DOI 10.1001/archneur.1990.00530110087022; Collier CH, 2013, MATERN CHILD HLTH J, V17, P1940, DOI 10.1007/s10995-013-1220-2; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Hardy JB, 2003, ANN EPIDEMIOL, V13, P303, DOI 10.1016/S1047-2797(02)00479-9; Huang LS, 2013, AM J EPIDEMIOL, V178, P1691, DOI 10.1093/aje/kwt248; Klebanoff MA, 2009, PAEDIATR PERINAT EP, V23, P2, DOI 10.1111/j.1365-3016.2008.00984.x; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martel MJ, 2009, EUR RESPIR J, V34, P579, DOI 10.1183/09031936.00074608; McKeever TM, 2002, AM J RESP CRIT CARE, V166, P827, DOI 10.1164/rccm.200202-158OC; MENEELY GR, 1962, AM REV RESPIR DIS, V85, P762; Metsala J, 2015, CLIN EXP ALLERGY, V45, P137, DOI 10.1111/cea.12356; Metsala J, 2008, AM J EPIDEMIOL, V168, P170, DOI 10.1093/aje/kwn105; Modi SR, 2014, J CLIN INVEST, V124, P4212, DOI 10.1172/JCI72333; NEFF RK, 1990, CHEST, V97, P1266, DOI 10.1378/chest.97.5.1266; OLSHAN AF, 1989, INT J EPIDEMIOL, V18, P891, DOI 10.1093/ije/18.4.891; Ortqvist AK, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6979; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Rautava S, 2012, NEONATOLOGY, V102, P178, DOI 10.1159/000339182; Rechavi E, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0072; Romano-Keeler J, 2015, PEDIATR RES, V77, P189, DOI 10.1038/pr.2014.163; Rusconi F, 2007, AM J RESP CRIT CARE, V175, P16, DOI 10.1164/rccm.200512-1978OC; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Stokholm J, 2014, CLIN MICROBIOL INFEC, V20, P629, DOI 10.1111/1469-0691.12411; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Winer RA, 2012, J ASTHMA, V49, P16, DOI 10.3109/02770903.2011.637594; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	31	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140443	10.1371/journal.pone.0140443	http://dx.doi.org/10.1371/journal.pone.0140443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488397	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400052
J	Mangin, O; Filliat, D; ten Bosch, L; Oudeyer, PY				Mangin, Olivier; Filliat, David; ten Bosch, Louis; Oudeyer, Pierre-Yves			MCA-NMF: Multimodal Concept Acquisition with Non-Negative Matrix Factorization	PLOS ONE			English	Article							LANGUAGE; SPEECH; PERCEPTION; CONSTRAINTS; IMITATION; OBJECTS; WORDS; VIEWS	In this paper we introduce MCA-NMF, a computational model of the acquisition of multimodal concepts by an agent grounded in its environment. More precisely our model finds patterns in multimodal sensor input that characterize associations across modalities (speech utterances, images and motion). We propose this computational model as an answer to the question of how some class of concepts can be learnt. In addition, the model provides a way of defining such a class of plausibly learnable concepts. We detail why the multimodal nature of perception is essential to reduce the ambiguity of learnt concepts as well as to communicate about them through speech. We then present a set of experiments that demonstrate the learning of such concepts from real non-symbolic data consisting of speech sounds, images, and motions. Finally we consider structure in perceptual signals and demonstrate that a detailed knowledge of this structure, named compositional understanding can emerge from, instead of being a prerequisite of, global understanding. An open-source implementation of the MCA-NMF learner as well as scripts and associated experimental data to reproduce the experiments are publicly available.	[Mangin, Olivier; Filliat, David; Oudeyer, Pierre-Yves] Inria, Flowers Team, Bordeaux, France; [Mangin, Olivier; Filliat, David; Oudeyer, Pierre-Yves] Univ Paris Saclay, ENSTA ParisTech, U2IS, Saclay, France; [ten Bosch, Louis] Radboud Univ Nijmegen, Ctr Language & Speech Technol, NL-6525 ED Nijmegen, Netherlands	Inria; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay; Radboud University Nijmegen	Mangin, O (corresponding author), Inria, Flowers Team, Bordeaux, France.	olivier@mangin.com	FILLIAT, David/ABD-6165-2020	FILLIAT, David/0000-0002-5739-1618; ten bosch, louis/0000-0002-0152-9024	ERC [240007]; Inria; ENSTA-Paristech; Universite de Bordeaux	ERC(European Research Council (ERC)European Commission); Inria; ENSTA-Paristech; Universite de Bordeaux	This research was partially supported by the ERC Explorers 240007 funding (http://erc.europa.eu), Inria (http://inria.fr), ENSTA-Paristech (http://ensta-paristech.fr), and Universite de Bordeaux (http://u-bordeaux.fr).	Akata Z, 2011, COMP VIS WINT WORKSH, P16; Akhtar N., 1999, FIRST LANG, V19, P347, DOI [10.1177/014272379901905703, DOI 10.1177/014272379901905703]; Altosaar T., 2008, LANG RESOUR EVAL, P1062; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Belpaeme T, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500312; BenAbdallah Jaafar, 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P128, DOI 10.1109/WI-IAT.2010.293; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Boves L, 2007, PROCEEDINGS OF THE SIXTH IEEE INTERNATIONAL CONFERENCE ON COGNITIVE INFORMATICS, P349, DOI 10.1109/COGINF.2007.4341909; Brent MR, 1999, SPEECH SEGMENTATION; Calinon S, 2009, ADV ROBOTICS, V23, P2059, DOI 10.1163/016918609X12529294461843; Cangelosi A, 2010, IEEE T AUTON MENT DE, V2, P167, DOI 10.1109/TAMD.2010.2053034; Cangelosi A, 2010, PHYS LIFE REV, V7, P139, DOI 10.1016/j.plrev.2010.02.001; Cederborg T, 2013, IEEE T AUTON MENT DE, V5, P222, DOI 10.1109/TAMD.2013.2279277; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Cover T. M., 1991, ELEMENTS INFORM THEO; Driesen Joris, 2010, Proceedings 2010 IEEE Spoken Language Technology Workshop (SLT 2010), P1, DOI 10.1109/SLT.2010.5700813; Driesen J., 2012, DISCOVERING WORDS SP; Driesen J., 2009, INTERSPEECH, P1; Driesen J, 2012, SAPA SCALE; Droniou A, 2014, ROBOTICS AUTONOMOUS; Filliat D, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P248, DOI 10.1109/IROS.2008.4650681; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Iwahashi N, 2003, INFORM SCIENCES, V156, P109, DOI 10.1016/S0020-0255(03)00167-1; Joachims T., 1997, TEXT CATEGORIZATION, P23; Konczak J, 2005, P 5 INT WORKSH EP RO, V123, P47; Kulic Dana, 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P1210, DOI 10.1109/ROMAN.2009.5326307; Landau B, 1998, TRENDS COGN SCI, V2, P19, DOI 10.1016/S1364-6613(97)01111-X; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Lienhart R., 2009, P ACM INT C IM VID R, P1, DOI DOI 10.1145/1646396.1646408; Lupyan G, 2007, PSYCHOL SCI, V18, P1077, DOI 10.1111/j.1467-9280.2007.02028.x; Lyubova N, 2012, IEEE IJCNN; Mangin O, 2013, JOINT IEEE INT C DEV, V3; Mangin O., 2014, EMERGENCE MULTIMODEL; Mangin O, 2010, 10 INT C EP ROB OR S, P73; Mangin O, 2012, INT C INT ROB SYST I; Mangin O., 2013, CHOREOGRAPHY 2 DATAS; MARKMAN EM, 1990, COGNITIVE SCI, V14, P57, DOI 10.1207/s15516709cog1401_4; Massera G, 2010, IEEE COMPUT INTELL M, V5, P33, DOI 10.1109/MCI.2010.937321; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Micusik B, 2009, IEEE WORKSH VID OR O; MUNKRES J, 1957, J SOC IND APPL MATH, V5, P32, DOI 10.1137/0105003; Mussa-Ivaldi FA, 2000, PHILOS T R SOC B, V355, P1755, DOI 10.1098/rstb.2000.0733; Ngiam J, 2011, INT C MACH LEARN, P28; Oudeyer P.-Y., 2014, TOPICS COGNITIVE SCI; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Potamianos G, 2003, P IEEE, V91, P1306, DOI 10.1109/JPROC.2003.817150; Quine W. V. O., 1960, WORD OBJECT; Roy D, 1999, LEARNING SIGHTS SOUN; Roy DK, 2002, COGNITIVE SCI, V26, P113, DOI 10.1207/s15516709cog2601_4; Saenko K, 2007, JOINT WORKSH MULT IN, P4; Schwartz JL, 2012, PHILOS T R SOC B, V367, P896, DOI 10.1098/rstb.2011.0254; Schwartz JL, 2010, J ACOUST SOC AM, V127, P1584, DOI 10.1121/1.3293001; Schwartz JL, 2004, COGNITION, V93, pB69, DOI 10.1016/j.cognition.2004.01.006; Sivic J, 2008, P IEEE, V96, P548, DOI 10.1109/JPROC.2008.916343; Smith L, 2008, COGNITION, V106, P1558, DOI 10.1016/j.cognition.2007.06.010; Sodoyer D, 2004, SPEECH COMMUN, V44, P113, DOI 10.1016/j.specom.2004.10.002; Srivastava N., 2012, ADV NEURAL INFORM PR, P2222, DOI [DOI 10.1162/NEC0_A_00311, DOI 10.1109/CVPR.2013.49]; STEELS L, 2002, LINGUISTIC EVOLUTION; Steels L, 2008, SYMBOLS EMBODIMENT D; Stouten V, 2008, IEEE SIGNAL PROC LET, V15, P131, DOI 10.1109/LSP.2007.911723; Sugita Y, 2005, ADAPT BEHAV, V13, P33, DOI 10.1177/105971230501300102; ten Bosch LFM, 2008, SPEECH ANAL PROCESSI; Tresch MC, 2009, CURR OPIN NEUROBIOL, V19, P601, DOI 10.1016/j.conb.2009.09.002; Tuci E., 2011, IEEE T AUTON MENT DE, V3, P1, DOI DOI 10.1109/TAMD.2011.2114659; Van Hamme H, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P2554; Versteegh M, 2011, INTERSPEECH 2011, P761; Waxman SR, 1995, COGNITIVE PSYCHOL, V29, P257, DOI 10.1006/cogp.1995.1016; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wrede B., 2012, HUM 2012 WORKSH DEV; Xu W, 2003, P 26 ANN INT ACM SIG, P267, DOI [10.1145/860435.860485, DOI 10.1145/860435.860485]; Yu C., 2004, ACM T APPL PERCEPT, V1, P57, DOI [DOI 10.1145/1008722.1008727, 10.1145/1008722.1008727]; Yurovsky D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00374	76	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140732	10.1371/journal.pone.0140732	http://dx.doi.org/10.1371/journal.pone.0140732			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489021	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400066
J	Saito, A; Akima, H				Saito, Akira; Akima, Hiroshi			Neuromuscular Activation of the Vastus Intermedius Muscle during Isometric Hip Flexion	PLOS ONE			English	Article							RECTUS FEMORIS MUSCLE; LOWER-LIMB MUSCLES; IN-VIVO; KNEE-EXTENSION; ELECTROMECHANICAL DELAY; HUMAN QUADRICEPS; EMG; AFFERENTS; PATTERN; COACTIVATION	Although activity of the rectus femoris (RF) differs from that of the other synergists in quadriceps femoris muscle group during physical activities in humans, it has been suggested that the activation pattern of the vastus intermedius (VI) is similar to that of the RF. The purpose of present study was to examine activation of the VI during isometric hip flexion. Ten healthy men performed isometric hip flexion contractions at 25%, 50%, 75%, and 100% of maximal voluntary contraction at hip joint angles of 90 degrees, 110 degrees and 130 degrees. Surface electromyography (EMG) was used to record activity of the four quadriceps femoris muscles and EMG signals were root mean square processed and normalized to EMG amplitude during an isometric knee extension with maximal voluntary contraction. The normalized EMG was significantly higher for the VI than for the vastus medialis during hip flexion at 100% of maximal voluntary contraction at hip joint angles of 110 degrees and 130 degrees (P < 0.05). The onset of VI activation was 230-240 ms later than the onset of RF activation during hip flexion at each hip joint angle, which was significantly later than during knee extension at 100% of maximal voluntary contraction (P < 0.05). These results suggest that the VI is activated later than the RF during hip flexion. Activity of the VI during hip flexion might contribute to stabilize the knee joint as an antagonist and might help to smooth knee joint motion, such as in the transition from hip flexion to knee extension during walking, running and pedaling.	[Saito, Akira; Akima, Hiroshi] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi 4648601, Japan; [Saito, Akira] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Akima, Hiroshi] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan	Nagoya University; Japan Society for the Promotion of Science; Nagoya University	Saito, A (corresponding author), Waseda Univ, Fac Sports Sci, Tokorozawa, Saitama, Japan.	a-saito@aoni.waseda.jp			Ministry of Education, Culture, Sports, Science and Technology [25-860, 23300239]; Yamaha Motors Foundation for Sports	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamaha Motors Foundation for Sports	The present study was supported in part by a Grant-in-Aid for Japan Society for the Promotion of Science (#25-860) to AS, and a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology Grant (#23300239) to HA. This work was also funded, in part, by the Yamaha Motors Foundation for Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2004, EUR J APPL PHYSIOL, V91, P7, DOI 10.1007/s00421-003-0942-z; Akima H, 2013, MUSCLE NERVE, V47, P682, DOI 10.1002/mus.23647; Akima H, 2012, MUSCLE NERVE, V46, P86, DOI 10.1002/mus.23268; Alkner BA, 2000, MED SCI SPORT EXER, V32, P459, DOI 10.1097/00005768-200002000-00030; Asakawa DS, 2002, J BIOMECH, V35, P1029, DOI 10.1016/S0021-9290(02)00048-9; Blazevich AJ, 2006, J ANAT, V209, P289, DOI 10.1111/j.1469-7580.2006.00619.x; Blemker SS, 2006, J BIOMECH, V39, P1383, DOI 10.1016/j.jbiomech.2005.04.012; Collins DF, 2005, J NEUROPHYSIOL, V94, P1699, DOI 10.1152/jn.00191.2005; Dorel S, 2008, J ELECTROMYOGR KINES, V18, P857, DOI 10.1016/j.jelekin.2007.03.002; Ebenbichler GR, 1998, MUSCLE NERVE, V21, P1706, DOI 10.1002/(SICI)1097-4598(199812)21:12<1706::AID-MUS13>3.3.CO;2-3; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; Gadikota HR, 2013, J ORTHOP SPORT PHYS, V43, P478, DOI 10.2519/jospt.2013.4506; GANDEVIA SC, 1994, J PHYSIOL-LONDON, V479, P499, DOI 10.1113/jphysiol.1994.sp020313; GASSEL MM, 1970, J NEUROL NEUROSUR PS, V33, P358, DOI 10.1136/jnnp.33.3.358; GASSEL MM, 1970, J NEUROL NEUROSUR PS, V33, P121, DOI 10.1136/jnnp.33.1.121; Gazendam MGJ, 2007, GAIT POSTURE, V25, P604, DOI 10.1016/j.gaitpost.2006.06.013; Hug F, 2010, J APPL PHYSIOL, V108, P1727, DOI 10.1152/japplphysiol.01305.2009; Kubo K, 2001, J APPL PHYSIOL, V91, P26, DOI 10.1152/jappl.2001.91.1.26; Larsen B, 2006, EXP BRAIN RES, V170, P555, DOI 10.1007/s00221-005-0237-1; Linford CW, 2006, ARCH PHYS MED REHAB, V87, P395, DOI 10.1016/j.apmr.2005.10.027; Merican AM, 2008, J BONE JOINT SURG BR, V90B, P527, DOI 10.1302/0301-620X.90B4.20085; Miyamoto N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034269; MONTGOMERY WH, 1994, AM J SPORT MED, V22, P272, DOI 10.1177/036354659402200220; Neptune RR, 2009, J BIOMECH, V42, P1282, DOI 10.1016/j.jbiomech.2009.03.009; Nichols T. Richard, 1999, P255; Rainoldi A, 2004, J NEUROSCI METH, V134, P37, DOI 10.1016/j.jneumeth.2003.10.014; Saito A, 2013, J ELECTROMYOGR KINES, V23, P1406, DOI 10.1016/j.jelekin.2013.08.009; Saito A, 2013, J ELECTROMYOGR KINES, V23, P831, DOI 10.1016/j.jelekin.2013.02.005; Solomonow M, 2001, SCAND J MED SCI SPOR, V11, P64, DOI 10.1034/j.1600-0838.2001.011002064.x; Watanabe K, 2012, J ELECTROMYOGR KINES, V22, P251, DOI 10.1016/j.jelekin.2011.11.004; Watanabe K, 2011, J NEUROSCI METH, V198, P332, DOI 10.1016/j.jneumeth.2011.03.014; Watanabe K, 2010, J ELECTROMYOGR KINES, V20, P661, DOI 10.1016/j.jelekin.2010.01.003; Watanabe Kohei, 2009, J Electromyogr Kinesiol, V19, pe280, DOI 10.1016/j.jelekin.2008.06.002; Watanabe K, 2009, EUR J APPL PHYSIOL, V106, P665, DOI 10.1007/s00421-009-1064-z; Zhang LQ, 2003, J ORTHOPAED RES, V21, P565, DOI 10.1016/S0736-0266(02)00196-1; ZHOU S, 1995, EUR J APPL PHYSIOL, V70, P138, DOI 10.1007/BF00361541	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141146	10.1371/journal.pone.0141146	http://dx.doi.org/10.1371/journal.pone.0141146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488742	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400109
J	Isticato, R; Sirec, T; Vecchione, S; Crispino, A; Saggese, A; Baccigalupi, L; Notomista, E; Driks, A; Ricca, E				Isticato, Rachele; Sirec, Teja; Vecchione, Stefano; Crispino, Anna; Saggese, Anella; Baccigalupi, Loredana; Notomista, Eugenio; Driks, Adam; Ricca, Ezio			The Direct Interaction between Two Morphogenetic Proteins Is Essential for Spore Coat Formation in Bacillus subtilis	PLOS ONE			English	Article							COTE; RESISTANCE; EXPRESSION; ENDOSPORE; GENETICS; HEAT	In Bacillus subtilis the protective layers that surround the mature spore are formed by over seventy different proteins. Some of those proteins have a regulatory role on the assembly of other coat proteins and are referred to as morphogenetic factors. CotE is a major morphogenetic factor, known to form a ring around the forming spore and organize the deposition of the outer surface layers. CotH is a CotE-dependent protein known to control the assembly of at least nine other coat proteins. We report that CotH also controls the assembly of CotE and that this mutual dependency is due to a direct interaction between the two proteins. The C-terminal end of CotE is essential for this direct interaction and CotH cannot bind to mutant CotE deleted of six or nine C-terminal amino acids. However, addition of a negatively charged amino acid to those deleted versions of CotE rescues the interaction.	[Isticato, Rachele; Sirec, Teja; Vecchione, Stefano; Crispino, Anna; Saggese, Anella; Baccigalupi, Loredana; Notomista, Eugenio; Ricca, Ezio] Univ Naples Federico II, Dept Biol, Naples, Italy; [Driks, Adam] Loyola Univ Chicago, Dept Microbiol & Immunol, Infect Dis & Immunol Res Inst, Maywood, IL USA	University of Naples Federico II; Loyola University Chicago	Ricca, E (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	ericca@unina.it	Saggese, Anella/AAL-1243-2021; Ricca, Ezio/AAG-2998-2020; ISTICATO, Rachele/AAX-9972-2021; Isticato, Rachele/J-3476-2012	Ricca, Ezio/0000-0002-7355-0332; ISTICATO, Rachele/0000-0001-9141-4038; NOTOMISTA, Eugenio/0000-0003-0097-6487; Saggese, Anella/0000-0002-0968-8644; Baccigalupi, Loredana/0000-0003-3070-161X	European Union	European Union(European Commission)	This work was supported by the European Union 7th Framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer T, 1999, J BACTERIOL, V181, P7043, DOI 10.1128/JB.181.22.7043-7051.1999; Cangiano G, 2014, APPL ENVIRON MICROB, V80, P7293, DOI 10.1128/AEM.02893-14; Costa T, 2007, J BACTERIOL, V189, P2401, DOI 10.1128/JB.01353-06; Costa T, 2006, J BACTERIOL, V188, P7731, DOI 10.1128/JB.00761-06; Cutting S., 1990, MOL BIOL METHODS BAC; de Francesco M, 2012, J BACTERIOL, V194, P4941, DOI 10.1128/JB.00914-12; DRIKS A, 1994, GENE DEV, V8, P234, DOI 10.1101/gad.8.2.234; Dworkin J, 2010, NAT REV MICROBIOL, V8, P890, DOI 10.1038/nrmicro2453; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Isticato R, 2004, J BACTERIOL, V186, P1129, DOI 10.1128/JB.186.4.1129-1135.2004; Isticato R, 2008, J BACTERIOL, V190, P1267, DOI 10.1128/JB.01425-07; Isticato R, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-98; Isticato R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074949; Isticato R, 2010, J BACTERIOL, V192, P949, DOI 10.1128/JB.01408-09; Kim H, 2006, MOL MICROBIOL, V59, P487, DOI 10.1111/j.1365-2958.2005.04968.x; Krajcikova D, 2009, J BACTERIOL, V191, P3212, DOI 10.1128/JB.01807-08; Little S, 2001, MOL MICROBIOL, V42, P1107, DOI 10.1046/j.1365-2958.2001.02708.x; LOSICK R, 1986, ANNU REV GENET, V20, P625, DOI 10.1146/annurev.ge.20.120186.003205; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; McPherson DC, 2005, J BACTERIOL, V187, P8278, DOI 10.1128/JB.187.24.8278-8290.2005; Naclerio G, 1996, J BACTERIOL, V178, P4375, DOI 10.1128/jb.178.15.4375-4380.1996; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Plata G, 2012, NAT CHEM BIOL, V8, P848, DOI 10.1038/NCHEMBIO.1063; SACCO M, 1995, J BACTERIOL, V177, P372, DOI 10.1128/jb.177.2.372-377.1995; Saggese A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104900; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Wang KH, 2009, MOL MICROBIOL, V74, P634, DOI 10.1111/j.1365-2958.2009.06886.x; ZHENG LB, 1988, GENE DEV, V2, P1047, DOI 10.1101/gad.2.8.1047; Zilhao R, 2004, J BACTERIOL, V186, P1110, DOI 10.1128/JB.186.4.1110-1119.2004; Zilhao R, 1999, J BACTERIOL, V181, P2631	32	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141040	10.1371/journal.pone.0141040	http://dx.doi.org/10.1371/journal.pone.0141040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484546	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100102
J	McEwan, GF; Groner, ML; Fast, MD; Gettinby, G; Revie, CW				McEwan, Gregor F.; Groner, Maya L.; Fast, Mark D.; Gettinby, George; Revie, Crawford W.			Using Agent-Based Modelling to Predict the Role of Wild Refugia in the Evolution of Resistance of Sea Lice to Chemotherapeutants	PLOS ONE			English	Article							FARMED ATLANTIC SALMON; EMAMECTIN BENZOATE RESISTANCE; LEPEOPHTHEIRUS-SALMONIS; SALAR L.; EPIDEMIOLOGIC PATTERNS; NEW-BRUNSWICK; INFESTATIONS; POPULATION; MANAGEMENT; SCOTLAND	A major challenge for Atlantic salmon farming in the northern hemisphere is infestation by the sea louse parasite Lepeophtheirus salmonis. The most frequent method of controlling these sea louse infestations is through the use of chemical treatments. However, most major salmon farming areas have observed resistance to common chemotherapeutants. In terrestrial environments, many strategies employed to manage the evolution of resistance involve the use of refugia, where a portion of the population is left untreated to maintain susceptibility. While refugia have not been deliberately used in Atlantic salmon farming, wild salmon populations that migrate close to salmon farms may act as natural refugia. In this paper we describe an agent-based model that explores the influence of different sizes of wild salmon populations on resistance evolution in sea lice on a salmon farm. Using the model, we demonstrate that wild salmon populations can act as refugia that limit the evolution of resistance in the sea louse populations. Additionally, we demonstrate that an increase in the size of the population of wild salmon results in an increased effect in slowing the evolution of resistance. We explore the effect of a population fitness cost associated with resistance, finding that in some cases it substantially reduces the speed of evolution to chemical treatments.	[McEwan, Gregor F.; Groner, Maya L.; Revie, Crawford W.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Ctr Vet & Epidemiol Res, Charlottetown, PE C1A 4P3, Canada; [Fast, Mark D.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Anat & Physiol, Charlottetown, PE C1A 4P3, Canada; [Gettinby, George] Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland	University of Prince Edward Island; University of Prince Edward Island; University of Strathclyde	McEwan, GF (corresponding author), Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Ctr Vet & Epidemiol Res, 550 Univ Ave, Charlottetown, PE C1A 4P3, Canada.	gmcewan@upei.ca	Revie, Crawford/B-5002-2011	Revie, Crawford/0000-0002-5018-0340; McEwan, Gregor/0000-0001-5959-0576	Atlantic Innovation Fund through the Atlantic Canada Opportunities Agency (ACOA); Canada Excellence Research Chairs Program (CERC); ACOA [199308]; CERC [214602]	Atlantic Innovation Fund through the Atlantic Canada Opportunities Agency (ACOA); Canada Excellence Research Chairs Program (CERC); ACOA; CERC	The work received funding from both the Atlantic Innovation Fund through the Atlantic Canada Opportunities Agency (ACOA, http://www.acoa-apeca.gc.ca), and the Canada Excellence Research Chairs Program (CERC, http://upei.ca/cerc). ACOA funding is through project 199308, Tools to Resolve Environmental Impacts and Treatment Resistance in Sea Lice -2 (TREAT2). CERC funding is through project 214602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Ahmed S, 1998, INSECT BIOCHEM MOLEC, V28, P629, DOI 10.1016/S0965-1748(98)00061-7; [Anonymous], 1758, FAO FISH AQ SPEC FAC; Bourguet D, 2010, EVOL APPL, V3, P375, DOI 10.1111/j.1752-4571.2010.00124.x; Burka JF, 1997, J VET PHARMACOL THER, V20, P333, DOI 10.1046/j.1365-2885.1997.00094.x; Carmichael SN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-408; CARRIERE Y, 1994, P ROY SOC B-BIOL SCI, V258, P35, DOI 10.1098/rspb.1994.0138; Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109; Connallon T, 2010, EVOLUTION, V64, P3417, DOI 10.1111/j.1558-5646.2010.01136.x; Connors BM, 2011, BEHAV ECOL, V22, P588, DOI 10.1093/beheco/arr024; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Eichner C, 2015, PARASITOL INT, V64, P86, DOI 10.1016/j.parint.2014.10.006; Elmoslemany A, 2013, J FISH DIS, V36, P241, DOI 10.1111/jfd.12051; Espedal PG, 2013, AQUACULTURE, V416, P111, DOI 10.1016/j.aquaculture.2013.09.001; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; GEORGHIOU GP, 1977, J ECON ENTOMOL, V70, P653, DOI 10.1093/jee/70.5.653; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Groner ML, 2013, J FISH DIS, V36, P195, DOI 10.1111/jfd.12017; Groner ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088465; Heuch PA, 2003, J FISH DIS, V26, P539, DOI 10.1046/j.1365-2761.2003.00490.x; Heuch PA, 2000, AQUAC RES, V31, P805, DOI 10.1046/j.1365-2109.2000.00512.x; Igboeli OO, 2014, PEST MANAG SCI, V70, P905, DOI 10.1002/ps.3620; Jansen M, 2011, ECOTOXICOLOGY, V20, P543, DOI 10.1007/s10646-011-0627-z; JONES MW, 1992, J FISH DIS, V15, P197, DOI 10.1111/j.1365-2761.1992.tb00654.x; Jones PG, 2013, J FISH DIS, V36, P209, DOI 10.1111/jfd.12022; Jones PG, 2012, DIS AQUAT ORGAN, V102, P53, DOI 10.3354/dao02517; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Kristoffersen AB, 2013, PREV VET MED, V111, P165, DOI 10.1016/j.prevetmed.2013.03.015; Leathwick DM, 2014, SMALL RUMINANT RES, V118, P31, DOI 10.1016/j.smallrumres.2013.12.020; Lees F, 2008, J FISH DIS, V31, P259, DOI 10.1111/j.1365-2761.2007.00897.x; Lees F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001549; Lenormand T, 1998, P ROY SOC B-BIOL SCI, V265, P1985, DOI 10.1098/rspb.1998.0529; Ljungfeldt LER, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-108; MacLean A, 2000, AQUACULTURE, V184, P291, DOI 10.1016/S0044-8486(99)00333-6; Murray AG, 2011, ECOL MODEL, V222, P1854, DOI 10.1016/j.ecolmodel.2011.03.016; Patanasatienkul T, 2013, DIS AQUAT ORGAN, V105, P149, DOI 10.3354/dao02616; Patel S. I., 2013, Agricultural Reviews, V34, P230, DOI 10.5958/j.0976-0741.34.3.008; Revie CW, 2003, DIS AQUAT ORGAN, V57, P85, DOI 10.3354/dao057085; Revie CW, 2002, VET REC, V151, P753; Revie CW, 2006, DEV EPI INFORM APPRO; Saksida SM, 2010, J FISH DIS, V33, P913, DOI 10.1111/j.1365-2761.2010.01192.x; Smith DT, 2011, J EVOLUTION BIOL, V24, P1351, DOI 10.1111/j.1420-9101.2011.02271.x; Stephenson JF, 2012, J FISH BIOL, V81, P1118, DOI 10.1111/j.1095-8649.2012.03347.x; Stien A, 2005, MAR ECOL PROG SER, V290, P263, DOI 10.3354/meps290263; Stone J, 2000, J FISH DIS, V23, P185, DOI 10.1046/j.1365-2761.2000.00233.x; Stormoen M, 2013, J FISH DIS, V36, P25, DOI 10.1111/j.1365-2761.2012.01415.x; Stratonovitch P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115631; Sutherland BJG, 2015, EVOL APPL, V8, P133, DOI 10.1111/eva.12237; Todd CD, 2005, MAR ECOL PROG SER, V303, P225, DOI 10.3354/meps303225; Todd CD, 2004, CAN J FISH AQUAT SCI, V61, P1176, DOI 10.1139/F04-069; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Wotton H. J., 2014, Journal of Aquaculture Research and Development, V5, P226; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349	53	39	39	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139128	10.1371/journal.pone.0139128	http://dx.doi.org/10.1371/journal.pone.0139128			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485023	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000363028100007
J	Mehdipoor, H; Zurita-Milla, R; Rosemartin, A; Gerst, KL; Weltzin, JF				Mehdipoor, Hamed; Zurita-Milla, Raul; Rosemartin, Alyssa; Gerst, Katharine L.; Weltzin, Jake F.			Developing a Workflow to Identify Inconsistencies in Volunteered Geographic Information: A Phenological Case Study	PLOS ONE			English	Article							MODEL; QUALITY; NETWORK; SCIENCE; ONSET; PLANT; TOOL	Recent improvements in online information communication and mobile location-aware technologies have led to the production of large volumes of volunteered geographic information. Widespread, large-scale efforts by volunteers to collect data can inform and drive scientific advances in diverse fields, including ecology and climatology. Traditional workflows to check the quality of such volunteered information can be costly and time consuming as they heavily rely on human interventions. However, identifying factors that can influence data quality, such as inconsistency, is crucial when these data are used in modeling and decision- making frameworks. Recently developed workflows use simple statistical approaches that assume that the majority of the information is consistent. However, this assumption is not generalizable, and ignores underlying geographic and environmental contextual variability that may explain apparent inconsistencies. Here we describe an automated workflow to check inconsistency based on the availability of contextual environmental information for sampling locations. The workflow consists of three steps: (1) dimensionality reduction to facilitate further analysis and interpretation of results, (2) model-based clustering to group observations according to their contextual conditions, and (3) identification of inconsistent observations within each cluster. The workflow was applied to volunteered observations of flowering in common and cloned lilac plants (Syringa vulgaris and Syringa x chinensis) in the United States for the period 1980 to 2013. About 97% of the observations for both common and cloned lilacs were flagged as consistent, indicating that volunteers provided reliable information for this case study. Relative to the original dataset, the exclusion of inconsistent observations changed the apparent rate of change in lilac bloom dates by two days per decade, indicating the importance of inconsistency checking as a key step in data quality assessment for volunteered geographic information. Initiatives that leverage volunteered geographic information can adapt this workflow to improve the quality of their datasets and the robustness of their scientific analyses.	[Mehdipoor, Hamed; Zurita-Milla, Raul] Univ Twente, Fac GeoInformat Sci & Earth Observat ITC, NL-7500 AE Enschede, Netherlands; [Rosemartin, Alyssa; Gerst, Katharine L.] Univ Arizona, Coll Agr & Life Sci, Sch Nat Resources & Environm, Tucson, AZ USA; [Rosemartin, Alyssa; Gerst, Katharine L.; Weltzin, Jake F.] USA Natl Phenol Network, Natl Coordinating Off, Tucson, AZ USA; [Weltzin, Jake F.] US Geol Survey, Tucson, AZ USA	University of Twente; University of Arizona; United States Department of the Interior; United States Geological Survey	Mehdipoor, H (corresponding author), Univ Twente, Fac GeoInformat Sci & Earth Observat ITC, POB 217, NL-7500 AE Enschede, Netherlands.	h.mehdipoor@utwente.nl	Zurita-Milla, Raul/E-9333-2010	Zurita-Milla, Raul/0000-0002-1769-6310; Rosemartin, Alyssa/0000-0002-8934-6539; Gerst, Katharine/0000-0002-6154-906X	Google Faculty Research Award; United States Geological Survey [G09AC00310, G14AC00405]	Google Faculty Research Award(Google Incorporated); United States Geological Survey(United States Geological Survey)	This research was supported in part by a Google Faculty Research Award to RZM and by Cooperative Agreements G09AC00310 and G14AC00405 from the United States Geological Survey to the University of Arizona. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Ali AL, 2014, LECT NOTES COMPUT SC, V8728, P126, DOI 10.1007/978-3-319-11593-1_9; Ault TR., 2013, EOS T AM GEOPHYS UN, V94, P181, DOI [10.1002/2013EO200001, DOI 10.1002/2013EO200001]; BANFIELD JD, 1993, BIOMETRICS, V49, P803, DOI 10.2307/2532201; Barr Alan, 2009, P3, DOI 10.1007/978-1-4419-0026-5_1; Biernacki C, 2000, IEEE T PATTERN ANAL, V22, P719, DOI 10.1109/34.865189; Bimonte S, 2014, LECT NOTES COMPUT SC, V8582, P69, DOI 10.1007/978-3-319-09147-1_6; Brabham DC, 2009, PLAN THEOR, V8, P242, DOI 10.1177/1473095209104824; Brunsdon C, 2012, GEOINFORMATICA, V16, P675, DOI 10.1007/s10707-012-0159-6; Butcher GS, 2007, COMBINING DATA CHRIS; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Coleman DJ, 2009, INT J SPAT DATA INFR, V4, P332, DOI 10.2902/1725-0463.2009.04.art16; Comber Alexis, 2013, Spatial Information Theory. 11th International Conference, COSIT 2013. Proceedings: LNCS 8116, P243, DOI 10.1007/978-3-319-01790-7_14; Comber A, 2013, INT J APPL EARTH OBS, V23, P37, DOI 10.1016/j.jag.2012.11.002; Council NR, 1998, FUT NAT WEATH SERV C, P78; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Denny EG, 2014, INT J BIOMETEOROL, V58, P591, DOI 10.1007/s00484-014-0789-5; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Donaldson J., 2010, PACKAGE TSNE; Eickhoff C., 2011, P ACM SIGIR WORKSH C, P21; Elwood S, 2008, GEOJOURNAL, V72, P133, DOI 10.1007/s10708-008-9187-z; Feick R., 2013, CROWDSOURCING GEOGRA, P15, DOI [10.1007/978-94-007-4587-2_2, DOI 10.1007/978-94-007-4587-2_2]; Ferster CJ, 2013, COMPUT GEOSCI-UK, V51, P339, DOI 10.1016/j.cageo.2012.09.009; Flanagin AJ, 2008, GEOJOURNAL, V72, P137, DOI 10.1007/s10708-008-9188-y; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C., 2012, NORMAL MIXTURE MODEL; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Galindo A, 2011, P 7 INT S SPAT DAT Q, P109; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; Goodchild M, 2009, J LOCAT BASED SERV, V3, P82, DOI 10.1080/17489720902950374; Goodchild MF, 2012, SPAT STAT-NETH, V1, P110, DOI 10.1016/j.spasta.2012.03.002; Goodchild MF, 2010, INT J DIGIT EARTH, V3, P231, DOI 10.1080/17538941003759255; Gouveia C, 2008, GEOJOURNAL, V72, P185, DOI 10.1007/s10708-008-9183-3; Keatley MR, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P1, DOI 10.1007/978-90-481-3335-2_1; Kelling S, 2011, EBIRD HUMAN COMPUTER, DOI [10.1609/aimag.v34i1.2431, DOI 10.1609/AIMAG.V34I1.2431]; Kelling S., 2011, ESCIENCEW, P20, DOI DOI 10.1109/ESCIENCEW.2011.13; KOCH E, 2010, GLOBAL FRAMEWORK DAT, P23, DOI DOI 10.1007/978-90-481-3335-2_2; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Logan M, 2010, ANAL COVARIANCE ANCO, P448, DOI [10.1002/9781444319620.ch15, DOI 10.1002/9781444319620.CH15]; Matyas S, 2011, LECT NOTES COMPUT SC, V6972, P331, DOI 10.1007/978-3-642-24500-8_36; Mayer A, 2010, BIOSCIENCE, V60, P172, DOI 10.1525/bio.2010.60.3.3; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Newell DA, 2012, FUTURE INTERNET, V4, P551, DOI 10.3390/fi4020551; Parker CJ, 2014, SPRINGERBRIEF GEOGR, P1, DOI 10.1007/978-3-319-03503-1; Ranta E, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P321, DOI 10.1007/978-90-481-3335-2_15; Rasmussen CE, 2000, ADV NEUR IN, V12, P554; Rosemartin AH, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.38; Schlieder C., 2010, P 2 ACM SIGSPATIAL I, P60, DOI [DOI 10.1145/1867699.1867711, 10.1145/1867699.1867711]; SCHWARTZ M D, 1990, Climate Research, V1, P23, DOI 10.3354/cr001023; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV, V39, DOI [10.1007/978-94-007-0632-3_21, DOI 10.1007/978-94-007-0632-3_21]; Schwartz MD, 2013, INT J CLIMATOL, V33, P2917, DOI 10.1002/joc.3625; Schwartz MD, 2012, FRONT ECOL ENVIRON, V10, P324, DOI 10.1890/110281; SCHWARTZ MD, 1994, INT J BIOMETEOROL, V38, P18, DOI 10.1007/BF01241799; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Schwartz MD, 2013, RESEARCH, DOI [10.1007/978-94-007-0632-3, DOI 10.1007/978-94-007-0632-3]; See L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069958; Sui D., 2013, CROWDSOURCING GEOGRA, DOI [10.1007/978-94-007-4587-2, DOI 10.1007/978-94-007-4587-2]; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Thornton P.E., 2014, DAYMET DAILY SURFACE, DOI DOI 10.3334/ORNLDAAC/1219; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Vliet AJH, 2003, INT J BIOMETEOROL, V47, P202, DOI 10.1007/s00484-003-0174-2; Yanenko O, 2012, LECT NOTES GEOINF CA, P429, DOI 10.1007/978-3-642-29063-3_23	63	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140811	10.1371/journal.pone.0140811	http://dx.doi.org/10.1371/journal.pone.0140811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485157	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100074
J	Rankin, K; Stuart-Fox, D				Rankin, Katrina; Stuart-Fox, Devi			Testosterone-Induced Expression of Male Colour Morphs in Females of the Polymorphic Tawny Dragon Lizard, Ctenophorus decresii	PLOS ONE			English	Article							SEXUALLY DIMORPHIC COLORATION; CAROTENOID-BASED COLORATION; SIGNAL CONSPICUOUSNESS; HORMONAL-CONTROL; SPINY LIZARD; EVOLUTION; MAINTENANCE; SELECTION; TRAITS; CORTICOSTERONE	Many colour polymorphisms are present only in one sex, usually males, but proximate mechanisms controlling the expression of sex-limited colour polymorphisms have received little attention. Here, we test the hypothesis that artificial elevation of testosterone in females of the colour polymorphic tawny dragon lizard, Ctenophorus decresii, can induce them to express the same colour morphs, in similar frequencies, to those found in males. Male C. decresii, express four discrete throat colour morphs (orange, yellow, grey and an orange central patch surrounded by yellow). We used silastic implants to experimentally elevate testosterone levels in mature females to induce colour expression. Testosterone elevation resulted in a substantial increase in the proportion and intensity of orange but not yellow colouration, which was present in a subset of females prior to treatment. Consequently, females exhibited the same set of colour morphs as males, and we confirmed that these morphs are objectively classifiable, by using digital image analyses and spectral reflectance measurements, and occur in similar frequencies as in males. These results indicate that the influence of testosterone differs for different colours, suggesting that their expression may be governed by different proximate hormonal mechanisms. Thus, caution must be exercised when using artificial testosterone manipulation to induce female expression of sex-limited colour polymorphisms. Nevertheless, the ability to express sex-limited colours (in this case orange) to reveal the same, objectively classifiable morphs in similar frequencies to males suggests autosomal rather than sex-linked inheritance, and can facilitate further research on the genetic basis of colour polymorphism, including estimating heritability and selection on colour morphs from pedigree data.	[Rankin, Katrina; Stuart-Fox, Devi] Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia	University of Melbourne	Rankin, K (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia.	katrina.rankin@unimelb.edu.au		Stuart-Fox, Devi/0000-0003-3362-1412	Australian Research Council [DP1092908]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council, http://www.arc.gov.au/, (grant number DP1092908) to DSF.	Bagnara J. T., 2007, PIGMENTARY SYSTEM PH, P11, DOI DOI 10.1002/9780470987100.CH2; Barbour HR, 2002, J COMP NEUROL, V450, P334, DOI 10.1002/cne.10308; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blows MW, 2003, EVOLUTION, V57, P1622, DOI 10.1111/j.0014-3820.2003.tb00369.x; Calisi RM, 2007, J COMP PHYSIOL B, V177, P641, DOI 10.1007/s00360-007-0162-7; Chapple DG, 2008, AUST J ZOOL, V56, P103, DOI 10.1071/ZO08040; Cooper W.E. Jr, 1992, P298; COOPER WE, 1988, HORM BEHAV, V22, P12, DOI 10.1016/0018-506X(88)90027-X; Cote J, 2008, J EVOLUTION BIOL, V21, P1165, DOI 10.1111/j.1420-9101.2008.01534.x; Cote J, 2010, J EXP BIOL, V213, P2116, DOI 10.1242/jeb.040220; Cox RM, 2005, COPEIA, P597; Cox RM, 2008, J EXP ZOOL PART A, V309A, P505, DOI 10.1002/jez.481; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; Fitze PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005111; Forsman A, 2008, ECOLOGY, V89, P34, DOI 10.1890/07-0572.1; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Healey M, 2009, AUSTRAL ECOL, V34, P636, DOI 10.1111/j.1442-9993.2009.01968.x; Hegrenes S, 2001, ECOL FRESHW FISH, V10, P35, DOI 10.1034/j.1600-0633.2001.100105.x; HEWS DK, 1994, HORM BEHAV, V28, P96, DOI 10.1006/hbeh.1994.1008; HUXLEY JULIAN, 1955, HEREDITY, V9, P1, DOI 10.1038/hdy.1955.1; Huyghe K, 2009, HORM BEHAV, V55, P488, DOI 10.1016/j.yhbeh.2009.02.005; Jessop TS, 2009, J COMP PHYSIOL A, V195, P619, DOI 10.1007/s00359-009-0437-4; KETTERSON ED, 1992, AM NAT, V140, pS33, DOI 10.1086/285396; King RB, 2003, HERPETOLOGICA, V59, P484, DOI 10.1655/02-93; Kingston JJ, 2003, ANIM BEHAV, V65, P735, DOI 10.1006/anbe.2003.2110; Knapp R, 2003, INTEGR COMP BIOL, V43, P658, DOI 10.1093/icb/43.5.658; Knapp R, 1997, GEN COMP ENDOCR, V107, P273, DOI 10.1006/gcen.1997.6923; Lank DB, 1999, P ROY SOC B-BIOL SCI, V266, P2323, DOI 10.1098/rspb.1999.0926; LANK DB, 1995, NATURE, V378, P59, DOI 10.1038/378059a0; Loew ER, 2002, J EXP BIOL, V205, P927; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; McLean CA, 2014, J EVOLUTION BIOL, V27, P2654, DOI 10.1111/jeb.12521; Mills MG, 2009, SEMIN CELL DEV BIOL, V20, P72, DOI 10.1016/j.semcdb.2008.11.012; Moore MC, 1998, AM ZOOL, V38, P133; MOORE MC, 1991, HORM BEHAV, V25, P154, DOI 10.1016/0018-506X(91)90048-M; MORRISON RL, 1995, COPEIA, P397; Olsson M, 2007, MOL ECOL, V16, P5307, DOI 10.1111/j.1365-294X.2007.03578.x; Olsson M, 2013, SEMIN CELL DEV BIOL, V24, P529, DOI 10.1016/j.semcdb.2013.04.001; Olsson M, 2012, J EXP BIOL, V215, P575, DOI 10.1242/jeb.059352; Olsson M, 2009, EVOLUTION, V63, P695, DOI 10.1111/j.1558-5646.2008.00569.x; Polo-Cavia N, 2013, BEHAV ECOL SOCIOBIOL, V67, P153, DOI 10.1007/s00265-012-1435-z; Pryke SR, 2010, EVOLUTION, V64, P1301, DOI 10.1111/j.1558-5646.2009.00897.x; Quinn AE, 2010, HEREDITY, V104, P410, DOI 10.1038/hdy.2009.133; Quinn VS, 2003, J INFORM, V2003; RAND MS, 1992, GEN COMP ENDOCR, V88, P461, DOI 10.1016/0016-6480(92)90241-B; RAND MS, 1990, AM MIDL NAT, V124, P352, DOI 10.2307/2426184; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Salvador A, 1997, BEHAV ECOL, V8, P135, DOI 10.1093/beheco/8.2.135; San-Jose LM, 2013, J EVOLUTION BIOL, V26, P2681, DOI 10.1111/jeb.12265; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Sinervo B, 2001, EVOLUTION, V55, P2040; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stuart-Fox DM, 2003, ANIM BEHAV, V66, P541, DOI 10.1006/anbe.2003.2235; Teasdale LC, 2013, J EVOLUTION BIOL, V26, P1035, DOI 10.1111/jeb.12115; THOMPSON CW, 1993, BEHAV ECOL SOCIOBIOL, V33, P137, DOI 10.1007/BF00216593; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Wellenreuther M, 2014, MOL ECOL, V23, P5398, DOI 10.1111/mec.12935; Ziegler I, 2003, PIGM CELL RES, V16, P172, DOI 10.1034/j.1600-0749.2003.00044.x	58	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140458	10.1371/journal.pone.0140458	http://dx.doi.org/10.1371/journal.pone.0140458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485705	Green Published, gold			2022-12-27	WOS:000363028100035
J	Ahmed, RH; Huri, HZ; Al-Hamodi, Z; Salem, SD; Muniandy, S				Ahmed, Radwan H.; Huri, Hasniza Zaman; Al-Hamodi, Zaid; Salem, Sameer D.; Muniandy, Sekaran			Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; DPP-4 INHIBITORS; ORAL GLUCOSE; DIPEPTIDYL; METFORMIN; CD26; INFLAMMATION	Background A soluble form of CD26/dipeptidyl peptidase-IV (sCD26/DPP-IV) induces DPP-IV enzymatic activity that degrades incretin. We investigated fasting serum levels of sCD26/DPP-IV and active glucagon-like peptide-1 (GLP-1) in Malaysian patients with type 2 diabetes mellitus (T2DM) with and without metabolic syndrome (MetS), as well as the associations between sCD26/DPP-IV levels, MetS, and antidiabetic therapy. Methods We assessed sCD26/DPP-IV levels, active GLP-1 levels, body mass index (BMI), glucose, insulin, A1c, glucose homeostasis indices, and lipid profiles in 549 Malaysian subjects (including 257 T2DM patients with MetS, 57 T2DM patients without MetS, 71 non-diabetics with MetS, and 164 control subjects without diabetes or metabolic syndrome). Results Fasting serum levels of sCD26/DPP-IV were significantly higher in T2DM patients with and without MetS than in normal subjects. Likewise, sCD26/DPP-IV levels were significantly higher in patients with T2DM and MetS than in non-diabetic patients with MetS. However, active GLP-1 levels were significantly lower in T2DM patients both with and without MetS than in normal subjects. In T2DM subjects, sCD26/DPP-IV levels were associated with significantly higher A1c levels, but were significantly lower in patients using monotherapy with metformin. In addition, no significant differences in sCD26/DPP-IV levels were found between diabetic subjects with and without MetS. Furthermore, sCD26/DPP-IV levels were negatively correlated with active GLP-1 levels in T2DM patients both with and without MetS. In normal subjects, sCD26/DPP-IV levels were associated with increased BMI, cholesterol, and LDL-cholesterol (LDL-c) levels. Conclusion Serum sCD26/DPP-IV levels increased in T2DM subjects with and without MetS. Active GLP-1 levels decreased in T2DM patients both with and without MetS. In addition, sCD26/DPP-IV levels were associated with Alc levels and negatively correlated with active GLP-1 levels. Moreover, metformin monotherapy was associated with reduced sCD26/DPP-IV levels. In normal subjects, sCD26/DPP-IV levels were associated with increased BMI, cholesterol, and LDL-c.	[Ahmed, Radwan H.; Muniandy, Sekaran] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Med Ctr, Clin Invest Ctr, Kuala Lumpur, Malaysia; [Al-Hamodi, Zaid; Salem, Sameer D.] Sanaa Univ, Fac Med, Dept Biochem & Mol Biol, Sanaa, Yemen	Universiti Malaya; Universiti Malaya; Universiti Malaya	Ahmed, RH (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	radwanalhamody@yahoo.com; sekaran@um.edu.my	MUNIANDY, SEKARAN/B-5345-2010; Ahmed, Radwan H./O-3803-2018; HURI, HASNIZA ZAMAN/B-8612-2010	MUNIANDY, SEKARAN/0000-0003-1310-3634; Ahmed, Radwan H./0000-0003-1398-6772; HURI, HASNIZA ZAMAN/0000-0002-6423-8515	University of Malaya [HIR/420001-E000046, RP024A-14HTM, PG035-2014A]	University of Malaya(Universiti Malaya)	This study was supported by research grants HIR/420001-E000046 and RP024A-14HTM and PPP Grant PG035-2014A from the University of Malaya.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2013, DIABETES ATLAS; Aso Y, 2013, TRANSL RES, V162, P309, DOI 10.1016/j.trsl.2013.07.011; Barnett A, 2006, INT J CLIN PRACT, V60, P1454, DOI 10.1111/j.1742-1241.2006.01178.x; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Blaslov K, 2015, J DIABETES COMPLICAT, V29, P390, DOI 10.1016/j.jdiacomp.2014.12.019; Blaslov K, 2015, J DIABETES, V7, P340, DOI 10.1111/1753-0407.12194; Busso N, 2005, AM J PATHOL, V166, P433, DOI 10.1016/S0002-9440(10)62266-3; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Fadini GP, 2012, DIABETES OBES METAB, V14, P518, DOI 10.1111/j.1463-1326.2011.01550.x; Feron D, 2009, PEPTIDES, V30, P256, DOI 10.1016/j.peptides.2008.11.004; Firneisz G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012226; Freeman Jeffrey S, 2009, Cleve Clin J Med, V76 Suppl 5, pS12, DOI 10.3949/ccjm.76.s5.03; Green BD, 2006, EUR J PHARMACOL, V547, P192, DOI 10.1016/j.ejphar.2006.07.043; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; *INT DIAB FED, 2014, DIABETES ATLAS; Kobayashi H, 2002, J RHEUMATOL, V29, P1858; Korosi J, 2001, J GERONTOL A-BIOL, V56, pM575, DOI 10.1093/gerona/56.9.M575; Kusunoki M, 2015, DRUG RES; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lee SA, 2013, J CLIN ENDOCR METAB, V98, P2553, DOI 10.1210/jc.2012-4288; Legakis IN, 2003, DIABETES CARE, V26, P252, DOI 10.2337/diacare.26.1.252; Lenhard JM, 2004, BIOCHEM BIOPH RES CO, V324, P92, DOI 10.1016/j.bbrc.2004.09.021; Lindsay JR, 2005, DIABETIC MED, V22, P654, DOI 10.1111/j.1464-5491.2005.01461.x; Liu Y, 2014, DIABETES OBES METAB, V16, P111, DOI 10.1111/dom.12128; Matsuzawa Y, 2008, INT J OBESITY, V32, pS83, DOI 10.1038/ijo.2008.243; Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKillop AM, 2008, DIABETES RES CLIN PR, V79, P79, DOI 10.1016/j.diabres.2007.08.001; Meneilly GS, 2000, DIABETIC MED, V17, P346, DOI 10.1046/j.1464-5491.2000.00236.x; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Pala L, 2005, DIABETOLOGIA, V48, P1168, DOI 10.1007/s00125-005-1749-8; Pala L, 2003, BIOCHEM BIOPH RES CO, V310, P28, DOI 10.1016/j.bbrc.2003.08.111; Pala L, 2010, DIABETIC MED, V27, P691, DOI 10.1111/j.1464-5491.2010.03010.x; Ryskjaer J, 2006, EUR J ENDOCRINOL, V155, P485, DOI 10.1530/eje.1.02221; Scheen AJ, 2012, DIABETES METAB, V38, P89, DOI 10.1016/j.diabet.2011.11.001; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Yang F., 2014, PLOS ONE, V9; Zhang F, 2012, INT J MED SCI, V9, P574, DOI 10.7150/ijms.4128; Zheng T, 2014, J HUMAN HYPERTENSION	42	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140618	10.1371/journal.pone.0140618	http://dx.doi.org/10.1371/journal.pone.0140618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474470	gold, Green Published, Green Submitted			2022-12-27	WOS:000363185500073
J	Misra, A; Anoop, S; Gulati, S; Mani, K; Bhatt, SP; Pandey, RM				Misra, Anoop; Anoop, Shajith; Gulati, Seema; Mani, Kalaivani; Bhatt, Surya Prakash; Pandey, Ravindra Mohan			Body Fat Patterning, Hepatic Fat and Pancreatic Volume of Non-Obese Asian Indians with Type 2 Diabetes in North India: A Case-Control Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ABDOMINAL ADIPOSE-TISSUE; INSULIN-RESISTANCE; LIVER-DISEASE; SOUTH ASIANS; OBESITY; MEN; SENSITIVITY; MELLITUS; HEALTHY	Objective To evaluate body fat patterning and phenotype including hepatic fat and pancreatic volume of non-obese (BMI: < 25 kg/m(2)) Asian Indians with type 2 diabetes residing in North India. Methods Non-obese patients with type 2 diabetes (n = 93) and non-obese, normo-glycemic subjects (n = 40) were recruited. BMI, waist & hip circumferences, skinfold thickness at 8 sites, body fat, lean mass and detailed abdominal fat evaluation [total abdominal fat, total subcutaneous fat (superficial, deep, anterior, and posterior), total intra-abdominal fat (intra-peritoneal, retroperitoneal)], liver span, grades of fatty liver and pancreatic volume were compared. Results Waist circumference, subscapular skinfolds and total truncal fat (on DEXA) were higher whereas calf, total peripheral skinfolds and total leg fat (on DEXA) lower in patients. Specifically, the following volumes were higher in cases as compared to controls; total abdominal fat (19.4%), total intra-abdominal fat (49.7%), intra-peritoneal fat (47.7%), retroperitoneal fat (70.7%), pancreatic volume (26.6%), pancreatic volume index (21.3%) and liver span (10.8%). In cases, significant positive correlations were observed for pancreatic volume with BMI, waist and hip circumferences, W-HR, subscapular, abdominal and total truncal skinfolds, truncal, total subcutaneous, total intra-abdominal, intra-peritoneal, retroperitoneal fat depots, liver span and fatty liver. Conclusions In non-obese Asian Indians with type 2 diabetes, subcutaneous and intra-abdominal obesity, including fatty liver, and pancreatic volume were higher and peripheral subcutaneous adiposity was lower than BMI matched non-diabetic subjects. Importantly, increased pancreatic volume in patients was highly correlated with multiple measures of abdominal obesity and liver fat.	[Misra, Anoop; Anoop, Shajith; Gulati, Seema; Bhatt, Surya Prakash] Natl Diabet Obes & Cholesterol Fdn N DOC, Ctr Nutr & Metab Res C NET, SDA, New Delhi, India; [Misra, Anoop; Anoop, Shajith; Gulati, Seema; Bhatt, Surya Prakash] Diabet Fdn India, SDA, New Delhi, India; [Misra, Anoop] Fortis C DOC Ctr Excellence Diabet Metab Dis & En, New Delhi, India; [Misra, Anoop] Fortis Flt Lt Rajan Dhall Hosp, New Delhi, India; [Mani, Kalaivani; Pandey, Ravindra Mohan] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Misra, A (corresponding author), Natl Diabet Obes & Cholesterol Fdn N DOC, Ctr Nutr & Metab Res C NET, SDA, New Delhi, India.	anoopmisra@gmail.com	Bhatt, Surya/K-5263-2019; Bhatt, Surya Prakash/X-5941-2018	Bhatt, Surya/0000-0001-9489-9747; Bhatt, Surya Prakash/0000-0001-9489-9747	Merck Pharma Ltd, India; National Diabetes, Obesity and cholesterol foundation	Merck Pharma Ltd, India; National Diabetes, Obesity and cholesterol foundation	This study was supported by a financial grant from Merck Pharma Ltd, India. The sponsors had no role in study design, experiments, data analysis and drafting the manuscript and decision to publish. National Diabetes, Obesity and cholesterol foundation provided internal financial assistance in the form of authors' salaries and research materials.	Abate N, 2004, J CLIN ENDOCR METAB, V89, P2750, DOI 10.1210/jc.2003-031843; ABATE N, 1995, J CLIN INVEST, V96, P88, DOI DOI 10.1172/JCI118083; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Bhatt SP, 2013, METAB SYNDR RELAT D, V11, P329, DOI 10.1089/met.2012.0064; Burute N, 2014, PANCREATOLOGY, V14, P268, DOI 10.1016/j.pan.2014.04.031; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Dudeja V, 2001, BRIT J NUTR, V86, P105, DOI 10.1079/BJN2001382; Frayling TM, 2003, DIABETES, V52, P1857, DOI 10.2337/diabetes.52.7.1857; Goda K, 2001, ACTA DIABETOL, V38, P145, DOI 10.1007/s005920170012; Goel K, 2010, HEART, V96, P579, DOI 10.1136/hrt.2009.183236; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Kruit JK, 2010, CURR OPIN LIPIDOL, V21, P178, DOI 10.1097/MOL.0b013e328339387b; Lindroos AS, 2002, J CLIN ENDOCR METAB, V87, P3023; Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; Misra A, 2003, NUTRITION, V19, P815, DOI 10.1016/S0899-9007(03)00141-2; Misra A, 2003, DIABETIC MED, V20, P361, DOI 10.1046/j.1464-5491.2003.00932.x; Misra A, 2008, DIABETES CARE, V31, P1282, DOI 10.2337/dc07-2316; Misra A, 2006, METABOLISM, V55, P1569, DOI 10.1016/j.metabol.2006.06.029; Misra A, 2013, NUTRIENTS, V5, P2708, DOI 10.3390/nu5072708; Misra A, 2010, METAB SYNDR RELAT D, V8, P243, DOI 10.1089/met.2009.0046; Nigam P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049286; Permutt Z, 2012, ALIMENT PHARM THER, V36, P22, DOI 10.1111/j.1365-2036.2012.05121.x; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Shen W, 2003, OBES RES, V11, P5, DOI 10.1038/oby.2003.3; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Yoon KH, 2011, DIABETES METAB J, V35, P26, DOI [10.4093/dmj.2011.35.1.26, 10.4093/dmj.2011.35.5.444]	30	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140447	10.1371/journal.pone.0140447	http://dx.doi.org/10.1371/journal.pone.0140447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474415	gold, Green Published, Green Submitted			2022-12-27	WOS:000363185500052
J	Cheslack-Postava, K; Susser, E; Liu, K; Bearman, PS				Cheslack-Postava, Keely; Susser, Ezra; Liu, Kayuet; Bearman, Peter S.			Can Sibling Sex Ratios Be Used as a Valid Test for the Prenatal Androgen Hypothesis of Autism Spectrum Disorders?	PLOS ONE			English	Article							MATERNAL HORMONE IMBALANCE; TESTOSTERONE; CHILDREN; INTRAUTERINE; HERITABILITY; INDIVIDUALS; CONSEQUENCE; PREVALENCE; DISABILITY; PROBANDS	Background Sibling sex ratios have been applied as an indirect test of a hypothesized association between prenatal testosterone levels and risk for autism, a developmental disorder disproportionately affecting males. Differences in sibling sex ratios between those with and without autism would provide evidence of a shared risk factor for autism and offspring sex. Conclusions related to prenatal testosterone, however, require additional assumptions. Here, we used directed acyclic graphs (DAGs) to clarify the elements required for a valid test of the hypothesis that sibling sex ratios differ between children with and without autism. We then conducted such a test using a large, population-based sample of children. Methods Over 1.1 million subjects, born in California from 1992-2007, and identified through birth records, were included. The association between autism diagnosis, determined using the administrative database of the California Department of Developmental Services, and the sex of the subsequent sibling was examined using generalized estimating equations. Sources of potential bias identified using DAGs were addressed. Results Among male children with autism, 52.2% of next-born siblings were brothers, versus 51.0% for unaffected males. For females with autism, 50.2% of following siblings were brothers versus 51.2% among control females. The relative risk of a subsequent male sibling associated with autism diagnosis was 1.02 (95% confidence interval: 0.99, 1.04). Conclusions In a large, population-based sample we failed to find evidence suggesting an excess of brothers among children with autism while controlling for several threats to validity. This test cannot rule out a role of any given exposure, including prenatal testosterone, in either risk of autism or offspring sex ratio, but suggests against a common cause of both.	[Cheslack-Postava, Keely] Columbia Univ, Dept Psychiat, New York, NY USA; [Susser, Ezra] Columbia Univ, Dept Epidemiol, New York, NY USA; [Susser, Ezra] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Liu, Kayuet] Univ Calif Los Angeles, Dept Sociol, Los Angeles, CA 90024 USA; [Bearman, Peter S.] Columbia Univ, Interdisciplinary Ctr Innovat Theory & Empir, New York, NY 10027 USA	Columbia University; Columbia University; New York State Psychiatry Institute; University of California System; University of California Los Angeles; Columbia University	Bearman, PS (corresponding author), Columbia Univ, Interdisciplinary Ctr Innovat Theory & Empir, New York, NY 10027 USA.	psb17@columbia.edu		bearman, peter/0000-0002-3745-3164	National Institutes of Health Director's Pioneer Award Program, NIH Roadmap for Medical Research [1 DP1 OD003635-01]; National Institute of Mental Health [5-T32-MH-13043]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH013043] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003635] Funding Source: NIH RePORTER	National Institutes of Health Director's Pioneer Award Program, NIH Roadmap for Medical Research; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support was provided by the National Institutes of Health Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research (grant 1 DP1 OD003635-01; PB) and by the National Institute of Mental Health (5-T32-MH-13043; KCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APTER D, 1990, J CLIN ENDOCR METAB, V71, P970, DOI 10.1210/jcem-71-4-970; Catalano R, 2013, AM J HUM BIOL, V25, P555, DOI 10.1002/ajhb.22414; Cheslack-Postava K, 2012, SOC SCI MED, V74, P1667, DOI 10.1016/j.socscimed.2011.06.013; Croen LA, 2002, J AUTISM DEV DISORD, V32, P207, DOI 10.1023/A:1015453830880; Flannery KA, 1996, J CHILD PSYCHOL PSYC, V37, P621, DOI 10.1111/j.1469-7610.1996.tb01450.x; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Glymour M.M., 2008, MODERN EPIDEMIOLOGY, P183; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Harris JA, 1998, BEHAV GENET, V28, P165, DOI 10.1023/A:1021466929053; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hoekstra RA, 2006, TWIN RES HUM GENET, V9, P558, DOI 10.1375/183242706778025071; James WH, 1999, J THEOR BIOL, V198, P301, DOI 10.1006/jtbi.1999.0916; James WH, 1998, J THEOR BIOL, V192, P1, DOI 10.1006/jtbi.1997.0591; James WH, 2000, TERATOLOGY, V62, P342, DOI 10.1002/1096-9926(200011)62:5<342::AID-TERA8>3.0.CO;2-8; James WH, 2004, BIRTH DEFECTS RES A, V70, P37, DOI 10.1002/bdra.10097; James WH, 2008, DEV MED CHILD NEUROL, V50, P15, DOI 10.1111/j.1469-8749.2007.02001.x; James WH, 2008, J ENDOCRINOL, V198, P3, DOI 10.1677/JOE-07-0446; Knickmeyer RC, 2006, J CHILD NEUROL, V21, P825, DOI 10.1177/08830738060210101601; Lai DC, 2012, RES DEV DISABIL, V33, P2301, DOI 10.1016/j.ridd.2012.07.001; Marco EJ, 2006, SOC COGN AFFECT NEUR, V1, P183, DOI 10.1093/scan/nsl028; Mouridsen SE, 2014, CHILD PSYCHIAT HUM D, V45, P493, DOI 10.1007/s10578-013-0419-1; Mouridsen SE, 2010, LOGOP PHONIATR VOCO, V35, P144, DOI 10.3109/14015430903518007; Mouridsen SE, 2010, DEV MED CHILD NEUROL, V52, P289, DOI 10.1111/j.1469-8749.2009.03368.x; Robinson EB, 2013, P NATL ACAD SCI USA, V110, P5258, DOI 10.1073/pnas.1211070110; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; Siontis GCM, 2011, INT J EPIDEMIOL, V40, P1292, DOI 10.1093/ije/dyr099; Subbaraman MS, 2010, HUM REPROD, V25, P2084, DOI 10.1093/humrep/deq166; Suren P, 2012, PEDIATRICS, V130, pE152, DOI 10.1542/peds.2011-3217	28	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141338	10.1371/journal.pone.0141338	http://dx.doi.org/10.1371/journal.pone.0141338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495967	gold, Green Published, Green Submitted			2022-12-27	WOS:000363309200095
J	Sherrill, AM; Eerland, A; Zwaan, RA; Magliano, JP				Sherrill, Andrew M.; Eerland, Anita; Zwaan, Rolf A.; Magliano, Joseph P.			Understanding How Grammatical Aspect Influences Legal Judgment	PLOS ONE			English	Article							VERB-ASPECT; COMPREHENSION; PREPOSITIONS; PSYCHOLOGY; ADVANTAGE; COHERENCE; MODELS	Recent evidence suggests that grammatical aspect can bias how individuals perceive criminal intentionality during discourse comprehension. Given that criminal intentionality is a common criterion for legal definitions (e.g., first-degree murder), the present study explored whether grammatical aspect may also impact legal judgments. In a series of four experiments participants were provided with a legal definition and a description of a crime in which the grammatical aspect of provocation and murder events were manipulated. Participants were asked to make a decision (first- vs. second-degree murder) and then indicate factors that impacted their decision. Findings suggest that legal judgments can be affected by grammatical aspect but the most robust effects were limited to temporal dynamics (i.e., imperfective aspect results in more murder actions than perfective aspect), which may in turn influence other representational systems (i.e., number of murder actions positively predicts perceived intentionality). In addition, findings demonstrate that the influence of grammatical aspect on situation model construction and evaluation is dependent upon the larger linguistic and semantic context. Together, the results suggest grammatical aspect has indirect influences on legal judgments to the extent that variability in aspect changes the features of the situation model that align with criteria for making legal judgments.	[Sherrill, Andrew M.; Magliano, Joseph P.] No Illinois Univ, Dept Psychol, De Kalb, IL 60115 USA; [Eerland, Anita] Univ Utrecht, Dept Languages Literature & Commun, Utrecht, Netherlands; [Zwaan, Rolf A.] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands	Northern Illinois University; Utrecht University; Erasmus University Rotterdam	Sherrill, AM (corresponding author), No Illinois Univ, Dept Psychol, De Kalb, IL 60115 USA.	andrew.sherrill@gmail.com		Sherrill, Andrew/0000-0002-7743-745X; Zwaan, Rolf/0000-0001-9967-7879	Center for the Interdisciplinary Study of Language and Literacy at Northern Illinois University	Center for the Interdisciplinary Study of Language and Literacy at Northern Illinois University	This research was supported by the Center for the Interdisciplinary Study of Language and Literacy at Northern Illinois University (http://www.niu.edu/cisll/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Anderson S. E., 2008, P 30 ANN C COGN SCI, P143; Anderson S, 2010, LECT NOTES ARTIF INT, V6222, P139; Anderson SE, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00337; Carreiras M, 1997, MEM COGNITION, V25, P438, DOI 10.3758/BF03201120; Comrie Bernard., 1985, TENSE, DOI [10.1017/CBO9781139165815, DOI 10.1017/CBO9781139165815]; Eerland A, 2011, PERSPECT PS IN PRESS; Elman JL, 2009, COGNITIVE SCI, V33, P547, DOI 10.1111/j.1551-6709.2009.01023.x; Fausey CM, 2011, POLIT PSYCHOL, V32, P563, DOI 10.1111/j.1467-9221.2010.00802.x; Ferretti TR, 2007, J EXP PSYCHOL LEARN, V33, P182, DOI 10.1037/0278-7393.33.1.182; Ferretti TR, 2009, J MEM LANG, V61, P191, DOI 10.1016/j.jml.2009.04.001; Fontaine RG, 2007, PSYCHOL PUBLIC POL L, V13, P143, DOI 10.1037/1076-8971.13.2.143; GERNSBACHER MA, 1988, J MEM LANG, V27, P699, DOI 10.1016/0749-596X(88)90016-2; GERNSBACHER MA, 1989, J MEM LANG, V28, P735, DOI 10.1016/0749-596X(89)90006-5; GIVON T, 1992, LINGUISTICS, V30, P5, DOI 10.1515/ling.1992.30.1.5; Hart W, 2011, PSYCHOL SCI, V22, P261, DOI 10.1177/0956797610395393; Johnson-Laird, 1983, MENTAL MODELS; KINTSCH W, 1988, PSYCHOL REV, V95, P163, DOI 10.1037/0033-295X.95.2.163; Kintsch W, 1998, COMPREHENSION PARADI; Madden CJ, 2009, EXPR COGN CATEG, V3, P217; Madden CJ, 2003, MEM COGNITION, V31, P663, DOI 10.3758/BF03196106; Magliano JP, 2000, DISCOURSE PROCESS, V29, P83, DOI 10.1207/S15326950dp2902_1; Magliano JP, 1999, CONSTRUCTION OF MENTAL REPRESENTATIONS DURING READING, P219; MORROW DG, 1986, COGNITIVE SCI, V10, P423, DOI 10.1207/s15516709cog1004_2; MORROW DG, 1990, DISCOURSE PROCESS, V13, P441, DOI 10.1080/01638539009544769; MORROW DG, 1985, J MEM LANG, V24, P390, DOI 10.1016/0749-596X(85)90036-1; Pinker S., 2007, STUFF THOUGHT LANGUA; Rohrer D, 2015, J EXP PSYCHOL GEN, V144, pE73, DOI 10.1037/xge0000058; Salomon MM, 2013, COGNITION, V128, P134, DOI 10.1016/j.cognition.2013.03.012; Shreves WB, 2014, COGNITION, V132, P455, DOI 10.1016/j.cognition.2014.05.007; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Toomin MP, 2007, J MARSHALL LAW REV, V41, P659; TRABASSO T, 1993, DISCOURSE PROCESS, V16, P3, DOI 10.1080/01638539309544827; Truitt TP, 1997, 38 ANN M PSYCH SOC; van Dijk T., 1983, STRATEGIES DISCOURSE; VENDLER Z, 1957, PHILOS REV, V66, P143, DOI 10.2307/2182371; WESH 2 News, 2013, WESH 2 NEWS; Zwaan RA, 2004, J EXP PSYCHOL LEARN, V30, P283, DOI 10.1037/0278-7393.30.1.283; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	38	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141181	10.1371/journal.pone.0141181	http://dx.doi.org/10.1371/journal.pone.0141181			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU1VG	26496364	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200071
J	Laukova, J; Kozubik, A; Hofmanova, J; Nekvindova, J; Sova, P; Moyer, MP; Ehrmann, J; Vaculova, AH				Laukova, Jarmila; Kozubik, Alois; Hofmanova, Jirina; Nekvindova, Jana; Sova, Petr; Moyer, Mary Pat; Ehrmann, Jiri; Vaculova, Alena Hyrslova			Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells	PLOS ONE			English	Article							PPAR-GAMMA; ANTITUMOR EFFICACY; CISPLATIN; LA-12; INHIBITION; GROWTH; ADAMANTYLAMINE; PROLIFERATION; ACTIVATION; RESISTANCE	We demonstrated for the first time an outstanding ability of rosiglitazone to mediate a profound enhancement of LA-12-induced apoptosis associated with activation of mitochondrial pathway in human colon cancer cells. This effect was preferentially observed in the G1 cell cycle phase, independent on p53 and PPAR. proteins, and accompanied with significant changes of selected Bcl-2 family protein levels. Further stimulation of cooperative synergic cytotoxic action of rosiglitazone and LA-12 was demonstrated in the cells deficient for PTEN, where mitochondrial apoptotic pathway was more stimulated and G1-phase-associated dying was reinforced. Our results suggest that combined treatment with rosiglitazone and LA-12 might be promising anticancer strategy in colon-derived tumours regardless of their p53 status, and also favourable in those defective in PTEN function.	[Laukova, Jarmila; Kozubik, Alois; Hofmanova, Jirina; Vaculova, Alena Hyrslova] Acad Sci Czech Republ, Inst Biophys, Dept Cytokinet, Vvi, CS-61265 Brno, Czech Republic; [Laukova, Jarmila; Kozubik, Alois; Hofmanova, Jirina] Masaryk Univ, Fac Sci, Dept Anim Physiol & Immunol, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Nekvindova, Jana] Univ Hosp Hradec Kralove, Inst Clin Biochem & Diagnost, Hradec Kralove, Czech Republic; [Sova, Petr] Platinum Pharmaceut As, Brno, Czech Republic; [Moyer, Mary Pat] INCELL Corp LLC, San Antonio, TX USA; [Ehrmann, Jiri] Palacky Univ, Dept Clin & Mol Pathol, Fac Med & Dent, CR-77147 Olomouc, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; University Hospital Hradec Kralove; Palacky University Olomouc	Vaculova, AH (corresponding author), Acad Sci Czech Republ, Inst Biophys, Dept Cytokinet, Vvi, Kralovopolska 135, CS-61265 Brno, Czech Republic.	vaculova@ibp.cz	Ehrmann, Jiri/C-9074-2009	Ehrmann, Jiri/0000-0002-8419-3414; Hyrslova Vaculova, Alena/0000-0002-0445-8807	Czech Science Foundation [15-06650S]; IGA of the Ministry of Health of the Czech Republic [NT 11201-5/2010]	Czech Science Foundation(Grant Agency of the Czech Republic); IGA of the Ministry of Health of the Czech Republic	This work was supported by the Czech Science Foundation (15-06650S)(http://www.gacr.cz; AHV) and IGA of the Ministry of Health of the Czech Republic (NT 11201-5/2010) (http://iga.mzcr.cz; AK). Platinum Pharmaceuticals, a. s. (Dr. Petr Sova) and INCELL Corporation LLC (Dr. Mary Pat Moyer) provided support in the form of research material, and their specific role is also indicated within the Author Contributions section of the online submission form.	Blanarova OV, 2013, CELL PROLIFERAT, V46, P665, DOI 10.1111/cpr.12061; Blanarova OV, 2011, CARCINOGENESIS, V32, P42, DOI 10.1093/carcin/bgq220; Brockman JA, 1998, GASTROENTEROLOGY, V115, P1049, DOI 10.1016/S0016-5085(98)70072-1; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burgermeister E, 2008, PPAR RES, V2008, DOI 10.1155/2008/309469; Chaffer CL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-53; Chiu SJ, 2010, BIOCHEM BIOPH RES CO, V394, P774, DOI 10.1016/j.bbrc.2010.03.068; Dai Y, 2008, INT J CANCER, V122, P2858, DOI 10.1002/ijc.23443; Elrod HA, 2008, PPAR RES, V2008, DOI 10.1155/2008/704165; Fajas L, 2003, ONCOGENE, V22, P4186, DOI 10.1038/sj.onc.1206530; Girnun GD, 2008, CLIN CANCER RES, V14, P6478, DOI 10.1158/1078-0432.CCR-08-1128; Girnun GD, 2007, CANCER CELL, V11, P395, DOI 10.1016/j.ccr.2007.02.025; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Han SW, 2006, MOL CANCER THER, V5, P430, DOI 10.1158/1535-7163.MCT-05-0347; He Q, 2008, PPAR RES, V2008, DOI 10.1155/2008/649808; Horvath V, 2006, GYNECOL ONCOL, V102, P32, DOI 10.1016/j.ygyno.2005.11.016; Hrstka R, 2008, ANTI-CANCER DRUG, V19, P369, DOI 10.1097/CAD.0b013e3282f7f500; Ikezoe T, 2001, CANCER RES, V61, P5307; Jelinkova I, 2014, BIOCHEM PHARMACOL, V92, P415, DOI 10.1016/j.bcp.2014.09.013; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001; Kozubik A, 2005, BIOCHEM PHARMACOL, V69, P373, DOI 10.1016/j.bcp.2004.09.005; Kozubik Alois, 2008, Metal-Based Drugs, P417897, DOI 10.1155/2008/417897; Kvardova V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-147; Lee C, 2004, CANCER RES, V64, P6906, DOI 10.1158/0008-5472.CAN-04-1767; Lefebvre AM, 1999, J ENDOCRINOL, V162, P331, DOI 10.1677/joe.0.1620331; Miao RZ, 2011, EXP THER MED, V2, P413, DOI 10.3892/etm.2011.227; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Qiao L, 2008, CANCER LETT, V268, P260, DOI 10.1016/j.canlet.2008.04.003; Roubalova E, 2010, INVEST NEW DRUG, V28, P445, DOI 10.1007/s10637-009-9270-4; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Shiau CW, 2005, CANCER RES, V65, P1561, DOI 10.1158/0008-5472.CAN-04-1677; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Sova P, 2006, ANTI-CANCER DRUG, V17, P201, DOI 10.1097/00001813-200602000-00012; Svihalkova-Sindlerova L, 2010, ANTICANCER RES, V30, P1183; Tikoo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-107; Vaculova A, 2004, FEBS LETT, V577, P309, DOI 10.1016/j.febslet.2004.10.013; Yang WL, 2001, CARCINOGENESIS, V22, P1379, DOI 10.1093/carcin/22.9.1379; Zak F, 2004, J MED CHEM, V47, P761, DOI 10.1021/jm030858+; Zhang YQ, 2007, WORLD J GASTROENTERO, V13, P1534, DOI 10.3748/wjg.v13.i10.1534; Zhu Y, 2006, APOPTOSIS, V11, P197, DOI 10.1007/s10495-006-3714-5	41	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141020	10.1371/journal.pone.0141020	http://dx.doi.org/10.1371/journal.pone.0141020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492315	gold, Green Published, Green Submitted			2022-12-27	WOS:000363249300023
J	Dar, RD; Razooky, BS; Weinberger, LS; Cox, CD; Simpson, ML				Dar, Roy D.; Razooky, Brandon S.; Weinberger, Leor S.; Cox, Chris D.; Simpson, Michael L.			The Low Noise Limit in Gene Expression	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRANSLATION INITIATION; PROTEIN EXPRESSION; GLOBAL ANALYSIS; TRANSCRIPTION; FLUCTUATIONS; REVEALS; DETERMINANTS; FREQUENCY; ABUNDANCE	Protein noise measurements are increasingly used to elucidate biophysical parameters. Unfortunately noise analyses are often at odds with directly measured parameters. Here we show that these inconsistencies arise from two problematic analytical choices: (i) the assumption that protein translation rate is invariant for different proteins of different abundances, which has inadvertently led to (ii) the assumption that a large constitutive extrinsic noise sets the low noise limit in gene expression. While growing evidence suggests that transcriptional bursting may set the low noise limit, variability in translational bursting has been largely ignored. We show that genome-wide systematic variation in translational efficiency can-and in the case of E. coli does-control the low noise limit in gene expression. Therefore constitutive extrinsic noise is small and only plays a role in the absence of a systematic variation in translational efficiency. These results show the existence of two distinct expression noise patterns: (1) a global noise floor uniformly imposed on all genes by expression bursting; and (2) high noise distributed to only a select group of genes.	[Dar, Roy D.; Weinberger, Leor S.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Dar, Roy D.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Dar, Roy D.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Razooky, Brandon S.; Simpson, Michael L.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Razooky, Brandon S.; Simpson, Michael L.] Univ Tennessee, Bredesen Ctr Interdisciplinary Res & Grad Educ, Knoxville, TN USA; [Razooky, Brandon S.] Rockefeller Univ, Lab Immune Cell Epigenet & Signaling, New York, NY 10021 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94143 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Cox, Chris D.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN USA; [Simpson, Michael L.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Tennessee System; University of Tennessee Knoxville; Rockefeller University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Simpson, ML (corresponding author), Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA.	simpsonML1@ornl.gov	Cox, Chris D/A-9451-2013; Simpson, Michael/A-8410-2011	Cox, Chris D/0000-0001-9818-5477; Simpson, Michael/0000-0002-3933-3457; Dar, Roy/0000-0002-6006-4888	NIH NRSA fellowship [AI104380]; K22 [AI120746]; Collective Phenomena in Nanophases Research Theme at the Center for Nanophase Materials Sciences - Office of Basic Energy Sciences, U.S. Department of Energy; Merck Postdoctoral Fellowship at The Rockefeller University; Pew Scholars Program in the Biomedical Sciences; W.M. Keck Foundation Research Excellence Award; Alfred P. Sloan Research Fellowship; NIH Director's New Innovator Award Program [OD006677]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, F32AI104380, K22AI120746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006677] Funding Source: NIH RePORTER	NIH NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); K22; Collective Phenomena in Nanophases Research Theme at the Center for Nanophase Materials Sciences - Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); Merck Postdoctoral Fellowship at The Rockefeller University; Pew Scholars Program in the Biomedical Sciences; W.M. Keck Foundation Research Excellence Award(W.M. Keck Foundation); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); NIH Director's New Innovator Award Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	RDD was supported by an NIH NRSA fellowship (AI104380) and K22 (AI120746). BSR and MLS were supported by the Collective Phenomena in Nanophases Research Theme at the Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Office of Basic Energy Sciences, U.S. Department of Energy. BSR was supported in part by funds from a Merck Postdoctoral Fellowship at The Rockefeller University. LSW acknowledges support from the Pew Scholars Program in the Biomedical Sciences, the W.M. Keck Foundation Research Excellence Award, the Alfred P. Sloan Research Fellowship, and the NIH Director's New Innovator Award Program (OD006677).	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Carey LB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001528; Chong SS, 2014, CELL, V158, P314, DOI 10.1016/j.cell.2014.05.038; Cox CD, 2008, P NATL ACAD SCI USA, V105, P10809, DOI 10.1073/pnas.0804829105; Cox CD, 2006, CHAOS, V16, DOI 10.1063/1.2204354; Dar RD, 2010, CHAOS, V20, DOI 10.1063/1.3486800; Dar RD, 2014, SCIENCE, V344, P1392, DOI 10.1126/science.1250220; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Doktycz MJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100165; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607; HARTZ D, 1991, J MOL BIOL, V218, P99, DOI 10.1016/0022-2836(91)90876-8; HARTZ D, 1991, J MOL BIOL, V218, P83, DOI 10.1016/0022-2836(91)90875-7; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Johnston IG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002416; Karig DK, 2013, ACS SYNTH BIOL, V2, P497, DOI 10.1021/sb400028c; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Kwon YC, 2008, ANAL BIOCHEM, V373, P192, DOI 10.1016/j.ab.2007.10.045; Larson DR, 2013, ELIFE, V2, DOI 10.7554/eLife.00750; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lipinski-Kruszka J, 2015, ACS SYNTH BIOL, V4, P258, DOI 10.1021/sb5000059; Mitarai N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000109; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nishimura K, 2015, ACS SYNTH BIOL, V4, P566, DOI 10.1021/sb500249g; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Pedraza JM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100121; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Retterer ST, 2012, CURR OPIN BIOTECH, V23, P522, DOI 10.1016/j.copbio.2012.01.002; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; Sharon E, 2014, GENOME RES, V24, P1698, DOI 10.1101/gr.168773.113; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Skupsky R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000952; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Stewart-Ornstein J, 2012, MOL CELL, V45, P483, DOI 10.1016/j.molcel.2011.11.035; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tanouchi Y, 2015, NATURE, V523, P357, DOI 10.1038/nature14562; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Vardi N, 2013, CURR BIOL, V23, P2051, DOI 10.1016/j.cub.2013.08.043; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Yang S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5761; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96	67	21	21	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140969	10.1371/journal.pone.0140969	http://dx.doi.org/10.1371/journal.pone.0140969			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488303	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400087
J	Hernandez-Torres, E; Wiggermann, V; Hametner, S; Baumeister, TR; Sadovnick, AD; Zhao, YS; Machan, L; Li, DKB; Traboulsee, A; Rauscher, A				Hernandez-Torres, Enedino; Wiggermann, Vanessa; Hametner, Simon; Baumeister, Tobias R.; Sadovnick, A. Dessa; Zhao, Yinshan; Machan, Lindsay; Li, David K. B.; Traboulsee, Anthony; Rauscher, Alexander			Orientation Dependent MR Signal Decay Differentiates between People with MS, Their Asymptomatic Siblings and Unrelated Healthy Controls	PLOS ONE			English	Article							APPEARING WHITE-MATTER; MULTIPLE-SCLEROSIS; MAGNETIZATION-TRANSFER; BRAIN; IRON; VALIDATION; HISTOGRAMS; RESONANCE; RELATIVES; LESIONS	R2* relaxometry of the brain is a quantitative magnetic resonance technique which is influenced by iron and myelin content across different brain regions. Multiple sclerosis (MS) is a common inflammatory, demyelinating disease affecting both white and grey matter regions of the CNS. Using R2*, increased iron deposition has been described in deep gray matter of MS patients. Iron accumulation might promote oxidative stress in the brain, which can lead to cell death and neurodegeneration. However, recent histological work indicates that iron may be reduced within the normal appearing white matter (WM) in MS. In the present study we analyzed the R2* signal across the white matter in 39 patients with MS, 31 asymptomatic age matched siblings of patients and 30 age-matched controls. The measurement of R2* in white matter is affected by the signal's dependency on white matter fibre orientation with respect to the main magnetic field which can be accounted using diffusion tensor imaging. We observed a clear separation of the three study groups in R2*. The values in the MS group were significantly lower compared to the siblings and controls, while the siblings group presented with significantly higher R2* values than both unrelated healthy controls and patients. Furthermore, we found significantly decreased normal-appearing white matter R2* values in patients with more severe disease course. Angle resolved analysis of R2* improves the sensitivity for detecting subtle differences in WM R2* compared to standard histogram based analyses. Our findings suggest that the decreased R2* values in MS are due to diffuse tissue damage and decreased myelin in the normal appearing and diffusely abnormal WM. The increased R2* in unaffected siblings may identify a predisposition to increased iron and the potential for oxidative stress as a risk factor for developing MS.	[Hernandez-Torres, Enedino; Wiggermann, Vanessa; Baumeister, Tobias R.; Li, David K. B.; Rauscher, Alexander] Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Hernandez-Torres, Enedino; Wiggermann, Vanessa; Rauscher, Alexander] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Wiggermann, Vanessa] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada; [Hametner, Simon] Med Univ Vienna, Ctr Brain Res, Dept Neuroimmunol, Vienna, Austria; [Baumeister, Tobias R.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada; [Baumeister, Tobias R.] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Sadovnick, A. Dessa; Zhao, Yinshan; Li, David K. B.; Traboulsee, Anthony] Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada; [Sadovnick, A. Dessa; Traboulsee, Anthony; Rauscher, Alexander] Univ British Columbia, Ctr Brain Hlth, Vancouver, BC V5Z 1M9, Canada; [Sadovnick, A. Dessa] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Machan, Lindsay; Li, David K. B.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Rauscher, Alexander] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Medical University of Vienna; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia	Rauscher, A (corresponding author), Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC V5Z 1M9, Canada.	rauscher@phas.ubc.ca	Hernández-Torres, Enedino/AAG-2483-2019; Wiggermann, Vanessa/I-2536-2019; Traboulsee, Anthony L/AAB-2051-2020	Hernández-Torres, Enedino/0000-0003-2873-5693; Wiggermann, Vanessa/0000-0001-5236-3039; Sadovnick, Dessa/0000-0003-2987-2008; Rauscher, Alexander/0000-0002-1961-8252	Natural Sciences and Engineering Research Council of Canada [402039-2011]; Multiple Sclerosis Society of Canada; John and Lotte Hecht Foundation; Milan and Maureen Ilich Foundation; Multiple Sclerosis Society of Canada [EGID 2002]; CONACyT; CIHR	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Multiple Sclerosis Society of Canada; John and Lotte Hecht Foundation; Milan and Maureen Ilich Foundation; Multiple Sclerosis Society of Canada; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CIHR(Canadian Institutes of Health Research (CIHR))	This study is supported by the Natural Sciences and Engineering Research Council of Canada [402039-2011], Multiple Sclerosis Society of Canada, the John and Lotte Hecht Foundation and the Milan and Maureen Ilich Foundation; VW is supported by a graduate studentship award from the Multiple Sclerosis Society of Canada [EGID 2002]; EHT is a recipient of a CONACyT postdoctoral award. AR is a recipient of the CIHR new investigator award.	Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Bartzokis G, 2007, NEUROBIOL AGING, V28, P414, DOI 10.1016/j.neurobiolaging.2006.02.005; Bjartmar C, 2001, NEUROLOGY, V57, P1248, DOI 10.1212/WNL.57.7.1248; Chao MJ, 2008, P NATL ACAD SCI USA, V105, P13069, DOI 10.1073/pnas.0801042105; De Mendiburu F., 2014, **DATA OBJECT**; De Stefano N, 2006, ANN NEUROL, V59, P634, DOI 10.1002/ana.20767; Denk C, 2011, NMR BIOMED, V24, P246, DOI 10.1002/nbm.1581; Dyment DA, 2006, J NEUROL NEUROSUR PS, V77, P258, DOI 10.1136/jnnp.2005.063008; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Fazekas F, 2001, NEUROLOGY, V57, P853, DOI 10.1212/WNL.57.5.853; Fernando KTM, 2005, BRAIN, V128, P2911, DOI 10.1093/brain/awh654; Filippi M, 1998, ANN NEUROL, V43, P809, DOI 10.1002/ana.410430616; Filippi M, 1997, J NEUROL SCI, V147, P151, DOI 10.1016/S0022-510X(96)05322-1; Gabelic T, 2014, AM J NEURORADIOL, V35, P106, DOI 10.3174/ajnr.A3653; Ge YL, 2012, J CEREBR BLOOD F MET, V32, P403, DOI 10.1038/jcbfm.2011.191; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; Jahanshad N, 2012, P NATL ACAD SCI USA, V109, pE851, DOI 10.1073/pnas.1105543109; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Khalil M, 2015, NEUROLOGY, V84, P2396, DOI 10.1212/WNL.0000000000001679; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; Lassmann H, 2008, NEUROIMAG CLIN N AM, V18, P563, DOI 10.1016/j.nic.2008.06.005; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Lee J, 2011, NEUROIMAGE, V57, P225, DOI 10.1016/j.neuroimage.2011.04.026; LONGO DL, 2005, HARRISONS PRINCIPLES; Misaki M, 2015, MAGN RESON MED, V74, P1609, DOI 10.1002/mrm.25560; Oh SH, 2013, NEUROIMAGE, V73, P71, DOI 10.1016/j.neuroimage.2013.01.051; Paling D, 2012, J NEUROL NEUROSUR PS, V83, P785, DOI 10.1136/jnnp-2012-302541; Sati P, 2010, NEUROIMAGE, V51, P1089, DOI 10.1016/j.neuroimage.2010.03.045; Schmierer K, 2008, MAGN RESON MED, V59, P268, DOI 10.1002/mrm.21487; Sedlacik J, 2007, MAGN RESON MED, V58, P1035, DOI 10.1002/mrm.21283; Seewann A, 2009, ARCH NEUROL-CHICAGO, V66, P601, DOI 10.1001/archneurol.2009.57; Stephenson E, 2014, NAT REV NEUROL, V10, P459, DOI 10.1038/nrneurol.2014.118; Traboulsee A, 2002, NEUROLOGY, V59, P126, DOI 10.1212/WNL.59.1.126; Walsh AJ, 2013, RADIOLOGY, V267, P531, DOI 10.1148/radiol.12120863; Whittall KP, 2002, MAGNET RESON MED, V47, P403, DOI 10.1002/mrm.10076; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Williams R, 2012, J NEUROCHEM, V120, P7, DOI 10.1111/j.1471-4159.2011.07536.x; World Health Organization (WHO), 2008, ATL MULT SCLER RES W	43	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140956	10.1371/journal.pone.0140956	http://dx.doi.org/10.1371/journal.pone.0140956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489078	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400085
J	Luo, HZ; Ge, LB; Zhang, JS; Zhao, YL; Ding, J; Li, ZG; He, ZN; Chen, R; Shi, ZP				Luo, Hongzhen; Ge, Laibing; Zhang, Jingshu; Zhao, Yanli; Ding, Jian; Li, Zhigang; He, Zhenni; Chen, Rui; Shi, Zhongping			Enhancing Butanol Production under the Stress Environments of Co-Culturing Clostridium acetobutylicum/Saccharomyces cerevisiae Integrated with Exogenous Butyrate Addition	PLOS ONE			English	Article							SACCHAROPERBUTYLACETONICUM N1-4; FERMENTATION; ACID; CULTURE; GENE; IMPROVEMENT; TOLERANCE; SELECTION; BIOFUELS; CASSAVA	In this study, an efficient acetone-butanol-ethanol (ABE) fermentation strategy integrating Clostridium acetobutylicum/Saccharomyces cerevisiae co-culturing system with exogenous butyrate addition, was proposed and experimentally conducted. In solventogenic phase, by adding 0.2 g-DCW/L-broth viable S. cerevisiae cells and 4.0 g/L-broth concentrated butyrate solution into C. acetobutylicum culture broth, final butanol concentration and butanol/acetone ratio in a 7 L anaerobic fermentor reached the highest levels of 15.74 g/L and 2.83 respectively, with the increments of 35% and 43% as compared with those of control. Theoretical and experimental analysis revealed that, the proposed strategy could, 1) extensively induce secretion of amino acids particularly lysine, which are favorable for both C. acetobutylicum survival and butanol synthesis under high butanol concentration environment; 2) enhance the utilization ability of C. acetobutylicum on glucose and over-produce intracellular NADH for butanol synthesis in C. acetobutylicum metabolism simultaneously; 3) direct most of extra consumed glucose into butanol synthesis route. The synergetic actions of effective amino acids assimilation, high rates of substrate consumption and NADH regeneration yielded highest butanol concentration and butanol ratio in C. acetobutylicum under this stress environment. The proposed method supplies an alternative way to improve ABE fermentation performance by traditional fermentation technology.	[Luo, Hongzhen; Ding, Jian; Li, Zhigang; He, Zhenni; Chen, Rui; Shi, Zhongping] Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Ge, Laibing; Zhang, Jingshu] China Shijiazhuang Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China; [Zhao, Yanli] Hebei Changshan Biochem Pharmaceut Co Ltd, Shijiazhuang, Hebei, Peoples R China	Jiangnan University	Shi, ZP (corresponding author), Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China.	zpshi@jiangnan.edu.cn	zhao, yan/GWC-9174-2022; Shi, Zhongping/K-9884-2019; Luo, Hongzhen/P-4730-2019	Luo, Hongzhen/0000-0002-2111-0917	National Natural Science Foundation Program of China [20976072]; Fundamental Research Funds for the Central Universities [JUSRP51504]; CSPC; CSBIO	National Natural Science Foundation Program of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); CSPC; CSBIO	This work was supported by the National Natural Science Foundation Program of China (No. 20976072) to Z. Shi and the Fundamental Research Funds for the Central Universities (JUSRP51504) to J. Ding. The financial funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors L. Ge and J. Zhang are employed by China Shijiazhuang Pharmaceutical Group Co., Ltd (CSPC). Co-author Y. Zhao is employed by Hebei Changshan Biochemical Pharmaceutical Co., Ltd (CSBIO). CSPC and CSBIO provided support in the form of salaries and consolation money for L. Ge, J. Zhang and Y. Zhao, respectively, but the companies did not have any additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alsaker KV, 2010, BIOTECHNOL BIOENG, V105, P1131, DOI 10.1002/bit.22628; Ashe MP, 2001, EMBO J, V20, P6464, DOI 10.1093/emboj/20.22.6464; Baba SI, 2012, J BIOTECHNOL, V157, P605, DOI 10.1016/j.jbiotec.2011.06.004; Bader J, 2010, J APPL MICROBIOL, V109, P371, DOI 10.1111/j.1365-2672.2009.04659.x; BAHL H, 1986, APPL ENVIRON MICROB, V52, P169, DOI 10.1128/AEM.52.1.169-172.1986; Chang JJ, 2008, INT J HYDROGEN ENERG, V33, P5137, DOI 10.1016/j.ijhydene.2008.05.021; Du YM, 2015, BIOTECHNOL BIOENG, V112, P705, DOI 10.1002/bit.25489; Duerre Peter, 2007, Biotechnology Journal, V2, P1525, DOI 10.1002/biot.200700168; Ezeji T, 2010, APPL MICROBIOL BIOT, V85, P1697, DOI 10.1007/s00253-009-2390-0; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Fontaine L, 2002, J BACTERIOL, V184, P821, DOI 10.1128/JB.184.3.821-830.2002; Girbal L, 1998, TRENDS BIOTECHNOL, V16, P11, DOI 10.1016/S0167-7799(97)01141-4; GIRBAL L, 1995, FEMS MICROBIOL REV, V16, P151; Heluane H, 2011, APPL ENVIRON MICROB, V77, P4473, DOI 10.1128/AEM.00116-11; Jang YS, 2012, MBIO, V3, DOI 10.1128/mBio.00314-12; Jiang Y, 2009, METAB ENG, V11, P284, DOI 10.1016/j.ymben.2009.06.002; Knoshaug EP, 2009, APPL BIOCHEM BIOTECH, V153, P13, DOI 10.1007/s12010-008-8460-4; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Lee SH, 2014, NEW BIOTECHNOL, V31, pS102, DOI 10.1016/j.nbt.2014.05.1858; Li L, 2013, BIORESOURCE TECHNOL, V143, P397, DOI 10.1016/j.biortech.2013.06.023; Li X, 2014, BIOPROC BIOSYST ENG, V37, P1609, DOI 10.1007/s00449-014-1133-5; Li X, 2012, BIORESOURCE TECHNOL, V125, P43, DOI 10.1016/j.biortech.2012.08.056; Li Z., 2014, THESIS JIANGNAN U WU; Li ZG, 2013, BIOTECHNOL BIOPROC E, V18, P759, DOI 10.1007/s12257-012-0775-x; Liu JH, 2004, BIOTECHNOL PROGR, V20, P1518, DOI 10.1021/bp049845v; Luo HZ, 2013, PROCESS BIOCHEM, V48, P1822, DOI 10.1016/j.procbio.2013.09.021; MASION E, 1987, FEMS MICROBIOL LETT, V43, P269; PEGUIN S, 1994, APPL MICROBIOL BIOT, V42, P611; Sillers R, 2009, BIOTECHNOL BIOENG, V102, P38, DOI 10.1002/bit.22058; Sun Z, 1987, CHIN J IND MICROBIOL, V17, P18; Tashiro Y, 2004, J BIOSCI BIOENG, V98, P263; Tashiro Y, 2007, J BIOSCI BIOENG, V104, P238, DOI 10.1263/jbb.104.238; The Japan Institute of Energy, 2002, BIOMASS HDB; Tran HTM, 2010, BIOCHEM ENG J, V48, P260, DOI 10.1016/j.bej.2009.11.001; Ventura JRS, 2013, BIOTECHNOL BIOPROC E, V18, P1142, DOI 10.1007/s12257-013-0150-6; Wang SH, 2012, APPL MICROBIOL BIOT, V93, P1021, DOI 10.1007/s00253-011-3570-2; Wang Y, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-138; Wu H, 2015, FUEL, V142, P109, DOI 10.1016/j.fuel.2014.10.009; Yu MR, 2011, METAB ENG, V13, P373, DOI 10.1016/j.ymben.2011.04.002; Zhang Longyun, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P1943	40	28	32	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141160	10.1371/journal.pone.0141160	http://dx.doi.org/10.1371/journal.pone.0141160			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489085	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400112
J	Marx, W; McKavanagh, D; McCarthy, AL; Bird, R; Ried, K; Chan, A; Isenring, L				Marx, Wolfgang; McKavanagh, Daniel; McCarthy, Alexandra L.; Bird, Robert; Ried, Karin; Chan, Alexandre; Isenring, Liz			The Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature Review	PLOS ONE			English	Review							ALTERNATIVE MEDICINE; ANTIPLATELET AGGREGATION; THROMBOXANE PRODUCTION; COMPLEMENTARY; CONSTITUENTS; NAUSEA; CONSUMPTION; NIFEDIPINE; COMPONENTS; WARFARIN	Background The potential effect of ginger on platelet aggregation is a widely-cited concern both within the published literature and to clinicians; however, there has been no systematic appraisal of the evidence to date. Methods Using the PRISMA guidelines, we systematically reviewed the results of clinical and observational trials regarding the effect of ginger on platelet aggregation in adults compared to either placebo or baseline data. Studies included in this review stipulated the independent variable was a ginger preparation or isolated ginger compound, and used measures of platelet aggregation as the primary outcome. Results Ten studies were included, comprising eight clinical trials and two observational studies. Of the eight clinical trials, four reported that ginger reduced platelet aggregation, while the remaining four reported no effect. The two observational studies also reported mixed findings. Discussion Many of the studies appraised for this review had moderate risks of bias. Methodology varied considerably between studies, notably the timeframe studied, dose of ginger used, and the characteristics of subjects recruited (e.g. healthy vs. patients with chronic diseases). Conclusion The evidence that ginger affects platelet aggregation and coagulation is equivocal and further study is needed to definitively address this question.	[Marx, Wolfgang; Isenring, Liz] Bond Univ, Hlth Sci & Med, Gold Coast, Qld, Australia; [McKavanagh, Daniel; McCarthy, Alexandra L.; Bird, Robert] Princess Alexandra Hosp, Div Canc Serv, Brisbane, Qld 4102, Australia; [McCarthy, Alexandra L.] Queensland Univ Technol, Inst Biomed Innovat, Brisbane, Qld 4001, Australia; [Bird, Robert] Griffith Univ, Sch Med, Nathan, Qld 4111, Australia; [Ried, Karin] Natl Inst Integrat Med, Melbourne, Vic, Australia; [Chan, Alexandre] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore; [Isenring, Liz] Princess Alexandra Hosp, Dept Nutr & Dietet, Brisbane, Qld 4102, Australia	Bond University; Queensland University of Technology (QUT); Griffith University; National University of Singapore	Marx, W (corresponding author), Bond Univ, Hlth Sci & Med, Gold Coast, Qld, Australia.	Wolfgang.marx@student.bond.edu.au	Marx, Wolfgang/AFO-7355-2022; Chan, Alexandre/D-5035-2016	Marx, Wolfgang/0000-0002-8556-8230; Chan, Alexandre/0000-0003-4391-4219; Isenring, Elizabeth/0000-0002-4478-9707; Bird, Robert/0000-0002-3110-1424				[Agricultural Research Service U.S. Department of Agriculture], 2014, USDA NAT NUTR DAT ST; Bordia A, 1997, PROSTAG LEUKOTR ESS, V56, P379, DOI 10.1016/S0952-3278(97)90587-1; Chaiyakunapruk N, 2006, AM J OBSTET GYNECOL, V194, P95, DOI 10.1016/j.ajog.2005.06.046; Chrubasik S, 2005, PHYTOMEDICINE, V12, P684, DOI 10.1016/j.phymed.2004.07.009; Davis EL, 2012, ONCOLOGIST, V17, P1475, DOI 10.1634/theoncologist.2012-0223; DORSO CR, 1980, NEW ENGL J MED, V303, P756; Elting LS, 2001, J CLIN ONCOL, V19, P1137, DOI 10.1200/JCO.2001.19.4.1137; FLYNN DL, 1986, PROSTAG LEUKOTR ESS, V24, P195, DOI 10.1016/0262-1746(86)90126-5; Heck AM, 2000, AM J HEALTH-SYST PH, V57, P1221, DOI 10.1093/ajhp/57.13.1221; Janssen PLTMK, 1996, EUR J CLIN NUTR, V50, P772; Jiang XM, 2005, BRIT J CLIN PHARMACO, V59, P425, DOI 10.1111/j.1365-2125.2005.02322.x; Koo KLK, 2001, THROMB RES, V103, P387, DOI 10.1016/S0049-3848(01)00338-3; Lesho EP, 2004, CLEV CLIN J MED, V71, P651, DOI 10.3949/ccjm.71.8.651; Leung VWY, 2009, ANN PHARMACOTHER, V43, P875, DOI 10.1345/aph.1L631; Liao YR, 2012, MOLECULES, V17, P8928, DOI 10.3390/molecules17088928; Lien HC, 2003, AM J PHYSIOL-GASTR L, V284, pG481, DOI 10.1152/ajpgi.00164.2002; LUMB AB, 1994, THROMB HAEMOSTASIS, V71, P110; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Marx WM, 2013, NUTR REV, V71, P245, DOI 10.1111/nure.12016; Miller LG, 1998, ARCH INTERN MED, V158, P2200, DOI 10.1001/archinte.158.20.2200; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; National Health and Medical Research Council, 2009, NHMRC LEV EV GRAD RE; Nie H, 2008, CHINESE MED J-PEKING, V121, P1226, DOI 10.1097/00029330-200807010-00015; Nievergelt A, 2011, J IMMUNOL, V187, P4140, DOI 10.4049/jimmunol.1100880; Nurtjahja-Tjendraputra E, 2003, THROMB RES, V111, P259, DOI 10.1016/j.thromres.2003.09.009; Ryan JL, 2012, SUPPORT CARE CANCER, V20, P1479, DOI 10.1007/s00520-011-1236-3; Schwertner HA, 2007, J CHROMATOGR B, V856, P41, DOI 10.1016/j.jchromb.2007.05.011; Schwertner HA, 2006, OBSTET GYNECOL, V107, P1337, DOI 10.1097/01.AOG.0000217697.33787.8c; Shalansky S, 2007, PHARMACOTHERAPY, V27, P1237, DOI 10.1592/phco.27.9.1237; Shih CY, 2014, J HYPERTENS, V32, P181, DOI 10.1097/HJH.0000000000000007; Srinivasan R, 2011, PLANTA MED, V77, P112, DOI [10.1055/s-0031-1273641, DOI 10.1055/S-0031-1273641]; SRIVASTAVA KC, 1989, PROSTAG LEUKOTR ESS, V35, P183, DOI 10.1016/0952-3278(89)90122-1; SRIVASTAVA KC, 1986, PROSTAG LEUKOTR ESS, V25, P187, DOI 10.1016/0262-1746(86)90065-X; SRIVASTAVA KC, 1984, BIOMED BIOCHIM ACTA, V43, pS335; Thomson M, 2002, PROSTAG LEUKOTR ESS, V67, P475, DOI 10.1054/plef.2002.0441; Thomson M, 2014, J AM BOARD FAM MED, V27, P115, DOI 10.3122/jabfm.2014.01.130167; Tjendraputra E, 2001, BIOORG CHEM, V29, P156, DOI 10.1006/bioo.2001.1208; VERMA SK, 1993, INDIAN J MED RES-B, V98, P240; Weidner MS, 2000, J ETHNOPHARMACOL, V73, P513, DOI 10.1016/S0378-8741(00)00340-8; Young HY, 2006, AM J CHINESE MED, V34, P545, DOI 10.1142/S0192415X06004089	40	33	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141119	10.1371/journal.pone.0141119	http://dx.doi.org/10.1371/journal.pone.0141119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488162	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400104
J	Muller, A; Trotzke, P; Mitchell, JE; de Zwaan, M; Brand, M				Mueller, Astrid; Trotzke, Patrick; Mitchell, James E.; de Zwaan, Martina; Brand, Matthias			The Pathological Buying Screener: Development and Psychometric Properties of a New Screening Instrument for the Assessment of Pathological Buying Symptoms	PLOS ONE			English	Article							PREVALENCE; SCALES; BEHAVIOR; GERMANY; NUMBER; MOOD	The study was designed to develop a new screening instrument for pathological buying (PB), and to examine its psychometric properties in a large-scale sample. By using a facet theoretical approach and based on literature as well as on clinical experience, a 20-item Pathological Buying Screener (PBS) was developed and administered to a representative German sample (n = 2,539). Valid data were available from 2,403 participants who were subjects for three subsequent empirical studies. The first study explored the factor structure using exploratory factor analyses in a subsample of 498 participants. Based on factor loadings, a 13-item version with the two factors loss of control / consequences and excessive buying behavior was revealed. This two-factor model was confirmed in study 2 by confirmatory factor analysis performed on another subsample (n = 1,905). Study 3 investigated age and gender effects and convergent validity of the PBS using the Compulsive Buying Scale (CBS) in the full sample (N = 2,403). The total PBS score was adequately correlated with the CBS score. Hierarchical regression analyses with the CBS score as the dependent variable and the two PBS factors as the predictors indicated an own incremental validity of the two factors in participants <= 65 years. The reliability of the total score as well as of the two subscales was good to excellent. Overall, the PBS represents a useful measure for PB. Future studies are needed to replicate the two-factor structure in clinical samples and to define a valid cutoff for PB.	[Mueller, Astrid; de Zwaan, Martina] Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany; [Trotzke, Patrick; Brand, Matthias] Univ Duisburg Essen, Gen Psychol Cognit, Duisburg, Germany; [Mitchell, James E.] Univ N Dakota, Sch Med & Hlth Sci, Dept Clin Psychiat & Behav Sci, Fargo, ND USA; [Mitchell, James E.] Neuropsychiat Res Unit, Fargo, ND USA; [Brand, Matthias] Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Essen, Germany	Hannover Medical School; University of Duisburg Essen; University of North Dakota Grand Forks; Neuropsychiatric Research Institute; University of Duisburg Essen	Muller, A (corresponding author), Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany.	mueller.astrid@mh-hannover.de	Trotzke, Patrick/Z-5589-2019	Brand, Matthias/0000-0002-4831-9542				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Black DW, 2015, PSYCHIAT RES, V226, P273, DOI 10.1016/j.psychres.2014.12.061; Black DW, 2011, PRACT CLIN GUIDEBK, P27; Black DW, 2012, OXFORD HDB IMPULSE C, P196; Borg I., 1995, FACET THEORY FORM CO, V5; Cole L, 1995, ADV CONSUM RES, V22, P419; Edwards EA., 1993, FINANCIAL COUNSELING, V4, P67, DOI [10.1037/t22901-000, DOI 10.1037/T22901-000]; FABER RJ, 1992, J CONSUM RES, V19, P459, DOI 10.1086/209315; Faber RJ, 1996, PSYCHOL MARKET, V13, P803, DOI 10.1002/(SICI)1520-6793(199612)13:8<803::AID-MAR6>3.3.CO;2-2; Ferguson E, 1993, INT J SEL ASSESS, V1, P84, DOI DOI 10.1111/J.1468-2389.1993.TB00092.X; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Frost RO, 2002, BEHAV THER, V33, P201, DOI 10.1016/S0005-7894(02)80025-9; Frost RO, 2014, OXFORD HDB HOARDING, P86, DOI DOI 10.1093/OXFORDHB/9780199937783.013.020; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hubert M, 2014, J VERBRAUCH LEBENSM, V9, P280; Jacobi F, 2014, INT J METH PSYCH RES, V23, P304, DOI 10.1002/mpr.1439; Kellett S, 2009, CLIN PSYCHOL PSYCHOT, V16, P83, DOI 10.1002/cpp.585; Koran LM, 2006, AM J PSYCHIAT, V163, P1806, DOI 10.1176/appi.ajp.163.10.1806; Lejoyeux M, 2010, AM J DRUG ALCOHOL AB, V36, P248, DOI 10.3109/00952990.2010.493590; Manolis C, 2008, PSYCHOL REP, V102, P153, DOI 10.2466/PRO.102.1.153-165; Otero-Lopez JM, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-101; Maraz A, 2015, PSYCHIAT RES, V225, P326, DOI 10.1016/j.psychres.2014.11.080; MCELROY SL, 1994, J CLIN PSYCHIAT, V55, P242; Meerkerk G-J., 2007, PWNED INTERNET EXPLO; Miltenberger RG, 2003, J BEHAV THER EXP PSY, V34, P1, DOI 10.1016/S0005-7916(03)00002-8; Moshagen M, 2016, STRUCT EQU MODELING, V23, P54, DOI 10.1080/10705511.2014.950896; Mueller A, 2012, OXFORD HDB IMPULSE C, P398; Muller A, 2015, AM J ADDICTION, V24, P132, DOI 10.1111/ajad.12111; Muller A, 2012, PSYCHIAT RES, V200, P575, DOI 10.1016/j.psychres.2012.04.015; Mueller A, 2010, Z KL PSYCH PSYCHOTH, V39, P161, DOI 10.1026/1616-3443/a000030; Mueller A, 2010, PSYCHIAT RES, V180, P137, DOI 10.1016/j.psychres.2009.12.001; Mueller A, 2009, BEHAV RES THER, V47, P705, DOI 10.1016/j.brat.2009.04.005; Muller A, OXFORD HDB DIGITAL T; Neuner M, 2005, J ECON PSYCHOL, V26, P509, DOI 10.1016/j.joep.2004.08.002; Psychiatrie Kraepelin E., 1909, LEHRBUCH STUDIERENDE, P408; Raab G, 2005, SKSK SCREENINGSVERFA; Ridgway NM, 2008, J CONSUM RES, V35, P622, DOI 10.1086/591108; SCHERHORN G, 1990, J CONSUM POLICY, V13, P355, DOI 10.1007/BF00412336; Smith GT, 1995, PSYCHOL ASSESSMENT, V7, P300, DOI 10.1037/1040-3590.7.3.300; Trotzke P, 2014, PSYCHOSOM MED, V76, P694, DOI 10.1097/PSY.0000000000000126; VALENCE G, 1988, J CONSUM POLICY, V11, P419, DOI 10.1007/BF00411854; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	44	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141094	10.1371/journal.pone.0141094	http://dx.doi.org/10.1371/journal.pone.0141094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488872	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400101
J	Wang, GR; Zhong, L; He, X; Lei, ZQ; Hu, G; Li, R; Wang, YH				Wang, Guorong; Zhong, Lin; He, Xia; Lei, Zhongqing; Hu, Gang; Li, Rong; Wang, Yunhai			Dynamic Behavior of Reciprocating Plunger Pump Discharge Valve Based on Fluid Structure Interaction and Experimental Analysis	PLOS ONE			English	Article							COMPRESSOR	The influence of spring stiffness and valve quality on the motion behaviors of reciprocating plunger pump discharge valves was investigated by fluid structure interaction (FSI) simulation and experimental analysis. The mathematical model of the discharge valve motion of a 2000-fracturing pump was developed and the discrete differential equations were solved according to FSI and results obtained by ANDINA software. Results indicate that spring stiffness influences the maximum lift, the opening resistance and shut-off lag angle, as well as the fluid velocity of the clearance, the impact stress and the volume efficiency of the pump valve in relation to the valve quality. An optimal spring stiffness parameter of 14.6 N/mm was obtained, and the volumetric efficiency of the pumping valve increased by 4% in comparison to results obtained with the original spring stiffness of 10.09N/mm. The experimental results indicated that the mathematical model and FSI method could provide an effective approach for the subsequent improvement of valve reliability, volumetric efficiency and lifespan.	[Wang, Guorong; Zhong, Lin; He, Xia; Lei, Zhongqing; Hu, Gang; Wang, Yunhai] Southwest Petr Univ, Sch Mechatron Engn, Chengdu, Sichuan, Peoples R China; [Li, Rong] China Petrochem Corp, SJ Petr Machinery Co, Jingzhou, Hubei, Peoples R China	Southwest Petroleum University; Sinopec	Zhong, L (corresponding author), Southwest Petr Univ, Sch Mechatron Engn, Chengdu, Sichuan, Peoples R China.	zhonglin858296@163.com			State Major Project for Science and Technology [2011ZX05048-04HZ]; National Natural Science Foundation of China [50905149]	State Major Project for Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project has been funded in whole or in part with the State Major Project for Science and Technology (grant number 2011ZX05048-04HZ) and the Program of National Natural Science Foundation of China (grant number 50905149). The funders only provided financial support in the form of authors' salaries and research work. They mainly required that the publishing manuscripts based on supported funding projects should involve the project numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, 062 ARD ADINA RD INC; Boswirth L., 1990, INT COMPR ENG C PURD; Boswirth L., 1982, P PURD INT COMPR C L, P38; Chaykosky S., 2002, RESOLUTION COMPRESSO; Choi YS, 2010, J MECH SCI TECHNOL, V24, P1371, DOI 10.1007/s12206-010-0423-3; Dong Shi-Min, 2000, Journal of System Simulation, V12, P116; Glaeser WA, 1999, WEAR, V225, P918, DOI 10.1016/S0043-1648(99)00069-1; Han XM, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTING AND INTELLIGENT SYSTEMS, PROCEEDINGS, VOL 4, P141, DOI 10.1109/ICICISYS.2009.5357726; Han XM, 2009, ICIC 2009: SECOND INTERNATIONAL CONFERENCE ON INFORMATION AND COMPUTING SCIENCE, VOL 4, PROCEEDINGS, P23, DOI 10.1109/ICIC.2009.314; Li XB, 2010, THESIS ZHEJIANG U CH; Liu YH, 2010, J OIL GAS TECHNOLOGY, V32, P385; Lu YF, 1995, J U PETROLEUM, V38, P66; Ma Y, 2012, APPL THERM ENG, V32, P13, DOI 10.1016/j.applthermaleng.2011.03.022; Reej I B, 2006, NUCL ENG DES, V227, P313; Robert K., 2003, COMPUT STRUCT, V81, P755; Saha BK, 2014, COMPUT FLUIDS, V101, P233, DOI 10.1016/j.compfluid.2014.06.011; Wang B L, 1998, DESIGN CALCULATION O; Wang Y, 2013, APPL THERM ENG, V61, P149, DOI 10.1016/j.applthermaleng.2013.07.046; [翁武钊 Weng Wuzhao], 2011, [计算机仿真, Computer Simulation], V28, P411; Xiao CL, 1994, THESIS U NEW BRUNSWI; Zienkiewicz O.C., FINITE ELEMENT METHO, V2	21	6	6	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140396	10.1371/journal.pone.0140396	http://dx.doi.org/10.1371/journal.pone.0140396			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488290	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400051
J	Anderson, LG; Rocliffe, S; Haddaway, NR; Dunn, AM				Anderson, Lucy G.; Rocliffe, Steve; Haddaway, Neal R.; Dunn, Alison M.			The Role of Tourism and Recreation in the Spread of Non-Native Species: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SKI SLOPE VEGETATION; MARINE RESERVES; BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; DISPERSAL; TRANSPORT; BIOSECURITY; FRAMEWORK; PATHWAYS; ISLANDS	Managing the pathways by which non-native species are introduced and spread is considered the most effective way of preventing species invasions. Tourism and outdoor recreation involve the frequent congregation of people, vehicles and vessels from geographically diverse areas. They are therefore perceived to be major pathways for the movement of non-native species, and ones that will become increasingly important with the continued growth of these sectors. However, a global assessment of the relationship between tourism activities and the introduction of non-native species-particularly in freshwater and marine environments- is lacking. We conducted a systematic review and meta-analysis to determine the impact of tourism and outdoor recreation on non-native species in terrestrial, marine and freshwater environments. Our results provide quantitative evidence that the abundance and richness of non-native species are significantly higher in sites where tourist activities take place than in control sites. The pattern was consistent across terrestrial, freshwater and marine environments; across a variety of vectors (e.g. horses, hikers, yachts); and across a range of taxonomic groups. These results highlight the need for widespread biosecurity interventions to prevent the inadvertent introduction of invasive non-native species (INNS) as the tourism and outdoor recreation sectors grow.	[Anderson, Lucy G.; Dunn, Alison M.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Anderson, Lucy G.] Ctr Environm Fisheries & Aquaculture Sci, Weymouth, England; [Rocliffe, Steve] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Haddaway, Neal R.] Royal Swedish Acad Sci, MISTRA EviEM, Stockholm, Sweden	University of Leeds; Centre for Environment Fisheries & Aquaculture Science; University of York - UK; Royal Swedish Academy of Sciences	Anderson, LG (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	anderson.lucyg@gmail.com		Haddaway, Neal R/0000-0003-3902-2234	BBSRC; Centre for Environment, Fisheries and Aquaculture Science (Cefas); LGA; NERC PhD studentship; NERC IAA grant	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Centre for Environment, Fisheries and Aquaculture Science (Cefas); LGA; NERC PhD studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC IAA grant	LGA was funded by a PhD case studentship funded by BBSRC (bbsrc.ac.uk) and the Centre for Environment, Fisheries and Aquaculture Science (Cefas) (cefas.co.uk). SR was funded by a NERC PhD studentship and AMD was funded by a NERC IAA grant (nerc.ac.uk).	Allen JA, 2009, BIOL INVASIONS, V11, P2195, DOI 10.1007/s10530-008-9376-1; Anderson LG, 2015, MANAGING AQUATIC NON; Anderson LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092788; Ansong Michael, 2013, Ecological Management & Restoration, V14, P216, DOI 10.1111/emr.12057; Bacela-Spychalska K, 2013, KILLER SHRIMP DIKERO; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Bancroft BA, 2007, ECOL LETT, V10, P332, DOI 10.1111/j.1461-0248.2007.01022.x; Barros A, 2014, MT RES DEV, V34, P13, DOI 10.1659/MRD-JOURNAL-D-13-00054.1; Barton E., 2015, EUROPEAN CODE CONDUC; Bataille A, 2009, P ROY SOC B-BIOL SCI, V276, P3769, DOI 10.1098/rspb.2009.0998; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Belz CE, 2012, J SHELLFISH RES, V31, P777, DOI 10.2983/035.031.0322; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Briski E, 2012, J APPL ECOL, V49, P1124, DOI 10.1111/j.1365-2664.2012.02186.x; Britton-Simmons KH, 2008, J ECOL, V96, P68, DOI 10.1111/j.1365-2745.2007.01319.x; Burfeind DD, 2013, BIOL INVASIONS, V15, P17, DOI 10.1007/s10530-012-0265-2; Byers JE, 2005, ECOLOGY, V86, P487, DOI 10.1890/03-0580; Byers JE, 2002, OIKOS, V97, P449, DOI 10.1034/j.1600-0706.2002.970316.x; Caffrey JM, 2014, MANAG BIOL INVASION, V5, P1, DOI 10.3391/mbi.2014.5.1.01; Canty A, 2014, BOOT BOOTSTRAP R S P; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; CEE, 2013, GUIDELINES SYSTEMATI; Chapple DG, 2013, EVOL APPL, V6, P324, DOI 10.1111/eva.12002; Christ C, 2003, TOURISM BIODIVERSITY; Clout MN, 2005, WEED TECHNOL, V19, P523, DOI 10.1614/WT-04-126.1; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cohen J.E., 1988, STAT POWER ANAL BEHA; Convention on Biological Diversity, 2014, PATHW INTR INV SPEC; Cooper H. M., 2009, RES SYNTHESIS METAAN, V2; COWIE ID, 1993, BIOL CONSERV, V63, P127, DOI 10.1016/0006-3207(93)90500-Z; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Cushman JH, 2008, J ECOL, V96, P766, DOI 10.1111/j.1365-2745.2008.01376.x; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Davenport L, 2002, ECOTOURISM TOOLS PAR, P279; Del Re, 2013, COMPUTEES COMPUTE EF; Deloitte, 2011, MAF EC IMP ASS DID O; Floerl O, 2003, P WORKSH CURR ISS PO, P22; Gallardo B, 2013, J APPL ECOL, V50, P757, DOI 10.1111/1365-2664.12079; Gallardo B, 2012, BIOL INVASIONS, V14, P1265, DOI 10.1007/s10530-011-0154-0; Glen AS, 2013, BIOL INVASIONS, V15, P2589, DOI 10.1007/s10530-013-0495-y; Haddaway NR, 2015, CONSERV BIOL, V29, P1242, DOI 10.1111/cobi.12449; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jauni M, 2015, OIKOS, V124, P122, DOI 10.1111/oik.01416; Kauri Dieback Programme Partners, 2014, KEEP KAUR STAND STOP; KELLY J., 2013, EC COST INVASIVE NON; Kilian JV, 2012, BIOL INVASIONS, V14, P1469, DOI 10.1007/s10530-012-0173-5; Kilroy C, 2011, AQUAT INVASIONS, V6, P249, DOI 10.3391/ai.2011.6.3.02; Knapp I.S., 2011, Marine Biodiversity Records, V4; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lee JE, 2009, ECOL APPL, V19, P1944, DOI 10.1890/08-2157.1; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McCrone A New Zealand. Department of Conservation, 2001, VISITOR IMPACTS MARI; Meyerson LA, 2002, BIOSCIENCE, V52, P593, DOI 10.1641/0006-3568(2002)052[0593:BMTACA]2.0.CO;2; Minchin Dan, 2003, Biology and Environment, V103B, P23, DOI 10.3318/BIOE.2003.103.1.23; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Monaco A., 2014, EUROPEAN GUIDELINES; Newsome D, 2008, CURR ISSUES TOUR, V11, P144, DOI 10.2167/cit336.0; Pickering C. M., 2007, Journal of Ecotourism, V6, P146, DOI 10.2167/joe162.0; Pickering C, 2010, J SUSTAIN TOUR, V18, P239, DOI 10.1080/09669580903406613; Pickering CM, 2010, J ENVIRON MANAGE, V91, P551, DOI 10.1016/j.jenvman.2009.09.025; Pickering CM, 2008, LIT REV HORSE RIDING; Pretto F, 2012, BIOL INVASIONS, V14, P2559, DOI 10.1007/s10530-012-0252-7; Pullin AS, 2001, CONSERV BIOL, V15, P50, DOI 10.1046/j.1523-1739.2001.99499.x; Pullin AS, 2004, BIOL CONSERV, V119, P245, DOI 10.1016/j.biocon.2003.11.007; R Core Team, 2021, R LANGUAGE ENV STAT; Rasband WS, 2011, IMAGEJ; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1111/j.0014-3820.2005.tb01004.x; Rothlisberger JD, 2010, FISHERIES, V35, P121, DOI 10.1577/1548-8446-35.3.121; Secretariat of the Convention on Biological Diversity, 2011, STRAT PLAN BIOD 2011; Secretariat of the Convention on Biological Diversity, 2004, GUID BIOD TOUR DEV I; Shackelford G, 2013, BIOL REV, V88, P1002, DOI 10.1111/brv.12040; Sikorski P, 2013, ENVIRON MONIT ASSESS, V185, P5823, DOI 10.1007/s10661-012-2987-0; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; Steven R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062598; Stewart G, 2010, BIOL LETTERS, V6, P78, DOI 10.1098/rsbl.2009.0546; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Tatem AJ, 2009, ECOGRAPHY, V32, P94, DOI 10.1111/j.1600-0587.2008.05588.x; Thresher RE, 1999, AUSTR J ENV MANAGEME, V6, P137, DOI [10.1080/14486563.1999.10648462, DOI 10.1080/14486563.1999.10648462]; Thurstan RH, 2012, MAR POLICY, V36, P1096, DOI 10.1016/j.marpol.2012.03.006; Titus JH, 1999, ARCT ANTARCT ALP RES, V31, P283, DOI 10.2307/1552259; Titus JH, 2003, SOUTHWEST NAT, V48, P491, DOI 10.1894/0038-4909(2003)048&lt;0491:SSVOLC&gt;2.0.CO;2; Tobin PC, 2010, J ENVIRON MANAGE, V91, P1991, DOI 10.1016/j.jenvman.2010.05.005; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Willette DA, 2014, AQUAT BOT, V112, P98, DOI 10.1016/j.aquabot.2013.10.001; Wittenberg R., 2001, Invasive alien species: a toolkit of best prevention and management practices, DOI 10.1079/9780851995694.0000; World Tourism Organization, 2014, UNWTO TOUR HIGHL 201	91	30	31	3	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140833	10.1371/journal.pone.0140833	http://dx.doi.org/10.1371/journal.pone.0140833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485300	Green Published, gold			2022-12-27	WOS:000363028100075
J	Caron, G; Marqueste, T; Decherchi, P				Caron, Guillaume; Marqueste, Tanguy; Decherchi, Patrick			Long-Term Effects of Botulinum Toxin Complex Type A Injection on Mechano- and Metabo-Sensitive Afferent Fibers Originating from Gastrocnemius Muscle	PLOS ONE			English	Article							GROUP-IV MUSCLE; TIBIALIS-ANTERIOR MUSCLE; BETA-ADRENERGIC-RECEPTOR; FAST SKELETAL-MUSCLE; EXERCISE PRESSOR REFLEX; GROUP-III; NERVE-FIBERS; INTERSTITIAL POTASSIUM; NEUROTOXIN LIGHT; RAT	The aim of the present study was to investigate long term effects of motor denervation by botulinum toxin complex type A (BoNT/A) from Clostridium Botulinum, on the afferent fibers originating from the gastrocnemius muscle of rats. Animals were divided in 2 experimental groups: 1) untreated animals acting as control and 2) treated animals in which the toxin was injected in the left muscle, the latter being itself divided into 3 subgroups according to their locomotor recovery with the help of a test based on footprint measurements of walking rats: i) no recovery (B0), ii) 50% recovery (B50) and iii) full recovery (B100). Then, muscle properties, metabosensitive afferent fiber responses to potassium chloride (KCl) and lactic acid injections and Electrically-Induced Fatigue (EIF), and mechanosensitive responses to tendon vibrations were measured. At the end of the experiment, rats were killed and the toxin injected muscles were weighted. After toxin injection, we observed a complete paralysis associated to a loss of force to muscle stimulation and a significant muscle atrophy, and a return to baseline when the animals recover. The response to fatigue was only decreased in the B0 group. The responses to KCl injections were only altered in the B100 groups while responses to lactic acid were altered in the 3 injected groups. Finally, our results indicated that neurotoxin altered the biphasic pattern of response of the mechanosensitive fiber to tendon vibrations in the B0 and B50 groups. These results indicated that neurotoxin injection induces muscle afferent activity alterations that persist and even worsen when the muscle has recovered his motor activity.	[Decherchi, Patrick] Aix Marseille Univ, F-13288 Marseille 09, France; Fac Sci Sport Marseille, Inst Sci Mouvement Etienne Jules MAREY ISM EJM Eq, CNRS, UMR 7287, F-13288 Marseille 09, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Decherchi, P (corresponding author), Aix Marseille Univ, F-13288 Marseille 09, France.	patrick.decherchi@univ-amu.fr	Marqueste, Tanguy/AAM-9751-2021; DECHERCHI, Patrick/AAE-7756-2019	Marqueste, Tanguy/0000-0002-2620-1551; DECHERCHI, Patrick/0000-0001-5639-852X; Caron, Guillaume/0000-0002-5906-0572	Aix-Marseille Universite (AMU); Centre National de la Recherche Scientifique (CNRS)	Aix-Marseille Universite (AMU); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by funding from Aix-Marseille Universite (AMU) and the Centre National de la Recherche Scientifique (CNRS).	Abbruzzese G, 2006, NEUROTOX RES, V9, P109, DOI 10.1007/BF03033927; Aguado F, 1999, NEUROSCIENCE, V88, P437, DOI 10.1016/S0306-4522(98)00247-4; AKAIKE N, 1983, J PHYSIOL-LONDON, V341, P245, DOI 10.1113/jphysiol.1983.sp014804; Akaike N, 2013, J PHYSIOL-LONDON, V591, P1031, DOI 10.1113/jphysiol.2012.242131; ALBUQUERQUE EX, 1971, PFLUG ARCH EUR J PHY, V328, P36, DOI 10.1007/BF00587359; ALBUQUERQUE EX, 1968, ACTA PHYSIOL SCAND, V73, P471, DOI 10.1111/j.1365-201X.1968.tb10886.x; Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Aoki KR, 2005, NEUROTOXICOLOGY, V26, P785, DOI 10.1016/j.neuro.2005.01.017; Apostolidis A, 2005, J UROLOGY, V174, P977, DOI 10.1097/01.ju.0000169481.42259.54; APSELOFF G, 1993, J PHARMACOL EXP THER, V264, P1071; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; BARKER D, 1981, PROC R SOC SER B-BIO, V212, P317, DOI 10.1098/rspb.1981.0042; BERECEK KH, 1982, AM J PHYSIOL, V242, pH593, DOI 10.1152/ajpheart.1982.242.4.H593; Bewick GS, 2015, PFLUG ARCH EUR J PHY, V467, P175, DOI 10.1007/s00424-014-1536-9; Billante CR, 2002, MUSCLE NERVE, V26, P395, DOI 10.1002/mus.10213; BROWN AG, 1967, EXP NEUROL, V18, P338, DOI 10.1016/0014-4886(67)90053-2; BROWN AG, 1967, J PHYSIOL-LONDON, V193, P707, DOI 10.1113/jphysiol.1967.sp008390; BROWN MC, 1967, J PHYSIOL-LONDON, V192, P773, DOI 10.1113/jphysiol.1967.sp008330; Buckwalter J B, 2001, Exerc Sport Sci Rev, V29, P159, DOI 10.1097/00003677-200110000-00005; BURKE D, 1976, J NEUROL NEUROSUR PS, V39, P729, DOI 10.1136/jnnp.39.8.729; Burniston JG, 2006, MUSCLE NERVE, V33, P655, DOI 10.1002/mus.20504; Burniston JG, 2005, J APPL PHYSIOL, V98, P1379, DOI 10.1152/japplphysiol.00642.2004; Caleo M, 2009, TOXICON, V54, P593, DOI 10.1016/j.toxicon.2008.12.026; Carmichael NME, 2010, PAIN, V149, P316, DOI 10.1016/j.pain.2010.02.024; Caron G, 2014, J NEUROSCI RES, V92, P904, DOI 10.1002/jnr.23370; Cartee G D, 1994, Exerc Sport Sci Rev, V22, P91; CASWELL AH, 1978, J BIOL CHEM, V253, P3049; Chiu CS, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-246; Cui ML, 2004, PAIN, V107, P125, DOI 10.1016/j.pain.2003.10.008; Curra A, 2004, MOVEMENT DISORD, V19, pS60, DOI 10.1002/mds.20011; Darques JL, 1998, NEUROSCI LETT, V257, P109; Darques JL, 1997, BRAIN RES, V750, P147, DOI 10.1016/S0006-8993(96)01341-8; Decherchi P, 1998, J PERIPHER NERV SYST, V3, P267; Decherchi P, 2001, MUSCLE NERVE, V24, P59, DOI 10.1002/1097-4598(200101)24:1<59::AID-MUS7>3.0.CO;2-S; DEGAIL P, 1966, J NEUROL NEUROSUR PS, V29, P1, DOI 10.1136/jnnp.29.1.1; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Di Castro A, 2006, P NATL ACAD SCI USA, V103, P4699, DOI 10.1073/pnas.0508005103; Dodd SL, 2005, TOXICON, V46, P196, DOI 10.1016/j.toxicon.2005.03.022; Dousset E, 2004, J NEUROSCI RES, V76, P734, DOI 10.1002/jnr.20110; Dressler D, 2000, EUR NEUROL, V43, P13, DOI 10.1159/000008122; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; DUCHATEAU J, 1990, J PHYSIOL-LONDON, V422, P55, DOI 10.1113/jphysiol.1990.sp017972; DUCHEN LW, 1971, J NEUROL SCI, V14, P47, DOI 10.1016/0022-510X(71)90129-8; DUCHEN LW, 1971, J NEUROL SCI, V14, P61, DOI 10.1016/0022-510X(71)90130-4; FILIPPI GM, 1993, ACTA OTO-LARYNGOL, V113, P400, DOI 10.3109/00016489309135834; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; FROMM C, 1977, BRAIN RES, V120, P459, DOI 10.1016/0006-8993(77)90399-7; Gao ZH, 2006, J APPL PHYSIOL, V100, P421, DOI 10.1152/japplphysiol.00659.2005; Ge WQ, 2003, J NEUROPHYSIOL, V89, P785, DOI 10.1152/jn.00624.2002; HAGBARTH K. E., 1966, BRAIN RES, V2, P201, DOI 10.1016/0006-8993(66)90029-1; HALLETT M, 1994, ANN NEUROL, V36, P449, DOI 10.1002/ana.410360321; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; HNIK P, 1976, PFLUG ARCH EUR J PHY, V362, P85, DOI 10.1007/BF00588685; HOLDS JB, 1990, OPHTHALMIC PLAST REC, V6, P252, DOI 10.1097/00002341-199012000-00005; Hott JS, 1998, NEUROLOGY, V50, P485, DOI 10.1212/WNL.50.2.485; HRUSKA RE, 1979, LIFE SCI, V25, P171, DOI 10.1016/0024-3205(79)90389-8; KAUFMAN MP, 1987, CIRC RES, V61, P60; KAUFMAN MP, 1984, CARDIOVASC RES, V18, P663, DOI 10.1093/cvr/18.11.663; KAUFMAN MP, 1982, CIRC RES, V50, P133, DOI 10.1161/01.RES.50.1.133; Kaufman MP, 1996, REFLEXES CONTROLLING; Kaur J, 2014, AM J PHYSL HEART CIR; Keller JE, 2006, NEUROSCIENCE, V139, P629, DOI 10.1016/j.neuroscience.2005.12.029; Kenagy J, 1997, BRAIN RES, V744, P175, DOI 10.1016/S0006-8993(96)01211-5; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Kim DY, 2006, INT J NEUROSCI, V116, P667, DOI 10.1080/00207450600674525; KIM YS, 1991, BIOCHEM PHARMACOL, V42, P1783, DOI 10.1016/0006-2952(91)90516-8; Koizumi H, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00098; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kostyukov AI, 2000, NEUROSCIENCE, V97, P789, DOI 10.1016/S0306-4522(00)00066-X; Legerlotz K, 2009, MUSCLE NERVE, V39, P472, DOI 10.1002/mus.21247; Lewis GE, 1981, BIOMEDICAL ASPECTS B; Lopez-Guajardo A, 2001, J APPL PHYSIOL, V90, P1909, DOI 10.1152/jappl.2001.90.5.1909; Lucioni A, 2008, BJU INT, V101, P366, DOI 10.1111/j.1464-410X.2007.07312.x; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Ma J, 2004, AM J PHYS MED REHAB, V83, P774, DOI 10.1097/01.PHM.0000137315.17214.93; Marqueste T, 2004, BRAIN RES, V1023, P222, DOI 10.1016/j.brainres.2004.07.027; Marqueste T, 2002, NEUROSCIENCE, V113, P257, DOI 10.1016/S0306-4522(02)00187-2; MARTIN WH, 1989, CIRC RES, V64, P1096, DOI 10.1161/01.RES.64.6.1096; MCCLOSKE.DI, 1972, J PHYSIOL-LONDON, V224, P173, DOI 10.1113/jphysiol.1972.sp009887; Meng JH, 2007, J CELL SCI, V120, P2864, DOI 10.1242/jcs.012211; MENSE S, 1986, NEUROSCI LETT, V66, P169, DOI 10.1016/0304-3940(86)90185-0; Mersmann HJ, 1998, J ANIM SCI, V76, P160; Paterson K, 2014, ANN NEUROL, V75, P591, DOI 10.1002/ana.24122; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; PRIORI A, 1995, BRAIN, V118, P801, DOI 10.1093/brain/118.3.801; Purkiss J, 2000, BIOCHEM PHARMACOL, V59, P1403, DOI 10.1016/S0006-2952(00)00260-4; Purkiss John R., 1997, Biochemical Society Transactions, V25, p542S; RATTIGAN S, 1986, BIOCHEM BIOPH RES CO, V136, P1071, DOI 10.1016/0006-291X(86)90442-0; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Rosales RL, 2010, EUR J NEUROL, V17, P71, DOI 10.1111/j.1468-1331.2010.03056.x; Rosales RL, 1996, MUSCLE NERVE, V19, P488, DOI 10.1002/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8; ROTTO DM, 1988, J APPL PHYSIOL, V64, P2306, DOI 10.1152/jappl.1988.64.6.2306; Rugiero F, 2009, NEUROPHARMACOLOGY, V56, P1138, DOI 10.1016/j.neuropharm.2009.03.012; Ryall JG, 2004, J PHYSIOL-LONDON, V555, P175, DOI 10.1113/jphysiol.2003.056770; Ryall JG, 2002, AM J PHYSIOL-REG I, V283, pR1386, DOI 10.1152/ajpregu.00324.2002; RYBICKI KJ, 1985, J APPL PHYSIOL, V58, P936, DOI 10.1152/jappl.1985.58.3.936; Sato S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/729598; SELLIN LC, 1981, J PHYSIOL-LONDON, V317, P487, DOI 10.1113/jphysiol.1981.sp013838; Shimizu T, 2012, NEUROBIOL DIS, V48, P367, DOI 10.1016/j.nbd.2012.07.010; Shoemaker CB, 2013, CURR TOP MICROBIOL, V364, P179, DOI 10.1007/978-3-642-33570-9_9; Simpson L, 2013, TOXICON, V68, P40, DOI 10.1016/j.toxicon.2013.02.014; Sloop RR, 1997, NEUROLOGY, V49, P189, DOI 10.1212/WNL.49.1.189; Smith SA, 2006, EXP PHYSIOL, V91, P89, DOI 10.1113/expphysiol.2005.032367; Smith SA, 2005, CIRCULATION, V112, P2293, DOI 10.1161/CIRCULATIONAHA.105.566745; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; THIMM F, 1987, PFLUG ARCH EUR J PHY, V410, P143, DOI 10.1007/BF00581907; TONGE DA, 1974, J PHYSIOL-LONDON, V241, P127, DOI 10.1113/jphysiol.1974.sp010644; Varejao ASP, 2001, MICROSURG, V21, P383, DOI 10.1002/micr.21803; Verderio C, 2007, TRAFFIC, V8, P142, DOI 10.1111/j.1600-0854.2006.00520.x; VICTOR RG, 1988, J CLIN INVEST, V82, P1301, DOI 10.1172/JCI113730; Vilceanu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012177; Welch MJ, 2000, TOXICON, V38, P245, DOI 10.1016/S0041-0101(99)00153-1; WIEGAND H, 1976, N-S ARCH PHARMACOL, V292, P161, DOI 10.1007/BF00498587; WILLIAMS RS, 1984, AM J PHYSIOL, V246, pE160, DOI 10.1152/ajpendo.1984.246.2.E160; YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130	118	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140439	10.1371/journal.pone.0140439	http://dx.doi.org/10.1371/journal.pone.0140439			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485650	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100034
J	Fahnoe, U; Pedersen, AG; Drager, C; Orton, RJ; Blome, S; Hoper, D; Beer, M; Rasmussen, TB				Fahnoe, Ulrik; Pedersen, Anders Gorm; Draeger, Carolin; Orton, Richard J.; Blome, Sandra; Hoeper, Dirk; Beer, Martin; Rasmussen, Thomas Bruun			Creation of Functional Viruses from Non-Functional cDNA Clones Obtained from an RNA Virus Population by the Use of Ancestral Reconstruction	PLOS ONE			English	Article							CLASSICAL SWINE-FEVER; SINGLE-NUCLEOTIDE SUBSTITUTIONS; MOUTH-DISEASE VIRUS; WILD BOAR; VIRULENCE; INFECTION; INFERENCE; FITNESS; STRAIN; REPLICATION	RNA viruses have the highest known mutation rates. Consequently it is likely that a high proportion of individual RNA virus genomes, isolated from an infected host, will contain lethal mutations and be non-functional. This is problematic if the aim is to clone and investigate high-fitness, functional cDNAs and may also pose problems for sequence-based analysis of viral evolution. To address these challenges we have performed a study of the evolution of classical swine fever virus (CSFV) using deep sequencing and analysis of 84 full-length cDNA clones, each representing individual genomes from a moderately virulent isolate. In addition to here being used as a model for RNA viruses generally, CSFV has high socio-economic importance and remains a threat to animal welfare and pig production. We find that the majority of the investigated genomes are non-functional and only 12% produced infectious RNA transcripts. Full length sequencing of cDNA clones and deep sequencing of the parental population identified substitutions important for the observed phenotypes. The investigated cDNA clones were furthermore used as the basis for inferring the sequence of functional viruses. Since each unique clone must necessarily be the descendant of a functional ancestor, we hypothesized that it should be possible to produce functional clones by reconstructing ancestral sequences. To test this we used phylogenetic methods to infer two ancestral sequences, which were then reconstructed as cDNA clones. Viruses rescued from the reconstructed cDNAs were tested in cell culture and pigs. Both reconstructed ancestral genomes proved functional, and displayed distinct phenotypes in vitro and in vivo. We suggest that reconstruction of ancestral viruses is a useful tool for experimental and computational investigations of virulence and viral evolution. Importantly, ancestral reconstruction can be done even on the basis of a set of sequences that all correspond to non-functional variants.	[Fahnoe, Ulrik; Rasmussen, Thomas Bruun] Tech Univ Denmark, DTU Natl Vet Inst, Lindholm, Kalvehave, Denmark; [Fahnoe, Ulrik; Pedersen, Anders Gorm] Tech Univ Denmark, Ctr Biol Sequence Anal, DTU Syst Biol, DK-2800 Lyngby, Denmark; [Draeger, Carolin; Blome, Sandra; Hoeper, Dirk; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Orton, Richard J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Orton, Richard J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Inflammat & Immun, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland	Technical University of Denmark; Technical University of Denmark; Friedrich Loeffler Institute; University of Glasgow; University of Glasgow	Rasmussen, TB (corresponding author), Tech Univ Denmark, DTU Natl Vet Inst, Lindholm, Kalvehave, Denmark.	tbrur@vet.dtu.dk		Fahnoe, Ulrik/0000-0002-2527-5751; Pedersen, Anders Gorm/0000-0001-9650-8965; Hoper, Dirk/0000-0001-8408-2274	European project Epi-SEQ [219235]; German Federal Ministry for Education and Research (BMBF) [01KI1016A]; BBSRC [BB/K004484/1] Funding Source: UKRI; MRC [G0801822] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K004484/1] Funding Source: researchfish; Medical Research Council [G0801822] Funding Source: researchfish	European project Epi-SEQ; German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European project Epi-SEQ (research project supported under the 2nd Joint Call for Transnational Research Projects by EMIDA ERA-NET [FP7 project no. 219235]) and by the German Federal Ministry for Education and Research (BMBF, grant 01KI1016A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Bonhoeffer S, 1997, P ROY SOC B-BIOL SCI, V264, P631; Carrasco P, 2007, J VIROL, V81, P12979, DOI 10.1128/JVI.00524-07; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Ciota AT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-58; Di Giallonardo F, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku537; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; DUARTE EA, 1994, J VIROL, V68, P4295, DOI 10.1128/JVI.68.7.4295-4301.1994; Fahnoe U, 2014, VIROLOGY, V468, P379, DOI 10.1016/j.virol.2014.08.021; Friis MB, 2012, J VIROL, V86, P8681, DOI 10.1128/JVI.00346-12; Gabriel C, 2012, VACCINE, V30, P2928, DOI 10.1016/j.vaccine.2012.02.065; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Hoffmann B, 2005, J VIROL METHODS, V130, P36, DOI 10.1016/j.jviromet.2005.05.030; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lee WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090581; Leifer I, 2010, J GEN VIROL, V91, P2687, DOI 10.1099/vir.0.023200-0; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mouchantat S, 2014, VET MICROBIOL, V170, P425, DOI 10.1016/j.vetmic.2014.03.004; Petrov A, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-134; Pybus OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/molbev/msm001; Rasmussen TB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-819; Rasmussen TB, 2010, VET MICROBIOL, V142, P13, DOI 10.1016/j.vetmic.2009.09.037; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; SOBRINO F, 1983, VIROLOGY, V128, P310, DOI 10.1016/0042-6822(83)90258-1; Tamura T, 2012, J VIROL, V86, P8602, DOI 10.1128/JVI.00551-12; Topfer A, 2013, VIROLOGY, V438, P14, DOI 10.1016/j.virol.2012.11.020; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Yang X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-674; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zeng JX, 2014, J VIROL, V88, P4008, DOI 10.1128/JVI.03594-13	35	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140912	10.1371/journal.pone.0140912	http://dx.doi.org/10.1371/journal.pone.0140912			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485566	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000363028100088
J	Lin, MF; Tsai, PW; Chen, JY; Lin, YY; Lan, CY				Lin, Ming-Feng; Tsai, Pei-Wen; Chen, Jeng-Yi; Lin, Yun-You; Lan, Chung-Yu			OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii	PLOS ONE			English	Article							MEMBRANE PROTEIN-A; ANTIBACTERIAL PEPTIDES; BIOFILM FORMATION; RESISTANCE; INDUCTION; PATHOGEN; MUTANTS; GENES; ROLES; CELLS	Multidrug-resistant Acinetobacter baumannii has recently emerged as an important pathogen in nosocomial infection; thus, effective antimicrobial regimens are urgently needed. Human antimicrobial peptides (AMPs) exhibit multiple functions and antimicrobial activities against bacteria and fungi and are proposed to be potential adjuvant therapeutic agents. This study examined the effect of the human cathelicidin-derived AMP LL-37 on A. baumannii and revealed the underlying mode of action. We found that LL-37 killed A. baumannii efficiently and reduced cell motility and adhesion. The bacteria-killing effect of LL-37 on A. baumannii was more efficient compared to other AMPs, including human beta-defensin 3 (hBD3) and histatin 5 (Hst5). Both flow cytometric analysis and immunofluorescence staining showed that LL-37 bound to A. baumannii cells. Moreover, far-western analysis demonstrated that LL-37 could bind to the A. baumannii OmpA (AbOmpA) protein. An ELISA assay indicated that biotin-labelled LL-37 (BA-LL37) bound to the AbOmpA(74-84) peptide in a dose-dependent manner. Using BA-LL37 as a probe, the similar to 38 kDa OmpA signal was detected in the wild type but the ompA deletion strain did not show the protein, thereby validating the interaction. Finally, we found that the ompA deletion mutant was more sensitive to LL-37 and decreased cell adhesion by 32% compared to the wild type. However, ompA deletion mutant showed a greatly reduced adhesion defect after LL-37 treatment compared to the wild strain. Taken together, this study provides evidence that LL-37 affects A. baumannii through OmpA binding.	[Lin, Ming-Feng] Natl Taiwan Univ Hosp, Dept Med, Chu Tung Branch, Tainan, Hsin Chu County, Taiwan; [Tsai, Pei-Wen; Chen, Jeng-Yi; Lin, Yun-You; Lan, Chung-Yu] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Lan, Chung-Yu] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Tsing Hua University	Lan, CY (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	cylan@life.nthu.edu.tw	林, 明鋒/AAX-7999-2020	林, 明鋒/0000-0002-4819-4057; Lan, Chung-Yu/0000-0002-1533-3049	Ministry of Science and Technology (Taiwan) [MOST104-2622-B-007-001-CC2]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by grant MOST104-2622-B-007-001-CC2 (to CYL) from the Ministry of Science and Technology (Taiwan).	Apetrei A, 2010, J BIOENERG BIOMEMBR, V42, P173, DOI 10.1007/s10863-010-9273-z; Aranda J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-279; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Chai H, 2014, INT J MED CHEM, V2014, DOI 10.1155/2014/809283; Chromek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046476; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Cuenca FF, 2003, J BASIC MICROB, V43, P194, DOI 10.1002/jobm.200390022; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Ding L, 2003, BIOCHEMISTRY-US, V42, P12251, DOI 10.1021/bi035130+; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x; Feng XR, 2013, PEPTIDES, V49, P131, DOI 10.1016/j.peptides.2013.09.007; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; Gudmundsson GH, 1999, J IMMUNOL METHODS, V232, P45, DOI 10.1016/S0022-1759(99)00152-0; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hell E, 2010, LETT APPL MICROBIOL, V50, P211, DOI 10.1111/j.1472-765X.2009.02778.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; Kim SA, 2008, FEMS IMMUNOL MED MIC, V54, P45, DOI 10.1111/j.1574-695X.2008.00446.x; Krauel K, 2012, BLOOD, V120, P3345, DOI 10.1182/blood-2012-06-434985; Krishnan S, 2012, FEBS J, V279, P919, DOI 10.1111/j.1742-4658.2012.08482.x; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lee JS, 2010, J MICROBIOL, V48, P387, DOI 10.1007/s12275-010-0155-1; Lin MF, 2017, J MICROBIOL IMMUNOL, V50, P224, DOI 10.1016/j.jmii.2015.04.004; Lin MF, 2014, WORLD J CLIN CASES, V2, P787, DOI 10.12998/wjcc.v2.i12.787; Lin MF, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-119; Lin YM, 2010, J BIOL CHEM, V285, P8985, DOI 10.1074/jbc.M109.078725; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Moffatt JH, 2013, INFECT IMMUN, V81, P684, DOI 10.1128/IAI.01362-12; Moon DC, 2012, J MICROBIOL, V50, P155, DOI 10.1007/s12275-012-1589-4; MORONA R, 1984, J BACTERIOL, V159, P570, DOI 10.1128/JB.159.2.570-578.1984; Mortensen BL, 2012, CELL MICROBIOL, V14, P1336, DOI 10.1111/j.1462-5822.2012.01817.x; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Napier BA, 2013, MBIO, V4, DOI 10.1128/mBio.00021-13; Navon-Venezia S, 2007, J ANTIMICROB CHEMOTH, V59, P772, DOI 10.1093/jac/dkm018; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; PUSPURS A, 1983, MOL GEN GENET, V189, P162, DOI 10.1007/BF00326070; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Sugawara E, 2012, J BACTERIOL, V194, P4089, DOI 10.1128/JB.00435-12; Tsai PW, 2014, J MICROBIOL, V52, P581, DOI 10.1007/s12275-014-3630-2; Tsai PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017755; van der Does AM, 2012, J LEUKOCYTE BIOL, V92, P735, DOI 10.1189/jlb.0412178; Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x	54	24	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141107	10.1371/journal.pone.0141107	http://dx.doi.org/10.1371/journal.pone.0141107			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484669	Green Submitted, gold, Green Published			2022-12-27	WOS:000363028100114
J	Veriter, S; Andre, W; Aouassar, N; Poirel, HA; Lafosse, A; Docquier, PL; Dufrane, D				Veriter, Sophie; Andre, Wivine; Aouassar, Najima; Poirel, Helene Antoine; Lafosse, Aurore; Docquier, Pierre-Louis; Dufrane, Denis			Human Adipose-Derived Mesenchymal Stem Cells in Cell Therapy: Safety and Feasibility in Different "Hospital Exemption" Clinical Applications	PLOS ONE			English	Article							KERATINOCYTE GROWTH-FACTOR; BONE-MARROW; STROMAL CELLS; BIOARTIFICIAL PANCREAS; DURA-MATER; RAT MODEL; IN-VIVO; TISSUE; TRANSPLANTATION; TRANSFORMATION	Based on immunomodulatory, osteogenic, and pro-angiogenic properties of adipose-derived stem cells (ASCs), this study aims to assess the safety and efficacy of ASC-derived cell therapies for clinical indications. Two autologous ASC-derived products were proposed to 17 patients who had not experienced any success with conventional therapies: (1) a scaffold-free osteogenic three-dimensional graft for the treatment of bone non-union and (2) a biological dressing for dermal reconstruction of non-healing chronic wounds. Safety was studied using the quality control of the final product (genetic stability, microbiological/mycoplasma/endotoxin contamination) and the in vivo evaluation of adverse events after transplantation. Feasibility was assessed by the ability to reproducibly obtain the final ASC-based product with specific characteristics, the time necessary for graft manufacturing, the capacity to produce enough material to treat the lesion, the surgical handling of the graft, and the ability to manufacture the graft in line with hospital exemption regulations. For 16 patients (one patient did not undergo grafting because of spontaneous bone healing), in-process controls found no microbiological/mycoplasma/endotoxin contamination, no obvious deleterious genomic anomalies, and optimal ASC purity. Each type of graft was reproducibly obtained without significant delay for implantation and surgical handling was always according to the surgical procedure and the implantation site. No serious adverse events were noted for up to 54 months. We demonstrated that autologous ASC transplantation can be considered a safe and feasible therapy tool for extreme clinical indications of ASC properties and physiopathology of disease.	[Veriter, Sophie; Andre, Wivine; Aouassar, Najima; Dufrane, Denis] Clin Univ St Luc, Endocrine Cell Therapy, Ctr Tissular & Cellular Therapy, B-1200 Brussels, Belgium; [Lafosse, Aurore] Clin Univ St Luc, Plast Surg, B-1200 Brussels, Belgium; [Docquier, Pierre-Louis] Clin Univ St Luc, Orthoped Surg, B-1200 Brussels, Belgium; [Poirel, Helene Antoine] Catholic Univ Louvain, Ctr Human Genet, Clin Univ St Luc, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Dufrane, D (corresponding author), Clin Univ St Luc, Endocrine Cell Therapy, Ctr Tissular & Cellular Therapy, B-1200 Brussels, Belgium.	denis.dufrane@uclouvain.be			Salus Sanguinis Foundation	Salus Sanguinis Foundation	This study was supported by the Salus Sanguinis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri FT, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.16323; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Coleman SR, 2001, CLIN PLAST SURG, V28, P111; Crane JL, 2014, J MOL MED, V92, P107, DOI 10.1007/s00109-013-1084-3; De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Dufrane D, 2003, J NEUROSURG, V98, P1198, DOI 10.3171/jns.2003.98.6.1198; Dufrane D, 2002, BIOMATERIALS, V23, P2979, DOI 10.1016/S0142-9612(02)00027-3; Dufrane D, 2008, BIOMATERIALS, V29, P2237, DOI 10.1016/j.biomaterials.2008.01.027; Duhoux FP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026311; Fawzi-Grancher S, 2009, J MATER SCI-MATER M, V20, P1709, DOI 10.1007/s10856-009-3726-0; Ferraro GA, 2013, J CELL BIOCHEM, V114, P1039, DOI 10.1002/jcb.24443; Friedenstein AJ, TRANSPLANTATION, V968, P230; Garcia S, 2010, EXP CELL RES, V316, P1648, DOI 10.1016/j.yexcr.2010.02.016; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Granchi D, 2013, J ORTHOP RES, V31, P249, DOI 10.1002/jor.22219; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272; Jeschke MG, 2005, WOUND REPAIR REGEN, V13, P269, DOI 10.1111/j.1067-1927.2005.130309.x; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Kuno S, 2015, CLIN PLAST SURG, V42, P191, DOI 10.1016/j.cps.2014.12.006; Lafosse A, 2015, PLAST RECONSTR SURG; Larsen M, 2014, MICROSURG, V34, P301, DOI 10.1002/micr.22221; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee SW, 2010, J PLAST RECONSTR AES, V63, pE364, DOI 10.1016/j.bjps.2009.10.027; Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071167; Moon MH, 2006, CELL PHYSIOL BIOCHEM, V17, P279, DOI 10.1159/000094140; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Schubert T, 2013, BIOMATERIALS, V34, P4428, DOI 10.1016/j.biomaterials.2013.02.053; Schubert T, 2013, BIOMATERIALS, V34, P3279, DOI 10.1016/j.biomaterials.2013.01.057; Schubert T, 2011, BIOMATERIALS, V32, P8880, DOI 10.1016/j.biomaterials.2011.08.009; SOTOZONO C, 1994, EXP EYE RES, V59, P385, DOI 10.1006/exer.1994.1122; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Tsuji Wakako, 2014, World J Stem Cells, V6, P312, DOI 10.4252/wjsc.v6.i3.312; Veriter S, 2014, CELL TRANSPLANT, V23, P1349, DOI 10.3727/096368913X663550; Veriter S, 2011, BIOMATERIALS, V32, P5945, DOI 10.1016/j.biomaterials.2011.02.061; Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	44	54	61	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139566	10.1371/journal.pone.0139566	http://dx.doi.org/10.1371/journal.pone.0139566			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485394	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100010
J	Jung, YJ; Woo, HI; Jeon, K; Koh, WJ; Jang, DK; Cha, HS; Koh, EM; Lee, NY; Kang, ES				Jung, Yu Jung; Woo, Hye In; Jeon, Kyeongman; Koh, Won-Jung; Jang, Dong Kyoung; Cha, Hoon Suk; Koh, Eun Mi; Lee, Nam Yong; Kang, Eun-Suk			The Significance of Sensitive Interferon Gamma Release Assays for Diagnosis of Latent Tuberculosis Infection in Patients Receiving Tumor Necrosis Factor-alpha Antagonist Therapy	PLOS ONE			English	Article							ACTIVE TUBERCULOSIS; BIOLOGIC AGENTS; TB; RISK; EFFICACY; UTILITY	Objective We compared two interferon gamma release assays (IGRAs), QuantiFERON-TB Gold In-Tube (QFT-GIT) and T-SPOT.TB, for diagnosis of latent tuberculosis infection (LTBI) in patients before and while receiving tumor necrosis factor (TNF)-alpha antagonist therapy. This study evaluated the significance of sensitive IGRAs for LTBI screening and monitoring. Methods Before starting TNF-alpha antagonist therapy, 156 consecutive patients with rheumatic diseases were screened for LTBI using QFT-GIT and T-SPOT.TB tests. According to our study protocol, QFT-GIT-positive patients received LTBI treatment. Patients positive by any IGRAs were subjected to follow-up IGRA tests after completing LTBI-treatment and/or during TNF-alpha antagonist therapy. Results At the initial LTBI screening, 45 (28.9%) and 70 (44.9%) patients were positive by QFT-GIT and T-SPOT.TB, respectively. The agreement rate between IGRA results was 78.8% (k = 0.56; 95% confidence interval [95% CI] = 0.43 to 0.68). Of 29 patients who were positive only by T-SPOT. TB in the initial screening, 83% (19/23) were persistently positive by T-SPOT.TB, while QFT-GIT testing showed that 36% (9/25) had conversion during TNF-alpha antagonist therapy. By the end of the follow-up period (218 to 1,264 days), four patients (4/137, 2.9%) developed active tuberculosis (TB) diseases during receiving TNF-alpha antagonist therapy. Among them, one was Q-T+, one was Q+T-, and the remaining two were Q-T- at the initial screening (Q, QuantiFERON-TB Gold In-Tube; T, T-SPOT.TB; +, positive; -, negative). Two (2/4, 50%) patients with TB reactivation had at least one prior risk factor consistent with previous TB infection. Conclusion This study demonstrated the need to capitalize on sensitive IGRAs to monitor for LTBI in at-risk patients for a more sensitive diagnosis in countries with an intermediate TB burden.	[Jung, Yu Jung; Lee, Nam Yong; Kang, Eun-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul, South Korea; [Jung, Yu Jung; Lee, Nam Yong; Kang, Eun-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Genet, Seoul, South Korea; [Woo, Hye In] Sungkyunkwan Univ, Sch Med, Dept Lab Med, Samsung Changwon Hosp, Chang Won, South Korea; [Jeon, Kyeongman; Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Clin Care Med,Dept Med, Seoul, South Korea; [Jang, Dong Kyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Cha, Hoon Suk; Koh, Eun Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Rheumatol,Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kang, ES (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul, South Korea.	eskang@skku.edu	Koh, Won Jung/C-9595-2011; Koh, Won-Jung/D-9586-2018; Jeon, Kyeongman/F-5963-2019	Koh, Won-Jung/0000-0002-4756-3527; Jeon, Kyeongman/0000-0002-4822-1772; Lee, Nam Yong/0000-0003-3688-0145	Oxford Immunotec, Abingdon, UK	Oxford Immunotec, Abingdon, UK	This study was supported by Oxford Immunotec, Abingdon, UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Calabrese C, 2014, ARTHRITIS CARE RES H; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Chang B, 2011, CLIN RHEUMATOL, V30, P1535, DOI 10.1007/s10067-011-1771-9; Chen DY, 2012, ANN RHEUM DIS, V71, P231, DOI 10.1136/annrheumdis-2011-200489; Dheda K, 2009, EUR RESPIR J, V34, P1118, DOI 10.1183/09031936.00005309; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Helwig U, 2012, J CROHNS COLITIS, V6, P419, DOI 10.1016/j.crohns.2011.09.011; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P1146; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim KH, 2011, KOREAN J LAB MED, V31, P271, DOI 10.3343/kjlm.2011.31.4.271; Korea Centers for Disease Control and Prevention, 2014, KOR GUID TUB; Korea Centers for Disease Control and Prevention, 2011, KOR GUID TUB; Lee H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119260; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Melath S, 2014, RHEUMATOL INT, V34, P149, DOI 10.1007/s00296-012-2641-8; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Minguez S, 2012, CLIN RHEUMATOL, V31, P785, DOI 10.1007/s10067-012-1938-z; Nordgaard-Lassen I, 2012, DAN MED J, V59; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Perry S, 2008, CLIN VACCINE IMMUNOL, V15, P425, DOI 10.1128/CVI.00398-07; Sauzullo I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005187; Schablon A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115322; Scrivo R, 2012, CLIN RHEUMATOL, V31, P1567, DOI 10.1007/s10067-012-2049-6; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307; Soborg B, 2009, J RHEUMATOL, V36, P1876, DOI 10.3899/jrheum.081292; Son CN, 2014, J KOREAN MED SCI, V29, P1090, DOI 10.3346/jkms.2014.29.8.1090; Trajman A, 2013, PULM MED, V2013, DOI 10.1155/2013/601737; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Vassilopoulos D, 2011, CLIN VACCINE IMMUNOL, V18, P2102, DOI 10.1128/CVI.05299-11; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Yun JW, 2014, J CLIN MICROBIOL, V52, P90, DOI 10.1128/JCM.01547-13	37	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0141033	10.1371/journal.pone.0141033	http://dx.doi.org/10.1371/journal.pone.0141033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474294	Green Submitted, Green Published, gold			2022-12-27	WOS:000363185500141
J	Chia, YC; Lim, HM; Ching, SM				Chia, Yook Chin; Lim, Hooi Min; Ching, Siew Mooi			Use of Chronic Kidney Disease to Enhance Prediction of Cardiovascular Risk in Those at Medium Risk	PLOS ONE			English	Article							POPULATION; PREVALENCE; MORTALITY; ATHEROSCLEROSIS; INFLAMMATION; ALBUMINURIA; PREVENTION; STATEMENT; MARKERS; ADULTS	Based on global cardiovascular (CV) risk assessment for example using the Framingham risk score, it is recommended that those with high risk should be treated and those with low risk should not be treated. The recommendation for those of medium risk is less clear and uncertain. We aimed to determine whether factoring in chronic kidney disease (CKD) will improve CV risk prediction in those with medium risk. This is a 10-year retrospective cohort study of 905 subjects in a primary care clinic setting. Baseline CV risk profile and serum creatinine in 1998 were captured from patients record. Framingham general cardiovascular disease risk score (FRS) for each patient was computed. All cardiovascular disease (CVD) events from 1998-2007 were captured. Overall, patients with CKD had higher FRS risk score (25.9% vs 20%, p = 0.001) and more CVD events (22.3% vs 11.9%, p = 0.002) over a 10-year period compared to patients without CKD. In patients with medium CV risk, there was no significant difference in the FRS score among those with and without CKD (14.4% vs 14.6%, p = 0.84) However, in this same medium risk group, patients with CKD had more CV events compared to those without CKD (26.7% vs 6.6%, p = 0.005). This is in contrast to patients in the low and high risk group where there was no difference in CVD events whether these patients had or did not have CKD. There were more CV events in the Framingham medium risk group when they also had CKD compared those in the same risk group without CKD. Hence factoring in CKD for those with medium risk helps to further stratify and identify those who are actually at greater risk, when treatment may be more likely to be indicated.	[Chia, Yook Chin; Lim, Hooi Min] Univ Malaya, Fac Med, UMPCRG, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Ching, Siew Mooi] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Malaysia; [Ching, Siew Mooi] Univ Putra Malaysia, Fac Med & Hlth Sci, Malaysian Res Inst Ageing, Serdang 43400, Malaysia	Universiti Malaya; Universiti Putra Malaysia; Universiti Putra Malaysia	Chia, YC (corresponding author), Univ Malaya, Fac Med, UMPCRG, Dept Primary Care Med, Kuala Lumpur, Malaysia.	chiayc@um.edu.my	Chia, Yook Chin/L-2977-2019; Ching, Siew Mooi/I-5817-2013; Chin, Chia Yook/B-8379-2010; Lim, Hooi Min/C-5010-2017	Ching, Siew Mooi/0000-0002-4425-7989; Chin, Chia Yook/0000-0003-1995-0359; Lim, Hooi Min/0000-0003-2481-9363	University of Malaya [UMRG 116/09HTM]	University of Malaya(Universiti Malaya)	This study was supported by a research grant from the University of Malaya (UMRG 116/09HTM). http://umresearch.um.edu.my/. The authors would like to acknowledge Department of Primary Care at the University of Malaya for providing the support during the data collection. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2015, PREVALENCE CHRONIC K; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Bombelli M, 2009, J HYPERTENS, V27, P2458, DOI 10.1097/HJH.0b013e328330b845; Chang A, 2011, NEPHRON CLIN PRACT, V119, pC171, DOI 10.1159/000325669; Chia YC, 2011, SINGAP MED J, V52, P116; Chia YC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007324; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Clase CM, 2011, ANN INTERN MED, V154, P310, DOI 10.7326/0003-4819-154-5-201103010-00005; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Drawz PE, 2012, AM HEART J, V164, P925, DOI 10.1016/j.ahj.2012.09.003; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hitha B, 2008, Saudi J Kidney Dis Transpl, V19, P411; Hooi LS, 2013, KIDNEY INT, V84, P1034, DOI 10.1038/ki.2013.220; Khalili D, 2012, AM J EPIDEMIOLOGY; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Nagata M, 2010, NEPHROL DIAL TRANSPL, V25, P2557, DOI 10.1093/ndt/gfq062; Olechnowicz-Tietz S, 2013, INT UROL NEPHROL, V45, P1605, DOI 10.1007/s11255-013-0407-1; Ong-Ajyooth L, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-35; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Weiner DE, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.05.054; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Zalba G, 2006, NEPHROL DIAL TRANSPL, V21, P2686, DOI 10.1093/ndt/gfl398; Zhang LX, 2006, J AM SOC NEPHROL, V17, P2617, DOI 10.1681/ASN.2006040402; Zomer E, 2011, EUR J CARDIOV PREV R, V18, P115, DOI 10.1097/HJR.0b013e32833ace24	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141344	10.1371/journal.pone.0141344	http://dx.doi.org/10.1371/journal.pone.0141344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496190	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000363309200097
J	Wehenkel, C; Brazao-Protazio, JM; Carrillo-Parra, A; Martinez-Guerrero, JH; Crecente-Campo, F				Wehenkel, Christian; Brazao-Protazio, Joao Marcelo; Carrillo-Parra, Artemio; Hugo Martinez-Guerrero, Jose; Crecente-Campo, Felipe			Spatial Distribution Patterns in the Very Rare and Species-Rich Picea chihuahuana Tree Community (Mexico)	PLOS ONE			English	Article							FOREST STRUCTURE; JACK-PINE; COMPETITION; POPULATIONS; DIVERSITY; SPRUCE; MARTINEZ; INDEXES	The very rare Mexican Picea chihuahuana tree community covers an area of no more than 300 ha in the Sierra Madre Occidental. This special tree community has been the subject of several studies aimed at learning more about the genetic structure and ecology of the species and the potential effects of climate change. The spatial distribution of trees is a result of many ecological processes and can affect the degree of competition between neighbouring trees, tree density, variability in size and distribution, regeneration, survival, growth, mortality, crown formation and the biological diversity within forest communities. Numerous scale-dependent measures have been established in order to describe spatial forest structure. The overall aim of most of these studies has been to obtain data to help design preservation and conservation strategies. In this study, we examined the spatial distribution pattern of trees in the P. chihuahuana tree community in 12 localities, in relation to i) tree stand density, ii) diameter distribution (vertical structure), iii) tree species diversity, iv) geographical latitude and v) tree dominance at a fine scale (in 0.25 ha plots), with the aim of obtaining a better understanding of the complex ecosystem processes and biological diversity. Because of the strongly mixed nature of this tree community, which often produces low population densities of each tree species and random tree fall gaps caused by tree death, we expect aggregated patterns in individual Picea chihuahuana trees and in the P. chihuahuana tree community, repulsive Picea patterns to other tree species and repulsive patterns of young to adult trees. Each location was represented by one plot of 50 x 50 m (0.25 ha) established in the centre of the tree community. The findings demonstrate that the hypothesis of aggregated tree pattern is not applicable to the mean pattern measured by Clark-Evans index, Uniform Angle index and Mean Directional index of the uneven-aged P. chihuahuana trees and P. chihuahuana tree community and but to specific spatial scales measured by the univariate L-function. The spatial distribution pattern of P. chihuahuana trees was found to be independent of patches of other tree species measured by the bivariate L-function. The spatial distribution was not significantly related to tree density, diameter distribution or tree species diversity. The index of Clark and Evans decreased significantly from the southern to northern plots containing all tree species. Self-thinning due to intra and inter-specific competition-induced mortality is probably the main cause of the decrease in aggregation intensity during the course of population development in this tree community. We recommend the use of larger sampling plots (> 0.25 ha) in uneven-aged and species-rich forest ecosystems to detect less obvious, but important, relationships between spatial tree pattern and functioning and diversity in these forests.	[Wehenkel, Christian; Carrillo-Parra, Artemio] Univ Juarez Estado Durango, Inst Silvicultura & Ind Madera, Durango, Mexico; [Brazao-Protazio, Joao Marcelo] Fed Univ Para, Fac Estat, Inst Ciencias Exatas & Nat, BR-66059 Belem, Para, Brazil; [Hugo Martinez-Guerrero, Jose] Univ Juarez Estado Durango, Fac Med Vet & Zootecnia, Cuerpo Acad Fauna Silvestre, Durango, Mexico; [Crecente-Campo, Felipe] Cerna Ingn & Asesoria Medioambiental SLP, Lugo, Spain	Universidad Juarez del Estado de Durango; Universidade Federal do Para; Universidad Juarez del Estado de Durango	Wehenkel, C (corresponding author), Univ Juarez Estado Durango, Inst Silvicultura & Ind Madera, Durango, Mexico.	wehenkel@ujed.mx	Crecente-Campo, Felipe/E-6111-2012; Protazio, Joao Marcelo Brazao/D-7433-2018	Protazio, Joao Marcelo Brazao/0000-0002-7976-0576; Carrillo-Parra, Artemio/0000-0003-0285-5224	Mexican Council of Science and Technology (CONACyT) [CB-2010-01 158054]; Ministry of Education (SEP); Torres Quevedo program - Spanish Ministry of Economy and Competitiveness; European Social Fund; Cerna Ingenieria y Asesoria Medioambiental, S.L.P.	Mexican Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministry of Education (SEP); Torres Quevedo program - Spanish Ministry of Economy and Competitiveness; European Social Fund(European Social Fund (ESF)); Cerna Ingenieria y Asesoria Medioambiental, S.L.P.	This study was supported by grant number CB-2010-01 158054 from the Mexican Council of Science and Technology (CONACyT): http://www.conacyt.gob.mx, and by the Ministry of Education (SEP): http://www.sep.gob.mx. FCC is partially supported by the Torres Quevedo program, financed by the Spanish Ministry of Economy and Competitiveness and the European Social Fund: http://www.idi.mineco.gob.es. Cerna Ingenieria y Asesoria Medioambiental, S.L.P. provided support in the form of salaries for author Felipe Crecente-Campo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Soto V, 2015, FORESTS, V6, P692, DOI 10.3390/f6030692; Aguirre O, 2003, FOREST ECOL MANAG, V183, P137, DOI 10.1016/S0378-1127(03)00102-6; Albert M., 1999, THESIS U GOTTINGEN G; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Begon M., 1996, ECOLOGY; Besag J., 1977, J R STAT SOC SER C A, V26, P327, DOI [10.2307/2346974, DOI 10.2307/2346974]; Brumelis G, 2005, SCAND J FOREST RES, V20, P471, DOI 10.1080/02827580500339526; Chen JQ, 1999, FOREST ECOL MANAG, V120, P219, DOI 10.1016/S0378-1127(98)00543-X; CHRISTENSEN NL, 1977, AM MIDL NAT, V97, P176, DOI 10.2307/2424693; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Corral-Rivas JJ., 2006, THESIS U GOTTINGEN; Development Core Team, 2014, R LANG ENV STAT COMP; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Dixon PM., 2006, ENCY ENV; Gadow K.v., 1998, CBL GES FORSTW, V115, P1; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; GORDON AG, 1968, ECOLOGY, V49, P880, DOI 10.2307/1936540; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gregorius HR, 2007, SILVAE GENET, V56, P190, DOI 10.1515/sg-2007-0029; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hui Gang-ying, 2001, Forest Research, V14, P23; Hui GY, 2002, ALLG FORST JAGDZTG, V173, P173; Illian J, 2008, STAT ANAL MODELLING; INEGI (Instituto Nacional de Estadistica y Geografia), 2015, EST HIST MEX 2014; Jaramillo-Correa JP, 2006, MOL ECOL, V15, P2787, DOI 10.1111/j.1365-294X.2006.02974.x; Corral-Rivas JJ, 2010, J FOREST RES-JPN, V15, P218, DOI 10.1007/s10310-010-0181-1; KENKEL NC, 1989, CAN J BOT, V67, P2630, DOI 10.1139/b89-339; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; KUULUVAINEN T, 1987, AGR FOREST METEOROL, V40, P215, DOI 10.1016/0168-1923(87)90060-8; Ledig F. T., 2012, Acta Silvatica & Lignaria Hungarica, V8, P57; Ledig F. Thomas, 2000, Madrono, V47, P71; Ledig FT, 2010, AM J BOT, V97, P970, DOI 10.3732/ajb.0900329; Ledig FT, 1997, EVOLUTION, V51, P1815, DOI [10.2307/2411004, 10.1111/j.1558-5646.1997.tb05105.x]; Simental-Rodriguez SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111623; LEPS J, 1987, ECOL MODEL, V39, P45, DOI 10.1016/0304-3800(87)90012-3; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; MALIK AR, 1976, AUST J BOT, V24, P265, DOI 10.1071/BT9760265; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mendoza-Maya E, 2015, REV FITOTEC MEX, V38, P235; MILLER TE, 1989, ECOLOGY, V70, P1188, DOI 10.2307/1941388; Moeur M., 1993, Forest Science, V39, P756; Narvaez FR, 1984, THESIS U AUTONOMA NU; Newton PF, 1998, CAN J FOREST RES, V28, P259, DOI 10.1139/cjfr-28-2-259; Parish R, 1999, CAN J FOREST RES, V29, P1347, DOI 10.1139/cjfr-29-9-1347; Pommerening A, 2006, FOREST ECOL MANAG, V224, P266, DOI 10.1016/j.foreco.2005.12.039; PRETZSCH H, 1995, ALLG FORST JAGDZTG, V166, P190; Quinones-Perez CZ, 2014, SILVAE GENET, V63, P149, DOI 10.1515/sg-2014-0020; Quinones-Perez C. Z., 2014, African Journal of Biotechnology, V13, P2786; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Saenz-Romero C, 2010, CLIMATIC CHANGE, V102, P595, DOI 10.1007/s10584-009-9753-5; Sanchez CJ, 1984, CIENC FOREST, V9, P51; Schroder J, 1999, CAN J FOREST RES, V29, P280, DOI 10.1139/cjfr-29-2-280; Schutz JP, 2002, FORESTRY, V75; Secretaria de Medio Ambiente Recursos Naturales (SEMARNAT), 2010, DIARIO OFICIAL FEDER, V1, P1; Shugart H. H., 1984, A theory of forest dynamics. The ecological implications of forest succession models.; Silva-Flores R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105034; Silverman BW, 1982, J ROYAL STAT SOC B, V39, P172; Spies TA, 1998, NORTHWEST SCI, V72, P34; Stoyan D., 1994, FRACTALS RANDOM SHAP; UPTON G, 1985, SPATIAL DATA ANAL EX, VI; Von Gadow K, 2012, MANAG FOR ECOSYST, V23, P29, DOI 10.1007/978-94-007-2202-6_2; Wehenkel C, 2015, GENETIC ERO IN PRESS; Wehenkel C, 2012, TREE GENET GENOMES, V8, P1085, DOI 10.1007/s11295-012-0488-5; Wehenkel C, 2011, ANN FOREST SCI, V68, P385, DOI 10.1007/s13595-011-0027-9; Wehenkel C, 2010, PLANT ECOL, V208, P47, DOI 10.1007/s11258-009-9685-1; WHIPPLE SA, 1980, B TORREY BOT CLUB, V107, P71, DOI 10.2307/2484854; WHITMORE TC, 1989, ECOLOGY, V70, P536, DOI 10.2307/1940195; WYKOFF WR, 1990, FOREST SCI, V36, P1077; Quinones-Perez CZ, 2014, POL J ECOL, V62, P55, DOI 10.3161/104.062.0106	72	22	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140442	10.1371/journal.pone.0140442	http://dx.doi.org/10.1371/journal.pone.0140442			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496189	gold, Green Published, Green Submitted			2022-12-27	WOS:000363309200016
J	Cappellari, AR; Pillat, MM; Souza, HDN; Dietrich, F; Oliveira, FH; Figueiro, F; Abujamra, AL; Roesler, R; Lecka, J; Sevigny, J; Battastini, AMO; Ulrich, H				Cappellari, Angelica R.; Pillat, Micheli M.; Souza, Hellio D. N.; Dietrich, Fabricia; Oliveira, Francine H.; Figueiro, Fabricio; Abujamra, Ana L.; Roesler, Rafael; Lecka, Joanna; Sevigny, Jean; Battastini, Ana Maria O.; Ulrich, Henning			Ecto-5 '-Nucleotidase Overexpression Reduces Tumor Growth in a Xenograph Medulloblastoma Model	PLOS ONE			English	Article							EXPRESSION; CD73; PROGNOSIS; CARCINOMA; APOPTOSIS	Background Ecto-5'-nucleotidase/CD73 (ecto-5'-NT) participates in extracellular ATP catabolism by converting adenosine monophosphate (AMP) into adenosine. This enzyme affects the progression and invasiveness of different tumors. Furthermore, the expression of ecto-5'-NT has also been suggested as a favorable prognostic marker, attributing to this enzyme contradictory functions in cancer. Medulloblastoma (MB) is the most common brain tumor of the cerebellum and affects mainly children. Materials and Methods The effects of ecto-5'-NT overexpression on human MB tumor growth were studied in an in vivo model. Balb/c immunodeficient (nude) 6 to 14-week-old mice were used for dorsal subcutaneous xenograph tumor implant. Tumor development was evaluated by pathophysiological analysis. In addition, the expression patterns of adenosine receptors were verified. Results The human MB cell line D283, transfected with ecto-5'-NT (D283hCD73), revealed reduced tumor growth compared to the original cell line transfected with an empty vector. D283hCD73 generated tumors with a reduced proliferative index, lower vascularization, the presence of differentiated cells and increased active caspase-3 expression. Prominent A1 adenosine receptor expression rates were detected in MB cells overexpressing ecto-5'-NT. Conclusion This work suggests that ecto-5'-NT promotes reduced tumor growth to reduce cell proliferation and vascularization, promote higher differentiation rates and initiate apoptosis, supposedly by accumulating adenosine, which then acts through A1 adenosine receptors. Therefore, ecto-5'-NT might be considered an important prognostic marker, being associated with good prognosis and used as a potential target for therapy.	[Cappellari, Angelica R.; Dietrich, Fabricia; Figueiro, Fabricio; Battastini, Ana Maria O.] Univ Fed Rio Grande do Sul, Programa Posgrad Cincias Biol Bioquim, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil; [Battastini, Ana Maria O.] Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas & Saude, Porto Alegre, RS, Brazil; [Pillat, Micheli M.; Souza, Hellio D. N.; Ulrich, Henning] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, SP, Brazil; [Oliveira, Francine H.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Serv Patol, Porto Alegre, RS, Brazil; [Abujamra, Ana L.; Roesler, Rafael] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Lab Pesquisa Canc, Porto Alegre, RS, Brazil; [Abujamra, Ana L.] ICI RS, Inst Canc Infantil RS, Porto Alegre, RS, Brazil; [Roesler, Rafael] Univ Fed Rio Grande do Sul, Dept Farmacol, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil; [Roesler, Rafael] Univ Fed Rio Grande do Sul, Inst Nacl Ciencia & Tecnol Translac Med, Porto Alegre, RS, Brazil; [Lecka, Joanna; Sevigny, Jean] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1V 0A6, Canada; [Lecka, Joanna; Sevigny, Jean] CHU Quebec, Ctr Rech, Quebec City, PQ G1V 4G2, Canada	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Laval University; Laval University	Battastini, AMO (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Cincias Biol Bioquim, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil.	abattastini@gmail.com; henning@iq.usp.br	Ulrich, Henning/AAX-8586-2021; Cappellari, Angélica/V-1481-2019; Pillat, Micheli/AAW-3423-2020; Sévigny, Jean/AGH-9323-2022; Sevigny, Jean/E-8039-2012; Battastini, Ana M/E-2809-2012; Roesler, Rafael/U-9261-2019; Figueiró, Fabrício/M-3625-2016; Dietrich, Fabrícia/F-8658-2019; Ulrich, Henning/C-5245-2013	Ulrich, Henning/0000-0002-2114-3815; Pillat, Micheli/0000-0002-6753-6083; Sévigny, Jean/0000-0003-2922-1600; Sevigny, Jean/0000-0003-2922-1600; Battastini, Ana M/0000-0001-6068-3278; Figueiró, Fabrício/0000-0003-0899-6407; Ulrich, Henning/0000-0002-2114-3815; Roesler, Rafael/0000-0001-6016-2261; Cappellari, Angelica Regina/0000-0002-8202-609X; Dietrich, Fabricia/0000-0002-6458-2359	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo = FAPESP [2012/50880-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [303016/2009-4]; Fundo de Incentivo a Pesquisa e Eventos - FIPE/HCPA [10-0132]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo = FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa e Eventos - FIPE/HCPA	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo = FAPESP (Proc. 2012/50880-4); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (Proc. 303016/2009-4); and Fundo de Incentivo a Pesquisa e Eventos - FIPE/HCPA (Proc. 10-0132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavaresco L, 2008, MOL CELL BIOCHEM, V319, P61, DOI 10.1007/s11010-008-9877-3; Bavaresco L, 2007, J NEURO-ONCOL, V84, P1, DOI 10.1007/s11060-007-9342-2; Bemardi A, 2007, EUR J PHARMACOL, V569, P8, DOI 10.1016/j.ejphar.2007.04.058; Cappellari AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047468; Cappellari AR, 2012, MOL CELL BIOCHEM, V359, P315, DOI 10.1007/s11010-011-1025-9; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Gao ZW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/460654; Hosseinzadeh Hossein, 2008, Iran Biomed J, V12, P203; Lecka J, 2010, BRIT J PHARMACOL, V161, P1150, DOI 10.1111/j.1476-5381.2010.00951.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; Oh HK, 2012, J GYNECOL ONCOL, V23, P274, DOI 10.3802/jgo.2012.23.4.274; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; RACKLEY RR, 1989, CANCER RES, V49, P3702; Sadej R, 2006, MELANOMA RES, V16, P213, DOI 10.1097/01.cmr.0000215030.69823.11; Sai K, 2006, NEUROTOXICOLOGY, V27, P458, DOI 10.1016/j.neuro.2005.12.008; Saito M, 2010, CANCER LETT, V290, P211, DOI 10.1016/j.canlet.2009.09.011; Spychala J, 2004, EXP CELL RES, V296, P99, DOI 10.1016/j.yexcr.2003.11.001; Supernat A, 2012, APPL IMMUNOHISTO M M, V20, P103, DOI 10.1097/PAI.0b013e3182311d82; Wang L, 2008, J CANCER RES CLIN, V134, P365, DOI 10.1007/s00432-007-0292-z; Wink MR, 2003, CANCER LETT, V198, P211, DOI 10.1016/S0304-3835(03)00308-2; Yang DQ, 2007, BIOCHEM PHARMACOL, V73, P1665, DOI 10.1016/j.bcp.2007.01.020; Yegutkin GG, 2011, EUR J IMMUNOL, V41, P1231, DOI 10.1002/eji.201041292	24	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140996	10.1371/journal.pone.0140996	http://dx.doi.org/10.1371/journal.pone.0140996			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491983	Green Published, Green Submitted, gold			2022-12-27	WOS:000363249300020
J	Kawano-Yamashita, E; Koyanagi, M; Wada, S; Tsukamoto, H; Nagata, T; Terakita, A				Kawano-Yamashita, Emi; Koyanagi, Mitsumasa; Wada, Seiji; Tsukamoto, Hisao; Nagata, Takashi; Terakita, Akihisa			Activation of Transducin by Bistable Pigment Parapinopsin in the Pineal Organ of Lower Vertebrates	PLOS ONE			English	Article							PARIETAL-EYE; G-PROTEINS; RHODOPSIN; OPSIN; DIVERSITY; PHOTORECEPTORS; INTERMEDIATE; MELANOPSIN; FAMILY; CELLS	Pineal organs of lower vertebrates contain several kinds of photosensitive molecules, opsins that are suggested to be involved in different light-regulated physiological functions. We previously reported that parapinopsin is an ultraviolet (UV)-sensitive opsin that underlies hyperpolarization of the pineal photoreceptor cells of lower vertebrates to achieve pineal wavelength discrimination. Although, parapinopsin is phylogenetically close to vertebrate visual opsins, it exhibits a property similar to invertebrate visual opsins and melanopsin: the photoproduct of parapinopsin is stable and reverts to the original dark states, demonstrating the nature of bistable pigments. Therefore, it is of evolutionary interest to identify a photo-transduction cascade driven by parapinopsin and to compare it with that in vertebrate visual cells. Here, we showed that parapinopsin is coupled to vertebrate visual G protein transducin in the pufferfish, zebrafish, and lamprey pineal organs. Biochemical analyses demonstrated that parapinopsins activated transducin in vitro in a light-dependent manner, similar to vertebrate visual opsins. Interestingly, transducin activation by parapinopsin was provoked and terminated by UV- and subsequent orange-lights irradiations, respectively, due to the bistable nature of parapinopsin, which could contribute to a wavelength-dependent control of a second messenger level in the cell as a unique optogenetic tool. Immunohistochemical examination revealed that parapinopsin was colocalized with Gt2 in the teleost, which possesses rod and cone types of transducin, Gt1, and Gt2. On the other hand, in the lamprey, which does not possess the Gt2 gene, in situ hybridization suggested that parapinopsin-expressing photoreceptor cells contained Gt1 type transducin GtS, indicating that lamprey parapinopsin may use GtS in place of Gt2. Because it is widely accepted that vertebrate visual opsins having a bleaching nature have evolved from non-bleaching opsins similar to parapinopsin, these results implied that ancestral bistable opsins might acquire coupling to the transducin-mediated cascade and achieve light-dependent hyperpolarizing response of the photoreceptor cells.	[Kawano-Yamashita, Emi; Koyanagi, Mitsumasa; Wada, Seiji; Tsukamoto, Hisao; Nagata, Takashi; Terakita, Akihisa] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Sumiyoshi Ku, Osaka 5588585, Japan; [Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, OCU Adv Res Inst Nat Sci & Technol OCARINA, Sumiyoshi Ku, Osaka 5588585, Japan; [Koyanagi, Mitsumasa] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Japan Science & Technology Agency (JST)	Terakita, A (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Sumiyoshi Ku, Osaka 5588585, Japan.	terakita@sci.osaka-cu.ac.jp	WADA, SEIJI/GZL-0272-2022; Nagata, Takashi/ABB-1780-2020	Nagata, Takashi/0000-0001-5379-2951; Terakita, Akihisa/0000-0002-8379-8913; Koyanagi, Mitsumasa/0000-0002-7741-918X	Japanese Ministry of Education, Culture, Sports, Science and Technology [23247011, 15H05777, 20770057, 22687005, 14J40094]; Human Frontier Science Program; PRESTO from the Japan Science and Technology Agency (JST); Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [26291070, 15H05777] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); PRESTO from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (nos 23247011, 15H05777 to A. T., nos 20770057, 22687005 to M.K. and no 14J40094 to E.K.-Y.), http://www.jsps.go.jp/english/e-grants/, Human Frontier Science Program (to A. T.), http://www.hfsp.org/, PRESTO from the Japan Science and Technology Agency (JST) (to M.K.), http://www.jst.go.jp/kisoken/presto/en/index.html, and Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (to E.K.-Y.), https://www.jsps.go.jp/english/e-pd/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Blackshaw S, 1997, J NEUROSCI, V17, P8083; DODT E, 1962, J NEUROPHYSIOL, V25, P405, DOI 10.1152/jn.1962.25.3.405; DODT E, 1973, HDB SENSORY PHYSIOLO, V7, P113; Friedmann D, 2015, CURR BIOL, V25, P69, DOI 10.1016/j.cub.2014.10.055; Gutierrez DV, 2011, J BIOL CHEM, V286, P25848, DOI 10.1074/jbc.M111.253674; Kasahara T, 2000, J NEUROCHEM, V75, P217, DOI 10.1046/j.1471-4159.2000.0750217.x; Kawano-Yamashita E., 2014, EVOLUTION VISUAL NON, P1, DOI DOI 10.1007/978-1-4614-4355-1_1; Kawano-Yamashita E, 2007, J EXP BIOL, V210, P3821, DOI 10.1242/jeb.007161; Kawano-Yamashita E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016402; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Koyanagi M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0174-9; Koyanagi M, 2014, BBA-BIOENERGETICS, V1837, P710, DOI 10.1016/j.bbabio.2013.09.003; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Masseck OA, 2014, NEURON, V81, P1263, DOI 10.1016/j.neuron.2014.01.041; MORITA Y, 1966, PFLUG ARCH GES PHYS, V289, P155, DOI 10.1007/BF00412906; Morita Y., 1973, NOVA ACTA LEOPOLDINA, V38, P331; Muradov H, 2008, VISION RES, V48, P2302, DOI 10.1016/j.visres.2008.07.006; Nagata T, 2012, SCIENCE, V335, P469, DOI 10.1126/science.1211667; Nakamura A, 2001, J BIOCHEM-TOKYO, V129, P329, DOI 10.1093/oxfordjournals.jbchem.a002861; Sakai K, 2012, BIOCHEMISTRY-US, V51, P1933, DOI 10.1021/bi2018283; Sato K, 2011, BIOCHEMISTRY-US, V50, P10484, DOI 10.1021/bi201212z; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SOLESSIO E, 1993, NATURE, V364, P442, DOI 10.1038/364442a0; Su CY, 2006, SCIENCE, V311, P1617, DOI 10.1126/science.1123802; Sun L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108209; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; Tsukamoto H, 2010, PHOTOCH PHOTOBIO SCI, V9, P1435, DOI 10.1039/c0pp00168f; Tsukamoto H, 2010, J BIOL CHEM, V285, P7351, DOI 10.1074/jbc.M109.078709; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; Wada S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039003	37	18	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141280	10.1371/journal.pone.0141280	http://dx.doi.org/10.1371/journal.pone.0141280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492337	gold, Green Published, Green Submitted			2022-12-27	WOS:000363249300042
J	Gould, MP; Bosworth, CM; McMahon, S; Grandhi, S; Grimerg, BT; LaFramboise, T				Gould, Meetha P.; Bosworth, Colleen M.; McMahon, Sarah; Grandhi, Sneha; Grimerg, Brian T.; LaFramboise, Thomas			PCR-Free Enrichment of Mitochondrial DNA from Human Blood and Cell Lines for High Quality Next-Generation DNA Sequencing	PLOS ONE			English	Article								Recent advances in sequencing technology allow for accurate detection of mitochondrial sequence variants, even those in low abundance at heteroplasmic sites. Considerable sequencing cost savings can be achieved by enriching samples for mitochondrial (relative to nuclear) DNA. Reduction in nuclear DNA (nDNA) content can also help to avoid false positive variants resulting from nuclear mitochondrial sequences (numts). We isolate intact mitochondrial organelles from both human cell lines and blood components using two separate methods: a magnetic bead binding protocol and differential centrifugation. DNA is extracted and further enriched for mitochondrial DNA (mtDNA) by an enzyme digest. Only 1 ng of the purified DNA is necessary for library preparation and next generation sequence (NGS) analysis. Enrichment methods are assessed and compared using mtDNA (versus nDNA) content as a metric, measured by using real-time quantitative PCR and NGS read analysis. Among the various strategies examined, the optimal is differential centrifugation isolation followed by exonuclease digest. This strategy yields >35% mtDNA reads in blood and cell lines, which corresponds to hundreds-fold enrichment over baseline. The strategy also avoids false variant calls that, as we show, can be induced by the long-range PCR approaches that are the current standard in enrichment procedures. This optimization procedure allows mtDNA enrichment for efficient and accurate massively parallel sequencing, enabling NGS from samples with small amounts of starting material. This will decrease costs by increasing the number of samples that may be multiplexed, ultimately facilitating efforts to better understand mitochondria-related diseases.	[Gould, Meetha P.; Bosworth, Colleen M.; McMahon, Sarah; Grandhi, Sneha; LaFramboise, Thomas] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Grimerg, Brian T.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [LaFramboise, Thomas] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [LaFramboise, Thomas] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA; [LaFramboise, Thomas] Cleveland Clin Fdn, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	LaFramboise, T (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	Thomas.LaFramboise@case.edu		Bosworth, Colleen/0000-0001-6241-3554	American Cancer Society [123436-RSG-12-159-01-DMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Cancer Society (Research Scholar Grant 123436-RSG-12-159-01-DMC).	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144; Fendt L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-139; Franko A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082392; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hornig-Do HT, 2009, ANAL BIOCHEM, V389, P1, DOI 10.1016/j.ab.2009.02.040; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; MORSE HG, 1993, CANCER GENET CYTOGEN, V69, P108, DOI 10.1016/0165-4608(93)90083-X; Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111; Quispe-Tintaya W, 2013, BIOTECHNIQUES, V55, P133, DOI 10.2144/000114077; Scharfe C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000374; Wolff JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037142	17	22	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139253	10.1371/journal.pone.0139253	http://dx.doi.org/10.1371/journal.pone.0139253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488301	gold, Green Submitted, Green Published			2022-12-27	WOS:000363248400024
J	He, K; Woodman, N; Boaglio, S; Roberts, M; Supekar, S; Maldonado, JE				He, Kai; Woodman, Neal; Boaglio, Sean; Roberts, Mariel; Supekar, Sunjana; Maldonado, Jesus E.			Molecular Phylogeny Supports Repeated Adaptation to Burrowing within Small-Eared Shrews Genus of Cryptotis (Eulipotyphla, Soricidae)	PLOS ONE			English	Article							CYTOCHROME-B GENE; MAMMALIA; SORICOMORPHA; MORPHOLOGY	Small-eared shrews of the New World genus Cryptotis (Eulipotyphla, Soricidae) comprise at least 42 species that traditionally have been partitioned among four or more species groups based on morphological characters. The Cryptotis mexicana species group is of particular interest, because its member species inhibit a subtly graded series of forelimb adaptations that appear to correspond to locomotory behaviors that range from more ambulatory to more fossorial. Unfortunately, the evolutionary relationships both among species in the C. mexicana group and among the species groups remain unclear. To better understand the phylogeny of this group of shrews, we sequenced two mitochondrial and two nuclear genes. To help interpret the pattern and direction of morphological changes, we also generated a matrix of morphological characters focused on the evolutionarily plastic humerus. We found significant discordant between the resulting molecular and morphological trees, suggesting considerable convergence in the evolution of the humerus. Our results indicate that adaptations for increased burrowing ability evolved repeatedly within the genus Cryptotis.	[He, Kai; Woodman, Neal; Maldonado, Jesus E.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [He, Kai] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Woodman, Neal] Smithsonian Inst, Natl Museum Nat Hist, USGS Patuxent Wildlife Res Ctr, Washington, DC 20560 USA; [Boaglio, Sean; Roberts, Mariel; Supekar, Sunjana; Maldonado, Jesus E.] Smithsonian Inst, Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Washington, DC 20008 USA; [Boaglio, Sean] Pacific Lutheran Univ, Dept Biol, Tacoma, WA 98447 USA; [Roberts, Mariel] Univ Penn, Philadelphia, PA 19104 USA; [Supekar, Sunjana] Oberlin Coll, Dept Biol, Oberlin, OH 44074 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Chinese Academy of Sciences; Kunming Institute of Zoology; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of the Interior; United States Geological Survey; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Pacific Lutheran University; University of Pennsylvania; Oberlin College	He, K (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA.	hek@si.edu	He, Kai/H-3164-2019; Maldonado, Jesus/AIE-8664-2022	He, Kai/0000-0002-6234-2589; Maldonado, Jesus/0000-0002-4282-1072; Woodman, Neal/0000-0003-2689-7373	NHRE program at the Smithsonian Institution	NHRE program at the Smithsonian Institution	NHRE program at the Smithsonian Institution provided funding internships and supplies to SB, MR, SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHOATE J R, 1970, University of Kansas Publications of the Museum of Natural History, V19, P195; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubey S, 2007, MOL PHYLOGENET EVOL, V44, P126, DOI 10.1016/j.ympev.2006.12.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esselstyn JA, 2015, SYST BIOL; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Guevara L, 2014, ACTA THERIOL, V59, P233, DOI 10.1007/s13364-013-0165-6; He K, 2015, HEREDITY; Hope AG, 2014, J MAMMAL, V95, P722, DOI 10.1644/13-MAMM-A-196; HUTTERER R, 1985, MAMMAL REV, V15, P43, DOI 10.1111/j.1365-2907.1985.tb00386.x; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; May SR, 2011, PALAEONTOL ELECTRON, V14; Miller MA, 2010, CREATING THE CIPRES; NEVO E, 1979, ANNU REV ECOL SYST, V10, P269, DOI 10.1146/annurev.es.10.110179.001413; Ohdachi SD, 2006, J ZOOL, V270, P177, DOI 10.1111/j.1469-7998.2006.00125.x; Pomel A.N., 1848, ARCH SCI PHYS NATURE, V9, P244; Springer MS, 2013, SCIENCE, V341, DOI 10.1126/science.1238025; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; SWOFFORD DL, PAUP PHYLOGENETIC AN; Woodman N, 2000, P BIOL SOC WASH, V113, P339; Woodman N, 2005, J MORPHOL, V266, P60, DOI 10.1002/jmor.10367; Woodman N, 2000, CARIBB J SCI, V36, P289; Woodman N, 1999, FIELDIANA ZOOLOGY, V91, P1, DOI [10.5962/bhl.title.2669, DOI 10.5962/BHL.TITLE.2669, DOI 10.5962/bhl.title.2669]; Woodman N., 2008, MAMMALS S AM, V1, P177; Woodman N., 2005, CONTRIBUCIONES MASTO, P523; Woodman N, 2015, J MAMMAL, V96, P159, DOI 10.1093/jmammal/gyu017; Woodman N, 2014, J MORPHOL, V275, P745, DOI 10.1002/jmor.20254; Woodman N, 2012, ANN CARNEGIE MUS, V80, P207; Woodman N, 2011, ZOOL J LINN SOC-LOND, V163, P1267, DOI 10.1111/j.1096-3642.2011.00754.x; Woodman N, 2010, BIOL J LINN SOC, V99, P118; Woodman Neal, 1993, Fieldiana Zoology, V74, P1	33	10	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140280	10.1371/journal.pone.0140280	http://dx.doi.org/10.1371/journal.pone.0140280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489020	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400048
J	Ito, C; Okuyama-Dobashi, K; Miyasaka, T; Masuda, C; Sato, M; Kawano, T; Ohkawara, Y; Kikuchi, T; Takayanagi, M; Ohno, I				Ito, Chihiro; Okuyama-Dobashi, Kaori; Miyasaka, Tomomitsu; Masuda, Chiaki; Sato, Miki; Kawano, Tasuku; Ohkawara, Yuichi; Kikuchi, Toshiaki; Takayanagi, Motoaki; Ohno, Isao			CD8(+) T Cells Mediate Female-Dominant IL-4 Production and Airway Inflammation in Allergic Asthma	PLOS ONE			English	Article							GAMMA RECEPTOR EXPRESSION; IFN-GAMMA; INTERFERON-GAMMA; MURINE MODEL; DENDRITIC CELLS; MESSENGER-RNA; MOUSE MODEL; RESPONSES; SUPPRESSION; HYPERREACTIVITY	The prevalence and severity of bronchial asthma are higher in females than in males after puberty. Although antigen-specific CD8(+) T cells play an important role in the development of asthma through their suppressive effect on cytokine production, the contribution of CD8(+) T cells to sex differences in asthmatic responses remains unclear. In the present study, we investigated the sex-specific effect of CD8(+) T cells in the suppression of asthma using an ovalbumin mouse model of asthma. The number of inflammatory cells in bronchoalveolar lavage (BAL) fluid, lung type 2 T-helper cytokine levels, and interleukin-4 (IL-4) production by bronchial lymph node cells were significantly higher in female wild-type (WT) mice compared with male mice, whereas no such sex differences were observed between male and female cd8a-disrupted mice. The adaptive transfer of male, but not female, CD8(+) T cells reduced the number of inflammatory cells in the recovered BAL fluid of male recipient mice, while no such sex difference in the suppressive activity of CD8(+) T cells was observed in female recipient mice. Male CD8(+) T cells produced higher levels of IFN-gamma than female CD8(+) T cells did, and this trend was associated with reduced IL-4 production by male, but not female, CD4(+) T cells. Interestingly, IFN-gamma receptor expression on CD4(+) T cells was significantly lower in female mice than in male mice. These results suggest that female-dominant asthmatic responses are orchestrated by the reduced production of IFN-gamma by CD8(+) T cells and the lower expression of IFN-gamma receptor on CD4(+) T cells in females compared with males.	[Ito, Chihiro; Okuyama-Dobashi, Kaori; Miyasaka, Tomomitsu; Masuda, Chiaki; Sato, Miki; Kawano, Tasuku; Ohkawara, Yuichi; Takayanagi, Motoaki; Ohno, Isao] Tohoku Pharmaceut Univ, Dept Pathophysiol, Sendai, Miyagi, Japan; [Kikuchi, Toshiaki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, Niigata, Japan	Tohoku Medical & Pharmaceutical University; Niigata University	Miyasaka, T (corresponding author), Tohoku Pharmaceut Univ, Dept Pathophysiol, Sendai, Miyagi, Japan.	t-miya13@tohoku-pharm.ac.jp	Kawano, Tasuku/L-1190-2013; ohno, isao/AAZ-9812-2020; Miyasaka, Tomomitsu/AAK-1676-2021	Kawano, Tasuku/0000-0001-6978-6361; Miyasaka, Tomomitsu/0000-0001-7218-6981	Promotion and Mutual Aid Corporation for Private Schools of Japan [25461164, 25893222]; Matching Fund Subsidy for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Matching Fund Subsidy for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 25461164) to I.O. (https://www.jsps.go.jp/english/index.html), a Grant-in-Aid for Research Activity Start-up (No. 25893222) to T.M. (https://www.jsps.go.jp/english/index.html), the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan to T. Kawano (http://www.shigaku.go.jp/s_home.htm), and by the Matching Fund Subsidy for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to I.O., T.M., and T. Kawano (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami Lara J, 2012, NCHS Data Brief, P1; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Betts RJ, 2009, PHARMACOL THERAPEUT, V121, P123, DOI 10.1016/j.pharmthera.2008.09.001; BRUSSELLE G, 1995, AM J RESP CELL MOL, V12, P254, DOI 10.1165/ajrcmb.12.3.7873190; Camargo C, 2000, J ALLERGY CLIN IMMUN, V105, pS262, DOI 10.1016/S0091-6749(00)91205-3; Choi P, 1998, CLIN EXP IMMUNOL, V113, P317; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; ELMASRY MN, 1989, J CLIN INVEST, V83, P1436, DOI 10.1172/JCI114035; Follenweider LM, 2013, NURS CLIN N AM, V48, P1, DOI 10.1016/j.cnur.2012.12.008; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Komai M, 2003, BRIT J PHARMACOL, V138, P912, DOI 10.1038/sj.bjp.0705105; Lloyd CM, 2001, ADV IMMUNOL, V77, P263, DOI 10.1016/S0065-2776(01)77019-8; Loza MJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-103; Mac Sharry J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098648; MAESTRELLI P, 1994, SCAND J WORK ENV HEA, V20, P376, DOI 10.5271/sjweh.1383; Marsland BJ, 2004, P NATL ACAD SCI USA, V101, P6116, DOI 10.1073/pnas.0401582101; MCMENAMIN C, 1993, J EXP MED, V178, P889, DOI 10.1084/jem.178.3.889; Melgert BN, 2010, AM J RESP CELL MOL, V42, P595, DOI 10.1165/rcmb.2009-0016OC; Moorman JE, 2012, VITAL HLTH STAT, V35, P1; Moorman JE, 2013, MMWR-MORBID MORTAL W, V62, P93; Nagafuku M, 2012, P NATL ACAD SCI USA, V109, pE336, DOI 10.1073/pnas.1114965109; Okuyama K, 2008, CLIN EXP ALLERGY, V38, P1212, DOI 10.1111/j.1365-2222.2008.03015.x; Okuyama K, 2013, INT ARCH ALLERGY IMM, V161, P58, DOI 10.1159/000350426; Perez-Perdomo R, 2003, J ASTHMA, V40, P465, DOI 10.1081/JAS-120018713; RENZ H, 1994, J IMMUNOL, V152, P351; ROBINSON D, 1993, J ALLERGY CLIN IMMUN, V92, P313, DOI 10.1016/0091-6749(93)90175-F; Rowe BH, 2008, ACAD EMERG MED, V15, P709, DOI 10.1111/j.1553-2712.2008.00176.x; Salem ML, 2000, INT ARCH ALLERGY IMM, V121, P161, DOI 10.1159/000024312; SANCEAU J, 1992, J IMMUNOL, V149, P1671; Schipf A, 2003, EUR J IMMUNOL, V33, P1697, DOI 10.1002/eji.200323809; Shirey KA, 2006, J INTERF CYTOK RES, V26, P53, DOI 10.1089/jir.2006.26.53; Steinke JW, 2001, RESP RES, V2, P66, DOI 10.1186/rr40; Stock P, 2004, EUR J IMMUNOL, V34, P1817, DOI 10.1002/eji.200324623; Suzuki M, 2002, J ALLERGY CLIN IMMUN, V109, P803, DOI 10.1067/mai.2002.123233; Suzuki M, 1999, J IMMUNOL, V163, P5574; Takeda K, 2009, J IMMUNOL, V183, P181, DOI 10.4049/jimmunol.0803967; Tang YF, 2012, J ALLERGY CLIN IMMUN, V129, P1611, DOI 10.1016/j.jaci.2011.12.976; Tsuchiya Kimitake, 2009, Immunology, V126, P45, DOI 10.1111/j.1365-2567.2008.02876.x; Wada K, 2010, RESPIROLOGY, V15, P629, DOI 10.1111/j.1440-1843.2010.01721.x; Wells JW, 2007, J ALLERGY CLIN IMMUN, V119, P226, DOI 10.1016/j.jaci.2006.09.004; Ying S, 1997, J IMMUNOL, V158, P3539	42	10	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140808	10.1371/journal.pone.0140808	http://dx.doi.org/10.1371/journal.pone.0140808			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488300	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400069
J	Paul, SC; Pell, JK; Blount, JD				Paul, Sarah C.; Pell, Judith K.; Blount, Jonathan D.			Reproduction in Risky Environments: The Role of Invasive Egg Predators in Ladybird Laying Strategies	PLOS ONE			English	Article							HETEROSPECIFIC LARVAL TRACKS; INTRAGUILD PREDATION; HARMONIA-AXYRIDIS; BEETLES COLEOPTERA; PATCH QUALITY; TRADE-OFF; OVIPOSITION; INVESTMENT; SIZE; AUTOMIMICRY	Reproductive environments are variable and the resources available for reproduction are finite. If reliable cues about the environment exist, mothers can alter offspring phenotype in a way that increases both offspring and maternal fitness ('anticipatory maternal effects'-AMEs). Strategic use of AMEs is likely to be important in chemically defended species, where the risk of offspring predation may be modulated by maternal investment in offspring toxin level, albeit at some cost to mothers. Whether mothers adjust offspring toxin levels in response to variation in predation risk is, however, unknown, but is likely to be important when assessing the response of chemically defended species to the recent and pervasive changes in the global predator landscape, driven by the spread of invasive species. Using the chemically defended two-spot ladybird, Adalia bipunctata, we investigated reproductive investment, including egg toxin level, under conditions that varied in the degree of simulated offspring predation risk from larval harlequin ladybirds, Harmonia axyridis. H. axyridis is a highly voracious alien invasive species in the UK and a significant intraguild predator of A. bipunctata. Females laid fewer, larger egg clusters, under conditions of simulated predation risk (P+) than when predator cues were absent (P-), but there was no difference in toxin level between the two treatments. Among P-females, when mean cluster size increased there were concomitant increases in both the mass and toxin concentration of eggs, however when P+ females increased cluster size there was no corresponding increase in egg toxin level. We conclude that, in the face of offspring predation risk, females either withheld toxins or were physiologically constrained, leading to a trade-off between cluster size and egg toxin level. Our results provide the first demonstration that the risk of offspring predation by a novel invasive predator can influence maternal investment in toxins within their offspring.	[Paul, Sarah C.; Blount, Jonathan D.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Exeter, Cornwall, England; [Pell, Judith K.] JK Pell Consulting, Luton, Beds, England	University of Exeter	Blount, JD (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn Campus, Exeter, Cornwall, England.	J.D.Blount@exeter.ac.uk	Blount, Jonathan/K-7695-2012	Blount, Jonathan/0000-0002-0016-0130; Paul, Sarah/0000-0001-5267-315X	Natural Environment Research Council; Natural Environment Research Council [1200250] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	S.C. Paul was funded by a Natural Environment Research Council PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JK Pell Consulting is the trading name of author J.K. Pell, who is a self employed science consultant (sole trader) in UK; this author contributed to study design and interpretation, decision to publish and preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Agarwala BK, 2003, J CHEM ECOL, V29, P357, DOI 10.1023/A:1022681928142; AGARWALA BK, 1993, FUNCT ECOL, V7, P541, DOI 10.2307/2390130; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Bernardo J, 1996, AM ZOOL, V36, P216; BERRIGAN D, 1991, OIKOS, V60, P313, DOI 10.2307/3545073; Bertram B.C.R., 1978, P64; Bestion E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0701; Blount JD, 2004, P ROY SOC B-BIOL SCI, V271, pS79, DOI 10.1098/rsbl.2003.0104; Blount JD, 2012, FUNCT ECOL, V26, P334, DOI 10.1111/j.1365-2435.2012.01961.x; Blount JD, 2009, P ROY SOC B-BIOL SCI, V276, P871, DOI 10.1098/rspb.2008.1407; Blum MS, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P61; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; BROWER LP, 1970, P NATL ACAD SCI USA, V66, P1059, DOI 10.1073/pnas.66.4.1059; Brown PMJ, 2008, BIOCONTROL, V53, P5, DOI 10.1007/s10526-007-9132-y; Burgess SC, 2014, OIKOS, V123, P769, DOI 10.1111/oik.01235; Burton T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0311; Coslovsky M, 2011, FUNCT ECOL, V25, P878, DOI 10.1111/j.1365-2435.2011.01834.x; Cottrell TE, 2007, ENVIRON ENTOMOL, V36, P390, DOI 10.1603/0046-225X(2007)36[390:PBAALL]2.0.CO;2; Crawley MJ, 2013, R BOOK, P557; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Daloze Desire, 1995, Chemoecology, V5-6, P173, DOI 10.1007/BF01240602; de Jong P.W., 1991, Chemoecology, V2, P15, DOI 10.1007/BF01240661; Doumbia M, 1998, OECOLOGIA, V113, P197, DOI 10.1007/s004420050368; Einum S, 1999, P ROY SOC B-BIOL SCI, V266, P2095, DOI 10.1098/rspb.1999.0893; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Ferrer A, 2011, PHYSIOL ENTOMOL, V36, P290, DOI 10.1111/j.1365-3032.2011.00780.x; Fischer K, 2003, P ROY SOC B-BIOL SCI, V270, P2051, DOI 10.1098/rspb.2003.2470; Frechette B, 2004, ECOL ENTOMOL, V29, P578, DOI 10.1111/j.0307-6946.2004.00633.x; Gamberale G, 1996, ANIM BEHAV, V52, P597, DOI 10.1006/anbe.1996.0200; Gamberale-Stille G, 2004, P ROY SOC B-BIOL SCI, V271, P2621, DOI 10.1098/rspb.2004.2893; Garbutt JS, 2014, FUNCT ECOL, V28, P424, DOI 10.1111/1365-2435.12197; Gardiner MM, 2009, DIVERS DISTRIB, V15, P554, DOI 10.1111/j.1472-4642.2009.00563.x; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; GUILFORD T, 1994, J THEOR BIOL, V170, P311, DOI 10.1006/jtbi.1994.1192; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hemptinne JL, 2012, J APPL ENTOMOL, V136, P161, DOI 10.1111/j.1439-0418.2011.01626.x; Hemptinne JL, 2000, CHEMOECOLOGY, V10, P123, DOI 10.1007/PL00001813; Hemptinne JL, 2001, CHEMOECOLOGY, V11, P43, DOI 10.1007/PL00001831; Higginson AD, 2011, J ANIM ECOL, V80, P384, DOI 10.1111/j.1365-2656.2010.01786.x; Holen OH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2588; Holen OH, 2012, AM NAT, V180, P629, DOI 10.1086/667890; Holloway G., 1991, CHEMOECOLOGY, V2, P7; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Ingels B, 2011, BIOCONTROL, V56, P871, DOI 10.1007/s10526-011-9363-9; Itoi S, 2014, TOXICON, V78, P35, DOI 10.1016/j.toxicon.2013.11.003; Jones RS, 2013, ETHOLOGY, V119, P52, DOI 10.1111/eth.12036; Kajita Y, 2010, OECOLOGIA, V163, P313, DOI 10.1007/s00442-009-1551-2; KAPLAN RH, 1992, ECOLOGY, V73, P280, DOI 10.2307/1938739; Katsanis A, 2013, BIOCONTROL, V58, P73, DOI 10.1007/s10526-012-9470-2; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Kojima Y, 2015, P ROYAL SOC B, V282, P2014; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lanzoni A, 2004, J APPL ENTOMOL, V128, P298, DOI 10.1111/j.1439-0418.2004.00847.x; Laurent P, 2002, INSECT BIOCHEM MOLEC, V32, P1017, DOI 10.1016/S0965-1748(02)00038-3; Lev-Yadun S, 2003, J THEOR BIOL, V224, P183, DOI 10.1016/S0022-5193(03)00156-5; Magro A, 2007, CHEMOECOLOGY, V17, P37, DOI 10.1007/s00049-006-0357-5; MANGEL M, 1989, AM NAT, V133, P688, DOI 10.1086/284945; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Marshall DJ, 2007, BIOL BULL-US, V212, P6, DOI 10.2307/25066575; Martini X, 2013, B ENTOMOL RES, V103, P14, DOI 10.1017/S000748531200034X; MCGINLEY MA, 1987, AM NAT, V130, P370, DOI 10.1086/284716; Messina FJ, 1999, PHYSIOL ENTOMOL, V24, P358, DOI 10.1046/j.1365-3032.1999.00151.x; Mishra G, 2004, J APPL ENTOMOL, V128, P605, DOI 10.1111/j.1439-0418.2004.00903.605-609; Monaghan P, 1998, P ROY SOC B-BIOL SCI, V265, P1731, DOI 10.1098/rspb.1998.0495; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Nager RG, 2000, ECOLOGY, V81, P1339, DOI 10.2307/177212; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Ou XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041143; Perry JC, 2006, OIKOS, V112, P706; Perry JC, 2005, BEHAV ECOL SOCIOBIOL, V58, P578, DOI 10.1007/s00265-005-0947-1; Rieder JP, 2008, ECOL ENTOMOL, V33, P53, DOI 10.1111/j.1365-2311.2007.00934.x; Riesch R, 2012, ENVIRON BIOL FISH, V94, P457, DOI 10.1007/s10641-011-9960-6; Riipi M, 2001, NATURE, V413, P512, DOI 10.1038/35097061; Roche DP, 2012, BIOL LETTERS, V8, P932, DOI 10.1098/rsbl.2012.0685; Rodgers GM, 2010, ANIM BEHAV, V79, P1025, DOI 10.1016/j.anbehav.2010.01.017; Roff Derek A., 1992; Rosenheim JA, 1999, EVOLUTION, V53, P376, DOI 10.1111/j.1558-5646.1999.tb03773.x; Rowland HM, 2013, BEHAV ECOL, V24, P942, DOI 10.1093/beheco/art013; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Ruzicka Z, 2001, EUR J ENTOMOL, V98, P183, DOI 10.14411/eje.2001.034; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schielzeth H, 2013, RPTR REPEATABILITY G; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Sevenster JG, 1998, EVOLUTION, V52, P1241, DOI [10.2307/2411256, 10.1111/j.1558-5646.1998.tb01853.x]; SILLENTULLBERG B, 1988, EVOLUTION, V42, P293, DOI 10.1111/j.1558-5646.1988.tb04133.x; Skelhorn J, 2007, ANIM BEHAV, V74, P1563, DOI 10.1016/j.anbehav.2007.03.021; Sloggett JJ, 2010, J EXP BIOL, V213, P237, DOI 10.1242/jeb.037127; Sloggett JJ, 2009, OIKOS, V118, P1396, DOI 10.1111/j.1600-0706.2009.17407.x; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Smith CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084448; Smith CA, 2013, BIOL CONTROL, V67, P235, DOI 10.1016/j.biocontrol.2013.07.019; Smith HG, 1989, PARUS MAJOR J ANIM E, V58, P383, DOI [10.2307/ 4837), DOI 10.2307/4837)]; Speed MP, 2014, EVOLUTION, V68, P2996, DOI 10.1111/evo.12498; Speed MP, 2006, BIOL J LINN SOC, V87, P393, DOI 10.1111/j.1095-8312.2006.00577.x; STAMP NE, 1980, AM NAT, V115, P367, DOI 10.1086/283567; Stearns S., 1992, EVOLUTION LIFE HIST; Storm JJ, 2010, AM NAT, V175, P382, DOI 10.1086/650443; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060364; Svennungsen TO, 2007, P R SOC B, V274, P2055, DOI 10.1098/rspb.2007.0456; Team RDC, 2013, R LANG ENV STAT COMP; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; TURSCH B, 1973, TETRAHEDRON LETT, P201; Uller T, 2005, BEHAV ECOL SOCIOBIOL, V57, P584, DOI 10.1007/s00265-004-0886-2; Veiga JP, 2004, HORM BEHAV, V46, P47, DOI 10.1016/j.yhbeh.2004.01.007; Verboven N, 2010, PHYSIOL BIOCHEM ZOOL, V83, P1009, DOI 10.1086/656568; Ware RL, 2008, BIOCONTROL, V53, P169, DOI 10.1007/s10526-007-9135-8; WERREN JH, 1994, J BACTERIOL, V176, P388, DOI 10.1128/JB.176.2.388-394.1994; Winters AE, 2014, FUNCT ECOL, V28, P1187, DOI 10.1111/1365-2435.12266; Yasuda H, 2000, EUR J ENTOMOL, V97, P551, DOI 10.14411/eje.2000.085; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; [No title captured]; [No title captured]	113	6	6	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139404	10.1371/journal.pone.0139404	http://dx.doi.org/10.1371/journal.pone.0139404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488753	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400028
J	Poulakakis, N; Edwards, DL; Chiari, Y; Garrick, RC; Russello, MA; Benavides, E; Watkins-Colwell, GJ; Glaberman, S; Tapia, W; Gibbs, JP; Cayot, LJ; Caccone, A				Poulakakis, Nikos; Edwards, Danielle L.; Chiari, Ylenia; Garrick, Ryan C.; Russello, Michael A.; Benavides, Edgar; Watkins-Colwell, Gregory J.; Glaberman, Scott; Tapia, Washington; Gibbs, James P.; Cayot, Linda J.; Caccone, Adalgisa			Description of a New Galapagos Giant Tortoise Species (Chelonoidis; Testudines: Testudinidae) from Cerro Fatal on Santa Cruz Island	PLOS ONE			English	Article							LINEAGE IDENTIFICATION; GENETIC-DIVERGENCE; LONESOME GEORGE; SOFTWARE; PROGRAM; EXTINCT; DIVERSIFICATION; PHYLOGEOGRAPHY; INFERENCE; TAXON	The taxonomy of giant Galapagos tortoises (Chelonoidis spp.) is currently based primarily on morphological characters and island of origin. Over the last decade, compelling genetic evidence has accumulated for multiple independent evolutionary lineages, spurring the need for taxonomic revision. On the island of Santa Cruz there is currently a single named species, C. porteri. Recent genetic and morphological studies have shown that, within this taxon, there are two evolutionarily and spatially distinct lineages on the western and eastern sectors of the island, known as the Reserva and Cerro Fatal populations, respectively. Analyses of DNA from natural populations and museum specimens, including the type specimen for C. porteri, confirm the genetic distinctiveness of these two lineages and support elevation of the Cerro Fatal tortoises to the rank of species. In this paper, we identify DNA characters that define this new species, and infer evolutionary relationships relative to other species of Galapagos tortoises.	[Poulakakis, Nikos] Univ Crete, Dept Biol, GR-71300 Iraklion, Greece; [Poulakakis, Nikos] Univ Crete, Nat Hist Museum Crete, GR-71409 Iraklion, Greece; [Edwards, Danielle L.; Benavides, Edgar; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Edwards, Danielle L.] Univ Calif Merced, Life & Environm Sci, Merced, CA 95343 USA; [Chiari, Ylenia; Glaberman, Scott] Univ S Alabama, Dept Biol, Mobile, AL 36688 USA; [Garrick, Ryan C.] Univ Mississippi, Dept Biol, Oxford, MS 38677 USA; [Russello, Michael A.] Univ British Columbia, Dept Biol, Kelowna, BC V1V 1V7, Canada; [Watkins-Colwell, Gregory J.] Yale Peabody Museum Nat Hist, Div Vertebrate Zool, New Haven, CT 06520 USA; [Tapia, Washington] Galapagos Natl Pk Serv, Dept Appl Res, Puerto Ayora, Galapagos, Ecuador; [Tapia, Washington; Cayot, Linda J.] Galapagos Conservancy, Fairfax, VA 22030 USA; [Gibbs, James P.] SUNY Coll Environm Sci & Forestry, Syracuse, NY 13210 USA	University of Crete; University of Crete; Yale University; University of California System; University of California Merced; University of South Alabama; University of Mississippi; University of British Columbia; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Caccone, A (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 21 Sachem St, New Haven, CT 06520 USA.	adalgisa.caccone@yale.edu	Caccone, Adalgisa/AAE-4238-2021; Chiari, Ylenia/AAW-3108-2020; Poulakakis, Nikos/E-7848-2011	Caccone, Adalgisa/0000-0002-8949-9260; Chiari, Ylenia/0000-0003-2338-8602; Glaberman, Scott/0000-0003-0594-4732; Tapia, Washington/0000-0002-5222-1804; Edwards, Danielle/0000-0002-1165-4427; Watkins-Colwell, Greg/0000-0002-7789-9806	Yale Institute for Biospheric Studies; Turtle Conservation Society; Galapagos Conservancy; Paul and Bay and Eppley foundation	Yale Institute for Biospheric Studies; Turtle Conservation Society; Galapagos Conservancy; Paul and Bay and Eppley foundation	This work was supported by funding from the Yale Institute for Biospheric Studies, the Turtle Conservation Society, Galapagos Conservancy, and the Paul and Bay and Eppley foundation to AC.	Beheregaray LB, 2004, P NATL ACAD SCI USA, V101, P6514, DOI 10.1073/pnas.0400393101; Beheregaray LB, 2003, CONSERV GENET, V4, P31, DOI 10.1023/A:1021864214375; Benavides E, 2012, ZOO BIOL, V31, P107, DOI 10.1002/zoo.20397; Blake S, 2015, BIOTROPICA, V47, P246, DOI 10.1111/btp.12195; Bour R., 1980, B MUSEUM NATL HIST N, V4, P546; Caccone A, 2002, EVOLUTION, V56, P2052; Caccone A, 1999, P NATL ACAD SCI USA, V96, P13223, DOI 10.1073/pnas.96.23.13223; Chiari Y, 2012, CR BIOL, V335, P62, DOI 10.1016/j.crvi.2011.10.007; Chiari Y, 2011, J MORPHOL, V272, P379, DOI 10.1002/jmor.10923; Chiari Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006272; Ciofi C, 2002, MOL ECOL, V11, P2265, DOI 10.1046/j.1365-294X.2002.01617.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRUMLY C R, 1984, Proceedings of the California Academy of Sciences, V43, P111; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards DL, 2013, BIOL CONSERV, V157, P225, DOI 10.1016/j.biocon.2012.10.014; Edwards DL, 2014, CONSERV GENET, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FRITTS TH, 1984, BIOL J LINN SOC, V21, P165, DOI 10.1111/j.1095-8312.1984.tb02059.x; Garrick RC, 2014, MOL ECOL, V23, P5276, DOI 10.1111/mec.12919; Garrick RC, 2012, CURR BIOL, V22, pR10, DOI 10.1016/j.cub.2011.12.004; Gibbs JP, 2008, RESTOR ECOL, V16, P88, DOI 10.1111/j.1526-100X.2007.00265.x; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Le M, 2006, MOL PHYLOGENET EVOL, V40, P517, DOI 10.1016/j.ympev.2006.03.003; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOVERIDGE ARTHUR, 1957, BULL MUS COMP ZOOL HARVARD UNIV, V115, P163; MACFARLAND C G, 1974, Biological Conservation, V6, P118, DOI 10.1016/0006-3207(74)90024-X; Mertens R., 1955, Zoologische Jahrbuecher Systematik, V83, P323; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Poulakakis N, 2008, P NATL ACAD SCI USA, V105, P15464, DOI 10.1073/pnas.0805340105; Poulakakis N, 2012, MOL ECOL, V21, P160, DOI 10.1111/j.1365-294X.2011.05370.x; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard Peter C.H., 1996, Chelonian Research Monographs, V1, P1; Rambaut A, 2008, MCMC TRACE ANAL TOOL; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rothschild W., 1903, Novitates Zoologicae, Vx, P119; Russello MA, 2007, ANIM CONSERV, V10, P304, DOI 10.1111/j.1469-1795.2007.00113.x; Russello MA, 2005, BIOL LETT-UK, V1, P287, DOI 10.1098/rsbl.2005.0317; Russello MA, 2007, CURR BIOL, V17, pR317, DOI 10.1016/j.cub.2007.03.002; Snow D. W., 1964, Oryx, V7, P277; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1992, GENETICS, V132, P619; Van Denburgh J., 1914, Proceedings of the California Academy of Science (4th Series), V2; van Dijk P. P., 2014, CHELONIAN RES MONOGR, V5; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001	53	43	44	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0138779	10.1371/journal.pone.0138779	http://dx.doi.org/10.1371/journal.pone.0138779			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488886	Green Published, gold			2022-12-27	WOS:000363248400011
J	Stachtea, XN; Tykesson, E; van Kuppevelt, TH; Feinstein, R; Malmstrom, A; Reijmers, RM; Maccarana, M				Stachtea, Xanthi N.; Tykesson, Emil; van Kuppevelt, Toin H.; Feinstein, Ricardo; Malmstrom, Anders; Reijmers, Rogier M.; Maccarana, Marco			Dermatan Sulfate-Free Mice Display Embryological Defects and Are Neonatal Lethal Despite Normal Lymphoid and Non-Lymphoid Organogenesis	PLOS ONE			English	Article							EHLERS-DANLOS-SYNDROME; ABDOMINAL-WALL DEFECTS; L-IDURONIC ACID; CHONDROITIN/DERMATAN SULFATE; GLUCURONYL C5-EPIMERASE; 4-O-SULFOTRANSFERASE 1; EPIMERASE 2; BIOSYNTHESIS; BRAIN; GENE	The epimerization of glucuronic acid into iduronic acid adds structural variability to chondroitin/dermatan sulfate polysaccharides. Iduronic acid-containing domains play essential roles in processes such as coagulation, chemokine and morphogen modulation, collagen maturation, and neurite sprouting. Therefore, we generated and characterized, for the first time, mice deficient in dermatan sulfate epimerase 1 and 2, two enzymes uniquely involved in dermatan sulfate biosynthesis. The resulting mice, termed DKO mice, were completely devoid of iduronic acid, and the resulting chondroitin sulfate chains were structurally different from the wild type chains, from which a different protein binding specificity can be expected. As a consequence, a vast majority of the DKO mice died perinatally, with greatly variable phenotypes at birth or late embryological stages such as umbilical hernia, exencephaly and a kinked tail. However, a minority of embryos were histologically unaffected, with apparently normal lung and bone/cartilage features. Interestingly, the binding of the chemokine CXCL13, an important modulator of lymphoid organogenesis, to mouse DKO embryonic fibroblasts was impaired. Nevertheless, the development of the secondary lymphoid organs, including the lymph nodes and spleen, was normal. Altogether, our results indicate an important role of dermatan sulfate in embryological development and perinatal survival.	[Stachtea, Xanthi N.; Tykesson, Emil; Malmstrom, Anders; Maccarana, Marco] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands; [Feinstein, Ricardo] Natl Vet Inst SVA, Dept Pathol, SE-75189 Uppsala, Sweden; [Reijmers, Rogier M.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands	Lund University; Radboud University Nijmegen; National Veterinary Institute SVA; Vrije Universiteit Amsterdam	Maccarana, M (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	marco.maccarana@med.lu.se	maccarana, marco/AAB-4764-2021; Tykesson, Emil/F-9879-2014; Reijmers, Rogier/M-2620-2019	Tykesson, Emil/0000-0002-0511-9831; Reijmers, Rogier/0000-0001-7471-7715; Malmstrom, Anders/0000-0002-6691-146X; Maccarana, Marco/0000-0003-3549-8921	Netherlands Organization for Scientific Research [916.13.011]; Medical Faculty Lund University; Swedish Research Council; Cancerfonden [14 0530]; Anna-Greta Crafoord; Mizutani [120115]; Greta and Johan Kock; FLAK research school	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Faculty Lund University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Anna-Greta Crafoord; Mizutani; Greta and Johan Kock; FLAK research school	This work was supported by Netherlands Organization for Scientific Research (916.13.011 to RR) http://www.nwo.nl; Medical Faculty Lund University to AM; http://www.med.lu.se; Swedish Research Council to AM; http://www.vr.se/; Cancerfonden (grant 14 0530 to MM) https://www.cancerfonden.se; Anna-Greta Crafoord to XS http://www.annagretacrafoord.se/; Mizutani (grant 120115 to MM) http://www.mizutanifdn.or.jp/; Greta and Johan Kock to ET http://www.kockskastiftelsen.se/; and FLAK research school to AM http://www.flak.lu.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsu C, 2011, GLYCOBIOLOGY, V21, P565, DOI 10.1093/glycob/cwq208; Akyuaz N, 2013, EXP NEUROL, V247, P517, DOI 10.1016/j.expneurol.2013.01.025; Bartolini B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066704; Bartolini B, 2012, GLYCOBIOLOGY, V22, P1007, DOI 10.1093/glycob/cws065; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Couchman JR, 2012, J HISTOCHEM CYTOCHEM, V60, P885, DOI 10.1369/0022155412464638; Cupedo T, 2004, IMMUNITY, V21, P655, DOI 10.1016/j.immuni.2004.09.006; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Goossens D, 2003, MOL PSYCHIATR, V8, P83, DOI 10.1038/sj.mp.4001190; Gustafsson R, 2014, BIRTH DEFECTS RES A, V100, P712, DOI 10.1002/bdra.23300; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Jia J, 2009, J BIOL CHEM, V284, P15942, DOI 10.1074/jbc.M809577200; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miyake N, 2010, HUM MUTAT, V31, P966, DOI 10.1002/humu.21300; Muller T, 2013, HUM MOL GENET, V22, P3761, DOI 10.1093/hmg/ddt227; Pacheco B, 2009, GLYCOBIOLOGY, V19, P1197, DOI 10.1093/glycob/cwp110; Prefumo F, 2014, BEST PRACT RES CL OB, V28, P391, DOI 10.1016/j.bpobgyn.2013.10.003; Reijmers RM, 2011, BLOOD, V117, P6162, DOI 10.1182/blood-2010-12-325522; Reijmers RM, 2010, J IMMUNOL, V184, P3656, DOI 10.4049/jimmunol.0902200; Shimizu K, 2011, AM J MED GENET A, V155A, P1949, DOI 10.1002/ajmg.a.34115; Syx D, 2015, HUM MUTAT, V36, P535, DOI 10.1002/humu.22774; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Thelin MA, 2013, FEBS J, V280, P2431, DOI 10.1111/febs.12214; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Volpi N, 2014, NAT PROTOC, V9, P541, DOI 10.1038/nprot.2014.026; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289; Zhao X, 2013, J BIOL CHEM, V288, P9226, DOI 10.1074/jbc.M112.437236; Zucker RM, 2006, CYTOM PART A, V69A, P1143, DOI 10.1002/cyto.a.20343	36	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140279	10.1371/journal.pone.0140279	http://dx.doi.org/10.1371/journal.pone.0140279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488883	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400047
J	Gu, YM; Lei, DQ; Qin, X; Chen, PY; Zou, YM; Hu, YL				Gu, Yinmin; Lei, Danqing; Qin, Xia; Chen, Panyu; Zou, Yi ming; Hu, Yanling			Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer	PLOS ONE			English	Article							NCBI GEO ARCHIVE; MICRORNA EXPRESSION; CIRCULATING MICRORNAS; BIOMARKERS; SIGNATURE; PROLIFERATION; TRANSITION	Research has shown that microRNAs are promising biomarkers that can be used to promote a more accurate diagnosis of cancer. In this study, we developed an integrated multi-step selection process to analyze available high-throughput datasets to obtain information on microRNAs as cancer biomarkers. Applying this approach to the microRNA expression profiles of prostate cancer and the datasets in The Cancer Genome Atlas Data Portal, we identified miRNA-182, miRNA-200c and miRNA-221 as possible biomarkers for prostate cancer. The associations between the expressions of these three microRNAs with clinical parameters as well as their diagnostic capability were studied. Several online databases were used to predict the target genes of these three microRNAs, and the results were confirmed by significant statistical correlations. Comparing with the other 18 types of cancers listed in The Cancer Genome Atlas Data Portal, we found that the combination of both miRNA-182 and miRNA-200c being up-regulated and miRNA-221 being down-regulated only happens in prostate cancer. This provides a unique biological characteristic for prostate cancer that can potentially be used for diagnosis based on tissue testing. In addition, our study also revealed that these three microRNAs are associated with the pathological status of prostate cancer.	[Gu, Yinmin; Lei, Danqing; Chen, Panyu; Hu, Yanling] Guangxi Med Univ, Expt Ctr Med Sci, Nanning, Peoples R China; [Qin, Xia] Guangxi Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanning, Peoples R China; [Hu, Yanling] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Peoples R China; [Zou, Yi ming] Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; University of Wisconsin System; University of Wisconsin Milwaukee	Zou, YM (corresponding author), Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA.	ymzou@uwm.edu; ylhupost@163.com			National Natural Science Foundation of China [81272853, 81472414]; Guangxi Natural Science Foundation [2012GXNSFAA053152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	The first four and the last authors were supported in part by grants from the National Natural Science Foundation of China (#81272853 and #81472414) and the Guangxi Natural Science Foundation (#2012GXNSFAA053152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Brys M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0391-9; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carlsson J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-362; Carlsson J, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-14; Chen ZH, 2012, PROSTATE, V72, P1443, DOI 10.1002/pros.22495; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devaux Y, 2012, CLIN CHEM, V58, P559, DOI 10.1373/clinchem.2011.173823; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feng Xiangling, 2014, Cancer Lett, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gonnissen A, 2013, INT J MOL SCI, V14, P13979, DOI 10.3390/ijms140713979; Guzel E, 2015, INT J CANCER, V136, P875, DOI 10.1002/ijc.29054; He HC, 2012, FEBS LETT, V586, P2451, DOI 10.1016/j.febslet.2012.06.003; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lin PC, 2013, CANCER RES, V73, P1232, DOI 10.1158/0008-5472.CAN-12-2968; Liu J, 2010, PROSTATE, V70, P1768, DOI 10.1002/pros.21213; Liu RY, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-155; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Mattila H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-327; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Polednak AP, 1997, CANCER, V79, P99, DOI 10.1002/(SICI)1097-0142(19970101)79:1<99::AID-CNCR14>3.3.CO;2-O; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Qu Y, 2013, INT J CANCER, V133, P544, DOI 10.1002/ijc.28056; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Selth LA, 2012, INT J CANCER, V131, P652, DOI 10.1002/ijc.26405; Sita-Lumsden A, 2013, BRIT J CANCER, V108, P1925, DOI 10.1038/bjc.2013.192; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Vallejo DM, 2011, EMBO J, V30, P756, DOI 10.1038/emboj.2010.358; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Walter BA, 2013, J CANCER, V4, P350, DOI 10.7150/jca.6394; Yang JH, STARBASE DATABASE EX, V39, pD202, DOI [10.1093/nar/gkq1056, DOI 10.1093/NAR/GKQ1056]; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956	56	7	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140862	10.1371/journal.pone.0140862	http://dx.doi.org/10.1371/journal.pone.0140862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484677	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100081
J	Wang, Y; Yi, L; Wang, SH; Fan, HJ; Ding, C; Mao, X; Lu, CP				Wang, Yang; Yi, Li; Wang, Shaohui; Fan, Hongjie; Ding, Chan; Mao, Xiang; Lu, Chengping			Crystal Structure and Identification of Two Key Amino Acids Involved in AI-2 Production and Biofilm Formation in Streptococcus suis LuxS	PLOS ONE			English	Article							S-RIBOSYLHOMOCYSTEINASE LUXS; QUORUM-SENSING PROTEIN; AUTOINDUCER-2; VIRULENCE; METABOLISM; MECHANISM; REVEALS	Streptococcus suis has emerged as an important zoonotic pathogen that causes meningitis, arthritis, septicemia and even sudden death in pigs and humans. Quorum sensing is the signaling network for cell-to-cell communication that bacterial cells can use to monitor their own population density through production and exchange of signal molecules. S-Ribosylhomocysteinase (LuxS) is the key enzyme involved in the activated methyl cycle. Autoinducer 2 (AI-2) is the adduct of borate and a ribose derivative and is produced from S-adenosylhomocysteine (SAH). AI-2 can mediate interspecies communication and in some species facilitate the bacterial behavior regulation such as biofilm formation and virulence in both Gram-positive and Gram-negative bacteria. Here, we reported the overexpression, purification and crystallographic structure of LuxS from S. suis. Our results showed the catalytically active LuxS exists as a homodimer in solution. Inductively coupled plasma-mass spectrometry (ICP-MS) revealed the presence of Zn2+ in LuxS. Although the core structure shares the similar topology with LuxS proteins from other bacterial species, structural analyses and comparative amino acid sequence alignments identified two key amino acid differences in S. suis LuxS, Phe80 and His87, which are located near the substrate binding site. The results of site-directed mutagenesis and enzymology studies confirmed that these two residues affect the catalytic activity of the enzyme. These in vitro results were corroborated in vivo by expression of the LuxS variants in a S. suis Delta luxS strain. The single and two amino acid of LuxS variant decreased AI-2 production and biofilm formation significantly compared to that of the parent strain. Our findings highlight the importance of key LuxS residues that influence the AI-2 production and biofilm formation in S. suis.	[Wang, Yang] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Luoyang, Peoples R China; [Wang, Yang; Wang, Shaohui; Ding, Chan; Mao, Xiang] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Yi, Li] Luoyang Normal Univ, Dept Life Sci, Luoyang, Peoples R China; [Yi, Li; Fan, Hongjie; Mao, Xiang; Lu, Chengping] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China	Henan University of Science & Technology; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Luoyang Normal University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Wang, Y (corresponding author), Henan Univ Sci & Technol, Coll Anim Sci & Technol, Luoyang, Peoples R China.	wangyocean@163.com; xmao@shvri.ac.cn			National Natural Science Foundation of China - Program for Science & Technology Innovation Talents in Universities of Henan Province [31201910, 14HASTIT024]; Foundation for University Key Teacher by the Ministry of Education of Henan Province [2013GGJS-068]; Science and Technology development project of Henan Province [142102310297]; Science and Technology Research Foundation of Henan Province Educational Committee [13A230261, 14A230003]	National Natural Science Foundation of China - Program for Science & Technology Innovation Talents in Universities of Henan Province; Foundation for University Key Teacher by the Ministry of Education of Henan Province; Science and Technology development project of Henan Province; Science and Technology Research Foundation of Henan Province Educational Committee	This work was supported by the National Natural Science Foundation of China (31201910), Sponsored by Program for Science & Technology Innovation Talents in Universities of Henan Province (14HASTIT024), and Foundation for University Key Teacher by the Ministry of Education of Henan Province (2013GGJS-068), the Science and Technology development project of Henan Province (142102310297), the Science and Technology Research Foundation of Henan Province Educational Committee (13A230261, 14A230003).	Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Cao M, 2011, J MICROBIOL, V49, P1000, DOI 10.1007/s12275-011-1523-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Galante J, 2015, CURR PHARM DESIGN, V21, P25; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Hilgers MT, 2001, P NATL ACAD SCI USA, V98, P11169, DOI 10.1073/pnas.191223098; Holmgren K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-73; Kendall MM, 2007, CURR OPIN GASTROEN, V23, P10, DOI 10.1097/MOG.0b013e3280118289; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; Lewis HA, 2001, STRUCTURE, V9, P527, DOI 10.1016/S0969-2126(01)00613-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ordog R, 2008, BIOINFORMATION, V2, P346, DOI 10.6026/97320630002346; Pei DH, 2004, CURR OPIN CHEM BIOL, V8, P492, DOI 10.1016/j.cbpa.2004.08.003; Plummer P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015876; Rajan R, 2005, BIOCHEMISTRY-US, V44, P3745, DOI 10.1021/bi0477384; Ruzheinikov SN, 2001, J MOL BIOL, V313, P111, DOI 10.1006/jmbi.2001.5027; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Wang Y, 2014, CURR MICROBIOL, V68, P575, DOI 10.1007/s00284-013-0509-0; Wang Y, 2013, SCI WORLD J, DOI 10.1155/2013/924276; Wang Y, 2011, VET MICROBIOL, V152, P151, DOI 10.1016/j.vetmic.2011.04.029; Winzer K, 2003, ADV APPL MICROBIOL, V53, P291, DOI 10.1016/S0065-2164(03)53009-X; Zhu J, 2004, BIOCHEMISTRY-US, V43, P10166, DOI 10.1021/bi0491088; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	28	20	26	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0138826	10.1371/journal.pone.0138826	http://dx.doi.org/10.1371/journal.pone.0138826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484864	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100006
J	Winship, A; Correia, J; Zhang, JG; Nicola, NA; Dimitriadis, E				Winship, Amy; Correia, Jeanne; Zhang, Jian-Guo; Nicola, Nicos A.; Dimitriadis, Evdokia			Leukemia Inhibitory Factor (LIF) Inhibition during Mid-Gestation Impairs Trophoblast Invasion and Spiral Artery Remodelling during Pregnancy in Mice	PLOS ONE			English	Article							BLASTOCYST IMPLANTATION; HUMAN ENDOMETRIUM; MOUSE; EXPRESSION; CELLS; RECEPTOR; UTERUS; BIOLOGY	The placenta forms the interface between the maternal and fetal circulation and is critical for the establishment of a healthy pregnancy. Trophoblast cell proliferation, migration and invasion into the endometrium are fundamental events in the initiation of placentation. Leukemia inhibitory factor (LIF) has been shown to promote trophoblast invasion in vitro, however its precise role in trophoblast invasion in vivo is unknown. We hypothesized that LIF would be required for normal trophoblast invasion and spiral artery remodeling in mice. Both LIF and its receptor (LIFR alpha) co-localized with cytokeratin-positive invasive endovascular extravillous trophoblasts (EVT) in mouse implantation sites during mid-gestation. Temporally blocking LIF action during specific periods of placental development via administration of our unique LIFR alpha antagonist, PEGLA, resulted in abnormal trophoblast invasion and impaired spiral artery remodeling compared to PEG control. PEGLA-treated mouse decidual vessels were characterized by retention of alpha-smooth muscle actin (alpha SMA)-positive vascular smooth muscle cells (VSMCs), while PEG control decidual vessels were remodelled by cytokeratin-positive trophoblasts. LIF blockade did not alter F4/80-positive decidual macrophage numbers between treatment groups, but resulted in down-regulation of decidual transcript levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-10 (IL-10), which are important immune cell activation factors that promote spiral artery remodeling during pregnancy. Our data suggest that LIF plays an important role in trophoblast invasion in vivo and may facilitate trophoblast-decidual-immune cell cross talk to enable adequate spiral artery remodeling.	[Winship, Amy; Correia, Jeanne; Dimitriadis, Evdokia] Hudson Inst, Melbourne, Vic, Australia; [Winship, Amy; Dimitriadis, Evdokia] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Zhang, Jian-Guo; Nicola, Nicos A.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Zhang, Jian-Guo; Nicola, Nicos A.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	Hudson Institute of Medical Research; Monash University; Walter & Eliza Hall Institute; University of Melbourne	Dimitriadis, E (corresponding author), Hudson Inst, Melbourne, Vic, Australia.	evdokia.dimitriadis@hudson.org	dimitriadis, e/AAD-7601-2021	Dimitriadis, Eva/0000-0001-8698-1927; Winship, Amy/0000-0001-7848-1447; dimitriadis, eva/0000-0003-1425-950X	Victorian Government's Operational Infrastructure Support Program; Australian Government NHMRC IRIISS; NHMRC Fellowships [550905, 637300]; NHMRC Program Grant [1016647]; Australian Postgraduate Award	Victorian Government's Operational Infrastructure Support Program; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	The authors acknowledge the support of the Victorian Government's Operational Infrastructure Support Program and the Australian Government NHMRC IRIISS. ED and NAN were supported by NHMRC Fellowships (#550905 and #637300, respectively). JGZ and NAN were supported by an NHMRC Program Grant (#1016647). AW was supported by an Australian Postgraduate Award.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Aghajanova L, 2004, ANN NY ACAD SCI, V1034, P176, DOI 10.1196/annals.1335.020; Aghajanova L, 2009, FERTIL STERIL, V91, P2602, DOI 10.1016/j.fertnstert.2008.04.010; Aplin JD, 2010, INT J DEV BIOL, V54, P323, DOI 10.1387/ijdb.082759ja; Benian A, 2008, INT J GYNECOL OBSTET, V100, P228, DOI 10.1016/j.ijgo.2007.09.023; BHATT H, 1991, P NATL ACAD SCI USA, V88, P11408, DOI 10.1073/pnas.88.24.11408; Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606; Charalambous F, 2012, BIOCHEM BIOPH RES CO, V417, P847, DOI 10.1016/j.bbrc.2011.12.057; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Classen-Linke I, 2004, MOL HUM REPROD, V10, P495, DOI 10.1093/molehr/gah069; Cox B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.37; DE M, 1991, J LEUKOCYTE BIOL, V50, P252, DOI 10.1002/jlb.50.3.252; Dilworth M, 2012, PLACENTA, V12, P1; Dimitriadis E, 2010, PLACENTA, V31, pS99, DOI 10.1016/j.placenta.2009.12.027; Dimitriadis E, 2010, INT J DEV BIOL, V54, P313, DOI 10.1387/ijdb.082772ed; Fest S, 2007, AM J REPROD IMMUNOL, V57, P55, DOI 10.1111/j.1600-0897.2006.00446.x; Harris LK, 2010, PLACENTA, V31, pS93, DOI 10.1016/j.placenta.2009.12.012; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Jasper MJ, 2011, BIOL REPROD, V84, P179, DOI 10.1095/biolreprod.110.085399; Kimber SJ, 2005, REPRODUCTION, V130, P131, DOI 10.1530/rep.1.00304; KOJIMA K, 1994, BIOL REPROD, V50, P882, DOI 10.1095/biolreprod50.4.882; Krishnan T, 2013, PLACENTA, V34, P1014, DOI 10.1016/j.placenta.2013.09.003; Menkhorst E, 2010, J REPROD IMMUNOL, V86, P33, DOI 10.1016/j.jri.2010.06.062; Menkhorst E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019665; PIJNENBORG R, 1994, REPRODUCTIVE MED REV, V3, P53; Poehlmann TG, 2005, PLACENTA, V26, pS37, DOI 10.1016/j.placenta.2005.01.007; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Salamonsen LA, 2009, REPROD FERT DEVELOP, V21, P923, DOI 10.1071/RD09145; Schofield G, 2005, BIOL REPROD, V72, P872, DOI 10.1095/biolreprod.104.034876; Sengupta J, 2006, CONTRACEPTION, V74, P419, DOI 10.1016/j.contraception.2006.05.070; Sharkey AM, 1999, BIOL REPROD, V60, P355, DOI 10.1095/biolreprod60.2.355; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; VINCE GS, 1990, J IMMUNOL METHODS, V132, P181, DOI 10.1016/0022-1759(90)90028-T; Wang WJ, 2011, J REPROD IMMUNOL, V92, P97, DOI 10.1016/j.jri.2011.08.004; WARE CB, 1995, DEVELOPMENT, V121, P1283; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104	42	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0129110	10.1371/journal.pone.0129110	http://dx.doi.org/10.1371/journal.pone.0129110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479247	Green Published, gold			2022-12-27	WOS:000363026600001
J	Bridoux, L; Deneyer, N; Bergiers, I; Rezsohazy, R				Bridoux, Laure; Deneyer, Noemie; Bergiers, Isabelle; Rezsohazy, Rene			Molecular Analysis of the HOXA2-Dependent Degradation of RCHY1	PLOS ONE			English	Article							UBIQUITIN-INDEPENDENT DEGRADATION; DNA-POLYMERASE ETA; CELL-CYCLE; PROTEASOMAL DEGRADATION; DEPENDENT DEGRADATION; HEMATOPOIETIC STEM; PROTEIN LIGASE; HOX GENES; PIRH2; PROMOTES	The homeodomain transcription factor Hoxa2 interacts with the RING-finger type E3 ubiquitin ligase RCHY1 and induces its proteasomal degradation. In this work, we dissected this non-transcriptional activity of Hoxa2 at the molecular level. The Hoxa2-mediated decay of RCHY1 involves both the 19S and 20S proteasome complexes. It relies on both the Hoxa2 homeodomain and C-terminal moiety although no single deletion in the Hoxa2 sequence could disrupt the RCHY1 interaction. That the Hoxa2 homeodomain alone could mediate RCHY1 binding is consistent with the shared ability all the Hox proteins we tested to interact with RCHY1. Nonetheless, the ability to induce RCHY1 degradation although critically relying on the homeodomain is not common to all Hox proteins. This identifies the homeodomain as necessary but not sufficient for what appears to be an almost generic Hox protein activity. Finally we provide evidence that the Hoxa2-induced degradation of RCHY1 is evolutionarily conserved among vertebrates. These data therefore support the hypothesis that the molecular and functional interaction between Hox proteins and RCHY1 is an ancestral Hox property.	[Bridoux, Laure; Deneyer, Noemie; Bergiers, Isabelle; Rezsohazy, Rene] Catholic Univ Louvain, Life Sci Inst ISV, Anim Mol & Cellular Biol Grp AMCB, Louvain, Belgium	Universite Catholique Louvain	Rezsohazy, R (corresponding author), Catholic Univ Louvain, Life Sci Inst ISV, Anim Mol & Cellular Biol Grp AMCB, Louvain, Belgium.	rene.rezsohazy@uclouvain.be		Bergiers, Isabelle/0000-0001-9622-7960	Belgian National Fund for Scientific Research (FRS-FNRS; FRSM grant) [3.4.536.06.F]; "Actions de Recherche Concertees -ARC" (ARC grant) [12/17-041]	Belgian National Fund for Scientific Research (FRS-FNRS; FRSM grant)(Fonds de la Recherche Scientifique - FNRS); "Actions de Recherche Concertees -ARC" (ARC grant)	This work was supported by the Belgian National Fund for Scientific Research (FRS-FNRS; FRSM grant #3.4.536.06.F) and the "Actions de Recherche Concertees -ARC" (ARC grant 12/17-041). LB and IB hold a FRIA fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Zeinab R, 2013, PLOS ONE, V8, DOI [10.1371/journalpone.0082603, DOI 10.1371/J0URNAL.P0NE.0082803]; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Banreti A, 2014, DEV CELL, V28, P56, DOI 10.1016/j.devcel.2013.11.024; Beitel LK, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290041; Bergiers I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080387; Bridoux L, 2015, BBA-GENE REGUL MECH, V1849, P1298, DOI 10.1016/j.bbagrm.2015.08.006; Chariot A, 1999, ONCOGENE, V18, P4007, DOI 10.1038/sj.onc.1202776; Corcoran CA, 2009, J BIOL CHEM, V284, P21955, DOI 10.1074/jbc.M109.024232; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Davenne M, 1999, NEURON, V22, P677, DOI 10.1016/S0896-6273(00)80728-X; Duan SS, 2007, EMBO J, V26, P3062, DOI 10.1038/sj.emboj.7601749; Goudet G, 1999, J BIOL CHEM, V274, P4067, DOI 10.1074/jbc.274.7.4067; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Hakem A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002360; Halaby MJ, 2013, CELL CYCLE, V12, P2733, DOI 10.4161/cc.25785; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Hu L, 2012, CARCINOGENESIS, V33, P1581, DOI 10.1093/carcin/bgs162; Hutlet B, 2016, BRAIN STRUCT FUNCT, V221, P1223, DOI 10.1007/s00429-014-0965-8; Jung YS, 2011, MOL CELL BIOL, V31, P3997, DOI 10.1128/MCB.05808-11; Jung YS, 2010, MOL CELL BIOL, V30, P1041, DOI 10.1128/MCB.01198-09; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lambert B, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-29; Lampe X, 2008, NUCLEIC ACIDS RES, V36, P3214, DOI 10.1093/nar/gkn148; Lee J, 2013, BLOOD, V121, P4082, DOI 10.1182/blood-2012-09-455204; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Logan IR, 2004, J BIOL CHEM, V279, P11696, DOI 10.1074/jbc.M312712200; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Mallo M, 1997, DEV DYNAM, V210, P146, DOI 10.1002/(SICI)1097-0177(199710)210:2<146::AID-AJA7>3.0.CO;2-G; Matis C, 2001, FEBS LETT, V499, P92, DOI 10.1016/S0014-5793(01)02532-7; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Ohno Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053161; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P21529, DOI 10.1073/pnas.1011054107; Remacle S, 2002, NUCLEIC ACIDS RES, V30, P2663, DOI 10.1093/nar/gkf372; Rezsohazy R, 2015, DEVELOPMENT, V142, P1212, DOI 10.1242/dev.109785; Rezsohazy R, 2014, DEV DYNAM, V243, P117, DOI 10.1002/dvdy.24060; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Salsi V, 2009, MOL CELL BIOL, V29, P5775, DOI 10.1128/MCB.00509-09; Santagati F, 2005, DEVELOPMENT, V132, P4927, DOI 10.1242/dev.02078; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shen WF, 2001, MOL CELL BIOL, V21, P7509, DOI 10.1128/MCB.21.21.7509-7522.2001; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; Wang ZH, 2011, CANCER SCI, V102, P909, DOI 10.1111/j.1349-7006.2011.01899.x; Zhang Y, 2003, EMBO J, V22, P6057, DOI 10.1093/emboj/cdg577; Zheng G, 2007, BIOCHEM BIOPH RES CO, V364, P344, DOI 10.1016/j.bbrc.2007.10.003; Zhou B, 2012, P NATL ACAD SCI USA, V109, P8931, DOI 10.1073/pnas.1200874109	52	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141347	10.1371/journal.pone.0141347	http://dx.doi.org/10.1371/journal.pone.0141347			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496426	Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200099
J	Conn, PB; Johnson, DS; Boveng, PL				Conn, Paul B.; Johnson, Devin S.; Boveng, Peter L.			On Extrapolating Past the Range of Observed Data When Making Statistical Predictions in Ecology	PLOS ONE			English	Article							MODELS; REGRESSION; SPACE; TIME	Ecologists are increasingly using statistical models to predict animal abundance and occurrence in unsampled locations. The reliability of such predictions depends on a number of factors, including sample size, how far prediction locations are from the observed data, and similarity of predictive covariates in locations where data are gathered to locations where predictions are desired. In this paper, we propose extending Cook's notion of an independent variable hull (IVH), developed originally for application with linear regression-models, to generalized regression models as a way to help assess the potential reliability of predictions in unsampled areas. Predictions occurring inside the generalized independent variable hull (gIVH) can be regarded as interpolations, while predictions occurring outside the gIVH can be regarded as extrapolations worthy of additional investigation or skepticism. We conduct a simulation study to demonstrate the usefulness of this metric for limiting the scope of spatial inference when conducting model-based abundance estimation from survey counts. In this case, limiting inference to the gIVH substantially reduces bias, especially when survey designs are spatially imbalanced. We also demonstrate the utility of the gIVH in diagnosing problematic extrapolations when estimating the relative abundance of ribbon seals in the Bering Sea as a function of predictive covariates. We suggest that ecologists routinely use diagnostics such as the gIVH to help gauge the reliability of predictions from statistical models (such as generalized linear, generalized additive, and spatio-temporal regression models).	[Conn, Paul B.; Johnson, Devin S.; Boveng, Peter L.] NOAA, Natl Marine Mammal Lab, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Conn, PB (corresponding author), NOAA, Natl Marine Mammal Lab, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, 7600 Sand Point Way NE, Seattle, WA 98115 USA.	paul.conn@noaa.gov			U.S. National Oceanic and Atmospheric Administration (NOAA); U.S. Bureau of Ocean Energy Management (BOEM) [M12PG00017]; NOAA	U.S. National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Bureau of Ocean Energy Management (BOEM); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding for Bering Sea aerial surveys was provided by the U.S. National Oceanic and Atmospheric Administration (NOAA; www.noaa.gov) and by the U.S. Bureau of Ocean Energy Management (BOEM; www.boem.gov) via Interagency Agreement M12PG00017. NOAA provided salary for all three authors and funded surveys. BOEM had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1938, BIOMETRIC B; Augustin NH, 2013, ENVIRONMETRICS, V24, P109, DOI 10.1002/env.2196; Conn PB, 2014, METHODS ECOL EVOL, V5, P1280, DOI 10.1111/2041-210X.12127; Conn PB, 2015, SPATPRED, DOI [Http://dx.doi.org/10.6084/m9.figshare.1381915, DOI 10.6084/M9.FIGSHARE.1381915]; Conn PB, ECOLOGICAL IN PRESS; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; COOK RD, 1979, J AM STAT ASSOC, V74, P169, DOI 10.2307/2286747; Draper NR., 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590]; EHRENBERG ASC, 1993, J ROY STAT SOC A STA, V156, P167, DOI 10.2307/2982727; ELITH J, 2009, REV ECOLOGY EVOLUTIO, V40, P677, DOI DOI 10.1146/ANNUREV.ECOLSYS.110308.120159; Gelman A., 2004, BAYESIAN DATA ANAL; Hastie T., 1999, GEN ADDITIVE MODELS; Hubbell Stephen P., 2001, V32, pi; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Mannocci L, 2015, J BIOGEOGR, V42, P1267, DOI 10.1111/jbi.12530; Marra G, 2012, STAT NEERL, V66, P133, DOI 10.1111/j.1467-9574.2011.00500.x; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Muller WG, 2007, OPTIMUM DESIGN OF EX; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; R Development Core Team, 2012, R A LANGUAGE AND ENV; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Thorson JT, ECOLOGY IN PRESS; VERHOEF JM, 2012, AM STAT, V66, P124, DOI [DOI 10.1080/00031305.2012.687494, DOI 10.1080/00031305.2012.68749]; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	25	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141416	10.1371/journal.pone.0141416	http://dx.doi.org/10.1371/journal.pone.0141416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496358	Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200107
J	Feng, XQ; Wilson, A				Feng, Xiaoqi; Wilson, Andrew			Getting Bigger, Quicker? Gendered Socioeconomic Trajectories in Body Mass Index across the Adult Lifecourse: A Longitudinal Study of 21,403 Australians	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; ALLOSTATIC LOAD; OBESITY; AGE; DEPRIVATION; MULTILEVEL; DISEASE; WEIGHT; PERIOD; CRIME	Do socioeconomic inequities in body mass index (BMI) widen across the adult lifecourse? BMI data for 29,104 male and 32,454 female person-years aged 15 years and older (21,403 persons in total) were extracted from the Household, Income and Labour Dynamics in Australia between 2006 and 2012. Multilevel linear regression was used to examine age and gender specific trajectories in BMI by quintiles of neighborhood socioeconomic circumstance. Models were adjusted for probable sources of confounding, including couple status, number of children resident, if somebody in the household had been pregnant in the last 12 months, the highest level of education achieved, the average household gross income, and the percentage of time in the last year spent unemployed. Approximately 9.6% of BMI variation was observed between neighborhoods. High neighborhood disadvantage was associated with 2.09 kg/m(2) heavier BMI (95% CI 1.82, 2.36). At age 15-24y, socioeconomic inequity in BMI was already evident among men and women especially (22.6 kg/m(2) among women in the most affluent areas compared with 25.4 kg/m(2) among the most disadvantaged). Among women only, the socioeconomic gap widened from 2.8 kg/m(2) at age 15-24y to 3.2 kg/m(2) by age 35-44y. Geographical factors may contribute to more rapid weight gain among women living in disadvantaged neighborhoods.	[Feng, Xiaoqi] Univ Wollongong, Early Start Res Inst, Wollongong, NSW, Australia; [Feng, Xiaoqi] Univ Wollongong, Sch Hlth & Soc, Wollongong, NSW, Australia; [Feng, Xiaoqi; Wilson, Andrew] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia; [Wilson, Andrew] Sax Inst, Australian Prevent Partnership Ctr, Sydney, NSW, Australia	University of Wollongong; University of Wollongong; University of Sydney; University of Sydney	Feng, XQ (corresponding author), Univ Wollongong, Early Start Res Inst, Wollongong, NSW, Australia.	xfeng@uow.edu.au	PAN, ZEQIANG/X-6341-2018; Feng, Xiaoqi/AAM-9592-2021	Feng, Xiaoqi/0000-0002-3421-220X; Wilson, Andrew/0000-0002-1809-7846				Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2004, LIFE COURSE APPROACH; Astell-Burt T, 2015, SOC SCI MED, V138, P68, DOI 10.1016/j.socscimed.2015.05.014; Bailey N, 2008, URBAN STUD, V45, P943, DOI 10.1177/0042098007088475; Bell A, 2014, DEMOGR RES, V30, P333, DOI 10.4054/DemRes.2014.30.11; Bell A, 2013, SOC SCI MED, V93, P163, DOI 10.1016/j.socscimed.2013.04.029; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Boyle PJ, 2009, SOC SCI MED, V68, P1835, DOI 10.1016/j.socscimed.2009.02.051; Colagiuri S, 2012, DIABETES OBES METAB, V14, P3, DOI 10.1111/j.1463-1326.2011.01506.x; Colagiuri S, 2010, MED J AUSTRALIA, V192, P260, DOI 10.5694/j.1326-5377.2010.tb03503.x; Coogan PF, 2010, OBESITY, V18, P2064, DOI 10.1038/oby.2010.69; Feng J, 2010, HEALTH PLACE, V16, P175, DOI 10.1016/j.healthplace.2009.09.008; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Giles-Corti B, 2013, SOC SCI MED, V77, P20, DOI 10.1016/j.socscimed.2012.10.016; GLENN ND, 1976, AM SOCIOL REV, V41, P900, DOI 10.2307/2094738; Health US, 2013, INT PERSP SHORT LIV; Herman WH, 2013, DIABETES CARE, V36, P775, DOI 10.2337/dc13-0270; Jokela M, 2014, AM J EPIDEMIOL; Jokela M, 2015, J EPIDEMIOL COMMUNIT; Kawachi I., 2003, NEIGHBORHOODS HLTH; Lee CMY, 2013, DIABETES RES CLIN PR; Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005; Maas R, 2015, URBAN STUDIES; Macintyre S, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-32; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Mujahid MS, 2005, OBES RES, V13, P1412, DOI 10.1038/oby.2005.171; Oakes J. Michael, 2015, CURRENT EPIDEMIOLOGY, V2, P1; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Pink B., 2011, TECHNICAL PAPER SOCI; Rasbash J., 2000, USERS GUIDE MLWIN, P286; RAUDENBUSH SW, 1992, J RES CRIME DELINQ, V29, P387, DOI 10.1177/0022427892029004001; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Ruel E, 2010, HEALTH PLACE, V16, P191, DOI 10.1016/j.healthplace.2009.09.009; Runciman Walter Garrison, 1966, RELATIVE DEPRIVATION; Sampson RJ, 2004, SOC PSYCHOL QUART, V67, P319, DOI 10.1177/019027250406700401; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Stafford M, 2010, AM J PREV MED, V39, P130, DOI 10.1016/j.amepre.2010.03.021; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P18, DOI 10.1097/EDE.0b013e31818f69ce; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; WOODEN M, 2002, AUSTR EC REV, V0035; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	45	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141499	10.1371/journal.pone.0141499	http://dx.doi.org/10.1371/journal.pone.0141499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU1VG	26496435	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200108
J	Labadorf, AT; Myers, RH				Labadorf, Adam T.; Myers, Richard H.			Evidence of Extensive Alternative Splicing in Post Mortem Human Brain HTT Transcription by mRNA Sequencing	PLOS ONE			English	Article							PROTEIN; GENE	Despite 20 years since its discovery, the gene responsible for Huntington's Disease, HTT, has still not had its function or transcriptional profile completely characterized. In response to a recent report by Ruzo et al. of several novel splice forms of HTT in human embryonic stem cell lines, we have analyzed a set of mRNA sequencing datasets from post mortem human brain from Huntington's disease, Parkinson's disease, and neurologically normal control subjects to evaluate support for previously observed and to identify novel splice patterns. A custom analysis pipeline produced supporting evidence for some of the results reported by two previous studies of alternative isoforms as well as identifying previously unreported splice patterns. All of the alternative splice patterns were of relatively low abundance compared to the canonical splice form.	[Labadorf, Adam T.; Myers, Richard H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Labadorf, Adam T.; Myers, Richard H.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Myers, Richard H.] Boston Univ, Sch Med, Genome Sci Inst, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Myers, RH (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.	rmyers@bu.edu		Labadorf, Adam/0000-0002-0753-8992	Jerry McDonald HD Research Fund; US National Institutes of Health [R01-NS073947, R01-NS076843]; Harvard Brain Tissue Resource Center [HHSN-271-2013-0030C]; NSF-EArly-concept Grants for Exploratory Research (EAGER) [PHY-1444389]; Direct For Mathematical & Physical Scien [1444389] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026, R01NS076843, R01NS073947] Funding Source: NIH RePORTER	Jerry McDonald HD Research Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Brain Tissue Resource Center; NSF-EArly-concept Grants for Exploratory Research (EAGER); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Jerry McDonald HD Research Fund (RHM) and by US National Institutes of Health (R01-NS073947, Epigenetic Markers in Huntington's disease Brain and R01-NS076843, Characterization of the role of cyclin G-associated kinase in Parkinson disease), The Harvard Brain Tissue Resource Center (Contract HHSN-271-2013-0030C), and PHY-1444389 NSF-EArly-concept Grants for Exploratory Research (EAGER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dao P, 2014, BIOINFORMATICS, V30, P644, DOI 10.1093/bioinformatics/btt591; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hughes AC, 2014, J MOL BIOL, V426, P1428, DOI 10.1016/j.jmb.2013.12.028; Labadorf A, 2015, PLOS ONE; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; NA J, 2011, SICKLE SLIDING WINDO; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Ruzo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127687; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110	14	13	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141298	10.1371/journal.pone.0141298	http://dx.doi.org/10.1371/journal.pone.0141298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496077	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200087
J	Peiris, D; Ossondo, M; Fry, S; Loizidou, M; Smith-Ravin, J; Dwek, MV				Peiris, Diluka; Ossondo, Marlene; Fry, Simon; Loizidou, Marilena; Smith-Ravin, Juliette; Dwek, Miriam V.			Identification of O-Linked Glycoproteins Binding to the Lectin Helix pomatia Agglutinin as Markers of Metastatic Colorectal Cancer	PLOS ONE			English	Article							BREAST-CANCER; PROTEOME ANALYSIS; EXPRESSION; ANNEXINS; TUMOR; CELLS; HISTOCHEMISTRY; GLCNACYLATION; CARCINOMAS; ROLES	Background Protein glycosylation is an important post-translational modification shown to be altered in all tumour types studied to date. Mucin glycoproteins have been established as important carriers of O-linked glycans but other glycoproteins exhibiting altered glycosylation repertoires have yet to be identified but offer potential as biomarkers for metastatic cancer. Methodology In this study a glycoproteomic approach was used to identify glycoproteins exhibiting alterations in glycosylation in colorectal cancer and to evaluate the changes in O-linked glycosylation in the context of the p53 and KRAS (codon 12/13) mutation status. Affinity purification with the carbohydrate binding protein from Helix pomatia agglutinin (HPA) was coupled to 2-dimensional gel electrophoresis with mass spectrometry to enable the identification of low abundance O-linked glycoproteins from human colorectal cancer specimens. Results Aberrant O-linked glycosylation was observed to be an early event that occurred irrespective of the p53 and KRAS status and correlating with metastatic colorectal cancer. Affinity purification using the lectin HPA followed by proteomic analysis revealed annexin 4, annexin 5 and CLCA1 to be increased in the metastatic colorectal cancer specimens. The results were validated using a further independent set of specimens and this showed a significant association between the staining score for annexin 4 and HPA and the time to metastasis; independently (annexin A4: Chi square 11.45, P = 0.0007; HPA: Chi square 9.065, P = 0.0026) and in combination (annexin 4 and HPA combined: Chi square 13.47; P = 0.0002). Conclusion Glycoproteins showing changes in O-linked glycosylation in metastatic colorectal cancer have been identified. The glycosylation changes were independent of p53 and KRAS status. These proteins offer potential for further exploration as biomarkers and potential targets for metastatic colorectal cancer.	[Peiris, Diluka; Fry, Simon; Dwek, Miriam V.] Univ Westminster, Fac Sci & Technol, Dept Biomed Sci, London W1R 8AL, England; [Ossondo, Marlene; Smith-Ravin, Juliette] Univ Antilles Guyane, Dept Sci Interfacultaire, AIHP GEODE BIOSPHERES EA929, Schoelcher, Martinique, France; [Loizidou, Marilena] UCL, Sch Life & Med Sci, Div Surg & Intervent Sci, London, England	University of Westminster; University of London; University College London	Dwek, MV (corresponding author), Univ Westminster, Fac Sci & Technol, Dept Biomed Sci, London W1R 8AL, England.	m.v.dwek@westminster.ac.uk		Dwek, Miriam/0000-0001-7184-2932; Loizidou, Marilena/0000-0002-0900-9795	Against Breast Cancer [1121258]	Against Breast Cancer	This study was supported by Against Breast Cancer, Registered Charity Number 1121258 (funded DP and SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany M, 2001, J BIOL CHEM, V276, P25438, DOI 10.1074/jbc.M100478200; Alfonso P, 2008, J PROTEOME RES, V7, P4247, DOI 10.1021/pr800152u; Arrington AK, 2012, INT J MOL SCI, V13, P12153, DOI 10.3390/ijms131012153; BHATTACHARYYA L, 1988, EUR J BIOCHEM, V176, P207, DOI 10.1111/j.1432-1033.1988.tb14270.x; BROOKS SA, 1991, LANCET, V338, P71, DOI 10.1016/0140-6736(91)90071-V; Brooks SA, 1996, J HISTOCHEM CYTOCHEM, V44, P519, DOI 10.1177/44.5.8627008; Bustin SA, 2001, DNA CELL BIOL, V20, P331, DOI 10.1089/10445490152122442; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; FUKUTOMI T, 1989, JPN J CLIN ONCOL, V19, P127; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Ghazarian H, 2011, ACTA HISTOCHEM, V113, P236, DOI 10.1016/j.acthis.2010.02.004; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Guzman-Aranguez A, 2005, J CELL BIOCHEM, V94, P178, DOI 10.1002/jcb.20293; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; IKEDA Y, 1994, DIS COLON RECTUM, V37, P181, DOI 10.1007/BF02047545; Kijima M, 2005, ANTICANCER RES, V25, P1327; Kim YS, 2008, PROTEOMICS, V8, P3229, DOI 10.1002/pmic.200800034; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEATHEM A, 1983, DIAGN HISTOPATHOL, V6, P171; Li Ning, 2008, Chinese Journal of Clinical Oncology, V5, P429, DOI 10.1007/s11805-008-0429-0; Markiv A, 2012, CURR OPIN PHARMACOL, V12, P408, DOI 10.1016/j.coph.2012.04.003; Markiv A, 2011, J BIOL CHEM, V286, P20260, DOI 10.1074/jbc.M110.184515; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Rambaruth NDS, 2012, GLYCOBIOLOGY, V22, P839, DOI 10.1093/glycob/cws051; Rambaruth NDS, 2011, ACTA HISTOCHEM, V113, P591, DOI 10.1016/j.acthis.2011.03.001; Saint-Guirons J, 2007, PROTEOMICS, V7, P4082, DOI 10.1002/pmic.200700434; Sanchez JF, 2006, J BIOL CHEM, V281, P20171, DOI 10.1074/jbc.M603452200; Schima Wolfgang, 2005, Cancer Imaging, V5 Spec No A, pS149, DOI 10.1102/1470-7330.2005.0035; Schnegelsberg B, 2011, ANTICANCER RES, V31, P1589; SCHUMACHER U, 1994, CANCER-AM CANCER SOC, V74, P3104, DOI 10.1002/1097-0142(19941215)74:12<3104::AID-CNCR2820741207>3.0.CO;2-0; Schumacher U, 1996, HISTOCHEM CELL BIOL, V106, P599; Xue G, 2009, J CLIN GASTROENTEROL, V43, P831, DOI 10.1097/MCG.0b013e31819cc731; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yehezkel G, 2012, J BIOL CHEM, V287, P28755, DOI 10.1074/jbc.M112.345546; Yeoh LC, 2011, WORLD J GASTROENTERO, V17, P2096, DOI 10.3748/wjg.v17.i16.2096; Zhang XH, 2012, CLIN TRANSL ONCOL, V14, P634, DOI 10.1007/s12094-012-0855-6; Zimmermann U, 2004, CANCER LETT, V209, P111, DOI 10.1016/j.canlet.2003.12.002	40	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0138345	10.1371/journal.pone.0138345	http://dx.doi.org/10.1371/journal.pone.0138345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495974	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000363309200005
J	Wu, YP; Beardall, J; Gao, KS				Wu, Yaping; Beardall, John; Gao, Kunshan			Physiological Responses of a Model Marine Diatom to Fast pH Changes: Special Implications of Coastal Water Acidification	PLOS ONE			English	Article							CARBON-CONCENTRATING MECHANISM; SOLAR UV-RADIATION; THALASSIOSIRA-PSEUDONANA; GROWTH-RATE; CO2; PHOTOSYNTHESIS; PHYTOPLANKTON; LIGHT; FIXATION; LIMITATION	Diatoms and other phytoplankton in coastal waters experience rapid pH changes in milieu due to high biological activities and/or upwelled CO2-rich waters. While CO2 concentrating mechanisms (CCMs) are employed by all diatoms tested to counter low CO2 availability in seawater, little is known how this mechanism responds to fast pH changes. In the present study, the model diatom Thalassiosira pseudonana was acclimated for 20 generations to low pH (7.81) at an elevated CO2 of 1000 mu atm (HC) or to high pH (8.18) at ambient CO2 levels of 390 mu atm (LC), then its physiological characteristics were investigated as cells were shifted from HC to LC or vice versa. The maximal electron transport rate (ETRmax) in the HC-acclimated cells was immediately reduced by decreased CO2 availability, showing much lower values compared to that of the LC-acclimated cells. However, the cells showed a high capacity to regain their photochemical performance regardless of the growth CO2 levels, with their ETRmax values recovering to initial levels in about 100 min. This result indicates that this diatom might modulate its CCMs quickly to maintain a steady state supply of CO2, which is required for sustaining photosynthesis. In addition, active uptake of CO2 could play a fundamental role during the induction of CCMs under CO2 limitation, since the cells maintained high ETR even when both intracellular and periplasmic carbonic anhy-drases were inhibited. It is concluded that efficient regulation of the CCM is one of the key strategies for diatoms to survive in fast changing pH environment, e.g. for the tested species, which is a dominant species in coastal waters where highly fluctuating pH is observed.	[Wu, Yaping; Gao, Kunshan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Beardall, John] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	Xiamen University; Monash University	Gao, KS (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	ksgao@xmu.edu.cn	Beardall, John/L-5262-2019; Wu, Yaping/C-7996-2014; Wu, Yaping/AAK-2810-2021; gao, kunshan/G-3374-2010	Beardall, John/0000-0001-7684-446X; Gao, Kunshan/0000-0001-7365-6332	National Natural Science Foundation [41120164007, 41430967, 41206091]; NSFC [U1406403]; Strategic Priority Research Program of CAS [XDA11020302]; Program for Chang-jiang Scholars and Innovative Research Team [IRT_13R51]; SOA [GASI-03-01-02-04, MELRI1403]; China-Japan collaboration project from MOST [S2012GR0290]; Fundamental Research Funds for the Central Universities [20720150076]; Australian Research Council; '111' project from the Ministry of Education; Shan-dong province [U1406403]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of CAS; Program for Chang-jiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); SOA; China-Japan collaboration project from MOST; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Australian Research Council(Australian Research Council); '111' project from the Ministry of Education(Ministry of Education, China - 111 Project); Shan-dong province	This study was supported by National Natural Science Foundation (41120164007, 41430967, 41206091), the Joint project of NSFC and Shan-dong province (Grant No. U1406403), Strategic Priority Research Program of CAS (Grant No. XDA11020302), Program for Chang-jiang Scholars and Innovative Research Team (IRT_13R51), SOA (GASI-03-01-02-04), MELRI1403, China-Japan collaboration project from MOST (S2012GR0290) and the Fundamental Research Funds for the Central Universities (20720150076). JB's work on climate change effects on algae has been funded by the Australian Research Council, and his visit to Xiamen was supported by '111' project from the Ministry of Education.	BEARDALL J, 1976, J PHYCOL, V12, P409; Beer S., 2014, PHOTOSYNTHESIS IN TH; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Campbell D.A., 2014, FUNCTIONAL PLANT BIO, P449; Cornwall CE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2201; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; Descamps-Julien B, 2005, ECOLOGY, V86, P2815, DOI 10.1890/04-1700; Doney SC, 2006, SCI AM, V294, P58, DOI 10.1038/scientificamerican0306-58; Ducklow Hugh W., 2001, Oceanography, V14, P50; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Fanesi A, 2014, PLANT CELL ENVIRON, V37, P512, DOI 10.1111/pce.12176; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Fukuzawa H, 2001, P NATL ACAD SCI USA, V98, P5347, DOI 10.1073/pnas.081593498; Gao KS, 2007, PLANT PHYSIOL, V144, P54, DOI 10.1104/pp.107.098491; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Giordano M, 2013, PLANT SCI, V211, P92, DOI 10.1016/j.plantsci.2013.07.008; Granum E, 2009, J PHYCOL, V45, P1083, DOI 10.1111/j.1529-8817.2009.00728.x; Hobson LA, 2001, J PHYCOL, V37, P717, DOI 10.1046/j.1529-8817.2001.00112.x; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; HOLLIGAN PM, 1985, NATURE, V314, P348, DOI 10.1038/314348a0; Hoppe C, 2014, OC SCI M HON HAW US; IGBP IOC SCOR, 2013, 3 S OC HIGH CO2 WORL; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Kustka AB, 2014, NEW PHYTOL, V204, P507, DOI 10.1111/nph.12926; Li G, 2011, PHOTOCHEM PHOTOBIOL, V87, P329, DOI 10.1111/j.1751-1097.2010.00862.x; Lin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017141; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; MOREL FMM, 1979, J PHYCOL, V15, P135, DOI 10.1111/j.0022-3646.1979.00135.x; PRICE NM, 1987, J PHYCOL, V23, P1; Raven JA, 2014, PHOTOSYNTH RES, V121, P111, DOI 10.1007/s11120-013-9962-7; Raven JA, 2013, PROG BOT, V74, P3, DOI 10.1007/978-3-642-30967-0_1; Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Reinfelder JR, 2004, PLANT PHYSIOL, V135, P2106, DOI 10.1104/pp.104.041319; Roberts K, 2007, PHOTOSYNTH RES, V93, P79, DOI 10.1007/s11120-007-9172-2; Scott KN, 2005, GEORGETOWN INT ENV L, V18, P57; SUKENIK A, 1987, BIOCHIM BIOPHYS ACTA, V891, P205, DOI 10.1016/0005-2728(87)90216-7; WILBUR KM, 1948, J BIOL CHEM, V176, P147; Woodger FJ, 2003, PLANT PHYSIOL, V133, P2069, DOI 10.1104/pp.103.029728; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Wu Y, 2014, LIMNOL OCEANOGR, V59, P1027, DOI 10.4319/lo.2014.59.3.1027; Yamano T, 2010, PLANT CELL PHYSIOL, V51, P1453, DOI 10.1093/pcp/pcq105; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002; Zheng Y, 2015, AQUAT BIOL, V23, P109, DOI 10.3354/ab00619	46	7	8	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141163	10.1371/journal.pone.0141163	http://dx.doi.org/10.1371/journal.pone.0141163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496125	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200069
J	Lee, JY; Lee, SH; Heo, SH; Kim, KS; Kim, C; Kim, DK; Ko, JJ; Park, KS				Lee, Jae-Young; Lee, Se-Hwan; Heo, Sun-Hee; Kim, Kwang-Soo; Kim, Changhoon; Kim, Dae-Kwan; Ko, Jeong-Jae; Park, Kyung-Soon			Novel Function of Lysine Methyltransferase G9a in the Regulation of Sox2 Protein Stability	PLOS ONE			English	Article							HISTONE H3 LYSINE-9; NEGATIVE REGULATION; DNA METHYLATION; BREAST-CANCER; CELLS; MAINTENANCE; DNMT1; TRANSCRIPTION; METASTASIS; EXPRESSION	G9a is a lysine methyltransferase (KMTase) for histone H3 lysine 9 that plays critical roles in a number of biological processes. Emerging evidence suggests that aberrant expression of G9a contributes to tumor metastasis and maintenance of a malignant phenotype in cancer by inducing epigenetic silencing of tumor suppressor genes. Here, we show that G9a regulates Sox2 protein stability in breast cancer cells. When G9a lysine methyltransferase activity was chemically inhibited in the ER(+) breast cancer cell line MCF7, Sox2 protein levels were decreased. In addition, ectopic overexpression of G9a induced accumulation of Sox2. Changes in cell migration, invasion, and mammosphere formation by MCF7 cells were correlated with the activity or expression level of G9a. Ectopic expression of G9a also increased Sox2 protein levels in another ER(+) breast cancer cell line, ZR-75-1, whereas it did not affect Sox2 expression in MDA-MB-231 cells, an ER(-) breast cancer cell line, or in glioblastoma cell lines. Furthermore, treatment of mouse embryonic stem cells with a KMT inhibitor, BIX-01294, resulted in a rapid reduction in Sox2 protein expression despite increased Sox2 transcript levels. This finding suggests that G9a has a novel function in the regulation of Sox2 protein stability in a cell type-dependent manner.	[Lee, Jae-Young; Lee, Se-Hwan; Heo, Sun-Hee; Kim, Kwang-Soo; Kim, Dae-Kwan; Ko, Jeong-Jae; Park, Kyung-Soon] CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea; [Kim, Changhoon] Hanyang Univ, Dept Biomed Sci, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea	Pochon Cha University; Hanyang University	Park, KS (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea.	kspark@cha.ac.kr		Kim, Changhoon/0000-0001-5971-863X	Rural Development Administration, Republic of Korea [PJ010033]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (PJ010033)", Rural Development Administration, Republic of Korea.	Apostolou P, 2012, CURR STEM CELL RES T, V7, P415, DOI 10.2174/157488812804484639; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Brown SE, 2001, MAMM GENOME, V12, P916, DOI 10.1007/s00335-001-3029-3; Chaturvedi CP, 2012, P NATL ACAD SCI USA, V109, P18845, DOI 10.1073/pnas.1213951109; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Cho HS, 2011, NEOPLASIA, V13, P676, DOI 10.1593/neo.11512; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Hua KT, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-189; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Islam K, 2013, P NATL ACAD SCI USA, V110, P16778, DOI 10.1073/pnas.1216365110; Kondo Y, 2007, HEPATOL RES, V37, P974, DOI 10.1111/j.1872-034X.2007.00141.x; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Wu H, 2011, CELL RES, V21, P365, DOI 10.1038/cr.2010.157; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176	26	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141118	10.1371/journal.pone.0141118	http://dx.doi.org/10.1371/journal.pone.0141118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492085	gold, Green Submitted, Green Published			2022-12-27	WOS:000363249300031
J	Dupuis-Desormeaux, M; Davidson, Z; Mwololo, M; Kisio, E; Taylor, S; MacDonald, SE				Dupuis-Desormeaux, Marc; Davidson, Zeke; Mwololo, Mary; Kisio, Edwin; Taylor, Sam; MacDonald, Suzanne E.			Testing the Prey-Trap Hypothesis at Two Wildlife Conservancies in Kenya	PLOS ONE			English	Article							TRANSBOUNDARY CONSERVATION; BEHAVIORAL-ADJUSTMENTS; LOXODONTA-AFRICANA; MOVEMENT PATTERNS; LARGE CARNIVORE; PREDATION RISK; SPOTTED HYENAS; NATIONAL-PARK; LIONS; ELEPHANTS	Protecting an endangered and highly poached species can conflict with providing an open and ecologically connected landscape for coexisting species. In Kenya, about half of the black rhino (Diceros bicornis) live in electrically fenced private conservancies. Purpose-built fence-gaps permit some landscape connectivity for elephant while restricting rhino from escaping. We monitored the usage patterns at these gaps by motion-triggered cameras and found high traffic volumes and predictable patterns of prey movement. The prey-trap hypothesis (PTH) proposes that predators exploit this predictable prey movement. We tested the PTH at two semi-porous reserves using two different methods: a spatial analysis and a temporal analysis. Using spatial analysis, we mapped the location of predation events with GPS and looked for concentration of kill sites near the gaps as well as conducting clustering and hot spot analysis to determine areas of statistically significant predation clustering. Using temporal analysis, we examined the time lapse between the passage of prey and predator and searched for evidence of active prey seeking and/or predator avoidance. We found no support for the PTH and conclude that the design of the fence-gaps is well suited to promoting connectivity in these types of conservancies.	[Dupuis-Desormeaux, Marc] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Davidson, Zeke] Marwell Wildlife, Winchester, Hants, England; [Mwololo, Mary; Kisio, Edwin] Lewa Wildlife Conservancy, Isiolo, Kenya; [Taylor, Sam] Borana Wildlife Conservancy, Borana, Kenya; [MacDonald, Suzanne E.] York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	MacDonald, SE (corresponding author), York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada.	suzmac@yorku.ca		Dupuis-Desormeaux, Marc/0000-0001-9224-697X				Albertson A, 1998, NO BOTSWANA VET FENC; Aresco MJ, 2005, J WILDLIFE MANAGE, V69, P549, DOI 10.2193/0022-541X(2005)069[0549:MMTRHM]2.0.CO;2; Bartlam-Brooks HLA, 2011, ORYX, V45, P210, DOI 10.1017/S0030605310000414; Berger J, 2006, BIOL LETT-UK, V2, P528, DOI 10.1098/rsbl.2006.0508; Bode M, 2010, CONSERV BIOL, V24, P182, DOI 10.1111/j.1523-1739.2009.01291.x; Brenneman RA, 2009, AFR J ECOL, V47, P711, DOI 10.1111/j.1365-2028.2008.01029.x; Brown JS, 1999, EVOL ECOL RES, V1, P49; Chester C. C., 2003, Journal of Sustainable Forestry, V17, P103, DOI 10.1300/J091v17n01_07; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Clements HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101054; Conover M. R., 2007, PREDATOR PREY DYNAMI; Cotterill A, 2015, LANDSCAPES COEXISTEN, DOI [10.1111/oik.02224, DOI 10.1111/0IK.02224]; Davidson Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055182; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; Davies-Mostert HT, 2013, J APPL ECOL, V50, P1358, DOI 10.1111/1365-2664.12129; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dodd Jr CK, 2002, EFFECTIVENESS WILDLI; Ford AT, 2010, CONSERV BIOL, V24, P1679, DOI 10.1111/j.1523-1739.2010.01564.x; FOSTER ML, 1995, WILDLIFE SOC B, V23, P95; Harrington JL, 2006, WILDLIFE SOC B, V34, P1295, DOI 10.2193/0091-7648(2006)34[1295:COUBAM]2.0.CO;2; Haynes G., 2011, GEOMORPHOLOGY; Hayward MW, 2009, ACTA THERIOL, V54, P219, DOI 10.4098/j.at.0001-7051.074.2008; Hayward MW, 2009, BIODIVERS CONSERV, V18, P887, DOI 10.1007/s10531-008-9452-y; Hayward MW, 2009, BIOL CONSERV, V142, P1, DOI 10.1016/j.biocon.2008.09.022; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; Hoare RE, 2001, S AFR J WILDL RES, V31, P179; Holekamp KE, 1997, J ZOOL, V242, P1, DOI 10.1111/j.1469-7998.1997.tb02925.x; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; HUNT A, 1987, Australian Zoologist, V24, P89; Kioko J, 2008, S AFR J WILDL RES, V38, P52, DOI 10.3957/0379-4369-38.1.52; Kioko JM, 2011, PACHYDERM, P70; Kissui BM, 2008, ANIM CONSERV, V11, P422, DOI 10.1111/j.1469-1795.2008.00199.x; Lewa Wildlife Conservancy Research Department, 2014, VEGETATION SURVEY 20; Little SJ, 2002, BIOL CONSERV, V107, P135, DOI 10.1016/S0006-3207(02)00059-9; Loarie SR, 2009, BIOL CONSERV, V142, P3099, DOI 10.1016/j.biocon.2009.08.021; Maclennan SD, 2009, BIOL CONSERV, V142, P2419, DOI 10.1016/j.biocon.2008.12.003; Massey AL, 2014, BIOL CONSERV, V176, P162, DOI 10.1016/j.biocon.2014.05.023; Mbaiwa J.E., 2006, INT J WILDERNESS, V12, P41; Miller SM, 2014, S AFR J WILDL RES, V44, P43, DOI 10.3957/056.044.0107; Mungai D, 2011, ENVIRONMENTAL SOCIAL; Mutinda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091749; Nasseri NA, 2011, AFR J ECOL, V49, P133, DOI 10.1111/j.1365-2028.2010.01238.x; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Nyaligu M.O., 2013, PARKS, V19, P91; O'Connell-Rodwell CE, 2000, BIOL CONSERV, V93, P381, DOI 10.1016/S0006-3207(99)00108-1; Olsson MPO, 2008, WILDLIFE BIOL, V14, P111, DOI 10.2981/0909-6396(2008)14[111:EOHFAW]2.0.CO;2; Osborn FV, 2003, AFR J ECOL, V41, P68, DOI 10.1046/j.1365-2028.2003.00413.x; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Pagnucco KS, 2011, HERPETOL CONSERV BIO, V6, P277; Periquet S, 2012, BEHAV ECOL, V23, P970, DOI 10.1093/beheco/ars060; Periquet S, 2010, ANIM BEHAV, V79, P665, DOI 10.1016/j.anbehav.2009.12.016; Plumptre AJ, 2007, BIOL CONSERV, V134, P279, DOI 10.1016/j.biocon.2006.08.012; Pratt LM, 2014, THE EFFECT OF PREDAT; Rhodes R, 2004, S AFR J WILDL RES, V34, P135; Romanach SS, 2008, ANIM CONSERV, V11, P111, DOI 10.1111/j.1469-1795.2007.00156.x; Romanach SS, 2007, ORYX, V41, P185, DOI 10.1017/S0030605307001779; Schaller G. B., 1972, THE SERENGETI LION A; SCHEEL D, 1993, ANIM BEHAV, V46, P695, DOI 10.1006/anbe.1993.1246; SCHEEL D, 1993, BEHAV ECOL, V4, P90, DOI 10.1093/beheco/4.1.90; Service KF, 2008, MOUNT KEN INT EC MAN; Sitienei AJ, 2014, EUR J WILDLIFE RES, V60, P323, DOI 10.1007/s10344-013-0789-5; STANDER PE, 1992, BEHAV ECOL SOCIOBIOL, V29, P445; THOULESS CR, 1995, BIOL CONSERV, V72, P99, DOI 10.1016/0006-3207(94)00071-W; Trinkel M, 2004, J ZOOL, V264, P125, DOI 10.1017/S0952836904005588; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; Valeix M, 2011, BIOL CONSERV, V144, P902, DOI 10.1016/j.biocon.2010.10.029; Valeix M, 2010, LANDSCAPE ECOL, V25, P337, DOI 10.1007/s10980-009-9425-x; Vanak AT, 2010, BIOL CONSERV, V143, P2631, DOI 10.1016/j.biocon.2010.07.005; Weise FJ, 2014, S AFR J WILDL RES, V44, P161, DOI 10.3957/056.044.0213; White F., 1983, VEGETATION AFRICA DE; Wikramanayake ED, 1998, CONSERV BIOL, V12, P865, DOI 10.1046/j.1523-1739.1998.96428.x; Wolmer W, 2003, J S AFR STUD, V29, P261, DOI 10.1080/0305707032000060449	73	9	9	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139537	10.1371/journal.pone.0139537	http://dx.doi.org/10.1371/journal.pone.0139537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489024	Green Published, gold			2022-12-27	WOS:000363248400030
J	Golovnin, A; Melnikova, L; Shapovalov, I; Kostyuchenko, M; Georgiev, P				Golovnin, Anton; Melnikova, Larisa; Shapovalov, Igor; Kostyuchenko, Margarita; Georgiev, Pavel			EAST Organizes Drosophila Insulator Proteins in the Interchromosomal Nuclear Compartment and Modulates CP190 Binding to Chromatin	PLOS ONE			English	Article							LONG-DISTANCE INTERACTIONS; ZINC-FINGER PROTEIN; HAIRY-WING PROTEIN; ENHANCER BLOCKING; SPINDLE MATRIX; SUPPRESSOR; GENE; MELANOGASTER; TRANSCRIPTION; CHROMOSOMES	Recent data suggest that insulators organize chromatin architecture in the nucleus. The best studied Drosophila insulator proteins, dCTCF (a homolog of the vertebrate insulator protein CTCF) and Su(Hw), are DNA-binding zinc finger proteins. Different isoforms of the BTB-containing protein Mod(mdg4) interact with Su(Hw) and dCTCF. The CP190 protein is a cofactor for the dCTCF and Su(Hw) insulators. CP190 is required for the functional activity of insulator proteins and is involved in the aggregation of the insulator proteins into specific structures named nuclear speckles. Here, we have shown that the nuclear distribution of CP190 is dependent on the level of EAST protein, an essential component of the interchromatin compartment. EAST interacts with CP190 and Mod(mdg4)-67.2 proteins in vitro and in vivo. Over-expression of EAST in S2 cells leads to an extrusion of the CP190 from the insulator bodies containing Su(Hw), Mod(mdg4)-67.2, and dCTCF. In consistent with the role of the insulator bodies in assembly of protein complexes, EAST over-expression led to a striking decrease of the CP190 binding with the dCTCF and Su(Hw) dependent insulators and promoters. These results suggest that EAST is involved in the regulation of CP190 nuclear localization.	[Golovnin, Anton; Melnikova, Larisa; Shapovalov, Igor; Kostyuchenko, Margarita] Russian Acad Sci, Inst Gene Biol, Dept Drosophila Mol Genet, Moscow 119334, Russia; [Georgiev, Pavel] Russian Acad Sci, Inst Gene Biol, Dept Control Genet Proc, Moscow 119334, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Golovnin, A (corresponding author), Russian Acad Sci, Inst Gene Biol, Dept Drosophila Mol Genet, 34-5 Vavilov St, Moscow 119334, Russia.	agolovnin@mail.ru; georgiev_p@mail.ru		Georgiev, Pavel/0000-0002-6509-3194	Russian Science Foundation [14-14-01067]; Ministry of Science and Education of the Russian Federation [16.552.11.7067]	Russian Science Foundation(Russian Science Foundation (RSF)); Ministry of Science and Education of the Russian Federation(Ministry of Education and Science, Russian Federation)	This study was supported by the Russian Science Foundation (http://www.rscf.ru) (project. 14-14-01067). Experiments were performed using the equipment of IGB RAS facilities supported by the Ministry of Science and Education of the Russian Federation [grant no. 16.552.11.7067].	Ahanger SH, 2013, NUCLEUS-AUSTIN, V4, P115, DOI 10.4161/nucl.23389; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Bonchuk A, 2011, J MOL BIOL, V412, P423, DOI 10.1016/j.jmb.2011.07.052; Buchner K, 2000, GENETICS, V155, P141; Butcher RDJ, 2004, J CELL SCI, V117, P1191, DOI 10.1242/jcs.00979; CALLAINI G, 1990, J CELL SCI, V97, P539; Capelson M, 2006, EMBO J, V25, P1906, DOI 10.1038/sj.emboj.7601068; Chetverina D, 2014, BIOESSAYS, V36, P163, DOI 10.1002/bies.201300125; Cho EJ, 2012, BIOPHYS J, V103, P424, DOI 10.1016/j.bpj.2012.07.007; Cuartero S, 2014, EMBO J, V33, P637, DOI 10.1002/embj.201386001; DORSETT D, 1990, P NATL ACAD SCI USA, V87, P4373, DOI 10.1073/pnas.87.11.4373; Erokhin M, 2010, CHROMOSOMA, V119, P243, DOI 10.1007/s00412-009-0253-1; Gause M, 2001, MOL CELL BIOL, V21, P4807, DOI 10.1128/MCB.21.14.4807-4817.2001; Georgieva SG, 2001, RUSS J GENET+, V37, P19, DOI 10.1023/A:1009010307221; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; Golovnin A, 2003, DEVELOPMENT, V130, P3249, DOI 10.1242/dev.00543; Golovnin A, 2008, EMBO REP, V9, P440, DOI 10.1038/embor.2008.32; Golovnin A, 2007, MOL CELL BIOL, V27, P963, DOI 10.1128/MCB.00795-06; Golovnin A, 2012, J CELL SCI, V125, P2064, DOI 10.1242/jcs.100172; HOLDRIDGE C, 1991, MOL CELL BIOL, V11, P1894, DOI 10.1128/MCB.11.4.1894; Johansen J, 2009, FLY, V3, P213; Johansen KM, 2011, CHROMOSOME RES, V19, P345, DOI 10.1007/s10577-011-9187-6; Kuhn-Parnell EJ, 2008, GENETICS, V179, P1263, DOI 10.1534/genetics.108.087254; Kurshakova M, 2007, MOL CELL, V27, P332, DOI 10.1016/j.molcel.2007.05.035; Kyrchanova O, 2014, FEBS LETT, V588, P8, DOI 10.1016/j.febslet.2013.10.039; Liang J, 2014, MOL CELL, V53, P672, DOI 10.1016/j.molcel.2013.12.029; Maksimenko O, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00028; Martins RP, 2012, ANNU REV BIOMED ENG, V14, P431, DOI [10.1146/annurev-bioeng-071910-124638, 10.1146/annurev.bioeng-071910-124638]; Matzat LH, 2014, BBA-GENE REGUL MECH, V1839, P203, DOI 10.1016/j.bbagrm.2013.10.007; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nora EP, 2013, BIOESSAYS, V35, P818, DOI 10.1002/bies.201300040; Oegema K, 1997, J CELL SCI, V110, P1573; Oliver D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-101; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Parnell TJ, 2006, MOL CELL BIOL, V26, P5983, DOI 10.1128/MCB.00698-06; Parnell TJ, 2003, P NATL ACAD SCI USA, V100, P13436, DOI 10.1073/pnas.2333111100; Qi HY, 2005, J CELL BIOCHEM, V95, P1284, DOI 10.1002/jcb.20495; Raab JR, 2010, NAT REV GENET, V11, P439, DOI 10.1038/nrg2765; Richter K, 2007, J CELL SCI, V120, P1673, DOI 10.1242/jcs.03440; Schoborg T, 2013, J CELL BIOL, V202, P261, DOI 10.1083/jcb.201304181; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Smigova J, 2013, BIOL CELL, V105, P519, DOI 10.1111/boc.201300022; Soshnev AA, 2012, NUCLEIC ACIDS RES, V40, P5415, DOI 10.1093/nar/gks225; SPANA C, 1990, GENE DEV, V4, P1505, DOI 10.1101/gad.4.9.1505; Tanay A, 2013, CURR OPIN GENET DEV, V23, P197, DOI 10.1016/j.gde.2012.12.009; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; Wasser M, 2000, NAT CELL BIOL, V2, P268, DOI 10.1038/35010535; Wasser M, 2003, J CELL SCI, V116, P1733, DOI 10.1242/jcs.00379; Wasser M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000412; WHITFIELD WGF, 1988, J CELL SCI, V89, P467	54	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140991	10.1371/journal.pone.0140991	http://dx.doi.org/10.1371/journal.pone.0140991			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489095	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400094
J	Hoerzer, S; Federolf, PA; Maurer, C; Baltich, J; Nigg, BM				Hoerzer, Stefan; Federolf, Peter A.; Maurer, Christian; Baltich, Jennifer; Nigg, Benno M.			Footwear Decreases Gait Asymmetry during Running	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; OLDER-ADULTS; SYMMETRY; FALLS; FREQUENCY; IDENTIFICATION; COORDINATION; VARIABILITY; KINEMATICS; BAREFOOT	Previous research on elderly people has suggested that footwear may improve neuromuscular control of motion. If footwear does in fact improve neuromuscular control, then such an influence might already be present in young, healthy adults. A feature that is often used to assess neuromuscular control of motion is the level of gait asymmetry. The objectives of the study were (a) to develop a comprehensive asymmetry index (CAI) that is capable of detecting gait asymmetry changes caused by external boundary conditions such as footwear, and (b) to use the CAI to investigate whether footwear influences gait asymmetry during running in a healthy, young cohort. Kinematic and kinetic data were collected for both legs of 15 subjects performing five barefoot and five shod over-ground running trials. Thirty continuous gait variables including ground reaction forces and variables of the hip, knee, and ankle joints were computed for each leg. For each individual, the differences between the variables for the right and left leg were calculated. Using this data, a principal component analysis was conducted to obtain the CAI. This study had two main outcomes. First, a sensitivity analysis suggested that the CAI had an improved sensitivity for detecting changes in gait asymmetry caused by external boundary conditions. The CAI may, therefore, have important clinical applications such as monitoring the progress of neuromuscular diseases (e.g. stroke or cerebral palsy). Second, the mean CAI for shod running (131.2 +/- 48.5; mean +/- standard deviation) was significantly lower (p = 0.041) than the CAI for barefoot running (155.7 +/- 39.5). This finding suggests that in healthy, young adults gait asymmetry is reduced when running in shoes compared to running barefoot, which may be a result of improved neuromuscular control caused by changes in the afferent sensory feedback.	[Hoerzer, Stefan; Maurer, Christian; Baltich, Jennifer; Nigg, Benno M.] Univ Calgary, Human Performance Lab, Fac Kinesiol, Calgary, AB, Canada; [Federolf, Peter A.] Univ Innsbruck, Inst Sport Sci, A-6020 Innsbruck, Tyrol, Austria; [Federolf, Peter A.] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Maurer, Christian] Red Bull Diagnost & Training Ctr, Salzburg, Austria	University of Calgary; University of Innsbruck; Norwegian University of Science & Technology (NTNU)	Hoerzer, S (corresponding author), Univ Calgary, Human Performance Lab, Fac Kinesiol, Calgary, AB, Canada.	stefan.hoerzer@ucalgary.ca	Federolf, Peter/H-4481-2019; Maurer, Christian/AAS-9688-2020	Federolf, Peter/0000-0002-0266-6813; Maurer, Christian/0000-0002-8426-813X	NSERC Create, Biomechanigg Sport & Health Research; da Vinci Foundation; Red Bull Diagnostic and Training Center	NSERC Create, Biomechanigg Sport & Health Research; da Vinci Foundation; Red Bull Diagnostic and Training Center	The authors would like to acknowledge NSERC Create, Biomechanigg Sport & Health Research, and the da Vinci Foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the Red Bull Diagnostic and Training Center provided support in the form of a salary for CM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	ALEXANDER BH, 1992, AM J PUBLIC HEALTH, V82, P1020, DOI 10.2105/AJPH.82.7.1020; Alfuth M, 2012, FOOTWEAR SCI, V4, P1, DOI 10.1080/19424280.2011.653990; Angeloni C., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P40, DOI 10.1109/86.296343; Ayoung-Chee P, 2014, J TRAUMA ACUTE CARE, V76, P498, DOI 10.1097/TA.0000000000000102; Bishop M, 2006, J ATHL TRAINING, V41, P387; Bohm H, 2012, GAIT POSTURE, V35, P322, DOI 10.1016/j.gaitpost.2011.10.003; Chau T, 2001, GAIT POSTURE, V13, P49, DOI 10.1016/S0966-6362(00)00094-1; Crenshaw SJ, 2006, GAIT POSTURE, V24, P515, DOI 10.1016/j.gaitpost.2005.12.002; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; De Wit B, 2000, J BIOMECH, V33, P269, DOI 10.1016/S0021-9290(99)00192-X; Exell TA, 2012, J BIOMECH, V45, P1108, DOI 10.1016/j.jbiomech.2012.01.007; Federolf PA, 2013, J BIOMECH, V46, P2173, DOI 10.1016/j.jbiomech.2013.06.032; Federolf PA, 2012, FOOTWEAR SCI, V4, P115, DOI 10.1080/19424280.2012.666270; Giakas G, 1997, GAIT POSTURE, V5, P189, DOI 10.1016/S0966-6362(96)01083-1; Hamill J, 2011, FOOTWEAR SCI, V3, P33, DOI 10.1080/19424280.2010.542187; Hendrickson J, 2014, GAIT POSTURE, V39, P177, DOI 10.1016/j.gaitpost.2013.06.022; Koepsell TD, 2004, J AM GERIATR SOC, V52, P1495, DOI 10.1111/j.1532-5415.2004.52412.x; Larsen ER, 2004, PREV MED, V39, P389, DOI 10.1016/j.ypmed.2004.02.001; Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023; Menz HB, 2006, GERONTOLOGY, V52, P174, DOI 10.1159/000091827; Moore JK, 2011, MULTIBODY SYST DYN, V25, P225, DOI 10.1007/s11044-010-9225-8; Muise SB, 2012, EXP BRAIN RES, V218, P63, DOI 10.1007/s00221-012-3002-2; Olney SJ, 1998, PHYS THER, V78, P814, DOI 10.1093/ptj/78.8.814; Orth D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060349; Patterson KK, 2010, GAIT POSTURE, V31, P241, DOI 10.1016/j.gaitpost.2009.10.014; ROBINSON RO, 1987, J MANIP PHYSIOL THER, V10, P172; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Sadeghi H, 1997, HUM MOVEMENT SCI, V16, P243, DOI 10.1016/S0167-9457(96)00054-1; Sadeghi H, 2003, GAIT POSTURE, V17, P197, DOI 10.1016/S0966-6362(02)00089-9; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; Shultz R, 2011, MED ENG PHYS, V33, P1309, DOI 10.1016/j.medengphy.2011.05.009; VAGENAS G, 1992, INT J SPORT BIOMECH, V8, P11, DOI 10.1123/ijsb.8.1.11; Yi YW, 2009, EXP BRAIN RES, V195, P361, DOI 10.1007/s00221-009-1796-3; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3; Zhang SQ, 2013, GAIT POSTURE, V37, P532, DOI 10.1016/j.gaitpost.2012.09.012; Zifchock RA, 2008, GAIT POSTURE, V27, P622, DOI 10.1016/j.gaitpost.2007.08.006	36	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0138631	10.1371/journal.pone.0138631	http://dx.doi.org/10.1371/journal.pone.0138631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488484	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400008
J	Moorhouse, TP; Dahlsjo, CAL; Baker, SE; D'Cruze, NC; Macdonald, DW				Moorhouse, Tom P.; Dahlsjoe, Cecilia A. L.; Baker, Sandra E.; D'Cruze, Neil C.; Macdonald, David W.			The Customer Isn't Always Right-Conservation and Animal Welfare Implications of the Increasing Demand for Wildlife Tourism	PLOS ONE			English	Article							ECOTOURISM; FRAMEWORK; EDUCATION; BENEFITS; SWIMMERS; DOLPHINS	Tourism accounts for 9% of global GDP and comprises 1.1 billion tourist arrivals per annum. Visits to wildlife tourist attractions (WTAs) may account for 20-40% of global tourism, but no studies have audited the diversity of WTAs and their impacts on the conservation status and welfare of subject animals. We scored these impacts for 24 types of WTA, visited by 3.6-6 million tourists per year, and compared our scores to tourists' feedback on TripAdvisor. Six WTA types (impacting 1,500-13,000 individual animals) had net positive conservation/ welfare impacts, but 14 (120,000-340,000 individuals) had negative conservation impacts and 18 (230,000-550,000 individuals) had negative welfare impacts. Despite these figures only 7.8% of all tourist feedback on these WTAs was negative due to conservation/ welfare concerns. We demonstrate that WTAs have substantial negative effects that are unrecognised by the majority of tourists, suggesting an urgent need for tourist education and regulation of WTAs worldwide.	[Moorhouse, Tom P.; Dahlsjoe, Cecilia A. L.; Baker, Sandra E.; D'Cruze, Neil C.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney, England; [D'Cruze, Neil C.] World Anim Protect, London, England	University of Oxford	Moorhouse, TP (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney, England.	tom.moorhouse@zoo.ox.ac.uk			World Animal Protection; Humane Society International, UK; Baker Trust	World Animal Protection; Humane Society International, UK; Baker Trust	This study was funded by World Animal Protection (http://www.worldanimalprotection.org.uk). SB was supported by the Humane Society International, UK and The Baker Trust during preparation of this manuscript. One author (NCDC) occupies a shared role between World Animal Protection and University of Oxford, and contributed to the experimental design, some aspects of the data collection and writing of the manuscript. The bulk of data collection, refining the study design and all of the analyses were carried out by TPM and CALD. The decision to publish was made jointly, and the authors are satisfied that the work represents an objective, impartial and fair assessment of the subject area.	Baker SE, 2013, BIOSCIENCE, V63, P928, DOI 10.1525/bio.2013.63.12.6; Ballantyne R, 2011, TOURISM MANAGE, V32, P770, DOI 10.1016/j.tourman.2010.06.012; Ballantyne R, 2009, TOURISM MANAGE, V30, P658, DOI 10.1016/j.tourman.2008.11.003; Baratay Eric, 2003, ZOO HIST ZOOLOGICAL; Bejder L, 1999, MAR MAMMAL SCI, V15, P738, DOI 10.1111/j.1748-7692.1999.tb00840.x; Care For The Wild, 2014, EXPL TIG ILL TRAD AN; Constantine R, 2008, MARINE WILDLIFE AND TOURISM MANAGEMENT: INSIGHTS FROM THE NATURAL AND SOCIAL SCIENCES, P321, DOI 10.1079/9781845933456.0321; Constantine R, 2001, MAR MAMMAL SCI, V17, P689, DOI 10.1111/j.1748-7692.2001.tb01293.x; Dawkins MS, 2008, ETHOLOGY, V114, P937, DOI 10.1111/j.1439-0310.2008.01557.x; DCruze N, 2014, J AGR ENVIRON ETHIC, P1; Eco Tourism Australia, 2015, CERT PROGR; Fernandez EJ, 2009, APPL ANIM BEHAV SCI, V120, P1, DOI 10.1016/j.applanim.2009.06.002; Fien J, 2001, ENVIRON EDUC RES, V7, P379, DOI [org/10.1080/13504620120081269, DOI 10.1080/13504620120081269]; Filion F. L., 1994, Protected area economics and policy: linking conservation and sustainable development., P235; Freese C.H., 1998, MANAGING MARKETS ECO; Green, 2001, POSITIVE EFFECTS WIL; Green R., 2001, NEGATIVE EFFECTS WIL; Higginbottom K, 2004, WILDLIFE TOURISM IMP; Hunter LTB, 2013, ORYX, V47, P19, DOI 10.1017/S0030605312000695; Karanth KK, 2012, ORYX, V46, P382, DOI 10.1017/S003060531100086X; Knight Richard L., 1995, P51; Kontogeorgopoulos N, 2009, CURR ISSUES TOUR, V12, P429, DOI 10.1080/13683500903042873; Luck M, 2003, OCEAN COAST MANAGE, V46, P943, DOI 10.1016/S0964-5691(03)00071-1; Lundquist D, 2013, NEW ZEAL J MAR FRESH, V47, P430, DOI 10.1080/00288330.2013.778301; McCulloch SP, 2013, J AGR ENVIRON ETHIC, V26, P959, DOI 10.1007/s10806-012-9434-7; Orams M. B., 1997, Progress in Tourism and Hospitality Research, V3, P295, DOI 10.1002/(SICI)1099-1603(199712)3:4<295::AID-PTH85>3.0.CO;2-D; Peters KJ, 2013, MAR MAMMAL SCI, V29, pE484, DOI 10.1111/mms.12003; Pirotta E, 2015, ECOL APPL, V25, P729, DOI 10.1890/14-0986.1; Powell RB, 2008, POLAR REC, V44, P233, DOI 10.1017/S0032247408007456; Powell RB, 2008, J SUSTAIN TOUR, V16, P467, DOI [10.2167/jost797.0, 10.1080/09669580802154223]; Reynolds PC, 2001, TOURISM MANAGE, V22, P31, DOI 10.1016/S0261-5177(00)00018-2; The Rainforest Alliance, 2014, OUR WORK SUST TOUR; UNWTO, 2018, UNWTO TOUR HIGHL 201, Vxxx; Zeppel Heather, 2008, Human Dimensions of Wildlife, V13, P280, DOI 10.1080/10871200802187105; Zeppel H, 2008, J ENVIRON EDUC, V39, P3, DOI 10.3200/JOEE.39.3.3-18; Zhou YB, 2013, BIOL CONSERV, V165, P18, DOI 10.1016/j.biocon.2013.05.007	36	79	82	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0138939	10.1371/journal.pone.0138939	http://dx.doi.org/10.1371/journal.pone.0138939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26489092	Green Published, gold			2022-12-27	WOS:000363248400013
J	Poizot-Martin, I; Naqvi, A; Obry-Roguet, V; Valantin, MA; Cuzin, L; Billaud, E; Cheret, A; Rey, D; Jacomet, C; Duvivier, C; Pugliese, P; Pradat, P; Cotte, L				Poizot-Martin, Isabelle; Naqvi, Alissa; Obry-Roguet, Veronique; Valantin, Marc-Antoine; Cuzin, Lise; Billaud, Eric; Cheret, Antoine; Rey, David; Jacomet, Christine; Duvivier, Claudine; Pugliese, Pascal; Pradat, Pierre; Cotte, Laurent		Hepadat'AIDS Study Grp	Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SOFOSBUVIR PLUS RIBAVIRIN; HIV-INFECTED PATIENTS; GENOTYPE 1; NATURAL-HISTORY; OPEN-LABEL; THERAPY; TELAPREVIR	Objectives Development of direct acting antivirals (DAA) offers new benefits for patients with chronic hepatitis C. The combination of these drugs with antiretroviral treatment (cART) is a real challenge in HIV/HCV coinfected patients. The aim of this study was to describe potential drug-drug interactions between DAAs and antiretroviral drugs in a cohort of HIV/HCV coinfected patients. Methods Cross-sectional study of all HIV/HCV coinfected patients attending at least one visit in 2012 in the multicenter French Dat'AIDS cohort. A simulation of drug-drug interactions between antiretroviral treatment and DAAs available in 2015 was performed. Results Of 16,634 HIV-infected patients, 2,511 had detectable anti-HCV antibodies, of whom 1,196 had a detectable HCV-RNA and were not receiving HCV treatment at the time of analysis. 97.1% of these patients were receiving cART and 81.2% had a plasma HIV RNA <50 copies/mL. cART included combinations of nucleoside reverse transcriptase inhibitors with a boosted protease inhibitor in 43.6%, a non-nucleoside reverse transcriptase inhibitor in 17.3%, an integrase inhibitor in 15.4% and various combinations or antiretroviral drugs in 23.7% of patients. A previous treatment against HCV had been administered in 64.4% of patients. Contraindicated associations/potential interactions were expected between cART and respectively sofosbuvir (0.2%/0%), sofosbuvir/ledipasvir (0.2%/67.6%), daclatasvir (0%/49.4%), ombitasvir/boosted paritaprevir (with or without dasabuvir) (34.4%/52.2%) and simeprevir (78.8%/0%). Conclusions Significant potential drug-drug interactions are expected between cART and the currently available DAAs in the majority of HIV/HCV coinfected patients. Sofosbuvir/ledipasvir and sofosbuvir/daclatasvir with or without ribavirin appeared the most suitable combinations in our population. A close collaboration between hepatologists and HIV/AIDS specialists appears necessary for the management of HCV treatment concomitantly to cART.	[Poizot-Martin, Isabelle; Obry-Roguet, Veronique] Aix Marseille Univ, Hop St Marguerite, APHM, Immunohematol Clin, Marseille, France; [Poizot-Martin, Isabelle] INSERM, U912, SESSTIM, F-13258 Marseille, France; [Naqvi, Alissa; Pugliese, Pascal] CHU Nice, Hop Archet 1, Serv Malad Infect, Unite Virol Clin, F-06202 Nice, France; [Valantin, Marc-Antoine] Univ Paris 06, Sorbonne Univ, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, F-75013 Paris, France; [Valantin, Marc-Antoine] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Serv Malad Infect & Trop, Paris, France; [Cuzin, Lise] INSERM, UMR 1027, F-31000 Toulouse, France; [Cuzin, Lise] Univ Toulouse 3, F-31000 Toulouse, France; [Cuzin, Lise] CHU Toulouse, COREVIH Toulouse, F-31000 Toulouse, France; [Billaud, Eric] CHU Nantes, Hotel Dieu, Serv Malad Infect, F-44035 Nantes 01, France; [Cheret, Antoine] Ctr Hosp Tourcoing, Serv Univ Malad Infect, Tourcoing, France; [Cheret, Antoine] CHU Bicetre, Serv Med Interne, Le Kremlin Bicetre, France; [Cheret, Antoine; Duvivier, Claudine] Univ Paris 05, Hop Necker, EA 7327, Lab Virol, Paris, France; [Rey, David] Hop Univ Strasbourg, Ctr HIV Care, Strasbourg, France; [Jacomet, Christine] CHU Clermont Ferrand, Serv Malad Infect & Trop, Clermont Ferrand, France; [Duvivier, Claudine] Hop Necker Enfants Malad, AP HP, Serv Malad Infect & Trop, Ctr Infectiol Necker Pasteur IHU Imagine, Paris, France; [Duvivier, Claudine] Inst Pasteur, Ctr Med, Ctr Infectiol Necker Pasteur, Paris, France; [Pradat, Pierre] Hosp Civils Lyon, Hop Croix Rousse, Serv Hepatol, Ctr Rech Clin, Lyon, France; [Pradat, Pierre; Cotte, Laurent] INSERM, U1052, F-69008 Lyon, France; [Cotte, Laurent] Hosp Civils Lyon, Hop Croix Rousse, Serv Malad Infect, Lyon, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU Nice; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Cotte, L (corresponding author), INSERM, U1052, F-69008 Lyon, France.	laurent.cotte@chu-lyon.fr	Delobel, Pierre/K-3166-2014	Delobel, Pierre/0000-0002-2874-3581; ADER, Florence/0000-0002-4778-4338; Poizot-Martin, Isabelle/0000-0002-5676-5411; MARCHOU, Bruno/0000-0002-0673-2945; ferry, tristan/0000-0003-3082-7001	Gilead; MSD; BMS; Janssen-Cilag; Gilead Science; ViiV Healthcare; Bristol-Myers Squibb; Merck/Schering-Plough; Janssen; Merck; Roche; Mylan; Abbott	Gilead(Gilead Sciences); MSD; BMS(Bristol-Myers Squibb); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Gilead Science(Gilead Sciences); ViiV Healthcare; Bristol-Myers Squibb(Bristol-Myers Squibb); Merck/Schering-Plough(Merck & CompanySchering Plough Corporation); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Roche(Roche Holding); Mylan; Abbott(Abbott Laboratories)	Isabelle POIZOT-MARTIN is member of advisory boards for GILEAD, BMS, and ABVIE. She received speaker fees from Gilead, MSD, and BMS, and travel/accommodation grants from BMS. Marc- Antoine VALANTIN has received honoraria for consulting/educational lectures and travel grants from Janssen-Cilag, Gilead Science, ViiV Healthcare, Bristol-Myers Squibb, and Merck/Schering-Plough. Lise CUZIN participated in advisory board meetings for BMS, ViiV Healthcare and received travel grants from BMS and MSD. Eric BILLAUD received travel grants from ViiV Healthcare, Janssen, Gilead, Merck, and BMS, and expertise fees from Gilead and BMS. He also participated in advisory board meetings for MSD. David REY is member of advisory board for Gilead, received speaker fees from MSD and travel grants from Gilead, BMS, and MSD. Christine JACOMET reports grants and nonfinancial support from MSD, nonfinancial support from ViiV, grants from Roche, grants, personal fees and non-financial support from Janssen, personal fees from Gilead, personal fees from BMS, personal fees from Mylan, personal fees and non-financial support from Abbott, outside the submitted work. Claudine DUVIVIER has received travel grants, honoraria or study grants from various pharmaceutical companies, including Bristol- Myers- Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare. Pascal PUGLIESE is member of advisory boards for Gilead and BMS. Laurent COTTE has received research grants from ViiV healthcare and MSD, personal fees from Mylan and non-financial support from BMS, Gilead Science, Janssen Cilag, MSD and ViiV healthcare. Alissa NAQVI, Veronique OBRY-ROGUET, Antoine CHERET, and Pierre PRADAT have no conflict of interest to disclose. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Beste LA, 2015, EPIDEMIOL REV, V37, P131, DOI 10.1093/epirev/mxu002; Cachay ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102883; Cacoub P, 2015, LIVER INT, V35, P65, DOI 10.1111/liv.12639; Cope R, 2015, AIDS PATIENT CARE ST, V29, P379, DOI 10.1089/apc.2015.0004; Cotte L, 2014, CLIN INFECT DIS, V59, P1768, DOI 10.1093/cid/ciu659; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Grint D, 2013, HIV MED, V14, P614, DOI 10.1111/hiv.12068; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Hezode C, 2015, LANCET, V385, P2502, DOI 10.1016/S0140-6736(15)60159-3; [IDSA IAS-USA. AASLD], 2015, REC TEST MAN TREAT H, DOI 10.1002/hep.27950; Karageorgopoulos DE, 2014, CURR OPIN INFECT DIS, V27, P36, DOI 10.1097/QCO.0000000000000034; Klein MB, 2013, ANTIVIR THER, V18, P717, DOI 10.3851/IMP2484; Kovari H, 2015, J HEPATOL, V63, P573, DOI 10.1016/j.jhep.2015.04.019; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Molina JM, 2015, LANCET, V385, P1098, DOI 10.1016/S0140-6736(14)62483-1; Morlat P., 2013, PRISE CHARGE MED PER; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Osinusi A, 2015, JAMA-J AM MED ASSOC, V313, P1232, DOI 10.1001/jama.2015.1373; Patel N, 2015, INFECT DIS THER, V4, P67, DOI 10.1007/s40121-015-0058-x; Patel N, 2015, AIDS RES HUM RETROV, V31, P189, DOI [10.1089/AID.2014.0215, 10.1089/aid.2014.0215]; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Piroth L, 2010, HEPATOLOGY, V52, P1915, DOI 10.1002/hep.23959; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Soriano V, 2015, EXPERT OPIN DRUG MET, V11, P333, DOI 10.1517/17425255.2015.998997; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; Yehia BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101554	33	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141164	10.1371/journal.pone.0141164	http://dx.doi.org/10.1371/journal.pone.0141164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488159	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400113
J	Bogliacino, F; Codagnone, C; Veltri, GA; Chakravarti, A; Ortoleva, P; Gaskell, G; Ivchenko, A; Lupianez-Villanueva, F; Mureddu, F; Rudisill, C				Bogliacino, Francesco; Codagnone, Cristiano; Veltri, Giuseppe Alessandro; Chakravarti, Amitav; Ortoleva, Pietro; Gaskell, George; Ivchenko, Andriy; Lupianez-Villanueva, Francisco; Mureddu, Francesco; Rudisill, Caroline			Pathos & Ethos: Emotions and Willingness to Pay for Tobacco Products	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; FINANCIAL INCENTIVES; WARNINGS; IMPACT; SMOKERS; AVERSION; DECISION; THINKING; POWER; BIAS	In this article we use data from a multi-country Randomized Control Trial study on the effect of anti-tobacco pictorial warnings on an individual's emotions and behavior. By exploiting the exogenous variations of images as an instrument, we are able to identify the effect of emotional responses. We use a range of outcome variables, from cognitive (risk perception and depth of processing) to behavioural (willingness to buy and willingness to pay). Our findings suggest that the odds of buying a tobacco product can be reduced by 80% if the negative affect elicited by the images increases by one standard deviation. More importantly from a public policy perspective, not all emotions behave alike, as eliciting shame, anger, or distress proves more effective in reducing smoking than fear and disgust.	[Bogliacino, Francesco] Univ Nacl Colombia, Bogota, Colombia; [Codagnone, Cristiano] Univ Milan, Milan, Italy; [Veltri, Giuseppe Alessandro] Univ Leicester, Leicester, Leics, England; [Chakravarti, Amitav; Gaskell, George; Rudisill, Caroline] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England; [Chakravarti, Amitav] Univ Calif Riverside, Riverside, CA 92521 USA; [Ortoleva, Pietro] Columbia Univ, New York, NY USA; [Ivchenko, Andriy] Univ Pompeu Fabra, Barcelona, Spain; [Lupianez-Villanueva, Francisco; Mureddu, Francesco] Univ Oberta Catalunya, Barcelona, Spain; [Mureddu, Francesco] CRENoS Ctr North South Econ Res, Cagliari, Italy	Universidad Nacional de Colombia; University of Milan; University of Leicester; University of London; London School Economics & Political Science; University of California System; University of California Riverside; Columbia University; Pompeu Fabra University; UOC Universitat Oberta de Catalunya	Bogliacino, F (corresponding author), Univ Nacl Colombia, Bogota, Colombia.	fbogliacino@unal.edu.co	Lupiáñez-Villanueva, Francisco/A-9181-2012; Veltri, Giuseppe Alessandro/R-1984-2018; Lupiáñez-Villanueva, Francisco/N-1178-2019	Lupiáñez-Villanueva, Francisco/0000-0001-5361-7678; Veltri, Giuseppe Alessandro/0000-0002-9472-2236; Lupiáñez-Villanueva, Francisco/0000-0001-5361-7678; Codagnone, Cristiano/0000-0001-5019-1712; Ivchenko, Andriy/0000-0003-0304-1126; Bogliacino, Francesco/0000-0001-8874-8846	European Commission [17.020200-17.030600/12/626060/SANCO.D.4, EAHC / 2011 / CP / 01/LSE]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the European Commission under Specific Contract No 17.020200-17.030600/12/626060/SANCO.D.4 implementing Framework Contract No EAHC / 2011 / CP / 01/LSE. The views expressed are those of the authors and should not be regarded as stating an official position of the European Commission. After a general discussion on design issues, the funders took no role in data collection, analysis, and interpretation of the findings and the preparation of this manuscript. The funding entity has been informed of the decision to publish the authors' article.	Andersen S, 2006, EXP ECON, V9, P383, DOI 10.1007/s10683-006-7055-6; Andrade EB, 2007, PSYCHOL SCI, V18, P668, DOI 10.1111/j.1467-9280.2007.01956.x; Andrade EB, 2009, J CONSUM RES, V36, P539, DOI 10.1086/599221; [Anonymous], 2008, HDB EMOTIONS; [Anonymous], 2002, HEURISTICS BIASES PS; Arnold M.B., 1960, EMOTION PERSONALITY; Azagba S, 2012, EFFECT GRAPHIC CIGAR; Basso M R, 1996, J Int Neuropsychol Soc, V2, P249; Bayer R, 2013, NEW ENGL J MED, V369, P206, DOI 10.1056/NEJMp1306205; Benartzi S, 2001, AM ECON REV, V91, P79, DOI 10.1257/aer.91.1.79; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Browne MJ, 2000, J RISK UNCERTAINTY, V20, P291, DOI 10.1023/A:1007823631497; Cahill K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004307.pub4; Callen M, 2014, AM ECON REV, V104, P123, DOI 10.1257/aer.104.1.123; Calvo MG, 2004, MOTIV EMOTION, V28, P221, DOI 10.1023/B:MOEM.0000040153.26156.ed; Camerer C., 1995, HDB EXPT EC, P587; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; Cameron LD, 2008, SOC PERSONAL PSYCHOL, V2, P262, DOI 10.1111/j.1751-9004.2007.00057.x; Cantrell J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052206; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Damasio A, 1994, DESCARTES ERROR EMOT; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Doxey J, 2011, TOB CONTROL, V20, P353, DOI 10.1136/tc.2010.038315; Elster J, 1998, J ECON LIT, V36, P47; Etter JF, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-88; Festinger L, 1975, THEORY COGNITIVE DIS; Frijda BH, 2008, HDB EMOTIONS, V3rd, P68; Gallopel-Morvan K, 2012, TOB CONTROL, V21, P502, DOI 10.1136/tobaccocontrol-2011-050079; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Hammond D, 2003, TOB CONTROL, V12, P391, DOI 10.1136/tc.12.4.391; Hammond D, 2007, AM J PREV MED, V32, P202, DOI 10.1016/j.amepre.2006.11.011; Hammond D, 2012, CANCER CAUSE CONTROL, V23, P57, DOI 10.1007/s10552-012-9902-4; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; Hiilamo H, 2014, TOB CONTROL, V23, DOI 10.1136/tobaccocontrol-2012-050541; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Huang Jidong, 2014, Tob Control, V23 Suppl 1, pi7, DOI 10.1136/tobaccocontrol-2013-051170; Hughes JR, 2003, J GEN INTERN MED, V18, P1053, DOI 10.1111/j.1525-1497.2003.20640.x; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Izard C.E., 1971, FACE EMOTION; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kraemer JD, 2013, AM J PREV MED, V45, P334, DOI 10.1016/j.amepre.2013.05.004; Levy D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001336; Loewenstein G, 2003, Q J ECON, V118, P1209, DOI 10.1162/003355303322552784; Loewenstein G, 2003, SER AFFECTIVE SCI, P619; Loewenstein G, 2000, AM ECON REV, V90, P426, DOI 10.1257/aer.90.2.426; Loewenstein G., 2013, BEHAV FDN PUBLIC POL, P361; Loewenstein G., ADV BEHAV EC; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; Matlin M, 1977, J PERS SOC PSYCHOL, V19, P295; McDougall W., 1926, INTRO SOCIAL PSYCHOL; MORELAND RL, 1977, J PERS SOC PSYCHOL, V35, P191, DOI 10.1037/0022-3514.35.4.191; MORELAND RL, 1979, J PERS SOC PSYCHOL, V37, P1085, DOI 10.1037/0022-3514.37.6.1085; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Oatley K., 1987, COGNITION EMOTION, V1, P29, DOI [10.1080/02699938708408362, DOI 10.1080/02699938708408362]; Ordonana JR, 2009, HUM COMMUN RES, V35, P195, DOI 10.1111/j.1468-2958.2009.01344.x; Orentlicher D, 2013, NEW ENGL J MED, V369, P204, DOI 10.1056/NEJMp1304513; ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315; PAULHUS DL, 1984, J PERS SOC PSYCHOL, V46, P598, DOI 10.1037/0022-3514.46.3.598; Romer PM, 2000, AM ECON REV, V90, P439, DOI 10.1257/aer.90.2.439; Schneider S, 2012, PATIENT EDUC COUNS, V86, P77, DOI 10.1016/j.pec.2011.03.005; Slade J, 1997, Tob Control, V6, P169; Thaler RH, 2004, J POLIT ECON, V112, pS164, DOI 10.1086/380085; Thaler RH, NUDGE IMPROVING DECI; Thrasher JF, 2007, ADDICT BEHAV, V32, P2916, DOI 10.1016/j.addbeh.2007.05.018; Thrasher JF, 2011, HEALTH POLICY, V102, P41, DOI 10.1016/j.healthpol.2011.06.003; Thrasher James Francis, 2006, Salud pública Méx, V48, ps65; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V81, P973, DOI 10.1037//0022-3514.81.6.973; Tomkins S.S., 1984, EMOTION HUMAN FACE, V163, P31; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819; Volpp KG, 2006, CANCER EPIDEM BIOMAR, V15, P12, DOI 10.1158/1055-9965.EPI-05-0314; Wakefield M, 2002, TOB CONTROL, V11, P73, DOI [DOI 10.1136/TC.11.SUPPL_1.I73, DOI 10.1136/tc.11.suppl_1.i73]; Weatherby Danielle, 2012, Albany Law Rev, V76, P121; Wilson LM, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/961724; Wilson W, 1975, J PERS SOC PSYCHOL, V37, P811; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	77	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139542	10.1371/journal.pone.0139542	http://dx.doi.org/10.1371/journal.pone.0139542			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7XI	26485272	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000363028100009
J	Hendrik, TC; in 'T Holt, AFV; Vos, MC				Hendrik, Tirza C.; in 't Holt, Anne F. Voor; Vos, Margreet C.			Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses	PLOS ONE			English	Review							INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTIONS; RISK-FACTORS; ESCHERICHIA-COLI; MULTIRESISTANT KLEBSIELLA; PNEUMONIAE INFECTION; NOSOCOMIAL OUTBREAK; INHIBITOR COMBINATIONS; CLONAL DISSEMINATION; HOSPITAL OUTBREAK	Healthcare-related infections caused by extended-spectrum beta-lactamase (ESBL)-producing Klebsiella spp. are of major concern. To control transmission, deep understanding of the transmission mechanisms is needed. This systematic review aimed to identify risk factors and sources, clonal relatedness using molecular techniques, and the most effective control strategies for ESBL-producing Klebsiella spp. A systematic search of PubMed, Embase, and Outbreak Database was performed. We identified 2771 articles from November 25th, 1960 until April 7th, 2014 of which 148 were included in the systematic review and 23 in a random-effects meta-analysis study. The random-effects meta-analyses showed that underlying disease or condition (odds ratio [OR] = 6.25; 95% confidence interval [CI] = 2.85 to 13.66) generated the highest pooled estimate. ESBL-producing Klebsiella spp. were spread through person-to-person contact and via sources in the environment; we identified both monoclonal and polyclonal presence. Multi-faceted interventions are needed to prevent transmission of ESBL-producing Klebsiella spp.	[Hendrik, Tirza C.; in 't Holt, Anne F. Voor; Vos, Margreet C.] Erasmus MC Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Vos, MC (corresponding author), Erasmus MC Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	m.vos@erasmusmc.nl		Voor in 't holt, Anne/0000-0002-3560-1725				Abdel-Hady H, 2008, J PERINATOL, V28, P685, DOI 10.1038/jp.2008.73; Abecasis F, 2011, MICROB DRUG RESIST, V17, P17, DOI 10.1089/mdr.2010.0060; Abel zur Wiesch Pia, 2014, PLoS Pathog, V10, pe1004225, DOI 10.1371/journal.ppat.1004225; Ahmed Z. Baba, 2012, Eastern Mediterranean Health Journal, V18, P382; Akpaka PE, 2010, W INDIAN MED J, V59, P591; Al Sweih N, 2011, INDIAN J MED MICROBI, V29, P130, DOI 10.4103/0255-0857.81791; Al-Obeid S, 2008, J CHEMOTHERAPY, V20, P709, DOI 10.1179/joc.2008.20.6.709; Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Alcantar-Curiel D, 2004, CLIN INFECT DIS, V38, P1067, DOI 10.1086/382354; Anderson DJ, 2006, ANTIMICROB AGENTS CH, V50, P1715, DOI 10.1128/AAC.50.5.1715-1720.2006; Andrade V, 2004, SALUD PUBLICA MEXICO, V46, P524, DOI 10.1590/S0036-36342004000600007; Apisarnthanarak A, 2008, INFECT CONT HOSP EP, V29, P1026, DOI 10.1086/591864; Arpin C, 2000, EPIDEMIOL INFECT, V124, P401, DOI 10.1017/S0950268899003908; Asensio A, 2000, CLIN INFECT DIS, V30, P55, DOI 10.1086/313590; Bagattini M, 2006, J ANTIMICROB CHEMOTH, V57, P979, DOI 10.1093/jac/dkl077; Barroso H, 2000, J ANTIMICROB CHEMOTH, V45, P611, DOI 10.1093/jac/45.5.611; BAUERNFEIND A, 1993, INFECTION, V21, P18, DOI 10.1007/BF01739303; Bedenic B, 2005, J CHEMOTHERAPY, V17, P367, DOI 10.1179/joc.2005.17.4.367; Bellissimo-Rodrigues F, 2006, MEM I OSWALDO CRUZ, V101, P415, DOI 10.1590/S0074-02762006000400012; Ben-Hamouda T, 2004, MICROB DRUG RESIST, V10, P132, DOI 10.1089/1076629041310118; Benenson S, 2013, NEONATOLOGY, V103, P155, DOI 10.1159/000343150; Bennett JW, 2010, J AM COLL SURGEONS, V211, P391, DOI 10.1016/j.jamcollsurg.2010.03.030; Bermudes H, 1997, EUR J CLIN MICROBIOL, V16, P523, DOI 10.1007/BF01708236; BINGEN EH, 1993, J CLIN MICROBIOL, V31, P179, DOI 10.1128/JCM.31.2.179-184.1993; Boo NY, 2005, J HOSP INFECT, V61, P68, DOI 10.1016/j.jhin.2005.01.025; Boszczowski I, 2005, PEDIATR INFECT DIS J, V24, P648, DOI 10.1097/01.inf.0000168844.55898.8f; Bouallegue-Godet O, 2005, PATHOL BIOL, V53, P75, DOI 10.1016/j.patbio.2004.04.015; Boukadida J, 2002, ARCH PEDIATRIE, V9, P463, DOI 10.1016/S0929-693X(01)00827-2; Branger C, 1998, J MED MICROBIOL, V47, P201, DOI 10.1099/00222615-47-3-201; Brinas L, 2004, MICROB DRUG RESIST, V10, P354, DOI 10.1089/mdr.2004.10.354; Bui KT, 2014, TRANSPLANTATION, V97, P590, DOI 10.1097/01.TP.0000436928.15650.59; Bush K, 2010, CRIT CARE, V14, DOI 10.1186/cc8892; Calbo E, 2011, CLIN INFECT DIS, V52, P743, DOI 10.1093/cid/ciq238; Cantey JB, 2013, J PEDIATR-US, V163, P672, DOI 10.1016/j.jpeds.2013.03.001; Gonzalez AC, 2011, REV CHIL INFECTOL, V28, P28, DOI /S0716-10182011000100005; Carpentier M, 2012, Med Mal Infect, V42, P501, DOI 10.1016/j.medmal.2012.07.011; Carrer A, 2009, MICROB DRUG RESIST, V15, P47, DOI 10.1089/mdr.2009.0868; Cassettari VC, 2009, J HOSP INFECT, V71, P340, DOI 10.1016/j.jhin.2008.11.019; Cassettari Valéria C., 2006, J. Pediatr. (Rio J.), V82, P313, DOI 10.2223/JPED.1519; Chanawong A, 2001, J ANTIMICROB CHEMOTH, V48, P839, DOI 10.1093/jac/48.6.839; Christian NA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-27; Conte MP, 2005, J CHEMOTHERAPY, V17, P66, DOI 10.1179/joc.2005.17.1.66; Cornejo-Juarez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035780; Dahmen S, 2010, MICROB DRUG RESIST, V16, P163, DOI 10.1089/mdr.2009.0108; Dashti AA, 2010, J MED MICROBIOL, V59, P687, DOI 10.1099/jmm.0.019208-0; De Almeida VC, 2005, MICROB DRUG RESIST, V11, P21, DOI 10.1089/mdr.2005.11.21; Decre D, 1998, CLIN INFECT DIS, V27, P834, DOI 10.1086/514938; Dedeic-Ljubovic A, 2010, CLIN MICROBIOL INFEC, V16, P152, DOI 10.1111/j.1469-0691.2009.03018.x; Demir S, 2008, J PAEDIATR CHILD H, V44, P548, DOI 10.1111/j.1440-1754.2008.01326.x; Demirdag K, 2010, J INFECT DEV COUNTR, V4, P717, DOI 10.3855/jidc.778; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dolejska M, 2012, INT J ANTIMICROB AG, V40, P510, DOI 10.1016/j.ijantimicag.2012.07.016; Du B, 2002, INTENS CARE MED, V28, P1718, DOI 10.1007/s00134-002-1521-1; Dumpis U, 2010, APMIS, V118, P713, DOI 10.1111/j.1600-0463.2010.02640.x; Elhani D, 2006, ANN BIOL CLIN-PARIS, V64, P237; Elhani D, 2010, CLIN MICROBIOL INFEC, V16, P157, DOI 10.1111/j.1469-0691.2009.03057.x; Field N, 2014, LANCET INFECT DIS, V14, P341, DOI 10.1016/S1473-3099(13)70324-4; Fiett J, 2000, ANTIMICROB AGENTS CH, V44, P1499, DOI 10.1128/AAC.44.6.1499-1505.2000; Filho JRDC, 2008, J CHEMOTHERAPY, V20, P600, DOI 10.1179/joc.2008.20.5.600; FlidelRimon O, 1996, AM J PERINAT, V13, P99, DOI 10.1055/s-2007-994301; Freeman JT, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-27; French GL, 1996, J CLIN MICROBIOL, V34, P358, DOI 10.1128/JCM.34.2.358-363.1996; Gaillot O, 1998, J CLIN MICROBIOL, V36, P1357, DOI 10.1128/JCM.36.5.1357-1360.1998; Garcia DD, 2008, ANTIMICROB AGENTS CH, V52, P1790, DOI 10.1128/AAC.01440-07; Garza-Gonzalez E, 2011, J MED MICROBIOL, V60, P84, DOI 10.1099/jmm.0.022970-0; Giraud-Morin C, 2003, J HOSP INFECT, V54, P25, DOI 10.1016/S0195-6701(03)00038-0; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Goering RV, 2010, INFECT GENET EVOL, V10, P866, DOI 10.1016/j.meegid.2010.07.023; Gonzalez-Vertiz A, 2001, INFECT CONT HOSP EP, V22, P723, DOI 10.1086/501854; Gray J, 2012, AM J INFECT CONTROL, V40, P516, DOI 10.1016/j.ajic.2012.02.031; Gregersen N, 1999, PEDIATR INFECT DIS J, V18, P963, DOI 10.1097/00006454-199911000-00005; Gruteke P, 2003, J CLIN MICROBIOL, V41, P1161, DOI 10.1128/JCM.41.3.1161-1166.2003; Gundes S, 2005, NEW MICROBIOL, V28, P231; Gupta A, 2004, INFECT CONT HOSP EP, V25, P210, DOI 10.1086/502380; Guyot K, 2012, EUR J CLIN MICROBIOL, V31, P2827, DOI 10.1007/s10096-012-1636-4; Guzman-Blanco M, 2014, BRAZ J INFECT DIS, V18, P421, DOI 10.1016/j.bjid.2013.10.005; Harris AD, 2007, CLIN INFECT DIS, V45, P1347, DOI 10.1086/522657; Hirakata Y., 1999, J Infect Chemother, V5, P91, DOI 10.1007/s101560050015; Hollander R, 2001, J HOSP INFECT, V48, P207, DOI 10.1053/jhin.2001.0997; Hosbul T, 2012, MIKROBIYOL BUL, V46, P101; Jeong SH, 2001, J HOSP INFECT, V48, P281, DOI 10.1053/jhin.2001.1018; Jutersek B, 2003, MICROB DRUG RESIST, V9, pS25; Kac G, 2004, INFECT CONT HOSP EP, V25, P852, DOI 10.1086/502308; Kang CI, 2004, INFECT CONT HOSP EP, V25, P860, DOI 10.1086/502310; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Komatsu M, 2001, J Infect Chemother, V7, P94, DOI 10.1007/s101560100015; Krawczyk Beata, 2005, Polish Journal of Microbiology, V54, P105; Kristof K, 2007, EUR J CLIN MICROBIOL, V26, P563, DOI 10.1007/s10096-007-0338-9; Kritsotakis EI, 2011, J ANTIMICROB CHEMOTH, V66, P1383, DOI 10.1093/jac/dkr116; Kuo Kuang-Che, 2007, Journal of Microbiology Immunology and Infection, V40, P248; Langer AJ, 2009, AM J INFECT CONTROL, V37, P73, DOI 10.1016/j.ajic.2008.02.005; Laurent C, 2008, INFECT CONT HOSP EP, V29, P517, DOI 10.1086/588004; Lavigne JP, 2004, J CLIN MICROBIOL, V42, P3805, DOI 10.1128/JCM.42.8.3805-3808.2004; Lee HL, 2013, J KOREAN MED SCI, V28, P1187, DOI 10.3346/jkms.2013.28.8.1187; Lee SO, 2004, INFECT CONT HOSP EP, V25, P832, DOI 10.1086/502304; Li D, 2013, IR J MED SCI; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lin CF, 2010, J MED MICROBIOL, V59, P665, DOI 10.1099/jmm.0.015818-0; Liu PYF, 1998, J CLIN MICROBIOL, V36, P2759, DOI 10.1128/JCM.36.9.2759-2762.1998; Lowe C, 2012, EMERG INFECT DIS, V18, P1242, DOI 10.3201/eid1808.111268; Lucet JC, 1996, CLIN INFECT DIS, V22, P430, DOI 10.1093/clinids/22.3.430; Lytsy B, 2008, APMIS, V116, P302, DOI 10.1111/j.1600-0463.2008.00922.x; Lytsy B, 2010, SCAND J INFECT DIS, V42, P439, DOI 10.3109/00365540903582434; Macrae MB, 2001, J HOSP INFECT, V49, P183, DOI 10.1053/jhin.2001.1066; Manageiro V, 2012, DIAGN MICR INFEC DIS, V72, P272, DOI 10.1016/j.diagmicrobio.2011.11.009; Mangeney N, 2000, J APPL MICROBIOL, V88, P504, DOI 10.1046/j.1365-2672.2000.00989.x; Mantilla José Ramón, 2006, Biomed., V26, P408; Marcade G, 2013, EPIDEMIOL INFECT, V141, P1705, DOI 10.1017/S0950268812002099; Marchese A, 1996, EUR J CLIN MICROBIOL, V15, P245, DOI 10.1007/BF01591363; Martinez-Aguilar G, 2001, INFECT CONT HOSP EP, V22, P725, DOI 10.1086/501855; Martins IS, 2006, MICROB DRUG RESIST, V12, P50, DOI 10.1089/mdr.2006.12.50; Martins-Loureiro M, 2001, Rev Latinoam Microbiol, V43, P88; Mena A, 2006, J CLIN MICROBIOL, V44, P2831, DOI 10.1128/JCM.00418-06; Minarini LAR, 2008, CURR MICROBIOL, V56, P587, DOI 10.1007/s00284-008-9129-5; Moodley P, 2005, SAMJ S AFR MED J, V95, P861; Moore KL, 2005, PEDIATR INFECT DIS J, V24, P590, DOI 10.1097/01.inf.0000168804.09875.95; Mosqueda-Gomez JL, 2008, INT J INFECT DIS, V12, P653, DOI 10.1016/j.ijid.2008.03.008; Moustaoui N, 2004, J HOSP INFECT, V57, P202, DOI 10.1016/j.jhin.2004.01.007; Mshana SE, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-466; Muro S, 2012, CHEMOTHERAPY, V58, P217, DOI 10.1159/000339483; Nedjai S, 2012, MED MALADIES INFECT, V42, P20, DOI 10.1016/j.medmal.2011.10.001; NOUVELLON M, 1994, J CLIN MICROBIOL, V32, P2625, DOI 10.1128/JCM.32.10.2625-2627.1994; Paniara O, 2000, J CHEMOTHERAPY, V12, P204, DOI 10.1179/joc.2000.12.3.204; Parasakthi  N, 2000, Int J Infect Dis, V4, P123, DOI 10.1016/S1201-9712(00)90072-9; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Pena C, 1997, J HOSP INFECT, V35, P9, DOI 10.1016/S0195-6701(97)90163-8; Pena C, 1998, ANTIMICROB AGENTS CH, V42, P53, DOI 10.1128/AAC.42.1.53; Pessoa-Silva CL, 2003, J HOSP INFECT, V53, P198, DOI 10.1053/jhin.2002.1373; PHILIPPON A, 1989, ANTIMICROB AGENTS CH, V33, P1131, DOI 10.1128/AAC.33.8.1131; Piroth L, 1998, CLIN INFECT DIS, V27, P76, DOI 10.1086/514643; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4; Rebuck JA, 2000, CLIN INFECT DIS, V31, P1368, DOI 10.1086/317474; REISH O, 1993, J HOSP INFECT, V25, P287, DOI 10.1016/0195-6701(93)90115-G; Rettedal S, 2013, SCAND J INFECT DIS, V45, P54, DOI 10.3109/00365548.2012.713116; Rettedal S, 2012, APMIS, V120, P612, DOI 10.1111/j.1600-0463.2012.02879.x; Rice LB, 1996, CLIN INFECT DIS, V23, P118, DOI 10.1093/clinids/23.1.118; Roy S, 2013, INDIAN J MED RES, V137, P791; Royle J, 1999, ARCH DIS CHILD-FETAL, V80, pF64, DOI 10.1136/fn.80.1.F64; Saely S, 2011, AM J INFECT CONTROL, V39, P390, DOI 10.1016/j.ajic.2010.08.010; Sanchez M, 2012, J BURN CARE RES, V33, P386, DOI 10.1097/BCR.0b013e318231df95; Severin JA, 2010, J ANTIMICROB CHEMOTH, V65, P465, DOI 10.1093/jac/dkp471; Shannon K, 1998, J HOSP INFECT, V39, P291, DOI 10.1016/S0195-6701(98)90294-8; Shu JC, 2010, EPIDEMIOL INFECT, V138, P253, DOI 10.1017/S0950268809990409; Silva J, 2001, J CLIN MICROBIOL, V39, P3193, DOI 10.1128/JCM.39.9.3193-3196.2001; Silva Nanci, 2006, Braz J Infect Dis, V10, P191, DOI 10.1590/S1413-86702006000300007; Skowska A, 2012, POL J MICROBIOL, V61, P311; Somily AM, 2014, AM J INFECT CONTROL, V42, P277, DOI 10.1016/j.ajic.2013.09.028; Starlander G, 2012, J HOSP INFECT, V82, P122, DOI 10.1016/j.jhin.2012.07.004; Sumer S, 2013, PEDIAT INT; Szabo D, 1999, J CLIN MICROBIOL, V37, P4167; Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427; Tamma PD, 2012, INFECT CONT HOSP EP, V33, P631, DOI 10.1086/665715; TAYLOR ME, 1991, J HOSP INFECT, V17, P271, DOI 10.1016/0195-6701(91)90271-9; Tollentino FM, 2011, MICROB DRUG RESIST, V17, P7, DOI 10.1089/mdr.2010.0055; Tumbarello M, 2006, ANTIMICROB AGENTS CH, V50, P498, DOI 10.1128/AAC.50.2.498-504.2006; Valverde A, 2008, J ANTIMICROB CHEMOTH, V61, P64, DOI 10.1093/jac/dkm403; van't Veen A, 2005, J CLIN MICROBIOL, V43, P4961, DOI 10.1128/JCM.43.10.4961-4967.2005; Velaphi S, 2009, ANN TROP PAEDIATR, V29, P101, DOI 10.1179/146532809X440716; Velasco C, 2009, J HOSP INFECT, V73, P157, DOI 10.1016/j.jhin.2009.06.013; VENEZIA RA, 1995, CLIN INFECT DIS, V21, P915, DOI 10.1093/clinids/21.4.915; Viale P, 2013, EXPERT REV ANTI-INFE, V11, P1053, DOI 10.1586/14787210.2013.836057; Villari P, 1998, J INFECTION, V37, P274, DOI 10.1016/S0163-4453(98)92107-7; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Wener KM, 2010, ANTIMICROB AGENTS CH, V54, P2010, DOI 10.1128/AAC.01131-09; WHO, 2009, GUID HAND HYG HLTH C; Wollheim C, 2011, BRAZ J INFECT DIS, V15, P138, DOI 10.1590/S1413-86702011000200008; World Health Organization, 2011, REP BURD END HLTH CA; Wu TL, 2006, MICROB DRUG RESIST, V12, P203, DOI 10.1089/mdr.2006.12.203; Yu FY, 2009, DIAGN MICR INFEC DIS, V64, P57, DOI 10.1016/j.diagmicrobio.2009.01.020; Zhang YJ, 2012, MICROB DRUG RESIST, V18, P465, DOI 10.1089/mdr.2012.0016	172	35	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140754	10.1371/journal.pone.0140754	http://dx.doi.org/10.1371/journal.pone.0140754			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485570	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100066
J	Knaepen, K; Mierau, A; Swinnen, E; Tellez, HF; Michielsen, M; Kerckhofs, E; Lefeber, D; Meeusen, R				Knaepen, Kristel; Mierau, Andreas; Swinnen, Eva; Tellez, Helio Fernandez; Michielsen, Marc; Kerckhofs, Eric; Lefeber, Dirk; Meeusen, Romain			Human-Robot Interaction: Does Robotic Guidance Force Affect Gait-Related Brain Dynamics during Robot-Assisted Treadmill Walking?	PLOS ONE			English	Article							EVENT-RELATED SYNCHRONIZATION; MUSCLE-ACTIVITY; EEG; CORTEX; REHABILITATION; COORDINATION; ACTIVATION; LOCOMOTION; ATTENTION; ORTHOSIS	In order to determine optimal training parameters for robot-assisted treadmill walking, it is essential to understand how a robotic device interacts with its wearer, and thus, how parameter settings of the device affect locomotor control. The aim of this study was to assess the effect of different levels of guidance force during robot-assisted treadmill walking on cortical activity. Eighteen healthy subjects walked at 2 km.h(-1) on a treadmill with and without assistance of the Lokomat robotic gait orthosis. Event-related spectral perturbations and changes in power spectral density were investigated during unassisted treadmill walking as well as during robot-assisted treadmill walking at 30%, 60% and 100% guidance force (with 0% body weight support). Clustering of independent components revealed three clusters of activity in the sensorimotor cortex during treadmill walking and robot-assisted treadmill walking in healthy subjects. These clusters demonstrated gait-related spectral modulations in the mu, beta and low gamma bands over the sensorimotor cortex related to specific phases of the gait cycle. Moreover, mu and beta rhythms were suppressed in the right primary sensory cortex during treadmill walking compared to robot-assisted treadmill walking with 100% guidance force, indicating significantly larger involvement of the sensorimotor area during treadmill walking compared to robot-assisted treadmill walking. Only marginal differences in the spectral power of the mu, beta and low gamma bands could be identified between robot-assisted treadmill walking with different levels of guidance force. From these results it can be concluded that a high level of guidance force (i.e., 100% guidance force) and thus a less active participation during locomotion should be avoided during robot-assisted treadmill walking. This will optimize the involvement of the sensorimotor cortex which is known to be crucial for motor learning.	[Knaepen, Kristel; Tellez, Helio Fernandez; Meeusen, Romain] Vrije Univ Brussel, Human Physiol Res Grp, Brussels, Belgium; [Mierau, Andreas] German Sport Univ Cologne, Inst Movement & Neurosci, Cologne, Germany; [Swinnen, Eva; Tellez, Helio Fernandez; Kerckhofs, Eric] Vrije Univ Brussel, Ctr Neurosci, Brussels, Belgium; [Swinnen, Eva; Kerckhofs, Eric] Vrije Univ Brussel, Dept Rehabil Res, Brussels, Belgium; [Michielsen, Marc] Jessa Hosp, Rehabil Ctr Sint Ursula, Herk De Stad, Belgium; [Lefeber, Dirk] Vrije Univ Brussel, Robot & Multibody Mech Res Grp, Brussels, Belgium; [Meeusen, Romain] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld, Australia	Vrije Universiteit Brussel; German Sport University Cologne; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel; James Cook University	Meeusen, R (corresponding author), Vrije Univ Brussel, Human Physiol Res Grp, Brussels, Belgium.	rmeeusen@vub.ac.be	, Kristel/ABH-4923-2020; Swinnen, Eva/H-7964-2014	Lefeber, Dirk/0000-0003-4442-4473; Swinnen, Eva/0000-0002-3771-9479; Mierau, Andreas/0000-0002-6305-3260	Vrije Universiteit Brussel [GOA 59]	Vrije Universiteit Brussel	The preparation of this paper was funded by the Vrije Universiteit Brussel (i.e., GOA 59 and the Strategic Research Program 'Exercise and the Brain in Health & Disease: the Added Value of Human-Centered Robotics'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ada L, 2010, J PHYSIOTHER, V56, P153, DOI 10.1016/S1836-9553(10)70020-5; Aguirre-Ollinger G, 2011, P I MECH ENG H, V225, P228, DOI 10.1243/09544119JEIM854; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernhardt M, 2005, P IEEE 9 INT C REH R; Brinkman L, 2014, J NEUROSCI, V34, P14783, DOI 10.1523/JNEUROSCI.2039-14.2014; Brown P, 2007, CURR OPIN NEUROBIOL, V17, P656, DOI 10.1016/j.conb.2007.12.001; Bulea TC, 2014, C IEEE 36 ANN INT EN; Carpino G, 2013, MEDIC, V21, P72; Castermans T, 2012, P BIOSIGNALS 2012 IN; Castermans T, 2014, BRAIN SCI, V4, P1, DOI 10.3390/brainsci4010001; Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059; Coghill RC, 2001, J NEUROPHYSIOL, V85, P2602, DOI 10.1152/jn.2001.85.6.2602; Colombo G, 2001, SPINAL CORD, V39, P252, DOI 10.1038/sj.sc.3101154; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duysens J, 1998, GAIT POSTURE, V7, P131, DOI 10.1016/S0966-6362(97)00042-8; Feige B, 2000, J NEUROPHYSIOL, V84, P2622, DOI 10.1152/jn.2000.84.5.2622; Gramann K, 2010, J COGNITIVE NEUROSCI, V22, P2836, DOI 10.1162/jocn.2009.21369; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Hornby TG, 2012, PHYS THER, V92, P1278, DOI 10.2522/ptj.20110310; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; Jain S, 2013, CLIN NEUROPHYSIOL, V124, P379, DOI 10.1016/j.clinph.2012.08.021; Jasper H., 1949, ARCH PSYCHIAT NERVEN, V183, P163, DOI [DOI 10.1007/BF01062488, 10.1007/BF01062488]; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kline JE, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046022; Kline JE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00288; Knaepen K, 2015, HUM MOVEMENT SCI, V40, P248, DOI 10.1016/j.humov.2015.01.001; Knaepen K, 2014, IEEE T NEUR SYS REH, V22, P1128, DOI 10.1109/TNSRE.2014.2324153; Krewer C, 2007, GAIT POSTURE, V26, P372, DOI 10.1016/j.gaitpost.2006.10.003; Lajoie K, 2010, J NEUROPHYSIOL, V103, P2234, DOI 10.1152/jn.01100.2009; Lau TroyM., 2012, J BEHAV BRAIN SCI, V02, P387, DOI [10.4236/jbbs.2012.23044, DOI 10.4236/JBBS.2012.23044]; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Lunenburger L, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-1; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Makeig S, 1996, ADV NEUR IN, V8, P145; McMenamin BW, 2010, NEUROIMAGE, V49, P2416, DOI 10.1016/j.neuroimage.2009.10.010; Mehrholz J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub3; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Moreno JC, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-79; Nakanishi Y, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-59; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Nymark JR, 2005, J REHABIL RES DEV, V42, P523, DOI 10.1682/JRRD.2004.05.0059; Oostenveld R, 2002, HUM BRAIN MAPP, V17, P179, DOI 10.1002/hbm.10061; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Poli P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/153872; Pons JL, 2013, IEEE ENG MED BIO, P6941, DOI 10.1109/EMBC.2013.6611154; Pons J.L., 2008, WEARABLE ROBOTS BIOM, DOI DOI 10.1002/9780470987667.FMATTER; Presacco A, 2011, J NEUROPHYSIOL, V106, P1875, DOI 10.1152/jn.00104.2011; Riener R, 2010, J HEALTHC ENG, V1, P197, DOI 10.1260/2040-2295.1.2.197; Sahyoun C, 2004, NEUROIMAGE, V21, P568, DOI 10.1016/j.neuroimage.2003.09.065; Sale P, 2012, EUR J PHYS REHAB MED, V48, P111; Schuck A, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-31; Seeber M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00485; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Severens M, 2012, IEEE ENG MED BIO, P2764, DOI 10.1109/EMBC.2012.6346537; Severens M, 2014, IEEE T NEUR SYS REH, VPP, P1534; Severens M, 2014, IEEE T NEUR SYS REH, VPP, P1, DOI DOI 10.1109/TNSRE.2014.2371391; Shin JC, 2014, ANN REHABIL MED-ARM, V38, P719, DOI 10.5535/arm.2014.38.6.719; Snyder KL, 2013, 6 ANN INT IEEE EMBS; Solis-Escalante T, 2012, P 3 TOOLS BRAIN COMP; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Swinnen E, 2015, CLIN BIOMEC IN PRESS, DOI [10.1016/j.clinbiomech.2015.01.006, DOI 10.1016/J.CLINBI0MECH.2015.01.006]; Swinnen E, 2015, DISABIL REHABIL-ASSI, V10, P252, DOI 10.3109/17483107.2014.888487; Swinnen E, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/240274; Swinnen E, 2010, J REHABIL MED, V42, P520, DOI 10.2340/16501977-0538; Tefertiller C, 2011, J REHABIL RES DEV, V48, P387, DOI 10.1682/JRRD.2010.04.0055; Tucker MR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-1; Van Kammen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107323; Wagner J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00093; Wagner J, 2012, NEUROIMAGE, V63, P1203, DOI 10.1016/j.neuroimage.2012.08.019; Wieser M, 2010, EXP BRAIN RES, V203, P181, DOI 10.1007/s00221-010-2223-5; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Youssofzadeh V, 2014, IEEE ENG MED BIO, P6361, DOI 10.1109/EMBC.2014.6945083; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686	79	28	30	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140626	10.1371/journal.pone.0140626	http://dx.doi.org/10.1371/journal.pone.0140626			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485148	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100052
J	Memczak, S; Papavasileiou, P; Peters, O; Rajewsky, N				Memczak, Sebastian; Papavasileiou, Panagiotis; Peters, Oliver; Rajewsky, Nikolaus			Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood	PLOS ONE			English	Article							GENE; TRANSCRIPTS; ABUNDANT	Covalently closed circular RNA molecules (circRNAs) have recently emerged as a class of RNA isoforms with widespread and tissue specific expression across animals, oftentimes independent of the corresponding linear mRNAs. circRNAs are remarkably stable and sometimes highly expressed molecules. Here, we sequenced RNA in human peripheral whole blood to determine the potential of circRNAs as biomarkers in an easily accessible body fluid. We report the reproducible detection of thousands of circRNAs. Importantly, we observed that hundreds of circRNAs are much higher expressed than corresponding linear mRNAs. Thus, circRNA expression in human blood reveals and quantifies the activity of hundreds of coding genes not accessible by classical mRNA specific assays. Our findings suggest that circRNAs could be used as biomarker molecules in standard clinical blood samples.	[Memczak, Sebastian; Papavasileiou, Panagiotis; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Syst Biol Gene Regulatory Elements, Berlin Inst Med Syst Biol, D-13125 Berlin, Germany; [Peters, Oliver] Charite, Dept Psychiat, D-12203 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rajewsky, N (corresponding author), Max Delbruck Ctr Mol Med, Syst Biol Gene Regulatory Elements, Berlin Inst Med Syst Biol, Robert Rossle Str 10, D-13125 Berlin, Germany.	rajewsky@mdc-berlin.de		Rajewsky, Nikolaus/0000-0002-4785-4332; Memczak, Sebastian/0000-0001-9518-7135; Papavasileiou, Panagiotis/0000-0002-9655-9612; Peters, Oliver/0000-0003-0568-2998	DFG [RA 838/7-1]; NYU/MDC Exchange Program; BIH [CRG 2a TP7]	DFG(German Research Foundation (DFG)); NYU/MDC Exchange Program; BIH	SM was supported by the grant DFG RA 838/7-1, PP was supported by the NYU/MDC Exchange Program, OP and NR were supported by the grant BIH CRG 2a TP7.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bahn JH, 2014, CLIN CHEM, P61; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chao CW, 1998, MOL MED, V4, P614, DOI 10.1007/BF03401761; COCQUERELLE C, 1992, EMBO J, V11, P1095, DOI 10.1002/j.1460-2075.1992.tb05148.x; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; GRABOWSKI PJ, 1981, CELL, V23, P467, DOI 10.1016/0092-8674(81)90142-2; Guo JU, 2014, EXPANDED IDENTIFICAT, V15, P1; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Ivanov A, 2015, CELL REP, V10, P170, DOI 10.1016/j.celrep.2014.12.019; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Kos A, 1986, HEPATITIS DELTA VIRU, P323; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li Y, 2015, CELL RES; Liang D, 2014, GENE DEV, P28; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P307, DOI [10.3389/fgene.2013.00307, 10.3389/fgene.2013.00077]; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Starke S, 2015, CELL REP, V10, P103, DOI 10.1016/j.celrep.2014.12.002; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; You X, 2015, NAT NEUROSCI; Zaphiropoulos PG, 1997, MOL CELL BIOL, V17, P2985, DOI 10.1128/MCB.17.6.2985; Zaphiropoulos PG, 1996, P NATL ACAD SCI USA, V93, P6536, DOI 10.1073/pnas.93.13.6536; Zhang X-O, 2014, CELL, P159; Zhang YH, 2013, INT J ADV ROBOT SYST, V10, DOI 10.5772/56439	40	451	484	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141214	10.1371/journal.pone.0141214	http://dx.doi.org/10.1371/journal.pone.0141214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485708	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000363028100123
J	Xu, J; Li, C; Zheng, LL; Han, F; Li, Y; Walline, J; Fu, YY; Yao, DQ; Zhang, XC; Zhang, H; Zhu, HD; Guo, SB; Wang, Z; Yu, XZ				Xu, Jun; Li, Chen; Zheng, Liangliang; Han, Fei; Li, Yan; Walline, Joseph; Fu, Yangyang; Yao, Dongqi; Zhang, Xiaocui; Zhang, Hui; Zhu, Huadong; Guo, Shubin; Wang, Zhong; Yu, Xuezhong			Pulse Oximetry: A Non-Invasive, Novel Marker for the Quality of Chest Compressions in Porcine Models of Cardiac Arrest	PLOS ONE			English	Article							RESUSCITATION COUNCIL GUIDELINES; CORONARY PERFUSION-PRESSURE; EUROPEAN RESUSCITATION; CARDIOPULMONARY-RESUSCITATION; LIFE-SUPPORT; SPONTANEOUS CIRCULATION; HYPOTHERMIA; OUTCOMES; RETURN	Objective Pulse oximetry, which noninvasively detects the blood flow of peripheral tissue, has achieved widespread clinical use. We have noticed that the better the quality of cardiopulmonary resuscitation (CPR), the better the appearance of pulse oximetry plethysmographic waveform (POP). We investigated whether the area under the curve (AUC) and/or the amplitude (Amp) of POP could be used to monitor the quality of CPR. Design Prospective, randomized controlled study. Setting Animal experimental center in Peking Union Medical Collage Hospital, Beijing, China. Subjects Healthy 3-month-old male domestic swine. Interventions 34 local pigs were enrolled in this study. After 4 minutes of untreated ventricular fibrillation, animals were randomly assigned into two resuscitation groups: a "low quality" group (with a compression depth of 3cm) and a "high quality" group (with a depth of 5cm). All treatments between the two groups were identical except for the depth of chest compressions. Hemodynamic parameters [coronary perfusion pressure (CPP), partial pressure of end-tidal carbon dioxide (PETCO2)] as well as AUC and Amp of POP were all collected and analyzed. Measurements and Findings There were statistical differences between the "high quality" group and the "low quality" group in AUC, Amp, CPP and PETCO2 during CPR (P<0.05). AUC, Amp and CPP were positively correlated with PETCO2, respectively (P<0.01). There was no statistical difference between the heart rate calculated according to the POP (F-CPR) and the frequency of mechanical CPR at the 3rd minute of CPR. The F-CPR was lower than the frequency of mechanical CPR at the 6th and the 9th minute of CPR. Conclusions Both the AUC and Amp of POP correlated well with CPP and PETCO2 in animal models. The frequency of POP closely matched the CPR heart rate. AUC and Amp of POP might be potential noninvasive quality monitoring markers for CPR.	[Xu, Jun; Li, Yan; Fu, Yangyang; Yao, Dongqi; Zhang, Hui; Zhu, Huadong; Guo, Shubin; Yu, Xuezhong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Emergency Dept, Beijing 100730, Peoples R China; [Li, Chen] Tianjin Med Univ, Gen Hosp, Emergency Dept, Tianjin, Peoples R China; [Zheng, Liangliang] Beijing Hosp, Emergency Dept, Beijing, Peoples R China; [Han, Fei; Zhang, Xiaocui] Mindray Corp, Inst Life Monitoring, Shenzhen, Peoples R China; [Walline, Joseph] St Louis Univ Hosp, Div Emergency Med, Dept Surg, St Louis, MO USA; [Wang, Zhong] Beijing Tsinghua Chang Gung Hosp, Emergency Dept, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Tianjin Medical University; Beijing Hospital; Saint Louis University; Tsinghua University	Yu, XZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Emergency Dept, Beijing 100730, Peoples R China.	yxzpumch@126.com	Walline, Joseph/K-6667-2019; Walline, Joseph/A-4001-2019	Walline, Joseph/0000-0001-9582-1044; Walline, Joseph/0000-0001-9582-1044; Zhu, Huadong/0000-0002-1592-3188	Capital Health Research and Development Fund [2011-4001-04]; National Health and Family Planning Commission of the People's Republic of China Special Research Fund [201502019]; Institute of Life Monitoring; Mindray Corporation	Capital Health Research and Development Fund; National Health and Family Planning Commission of the People's Republic of China Special Research Fund; Institute of Life Monitoring; Mindray Corporation	This study received funding from the Capital Health Research and Development Fund (2011-4001-04), http://www.bjhbkj.com/, JX received this funding; the National Health and Family Planning Commission of the People's Republic of China Special Research Fund (201502019), http://www.moh.gov.cn/qjjys/s3577/201401/e9f3635e7acb47778225ccb729ffec62.shtml, XY received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Institute of Life Monitoring, Mindray Corporation provided support in the form of salaries for authors FH and XZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Arntz HR, 2010, RESUSCITATION, V81, P1353, DOI 10.1016/j.resuscitation.2010.08.016; Biarent D, 2010, RESUSCITATION, V81, P1364, DOI 10.1016/j.resuscitation.2010.08.012; CALLAHAM M, 1992, CRIT CARE MED, V20, P337, DOI 10.1097/00003246-199203000-00008; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; Edelson DP, 2014, J HOSP MED, V9, P353, DOI 10.1002/jhm.2174; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Gupta T, 2014, AM J CARDIOL, V114, P169, DOI 10.1016/j.amjcard.2014.04.021; Hsin T, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2014.04.035; Hutchens MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099910; Hutchens MP, 2014, THER HYPOTHERMIA TEM, V4, P79, DOI 10.1089/ther.2014.0003; Idris AH, 2012, CIRCULATION, V125, P3004, DOI 10.1161/CIRCULATIONAHA.111.059535; Kantamineni P, 2014, AM J MED SCI, V348, P377, DOI 10.1097/MAJ.0000000000000290; Koster RW, 2010, RESUSCITATION, V81, P1277, DOI 10.1016/j.resuscitation.2010.08.009; Lee JH, 2014, KOREAN J ANESTHESIOL, V66, P383, DOI 10.4097/kjae.2014.66.5.383; LEWIS LM, 1992, ANN EMERG MED, V21, P1131, DOI 10.1016/S0196-0644(05)80658-4; Lippert FK, 2010, RESUSCITATION, V81, P1445, DOI 10.1016/j.resuscitation.2010.08.013; Lopez-de-Sa E, 2013, REV ESP CARDIOL, V66, P606, DOI [10.1016/j.recesp.2013.04.003, 10.1016/j.rec.2013.04.002]; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; Pizov R, 2010, ANESTHESIOLOGY, V113, P83, DOI 10.1097/ALN.0b013e3181da839f; Reisner A, 2008, ANESTHESIOLOGY, V108, P950, DOI 10.1097/ALN.0b013e31816c89e1; Reynolds JC, 2010, PREHOSP EMERG CARE, V14, P78, DOI 10.3109/10903120903349796; Richmond S, 2010, RESUSCITATION, V81, P1389, DOI 10.1016/j.resuscitation.2010.08.018; Sawyer KN, 2014, RESUSCITATION, DOI [10.1016/j.resuscitation.2014.05.018, DOI 10.1016/J.RESUSCITATI0N.2014.05.018]; Soar J, 2011, CURR OPIN CRIT CARE, V17, P225, DOI 10.1097/MCC.0b013e3283468b5c; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Soar J, 2010, RESUSCITATION, V81, P1434, DOI 10.1016/j.resuscitation.2010.08.014; Sutton RM, 2014, RESUSCITATION, DOI [10.1016/j.resuscitation.2014.04.015, DOI 10.1016/J.RESUSCITATI0N.2014.04.015]	28	8	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139707	10.1371/journal.pone.0139707	http://dx.doi.org/10.1371/journal.pone.0139707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485651	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100012
J	Bastianini, S; Silvani, A; Berteotti, C; Lo Martire, V; Cohen, G; Ohtsu, H; Lin, JS; Zoccoli, G				Bastianini, Stefano; Silvani, Alessandro; Berteotti, Chiara; Lo Martire, Viviana; Cohen, Gary; Ohtsu, Hiroshi; Lin, Jian-Sheng; Zoccoli, Giovanna			Histamine Transmission Modulates the Phenotype of Murine Narcolepsy Caused by Orexin Neuron Deficiency	PLOS ONE			English	Article							CEREBROSPINAL-FLUID HISTAMINE; BLOOD-PRESSURE; KNOCKOUT MICE; SLEEP-APNEA; HEART-RATE; HYPOCRETIN; CATAPLEXY; OREXIN/HYPOCRETIN; REM; WAKEFULNESS	Narcolepsy type 1 is associated with loss of orexin neurons, sleep-wake derangements, cataplexy, and a wide spectrum of alterations in other physiological functions, including energy balance, cardiovascular, and respiratory control. It is unclear which narcolepsy signs are directly related to the lack of orexin neurons or are instead modulated by dysfunction of other neurotransmitter systems physiologically controlled by orexin neurons, such as the histamine system. To address this question, we tested whether some of narcolepsy signs would be detected in mice lacking histamine signaling (HDC-KO). Moreover, we studied double-mutant mice lacking both histamine signaling and orexin neurons (DM) to evaluate whether the absence of histamine signaling would modulate narcolepsy symptoms produced by orexin deficiency. Mice were instrumented with electrodes for recording the electroencephalogram and electromyogram and a telemetric arterial pressure transducer. Sleep attacks fragmenting wakefulness, cataplexy, excess rapid-eye-movement sleep (R) during the activity period, and enhanced increase of arterial pressure during R, which are hallmarks of narcolepsy in mice, did not occur in HDC-KO, whereas they were observed in DM mice. Thus, these narcolepsy signs are neither caused nor abrogated by the absence of histamine. Conversely, the lack of histamine produced obesity in HDC-KO and to a greater extent also in DM. Moreover, the regularity of breath duration during R was significantly increased in either HDC-KO or DM relative to that in congenic wild-type mice. Defects of histamine transmission may thus modulate the metabolic and respiratory phenotype of murine narcolepsy.	[Bastianini, Stefano; Silvani, Alessandro; Berteotti, Chiara; Lo Martire, Viviana; Zoccoli, Giovanna] Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, PRISM Lab, Bologna, Italy; [Cohen, Gary] Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden; [Ohtsu, Hiroshi] Tohoku Univ, Grad Sch Engn, Appl Quantum Med Engn, Sendai, Miyagi 980, Japan; [Lin, Jian-Sheng] Univ Lyon 1, Physiol Integree Syst Eveil, Ctr Rech Neurosci Lyon, INSERM,CNRS,Fac Med,U1028,UMR 5292, F-69365 Lyon, France	University of Bologna; Karolinska Institutet; Tohoku University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Zoccoli, G (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, PRISM Lab, Bologna, Italy.	giovanna.zoccoli@unibo.it	berteotti, chiara/AAK-9065-2020; Lin, Jian-Sheng/G-4395-2013; Zoccoli, Giovanna/CAH-3382-2022; Bastianini, Stefano/AAO-7982-2020; Silvani, Alessandro/A-1027-2015	Lin, Jian-Sheng/0000-0002-2004-6079; Bastianini, Stefano/0000-0003-2468-1704; Silvani, Alessandro/0000-0003-3992-3892; Cohen, Gary/0000-0001-9677-2870; Zoccoli, Giovanna/0000-0002-9670-9959; BERTEOTTI, CHIARA/0000-0002-4143-9445; Lo Martire, Viviana/0000-0001-8696-0835				Anaclet C, 2010, J SLEEP RES S2, V19, P154; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; [Anonymous], 2014, INT CLASSIFICATION S; Bassetti CL, 2010, J SLEEP RES, V19, P620, DOI 10.1111/j.1365-2869.2010.00819.x; Bastianini S, 2011, SLEEP, V34, P213, DOI 10.1093/sleep/34.2.213; Bhuiyan ME, 2011, AM J PHYSIOL-HEART C, V301, pH523, DOI 10.1152/ajpheart.00263.2011; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Chabas D, 2007, SLEEP, V30, P1267, DOI 10.1093/sleep/30.10.1267; Chapuis C, 2014, J PHYSIOL-LONDON, V592, P2169, DOI 10.1113/jphysiol.2013.268730; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; CHOKROVERTY S, 1986, SLEEP, V9, P250, DOI 10.1093/sleep/9.1.250; Dahmen N, 2009, SLEEP, V32, P962; DANTZ B, 1994, ELECTROEN CLIN NEURO, V90, P24, DOI 10.1016/0013-4694(94)90110-4; Dauvilliers Y, 2013, LANCET NEUROL, V12, P1068, DOI 10.1016/S1474-4422(13)70225-4; Dauvilliers Y, 2012, SLEEP, V35, P1359, DOI 10.5665/sleep.2114; Dauvilliers Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038977; Donadio V, 2014, NEUROLOGY, V83, P1080, DOI 10.1212/WNL.0000000000000793; Donadio V, 2014, SLEEP MED, V15, P315, DOI 10.1016/j.sleep.2013.12.005; Dutschmann M, 2003, PFLUG ARCH EUR J PHY, V445, P570, DOI 10.1007/s00424-002-0904-z; Eriksson KS, 2004, EUR J NEUROSCI, V19, P1278, DOI 10.1111/j.1460-9568.2004.03243.x; Eriksson KS, 2001, J NEUROSCI, V21, P9273, DOI 10.1523/JNEUROSCI.21-23-09273.2001; Fujiki N, 2006, PEPTIDES, V27, P2326, DOI 10.1016/j.peptides.2006.03.011; Fujiki N, 2009, EXP NEUROL, V217, P46, DOI 10.1016/j.expneurol.2009.01.015; Grimaldi D, 2014, NEUROLOGY, V82, P271, DOI 10.1212/WNL.0000000000000045; Grimaldi D, 2012, SLEEP, V35, P519, DOI 10.5665/sleep.1738; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hermida RC, 2013, CHRONOBIOL INT, V30, P87, DOI 10.3109/07420528.2012.701127; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Inocente CO, 2013, CNS NEUROSCI THER, V19, P521, DOI 10.1111/cns.12105; John J, 2013, ANN NEUROL, V74, P786, DOI 10.1002/ana.23968; Kantor S, 2009, SLEEP, V32, P1127, DOI 10.1093/sleep/32.9.1127; Khatami R, 2008, SLEEP, V31, P859, DOI 10.1093/sleep/31.6.859; Kukkonen JP, 2013, AM J PHYSIOL-CELL PH, V304, pC2, DOI 10.1152/ajpcell.00227.2012; Lin JS, 2008, NEUROBIOL DIS, V30, P74, DOI 10.1016/j.nbd.2007.12.003; Lo Martire V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047032; Lubkin M, 1998, BIOCHEM BIOPH RES CO, V253, P241, DOI 10.1006/bbrc.1998.9750; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Miyamoto K, 2004, RESP PHYSIOL NEUROBI, V144, P25, DOI 10.1016/j.resp.2004.07.016; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Nakamura A, 2007, J APPL PHYSIOL, V102, P241, DOI 10.1152/japplphysiol.00679.2006; Nanduri J, 2012, P NATL ACAD SCI USA, V109, P2515, DOI 10.1073/pnas.1120600109; Nishino S, 2009, SLEEP, V32, P175, DOI 10.1093/sleep/32.2.175; Ohayon MM, 2014, SLEEP, V37, P439, DOI 10.5665/sleep.3470; Ohayon MM, 2013, SLEEP MED, V14, P488, DOI 10.1016/j.sleep.2013.03.002; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Parmentier R, 2002, J NEUROSCI, V22, P7695; Pataka AD, 2012, EUR J NEUROL, V19, P696, DOI 10.1111/j.1468-1331.2011.03610.x; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pizza F, 2013, EUR NEUROL, V70, P22, DOI 10.1159/000348719; Poli F, 2009, SLEEP, V32, P1491, DOI 10.1093/sleep/32.11.1491; Raghuraman S, 2014, P NATL ACAD SCI USA, V111, P6449, DOI 10.1073/pnas.1404421111; Rocca FL, 2015, NEUROPEDIATRICS, V46, P181, DOI 10.1055/s-0035-1550152; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sansa G, 2010, SLEEP MED, V11, P93, DOI 10.1016/j.sleep.2009.02.009; Scammell TE, 2009, SLEEP, V32, P111; Schone C, 2012, J NEUROSCI, V32, P12437, DOI 10.1523/JNEUROSCI.0706-12.2012; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100536; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089432; Silvani A, 2014, J SLEEP RES, V23, P98, DOI 10.1111/jsr.12081; Silvani A, 2013, AM J PHYSIOL-HEART C, V305, pH1683, DOI 10.1152/ajpheart.00554.2013; Silvani A, 2009, HYPERTENSION, V53, P251, DOI 10.1161/HYPERTENSIONAHA.108.125542; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Terada J, 2008, J APPL PHYSIOL, V104, P499, DOI 10.1152/japplphysiol.00919.2007; Valko PO, 2013, ANN NEUROL, V74, P794, DOI 10.1002/ana.24019; Vu MH, 2011, J SLEEP RES, V20, P50, DOI 10.1111/j.1365-2869.2010.00851.x; Young JK, 2005, J APPL PHYSIOL, V98, P1387, DOI 10.1152/japplphysiol.00914.2004; Zhang SW, 2007, J PHYSIOL-LONDON, V581, P649, DOI 10.1113/jphysiol.2007.129510	70	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140520	10.1371/journal.pone.0140520	http://dx.doi.org/10.1371/journal.pone.0140520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474479	Green Published, Green Submitted, gold			2022-12-27	WOS:000363185500063
J	Croteau-Chonka, DC; Rogers, AJ; Raj, T; McGeachie, MJ; Qiu, WL; Ziniti, JP; Stubbs, BJ; Liang, LM; Martinez, FD; Strunk, RC; Lemanske, RF; Liu, AH; Stranger, BE; Carey, VJ; Raby, BA				Croteau-Chonka, Damien C.; Rogers, Angela J.; Raj, Towfique; McGeachie, Michael J.; Qiu, Weiliang; Ziniti, John P.; Stubbs, Benjamin J.; Liang, Liming; Martinez, Fernando D.; Strunk, Robert C.; Lemanske, Robert F., Jr.; Liu, Andrew H.; Stranger, Barbara E.; Carey, Vincent J.; Raby, Benjamin A.			Expression Quantitative Trait Loci Information Improves Predictive Modeling of Disease Relevance of Non-Coding Genetic Variation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHILDHOOD ASTHMA; EQTLS; BIOCONDUCTOR; POPULATIONS; RATIONALE; DESIGN	Disease-associated loci identified through genome-wide association studies (GWAS) frequently localize to non-coding sequence. We and others have demonstrated strong enrichment of such single nucleotide polymorphisms (SNPs) for expression quantitative trait loci (eQTLs), supporting an important role for regulatory genetic variation in complex disease pathogenesis. Herein we describe our initial efforts to develop a predictive model of disease-associated variants leveraging eQTL information. We first catalogued cis-acting eQTLs (SNPs within 100kb of target gene transcripts) by meta-analyzing four studies of three blood-derived tissues (n = 586). At a false discovery rate < 5%, we mapped eQTLs for 6,535 genes; these were enriched for disease-associated genes (P < 10(-04)), particularly those related to immune diseases and metabolic traits. Based on eQTL information and other variant annotations (distance from target gene transcript, minor allele frequency, and chromatin state), we created multivariate logistic regression models to predict SNP membership in reported GWAS. The complete model revealed independent contributions of specific annotations as strong predictors, including evidence for an eQTL (odds ratio (OR) = 1.2-2.0, P < 10(-11)) and the chromatin states of active promoters, different classes of strong or weak enhancers, or transcriptionally active regions (OR = 1.5-2.3, P < 10(-11)). This complete prediction model including eQTL association information ultimately allowed for better discrimination of SNPs with higher probabilities of GWAS membership (6.3-10.0%, compared to 3.5% for a random SNP) than the other two models excluding eQTL information. This eQTL-based prediction model of disease relevance can help systematically prioritize non-coding GWAS SNPs for further functional characterization.	[Croteau-Chonka, Damien C.; Rogers, Angela J.; McGeachie, Michael J.; Qiu, Weiliang; Ziniti, John P.; Stubbs, Benjamin J.; Carey, Vincent J.; Raby, Benjamin A.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Croteau-Chonka, Damien C.; Rogers, Angela J.; Raj, Towfique; McGeachie, Michael J.; Qiu, Weiliang; Ziniti, John P.; Stubbs, Benjamin J.; Stranger, Barbara E.; Carey, Vincent J.; Raby, Benjamin A.] Harvard Univ, Sch Med, Boston, MA USA; [Rogers, Angela J.] Stanford Univ, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Raj, Towfique] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Raj, Towfique; Stranger, Barbara E.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Raj, Towfique; Stranger, Barbara E.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Martinez, Fernando D.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Martinez, Fernando D.] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Strunk, Robert C.] Washington Univ, Sch Med, Dept Pediat, Div Allergy Immunol & Pulm Med, St Louis, MO 63110 USA; [Lemanske, Robert F., Jr.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Liu, Andrew H.] Natl Jewish Hlth, Dept Pediat, Div Allergy & Clin Immunol, Denver, CO USA; [Liu, Andrew H.] Univ Colorado, Sch Med, Denver, CO USA; [Stranger, Barbara E.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Raby, Benjamin A.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, BWH Pulm Genet Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Arizona; University of Arizona; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Chicago; Harvard University; Brigham & Women's Hospital	Raby, BA (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	benjamin.raby@channing.harvard.edu	Raby, Benjamin/AAK-3866-2021; Raj, Towfique/ABD-7620-2021	Rogers, Angela/0000-0001-6969-6200; Stranger, Barbara/0000-0001-9021-7331	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01 HL086601, RC2 HL101543, K12 HL089990, T32 HL007427]; Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101543, R01HL086601, T32HL007427, R01HL118455, K12HL089990] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01 HL086601, RC2 HL101543, K12 HL089990, and T32 HL007427) and from the Parker B. Francis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Carey VJ, 2009, BIOINFORMATICS, V25, P1447, DOI 10.1093/bioinformatics/btp169; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ertekin-Taner N, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-31; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gagliano SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098122; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; Hastie T., 2009, UNSUPERVISED LEARNIN; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Li Lin, 2013, Frontiers in Genetics, V4, P103, DOI 10.3389/fgene.2013.00103; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sul JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003491; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Trynka G, 2013, CURR OPIN GENET DEV, V23, P635, DOI 10.1016/j.gde.2013.10.009; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Westra HJ, 2014, BBA-MOL BASIS DIS, V1842, P1896, DOI 10.1016/j.bbadis.2014.04.024; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wright FA, 2014, NAT GENET; Xia K, 2012, BIOINFORMATICS, V28, P451, DOI 10.1093/bioinformatics/btr678	42	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140758	10.1371/journal.pone.0140758	http://dx.doi.org/10.1371/journal.pone.0140758			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474488	Green Published, gold, Green Submitted			2022-12-27	WOS:000363185500103
J	Pasiakos, SM; McClung, HL; Margolis, LM; Murphy, NE; Lin, GG; Hydren, JR; Young, AJ				Pasiakos, Stefan M.; McClung, Holly L.; Margolis, Lee M.; Murphy, Nancy E.; Lin, Gregory G.; Hydren, Jay R.; Young, Andrew J.			Human Muscle Protein Synthetic Responses during Weight-Bearing and Non-Weight-Bearing Exercise: A Comparative Study of Exercise Modes and Recovery Nutrition	PLOS ONE			English	Article							SIGNALING MOLECULE PHOSPHORYLATION; RESISTANCE EXERCISE; ENDURANCE EXERCISE; SKELETAL-MUSCLE; YOUNG MEN; ENERGY-BALANCE; LOAD CARRIAGE; OLDER MEN; MYOFIBRILLAR; INGESTION	Effects of conventional endurance (CE) exercise and essential amino acid (EAA) supplementation on protein turnover are well described. Protein turnover responses to weighted endurance exercise (i.e., load carriage, LC) and EAA may differ from CE, because the mechanical forces and contractile properties of LC and CE likely differ. This study examined muscle protein synthesis (MPS) and whole-body protein turnover in response to LC and CE, with and without EAA supplementation, using stable isotope amino acid tracer infusions. Forty adults (mean +/- SD, 22 +/- 4 y, 80 +/- 10 kg, VO2peak 4.0 +/- 0.5 L.min(-1)) were randomly assigned to perform 90 min, absolute intensity-matched (2.2 +/- 0.1 VO2 L.m(-1)) LC (performed on a treadmill wearing a vest equal to 30% of individual body mass, mean +/- SD load carried 24 +/- 3 kg) or CE (cycle ergometry performed at the same absolute VO2 as LC) exercise, during which EAA (10 g EAA, 3.6 g leucine) or control (CON, non-nutritive) drinks were consumed. Mixed-muscle and myofibrillar MPS were higher during exercise for LC than CE (mode main effect, P < 0.05), independent of dietary treatment. EAA enhanced mixed-muscle and sarcoplasmic MPS during exercise, regardless of mode (drink main effect, P < 0.05). Mixed-muscle and sarcoplasmic MPS were higher in recovery for LC than CE (mode main effect, P < 0.05). No other differences or interactions (mode x drink) were observed. However, EAA attenuated whole-body protein breakdown, increased amino acid oxidation, and enhanced net protein balance in recovery compared to CON, regardless of exercise mode (P < 0.05). These data show that, although whole-body protein turnover responses to absolute VO2-matched LC and CE are the same, LC elicited a greater muscle protein synthetic response than CE.	[Pasiakos, Stefan M.; McClung, Holly L.; Margolis, Lee M.; Murphy, Nancy E.; Lin, Gregory G.; Young, Andrew J.] US Army Res Inst Environm Med, Mil Nutr Div, Natick, MA 01760 USA; [Hydren, Jay R.] US Army Res Inst Environm Med, Mil Performance Div, Natick, MA USA	United States Department of Defense; United States Army; United States Department of Defense; United States Army	Pasiakos, SM (corresponding author), US Army Res Inst Environm Med, Mil Nutr Div, Natick, MA 01760 USA.	stefan.m.pasiakos.civ@mail.mil	Hydren, Jay/H-3654-2016; Pasiakos, Stefan M/E-6295-2014	Hydren, Jay/0000-0001-9385-8898; Pasiakos, Stefan M/0000-0002-5378-5820; Margolis, Lee/0000-0003-1697-825X; , Lee/0000-0002-0652-1304	US Army Medical Research and Materiel Command; US Army Natick Soldier Research Development and Engineering Center	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); US Army Natick Soldier Research Development and Engineering Center	The study was funded by the US Army Medical Research and Materiel Command and the US Army Natick Soldier Research Development and Engineering Center.	Atherton PJ, 2010, AM J CLIN NUTR, V92, P1080, DOI 10.3945/ajcn.2010.29819; Burd NA, 2012, J APPL PHYSIOL, V113, P896, DOI 10.1152/japplphysiol.00513.2012; Burd NA, 2012, J PHYSIOL-LONDON, V590, P351, DOI 10.1113/jphysiol.2011.221200; Burd Nicholas A, 2011, Nutr Metab (Lond), V8, P15, DOI 10.1186/1743-7075-8-15; Burd NA, 2010, J PHYSIOL-LONDON, V588, P3119, DOI 10.1113/jphysiol.2010.192856; Burd NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012033; Camera DM, 2015, MED SCI SPORT EXER, V47, P82, DOI 10.1249/MSS.0000000000000390; Di Donato DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1025, DOI 10.1152/ajpendo.00487.2013; Dickinson JM, 2014, J NUTR, V144, P1694, DOI 10.3945/jn.114.198671; Donges CE, 2012, J APPL PHYSIOL, V112, P1992, DOI 10.1152/japplphysiol.00166.2012; EVANS WJ, 1982, MED SCI SPORT EXER, V14, P101; Glynn EL, 2013, J NUTR, V143, P307, DOI 10.3945/jn.112.168203; Grenier JG, 2012, MED SCI SPORT EXER, V44, P1131, DOI 10.1249/MSS.0b013e3182456057; HOERR RA, 1989, AM J PHYSIOL, V257, pE426, DOI 10.1152/ajpendo.1989.257.3.E426; Huang TWP, 2014, J EXP BIOL, V217, P605, DOI 10.1242/jeb.091587; Hulston CJ, 2011, MED SCI SPORT EXER, V43, P1635, DOI 10.1249/MSS.0b013e31821661ab; Koopman R, 2004, AM J PHYSIOL-ENDOC M, V287, pE712, DOI 10.1152/ajpendo.00543.2003; Margolis LM, 2014, APPL PHYSIOL NUTR ME, V39, P1395, DOI 10.1139/apnm-2014-0212; Margolis LM, 2013, APPL PHYSIOL NUTR ME, V38, P396, DOI 10.1139/apnm-2012-0323; MATTHEWS DE, 1980, AM J PHYSIOL, V238, pE473, DOI 10.1152/ajpendo.1980.238.5.E473; Miller SL, 2007, INT J SPORT NUTR EXE, V17, P456, DOI 10.1123/ijsnem.17.5.456; Mitchell WK, 2015, J NUTR, V145, P207, DOI 10.3945/jn.114.199604; Montain SJ, 2000, J APPL PHYSIOL, V89, P1123, DOI 10.1152/jappl.2000.89.3.1123; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Nindl BC, 2013, EUR J APPL PHYSIOL, V113, P2655, DOI 10.1007/s00421-013-2591-1; Pasiakos SM, 2015, FASEB J, V29, P1136, DOI 10.1096/fj.14-266890; Pasiakos SM, 2013, FASEB J, V27, P3837, DOI 10.1096/fj.13-230227; Pasiakos SM, 2012, NUTRIENTS, V4, P740, DOI 10.3390/nu4070740; Pasiakos SM, 2011, AM J CLIN NUTR, V94, P809, DOI 10.3945/ajcn.111.017061; Pasiakos SM, 2010, INT J SPORT NUTR EXE, V20, P282, DOI 10.1123/ijsnem.20.4.282; Pasiakos SM, 2010, J NUTR, V140, P745, DOI 10.3945/jn.109.118372; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Reidy PT, 2013, J NUTR, V143, P410, DOI 10.3945/jn.112.168021; Rennie MJ, 2000, ANNU REV NUTR, V20, P457, DOI 10.1146/annurev.nutr.20.1.457; Rodriguez NR, 2007, CURR OPIN CLIN NUTR, V10, P40, DOI 10.1097/MCO.0b013e3280115e3b; Rowlands DS, 2015, MED SCI SPORT EXER, V47, P547, DOI 10.1249/MSS.0000000000000447; West DWD, 2011, AM J CLIN NUTR, V94, P795, DOI 10.3945/ajcn.111.013722; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916	38	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140863	10.1371/journal.pone.0140863	http://dx.doi.org/10.1371/journal.pone.0140863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474292	gold, Green Published, Green Submitted			2022-12-27	WOS:000363185500121
J	Slagter, SN; van Vliet-Ostaptchouk, JV; van Beek, AP; Keers, JC; Lutgers, HL; van der Klauw, MM; Wolffenbuttel, BHR				Slagter, Sandra N.; van Vliet-Ostaptchouk, Jana V.; van Beek, Andre P.; Keers, Joost C.; Lutgers, Helen L.; van der Klauw, Melanie M.; Wolffenbuttel, Bruce H. R.			Health-Related Quality of Life in Relation to Obesity Grade, Type 2 Diabetes, Metabolic Syndrome and Inflammation	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; CHRONIC KIDNEY-DISEASE; FUNCTIONAL-CAPACITY; INDIVIDUALS; SF-36; MEN; ASSOCIATION; OVERWEIGHT; WEIGHT	Background Health-related quality of life (HR-QoL) may be compromised in obese individuals, depending on the presence of other complications. The aim of this study is to assess the effect of obesity-related conditions on HR-QoL. These conditions are i) grade of obesity with and without type 2 diabetes (T2D), ii) metabolic syndrome (MetS), and iii) level of inflammation. Methods From the Dutch LifeLines Cohort Study we included 13,686 obese individuals, aged 18-80 years. HR-QoL was measured with the RAND 36-Item Health Survey which encompasses eight health domains. We calculated the percentage of obese individuals with poor HR-QoL, i.e. those scoring below the domain and sex specific cut-off value derived from the normal weight population. Logistic regression analysis was used to calculate the probability of having poor domain scores according to the conditions under study. Results Higher grades of obesity and the additional presence of T2D were associated with lower HR-QoL, particularly in the domains physical functioning (men: odds ratios (ORs) 1.48-11.34, P<0.005, and women: ORs 1.66-5.05, P<0.001) and general health (men: ORs 1.44-3.07, P<0.005, and women: ORs 1.36-3.73, P<0.001). A higher percentage of obese individuals with MetS had a poor HR-QoL than those without MetS. Furthermore, we observed a linear trend between inflammation and the percentage of obese individuals with poor scores on the HR-QoL domains. Individuals with MetS were more likely to have poor scores in the domains general health, vitality, social functioning and role limitations due to emotional problems. Obese women with increased inflammation levels were more likely to have poor scores on all domains except role limitations due to emotional problems and mental health. Conclusions The impact of obesity on an individual's quality of life is enhanced by grade of obesity, T2D, MetS and inflammation and are mainly related to reduced physical health. The mental wellbeing is less often impaired.	[Slagter, Sandra N.; van Vliet-Ostaptchouk, Jana V.; van Beek, Andre P.; Keers, Joost C.; Lutgers, Helen L.; van der Klauw, Melanie M.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Keers, Joost C.] Martini Hosp, Van Swieten Res Inst, Groningen, Netherlands	University of Groningen; Martini Hospital	Wolffenbuttel, BHR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.	bwo@umcg.nl	van Beek, Andre/O-3753-2014; van der Klauw, Melanie/A-2138-2014	van Beek, Andre/0000-0002-0335-8177; van der Klauw, Melanie/0000-0001-7178-009X; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153	Netherlands Organization of Scientific Research (NWO) [175.010.2007.006]; Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; National Consortium for Healthy Ageing; European Union's Seventh Framework programme (FP7) through the BioSHaRE-EU (Biobank Standardisation and Harmonisation for Research Excellence in the European Union) [261433]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; National Consortium for Healthy Ageing; European Union's Seventh Framework programme (FP7) through the BioSHaRE-EU (Biobank Standardisation and Harmonisation for Research Excellence in the European Union)	The LifeLines Cohort Study was supported by the Netherlands Organization of Scientific Research (NWO) [grant 175.010.2007.006]; the Economic Structure Enhancing Fund (FES) of the Dutch government; the Ministry of Economic Affairs; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the Northern Netherlands Collaboration of Provinces (SNN); the Province of Groningen; University Medical Center Groningen; the University of Groningen; the Dutch Kidney Foundation; and the Dutch Diabetes Research Foundation. This work was supported by the National Consortium for Healthy Ageing, and the European Union's Seventh Framework programme (FP7/2007-2013) through the BioSHaRE-EU (Biobank Standardisation and Harmonisation for Research Excellence in the European Union) project, grant agreement 261433.	Amiri P, 2010, J WOMENS HEALTH, V19, P1201, DOI 10.1089/jwh.2009.1710; Baiano M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-165; Bentley TGK, 2011, QUAL LIFE RES, V20, P665, DOI 10.1007/s11136-011-9878-7; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cameron AJ, 2012, INT J OBESITY, V36, P295, DOI 10.1038/ijo.2011.103; Choo J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003954; Cummings DM, 2003, ANN PHARMACOTHER, V37, P1593, DOI 10.1345/aph.1D029; de Zwaan M, 2009, PSYCHOSOMATICS, V50, P474, DOI 10.1176/appi.psy.50.5.474; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; Farag YMK, 2011, CLIN NEPHROL, V75, P524, DOI 10.5414/CNP75524; Farivar SS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-54; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Ford ES, 1999, DIABETES CARE, V22, P1971, DOI 10.2337/diacare.22.12.1971; Formiguera X, 2004, BEST PRACT RES CL GA, V18, P1125, DOI [10.1016/S1521-6918(04)00091-5, 10.1016/j.bpg.2004.06.030]; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Jagielski AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092859; Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025; Kalender B, 2007, INT J CLIN PRACT, V61, P569, DOI 10.1111/j.1742-1241.2006.01251.x; Kolotkin RL, 2002, OBES RES, V10, P748, DOI 10.1038/oby.2002.102; Korhonen PE, 2014, QUAL LIFE RES, V23, P67, DOI 10.1007/s11136-013-0433-6; Lakoski SG, 2006, AM HEART J, V152, P593, DOI 10.1016/j.ahj.2006.02.015; Levinger I, 2007, DIABETES CARE, V30, P2205, DOI 10.2337/dc07-0841; Levinger I, 2009, INT J CARDIOL, V133, P281, DOI 10.1016/j.ijcard.2007.11.046; Mommersteeg PMC, 2012, BRAIN BEHAV IMMUN, V26, P301, DOI 10.1016/j.bbi.2011.09.010; Motie M, 2014, EXP THER MED, V8, P181, DOI 10.3892/etm.2014.1673; Renzaho A, 2010, QUAL LIFE RES, V19, P515, DOI 10.1007/s11136-010-9610-z; Ridker PM, 2003, CIRCULATION, V108, pE81, DOI 10.1161/01.CIR.0000093381.57779.67; Rieger E, 2005, INT J EAT DISORDER, V37, P234, DOI 10.1002/eat.20101; Serrano-Aguilar P, 2009, QUAL LIFE RES, V18, P171, DOI 10.1007/s11136-008-9427-1; Soltoft F, 2009, QUAL LIFE RES, V18, P1293, DOI 10.1007/s11136-009-9541-8; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Taft C, 2001, QUAL LIFE RES, V10, P395, DOI 10.1023/A:1012552211996; Tapp RJ, 2006, DIABETES RES CLIN PR, V74, P154, DOI 10.1016/j.diabres.2006.03.012; Tsai AG, 2008, OBESITY, V16, P59, DOI 10.1038/oby.2007.8; van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Vetter ML, 2011, INT J OBESITY, V35, P1087, DOI 10.1038/ijo.2010.230; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wong YYE, 2012, MATURITAS, V73, P158, DOI 10.1016/j.maturitas.2012.06.007	40	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140599	10.1371/journal.pone.0140599	http://dx.doi.org/10.1371/journal.pone.0140599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0DF	26474291	Green Published, Green Submitted, gold			2022-12-27	WOS:000363185500071
J	Eichhorn, T; Ludwig, U; Fischer, E; Grobner, J; Gopper, M; Eisenbeiss, AK; Flugge, T; Hennig, J; von Elverfeldt, D; Hovener, JB				Eichhorn, Timon; Ludwig, Ute; Fischer, Elmar; Groebner, Jens; Goepper, Michael; Eisenbeiss, Anne-Katrin; Fluegge, Tabea; Hennig, Juergen; von Elverfeldt, Dominik; Hoevener, Jan-Bernd			Modular Coils with Low Hydrogen Content Especially for MRI of Dry Solids	PLOS ONE			English	Article							RESOLUTION; TIME	Introduction Recent advances have enabled fast magnetic resonance imaging (MRI) of solid materials. This development has opened up new applications for MRI, but, at the same time, uncovered new challenges. Previously, MRI-invisible materials like the housing of MRI detection coils are now readily depicted and either cause artifacts or lead to a decreased image resolution. In this contribution, we present versatile, multi-nuclear single and dual-tune MRI coils that stand out by (1) a low hydrogen content for high-resolution MRI of dry solids without artifacts; (2) a modular approach with exchangeable inductors of variable volumes to optimally enclose the given object; (3) low cost and low manufacturing effort that is associated with the modular approach; (4) accurate sample placement in the coil outside of the bore, and (5) a wide, single-or dual-tune frequency range that covers several nuclei and enables multinuclear MRI without moving the sample. Materials and Methods The inductors of the coils were constructed from self-supporting copper sheets to avoid all plastic materials within or around the resonator. The components that were mounted at a distance from the inductor, including the circuit board, coaxial cable and holder were manufactured from polytetrafluoroethylene. Results and Conclusion Residual hydrogen signal was sufficiently well suppressed to allow H-1-MRI of dry solids with a minimum field of view that was smaller than the sensitive volume of the coil. The SNR was found to be comparable but somewhat lower with respect to commercial, proton-rich quadrature coils, and higher with respect to a linearly-polarized commercial coil. The potential of the setup presented was exemplified by H-1/Na-23 high-resolution zero echo time (ZTE) MRI of a model solution and a dried human molar at 9.4 T. A full 3D image dataset of the tooth was obtained, rich in contrast and similar to the resolution of standard cone-beam computed tomography.	[Eichhorn, Timon; Ludwig, Ute; Fischer, Elmar; Groebner, Jens; Eisenbeiss, Anne-Katrin; Hennig, Juergen; von Elverfeldt, Dominik; Hoevener, Jan-Bernd] Univ Med Ctr Freiburg, Dept Radiol, Med Phys, Freiburg, Germany; [Goepper, Michael] Univ Med Ctr Freiburg, Biol Anthropol, Freiburg, Germany; [Eisenbeiss, Anne-Katrin; Fluegge, Tabea] Univ Med Ctr Freiburg, Dept Craniomaxillofacial Surg, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Hovener, JB (corresponding author), Univ Med Ctr Freiburg, Dept Radiol, Med Phys, Freiburg, Germany.	jan.hoevener@uniklinik-freiburg.de	Hövener, Jan-Bernd/HFF-6498-2022; Flügge, Tabea/ABF-6696-2021; Hövener, Jan-Bernd/I-9056-2016; Flügge, Tabea/AGG-6442-2022; Hennig, Jürgen/F-2424-2010	Hövener, Jan-Bernd/0000-0001-7255-7252; Flügge, Tabea/0000-0002-1288-8452; Hövener, Jan-Bernd/0000-0001-7255-7252; Flügge, Tabea/0000-0002-1288-8452; Hennig, Jürgen/0000-0002-2273-3497; von Elverfeldt, Dominik/0000-0002-6219-3528	DFG [HO 4604/2-1]	DFG(German Research Foundation (DFG))	We are grateful for the support and helpful discussions with Waldemar Schimpf, Frank Huthe, Gerd Strohmeier, Thomas Gunter and Jochen Leupold. JBH wishes to acknowledge support by the DFG, HO 4604/2-1.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bracher AK, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120321; EMID S, 1985, PHYSICA B & C, V128, P81, DOI 10.1016/0378-4363(85)90087-7; Garwood M, 2012, EMAGRES, V1, P367, DOI 10.1002/9780470034590.emrstm1259; GRAVINA S, 1994, J MAGN RESON SER B, V104, P53, DOI 10.1006/jmrb.1994.1052; Hovener JB, 2012, J MAGN RESON IMAGING, V36, P841, DOI 10.1002/jmri.23712; Horch RA, 2010, MAGN RESON MED, V64, P1652, DOI 10.1002/mrm.22558; Idiyatullin D, 2014, MAGN RESON MED, V72, P160, DOI 10.1002/mrm.24893; Ludwig U, 2014, P JOINT ANN M ISMRM; McAuliffe MJ, 2001, COMP MED SY, P381; Ruhli FJ, 2007, JAMA-J AM MED ASSOC, V298, P2618, DOI 10.1001/jama.298.22.2618-b; Shin DH, 2010, J ANAT, V216, P329, DOI 10.1111/j.1469-7580.2009.01185.x; Weiger M, 2012, EMAGRES, V1, P311, DOI 10.1002/9780470034590.emrstm1292; Weiger M, 2012, NMR BIOMED; Weiger M, 2011, P INT SOC MAG RESON, V19, P2612; Weiger M, 2013, BONE, V54, P44, DOI 10.1016/j.bone.2013.01.027; Weiger M, 2011, MAGN RESON MED, V66, P379, DOI 10.1002/mrm.22799; Zwick S, 2011, P 19 ANN M ISMRM MON	18	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0139763	10.1371/journal.pone.0139763	http://dx.doi.org/10.1371/journal.pone.0139763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496192	gold, Green Published			2022-12-27	WOS:000363309200007
J	Ge, XZ; He, SY; Wang, T; Yan, W; Zong, SX				Ge, Xuezhen; He, Shanyong; Wang, Tao; Yan, Wei; Zong, Shixiang			Potential Distribution Predicted for Rhynchophorus ferrugineus in China under Different Climate Warming Scenarios	PLOS ONE			English	Article							ORIENTAL FRUIT-FLY; RED PALM WEEVIL; GEOGRAPHICAL-DISTRIBUTION; COLEOPTERA-CURCULIONIDAE; DISTRIBUTION RANGES; DIPTERA; OLIVIER; EUROPE	As the primary pest of palm trees, Rhynchophorus ferrugineus (Olivier) (Coleoptera: Curculionidae) has caused serious harm to palms since it first invaded China. The present study used CLIMEX 1.1 to predict the potential distribution of R. ferrugineus in China according to both current climate data (1981-2010) and future climate warming estimates based on simulated climate data for the 2020s (2011-2040) provided by the Tyndall Center for Climate Change Research (TYN SC 2.0). Additionally, the Ecoclimatic Index (EI) values calculated for different climatic conditions (current and future, as simulated by the B2 scenario) were compared. Areas with a suitable climate for R. ferrugineus distribution were located primarily in central China according to the current climate data, with the northern boundary of the distribution reaching to 40.1 degrees N and including Tibet, north Sichuan, central Shaanxi, south Shanxi, and east Hebei. There was little difference in the potential distribution predicted by the four emission scenarios according to future climate warming estimates. The primary prediction under future climate warming models was that, compared with the current climate model, the number of highly favorable habitats would increase significantly and expand into northern China, whereas the number of both favorable and marginally favorable habitats would decrease. Contrast analysis of EI values suggested that climate change and the density of site distribution were the main effectors of the changes in EI values. These results will help to improve control measures, prevent the spread of this pest, and revise the targeted quarantine areas.	[Ge, Xuezhen; He, Shanyong; Zong, Shixiang] Beijing Forestry Univ, Key Lab Beijing Control Forest Pests, Beijing, Peoples R China; [Wang, Tao] Mentougou Forestry Stn, Beijing, Peoples R China; [Yan, Wei] Chinese Acad Trop Agr Sci, Coconut Res Inst, Wenchang, Hainan, Peoples R China	Beijing Forestry University; Chinese Academy of Tropical Agricultural Sciences	Zong, SX (corresponding author), Beijing Forestry Univ, Key Lab Beijing Control Forest Pests, Beijing, Peoples R China.	zongsx@126.com	Ge, Xuezhen/AAU-3054-2021		Fundamental Research Funds for the Central Universities [TD2011-06]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This project was supported by the Fundamental Research Funds for the Central Universities (TD2011-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2008, Bulletin OEPP, V38, P55; Chejara VK, 2010, WEED RES, V50, P174, DOI 10.1111/j.1365-3180.2010.00765.x; [陈瑜 CHEN Yu], 2010, [生态学报, Acta Ecologica Sinica], V30, P2159; [冯益明 Feng Yiming], 2010, [华中农业大学学报, Journal of Huazhong Agricultural University], V29, P552; Fiaboe KKM, 2012, FLA ENTOMOL, V95, P659, DOI 10.1653/024.095.0317; Fu L, 2014, INSECT SCI, V21, P234, DOI 10.1111/1744-7917.12018; Ge XZ, 2014, ENTOMOL EXP APPL, V153, P256, DOI 10.1111/eea.12247; Geng J, 2011, INSECT SCI, V18, P575, DOI 10.1111/j.1744-7917.2010.01402.x; [韩宙 Han Zhou], 2013, [广东农业科学, Guangdong Agricultural Sciences], V40, P68; He S, 2015, B ENTOMOL RES, P1; He Shanyong, 2011, Scientia Silvae Sinicae, V47, P107; He SY, 2011, SCI SLIVAE SINICAE, V47, P197; Huang SC, 2008, CHINA FORESTRY SCI T, V22, P94; Ju Rui-Ting, 2010, Acta Entomologica Sinica, V53, P226; Ju RuiTing, 2008, Scientia Agricultura Sinica, V41, P2318; Li L, 2008, 2 NAT C BIOL INV GUA; Li L, 2010, THESIS HAINAN U; Li L, 2010, ENVIRON ENTOMOL, V39, P999, DOI 10.1603/EN09316; [林秀香 Lin Xiuxiang], 2007, [热带作物学报, Chinese Journal of Tropical Crops], V28, P115; Mika AM, 2008, GLOBAL CHANGE BIOL, V14, P1721, DOI 10.1111/j.1365-2486.2008.01620.x; Mika AM, 2010, AGR FOREST ENTOMOL, V12, P213, DOI 10.1111/j.1461-9563.2009.00464.x; Nardi S., 2011, Bulletin OEPP, V41, P103, DOI 10.1111/j.1365-2338.2011.02459.x; Nooten SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085987; Ou SS, 2010, ENTOMOL KNOWL, V47, P592; Qin WQ, 2009, ACTA AGR JIANGXI, V21, P79; Salama HS, 2002, ANZ SCHADL-J PEST SC, V75, P26, DOI 10.1046/j.1439-0280.2002.02004.x; Sambaraju KR, 2012, ECOGRAPHY, V35, P211, DOI 10.1111/j.1600-0587.2011.06847.x; Shabani F, 2012, CLIMATE CHANGE IMPAC; She DeSong, 2013, Journal of Zhejiang Forestry Science and Technology, V33, P56; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song Hong-Min, 2004, Entomological Knowledge, V41, P379; Sridhar V, 2014, CURR SCI INDIA, V106, P1702; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Sutherst R, 1998, CLIMEX WINDOWS VERSI; Vanhanen H., 2008, Bulletin OEPP, V38, P249, DOI 10.1111/j.1365-2338.2008.01212.x; Vanhanen H., 2008, Bulletin OEPP, V38, P239, DOI 10.1111/j.1365-2338.2008.01211.x; Wang CY, 2008, J JINLING I TECHNOLO, V24, P81; [王淑瑜 Wang Shuyu], 2004, [气候与环境研究, Climatic and environmental research], V9, P240; Watt MS, 2011, WEED SCI, V59, P538, DOI 10.1614/WS-D-11-00032.1; [魏娟 WEI Juan], 2009, [广东农业科学, Guangdong Agricultural Sciences], P110; Wei ZF, 1995, J TROPICAL SUBTROPIC, V3, P1; Wu XG, 2003, CHINA FORESTRY SCI T, V17, P90; Wu YS, 1998, GUANGDONG LANDSCAPE, V38; Xiong W, 2004, THESIS CHINA AGR U; Yu FS, 2001, TROPICAL FORESTRY, V29, P141; Yuan ZL, 2007, HUNAN SCI, V25, P586; Zhang RZ, 2003, CHINA FOREST INSECT, V22, P3, DOI DOI 10.1673/031.013.9101; Zhao Ming, 2010, Acta Phytophylacica Sinica, V37, P517	48	23	26	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141111	10.1371/journal.pone.0141111	http://dx.doi.org/10.1371/journal.pone.0141111			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496438	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200063
J	Szurek, E; Cebula, A; Wojciech, L; Pietrzak, M; Rempala, G; Kisielow, P; Ignatowicz, L				Szurek, Edyta; Cebula, Anna; Wojciech, Lukasz; Pietrzak, Maciej; Rempala, Grzegorz; Kisielow, Pawel; Ignatowicz, Leszek			Differences in Expression Level of Helios and Neuropilin-1 Do Not Distinguish Thymus-Derived from Extrathymically-Induced CD4(+)Foxp3(+) Regulatory T Cells	PLOS ONE			English	Article							SELF; SELECTION; RECEPTOR; FOXP3; MICE; INDUCTION; TOLERANCE; DIVERSITY; RESPONSES; IDENTITY	Helios transcription factor and semaphorin receptor Nrp-1 were originally described as constitutively expressed at high levels on CD4(+)Foxp3(+) T regulatory cells of intrathymic origin (tTregs). On the other hand, CD4(+)Foxp3(+) Tregs generated in the periphery (pTregs) or induced ex vivo (iTregs) were reported to express low levels of Helios and Nrp-1. Soon afterwards the reliability of Nrp-1 and Helios as markers discriminating between tTregs and pTregs was questioned and until now no consensus has been reached. Here, we used several genetically modified mouse strains that favor pTregs or tTregs formation and analyzed the TCR repertoire of these cells. We found that Tregs with variable levels of Nrp-1 and Helios were abundant in mice with compromised ability to support natural differentiation of tTregs or pTregs. We also report that TCR repertoires of Treg clones expressing high or low levels of Nrp-1 or Helios are similar and more alike repertoire of CD4(+)Foxp3(+) than repertoire of CD4(+)Foxp3(-) thymocytes. These results show that high vs. low expression of Nrp-1 or Helios does not unequivocally identify Treg clones of thymic or peripheral origin.	[Szurek, Edyta; Cebula, Anna; Wojciech, Lukasz; Ignatowicz, Leszek] Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Pietrzak, Maciej; Rempala, Grzegorz] Ohio State Univ, Coll Publ Hlth, Math Biosci Inst, Columbus, OH 43210 USA; [Kisielow, Pawel] Ludwik Hirszfeld Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland	University System of Georgia; Augusta University; University System of Ohio; Ohio State University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Ignatowicz, L (corresponding author), Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	lignatowicz@gru.edu	Rempala, Grzegorz/C-3576-2013; Pietrzak, Maciej/GNH-5768-2022	Pietrzak, Maciej/0000-0001-5768-7884	National Institutes of Health [R01 DK099264, R56 AI110785-01, R01CA152158]; National Institutes of Health (National Science Foundation) [DMS1106485]; NATIONAL CANCER INSTITUTE [R01CA152158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI110785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (National Science Foundation)(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by basic research grants from the National Institutes of Health (R01 DK099264 and R56 AI110785-01 to LI, R01CA152158 to GR and National Science Foundation DMS1106485 to GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2012, BLOOD, V119, P2443, DOI 10.1182/blood-2011-10-292003; Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Baine I, 2013, J IMMUNOL, V190, P1008, DOI 10.4049/jimmunol.1200792; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Corbel C, 2007, DEV COMP IMMUNOL, V31, P1082, DOI 10.1016/j.dci.2007.01.009; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; Daniely D, 2010, J IMMUNOL, V184, P6865, DOI 10.4049/jimmunol.0903609; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Delgoffe GM, 2012, IMMUNITY, V37, P759, DOI 10.1016/j.immuni.2012.10.012; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Feuerer M, 2007, P NATL ACAD SCI USA, V104, P18181, DOI 10.1073/pnas.0708899104; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Glinka Y, 2011, CARCINOGENESIS, V32, P613, DOI 10.1093/carcin/bgq281; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Graziani G, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00125; Hansen W, 2012, J EXP MED, V209, P2001, DOI 10.1084/jem.20111497; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huang YJ, 2014, EUR J IMMUNOL, V44, P460, DOI 10.1002/eji.201343463; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Ju Shyr-Te, 2012, Biology (Basel), V1, P18, DOI 10.3390/biology1010018; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kuczma M, 2009, J IMMUNOL, V183, P3731, DOI 10.4049/jimmunol.0800601; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Lee HM, 2011, ADV IMMUNOL, V112, P25, DOI 10.1016/B978-0-12-387827-4.00002-4; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Mayer CT, 2014, EUR J IMMUNOL, V44, P2990, DOI 10.1002/eji.201344315; Milpied P, 2009, EUR J IMMUNOL, V39, P1466, DOI 10.1002/eji.200839040; Pacholczyk R, 2002, J IMMUNOL, V168, P613, DOI 10.4049/jimmunol.168.2.613; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Petzold C, 2014, EUR J IMMUNOL, V44, P3632, DOI 10.1002/eji.201444750; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Rempala GA, 2013, J MATH BIOL, V67, P1339, DOI 10.1007/s00285-012-0589-7; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2012, NAT MED, V18, P54, DOI 10.1038/nm.2622; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Satou Y, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-46; Schlenner SM, 2012, J EXP MED, V209, P1529, DOI 10.1084/jem.20112646; Schliesser U, 2013, EUR J IMMUNOL, V43, P3291, DOI 10.1002/eji.201243292; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Singh K, 2015, SCI REP-UK, V5, DOI 10.1038/srep07767; Solomon BD, 2011, P NATL ACAD SCI USA, V108, P2040, DOI 10.1073/pnas.1008721108; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wojciech L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6061; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547	70	105	105	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141161	10.1371/journal.pone.0141161	http://dx.doi.org/10.1371/journal.pone.0141161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495986	Green Submitted, gold, Green Published			2022-12-27	WOS:000363309200068
J	Sachdeva, M; Sharma, A; Arora, SK				Sachdeva, Meenakshi; Sharma, Aman; Arora, Sunil K.			Functional Impairment of Myeloid Dendritic Cells during Advanced Stage of HIV-1 Infection: Role of Factors Regulating Cytokine Signaling	PLOS ONE			English	Article							NF-KAPPA-B; T-CELLS; 1-INFECTED INDIVIDUALS; ANTIRETROVIRAL THERAPY; NEGATIVE REGULATION; AIDS PATHOGENESIS; BLOOD; SUPPRESSOR; MATURATION; IMMUNITY	Introduction Severely immunocompromised state during advanced stage of HIV-1 infection has been linked to functionally defective antigen presentation by dendritic cells (DCs). The molecular mechanisms behind DC impairment are still obscure. We investigated changes in DC function and association of key regulators of cytokine signaling during different stages of HIV-1 infection and following antiretroviral therapy (ART). Methods Phenotypic and functional characteristics of circulating myeloid DCs (mDCs) in 56 ART-naive patients (23 in early and 33 in advanced stage of disease), 36 on ART and 24 healthy controls were evaluated. Sixteen patients were studied longitudinally prior-to and 6 months after the start of ART. For functional studies, monocyte-derived DCs (Mo-DCs) were evaluated for endocytosis, allo-stimulation and cytokine secretion. The expression of suppressor of cytokine signaling (SOCS)-1 and other regulators of cytokine signaling was evaluated by real-time RT-PCR. Results The ability to respond to an antigenic stimulation was severely impaired in patients in advanced HIV-1 disease which showed partial recovery in the treated group. Mo-DCs from patients with advanced HIV-disease remained immature with low allo-stimulation and reduced cytokine secretion even after TLR-4 mediated stimulation ex-vivo. The cells had an increased expression of negative regulatory factors like SOCS-1, SOCS-3, SH2-containing phosphatase(SHP)-1 and a reduced expression of positive regulators like Janus kinase (JAK) 2 and Nuclear factor kappa-light-chain-enhancer of activated B cells(NF-kappa B) 1. A functional recovery after siRNA mediated silencing of SOCS-1 in these mo-DCs confirms the role of negative regulatory factors in functional impairment of these cells. Conclusions Functionally defective DCs in advanced stage of HIV-1 infection seems to be due to imbalanced state of negative and positive regulatory gene expression. Whether this is a cause or effect of increased viral replication at this stage of disease, needs further investigation. The information may be useful in design of novel therapeutic targets for better management of disease.	[Sachdeva, Meenakshi; Arora, Sunil K.] Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India; [Sharma, Aman] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Arora, SK (corresponding author), Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India.	arora.sunil@pgimer.edu.in	Arora, Sunil K/V-9083-2019					Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Bartz H, 2006, BLOOD, V108, P4102, DOI 10.1182/blood-2006-03-008946; Benlahrech A, 2012, CLIN EXP IMMUNOL, V170, P212, DOI 10.1111/j.1365-2249.2012.04647.x; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bordoni V, 2013, JAIDS-J ACQ IMM DEF, V64, P342, DOI 10.1097/QAI.0b013e3182a40ff7; Buisson S, 2009, J INFECT DIS, V199, P1862, DOI 10.1086/599122; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Fantuzzi L, 2004, J VIROL, V78, P9763, DOI 10.1128/JVI.78.18.9763-9772.2004; Finke JS, 2004, J CLIN IMMUNOL, V24, P647, DOI 10.1007/s10875-004-6250-5; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Greenhalgh CJ, 2001, J LEUKOCYTE BIOL, V70, P348; Harman AN, 2006, J IMMUNOL, V177, P7103, DOI 10.4049/jimmunol.177.10.7103; Ida JA, 2006, J IMMUNOL METHODS, V310, P86, DOI 10.1016/j.jim.2005.12.008; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; Kimura A, 2005, P NATL ACAD SCI USA, V102, P17089, DOI 10.1073/pnas.0508517102; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Levy JA, 2003, CLIN IMMUNOL, V108, P167, DOI 10.1016/S1521-6616(03)00178-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; MCILROY D, 1995, J VIROL, V69, P4737, DOI 10.1128/JVI.69.8.4737-4745.1995; Miller EA, 2012, JAIDS-J ACQ IMM DEF, V61, P535, DOI 10.1097/QAI.0b013e31826afbce; Mojumdar K, 2010, INDIAN J MED RES, V132, P318; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Planes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074551; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Quaranta MG, 2004, FASEB J, V18, P1459, DOI 10.1096/fj.04-1633fje; Ramachandran IR, 2011, J IMMUNOL, V186, P3934, DOI 10.4049/jimmunol.1001675; Rowland-Jones SL, 2003, NAT REV IMMUNOL, V3, P343, DOI 10.1038/nri1058; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sabado RL, 2010, BLOOD, V116, P3839, DOI 10.1182/blood-2010-03-273763; Sachdeva M, 2012, BMC INFECT DIS, V12, pP88; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Strebovsky J, 2012, FRONT BIOSCI-LANDMRK, V17, P1627, DOI 10.2741/4008; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vanham G, 1999, CLIN EXP IMMUNOL, V117, P335; Wijewardana V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001235; Yadav A, 2009, VIROLOGY, V385, P126, DOI 10.1016/j.virol.2008.11.039; Yoshimura S, 2001, INT IMMUNOL, V13, P675, DOI 10.1093/intimm/13.5.675; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223	46	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140852	10.1371/journal.pone.0140852	http://dx.doi.org/10.1371/journal.pone.0140852			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492336	Green Published, Green Submitted, gold			2022-12-27	WOS:000363249300015
J	Contreras, CL; Verani, JR; Lopez, MR; Paredes, A; Bernart, C; Moscoso, F; Roldan, A; Arvelo, W; Lindblade, KA; McCracken, JP				Contreras, Carmen Luca; Verani, Jennifer R.; Lopez, Maria Renee; Paredes, Antonio; Bernart, Chris; Moscoso, Fabiola; Roldan, Aleida; Arvelo, Wences; Lindblade, Kim A.; McCracken, John P.			Incidence of Hospitalized Pneumococcal Pneumonia among Adults in Guatemala, 2008-2012	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; RISK-FACTORS; ANTIGEN TEST; DISEASE; ETIOLOGY; VIRUS; EPIDEMIOLOGY; PREVALENCE	Background Streptococcus pneumoniae is a leading cause of pneumonia worldwide. However, the burden of pneumococcal pneumonia among adults in low-and middle-income countries is not well described. Methods Data from 2008-2012 was analyzed from two surveillance sites in Guatemala to describe the incidence of pneumococcal pneumonia in adults. A case of hospitalized pneumococcal pneumonia was defined as a positive pneumococcal urinary antigen test or blood culture in persons aged >= 18 years hospitalized with an acute respiratory infection (ARI). Results Among 1595 adults admitted with ARI, 1363 (82%) had either urine testing (n = 1286) or blood culture (n = 338) performed. Of these, 188 (14%) had pneumococcal pneumonia, including 173 detected by urine only, 8 by blood culture only, and 7 by both methods. Incidence rates increased with age, with the lowest rate among 18-24 year-olds (2.75/100,000) and the highest among >= 65 year-olds (31.3/100,000). The adjusted incidence of hospitalized pneumococcal pneumonia was 18.6/100,000 overall, with in-hospital mortality of 5%. Conclusions An important burden of hospitalized pneumococcal pneumonia in adults was described, particularly for the elderly. However, even adjusted rates likely underestimate the true burden of pneumococcal pneumonia in the community. These data provide a baseline against which to measure the indirect effects of the 2013 introduction of the pneumococcal conjugate vaccine in children in Guatemala.	[Contreras, Carmen Luca; Lopez, Maria Renee; Bernart, Chris; Moscoso, Fabiola; Roldan, Aleida; McCracken, John P.] Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala; [Verani, Jennifer R.] Ctr Dis Control & Prevent CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Paredes, Antonio] Minist Publ Hlth & Social Welf MSPAS, Natl Ctr Epidemiol, Guatemala City, Guatemala; [Arvelo, Wences; Lindblade, Kim A.] Ctr Dis Control & Prevent CDC, Div Global Dis Detect & Emergency Response, Atlanta, GA USA	Universidad del Valle de Guatemala; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Contreras, CL (corresponding author), Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala.	ccontreras@ces.uvg.edu.gt		Lindblade, Kim/0000-0002-5593-0470	US Centers for Disease Control and Prevention (CDC) [1U01GH000028]	US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by Cooperative Agreement Number 1U01GH000028 from the US Centers for Disease Control and Prevention (CDC). The CDC participated in all aspects of study design, data collection, data analysis and manuscript preparation.	Baggett HTS, 2010, INTERNATIONAL SYMPOS; Bewick T, 2012, THORAX, V67, P540, DOI 10.1136/thoraxjnl-2011-201092; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cook AZ, 2009, MANSON S TROPICAL DI, P953; Corbo J, 2004, EMERG MED J, V21, P446, DOI 10.1136/emj.2003.005306; Davis SM, 2013, VACCINE, V16, P00561; Davis SM, 2013, VACCINE, V32, P133, DOI 10.1016/j.vaccine.2013.05.005; Diavatopoulos DA, 2010, FASEB J, V24, P1789, DOI 10.1096/fj.09-146779; Diaz A, 2007, CHEST, V131, P779, DOI 10.1378/chest.06-1800; Diseases TAGoV-p, 2013, MEETING VACCINATION; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Novaes HMD, 2011, REV SAUDE PUBL, V45, P539, DOI 10.1590/S0034-89102011005000028; Fedson DS, 2011, EXPERT REV VACCINES, V10, P1143, DOI [10.1586/ERV.11.99, 10.1586/erv.11.99]; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Flory JH, 2009, EPIDEMIOL INFECT, V137, P717, DOI 10.1017/S0950268808001489; GAVI, 2014, COUNTRIES ELIGIBLE F; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Huijts SM, 2013, EUR RESPIR J, V42, P1283, DOI 10.1183/09031936.00137412; Isturiz RE, 2010, INT J INFECT DIS, V14, pE852, DOI 10.1016/j.ijid.2010.02.2262; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Jokinen J, 2010, EPIDEMIOLOGY, V21, P719, DOI 10.1097/EDE.0b013e3181e4c4d5; Klugman KP, 2007, CURR OPIN INFECT DIS, V20, P11, DOI 10.1097/QCO.0b013e328012c5f1; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lindblade KA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-885; Lindblade KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015826; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Maldonado A, 2007, REV CHIL INFECTOL, V24, P446, DOI /S0716-10182007000600003; Matute AJ, 2006, INT J ANTIMICROB AG, V28, P423, DOI 10.1016/j.ijantimicag.2006.07.016; McCracken JP, 2013, J INFECT DIS, V208, pS197, DOI 10.1093/infdis/jit517; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Morgan FG, 2009, 2009 INTERNATIONAL C; Myers AL, 2013, PEDIATR INFECT DIS J, V32, P736, DOI 10.1097/INF.0b013e318290bf63; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Palmu AA, 2012, SCAND J INFECT DIS, V44, P433, DOI 10.3109/00365548.2011.652162; Peto L, 2014, T ROY SOC TROP MED H, V108, P326, DOI 10.1093/trstmh/tru058; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Sherwin RL, 2013, J INFECT DIS, V208, P1813, DOI 10.1093/infdis/jit506; Shrestha S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005982; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Sinclair A, 2013, J CLIN MICROBIOL, V51, P2303, DOI 10.1128/JCM.00137-13; Social MdSPyA, 2012, GUIA OPERATIVA VACUN, P33; Tomczyk S. B N, 2014, MORBIDITY AND MORTAL, V63; Turner P, 2011, BMC INFECT DIS, V11, P1471; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Verani JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083600; Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2014, PEDIATR INFECT DIS J, V33, pS172, DOI 10.1097/INF.0000000000000076	52	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140939	10.1371/journal.pone.0140939	http://dx.doi.org/10.1371/journal.pone.0140939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488871	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400083
J	Pierotti, F; Palla, I; Treur, M; Pippo, L; Turchetti, G				Pierotti, Francesca; Palla, Ilaria; Treur, Maarten; Pippo, Lara; Turchetti, Giuseppe			Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							DISEASE-ACTIVITY; COHORT; MORTALITY; DAMAGE; RECOMMENDATIONS; PATTERNS; BURDEN; EUROPE; SAFETY; DEATH	Objective The purpose of this analysis is to evaluate the cost-effectiveness of belimumab, a new biological treatment specifically developed for the treatment of Systemic Lupus Erythematosus (SLE), in the Italian setting. SLE is a chronic non-organ specific autoimmune disease characterized by a disregulation of the immune system that involves many organs and systems. Methods A cost-effectiveness micro-simulation model with a lifetime horizon originally developed for the UK was adapted to the Italian setting. The analysis compared Standard of Care (SoC) alone vs belimumab plus SoC from a National Healthcare Service (NHS) and societal perspective. Health-economic consequences of treatments and organ damage progression were calculated. When available, Italian data were used, otherwise UK costs were converted using Purchasing Power Parities (PPPs). Utility values were based on the EQ-5D (TM) assessments in the belimumab clinical trials (BLISS 52 and 76). Results were discounted with 3% for costs and effects. A maximum belimumab treatment duration of 6 years was assumed and wastage costs were considered. Results Cost per life year gained (Incremental Cost-Effectiveness Ratio, ICER) and cost per Quality Adjusted Life Year (QALY) (Incremental Cost-Utility Ratio, ICUR) were (sic) 22,990 and (sic) 32,859, respectively. These values reduced to *(sic) 20,119 and (sic) 28,754, respectively, when indirect costs were included. Conclusions It may be concluded that in the Italian setting and according to the guidelines of the Italian Association of Health Economics (IAHE), belimumab was shown to be cost-effective, in terms of both ICER and ICUR, ((sic)25-40,000/QALY).	[Pierotti, Francesca; Palla, Ilaria; Turchetti, Giuseppe] Scuola Super Sant Anna, Inst Management, Pisa, Italy; [Treur, Maarten] Pharmerit Int, Rotterdam, Netherlands; [Pippo, Lara] GlaxoSmithKline, Verona, Italy	Scuola Superiore Sant'Anna; GlaxoSmithKline	Turchetti, G (corresponding author), Scuola Super Sant Anna, Inst Management, Pisa, Italy.	g.turchetti@sssup.it	Turchetti, Giuseppe/K-5393-2018	Turchetti, Giuseppe/0000-0002-1877-5459	GlaxoSmithKline; Pharmerit International	GlaxoSmithKline(GlaxoSmithKline); Pharmerit International	The work was supported by GlaxoSmithKline which sponsored the study. The authors declare that their university has received a research grant from the company in order to carry out the project. The funder provided support in the form of salaries for one author [LP]. The specific roles of these authors are articulated in the 'author contributions' section. GlaxoSmithKline played a marginal role in the study design and data collection. GlaxoSmithKline did not play role in the analysis of the data and did not oppose the authors' decision to publish the study after having read the manuscript. Pharmerit International provided support in the form of salaries for author MT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agmon-Levin N, 2012, AUTOIMMUN REV, V11, P593, DOI 10.1016/j.autrev.2011.10.020; Baker K, 2009, RHEUMATOLOGY, V48, P281, DOI 10.1093/rheumatology/ken477; Barr SG, 1999, ARTHRITIS RHEUM, V42, P2682, DOI 10.1002/1529-0131(199912)42:12<2682::AID-ANR26>3.0.CO;2-6; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Briggs A, 2006, DECISION MODELING HL; Capri S, 2001, DRUG INF J, V35, P189, DOI 10.1177/009286150103500122; Díaz-Cerezo Silvia, 2015, Farm Hosp., V39, P161, DOI 10.7399/fh.2015.39.3.8814; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Doria A, 2014, ANN RHEUM DIS, V73, P154, DOI 10.1136/annrheumdis-2012-202443; European Agency Medicines, 2014, BENL; Furie R, 2010, PANLAR 2010 APR 25 2; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Furneri G, 2012, CLIN EXP RHEUMATOL, V30, pS72; Ginzler EM, 2014, J RHEUMATOL, V41, P300, DOI 10.3899/jrheum.121368; Italian Association of Health Economics (IAHE), 2009, PROP LINN GUID VAL E, DOI [10.1706/441.5195, DOI 10.1706/441.5195]; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Kotler P, 2010, MARKETING SANITA LOG; Lopez R, 2012, RHEUMATOLOGY, V51, P491, DOI 10.1093/rheumatology/ker368; Mantovani LG, 2011, HLTH TECHNOLOGY ASSE; Mathieu A, 2012, 9 HTA INT ANN M BILB; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; Meacock R, 2013, PHARMACOECONOMICS, V31, P49, DOI 10.1007/s40273-012-0007-4; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Mitka M, 2011, JAMA-J AM MED ASSOC, V305, P1754, DOI 10.1001/jama.2011.548; Mosca M, 2012, CLIN EXP RHEUMATOL, V30, pS112; Mosca M, 2011, CLIN EXP RHEUMATOL, V29, pS126; Mosca M, 2011, AUTOIMMUN REV, V10, P383, DOI 10.1016/j.autrev.2010.12.008; Mosca M, 2010, ANN RHEUM DIS, V69, P1269, DOI 10.1136/ard.2009.117200; Mosca M, 2010, INT J CLIN RHEUMATOL, V5, P291; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Nossent J, 2007, LUPUS, V16, P309, DOI 10.1177/0961203307077987; Nossent J, 2010, LUPUS, V19, P949, DOI 10.1177/0961203310366572; Palla I, 2012, CLIN EXP RHEUMATOL, V30, pS136; Petri MA, 2010, ARTHRITIS RHEUMA S10, V62, P452; Piscitelli P, 2011, AGING CLIN EXP RES, V23, P49, DOI 10.3275/7201; Pugliatti M, 2008, NEUROL SCI, V29, P99, DOI 10.1007/s10072-008-0868-7; Souza DCC, 2012, J RHEUMATOL, V39, P496, DOI 10.3899/jrheum.110241; Sutcliffe N, 2001, RHEUMATOLOGY, V40, P37, DOI 10.1093/rheumatology/40.1.37; Treur M, 2011, COST EFFECTIVENESS B; Trieste L, 2012, CLIN EXP RHEUMATOL, V30, pS154; Trieste L, 2012, CLIN EXP RHEUMATOL, V30, pS145; Turchetti G, 2012, CLIN EXP RHEUMATOL, V30, pS116; Turchetti G, 2012, CLIN EXP RHEUMATOL, V30, pS64; Turchetti G, 2013, LINEE GUIDA NUOVA GO; Turchetti G, 2013, QUADERNI ITALIAN J P, P91; Turchetti G, 2010, IEEE ENG MED BIOL, V29, P70, DOI 10.1109/MEMB.2010.936553; Urowitz MB, 2005, J RHEUMATOL, V32, P1467; Watson P, 2015, RHEUMATOLOGY, V54, P623, DOI 10.1093/rheumatology/keu375; Zen M, 2012, CLIN EXP RHEUMATOL, V30, P856	49	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140843	10.1371/journal.pone.0140843	http://dx.doi.org/10.1371/journal.pone.0140843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488751	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400073
J	Ping, SN; Li, YH; Liu, SY; Zhang, ZY; Wang, JJ; Zhou, YH; Liu, KF; Huang, JT; Chen, DD; Wang, JM; Li, CH				Ping, Suning; Li, Yuhuang; Liu, Shuying; Zhang, Zhengyu; Wang, Jingjing; Zhou, Yuhuan; Liu, Kefeng; Huang, Jintao; Chen, Dadi; Wang, Junmei; Li, Chaohong			Simultaneous Increases in Proliferation and Apoptosis of Vascular Smooth Muscle Cells Accelerate Diabetic Mouse Venous Atherosclerosis	PLOS ONE			English	Article							VEIN GRAFT FAILURE; NF-KAPPA-B; PULMONARY-HYPERTENSION; MECHANICAL-STRESS; KINASE; ACTIVATION; CANCER; MODULATION; EXPRESSION; RECEPTORS	Aims This study was designed to demonstrate simultaneous increases in proliferation and apoptosis of vascular smooth muscle cells (VSMCs) leading to accelerated vein graft remodeling and to explore the underlying mechanisms. Methods Vein grafts were performed in non-diabetic and diabetic mice. The cultured quiescent VSMCs were subjected to mechanical stretch stress (SS) and/or advanced glycosylation end products (AGEs). Harvested vein grafts and treated VSMCs were used to detect cell proliferation, apoptosis, mitogen-activated protein kinases (MAPKs) activation and SM-alpha-actin expression. Results Significantly thicker vessel walls and greater increases in proliferation and apoptosis were observed in diabetic vein grafts than those in non-diabetic. Both SS and AGEs were found to induce different activation of three members of MAPKs and simultaneous increases in proliferation and apoptosis of VSMCs, and combined treatment with both had a synergistic effect. VSMCs with strong SM-a-actin expression represented more activated JNKs or p38MAPK, and cell apoptosis, while the cells with weak SM-a-actin expression demonstrated preferential activation of ERKs and cell proliferation. In contrast, inhibition of MAPKs signals triggered significant decreases in VSMC proliferation, and apoptosis. Treatment of the cells with RNA interference of receptor of AGEs (RAGE) also resulted in significant decreases in both proliferation and apoptosis. Conclusions Increased pressure-induced SS triggers simultaneous increases in proliferation and apoptosis of VSMCs in the vein grafts leading to vein arterializations, which can be synergistically accelerated by high glucose-induced AGEs resulting in vein graft atherosclerosis. Either SS or AGEs and their combination induce simultaneous increases in proliferation and apoptosis of VSMCs via different activation of three members of MAPKs resulting from different VSMC subtypes classified by SM-alpha-actin expression levels.	[Ping, Suning; Li, Yuhuang; Liu, Shuying; Zhang, Zhengyu; Wang, Jingjing; Zhou, Yuhuan; Liu, Kefeng; Wang, Junmei; Li, Chaohong] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Jintao; Chen, Dadi] Sun Yat Sen Univ, Zhongshan Sch Med, Expt Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Zhengyu] Guangzhou Med Univ, Basic Med Coll, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Li, CH (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Guangzhou 510275, Guangdong, Peoples R China.	lichaoh@mail.sysu.edu.cn	Zhang, Zhengyu/AAJ-3821-2020	Li, Chaohong/0000-0002-7979-1639	National Nature Science Foundation of China [30871023, 81070124]; Nature Science Foundation of Guangdong Province [S2012010009199]; Doctoral Foundation of Chinese Ministry of Education [20090171110049]; Natural Science Foundation of Guangdong Province [S2013040015441]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Doctoral Foundation of Chinese Ministry of Education(Ministry of Education, China); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	The work was supported by the following: LC: National Nature Science Foundation of China (30871023, 81070124), the Nature Science Foundation of Guangdong Province (S2012010009199) and Doctoral Foundation of Chinese Ministry of Education (20090171110049); and LS: Natural Science Foundation of Guangdong Province (S2013040015441).	BENES AJ, 1985, J CELL SCI, V75, P35; Bhatwadekar AD, 2005, J CLIN LAB ANAL, V19, P11, DOI 10.1002/jcla.20048; Cai YJ, 2012, J PHARMACOL EXP THER, V343, P479, DOI 10.1124/jpet.112.195446; Chang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088089; Cheng WP, 2012, CARDIOVASC RES, V93, P181, DOI 10.1093/cvr/cvr280; Dromparis P, 2013, CIRCULATION, V127, P115, DOI 10.1161/CIRCULATIONAHA.112.133413; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fisher SA, 2000, CIRC RES, V87, P856, DOI 10.1161/01.RES.87.10.856; FITZGIBBON GM, 1991, J AM COLL CARDIOL, V17, P1075, DOI 10.1016/0735-1097(91)90834-V; Golovina VA, 2006, NAT PROTOC, V1, P2681, DOI 10.1038/nprot.2006.425; Harskamp RE, 2013, ANN SURG, V257, P824, DOI 10.1097/SLA.0b013e318288c38d; Kalra M, 2000, J VASC RES, V37, P576, DOI 10.1159/000054091; Kim HJ, 2010, ARTERIOSCL THROM VAS, V30, P2164, DOI 10.1161/ATVBAHA.110.212308; Kravtsova-Ivantsiv Y, 2015, CELL, V161, P333, DOI 10.1016/j.cell.2015.03.001; Li CH, 1999, J BIOL CHEM, V274, P25273, DOI 10.1074/jbc.274.36.25273; Li CH, 2007, CELL SIGNAL, V19, P881, DOI 10.1016/j.cellsig.2007.01.004; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035016; Liu G, 2011, EXP CELL RES, V317, P2420, DOI 10.1016/j.yexcr.2011.07.016; Liu SY, 2013, J VASC SURG, V57, P1645, DOI 10.1016/j.jvs.2012.09.061; Lorusso R, 2003, DIABETES, V52, P2814, DOI 10.2337/diabetes.52.11.2814; Mollereau B, 2013, CELL DEATH DIFFER, V20, P181, DOI 10.1038/cdd.2012.82; Owens CD, 2015, J VASC SURG, V61, P203, DOI 10.1016/j.jvs.2013.08.019; Parang P, 2009, CAN J CARDIOL, V25, pE57, DOI 10.1016/S0828-282X(09)70486-6; Peng X, 2014, MOL CELL BIOCHEM, V396, P87, DOI 10.1007/s11010-014-2145-9; Perez-Vizcaino F, 2006, BIOCHEM BIOPH RES CO, V346, P919, DOI 10.1016/j.bbrc.2006.05.198; Qu MJ, 2007, J VASC RES, V44, P345, DOI 10.1159/000102278; Reimers MS, 2014, INT J COLORECTAL DIS, V29, P1043, DOI 10.1007/s00384-014-1930-y; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Runchel C, 2011, ANTIOXID REDOX SIGN, V15, P205, DOI 10.1089/ars.2010.3733; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Salzberg SP, 2006, CIRCULATION, V114, pI302, DOI 10.1161/CIRCULATIONAHA.105.001339; Simard E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128881; Simon R, 2014, APOPTOSIS, V19, P1430, DOI 10.1007/s10495-014-1000-5; Thornalley PJ, 2007, MOL NUTR FOOD RES, V51, P1107, DOI 10.1002/mnfr.200700017; Tsumagari K, 2015, CANCER LETT, V368, P46, DOI 10.1016/j.canlet.2015.07.011; Weihs AM, 2014, J BIOL CHEM, V289, P27090, DOI 10.1074/jbc.M114.580936; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Zhang ZY, 2013, CELL SIGNAL, V25, P332, DOI 10.1016/j.cellsig.2012.10.006; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1	39	31	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141375	10.1371/journal.pone.0141375	http://dx.doi.org/10.1371/journal.pone.0141375			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488175	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400122
J	Qian, Y; Forssberg, H; Heijtz, RD				Qian, Yu; Forssberg, Hans; Heijtz, Rochellys Diaz			Motor Skill Learning Is Associated with Phase-Dependent Modifications in the Striatal cAMP/PKA/DARPP-32 Signaling Pathway in Rodents	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; IMMUNOCYTOCHEMICAL LOCALIZATION; REGULATED PHOSPHOPROTEIN; GENE-EXPRESSION; CEREBRAL-PALSY; DOPAMINE D1; RECEPTOR; DARPP-32; RAT; PROTEIN	Abundant evidence points to a key role of dopamine in motor skill learning, although the underlying cellular and molecular mechanisms are still poorly understood. Here, we used a skilled-reaching paradigm to first examine changes in the expression of the plasticity-related gene Arc to map activity in cortico-striatal circuitry during different phases of motor skill learning in young animals. In the early phase, Arc mRNA was significantly induced in the medial prefrontal cortex (mPFC), cingulate cortex, primary motor cortex, and striatum. In the late phase, expression of Arc did not change in most regions, except in the mPFC and dorsal striatum. In the second series of experiments, we studied the learning-induced changes in the phosphorylation state of dopamine and cAMP-regulated phosphoprotein, 32k Da (DARPP-32). Western blot analysis of the phosphorylation state of DARPP-32 and its downstream target cAMP response element-binding protein (CREB) in the striatum revealed that the early, but not late, phase of motor skill learning was associated with increased levels of phospho-Thr34-DARPP-32 and phospho-Ser133-CREB. Finally, we used the DARPP-32 knock-in mice with a point mutation in the Thr34 regulatory site (i.e., protein kinase A site) to test the significance of this pathway in motor skill learning. In accordance with our hypothesis, inhibition of DARPP-32 activity at the Thr34 regulatory site strongly attenuated the motor learning rate and skilled reaching performance of mice. These findings suggest that the cAMP/PKA/DARPP-32 signaling pathway is critically involved in the acquisition of novel motor skills, and also demonstrate a dynamic shift in the contribution of cortico-striatal circuitry during different phases of motor skill learning.	[Qian, Yu; Heijtz, Rochellys Diaz] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; [Forssberg, Hans] Karolinska Inst, Dept Womens & Childrens Hlth, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Heijtz, RD (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, SE-17177 Stockholm, Sweden.	rochellys.heijtz@ki.se	Forssberg, Hans/A-2944-2009	Forssberg, Hans/0000-0003-2069-6618; Qian, Yu/0000-0003-1641-2053	Foundation Olle Engkvist Byggmastare; Swedish Brain Foundation; Foundation Frimurarna Barnhuset; Swedish Research Council [5925]; Swedish Foundation for Strategic Research; Berzelii Center Stockholm Brain Institute (Vinnova); Berzelii Center Stockholm Brain Institute (Swedish Research Council); Strategic Neuroscience Program at Karolinska Institutet; Knut and Alice Wallenberg Foundation; Foundation Promoblilia	Foundation Olle Engkvist Byggmastare; Swedish Brain Foundation; Foundation Frimurarna Barnhuset; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Berzelii Center Stockholm Brain Institute (Vinnova)(Vinnova); Berzelii Center Stockholm Brain Institute (Swedish Research Council); Strategic Neuroscience Program at Karolinska Institutet; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Foundation Promoblilia	This work was supported by the Foundation Olle Engkvist Byggmastare, Swedish Brain Foundation, Foundation Frimurarna Barnhuset, Swedish Research Council (grant no. 5925), Swedish Foundation for Strategic Research, Berzelii Center Stockholm Brain Institute (Vinnova & Swedish Research Council), Strategic Neuroscience Program at Karolinska Institutet, Knut and Alice Wallenberg Foundation, and Foundation Promoblilia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita H, 2006, BRAIN RES, V1095, P178, DOI 10.1016/j.brainres.2006.04.039; Ariano MA, 1997, BRAIN RES, V746, P141, DOI 10.1016/S0006-8993(96)01219-X; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bonnier Beatrice, 2006, Scand J Occup Ther, V13, P13, DOI 10.1080/11038120510031833; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Ciliax BJ, 2000, SYNAPSE, V37, P125, DOI 10.1002/1098-2396(200008)37:2<125::AID-SYN7>3.0.CO;2-7; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ena S, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00047; Gangarossa G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019415; Girault JA, 2012, ADV EXP MED BIOL, V970, P407, DOI 10.1007/978-3-7091-0932-8_18; Gordon AM, 2011, NEUROREHAB NEURAL RE, V25, P692, DOI 10.1177/1545968311402508; Greengard P, 2001, BIOSCIENCE REP, V21, P247, DOI 10.1023/A:1013205230142; Heijtz RD, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-18; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Kawashima S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031728; Kida S, 2014, BRAIN RES BULL, V105, P17, DOI 10.1016/j.brainresbull.2014.04.011; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Kuroiwa M, 2012, PSYCHOPHARMACOLOGY, V219, P1065, DOI 10.1007/s00213-011-2436-8; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Nairn AC, 2004, NEUROPHARMACOLOGY, V47, P14, DOI 10.1016/j.neuropharm.2004.05.010; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 1997, J NEUROSCI, V17, P8147; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Ogura T, 2005, NEUROSCI RES, V51, P299, DOI 10.1016/j.neures.2004.12.006; Oliveira AMM, 2006, BEHAV NEUROSCI, V120, P724, DOI 10.1037/0735-7044.120.3.724; OUIMET CC, 1984, J NEUROSCI, V4, P111; OUIMET CC, 1992, J COMP NEUROL, V323, P209, DOI 10.1002/cne.903230206; Paxinos G., 1998, STEREOTAXIC COORDINA; Pearson-Fuhrhop KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061197; PEREZ RG, 1992, J COMP NEUROL, V318, P304, DOI 10.1002/cne.903180307; Pittenger C, 2006, J NEUROSCI, V26, P2808, DOI 10.1523/JNEUROSCI.5406-05.2006; Qian Y, 2013, GENES BRAIN BEHAV, V12, P604, DOI 10.1111/gbb.12062; Rioult-Pedotti MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124986; Sahu A, 2009, MOL PHARMACOL, V75, P447, DOI 10.1124/mol.108.053017; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; SANTORI EM, 1986, J NEUROSCI, V6, P463; SCHAMBRA B, 1994, NEUROSCIENCE, V62, P65, DOI 10.1016/0306-4522(94)90315-8; Soiza-Reilly M, 2004, BRAIN RES, V1004, P217, DOI 10.1016/j.brainres.2004.01.050; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 2003, SCIENCE, V302, P1412, DOI 10.1126/science.1089681; Undieh AS, 2010, PHARMACOL THERAPEUT, V128, P37, DOI 10.1016/j.pharmthera.2010.05.003; Vergara-Aragon P, 2003, J NEUROSCI, V23, P579, DOI 10.1523/JNEUROSCI.23-02-00579.2003; Wachter T, 2010, EXP BRAIN RES, V200, P319, DOI 10.1007/s00221-009-2027-7; Walaas SI, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00050; Wang DC, 2014, J COMP PHYSIOL A, V200, P959, DOI 10.1007/s00359-014-0942-y; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	57	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140974	10.1371/journal.pone.0140974	http://dx.doi.org/10.1371/journal.pone.0140974			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488498	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400089
J	Nakashima, H; Oniki, K; Nishimura, M; Ogusu, N; Shimomasuda, M; Ono, T; Matsuda, K; Yasui-Furukori, N; Nakagawa, K; Ishitsu, T; Saruwatari, J				Nakashima, Hiroo; Oniki, Kentaro; Nishimura, Miki; Ogusu, Naoki; Shimomasuda, Masatsugu; Ono, Tatsumasa; Matsuda, Kazuki; Yasui-Furukori, Norio; Nakagawa, Kazuko; Ishitsu, Takateru; Saruwatari, Junji			Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis	PLOS ONE			English	Article							ANTIEPILEPTIC DRUGS; POLYMORPHISMS; CARBAMAZEPINE; SCN1A; ASSOCIATION; RECEPTOR	Valproic acid (VPA) is one of the most widely prescribed antiepileptic drugs for the treatment of epileptic seizures. Although it is well known that the doses of VPA and its plasma concentrations are highly correlated, the plasma concentrations do not correlate well with the therapeutic effects of the VPA. In this study, we developed a population-based pharmacokinetic (PK)-pharmacodynamic (PD) model to determine the optimal concentration of VPA according to the clinical characteristics of each patient. This retrospective study included 77 VPA-treated Japanese patients with epilepsy. A nonlinear mixed-effects model best represented the relationship between the trough concentrations of VPA at steady-state and an over 50% reduction in seizure frequency. The model was fitted using a logistic regression model, in which the logit function of the probability was a linear function of the predicted trough concentration of VPA. The model showed that the age, seizure locus, the sodium channel neuronal type I alpha subunit rs3812718 polymorphism and co-administration of carbamazepine, clonazepam, phenytoin or topiramate were associated with an over 50% reduction in the seizure frequency. We plotted the receiver operating characteristic (ROC) curve for the logit(Pr) value of the model and the presence or absence of a more than 50% reduction in seizure frequency, and the areas under the curves with the 95% confidence interval from the ROC curve were 0.823 with 0.793-0.853. A logit(Pr) value of 0.1 was considered the optimal cut-off point (sensitivity = 71.8% and specificity = 80.4%), and we calculated the optimal trough concentration of VPA for each patient. Such parameters may be useful to determine the recommended therapeutic concentration of VPA for each patient, and the procedure may contribute to the further development of personalized pharmacological therapy for epilepsy.	[Nakashima, Hiroo; Oniki, Kentaro; Nishimura, Miki; Ogusu, Naoki; Shimomasuda, Masatsugu; Ono, Tatsumasa; Matsuda, Kazuki; Nakagawa, Kazuko; Saruwatari, Junji] Kumamoto Univ, Div Pharmacol & Therapeut, Grad Sch Pharmaceut Sci, Kumamoto, Japan; [Yasui-Furukori, Norio] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan; [Nakagawa, Kazuko; Saruwatari, Junji] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto, Japan; [Ishitsu, Takateru] Kumamoto Saishunso Natl Hosp, Kumamoto, Japan; [Ishitsu, Takateru] Kumamoto Ezuko Ryoiku Iryo Ctr, Kumamoto, Japan	Kumamoto University; Hirosaki University; Kumamoto University	Saruwatari, J (corresponding author), Kumamoto Univ, Div Pharmacol & Therapeut, Grad Sch Pharmaceut Sci, Kumamoto, Japan.	junsaru@gpo.kumamoto-u.ac.jp	Saruwatari, Junji/Q-7748-2019	Saruwatari, Junji/0000-0001-6266-1347	Ministry of Education, Culture, Sports, Science and Technology, Japan [25860117, 26360049, 15K18925]; Smoking Research Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation	The work was supported in full by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.jsps.go.jp/english/index.html) Grant Numbers: 25860117, 26360049 and 15K18925, and in part by a grant from Smoking Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, BRIT J CLIN PHARMACO, V66, P304, DOI 10.1111/j.1365-2125.2008.03203.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blanco-Serrano B, 1999, BIOPHARM DRUG DISPOS, V20, P233, DOI 10.1002/(SICI)1099-081X(199907)20:5<233::AID-BDD179>3.0.CO;2-5; Brunklaus A, 2014, EPILEPSIA, V55, P979, DOI 10.1111/epi.12652; Ding JJ, 2015, CLIN PHARMACOKINET, V54, P305, DOI 10.1007/s40262-014-0212-8; El Desoky ES, 2004, EUR J CLIN PHARMACOL, V59, P783, DOI 10.1007/s00228-003-0699-7; Fletcher EV, 2011, J BIOL CHEM, V286, P36700, DOI 10.1074/jbc.M111.250225; Ghodke-Puranik Y, 2013, PHARMACOGENET GENOM, V23, P236, DOI 10.1097/FPC.0b013e32835ea0b2; Haerian BS, 2015, GENOMICS, V105, P229, DOI 10.1016/j.ygeno.2015.02.001; Heinzen EL, 2007, AM J HUM GENET, V80, P876, DOI 10.1086/516650; Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048; Keizer RJ, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.24; Lin WW, 2015, THER DRUG MONIT, V37, P76, DOI 10.1097/FTD.0000000000000100; Ma CL, 2014, PHARMACOGENOMICS, V15, P1323, DOI [10.2217/pgs.14.89, 10.2217/PGS.14.89]; Moshe SL, 2015, LANCET, V385, P884, DOI 10.1016/S0140-6736(14)60456-6; Nanau RM, 2013, CLIN BIOCHEM, V46, P1323, DOI 10.1016/j.clinbiochem.2013.06.012; Ogusu N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111066; Saghazadeh A, 2014, REV NEUROSCIENCE, V25, P129, DOI 10.1515/revneuro-2013-0053; Saruwatari J, 2014, PHARMACOGENET GENOM, V24, P162, DOI 10.1097/FPC.0000000000000030; Schmidt D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g254; Sundqvist A, 1997, THER DRUG MONIT, V19, P153, DOI 10.1097/00007691-199704000-00006; Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102; TURNBULL DM, 1983, ANN NEUROL, V14, P38, DOI 10.1002/ana.410140107; Vajda FJE, 2014, EPILEPTIC DISORD, V16, P395, DOI 10.1684/epd.2014.0704; Wassenaar M, 2013, EPILEPSY RES, V106, P301, DOI 10.1016/j.eplepsyres.2013.06.013; Yun WT, 2013, EPILEPSY RES, V107, P231, DOI 10.1016/j.eplepsyres.2013.09.011	26	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141266	10.1371/journal.pone.0141266	http://dx.doi.org/10.1371/journal.pone.0141266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484865	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100127
J	Tappis, H; Kazi, A; Hameed, W; Dahar, Z; Ali, A; Agha, S				Tappis, Hannah; Kazi, Anis; Hameed, Waqas; Dahar, Zaib; Ali, Anayat; Agha, Sohail			The Role of Quality Health Services and Discussion about Birth Spacing in Postpartum Contraceptive Use in Sindh, Pakistan: A Multilevel Analysis	PLOS ONE			English	Article							FAMILY-PLANNING-SERVICES; ANTENATAL CARE; WOMEN; DETERMINANTS; CHALLENGES; ADOLESCENT; DYNAMICS; ETHIOPIA; PROGRAM; AFRICA	Introduction Rapid population growth, stagnant contraceptive prevalence, and high unmet need for family planning present significant challenges for meeting Pakistan's national and international development goals. Although health behaviors are shaped by multiple social and environmental factors, research on contraceptive uptake in Pakistan has focused on individual and household determinants, and little attention has been given to community characteristics that may affect access to services and reproductive behavior. Methods Individual and community determinants of contraceptive use were identified using multivariable multilevel logistic regression to analyze data from a 2014 cross-sectional survey of 6,200 mothers in 503 communities in Sindh, Pakistan. Results Only 27% of women who had given birth in the two years before the study reported using contraceptives. After adjusting for individual and community characteristics, there was no difference in the odds of contraceptive use between urban and rural women. Women who had delivered at a health facility had 1.4 times higher odds of contraceptive use than women who delivered at home. Those who received information about birth spacing from a doctor or relatives/friends had 1.81 and 1.38 times higher odds of contraceptive use, respectively, than those who did not. Living in a community where a higher proportion of women received quality antenatal care and where discussion of birth spacing was more common was significantly associated with contraceptive use. Community-wide poverty lowered contraceptive use. Conclusions Quality of care at the community level has strong effects on contraceptive use, independent of the characteristics of individual households or women. These findings suggest that powerful gains in contraceptive use may be realized by improving the quality of antenatal care in Pakistan. Community health workers should focus on generating discussion of birth spacing in the community. Outreach efforts should target communities where the demand for contraception appears to be depressed due to high levels of poverty.	[Tappis, Hannah] Jhpiego USA, Baltimore, MD USA; [Kazi, Anis] Heartfile, Islamabad, Pakistan; [Hameed, Waqas] Marie Stopes Soc, Karachi, Pakistan; [Dahar, Zaib; Ali, Anayat; Agha, Sohail] Jhpiego Pakistan, Karachi, Pakistan	Jhpiego; Jhpiego	Agha, S (corresponding author), Jhpiego Pakistan, Karachi, Pakistan.	sohailagha@gmail.com	Agha, Sohail/AAK-1616-2021; Tappis, Hannah/F-5005-2011	Tappis, Hannah/0000-0002-4289-5418	United States Agency for International Development (USAID) [AID-391-LA-13-00001]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was made possible through support provided by the United States Agency for International Development (USAID), under the terms of Associate Cooperative Agreement No. AID-391-LA-13-00001, Maternal, Newborn and Child Health Services Project. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID. USAID had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbas K, 2012, J PAKISTAN MED ASS; Agha S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-450; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Andrew EVW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093025; Azmat Syed Khurram, 2013, J Pak Med Assoc, V63, pS40; BENEFO KD, 1995, DEMOGRAPHY, V32, P139, DOI 10.2307/2061737; Bernard P, 2007, SOC SCI MED, V65, P1839, DOI 10.1016/j.socscimed.2007.05.037; BONGAARTS J, 1995, STUD FAMILY PLANN, V26, P57, DOI 10.2307/2137932; Bongaarts J, 2013, POPULATION COUNCIL B, V1, P10; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; Byrne A, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-27; Carton TW, 2012, HEALTH POLICY PLANN, V27, P166, DOI 10.1093/heapol/czr022; Casterline JB, 2001, STUD FAMILY PLANN, V32, P95, DOI 10.1111/j.1728-4465.2001.00095.x; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Davis R, 2009, RAPID HOUSEHOLD SURV; Dehlendorf C, 2010, CONTRACEPTION, V81, P292, DOI 10.1016/j.contraception.2009.11.006; Douthwaite M, 2005, HEALTH POLICY PLANN, V20, P117, DOI 10.1093/heapol/czi014; Dynes M, 2012, HEALTH PLACE, V18, P766, DOI 10.1016/j.healthplace.2012.04.006; Elfstrom KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040670; Ezeh AC, 2012, LANCET, V380, P142, DOI 10.1016/S0140-6736(12)60696-5; Few R, 2003, HEALTH PLACE, V9, P45, DOI 10.1016/S1353-8292(02)00029-1; Goldie SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000264; Goodyear-Smith F, 2001, HLTH CARE ANAL; Government of Pakistan, 2013, PAK EC SURV 2012 201; Gross K, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-16; Gupta N, 2000, STUD FAMILY PLANN, V31, P228, DOI 10.1111/j.1728-4465.2000.00228.x; Hafeez A, 2011, J PAK MED ASSOC, V61, P210; Hameed W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104633; Hamid S, 2006, INT FAM PLAN PERSPEC, V32, P71, DOI 10.1363/3207106; Haq Zaeem, 2008, Int J Ment Health Syst, V2, P15, DOI 10.1186/1752-4458-2-15; Hardee K, 2008, POPULATION FERTILITY, V3; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Jacobstein R, 2013, INT J GYNECOL OBSTET, V121, pS9, DOI 10.1016/j.ijgo.2013.02.005; Kamran I, 2011, GLOB PUBLIC HEALTH, V6, pS38, DOI 10.1080/17441692.2011.590814; Kayembe PK, 2006, CONTRACEPTION, V74, P400, DOI 10.1016/j.contraception.2006.06.006; Kayode GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109333; Kish L, 1949, J AM STAT ASSOC, V44, P7; Kyegombe N, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19232; Kyei NNA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046475; Mahmood N, 1998, Pak Dev Rev, V37, P19; Marvi K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003279; Moazam F, 2000, HASTINGS CENT REP, V30, P28, DOI 10.2307/3528451; Mumtaz Z, 2013, SOC SCI MED, V91, P48, DOI 10.1016/j.socscimed.2013.05.007; National Institute of Population Studies (NIPS) [Pakistan] Macro International Inc, 2013, PAK DEM HLTH SURV 20; Nishtar Noureen Aleem, 2012, Glob J Health Sci, V5, P84, DOI 10.5539/gjhs.v5n2p84; Nishtar Noureen Aleem, 2013, Glob J Health Sci, V5, P1, DOI 10.5539/gjhs.v5n3p1; Nishtar Sania, 2006, J Pak Med Assoc, V56, pS51; Nishtar S, 2010, B WORLD HEALTH ORGAN, V88, P74, DOI 10.2471/BLT.09.067868; Ong L, 1995, DOCTOR PATIENT COMMU; Pakistan Bureau of Statistics, 2014, CONTR PERF REP 2013; Sarfraz M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-59; Sathar ZA, 2013, LANCET, V381, P2140, DOI 10.1016/S0140-6736(13)60763-1; Shah NM, 2011, HEALTH POLICY PLANN, V26, pi63, DOI 10.1093/heapol/czr027; Steele F, 1999, STUD FAMILY PLANN, V30, P28, DOI 10.1111/j.1728-4465.1999.00028.x; Stephenson R, 2007, AM J PUBLIC HEALTH, V97, P1233, DOI 10.2105/AJPH.2005.071522; Sultan M, 2002, AM J PUBLIC HEALTH, V92, P1168, DOI 10.2105/AJPH.92.7.1168; UKAID Bill and Melinda Gates Foundation, 2012, LOND SUMM FAM PLANN; Wazir MS, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-60; World Health Organization (WHO) United States Agency for International Development (USAID) Maternal and Child Health Integrated Program (MCHIP), 2013, MAT CHILD HLTH INT P	59	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139628	10.1371/journal.pone.0139628	http://dx.doi.org/10.1371/journal.pone.0139628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7XI	26485524	Green Submitted, gold, Green Published			2022-12-27	WOS:000363028100011
J	Bain, RES; Woodall, C; Elliott, J; Arnold, BF; Tung, R; Morley, R; du Preez, M; Bartram, JK; Davis, AP; Gundry, SW; Pedley, S				Bain, Robert E. S.; Woodall, Claire; Elliott, John; Arnold, Benjamin F.; Tung, Rosalind; Morley, Robert; du Preez, Martella; Bartram, Jamie K.; Davis, Anthony P.; Gundry, Stephen W.; Pedley, Stephen			Evaluation of an Inexpensive Growth Medium for Direct Detection of Escherichia coli in Temperate and Sub-Tropical Waters	PLOS ONE			English	Article							BETA-D-GLUCURONIDASE; DRINKING-WATER; TOTAL COLIFORMS; FRESH-WATER; H2S TEST; ENUMERATION; TESTS; COLILERT-18; COUNTRIES; BACTERIA	The cost and complexity of traditional methods for the detection of faecal indicator bacteria, including E. coli, hinder widespread monitoring of drinking water quality, especially in low-income countries and outside controlled laboratory settings. In these settings the problem is exacerbated by the lack of inexpensive media for the detection of E. coli in drinking water. We developed a new low-cost growth medium, aquatest (AT), and validated its use for the direct detection of E. coli in temperate and sub-tropical drinking waters using IDEXX Quanti-Tray (R). AT was compared with IDEXX Colilert-18 (R) and either EC-MUG or MLSB for detecting low levels of E. coli from water samples from temperate (n = 140; Bristol, UK) and subtropical regions (n = 50, Pretoria/Tshwane, South Africa). Confirmatory testing (n = 418 and 588, respectively) and the comparison of quantitative results were used to assess performance. Sensitivity of AT was higher than Colilert-18 (R) for water samples in the UK [98.0% vs. 86.9%; p<0.0001] and South Africa [99.5% vs. 93.2%; p = 0.0030]. There was no significant difference in specificity, which was high for both media (>95% in both settings). Quantitative results were comparable and within expected limits. AT is reliable and accurate for the detection of E. coli in temperate and subtropical drinking water. The composition of the new medium is reported herein and can be used freely.	[Bain, Robert E. S.] UNICEF, New York, NY 10038 USA; [Woodall, Claire; Davis, Anthony P.] Univ Bristol, Sch Chem, Bristol, Avon, England; [Elliott, John; Pedley, Stephen] Univ Surrey, Dept Civil & Environm Engn, Guildford GU2 5XH, Surrey, England; [Arnold, Benjamin F.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; [Tung, Rosalind] CPI Int, Santa Rosa, CA USA; [Morley, Robert] Publ Hlth England, Bristol, Avon, England; [du Preez, Martella] CSIR, ZA-0001 Pretoria, South Africa; [Bartram, Jamie K.] Univ N Carolina, Water Inst, Chapel Hill, NC USA; [Gundry, Stephen W.] Brightwater Diagnost Ltd, Bath, Avon, England	UNICEF; University of Bristol; University of Surrey; University of California System; University of California Berkeley; Public Health England; Council for Scientific & Industrial Research (CSIR) - South Africa; University of North Carolina; University of North Carolina Chapel Hill	Bain, RES (corresponding author), UNICEF, New York, NY 10038 USA.	rbain@unicef.org	Davis, Anthony/F-2794-2017; xinyu, ying/O-3847-2015; Arnold, Benjamin/AAE-9656-2020; Woodall, Claire/DHF-9710-2022	Davis, Anthony/0000-0001-5213-624X; Arnold, Benjamin/0000-0001-6105-7295; Woodall, Claire/0000-0002-7230-4105; Bartram, Jamie/0000-0002-6542-6315	Bill & Melinda Gates Foundation [48599]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was funded by the Bill & Melinda Gates Foundation under grant reference 48599 to the University of Bristol. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abramson A, 2013, ENVIRON SCI TECHNOL, V47, P10494, DOI 10.1021/es402175n; Alam M, 2006, APPL ENVIRON MICROB, V72, P2185, DOI 10.1128/AEM.72.3.2185-2190.2006; Alonso JL, 1996, APPL ENVIRON MICROB, V62, P1885, DOI 10.1128/AEM.62.6.1885-1888.1996; Aulenbach BT, 2010, ENVIRON MONIT ASSESS, V161, P147, DOI 10.1007/s10661-008-0734-3; Bain R, 2012, INT J ENV RES PUB HE, V9, P1609, DOI 10.3390/ijerph9051609; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonadonna L, 2007, DESALINATION, V213, P18, DOI 10.1016/j.desal.2006.03.601; BRADLEY EL, 1989, AM STAT, V43, P234, DOI 10.2307/2685368; BRENNER KP, 1993, APPL ENVIRON MICROB, V59, P3534, DOI 10.1128/AEM.59.11.3534-3544.1993; Brown J, 2011, J APPL MICROBIOL; Chao KK, 2004, APPL ENVIRON MICROB, V70, P1242, DOI 10.1128/AEM.70.2.1242-1244.2004; Chao WL, 2006, LETT APPL MICROBIOL, V42, P115, DOI 10.1111/j.1472-765X.2005.01814.x; CIEBIN BW, 1995, APPL ENVIRON MICROB, V61, P3940, DOI 10.1128/AEM.61.11.3940-3942.1995; COCHRAN WG, 1950, BIOMETRICS, V6, P105, DOI 10.2307/3001491; Cole SR, 2009, INT J EPIDEMIOL, V38, P1674, DOI 10.1093/ije/dyp269; Crocker J, 2014, INT J ENV RES PUB HE, V11, P7333, DOI 10.3390/ijerph110707333; Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x; Eaton A. D., 2005, STANDARD METHODS EXA; EDBERG SC, 1988, APPL ENVIRON MICROB, V54, P1595, DOI 10.1128/AEM.54.6.1595-1601.1988; Edberg SC, 2000, J APPL MICROBIOL, V29, P106, DOI DOI 10.1111/JAM.2000.88.ISSUE-S1; Environment Agency The Microbiology of Drinking Water, 2009, MICR DRINK WAT 4; FENG PCS, 1982, APPL ENVIRON MICROB, V43, P1320, DOI 10.1128/AEM.43.6.1320-1329.1982; Halvorson HO, 1933, J BACTERIOL, V26, P559, DOI 10.1128/JB.26.6.559-567.1933; Horman A, 2006, WATER RES, V40, P3249, DOI 10.1016/j.watres.2006.06.024; [IMRB PATH], 2009, AQ MARK ASS IND; Kodaka H, 2008, J APPL MICROBIOL, V104, P1112, DOI 10.1111/j.1365-2672.2007.03627.x; Macy J. T., 2005, Journal of Water and Health, V3, P221; Magro G, 2014, ENVIRON SCI TECHNOL, V48, P9624, DOI 10.1021/es502319n; Maheux AF, 2008, J MICROBIOL METH, V75, P506, DOI 10.1016/j.mimet.2008.08.001; MANJA KS, 1982, B WORLD HEALTH ORGAN, V60, P797; McDaniels AE, 1996, APPL ENVIRON MICROB, V62, P3350, DOI 10.1128/AEM.62.9.3350-3354.1996; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NOBLE RE, 1955, J BACTERIOL, V70, P249, DOI 10.1128/JB.70.2.249-250.1955; OLDHAM PD, 1962, J CHRON DIS, V15, P969, DOI 10.1016/0021-9681(62)90116-9; Olstadt J, 2007, J WATER HEALTH, V5, P267, DOI 10.2166/wh.2007.008b; Onda K, 2012, INT J ENV RES PUB HE, V9, P880, DOI 10.3390/ijerph9030880; Orenga S, 2009, J MICROBIOL METH, V79, P139, DOI 10.1016/j.mimet.2009.08.001; Prescott S. C., 1904, ELEMENTS BACTERIOLOG; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Rai S K, 2009, Nepal Med Coll J, V11, P281; Roberts R.B., 1955, Q REV BIOL, V31, P155; Rompre A, 2002, J MICROBIOL METH, V49, P31, DOI 10.1016/S0167-7012(01)00351-7; SARTORY DP, 1995, WATER SCI TECHNOL, V31, P255, DOI 10.1016/0273-1223(95)00276-S; Stauber C, 2014, J MICROBIOL METH, V99, P66, DOI 10.1016/j.mimet.2014.02.008; TAPSALL JW, 1995, DIAGN MICR INFEC DIS, V22, P261, DOI 10.1016/0732-8893(95)00097-T; Tung R, 2014, J WATER HLTH; UNICEF and WHO, 2015, PROGR SAN DRINK WAT; US EPA, 2004, EPA MICR ALT TEST PR; WHO, 2011, GUID DRINK WAT QUAL; Wright JA, 2012, TROP MED INT HEALTH, V17, P94, DOI 10.1111/j.1365-3156.2011.02887.x; Yang H, 2013, J WATER HEALTH, V11, P173, DOI 10.2166/wh.2013.225	51	13	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140997	10.1371/journal.pone.0140997	http://dx.doi.org/10.1371/journal.pone.0140997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495983	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200050
J	Curado, MR; Cossio, EG; Broetz, D; Agostini, M; Cho, W; Brasil, FL; Yilmaz, O; Liberati, G; Lepski, G; Birbaumer, N; Ramos-Murguialday, A				Curado, Marco Rocha; Cossio, Eliana Garcia; Broetz, Doris; Agostini, Manuel; Cho, Woosang; Brasil, Fabricio Lima; Yilmaz, Oezge; Liberati, Giulia; Lepski, Guilherme; Birbaumer, Niels; Ramos-Murguialday, Ander			Residual Upper Arm Motor Function Primes Innervation of Paretic Forearm Muscles in Chronic Stroke after Brain-Machine Interface (BMI) Training	PLOS ONE			English	Article							UPPER-EXTREMITY; UPPER-LIMB; RECOVERY; SYNERGIES; BCI; EMG	Background Abnormal upper arm-forearm muscle synergies after stroke are poorly understood. We investigated whether upper arm function primes paralyzed forearm muscles in chronic stroke patients after Brain-Machine Interface (BMI)-based rehabilitation. Shaping upper arm-forearm muscle synergies may support individualized motor rehabilitation strategies. Methods Thirty-two chronic stroke patients with no active finger extensions were randomly assigned to experimental or sham groups and underwent daily BMI training followed by physiotherapy during four weeks. BMI sessions included desynchronization of ipsilesional brain activity and a robotic orthosis to move the paretic limb (experimental group, n = 16). In the sham group (n = 16) orthosis movements were random. Motor function was evaluated with electromyography (EMG) of forearm extensors, and upper arm and hand Fugl-Meyer assessment (FMA) scores. Patients performed distinct upper arm (e.g., shoulder flexion) and hand movements (finger extensions). Forearm EMG activity significantly higher during upper arm movements as compared to finger extensions was considered facilitation of forearm EMG activity. Intraclass correlation coefficient (ICC) was used to test inter-session reliability of facilitation of forearm EMG activity. Results Facilitation of forearm EMG activity ICC ranges from 0.52 to 0.83, indicating fair to high reliability before intervention in both limbs. Facilitation of forearm muscles is higher in the paretic as compared to the healthy limb (p<0.001). Upper arm FMA scores predict facilitation of forearm muscles after intervention in both groups (significant correlations ranged from R = 0.752, p = 0.002 to R = 0.779, p = 0.001), but only in the experimental group upper arm FMA scores predict changes in facilitation of forearm muscles after intervention (R = 0.709, p = 0.002; R = 0.827, p<0.001). Conclusions Residual upper arm motor function primes recruitment of paralyzed forearm muscles in chronic stroke patients and predicts changes in their recruitment after BMI training. This study suggests that changes in upper arm-forearm synergies contribute to stroke motor recovery, and provides candidacy guidelines for similar BMI-based clinical practice.	[Curado, Marco Rocha; Cossio, Eliana Garcia; Broetz, Doris; Agostini, Manuel; Cho, Woosang; Yilmaz, Oezge; Birbaumer, Niels; Ramos-Murguialday, Ander] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72076 Tubingen, Germany; [Curado, Marco Rocha; Cossio, Eliana Garcia; Yilmaz, Oezge] Int Max Planck Res Sch Neural & Behav Sci, Tubingen, Germany; [Brasil, Fabricio Lima] Inst Santos Dumond, Edmond & Lily Safra Int Inst Neurosci, Natal, RN, Brazil; [Lepski, Guilherme] Catholic Univ Louvain, Inst Neurosci, Louvain, Belgium; [Lepski, Guilherme] Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil; [Lepski, Guilherme] Univ Tubingen, Dept Neurosurg, D-72076 Tubingen, Germany; [Birbaumer, Niels] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, D-72076 Tubingen, Germany; [Ramos-Murguialday, Ander] TECNALIA Hlth Technol, San Sebastian, Spain	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; Universite Catholique Louvain; Universidade de Sao Paulo; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Curado, MR (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Silcherstr 5, D-72076 Tubingen, Germany.	marco.curado@gmail.com	Lepski, Guilherme A/C-1951-2014; Coish, Elizabeth/AAU-1245-2020; Lepski, Guilherme/E-1508-2012; Brasil, Fabricio Lima/I-7529-2015; yilmaz, ozge/B-3866-2014; Lepski, Guilherme/V-6905-2019	Lepski, Guilherme/0000-0002-9030-4192; Brasil, Fabricio Lima/0000-0002-9984-1007; Birbaumer, Niels/0000-0002-6786-5127; Ramos-Murguialday, Dr. Ander/0000-0002-1549-4029; Liberati, Giulia/0000-0002-5684-4443	German Federal Ministry of Education and Research (BMBF) [01GQ0831, 01GI0925]; Deutsche Forschungsgemeinschaft (DFG); European Research Council [ERC 227632]; European Union Information and Communication Technologies Framework Programme 7 (ICT-FP7) [HUMOUR 231724]; TECNALIA; Baden Wuerttemberg Stiftung [ROB-1]; Natural Science Foundation of China [NSFC 31450110072]; Volkswagen Stiftung; CAPES (Coordination for the Improvement of Higher Level -or Education-Personnel, Brazil); CNPq (Brazilian National Counsel of Technological and Scientific Development); DAAD (Deutscher Akademischer Austauschdienst); Interuniversity Center for the Research in Cognitive Processing of Natural and Artificial Systems (ECoNa); Sapienza University of Rome	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); European Union Information and Communication Technologies Framework Programme 7 (ICT-FP7); TECNALIA; Baden Wuerttemberg Stiftung; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Volkswagen Stiftung(Volkswagen); CAPES (Coordination for the Improvement of Higher Level -or Education-Personnel, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Brazilian National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DAAD (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD)); Interuniversity Center for the Research in Cognitive Processing of Natural and Artificial Systems (ECoNa); Sapienza University of Rome	This work was supported by the German Federal Ministry of Education and Research (BMBF, Forderzeichen 01GQ0831, http://www.bmbf.de/, and DZD, 01GI0925); Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/); European Research Council (ERC 227632, http://erc.europa.eu/) and European Union Information and Communication Technologies Framework Programme 7 (ICT-FP7, http://cordis.europa.eu/fp7/ict/) (HUMOUR 231724); TECNALIA (http://www.tecnalia.com/en/); Baden Wuerttemberg Stiftung (ROB-1, http://www.bwstiftung.de/); Natural Science Foundation of China (NSFC 31450110072) and Volkswagen Stiftung. MRC was funded by CAPES (Coordination for the Improvement of Higher Level -or Education-Personnel, Brazil, http://www.capes.gov.br/); FLB by CNPq (Brazilian National Counsel of Technological and Scientific Development, http://www.cnpq.br/); MRC, ECG, FLB, WC and OY were funded by DAAD (Deutscher Akademischer Austauschdienst, https://www.daad.org/) scholarship; and GLi was funded by the Interuniversity Center for the Research in Cognitive Processing of Natural and Artificial Systems (ECoNa, http://w3.uniroma1.it/econa/), Sapienza University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang K. K., 2014, CLIN EEG NE IN PRESS; Beaglehole R, 2003, WORLD HLTH REPORT 20, P1; Caria A, 2011, PSYCHOPHYSIOLOGY, V48, P578, DOI 10.1111/j.1469-8986.2010.01117.x; Chae J, 2002, NEUROREHAB NEURAL RE, V16, P241, DOI 10.1177/154596802401105180; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Cheung VCK, 2009, P NATL ACAD SCI USA, V106, P19563, DOI 10.1073/pnas.0910114106; Crow JL, 2008, PHYS THER, V88, P1554, DOI 10.2522/ptj.20070186; Daly JJ, 2009, J NEUROL PHYS THER, V33, P203, DOI 10.1097/NPT.0b013e3181c1fc0b; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Garcia-Cossio E, 2013, I IEEE EMBS C NEUR E, P1545, DOI 10.1109/NER.2013.6696241; Grefkes C, 2014, NEUROSCIENTIST, V20, P56, DOI 10.1177/1073858413491147; Houwink A, 2013, ARCH PHYS MED REHAB, V94, P839, DOI 10.1016/j.apmr.2012.11.031; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Latash ML, 2006, PHYS THER, V86, P1151, DOI 10.1093/ptj/86.8.1151; Lee SW, 2011, IEEE T NEUR SYS REH, V19, P558, DOI 10.1109/TNSRE.2010.2079334; Li XY, 2014, CLIN NEUROPHYSIOL, V125, P988, DOI 10.1016/j.clinph.2013.09.044; Liu ZW, 2013, STROKE, V44, P1951, DOI 10.1161/STROKEAHA.113.001162; Manschot S, 1998, J NEUROL NEUROSUR PS, V64, P253, DOI 10.1136/jnnp.64.2.253; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Miller LC, 2012, CLIN NEUROPHYSIOL, V123, P1216, DOI 10.1016/j.clinph.2012.01.009; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Ono Takashi, 2014, Front Neuroeng, V7, P19, DOI 10.3389/fneng.2014.00019; Pandian S, 2012, TOP STROKE REHABIL, V19, P545, DOI 10.1310/tsr1906-545; Patten C, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-1; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Roh J, 2013, J NEUROPHYSIOL, V109, P768, DOI 10.1152/jn.00670.2012; Starkey ML, 2012, BRAIN, V135, P3265, DOI 10.1093/brain/aws270; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Taub E, 2006, STROKE, V37, P1045, DOI 10.1161/01.STR.0000206463.66461.97; Turk R, 2008, NEUROREHAB NEURAL RE, V22, P684, DOI 10.1177/1545968308315599; TWITCHELL TE, 1951, BRAIN, V74, P443, DOI 10.1093/brain/74.4.443; Whitall J, 2000, STROKE, V31, P2390, DOI 10.1161/01.STR.31.10.2390; Wright ZA, 2012, IEEE ENG MED BIO, P879, DOI 10.1109/EMBC.2012.6346072	34	15	17	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140161	10.1371/journal.pone.0140161	http://dx.doi.org/10.1371/journal.pone.0140161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495971	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200014
J	Magbanua, MJM; Pugia, M; Lee, JS; Jabon, M; Wang, V; Gubens, M; Marfurt, K; Pence, J; Sidhu, H; Uzgiris, A; Rugo, HS; Park, JW				Magbanua, Mark Jesus M.; Pugia, Michael; Lee, Jin Sun; Jabon, Marc; Wang, Victoria; Gubens, Matthew; Marfurt, Karen; Pence, Julia; Sidhu, Harwinder; Uzgiris, Arejas; Rugo, Hope S.; Park, John W.			A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ONCOFETAL ANTIGEN-EXPRESSION; TUMOR-CELLS; ENDOTHELIAL-CELLS; BREAST-CANCER; STEM-CELL; PERIPHERAL-BLOOD; MOLECULAR CHARACTERIZATION; HEALTHY-SUBJECTS; CLINICAL-VALUE	Size selection via filtration offers an antigen-independent approach for the enrichment of rare cell populations in blood of cancer patients. We evaluated the performance of a novel approach for multiplex rare cell detection in blood samples from metastatic breast (n = 19) and lung cancer patients (n = 21), and healthy controls (n = 30) using an automated microfluidic filtration and multiplex immunoassay strategy. Captured cells were enumerated after sequential staining for specific markers to identify circulating tumor cells (CTCs), circulating mesenchymal cells (CMCs), putative circulating stem cells (CSCs), and circulating endothelial cells (CECs). Preclinical validation experiments using cancer cells spiked into healthy blood demonstrated high recovery rate (mean = 85%) and reproducibility of the assay. In clinical studies, CTCs and CMCs were detected in 35% and 58% of cancer patients, respectively, and were largely absent from healthy controls (3%, p = 0.001). Mean levels of CTCs were significantly higher in breast than in lung cancer patients (p = 0.03). Fifty-three percent (53%) of cancer patients harbored putative CSCs, while none were detectable in healthy controls (p<0.0001). In contrast, CECs were observed in both cancer and control groups. Direct comparison of CellSearch (R) vs. our microfluidic filter method revealed moderate correlation (R-2 = 0.46, kappa = 0.47). Serial blood analysis in breast cancer patients demonstrated the feasibility of monitoring circulating rare cell populations over time. Simultaneous assessment of CTCs, CMCs, CSCs and CECs may provide new tools to study mechanisms of disease progression and treatment response/resistance.	[Magbanua, Mark Jesus M.; Lee, Jin Sun; Jabon, Marc; Wang, Victoria; Gubens, Matthew; Rugo, Hope S.; Park, John W.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94115 USA; [Pugia, Michael; Marfurt, Karen; Pence, Julia; Sidhu, Harwinder; Uzgiris, Arejas] Siemens Healthcare Diagnost, Elkhart, IN 46516 USA	University of California System; University of California San Francisco; Siemens AG	Magbanua, MJM (corresponding author), Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94115 USA.	mark.magbanua@ucsf.edu; john.park@ucsf.edu		Uzgiris, Arejas/0000-0002-3394-9787	Siemens Healthcare Diagnostics (SHD); Breast Cancer Research Foundation (BCRF)	Siemens Healthcare Diagnostics (SHD); Breast Cancer Research Foundation (BCRF)	This study was funded by Siemens Healthcare Diagnostics (SHD). Additional funding was obtained from the Breast Cancer Research Foundation (BCRF). BCRF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SHD was involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Beerepoot LV, 2004, ANN ONCOL, V15, P139, DOI 10.1093/annonc/mdh017; Bidard FC, 2010, ANN ONCOL, V21, P1765, DOI 10.1093/annonc/mdq052; Bidard FC, 2014, LANCET ONCOL, V15, P406, DOI 10.1016/S1470-2045(14)70069-5; Boos CJ, 2006, J AM COLL CARDIOL, V48, P1538, DOI 10.1016/j.jacc.2006.02.078; BOYLE JM, 1990, HUM GENET, V84, P455; Chen L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000293; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2010, ANN ONCOL, V21, P1851, DOI 10.1093/annonc/mdq030; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061774; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Cummings J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-226; Damani S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003451; Damelin M, 2011, CANCER RES, V71, P4236, DOI 10.1158/0008-5472.CAN-10-3919; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Desitter I, 2011, ANTICANCER RES, V31, P427; El-Heliebi A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-214; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; Hofman V, 2012, CYTOPATHOLOGY, V23, P30, DOI 10.1111/j.1365-2303.2010.00835.x; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Hosokawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067466; Huang T, 2014, BIOSENS BIOELECTRON, V51, P213, DOI 10.1016/j.bios.2013.07.044; Ilie M, 2014, BRIT J CANCER, V110, P1236, DOI 10.1038/bjc.2014.11; Jackson JM, 2014, LAB CHIP, V14, P106, DOI [10.1039/c3lc50618e, 10.1039/c31c50618e]; Karabacak NM, 2014, NAT PROTOC, V9, P694, DOI 10.1038/nprot.2014.044; Kasimir-Bauer S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3099; Lang JE, 2015, BREAST CANCER RES TR, V149, P121, DOI 10.1007/s10549-014-3215-0; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Ligthart ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067148; Liu JJ, 2010, INT J CLIN EXP PATHO, V3, P328; Lopez M, 2012, AIDS REV, V14, P223; Lustberg MB, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3622; Magbanua MJM, 2014, CANCER METAST REV, V33, P757, DOI 10.1007/s10555-014-9503-7; Magbanua MJM, 2013, METHODS, V64, P114, DOI 10.1016/j.ymeth.2013.07.029; Magbanua MJM, 2013, CANCER RES, V73, P30, DOI 10.1158/0008-5472.CAN-11-3017; Magbanua MJM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-78; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Mehran R, 2014, CANCER RES, V74, P2731, DOI 10.1158/0008-5472.CAN-13-2044; Naganuma H, 2002, ANTICANCER RES, V22, P1033; O'Flaherty JD, 2012, J THORAC ONCOL, V7, P1880, DOI 10.1097/JTO.0b013e31826bfbc6; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Rowand JL, 2007, CYTOM PART A, V71A, P105, DOI 10.1002/cyto.a.20364; Sapra P, 2013, MOL CANCER THER, V12, P38, DOI 10.1158/1535-7163.MCT-12-0603; Sieuwerts AM, 2009, J NATL CANCER I, V101, P61, DOI 10.1093/jnci/djn419; Sollier E, 2014, LAB CHIP, V14, P63, DOI 10.1039/c3lc50689d; STARZYNSKA T, 1994, BRIT J CANCER, V69, P899, DOI 10.1038/bjc.1994.173; Sterlacci W, 2014, J THORAC ONCOL, V9, P41, DOI 10.1097/JTO.0000000000000021; Thege FI, 2014, LAB CHIP, V14, P1775, DOI 10.1039/c4lc00041b; Theodoropoulos PA, 2010, CANCER LETT, V288, P99, DOI 10.1016/j.canlet.2009.06.027; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Williams A, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.6.066007; WRIGLEY E, 1995, INT J GYNECOL CANCER, V5, P269, DOI 10.1046/j.1525-1438.1995.05040269.x; Yokobori T, 2013, CANCER RES, V73, P2059, DOI 10.1158/0008-5472.CAN-12-0326; Zhang H, 2013, SURG ONCOL, V22, P217, DOI 10.1016/j.suronc.2013.07.001; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	61	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141166	10.1371/journal.pone.0141166	http://dx.doi.org/10.1371/journal.pone.0141166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496203	Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200070
J	Zomerman, WW; Plasschaert, SLA; Diks, SH; Lourens, HJ; Meeuwsen-de Boer, T; Hoving, EW; den Dunnen, WFA; de Bont, ESJM				Zomerman, Walderik W.; Plasschaert, Sabine L. A.; Diks, Sander H.; Lourens, Harm-Jan; Meeuwsen-de Boer, Tiny; Hoving, Eelco W.; den Dunnen, Wilfred F. A.; de Bont, Eveline S. J. M.			Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; GROWTH-FACTOR; C-MET; BRAIN-TUMORS; CHILDHOOD MEDULLOBLASTOMA; PROGNOSTIC-SIGNIFICANCE; CRANIAL RADIATION; IN-VIVO; CONSORTIUM; RESISTANCE	Recent clinical trials investigating receptor tyrosine kinase (RTK) inhibitors showed a limited clinical response in medulloblastoma. The present study investigated the role of micro-environmental growth factors expressed in the brain, such as HGF and EGF, in relation to the effects of hepatocyte growth factor receptor (MET) and epidermal growth factor receptor family (ErbB1-4) inhibition in medulloblastoma cell lines. Medulloblastoma cell lines were treated with tyrosine kinase inhibitors crizotinib or canertinib, targeting MET and ErbB1-4, respectively. Upon treatment, cells were stimulated with VEGF-A, PDGF-AB, HGF, FGF-2 or EGF. Subsequently, we measured cell viability and expression levels of growth factors and downstream signaling proteins. Addition of HGF or EGF phosphorylated MET or EGFR, respectively, and demonstrated phosphorylation of Akt and ERK1/2 as well as increased tumor cell viability. Crizotinib and canertinib both inhibited cell viability and phosphorylation of Akt and ERK1/2. Specifically targeting MET using shRNA's resulted in decreased cell viability. Interestingly, addition of HGF to canertinib significantly enhanced cell viability as well as phosphorylation of Akt and ERK1/2. The HGF-induced bypass of canertinib was reversed by addition of crizotinib. HGF protein was hardly released by medulloblastoma cells itself. Addition of canertinib did not affect RTK cell surface or growth factor expression levels. This manuscript points to the bypassing capacity of exogenous HGF in medulloblastoma cell lines. It might be of great interest to anticipate on these results in developing novel clinical trials with a combination of MET and EGFR inhibitors in medulloblastoma.	[Zomerman, Walderik W.; Plasschaert, Sabine L. A.; Diks, Sander H.; Lourens, Harm-Jan; Meeuwsen-de Boer, Tiny; de Bont, Eveline S. J. M.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Oncol Hematol, NL-9713 AV Groningen, Netherlands; [Plasschaert, Sabine L. A.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Hoving, Eelco W.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, NL-9713 AV Groningen, Netherlands; [den Dunnen, Wilfred F. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Plasschaert, SLA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Oncol Hematol, NL-9713 AV Groningen, Netherlands.	splasschaert@prinsesmaximacentrum.nl		den Dunnen, Wilfred/0000-0002-4168-1207	Stichting Kinder Kankervrij (KiKa)-project [94]	Stichting Kinder Kankervrij (KiKa)-project	This project is supported by a grant from "Stichting Kinder Kankervrij (KiKa)-project 94". The funders had no role in study design, data collection and analysis, decision to publish, or preperation of the manuscript.	Bobola MS, 2005, CLIN CANCER RES, V11, P2747, DOI 10.1158/1078-0432.CCR-04-2045; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Faria CC, 2015, CANCER RES, V75, P134, DOI 10.1158/0008-5472.CAN-13-3629; Fouladi M, 2013, J NEURO-ONCOL, V114, P173, DOI 10.1007/s11060-013-1166-7; Gilbertson RJ, 1997, CANCER RES, V57, P3272; GILBERTSON RJ, 1995, BRIT J CANCER, V71, P473, DOI 10.1038/bjc.1995.96; Gremo F, 2000, INT J DEV NEUROSCI, V18, P271, DOI 10.1016/S0736-5748(99)00095-7; Guessous F, 2008, J CELL PHYSIOL, V217, P577, DOI 10.1002/jcp.21542; Guessous F, 2010, ANTI-CANCER AGENT ME, V10, P28, DOI 10.2174/1871520611009010028; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jakacki RI, 2008, J CLIN ONCOL, V26, P4921, DOI 10.1200/JCO.2007.15.2306; Jun HJ, 2012, ONCOGENE, V31, P3039, DOI 10.1038/onc.2011.474; Kongkham PN, 2010, TRANSL ONCOL, V3, P336, DOI 10.1593/tlo.10121; Li YQ, 2005, CANCER RES, V65, P9355, DOI 10.1158/0008-5472.CAN-05-1946; Li YQ, 2008, LAB INVEST, V88, P98, DOI 10.1038/labinvest.3700702; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; Mabbott DJ, 2008, NEUROPSYCHOLOGY, V22, P159, DOI 10.1037/0894-4105.22.2.159; Meco D, 2009, NEURO-ONCOLOGY, V11, P250, DOI 10.1215/15228517-2008-095; Minuti G, 2012, BRIT J CANCER, V107, P793, DOI 10.1038/bjc.2012.335; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Namba H, 2009, NEUROSCIENCE, V158, P1731, DOI 10.1016/j.neuroscience.2008.10.057; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Rickert CH, 2001, CHILD NERV SYST, V17, P503, DOI 10.1007/s003810100496; Rutkowski S, 2010, J CLIN ONCOL, V28, P4961, DOI 10.1200/JCO.2010.30.2299; Severinsson EAD, 2011, BIOCHEM BIOPH RES CO, V414, P563, DOI 10.1016/j.bbrc.2011.09.118; Shao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080832; Sie M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122555; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Spiegler BJ, 2004, J CLIN ONCOL, V22, P706, DOI 10.1200/JCO.2004.05.186; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thewke DP, 1999, BRAIN RES, V821, P356, DOI 10.1016/S0006-8993(99)01115-4; Lafuente JV, 2012, INT REV NEUROBIOL, V102, P317, DOI 10.1016/B978-0-12-386986-9.00012-0; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Zhang Y, 2013, CLIN CANCER RES, V19, P1433, DOI 10.1158/1078-0432.CCR-12-2832	36	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141381	10.1371/journal.pone.0141381	http://dx.doi.org/10.1371/journal.pone.0141381			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496080	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200105
J	Earley, H; Lennon, G; Balfe, A; Kilcoyne, M; Clyne, M; Joshi, L; Carrington, S; Martin, ST; Coffey, JC; Winter, DC; O'Connell, PR				Earley, Helen; Lennon, Grainne; Balfe, Aine; Kilcoyne, Michelle; Clyne, Marguerite; Joshi, Lokesh; Carrington, Stephen; Martin, Sean T.; Coffey, J. Calvin; Winter, Desmond C.; O'Connell, P. Ronan			A Preliminary Study Examining the Binding Capacity of Akkermansia muciniphila and Desulfovibrio spp., to Colonic Mucin in Health and Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SULFATE-REDUCING BACTERIA; ACID O-ACETYLATION; CAMPYLOBACTER-JEJUNI; INTESTINAL BARRIER; MUCUS LAYERS; SULFIDE; MICROBIOME; MUCOSA; MODULATION	Background Akkermansia muciniphila and Desulfovibrio spp. are commensal microbes colonising the mucus gel layer of the colon. Both species have the capacity to utilise colonic mucin as a substrate. A. muciniphila degrades colonic mucin, while Desulfovibrio spp. metabolise the sulfate moiety of sulfated mucins. Altered abundances of these microorganisms have been reported in ulcerative colitis (UC). However their capacity to bind to human colonic mucin, and whether this binding capacity is affected by changes in mucin associated with UC, remain to be defined. Methods Mucin was isolated from resected colon from control patients undergoing resection for colonic cancer (n = 7) and patients undergoing resection for UC (n = 5). Isolated mucin was purified and printed onto mucin microarrays. Binding of reference strains and three clinical isolates of A. muciniphila and Desulfovibrio spp. to purified mucin was investigated. Results Both A. muciniphila and Desulfovibro spp. bound to mucin. The reference strain and all clinical isolates of A. muciniphila showed increased binding capacity for UC mucin (p < .005). The Desulfovibrio reference strain showed increased affinity for UC mucin. The mucin binding profiles of clinical isolates of Desulfovibrio spp. were specific to each isolate. Two isolates showed no difference in binding. One UC isolate bound with increased affinity to UC mucin (p < .005). Conclusion These preliminary data suggest that differences exist in the mucin binding capacity of isolates of A. muciniphila and Desulfovibrio spp. This study highlights the mucin microarray platform as a means of studying the ability of bacteria to interact with colonic mucin in health and disease.	[Earley, Helen; Lennon, Grainne; Balfe, Aine; Clyne, Marguerite; O'Connell, P. Ronan] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Earley, Helen; Lennon, Grainne; Balfe, Aine; Martin, Sean T.; Winter, Desmond C.; O'Connell, P. Ronan] St Vincents Univ Hosp, Ctr Colorectal Dis, Dublin 4, Ireland; [Kilcoyne, Michelle; Joshi, Lokesh] Natl Univ Ireland, Glycosci Grp, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Kilcoyne, Michelle] Natl Univ Ireland, Sch Nat Sci, Microbiol, Galway, Ireland; [Carrington, Stephen] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Coll Life Sci, Dublin 4, Ireland; [Coffey, J. Calvin] Grad Entry Med Sch, Limerick, Ireland	University College Dublin; University College Dublin; Saint Vincent's University Hospital; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University College Dublin	O'Connell, PR (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland.	ronan.oconnell@ucd.ie	O'Connell, Patrick Ronan/H-6583-2019; Clyne, Marguerite M/H-4179-2012	O'Connell, Patrick Ronan/0000-0002-1846-5629; Clyne, Marguerite M/0000-0003-2547-9129; Kilcoyne, Michelle/0000-0002-8870-1308; Joshi, Lokesh/0000-0002-3612-0747	Science Foundation Ireland [09/IN.1/B2606, 08/SRC/B1393]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	Science Foundation Ireland Grant Numbers: 09/IN.1/B2606, 08/SRC/B1393 (URL: http://www.sfi.ie). Authors receiving funding: P.R.O., L.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni L, 2014, WORLD J GASTROENTERO, V20, P1165, DOI 10.3748/wjg.v20.i5.1165; Attene-Ramos MS, 2010, ENVIRON MOL MUTAGEN, V51, P304, DOI 10.1002/em.20546; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2012, NUTR REV, V70, pS14, DOI 10.1111/j.1753-4887.2012.00496.x; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Carrington SD, 2012, METHODS MOL BIOL, V842, P191, DOI 10.1007/978-1-61779-513-8_11; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Corfield AP, 1999, GLYCOCONJUGATE J, V16, P307, DOI 10.1023/A:1007026314792; Corfield AP, 1996, GLYCOCONJUGATE J, V13, P809, DOI 10.1007/BF00702345; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; Fite A, 2004, GUT, V53, P523, DOI 10.1136/gut.2003.031245; Forgue-Lafitte ME, 2007, INT J CANCER, V121, P1543, DOI 10.1002/ijc.22865; Gao SH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-24; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Harris SL, 2001, J BACTERIOL, V183, P4099, DOI 10.1128/JB.183.13.4099-4102.2001; Hsu KL, 2006, NAT CHEM BIOL, V2, P153, DOI 10.1038/nchembio767; James SL, 2015, GUT, V64, P562, DOI 10.1136/gutjnl-2014-307198; Jia WJ, 2012, FEMS IMMUNOL MED MIC, V65, P55, DOI 10.1111/j.1574-695X.2012.00935.x; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kilcoyne M, 2014, CARBOHYD RES, V389, P123, DOI 10.1016/j.carres.2014.02.005; Kilcoyne M, 2012, ANAL CHEM, V84, P3330, DOI 10.1021/ac203404n; Klein A, 1998, BIOCHIMIE, V80, P49, DOI 10.1016/S0300-9084(98)80056-4; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Larsson JMH, 2011, INFLAMM BOWEL DIS, V17, P2299, DOI 10.1002/ibd.21625; Lennon G, 2014, COLORECTAL DIS, V16, pO161, DOI 10.1111/codi.12503; Lennon G, 2014, GUT MICROBES, V5, P277, DOI 10.4161/gmic.28793; Longman RJ, 2006, J HISTOCHEM CYTOCHEM, V54, P1335, DOI 10.1369/jhc.5A6904.2006; Mahdavi J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130048; McCann JR, 2014, J BACTERIOL, V196, P1780, DOI 10.1128/JB.01409-13; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mello LV, 2010, FEBS LETT, V584, P2421, DOI 10.1016/j.febslet.2010.04.045; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Natividad JMM, 2013, PHARMACOL RES, V69, P42, DOI 10.1016/j.phrs.2012.10.007; Naughton JA, 2013, INFECT IMMUN, V81, P2838, DOI 10.1128/IAI.00415-13; Ouwehand AC, 2002, LAIT, V82, P123, DOI 10.1051/lait:2001011; Ouwerkerk JP, 2013, BEST PRACT RES CL GA, V27, P25, DOI 10.1016/j.bpg.2013.03.001; Pitcher MCL, 2000, GUT, V46, P64, DOI 10.1136/gut.46.1.64; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Prorok-Hamon M, 2014, GUT, V63, P761, DOI 10.1136/gutjnl-2013-304739; PULLAN RD, 1994, GUT, V35, P353, DOI 10.1136/gut.35.3.353; RAOUF AH, 1992, CLIN SCI, V83, P623, DOI 10.1042/cs0830623; Reunanen J, 2015, APPL ENVIRON MICROB, V81, P3655, DOI 10.1128/AEM.04050-14; Roediger WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920; ROEDIGER WEW, 1993, CLIN SCI, V85, P623, DOI 10.1042/cs0850623; Rowan F, 2010, DIS COLON RECTUM, V53, P1530, DOI 10.1007/DCR.0b013e3181f1e620; Schultsz C, 1999, GASTROENTEROLOGY, V117, P1089, DOI 10.1016/S0016-5085(99)70393-8; Shen YQ, 2004, BIOL CHEM, V385, P145, DOI 10.1515/BC.2004.033; Skoog EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036378; Tang ZZ, 2014, J MICROBIOL BIOTECHN, V24, P440, DOI 10.4014/jmb.1311.11007; Tremaroli V, 2010, GUT, V59, P1589, DOI 10.1136/gut.2010.223594; TSAI HH, 1995, GUT, V36, P570, DOI 10.1136/gut.36.4.570; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876	60	33	37	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0135280	10.1371/journal.pone.0135280	http://dx.doi.org/10.1371/journal.pone.0135280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491870	gold, Green Published, Green Submitted			2022-12-27	WOS:000363249300001
J	Grayson, ML; Macesic, N; Huang, GK; Bond, K; Fletcher, J; Gilbert, GL; Gordon, DL; Hellsten, JF; Iredell, J; Keighley, C; Stuart, RL; Xuereb, CS; Cruickshank, M				Grayson, M. Lindsay; Macesic, Nenad; Huang, G. Khai; Bond, Katherine; Fletcher, Jason; Gilbert, Gwendolyn L.; Gordon, David L.; Hellsten, Jane F.; Iredell, Jonathan; Keighley, Caitlin; Stuart, Rhonda L.; Xuereb, Charles S.; Cruickshank, Marilyn			Use of an Innovative Personality-Mindset Profiling Tool to Guide Culture-Change Strategies among Different Healthcare Worker Groups	PLOS ONE			English	Article							HAND-HYGIENE; CLINICAL-PRACTICE; BEHAVIOR-CHANGE; PHYSICIANS; DETERMINANTS; BACTEREMIA; PROGRAM	Introduction Important culture-change initiatives (e.g. improving hand hygiene compliance) are frequently associated with variable uptake among different healthcare worker (HCW) categories. Inherent personality differences between these groups may explain change uptake and help improve future intervention design. Materials and Methods We used an innovative personality-profiling tool (ColourGrid1) to assess personality differences among standard HCW categories at five large Australian hospitals using two data sources (HCW participant surveys [PS] and generic institution-wide human resource [HR] data) to: a) compare the relative accuracy of these two sources; b) identify differences between HCW groups and c) use the observed profiles to guide design strategies to improve uptake of three clinically-important initiatives (improved hand hygiene, antimicrobial stewardship and isolation procedure adherence). Results Results from 34,243 HCWs (HR data) and 1045 survey participants (PS data) suggest that HCWs were different from the general population, displaying more individualism, lowerpower distance, less uncertainty avoidance and greater cynicism about advertising messages. HR and PS data were highly concordant in identifying differences between the three key HCW categories (doctors, nursing/allied-health, support services) and predicting appropriate implementation strategies. Among doctors, the data suggest that key messaging should differ between full-time vs part-time (visiting) senior medical officers (SMO, VMO) and junior hospital medical officers (HMO), with SMO messaging focused on evidence-based compliance, VMO initiatives emphasising structured mandatory controls and prestige loss for non-adherence, and for HMOs focusing on leadership opportunity and future career risk for non-adherence. Discussion Compared to current standardised approaches, targeted interventions based on personality differences between HCW categories should result in improved infection control-related culture-change uptake. Personality profiling based on HR data may represent a useful means of developing a national culture-change "blueprint" for HCW education.	[Grayson, M. Lindsay; Macesic, Nenad; Huang, G. Khai; Bond, Katherine] Austin Hlth, Infect Dis & Microbiol Dept, Melbourne, Vic, Australia; [Grayson, M. Lindsay] Australian Commiss Safety & Qual Hlth Care, Hand Hyg Australia, Melbourne, Vic, Australia; [Grayson, M. Lindsay] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Grayson, M. Lindsay] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Fletcher, Jason; Hellsten, Jane F.] Bendigo Hlth, Infect Prevent & Control Dept, Bendigo, Australia; [Gilbert, Gwendolyn L.; Iredell, Jonathan; Keighley, Caitlin] ICPMR Westmead Hosp, Ctr Infect Dis & Microbiol, Sydney, NSW, Australia; [Gilbert, Gwendolyn L.; Iredell, Jonathan] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Gordon, David L.] Flinders Med Ctr, Dept Microbiol & Infect Dis, SA Pathol, Adelaide, SA, Australia; [Stuart, Rhonda L.] Monash Univ, Monash Hlth, Infect Control Dept, Clayton, Vic, Australia; [Stuart, Rhonda L.] Monash Univ, Monash Hlth, Dept Infect Dis, Clayton, Vic, Australia; [Xuereb, Charles S.] XAX Pty Ltd, Melbourne, Vic, Australia; [Cruickshank, Marilyn] Australian Commiss Safety & Qual Hlth Care, Sydney, NSW, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; University of Sydney; University of Sydney; Flinders Medical Centre; SA Pathology; Monash University; Monash University	Grayson, ML (corresponding author), Austin Hlth, Infect Dis & Microbiol Dept, Melbourne, Vic, Australia.	Lindsay.Grayson@austin.org.au; Katherine.Bond@austin.org.au	Gilbert, Gwendolyn/B-7733-2013	Gilbert, Gwendolyn/0000-0001-7490-6727; Gordon, David/0000-0003-3276-9685; Bond, Katherine/0000-0002-4473-9232	Hand Hygiene Australia; Australian Commission on Safety and Quality in Health Care; XAX Pty. Ltd	Hand Hygiene Australia; Australian Commission on Safety and Quality in Health Care; XAX Pty. Ltd	This work was funded by Hand Hygiene Australia and the Australian Commission on Safety and Quality in Health Care. The marketing research company XAX Pty. Ltd., (Melbourne, Australia) was contracted to conduct ColourGrid surveys and analyses - this was undertaken by one co-investigator (CSX), who is an employee (CEO) of XAX Pty. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. XAX Pty. Ltd provided support in the form of salary for author CSX, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2015, FOR TOOL COLOURGRID; Australia CGo, 2015, RESP THREAT ANT RES; Azim S, 2014, MED J AUSTRALIA, V200, P534, DOI 10.5694/mja13.11203; Borg MA, 2014, J HOSP INFECT, V86, P161, DOI 10.1016/j.jhin.2013.12.006; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Charani E, 2013, CLIN INFECT DIS, V57, P188, DOI 10.1093/cid/cit212; Charani E, 2011, CLIN INFECT DIS, V53, P651, DOI 10.1093/cid/cir445; Edwards R, 2012, LANCET INFECT DIS, V12, P318, DOI 10.1016/S1473-3099(11)70283-3; Erasmus V, 2009, INFECT CONT HOSP EP, V30, P415, DOI 10.1086/596773; Gammon J, 2008, J CLIN NURS, V17, P157, DOI 10.1111/j.1365-2702.2006.01852.x; Gordon R, 2006, PUBLIC HEALTH, V120, P1133, DOI 10.1016/j.puhe.2006.10.008; Grabsch EA, 2012, J HOSP INFECT, V82, P234, DOI 10.1016/j.jhin.2012.08.010; Grayson ML, 2008, MED J AUSTRALIA, V188, P633, DOI 10.5694/j.1326-5377.2008.tb01820.x; Grayson ML, 2011, MED J AUSTRALIA, V195, P615, DOI 10.5694/mja11.10747; Hand Hygiene Australia - Home, 2015, HOME; Hand Hygiene Policy - New South Wales Government Ministry of Health, 2010, HAND HYG POL; Hofstede G., 1980, INT STUD MANAG ORG, V10, P15, DOI [DOI 10.1080/00208825.1980.11656300, 10.1080/00208825.1980.11656300]; Hofstede G., 2001, CULTURES CONSEQUENCE; Hulscher MEJL, 2010, LANCET INFECT DIS, V10, P167, DOI 10.1016/S1473-3099(10)70027-X; Lam BCC, 2004, PEDIATRICS, V114, pE565, DOI 10.1542/peds.2004-1107; McDonald R, 2005, QUAL SAF HEALTH CARE, V14, P290, DOI 10.1136/qshc.2005.013912; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 2004, J HOSP INFECT, V58, P1, DOI 10.1016/j.jhin.2004.06.002; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Rello J, 2002, CHEST, V122, P656, DOI 10.1378/chest.122.2.656; Sax H, 2007, INFECT CONT HOSP EP, V28, P1267, DOI 10.1086/521663; Victorian Public Hospitals, 2015, VICTORIAL PUBLIC HOS; World Health Organization (WHO), 2009, WHO GUID HAND HYG HL	29	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140509	10.1371/journal.pone.0140509	http://dx.doi.org/10.1371/journal.pone.0140509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489012	Green Published, gold			2022-12-27	WOS:000363248400057
J	Benedetti-Cecchi, L; Canepa, A; Fuentes, V; Tamburello, L; Purcell, JE; Piraino, S; Roberts, J; Boero, F; Halpin, P				Benedetti-Cecchi, Lisandro; Canepa, Antonio; Fuentes, Veronica; Tamburello, Laura; Purcell, Jennifer E.; Piraino, Stefano; Roberts, Jason; Boero, Ferdinando; Halpin, Patrick			Deterministic Factors Overwhelm Stochastic Environmental Fluctuations as Drivers of Jellyfish Outbreaks	PLOS ONE			English	Article							GELATINOUS ZOOPLANKTON BIOMASS; PELAGIA-NOCTILUCA CNIDARIA; WESTERN MEDITERRANEAN-SEA; CTENOPHORE BLOOMS; CLIMATE-CHANGE; NORTH-SEA; ECOLOGY; TEMPERATURE; VARIABILITY; EXTREMES	Jellyfish outbreaks are increasingly viewed as a deterministic response to escalating levels of environmental degradation and climate extremes. However, a comprehensive understanding of the influence of deterministic drivers and stochastic environmental variations favouring population renewal processes has remained elusive. This study quantifies the deterministic and stochastic components of environmental change that lead to outbreaks of the jellyfish Pelagia noctiluca in the Mediterranen Sea. Using data of jellyfish abundance collected at 241 sites along the Catalan coast from 2007 to 2010 we: (1) tested hypotheses about the influence of time-varying and spatial predictors of jellyfish outbreaks; (2) evaluated the relative importance of stochastic vs. deterministic forcing of outbreaks through the environmental bootstrap method; and (3) quantified return times of extreme events. Outbreaks were common in May and June and less likely in other summer months, which resulted in a negative relationship between outbreaks and SST. Cross- and along-shore advection by geostrophic flow were important concentrating forces of jellyfish, but most outbreaks occurred in the proximity of two canyons in the northern part of the study area. This result supported the recent hypothesis that canyons can funnel P. noctiluca blooms towards shore during upwelling. This can be a general, yet unappreciated mechanism leading to outbreaks of holoplanktonic jellyfish species. The environmental bootstrap indicated that stochastic environmental fluctuations have negligible effects on return times of outbreaks. Our analysis emphasized the importance of deterministic processes leading to jellyfish outbreaks compared to the stochastic component of environmental variation. A better understanding of how environmental drivers affect demographic and population processes in jellyfish species will increase the ability to anticipate jellyfish outbreaks in the future.	[Benedetti-Cecchi, Lisandro; Tamburello, Laura] Univ Pisa, CoNISMa, Dept Biol, Pisa, Italy; [Canepa, Antonio; Fuentes, Veronica] CSIC, ICM, E-08003 Barcelona, Spain; [Purcell, Jennifer E.; Piraino, Stefano; Boero, Ferdinando] Univ Salento, CoNISMa, I-73100 Lecce, LE, Italy; [Purcell, Jennifer E.] Western Washington Univ, Shannon Point Marine Ctr, Anacortes, WA 98221 USA; [Roberts, Jason; Halpin, Patrick] Duke Univ, Nicholas Sch Environm, Marine Geospatial Ecol Lab, Durham, NC 27708 USA; [Boero, Ferdinando] CNR, ISMAR, Genoa, Italy	CoNISMa; University of Pisa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); CoNISMa; University of Salento; Western Washington University; Duke University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Benedetti-Cecchi, L (corresponding author), Univ Pisa, CoNISMa, Dept Biol, Via Derna 1, Pisa, Italy.	lisandro.benedetti.cecchi@unipi.it	Benedetti-Cecchi, Lisandro/J-8225-2019; Piraino, Stefano/J-5234-2012; Canepa, Antonio/R-5260-2018	Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Piraino, Stefano/0000-0002-8752-9390; Canepa, Antonio/0000-0002-0608-2743; TAMBURELLO, LAURA/0000-0003-1305-8802; Boero, Ferdinando/0000-0002-6317-2710	European Community [266445]; Chilean National Commission for Scientific and Technological Research (CONICYT) [72120016]	European Community(European Commission); Chilean National Commission for Scientific and Technological Research (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	The authors gratefully acknowledge financial support by the European Community Seventh Framework Programme (FP7/2007-2013) for the project VECTORS (grant agreement no. 266445) (URL:http://cordis.europa.eu/fp7/home_en.html). AC was supported by a doctoral fellowship from the Chilean National Commission for Scientific and Technological Research (CONICYT - PFCHA/Doctorado al Extranjero 4a Convocatoria, 72120016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attrill MJ, 2007, LIMNOL OCEANOGR, V52, P480, DOI 10.4319/lo.2007.52.1.0480; Augustine S, 2014, J SEA RES, V94, P52, DOI 10.1016/j.seares.2014.06.007; Berline L, 2013, MAR POLLUT BULL, V70, P90, DOI 10.1016/j.marpolbul.2013.02.016; Birol F, 2010, J MARINE SYST, V81, P297, DOI 10.1016/j.jmarsys.2010.01.005; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boero F, 1996, MAR ECOL-P S Z N I, V17, P237, DOI 10.1111/j.1439-0485.1996.tb00505.x; BOERO F, 1994, MAR ECOL-P S Z N I, V15, P3, DOI 10.1111/j.1439-0485.1994.tb00038.x; Boero Ferdinando, 2013, General Fisheries Commission for the Mediterranean Studies and Reviews, V92, P1; Cameletti M, 2013, ASTA-ADV STAT ANAL, V97, P109, DOI 10.1007/s10182-012-0196-3; Canepa Antonio, 2014, P237; Cartes JE, 2009, PROG OCEANOGR, V82, P32, DOI 10.1016/j.pocean.2009.03.003; Chown SL, 1999, BIOL REV, V74, P87, DOI 10.1017/S000632319800526X; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Daly Yahia MN, 2010, ICES COOP REP, V300, P14; Danovaro R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007006; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; De Donno A, 2014, INT J ENV RES PUB HE, V11, P2488, DOI 10.3390/ijerph110302488; Denny M, 2012, ANNU REV ECOL EVOL S, V43, P1, DOI 10.1146/annurev-ecolsys-102710-145103; Denny MW, 2009, ECOL MONOGR, V79, P397, DOI 10.1890/08-0579.1; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duarte CM, 2013, FRONT ECOL ENVIRON, V11, P91, DOI 10.1890/110246; Ferraris M, 2012, J PLANKTON RES; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; GAINES SD, 1993, ECOLOGY, V74, P1677, DOI 10.2307/1939926; GILI JM, 1988, J PLANKTON RES, V10, P385, DOI 10.1093/plankt/10.3.385; GOY J, 1989, DEEP-SEA RES, V36, P269, DOI 10.1016/0198-0149(89)90138-6; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; HAY SJ, 1990, NETH J SEA RES, V25, P113, DOI 10.1016/0077-7579(90)90013-7; Jordi A, 2005, PROG OCEANOGR, V66, P120, DOI 10.1016/j.pocean.2004.07.009; Katz RW, 2005, ECOLOGY, V86, P1124, DOI 10.1890/04-0606; Kreyling J, 2011, ECOL LETT, V14, P758, DOI 10.1111/j.1461-0248.2011.01637.x; Lebrato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082070; Licandro P, 2010, BIOL LETTERS, V6, P688, DOI 10.1098/rsbl.2010.0150; Lilley MKS, 2011, MAR BIOL, V158, P2429, DOI 10.1007/s00227-011-1744-1; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2065, DOI 10.1111/j.1365-2486.2007.01424.x; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Lucas Cathy H., 2014, P9; Lucas CH, 2014, GLOBAL ECOL BIOGEOGR, V23, P701, DOI 10.1111/geb.12169; Martino S, 2010, CONTRIB STAT, P99, DOI 10.1007/978-88-470-1386-5_8; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Nelson WA, 2013, SCIENCE, V341, P796, DOI 10.1126/science.1238477; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Purcell JE, 1999, COAST ESTUAR STUD, V55, P241; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 2012, HYDROBIOLOGIA, V690, P169, DOI 10.1007/s10750-012-1047-7; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; R Foundation for Statistical Computing, 2013, LANG ENV STAT COMP; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Rosa S, 2013, J MARINE SYST, V111, P97, DOI 10.1016/j.jmarsys.2012.10.001; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sabates A, 2010, HYDROBIOLOGIA, V645, P153, DOI 10.1007/s10750-010-0221-z; Thompson RM, 2013, ECOL LETT, V16, P799, DOI 10.1111/ele.12095; Volney WJA, 2007, GLOBAL CHANGE BIOL, V13, P1630, DOI 10.1111/j.1365-2486.2007.01402.x	57	24	24	6	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141060	10.1371/journal.pone.0141060	http://dx.doi.org/10.1371/journal.pone.0141060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485278	Green Submitted, gold, Green Published			2022-12-27	WOS:000363028100108
J	Busser, BW; Lin, YS; Yang, YQ; Zhu, J; Chen, GK; Michelson, AM				Busser, Brian W.; Lin, Yongshun; Yang, Yanqin; Zhu, Jun; Chen, Guokai; Michelson, Alan M.			An Orthologous Epigenetic Gene Expression Signature Derived from Differentiating Embryonic Stem Cells Identifies Regulators of Cardiogenesis	PLOS ONE			English	Article							TRANSGENIC RNAI; DROSOPHILA; MUTATIONS; CHROMATIN; NETWORKS; RESOURCE; TARGET; TINMAN; MODEL; WNT	Here we used predictive gene expression signatures within a multi-species framework to identify the genes that underlie cardiac cell fate decisions in differentiating embryonic stem cells. We show that the overlapping orthologous mouse and human genes are the most accurate candidate cardiogenic genes as these genes identified the most conserved developmental pathways that characterize the cardiac lineage. An RNAi-based screen of the candidate genes in Drosophila uncovered numerous novel cardiogenic genes. shRNA knockdown combined with transcriptome profiling of the newly-identified transcription factors zinc finger protein 503 and zinc finger E-box binding homeobox 2 and the well-known cardiac regulatory factor NK2 homeobox 5 revealed that zinc finger E-box binding homeobox 2 activates terminal differentiation genes required for cardiomyocyte structure and function whereas zinc finger protein 503 and NK2 homeobox 5 are required for specification of the cardiac lineage. We further demonstrated that an essential role of NK2 homeobox 5 and zinc finger protein 503 in specification of the cardiac lineage is the repression of gene expression programs characteristic of alternative cell fates. Collectively, these results show that orthologous gene expression signatures can be used to identify conserved cardiogenic pathways.	[Busser, Brian W.; Yang, Yanqin; Zhu, Jun; Michelson, Alan M.] NHLBI, Syst Biol Ctr, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Lin, Yongshun; Chen, Guokai] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Busser, BW (corresponding author), NHLBI, Syst Biol Ctr, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	brian.busser@cellectis.com; michelsonam@nhlbi.nih.gov			National Heart Lung and Blood Institute Division of Intramural Research	National Heart Lung and Blood Institute Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart Lung and Blood Institute Division of Intramural Research [to AMM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2010, HEART RHYTHM, V7, P117, DOI 10.1016/j.hrthm.2009.08.005; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Benarroch EE, 2013, NEUROLOGY, V80, P304, DOI 10.1212/WNL.0b013e31827dec42; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Bodmer R, 2010, DEV AGING DROSOPHILA; Brade T, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a013847; Bruneau BG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008292; Busser BW, 2015, NUCLEIC ACIDS RES, V43, P1726, DOI 10.1093/nar/gkv011; Busser BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069385; Busser BW, 2012, P NATL ACAD SCI USA, V109, P20768, DOI 10.1073/pnas.1210415109; Busser BW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002531; Busser BW, 2012, DEVELOPMENT, V139, P1164, DOI 10.1242/dev.077362; Busser BW, 2008, CURR OPIN GENET DEV, V18, P521, DOI 10.1016/j.gde.2008.09.003; Caprioli A, 2011, CIRCULATION, V123, P1633, DOI 10.1161/CIRCULATIONAHA.110.008185; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Davidson EH, 2006, REG GEN GEN REG; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Kasahara H, 2000, J CLIN INVEST, V106, P299, DOI 10.1172/JCI9860; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mowat DR, 2003, J MED GENET, V40, P305, DOI 10.1136/jmg.40.5.305; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Raid R, 2009, MECH DEVELOP, V126, P80, DOI 10.1016/j.mod.2008.10.001; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wolf MJ, 2011, CIRC RES, V109, P794, DOI 10.1161/CIRCRESAHA.111.244897; Yin ZZ, 1997, DEVELOPMENT, V124, P4971; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	46	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141066	10.1371/journal.pone.0141066	http://dx.doi.org/10.1371/journal.pone.0141066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485529	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100110
J	Chacon, R; Clara, AW; Jara, J; Armero, J; Lozano, C; El Omeiri, N; Widdowson, MA; Azziz-Baumgartner, E				Chacon, Rafael; Wilfrido Clara, Alexey; Jara, Jorge; Armero, Julio; Lozano, Celina; El Omeiri, Nathalie; Widdowson, Marc-Alain; Azziz-Baumgartner, Eduardo			Influenza Illness among Case-Patients Hospitalized for Suspected Dengue, El Salvador, 2012	PLOS ONE			English	Article								We estimate the proportion of patients hospitalized for suspected dengue that tested positive for influenza virus in El Salvador during the 2012 influenza season. We tested specimens from 321 hospitalized patients: 198 patients with SARI and 123 patients with suspected dengue. Among 121 hospitalized suspected dengue (two co-infected excluded) patients, 28% tested positive for dengue and 19% positive for influenza; among 35 with suspected dengue and respiratory symptoms, 14% were positive for dengue and 39% positive for influenza. One percent presented co-infection between influenza and dengue. Clinicians should consider the diagnosis of influenza among patients with suspected dengue during the influenza season.	[Chacon, Rafael; Jara, Jorge] Univ Valley Guatemala, Influenza Unit, Guatemala City, Guatemala; [Wilfrido Clara, Alexey] Centers Dis Control & Prevent Cent Amer Reg, Influenza Program, Guatemala City, Guatemala; [Armero, Julio] Minist Hlth El Salvador, Hlth Surveillance Directorate, San Salvador, El Salvador; [Lozano, Celina] Minist Hlth El Salvador, Natl Influenza Ctr, San Salvador, El Salvador; [El Omeiri, Nathalie] Training Programs Epidemiol & Publ Hlth Intervent, Influenza Unit, Guatemala City, Guatemala; [Widdowson, Marc-Alain; Azziz-Baumgartner, Eduardo] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Universidad del Valle de Guatemala; Centers for Disease Control & Prevention - USA	Chacon, R (corresponding author), Univ Valley Guatemala, Influenza Unit, Guatemala City, Guatemala.	rchaconf@gmail.com		Chacon-Fuentes, Rafael/0000-0002-0238-3899	U.S. Centers for Disease Control and Prevention [1U01GH000028-03]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the Cooperative Agreement No. 1U01GH000028-03 from the U.S. Centers for Disease Control and Prevention. None of the coauthors have any conflicts of interest to declare. The findings and conclusions in this report are those of the authors and do not necessarily reflect the official position of the Centers for Disease Control and Prevention or the institutions with which the authors are affiliated.	American Academy of Audiology, 2011, CLIN PRACTICE GUIDEL, P1; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Center for Disease Control and Prevention, 2010, UPD INT REC US ANT M; Durand LO, 2014, REVELAC 1 C CA UNPUB; Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400; Huang SY, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0623-z; Leelarasamee Amorn, 2004, Journal of the Medical Association of Thailand, V87, P464; Lorenzi OD, 2013, AM J TROP MED HYG, V88, P472, DOI 10.4269/ajtmh.12-0373; Ministry of Healt El Salvador, 2010, UPD GUID TREATM DENG; Ministry of Healt El Salvador, 2009, OFF LIST DRUGS; PAHO, 2011, OP GUID NAT INT SURV; Rodriguez L, 2010, EMERG INFECT DIS, P16; Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13; WHO, 2009, WHO TECH REP SER, V958, P1; WHO Global Influenza Programme Surveillance and Epidemiology team, 2012, WHO INT GLOB EP SURV; World Health Organization (WHO), 2016, INT HLTH REG 2005; Zambrano LI, 2012, TROP BIOMED, V29, P499	18	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140890	10.1371/journal.pone.0140890	http://dx.doi.org/10.1371/journal.pone.0140890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485296	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100086
J	Kusuma, GD; Menicanin, D; Gronthos, S; Manuelpillai, U; Abumaree, MH; Pertile, MD; Brennecke, SP; Kalionis, B				Kusuma, Gina D.; Menicanin, Danijela; Gronthos, Stan; Manuelpillai, Ursula; Abumaree, Mohamed H.; Pertile, Mark D.; Brennecke, Shaun P.; Kalionis, Bill			Ectopic Bone Formation by Mesenchymal Stem Cells Derived from Human Term Placenta and the Decidua	PLOS ONE			English	Article							IN-VIVO; STROMAL CELLS; CHORIONIC VILLI; VASCULAR NICHE; DENTAL-PULP; MARROW; IDENTIFICATION; REGENERATION; EXHIBIT; RESIDE	Mesenchymal stem cells (MSCs) are one of the most attractive cell types for cell-based bone tissue repair applications. Fetal-derived MSCs and maternal-derived MSCs have been isolated from chorionic villi of human term placenta and the decidua basalis attached to the placenta following delivery, respectively. Chorionic-derived MSCs (CMSCs) and decidua-derived MSCs (DMSCs) generated in this study met the MSCs criteria set by International Society of Cellular Therapy. These criteria include: (i) adherence to plastic; (ii) >90% expression of CD73, CD105, CD90, CD146, CD44 and CD166 combined with <5% expression of CD45, CD19 and HLA-DR; and (iii) ability to differentiate into osteogenic, adipogenic, and chondrogenic lineages. In vivo subcutaneous implantation into SCID mice showed that both bromo-deoxyuridine (BrdU)-labelled CMSCs and DMSCs when implanted together with hydroxyapatite/tricalcium phosphate particles were capable of forming ectopic bone at 8-weeks post-transplantation. Histological assessment showed expression of bone markers, osteopontin (OPN), osteocalcin (OCN), biglycan (BGN), bone sialoprotein (BSP), and also a marker of vasculature, alpha-smooth muscle actin (a-SMA). This study provides evidence to support CMSCs and DMSCs as cellular candidates with potent bone forming capacity.	[Kusuma, Gina D.; Brennecke, Shaun P.; Kalionis, Bill] Univ Melbourne, Dept Obstet & Gynaecol, Royal Womens Hosp, Parkville, Vic 3052, Australia; [Kusuma, Gina D.; Manuelpillai, Ursula; Brennecke, Shaun P.; Kalionis, Bill] Royal Womens Hosp, Pregnancy Res Ctr, Dept Perinatal Med, Parkville, Vic, Australia; [Menicanin, Danijela; Gronthos, Stan] Univ Adelaide, Mesenchymal Stem Cell Lab, Sch Med Sci, Fac Hlth Sci, Adelaide, SA, Australia; [Menicanin, Danijela] Univ Adelaide, Sch Dent, Colgate Australian Clin Dent Res Ctr, Adelaide, SA, Australia; [Manuelpillai, Ursula] Prince Henrys Inst Med Res, Ctr Genet Dis, Monash Inst Med Res, Clayton, Vic, Australia; [Manuelpillai, Ursula] Monash Univ, Clayton, Vic, Australia; [Abumaree, Mohamed H.] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Coll Sci & Hlth Profess, King Abdulaziz Med City Natl Guard Hlth Affairs, Riyadh, Saudi Arabia; [Pertile, Mark D.] Royal Childrens Hosp, VCGS, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Pertile, Mark D.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia	University of Melbourne; University of Adelaide; University of Adelaide; Monash University; Prince Henry's Institute of Medical Research; Monash University; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Kalionis, B (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Royal Womens Hosp, Parkville, Vic 3052, Australia.	bill.kalionis@thewomens.org.au	Gronthos, Stan/Y-4419-2019; Kusuma, Gina/AAF-3381-2019; KALIONIS, BILL/B-4766-2011; Brennecke, Shaun/AFV-3919-2022; Pertile, Mark/K-9510-2019	Gronthos, Stan/0000-0002-6225-3084; Kusuma, Gina/0000-0001-7042-3795; Brennecke, Shaun/0000-0003-3070-6971; Pertile, Mark/0000-0001-8363-2879	King Abdullah International Medical Research Centre [RC08/114]; Royal Women's Hospital Foundation; Australian Postgraduate Award; Australian Stem Cell Centre Postgraduate Scholarship	King Abdullah International Medical Research Centre; Royal Women's Hospital Foundation; Australian Postgraduate Award(Australian Government); Australian Stem Cell Centre Postgraduate Scholarship	BK and SPB were supported by grants from King Abdullah International Medical Research Centre (Grant No. RC08/114) and the Royal Women's Hospital Foundation. GK was supported by Australian Postgraduate Award and an Australian Stem Cell Centre Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree MH, 2013, STEM CELL REV REP, V9, P16, DOI 10.1007/s12015-012-9385-4; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Brooke G, 2009, BRIT J HAEMATOL, V144, P571, DOI 10.1111/j.1365-2141.2008.07492.x; Castrechini NM, 2012, REPROD SCI, V19, P1302, DOI 10.1177/1933719112450334; Castrechini NM, 2010, PLACENTA, V31, P203, DOI 10.1016/j.placenta.2009.12.006; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hayati AR, 2011, ARCH MED RES, V42, P291, DOI 10.1016/j.arcmed.2011.06.005; Heazlewood CF, 2014, STEM CELL TRANSL MED, V3, P1305, DOI 10.5966/sctm.2014-0051; Huang YC, 2009, STEM CELL REV REP, V5, P247, DOI 10.1007/s12015-009-9069-x; Hynes K, 2014, STEM CELLS DEV, V23, P1084, DOI 10.1089/scd.2013.0111; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Jin J, 2014, J BIOSCIENCE BIOENGI; Kameyama H, 2014, HISTOL HISTOPATHOL, V29, P659, DOI 10.14670/HH-29.10.659; Kinzer M, 2014, PLACENTA, V35, P517, DOI 10.1016/j.placenta.2014.04.004; Kusuma G.D., 2015, PLACENTA; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Li X, 2011, STEM CELLS, V29, P263, DOI 10.1002/stem.572; Maeshima A, 2003, J AM SOC NEPHROL, V14, P3138, DOI 10.1097/01.ASN.0000098685.43700.28; Menicanin D, 2014, STEM CELLS DEV, V23, P1001, DOI 10.1089/scd.2013.0490; OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Parolini O, 2010, STEM CELLS DEV, V19, P143, DOI 10.1089/scd.2009.0404; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pochampally Radhika, 2008, V449, P83, DOI 10.1007/978-1-60327-169-1_6; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Soncini M, 2007, J TISSUE ENG REGEN M, V1, P296, DOI 10.1002/term.40; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zhang XH, 2006, BIOCHEM BIOPH RES CO, V351, P853, DOI 10.1016/j.bbrc.2006.10.125	33	25	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141246	10.1371/journal.pone.0141246	http://dx.doi.org/10.1371/journal.pone.0141246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484666	Green Published, gold			2022-12-27	WOS:000363028100125
J	Luedike, P; Rammos, C; Pohl, J; Heisler, M; Totzeck, M; Kleophas, W; Hetzel, GR; Kelm, M; Hendgen-Cotta, U; Rassaf, T				Luedike, Peter; Rammos, Christos; Pohl, Julia; Heisler, Martin; Totzeck, Matthias; Kleophas, Werner; Hetzel, Gerd R.; Kelm, Malte; Hendgen-Cotta, Ulrike; Rassaf, Tienush			Filtration of Macrophage Migration Inhibitory Factor (MIF) in Patients with End Stage Renal Disease Undergoing Hemodialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR OUTCOMES; OXIDATIVE STRESS; DYSFUNCTION; EXPRESSION; CHEMOKINE; INFLAMMATION; ACTIVATION; PLATELETS; SECRETION	Background End stage renal disease (ESRD) patients are characterized by increased morbidity and mortality due to highest prevalence of cardiovascular disease. Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine that controls cellular signaling in human physiology, pathophysiology, and diseases. Increased MIF plasma levels promote vascular inflammation and development of atherosclerosis. We have shown that MIF is associated with vascular dysfunction in ESRD patients. Whether hemodialysis (HD) affects circulating MIF plasma levels is unknown. We here aimed to investigate whether HD influences the circulating MIF pool in ESRD patients. Methods and Results An observational single-center study was conducted. MIF plasma levels in ESRD patients were assessed before, during, and after a HD session (n = 29). Healthy age-matched volunteers served as controls to compare correlations of MIF plasma levels with inflammatory plasma components (n = 20). MIF removed from the circulating blood pool could be detected in the dialysate and allowed for calculation of totally removed MIF (MIF content in dialysate 219 +/- 4 mu g/HD-session). MIF plasma levels were markedly decreased 2 hour after initiation of HD (MIF plasma level pre-HD 84.8 +/- 6 ng/ml to intra-HD 61.2 +/- 5 ng/ml p<0.001) and were replenished already 20 min after termination of HD to basal levels (intra-HD 61.2 +/- 5 ng/ml to post-HD 79.8 +/- 5 ng/ml, p<0.001). Conclusion MIF is a dialyzable plasma component that is effectively filtrated during HD from the patient blood pool in large amounts. After removal of remarkable amounts of MIF during a single HD session, MIF plasma pool is early reconstituted after termination of HD from unknown sources.	[Luedike, Peter; Rammos, Christos; Pohl, Julia; Heisler, Martin; Totzeck, Matthias; Kelm, Malte; Hendgen-Cotta, Ulrike; Rassaf, Tienush] Univ Hosp Dusseldorf, Fac Med, Div Cardiol Pulmonol & Vasc Med, D-40225 Dusseldorf, Germany; [Kleophas, Werner; Hetzel, Gerd R.] DaVita Renal Ctr, D-40210 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Rassaf, T (corresponding author), Univ Hosp Essen, Dept Cardiol, West German Heart & Vasc Ctr Essen, Hufelandstr 55, D-45122 Essen, Germany.	Tienush.Rassaf@uk-essen.de		Kelm, Malte/0000-0003-0060-1052	Research Committee of the medical faculty of the University of Duesseldorf [23/2013, 86/2012]; DFG [Ra969/7-2]	Research Committee of the medical faculty of the University of Duesseldorf; DFG(German Research Foundation (DFG))	PL and MT were funded by the Research Committee of the medical faculty of the University of Duesseldorf (23/2013 to PL, 86/2012 to MT). TR is a Heisenberg professor funded by the DFG (Ra969/7-2).	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Chatterjee M, 2014, CIRC RES, V115, P939, DOI 10.1161/CIRCRESAHA.115.305171; Fassbinder W, 2003, KIDNEY BLOOD PRESS R, V26, P96, DOI 10.1159/000070990; Filiopoulos V, 2009, INT J ARTIF ORGANS, V32, P872, DOI 10.1177/039139880903201206; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gremmel T, 2013, NEPHROL DIAL TRANSPL, V28, P2116, DOI 10.1093/ndt/gft103; Luedike P, 2012, CIRCULATION, V125, P1880, DOI 10.1161/CIRCULATIONAHA.111.069104; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Meyer C, 2010, J AM COLL CARDIOL, V55, P454, DOI 10.1016/j.jacc.2009.07.068; Miyazaki H, 2000, CIRCULATION, V101, P1002, DOI 10.1161/01.CIR.101.9.1002; Petrovsky N, 2003, IMMUNOL CELL BIOL, V81, P137, DOI 10.1046/j.0818-9641.2002.01148.x; Rammos C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/582586; Rammos C, 2014, MECH AGEING DEV, V135, P15, DOI 10.1016/j.mad.2014.01.001; Rammos C, 2013, INT J CARDIOL, V168, P5249, DOI 10.1016/j.ijcard.2013.08.021; Rassaf T, 2014, CARDIOVASC RES, V102, P321, DOI 10.1093/cvr/cvu071; Rex S, 2014, MINI-REV MED CHEM, V14, P1116; Schober A, 2004, CIRCULATION, V109, P380, DOI 10.1161/01.CIR.0000109201.72441.09; Schober A, 2008, J MOL MED, V86, P761, DOI 10.1007/s00109-008-0334-2; Simons D, 2011, J CELL MOL MED, V15, P668, DOI 10.1111/j.1582-4934.2010.01041.x; Sobierajski J, 2013, FREE RADICAL BIO MED, V63, P236, DOI 10.1016/j.freeradbiomed.2013.05.018; Stenvinkel P, 2006, NEPHROLOGY, V11, P36, DOI 10.1111/j.1440-1797.2006.00541.x; Stoppe C, 2013, ANTIOXID REDOX SIGN, V19, P231, DOI 10.1089/ars.2012.5015; Stoppe C, 2012, MOL MED, V18, P843, DOI 10.2119/molmed.2012.00071; Stoppe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033512; Strussmann T, 2013, THROMB HAEMOSTASIS, V110, P1004, DOI 10.1160/TH13-01-0049; Tillmann S, 2012, CYTOKINE, V59, P499, DOI 10.1016/j.cyto.2012.06.032; Wirtz TH, 2015, ATHEROSCLEROSIS, V239, P1, DOI 10.1016/j.atherosclerosis.2014.12.039; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140215	10.1371/journal.pone.0140215	http://dx.doi.org/10.1371/journal.pone.0140215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485680	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100023
J	Oddone, F; Rossetti, L; Tanga, L; Berardo, F; Ferrazza, M; Michelessi, M; Roberti, G; Manni, G; Centofanti, M				Oddone, Francesco; Rossetti, Luca; Tanga, Lucia; Berardo, Francesca; Ferrazza, Manuela; Michelessi, Manuele; Roberti, Gloria; Manni, Gianluca; Centofanti, Marco			Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial	PLOS ONE			English	Article							24-HOUR INTRAOCULAR-PRESSURE; OPEN-ANGLE GLAUCOMA; RISK-FACTORS; METAANALYSIS; LATANOPROST; PROGRESSION; MALEATE; DRUGS	Purpose To compare the 24-hour (24h) effects on intraocular pressure (IOP) and cardiovascular parameters of timolol 0.5% and bimatoprost 0.01% in open angle glaucoma and ocular hypertensive subjects. Methods In this prospective, randomized, double masked, crossover, clinical trial, after washout from previous medications enrolled subjects underwent 24h IOP, blood pressure (BP) and heart rate (HR) measurements and were randomized to either topical bimatoprost 0.01% at night plus placebo in the morning or to timolol 0.5% bid. After 8 weeks of treatment a second 24h assessment of IOP, BP and HR was performed and then subjects switched to the opposite treatment for additional 8 weeks when a third 24h assessment was performed. The primary endpoint was the comparison of the mean 24h IOP after each treatment. Secondary endpoints included the comparisons of IOP at each timepoint of the 24h curve and the comparison of BP, HR, ocular perfusion pressure and tolerability. Results Mean untreated 24h IOP was 20.3 mmHg (95% CI 19.0 to 21.6). Mean 24h IOP was significantly lower after 8 weeks of treatment with bimatoprost 0.01% than after 8 weeks of treatment with timolol 0.5% bid (15.7 vs 16.8 mmHg, p = 0.0003). Mean IOP during the day hours was significantly reduced from baseline by both drugs while mean IOP during the night hours was reduced by -2.3 mmHg (p = 0.0002) by bimatoprost 0.01% plus placebo and by -1.1 mmHg by timolol 0.5% bid (p = 0.06). Timolol 0.5% significantly reduced the mean 24h systolic BP from baseline, the diastolic BP during the day hours, the HR during the night hours, and the mean 24h systolic ocular perfusion pressure. Conclusion Both Bimatoprost 0.01% and Timolol 0.5% are effective in reducing the mean 24h IOP from an untreated baseline but Bimatoprost 0.01% is more effective than timolol 0.5% throughout the 24h. Timolol 0.5% effect on IOP is reduced during the night hours and is associated with reduced BP, HR and ocular perfusion pressure.	[Oddone, Francesco; Tanga, Lucia; Berardo, Francesca; Ferrazza, Manuela; Michelessi, Manuele; Roberti, Gloria; Centofanti, Marco] IRCCS Fdn GB Bietti, Clin & Res Inst Ophthalmol, I-00198 Rome, Italy; [Rossetti, Luca] Univ Milan, San Paolo Hosp, Clin Oculist, Dipartimento Sci Salute, I-820142 Milan, Italy; [Manni, Gianluca; Centofanti, Marco] Univ Roma Tor Vergata, Clin Sci & Translat Med Dept, I-00133 Rome, Italy	IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University of Milan; University of Rome Tor Vergata	Oddone, F (corresponding author), IRCCS Fdn GB Bietti, Clin & Res Inst Ophthalmol, Via Livenza 3, I-00198 Rome, Italy.	oddonef@gmail.com	Oddone, Francesco/K-8876-2016	Oddone, Francesco/0000-0002-2504-0004; manni, gianluca/0000-0002-9006-8556; Rossetti, Luca/0000-0002-7027-3173	Italian Ministry of Health; Fondazione Roma; Allergan	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission); Allergan(AbbVieAllergan)	The research for this paper was financially supported by the Italian Ministry of Health and by Fondazione Roma. This study was also supported by a unrestricted grant provided by Allergan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TERM GUID GLAUC; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Chauhan BC, 2008, ARCH OPHTHALMOL-CHIC, V126, P1030, DOI 10.1001/archopht.126.8.1030; Graham SL, 1999, SURV OPHTHALMOL, V43, pS10, DOI 10.1016/S0039-6257(99)00016-8; Gulati V, 2012, ARCH OPHTHALMOL-CHIC, V130, P677, DOI 10.1001/archophthalmol.2011.2573; Hayreh SS, 1999, AM J OPHTHALMOL, V128, P301, DOI 10.1016/S0002-9394(99)00160-9; Katz LJ, 2010, AM J OPHTHALMOL, V149, P661, DOI 10.1016/j.ajo.2009.12.003; Konstas AGP, 1999, AM J OPHTHALMOL, V128, P15, DOI 10.1016/S0002-9394(99)00073-2; Lee PWY, 2010, EUR J OPHTHALMOL, V20, P1035, DOI 10.1177/112067211002000602; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Liu JHK, 2004, AM J OPHTHALMOL, V138, P389, DOI 10.1016/j.ajo.2004.04.022; Liu JHK, 1999, INVEST OPHTH VIS SCI, V40, P2912; Maier PC, 2005, BMJ-BRIT MED J, V331, P134, DOI 10.1136/bmj.38506.594977.E0; Netland PA, 1997, AM J OPHTHALMOL, V123, P465, DOI 10.1016/S0002-9394(14)70172-2; NICE, 2009, PUBL CLIN GUID CG85; Orzalesi N, 2000, INVEST OPHTH VIS SCI, V41, P2566; Quaranta L, 2006, INVEST OPHTH VIS SCI, V47, P2917, DOI 10.1167/iovs.05-1253; Stewart WC, 2008, OPHTHALMOLOGY, V115, P1117, DOI 10.1016/j.ophtha.2007.10.004; Tung JD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001106; van der Valk R, 2005, OPHTHALMOLOGY, V112, P1177, DOI 10.1016/j.ophtha.2005.01.042; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Walters TR, 2004, SURV OPHTHALMOL, V49, pS26, DOI 10.1016/j.survophthal.2003.12.017	23	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140601	10.1371/journal.pone.0140601	http://dx.doi.org/10.1371/journal.pone.0140601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484767	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100049
J	Wang, YM; Wan, M; Zhou, QX; Wang, H; Wang, ZD; Zhong, XY; Zhang, L; Tai, S; Cui, YF				Wang, Yimin; Wan, Ming; Zhou, Qingxin; Wang, Hao; Wang, Zhidong; Zhong, Xiangyu; Zhang, Lei; Tai, Sheng; Cui, Yunfu			The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; NF-KAPPA-B; INTRAHEPATIC CHOLANGIOCARCINOMA; EXTRAHEPATIC MALIGNANCIES; BREAST-CANCER; CELL LYMPHOMA; EXPRESSION; STAT3; INFLAMMATION; CARCINOMA	As an antagonist of the JAK/STAT pathway, suppressor of cytokine signaling 3 (SOCS3) plays an integral role in shaping the inflammatory environment, tumorigenesis and disease progression in cholangiocarcinoma (CCA); however, its prognostic significance remains unclear. Although tumor necrosis factor alpha-induced protein 3 (TNFAIP3, also known as A20) can decrease SOCS3 expression and is involved in the regulation of tumorigenesis in certain malignancies, its role in CCA remains unknown. In this study, we investigated the expression of SOCS3 and A20 in human CCA tissues to assess the prognostic significance of these proteins. The expression of SOCS3 and A20 was initially detected by western blot in 22 cases of freshly frozen CCA tumors with corresponding peritumoral tissues and 22 control normal bile duct tissues. Then, these proteins were investigated in 86 CCA patients by immunohistochemistry (IHC) and were evaluated for their association with clinicopathological parameters in human CCA. The results indicated that SOCS3 expression was significantly lower in CCA tumor tissues than in corresponding peritumoral biliary tissues and normal bile duct tissues. Conversely, A20 was overexpressed in CCA tissues. Thus, an inverse correlation between the expression of SOCS3 and A20 was discovered. Furthermore, patients with low SOCS3 expression or high A20 expression showed a dramatically lower overall survival rate. These proteins were both associated with CCA lymph node metastasis, postoperative recurrence and overall survival rate. However, only A20 showed a significant association with the tumor node metastasis (TNM) stage, while SOCS3 showed a significant association with tumor differentiation. Multivariate Cox analysis revealed that SOCS3 and A20 were independent prognostic indicators for overall survival in CCA. Thus, our study demonstrated that SOCS3 and A20 represent novel prognostic factors for human CCA.	[Wang, Yimin; Wan, Ming; Zhou, Qingxin; Wang, Hao; Wang, Zhidong; Zhong, Xiangyu; Zhang, Lei; Tai, Sheng; Cui, Yunfu] Harbin Med Univ, Dept Hepatopancreatobiliary Surg, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Wang, Yimin] Minist Educ, Key Lab Myocardial Ischemia Mech & Treatment, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Cui, YF (corresponding author), Harbin Med Univ, Dept Hepatopancreatobiliary Surg, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China.	yfcui777@hotmail.com		cui, yunfu/0000-0001-7393-1680	National Natural Science Foundation of China [81170426]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (no. 81170426), URL: http://www.nsfc.gov.cn/.YC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Bergquist A, 2002, J HEPATOL, V36, P321, DOI 10.1016/S0168-8278(01)00288-4; Bergquist A, 2001, BEST PRACT RES CL GA, V15, P643, DOI 10.1053/bega.2001.0210; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Broome U, 1996, GUT, V38, P610, DOI 10.1136/gut.38.4.610; Chapman MH, 2012, EUR J GASTROEN HEPAT, V24, P1051, DOI 10.1097/MEG.0b013e3283554bbf; Sandoval-Usme MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087769; Codd JD, 1999, J PATHOL, V187, P549; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Culig Zoran, 2013, Front Biosci (Schol Ed), V5, P277; da Silva CG, 2013, HEPATOLOGY, V57, P2014, DOI 10.1002/hep.26197; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Dong BF, 2012, BIOCHEM BIOPH RES CO, V418, P433, DOI 10.1016/j.bbrc.2012.01.056; El Khatib M, 2013, HEPATOLOGY, V57, P1035, DOI 10.1002/hep.26147; Feng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091829; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guo QD, 2009, EXPERT OPIN THER TAR, V13, P733, DOI 10.1517/14728220903045018; Hao XP, 2000, CANCER RES, V60, P18; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Hjelmeland AB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000319; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Isomoto H, 2007, GASTROENTEROLOGY, V132, P384, DOI 10.1053/j.gastro.2006.10.037; Jiang GX, 2010, MOL BIOL REP, V37, P3813, DOI 10.1007/s11033-010-0036-z; Kang PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090308; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Kim KH, 2015, J CLIN INVEST, V125, P1886, DOI 10.1172/JCI79327; Kim MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123133; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Liu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058883; Malhi H, 2006, J HEPATOL, V45, P856, DOI 10.1016/j.jhep.2006.09.001; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Palmer WC, 2012, J HEPATOL, V57, P69, DOI 10.1016/j.jhep.2012.02.022; Park EJ, 2003, J BIOL CHEM, V278, P14747, DOI 10.1074/jbc.M210819200; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Rossa C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045197; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Tocchi A, 2001, ANN SURG, V234, P210, DOI 10.1097/00000658-200108000-00011; Vendrell JA, 2007, ONCOGENE, V26, P4656, DOI 10.1038/sj.onc.1210269; Verbrugge I, 2012, CANCER DISCOV, V2, P112, DOI 10.1158/2159-8290.CD-11-0350; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zheng TS, 2014, HEPATOLOGY, V59, P935, DOI 10.1002/hep.26705; Zhou QX, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0553-7	50	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141165	10.1371/journal.pone.0141165	http://dx.doi.org/10.1371/journal.pone.0141165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485275	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100119
J	Won, JH; Moon, IJ; Jin, S; Park, H; Woo, J; Cho, YS; Chung, WH; Hong, SH				Won, Jong Ho; Moon, Il Joon; Jin, Sunhwa; Park, Heesung; Woo, Jihwan; Cho, Yang-Sun; Chung, Won-Ho; Hong, Sung Hwa			Spectrotemporal Modulation Detection and Speech Perception by Cochlear Implant Users	PLOS ONE			English	Article							SPECTRAL-RIPPLE DISCRIMINATION; NORMAL-HEARING; RECOGNITION; RESOLUTION; FREQUENCY; IDENTIFICATION; SENSITIVITY; PATTERNS; VOWEL; NOISE	Spectrotemporal modulation (STM) detection performance was examined for cochlear implant (CI) users. The test involved discriminating between an unmodulated steady noise and a modulated stimulus. The modulated stimulus presents frequency modulation patterns that change in frequency over time. In order to examine STM detection performance for different modulation conditions, two different temporal modulation rates (5 and 10 Hz) and three different spectral modulation densities (0.5, 1.0, and 2.0 cycles/octave) were employed, producing a total 6 different STM stimulus conditions. In order to explore how electric hearing constrains STM sensitivity for CI users differently from acoustic hearing, normal-hearing (NH) and hearing-impaired (HI) listeners were also tested on the same tasks. STM detection performance was best in NH subjects, followed by HI subjects. On average, CI subjects showed poorest performance, but some CI subjects showed high levels of STM detection performance that was comparable to acoustic hearing. Significant correlations were found between STM detection performance and speech identification performance in quiet and in noise. In order to understand the relative contribution of spectral and temporal modulation cues to speech perception abilities for CI users, spectral and temporal modulation detection was performed separately and related to STM detection and speech perception performance. The results suggest that that slow spectral modulation rather than slow temporal modulation may be important for determining speech perception capabilities for CI users. Lastly, test-retest reliability for STM detection was good with no learning. The present study demonstrates that STM detection may be a useful tool to evaluate the ability of CI sound processing strategies to deliver clinically pertinent acoustic modulation information.	[Won, Jong Ho] US FDA, Div Ophthalm & Ear Nose & Throat Devices, Off Device Evaluat, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Moon, Il Joon; Jin, Sunhwa; Park, Heesung; Cho, Yang-Sun; Chung, Won-Ho; Hong, Sung Hwa] Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul 135710, South Korea; [Woo, Jihwan] Univ Ulsan, Sch Elect Engn, Biomed Engn, Ulsan 680749, South Korea	US Food & Drug Administration (FDA); Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan	Moon, IJ (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul 135710, South Korea.	moonij@skku.edu	Cho, Yang Sun/F-4611-2014		IN-SUNG Foundation for Medical Research [CB14011]; Samsung Medical Center; University of Tennessee Health Science Center; Korean Health Technology R&D Project, Ministry of Health Welfare [HI12C1460]	IN-SUNG Foundation for Medical Research; Samsung Medical Center(Samsung); University of Tennessee Health Science Center; Korean Health Technology R&D Project, Ministry of Health Welfare	This research was supported by the Samsung Medical Center, IN-SUNG Foundation for Medical Research (CB14011), the University of Tennessee Health Science Center, and the grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare (HI12C1460).	Anderson ES, 2012, J ACOUST SOC AM, V132, P3925, DOI 10.1121/1.4763999; Anderson ES, 2011, J ACOUST SOC AM, V130, P364, DOI 10.1121/1.3589255; BACON SP, 1985, AUDIOLOGY, V24, P117; Baskent D, 2006, J ACOUST SOC AM, V120, P2908, DOI 10.1121/1.2354017; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein JGW, 2013, J AM ACAD AUDIOL, V24, P293, DOI 10.3766/jaaa.24.4.5; CAZALS Y, 1994, J ACOUST SOC AM, V96, P2048, DOI 10.1121/1.410146; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; Drennan WR, 2010, HEARING RES, V262, P1, DOI 10.1016/j.heares.2010.02.003; Eddins DA, 2007, J ACOUST SOC AM, V121, P363, DOI 10.1121/1.2382347; Elhilali M, 2003, SPEECH COMMUN, V41, P331, DOI 10.1016/S0167-6393(02)00134-6; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2002, NEUROREPORT, V13, P1635, DOI 10.1097/00001756-200209160-00013; Fullgrabe C, 2003, HEARING RES, V178, P35, DOI 10.1016/S0378-5955(03)00027-3; Garadat SN, 2012, J ACOUST SOC AM, V131, P4030, DOI 10.1121/1.3701879; Gnansia D, 2014, INT J AUDIOL, V53, P48, DOI 10.3109/14992027.2013.844367; Henry BA, 2005, J ACOUST SOC AM, V118, P1111, DOI 10.1121/1.1944567; Henry BA, 2003, J ACOUST SOC AM, V113, P2861, DOI 10.1121/1.1561900; Hughes ML, 2010, EAR HEARING, V31, P679, DOI 10.1097/AUD.0b013e3181e1d19e; Imennov NS, 2013, HEARING RES, V298, P60, DOI 10.1016/j.heares.2013.01.004; Jeon EK, 2015, 2015 C IMPL AUD PROS, P224; Jones GL, 2013, J ACOUST SOC AM, V133, P425, DOI 10.1121/1.4768881; Kong YY, 2009, J ACOUST SOC AM, V125, P1649, DOI 10.1121/1.3068457; 장정훈, 2012, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V55, P85; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Litvak LM, 2007, J ACOUST SOC AM, V122, P982, DOI 10.1121/1.2749413; Lorenzi C, 2012, JARO-J ASSOC RES OTO, V13, P853, DOI 10.1007/s10162-012-0350-3; Mehraei G, 2014, J ACOUST SOC AM, V136, P301, DOI 10.1121/1.4881918; Middlebrooks JC, 2008, J NEUROPHYSIOL, V100, P92, DOI 10.1152/jn.01114.2007; Moon SK, 2008, INT J AUDIOL, V47, P375, DOI 10.1080/14992020701882457; Moore BCJ, 2001, J ACOUST SOC AM, V110, P1067, DOI 10.1121/1.1385177; Pfingst BE, 2011, HEARING RES, V281, P65, DOI 10.1016/j.heares.2011.05.002; Saoji AA, 2009, J ACOUST SOC AM, V126, P955, DOI 10.1121/1.3179670; SHANNON RV, 1992, J ACOUST SOC AM, V91, P2156, DOI 10.1121/1.403807; SUPIN AY, 1994, HEARING RES, V78, P31, DOI 10.1016/0378-5955(94)90041-8; TOWNSHEND B, 1987, J ACOUST SOC AM, V82, P106, DOI 10.1121/1.395554; VIEMEISTER NF, 1979, J ACOUST SOC AM, V66, P1364, DOI 10.1121/1.383531; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Won JH, 2007, JARO-J ASSOC RES OTO, V8, P384, DOI 10.1007/s10162-007-0085-8; Won JH, 2014, J ACOUST SOC AM, V136, P2714, DOI 10.1121/1.4895702; Won JH, 2014, JARO-J ASSOC RES OTO, V15, P423, DOI 10.1007/s10162-014-0444-1; Won JH, 2012, TRENDS AMPLIF, V16, P201, DOI 10.1177/1084713812467855; Won JH, 2011, J ACOUST SOC AM, V130, P376, DOI 10.1121/1.3592521; Zeng Fan-Gang, 2008, IEEE Rev Biomed Eng, V1, P115, DOI 10.1109/RBME.2008.2008250; Zhang T, 2013, EAR HEARING, V34, P133, DOI 10.1097/AUD.0b013e31826709af	45	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140920	10.1371/journal.pone.0140920	http://dx.doi.org/10.1371/journal.pone.0140920			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485715	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100090
J	Landreat, MG; Rozaire, C; Guillet, JY; Vigneau, CV; Le Reste, JY; Bronnec, MG				Landreat, Morgane Guillou; Rozaire, Charles; Guillet, Jean Yves; Vigneau, Caroline Victorri; Le Reste, Jean Yves; Bronnec, Marie Grall			French Experience with Buprenorphine : Do Physicians Follow the Guidelines?	PLOS ONE			English	Article							HIGH-DOSAGE	Opiate dependence affects about 15,479,000 people worldwide. The effectiveness of opiate substitution treatments (OST) has been widely demonstrated. Buprenorphine plays a particular role in opiate dependence care provision in France. It is widely prescribed by physicians and national opiate substitution treatment guidelines have been available since 2004. In order to study the prescribing of buprenorphine, we used a questionnaire sent by email, to a large sample of physicians. These physicians were either in practice, or belonged to an addiction treatment network or a hospital. The main objective of this work was to measure the extent to which the theoretical, clinical attitude of physicians towards prescribing buprenorphine (BHD) complied with the statutory guidelines. We showed that the physicians we interviewed rarely took into account the guidelines regarding buprenorphine prescription. The actual prescribing of Buprenorphine differed from the guidelines. Only 42% of independent Family Physicians (FPs), working outside the national health care system, had prescribed buprenorphine as a first-time prescription and 40% of FPs do not follow up patients on buprenorphine. In terms of compliance with the guidelines, 55% of FPs gave theoretical answers that only partially complied with the guidelines. The variations in compliance with the guidelines was noted according to different variables and took into particular account whether the physician were affiliated to a network or in training.	[Landreat, Morgane Guillou] Univ Bretagne Occidentale, ERCR SPURBO, Dept Addict Disorders, Brest, France; [Rozaire, Charles] CHU Nantes, Addict Psychiat, F-44035 Nantes 01, France; [Guillet, Jean Yves] Addict Dept Les Apsyades, Nantes, France; [Vigneau, Caroline Victorri; Bronnec, Marie Grall] Univ Hosp Nantes, Dept Pharmacol, Nantes, France; [Vigneau, Caroline Victorri] Fac Med Nantes, EA 4275, Nantes, France; [Le Reste, Jean Yves] Univ Bretagne Occidentale, ERCR SPURBO, Dept Gen Practice, Brest, France; [Bronnec, Marie Grall] Univ Hosp Nantes, Addict Psychiat, Nantes, France	Universite de Bretagne Occidentale; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; Universite de Bretagne Occidentale; Nantes Universite; CHU de Nantes	Landreat, MG (corresponding author), Univ Bretagne Occidentale, ERCR SPURBO, Dept Addict Disorders, Brest, France.	morgane.guillou@chu-brest.fr	Grall-Bronnec, Marie/L-9036-2015; Victorri Vigneau, Caroline/L-9030-2015	Victorri-Vigneau, Caroline/0000-0002-3745-2532; grall-bronnec, marie/0000-0003-0722-7243	Arrow	Arrow	The authors received a grant from Arrow for this work. This grant was used to build the e-mail questionnaire and to manage the platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Act UP-Paris, 2004, Presse Med, V33, P41; AURIACOMBE M, 1994, ANN MED INTERNE, V145, P27; Auriacombe M, 2003, REV PRATICIEN, V53, P137; Benyamina A, 2014, INT J GEN MED, V7, P449, DOI 10.2147/IJGM.S61014; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; DOLE VP, 1965, J AMER MED ASSOC, V193, P646, DOI 10.1001/jama.1965.03090080008002; Feroni I, 2004, REV EPIDEMIOL SANTE, V52, P511, DOI 10.1016/S0398-7620(04)99091-8; Feroni I, 2005, ADDICT BEHAV, V30, P187, DOI 10.1016/j.addbeh.2004.04.019; Guignard R., 2011, TREATMENT CARE OPIOI, P177; Guillou Landreat M., 2013, PSYCHOTROPES, V19, P23; Ksouda K, 2013, PRESSE MED, V42, P28; Landreat MG, 2013, ANN MED-PSYCHOL, V171, P367, DOI 10.1016/j.amp.2010.11.019; Langlois E, 2012, TENDANCES, V83; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Michael Kidd Am Prof, 2013, J Family Med Prim Care, V2, P211, DOI 10.4103/2249-4863.120712; Observatoire Francais des drogues et Toxicomanies (OFDT), 2002, OP SUBST TREATM 5 PL; OFDT, 2013, DROG CHIFFR CLES; Orman JS, 2009, DRUGS, V69, P577, DOI 10.2165/00003495-200969050-00006; Pauly V, 2012, DRUG ALCOHOL DEPEN, V126, P13, DOI 10.1016/j.drugalcdep.2012.03.009; Roux P, 2008, ADDICT BEHAV, V33, P1625, DOI 10.1016/j.addbeh.2008.07.018; Soyka M, 2011, WORLD J BIOL PSYCHIA, V12, P160, DOI 10.3109/15622975.2011.561872; Wisniewski AM, 2013, SUBST ABUS, V34, P105, DOI 10.1080/08897077.2012.677753	22	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0137708	10.1371/journal.pone.0137708	http://dx.doi.org/10.1371/journal.pone.0137708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479400	Green Published, Green Submitted, gold			2022-12-27	WOS:000363026600002
J	Gioia, M; Vindigni, G; Testa, B; Raniolo, S; Fasciglione, GF; Coletta, M; Biocca, S				Gioia, Magda; Vindigni, Giulia; Testa, Barbara; Raniolo, Sofia; Fasciglione, Giovanni Francesco; Coletta, Massimiliano; Biocca, Silvia			Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial Cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; MATRIX METALLOPROTEINASE-1 EXPRESSION; HUMAN LECTIN-LIKE; CELLULAR CHOLESTEROL; TISSUE INHIBITORS; RECEPTOR FUNCTION; CRYSTAL-STRUCTURE; LIPID RAFTS; DEPLETION; APOPTOSIS	The lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a scavenger receptor responsible for ox-LDL recognition, binding and internalization, which is up-regulated during atherogenesis. Its activation triggers endothelium dysfunction and induces inflammation. A soluble form of LOX-1 has been identified in the human blood and its presence considered a biomarker of cardiovascular diseases. We recently showed that cholesterol-lowering drugs inhibit ox-LDL binding and internalization, rescuing the ox-LDL induced apoptotic phenotype in primary endothelial cells. Here we have investigated the molecular bases of human LOX-1 shedding by metalloproteinases and the role of cell membrane cholesterol on the regulation of this event by modulating its level with M beta CD and statins. We report that membrane cholesterol affects the release of different forms of LOX-1 in cells transiently and stably expressing human LOX-1 and in a human endothelial cell line (EA.hy926). In particular, our data show that i) cholesterol depletion triggers the release of LOX-1 in exosomes as a full-length transmembrane isoform and as a truncated ectodomain soluble fragment (sLOX-1); ii) endothelial cells secrete a soluble metalloproteinase which induces LOX-1 ectodomain shedding and iii) long term statins treatment enhances sLOX-1 proteolytic shedding.	[Gioia, Magda; Fasciglione, Giovanni Francesco; Coletta, Massimiliano] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, I-00133 Rome, Italy; [Vindigni, Giulia; Testa, Barbara; Raniolo, Sofia; Biocca, Silvia] Univ Roma Tor Vergata, Dept Syst Med, I-00133 Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata	Biocca, S (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Via Montpellier 1, I-00133 Rome, Italy.	biocca@med.uniroma2.it	Coletta, Massimiliano/GSN-5927-2022; Fasciglione, Giovanni Francesco/ABF-7738-2020; Testa, Barbara/AIA-0048-2022; Coletta, Massimo/N-9049-2015; Biocca, Silvia/AAH-7310-2021; Gioia, Magda/ABF-8909-2020; Gioia, Magda/AAD-4781-2022	Testa, Barbara/0000-0003-3516-2379; Biocca, Silvia/0000-0001-5838-4674; Gioia, Magda/0000-0003-0352-3547; Raniolo, Sofia/0000-0003-2454-6238; COLETTA, Massimiliano/0000-0002-5489-9467	FILAS	FILAS	This work was supported by FILAS for the fellowship granted to GV under the project "Caratterizzazione di principi attivi, di origine naturale e non, per patologie tumorali cardiovascolari e infettive".	Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Altieri P, 2003, EUR J CLIN INVEST, V33, P648, DOI 10.1046/j.1365-2362.2003.01187.x; Atkinson SJ, 2004, FEBS LETT, V566, P65, DOI 10.1016/j.febslet.2004.04.040; Biocca S, 2008, J MOL CELL CARDIOL, V44, P561, DOI 10.1016/j.yjmcc.2007.11.017; Biocca S, 2015, CELL CYCLE, V14, P1583, DOI 10.1080/15384101.2015.1026486; Biocca S, 2013, ARCH BIOCHEM BIOPHYS, V540, P9, DOI 10.1016/j.abb.2013.10.001; Biocca S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004648; Cao W, 2009, FEBS J, V276, P4909, DOI 10.1111/j.1742-4658.2009.07190.x; Chen XP, 2007, VASC PHARMACOL, V47, P1, DOI 10.1016/j.vph.2007.01.004; Civelek S, 2015, J CLIN LAB ANAL, V29, P184, DOI 10.1002/jcla.21748; Claise C, 1997, CELL MOL LIFE SCI, V53, P156, DOI 10.1007/PL00000587; Claise C, 1999, ATHEROSCLEROSIS, V147, P95, DOI 10.1016/S0021-9150(99)00170-7; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Gioia M, 2010, J BIOL INORG CHEM, V15, P1219, DOI 10.1007/s00775-010-0680-8; Hayashida K, 2005, CIRCULATION, V112, P812, DOI 10.1161/CIRCULATIONAHA.104.468397; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Huang Y, 1999, ARTERIOSCL THROM VAS, V19, P2640, DOI 10.1161/01.ATV.19.11.2640; Huang Y, 2001, ATHEROSCLEROSIS, V156, P119, DOI 10.1016/S0021-9150(00)00638-9; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Ishigaki T, 2007, J BIOCHEM, V141, P855, DOI 10.1093/jb/mvm093; Ishikawa M, 2012, ARTHRITIS RHEUM-US, V64, P1024, DOI 10.1002/art.33452; Izidoro-Toledo TC, 2011, N-S ARCH PHARMACOL, V383, P547, DOI 10.1007/s00210-011-0623-0; Jeppesen DK, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25011; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kim S, 2010, ANN DERMATOL, V22, P379, DOI 10.5021/ad.2010.22.4.379; Kobayashi N, 2013, INT J CARDIOL, V165, P557, DOI 10.1016/j.ijcard.2012.09.001; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kume N, 2010, J CARDIOL, V56, P159, DOI 10.1016/j.jjcc.2010.05.002; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; Levitt ES, 2009, J BIOL CHEM, V284, P22108, DOI 10.1074/jbc.M109.030411; Li DY, 2003, CIRCULATION, V107, P612, DOI 10.1161/01.CIR.0000047276.52039.FB; Li L, 2009, ATHEROSCLEROSIS, V204, P40, DOI 10.1016/j.atherosclerosis.2008.08.008; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Lin JT, 2014, CURR DRUG TARGETS, V15, P442, DOI 10.2174/1389450115666140211115805; Matarazzo S, 2012, MOL PHARMACOL, V82, P246, DOI 10.1124/mol.112.078915; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Mitsuoka H, 2009, ATHEROSCLEROSIS, V202, P176, DOI 10.1016/j.atherosclerosis.2008.04.002; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Murphy JE, 2008, J CELL SCI, V121, P2136, DOI 10.1242/jcs.020917; Navarra T, 2010, J ATHEROSCLER THROMB, V17, P317, DOI 10.5551/jat.3228; Newby AC, 2015, MATRIX BIOL, DOI [10.1016/j.matbio.2015.01.015, DOI 10,1016/J.MATBIO.2015.01.015]; Newby AC, 2014, CURR OPIN LIPIDOL, V25, P358, DOI 10.1097/MOL.0000000000000111; Nowicki M, 2007, EUR J CELL BIOL, V86, P605, DOI 10.1016/j.ejcb.2007.06.006; Ohki I, 2005, STRUCTURE, V13, P905, DOI 10.1016/j.str.2005.03.016; Ohki I, 2011, BBA-PROTEINS PROTEOM, V1814, P345, DOI 10.1016/j.bbapap.2010.10.006; Park H, 2005, J BIOL CHEM, V280, P13593, DOI 10.1074/jbc.M500768200; Pirillo A, 2013, DIS MARKERS, V2013, P413, DOI 10.1155/2013/716325; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Rajavashisth TB, 1999, J BIOL CHEM, V274, P11924, DOI 10.1074/jbc.274.17.11924; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Saito A, 2010, ACTA NEUROCHIR, V152, P589, DOI 10.1007/s00701-009-0573-1; Sattler W, 1992, ISOLATION HUMAN VLDL; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Sbardella D, 2012, IUBMB LIFE, V64, P988, DOI 10.1002/iub.1095; Selvais C, 2011, FASEB J, V25, P2770, DOI 10.1096/fj.10-169508; STEPHAN ZF, 1993, J LIPID RES, V34, P325; Sugimoto K, 2009, CARDIOVASC RES, V84, P127, DOI 10.1093/cvr/cvp177; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tuten A, 2015, ARCH GYNECOL OBSTET, V291, P563, DOI 10.1007/s00404-014-3457-4; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Xu SW, 2013, CELL MOL LIFE SCI, V70, P2859, DOI 10.1007/s00018-012-1194-z; Yamamoto K., 2015, MATRIX BIOL; Zaltsman AB, 1999, ARTERIOSCL THROM VAS, V19, P1700, DOI 10.1161/01.ATV.19.7.1700	69	15	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141270	10.1371/journal.pone.0141270	http://dx.doi.org/10.1371/journal.pone.0141270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495844	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200085
J	Guo, R; Wang, H; Cui, JW; Wang, GJ; Li, W; Hu, JF				Guo, Rui; Wang, Hong; Cui, Jiuwei; Wang, Guanjun; Li, Wei; Hu, Ji-Fan			Inhibition of HIV-1 Viral Infection by an Engineered CRISPR Csy4 RNA Endoribonuclease	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG NONCODING RNA; HEMATOPOIETIC MALIGNANCIES; GENE-THERAPY; DNA; GENOME; CURE; ENDONUCLEASE; RECOMBINASE; ACTIVATION	The bacterial defense system CRISPR (clustered regularly interspaced short palindromic repeats) has been explored as a powerful tool to edit genomic elements. In this study, we test the potential of CRISPR Csy4 RNA endoribonuclease for targeting HIV-1. We fused human codon-optimized Csy4 endoribonuclease with VPR, a HIV-1 viral preintegration complex protein. An HIV-1 cell model was modified to allow quantitative detection of active virus production. We found that the trans-expressing VPR-Csy4 almost completely blocked viral infection in two target cell lines (SupT1, Ghost). In the MAGI cell assay, where the HIV-1 LTR beta-galactosidase is expressed under the control of the tat gene from an integrated provirus, VPR-Csy4 significantly blocked the activity of the provirus-activated HIV-1 reporter. This proof-of-concept study demonstrates that Csy4 endoribonuclease is a promising tool that could be tailored further to target HIV-1.	[Guo, Rui; Wang, Hong; Cui, Jiuwei; Wang, Guanjun; Li, Wei; Hu, Ji-Fan] Jilin Univ, Hosp 1, Stem Cell & Canc Ctr, Changchun 130023, Peoples R China; [Guo, Rui; Wang, Hong; Hu, Ji-Fan] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Jilin University; Stanford University	Hu, JF (corresponding author), Jilin Univ, Hosp 1, Stem Cell & Canc Ctr, Changchun 130023, Peoples R China.	jdyylw@163.com; jifan@stanford.edu	Hu, Jifan/Q-3003-2019	WANG, HONG/0000-0003-0212-5379	California Institute for Regenerative Medicine (CIRM) [RT2-01942]; Jilin International Collaboration Grant [20120720]; National Natural Science Foundation of China [81272294, 31430021, 81071920, 81372835]; Jilin Science and Technique Program grant [11GG003]; Key Project of Chinese Ministry of Education [311015]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Jilin International Collaboration Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Science and Technique Program grant; Key Project of Chinese Ministry of Education(Ministry of Education, China)	This work was supported by a California Institute for Regenerative Medicine (CIRM) grant (RT2-01942), a Jilin International Collaboration Grant (#20120720), the National Natural Science Foundation of China grant (#81272294, #31430021) to J.F.H.; the National Natural Science Foundation of China grant (#81071920, #81372835) and Jilin Science and Technique Program grant (11GG003) to W.L.; and a grant of the Key Project of Chinese Ministry of Education (#311015) to C.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Ghanem J, 2013, NUCLEIC ACIDS RES, V41, P2394, DOI 10.1093/nar/gks1308; ABLASHI DV, 1995, CLIN DIAGN VIROL, V4, P1, DOI 10.1016/0928-0197(95)00005-S; Buchholz F, 2013, ANTIVIR RES, V97, P211, DOI 10.1016/j.antiviral.2012.12.017; Buchholz F, 2011, METHODS, V53, P102, DOI 10.1016/j.ymeth.2010.06.014; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahabieh MS, 2013, J VIROL, V87, P4716, DOI 10.1128/JVI.03478-12; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Didigu C, 2014, VIRUSES-BASEL, V6, P1395, DOI 10.3390/v6031395; Fletcher TM, 1997, EMBO J, V16, P5123, DOI 10.1093/emboj/16.16.5123; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hauber I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003587; Haurwitz RE, 2012, EMBO J, V31, P2824, DOI 10.1038/emboj.2012.107; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kulkosky J, 1999, VIROLOGY, V255, P77, DOI 10.1006/viro.1998.9544; Li T, 2014, HUM MOL GENET, V23, P117, DOI 10.1093/hmg/ddt405; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manjunath N, 2013, VIRUSES-BASEL, V5, P2748, DOI 10.3390/v5112748; Mariyanna L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031576; Morner A, 1999, J VIROL, V73, P2343; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Pennings PS, 2013, INFECT DIS REP, V5, P21, DOI 10.4081/idr.2013.s1.e5; Poluri A, 2003, EXPERT OPIN BIOL TH, V3, P951, DOI 10.1517/14712598.3.6.951; Przybilski R, 2011, RNA BIOL, V8, P517, DOI 10.4161/rna.8.3.15190; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Smith SD, 1984, CANCER RES, V44, P15660; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Sun JN, 2014, NUCLEIC ACIDS RES, V42, P9588, DOI 10.1093/nar/gku549; van Lunzen Jan, 2011, Curr HIV/AIDS Rep, V8, P78, DOI 10.1007/s11904-011-0073-9; Wang H, 2014, INT J CANCER, V135, P2783, DOI 10.1002/ijc.28922; Wolkowicz R, 2005, GENE THER, V12, P467, DOI 10.1038/sj.gt.3302488; WU XY, 1995, J VIROL, V69, P3389, DOI 10.1128/JVI.69.6.3389-3398.1995; Zhang H, 2013, CELL STEM CELL, V13, P30, DOI 10.1016/j.stem.2013.05.012; Zhang SH, 2014, INT J CANCER, V134, P1583, DOI 10.1002/ijc.28487	39	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141335	10.1371/journal.pone.0141335	http://dx.doi.org/10.1371/journal.pone.0141335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495836	gold, Green Published, Green Submitted			2022-12-27	WOS:000363309200094
J	McParland, AL; Follansbee, TL; Vesenka, GD; Panaitiu, AE; Ganter, GK				McParland, Aidan L.; Follansbee, Taylor L.; Vesenka, Gwendolyn D.; Panaitiu, Alexandra E.; Ganter, Geoffrey K.			Steroid Receptor Isoform Expression in Drosophila Nociceptor Neurons Is Required for Normal Dendritic Arbor and Sensitivity	PLOS ONE			English	Article							B ECDYSONE RECEPTOR; MEDIAL AMYGDALA; PAIN; HORMONE; NUMBER; GENE	Steroid hormones organize many aspects of development, including that of the nervous system. Steroids also play neuromodulatory and other activational roles, including regulation of sensitivity to painful stimuli in mammals. In Drosophila, ecdysteroids are the only steroid hormones, and therefore the fly represents a simplified model system in which to explore mechanisms of steroid neuromodulation of nociception. In this report, we present evidence that ecdysteroids, acting through two isoforms of their nuclear ecdysone receptor (EcR), modulate sensitivity to noxious thermal and mechanical stimuli in the fly larva. We show that EcRA and EcRB1 are expressed by third instar larvae in the primary nociceptor neurons, known as the class IV multidendritic neurons. Suppression of EcRA by RNA interference in these cells leads to hyposensitivity to noxious stimulation. Suppression of EcRB1 leads to reduction of dendritic branching and length of nociceptor neurons. We show that specific isoforms of the ecdysone receptor play critical cell autonomous roles in modulating the sensitivity of nociceptor neurons and may indicate human orthologs that represent targets for novel analgesic drugs.	[McParland, Aidan L.; Follansbee, Taylor L.; Vesenka, Gwendolyn D.; Panaitiu, Alexandra E.; Ganter, Geoffrey K.] Univ New England, Coll Arts & Sci, Dept Biol, Biddeford, ME 04005 USA	University of New England - Maine	Ganter, GK (corresponding author), Univ New England, Coll Arts & Sci, Dept Biol, Biddeford, ME 04005 USA.	gganter@une.edu			National Institutes of Health - National Institute of General Medical Sciences [NIH P20GM103643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103643] Funding Source: NIH RePORTER	National Institutes of Health - National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health - National Institute of General Medical Sciences (http://www.nigms.nih.gov/), Grant number: NIH P20GM103643 to I. Meng (PI Meng not an author, but GG was a Project Leader on this grant.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Aloisi AM, 2004, NEUROSCI LETT, V361, P262, DOI 10.1016/j.neulet.2003.12.023; Babcock DT, 2011, CURR BIOL, V21, P1525, DOI 10.1016/j.cub.2011.08.020; Babcock DT, 2009, CURR BIOL, V19, P799, DOI 10.1016/j.cub.2009.03.062; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Boulanger A, 2015, BBA-GENE REGUL MECH, V1849, P187, DOI 10.1016/j.bbagrm.2014.05.024; Carney GE, 2000, GENETICS, V154, P1203; Colloca L, 2008, PAIN, V136, P211, DOI 10.1016/j.pain.2008.02.006; Cooke BM, 2006, NEUROSCIENCE, V138, P997, DOI 10.1016/j.neuroscience.2005.06.018; De Lorme KC, 2012, BRAIN RES, V1460, P33, DOI 10.1016/j.brainres.2012.04.035; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; GOLDSTEIN LA, 1990, J NEUROBIOL, V21, P719, DOI 10.1002/neu.480210506; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Kirilly D, 2011, NEURON, V72, P86, DOI 10.1016/j.neuron.2011.08.003; Kirilly D, 2009, NAT NEUROSCI, V12, P1497, DOI 10.1038/nn.2415; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Mantyselka P, 2001, PAIN, V89, P175, DOI 10.1016/S0304-3959(00)00361-4; McParland AL, 2015, JOVE-J VIS EXP, DOI 10.3791/52684; Melcangi RC, 2008, CELL MOL LIFE SCI, V65, P777, DOI 10.1007/s00018-007-7403-5; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Patte-Mensah C, 2006, J MOL NEUROSCI, V28, P17, DOI 10.1385/JMN:28:1:17; Schubiger M, 1998, DEVELOPMENT, V125, P2053; SLITER TJ, 1987, INSECT BIOCHEM, V17, P161, DOI 10.1016/0020-1790(87)90156-9; Sulkowski MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022611; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Zwart MF, 2013, PNAS, V110, P3878	29	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140785	10.1371/journal.pone.0140785	http://dx.doi.org/10.1371/journal.pone.0140785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495837	Green Submitted, gold, Green Published			2022-12-27	WOS:000363309200031
J	Buljubasic, N; Akkerhuis, KM; de Boer, SPM; Cheng, JM; Garcia-Garcia, HM; Lenzen, MJ; Oemrawsingh, RM; Battes, LC; Rijndertse, M; Regar, E; Serruys, PW; van Geuns, RJ; Boersma, E; Kardys, I				Buljubasic, Nermina; Akkerhuis, K. Martijn; de Boer, Sanneke P. M.; Cheng, Jin M.; Garcia-Garcia, Hector M.; Lenzen, Mattie J.; Oemrawsingh, Rohit M.; Battes, Linda C.; Rijndertse, Melissa; Regar, Evelyn; Serruys, Patrick W.; van Geuns, Robert-Jan; Boersma, Eric; Kardys, Isabella			Smoking in Relation to Coronary Atherosclerotic Plaque Burden, Volume and Composition on Intravascular Ultrasound	PLOS ONE			English	Article							RADIOFREQUENCY DATA-ANALYSIS; RISK-FACTORS; CIGARETTE-SMOKING; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; TISSUE CHARACTERIZATION; VULNERABLE PLAQUE; SUDDEN; THROMBOSIS; DEATH	Background This study aimed to evaluate the relationship between cigarette smoking and coronary atherosclerotic burden, volume and composition as determined in-vivo by grayscale and virtual histology (VH) intravascular ultrasound (IVUS). Methods and Results Between 2008 and 2011, (VH-) IVUS of a non-culprit coronary artery was performed in 581 patients undergoing coronary angiography. To account for differences in baseline characteristics, current smokers were matched to never smokers by age, gender and indication for catheterization, resulting in 280 patients available for further analysis. Coronary atherosclerotic plaque volume, burden, composition (fibrous, fibro-fatty, dense calcium and necrotic core) and high-risk lesions (VH-IVUS derived thin-cap fibroatheroma (TCFA), plaque burden >= 70%, minimal luminal area <= 4.0 mm(2)) were assessed. Cigarette smoking showed a tendency towards higher coronary plaque burden (mean +/- SD, 38.6 +/- 12.5% in current versus 36.4 +/- 11.0% in never smokers, p = 0.080; and odds ratio (OR) of current smoking for plaque burden above versus below the median 1.69 (1.04-2.75), p = 0.033). This effect was driven by an association in patients presenting with an acute coronary syndrome (ACS) (current smokers, plaque burden 38.3 +/- 12.8% versus never smokers, plaque burden 35.0 +/- 11.2%, p = 0.049; OR 1.88 (1.02-3.44), p = 0.042). Fibrous tissue tended to be lower in current smokers (mean +/- SD, 57.7 +/- 10.5% versus 60.4 +/- 12.6%, p = 0.050) and fibro-fatty tissue was higher in current smokers (median[IQR], 9.6[6.0-13.7]% versus 8.6[5.8-12.2]%, p = 0.039). However, differences in percentage necrotic core and dense calcium could not be demonstrated. Also, no differences were found with regard to high-risk lesions. Conclusions An association between smoking and degree of coronary atherosclerosis was present in patients undergoing coronary angiography who presented with ACS. Although smoking was associated with higher fibro-fatty percentage, no associations could be demonstrated with percentage necrotic core, nor with VH-IVUS derived TCFA lesions. Since the magnitude of the differences in both degree and composition of atherosclerosis was modest, clinical relevance of the findings may be questioned.	[Buljubasic, Nermina; Akkerhuis, K. Martijn; de Boer, Sanneke P. M.; Cheng, Jin M.; Garcia-Garcia, Hector M.; Lenzen, Mattie J.; Oemrawsingh, Rohit M.; Battes, Linda C.; Rijndertse, Melissa; Regar, Evelyn; Serruys, Patrick W.; van Geuns, Robert-Jan; Boersma, Eric; Kardys, Isabella] Erasmus MC, Dept Cardiol, Clin Epidemiol Unit, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Kardys, I (corresponding author), Erasmus MC, Dept Cardiol, Clin Epidemiol Unit, Rotterdam, Netherlands.	i.kardys@erasmusmc.nl	Regar, Evelyn/AAD-8201-2019; Garcia-Garcia, Hector Manuel/AAG-7471-2020; Regar, E/ABA-3301-2020; van Geuns, Robert-Jan M/N-7976-2017; van Geuns, Robert/AAR-6386-2021	Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; van Geuns, Robert-Jan M/0000-0003-2943-5932; Oemrawsingh, Rohit M./0000-0002-3617-3929	Seventh Framework Programme (FP7) [FP7-HEALTH-2007-2.4.2-1]; Netherlands Heart Foundation [NHS2009B091, NHS2007B012]	Seventh Framework Programme (FP7)(European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation)	The ATHEROREMO-IVUS study was embedded in The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis (ATHEROREMO) and was funded by the Seventh Framework Programme (FP7), theme FP7-HEALTH-2007-2.4.2-1. JMC and RMO are supported by the Netherlands Heart Foundation (grant numbers NHS2009B091 and NHS2007B012, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Barua RS, 2013, ARTERIOSCL THROM VAS, V33, P1460, DOI 10.1161/ATVBAHA.112.300154; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Burke AP, 1998, CIRCULATION, V97, P2110, DOI 10.1161/01.CIR.97.21.2110; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Burke AP, 2002, J NUCL CARDIOL, V9, P95, DOI 10.1067/mnc.2002.121771; Cheng JM, 2014, EUR HEART J, V35, P639, DOI 10.1093/eurheartj/eht484; de Boer SPM, 2014, EUROINTERVENTION, V10, P953, DOI 10.4244/EIJY13M08_01; Escobedo LG, 1996, CIRCULATION, V93, P2033, DOI 10.1161/01.CIR.93.11.2033; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Garcia-Garcia HM, 2010, EUR HEART J, V31, P2456, DOI 10.1093/eurheartj/ehq280; Garcia-Garcia HM, 2009, EUROINTERVENTION, V5, P177, DOI 10.4244/EIJV5I2A29; GRINES CL, 1995, CIRCULATION, V91, P298, DOI 10.1161/01.CIR.91.2.298; Kahlon JPS, 2006, ECHOCARDIOGR-J CARD, V23, P308, DOI 10.1111/j.1540-8175.2006.00208.x; Kim JA, 2013, INT J CARDIOVAS IMAG, V29, P21, DOI 10.1007/s10554-013-0224-8; Korshunov VA, 2007, ARTERIOSCL THROM VAS, V27, P1722, DOI 10.1161/ATVBAHA.106.129254; LAKIER JB, 1992, AM J MED, V93, pS8, DOI 10.1016/0002-9343(92)90620-Q; Libby P, 2006, AM J CARDIOL, V98, p3Q, DOI 10.1016/j.amjcard.2006.09.020; Missel E, 2008, EUR HEART J, V29, P2141, DOI 10.1093/eurheartj/ehn293; Newby DE, 2010, HEART, V96, P1247, DOI 10.1136/hrt.2009.175141; Newby DE, 2001, CIRCULATION, V103, P1936; Nicholls SJ, 2006, J AM COLL CARDIOL, V47, P1967, DOI 10.1016/j.jacc.2005.12.058; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Njolstad I, 1996, CIRCULATION, V93, P450; Philipp S, 2010, EUR HEART J, V31, P196, DOI 10.1093/eurheartj/ehp428; Puri R, 2013, EUR HEART J, V34, P3182, DOI 10.1093/eurheartj/eht260; Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064; Sano K, 2005, CIRC J, V 69, P543, DOI 10.1253/circj.69.543; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2011, JACC-CARDIOVASC IMAG, V4, P656, DOI 10.1016/j.jcmg.2011.01.019; von Birgelen C, 2004, CIRCULATION, V110, P1579, DOI 10.1161/01.CIR.0000142048.94084.CA; Waters D, 1996, CIRCULATION, V94, P614, DOI 10.1161/01.CIR.94.4.614; Zieske AW, 2005, ATHEROSCLEROSIS, V180, P87, DOI 10.1016/j.atherosclerosis.2004.10.039	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141093	10.1371/journal.pone.0141093	http://dx.doi.org/10.1371/journal.pone.0141093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491969	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300029
J	Chen, HJ; Shen, YC; Shiao, YJ; Liou, KT; Hsu, WH; Hsieh, PH; Lee, CY; Chen, YR; Lin, YL				Chen, Hong-Jhang; Shen, Yuh-Chiang; Shiao, Young-Ji; Liou, Kuo-Tong; Hsu, Wei-Hsiang; Hsieh, Pei-Hsuan; Lee, Chi-Ying; Chen, Yet-Ran; Lin, Yun-Lian			Multiplex Brain Proteomic Analysis Revealed the Molecular Therapeutic Effects of Buyang Huanwu Decoction on Cerebral Ischemic Stroke Mice	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; TISSUE-PLASMINOGEN ACTIVATOR; CHINESE MEDICINE; ARTERY OCCLUSION; NEURONAL DEATH; STEM-CELLS; MODEL; RAT; RECEPTOR; INJURY	Stroke is the second-leading cause of death worldwide, and tissue plasminogen activator (TPA) is the only drug used for a limited group of stroke patients in the acute phase. Buyang Huanwu Decoction (BHD), a traditional Chinese medicine prescription, has long been used for improving neurological functional recovery in stroke. In this study, we characterized the therapeutic effect of TPA and BHD in a cerebral ischemia/reperfusion (CIR) injury mouse model using multiplex proteomics approach. After the iTRAQ-based proteomics analysis, 1310 proteins were identified from the mouse brain with <1% false discovery rate. Among them, 877 quantitative proteins, 10.26% (90/877), 1.71% (15/877), and 2.62% (23/877) of the proteins was significantly changed in the CIR, BHD treatment, and TPA treatment, respectively. Functional categorization analysis showed that BHD treatment preserved the integrity of the blood-brain barrier (BBB) (Alb, Fga, and Trf), suppressed excitotoxicity (Grm5, Gnai, and Gdi), and enhanced energy metabolism (Bdh), thereby revealing its multiple effects on ischemic stroke mice. Moreover, the neurogenesis marker doublecortin was upregulated, and the activity of glycogen synthase kinase 3 (GSK-3) and Tau was inhibited, which represented the neuroprotective effects. However, TPA treatment deteriorated BBB breakdown. This study highlights the potential of BHD in clinical applications for ischemic stroke.	[Chen, Hong-Jhang; Shen, Yuh-Chiang; Shiao, Young-Ji; Hsu, Wei-Hsiang; Lin, Yun-Lian] Natl Res Inst Chinese Med, Taipei, Taiwan; [Chen, Hong-Jhang] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10764, Taiwan; [Liou, Kuo-Tong] Chinese Culture Univ, Dept Chinese Martial Arts, Taipei, Taiwan; [Liou, Kuo-Tong] Chinese Culture Univ, Grad Inst Sport Coaching Sci, Taipei, Taiwan; [Hsieh, Pei-Hsuan; Lee, Chi-Ying; Chen, Yet-Ran] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Lin, Yun-Lian] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Lin, Yun-Lian] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan	National Research Institute of Chinese Medicine; National Taiwan University; Chinese Culture University; Chinese Culture University; Academia Sinica - Taiwan; China Medical University Taiwan; National Taiwan University	Chen, YR (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	yetran@gate.sinica.edu.tw; yllin5212@gmail.com	Shiao, Young-Ji/AAA-9647-2022		National Science Council Taiwan [NSC-101-2325-B-077-001, NSC102-2325-B-077-001, NSC 103 2320-B-077-001]; Ministry of Science and Technology Taiwan (MOST) [103-2320-B-077-003-MY3]	National Science Council Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	This work was supported by the grants from the National Science Council Taiwan (NSC-101-2325-B-077-001, NSC102-2325-B-077-001, and NSC 103 2320-B-077-001) and Ministry of Science and Technology Taiwan (MOST 103-2320-B-077-003-MY3).	Altamura C, 2009, STROKE, V40, P1282, DOI 10.1161/STROKEAHA.108.536714; Armogida M, 2012, BRIT J PHARMACOL, V166, P1211, DOI 10.1111/j.1476-5381.2012.01912.x; Bao WL, 2001, BRAIN RES, V922, P173, DOI 10.1016/S0006-8993(01)03062-1; Beschorner R, 2007, HISTOPATHOLOGY, V50, P897, DOI 10.1111/j.1365-2559.2007.02703.x; Cai GX, 2007, J ETHNOPHARMACOL, V113, P292, DOI 10.1016/j.jep.2007.06.007; Chang WH, 2013, ANAL CHEM, V85, P890, DOI 10.1021/ac302281j; Chen CJ, 2010, ANAL CHEM, V82, P8283, DOI 10.1021/ac1017937; Chen HJ, 2012, METABOLOMICS, V8, P974, DOI 10.1007/s11306-011-0394-0; Chen YS, 2001, AM J CHINESE MED, V29, P423, DOI 10.1142/S0192415X01000447; Chern CM, 2012, FREE RADICAL BIO MED, V52, P1634, DOI 10.1016/j.freeradbiomed.2012.01.030; Cho WCS, 2007, AM J CHINESE MED, V35, P911, DOI 10.1142/S0192415X07005375; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Datta A, 2011, J PROTEOME RES, V10, P5199, DOI 10.1021/pr200673y; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; Fan LZ, 2006, J FUTURES MARKETS, V26, P153, DOI 10.1002/fut.20191; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Gao MX, 2007, J SEP SCI, V30, P785, DOI 10.1002/jssc.200600372; Gold AB, 2011, CURR DRUG TARGETS, V12, P243; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guo WX, 2012, HUM MOL GENET, V21, P681, DOI 10.1093/hmg/ddr501; Hao CZ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/630124; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imhof A, 2006, NEUROBIOL DIS, V22, P274, DOI 10.1016/j.nbd.2005.11.009; Jin R, 2010, NEUROBIOL DIS, V38, P376, DOI 10.1016/j.nbd.2010.03.008; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelly S, 2004, EXP NEUROL, V188, P378, DOI 10.1016/j.expneurol.2004.04.004; Kim N, 2006, PROTEOMICS, V6, P1237, DOI 10.1002/pmic.200500291; Korshunova I, 2008, J NEUROSCI RES, V86, P2201, DOI 10.1002/jnr.21678; Kunz A, 2008, J NEUROSCI, V28, P1649, DOI 10.1523/JNEUROSCI.5205-07.2008; Lansberg MG, 2009, STROKE, V40, P2438, DOI 10.1161/STROKEAHA.109.552547; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li HL, 2013, ASN NEURO, V5, DOI 10.1042/AN20130002; Li XM, 2003, NEUROSCI LETT, V346, P29, DOI 10.1016/S0304-3940(03)00522-6; Lindvall O, 2011, STROKE, V42, P2369, DOI 10.1161/STROKEAHA.110.599654; Liu CP, 2003, ACTA PHARMACOL SIN, V24, P1205; Liu J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009622.pub2; Liu X, 2011, BIOCHEM SOC T, V39, P1348, DOI 10.1042/BST0391348; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Marchi N, 2003, J NEUROSCI, V23, P1949; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Nochi R, 2012, EUR J NEUROSCI, V36, P2273, DOI 10.1111/j.1460-9568.2012.08128.x; Prajapati KD, 2010, BRAIN RES, V1327, P118, DOI 10.1016/j.brainres.2010.02.063; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ryu JK, 2009, J THROMB HAEMOST, V7, P151, DOI 10.1111/j.1538-7836.2009.03438.x; Shimamura N, 2006, STROKE, V37, P1902, DOI 10.1161/01.STR.0000226991.27540.f2; Sirerol-Piquer M, 2011, HIPPOCAMPUS, V21, P910, DOI 10.1002/hipo.20805; Song B, 2010, J BIOL CHEM, V285, P41122, DOI 10.1074/jbc.M110.130351; Tan ZJ, 2013, STROKE, V44, P3490, DOI 10.1161/STROKEAHA.113.002411; Urich-Merzenich G, 2007, PHYTOMEDICINE, V14, P70, DOI 10.1016/j.phymed.2006.11.011; Wang HW, 2011, J ETHNOPHARMACOL, V138, P22, DOI 10.1016/j.jep.2011.06.033; Whiteley W, 2009, STROKE, V40, pE380, DOI 10.1161/STROKEAHA.108.528752; World Health Organization, 10 LEAD CAUS DEATH W; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1352, DOI 10.1038/sj.jcbfm.9600441; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zheng GQ, 2010, J CELL BIOCHEM, V109, P26, DOI 10.1002/jcb.22408; Ziegler G, 2009, BBA-MOL BASIS DIS, V1792, P1198, DOI 10.1016/j.bbadis.2009.10.003	65	19	22	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140823	10.1371/journal.pone.0140823	http://dx.doi.org/10.1371/journal.pone.0140823			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492191	Green Submitted, Green Published, gold			2022-12-27	WOS:000363249300014
J	Hossain, FS; Ali, ML				Hossain, Fakir Sharif; Ali, Md. Liakot			A Novel Byte-Substitution Architecture for the AES Cryptosystem	PLOS ONE			English	Article							S-BOX	The performance of Advanced Encryption Standard (AES) mainly depends on speed, area and power. The S-box represents an important factor that affects the performance of AES on each of these factors. A number of techniques have been presented in the literature, which have attempted to improve the performance of the S-box byte-substitution. This paper proposes a new S-box architecture, defining it as ultra low power, robustly parallel and highly efficient in terms of area. The architecture is discussed for both CMOS and FPGA platforms, and the pipelined architecture of the proposed S-box is presented for further time savings and higher throughput along with higher hardware resources utilization. A performance analysis and comparison of the proposed architecture is also conducted with those achieved by the existing techniques. The results of the comparison verify the outperformance of the proposed architecture in terms of power, delay and size.	[Hossain, Fakir Sharif] Int Islamic Univ Chittagong, Dept Elect & Elect Engn, Chittagong, Bangladesh; [Ali, Md. Liakot] Bangladesh Univ Engn & Technol, Inst Informat & Commun Technol, Dhaka, Bangladesh	International Islamic University Chittagong (IIUC); Bangladesh University of Engineering & Technology (BUET)	Hossain, FS (corresponding author), Int Islamic Univ Chittagong, Dept Elect & Elect Engn, Chittagong, Bangladesh.	fshossain@eee.iiuc.ac.bd						Abd-El-Barr Mostafa, 2005, FUNDAMENTALS COMPUTE; Ahmad N, 2010, S IND EL APPL ISIEA; AMS Corp, SPEC PROC 0 35MUM CM; [Anonymous], 2001, FIPS PUB; Bertoni G, 2004, P 14 ACM GREAT LAK S, P277, DOI DOI 10.1145/988952.989019; Canright D, 2005, LECT NOTES COMPUT SC, V3659, P441; Choi HS, 2008, ICHIT 2008: INTERNATIONAL CONFERENCE ON CONVERGENCE AND HYBRID INFORMATION TECHNOLOGY, PROCEEDINGS, P413, DOI 10.1109/ICHIT.2008.191; Chow CT, 2005, FPT 05: 2005 IEEE INTERNATIONAL CONFERENCE ON FIELD PROGRAMMABLE TECHNOLOGY, PROCEEDINGS, P173, DOI 10.1109/FPT.2005.1568543; Elazm L. A., 2010, 2010 5th International Design and Test Workshop (IDT), P24, DOI 10.1109/IDT.2010.5724400; Good T, 2006, IEEE T CIRCUITS-I, V53, P1477, DOI 10.1109/TCSI.2006.875179; Granado-Criado JM, 2010, INTEGRATION, V43, P72, DOI 10.1016/j.vlsi.2009.05.003; Hodjat A, 2005, 12 IEEE S FIELD PROG, P308; Hossain F. S., 2011, 2011 14th International Conference on Computer and Information Technology (ICCIT), P339, DOI 10.1109/ICCITechn.2011.6164810; Hossain F. S., 2010, 2010 6th International Conference on Electrical & Computer Engineering (ICECE 2010), P562, DOI 10.1109/ICELCE.2010.5700754; Kamel D, 2009, IEEE INT SYMP CIRC S, P1385, DOI 10.1109/ISCAS.2009.5118023; Li H, 2004, 2004 INTERNATIONAL CONFERENCE ON COMMUNICATION, CIRCUITS, AND SYSTEMS, VOLS 1 AND 2, P1; Li HG, 2012, MICROELECTRON RELIAB, V52, P2829, DOI 10.1016/j.microrel.2012.04.020; Maslennikow O, 2007, 2007 PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON THE EXPERIENCE OF DESIGNING AND APPLICATION OF CAD SYSTEMS IN MICROELECTRONICS, P211, DOI 10.1109/CADSM.2007.4297528; Ming WM, 2013, INT C CIRC SYST ICCA; Morioka S, 2002, LECT NOTES COMPUT SC, V2523, P172; Nabihah A, 2014, VLSI J, V46; Natale G, 2009, J ELECTRON TEST, V25, P269, DOI 10.1007/s10836-009-5106-6; Nikova S, 2008, LECT NOTES COMPUT SC, V5229, P236, DOI 10.1007/978-3-540-85855-3_16; Rejeb J., 2006, INT C WIR MOB COMM I, P88; Rijmen V., 2002, EFFICIENT IMPLEMENTA; Rouvroy G, 2004, ITCC 2004: INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY: CODING AND COMPUTING, VOL 2, PROCEEDINGS, P583, DOI 10.1109/ITCC.2004.1286716; Satoh A., 2001, LECT NOTES COMPUTER, V2248, P239, DOI [DOI 10.1007/3-540-45682-1, 10.1007/3-540-45682-1, DOI 10.1007/3-540-45682-1_15]; Shanmugam M., 2014, P INT C COMPUTER INF, P1; Tillich S, 2008, J SIGNAL PROCESS SYS, V50, P251, DOI 10.1007/s11265-007-0158-2; Wilton SJE, 2004, LECT NOTES COMPUT SC, V3203, P719; Wolkerstorfer J., 2002, Topics in Cryptology - CT-RSA 2002. Cryptographers' Track at the RSA Conference 2002. Proceedings (Lecture Notes in Computer Science Vol.2271), P67; Wong M. M., 2010, 2010 2nd Asia Symposium on Quality Electronic Design (ASQED 2010), P318, DOI 10.1109/ASQED.2010.5548317; Zhang JY, 2007, I C WIREL COMM NETW, P2226, DOI 10.1109/WICOM.2007.555; Zhang X, 2004, IEEE T VERY LARGE SC, P45; Zhang Y, 2006, DSD 2006: 9TH EUROMICRO CONFERENCE ON DIGITAL SYSTEM DESIGN: ARCHITECTURES, METHODS AND TOOLS, PROCEEDINGS, P584	35	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0138457	10.1371/journal.pone.0138457	http://dx.doi.org/10.1371/journal.pone.0138457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491967	Green Submitted, Green Published, gold			2022-12-27	WOS:000363249300002
J	Tapia, E; Spetale, F; Krsticevic, F; Angelone, L; Bulacio, P				Tapia, Elizabeth; Spetale, Flavio; Krsticevic, Flavia; Angelone, Laura; Bulacio, Pilar			DNA Barcoding through Quaternary LDPC Codes	PLOS ONE			English	Article							RARE MUTATIONS; DESIGN; PRIMERS; ALGORITHMS; SAMPLES; TURBO	For many parallel applications of Next-Generation Sequencing (NGS) technologies short barcodes able to accurately multiplex a large number of samples are demanded. To address these competitive requirements, the use of error-correcting codes is advised. Current barcoding systems are mostly built from short random error-correcting codes, a feature that strongly limits their multiplexing accuracy and experimental scalability. To overcome these problems on sequencing systems impaired by mismatch errors, the alternative use of binary BCH and pseudo-quaternary Hamming codes has been proposed. However, these codes either fail to provide a fine-scale with regard to size of barcodes (BCH) or have intrinsic poor error correcting abilities (Hamming). Here, the design of barcodes from shortened binary BCH codes and quaternary Low Density Parity Check (LDPC) codes is introduced. Simulation results show that although accurate barcoding systems of high multiplexing capacity can be obtained with any of these codes, using quaternary LDPC codes may be particularly advantageous due to the lower rates of read losses and undetected sample mis-identification errors. Even at mismatch error rates of 10(-2) per base, 24-nt LDPC barcodes can be used to multiplex roughly 2000 samples with a sample misidentification error rate in the order of 10(-9) at the expense of a rate of read losses just in the order of 10(-6).	[Tapia, Elizabeth; Spetale, Flavio; Krsticevic, Flavia; Angelone, Laura; Bulacio, Pilar] CIFASIS Conicet Inst, Rosario, Santa Fe, Argentina; [Tapia, Elizabeth; Spetale, Flavio; Angelone, Laura; Bulacio, Pilar] Univ Nacl Rosario, Fac Cs Exactas & Ingn, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Tapia, E (corresponding author), CIFASIS Conicet Inst, Rosario, Santa Fe, Argentina.	tapia@cifasis-conicet.gov.ar	Spetale, Flavio Ezequiel/AAT-6556-2021; Tapia, Elizabeth/AAS-4263-2021	Spetale, Flavio Ezequiel/0000-0002-0226-8372; Tapia, Elizabeth/0000-0002-9363-4824	National Agency for Science and Technology Promotion, Argentina [2012-2513]	National Agency for Science and Technology Promotion, Argentina	This work was supported by project PICT 2012-2513, "Multiplex systems for targeted microfluidic amplification and NGS sequencing," National Agency for Science and Technology Promotion, Argentina. Institution: National Scientific and Technical Research Council (CONICET). Researcher: Elizabeth Tapia.	Ash R.B., 1990, INFORM THEORY; Baird DC., 1995, EXPERIMENTATION INTR, V3 rd edn; Balzer S, 2010, BIOINFORMATICS, V26, pi420, DOI 10.1093/bioinformatics/btq365; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Blahut Richard E, 2003, ALGEBRAIC CODES DATA; Buschmann T, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-264; Byers G. J., 2004, P SO AFR TEL NETW AP P SO AFR TEL NETW AP; Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852; Calderbank AR, 1998, IEEE T INFORM THEORY, V44, P2561, DOI 10.1109/18.720549; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carneiro MO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-375; CHASE D, 1972, IEEE T INFORM THEORY, V18, P170, DOI 10.1109/TIT.1972.1054746; Costea PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057521; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Davey MC, 1998, IEEE COMMUN LETT, V2, P165, DOI 10.1109/4234.681360; Davey MC, 2001, IEEE T INFORM THEORY, V47, P687, DOI 10.1109/18.910582; Declercq D, 2007, IEEE T COMMUN, V55, P633, DOI 10.1109/TCOMM.2007.894088; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gallager R., 1968, INFORM THEORY RELIAB; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hu XY, 2005, IEEE T INFORM THEORY, V51, P386, DOI 10.1109/TIT.2004.839541; Huang J, 2010, IEEE T COMMUN, V58, P3436, DOI 10.1109/TCOMM.2010.101210.090757; Huffman W., 2003, FUNDAMENTALS ERROR C; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Jin H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-6; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Knief C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00216; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kozintsev I, MATLAB PROGRAMMS ENC; Krishnan AR, 2011, ELECTRON LETT, V47, P236, DOI 10.1049/el.2010.3546; Krsticevic FJ, 2015, G3 BETHESDA      APR, P1; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Li MK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r34; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; MacKay D. J., 2003, OPTIMIZING SPARSE GR; MacKay DJC, 1999, IEEE T INFORM THEORY, V45, P399, DOI 10.1109/18.748992; MacWilliams FJ, 1988, THEORY ERROR CORRECT; Mardis ER, 2013, ANNU REV ANAL CHEM, V6, P287, DOI 10.1146/annurev-anchem-062012-092628; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MASEK WJ, 1980, J COMPUT SYST SCI, V20, P18, DOI 10.1016/0022-0000(80)90002-1; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Mir K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082933; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Poulliat C, 2008, IEEE T COMMUN, V56, P1626, DOI 10.1109/TCOMM.2008.060527; REED IS, 1990, IEE PROC-E, V137, P202, DOI 10.1049/ip-e.1990.0025; Renaud G, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-329; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sadjadpour HR, 2001, IEEE J SEL AREA COMM, V19, P831, DOI 10.1109/49.924867; Sam D., 1995, TDA PROGR REPORT, V42, P56; Schadt EE, 2010, HUM MOL GENET, V19, pR227, DOI 10.1093/hmg/ddq416; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368; Song HX, 2003, IEEE T MAGN, V39, P1081, DOI 10.1109/TMAG.2003.808600; Spagnol C, 2009, IEEE T CIRCUITS-I, V56, P2609, DOI 10.1109/TCSI.2009.2016621; Takamura S., C IMPLEMENTATION LDP; Tapia E, 2010, PATTERN RECOGN LETT, V31, P210, DOI 10.1016/j.patrec.2009.09.031; Tapia E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-59; Tarable A, 2004, IEEE T INFORM THEORY, V50, P2002, DOI 10.1109/TIT.2004.833353; Voicila A, 2010, IEEE T COMMUN, V58, P1365, DOI 10.1109/TCOMM.2010.05.070096; Wymeersch H, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, VOLS 1-7, P772, DOI 10.1109/ICC.2004.1312606	70	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140459	10.1371/journal.pone.0140459	http://dx.doi.org/10.1371/journal.pone.0140459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492348	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300006
J	Bix, L; Sundar, RP; Bello, NM; Peltier, C; Weatherspoon, LJ; Becker, MW				Bix, Laura; Sundar, Raghav Prashant; Bello, Nora M.; Peltier, Chad; Weatherspoon, Lorraine J.; Becker, Mark W.			To See or Not to See: Do Front of Pack Nutrition Labels Affect Attention to Overall Nutrition Information?	PLOS ONE			English	Article							VISUAL-ATTENTION; CONSUMERS; HEALTH; MOTIVATION; CAPTURE; CHOICES; SEARCH	Background Front of pack (FOP) nutrition labels are concise labels located on the front of food packages that provide truncated nutrition information. These labels are rapidly gaining prominence worldwide, presumably because they attract attention and their simplified formats enable rapid comparisons of nutritional value. Methods Eye tracking was conducted as US consumers interacted with actual packages with and without FOP labels to (1) assess if the presence of an FOP label increases attention to nutrition information when viewers are not specifically tasked with nutrition-related goals; and (2) study the effect of FOP presence on consumer use of more comprehensive, traditional nutrition information presented in the Nutritional Facts Panel (NFP), a mandatory label for most packaged foods in the US. Results Our results indicate that colored FOP labels enhanced the probability that any nutrition information was attended, and resulted in faster detection and longer viewing of nutrition information. However, for cereal packages, these benefits were at the expense of attention to the more comprehensive NFP. Our results are consistent with a potential short cut effect of FOP labels, such that if an FOP was present, participants spent less time attending the more comprehensive NFP. For crackers, FOP labels increased time spent attending to nutrition information, but we found no evidence that their presence reduced the time spent on the nutrition information in the NFP. Conclusions The finding that FOP labels increased attention to overall nutrition information by people who did not have an explicit nutritional goal suggests that these labels may have an advantage in conveying nutrition information to a wide segment of the population. However, for some food types this benefit may come with a short-cut effect; that is, decreased attention to more comprehensive nutrition information. These results have implications for policy and warrant further research into the mechanisms by which FOP labels impact use of nutrition information by consumers for different foods.	[Bix, Laura; Sundar, Raghav Prashant] Michigan State Univ, Sch Packaging, E Lansing, MI 48824 USA; [Bello, Nora M.] Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA; [Peltier, Chad; Becker, Mark W.] Michigan State Univ, Psychol Cognit & Cognit Neurosci Grp, E Lansing, MI 48824 USA; [Weatherspoon, Lorraine J.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA	Michigan State University; Kansas State University; Michigan State University; Michigan State University	Bix, L (corresponding author), Michigan State Univ, Sch Packaging, E Lansing, MI 48824 USA.	bixlaura@msu.edu	Bix, Laura/T-5117-2019	Bix, Laura/0000-0002-5779-7474	National Cancer Institute [R21CA155818]; NATIONAL CANCER INSTITUTE [R21CA155818] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project described was supported by Award Number R21CA155818 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. Further, Laura Bix, one of the coauthors, has salary support through the Hatch Act (USDA) as a Michigan Ag Bio Station researcher.	Alexander D., 2008, FRONT OF PACK NUTR L; Antunez L, 2013, INT J FOOD SCI NUTR, V64, P515, DOI 10.3109/09637486.2012.759187; Ares G, 2013, J SENS STUD, V28, P138, DOI 10.1111/joss.12031; Becker MW, 2002, PSYCHON B REV, V9, P744, DOI 10.3758/BF03196330; Bialkova S, 2014, APPETITE, V76, P66, DOI 10.1016/j.appet.2013.11.021; Bialkova S, 2011, FOOD QUAL PREFER, V22, P592, DOI 10.1016/j.foodqual.2011.03.010; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; Bix L, 2009, P NATL ACAD SCI USA, V106, P6550, DOI 10.1073/pnas.0810665106; Centers for Disease Control and Prevention, 2011, PREV WEIGHT GAIN; Chandon P, 2006, MEASURING VALUE POIN; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Daehaene S, 2006, TRENDS COGN SCI, P1; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; Denby N, 2009, DIETARY EXPERTS STOR; European Food Information Council, 2013, GLOB UPD NUTR LAB EX; Feunekes GI, 2008, APPETITE, V50, P57, DOI 10.1016/j.appet.2007.05.009; Finkelstein EA, 2003, NATL MED EXPENDITURE; Food Standards Agency, 2007, FRONT OF PACK TRAFF; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Goldberg JH, 1999, HUM FACTORS, V41, P425, DOI 10.1518/001872099779611021; Graham DJ, 2012, FOOD POLICY, V37, P378, DOI 10.1016/j.foodpol.2012.03.004; Gray N, HLTH LOGO NETHERLAND; Grocery Manufacturers Association, 2014, FACTS UP FRONT OV; Grunert KG, 2010, APPETITE, V55, P177, DOI 10.1016/j.appet.2010.05.045; Hawley K.L., 2012, PUBLIC HEALTH NUTR, V1, P1; Hodgkins C, 2012, APPETITE, V59, P806, DOI 10.1016/j.appet.2012.08.014; Jones G, 2007, PUBLIC HEALTH NUTR, V10, P238, DOI 10.1017/S1368980007258513; Kelly B, 2009, HEALTH PROMOT INT, V24, P120, DOI 10.1093/heapro/dap012; Koenigstorfer J, 2014, PUBLIC HEALTH NUTR, V17, P2115, DOI 10.1017/S136898001300219X; Langton SRH, 2008, COGNITION, V107, P330, DOI 10.1016/j.cognition.2007.07.012; Leong S, 1993, J CONSUM PSYCHOL, V2, P193, DOI DOI 10.1016/S1057-7408(08)80024-1; Levy DE, 2012, AM J PREV MED, V43, P240, DOI 10.1016/j.amepre.2012.05.004; Mack A, 2002, CONSCIOUS COGN, V11, P488, DOI 10.1016/S1053-8100(02)00028-4; Mackintosh A, 2008, THE TICK UPDATE; McCullum C, 1997, ADOLESCENCE, V32; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Nestle M, 2010, JAMA-J AM MED ASSOC, V303, P771, DOI 10.1001/jama.2010.179; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Rock I, 1998, INATTENTIONAL BLINDE; Roe B, 1999, J PUBLIC POLICY MARK, V18, P89, DOI 10.1177/074391569901800110; Scholderer J, 2011, J EYE TRACKING VISUA; Siegrist M, 2015, FOOD QUAL PREFER, V39, P183, DOI 10.1016/j.foodqual.2014.07.010; Smart Choices Program, 2015, SMART CHOIC PROGR HE; Smith NK, 2003, NEUROPSYCHOLOGIA, V41, P171, DOI 10.1016/S0028-3932(02)00147-1; Sundar R, 2009, EFFECT COLOR CONTRAS; Swedish National Food Administration, 2015, AB THE KEYH; Thorndike AN, 2014, AM J PREV MED, V46, P143, DOI 10.1016/j.amepre.2013.10.002; Turner MM, 2014, J HEALTH COMMUN, V19, P1017, DOI 10.1080/10810730.2013.864726; US Food and Drug Administration, 2014, FRONT OF PACK LAB IN; van Herpen E, 2011, APPETITE, V57, P148, DOI 10.1016/j.appet.2011.04.011; Visschers VHM, 2010, PUBLIC HEALTH NUTR, V13, P1099, DOI 10.1017/S1368980009993235; Wansink B, 2003, J CONSUM AFF, V37, P305, DOI 10.1111/j.1745-6606.2003.tb00455.x; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wolf M.A., 1998, CURRENT ESTIMATES EC	57	31	31	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139732	10.1371/journal.pone.0139732	http://dx.doi.org/10.1371/journal.pone.0139732			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488611	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400036
J	Kang, J; Hong, JH; Jang, MU; Kim, BJ; Bae, HJ; Han, MK				Kang, Jihoon; Hong, Jeong-Ho; Jang, Min Uk; Kim, Beom Joon; Bae, Hee-Joon; Han, Moon-Ku			Cardioembolism and Involvement of the Insular Cortex in Patients with Ischemic Stroke	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; STENOSIS; SUBTYPE	Background To evaluate whether topographical characteristics of insular involvement in ischemic stroke are associated with cardioembolism. Methods and Findings A consecutive series of patients hospitalized for ischemic stroke within 7 days of symptom onset were identified. Based on diffusion-weighted imaging, we included those who had ischemic lesions in the middle cerebral artery (MCA) territory. Each patient was assigned to one of two groups based on the presence or absence of insular involvement. The primary outcome was the frequency of cardioembolism, which was compared based on insular involvement. Of 1,311 patients with ischemic stroke in the MCA territory, 112 had insular involvement (8.5%). The frequency of cardioembolism in patients with insular involvement (52.7%) was significantly higher than that in patients without insular involvement (30.4%, P < 0.001). Although insular involvement was associated with a severe baseline National Institutes of Health Stroke Scale score (13 vs. 4), it did not independently affect the 3-month functional outcome. Conclusions In cases of stroke in the MCA territory, involvement of the insular cortex may be associated with a risk of cardioembolism.	[Kang, Jihoon] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Neurol, Chang Won, South Korea; [Hong, Jeong-Ho] Keimyung Univ, Sch Med, Dongsan Med Ctr, Dept Neurol, Daegu, South Korea; [Jang, Min Uk] Hallym Univ, Sch Med, Chuncheon Sacred Heart Hosp, Dept Neurol, Chunchon, South Korea; [Kim, Beom Joon; Bae, Hee-Joon; Han, Moon-Ku] Seoul Natl Univ, Bundang Hosp, Cerebrovasc Ctr, Dept Neurol, Songnam, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Keimyung University; Hallym University; Seoul National University (SNU)	Han, MK (corresponding author), Seoul Natl Univ, Bundang Hosp, Cerebrovasc Ctr, Dept Neurol, Songnam, South Korea.	mkhan@snu.ac.kr	Hong, Jeong-Ho/T-8099-2018; Hong, Jeong-Ho/AAE-1002-2022; Kim, Beom Joon/C-2904-2011	Hong, Jeong-Ho/0000-0002-8235-9855; Hong, Jeong-Ho/0000-0002-8235-9855; Kim, Beom Joon/0000-0002-2719-3012; HAN, MOON-KU/0000-0003-0166-387X; Kang, Jihoon/0000-0001-5715-6610				Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Ay H, 2008, STROKE, V39, P373, DOI 10.1161/STROKEAHA.107.499095; Bae HJ, 2012, CLIN RES CTR STROKE; Boussel L, 2011, RADIOLOGY, V258, P206, DOI 10.1148/radiol.10100804; Cereda C, 2002, NEUROLOGY, V59, P1950, DOI 10.1212/01.WNL.0000038905.75660.BD; Christensen H, 2005, J NEUROL NEUROSUR PS, V76, P269, DOI 10.1136/jnnp.2004.037531; Coull AJ, 2004, STROKE, V35, P1925, DOI 10.1161/01.STR.0000133129.58126.67; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Fink JN, 2005, ARCH NEUROL-CHICAGO, V62, P1081, DOI 10.1001/archneur.62.7.1081; Gao S, 2004, STROKE, V35, P2832, DOI 10.1161/01.STR.0000147035.31297.b6; 유경호, 2006, [Journal of the Korean Neurological Association, 대한신경과학회지], V24, P535; Idicula TT, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-79; Jiang WJ, 2004, STROKE, V35, P1375, DOI 10.1161/01.STR.0000128018.57526.3a; Ko Y, 2014, J STROKE, V16, P161, DOI 10.5853/jos.2014.16.3.161; Lee PH, 2004, J NEUROL NEUROSUR PS, V75, P727, DOI 10.1136/jnnp.2003.022574; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Megherbi SE, 2003, STROKE, V34, P688, DOI 10.1161/01.STR.0000057975.15221.40; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Park JH, 2012, NEUROLOGY, V78, P421, DOI 10.1212/WNL.0b013e318245d22c; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Sander D, 2001, NEUROLOGY, V57, P833, DOI 10.1212/WNL.57.5.833; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; Tokgozoglu SL, 1999, STROKE, V30, P1307, DOI 10.1161/01.STR.30.7.1307	23	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139540	10.1371/journal.pone.0139540	http://dx.doi.org/10.1371/journal.pone.0139540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489090	Green Submitted, gold, Green Published			2022-12-27	WOS:000363248400031
J	Barnawi, J; Tran, H; Jersmann, H; Pitson, S; Roscioli, E; Hodge, G; Meech, R; Haberberger, R; Hodge, S				Barnawi, Jameel; Hai Tran; Jersmann, Hubertus; Pitson, Stuart; Roscioli, Eugene; Hodge, Greg; Meech, Robyn; Haberberger, Rainer; Hodge, Sandra			Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD)	PLOS ONE			English	Article							SPHINGOSINE KINASE-ACTIVITY; APOPTOTIC CELLS; LUNG INJURY; SPHINGOLIPID METABOLISM; EPITHELIAL-CELLS; INFLAMMATION; CLEARANCE; RECEPTOR; 1-PHOSPHATE; RECOGNITION	Introduction We previously reported that alveolar macrophages from patients with chronic obstructive pulmonary disease (COPD) are defective in their ability to phagocytose apoptotic cells, with a similar defect in response to cigarette smoke. The exact mechanisms for this defect are unknown. Sphingolipids including ceramide, sphingosine and sphingosine-1-phosphate (S1P) are involved in diverse cellular processes and we hypothesised that a comprehensive analysis of this system in alveolar macrophages in COPD may help to delineate the reasons for defective phagocytic function. Methods We compared mRNA expression of sphingosine kinases (SPHK1/2), S1P receptors (S1PR1-5) and S1P-degrading enzymes (SGPP1, SGPP2, SGPL1) in bronchoalveolar lavage-derived alveolar macrophages from 10 healthy controls, 7 healthy smokers and 20 COPD patients (10 current- and 10 ex-smokers) using Real-Time PCR. Phagocytosis of apoptotic cells was investigated using flow cytometry. Functional associations were assessed between sphingosine signalling system components and alveolar macrophage phagocytic ability in COPD. To elucidate functional effects of increased S1PR5 on macrophage phagocytic ability, we performed the phagocytosis assay in the presence of varying concentrations of suramin, an antagonist of S1PR3 and S1PR5. The effects of cigarette smoking on the S1P system were investigated using a THP-1 macrophage cell line model. Results We found significant increases in SPHK1/2 (3.4- and 2.1-fold increases respectively), S1PR2 and 5 (4.3- and 14.6-fold increases respectively), and SGPL1 (4.5-fold increase) in COPD vs. controls. S1PR5 and SGPL1 expression was unaffected by smoking status, suggesting a COPD "disease effect" rather than smoke effect per se. Significant associations were noted between S1PR5 and both lung function and phagocytosis. Cigarette smoke extract significantly increased mRNA expression of SPHK1, SPHK2, S1PR2 and S1PR5 by THP-1 macrophages, confirming the results in patient-derived macrophages. Antagonising SIPR5 significantly improved phagocytosis. Conclusion Our results suggest a potential link between the S1P signalling system and defective macrophage phagocytic function in COPD and advise therapeutic targets.	[Barnawi, Jameel; Hai Tran; Jersmann, Hubertus; Roscioli, Eugene; Hodge, Greg; Hodge, Sandra] Hanson Inst, Lung Res, Adelaide, SA, Australia; [Barnawi, Jameel; Jersmann, Hubertus; Pitson, Stuart; Hodge, Greg; Hodge, Sandra] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia; [Barnawi, Jameel] Univ Tabuk, Dept Med Lab Technol, Tabuk, Saudi Arabia; [Pitson, Stuart] Univ S Australia, Ctr Canc Biol, Adelaide, SA 5001, Australia; [Pitson, Stuart] SA Pathol, Adelaide, SA, Australia; [Meech, Robyn] Flinders Univ S Australia, Dept Clin Pharmacol, Adelaide, SA 5001, Australia; [Haberberger, Rainer] Flinders Univ S Australia, Ctr Neurosci Anat & Histol, Adelaide, SA 5001, Australia	Hanson Institute; University of Adelaide; University of Tabuk; Centre for Cancer Biology; University of South Australia; SA Pathology; Flinders University South Australia; Flinders University South Australia	Hodge, S (corresponding author), Hanson Inst, Lung Res, Adelaide, SA, Australia.	sandra.hodge@health.sa.gov.au	Jersmann, Hubertus/ABC-5287-2020; Pitson, Stuart/B-9342-2009	Jersmann, Hubertus/0000-0003-1763-2736; Pitson, Stuart/0000-0002-9527-2740; Meech, Robyn/0000-0002-6831-0801; Roscioli, Eugene/0000-0002-3201-3899; Haberberger, Rainer Viktor/0000-0001-8043-3786	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council Project Grant (SH, HJ, RH, RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Becker KA, 2010, AM J RESP CELL MOL, V42, P716, DOI 10.1165/rcmb.2009-0174OC; Bertelmann E, 2003, OPHTHALMOLOGE, V100, P696, DOI 10.1007/s00347-003-0898-8; Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Blondeau N, 2007, J NEUROCHEM, V103, P509, DOI 10.1111/j.1471-4159.2007.04755.x; Chen YF, 2009, J IMMUNOL, V183, P1346, DOI 10.4049/jimmunol.0900948; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Cordts F, 2011, LIFE SCI, V89, P806, DOI 10.1016/j.lfs.2011.08.018; Dehle FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061573; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Filosto S, 2011, AM J RESP CELL MOL, V44, P350, DOI 10.1165/rcmb.2009-0422OC; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Fischer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023905; Fukuda Y, 2003, BIOCHEM BIOPH RES CO, V309, P155, DOI 10.1016/S0006-291X(03)01551-1; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; Hammad SM, 2008, PROSTAG OTH LIPID M, V85, P107, DOI 10.1016/j.prostaglandins.2007.11.002; Hart SP, 1996, EXPERIENTIA, V52, P950, DOI 10.1007/BF01920103; Hart SP, 2004, CLIN EXP IMMUNOL, V135, P181, DOI 10.1111/j.1365-2249.2003.02330.x; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hodge S, 2006, EUR RESPIR J, V28, P486, DOI 10.1183/09031936.06.00001506; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2012, RESPIROLOGY, V17, P802, DOI 10.1111/j.1440-1843.2012.02135.x; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hodge S, 2010, AM J RESP CELL MOL, V42, P235, DOI 10.1165/rcmb.2008-0486OC; Hodge SJ, 2004, CYTOM PART B-CLIN CY, V61B, P27, DOI 10.1002/cyto.b.20020; Igarashi Y, 1997, J BIOCHEM-TOKYO, V122, P1080; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Kohno T, 2003, GENES CELLS, V8, P685, DOI 10.1046/j.1365-2443.2003.00667.x; Kuebler WM, 2010, CELL PHYSIOL BIOCHEM, V26, P29, DOI 10.1159/000315103; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; McQuiston T, 2011, MICROBIOL-SGM, V157, P1416, DOI 10.1099/mic.0.045989-0; McQuiston T, 2010, INFECT IMMUN, V78, P2342, DOI 10.1128/IAI.01140-09; Miron VE, 2010, AM J PATHOL, V176, P2682, DOI 10.2353/ajpath.2010.091234; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Mukaro VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056147; Mukaro VRS, 2011, CURR DRUG TARGETS, V12, P460; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Ndozangue-Touriguine O, 2008, BIOCHEM PHARMACOL, V76, P11, DOI 10.1016/j.bcp.2008.03.016; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Oskouian B, 2010, ADV EXP MED BIOL, V688, P185; Parekh Dhruv, 2013, Inflammation & Allergy Drug Targets, V12, P253; Pauwels R A, 2001, Respir Care, V46, P798; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Peng YF, 2005, MOL IMMUNOL, V42, P781, DOI 10.1016/j.molimm.2004.07.045; Petrusca DN, 2010, J BIOL CHEM, V285, P40322, DOI 10.1074/jbc.M110.137604; Reardon BJ, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-122; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Romme EAPM, 2013, EXPERT REV RESP MED, V7, P397, DOI 10.1586/17476348.2013.814402; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Skoura A, 2011, ARTERIOSCL THROM VAS, V31, P81, DOI 10.1161/ATVBAHA.110.213496; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; Tran HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098571; Treede I, 2007, J BIOL CHEM, V282, P27155, DOI 10.1074/jbc.M704408200; Uhlig S, 2008, AM J RESP CRIT CARE, V178, P1100, DOI 10.1164/rccm.200804-595SO; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Wang F, 2010, J CLIN INVEST, V120, P3979, DOI 10.1172/JCI42315; Weichand B, 2013, EUR J IMMUNOL, V43, P3306, DOI 10.1002/eji.201343441; Weigert A, 2011, ANTI-CANCER AGENT ME, V11, P818, DOI 10.2174/187152011797655096; Weigert A, 2009, IMMUNOBIOLOGY, V214, P748, DOI 10.1016/j.imbio.2009.06.003; Wood AM, 2011, THORAX, V66, P205, DOI 10.1136/thx.2010.140921; Yang Yang, 2011, Ther Adv Respir Dis, V5, P325, DOI 10.1177/1753465811406772	71	32	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0122771	10.1371/journal.pone.0122771	http://dx.doi.org/10.1371/journal.pone.0122771			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485657	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000363028100001
J	De Salvador-Guillouet, F; Sakarovitch, C; Durant, J; Risso, K; Demonchy, E; Roger, M; Fontas, E				De Salvador-Guillouet, F.; Sakarovitch, C.; Durant, J.; Risso, K.; Demonchy, E.; Roger, M.; Fontas, E.			Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study	PLOS ONE			English	Article							T-CELL-ACTIVATION; HIV-1-INFECTED PATIENTS; IMMUNE ACTIVATION; RALTEGRAVIR INTENSIFICATION; HAART; SUPPRESSION; THERAPY; REPLICATION; BIOMARKERS; DECREASES	Background As CD4/CD8 ratio inversion has been associated with non-AIDS morbidity and mortality, predictors of ratio normalization after cART need to be studied. Here, we aimed to investigate the association of antiretroviral regimens with CD4/CD8 ratio normalization within an observational cohort. Methods We selected, from a French cohort at the Nice University Hospital, HIV-1 positive treatment-naive patients who initiated cART between 2000 and 2011 with a CD4/CD8 ratio <1. Association between cART and ratio normalization (>1) in the first year was assessed using multi-variate logistic regression models. Specific association with INSTI-containing regimens was examined. Results 567 patients were included in the analyses; the median CD4/CD8 ratio was 0.36. Respectively, 52.9%, 29.6% and 10.4% initiated a PI-based, NNRTI-based or NRTI-based cART regimens. About 8% of the population started an INSTI-containing regimen. 62 (10.9%) patients achieved a CD4/CD8 ratio >= 1 (N group). cART regimen was not associated with normalization when coded as PI-, NNRTI- or NRTI-based regimen. However, when considering INSTI-containing regimens alone, there was a strong association with normalization [OR, 7.67 (2.54-23.2)]. Conclusions Our findings suggest an association between initiation of an INSTI-containing regimen and CD4/CD8 ratio normalization at one year in naive patients. Should it be confirmed in a larger population, it would be another argument for their use as first-line regimen as it is recommended in the recent update of the "Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents".	[De Salvador-Guillouet, F.; Durant, J.; Risso, K.; Demonchy, E.; Roger, M.] Nice Univ Hosp, Dept Infectiol, F-06003 Nice, France; [Sakarovitch, C.; Fontas, E.] Nice Univ Hosp, Dept Clin Res & Innovat, F-06003 Nice, France	CHU Nice; CHU Nice	Fontas, E (corresponding author), Nice Univ Hosp, Dept Infectiol, F-06003 Nice, France.	fontas.e@chu-nice.fr						Adolescents PoAGfAa, GUIDELINES USE ANTIR; Aiuti F, 2006, AIDS REV, V8, P88; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Babiker AG, 2013, CLIN TRIALS, V10, pS5, DOI 10.1177/1740774512440342; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Crum-Cianflone NF, 2011, CLIN VACCINE IMMUNOL, V18, P940, DOI 10.1128/CVI.00020-11; Gupta SK, 2013, JAIDS-J ACQ IMM DEF, V64, P279, DOI 10.1097/QAI.0b013e3182a97c39; Hoen B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19034; Lake JE, 2014, HIV MED, V15, P431, DOI 10.1111/hiv.12128; Leung V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077665; Lichtenstein KA, 2012, ANTIVIR THER, V17, P1301, DOI 10.3851/IMP2350; Martinez E, 2012, AIDS, V26, P2315, DOI 10.1097/QAD.0b013e328359f29c; Massanella M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114142; Massanella M, 2013, JAIDS-J ACQ IMM DEF, V63, P152, DOI 10.1097/QAI.0b013e318289439a; Massanella M, 2012, AIDS, V26, P2285, DOI 10.1097/QAD.0b013e328359f20f; Monteiro P, 2014, J ANTIMICROB CHEMOTH, V69, P742, DOI 10.1093/jac/dkt406; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Poizot-Martin I, 2013, J CLIN VIROL, V57, P351, DOI 10.1016/j.jcv.2013.04.007; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Ronsholt FF, 2012, JAIDS-J ACQ IMM DEF, V61, P270, DOI 10.1097/QAI.0b013e31825e7ac1; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Sajadi MM, 2012, AIDS, V26, P1879, DOI 10.1097/QAD.0b013e328357f5d1; Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Serrano-Villar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085798; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Silva EF, 2013, J INFECT DIS, V208, P892, DOI 10.1093/infdis/jit280; Stokes KY, 2002, MICROCIRCULATION, V9, P407, DOI 10.1038/sj.mn.7800148; Tinago W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097011; Torti C, 2012, CLIN MICROBIOL INFEC, V18, P449, DOI 10.1111/j.1469-0691.2011.03650.x; Zheng L, 2014, JAIDS-J ACQ IMM DEF, V67, P153, DOI 10.1097/QAI.0000000000000286	31	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140519	10.1371/journal.pone.0140519	http://dx.doi.org/10.1371/journal.pone.0140519			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485149	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100041
J	Qi, YJ; Xiong, W; Liu, WQ; Fang, H; Lu, WD				Qi, Yujun; Xiong, Wei; Liu, Weiqing; Fang, Hai; Lu, Weidong			Experimental Study of the Flexural and Compression Performance of an Innovative Pultruded Glass-Fiber-Reinforced Polymer-Wood Composite Profile	PLOS ONE			English	Article							GFRP BRIDGE DECK; STATIC BEHAVIOR; PULTRUSION; FAILURE; REBAR	The plate of a pultruded fiber-reinforced polymer or fiber-reinforced plastic (FRP) profile produced via a pultrusion process is likely to undergo local buckling and cracking along the fiber direction under an external load. In this study, we constructed a pultruded glass-fiber-reinforced polymer-light wood composite (PGWC) profile to explore its mechanical performance. A rectangular cross-sectional PGWC profile was fabricated with a paulownia wood core, alkali-free glass fiber filaments, and unsaturated phthalate resin. Three-point bending and short column axial compression tests were conducted. Then, the stress calculation for the PGWC profile in the bending and axial compression tests was performed using the Timoshenko beam theory and the composite component analysis method to derive the flexural and axial compression rigidity of the profile during the elastic stress stage. The flexural capacity for this type of PGWC profile is 3.3-fold the sum of the flexural capacities of the wood core and the glass-fiber-reinforced polymer (GFRP) shell. The equivalent flexural rigidity is 1.5-fold the summed flexural rigidity of the wood core and GFRP shell. The maximum axial compressive bearing capacity for this type of PGWC profile can reach 1.79-fold the sum of those of the wood core and GFRP shell, and its elastic flexural rigidity is 1.2-fold the sum of their rigidities. These results indicate that in PGWC profiles, GFRP and wood materials have a positive combined effect. This study produced a pultruded composite material product with excellent mechanical performance for application in structures that require a large bearing capacity.	[Qi, Yujun; Xiong, Wei; Liu, Weiqing; Fang, Hai; Lu, Weidong] Nanjing Tech Univ, Coll Civil Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Tech University	Qi, YJ (corresponding author), Nanjing Tech Univ, Coll Civil Engn, Nanjing, Jiangsu, Peoples R China.	qiyujun@njtech.edu.cn			Key Program of National Natural Science Foundation of China [51238003]; National Natural Science Foundation of China [51308287]; Natural Science Foundation of Jiangsu Province [BK20130936]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The research described in this study was supported by the Key Program of National Natural Science Foundation of China (No. 51238003), the National Natural Science Foundation of China (No. 51308287) and the Natural Science Foundation of Jiangsu Province (No. BK20130936). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, C297C297M04 ASTM; [Anonymous], C273C273M11 ASTM; [Anonymous], 2010, D69510 ASTM; ASTM, 2007, D4255 ASTM; ASTM C365 / C365M-16,, 2016, STANDARD TEST METHOD; Bai Y, 2013, MATER STRUCT, V46, P1143, DOI 10.1617/s11527-012-9960-9; Bakis CE, 2002, J COMPOS CONSTR, V6, P73, DOI 10.1061/(ASCE)1090-0268(2002)6:2(73); Bank L.C., 2006, COMPOSITES CONSTRUCT; Baran I, 2015, INT J MATER FORM, V8, P379, DOI 10.1007/s12289-014-1179-6; Baran I, 2015, INT J MATER FORM, V8, P367, DOI 10.1007/s12289-014-1178-7; Baran I, 2015, COMPOS PART B-ENG, V68, P365, DOI 10.1016/j.compositesb.2014.07.032; Baran I, 2014, COMPOS STRUCT, V118, P37, DOI 10.1016/j.compstruct.2014.07.018; Baran I, 2013, COMPOS PART B-ENG, V51, P148, DOI 10.1016/j.compositesb.2013.03.031; Carlone P, 2006, MATH COMPUT MODEL, V44, P701, DOI 10.1016/j.mcm.2006.02.006; Di Tommaso A, 2003, MECH COMPOS MATER, V39, P329, DOI 10.1023/A:1025694427941; Ely T, 2001, J COMPOS MATER, V35, P751, DOI 10.1106/N8RB-5G5E-HVC9-A6F7; Fam A, 2016, J BRIDGE ENG, V21, DOI 10.1061/(ASCE)BE.1943-5592.0000768; Feo L, 2013, COMPOS PART B-ENG, V48, P18, DOI 10.1016/j.compositesb.2012.11.001; Hashem ZA, 2000, COMPOS PART B-ENG, V31, P611, DOI 10.1016/S1359-8368(99)00042-6; Keller T., 2003, USE FIBRE REINFORCED; Keller T, 2014, J COMPOS CONSTR, V18, DOI 10.1061/(ASCE)CC.1943-5614.0000423; Manalo AC, 2010, COMPOS STRUCT, V92, P2703, DOI 10.1016/j.compstruct.2010.03.006; Manalo AC, 2010, COMPOS STRUCT, V92, P984, DOI 10.1016/j.compstruct.2009.09.046; Osei-Antwi M, 2013, J COMPOS CONSTR, V17, DOI 10.1061/(ASCE)CC.1943-5614.0000435; Rochette P, 2000, J COMPOS CONSTR, V4, P129, DOI DOI 10.1061/(ASCE)1090-0268(2000)4:3(129); Sawpan MA, 2014, MATER DESIGN, V57, P616, DOI 10.1016/j.matdes.2014.01.049; Sawpan MA, 2012, MATER DESIGN, V42, P272, DOI 10.1016/j.matdes.2012.06.008; Scott DW, 1998, COMPOS SCI TECHNOL, V58, P1361, DOI 10.1016/S0266-3538(98)00009-8; Shi D, 2014, ACTA MATERIAE COMPOS, V6, P1428; Standard A.S.T.M, 2008, D3039DM3039 ASTM; Turvey GJ, 2006, COMPUT STRUCT, V84, P1527, DOI 10.1016/j.compstruc.2006.01.028; Wang L, 2014, COMPOS PART B-ENG, V60, P495, DOI 10.1016/j.compositesb.2014.01.013; Wu C, 2015, THIN WALL STRUCT, V89, P67, DOI 10.1016/j.tws.2014.12.006; Wu C, 2014, COMPOS STRUCT, V108, P789, DOI 10.1016/j.compstruct.2013.10.020; Yu M, 2013, ENG STRUCT, V49, P1, DOI 10.1016/j.engstruct.2012.10.018; Zi G, 2008, COMPOS STRUCT, V85, P155, DOI 10.1016/j.compstruct.2007.10.015; Zi G, 2008, COMPOS STRUCT, V82, P257, DOI 10.1016/j.compstruct.2007.01.010; Zureick A., 1998, PROG STRUCT ENG MAT, V1, P143	38	2	2	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140893	10.1371/journal.pone.0140893	http://dx.doi.org/10.1371/journal.pone.0140893			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485431	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100087
J	Sagari, A; Iso, N; Moriuchi, T; Ogahara, K; Kitajima, E; Tanaka, K; Tabira, T; Higashi, T				Sagari, Akira; Iso, Naoki; Moriuchi, Takefumi; Ogahara, Kakuya; Kitajima, Eiji; Tanaka, Koji; Tabira, Takayuki; Higashi, Toshio			Changes in Cerebral Hemodynamics during Complex Motor Learning by Character Entry into Touch-Screen Terminals	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CORTICAL ACTIVATION PATTERNS; PREFRONTAL CORTEX; FUNCTIONAL SPECIALIZATION; BRAIN ACTIVATION; PIANO PLAYERS; NON-MUSICIANS; BLOOD-FLOW; SUPPLEMENTARY; TASK	Introduction Studies of cerebral hemodynamics during motor learning have mostly focused on neurorehabilitation interventions and their effectiveness. However, only a few imaging studies of motor learning and the underlying complex cognitive processes have been performed. Methods We measured cerebral hemodynamics using near-infrared spectroscopy (NIRS) in relation to acquisition patterns of motor skills in healthy subjects using character entry into a touchscreen terminal. Twenty healthy, right-handed subjects who had no previous experience with character entry using a touch-screen terminal participated in this study. They were asked to enter the characters of a randomly formed Japanese syllabary into the touchscreen terminal. All subjects performed the task with their right thumb for 15 s alternating with 25 s of rest for 30 repetitions. Performance was calculated by subtracting the number of incorrect answers from the number of correct answers, and gains in motor skills were evaluated according to the changes in performance across cycles. Behavioral and oxygenated hemoglobin concentration changes across task cycles were analyzed using Spearman's rank correlations. Results Performance correlated positively with task cycle, thus confirming motor learning. Hemodynamic activation over the left sensorimotor cortex (SMC) showed a positive correlation with task cycle, whereas activations over the right prefrontal cortex (PFC) and supplementary motor area (SMA) showed negative correlations. Conclusions We suggest that increases in finger momentum with motor learning are reflected in the activity of the left SMC. We further speculate that the right PFC and SMA were activated during the early phases of motor learning, and that this activity was attenuated with learning progress.	[Sagari, Akira; Iso, Naoki; Moriuchi, Takefumi; Higashi, Toshio] Nagasaki Univ, Grad Sch Biomed Sci, Unit Rehabil Sci, Nagasaki 852, Japan; [Sagari, Akira] Nagasaki Genbaku Hosp, Japanese Red Cross Soc, Nagasaki, Japan; [Iso, Naoki; Moriuchi, Takefumi] Tojinkai Miharadai Hosp, Med Corp, Nagasaki, Japan; [Ogahara, Kakuya] Kanagawa Univ Human Serv, Fac Hlth & Social Work, Sch Rehabil, Kanagawa, Japan; [Kitajima, Eiji] Nagasaki Univ, Univ & Govt Cooperat, Ctr Ind, Nagasaki 852, Japan; [Tanaka, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Unit Phys & Occupat Therapy, Nagasaki 852, Japan; [Tabira, Takayuki] Nishikyushu Univ, Fac Rehabil Sci, Saga, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Higashi, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Rehabil Sci, Nagasaki 852, Japan.	higashi-t@nagasaki-u.ac.jp	TANAKA, KOJI/ABC-4601-2021; Tabira, takayuki/AAS-4222-2021	TANAKA, KOJI/0000-0002-7932-8601; 	Grants-in-Aid for Scientific Research [26350613] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amemiya K, 2010, BRAIN RES, V1343, P93, DOI 10.1016/j.brainres.2010.04.048; Anguera JA, 2010, J COGNITIVE NEUROSCI, V22, P1917, DOI 10.1162/jocn.2009.21351; Awh E, 1996, DISSOCIATION STORAGE, P25; Bedard P, 2014, NEUROIMAGE, V101, P225, DOI 10.1016/j.neuroimage.2014.07.009; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; Debaere F, 2004, NEUROPSYCHOLOGIA, V42, P855, DOI 10.1016/j.neuropsychologia.2003.12.010; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Deiber MP, 1997, J NEUROPHYSIOL, V78, P977, DOI 10.1152/jn.1997.78.2.977; Deluca C, 2014, CORTEX, V58, P52, DOI 10.1016/j.cortex.2014.04.017; eMarketer, 2014, SMARTPH US WORLDW WI; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Floel A, 2004, CEREB CORTEX, V14, P404, DOI 10.1093/cercor/bhh002; Floyer-Lea A, 2005, J NEUROPHYSIOL, V94, P512, DOI 10.1152/jn.00717.2004; Gentili RJ, FUNCTIONAL NEAR INFR; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Grafton ST, 2002, EXP BRAIN RES, V146, P369, DOI 10.1007/s00221-002-1181-y; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; Hanakawa T, 2002, CEREB CORTEX, V12, P1157, DOI 10.1093/cercor/12.11.1157; Harada T, 2009, EXP BRAIN RES, V193, P445, DOI 10.1007/s00221-008-1643-y; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Hatakenaka M, 2007, NEUROIMAGE, V34, P109, DOI 10.1016/j.neuroimage.2006.08.014; Hatta A, 2009, NEUROSCI LETT, V459, P105, DOI 10.1016/j.neulet.2009.05.005; Herbster AN, 1997, HUM BRAIN MAPP, V5, P84, DOI 10.1002/(SICI)1097-0193(1997)5:2<84::AID-HBM2>3.0.CO;2-I; Hikosaka O, 1996, J NEUROPHYSIOL, V76, P617, DOI 10.1152/jn.1996.76.1.617; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hiroyuki H, 2002, EUR J APPL PHYSIOL, V87, P343, DOI 10.1007/s00421-002-0644-y; Holper L, 2009, NEUROIMAGE, V46, P1105, DOI 10.1016/j.neuroimage.2009.03.027; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Hund-Georgiadis M, 1999, EXP BRAIN RES, V125, P417, DOI 10.1007/s002210050698; Ide K, 2014, CEREBRAL METABOLIC R, P1604; Ikegami T, 2008, EXP BRAIN RES, V191, P221, DOI 10.1007/s00221-008-1518-2; Ito M, 2005, NEUROPSYCHOBIOLOGY, V52, P45, DOI 10.1159/000086177; James DRC, 2013, NEUROIMAGE, V64, P267, DOI 10.1016/j.neuroimage.2012.08.056; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kikuchi S, 2007, PSYCHIAT RES-NEUROIM, V156, P199, DOI 10.1016/j.pscychresns.2007.01.002; King BR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00142; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Kubo M, 2008, NEUROPSYCHOBIOLOGY, V58, P200, DOI 10.1159/000201717; Kuboyama Naomi, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P201, DOI 10.2114/jpa.24.201; Kuboyama Naomi, 2004, Journal of Physiological Anthropology and Applied Human Science, V23, P105, DOI 10.2114/jpa.23.105; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; Leek EC, 2009, NAT REV NEUROSCI, V10, P78, DOI 10.1038/nrn2478-c1; Lefebvre S, 2012, NEUROIMAGE, V62, P290, DOI 10.1016/j.neuroimage.2012.04.052; Leff DR, 2008, NEUROIMAGE, V39, P805, DOI 10.1016/j.neuroimage.2007.09.032; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Miyai I, 2002, ANN NEUROL, V52, P188, DOI 10.1002/ana.10274; Miyai I, 2003, STROKE, V34, P2866, DOI 10.1161/01.STR.0000100166.81077.8A; Miyata H, 2011, BRAIN RES, V1374, P90, DOI 10.1016/j.brainres.2010.12.047; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nakahachi T, 2010, BEHAV BRAIN RES, V215, P21, DOI 10.1016/j.bbr.2010.06.016; Nakata H, 2014, J PHYSIOL SCI, V64, P233, DOI 10.1007/s12576-014-0320-0; Norris DG, 2006, J MAGN RESON IMAGING, V23, P794, DOI 10.1002/jmri.20587; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Ohsugi H, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-10; Okamoto M, 2004, NEUROIMAGE, V21, P1275, DOI 10.1016/j.neuroimage.2003.12.003; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Okamoto M, 2007, J BIOSCI BIOENG, V103, P207, DOI 10.1263/jbb.103.207; Opitz B, 2000, LEARN MEMORY, V7, P85, DOI 10.1101/lm.7.2.85; Otte A, 2006, J PHYSIOL-PARIS, V99, P281, DOI 10.1016/j.jphysparis.2006.03.011; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; ROLAND PE, 1980, J NEUROPHYSIOL, V43, P118, DOI 10.1152/jn.1980.43.1.118; Seidler RD, 2008, J NEUROPHYSIOL, V99, P1836, DOI 10.1152/jn.01187.2007; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Shibuya K, 2007, BRAIN RES, V1156, P120, DOI 10.1016/j.brainres.2007.05.009; Stern JM, 2006, EPILEPSY BEHAV, V8, P683, DOI 10.1016/j.yebeh.2006.03.002; Stewart JC, 2014, NEUROIMAGE, V86, P326, DOI 10.1016/j.neuroimage.2013.10.016; Subudhi AW, 2007, J APPL PHYSIOL, V103, P177, DOI 10.1152/japplphysiol.01460.2006; Subudhi AW, 2009, J APPL PHYSIOL, V106, P1153, DOI 10.1152/japplphysiol.91475.2008; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Tanji J, 1996, CURR OPIN NEUROBIOL, V6, P782, DOI 10.1016/S0959-4388(96)80028-6; Toni I, 1998, NEUROIMAGE, V8, P50, DOI 10.1006/nimg.1998.0349; van Eimeren T, 2006, CURR OPIN NEUROL, V19, P412, DOI 10.1097/01.wco.0000236623.68625.54; Whitmer AJ, 2012, COGN AFFECT BEHAV NE, V12, P661, DOI 10.3758/s13415-012-0118-6; Wilson TW, 2014, NEUROIMAGE, V85, P445, DOI 10.1016/j.neuroimage.2013.04.112; Wright DJ, 2012, HUM MOVEMENT SCI, V31, P567, DOI 10.1016/j.humov.2011.07.001; Yamauchi Y, 2013, NEUROPSYCHOBIOLOGY, V68, P24, DOI 10.1159/000350948	81	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140552	10.1371/journal.pone.0140552	http://dx.doi.org/10.1371/journal.pone.0140552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485534	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100044
J	Sanchez, B; Li, J; Yim, S; Pacheck, A; Widrick, JJ; Rutkove, SB				Sanchez, Benjamin; Li, Jia; Yim, Sung; Pacheck, Adam; Widrick, Jeffrey J.; Rutkove, Seward B.			Evaluation of Electrical Impedance as a Biomarker of Myostatin Inhibition in Wild Type and Muscular Dystrophy Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; IIB RECEPTOR; MOUSE MODEL; IDENTIFICATION; SPECTROSCOPY; MYOGRAPHY; BLOCKADE; GROWTH; INJURY; TISSUE	Objectives Non-invasive and effort independent biomarkers are needed to better assess the effects of drug therapy on healthy muscle and that affected by muscular dystrophy (mdx). Here we evaluated the use of multi-frequency electrical impedance for this purpose with comparison to force and histological parameters. Methods Eight wild-type (wt) and 10 mdx mice were treated weekly with RAP-031 activin type IIB receptor at a dose of 10 mg kg(-1) twice weekly for 16 weeks; the investigators were blinded to treatment and disease status. At the completion of treatment, impedance measurements, in situ force measurements, and histology analyses were performed. Results As compared to untreated animals, RAP-031 wt and mdx treated mice had greater body mass (18% and 17%, P < 0.001 respectively) and muscle mass (25% P < 0.05 and 22% P < 0.001, respectively). The Cole impedance parameters in treated wt mice, showed a 24% lower central frequency (P < 0.05) and 19% higher resistance ratio (P < 0.05); no significant differences were observed in the mdx mice. These differences were consistent with those seen in maximum isometric force, which was greater in the wt animals (P < 0.05 at >70 Hz), but not in the mdx animals. In contrast, maximum force normalized by muscle mass was unchanged in the wt animals and lower in the mdx animals by 21% (P < 0.01). Similarly, myofiber size was only non-significantly higher in treated versus untreated animals (8% p = 0.44 and 12% p = 0.31 for wt and mdx animals, respectively). Conclusions Our findings demonstrate electrical impedance of muscle reproduce the functional and histological changes associated with myostatin pathway inhibition and do not reflect differences in muscle size or volume. This technique deserves further study in both animal and human therapeutic trials.	[Sanchez, Benjamin; Li, Jia; Yim, Sung; Pacheck, Adam; Rutkove, Seward B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Neuromuscular Dis, Boston, MA 02215 USA; [Widrick, Jeffrey J.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Sanchez, B (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Neuromuscular Dis, Boston, MA 02215 USA.	bsanchez@bidmc.harvard.edu	Sanchez, Benjamin/K-8148-2015	Sanchez, Benjamin/0000-0002-1594-9847; Rutkove, Seward/0000-0002-6375-3312	Beth Israel Deaconess Medical Center General Clinical Research Center from the National Institute of Health [R01 NS055099]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055099] Funding Source: NIH RePORTER	Beth Israel Deaconess Medical Center General Clinical Research Center from the National Institute of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grant R01 NS055099 to the Beth Israel Deaconess Medical Center General Clinical Research Center from the National Institute of Health.	ASHTONMILLER JA, 1992, J APPL PHYSIOL, V72, P1205, DOI 10.1152/jappl.1992.72.3.1205; Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII; Bartok C, 2004, J APPL PHYSIOL, V96, P161, DOI 10.1152/japplphysiol.00686.2002; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cadena SM, 2010, J APPL PHYSIOL, V109, P635, DOI 10.1152/japplphysiol.00866.2009; Cole K. S., 1940, Cold Spring Harbor Symposia on Quantitative Biology, V8, P110; Cole K.S., 1968, MEMBRANES IONS IMPUL, V5; Cole KS, 1928, J GEN PHYSIOL, V12, P37, DOI 10.1085/jgp.12.1.37; Cole KS, 1936, P COLD SPRING HARB S, V4, P73, DOI DOI 10.1101/SQB.1936.004.01.010; Eisenberg R S, 2010, HDB PHYSL SKELET MUS, P301; EISENBERG RS, 1986, ANN NY ACAD SCI, V481, P116, DOI 10.1111/j.1749-6632.1986.tb27143.x; Eisenberg RS, 1965, AC IMPEDANCE SINGLE; Estrada-Leypon O, 2015, BIOELECTROCHEMISTRY, V105, P56, DOI 10.1016/j.bioelechem.2015.05.006; FATT P, 1964, PROC R SOC SER B-BIO, V159, P606, DOI 10.1098/rspb.1964.0023; Fricke H, 1925, J GEN PHYSIOL, V9, P153, DOI 10.1085/jgp.9.2.153; Gersing E, 1998, BIOELECTROCH BIOENER, V45, P145, DOI 10.1016/S0302-4598(98)00079-8; Grimnes S, 2005, IEEE T BIO-MED ENG, V52, P132, DOI 10.1109/TBME.2004.836499; Grimnes S., 2014, BIOIMPEDANCE BIOELEC, VVolume 4; Gudivaka R, 1999, J APPL PHYSIOL, V87, P1087, DOI 10.1152/jappl.1999.87.3.1087; Hakim CH, 2013, JOVE-J VIS EXP, DOI 10.3791/50183; HOFFER EC, 1969, J APPL PHYSIOL, V27, P531, DOI 10.1152/jappl.1969.27.4.531; Ishiguro N, 2006, J APPL PHYSIOL, V100, P572, DOI 10.1152/japplphysiol.00094.2005; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Li J, 2014, MUSCLE NERVE, V49, P829, DOI 10.1002/mus.24086; Li JLL, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-678; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mellert F, 2011, IEEE T BIO-MED ENG, V58, P1511, DOI 10.1109/TBME.2010.2054090; Mendias CL, 2011, J APPL PHYSIOL, V111, P185, DOI 10.1152/japplphysiol.00126.2011; Morine KJ, 2010, MUSCLE NERVE, V42, P722, DOI 10.1002/mus.21743; Nescolarde L, 2015, PHYSIOL MEAS, V36, P27, DOI 10.1088/0967-3334/36/1/27; Pistilli EE, 2011, AM J PATHOL, V178, P1287, DOI 10.1016/j.ajpath.2010.11.071; Relizani K, 2014, MOL THER, V22, P1423, DOI 10.1038/mt.2014.90; RIGAUD B, 1995, PHYSIOL MEAS, V16, pA15, DOI 10.1088/0967-3334/16/3A/002; Rutkove SB, 2002, MUSCLE NERVE, V25, P390, DOI 10.1002/mus.10048; Rutkove SB, 2012, AMYOTROPH LATERAL SC, V13, P439, DOI 10.3109/17482968.2012.688837; Sanchez B, 2015, PHYSIOL MEAS, V36, P595, DOI 10.1088/0967-3334/36/3/595; Sanchez B, 2014, PHYS MED BIOL, V59, P2369, DOI 10.1088/0031-9155/59/10/2369; Sanchez B, 2013, PHYSIOL MEAS, V34, P1217, DOI 10.1088/0967-3334/34/10/1217; Sanchez B, 2013, PHYSIOL MEAS, V34, P339, DOI 10.1088/0967-3334/34/3/339; Sarro E, 2012, BIOSENS BIOELECTRON, V31, P257, DOI 10.1016/j.bios.2011.10.028; Shiffman CA, 2013, PHYSIOL MEAS, V34, P1513, DOI 10.1088/0967-3334/34/11/1513; Shiffman CA, 2013, PHYSIOL MEAS, V34, P487, DOI 10.1088/0967-3334/34/5/487; Vosika ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059483; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Widrick JJ, 2011, MUSCLE NERVE, V44, P563, DOI 10.1002/mus.22126	47	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140521	10.1371/journal.pone.0140521	http://dx.doi.org/10.1371/journal.pone.0140521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485280	Green Published, gold			2022-12-27	WOS:000363028100042
J	Spring-Pearson, SM; Stone, JK; Doyle, A; Allender, CJ; Okinaka, RT; Mayo, M; Broomall, SM; Hill, JM; Karavis, MA; Hubbard, KS; Insalaco, JM; Mcnew, LA; Rosenzweig, CN; Gibbons, HS; Currie, BJ; Wagner, DM; Keim, P; Tuanyok, A				Spring-Pearson, Senanu M.; Stone, Joshua K.; Doyle, Adina; Allender, Christopher J.; Okinaka, Richard T.; Mayo, Mark; Broomall, Stacey M.; Hill, Jessica M.; Karavis, Mark A.; Hubbard, Kyle S.; Insalaco, Joseph M.; Mcnew, Lauren A.; Rosenzweig, C. Nicole; Gibbons, Henry S.; Currie, Bart J.; Wagner, David M.; Keim, Paul; Tuanyok, Apichai			Pangenome Analysis of Burkholderia pseudomallei: Genome Evolution Preserves Gene Order despite High Recombination Rates	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONSERVATION; DNA; IDENTIFICATION; MELIOIDOSIS; REPLICATION; DIVERSITY; SECRETION; EXCHANGE	The pangenomic diversity in Burkholderia pseudomallei is high, with approximately 5.8% of the genome consisting of genomic islands. Genomic islands are known hotspots for recombination driven primarily by site-specific recombination associated with tRNAs. However, recombination rates in other portions of the genome are also high, a feature we expected to disrupt gene order. We analyzed the pangenome of 37 isolates of B. pseudomallei and demonstrate that the pangenome is 'open', with approximately 136 new genes identified with each new genome sequenced, and that the global core genome consists of 4568 +/- 16 homologs. Genes associated with metabolism were statistically overrepresented in the core genome, and genes associated with mobile elements, disease, and motility were primarily associated with accessory portions of the pangenome. The frequency distribution of genes present in between 1 and 37 of the genomes analyzed matches well with a model of genome evolution in which 96% of the genome has very low recombination rates but 4% of the genome recombines readily. Using homologous genes among pairs of genomes, we found that gene order was highly conserved among strains, despite the high recombination rates previously observed. High rates of gene transfer and recombination are incompatible with retaining gene order unless these processes are either highly localized to specific sites within the genome, or are characterized by symmetrical gene gain and loss. Our results demonstrate that both processes occur: localized recombination introduces many new genes at relatively few sites, and recombination throughout the genome generates the novel multi-locus sequence types previously observed while preserving gene order.	[Spring-Pearson, Senanu M.; Stone, Joshua K.; Doyle, Adina; Allender, Christopher J.; Okinaka, Richard T.; Wagner, David M.; Keim, Paul; Tuanyok, Apichai] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Mayo, Mark; Currie, Bart J.] Royal Darwin Hosp, Menzies Sch Hlth Res, Darwin, NT, Australia; [Mayo, Mark; Currie, Bart J.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia; [Broomall, Stacey M.; Hill, Jessica M.; Karavis, Mark A.; Hubbard, Kyle S.; Insalaco, Joseph M.; Mcnew, Lauren A.; Rosenzweig, C. Nicole; Gibbons, Henry S.] Edgewood Chem Biol Ctr, BioSci Div, Aberdeen Proving Ground, MD USA; [Tuanyok, Apichai] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL USA	Northern Arizona University; Charles Darwin University; Menzies School of Health Research; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); State University System of Florida; University of Florida	Keim, P (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Paul.Keim@nau.edu		Wagner, David/0000-0003-2684-6007; Gibbons, Henry/0000-0002-5603-8679	US Department of Homeland Security [HSHQDC-10-C-00149]; US Defense Threat Reduction Agency [CB2847]	US Department of Homeland Security(United States Department of Homeland Security (DHS)); US Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was funded by the US Department of Homeland Security contract no. HSHQDC-10-C-00149 to AT and by the US Defense Threat Reduction Agency under project #CB2847 to HSG and CNR. This report does not represent official policy of the US Government or any of its agencies. This report has been cleared for public release. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIENNIAL REV, V77, p[194, 61084]; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Brook MD, 1997, J APPL MICROBIOL, V82, P589, DOI 10.1111/j.1365-2672.1997.tb02867.x; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Choy JL, 2000, ACTA TROP, V74, P153, DOI 10.1016/S0001-706X(99)00065-0; Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2; de Vries J, 2002, P NATL ACAD SCI USA, V99, P2094, DOI 10.1073/pnas.042263399; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Eisen JA, 2000, GENOME BIOL, V1; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Haegeman B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-196; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Housworth EA, 2002, GENETICS, V162, P441; Hughes D, 2000, GENOME BIOL, V1; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Kislyuk AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-32; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Lawrence JG, 1996, GENETICS, V143, P1843; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LIU SL, 1995, J BACTERIOL, V177, P6585, DOI 10.1128/jb.177.22.6585-6592.1995; Lovell SC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-521; Majewski J, 2000, J BACTERIOL, V182, P1016, DOI 10.1128/JB.182.4.1016-1023.2000; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Morrow JD, 2012, GENOME BIOL EVOL, V4, P1256, DOI 10.1093/gbe/evs099; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Nikolaichik YA, 2000, GENETICA, V108, P1, DOI 10.1023/A:1004077806910; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Popa O, 2011, GENOME RES, V21, P599, DOI 10.1101/gr.115592.110; Price EP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037723; Rasmussen T, 2007, EMBO J, V26, P3124, DOI 10.1038/sj.emboj.7601747; ROBERTS MS, 1993, GENETICS, V134, P402; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tuanyok A, 2007, J BACTERIOL, V189, P9044, DOI 10.1128/JB.01264-07; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Worning P, 2006, ENVIRON MICROBIOL, V8, P353, DOI 10.1111/j.1462-2920.2005.00917.x	53	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140274	10.1371/journal.pone.0140274	http://dx.doi.org/10.1371/journal.pone.0140274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484663	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100026
J	Wojcik, S; Spodnik, JH; Dziewiatkowski, J; Spodnik, E; Morys, J				Wojcik, Slawomir; Spodnik, Jan Henryk; Dziewiatkowski, Jerzy; Spodnik, Edyta; Morys, Janusz			Morphological Changes within the Rat Lateral Ventricle after the Administration of Proteasome Inhibitors	PLOS ONE			English	Article							NEURON DEGENERATION; CELL-DEATH; EPENDYMAL REACTIONS; HEAT-SHOCK; IN-VIVO; BRAIN; HYDROCEPHALUS; ACTIVATION; SYSTEM; APOPTOSIS	The broad variety of substances that inhibit the action of the ubiquitin-proteasome system (UPS)-known as proteasome inhibitors-have been used extensively in previous studies, and they are currently frequently proposed as a novel form of cancer treatment and as a protective factor in intracerebral hemorrhage treatment. The experimental data on the safest route of proteasome inhibitor administration, their associated side effects, and the possible ways of minimizing these effects have recently become a very important topic. The aim of our present study was to determine the effects of administering of MG-132, lactacystin and epoxomicin, compounds belonging to three different classes of proteasome inhibitors, on the ependymal walls of the lateral ventricle. Observations were made 2 and 8 weeks after the intraventricular administration of the studied substances dissolved in dimethyl sulfoxide (DMSO) into the lateral ventricle of adult Wistar rats. Qualitative and quantitative analysis of brain sections stained with histochemical and inmmunofluorescence techniques showed that the administration of proteasome inhibitors caused a partial occlusion of the injected ventricle in all of the studied animals. The occlusion was due to ependymal cells damage and subsequent ependymal discontinuity, which caused direct contact between the striatum and the lateral nuclei of the septum, mononuclear cell infiltration and the formation of a glial scar between these structures (with the activation of astroglia, microglia and oligodendroglia). Morphologically, the ubiquitin-positive aggregates corresponded to aggresomes, indicating impaired activity of the UPS and the accumulation and aggregation of ubiquitinated proteins that coincided with the occurrence of glial scars. The most significant changes were observed in the wall covering the striatum in animals that were administered epoxomicin, and milder changes were observed in animals administered lactacystin and MG-132. Interestingly, DMSO administration also caused damage to some of the ependymal cells, but the aggresome-like structures were not formed. Our results indicate that all of the studied classes of proteasome inhibitors are detrimental to ependymal cells to some extent, and may cause severe changes in the ventricular system. The safety implications of their usage in therapeutic strategies to attenuate intracerebral hemorrhagic injury and in brain cancer treatment will require further studies.	[Wojcik, Slawomir; Spodnik, Jan Henryk; Dziewiatkowski, Jerzy; Spodnik, Edyta; Morys, Janusz] Med Univ Gdansk, Dept Anat & Neurobiol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk	Wojcik, S (corresponding author), Med Univ Gdansk, Dept Anat & Neurobiol, Gdansk, Poland.	swoj@gumed.edu.pl	Janusz Morys, Professor//ABF-9423-2020; Spodnik, Jan/ABC-3195-2021; Wojcik, Slawomir/U-5266-2018	Janusz Morys, Professor//0000-0002-4048-1721; Spodnik, Jan/0000-0002-6311-9936; Wojcik, Slawomir/0000-0002-9635-2005; Morys, Janusz/0000-0001-5037-4607	Polish Ministry of Science and Higher Education [NN401 005735, ST-11, ST-0011/07/211]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by a Polish Ministry of Science and Higher Education grant - NN401 005735 (to SW) and by a statutory (ST-11) grant from the Polish Ministry of Science and Higher Education ST-0011/07/211. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Ahn TB, 2006, BRAIN RES, V1087, P159, DOI 10.1016/j.brainres.2006.02.097; Akbari E, 2013, RES MOL MED, V1, P22; Al-Senani FM, 2012, TRANSL STROKE RES, V3, P146, DOI 10.1007/s12975-011-0108-y; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Caldeira MV, 2014, PROG NEUROBIOL, V112, P50, DOI 10.1016/j.pneurobio.2013.10.003; Carbonell WS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-5; Carvalho PG, 2011, BRAIN RES, V1385, P107, DOI 10.1016/j.brainres.2011.02.044; Choi SC, 2015, J CELL PHYSIOL, V230, P1807, DOI 10.1002/jcp.24892; D'Cruz BJ, 2005, BRAIN RES, V1064, P108, DOI 10.1016/j.brainres.2005.09.052; Dasuri K, 2010, FREE RADICAL BIO MED, V49, P1290, DOI 10.1016/j.freeradbiomed.2010.07.014; DELBIGIO MR, 1995, J NEUROPATH EXP NEUR, V54, P405, DOI 10.1097/00005072-199505000-00014; Delli Pizzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056501; Di Giorgio AM, 2008, RESTOR NEUROL NEUROS, V26, P501; Ding QX, 2003, J NEUROCHEM, V86, P489, DOI 10.1046/j.1471-4159.2003.01885.x; Elkharaz J, 2013, BBA-MOL BASIS DIS, V1832, P1930, DOI 10.1016/j.bbadis.2013.07.002; Fine SM, 1999, J NEUROIMMUNOL, V95, P55, DOI 10.1016/S0165-5728(98)00267-7; Galvao J, 2014, FASEB J, V28, P1317, DOI 10.1096/fj.13-235440; Gao C, 2014, J CEREBR BLOOD F MET, V34, P1070, DOI 10.1038/jcbfm.2014.56; Gao F, 2014, J CEREBR BLOOD F MET, V34, P489, DOI 10.1038/jcbfm.2013.225; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Goldbaum O, 2006, GLIA, V53, P891, DOI 10.1002/glia.20348; Goldbaum O, 2009, GLIA, V57, P1566, DOI 10.1002/glia.20870; Gomez-Roldan MDC, 2008, J COMP NEUROL, V507, P1571, DOI 10.1002/cne.21618; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Grondona JM, 1996, J NEUROPATH EXP NEUR, V55, P999, DOI 10.1097/00005072-199609000-00007; Hamano T, 2009, INT J CLIN EXP PATHO, V2, P561; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Hirst RA, 2009, CHILD NERV SYST, V25, P559, DOI 10.1007/s00381-008-0768-4; Jansen AHP, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00073; Kandilis AN, 2014, EXPERT OPIN INV DRUG, V23, P67, DOI 10.1517/13543784.2013.840287; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Kwon SJ, 2008, BRAIN RES, V1205, P116, DOI 10.1016/j.brainres.2008.02.030; Chala CL, 2013, COLOMB MEDICA, V44, P32; Lattke M, 2012, J NEUROSCI, V32, P11511, DOI 10.1523/JNEUROSCI.0182-12.2012; Li XP, 2007, J GERONTOL A-BIOL, V62, P943, DOI 10.1093/gerona/62.9.943; Liu J, 2001, INT IMMUNOPHARMACOL, V1, P63, DOI 10.1016/S1567-5769(00)00016-3; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Millet V, 2009, EXP NEUROL, V217, P282, DOI 10.1016/j.expneurol.2009.03.005; Miwa H, 2005, NEUROSCI LETT, V380, P93, DOI 10.1016/j.neulet.2005.01.024; Notman R, 2006, J AM CHEM SOC, V128, P13982, DOI 10.1021/ja063363t; OACU, 1996, GUID ENDP AN STUD PR; OECD, 2000, OECD GUID DOC REC AS; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Pasquini LA, 2003, J NEUROSCI, V23, P4635; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Redwine JM, 2002, CURR TOP MICROBIOL, V265, P119; Rogers N, 2010, NEUROPATH APPL NEURO, V36, P113, DOI [10.1111/j.1365-2990.2009.01063.x, 10.1111/j.1365-2990.2010.01063.x]; SARNAT HB, 1995, J NEUROPATH EXP NEUR, V54, P1, DOI 10.1097/00005072-199501000-00001; Schaeffer EL, 2015, J NEURAL TRANSM, V122, P619, DOI 10.1007/s00702-014-1305-0; Shoham S, 2003, EXP NEUROL, V184, P1043, DOI 10.1016/j.expneurol.2003.08.015; Sujashvili R, 2008, Georgian Med News, P48; SZMANT HH, 1975, ANN NY ACAD SCI, V243, P20, DOI 10.1111/j.1749-6632.1975.tb25340.x; Titler AM, 2013, CELL TISSUE RES, V352, P427, DOI 10.1007/s00441-013-1571-4; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Vernon AC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-1; Villamar-Cruz O, 2006, BRAIN RES BULL, V69, P276, DOI 10.1016/j.brainresbull.2005.12.006; Wang HF, 2013, J INT MED RES, V41, P72, DOI 10.1177/0300060513476992; Wojcik S, 2014, FOLIA NEUROPATHOL, V52, P41, DOI 10.5114/fn.2014.41743; Wojcik S, 2013, FOLIA HISTOCHEM CYTO, V51, P249, DOI 10.5603/FHC.2013.0036; Wu WKK, 2010, CANCER LETT, V293, P15, DOI 10.1016/j.canlet.2009.12.002; Xie WJ, 2010, J NEUROCHEM, V115, P188, DOI 10.1111/j.1471-4159.2010.06914.x; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447; Zhang LP, 2013, J CANCER RES CLIN, V139, P1105, DOI 10.1007/s00432-013-1412-6	64	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140536	10.1371/journal.pone.0140536	http://dx.doi.org/10.1371/journal.pone.0140536			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479862	Green Published, Green Submitted, gold			2022-12-27	WOS:000363026600013
J	Ji, P; Parks, J; Edwards, MA; Pruden, A				Ji, Pan; Parks, Jeffrey; Edwards, Marc A.; Pruden, Amy			Impact of Water Chemistry, Pipe Material and Stagnation on the Building Plumbing Microbiome	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; UNCHLORINATED DRINKING-WATER; AMMONIUM-OXIDIZING BACTERIA; DISTRIBUTION-SYSTEM; OPPORTUNISTIC PATHOGENS; PSEUDOMONAS-AERUGINOSA; LEGIONELLA-PNEUMOPHILA; TREATMENT-PLANT; ORGANIC-CARBON; UNITED-STATES	A unique microbiome establishes in the portion of the potable water distribution system within homes and other buildings (i.e., building plumbing). To examine its composition and the factors that shape it, standardized cold water plumbing rigs were deployed at the treatment plant and in the distribution system of five water utilities across the U.S. Three pipe materials (copper with lead solder, CPVC with brass fittings or copper/lead combined pipe) were compared, with 8 hour flush cycles of 10 minutes to simulate typical daily use patterns. High throughput Illumina sequencing of 16S rRNA gene amplicons was employed to profile and compare the resident bulk water bacteria and archaea. The utility, location of the pipe rig, pipe material and stagnation all had a significant influence on the plumbing microbiome composition, but the utility source water and treatment practices were dominant factors. Examination of 21 water chemistry parameters suggested that the total chlorine concentration, pH, P, SO42- and Mg were associated with the most of the variation in bulk water microbiome composition. Disinfectant type exerted a notably low-magnitude impact on microbiome composition. At two utilities using the same source water, slight differences in treatment approaches were associated with differences in rare taxa in samples. For genera containing opportunistic pathogens, Utility C samples (highest pH of 9-10) had the highest frequency of detection for Legionella spp. and lowest relative abundance of Mycobacterium spp. Data were examined across utilities to identify a true universal core, special core, and peripheral organisms to deepen insight into the physical and chemical factors that shape the building plumbing microbiome.	[Ji, Pan; Parks, Jeffrey; Edwards, Marc A.; Pruden, Amy] Virginia Tech, Via Dept Civil & Environm Engn, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Pruden, A (corresponding author), Virginia Tech, Via Dept Civil & Environm Engn, Blacksburg, VA 24061 USA.	apruden@vt.edu	Edwards, Marc/J-3557-2012		Alfred P. Sloan Foundation Microbiology of the Built Environment Program; Virginia Tech Institute for Critical Technology and Applied Science; Water Research Foundation [4317]	Alfred P. Sloan Foundation Microbiology of the Built Environment Program; Virginia Tech Institute for Critical Technology and Applied Science; Water Research Foundation	This research was primarily funded by The Alfred P. Sloan Foundation Microbiology of the Built Environment Program. Additional funding was received by the Virginia Tech Institute for Critical Technology and Applied Science and the Water Research Foundation Project 4317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbolt Nicholas J, 2015, Curr Environ Health Rep, V2, P95, DOI 10.1007/s40572-014-0037-5; Baron JL, 2015, SYST APPL MICROBIOL, V38, P198, DOI 10.1016/j.syapm.2015.02.006; Baron JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102679; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Brunkard Joan M., 2011, Morbidity and Mortality Weekly Report, V60, P38; Burleigh TD, 2014, MATERIALS, V7, P4321, DOI 10.3390/ma7064321; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Darcy JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023742; Dimitriadi D, 2014, J PATHOG, V2014, DOI 10.1155/2014/407385; Douterelo I, 2014, WATER RES, V54, P100, DOI 10.1016/j.watres.2014.01.049; Douterelo I, 2013, WATER RES, V47, P503, DOI 10.1016/j.watres.2012.09.053; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dworkin M, 2006, PROKARYOTES HDB BIOL, V5, P275; Edagawa A, 2008, J APPL MICROBIOL, V105, P2104, DOI 10.1111/j.1365-2672.2008.03932.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; Falkinham JO, 2015, ENVIRON HEALTH PERSP, V123, P749, DOI 10.1289/ehp.1408692; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Felfoldi T, 2010, CLIN MICROBIOL INFEC, V16, P89, DOI 10.1111/j.1469-0691.2009.02795.x; Fierer Noah, 2008, P95; Gomez-Alvarez V, 2012, APPL ENVIRON MICROB, V78, P6095, DOI 10.1128/AEM.01018-12; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hilborn ED, 2013, MMWR-MORBID MORTAL W, V62, P714; Holinger EP, 2014, WATER RES, V49, P225, DOI 10.1016/j.watres.2013.11.027; Holm NC, 1996, APPL ENVIRON MICROB, V62, P522, DOI 10.1128/AEM.62.2.522-528.1996; Hwang C, 2012, APPL ENVIRON MICROB, V78, P7856, DOI 10.1128/AEM.01892-12; Jang HJ, 2011, J MICROBIOL BIOTECHN, V21, P115, DOI 10.4014/jmb.1010.10012; KLOOS WE, 1975, INT J SYST BACTERIOL, V25, P62, DOI 10.1099/00207713-25-1-62; Lautenschlager K, 2010, WATER RES, V44, P4868, DOI 10.1016/j.watres.2010.07.032; Le Dantec C, 2002, APPL ENVIRON MICROB, V68, P1025, DOI 10.1128/AEM.68.3.1025-1032.2002; LECHEVALLIER MW, 1980, APPL ENVIRON MICROB, V39, P739, DOI 10.1128/AEM.39.4.739-742.1980; LeChevallier MW, 1991, APPL ENVIRON MICROB, V57, P867; Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768; Lehtola MJ, 2004, WATER RES, V38, P3769, DOI 10.1016/j.watres.2004.06.024; Lehtola MJ, 2001, WATER RES, V35, P1635, DOI 10.1016/S0043-1354(00)00449-8; Li B, 2007, J ENVIRON ENG SCI, V6, P651, DOI 10.1139/S07-008; Li D, 2010, APPL ENVIRON MICROB, V76, P7171, DOI 10.1128/AEM.00832-10; Lin WF, 2014, WATER RES, V52, P218, DOI 10.1016/j.watres.2013.10.071; Liu G, 2014, ENVIRON SCI TECHNOL, V48, P5467, DOI 10.1021/es5009467; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lu HS, 2011, INT J SYST EVOL MICR, V61, P404, DOI 10.1099/ijs.0.020206-0; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Masters S, 2015, WATER RES, V68, P140, DOI 10.1016/j.watres.2014.09.048; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miettinen IT, 1997, APPL ENVIRON MICROB, V63, P3242, DOI 10.1128/AEM.63.8.3242-3245.1997; National Research Council, 2006, DRINK WAT DISTR SYST, P317; Nguyen C, 2012, WATER RES, V46, P611, DOI 10.1016/j.watres.2011.11.006; Nguyen M H, 1991, Infect Dis Clin North Am, V5, P561; Niquette P, 2000, WATER RES, V34, P1952, DOI 10.1016/S0043-1354(99)00307-3; Nogueira R, 2006, BIOTECHNOL BIOENG, V95, P169, DOI 10.1002/bit.21004; Ohno A, 2003, APPL ENVIRON MICROB, V69, P2540, DOI 10.1128/AEM.69.5.2540-2547.2003; Parks J., 2014, NONINTRUSIVE METHODO; Pinto AJ, 2014, MBIO, V5, DOI 10.1128/mBio.01135-14; Pinto AJ, 2012, ENVIRON SCI TECHNOL, V46, P8851, DOI 10.1021/es302042t; Poitelon JB, 2010, J IND MICROBIOL BIOT, V37, P117, DOI 10.1007/s10295-009-0653-5; Prevost M, 2014, MICROBIAL GROWTH IN DRINKING-WATER SUPPLIES: PROBLEMS, CAUSES, CONTROL AND RESEARCH NEEDS, P261; Prevost M, 1997, J AM WATER WORKS ASS, V89, P78; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Proctor CR, 2015, CURR OPIN BIOTECH, V33, P87, DOI 10.1016/j.copbio.2014.12.014; Pruden A, 2013, STATE SCI RES NEEDS; QIIME, COMP COR MICR PY ID; QIIME, 454 OV TUT DE NOV OT; R Core Team, 2021, R LANGUAGE ENV STAT; Regan JM, 2003, WATER RES, V37, P197, DOI 10.1016/S0043-1354(02)00237-3; Regan JM, 2002, APPL ENVIRON MICROB, V68, P73, DOI 10.1128/AEM.68.1.73-81.2002; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Roeselers G, 2015, ENVIRON MICROBIOL, V17, P2505, DOI 10.1111/1462-2920.12739; Shaw JLA, 2014, CHEMOSPHERE, V117, P185, DOI 10.1016/j.chemosphere.2014.06.077; Sidari FP, 2014, J AM WATER WORKS ASS, V106, P24, DOI 10.5942/jawwa.2014.106.0147; STATES SJ, 1987, APPL ENVIRON MICROB, V53, P1775, DOI 10.1128/AEM.53.8.1775-1779.1987; Sun W, 2014, MICROBIOL RES, V169, P897, DOI 10.1016/j.micres.2014.05.003; Tal Y, 2006, APPL ENVIRON MICROB, V72, P2896, DOI 10.1128/AEM.72.4.2896-2904.2006; van der Wielen PWJJ, 2013, APPL ENVIRON MICROB, V79, P825, DOI 10.1128/AEM.02748-12; van Ingen J, 2010, APPL ENVIRON MICROB, V76, P6017, DOI 10.1128/AEM.00843-10; van Niftrik L, 2012, MICROBIOL MOL BIOL R, V76, P585, DOI 10.1128/MMBR.05025-11; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wagner D, 1997, BIODEGRADATION, V8, P177, DOI 10.1023/A:1008206918628; Wang H, 2015, ENVIRON SCI TECHNOL, V49, P8416, DOI 10.1021/acs.est.5b01538; Wang H, 2014, ENVIRON SCI TECHNOL, V48, P10624, DOI 10.1021/es502646d; Wang H, 2014, ENVIRON SCI TECHNOL, V48, P1426, DOI 10.1021/es402636u; Wang H, 2013, ENVIRON SCI TECHNOL, V47, P10117, DOI 10.1021/es402455r; Wang H, 2012, ENVIRON SCI TECHNOL, V46, P11566, DOI 10.1021/es303212a; Wang H, 2012, APPL ENVIRON MICROB, V78, P6285, DOI 10.1128/AEM.01492-12; WILLEMS A, 1989, INT J SYST BACTERIOL, V39, P319, DOI 10.1099/00207713-39-3-319; Williams K, 2015, PATHOGENS, V4, P355, DOI 10.3390/pathogens4020355; WOLFE RL, 1990, APPL ENVIRON MICROB, V56, P451, DOI 10.1128/AEM.56.2.451-462.1990; World Health Organization (WHO), 2006, HLTH ASP PLUMB; Wu QL, 2006, APPL ENVIRON MICROB, V72, P5478, DOI 10.1128/AEM.00767-06; Yu J, 2010, WATER SCI TECHNOL, V61, P163, DOI 10.2166/wst.2010.813; Zeng DN, 2013, WORLD J MICROB BIOT, V29, P1573, DOI 10.1007/s11274-013-1321-5	95	84	87	5	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141087	10.1371/journal.pone.0141087	http://dx.doi.org/10.1371/journal.pone.0141087			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495985	gold, Green Published, Green Submitted			2022-12-27	WOS:000363309200059
J	Mathur, A; Kumari, J; Parashar, A; Chandrasekaran, LTN; Mukherjee, A				Mathur, Ankita; Kumari, Jyoti; Parashar, Abhinav; Chandrasekaran, Lavanya T. N.; Mukherjee, Amitava			Decreased Phototoxic Effects of TiO2 Nanoparticles in Consortium of Bacterial Isolates from Domestic Waste Water	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; TITANIUM-DIOXIDE NANOPARTICLES; EXIGUOBACTERIUM-ACETYLICUM; ENGINEERED NANOPARTICLES; BIOFILM FORMATION; OXIDATIVE STRESS; REMOVAL; PARTICLES; MEMBRANE; TOXICITY	This study is aimed to explore the toxicity of TiO2 nanoparticles at low concentrations (0.25, 0.50 & 1.00 mu g/ml); on five bacterial isolates and their consortium in waste water medium both in dark and UVA conditions. To critically examine the toxic effects of nanoparticles and the response mechanism(s) offered by microbes, several aspects were monitored viz. cell viability, ROS generation, SOD activity, membrane permeability, EPS release and biofilm formation. A dose and time dependent loss in viability was observed for treated isolates and the consortium. At the highest dose, after 24h, oxidative stress was examined which conclusively showed more ROS generation & cell permeability and less SOD activity in single isolates as compared to the consortium. As a defense mechanism, EPS release was enhanced in case of the consortium against the single isolates, and was observed to be dose dependent. Similar results were noticed for biofilm formation, which substantially increased at highest dose of nanoparticle exposure. Concluding, the consortium showed more resistance against the toxic effects of the TiO2 nanoparticles compared to the individual isolates.	[Mathur, Ankita; Kumari, Jyoti; Parashar, Abhinav; Chandrasekaran, Lavanya T. N.; Mukherjee, Amitava] VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Mukherjee, A (corresponding author), VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India.	amit.mookerjea@gmail.com	Chandrasekaran, Natarajan/F-2312-2018; Mukherjee, Amitava/H-5560-2011; Parashar, Abhinav/G-2921-2019	Chandrasekaran, Natarajan/0000-0002-0586-134X; Mukherjee, Amitava/0000-0001-8682-4278; Parashar, Abhinav/0000-0003-4229-0248				Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; Adedayo O, 2004, WORLD J MICROB BIOT, V20, P545, DOI 10.1023/B:WIBI.0000043150.37318.5f; Ahluwalia SS, 2005, ENG LIFE SCI, V5, P158, DOI 10.1002/elsc.200420066; Ammendolia MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084986; Andersson S, 2008, FEMS MICROBIOL LETT, V283, P83, DOI 10.1111/j.1574-6968.2008.01149.x; Applerot G, 2012, SMALL, V8, P3326, DOI 10.1002/smll.201200772; Baan R, 2006, LANCET ONCOL, V7, P295, DOI 10.1016/S1470-2045(06)70651-9; Block SS, 1997, J SOL ENERG-T ASME, V119, P85, DOI 10.1115/1.2871858; Bramhachari PV, 2007, J MICROBIOL BIOTECHN, V17, P44; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240; Brunet L, 2009, ENVIRON SCI TECHNOL, V43, P4355, DOI 10.1021/es803093t; Burello E, 2011, NANOTOXICOLOGY, V5, P228, DOI 10.3109/17435390.2010.502980; Butler M, 2007, INFLAMM RES, V56, P353, DOI 10.1007/s00011-007-7068-4; Cao B, 2011, ENVIRON MICROBIOL, V13, P1018, DOI 10.1111/j.1462-2920.2010.02407.x; Chaturvedi P, 2006, INT J SYST EVOL MICR, V56, P2765, DOI 10.1099/ijs.0.64508-0; Coates J., 2000, ENCY ANAL CHEM, DOI DOI 10.1002/9780470027318.A5606; Connolly S, 2009, ROLE REACTIVE OXYGEN; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fenoglio I, 2009, CHEM-EUR J, V15, P4614, DOI 10.1002/chem.200802542; Gogniat G, 2006, FEMS MICROBIOL LETT, V258, P18, DOI 10.1111/j.1574-6968.2006.00190.x; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Green MR, 2012, MOL CLONING LAB MANU, V1; Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007; Hessler CM, 2012, WATER RES, V46, P4687, DOI 10.1016/j.watres.2012.06.009; Horst AM, 2010, APPL ENVIRON MICROB, V76, P7292, DOI 10.1128/AEM.00324-10; Hossain M.S., 2007, J PHARM SCI, V6, P43, DOI DOI 10.3329/DUJPS.V6I1.342; Jiang GX, 2011, J ENVIRON MONITOR, V13, P42, DOI 10.1039/c0em00499e; Kavita K, 2013, CARBOHYD POLYM, V94, P882, DOI 10.1016/j.carbpol.2013.02.010; Kiser MA, 2009, ENVIRON SCI TECHNOL, V43, P6757, DOI 10.1021/es901102n; Kwak SY, 2001, ENVIRON SCI TECHNOL, V35, P2388, DOI 10.1021/es0017099; Landsiedel R, 2010, ADV MATER, V22, P2601, DOI 10.1002/adma.200902658; Leung TY, 2008, WATER RES, V42, P4827, DOI 10.1016/j.watres.2008.08.031; Li D, 2009, ENVIRON MICROBIOL, V11, P1506, DOI 10.1111/j.1462-2920.2009.01878.x; Li MH, 2011, ENVIRON SCI TECHNOL, V45, P755, DOI 10.1021/es102266g; Liu R, 2014, BIOMED RES INT; Lyon DY, 2008, ENVIRON SCI TECHNOL, V42, P8127, DOI 10.1021/es801869m; Markowska-Szczupak A, 2011, CATAL TODAY, V169, P249, DOI 10.1016/j.cattod.2010.11.055; Mathur A, 2015, J ENVIRON CHEM ENG, V3, P1837, DOI 10.1016/j.jece.2015.06.026; Maurer-Jones MA, 2013, ANAL CHEM, V85, P3036, DOI 10.1021/ac303636s; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Mishra A, 2009, BIORESOURCE TECHNOL, V100, P3382, DOI 10.1016/j.biortech.2009.02.006; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x; Nwodo UU, 2013, J APPL MICROBIOL, V114, P1325, DOI 10.1111/jam.12095; O'Brien N, 2010, J ENVIRON SCI HEAL A, V45, P992, DOI 10.1080/10934521003772410; Pawley J. B., 1996, OPT ENG, V35, P2765; Pigeot-Remy S, 2011, APPL CATAL B-ENVIRON, V104, P390, DOI 10.1016/j.apcatb.2011.03.001; Planchon M, 2013, J COLLOID INTERF SCI, V405, P35, DOI 10.1016/j.jcis.2013.05.061; Pongjanyakul T, 2007, INT J PHARMACEUT, V331, P61, DOI 10.1016/j.ijpharm.2006.09.011; Prasad GK, 2009, J HAZARD MATER, V165, P506, DOI 10.1016/j.jhazmat.2008.10.009; Robertson PKJ, 2012, J HAZARD MATER, V211, P161, DOI 10.1016/j.jhazmat.2011.11.058; SAITO T, 1992, J PHOTOCH PHOTOBIO B, V14, P369, DOI 10.1016/1011-1344(92)85115-B; Samuel J, 2012, IND ENG CHEM RES, V51, P3740, DOI 10.1021/ie201796s; Selvakumar G, 2010, INDIAN J MICROBIOL, V50, P50, DOI 10.1007/s12088-009-0024-y; Sharaf-Yazdi MK, 2001, IRAN J PUBL HLTH, V30, P91; Sheng GP, 2010, BIOTECHNOL ADV, V28, P882, DOI 10.1016/j.biotechadv.2010.08.001; Siboni N, 2007, FEMS MICROBIOL LETT, V274, P24, DOI 10.1111/j.1574-6968.2007.00809.x; Simon-Deckers A, 2009, ENVIRON SCI TECHNOL, V43, P8423, DOI 10.1021/es9016975; Tsuang YH, 2008, ARTIF ORGANS, V32, P167, DOI 10.1111/j.1525-1594.2007.00530.x; Tsuneda S, 2003, FEMS MICROBIOL LETT, V223, P287, DOI 10.1016/S0378-1097(03)00399-9; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Weir A, 2012, ENVIRON SCI TECHNOL, V46, P2242, DOI 10.1021/es204168d; Westerhoff P, 2011, J ENVIRON MONITOR, V13, P1195, DOI 10.1039/c1em10017c; WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337	65	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141301	10.1371/journal.pone.0141301	http://dx.doi.org/10.1371/journal.pone.0141301			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496250	gold, Green Submitted, Green Published			2022-12-27	WOS:000363309200089
J	Woodfield, R; Grant, I; Sudlow, CLM				Woodfield, Rebecca; Grant, Ian; Sudlow, Cathie L. M.		UK Biobank Stroke Outcomes Grp; UK Biobank Follow-Up Outcomes	Accuracy of Electronic Health Record Data for Identifying Stroke Cases in Large-Scale Epidemiological Studies: A Systematic Review from the UK Biobank Stroke Outcomes Group	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; RISK-FACTORS; HEMORRHAGIC STROKE; ADMINISTRATIVE DATA; CASE-FATALITY; VALIDATION; POPULATION; QUALITY; IDENTIFICATION; DIAGNOSES	Objective Long-term follow-up of population-based prospective studies is often achieved through linkages to coded regional or national health care data. Our knowledge of the accuracy of such data is incomplete. To inform methods for identifying stroke cases in UK Biobank (a prospective study of 503,000 UK adults recruited in middle-age), we systematically evaluated the accuracy of these data for stroke and its main pathological types (ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage), determining the optimum codes for case identification. Methods We sought studies published from 1990-November 2013, which compared coded data from death certificates, hospital admissions or primary care with a reference standard for stroke or its pathological types. We extracted information on a range of study characteristics and assessed study quality with the Quality Assessment of Diagnostic Studies tool (QUADAS-2). To assess accuracy, we extracted data on positive predictive values (PPV) and-where available-on sensitivity, specificity, and negative predictive values (NPV). Results 37 of 39 eligible studies assessed accuracy of International Classification of Diseases (ICD)-coded hospital or death certificate data. They varied widely in their settings, methods, reporting, quality, and in the choice and accuracy of codes. Although PPVs for stroke and its pathological types ranged from 6-97%, appropriately selected, stroke-specific codes (rather than broad cerebrovascular codes) consistently produced PPVs >70%, and in several studies >90%. The few studies with data on sensitivity, specificity and NPV showed higher sensitivity of hospital versus death certificate data for stroke, with specificity and NPV consistently >96%. Few studies assessed either primary care data or combinations of data sources. Conclusions Particular stroke-specific codes can yield high PPVs (>90%) for stroke/stroke types. Inclusion of primary care data and combining data sources should improve accuracy in large epidemiological studies, but there is limited published information about these strategies.	[Woodfield, Rebecca; Sudlow, Cathie L. M.] Univ Edinburgh, Div Clin Neurosci, Clin Ctr Brain Sci, Edinburgh, Midlothian, Scotland; [Grant, Ian] NHS, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Sudlow, Cathie L. M.] UK Biobank, Stockport, Lancs, England	University of Edinburgh	Sudlow, CLM (corresponding author), Univ Edinburgh, Div Clin Neurosci, Clin Ctr Brain Sci, Edinburgh, Midlothian, Scotland.	cathie.sudlow@ed.ac.uk		Sudlow, Cathie/0000-0002-7725-7520	UK Biobank; UK Biobank; MRC [MR/K007017/1, MC_U137686860] Funding Source: UKRI; Medical Research Council [MR/K007017/1, MC_qA137853, MC_U137686860] Funding Source: researchfish	UK Biobank; UK Biobank; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by UK Biobank (www.ukbiobank.ac.uk/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation in the analysis.	Aboa-Eboule C, 2013, J NEUROL, V260, P605, DOI 10.1007/s00415-012-6686-0; Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; Andrade SE, 2012, PHARMACOEPIDEM DR S, V21, P100, DOI 10.1002/pds.2312; Appelros P, 2011, ACTA NEUROL SCAND, V123, P289, DOI 10.1111/j.1600-0404.2010.01402.x; Appelros P, 2003, ACTA NEUROL SCAND, V107, P145, DOI 10.1034/j.1600-0404.2003.02120.x; BAMFORD J, 1986, BRIT MED J, V292, P1369, DOI 10.1136/bmj.292.6532.1369; Barer D, 1996, BRIT MED J, V313, P1005; Bejot Y, 2013, STROKE, V44, P1796, DOI 10.1161/STROKEAHA.113.000949; Benesch C, 1997, NEUROLOGY, V49, P660, DOI 10.1212/WNL.49.3.660; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Brown M, 2003, NEW ENGL J MED, V348, P16; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Davenport R J, 1996, Health Bull (Edinb), V54, P402; Derby CA, 2000, STROKE, V31, P875, DOI 10.1161/01.STR.31.4.875; Derby CA, 2001, STROKE, V32, P1487, DOI 10.1161/01.STR.32.7.1487; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; Ellekjaer H, 1999, STROKE, V30, P56, DOI 10.1161/01.STR.30.1.56; Ferro JM, 1996, STROKE, V27, P2225, DOI 10.1161/01.STR.27.12.2225; Fiebach JB, 2002, STROKE, V33, P2206, DOI 10.1161/01.STR.0000026864.20339.CB; Flynn RWV, 2010, PHARMACOEPIDEM DR S, V19, P843, DOI 10.1002/pds.1981; Gaist D, 2013, PHARMACOEPIDEM DR S, V22, P176, DOI 10.1002/pds.3391; Giroud M, 1997, NEUROEPIDEMIOLOGY, V16, P15, DOI 10.1159/000109666; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Haesebaert J, 2013, STROKE, V44, P1770, DOI 10.1161/STROKEAHA.113.001300; Harriss LR, 2011, AUST NZ J PUBL HEAL, V35, P466, DOI 10.1111/j.1753-6405.2011.00739.x; Hasan M, 1995, INT J QUAL HEALTH C, V7, P407, DOI 10.1093/intqhc/7.4.407; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jackson CA, 2010, STROKE, V41, P624, DOI 10.1161/STROKEAHA.109.558809; Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8; Jordan K, 2004, FAM PRACT, V21, P396, DOI 10.1093/fampra/cmh409; KESSLER C, 1991, CEREBROVASC DIS, V1, P43, DOI 10.1159/000108815; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kirkman MA, 2009, ACTA NEUROL BELG, V109, P114; Klatsky AL, 2005, NEUROEPIDEMIOLOGY, V25, P26, DOI 10.1159/000085310; Koster M, 2013, NEUROEPIDEMIOLOGY, V40, P240, DOI 10.1159/000345953; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Lakshminarayan K, 2009, AM J EPIDEMIOL, V169, P1070, DOI 10.1093/aje/kwp029; LEIBSON CL, 1994, STROKE, V25, P2348, DOI 10.1161/01.STR.25.12.2348; Leone MA, 2004, NEUROL SCI, V25, P281, DOI 10.1007/s10072-004-0355-8; Liu LY, 1999, CEREBROVASC DIS, V9, P224, DOI 10.1159/000015960; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mant J, 2003, BRIT J GEN PRACT, V53, P520; Mant J, 1997, HLTH TRENDS, V29, P96; Manuel DG, 2010, BMJ-BRIT MED J, V341, P440; Mayo N, 1993, CAN J CARDIOL SD, V9, p121D; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Palmieri L, 2007, CEREBROVASC DIS, V24, P530, DOI 10.1159/000110423; Panayiotou B, 1993, MED AUDIT NEWS, V3, P153; Reker DM, 2001, J REHABIL RES DEV, V38, P281; Rinaldi R, 2003, NEUROL SCI, V24, P65, DOI 10.1007/s100720300074; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Ruigomez A, 2010, PHARMACOEPIDEM DR S, V19, P579, DOI 10.1002/pds.1919; Schulz UGR, 2003, STROKE, V34, P2050, DOI 10.1161/01.STR.0000079818.08343.8C; Sinha S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-74; Spolaore P, 2005, STROKE, V36, P1031, DOI 10.1161/01.STR.0000160755.94884.4a; STEGMAYR B, 1992, NEUROEPIDEMIOLOGY, V11, P204, DOI 10.1159/000110933; Stuart-Buttle C D, 1996, Proc AMIA Annu Fall Symp, P75; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Thiru K, 2003, BMJ-BRIT MED J, V326, P1070, DOI 10.1136/bmj.326.7398.1070; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Tolonen H, 2007, EUR J CARDIOV PREV R, V14, P380, DOI 10.1097/01.hjr.0000239466.26132.f2; Tu K, 2013, CAN J CARDIOL, V29, P1388, DOI 10.1016/j.cjca.2013.07.676; Van Staa TP, 1994, PHARMACOEPIDEM DR S, V3, P15, DOI DOI 10.1002/PDS.2630030106; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924; Wardlaw JM, 2005, RADIOLOGY, V235, P444, DOI 10.1148/radiol.2352040262; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wright FL, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-161	75	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140533	10.1371/journal.pone.0140533	http://dx.doi.org/10.1371/journal.pone.0140533			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU1VG	26496350	gold, Green Published			2022-12-27	WOS:000363309200017
J	Zhang, JY; Wang, JJ; Wang, XY; Gao, X; Feng, DG				Zhang, Jingya; Wang, Jiajun; Wang, Xiuying; Gao, Xin; Feng, Dagan			Physical Constraint Finite Element Model for Medical Image Registration	PLOS ONE			English	Article							REAL-TIME; DEFORMATION; ALGORITHM; MOTION	Due to being derived from linear assumption, most elastic body based non-rigid image registration algorithms are facing challenges for soft tissues with complex nonlinear behavior and with large deformations. To take into account the geometric nonlinearity of soft tissues, we propose a registration algorithm on the basis of Newtonian differential equation. The material behavior of soft tissues is modeled as St. Venant-Kirchhoff elasticity, and the nonlinearity of the continuum represents the quadratic term of the deformation gradient under the Green-St. Venant strain. In our algorithm, the elastic force is formulated as the derivative of the deformation energy with respect to the nodal displacement vectors of the finite element; the external force is determined by the registration similarity gradient flow which drives the floating image deforming to the equilibrium condition. We compared our approach to three other models: 1) the conventional linear elastic finite element model (FEM); 2) the dynamic elastic FEM; 3) the robust block matching (RBM) method. The registration accuracy was measured using three similarities: MSD (Mean Square Difference), NC (Normalized Correlation) and NMI (Normalized Mutual Information), and was also measured using the mean and max distance between the ground seeds and corresponding ones after registration. We validated our method on 60 image pairs including 30 medical image pairs with artificial deformation and 30 clinical image pairs for both the chest chemotherapy treatment in different periods and brain MRI normalization. Our method achieved a distance error of 0.320 +/- 0.138 mm in x direction and 0.326 +/- 0.111 mm in y direction, MSD of 41.96 +/- 13.74, NC of 0.9958 +/- 0.0019, NMI of 1.2962 +/- 0.0114 for images with large artificial deformations; and average NC of 0.9622 +/- 0.008 and NMI of 1.2764 +/- 0.0089 for the real clinical cases. Student's t-test demonstrated that our model statistically outperformed the other methods in comparison (p-values <0.05).	[Zhang, Jingya; Wang, Jiajun] Soochow Univ, Sch Elect & Informat Engn, Suzhou 215006, Peoples R China; [Zhang, Jingya] Changshu Inst Technol, Dept Phys, Changshu 215500, Peoples R China; [Wang, Xiuying; Feng, Dagan] Univ Sydney, Inst Biomed Engn & Technol, Sydney, NSW 2006, Australia; [Wang, Xiuying; Feng, Dagan] Univ Sydney, Sch Informat Technol, Sydney, NSW 2006, Australia; [Gao, Xin] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou 215006, Peoples R China; [Feng, Dagan] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Soochow University - China; Changshu Institute of Technology; University of Sydney; University of Sydney; Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS; Shanghai Jiao Tong University	Wang, JJ (corresponding author), Soochow Univ, Sch Elect & Informat Engn, Suzhou 215006, Peoples R China.	jjwang@suda.edu.cn; xingaosam@sina.com		Feng, Dagan/0000-0002-3381-214X; Wang, Xiu Ying/0000-0001-7160-5929	Natural Science Foundation of Jiangsu Province China [BK2008159]; Natural Science Foundation of Suzhou [SYG201113]	Natural Science Foundation of Jiangsu Province China(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Suzhou	This study supported by the Natural Science Foundation of Jiangsu Province China through Grant Number BK2008159 (http://jstd.gov.cn) and the Natural Science Foundation of Suzhou Number SYG201113 (http://www.szkj.gov.cn) provided to the co-author Jiajun Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buerger C, 2011, MED IMAGE ANAL, V15, P551, DOI 10.1016/j.media.2011.02.009; Bullitt E, 2005, ACAD RADIOL, V12, P1232, DOI 10.1016/j.acra.2005.05.027; Davatzikos C, 1997, COMPUT VIS IMAGE UND, V66, P207, DOI 10.1006/cviu.1997.0605; De Craene M, 2012, MED IMAGE ANAL, V16, P427, DOI 10.1016/j.media.2011.10.006; Ferrant M, 2002, MED IMAGE ANAL, V6, P337, DOI 10.1016/S1361-8415(02)00060-9; George P.L., 1996, HDB NUMER ANAL, V4, P69, DOI [DOI 10.1016/S1570-8659(96)80003-2, 10.1016/S1570-8659(96)80003-2]; Han Z, 2012, MAGN RESON IMAGING, V30, P774, DOI 10.1016/j.mri.2012.02.005; Horton A, 2010, INT J NUMER METH BIO, V26, P977, DOI 10.1002/cnm.1374; Hua X, 2013, NEUROIMAGE, V66, P648, DOI 10.1016/j.neuroimage.2012.10.086; Joldes GR, 2009, COMPUT METHOD APPL M, V198, P3313, DOI 10.1016/j.cma.2009.06.012; Liu W, 2011, IMAGE VISION COMPUT, V29, P509, DOI 10.1016/j.imavis.2011.03.003; Lombaert H, 2014, INT J COMPUT VISION, V107, P254, DOI 10.1007/s11263-013-0681-5; Lu XQ, 2013, OPTIK, V124, P4266, DOI 10.1016/j.ijleo.2012.12.055; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Marami B, 2011, LECT NOTES COMPUT SC, V6891, P460, DOI 10.1007/978-3-642-23623-5_58; Markelj P, 2012, MED IMAGE ANAL, V16, P642, DOI 10.1016/j.media.2010.03.005; Miller K, 2012, J BIOMECH, V45, P2698, DOI 10.1016/j.jbiomech.2012.07.031; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Oliveira FPM, 2014, COMPUT METHOD BIOMEC, V17, P73, DOI 10.1080/10255842.2012.670855; Otake Y, 2012, IEEE T MED IMAGING, V31, P948, DOI 10.1109/TMI.2011.2176555; Periaswamy S, 2003, IEEE T MED IMAGING, V22, P865, DOI 10.1109/TMI.2003.815069; Picinbono G, 2003, GRAPH MODELS, V65, P305, DOI 10.1016/S1524-0703(03)00045-6; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Roujol S, 2012, IEEE T INF TECHNOL B, V16, P365, DOI 10.1109/TITB.2012.2190366; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sotiras A, 2013, IEEE T MED IMAGING, V32, P1153, DOI 10.1109/TMI.2013.2265603; Taylor ZA, 2008, IEEE T MED IMAGING, V27, P650, DOI 10.1109/TMI.2007.913112; Van Dyke TJ, 2000, INT J SOLIDS STRUCT, V37, P5873, DOI 10.1016/S0020-7683(99)00157-2; Wang XY, 2008, ACAD PR SER BIOM ENG, P187, DOI 10.1016/B978-012373583-6.50012-8; Wittek A, 2010, PROG BIOPHYS MOL BIO, V103, P292, DOI 10.1016/j.pbiomolbio.2010.09.001; Xu SP, 2011, IEEE T INSTRUM MEAS, V60, P14, DOI 10.1109/TIM.2010.2065450; Zhang GY, 2014, ENG ANAL BOUND ELEM, V42, P60, DOI 10.1016/j.enganabound.2013.08.014; Zhang JY, 2014, PHYS MED BIOL, V59, P97, DOI 10.1088/0031-9155/59/1/97; Zhuang XH, 2011, IEEE T MED IMAGING, V30, P1819, DOI 10.1109/TMI.2011.2150240	34	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140567	10.1371/journal.pone.0140567	http://dx.doi.org/10.1371/journal.pone.0140567			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495841	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200022
J	Duffield, C; Wilson, AJ; Thornton, A				Duffield, Callum; Wilson, Alastair J.; Thornton, Alex			Desperate Prawns: Drivers of Behavioural Innovation Vary across Social Contexts in Rock Pool Crustaceans	PLOS ONE			English	Article							PROBLEM-SOLVING PERFORMANCE; IN-HOUSE SPARROWS; CALLITRICHID MONKEYS; COMPETITIVE ABILITY; FORAGING INNOVATION; MINIATURE BRAINS; LARGER GROUPS; WILD; BIRDS; FLEXIBILITY	Innovative behaviour may allow animals to cope with changes in their environment. Innovative propensities are known to vary widely both between and within species, and a growing body of research has begun to examine the factors that drive individuals to innovate. Evidence suggests that individuals are commonly driven to innovate by necessity; for instance by hunger or because they are physically unable to outcompete others for access to resources. However, it is not known whether the factors that drive individuals to innovate are stable across contexts. We examined contextual variation in the drivers of innovation in rock pool prawns (Palaemon spp), invertebrates that face widely fluctuating environments and may, through the actions of tides and waves, find themselves isolated or in groups. Using two novel foraging tasks, we examined the effects of body size and hunger in prawns tested in solitary and group contexts. When tested alone, small prawns were significantly more likely to succeed in a spatial task, and faster to reach the food in a manipulation task, while hunger state had no effect. In contrast, size had no effect when prawns were tested in groups, but food-deprived individuals were disproportionately likely to innovate in both tasks. We suggest that contextual variation in the drivers of innovation is likely to be common in animals living in variable environments, and may best be understood by considering variation in the perception of relative risks and rewards under different conditions.	[Duffield, Callum; Wilson, Alastair J.; Thornton, Alex] Univ Exeter, Ctr Ecol & Conservat, Exeter, Cornwall, England	University of Exeter	Thornton, A (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Exeter, Cornwall, England.	alex.thornton@exeter.ac.uk		Thornton, Alex/0000-0002-1607-2047; Wilson, Alastair/0000-0002-5045-2051	Biotechnology and Biological Sciences Research Council [BB/H021817/1]; BBSRC [BB/L022656/1, BB/H021817/1, BB/H021817/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H021817/2, BB/L022656/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	A.T. was supported by a David Phillips Fellowship from the Biotechnology and Biological Sciences Research Council (www.bbsrc.co.uk; grant number: BB/H021817/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson-Amram S, 2013, ANIM BEHAV, V85, P349, DOI 10.1016/j.anbehav.2012.11.003; Benson-Amram S, 2012, P ROY SOC B-BIOL SCI, V279, P4087, DOI 10.1098/rspb.2012.1450; BERGLUND A, 1981, OIKOS, V36, P158, DOI 10.2307/3544440; Bokony V, 2014, BEHAV ECOL, V25, P124, DOI 10.1093/beheco/art094; Cauchard L, 2013, ANIM BEHAV, V85, P19, DOI 10.1016/j.anbehav.2012.10.005; Chapman BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059437; Chittka L, 2011, P ROY SOC B-BIOL SCI, V278, P885, DOI 10.1098/rspb.2010.2699; Cole EF, 2012, CURR BIOL, V22, P1808, DOI 10.1016/j.cub.2012.07.051; Cole EF, 2012, P ROY SOC B-BIOL SCI, V279, P1168, DOI 10.1098/rspb.2011.1539; Day RL, 2003, ANIM BEHAV, V65, P559, DOI 10.1006/anbe.2003.2074; FORSTER GR, 1951, J MAR BIOL ASSOC UK, V30, P333, DOI 10.1017/S0025315400012819; Godin DM, 1996, AQUACULTURE, V139, P243, DOI 10.1016/0044-8486(95)01174-9; Grenfell C, 2013, THESIS BANGOR U, P59; Griffin AS, 2014, BEHAV PROCESS, V109, P121, DOI 10.1016/j.beproc.2014.08.027; Griffin AS, 2014, ANIM BEHAV, V92, P221, DOI 10.1016/j.anbehav.2014.04.009; Griffin AS, 2013, ANIM BEHAV, V86, P1291, DOI 10.1016/j.anbehav.2013.09.035; Guerao G, 1996, CRUSTACEANA, V69, P101, DOI 10.1163/156854096X00132; HARTNOLL R. G, 1985, FACTORS ADULT GROWTH, V3, P101; KATZIR G, 1982, BEHAVIOUR, V81, P231, DOI 10.1163/156853982X00157; Keagy J, 2009, ANIM BEHAV, V78, P809, DOI 10.1016/j.anbehav.2009.07.011; Kendal RL, 2005, AM J PRIMATOL, V66, P167, DOI 10.1002/ajp.20136; Kummer H., 1985, T ROYAL SOC LONDON B, V308, P203, DOI DOI 10.1098/RSTB.1985.0020; Laland KN, 1999, BEHAV ECOL, V10, P270, DOI 10.1093/beheco/10.3.270; Laland KN, 1999, ANIM BEHAV, V57, P331, DOI 10.1006/anbe.1998.0967; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Biondi LM, 2010, ANIM COGN, V13, P701, DOI 10.1007/s10071-010-0319-8; Morand-Ferron J, 2011, BEHAV ECOL, V22, P1241, DOI 10.1093/beheco/arr120; Morand-Ferron J, 2011, P NATL ACAD SCI USA, V108, P15898, DOI 10.1073/pnas.1111560108; Persson M, 2008, MAR ECOL PROG SER, V371, P203, DOI 10.3354/meps07674; Reader S.M., 2003, ANIMAL INNOVATION; Reader SM, 2001, INT J PRIMATOL, V22, P787, DOI 10.1023/A:1012069500899; Reader SM, 2003, ANIMAL INNOVATION, P4; Rowe C, 2014, BEHAV ECOL, V25, P1287, DOI 10.1093/beheco/aru090; Sol D, 2006, J ORNITHOL, V147, P34; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Thornton A, 2014, BEHAV ECOL, V25, P1299, DOI 10.1093/beheco/aru095; Thornton A, 2012, ANIM BEHAV, V83, P1459, DOI 10.1016/j.anbehav.2012.03.018	40	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139050	10.1371/journal.pone.0139050	http://dx.doi.org/10.1371/journal.pone.0139050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488728	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400019
J	Kuhelj, A; de Groot, M; Blejec, A; Virant-Doberlet, M				Kuhelj, Anka; de Groot, Maarten; Blejec, Andrej; Virant-Doberlet, Meta			The Effect of Timing of Female Vibrational Reply on Male Signalling and Searching Behaviour in the Leafhopper Aphrodes makarovi	PLOS ONE			English	Article							BINOTATA SPECIES COMPLEX; AUSTRALIAN BUSH-CRICKET; VIBRATORY COMMUNICATION; ACOUSTIC COMMUNICATION; REPRODUCTIVE ISOLATION; TREEHOPPERS HEMIPTERA; MATE RECOGNITION; HOMOPTERA; SONG; SEX	Sexual communication in animals often involves duetting characterized by a coordinated reciprocal exchange of acoustic signals. We used playback experiments to study the role of timing of a female reply in the species-specific duet structure in the leafhopper Aphrodes makarovi (Hemiptera: Cicadellidae). In leafhoppers, mate recognition and location is mediated exclusively by species-and sex-specific substrate-borne vibrational signals and a female signal emitted in reply to male advertisement calls is essential for recognition and successful location of the female. In A. makarovi, males have to initiate each exchange of vibrational signals between partners, and in a duet the beginning of a female reply overlaps the end of the male advertisement call. Results of playback treatments in which female replies were delayed and did not overlap with the male call revealed that in order to trigger an appropriate behavioural response of the male, female reply has to appear in a period less than 400 ms after the end of the initiating male call. Results also suggest that males are not able to detect a female reply while calling, since female reply that did not continue after the end of male call triggered male behaviour similar to behaviour observed in the absence of female reply. Together, our results show that vibrational duets are tightly coordinated and that the species-specific duet structure plays an important role in mate recognition in location processes.	[Kuhelj, Anka; de Groot, Maarten; Blejec, Andrej; Virant-Doberlet, Meta] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia	National Institute of Biology - Slovenia	Virant-Doberlet, M (corresponding author), Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia.	meta.virant@nib.si	Virant-Doberlet, Meta/G-9251-2019; Kuhelj, Anka/ABE-5758-2021; de Groot, Maarten/AER-0020-2022; Blejec, Andrej/M-5215-2019	Virant-Doberlet, Meta/0000-0001-7510-2392; Kuhelj, Anka/0000-0002-8164-2843; Blejec, Andrej/0000-0001-7484-6031; de Groot, Maarten/0000-0002-5721-6676	Slovenian National Research Agency [J1-2181, P1-0255];  [1000-11-310197]	Slovenian National Research Agency(Slovenian Research Agency - Slovenia); 	Funding provided by PhD Fellowship: 1000-11-310197; Slovenian National Research Agency; http://www.arrs.gov.si/sl/; AK, research grant: J1-2181; Slovenian National Research Agency; http://www.arrs.gov.si/sl/; MVD and Research Programme: P1-0255; Slovenian National Research Agency; http://www.arrs.gov.si/sl/; AB & MVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT JC, 1993, J INSECT BEHAV, V6, P467, DOI 10.1007/BF01049526; Bailey WJ, 2000, ANIM BEHAV, V59, P361, DOI 10.1006/anbe.1999.1325; Bailey WJ, 2004, J EXP BIOL, V207, P803, DOI 10.1242/jeb.00840; Bailey WJ, 2003, PHYSIOL ENTOMOL, V28, P157, DOI 10.1046/j.1365-3032.2003.00337.x; BARTH FG, 1988, OECOLOGIA, V77, P194, DOI 10.1007/BF00379186; Bluemel JK, 2014, SYST ENTOMOL, V39, P304, DOI 10.1111/syen.12056; Boumans L, 2015, J ETHOL, V33, P87, DOI 10.1007/s10164-015-0423-y; Cocroft RB, 2006, ETHOLOGY, V112, P779, DOI 10.1111/j.1439-0310.2006.01226.x; Cocroft R.B., 2014, STUDYING VIBRATIONAL; Cocroft R.B., 2014, STUDYING VIBRATIONAL, P3; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cokl A, 2007, BEHAV PROCESS, V75, P40, DOI 10.1016/j.beproc.2007.01.003; Cokl A, 2006, CONT T ENT, P71; Cooley JR, 2001, BEHAVIOUR, V138, P827, DOI 10.1163/156853901753172674; Davidian M., 1995, NONLINEAR MODELS REP; de Groot M, 2012, J INSECT BEHAV, V25, P419, DOI 10.1007/s10905-011-9304-6; de Groot M, 2011, CENT EUR J BIOL, V6, P756, DOI 10.2478/s11535-011-0056-2; De Luca PA, 2011, ETHOLOGY, V117, P440, DOI 10.1111/j.1439-0310.2011.01893.x; Derlink M, 2014, THESIS U LJUBLJANA; Derlink M, 2014, ANIM BEHAV, V90, P181, DOI 10.1016/j.anbehav.2014.01.023; DEVRIJER PWF, 1984, NETH J ZOOL, V34, P388, DOI 10.1163/002829684X00218; DEWINTER AJ, 1990, BIOL J LINN SOC, V40, P191, DOI 10.1111/j.1095-8312.1990.tb01975.x; Dietrich CH, 2004, SYST ENTOMOL, V29, P455, DOI 10.1111/j.0307-6970.2004.00250.x; DOBLER S, 1994, J COMP PHYSIOL A, V175, P67, DOI 10.1007/BF00217437; Emerson SB, 1999, BRAIN BEHAV EVOLUT, V53, P187, DOI 10.1159/000006594; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; Hall ML, 2009, ADV STUD BEHAV, V40, P67, DOI 10.1016/S0065-3454(09)40003-2; Hall ML, 2004, BEHAV ECOL SOCIOBIOL, V55, P415, DOI 10.1007/s00265-003-0741-x; Heller K.-G., 1990, P130; HELLER KG, 1986, BEHAV ECOL SOCIOBIOL, V18, P189, DOI 10.1007/BF00290822; HENNIG RM, 1994, J EXP BIOL, V187, P45; Henry CS, 2006, BEHAV ECOL SOCIOBIOL, V61, P39, DOI 10.1007/s00265-006-0235-8; Henry CS, 2013, BIOL REV, V88, P787, DOI 10.1111/brv.12027; Henry CS, 2009, J INSECT BEHAV, V22, P289, DOI 10.1007/s10905-009-9174-3; Hill P.S., 2008, VIBRATIONAL COMMUNIC, DOI DOI 10.4159/9780674273825; Hochberg Y., 1987, MULTIPLE COMP PROCED; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hoy R, 2002, NATURE, V418, P831, DOI 10.1038/418831a; HUNT RE, 1991, BEHAV ECOL SOCIOBIOL, V28, P315, DOI 10.1007/BF00164380; HUNT RE, 1992, J INSECT BEHAV, V5, P1, DOI 10.1007/BF01049154; irant-Doberlet M., 2014, STUDYING VIBRATIONAL, P93; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kokko H, 2007, EVOLUTION, V61, P1162, DOI 10.1111/j.1558-5646.2007.00090.x; Kuhelj A, 2015, THESIS U LJUBLJANA; Kuhelj A, 2015, BEHAV ECOL SOCIOBIOL, V69, P815, DOI 10.1007/s00265-015-1898-9; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lakes-Harlan R., 2014, STUDYING VIBRATIONAL, DOI 10.1007/978-3-662-43607-3_14; Legendre F, 2012, ANIM BEHAV, V83, P361, DOI 10.1016/j.anbehav.2011.11.003; Mazzoni V, 2009, ENTOMOL EXP APPL, V133, P174, DOI 10.1111/j.1570-7458.2009.00911.x; Mazzoni V, 2009, B ENTOMOL RES, V99, P401, DOI 10.1017/S0007485308006408; McNett GD, 2010, BEHAV ECOL SOCIOBIOL, V64, P2043, DOI 10.1007/s00265-010-1018-9; MICHELSEN A, 1982, BEHAV ECOL SOCIOBIOL, V11, P269, DOI 10.1007/BF00299304; Ossiannilsson F, 1949, OPUSCULA ENTOMOLOGIC, V10, P1; Percy DM, 2006, INVERTEBR SYST, V20, P431, DOI 10.1071/IS05057; Polajnar J, 2014, BEHAV PROCESS, V107, P68, DOI 10.1016/j.beproc.2014.07.013; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Pringle J. W. S., 1957, Proceedings of the Linnean Society of London, V167, P144; R Development Core Team, 2015, LANG ENV STAT COMP; ROBINSON D, 1986, PHYSIOL ENTOMOL, V11, P317, DOI 10.1111/j.1365-3032.1986.tb00419.x; Robinson DJ, 2002, ADV INSECT PHYSIOL, V29, P151, DOI 10.1016/S0065-2806(02)29003-7; Rodriguez R. L., 2014, STUDYING VIBRATIONAL, P147, DOI [10.1007/978-3-662-43607-3_9, DOI 10.1007/978-3-662-43607-3_9]; Rodriguez RL, 2006, ETHOLOGY, V112, P1231, DOI 10.1111/j.1439-0310.2006.01285.x; Rodriguez RL, 2004, EVOLUTION, V58, P571, DOI 10.1111/j.0014-3820.2004.tb01679.x; Rohde B, 2013, ANN ENTOMOL SOC AM, V106, P392, DOI 10.1603/AN12150; RUPPRECHT R, 1975, J INSECT PHYSIOL, V21, P305, DOI 10.1016/0022-1910(75)90026-8; Shuster S. M., 2003, MATING SYSTEMS STRAT; Stewart KW, 2006, CONT T ENT, P179; Stumpner A, 2001, J INSECT BEHAV, V14, P511, DOI 10.1023/A:1011176106943; Tishechkin D. Yu., 2000, Russian Entomological Journal, V9, P1; Tishechkin D. Yu., 2007, Russian Entomological Journal, V16, P39; Todt D, 2000, ADV STUD BEHAV, V29, P247, DOI 10.1016/S0065-3454(08)60107-2; Uhl G., 2011, SPIDER BEHAV FLEXIBI, P128; Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001; Virant-Doberlet M, 2011, MOL ECOL, V20, P2204, DOI 10.1111/j.1365-294X.2011.05038.x; Virant-Doberlet M, 2006, CONT T ENT, P81; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; ZIMMERMANN U, 1989, J COMP PHYSIOL A, V164, P621, DOI 10.1007/BF00614504; Zorovic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026843	78	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139020	10.1371/journal.pone.0139020	http://dx.doi.org/10.1371/journal.pone.0139020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488472	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400017
J	Liu, Y; Pike, MC; Wu, N; Lin, YG; Mucowski, S; Punj, V; Tang, Y; Yen, HY; Stanczyk, FZ; Enbom, E; Austria, T; Widschwendter, M; Maxson, R; Dubeau, L				Liu, Ying; Pike, Malcolm C.; Wu, Nancy; Lin, Yvonne G.; Mucowski, Sara; Punj, Vasu; Tang, Yuan; Yen, Hai-Yun; Stanczyk, Frank Z.; Enbom, Elena; Austria, Theresa; Widschwendter, Martin; Maxson, Robert; Dubeau, Louis			Brca1 Mutations Enhance Mouse Reproductive Functions by Increasing Responsiveness to Male-Derived Scent	PLOS ONE			English	Article							OVARIAN GRANULOSA-CELLS; OLFACTORY RECEPTORS; VOMERONASAL NEURONS; OESTROUS CYCLE; CANCER RISK; MALE ODOR; EXPRESSION; STIMULI; WOMEN; MICE	We compared the gene expression profiles of ovarian granulosa cells harboring either mutant or wild type Brca1 to follow up on our earlier observation that absence of a functional Brca1 in these important regulators of menstrual/estrous cycle progression leads to prolongation of the pre-ovulatory phase of the estrous cycle and to increased basal levels of circulating estradiol. Here we show that ovarian granulosa cells from mice carrying a conditional Brca1 gene knockout express substantially higher levels of olfactory receptor mRNA than granulosa cells from wild type littermates. This led us to hypothesize that reproductive functions in mutant female mice might be more sensitive to male-derived scent than in wild type female mice. Indeed, it is well established that isolation from males leads to complete cessation of mouse estrous cycle activity while exposure to olfactory receptor ligands present in male urine leads to resumption of such activity. We found that Brca1(-/-) female mice rendered anovulatory by unisexual isolation resumed ovulatory activity more rapidly than their wild type littermates when exposed to bedding from cages where males had been housed. The prime mediator of this increased responsiveness appears to be the ovary and not olfactory neurons. This conclusion is supported by the fact that wild type mice in which endogenous ovaries had been replaced by Brca1-deficient ovarian transplants responded to male-derived scent more robustly than mutant mice in which ovaries had been replaced by wild type ovarian transplants. Our findings not only have important implications for our understanding of the influence of olfactory signals on reproductive functions, but also provide insights into mechanisms whereby genetic risk factors for breast and extra uterine mLLERIAN carcinomas may influence menstrual activity in human, which is itself an independent risk factor for these cancers.	[Liu, Ying; Tang, Yuan; Enbom, Elena; Austria, Theresa; Dubeau, Louis] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Wu, Nancy; Yen, Hai-Yun; Maxson, Robert] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Lin, Yvonne G.; Mucowski, Sara; Stanczyk, Frank Z.] Univ So Calif, Dept Obstet & Gynecol, Los Angeles, CA 90089 USA; [Punj, Vasu] Univ So Calif, USC Norris Comprehens Canc Ctr, Bioinformat Core, Los Angeles, CA 90089 USA; [Punj, Vasu] Univ So Calif, Div Hematol, Los Angeles, CA 90089 USA; [Widschwendter, Martin] UCL, Dept Womens Canc, London, England	University of Southern California; Memorial Sloan Kettering Cancer Center; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of London; University College London	Dubeau, L (corresponding author), Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA.	ldubeau@usc.edu		Widschwendter, Martin/0000-0002-7778-8380; Stanczyk, Frank/0000-0002-3607-121X	US National Institutes of Health [R01 CA119078, R01 CA133117]; Eve Appeal; NATIONAL CANCER INSTITUTE [R01CA119078, R01CA133117] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eve Appeal; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was aided by grants R01 CA119078 and R01 CA133117 from the US National Institutes of Health to LD, by a gift from the Ovarian Cancer Coalition of Greater California to LD, and by funds from Eve Appeal to MW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Chodankar R, 2005, CURR BIOL, V15, P561, DOI 10.1016/j.cub.2005.01.052; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Dalton RP, 2013, CELL, V155, P321, DOI 10.1016/j.cell.2013.09.033; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Finch A, 2013, FERTIL STERIL, V99, P1724, DOI 10.1016/j.fertnstert.2013.01.109; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hong H, 2010, CANCER RES, V70, P221, DOI 10.1158/0008-5472.CAN-09-3232; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; JEMIOLO B, 1986, P NATL ACAD SCI USA, V83, P4576, DOI 10.1073/pnas.83.12.4576; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; LYNCH JW, 1994, J GEN PHYSIOL, V103, P87, DOI 10.1085/jgp.103.1.87; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; MCCLINTOCK MK, 1971, NATURE, V229, P244, DOI 10.1038/229244a0; Minic J, 2005, FEBS J, V272, P524, DOI 10.1111/j.1742-4658.2004.04494.x; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Pal T, 2010, FERTIL STERIL, V93, P1805, DOI 10.1016/j.fertnstert.2008.12.052; Pike MC, 2004, FERTIL STERIL, V82, P186, DOI 10.1016/j.fertnstert.2004.03.013; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Smith KR, 2012, P ROY SOC B-BIOL SCI, V279, P1389, DOI 10.1098/rspb.2011.1697; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; VANDERLEE S, 1956, ACTA PHYSIOL PHARM N, V5, P213; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1184, DOI 10.1093/oxfordjournals.aje.a116427; WHITTEN WK, 1956, J ENDOCRINOL, V13, P399, DOI 10.1677/joe.0.0130399; WHITTEN WK, 1958, J ENDOCRINOL, V17, P307, DOI 10.1677/joe.0.0170307; Widschwendter M, 2013, LANCET ONCOL, V14, P1226, DOI 10.1016/S1470-2045(13)70448-0; Yen HY, 2012, LAB INVEST, V92, P802, DOI 10.1038/labinvest.2012.58	37	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139013	10.1371/journal.pone.0139013	http://dx.doi.org/10.1371/journal.pone.0139013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488398	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400016
J	Maron, CF; Beltramino, L; Di Martino, M; Chirife, A; Seger, J; Uhart, M; Sironi, M; Rowntree, VJ				Maron, Carina F.; Beltramino, Lucas; Di Martino, Matias; Chirife, Andrea; Seger, Jon; Uhart, Marcela; Sironi, Mariano; Rowntree, Victoria J.			Increased Wounding of Southern Right Whale (Eubalaena australis) Calves by Kelp Gulls (Larus dominicanus) at Peninsula Valdes, Argentina	PLOS ONE			English	Article							FIN WHALES; REPRODUCTION; STOMOXYS; BLUBBER; FOOD	At least 626 southern right whale (Eubalaena australis) calves died at the Peninsula Valdes calving ground, Argentina, between 2003 and 2014. Intense gull harassment may have contributed to these deaths. In the 1970s, Kelp Gulls (Larus dominicanus) began feeding on skin and blubber pecked from the backs of living right whales at Valdes. The frequency of gull attacks has increased dramatically over the last three decades and mother-calf pairs are the primary targets. Pairs attacked by gulls spend less time nursing, resting and playing than pairs not under attack. In successive attacks, gulls open new lesions on the whales' backs or enlarge preexisting ones. Increased wounding could potentially lead to dehydration, impaired thermoregulation, and energy loss to wound healing. The presence, number and total area of gull-inflicted lesions were assessed using aerial survey photographs of living mother-calf pairs in 1974-2011 (n = 2680) and stranding photographs of dead calves (n = 192) in 2003-2011. The percentage of living mothers and calves with gull lesions increased from an average of 2% in the 1970s to 99% in the 2000s. In the 1980s and 1990s, mothers and calves had roughly equal numbers of lesions (one to five), but by the 2000s, calves had more lesions (nine or more) covering a greater area of their backs compared to their mothers. Living mother-calf pairs and dead calves in Golfo Nuevo had more lesions than those in Golfo San Jose in the 2000s. The number and area of lesions increased with calf age during the calving season. Intensified Kelp Gull harassment at Peninsula Valdes could be compromising calf health and thereby contributing to the high average rate of calf mortality observed in recent years, but it cannot explain the large year-to-year variance in calf deaths since 2000.	[Maron, Carina F.; Seger, Jon; Rowntree, Victoria J.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Maron, Carina F.; Sironi, Mariano; Rowntree, Victoria J.] Inst Conservac Ballenas, Buenos Aires, DF, Argentina; [Beltramino, Lucas; Di Martino, Matias; Chirife, Andrea; Uhart, Marcela; Sironi, Mariano; Rowntree, Victoria J.] Programa Monitoreo Sanitario Ballena Franca Austr, Puerto Madryn, Chubut, Argentina; [Uhart, Marcela] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Sironi, Mariano] Univ Nacl Cordoba, Diversidad Anim 2, RA-5000 Cordoba, Argentina; [Rowntree, Victoria J.] Ocean Alliance, Whale Conservat Inst, Gloucester, MA USA	Utah System of Higher Education; University of Utah; University of California System; University of California Davis; National University of Cordoba	Maron, CF (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	carimaron@icb.org.ar		Beltramino, Lucas Esteban/0000-0002-2182-088X	Office of Protected Resources of the US National Marine Fisheries Service, National Ocean and Atmospheric Administration [DG133F-02-SE-0901, DG-133F-06-SE-5823, DG133F07SE4651]; US Marine Mammal Commission [E4047315, E4061768]; Ocean Foundation; Island Foundation Inc.; Pacific Life Foundation; Lawrence Foundation; Conservation, Research and Education Opportunities International (CREOI); Wildlife Conservation Society; Instituto de Conservacion de Ballenas; Ocean Alliance	Office of Protected Resources of the US National Marine Fisheries Service, National Ocean and Atmospheric Administration; US Marine Mammal Commission; Ocean Foundation; Island Foundation Inc.; Pacific Life Foundation; Lawrence Foundation; Conservation, Research and Education Opportunities International (CREOI); Wildlife Conservation Society; Instituto de Conservacion de Ballenas; Ocean Alliance	The Office of Protected Resources of the US National Marine Fisheries Service, National Ocean and Atmospheric Administration (Order #s DG133F-02-SE-0901, DG-133F-06-SE-5823 and DG133F07SE4651), the US Marine Mammal Commission (Grants #E4047315 and E4061768), the Ocean Foundation, the Island Foundation Inc., the Pacific Life Foundation, the Lawrence Foundation, the Conservation, Research and Education Opportunities International (CREOI), the Wildlife Conservation Society, Instituto de Conservacion de Ballenas and Ocean Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR A, 1990, J MAMMAL, V71, P544, DOI 10.2307/1381793; Barros ATM, 2010, PESQUISA VET BRASIL, V30, P945, DOI 10.1590/S0100-736X2010001100008; Best P.B, 1981, INVESTL REP SEA FISH, V123, P1; BEST PB, 1994, J ZOOL, V232, P175, DOI 10.1111/j.1469-7998.1994.tb01567.x; BEST PB, 1992, J ZOOL, V228, P595, DOI 10.1111/j.1469-7998.1992.tb04458.x; BYERS JA, 1995, AM NAT, V146, P25, DOI 10.1086/285785; Byers JA, 1998, CHILD DEV, V69, P599, DOI 10.2307/1132188; Cooke J.G., 2003, SC55023; CUMMINGS W C, 1972, Transactions of the San Diego Society of Natural History, V17, P1; Elkan PW, 2009, AFR J ECOL, V47, P528, DOI 10.1111/j.1365-2028.2008.00980.x; Fazio A, 2013, ALIMENTACION GAVIOTA; Fazio A, 2015, MAR BIOL, V162, P267, DOI 10.1007/s00227-014-2576-6; Gallagher AJ, 2015, AFR J MAR SCI, V37, P411, DOI 10.2989/1814232X.2015.1071718; Geraci J., 2005, MARINE MAMMALS ASHOR, P176; Groch Karina Rejane, 2001, Biotemas, V14, P147; Gulland FMD, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P47; Hoffmeyer MS, 2010, REV BIOL MAR OCEANOG, V45, P131; Image J, IMAGEJ JAVA 1 6 0; International Whaling Commission, 2011, J CETACEAN RES MAN S, V12, P367; Leandro LF, 2010, J EXP MAR BIOL ECOL, V382, P88, DOI 10.1016/j.jembe.2009.11.002; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; LOCKYER C, 1986, CAN J FISH AQUAT SCI, V43, P142, DOI 10.1139/f86-015; Lockyer C., 1981, FAO FISHERIES SERIES, V5, P379; Lockyer C.H., 1987, APPROACHES MARINE MA, P183; McLellan W, 2004, 40AANF112525; Mihok S, 1996, MED VET ENTOMOL, V10, P392, DOI 10.1111/j.1365-2915.1996.tb00762.x; Miller CA, 2011, MAR ECOL PROG SER, V438, P267, DOI 10.3354/meps09174; Payne R., 1986, Reports of the International Whaling Commission Special Issue, P161; Payne R, 1995, AMONG WHALES, P431; Payne R., 1983, COMMUNICATION BEHAV, P371; R Core Team, 2021, R LANGUAGE ENV STAT; Reeb D, 2007, ANAT REC, V290, P596, DOI 10.1002/ar.20535; Reeves R, 2001, 0116 WOODS HOL; Rowntree VJ, 2013, MAR ECOL PROG SER, V493, P275, DOI 10.3354/meps10506; Rowntree Victoria J., 2001, Journal of Cetacean Research and Management Special Issue, V2, P133; Rowntree VJ, 1998, MAR MAMMAL SCI, V14, P99, DOI 10.1111/j.1748-7692.1998.tb00693.x; Sironi M, 2004, BEHAV SOCIAL DEV JUV; Sironi M, 2013, ANN RES REPORT I CON; Sironi M., 2014, SC65BBRG06; Sironi M, 2009, SC61BRG19; Spinka M, 2001, Q REV BIOL, V76, P141, DOI 10.1086/393866; TABER S, 1982, ANIM BEHAV, V30, P1072, DOI 10.1016/S0003-3472(82)80197-8; Thomas P., 2013, WORKSH SO RIGHT WHAL; THOMAS PO, 1984, BEHAVIOUR, V88, P42, DOI 10.1163/156853984X00470; THOMAS PO, 1988, ETHOLOGY, V79, P89; Uhart M., 2008, SC60BRG15; Uhart M., 2009, SC61BRG18; Whitehead H., 1981, MAMMALS SEAS REPORT, V3, P189	48	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139291	10.1371/journal.pone.0139291	http://dx.doi.org/10.1371/journal.pone.0139291			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488493	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400026
J	Stingl, JC; Welker, S; Hartmann, G; Damann, V; Gerzer, R				Stingl, Julia C.; Welker, Susanne; Hartmann, Gunther; Damann, Volker; Gerzer, Ruppert			Where Failure Is Not an Option - Personalized Medicine in Astronauts	PLOS ONE			English	Article							DRUG-METABOLIZING-ENZYMES; PROTON PUMP INHIBITORS; GENETIC POLYMORPHISMS; CYTOCHROME-P450 2D6; ULTRARAPID METABOLIZER; CLINICAL CONSEQUENCES; CYP2C19 GENOTYPE; CYP2D6 GENOTYPE; CYP1A2 GENE; IN-VITRO	Drug safety and efficacy are highly variable among patients. Most patients will experience the desired drug effect, but some may suffer from adverse drug reactions or gain no benefit. Pharmacogenetic testing serves as a pre-treatment diagnostic option in situations where failure or adverse events should be avoided at all costs. One such situation is human space flight. On the international space station (ISS), a list of drugs is available to cover typical emergency settings, as well as the long-term treatment of common conditions for the use in self-medicating common ailments developing over a definite period. Here, we scrutinized the list of the 78 drugs permanently available at the ISS (year 2014) to determine the extent to which their metabolism may be affected by genetic polymorphisms, potentially requiring genotype-specific dosing or choice of an alternative drug. The purpose of this analysis was to estimate the potential benefit of pharmacogenetic diagnostics in astronauts to prevent therapy failure or side effects.	[Stingl, Julia C.; Welker, Susanne] Fed Inst Drugs & Med Devices, Div Res, Bonn, Germany; [Stingl, Julia C.] Univ Bonn, Fac Med, Ctr Translat Med, Bonn, Germany; [Hartmann, Gunther] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Damann, Volker] European Space Agcy, Space Med Off, Cologne, Germany; [Gerzer, Ruppert] German Aerosp Ctr, Inst Aerosp Med, Cologne, Germany	University of Bonn; University of Bonn; European Space Agency; Helmholtz Association; German Aerospace Centre (DLR)	Stingl, JC (corresponding author), Fed Inst Drugs & Med Devices, Div Res, Bonn, Germany.	Julia.stingl@bfarm.de	Hartmann, Gunther/P-7492-2017; Stingl, Julia C./ABA-7201-2020	Hartmann, Gunther/0000-0003-1021-2018; Stingl, Julia C./0000-0002-1566-8156				Batty JA, 2014, CLIN PHARMACOL THER, V95, P321, DOI 10.1038/clpt.2013.193; BERTILSSON L, 1995, CLIN PHARMACOKINET, V29, P192, DOI 10.2165/00003088-199529030-00005; Bijl MJ, 2009, CLIN PHARMACOL THER, V85, P45, DOI 10.1038/clpt.2008.172; Candiotti KA, 2005, ANESTHESIOLOGY, V102, P543, DOI 10.1097/00000542-200503000-00011; Choi CI, 2012, J CLIN PHARMACOL, V52, P1934, DOI 10.1177/0091270011432168; Chung WH, 2014, JAMA-J AM MED ASSOC, V312, P525, DOI 10.1001/jama.2014.7859; de Leon J, 2008, CNS SPECTRUMS, V13, P133, DOI 10.1017/S109285290001628X; Dong HJ, 2000, DRUG METAB DISPOS, V28, P1397; Eichler HG, 2011, NAT REV DRUG DISCOV, V10, P495, DOI [10.1038/nrd3501, 10.1038/nrd3348]; Foster Adriana, 2007, Pain Pract, V7, P352, DOI 10.1111/j.1533-2500.2007.00153.x; Fukuda T, 1999, BRIT J CLIN PHARMACO, V47, P450, DOI 10.1046/j.1365-2125.1999.00913.x; Furuta K, 2010, J INT MED RES, V38, P1473, DOI 10.1177/147323001003800430; Furuta T, 2002, CLIN PHARMACOL THER, V72, P453, DOI 10.1067/mcp.2002.127637; Gaedigk A, 2008, CLIN PHARMACOL THER, V83, P234, DOI 10.1038/sj.clpt.6100406; Garcia-Martin E, 2004, CLIN PHARMACOL THER, V76, P119, DOI 10.1016/j.clpt.2004.04.006; Garcia-Martin E, 2006, MOL DIAGN THER, V10, P29, DOI 10.1007/BF03256440; Ghosal Anima, 2009, Drug Metab Lett, V3, P162; Gill HJ, 1999, PHARMACOGENETICS, V9, P43, DOI 10.1097/00008571-199902000-00007; Hartter S, 2006, BASIC CLIN PHARMACOL, V99, P300, DOI 10.1111/j.1742-7843.2006.pto_491.x; Hamadeh IS, 2014, CLIN PHARMACOL THER, V96, P175, DOI 10.1038/clpt.2014.62; Hendset M, 2007, EUR J CLIN PHARMACOL, V63, P1147, DOI 10.1007/s00228-007-0373-6; Hijazi Y, 2002, DRUG METAB DISPOS, V30, P853, DOI 10.1124/dmd.30.7.853; Hutchinson MR, 2004, BRIT J CLIN PHARMACO, V57, P287, DOI 10.1111/j.1365-2125.2003.02002.x; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Inomata S, 2005, CLIN PHARMACOL THER, V78, P647, DOI 10.1016/j.clpt.2005.08.020; Kawamura M, 2003, ALIMENT PHARM THER, V17, P965, DOI 10.1046/j.1365-2036.2003.01539.x; Kawamura M, 2007, J GASTROEN HEPATOL, V22, P222, DOI 10.1111/j.1440-1746.2006.04419.x; Kim KA, 2004, EUR J CLIN PHARMACOL, V60, P575, DOI 10.1007/s00228-004-0815-3; Kirchheiner J, 2005, NAT REV DRUG DISCOV, V4, P639, DOI 10.1038/nrd1801; Kirchheiner J, 2005, CLIN PHARMACOL THER, V77, P1, DOI 10.1016/j.clpt.2004.08.009; Kirchheiner J, 2004, MOL PSYCHIATR, V9, P442, DOI 10.1038/sj.mp.4001494; Kirchheiner J, 2004, CLIN PHARMACOL THER, V76, P302, DOI 10.1016/j.clpt.2004.07.002; Klotz U, 2004, BASIC CLIN PHARMACOL, V95, P2, DOI 10.1111/j.1600-0773.2004.pto950102.x; Lessard E, 1999, PHARMACOGENETICS, V9, P435; Nakajima M, 1999, J BIOCHEM-TOKYO, V125, P803, DOI 10.1093/oxfordjournals.jbchem.a022352; Nelson DR, 2011, CYTOCHROME P450 CYP; Nicolas JM, 1999, CHEM-BIOL INTERACT, V123, P63, DOI 10.1016/S0009-2797(99)00131-3; Olkkola K. T., 2008, V182, P335, DOI 10.1007/978-3-540-74806-9_16; Otton SV, 1996, BRIT J CLIN PHARMACO, V41, P149, DOI 10.1111/j.1365-2125.1996.tb00173.x; Palikhe NS, 2011, ALLERGY ASTHMA IMMUN, V3, P273, DOI 10.4168/aair.2011.3.4.273; Park MW, 2013, PHARMACOGENET GENOM, V23, P558, DOI 10.1097/FPC.0b013e328364eb92; Phillips KA, 2001, JAMA-J AM MED ASSOC, V286, P2270, DOI 10.1001/jama.286.18.2270; Rasmussen BB, 2002, PHARMACOGENETICS, V12, P473, DOI 10.1097/00008571-200208000-00008; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Renwick AB, 1998, XENOBIOTICA, V28, P337, DOI 10.1080/004982598239452; Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x; Schwab M, 2004, CLIN PHARMACOL THER, V76, P201, DOI 10.1016/j.clpt.2004.05.002; Shams MEE, 2006, J CLIN PHARM THER, V31, P493, DOI 10.1111/j.1365-2710.2006.00763.x; Shen M, 2013, FORENSIC SCI INT, V227, P77, DOI 10.1016/j.forsciint.2012.08.035; Siegle I, 2001, PHARMACOGENETICS, V11, P237, DOI 10.1097/00008571-200104000-00007; Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002; Stingl JC, 2013, MOL PSYCHIATR, V18, P273, DOI 10.1038/mp.2012.42; Swen JJ, 2008, CLIN PHARMACOL THER, V83, P781, DOI 10.1038/sj.clpt.6100507; Swen JJ, 2011, CLIN PHARMACOL THER, V89, P662, DOI 10.1038/clpt.2011.34; Veefkind AH, 2000, THER DRUG MONIT, V22, P202, DOI 10.1097/00007691-200004000-00011; Wang JS, 2000, DRUG METAB DISPOS, V28, P959; Wang ZJ, 2012, J CLIN PHARMACOL, V52, P1343, DOI 10.1177/0091270011414575	58	14	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140764	10.1371/journal.pone.0140764	http://dx.doi.org/10.1371/journal.pone.0140764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489089	Green Published, gold			2022-12-27	WOS:000363248400067
J	Pham, TM; Ekwaru, JP; Loehr, SA; Veugelers, PJ				Truong-Minh Pham; Ekwaru, John Paul; Loehr, Sarah A.; Veugelers, Paul J.			The Relationship of Serum 25-Hydroxyvitamin D and Insulin Resistance among Nondiabetic Canadians: A Longitudinal Analysis of Participants of a Preventive Health Program	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; GLUCOSE CLAMP TECHNIQUE; PARATHYROID-HORMONE; PHYSICAL-ACTIVITY; MODEL ASSESSMENT; LINKING OBESITY; D DEFICIENCY; IN-VIVO; SENSITIVITY; RISK	Observational and intervention studies have revealed inconsistent findings with respect to the relationship between vitamin D and insulin resistance. No intervention studies have been conducted in community samples whereas this may be particularly relevant to the primary prevention of type 2 diabetes (T2D)and cardiovascular disease (CVD). In the present study we examined whether temporal improvements in vitamin D status, measured as serum 25-hydroxyvitamin D [25(OH)D], reduce the risk of insulin resistance among individuals without T2D. We accessed and analyzed data from 5730 nondiabetic participants with repeated measures of serum 25(OH)D who enrolled in a preventive health program. We used the homeostatic model assessment for insulin resistance (HOMA-IR)and applied logistic regression to quantify the independent contribution of baseline serum 25(OH)D and temporal increases in 25(OH)D on HOMA-IR. The median time between baseline and follow up was 1.1 year. On average serum 25(OH)D concentrations increased from 89 nanomoles per liter (nmol/L)at baseline to 122 nmol/L at follow up. Univariate analyses showed that relative to participants with baseline serum 25(OH)D less than 50 nmol/L, participants with baseline concentrations of "50-<75", "75-<100", "100-<125", and >= 125 nmol/L were 0.76 (95% confidence intervals: 0.61-0.95), 0.54 (0.43-0.69), 0.48 (0.36-0.64)and 0.36 (0.27-0.49) times as likely to have insulin resistance at follow up, respectively. More importantly, relative to participants without temporal increases in 25(OH)D, those with increases in serum 25(OH)D of "<25", "25-<50", "50-<75", ">= 75" nmol/L were 0.92 (0.72-1.17), 0.86 (0.65-1.13), 0.66 (0.47-0.93), and 0.74 (0.55-0.99)times as likely to have insulin resistance at follow up, respectively. In the subgroup of participants without insulin resistance at baseline, this was 0.96 (0.72-1.27), 0.78 (0.56-1.10), 0.66 (0.44-0.99), and 0.67 (0.48-0.94), respectively. These observations suggest that improvements in vitamin D status reduce the risk for insulin resistance and herewith may contribute to the primary prevention of T2D and CVD.	[Truong-Minh Pham; Ekwaru, John Paul; Loehr, Sarah A.; Veugelers, Paul J.] Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada	University of Alberta	Veugelers, PJ (corresponding author), Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada.	Paul.Veugelers@ualberta.ca		Pham, Truong-Minh/0000-0001-9442-2930; Veugelers, Paul/0000-0001-8996-0822	Alberta Innovates Health Scholarship; Canadian Institutes for Health Research; School of Public Health at the University of Alberta; Pure North S'Energy Foundation; Alberta provincial government through Alberta Innovates Health Solutions	Alberta Innovates Health Scholarship; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); School of Public Health at the University of Alberta; Pure North S'Energy Foundation; Alberta provincial government through Alberta Innovates Health Solutions	This is an analysis of secondary data. The data had been collected for the purpose of lifestyle counseling of participants by a preventive health program. None of the authors were involved in the execution of this program; neither did they provide financial support. P.J.V. holds a Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention, and an Alberta Innovates Health Scholarship. The funding for the Canada Research Chair is provided through the Canadian Institutes for Health Research to the University of Alberta. The Alberta Research Chair is awarded by the School of Public Health at the University of Alberta through a thematic research contract with the Pure North S'Energy Foundation. The Health Scholarship is funded by the Alberta provincial government through Alberta Innovates Health Solutions. The funders had no role in analytic design, data analysis, decision to publish, or preparation of this manuscript.	Balkau B, 2008, DIABETES, V57, P2613, DOI 10.2337/db07-1605; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Chiu KC, 2000, METABOLISM, V49, P1501, DOI 10.1053/meta.2000.17708; Davidson MB, 2013, DIABETES CARE, V36, P260, DOI 10.2337/dc12-1204; de las Heras J, 2013, DIABETES CARE, V36, P2048, DOI 10.2337/dc12-1288; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; FACCHINI F, 1994, DIABETES CARE, V17, P115, DOI 10.2337/diacare.17.2.115; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Heaney RP, 2013, ADV NUTR, V4, P303, DOI 10.3945/an.113.003731; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Janz T, 2013, STATISTICS CANADA; Jorde R, 2010, J INTERN MED, V267, P462, DOI 10.1111/j.1365-2796.2009.02181.x; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kayaniyil S, 2010, DIABETES CARE, V33, P1379, DOI 10.2337/dc09-2321; Kuo HK, 2015, CLIN RES CARDIOL; Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mayer-Davis EJ, 1998, JAMA-J AM MED ASSOC, V279, P669, DOI 10.1001/jama.279.9.669; Moore A, 2015, PUBLIC HEALTH NUTR, V18, P1324, DOI 10.1017/S1368980014001475; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; Public Health Agency of Canada, 2011, DIAB CAN FACTS FIG P; Rajakumar K, 2012, DIABETES CARE, V35, P627, DOI 10.2337/dc11-1825; Rosella LC, 2015, PREVALENCE UNDIAGNOS; Seida JC, 2014, J CLIN ENDOCR METAB, V99, P3551, DOI 10.1210/jc.2014-2136; Steingrimsdottir L, 2005, JAMA-J AM MED ASSOC, V294, P2336, DOI 10.1001/jama.294.18.2336; SUH I, 1992, ANN INTERN MED, V116, P881, DOI 10.7326/0003-4819-116-11-881; Sumner AE, 2008, ATHEROSCLEROSIS, V196, P696, DOI 10.1016/j.atherosclerosis.2006.12.018; Teegarden D, 2009, NUTR RES REV, V22, P82, DOI 10.1017/S0954422409389301; Pham TM, 2015, NUTRIENTS, V7, P7271, DOI 10.3390/nu7095338; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Wallace IR, 2015, CLIN ENDOCR IN PRESS; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zhao GX, 2010, DIABETES CARE, V33, P344, DOI 10.2337/dc09-0924	41	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141081	10.1371/journal.pone.0141081	http://dx.doi.org/10.1371/journal.pone.0141081			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488726	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400100
J	Asaoka, R; Nakakura, S; Tabuchi, H; Murata, H; Nakao, Y; Ihara, N; Rimayanti, U; Aihara, M; Kiuchi, Y				Asaoka, Ryo; Nakakura, Shunsuke; Tabuchi, Hitoshi; Murata, Hiroshi; Nakao, Yoshitaka; Ihara, Noriko; Rimayanti, Ulfah; Aihara, Makoto; Kiuchi, Yoshiaki			The Relationship between Corvis ST Tonometry Measured Corneal Parameters and Intraocular Pressure, Corneal Thickness and Corneal Curvature	PLOS ONE			English	Article							OCULAR RESPONSE ANALYZER; GOLDMANN APPLANATION TONOMETER; OPEN-ANGLE GLAUCOMA; BIOMECHANICAL PROPERTIES; DIABETES-MELLITUS; IN-VIVO; TONO-PEN; HYSTERESIS; AGE; PNEUMOTONOMETRY	The purpose of the study was to investigate the correlation between Corneal Visualization Scheimpflug Technology (Corvis ST tonometry: CST) parameters and various other ocular parameters, including intraocular pressure (IOP) with Goldmann applanation tonometry. IOP with Goldmann applanation tonometry (IOP-G), central corneal thickness (CCT), axial length (AL), corneal curvature, and CST parameters were measured in 94 eyes of 94 normal subjects. The relationship between ten CST parameters against age, gender, IOP-G, AL, CST-determined CCT and average corneal curvature was investigated using linear modeling. In addition, the relationship between IOP-G versus CST-determined CCT, AL, and other CST parameters was also investigated using linear modeling. Linear modeling showed that the CST measurement 'A time-1' is dependent on IOP-G, age, AL, and average corneal curvature; 'A length-1' depends on age and average corneal curvature; 'A velocity-1' depends on IOP-G and AL; 'A time-2' depends on IOP-G, age, and AL; 'A length-2' depends on CCT; 'A velocity-2' depends on IOP-G, age, AL, CCT, and average corneal curvature; 'peak distance' depends on gender; 'maximum deformation amplitude' depends on IOP-G, age, and AL. In the optimal model for IOP-G, A time-1, A velocity-1, and highest concavity curvature, but not CCT, were selected as the most important explanatory variables. In conclusion, many CST parameters were not significantly related to CCT, but IOP usually was a significant predictor, suggesting that an adjustment should be made to improve their usefulness for clinical investigations. It was also suggested CST parameters were more influential for IOP-G than CCT and average corneal curvature.	[Asaoka, Ryo; Murata, Hiroshi; Aihara, Makoto] Univ Tokyo, Dept Ophthalmol, Tokyo 113, Japan; [Nakakura, Shunsuke; Tabuchi, Hitoshi] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Nakao, Yoshitaka; Ihara, Noriko; Rimayanti, Ulfah; Kiuchi, Yoshiaki] Hiroshima Univ, Dept Ophthalmol & Visual Sci, Hiroshima, Japan; [Rimayanti, Ulfah] UIN Alauddin Makassar, Fac Hlth Sci, Sulawesi Selatan, Indonesia	University of Tokyo; Hiroshima University	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Tokyo 113, Japan.	rasaoka-tky@umin.ac.jp		Nakao, Yoshitaka/0000-0003-1280-2791	Ministry of Education, Culture, Sports, Science and Technology of Japan [26462679]; Grants-in-Aid for Scientific Research [26462688] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported, in part, by Research Grant 26462679 (to RA) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ariza-Gracia MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121486; Asaoka R, 2008, EFFECTS MAXIMUM AIR; Bak-Nielsen S, 2015, CORNEA, V34, P71, DOI 10.1097/ICO.0000000000000293; Bhan A, 2002, INVEST OPHTH VIS SCI, V43, P1389; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Costin BR, 2014, J GLAUCOMA, V23, P69, DOI 10.1097/IJG.0b013e318269804b; EHLERS N, 1975, ACTA OPHTHALMOL, P32; EHLERS N, 1975, ACTA OPHTHALMOL, V53, P34; Ewing J.A., 1889, BR ASS REP, V502; FORBES M, 1974, ARCH OPHTHALMOL-CHIC, V91, P134, DOI 10.1001/archopht.1974.03900060140012; Foster PJ, 1998, OPHTHALMOLOGY, V105, P969, DOI 10.1016/S0161-6420(98)96021-3; GmbH OO, 2012, CORV ST POCK BOOK; Goldich Y, 2009, J CATARACT REFR SURG, V35, P715, DOI 10.1016/j.jcrs.2008.12.013; Gunvant P, 2004, BRIT J OPHTHALMOL, V88, P518, DOI 10.1136/bjo.2003.019331; Hirneiss C, 2013, GRAEF ARCH CLIN EXP, V251, P2383, DOI 10.1007/s00417-013-2416-2; Inoue K, 2003, JPN J OPHTHALMOL, V47, P129, DOI 10.1016/S0021-5155(02)00667-6; Kaminski S, 1998, ACTA OPHTHALMOL SCAN, V76, P78, DOI 10.1034/j.1600-0420.1998.760114.x; Khawaja AP, 2014, INVEST OPHTH VIS SCI, V55, P117, DOI 10.1167/iovs.13-13290; Koprowski R, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-150; Kotecha A, 2006, INVEST OPHTH VIS SCI, V47, P5337, DOI 10.1167/iovs.06-0557; Kotecha A, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-11; Kotecha A, 2010, J CATARACT REFR SURG, V36, P1822, DOI 10.1016/j.jcrs.2010.08.027; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P4229, DOI 10.1167/iovs.08-2955; Lascaratos G, 2014, INTRAOCULAR PRESSURE, pA0221; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; Luce DA, 2005, J CATARACT REFR SURG, V31, P156, DOI 10.1016/j.jcrs.2004.10.044; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Mansouri K, 2012, AM J OPHTHALMOL, V153, P419, DOI 10.1016/j.ajo.2011.08.022; NIELSEN CB, 1985, ACTA OPHTHALMOL, V63, P351; Orssengo GJ, 1999, B MATH BIOL, V61, P551, DOI 10.1006/bulm.1999.0102; Ozkok A, 2013, J GLAUCOMA, V22, P740, DOI 10.1097/IJG.0000000000000036; Pensyl D, 2012, EYE, V26, P1349, DOI 10.1038/eye.2012.164; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Roberts CJ, 2014, J CATARACT REFR SURG, V40, P862, DOI 10.1016/j.jcrs.2014.04.019; Roy AS, 2015, J MECH BEHAV BIOMED, V48, P173, DOI 10.1016/j.jmbbm.2015.04.010; Sahin A, 2009, INVEST OPHTH VIS SCI, V50, P4597, DOI 10.1167/iovs.08-2763; Salvetat ML, 2014, J GLAUCOMA; Shah S, 1999, OPHTHALMOLOGY, V106, P2154, DOI 10.1016/S0161-6420(99)90498-0; Shimmyo M, 2003, AM J OPHTHALMOL, V136, P603, DOI 10.1016/S0002-9394(03)00424-0; Shin J, 2015, AM J OPHTHALMOL, V159, P144, DOI 10.1016/j.ajo.2014.10.007; Stodtmeister R, 1998, ACTA OPHTHALMOL SCAN, V76, P319, DOI 10.1034/j.1600-0420.1998.760313.x; Terai N, 2012, CURR EYE RES, V37, P553, DOI 10.3109/02713683.2012.669007; Tibshirani RJ, 2012, ANN STAT, V40, P1198, DOI 10.1214/12-AOS1003; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; Valbon BF, 2014, J REFRACT SURG, V30, P468, DOI 10.3928/1081597X-20140521-01; Wells AP, 2008, INVEST OPHTH VIS SCI, V49, P3262, DOI 10.1167/iovs.07-1556; WHITACRE MM, 1993, AM J OPHTHALMOL, V115, P592, DOI 10.1016/S0002-9394(14)71455-2; Wilcox R.R., 2011, INTRO ROBUST ESTIMAT, DOI DOI 10.1016/C2010-0-67044-1; Wolfs RC, 1997, AM J OPHTHALMOL, V123, P767, DOI 10.1016/S0002-9394(14)71125-0; Zhong YS, 2011, CORNEA, V30, P861, DOI 10.1097/ICO.0b013e3182000c27	51	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140385	10.1371/journal.pone.0140385	http://dx.doi.org/10.1371/journal.pone.0140385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485129	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100030
J	Bendor, L; Weyrich, LS; Linz, B; Rolin, OY; Taylor, DL; Goodfield, LL; Smallridge, WE; Kennett, MJ; Harvill, ET				Bendor, Liron; Weyrich, Laura S.; Linz, Bodo; Rolin, Olivier Y.; Taylor, Dawn L.; Goodfield, Laura L.; Smallridge, William E.; Kennett, Mary J.; Harvill, Eric T.			Type Six Secretion System of Bordetella bronchiseptica and Adaptive Immune Components Limit Intracellular Survival During Infection	PLOS ONE			English	Article							HOST-DEFENSE; MURINE MODEL; LYMPH-NODES; PERTUSSIS; BACTERIAL; CELL; MACROPHAGES; VIRULENCE; RESPONSES; MICE	The Type Six Secretion System (T6SS) is required for Bordetella bronchiseptica cytotoxicity, cytokine modulation, infection, and persistence. However, one-third of recently sequenced Bordetella bronchiseptica strains of the predominantly human-associated Complex IV have lost their T6SS through gene deletion or degradation. Since most human B. bronchiseptica infections occur in immunocompromised patients, we determine here whether loss of Type Six Secretion is beneficial to B. bronchiseptica during infection of immunocompromised mice. Infection of mice lacking adaptive immunity (Rag1(-/-)mice) with a T6SS-deficient mutant results in a hypervirulent phenotype that is characterized by high numbers of intracellular bacteria in systemic organs. In contrast, wild-type B. bronchiseptica kill their eukaryotic cellular hosts via a T6SS-dependent mechanism that prevents survival in systemic organs. High numbers of intracellular bacteria recovered from immunodeficient mice but only low numbers from wild-type mice demonstrates that B. bronchiseptica survival in an intracellular niche is limited by B and T cell responses. Understanding the nature of intracellular survival during infection, and its effects on the generation and function of the host immune response, are important to contain and control the spread of Bordetella-caused disease.	[Bendor, Liron; Weyrich, Laura S.; Linz, Bodo; Rolin, Olivier Y.; Taylor, Dawn L.; Goodfield, Laura L.; Smallridge, William E.; Kennett, Mary J.; Harvill, Eric T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Harvill, Eric T.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Harvill, Eric T.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Harvill, ET (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	eth10@psu.edu		Harvill, Eric/0000-0001-8893-2133; Weyrich, Laura/0000-0001-5243-4634	National Institutes of Health [GM083113, AI107016, AI116186, GM113681]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI116186, R56AI107016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113681, R01GM083113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants GM083113, AI107016, AI116186, GM113681 (to ETH, http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banemann A, 1997, INFECT IMMUN, V65, P3469, DOI 10.1128/IAI.65.8.3469-3473.1997; Barry AO, 2011, J LEUKOCYTE BIOL, V89, P373, DOI 10.1189/jlb.0510270; BROMBERG K, 1991, INFECT IMMUN, V59, P4715, DOI 10.1128/IAI.59.12.4715-4719.1991; Buboltz AM, 2009, INFECT IMMUN, V77, P3969, DOI 10.1128/IAI.01362-08; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; COOKSON BT, 1994, J CLIN MICROBIOL, V32, P2569, DOI 10.1128/JCM.32.10.2569-2571.1994; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; DELAFUENTE J, 1994, THORAX, V49, P719, DOI 10.1136/thx.49.7.719; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Dworkin MS, 1999, CLIN INFECT DIS, V28, P1095, DOI 10.1086/514761; Folkesson A, 2002, RES MICROBIOL, V153, P537, DOI 10.1016/S0923-2508(02)01348-7; Forde CB, 1998, INFECT IMMUN, V66, P3198, DOI 10.1128/IAI.66.7.3198-3207.1998; Forde CB, 1999, INFECT IMMUN, V67, P5972, DOI 10.1128/IAI.67.11.5972-5978.1999; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; FRIEDMAN RL, 1992, INFECT IMMUN, V60, P4578, DOI 10.1128/IAI.60.11.4578-4585.1992; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Gorgojo J, 2012, INFECT IMMUN, V80, P4309, DOI 10.1128/IAI.00662-12; Gueirard P, 2003, INFECT IMMUN, V71, P4137, DOI 10.1128/IAI.71.7.4137-4143.2003; GUZMAN CA, 1994, INFECT IMMUN, V62, P5528, DOI 10.1128/IAI.62.12.5528-5537.1994; Hellwig SMM, 1999, FEMS IMMUNOL MED MIC, V26, P203, DOI 10.1111/j.1574-695X.1999.tb01391.x; Huebner ES, 2006, J CLIN MICROBIOL, V44, P2581, DOI 10.1128/JCM.00510-06; Jungnitz H, 1998, INFECT IMMUN, V66, P4640, DOI 10.1128/IAI.66.10.4640-4650.1998; Kinkel TL, 2008, INFECT IMMUN, V76, P3451, DOI 10.1128/IAI.00343-08; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Koh AY, 2005, INFECT IMMUN, V73, P2262, DOI 10.1128/IAI.73.4.2262-2272.2005; KRATZ SS, 1988, J IMMUNOL, V141, P598; Lamberti YA, 2010, INFECT IMMUN, V78, P907, DOI 10.1128/IAI.01031-09; Li JQ, 2014, INFECT IMMUN, V82, P1579, DOI 10.1128/IAI.01458-13; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Mann PB, 2004, J INFECT DIS, V189, P833, DOI 10.1086/381898; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; MEIS JFGM, 1990, EUR J CLIN MICROBIOL, V9, P366, DOI 10.1007/BF01973748; MILLS KHG, 1993, INFECT IMMUN, V61, P399, DOI 10.1128/IAI.61.2.399-410.1993; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; MULLER I, 1989, IMMUNOL REV, V112, P95, DOI 10.1111/j.1600-065X.1989.tb00554.x; Park J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-545; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; PETERSEN JW, 1992, INFECT IMMUN, V60, P4563, DOI 10.1128/IAI.60.11.4563-4570.1992; Register KB, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00152-15; Register KB, 2015, MICROBIOL-SGM, V161, P580, DOI 10.1099/mic.0.000035; SCHIPPER H, 1994, INFECT IMMUN, V62, P3008, DOI 10.1128/IAI.62.7.3008-3011.1994; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Schneider B, 2000, INFECT IMMUN, V68, P7039, DOI 10.1128/IAI.68.12.7039-7048.2000; STEED LL, 1991, J LEUKOCYTE BIOL, V50, P321, DOI 10.1002/jlb.50.4.321; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Subashchandrabose S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003788; Trevejo RT, 2005, VET RES, V36, P493, DOI 10.1051/vetres:2005011; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; Weyrich LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045892; WOOLFREY BF, 1991, CLIN MICROBIOL REV, V4, P243, DOI 10.1128/CMR.4.3.243-255.1991; Yuk MH, 2000, MOL MICROBIOL, V35, P991, DOI 10.1046/j.1365-2958.2000.01785.x	59	14	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140743	10.1371/journal.pone.0140743	http://dx.doi.org/10.1371/journal.pone.0140743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485303	gold, Green Published			2022-12-27	WOS:000363028100064
J	Cingolani, I; Piccardi, C; Tajoli, L				Cingolani, Isabella; Piccardi, Carlo; Tajoli, Lucia			Discovering Preferential Patterns in Sectoral Trade Networks	PLOS ONE			English	Article							COMMUNITY STRUCTURE	We analyze the patterns of import/export bilateral relations, with the aim of assessing the relevance and shape of "preferentiality" in countries' trade decisions. Preferentiality here is defined as the tendency to concentrate trade on one or few partners. With this purpose, we adopt a systemic approach through the use of the tools of complex network analysis. In particular, we apply a pattern detection approach based on community and pseudocommunity analysis, in order to highlight the groups of countries within which most of members' trade occur. The method is applied to two intra-industry trade networks consisting of 221 countries, relative to the low-tech "Textiles and Textile Articles" and the high-tech "Electronics" sectors for the year 2006, to look at the structure of world trade before the start of the international financial crisis. It turns out that the two networks display some similarities and some differences in preferential trade patterns: they both include few significant communities that define narrow sets of countries trading with each other as preferential destinations markets or supply sources, and they are characterized by the presence of similar hierarchical structures, led by the largest economies. But there are also distinctive features due to the characteristics of the industries examined, in which the organization of production and the destination markets are different. Overall, the extent of preferentiality and partner selection at the sector level confirm the relevance of international trade costs still today, inducing countries to seek the highest efficiency in their trade patterns.	[Cingolani, Isabella; Tajoli, Lucia] Politecn Milan, Dept Management Econ & Ind Engn, Milan, Italy; [Piccardi, Carlo] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy	Polytechnic University of Milan; Polytechnic University of Milan	Tajoli, L (corresponding author), Politecn Milan, Dept Management Econ & Ind Engn, Milan, Italy.	lucia.tajoli@polimi.it	Tajoli, Lucia/AGR-6719-2022; Tajoli, Lucia/AAF-3221-2020	Tajoli, Lucia/0000-0002-7471-1302; Cingolani, Isabella/0000-0002-1792-0124; Piccardi, Carlo/0000-0002-8373-539X	FARB grant from Politecnico di Milano	FARB grant from Politecnico di Milano	LT acknowledges the support of FARB grant from Politecnico di Milano (www.polimi.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JE, 2004, J ECON LIT, V42, P691, DOI 10.1257/0022051042177649; Bagrow JP, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046108; Baier SL, 2007, J INT ECON, V71, P72, DOI 10.1016/j.jinteco.2006.02.005; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bhattacharya K, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/02/P02002; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; De Benedictis L, 2014, GLOB ECON J, V14, P287, DOI 10.1515/gej-2014-0032; De Benedictis L, 2011, WORLD ECON, V34, P1417, DOI 10.1111/j.1467-9701.2011.01360.x; Della Rossa F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01467; Eaton J, 2002, ECONOMETRICA, V70, P1741, DOI 10.1111/1468-0262.00352; Egger P, 2011, AM ECON J-ECON POLIC, V3, P113, DOI 10.1257/pol.3.3.113; Evenett SJ, 2002, J POLIT ECON, V110, P281, DOI 10.1086/338746; Fagiolo G, 2008, PHYSICA A, V387, P3868, DOI 10.1016/j.physa.2008.01.050; Gaulier G., 2020, 201223 CEPII, DOI [10.2139/ssrn.1994500, DOI 10.2139/SSRN.1994500]; Hanson GH, 2012, J ECON PERSPECT, V26, P41, DOI 10.1257/jep.26.2.41; Hatzichronoglou T., 1997, OECD SCI TECHNOLOGY, V1997/02, DOI DOI 10.1787/134337307632; He JK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.198701; Helpman E, 2008, Q J ECON, V123, P441, DOI 10.1162/qjec.2008.123.2.441; Hummels D, 2007, J ECON PERSPECT, V21, P131, DOI 10.1257/jep.21.3.131; Landi P, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012814; Newman M.E.J., 2010, NETWORKS INTRO; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Piccardi C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066119; Piccardi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027028; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Subramanian A, 2007, J INT ECON, V72, P151, DOI 10.1016/j.jinteco.2006.07.007; Tzekina I, 2008, EUR PHYS J B, V63, P541, DOI 10.1140/epjb/e2008-00181-2; United Nations, COMM TRAD STAT DAT; Yi KM, 2003, J POLIT ECON, V111, P52, DOI 10.1086/344805; Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105496	30	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140951	10.1371/journal.pone.0140951	http://dx.doi.org/10.1371/journal.pone.0140951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7XI	26485163	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100096
J	Fu, JZ; Huang, J; Lei, M; Luo, ZM; Zhong, XY; Huang, YH; Zhang, H; Liu, RG; Tong, JR; He, F				Fu, Junzhou; Huang, Jun; Lei, Ming; Luo, Zhengmao; Zhong, Xianyang; Huang, Yuanhang; Zhang, Hong; Liu, Riguang; Tong, Junrong; He, Feng			Prevalence and Impact on Stroke in Patients Receiving Maintenance Hemodialysis versus Peritoneal Dialysis: A Prospective Observational Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CARDIOVASCULAR RISK-FACTORS; AMERICAN-HEART-ASSOCIATION; ISCHEMIC-STROKE; SINGLE-CENTER; ALL-CAUSE; MORTALITY; EVENTS; UPDATE; COHORT	Background Patients undergoing maintenance dialysis are at increased risk of stroke, however, less is known about the prevalence and impact on stroke in the patients. Methods In this prospective cohort study, 590 patients undergoing hemodialysis (HD; n = 285) or peritoneal dialysis (PD; n = 305) from January 1, 2008 to December 31, 2012 were recruited. Baseline demographic, clinical, and laboratory data were collected. Timeline incidence data were analyzed using a Poisson model. The Cox proportional hazards regression assessed adjusted differences in stroke risk, a multivariate analysis was also performed. Results 62 strokes occurred during 1258 total patient-years of follow-up. Stroke occurred at a rate of 49.2/1,000 patient-years with a predominance in HD patients compared with PD patients (74.0 vs. 31.8/1,000 patient-years). The cumulative hazard of developing stroke was significantly higher in HD patients (hazard ratio [HR], 1.75; 95% confidence interval [CI], 1.15-3.62; p = 0.046) after adjusting for potential confounders. HD patients had an increased risk of ischemic stroke (HR, 2.62; 95% CI, 1.56-4.58; p = 0.002). The risk of hemorrhagic stroke was not significantly different between PD and HD patients. On multivariate Cox analysis, risk factors of stroke in both HD and PD patients were older age, diabetes, and cardiovascular disease. Other independent risk factors of stroke were lower albumin-corrected calcium in HD patients and higher triglycerides in PD patients. Conclusions Patients undergoing PD were less likely to develop ischemic stroke than those undergoing HD. Comprehensive control of diabetes, cardiovascular disease, calcium-phosphorus metabolism, and triglyceride levels may be useful preventive strategies for stroke in dialysis patients.	[Fu, Junzhou; Liu, Riguang; He, Feng] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Nephrol, Guangzhou 510180, Guangdong, Peoples R China; [Huang, Jun] Southern Med Univ, Grad Sch, Guangzhou 510515, Guangdong, Peoples R China; [Lei, Ming; Luo, Zhengmao; Zhong, Xianyang; Huang, Yuanhang; Zhang, Hong; Tong, Junrong] PLA, Guangzhou Mil Command, Gen Hosp, Dept Nephrol, Guangzhou 510010, Guangdong, Peoples R China	Guangzhou Medical University; Southern Medical University - China; Southern Theater Command General Hospital	Tong, JR (corresponding author), PLA, Guangzhou Mil Command, Gen Hosp, Dept Nephrol, Guangzhou 510010, Guangdong, Peoples R China.	tongjr63@163.com; hefengmm@163.com			National Natural Science Foundation of China [81270895, 81360137]; Guangdong Natural Science Foundation [2014A030310060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was funded by the National Natural Science Foundation of China (Grant No. 81270895; 81360137), and the Guangdong Natural Science Foundation (Grant No. 2014A030310060). The funders had no role in the design or conduct of this research.	Soriano LC, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0204-5; Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319; Cheung AK, 2009, CLIN J AM SOC NEPHRO, V4, pS95, DOI 10.2215/CJN.04780709; Goldfarb-Rumyantzev AS, 2007, AM J KIDNEY DIS, V50, P791, DOI 10.1053/j.ajkd.2007.07.023; He F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061497; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Iseki K, 2000, NEPHROL DIAL TRANSPL, V15, P1808, DOI 10.1093/ndt/15.11.1808; ISEKI K, 1993, KIDNEY INT, V44, P1086, DOI 10.1038/ki.1993.352; Karopadi AN, 2014, NEPHROL DIAL TRANSPL, V29, P885, DOI 10.1093/ndt/gft528; Kawamura M, 1998, AM J KIDNEY DIS, V31, P991, DOI 10.1053/ajkd.1998.v31.pm9631844; Liu XH, 2014, CLIN J AM SOC NEPHRO, V9, P771, DOI 10.2215/CJN.08280813; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Losito A, 2012, NEPHROL DIAL TRANSPL, V27, P1054, DOI 10.1093/ndt/gfr378; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Power A, 2012, AM J KIDNEY DIS, V59, P249, DOI 10.1053/j.ajkd.2011.07.016; Sanchez-Perales C, 2010, NEPHROL DIAL TRANSPL, V25, P3343, DOI 10.1093/ndt/gfq220; Seliger SL, 2003, J AM SOC NEPHROL, V14, P2623, DOI 10.1097/01.ASN.0000088722.56342.A8; Seliger SL, 2003, KIDNEY INT, V64, P603, DOI 10.1046/j.1523-1755.2003.00101.x; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Sozio SM, 2009, AM J KIDNEY DIS, V54, P468, DOI 10.1053/j.ajkd.2009.01.261; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; Toyoda K, 2005, AM J KIDNEY DIS, V45, P1058, DOI 10.1053/j.ajkd.2005.02.028; Wang HH, 2014, AM J KIDNEY DIS, V63, P604, DOI 10.1053/j.ajkd.2013.10.013; Westra WM, 2007, PERITON DIALYSIS INT, V27, P192; Xia X, 2014, AM J KIDNEY DIS, V64, P257, DOI 10.1053/j.ajkd.2013.08.027; Zoccali C, 2003, KIDNEY INT, V63, pS105, DOI 10.1046/j.1523-1755.63.s85.25.x	26	14	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140887	10.1371/journal.pone.0140887	http://dx.doi.org/10.1371/journal.pone.0140887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485155	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100085
J	Jonkman, LE; Rosenthal, DM; Sormani, MP; Miles, L; Herbert, J; Grossman, RI; Inglese, M				Jonkman, Laura E.; Rosenthal, Diana M.; Sormani, Maria Pia; Miles, Laura; Herbert, Joseph; Grossman, Robert I.; Inglese, Matilde			Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis	PLOS ONE			English	Article							CORTICAL ATROPHY; GREY-MATTER; CEREBRAL-CORTEX; MS PATIENTS; IMPAIRMENT; WHITE; LESIONS; VOLUME; DISABILITY; SECONDARY	Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the central nervous system (CNS). Most patients experience a relapsing-remitting (RR) course, while about 15-20% of patients experience a primary progressive (PP) course. Cognitive impairment affects approximately 40-70% of all MS patients and differences in cognitive impairment between RR-MS and PP-MS have been found. We aimed to compare RR-MS and PP-MS patients in terms of cognitive performance, and to investigate the MRI correlates of cognitive impairment in the two groups using measures of brain volumes and cortical thickness. Fifty-seven patients (42 RR-MS, 15 PP-MS) and thirty-eight matched controls underwent neuropsychological (NP) testing and MRI. PP-MS patients scored lower than RR-MS patients on most of the NP tests in absence of any specific pattern. PP-MS patients showed significantly lower caudate volume. There was no significant difference in MRI correlates of cognitive impairment between the two groups except for a prevalent association with MRI measures of cortical GM injury in RR-MS patients and with MRI measures of subcortical GM injury in PP-MS patients. This suggests that although cognitive impairment results from several factors, cortical and subcortical GM injury may play a different role depending on the disease course.	[Jonkman, Laura E.; Inglese, Matilde] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Jonkman, Laura E.] Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands; [Rosenthal, Diana M.; Miles, Laura; Grossman, Robert I.] NYU, Dept Radiol, Sch Med, New York, NY 10016 USA; [Rosenthal, Diana M.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Herbert, Joseph] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA; [Inglese, Matilde] Mt Sinai Sch Med, Dept Radiol, New York, NY USA; [Inglese, Matilde] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Inglese, Matilde] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy	Icahn School of Medicine at Mount Sinai; Vrije Universiteit Amsterdam; New York University; New York University; University of Genoa; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Genoa	Inglese, M (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	matilde.inglese@mssm.edu	Inglese, Matilde/AAH-3189-2020; Jonkman, Laura/AAS-5003-2020; Sormani, Maria Pia/ABH-8756-2020	Inglese, Matilde/0000-0002-9610-0297; Rosenthal, Diana Margot/0000-0002-1238-5003; Jonkman, Laura/0000-0003-1479-3649; SORMANI, MARIA PIA/0000-0001-6892-104X	National Institute of Health [RO1 NS29029, R56 NS051623]; Noto Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS051623, R01NS029029] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Noto Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by grants from the National Institute of Health RO1 NS29029 to R.G. and R56 NS051623 to M.I. and funds from the Noto Foundation to M.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071058; Achiron A, 2013, BRAIN STRUCT FUNCT, V218, P943, DOI 10.1007/s00429-012-0440-3; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Bakshi R, 2001, J NEUROL SCI, V185, P19, DOI 10.1016/S0022-510X(01)00477-4; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Benedict RHB, 2004, ARCH NEUROL-CHICAGO, V61, P226, DOI 10.1001/archneur.61.2.226; Bermel RA, 2003, NEUROREPORT, V14, P335, DOI 10.1097/01.wnr.0000059773.23122.ce; Bester M, 2013, J NEUROL SCI, V330, P61, DOI 10.1016/j.jns.2013.04.005; Bruck W, 2002, MULT SCLER, V8, P93, DOI 10.1191/1352458502ms785rr; Calabrese M, 2010, NEUROLOGY, V75, P1234, DOI 10.1212/WNL.0b013e3181f5d4da; Calabrese M, 2010, NEUROLOGY, V74, P321, DOI 10.1212/WNL.0b013e3181cbcd03; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2013, PRION, V7, P20, DOI 10.4161/pri.22580; Calabrese M, 2012, BRAIN, V135, P2952, DOI 10.1093/brain/aws246; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Carone DA, 2006, NEUROIMAGE, V29, P505, DOI 10.1016/j.neuroimage.2005.07.053; Ceccarelli A, 2008, NEUROIMAGE, V42, P315, DOI 10.1016/j.neuroimage.2008.04.173; Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Sonneville LMJ, 2002, NEUROPSYCHOLOGIA, V40, P1751, DOI 10.1016/S0028-3932(02)00041-6; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delis DC., 2000, CALIFORNIA VERBAL LE; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Feys P, 2014, EUR J PHYS REHABIL M; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Gaudino EA, 2001, NEUROPSY NEUROPSY BE, V14, P32; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Huijbregts SCJ, 2004, NEUROLOGY, V63, P335, DOI 10.1212/01.WNL.0000129828.03714.90; Huijbregts SCJ, 2006, J NEUROL SCI, V245, P187, DOI 10.1016/j.jns.2005.07.018; Hulst HE, 2013, NEUROLOGY, V80, P1025, DOI 10.1212/WNL.0b013e31828726cc; Inglese M, 2004, NEUROLOGY, V63, P170, DOI 10.1212/01.WNL.0000133133.77952.7C; Inglese M, 2007, ARCH NEUROL-CHICAGO, V64, P196, DOI 10.1001/archneur.64.2.196; Inglese M, 2011, MT SINAI J MED, V78, P258, DOI 10.1002/msj.20247; Kuchling J, 2014, MULT SCLER J, V20, P1866, DOI 10.1177/1352458514531084; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Liu Y, 2014, EUR RADIOL, V24, P2334, DOI 10.1007/s00330-014-3239-1; Modica CM, 2015, AM J NEURORADIOL, V36, P57, DOI 10.3174/ajnr.A3998; Morgen K, 2006, NEUROIMAGE, V30, P891, DOI 10.1016/j.neuroimage.2005.10.032; Narayana PA, 2013, NEUROIMAGE-CLIN, V2, P120, DOI 10.1016/j.nicl.2012.11.009; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pagani E, 2005, AM J NEURORADIOL, V26, P341; Papadopoulou A, 2013, MULT SCLER J, V19, P1290, DOI 10.1177/1352458513475490; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Potagas C, 2008, J NEUROL SCI, V267, P100, DOI 10.1016/j.jns.2007.10.002; Prinster A, 2006, NEUROIMAGE, V29, P859, DOI 10.1016/j.neuroimage.2005.08.034; Ramasamy DP, 2009, J NEUROL SCI, V282, P47, DOI 10.1016/j.jns.2008.12.034; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Rovaris M, 2002, ARCH NEUROL-CHICAGO, V59, P1406, DOI 10.1001/archneur.59.9.1406; Ruet A, 2013, NEUROLOGY, V80, P1501, DOI 10.1212/WNL.0b013e31828cf82f; Sailer M, 2003, BRAIN, V126, P1734, DOI 10.1093/brain/awg175; Sepulcre J, 2006, ARCH NEUROL-CHICAGO, V63, P1175, DOI 10.1001/archneur.63.8.1175; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith A, 1982, SYMBOL DIGITS MODALI; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Spreen O., 1977, NEUROSENSORY CTR COM; Tiberio M, 2005, NEUROLOGY, V64, P1001, DOI 10.1212/01.WNL.0000154526.22878.30; van Waesberghe JHTM, 1998, AM J NEURORADIOL, V19, P675	65	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0129380	10.1371/journal.pone.0129380	http://dx.doi.org/10.1371/journal.pone.0129380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485710	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100002
J	Sanna, G; Madeddu, S; Giliberti, G; Ntalli, NG; Cottiglia, F; De Logu, A; Agus, E; Caboni, P				Sanna, Giuseppina; Madeddu, Silvia; Giliberti, Gabriele; Ntalli, Nikoletta G.; Cottiglia, Filippo; De Logu, Alessandro; Agus, Emanuela; Caboni, Pierluigi			Limonoids from Melia azedarach Fruits as Inhibitors of Flaviviruses and Mycobacterium tubercolosis	PLOS ONE			English	Article							CYTOTOXIC LIMONOIDS; DENGUE VIRUS; L. DIPTERA; EXTRACTS; ANTIMYCOBACTERIAL; TRITERPENOIDS; LEAVES; ENTRY	The biological diversity of nature is the source of a wide range of bioactive molecules. The natural products, either as pure compounds or as standardized plant extracts, have been a successful source of inspiration for the development of new drugs. The present work was carried out to investigate the cytotoxicity, antiviral and antimycobacterial activity of the methanol extract and of four identified limonoids from the fruits of Melia azedarach (Meliaceae). The extract and purified limonoids were tested in cell-based assays for antiviral activity against representatives of ssRNA, dsRNA and dsDNA viruses and against Mycobacterium tuberculosis. Very interestingly, 3-alpha-tigloyl-melianol and melianone showed a potent antiviral activity (EC50 in the range of 3-11 mu M) against three important human pathogens, belonging to Flaviviridae family, West Nile virus, Dengue virus and Yellow Fever virus. Mode of action studies demonstrated that title compounds were inhibitors of West Nile virus only when added during the infection, acting as inhibitors of the entry or of a very early event of life cycle. Furthermore, 3-alpha-tigloyl-melianol and methyl kulonate showed interesting antimycobacterial activity (with MIC values of 29 and 70 mu M respectively). The limonoids are typically lipophilic compounds present in the fruits of Melia azeradach. They are known as cytotoxic compounds against different cancer cell lines, while their potential as antiviral and antibacterial was poorly investigated. Our studies show that they may serve as a good starting point for the development of novel drugs for the treatment of infections by Flaviviruses and Mycobacterium tuberculosis, for which there is a continued need.	[Sanna, Giuseppina; Madeddu, Silvia; Giliberti, Gabriele] Univ Cagliari, Dept Biomed Sci, Sect Microbiol & Virol, I-09124 Cagliari, Italy; [Ntalli, Nikoletta G.; Cottiglia, Filippo; Caboni, Pierluigi] Univ Cagliari, Dept Life & Environm Sci, High Resolut Mass Spectrometry Lab, I-09124 Cagliari, Italy; [De Logu, Alessandro; Agus, Emanuela] Univ Cagliari, Dept Life & Environm Sci, Sect Med Microbiol, I-09124 Cagliari, Italy	University of Cagliari; University of Cagliari; University of Cagliari	Giliberti, G (corresponding author), Univ Cagliari, Dept Biomed Sci, Sect Microbiol & Virol, I-09124 Cagliari, Italy.	ggiliberti@unica.it	Sanna, Giuseppina/AAR-5370-2020	Sanna, Giuseppina/0000-0002-3999-4263; Ntalli, Nikoletta/0000-0002-2017-2972				Akihisa T, 2013, PHYTOCHEMISTRY, V89, P59, DOI 10.1016/j.phytochem.2013.01.015; Balestrieri E, 2011, BIOORGAN MED CHEM, V19, P2084, DOI 10.1016/j.bmc.2011.01.024; Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018; Bueno CA, 2010, BIOCHEM BIOPH RES CO, V393, P32, DOI 10.1016/j.bbrc.2010.01.068; Bueno CA, 2009, VIRUS RES, V141, P47, DOI 10.1016/j.virusres.2008.12.013; Cabral MMO, 2008, REV BRAS FARMACOGN, V18, P699, DOI 10.1590/S0102-695X2008000500011; Cantrell CL, 1999, J NAT PROD, V62, P546, DOI 10.1021/np980288u; Cheng YB, 2014, J NAT PROD, V77, P2367, DOI 10.1021/np5002829; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Coria C, 2008, BIORESOURCE TECHNOL, V99, P3066, DOI 10.1016/j.biortech.2007.06.012; Della Bona A, 2015, J MED FOOD, V18, P259, DOI 10.1089/jmf.2013.0181; Diosa-Toro M, 2013, ADV VIRUS RES, V85, P91, DOI 10.1016/B978-0-12-408116-1.00004-5; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gubler D, 2007, FIELDS VIROLOGY, P1155; ITOKAWA H, 1995, CHEM PHARM BULL, V43, P1171, DOI 10.1248/cpb.43.1171; Li Y, 2007, PHYTOTHER RES, V21, P466, DOI 10.1002/ptr.1962; Liang CQ, 2013, J NAT PROD, V76, P2350, DOI 10.1021/np400546z; Lim SP, 2013, VIRUSES-BASEL, V5, P2977, DOI 10.3390/v5122977; Maneerata W, 2008, PHYTOMEDICINE, V15, P1130, DOI 10.1016/j.phymed.2008.05.004; Ntalli NG, 2010, MOLECULES, V15, P5866, DOI 10.3390/molecules15095866; Pan X, 2014, CHEM BIODIVERS, V11, P1121, DOI 10.1002/cbdv.201400190; Pan X, 2014, CHEM BIODIVERS, V11, P987, DOI 10.1002/cbdv.201400052; Parida MM, 2002, J ETHNOPHARMACOL, V79, P273, DOI 10.1016/S0378-8741(01)00395-6; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069; Rahman AKMS, 2009, J NAT MED-TOKYO, V63, P41, DOI 10.1007/s11418-008-0287-3; Roy A, 2006, BIOL PHARM BULL, V29, P191, DOI 10.1248/bpb.29.191; Sanna G, 2015, NAT PROD RES, V23, P1; Solomon T, 2001, J INFECTION, V42, P104, DOI 10.1053/jinf.2001.0802; Szewczuk VD, 2006, PHYTOTHER RES, V20, P993, DOI 10.1002/ptr.1929; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; Vila S, 2010, BIOCELL, V34, P7; Vila SK, 2004, BIOCELL, V28, P35; Xiao J, 2014, NAT PROD RES, V28, P1388, DOI 10.1080/14786419.2014.904308; Yuan CM, 2013, PLANTA MED, V79, P163, DOI 10.1055/s-0032-1328069; Zahoor M, 2014, NAT PROD RES, V26, P1; Zhao JQ, 2014, NAT PRODUCT BIOPROSP, V4, P233, DOI 10.1007/s13659-014-0026-2; Zhou HL, 2005, CHEM PHARM BULL, V53, P1362, DOI 10.1248/cpb.53.1362	38	16	18	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141272	10.1371/journal.pone.0141272	http://dx.doi.org/10.1371/journal.pone.0141272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485025	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100128
J	Allam, SL; Bouteiller, JMC; Hu, EY; Ambert, N; Greget, R; Bischoff, S; Baudry, M; Berger, TW				Allam, Sushmita L.; Bouteiller, Jean-Marie C.; Hu, Eric Y.; Ambert, Nicolas; Greget, Renaud; Bischoff, Serge; Baudry, Michel; Berger, Theodore W.			Synaptic Efficacy as a Function of Ionotropic Receptor Distribution: A Computational Study	PLOS ONE			English	Article							GLUTAMATERGIC SYNAPSES; HIPPOCAMPAL SYNAPSES; RAT HIPPOCAMPUS; NMDA RECEPTORS; EXCITATORY SYNAPSES; QUANTAL VARIABILITY; DENDRITIC SPINES; AMPA RECEPTORS; CA1; TRANSMISSION	Glutamatergic synapses are the most prevalent functional elements of information processing in the brain. Changes in pre-synaptic activity and in the function of various post-synaptic elements contribute to generate a large variety of synaptic responses. Previous studies have explored postsynaptic factors responsible for regulating synaptic strength variations, but have given far less importance to synaptic geometry, and more specifically to the subcellular distribution of ionotropic receptors. We analyzed the functional effects resulting from changing the subsynaptic localization of ionotropic receptors by using a hippocampal synaptic computational framework. The present study was performed using the EONS (Elementary Objects of the Nervous System) synaptic modeling platform, which was specifically developed to explore the roles of subsynaptic elements as well as their interactions, and that of synaptic geometry. More specifically, we determined the effects of changing the localization of ionotropic receptors relative to the presynaptic glutamate release site, on synaptic efficacy and its variations following single pulse and paired-pulse stimulation protocols. The results indicate that changes in synaptic geometry do have consequences on synaptic efficacy and its dynamics.	[Allam, Sushmita L.; Bouteiller, Jean-Marie C.; Hu, Eric Y.; Berger, Theodore W.] Univ So Calif, Dept Biomed Engn, Ctr Neural Engn, Los Angeles, CA 90089 USA; [Bouteiller, Jean-Marie C.; Ambert, Nicolas; Greget, Renaud; Bischoff, Serge; Baudry, Michel] Rhenovia Pharma, Mulhouse, France; [Baudry, Michel] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA USA	University of Southern California; Western University of Health Sciences	Bouteiller, JMC (corresponding author), Univ So Calif, Dept Biomed Engn, Ctr Neural Engn, Los Angeles, CA 90089 USA.	jbouteil@usc.edu	bouteiller, jean-marie/L-4298-2019	bouteiller, jean-marie/0000-0003-3069-0826	National Institute of Biomedical Imaging and Bioengineering from National Institute of Neurological Disorders and Stroke [P41 EB001978-24, U01 GM104604, 1R01NS057128-01A2]; EC via Eurostars; French Association against Myopathies; Alsace Region; French Ministry of Defense; Mulhouse Area; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM104604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057128] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering from National Institute of Neurological Disorders and Stroke; EC via Eurostars; French Association against Myopathies; Alsace Region(Region Grand-Est); French Ministry of Defense; Mulhouse Area; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work supported by National Institute of Biomedical Imaging and Bioengineering - grant P41 EB001978-24 and U01 GM104604 to TWB, 1R01NS057128-01A2 to MB and TWB from National Institute of Neurological Disorders and Stroke. RHENOVIA Pharma acknowledges support from the EC via Eurostars, French Association against Myopathies, Alsace Region and Mulhouse Area, and the French Ministry of Defense.	Allam SL, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00070; Ambert Nicolas, 2010, Open Access Bioinformatics, V2, P113; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Bellingham MC, 1998, J PHYSIOL-LONDON, V511, P861, DOI 10.1111/j.1469-7793.1998.861bg.x; Bergles DE, 1998, J NEUROSCI, V18, P7709; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Boucher J, 2010, BRAIN STRUCT FUNCT, V215, P49, DOI 10.1007/s00429-010-0273-x; Bouteiller JMC, 2011, IEEE T BIO-MED ENG, V58, P3008, DOI 10.1109/TBME.2011.2158605; Bouteiller JMC, 2010, IEEE ENG MED BIO, P787, DOI 10.1109/IEMBS.2010.5626491; Bouteiller Jean-Marie C., 2008, Journal of Integrative Neuroscience, V7, P185, DOI 10.1142/S0219635208001770; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Choquet D, 2010, EUR J NEUROSCI, V32, P250, DOI 10.1111/j.1460-9568.2010.07350.x; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; Franks KM, 2003, J NEUROSCI, V23, P3186; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Johnston D, 1992, Ion Channels, V3, P39; Jonas P, 1993, EXS, V66, P61; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Lisman J., 2006, SCI STKE, V2006, pr; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; MacGillavry HD, 2011, MOL CELL NEUROSCI, V48, P321, DOI 10.1016/j.mcn.2011.09.001; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Racca C, 2000, J NEUROSCI, V20, P2512; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Robert A, 2003, J NEUROSCI, V23, P847; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Savtchenko LP, 2007, P NATL ACAD SCI USA, V104, P1823, DOI 10.1073/pnas.0606636104; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Tarusawa E, 2009, J NEUROSCI, V29, P12896, DOI 10.1523/JNEUROSCI.6160-08.2009; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Vautrin J, 2003, SYNAPSE, V47, P184, DOI 10.1002/syn.10161; Wang JH, 1996, J NEUROPHYSIOL, V76, P276, DOI 10.1152/jn.1996.76.1.276; Xie XP, 1997, P NATL ACAD SCI USA, V94, P6983, DOI 10.1073/pnas.94.13.6983; Zhang W, 2008, NAT NEUROSCI, V11, P1373, DOI 10.1038/nn.2214; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	51	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140333	10.1371/journal.pone.0140333	http://dx.doi.org/10.1371/journal.pone.0140333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480028	Green Submitted, Green Published, gold			2022-12-27	WOS:000363026600006
J	Fiarresga, A; Mata, MF; Cavaco-Goncalves, S; Selas, M; Simoes, IN; Oliveira, E; Carrapico, B; Cardim, N; Cabral, JMS; Ferreira, RC; da Silva, CL				Fiarresga, Antonio; Mata, Marcia F.; Cavaco-Goncalves, Sandra; Selas, Mafalda; Simoes, Irina N.; Oliveira, Eunice; Carrapico, Belmira; Cardim, Nuno; Cabral, Joaquim M. S.; Ferreira, Rui Cruz; da Silva, Claudia L.			Intracoronary Delivery of Human Mesenchymal/Stromal Stem Cells: Insights from Coronary Microcirculation Invasive Assessment in a Swine Model	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; MAGNETIC-RESONANCE; CARDIAC REPAIR; STROMAL CELLS; HEART; THERAPY; TRANSPLANTATION; THERAPEUTICS; INJECTION; EXPANSION	Background Mesenchymal stem/stromal cells have unique properties favorable to their use in clinical practice and have been studied for cardiac repair. However, these cells are larger than coronary microvessels and there is controversy about the risk of embolization and microinfarctions, which could jeopardize the safety and efficacy of intracoronary route for their delivery. The index of microcirculatory resistance (IMR) is an invasive method for quantitatively assessing the coronary microcirculation status. Objectives To examine heart microcirculation after intracoronary injection of mesenchymal stem/stromal cells with the index of microcirculatory resistance. Methods Healthy swine were randomized to receive by intracoronary route either 30x10(6) MSC or the same solution with no cells (1% human albumin/PBS) (placebo). Blinded operators took coronary pressure and flow measurements, prior to intracoronary infusion and at 5 and 30 minutes post-delivery. Coronary flow reserve (CFR) and the IMR were compared between groups. Results CFR and IMR were done with a variance within the 3 transit time measurements of 6% at rest and 11% at maximal hyperemia. After intracoronary infusion there were no significant differences in CFR. The IMR was significantly higher in MSC-injected animals (at 30 minutes, 14.2U vs. 8.8U, p = 0.02) and intragroup analysis showed a significant increase of 112% from baseline to 30 minutes after cell infusion, although no electrocardiographic changes or clinical deterioration were noted. Conclusion Overall, this study provides definitive evidence of microcirculatory disruption upon intracoronary administration of mesenchymal stem/stromal cells, in a large animal model closely resembling human cardiac physiology, function and anatomy.	[Fiarresga, Antonio; Selas, Mafalda; Oliveira, Eunice; Ferreira, Rui Cruz] Hosp Santa Marta, Dept Cardiol, Lisbon, Portugal; [Fiarresga, Antonio; Cardim, Nuno] Univ Nova Lisboa, Nova Med Sch, P-1200 Lisbon, Portugal; [Mata, Marcia F.; Simoes, Irina N.; Cabral, Joaquim M. S.; da Silva, Claudia L.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal; [Mata, Marcia F.; Simoes, Irina N.; Cabral, Joaquim M. S.; da Silva, Claudia L.] Univ Lisbon, Inst Super Tecn, iBB Inst Bioengn & Biosci, P-1699 Lisbon, Portugal; [Cavaco-Goncalves, Sandra] Natl Inst Agr & Vet Res, Oeiras, Portugal; [Carrapico, Belmira] Univ Lisbon, Fac Vet Med, P-1699 Lisbon, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa	Fiarresga, A (corresponding author), Hosp Santa Marta, Dept Cardiol, Lisbon, Portugal.	a.fiarresga@gmail.com	da Silva, Claudia L./K-6104-2012; Mata, Márcia/M-5544-2016; Cabral, Joaquim M S/G-2052-2010	da Silva, Claudia L./0000-0002-1091-7651; Mata, Márcia/0000-0001-7034-1386; Cabral, Joaquim M S/0000-0002-2405-5845; Cavaco-Goncalves, Sandra/0000-0003-1280-229X	Cardiology Department of Hospital de Santa Marta; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [EXPL/BIM-MED/1970/2013 CARDIOSAFER, SFRH/BD/90001/2012, SFRH/BD/51572/2011]; Fundação para a Ciência e a Tecnologia [EXPL/BIM-MED/1970/2013] Funding Source: FCT	Cardiology Department of Hospital de Santa Marta; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was financially supported by research funds from the Cardiology Department of Hospital de Santa Marta and by Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, through the project EXPL/BIM-MED/1970/2013 CARDIOSAFER and grants SFRH/BD/90001/2012 and SFRH/BD/51572/2011 awarded to M. F. Mata and I. N. Simoes, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Bartunek J, 2008, J CARDIOVASC TRANSL, V1, P115, DOI 10.1007/s12265-008-9021-5; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; dos Santos F, 2011, METHODS MOL BIOL, V698, P189, DOI 10.1007/978-1-60761-999-4_15; Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148; Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1; Fiarresga A, 2014, REV PORT CARDIOL, V33, P207, DOI 10.1016/j.repc.2013.09.007; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Grieve SM, 2010, CIRC-HEART FAIL, V3, pE5, DOI 10.1161/CIRCHEARTFAILURE.109.931360; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hong SJ, 2012, CATHETER CARDIOVASC, V83, pE17; Houtgraaf JH, 2013, CIRC RES, V113, P153, DOI 10.1161/CIRCRESAHA.112.300730; Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E; Kudo M, 2003, J MOL CELL CARDIOL, V35, P1113, DOI 10.1016/S0022-2828(03)00211-6; Lennon DP, 2006, EXP HEMATOL, V34, P1604, DOI 10.1016/j.exphem.2006.07.014; Llano R, 2009, CATHETER CARDIO INTE, V73, P251, DOI 10.1002/ccd.21781; Lopes JP, 2013, REV PORT CARDIOL, V32, P43, DOI 10.1016/j.repc.2012.05.014; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mozid AM, 2011, BRIT MED BULL, V98, P143, DOI 10.1093/bmb/ldr014; Patel DM, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/496218; Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Toma C, 2009, CIRC RES, V104, P398, DOI 10.1161/CIRCRESAHA.108.187724; Vulliet PR, 2004, LANCET, V363, P783, DOI 10.1016/S0140-6736(04)15695-X; Wang D, 2011, IRISH J MED SCI, V180, P379, DOI 10.1007/s11845-011-0687-3	32	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0139870	10.1371/journal.pone.0139870	http://dx.doi.org/10.1371/journal.pone.0139870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479722	Green Published, gold, Green Submitted			2022-12-27	WOS:000363026600004
J	Guttenberg, N; Laneuville, M; Ilardo, M; Aubert-Kato, N				Guttenberg, Nicholas; Laneuville, Matthieu; Ilardo, Melissa; Aubert-Kato, Nathanael			Transferable Measurements of Heredity in Models of the Origins of Life	PLOS ONE			English	Article							EVOLUTION; SETS	We propose a metric which can be used to compute the amount of heritable variation enabled by a given dynamical system. A distribution of selection pressures is used such that each pressure selects a particular fixed point via competitive exclusion in order to determine the corresponding distribution of potential fixed points in the population dynamics. This metric accurately detects the number of species present in artificially prepared test systems, and furthermore can correctly determine the number of heritable sets in clustered transition matrix models in which there are no clearly defined genomes. Finally, we apply our metric to the GARD model and show that it accurately reproduces prior measurements of the model's heritability.	[Guttenberg, Nicholas; Laneuville, Matthieu] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 152, Japan; [Ilardo, Melissa] Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, Copenhagen, Denmark; [Aubert-Kato, Nathanael] Ochanomizu Univ, Dept Informat Sci, Tokyo 112, Japan; [Aubert-Kato, Nathanael] Ochanomizu Univ, Leading Grad Sch Promot Ctr, Tokyo 112, Japan	Tokyo Institute of Technology; University of Copenhagen; Ochanomizu University; Ochanomizu University	Guttenberg, N (corresponding author), Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 152, Japan.	ngutten@gmail.com	Laneuville, Matthieu/F-8523-2010	Laneuville, Matthieu/0000-0001-6022-0046; Ilardo, Melissa/0000-0001-6535-8802; Aubert-Kato, Nathanael/0000-0002-9100-1855				Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; BURGER R, 1989, EVOLUTION, V43, P1748, DOI [10.2307/2409390, 10.1111/j.1558-5646.1989.tb02624.x]; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; England JL, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818538; FALCONER DS, 1953, J GENET, V51, P470, DOI 10.1007/BF02982939; FONTANA W, 1994, B MATH BIOL, V56, P1; Gross R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0265-1; Gutierrez JMP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6571; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hordijk W, 2004, J THEOR BIOL, V227, P451, DOI 10.1016/j.jtbi.2003.11.020; KAUFFMAN SA, 1986, J THEOR BIOL, V119, P1, DOI 10.1016/S0022-5193(86)80047-9; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; Markovitch O, 2012, ARTIF LIFE, V18, P243, DOI 10.1162/artl_a_00064; Orgel LE, 2000, P NATL ACAD SCI USA, V97, P12503, DOI 10.1073/pnas.220406697; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Saladino R, 2012, PHYS LIFE REV, V9, P84, DOI 10.1016/j.plrev.2011.12.002; Segre D, 2001, ORIGINS LIFE EVOL B, V31, P119, DOI 10.1023/A:1006746807104; Segre D, 1998, ORIGINS LIFE EVOL B, V28, P501, DOI 10.1023/A:1006583712886; Segre D, 2000, P NATL ACAD SCI USA, V97, P4112, DOI 10.1073/pnas.97.8.4112; Steppan SJ, 2002, TRENDS ECOL EVOL, V17, P320, DOI 10.1016/S0169-5347(02)02505-3; Vasas V, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-1; Vasas V, 2010, P NATL ACAD SCI USA, V107, P1470, DOI 10.1073/pnas.0912628107; Virgo N, 2013, ADV ARTIFICIAL LIFE, V12, P240, DOI DOI 10.7551/978-0-262-31709-2-CH036	23	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140663	10.1371/journal.pone.0140663	http://dx.doi.org/10.1371/journal.pone.0140663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480478	Green Submitted, Green Published, gold			2022-12-27	WOS:000363026600016
J	Szameitat, AJ; Hamaida, Y; Tulley, RS; Saylik, R; Otermans, PCJ				Szameitat, Andre J.; Hamaida, Yasmin; Tulley, Rebecca S.; Saylik, Rahmi; Otermans, Pauldy C. J.			"Women Are Better Than Men"-Public Beliefs on Gender Differences and Other Aspects in Multitasking	PLOS ONE			English	Article							DUAL-TASK PERFORMANCE; NULL HYPOTHESIS	Reports in public media suggest the existence of a stereotype that women are better at multitasking than men. The present online survey aimed at supporting this incidental observation by empirical data. For this, 488 participants from various ethnic backgrounds (US, UK, Germany, the Netherlands, Turkey, and others) filled out a self-developed online-questionnaire. Results showed that overall more than 50% of the participants believed in gender differences in multitasking abilities. Of those who believed in gender differences, a majority of 80% believed that women were better at multitasking. The main reasons for this were believed to be an evolutionary advantage and more multitasking practice in women, mainly due to managing children and household and/or family and job. Findings were consistent across the different countries, thus supporting the existence of a widespread gender stereotype that women are better at multitasking than men. Further questionnaire results provided information about the participants' self-rated own multitasking abilities, and how they conceived multitasking activities such as childcare, phoning while driving, and office work.	[Szameitat, Andre J.; Hamaida, Yasmin; Tulley, Rebecca S.; Saylik, Rahmi; Otermans, Pauldy C. J.] Brunel Univ London, Dept Life Sci, Div Psychol, Uxbridge, Middx, England	Brunel University	Szameitat, AJ (corresponding author), Brunel Univ London, Dept Life Sci, Div Psychol, Uxbridge, Middx, England.	Andre.Szameitat@Brunel.ac.uk	saylik, rahmi/ABI-7776-2020	SAYLIK, RAHMI/0000-0003-3337-5266				Allport G. W., 1954, NATURE PREJUDICE; Boesveld S, 2013, NATL POST; Buser T, 2012, EXP ECON, V15, P641, DOI 10.1007/s10683-012-9318-8; Cortina JM, 1998, ORGAN RES METHODS, V1, P334, DOI 10.1177/109442819813004; DeLuca AN, 2013, NATL GEOGRAPHIC; Hossain A., 2013, FORBES; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jersild AT, 1927, ARCH PSYCHOL, V14; Jimenez F., 2014, DIE WELT GERMAN; Joel D, 2014, P NATL ACAD SCI USA, V111, pE637, DOI 10.1073/pnas.1323319111; Kluger AN, 2001, PSYCHOL BULL, V127, P408, DOI 10.1037//0033-2909.127.3.408; Lauda L., 2013, BEWIESEN WAS FRAUEN; Mantyla T, 2013, PSYCHOL SCI, V24, P514, DOI 10.1177/0956797612459660; McCauley C.R., 1995, STEREOTYPE ACCURACY, P293, DOI 10.1037/10495-012; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Morgan J., 2013, BBC UK; Paridon HM, 2010, EUR J PSYCHOL, V6, P110; Pavlova MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114802; Pavlova MA, 2010, BRAIN RES, V1311, P81, DOI 10.1016/j.brainres.2009.11.046; Pease B, 2003, WHY MEN CAN ONLY DO; Redick TS, 2012, EUR J PSYCHOL ASSESS, V28, P164, DOI 10.1027/1015-5759/a000123; Sax LJ, 2003, RES HIGH EDUC, V44, P409, DOI 10.1023/A:1024232915870; Sayer LC, 2007, RES SOCIOL WORK, V17, P403, DOI 10.1016/S0277-2833(07)17013-8; Silverman I, 1992, ADAPTED MIND EVOLUTI, P487; Spencer B., 2013, DAILY MAIL; Stoet G., 2013, BMC PSYCHOL, V1, DOI [10.1186/2050-7283-1-18, DOI 10.1186/2050-7283-1-18]; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Szameitat AJ, 2006, PSYCHOL RES-PSYCH FO, V70, P541, DOI 10.1007/s00426-005-0015-5; Tomsic ML, 2000, 40 ANN M ASS I RES M; Underwood D, 2000, AIR 2000 ANN FOR; Watson JM, 2010, PSYCHON B REV, V17, P479, DOI 10.3758/PBR.17.4.479	32	14	14	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140371	10.1371/journal.pone.0140371	http://dx.doi.org/10.1371/journal.pone.0140371			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7WW	26479359	gold, Green Published, Green Submitted			2022-12-27	WOS:000363026600010
J	Solari, D; Cavallo, LM; Somma, T; Chiaramonte, C; Esposito, F; De Caro, MD; Cappabianca, P				Solari, Domenico; Cavallo, Luigi Maria; Somma, Teresa; Chiaramonte, Carmela; Esposito, Felice; De Caro, Marialaura Del Basso; Cappabianca, Paolo			Endoscopic Endonasal Approach in the Management of Rathke's Cleft Cysts	PLOS ONE			English	Article							EXTENDED TRANSSPHENOIDAL APPROACH; SURGICAL-MANAGEMENT; CLINICAL-FEATURES; SUPRASELLAR LESIONS; NASOSEPTAL FLAP; SELLAR REGION; OUTCOMES; SURGERY; RESECTION; RECONSTRUCTION	Objective Rathke's cleft cysts (RCCs) are quite uncommon sellar lesions that can extend or even arise in the suprasellar area. The purpose of this study is to evaluate the effectiveness of both standard and extended endoscopic endonasal approaches in the management of different located RCCs. Methods We retrospectively analyzed a series of 29 patients (9 males, 20 females) complaining of a RCC, who underwent a standard or an extended endoscopic transsphenoidal approach at the Division of Neurosurgery, Department of Neurosciences and Reproductive and Odontostomatological Sciences, of the Universita degli Studi di Napoli "Federico II". Data regarding patients' demographics, clinical evaluation, cyst characteristics, surgical treatments, complications and outcomes were extracted from our electronic database (Filemaker Pro 11, File Maker Inc., Santa Clara, California, USA). Results A standard transsphenoidal approach was used in 19 cases, while the extended variation of the approach in 10 cases (5 purely suprasellar and 5 intra-suprasellar RCC). Cysts contents was fully drained in all the 29 cases, whilst a gross total removal, that accounts on the complete cyst wall removal, was achieved in an overall 55,1% of patients (16/29), specifically 36,8% (7/19) that received standard approach and 90% (9/10) of those that underwent to extended approach. We reported a 56.2% of recovery from headache, 38.5% of complete recovery and 53.8% of improvement from visual field defect and an overall 46.7% of improvement of the endocrine functions. Postoperative permanent DI rate was 10.3%, overall post-operative CSF leak rate 6.9%; recurrence/regrowth occurred in 4 patients (4/29, 13.8%), but only one required a second surgery. Conclusion The endoscopic transsphenoidal approach for the removal of a symptomatic RCC offers several advantages in terms of visualization of the surgical field during both the exposure and removal of the lesion. The "extended" variation of the endoscopic approach provides a direct access to the supradiaphragmatic space, allowing adequate view and room for the safe removal of selected supradiaphragmatic RCCs, regardless of the sellar size (even a not enlarged sella), and provides a higher likelihood of preserving normal pituitary tissue and functions.	[Solari, Domenico; Cavallo, Luigi Maria; Somma, Teresa; Chiaramonte, Carmela; Cappabianca, Paolo] Univ Naples Federico II, Div Neurosurg, Dept Neurosci & Reprod & Odontostomatol Sci, Naples, Italy; [Esposito, Felice] Univ Messina, Div Neurosurg, Dept Neurosci, Messina, Italy; [De Caro, Marialaura Del Basso] Univ Naples Federico II, Div Pathol & Cytopathol, Dept Biomorphol & Funct Sci, Naples, Italy	University of Naples Federico II; University of Messina; University of Naples Federico II	Cavallo, LM (corresponding author), Univ Naples Federico II, Div Neurosurg, Dept Neurosci & Reprod & Odontostomatol Sci, Naples, Italy.	lcavallo@unina.it	Esposito, Felice/AAC-4646-2019; Somma, Teresa/HGT-8889-2022; Esposito, Felice/F-4238-2012	Esposito, Felice/0000-0003-1051-5924; Esposito, Felice/0000-0003-1051-5924				Aho CJ, 2005, J NEUROSURG, V102, P189, DOI 10.3171/jns.2005.102.2.0189; Alfieri A, 2002, MINIM INVAS NEUROSUR, V45, P47, DOI 10.1055/s-2002-23582; Arai T, 2011, NEUROL MED-CHIR, V51, P535, DOI 10.2176/nmc.51.535; Benveniste RJ, 2004, J NEUROSURG, V101, P577, DOI 10.3171/jns.2004.101.4.0577; Brassier G, 1999, J NEURORADIOLOGY, V26, P162; Cappabianca P, 2004, NEUROSURGERY, V55, P933, DOI 10.1227/01.NEU.0000137330.02549.0D; Cappabianca P, 2008, ADV TECHNICAL STANDA, P152; Cavallo LM, 2008, NEUROSURG REV, V31, P55, DOI 10.1007/s10143-007-0098-0; Cavallo LM, 2007, NEUROSURGERY, V61, P24, DOI 10.1227/01.NEU.0000280005.26449.2D; Cavallo LM, 2007, J NEUROSURG, V107, P713, DOI 10.3171/JNS-07/10/0713; Ceylan S, 2009, NEUROSURG REV, V32, P309, DOI 10.1007/s10143-009-0201-9; Cohan P, 2004, J ENDOCRINOL INVEST, V27, P943, DOI 10.1007/BF03347537; Couldwell WT, 2004, NEUROSURGERY, V55, P539, DOI 10.1227/01.NEU.0000134287.19377.A2; de Divitiis E, 2007, NEUROSURGERY, V60, P46, DOI 10.1227/01.NEU.0000249211.89096.25; de Notaris M, 2012, J NEUROSURG, V116, P622, DOI 10.3171/2011.11.JNS111162; Dusick JR, 2005, J NEUROSURG, V102, P832, DOI 10.3171/jns.2005.102.5.0832; El-Mahdy W, 1998, NEUROSURGERY, V42, P7, DOI 10.1097/00006123-199801000-00003; Esposito F, 2007, NEUROSURGERY, V60, P295, DOI 10.1227/01.NEU.0000255354.64077.66; FAGER CA, 1966, J NEUROSURG, V24, P77, DOI 10.3171/jns.1966.24.1.0077; Fan J, 2013, J NEUROSURG, V119, P1437, DOI 10.3171/2013.8.JNS13777; Fan MC, 2012, CHINESE MED J-PEKING, V125, P2919, DOI 10.3760/cma.j.issn.0366-6999.2012.16.022; Frank G, 2005, NEUROSURGERY, V56, P124, DOI 10.1227/01.NEU.0000144824.80046.1F; Frank G, 2001, J NEUROSURG, V95, P917; Hadad G, 2006, LARYNGOSCOPE, V116, P1882, DOI 10.1097/01.mlg.0000234933.37779.e4; Han SJ, 2014, J NEURO-ONCOL, V117, P197, DOI 10.1007/s11060-013-1272-6; HARRISON MJ, 1994, J NEUROSURG, V80, P1018, DOI 10.3171/jns.1994.80.6.1018; HIRANO A, 1988, CHILD NERV SYST, V4, P325, DOI 10.1007/BF00270605; Ikeda H, 2002, CLIN NEUROPATHOL, V21, P82; Jahangiri A, 2014, J CLIN NEUROSCI, V21, P779, DOI 10.1016/j.jocn.2013.07.023; Jahangiri A, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.5.FOCUS1178; Kassam AB, 2008, NEUROSURGERY, V63, p0NS52; Kassam Amin, 2005, Neurosurg Focus, V19, pE3; Kassam AB, 2008, NEUROSURGERY, V63, P44, DOI 10.1227/01.NEU.0000297074.13423.F5; Kim E, 2012, WORLD NEUROSURG, V78, P527, DOI 10.1016/j.wneu.2011.12.091; Kim E, 2012, J KOREAN NEUROSURG S, V52, P404, DOI 10.3340/jkns.2012.52.4.404; Kim JE, 2004, J NEUROSURG, V100, P33, DOI 10.3171/jns.2004.100.1.0033; Koutourousiou M, 2009, J CLIN NEUROSCI, V16, P900, DOI 10.1016/j.jocn.2008.10.007; Laufer I, 2007, J NEUROSURG, V106, P400, DOI 10.3171/jns.2007.106.3.400; Laws ER, 2005, J NEUROSURG, V102, P825, DOI 10.3171/jns.2005.102.5.0825; Leng LZ, 2008, NEUROSURGERY, V62, P342, DOI [10.1227/01.NEU.0000312720.93685.17, 10.1227/01.neu.0000326017.84315.1f]; Locatelli Davide, 2010, Neurosurgery, V66, pE400, DOI 10.1227/01.NEU.0000363746.84763.A5; Madhok R, 2010, J NEUROSURG, V112, P1333, DOI 10.3171/2009.10.JNS09348; MIDHA R, 1991, SURG NEUROL, V35, P446, DOI 10.1016/0090-3019(91)90178-C; Oyama N, 2013, ENDOCR J, V60, P207, DOI 10.1507/endocrj.EJ12-0039; Post KD, 2004, J NEUROSURG, V101, P571; Potts MB, 2011, NEUROSURGERY, V69, P1058, DOI 10.1227/NEU.0b013e318228bcea; ROSS DA, 1992, NEUROSURGERY, V30, P173, DOI 10.1227/00006123-199202000-00004; SHANKLIN WM, 1951, ACTA ANAT, V11, P361; Trifanescu R, 2012, CLIN ENDOCRINOL, V76, P151, DOI 10.1111/j.1365-2265.2011.04235.x; Xie T, 2011, J CLIN NEUROSCI, V18, P760, DOI 10.1016/j.jocn.2010.10.014; YOSHIDA J, 1977, J NEUROSURG, V47, P451, DOI 10.3171/jns.1977.47.3.0451; Zada G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.5.FOCUS1183	52	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0139609	10.1371/journal.pone.0139609	http://dx.doi.org/10.1371/journal.pone.0139609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474185	gold, Green Published, Green Submitted			2022-12-27	WOS:000363185500010
J	Tung, CW; Hsu, YC; Shih, YH; Lin, CL				Tung, Chun-Wu; Hsu, Yung-Chien; Shih, Ya-Hsueh; Lin, Chun-Liang			Association of Adiponectin with High-Sensitivity C-Reactive Protein and Clinical Outcomes in Peritoneal Dialysis Patients: A 3.5-Year Follow-Up Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; ALL-CAUSE MORTALITY; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE; PLASMA ADIPONECTIN; CIRCULATING ADIPONECTIN; RECIPROCAL ASSOCIATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; KIDNEY-DISEASE	Introduction Adiponectin (ADPN), one of most abundant fat-derived biologically active substances, plays an important role in anti-atherosclerotic process. There are conflicting results about the impact of ADPN on cardiovascular (CV) outcomes and mortality, particularly in patients undergoing peritoneal dialysis (PD). Moreover, the relationship between ADPN and inflammatory mediators has been seldom explored in this population. Therefore, we examined the relationship between ADPN and longitudinal high-sensitivity C-reactive protein (hs-CRP) changes and investigated whether ADPN or hs-CRP levels could predict CV outcomes and mortality in prevalent PD patients after comprehensive adjustment of possible confounders. Methods In this prospective cohort study, 78 PD patients were enrolled and followed from February 2009 to August 2012. During follow-up, CV events and all-cause mortality were recorded. Results The mean baseline ADPN value was 29.46 +/- 18.01 mu g/ml and duration of PD treatment was 37.76 +/- 36.96 months. In multiple linear regression analysis, plasma ADPN levels positively correlated with high-density lipoprotein and negatively associated with hs-CRP, body mass index, D4/D0 glucose, triglyceride, and duration of PD treatment. After stratified by genders, the inverse association between baseline ADPN and hs-CRP was more significant in the female group. The hs-CRP levels were followed up annually and remained significantly lower in the high ADPN group in the first 2 years. Patients were then stratified into two groups according to the median ADPN value (23.8 mu g/ml). The results of Kaplan-Meier survival analysis demonstrated less CV events and better survival in high ADPN group. On multivariate Cox regression analysis, only ADPN level (HR: 0.93, 95% CI: 0.88-0.98, p = 0.02), age and history of CV diseases were independent risk factors for future CV events. Furthermore, hs-CRP (HR: 1.11, 95% CI: 1.001-1.22, p = 0.04) was identified as independent predictor of all-cause mortality. Conclusions Serum hs-CRP levels were consistently lower in the high ADPN group during 2-year follow-up. We also demonstrated the importance of ADPN and hs-CRP in predicting CV events and all-cause mortality in PD population during 3.5-year follow-up.	[Tung, Chun-Wu; Hsu, Yung-Chien; Shih, Ya-Hsueh; Lin, Chun-Liang] Chang Gung Mem Hosp, Dept Nephrol, Chiayi, Taiwan; [Tung, Chun-Wu] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Tung, Chun-Wu; Hsu, Yung-Chien; Shih, Ya-Hsueh; Lin, Chun-Liang] Chang Gung Mem Hosp, Dept Kidney & Diabet Complicat Res Team KDCRT, Chiayi, Taiwan; [Tung, Chun-Wu; Hsu, Yung-Chien; Shih, Ya-Hsueh; Lin, Chun-Liang] Chang Gung Mem Hosp, Chron Kidney Dis Ctr, Chiayi, Taiwan; [Lin, Chun-Liang] Chang Gung Univ, Sch Tradit Chinese Med, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lin, CL (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Chiayi, Taiwan.	linchunliang@cgmh.org.tw			Chang Gung Memorial Hospital at Chiayi, Taiwan [CMRPG690191]	Chang Gung Memorial Hospital at Chiayi, Taiwan	This work was supported by grants from Chang Gung Memorial Hospital at Chiayi, Taiwan (CMRPG690191, to CWT), https://www.cgmh.org.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hamodi Z, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-99; Alemzadeh R, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-35; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Chaudhary K, 2011, CLIN J AM SOC NEPHRO, V6, P447, DOI 10.2215/CJN.07920910; Disthabanchong S, 2011, NEPHROL DIAL TRANSPL, V26, P592, DOI 10.1093/ndt/gfq410; Ducloux D, 2002, KIDNEY INT, V62, P1417, DOI 10.1111/j.1523-1755.2002.kid562.x; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Funahashi T, 1999, INTERNAL MED, V38, P202, DOI 10.2169/internalmedicine.38.202; Huang JW, 2004, AM J KIDNEY DIS, V43, P1047, DOI 10.1053/j.ajkd.2004.02.017; Huh JY, 2012, PERITON DIALYSIS INT, V32, P20, DOI 10.3747/pdi.2009.00228; Ignacy W, 2005, NEPHRON CLIN PRACT, V101, pC18, DOI 10.1159/000085707; James LR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0052350, DOI 10.1371/JOURNAL.PONE.0052350]; Johnson DW, 2009, CLIN J AM SOC NEPHRO, V4, P1620, DOI 10.2215/CJN.01750309; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; Kalantar-Zadeh K, 2006, CONTRIB NEPHROL, V151, P57, DOI 10.1159/000095319; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lai KN, 2012, PERITON DIALYSIS INT, V32, P280, DOI 10.3747/pdi.2010.00176; Li Y, 2012, PERITON DIALYSIS INT, V32, P507, DOI 10.3747/pdi.2011.00116; Liu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093063; Lui SL, 2012, AM J KIDNEY DIS, V60, P966, DOI 10.1053/j.ajkd.2012.05.018; Matsushita K, 2006, ATHEROSCLEROSIS, V188, P184, DOI 10.1016/j.atherosclerosis.2005.10.031; Mcdonald SP, 2003, J AM SOC NEPHROL, V14, P2894, DOI 10.1097/01.ASN.0000091587.55159.5F; Menon V, 2006, J AM SOC NEPHROL, V17, P2599, DOI 10.1681/ASN.2006040331; Ohashi N, 2008, INTERNAL MED, V47, P485, DOI 10.2169/internalmedicine.47.0614; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ozdemir FN, 2001, ARTIF ORGANS, V25, P448, DOI 10.1046/j.1525-1594.2001.025006448.x; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P4277, DOI 10.1210/jc.2006-0836; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Pliakogiannis T, 2007, INT UROL NEPHROL, V39, P281, DOI 10.1007/s11255-006-9142-1; Prichard S, 1999, PERITON DIALYSIS INT, V19, pS133; Rhee CM, 2015, AM J KIDNEY DIS, V66, P313, DOI 10.1053/j.ajkd.2015.02.325; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rodriguez-Carmona A, 2012, NEPHROL DIAL TRANSPL, V27, P369, DOI 10.1093/ndt/gfr244; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Selby NM, 2007, NEPHROL DIAL TRANSPL, V22, P870, DOI 10.1093/ndt/gfl654; Takeguchi F, 2008, THER APHER DIAL, V12, P243, DOI 10.1111/j.1744-9987.2008.00581.x; Tan CC, 2005, KIDNEY INT, V67, pS19, DOI 10.1111/j.1523-1755.2005.09405.x; Tsao YT, 2008, J NEPHROL, V21, P744; Tsigalou C, 2013, J RENAL NUTR, V23, P45, DOI 10.1053/j.jrn.2011.12.007; TWARDOWSKI ZJ, 1989, BLOOD PURIFICAT, V7, P95, DOI 10.1159/000169582; US Renal Data System, USRDS 2013 ANN DAT R; Wannamethee SG, 2007, ARCH INTERN MED, V167, P1510, DOI 10.1001/archinte.167.14.1510; Wu ZJ, 2014, METABOLISM, V63, P1157, DOI 10.1016/j.metabol.2014.05.001; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9; Yu ZZ, 2008, BLOOD PURIFICAT, V26, P386, DOI 10.1159/000141930; Zoccali C, 2005, J RENAL NUTR, V15, P125, DOI 10.1053/j.jrn.2004.09.036; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	51	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0141058	10.1371/journal.pone.0141058	http://dx.doi.org/10.1371/journal.pone.0141058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474473	gold, Green Published, Green Submitted			2022-12-27	WOS:000363185500143
J	Lee, J; Kim, HJ; Cho, B; Park, JH; Choi, HC; Lee, CM; Oh, SW; Kwon, H; Heo, NJ				Lee, Jeonghwan; Kim, Hye Jin; Cho, Belong; Park, Jin Ho; Choi, Ho Chun; Lee, Cheol Min; Oh, Seung Won; Kwon, Hyuktae; Heo, Nam Ju			Abdominal Adipose Tissue was Associated with Glomerular Hyperfiltration among Non-Diabetic and Normotensive Adults with a Normal Body Mass Index	PLOS ONE			English	Article							METABOLIC SYNDROME; RENAL HEMODYNAMICS; FAT DISTRIBUTION; RISK-FACTORS; OBESITY; DISEASE; KIDNEY; ALBUMINURIA; MECHANISMS; RESISTANCE	Glomerular hyperfiltration is recognized as an early marker of progressive kidney dysfunction in the obese population. This study aimed to identify the relationship between glomerular hyperfiltration and body fat distribution measured by computed tomography (CT) in healthy Korean adults. The study population included individuals aged 20-64 years who went a routine health check-up including an abdominal CT scan. We selected 4,378 individuals without diabetes and hypertension. Glomerular filtration rate was estimated using the CKD-EPI equation, and glomerular hyperfiltration was defined as the highest quintile of glomerular filtration rate. Abdominal adipose tissue areas were measured at the level of the umbilicus using a 16-detector CT scanner, and the cross-sectional area was calculated using Rapidia 2.8 CT software. The prevalence of glomerular hyperfiltration increased significantly according to the subcutaneous adipose tissue area in men (OR = 1.74 (1.16-2.61), P for trend 0.016, for the comparisons of lowest vs. highest quartile) and visceral adipose tissue area in women (OR = 2.34 (1.46-3.75), P for trend < 0.001) in multivariate analysis. After stratification by body mass index (normal < 23 kg/m(2), overweight >= 23 kg/m(2)), male subjects with greater subcutaneous adipose tissue, even those in the normal BMI group, had a higher prevalence of glomerular hyperfiltration (OR = 2.11 (1.17-3.80), P for trend = 0.009). Among women, the significance of visceral adipose tissue area on glomerular hyperfiltration resulted from the normal BMI group (OR = 2.14 (1.31-3.49), P for trend = 0.002). After menopause, the odds ratio of the association of glomerular hyperfiltration with subcutaneous abdominal adipose tissue increased (OR = 2.96 (1.21-7.25), P for trend = 0.013). Subcutaneous adipose tissue areas and visceral adipose tissue areas are positively associated with glomerular hyperfiltration in healthy Korean adult men and women, respectively. In post-menopausal women, visceral adipose tissue area shows significant positive association with glomerular hyperfiltration as in men.	[Lee, Jeonghwan] Hallym Univ, Hangang Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Hye Jin; Cho, Belong; Park, Jin Ho; Choi, Ho Chun] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Lee, Cheol Min; Oh, Seung Won; Kwon, Hyuktae] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Family Med, Seoul 110744, South Korea; [Heo, Nam Ju] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Internal Med, Subdiv Nephrol, Seoul 110744, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Heo, NJ (corresponding author), Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Internal Med, Subdiv Nephrol, Seoul 110744, South Korea.	hyuktae@gmail.com; njheo@snuh.org	Lee, Jeonghwan/C-5214-2011; Oh, Seung-Won/GLS-0494-2022; Cho, Belong/GLU-3443-2022	Lee, Jeonghwan/0000-0003-3199-635X; Cho, Belong/0000-0001-9558-689X; Lee, Cheolmin/0000-0001-8652-4355	Hallym University Research Fund [HURF-2014-58]	Hallym University Research Fund	This research was supported by Hallym University Research Fund 2014(HURF-2014-58) that was presented to JL (1st author). URL of Hallym University: http://www.hallym.ac.kr/indexpc.php. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANK N, 1991, KIDNEY INT, V40, P792, DOI 10.1038/ki.1991.277; Bosma RJ, 2006, CONTRIB NEPHROL, V151, P184, DOI 10.1159/000095329; Bosma RJ, 2004, KIDNEY INT, V65, P259, DOI 10.1111/j.1523-1755.2004.00351.x; Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chagnac A, 2008, NEPHROL DIAL TRANSPL, V23, P3946, DOI 10.1093/ndt/gfn379; Choi SY, 2010, ATHEROSCLEROSIS, V213, P273, DOI 10.1016/j.atherosclerosis.2010.07.052; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; DeMarco VG, 2014, NAT REV ENDOCRINOL, V10, P364, DOI 10.1038/nrendo.2014.44; Goel K, 2010, HEART, V96, P579, DOI 10.1136/hrt.2009.183236; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Goumenos DS, 2009, NEPHROL DIAL TRANSPL, V24, P3732, DOI 10.1093/ndt/gfp329; Griffin KA, 2008, AM J PHYSIOL-RENAL, V294, pF695, DOI 10.1152/ajprenal.00324.2007; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Kaess BM, 2012, DIABETOLOGIA, V55, P2622, DOI 10.1007/s00125-012-2639-5; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Keller CK, 1996, J AM SOC NEPHROL, V7, P2627; Kwakernaak AJ, 2013, J AM SOC NEPHROL, V24, P987, DOI 10.1681/ASN.2012050460; Lee JW, 2008, KIDNEY BLOOD PRESS R, V31, P416, DOI 10.1159/000190787; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Levine DZ, 2008, CLIN SCI, V114, P109, DOI 10.1042/CS20070088; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; LOSITO A, 1988, NEPHRON, V49, P84, DOI 10.1159/000184992; Loutzenhiser R, 2006, AM J PHYSIOL-REG I, V290, pR1153, DOI 10.1152/ajpregu.00402.2005; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meijer E, 2010, CLIN J AM SOC NEPHRO, V5, P1091, DOI 10.2215/CJN.00360110; Monami M, 2009, ACTA DIABETOL, V46, P191, DOI 10.1007/s00592-008-0074-3; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; ODONNELL MP, 1985, J LAB CLIN MED, V106, P605; Palatini P, 2012, NEPHROL DIAL TRANSPL, V27, P1708, DOI 10.1093/ndt/gfs037; Park Sung Kwang, 1995, Korean Journal of Internal Medicine (English Edition), V10, P48; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Rahmouni K, 2005, DIABETES, V54, P2012, DOI 10.2337/diabetes.54.7.2012; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Reis JP, 2009, OBESITY, V17, P1232, DOI 10.1038/oby.2008.664; SCHMIEDER RE, 1995, J AM SOC NEPHROL, V5, P1709; Shaw PKC, 2007, DIABETES CARE, V30, P1840, DOI 10.2337/dc07-0028; Solerte SB, 1999, INT J OBESITY, V23, P997, DOI 10.1038/sj.ijo.0801032; Stenvinkel P, 2013, J AM SOC NEPHROL, V24, P1727, DOI 10.1681/ASN.2013040330; Tamba S, 2010, ATHEROSCLEROSIS, V211, P601, DOI 10.1016/j.atherosclerosis.2010.02.037; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Tsuboi N, 2012, CLIN J AM SOC NEPHRO, V7, P735, DOI 10.2215/CJN.07270711; VORA JP, 1992, KIDNEY INT, V41, P829, DOI 10.1038/ki.1992.127; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Wuerzner G, 2010, AM J KIDNEY DIS, V56, P303, DOI 10.1053/j.ajkd.2010.03.017; Yang X, 2007, DIABETOLOGIA, V50, P1127, DOI 10.1007/s00125-007-0640-1; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141364	10.1371/journal.pone.0141364	http://dx.doi.org/10.1371/journal.pone.0141364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495973	Green Published, gold			2022-12-27	WOS:000363309200104
J	Berger, RCM; Vassallo, PF; Crajoinas, RD; Oliveira, ML; Martins, FL; Nogueira, BV; Motta-Santos, D; Araujo, IB; Forechi, L; Girardi, ACC; Santos, RAS; Mill, JG				Machado Berger, Rebeca Caldeira; Vassallo, Paula Frizera; Crajoinas, Renato de Oliveira; Oliveira, Marilene Luzia; Martins, Flavia Leticia; Nogueira, Breno Valentim; Motta-Santos, Daisy; Araujo, Isabella Binotti; Forechi, Ludimila; Costa Girardi, Adriana Castello; Souza Santos, Robson Augusto; Mill, Jose Geraldo			Renal Effects and Underlying Molecular Mechanisms of Long-Term Salt Content Diets in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; BLOOD-PRESSURE; SODIUM RESTRICTION; OXIDATIVE STRESS; NEPHRIN EXPRESSION; KIDNEY; HYPERTROPHY; PROTEINURIA; REDUCTION; BLOCKADE	Several evidences have shown that salt excess is an important determinant of cardiovascular and renal derangement in hypertension. The present study aimed to investigate the renal effects of chronic high or low salt intake in the context of hypertension and to elucidate the molecular mechanisms underlying such effects. To this end, newly weaned male SHR were fed with diets only differing in NaCl content: normal salt (NS: 0.3%), low salt (LS: 0.03%), and high salt diet (HS: 3%) until 7 months of age. Analysis of renal function, morphology, and evaluation of the expression of the main molecular components involved in the renal handling of albumin, including podocyte slit-diaphragm proteins and proximal tubule endocytic receptors were performed. The relationship between diets and the balance of the renal angiotensin-converting enzyme (ACE) and ACE2 enzymes was also examined. HS produced glomerular hypertrophy and decreased ACE2 and nephrin expressions, loss of morphological integrity of the podocyte processes, and increased proteinuria, characterized by loss of albumin and high molecular weight proteins. Conversely, severe hypertension was attenuated and renal dysfunction was prevented by LS since proteinuria was much lower than in the NS SHRs. This was associated with a decrease in kidney ACE/ ACE2 protein and activity ratio and increased cubilin renal expression. Taken together, these results suggest that LS attenuates hypertension progression in SHRs and preserves renal function. The mechanisms partially explaining these findings include modulation of the intrarenal ACE/ACE2 balance and the increased cubilin expression. Importantly, HS worsens hypertensive kidney injury and decreases the expression nephrin, a key component of the slit diaphragm.	[Machado Berger, Rebeca Caldeira; Vassallo, Paula Frizera; Forechi, Ludimila; Mill, Jose Geraldo] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Crajoinas, Renato de Oliveira; Martins, Flavia Leticia; Motta-Santos, Daisy; Costa Girardi, Adriana Castello] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, SP, Brazil; [Oliveira, Marilene Luzia; Souza Santos, Robson Augusto] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Nogueira, Breno Valentim; Araujo, Isabella Binotti] Univ Fed Espirito Santo, Dept Morphol, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; Universidade Federal do Espirito Santo	Mill, JG (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil.	josegmill@gmail.com	NOGUEIRA, BRENO/X-7418-2019; Santos, Robson A S/C-9336-2011; Girardi, Adriana/C-4827-2012; Girardi, Adriana C. C./B-4334-2014; NOGUEIRA, BRENO VALENTIM/O-7459-2016; Motta-Santos, Daisy/A-9191-2010	NOGUEIRA, BRENO/0000-0002-2199-0635; Santos, Robson A S/0000-0001-8738-5852; Girardi, Adriana/0000-0003-3715-6917; Girardi, Adriana C. C./0000-0003-3715-6917; NOGUEIRA, BRENO VALENTIM/0000-0002-2199-0635; Motta-Santos, Daisy/0000-0002-3265-7838; Forechi, Ludimila/0000-0002-6657-0503	National Council for Scientific and Technological Development, CNPq [302563-2011/3, 400484/2013-7]; Support Foundation of Sao Paulo Research, FAPESP [2012/10146-0, 2013/10619-8]; Support Foundation of Minas Gerais, FAPEMIG	National Council for Scientific and Technological Development, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Support Foundation of Sao Paulo Research, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Support Foundation of Minas Gerais, FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by the grants from the National Council for Scientific and Technological Development, CNPq, http://lattes.cnpq.br/ (No. 302563-2011/3 and No. 400484/2013-7) to JGM, Support Foundation of Sao Paulo Research, FAPESP, http://www.fapesp.br/ (2012/10146-0 and 2013/10619-8) to ACCG, and Support Foundation of Minas Gerais, FAPEMIG, http://www.fapemig.br/, to RAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda DF, 2014, HORM MOL BIOL CLIN I, V18, P105, DOI 10.1515/hmbci-2013-0061; Baldo MP, 2011, PHARMACOL REP, V63, P975, DOI 10.1016/S1734-1140(11)70613-2; BENSTEIN JA, 1990, AM J PHYSIOL, V258, pF1675, DOI 10.1152/ajprenal.1990.258.6.F1675; Bernardi S, 2012, NEPHROL DIAL TRANSPL, V27, P1793, DOI 10.1093/ndt/gfr600; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Bonnet F, 2002, CLIN EXP HYPERTENS, V24, P371, DOI 10.1081/CEH-120004798; Bonnet F, 2001, DIABETOLOGIA, V44, P874; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Burchill L, 2008, EXP PHYSIOL, V93, P622, DOI 10.1113/expphysiol.2007.040386; Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S; Dworkin LD, 1996, J AM SOC NEPHROL, V7, P437; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087843; Farquhar WB, 2015, J AM COLL CARDIOL, V65, P1042, DOI 10.1016/j.jacc.2014.12.039; Ferrario CM, 2005, KIDNEY INT, V68, P2189, DOI 10.1111/j.1523-1755.2005.00675.x; HEEG JE, 1989, KIDNEY INT, V36, P272, DOI 10.1038/ki.1989.190; HEEG JE, 1991, KIDNEY INT, V40, P734, DOI 10.1038/ki.1991.268; Huentelman MJ, 2004, HYPERTENSION, V44, P903, DOI 10.1161/01.HYP.0000146120.29648.36; Roson MI, 2011, J NEPHROL, V24, P119, DOI 10.5301/JN.2010.5824; Inoue BH, 2013, AM J PHYSIOL-RENAL, V305, pF216, DOI 10.1152/ajprenal.00255.2012; Kawachi H, 2009, CLIN EXP NEPHROL, V13, P275, DOI 10.1007/s10157-009-0162-x; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lew RA, 2008, EXP PHYSIOL, V93, P685, DOI 10.1113/expphysiol.2007.040352; Li NJ, 2005, AM J PHYSIOL-RENAL, V288, pF353, DOI 10.1152/ajprenal.00144.2004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Morgan TO, 1998, KIDNEY INT, V54, pS213, DOI 10.1046/j.1523-1755.1998.06751.x; National Research Council, 2011, GUIDE CARE USE LAB A; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; Oudot C, 2013, KIDNEY INT, V83, P674, DOI 10.1038/ki.2012.478; Rugale C, 2003, AM J PHYSIOL-HEART C, V284, pH1744, DOI 10.1152/ajpheart.00864.2002; Russo LM, 2003, AM J NEPHROL, V23, P61, DOI 10.1159/000068039; Sanders PW, 2004, HYPERTENSION, V43, P142, DOI 10.1161/01.HYP.0000114022.20424.22; SANTOS RAS, 1985, HYPERTENSION, V7, P244, DOI 10.1161/01.HYP.7.2.244; Sasso FC, 2002, DIABETES CARE, V25, P1909, DOI 10.2337/diacare.25.11.1909; Slagman MCJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4366; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Susic D, 2011, CARDIORENAL MED, V1, P139, DOI 10.1159/000329334; Susic D, 2011, J HYPERTENS, V29, P716, DOI 10.1097/HJH.0b013e3283440683; Takahashi Y, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3012; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; Tikellis C, 2003, HYPERTENSION, V41, P392, DOI 10.1161/01.HYP.0000060689.38912.CB; Tikellis C, 2005, CURR ENZ INHIB, V1, P35; Tikellis C, 2011, CURR OPIN NEPHROL HY, V20, P62, DOI 10.1097/MNH.0b013e328341164a; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Varagic J, 2008, AM J PHYSIOL-HEART C, V294, pH853, DOI 10.1152/ajpheart.00737.2007; Varagic J, 2013, AM J HYPERTENS, V26, P583, DOI 10.1093/ajh/hps090; Viberti G, 2002, CIRCULATION, V106, P672, DOI 10.1161/01.CIR.0000024416.33113.0A; Vogt L, 2008, J AM SOC NEPHROL, V19, P999, DOI 10.1681/ASN.2007060693; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; Yu HCM, 1998, CIRCULATION, V98, P2621, DOI 10.1161/01.CIR.98.23.2621; Zhong JC, 2004, HYPERTENSION, V44, P907, DOI 10.1161/01.HYP.0000146400.57221.74	52	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141288	10.1371/journal.pone.0141288	http://dx.doi.org/10.1371/journal.pone.0141288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495970	gold, Green Published, Green Submitted			2022-12-27	WOS:000363309200086
J	Tadesse, W; Ogbonnaya, FC; Jighly, A; Sanchez-Garcia, M; Sohail, Q; Rajaram, S; Baum, M				Tadesse, W.; Ogbonnaya, F. C.; Jighly, A.; Sanchez-Garcia, M.; Sohail, Q.; Rajaram, S.; Baum, M.			Genome-Wide Association Mapping of Yield and Grain Quality Traits in Winter Wheat Genotypes	PLOS ONE			English	Article							BREAD-MAKING QUALITY; TRITICUM-AESTIVUM L.; GLUTENIN SUBUNIT; GENETIC-ANALYSIS; MOLECULAR MARKERS; ALLELIC VARIATION; COMMON WHEATS; GLIADIN LOCI; QTL ANALYSIS; POPULATION	The main goal of this study was to investigate the genetic basis of yield and grain quality traits in winter wheat genotypes using association mapping approach, and identify linked molecular markers for marker assisted selection. A total of 120 elite facultative/winter wheat genotypes were evaluated for yield, quality and other agronomic traits under rain-fed and irrigated conditions for two years (2011-2012) at the Tel Hadya station of ICARDA, Syria. The same genotypes were genotyped using 3,051 Diversity Array Technologies (DArT) markers, of which 1,586 were of known chromosome positions. The grain yield performance of the genotypes was highly significant both in rain-fed and irrigated sites. Average yield of the genotypes ranged from 2295 to 4038 kg/ha and 4268 to 7102 kg/ha under rain-fed and irrigated conditions, respectively. Protein content and alveograph strength (W) ranged from 13.6-16.1% and 217.6-375 Jx10-4, respectively. DArT markers wPt731910 (3B), wPt4680 (4A), wPt3509 (5A), wPt8183 (6B), and wPt0298 (2D) were significantly associated with yield under rain-fed conditions. Under irrigated condition, tPt4125 on chromosome 2B was significantly associated with yield explaining about 13% of the variation. Markers wPt2607 and wPt1482 on 5B were highly associated with protein content and alveograph strength explaining 16 and 14% of the variations, respectively. The elite genotypes have been distributed to many countries using ICARDA's International system for potential direct release and/or use as parents after local adaptation trials by the NARSs of respective countries. The QTLs identified in this study are recommended to be used for marker assisted selection after through validation using bi-parental populations.	[Tadesse, W.; Ogbonnaya, F. C.; Jighly, A.; Sanchez-Garcia, M.; Sohail, Q.; Rajaram, S.; Baum, M.] ICARDA, Beirut, Lebanon	CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA)	Tadesse, W (corresponding author), ICARDA, Beirut, Lebanon.	w.tadesse@cgiar.org	Ogbonnaya, Francis C/C-5237-2014; Jighly, Abdulqder/J-1625-2019; Sanchez-Garcia, Miguel/B-1465-2019	Ogbonnaya, Francis C/0000-0002-8596-7362; Jighly, Abdulqder/0000-0002-2712-3698; Sanchez-Garcia, Miguel/0000-0002-9257-4583	International Center for Agricultural Research in the Dry Areas (ICARDA); Grains Research Development Corporation (GRDC), Australia	International Center for Agricultural Research in the Dry Areas (ICARDA)(CGIAR); Grains Research Development Corporation (GRDC), Australia(Grains R&D Corp)	This project was funded by the International Center for Agricultural Research in the Dry Areas (ICARDA) and the Grains Research Development Corporation (GRDC), Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC, 1995, APPR METH AN, Vninth; Adhikari TB, 2011, PHYTOPATHOLOGY, V101, P1301, DOI 10.1094/PHYTO-03-11-0076; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; BRANLARD G, 1985, J CEREAL SCI, V3, P329, DOI 10.1016/S0733-5210(85)80006-0; Branlard G, 2003, GENET RESOUR CROP EV, V50, P669, DOI 10.1023/A:1025077005401; BRANLARD G, 1992, THEOR APPL GENET, V84, P57, DOI 10.1007/BF00223981; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Cadalen T, 1998, THEOR APPL GENET, V96, P933, DOI 10.1007/s001220050823; Cornish GB, 2001, AUST J AGR RES, V52, P1339, DOI 10.1071/AR01060; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Falush D, 2003, GENETICS, V164, P1567; FAO, 2012, FAOSTAT AGR PROD; FINNEY KF, 1948, CEREAL CHEM, V25, P291; Gupta PK, 1999, PLANT BREEDING, V118, P369, DOI 10.1046/j.1439-0523.1999.00401.x; GUPTA RB, 1994, J CEREAL SCI, V19, P19, DOI 10.1006/jcrs.1994.1004; GUPTA RB, 1994, J CEREAL SCI, V19, P9, DOI 10.1006/jcrs.1994.1003; Heo H. Y., 2013, Plant Breeding and Biotechnology, V1, P347, DOI 10.9787/PBB.2013.1.4.347; Huang BE, 2012, PLANT BIOTECHNOL J, V10, P826, DOI 10.1111/j.1467-7652.2012.00702.x; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; ICC, 1992, 121 ICC INT ASS CER; Jannink Jean-Luc, 2002, P59, DOI 10.1079/9780851996011.0059; JENNER CF, 1991, AUST J PLANT PHYSIOL, V18, P211, DOI 10.1071/PP9910211; Jighly A, 2015, THEOR APPL GENET, V128, P1; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Joukhadar R, 2013, MOL BREEDING, V32, P943, DOI 10.1007/s11032-013-9924-y; Kerfal S, 2010, J CEREAL SCI, V52, P46, DOI 10.1016/j.jcs.2010.03.001; Kirigwi FM, 2007, MOL BREEDING, V20, P401, DOI 10.1007/s11032-007-9100-3; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; LAWRENCE GJ, 1988, J CEREAL SCI, V7, P109, DOI [10.1016/S0733-5210(88)80012-2, 10.1006/jcrs.1997.0158]; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; Lopes MS, 2012, FIELD CROP RES, V128, P129, DOI 10.1016/j.fcr.2011.12.017; Lopes MS, 2013, THEOR APPL GENET, V126, P971, DOI 10.1007/s00122-012-2030-4; Lynch Michael, 1998; Massman J, 2011, MOL BREEDING, V27, P439, DOI 10.1007/s11032-010-9442-0; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; MIURA H, 1994, PLANT BREEDING, V113, P160, DOI 10.1111/j.1439-0523.1994.tb00718.x; Nelson JC, 2006, EUPHYTICA, V149, P145, DOI 10.1007/s10681-005-9062-7; Ogbonnaya FC, 2001, THEOR APPL GENET, V102, P623, DOI 10.1007/s001220051689; Ogbonnaya FC, 2010, INT DIMENSION AM SOC, P89; OrtizMonasterio JI, 1997, CROP SCI, V37, P892, DOI 10.2135/cropsci1997.0011183X003700030032x; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Payne RW, 2006, GENSTAT RELEASE 9 RE; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rajaram S, 1996, EUPHYTICA, V92, P147, DOI 10.1007/BF00022840; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Rasheed A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-128; Ravel C, 2006, THEOR APPL GENET, V112, P738, DOI 10.1007/s00122-005-0178-x; Sanchez-Garcia M, 2015, EUR J AGRON, V63, P79, DOI 10.1016/j.eja.2014.11.006; Sharma RC, 2010, EUPHYTICA, V171, P53, DOI 10.1007/s10681-009-9992-6; Sun HY, 2008, PROG NAT SCI-MATER, V18, P825, DOI 10.1016/j.pnsc.2007.12.013; Tadesse W, 2007, THEOR APPL GENET, V114, P855, DOI 10.1007/s00122-006-0484-y; Tadesse W, 2014, CROP SCI, V54, P607, DOI 10.2135/cropsci2013.05.0289; Tadesse W, 2013, EUPHYTICA, V194, P177, DOI 10.1007/s10681-013-0903-5; Tohver M, 2007, GENET RESOUR CROP EV, V54, P67, DOI 10.1007/s10722-005-1885-5; Trethowan RM, 2002, CROP SCI, V42, P1441, DOI 10.2135/cropsci2002.1441; Tsilo TJ, 2013, EUPHYTICA, V194, P293, DOI 10.1007/s10681-013-0906-2; Vawser MJ, 2004, AUST J AGR RES, V55, P577, DOI 10.1071/AR03227; White J, 2008, THEOR APPL GENET, V116, P439, DOI 10.1007/s00122-007-0681-3; Worland AJ, 1998, THEOR APPL GENET, V96, P1110, DOI 10.1007/s001220050846; Wrigley C, 2009, WHEAT SCI TRADE, P439; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	69	73	77	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141339	10.1371/journal.pone.0141339	http://dx.doi.org/10.1371/journal.pone.0141339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496075	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200096
J	Ranganathan, S; Halagowder, D; Sivasithambaram, ND				Ranganathan, Santhalakshmi; Halagowder, Devaraj; Sivasithambaram, Niranjali Devaraj			Quercetin Suppresses Twist to Induce Apoptosis in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LYMPH-NODE METASTASIS; CYCLIN D1 LEVELS; ESTROGEN-RECEPTOR; TISSUE-CULTURE; UP-REGULATION; COLON-CANCER; PROGRESSION; CARCINOMA; PROTEIN	Quercetin is a dietary flavonoid which exerts anti-oxidant, anti-inflammatory and anti-cancer properties. In this study, we investigated the anti-proliferative effect of quercetin in two breast cancer cell lines (MCF-7 and MDA-MB-231), which differed in hormone receptor. IC50 value (37 mu M) of quercetin showed significant cytotoxicity in MCF-7 cells, which was not observed in MDA-MB-231 cells even at 100 mu M of quercetin treatment. To study the response of cancer cells to quercetin, with respect to different hormone receptors, both the cell lines were treated with a fixed concentration (40 mu M) of quercetin. MCF-7 cells on quercetin treatment showed more apoptotic cells with G1 phase arrest. In addition, quercetin effectively suppressed the expression of CyclinD1, p21, Twist and phospho p38MAPK, which was not observed in MDA-MB-231 cells. To analyse the molecular mechanism of quercetin in exerting an apoptotic effect in MCF-7 cells, Twist was over-expressed and the molecular changes were observed after quercetin administration. Quercetin effectively regulated the expression of Twist, in turn p16 and p21 which induced apoptosis in MCF-7 cells. In conclusion, quercetin induces apoptosis in breast cancer cells through suppression of Twist via p38MAPK pathway.	[Ranganathan, Santhalakshmi; Sivasithambaram, Niranjali Devaraj] Univ Madras, Dept Biochem, Madras, Tamil Nadu, India; [Halagowder, Devaraj] Univ Grants Commiss, New Delhi, India	University of Madras	Ranganathan, S (corresponding author), Univ Madras, Dept Biochem, Guindy Campus, Madras, Tamil Nadu, India.	santhalaxmi@gmail.com			Council for Scientific and Industrial Research (CSIR)	Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	We thank Dr. Venu Raman, Associate Professor, and John's Hopkins University, USA for providing us with twist plasmid. The first author thanks Council for Scientific and Industrial Research (CSIR) for financial assistance in the form of Senior Research Fellowship (SRF).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; ACS American Cancer Society, 2015, BREAST CANC FACTS FI; AITKEN SC, 1985, CANCER RES, V45, P1611; Anjaneyulu Muragundla, 2003, Journal of Medicinal Food, V6, P391; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Choi EJ, 2008, ARCH PHARM RES, V31, P1281, DOI 10.1007/s12272-001-2107-0; deVries JHM, 1997, CANCER LETT, V114, P141, DOI 10.1016/S0304-3835(97)04645-4; Djuric Z, 2012, NUTR CANCER, V64, P351, DOI 10.1080/01635581.2012.658950; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Gong XQ, 2002, J BIOL CHEM, V277, P12310, DOI 10.1074/jbc.M110228200; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; HORWITZ KB, 1978, J BIOL CHEM, V253, P2223; IARC, 2012, GLOBOCAN 2012 EST CA; ISHIKAWA M, 1985, NEOPLASMA, V32, P435; KATZENELLENBOGEN BS, 1987, CANCER RES, V47, P4355; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lamson D W, 2000, Altern Med Rev, V5, P196; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Li N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100314; Lim SC, 2002, ONCOL REP, V9, P915; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; LIPPMAN M, 1976, CANCER RES, V36, P4595; Liu XA, 2010, ACTA BIOCH BIOPH SIN, V42, P496, DOI 10.1093/abbs/gmq043; Lu SM, 2011, CHINESE MED J-PEKING, V124, P1483, DOI 10.3760/cma.j.issn.0366-6999.2011.10.008; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Nitsinskaia L E, 2010, Ross Fiziol Zh Im I M Sechenova, V96, P283; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Rice S, 2006, ENDOCR-RELAT CANCER, V13, P995, DOI 10.1677/erc.1.01159; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Singh B, 2010, TOXICOL APPL PHARM, V247, P83, DOI 10.1016/j.taap.2010.06.011; van Meeuwen JA, 2007, FOOD CHEM TOXICOL, V45, P2319, DOI 10.1016/j.fct.2007.06.011; Wang G, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039700, 10.1371/journal.pone.0051764, 10.1371/journal.pone.0047051]; Wang Hai-yan, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P585; Wenzel U, 2004, PROTEOMICS, V4, P2160, DOI 10.1002/pmic.200300726; WESTLEY B, 1979, BIOCHEM BIOPH RES CO, V90, P410, DOI 10.1016/0006-291X(79)91250-6; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang JH, 2006, DRUG METAB DISPOS, V34, P296, DOI 10.1124/dmd.105.005280; Yang K, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-32; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099; Zhang JD, 2012, HUM PATHOL, V43, P1044, DOI 10.1016/j.humpath.2011.08.013	44	91	98	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141370	10.1371/journal.pone.0141370	http://dx.doi.org/10.1371/journal.pone.0141370			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491966	gold, Green Submitted, Green Published			2022-12-27	WOS:000363249300047
J	Shen, GM; Upadhyay, C; Zhang, J; Pan, RM; Zolla-Pazner, S; Kong, XP; Hioe, CE				Shen, Guomiao; Upadhyay, Chitra; Zhang, Jing; Pan, Ruimin; Zolla-Pazner, Susan; Kong, Xiang-Peng; Hioe, Catarina E.			Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies	PLOS ONE			English	Article							V3 LOOP; VACCINE TRIAL; CRYSTAL-STRUCTURE; TYPE-1; GP120; EPITOPES; GLYCOPROTEIN; PROTECTION; ENV; RECOGNITION	HIV-1 envelope glycoproteins (Env) are the only viral antigens present on the virus surface and serve as the key targets for virus-neutralizing antibodies. However, HIV-1 deploys multiple strategies to shield the vulnerable sites on its Env from neutralizing antibodies. The V1V2 domain located at the apex of the HIV-1 Env spike is known to encompass highly variable loops, but V1V2 also contains immunogenic conserved elements recognized by cross-reactive antibodies. This study evaluates human monoclonal antibodies (mAbs) against V2 epitopes which overlap with the conserved integrin alpha 4 beta 7-binding LDV/I motif, designated as the V2i (integrin) epitopes. We postulate that the V2i Abs have weak or no neutralizing activities because the V2i epitopes are often occluded from antibody recognition. To gain insights into the mechanisms of the V2i occlusion, we evaluated three elements at the distal end of the V1V2 domain shown in the structure of V2i epitope complexed with mAb 830A to be important for antibody recognition of the V2i epitope. Amino-acid substitutions at position 179 that restore the LDV/I motif had minimal effects on virus sensitivity to neutralization by most V2i mAbs. However, a charge change at position 153 in the V1 region significantly increased sensitivity of subtype C virus ZM109 to most V2i mAbs. Separately, a disulfide bond introduced to stabilize the hypervariable region of V2 loop also enhanced virus neutralization by some V2i mAbs, but the effects varied depending on the virus. These data demonstrate that multiple elements within the V1V2 domain act independently and in a virus-dependent fashion to govern the antibody recognition and accessibility of V2i epitopes, suggesting the need for multi-pronged strategies to counter the escape and the shielding mechanisms obstructing the V2i Abs from neutralizing HIV-1.	[Shen, Guomiao; Upadhyay, Chitra; Zhang, Jing; Zolla-Pazner, Susan; Hioe, Catarina E.] Vet Affairs New York Harbor Healthcare Syst Manha, New York, NY USA; [Shen, Guomiao; Upadhyay, Chitra; Zhang, Jing; Zolla-Pazner, Susan; Hioe, Catarina E.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Pan, Ruimin; Kong, Xiang-Peng] NYU, Sch Med, Dept Biochem & Pharmacol, New York, NY USA	New York University; New York University	Hioe, CE (corresponding author), James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA.	catarina.hioe@mssm.edu	Zolla-Pazner, Susan/S-1864-2019; Upadhyay, Chitra/K-8756-2019	Zolla-Pazner, Susan/0000-0002-0750-2666; Kong, Xiang-Peng/0000-0001-5773-2681	NIH [R01 AI102740]; HIVRAD [P01 AI100151]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100151, R01AI102740] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIVRAD; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grants R01 AI102740 (CEH.) and HIVRAD P01 AI100151 (XPK, SZP) and by research funds from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (VA Merit Review and Research Career Scientist CEH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, VACCINE, V29, P6736, DOI 10.1016/j.vaccine.2010.12.052; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; Davenport TM, 2011, J VIROL, V85, P7095, DOI 10.1128/JVI.00411-11; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Gigler A, 1999, J VIROL, V73, P1974, DOI 10.1128/JVI.73.3.1974-1979.1999; Gordon SN, 2014, J IMMUNOL, V193, P6172, DOI 10.4049/jimmunol.1401504; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Kim JH, 2015, ANNU REV MED, V66, P423, DOI 10.1146/annurev-med-052912-123749; Kimura Tetsuya, 2009, Human Antibodies, V18, P35, DOI 10.3233/HAB-2009-0200; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Kumar R, 2015, J VIROL, V89, P9090, DOI 10.1128/JVI.01280-15; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Losman B, 2001, AIDS RES HUM RETROV, V17, P1067, DOI 10.1089/088922201300343753; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; Mayr LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070859; Mbah HA, 2001, J VIROL, V75, P7785, DOI 10.1128/JVI.75.16.7785-7788.2001; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Musich T, 2011, J VIROL, V85, P2397, DOI 10.1128/JVI.02187-10; Nyambi PN, 2000, J VIROL, V74, P7096, DOI 10.1128/JVI.74.15.7096-7107.2000; Pan RM, 2015, J VIROL, V89, P8003, DOI 10.1128/JVI.00754-15; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055701; Pegu P, 2013, J VIROL, V87, P1708, DOI 10.1128/JVI.02544-12; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roederer M, 2014, NATURE, V505, P502, DOI 10.1038/nature12893; Salomon A, 2014, VIROLOGY, V448, P363, DOI 10.1016/j.virol.2013.10.007; Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005; Spurrier B, 2014, J VIROL, V88, P4100, DOI 10.1128/JVI.03153-13; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; Totrov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094002; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Upadhyay C, 2014, J VIROL, V88, P12853, DOI 10.1128/JVI.02125-14; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wiehe K, 2014, IMMUNITY, V41, P909, DOI 10.1016/j.immuni.2014.11.014; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141233	10.1371/journal.pone.0141233	http://dx.doi.org/10.1371/journal.pone.0141233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491873	gold, Green Published, Green Submitted			2022-12-27	WOS:000363249300037
J	Bastian, KA; Maximova, K; McGavock, J; Veugelers, P				Bastian, Kerry A.; Maximova, Katerina; McGavock, Jonathan; Veugelers, Paul			Does School-Based Health Promotion Affect Physical Activity on Weekends? And, Does It Reach Those Students Most in Need of Health Promotion?	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; CHILDHOOD OBESITY; BODY-COMPOSITION; AGED CHILDREN; INTERVENTIONS; ADOLESCENCE; PEDOMETERS; VALIDITY; YOUTH; INEQUALITIES	Objective To determine whether a school-based health promotion program affects children's weekend physical activity and whether this effect varies according to socioeconomic-status. Methods This was a quasi-experimental trial of school-based programs on physical activity levels implemented in disadvantaged neighborhoods in Alberta, Canada. In 2009 and 2011, 7 full days of pedometer data were collected from cross-sectional samples of grade 5 students (age 10-11 years) from 10 intervention schools in low-socioeconomic neighbourhoods and 20 comparison schools in middle-socioeconomic neighbourhoods. Multilevel models assessed differences in step-counts between intervention and comparison groups overtime by weight (objectively measured) and socioeconomic status subgroups. Results In 2009, children from intervention schools were less active on weekends relative to comparison schools (9212 vs. 11186 steps/day p<0.01). Two years later, daily step-counts on weekend days among children in low socioeconomic intervention schools increased such that they approximated those of children from middle socioeconomic comparison schools (12148 vs. 12121 steps/day p = 0.96). The relative difference in steps between intervention and comparison schools on weekends reduced from -21.4% to 0.2% following the intervention. The normalization of weekend step counts was similar for normal weight (-21.4% to +2.0%) and overweight (-19.1 to +3.9%) children, and was balanced across socioeconomic subgroups. Conclusions These data suggest that school-based health promotion is effective for reducing inequities in physical activity levels outside school hours. Investments in school-based health promotion lead to behavior modification beyond the school environment.	[Bastian, Kerry A.; Veugelers, Paul] Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada; [Maximova, Katerina] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [McGavock, Jonathan] Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Manitoba Inst Child Hlth, Winnipeg, MB, Canada	University of Alberta; University of Alberta; University of Manitoba	Veugelers, P (corresponding author), Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada.	paul.veugelers@ualberta.ca		Veugelers, Paul/0000-0001-8996-0822; Maximova, Katerina/0000-0001-9842-1927	Canada Research Chair in Population Health; Alberta Innovates-Health Solutions Health Scholarship; Alberta Innovates [201300671] Funding Source: researchfish	Canada Research Chair in Population Health; Alberta Innovates-Health Solutions Health Scholarship; Alberta Innovates	The Alberta Project Promoting active Living and healthy Eating in Schools (APPLE Schools) was funded through a philanthropic donation to the school of Public Health at the University of Alberta. The research was funded through a Canada Research Chair in Population Health and Alberta Innovates-Health Solutions Health Scholarship to Dr. Veugelers.	Aaron DJ, 2002, ARCH PEDIAT ADOL MED, V156, P1075, DOI 10.1001/archpedi.156.11.1075; Ahmed ML, 1999, J CLIN ENDOCR METAB, V84, P899, DOI 10.1210/jc.84.3.899; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Colley R. C., 2011, HLTH REPORTS, V22, P15, DOI DOI 10.1016/j.yspm.2011.03.006; Comte M, 2013, APPL PHYSIOL NUTR ME, V38, P115, DOI 10.1139/apnm-2012-0100; Corder K, 2010, PEDIATRICS, V126, pE926, DOI 10.1542/peds.2010-0048; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Deschesnes M, 2003, HEALTH PROMOT INT, V18, P387, DOI 10.1093/heapro/dag410; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Guo SS, 1997, INT J OBESITY, V21, P1167, DOI 10.1038/sj.ijo.0800531; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hasson RE, 2009, MED SCI SPORT EXER, V41, P805, DOI 10.1249/MSS.0b013e31818d9fc2; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Holbrook EA, 2009, MED SCI SPORT EXER, V41, P669, DOI 10.1249/MSS.0b013e3181886095; Jago R, 2006, J SPORT SCI, V24, P241, DOI 10.1080/02640410500141661; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Joint Consortium for School Health, WHAT IS COMPREHENSIV; Kang M, 2003, RES Q EXERCISE SPORT, V74; Katz DL, 2009, ANNU REV PUBL HEALTH, V30, P253, DOI 10.1146/annurev.publhealth.031308.100307; Kimm SYS, 2000, MED SCI SPORT EXER, V32, P1445, DOI 10.1097/00005768-200008000-00013; Koivusilta LK, 2012, EUR J PUBLIC HEALTH, V22, P203, DOI 10.1093/eurpub/ckr037; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Maher CA, 2011, J EPIDEMIOL COMMUN H, V65, P160, DOI 10.1136/jech.2009.099796; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; Maziak W, 2008, OBES REV, V9, P35, DOI 10.1111/j.1467-789X.2007.00376.x; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nakae Satoshi, 2008, Journal of Physiological Anthropology, V27, P233, DOI 10.2114/jpa2.27.233; Penpraze V, 2006, PEDIATR EXERC SCI, V18, P483, DOI 10.1123/pes.18.4.483; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Salmon J, 2007, EPIDEMIOL REV, V29, P144, DOI 10.1093/epirev/mxm010; Salmon J, 2011, AM J PREV MED, V41, P197, DOI 10.1016/j.amepre.2011.05.001; Seabra AF, 2008, CAD SAUDE PUBLICA, V24, P721, DOI 10.1590/S0102-311X2008000400002; Simen-Kapeu A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-340; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Vander Ploeg KA, 2014, SOC SCI MED, V112, P80, DOI 10.1016/j.socscimed.2014.04.032; Vander Ploeg KA, 2014, PEDIATRICS, V133, pE371, DOI 10.1542/peds.2013-2383; Vander Ploeg KA, 2012, J PHYS ACT HEALTH, V9, P1138, DOI 10.1123/jpah.9.8.1138; Veugelers PJ, 2010, CAN J PUBLIC HEALTH, V101, pS5, DOI 10.1007/BF03405617; Zhu WM, 2010, J PHYS ACT HEALTH, V7, P706, DOI 10.1123/jpah.7.6.706	46	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0137987	10.1371/journal.pone.0137987	http://dx.doi.org/10.1371/journal.pone.0137987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488168	gold, Green Published			2022-12-27	WOS:000363248400005
J	Ivarsson, M; Bengtson, S; Skogby, H; Lazor, P; Broman, C; Belivanova, V; Marone, F				Ivarsson, Magnus; Bengtson, Stefan; Skogby, Henrik; Lazor, Peter; Broman, Curt; Belivanova, Veneta; Marone, Federica			A Fungal-Prokaryotic Consortium at the Basalt-Zeolite Interface in Subseafloor Igneous Crust	PLOS ONE			English	Article							SEA-FLOOR; OCEAN CRUST; IRON; DIVERSITY; LIFE; ROCKS; GEOMICROBIOLOGY; BACTERIAL; MINERALS; METALS	We have after half a century of coordinated scientific drilling gained insight into Earth's largest microbial habitat, the subseafloor igneous crust, but still lack substantial understanding regarding its abundance, diversity and ecology. Here we describe a fossilized microbial consortium of prokaryotes and fungi at the basalt-zeolite interface of fractured subseafloor basalts from a depth of 240 m below seafloor (mbsf). The microbial consortium and its relationship with the surrounding physical environment are revealed by synchrotron-based X-ray tomographic microscopy (SRXTM), environmental scanning electron microscopy (ESEM), and Raman spectroscopy. The base of the consortium is represented by micro-stromatolites- remains of bacterial communities that oxidized reduced iron directly from the basalt. The microstromatolites and the surrounding basalt were overlaid by fungal cells and hyphae. The consortium was overgrown by hydrothermally formed zeolites but remained alive and active during this event. After its formation, fungal hyphae bored in the zeolite, producing millimetre-long tunnels through the mineral substrate. The dissolution could either serve to extract metals like Ca, Na and K essential for fungal growth and metabolism, or be a response to environmental stress owing to the mineral overgrowth. Our results show how microbial life may be maintained in a nutrient-poor and extreme environment by close ecological interplay and reveal an effective strategy for nutrient extraction from minerals. The prokaryotic portion of the consortium served as a carbon source for the eukaryotic portion. Such an approach may be a prerequisite for prokaryotic-eukaryotic colonisation of, and persistence in, subseafloor igneous crust.	[Ivarsson, Magnus; Bengtson, Stefan] Swedish Museum Nat Hist, Dept Palaeobiol, SE-10405 Stockholm, Sweden; [Ivarsson, Magnus; Bengtson, Stefan] Swedish Museum Nat Hist, Nord Ctr Earth Evolut, SE-10405 Stockholm, Sweden; [Skogby, Henrik] Swedish Museum Nat Hist, Dept Geosci, SE-10405 Stockholm, Sweden; [Lazor, Peter] Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden; [Broman, Curt] Stockholm Univ, Dept Geol Sci, SE-10691 Stockholm, Sweden; [Belivanova, Veneta] Swedish Museum Nat Hist, Dept Palaeobiol, SE-10405 Stockholm, Sweden; [Marone, Federica] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	Swedish Museum of Natural History; Swedish Museum of Natural History; Swedish Museum of Natural History; Uppsala University; Stockholm University; Swedish Museum of Natural History; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Ivarsson, M (corresponding author), Swedish Museum Nat Hist, Dept Palaeobiol, Box 50007, SE-10405 Stockholm, Sweden.	Magnus.ivarsson@nrm.se	Marone, Federica/J-4420-2013	Bengtson, Stefan/0000-0003-0206-5791	Swedish Research Council [2010-3929, 2012-4364]; Danish National Research Foundation [DNRF53]; Paul Scherrer Institute [20130185, 20141047]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Paul Scherrer Institute	SB and MI was funded by the Swedish Research Council (Contracts No. 2010-3929 and 2012-4364): http://www.vr.se/, and the Danish National Research Foundation (DNRF53): http://dg.dk/en/. The work was also funded by a grant to Phil Donoghue (PI) and SB (Co-PI) by Paul Scherrer Institute (20130185 and 20141047): http://www.psi.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; Bengtson S, 2014, GEOBIOLOGY, V12, P489, DOI 10.1111/gbi.12100; Chafetz HS, 1999, SEDIMENT GEOL, V126, P57, DOI 10.1016/S0037-0738(99)00032-9; Connell L, 2009, GEOMICROBIOL J, V26, P597, DOI 10.1080/01490450903316174; Downs R. T., 2006, PROGR ABSTR 19 GEN M, V3, P13; Edwards KJ, 2003, BIOL BULL-US, V204, P180, DOI 10.2307/1543555; Fisher AT, 2000, NATURE, V403, P71, DOI 10.1038/47463; Fisk MR, 1998, SCIENCE, V281, P978, DOI 10.1126/science.281.5379.978; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; Gao HC, 2006, INT J SYST EVOL MICR, V56, P1911, DOI 10.1099/ijs.0.64354-0; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; Ivarsson M, 2008, GEOBIOLOGY, V6, P155, DOI 10.1111/j.1472-4669.2007.00139.x; Ivarsson M, 2013, GEO-MAR LETT, V33, P233, DOI 10.1007/s00367-013-0321-7; Ivarsson M, 2012, GEOLOGY, V40, P163, DOI 10.1130/G32590.1; Ivarsson M, 2011, GEOCHEM T, V12, DOI 10.1186/1467-4866-12-5; Jongmans AG, 1997, NATURE, V389, P682, DOI 10.1038/39493; Jungbluth SP, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00119; Lalonde K, 2012, NATURE, V483, P198, DOI 10.1038/nature10855; Langmi HW, 2003, J ALLOY COMPD, V356, P710, DOI 10.1016/S0925-8388(03)00368-2; Lazar I, 2013, FACIES, V59, P359, DOI 10.1007/s10347-012-0313-5; Lever MA, 2013, SCIENCE, V339, P1305, DOI 10.1126/science.1229240; Li M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4192; Lysnes K, 2004, FEMS MICROBIOL ECOL, V50, P213, DOI 10.1016/j.femsec.2004.06.014; Marone F, 2012, J SYNCHROTRON RADIAT, V19, P1029, DOI 10.1107/S0909049512032864; Mason OU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015399; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Orcutt BN, 2011, ISME J, V5, P692, DOI 10.1038/ismej.2010.157; Orsi WD, 2013, NATURE, V499, P205, DOI 10.1038/nature12230; Preat A, 2000, SEDIMENT GEOL, V137, P107, DOI 10.1016/S0037-0738(00)00101-9; Rahl JM, 2005, EARTH PLANET SC LETT, V240, P339, DOI 10.1016/j.epsl.2005.09.055; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Schrenk MO, 2010, ANNU REV MAR SCI, V2, P279, DOI 10.1146/annurev-marine-120308-081000; Schumann G, 2004, GEOMICROBIOL J, V21, P241, DOI 10.1080/01490450490438748; Selbmann L, 2005, STUD MYCOL, P1; SHERMAN DM, 1988, AM MINERAL, V73, P1346; Sheta AS, 2003, MICROPOR MESOPOR MAT, V61, P127, DOI 10.1016/S1387-1811(03)00360-3; Stampanoni M, 2006, PROC SPIE, V6318, DOI 10.1117/12.679497; Staudigel H, 2004, SUBSEAFLOOR BIOSPHER, V3, P25; Staudigel H, 2008, EARTH-SCI REV, V89, P156, DOI 10.1016/j.earscirev.2008.04.005; Sundqvist T, 1983, VERSATILE MOSSBAUER; Tapanila L, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P3, DOI 10.1007/978-3-540-77598-0_1; Tarduno J. A., 2002, P OCEAN DRILLING PRO, V197, P1, DOI DOI 10.2973/ODP.PROC.IR.197.105.2002; Thorseth IH, 2003, EARTH PLANET SC LETT, V215, P237, DOI 10.1016/S0012-821X(03)00427-8; Thorseth IH, 2001, EARTH PLANET SC LETT, V194, P31, DOI 10.1016/S0012-821X(01)00537-4; Thorseth IH, 1995, CHEM GEOL, V126, P137, DOI 10.1016/0009-2541(95)00114-8	46	30	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140106	10.1371/journal.pone.0140106	http://dx.doi.org/10.1371/journal.pone.0140106			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488482	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000363248400044
J	Wang, J; Wang, H; Chang, SY; Zhao, LY; Fu, P; Yu, WT; Man, QQ; Scherpbier, R; Pan, LL; Duan, YF; Yin, SA				Wang, Jie; Wang, Hui; Chang, Suying; Zhao, Liyun; Fu, Ping; Yu, Wentao; Man, Qingqing; Scherpbier, Robert; Pan, Lili; Duan, Yifan; Yin, Shi-an			The Influence of Malnutrition and Micronutrient Status on Anemic Risk in Children under 3 Years Old in Poor Areas in China	PLOS ONE			English	Article							INDIGENOUS PEOPLES HEALTH; VITAMIN-D DEFICIENCY; 1ST NATIONAL-SURVEY; NUTRITIONAL-STATUS; CHILDBEARING AGE; IRON-DEFICIENCY; FOOD INSECURITY; PREVALENCE; WOMEN; ASSOCIATION	Background Malnutrition and anemia affect large numbers of young children living in poor areas of China. Multi-micronutrient deficiencies may be related to the prevalence of anemia in different populations, and identifying the risk factors that render children susceptible to anemia is the first step in combating anemia effectively. Methods In this cross-sectional study, a total of 1370 children under 3 years old were selected based on probability proportional to size sampling principles from poor counties of China. Basic characteristics data were collected by questionnaire; then anthropometrics and hemoglobin were measured in the field and anemia prevalence evaluated. Venous blood was drawn from children aged 12-35 months (N = 553) to evaluate micronutrient status. Logistic regression was used to identify the risk factors for children's anemia. Results Among children aged 0-35 months, the prevalence of stunting, low body weight and wasting was 17.5%, 8.6% and 5.1%, respectively, and 25.6% of the children were affected by anemia, with more anemic infants and younger children than older children (P < 0.01). There were 26.5%, 12.8%, 14.1% and 20.0% of the children aged 12-35 months affected by iron deficiency, vitamin D deficiency, folic acid deficiency and vitamin B-12 deficiency, respectively. For children aged 0-11 months who were breastfed, the mothers' anemic status was the only factor associated with the child's anemia (OR = 2.6; 95% CI: 1.2-5.4, P < 0.05). For children aged 12-35 months, multivariate logistic regression indicated that anemia was significantly associated with iron and vitamin B-12 deficiency (OR = 5.3; 95% CI: 1.9-14.5, P < 0.01) and monotonous diet (OR = 2.3; 95% CI: 1.1-4.7, P < 0.05) after adjusting for age and gender. Conclusion The prevalence of anemia was higher in children under 2 years old and requires urgent intervention. An effective intervention strategy should include iron and vitamin B12 supplements, improving dietary diversity and controlling breastfeeding mothers' anemia.	[Wang, Jie; Pan, Lili; Duan, Yifan; Yin, Shi-an] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Dept Maternal & Child Nutr, Beijing, Peoples R China; [Wang, Hui] China Populat & Dev Res Ctr, Dept Populat Res, Beijing, Peoples R China; [Chang, Suying; Scherpbier, Robert] United Nations Childrens Fund, Sect Hlth & Nutr & Water Environm & Sanitat, Beijing, Peoples R China; [Zhao, Liyun; Yu, Wentao] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Dept Nutr Surveillance, Beijing, Peoples R China; [Fu, Ping; Man, Qingqing] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Dept Nutr Aging, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Yin, SA (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Dept Maternal & Child Nutr, Beijing, Peoples R China.	shianyin@126.com			Millennium Development Goals Spanish Achievement Fund (MDG-F)	Millennium Development Goals Spanish Achievement Fund (MDG-F)	This study was one part of the programme of "Improving nutrition and food safety for China's most vulnerable women and children" funded by the Millennium Development Goals Spanish Achievement Fund (MDG-F [http://mdgfund.org/page/ourprogrammes]), and SY received the funding. The funder had no role in study design, data collection and analysis, desicion to publish or preparation of the manuscript.	Akin F, 2013, ANEMIA, V2013, DOI 10.1155/2013/514801; Ayoya MA, 2013, ANEMIA, V2013, DOI 10.1155/2013/502968; Balci YI, 2012, IRAN J PEDIATR, V22, P77; Bottalico DM, 2015, SPAT SPATIO-TEMPORAL, V12, P19, DOI 10.1016/j.sste.2014.12.001; Chang Suying, 2007, Wei Sheng Yan Jiu, V36, P210; Chen CM, 2011, BIOMED ENVIRON SCI, V24, P321, DOI 10.3967/0895-3988.2011.04.001; Dawodu A, 2005, J PEDIATR-US, V147, P109, DOI 10.1016/j.jpeds.2005.03.001; Eicher-Miller HA, 2009, AM J CLIN NUTR, V90, P1358, DOI 10.3945/ajcn.2009.27886; Fischer NC, 2014, J NUTR, V144, P2066, DOI 10.3945/jn.114.197095; Gao WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062883; Heidkamp RA, 2013, FOOD NUTR BULL, V34, P462, DOI 10.1177/156482651303400411; Horta BL, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-23; IOM Institute of Medicine Food and Nutrition Board, 2010, DIET REF INT CALC VI; Kavosi E, 2014, INT J HEALTH POLICY, V3, P71, DOI 10.15171/ijhpm.2014.63; Kinyoki DK, 2015, PUBLIC HEALTH NUTR, P1; Leite MS, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-69; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mehta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008770; Moshe G, 2013, J PEDIATR GASTR NUTR, V57, P722, DOI 10.1097/MPG.0b013e3182a80c42; Nozza JM, 2001, MED J AUSTRALIA, V175, P253, DOI 10.5694/j.1326-5377.2001.tb143559.x; Oliveira MAA, 2007, J PEDIAT-BRAZIL, V83, P39, DOI [10.2223/JPED.1579, 10.1590/S0021-75572007000100008]; Rocha Daniela da Silva, 2012, Rev. bras. epidemiol., V15, P675, DOI 10.1590/S1415-790X2012000300020; Rosado JL, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-40; Saraiva Bárbara C.A., 2014, J. Pediatr. (Rio J.), V90, P593, DOI 10.1016/j.jped.2014.03.003; Semba RD, 2008, INT J INFECT DIS, V12, P62, DOI 10.1016/j.ijid.2007.04.011; Shin JY, 2013, CLIN CHIM ACTA, V421, P177, DOI 10.1016/j.cca.2013.02.025; Sim JJ, 2010, ANN HEMATOL, V89, P447, DOI 10.1007/s00277-009-0850-3; Van Nhien N, 2008, ASIA PAC J CLIN NUTR, V17, P48; Verzijl JM, 2014, INT J GYNAECOL OBSTE; Wang J, 2008, AM J CLIN NUTR, V87, P1730, DOI 10.1093/ajcn/87.6.1730; WHO, 2015, RED BLOOD CELL; WHO, 2008, CONCL WHO TECHN CONS; WHO, 2004, GUID COND COMM SURV; *WHO, 1996, IND ASS VIT A DEF TH; WHO, C REACT PROT CONC MA; WHO, 2001, IRON DEFICIENCY ANAE; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2010, IND ASS INF YOUNG CH; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S21; Yoo EH, 2015, J CLIN LAB ANAL, V29, P129, DOI 10.1002/jcla.21740; Yoon Jung Won, 2012, Korean J Pediatr, V55, P206, DOI 10.3345/kjp.2012.55.6.206; Zangmo U, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-151; Zhao A, 2012, AM J TROP MED HYG, V87, P306, DOI 10.4269/ajtmh.2012.11-0660; Zhu JH, 2010, INT J VITAM NUTR RES, V80, P144, DOI 10.1024/0300-9831/a000014; Ziemann M, 2011, TRANSFUSION, V51, P2714, DOI 10.1111/j.1537-2995.2011.03183.x	46	22	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140840	10.1371/journal.pone.0140840	http://dx.doi.org/10.1371/journal.pone.0140840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488490	gold, Green Submitted, Green Published			2022-12-27	WOS:000363248400071
J	Bai, X; Kim, J; Kang, S; Kim, W; Shim, H				Bai, Xuelian; Kim, Jihye; Kang, Seungmin; Kim, Wankyu; Shim, Hyunbo			A Novel Human scFv Library with Non-Combinatorial Synthetic CDR Diversity	PLOS ONE			English	Article							PHAGE DISPLAY LIBRARY; ANTIBODY LIBRARIES; MONOCLONAL-ANTIBODIES; ANTIGEN RECOGNITION; AFFINITY; CONSTRUCTION; REPERTOIRES; PERFORMANCE; GENERATION; DISCOVERY	The present work describes the construction and validation of a human scFv library with a novel design approach to synthetic complementarity determining region (CDR) diversification. The advantage of synthetic antibody libraries includes the possibility of exerting fine control over factors like framework sequences, amino acid and codon usage, and CDR diversity. However, random combinatorial synthesis of oligonucleotides for CDR sequence diversity also produces many clones with unnatural sequences and/or undesirable modification motifs. To alleviate these issues, we designed and constructed a novel semi-synthetic human scFv library with non-combinatorial, pre-designed CDR diversity and a single native human framework each for heavy, kappa, and lambda chain variable domains. Next-generation sequencing analysis indicated that the library consists of antibody clones with highly nature-like CDR sequences and the occurrence of the post-translational modification motifs is minimized. Multiple unique clones with nanomolar affinity could be isolated from the library against a number of target antigens, validating the library design strategy. The results demonstrate that it is possible to construct a functional antibody library using low, non-combinatorial synthetic CDR diversity, and provides a new strategy for the design of antibody libraries suitable for demanding applications.	[Bai, Xuelian; Kim, Jihye; Kang, Seungmin; Kim, Wankyu; Shim, Hyunbo] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Shim, Hyunbo] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Shim, H (corresponding author), Ewha Womans Univ, Dept Life Sci, Seoul, South Korea.	hshim@ewha.ac.kr		kim, wankyu/0000-0003-3181-0594	National Research Foundation of Korea (NRF) [NRF-2013M3A6A4044991]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea (NRF, http://nrf.re.kr) grant for the Medical Bioconvergence Research Center (NRF-2013M3A6A4044991) to HS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Finlay WJJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00342; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Gonzalez-Munoz A, 2012, MABS-AUSTIN, V4, P664, DOI 10.4161/mabs.21728; Haberger M, 2014, MABS-AUSTIN, V6, P327, DOI 10.4161/mabs.27876; Kabat EA, 1991, SEQUENCES PROTEINS I; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kugler J, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0125-0; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Lloyd C, 2009, PROTEIN ENG DES SEL, V22, P159, DOI 10.1093/protein/gzn058; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marks J.D., 2020, MOL BIOL B CELLS, P511, DOI [10.1016/B978-012053641-2/50033-2, DOI 10.1016/B978-012053641-2/50033-2]; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Ofran Y, 2008, J IMMUNOL, V181, P6230, DOI 10.4049/jimmunol.181.9.6230; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; Prassler J, 2011, J MOL BIOL, V413, P261, DOI 10.1016/j.jmb.2011.08.012; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Schwimmer LJ, 2013, J IMMUNOL METHODS, V391, P60, DOI 10.1016/j.jim.2013.02.010; Silacci M, 2005, PROTEOMICS, V5, P2340, DOI 10.1002/pmic.200401273; Soderlind E, 2000, NAT BIOTECHNOL, V18, P852, DOI 10.1038/78458; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Tiller T, 2013, MABS-AUSTIN, V5, P445, DOI 10.4161/mabs.24218; Vlasak J, 2011, MABS-AUSTIN, V3, P253, DOI 10.4161/mabs.3.3.15608; Yang HY, 2009, MOL CELLS, V27, P225, DOI 10.1007/s10059-009-0028-9; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007; Zhai WW, 2011, J MOL BIOL, V412, P55, DOI 10.1016/j.jmb.2011.07.018	29	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141045	10.1371/journal.pone.0141045	http://dx.doi.org/10.1371/journal.pone.0141045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484868	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100105
J	Chen, Y; Huang, XJ; Yu, N; Xie, Y; Zhang, K; Wen, F; Liu, H; Di, Q				Chen, Yan; Huang, Xian-Jing; Yu, Nian; Xie, Yuan; Zhang, Kang; Wen, Fang; Liu, Hao; Di, Qing			HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products	PLOS ONE			English	Article							NF-KAPPA-B; MOBILITY GROUP BOX-1; ANTIEPILEPTIC DRUGS; ENDOTHELIAL-CELLS; RESISTANCE; PROTEINS; MODEL; INFLAMMATION; HIPPOCAMPUS; TRANSPORT	(HMGB1) in the seizure-induced P-glycoprotein (P-gp) overexpression and the underlying mechanism. Kainic acid (KA)-induced mouse seizure model was used for in vivo experiments. Male C57BL/6 mice were divided into four groups: normal saline control (NS) group, KA-induced epileptic seizure (EP) group, and EP group pretreated with HMGB1 (EP+HMGB1 group) or BoxA (HMGB1 antagonist, EP+BoxA group). Compared to the NS group, increased levels of HMGB1 and P-gp in the brain were observed in the EP group. Injection of HMGB1 before the induction of KA further increased the expression of P-gp while pre-treatment with BoxA abolished this up-regulation. Next, the regulatory role of HMGB1 and its potential involved signal pathways were investigated in mouse microvascular endothelial bEnd. 3 cells in vitro. Cells were treated with HMGB1, HMGB1 plus lipopolysaccharide from Rhodobacter sphaeroides (LPS-RS) [toll-like receptor 4 (TLR4) antagonist], HMGB1 plus FPS-ZM1 [receptor for advanced glycation end products (RAGE) inhibitor], HMGB1 plus SN50 [nuclear factor-kappa B (NF-kappa B) inhibitor], or vehicle. Treatment with HMGB1 increased the expression levels of P-gp, TLR4, RAGE and the activation of NF-kappa B in bEnd. 3 cells. These effects were inhibited by the pre-treatment with either LPS-RS or FPS-ZM1, and were abolished by the pre-treatment of SN50 or a combination treatment of both LPS-RS and FPS-ZM1. Luciferase reporter assays showed that exogenous expression of NF-kappa B p65 increased the promoter activity of multidrug resistance 1a (P-gp-encoding gene) in endothelial cells. These data indicate that HMGB1 contributes to the overexpression of P-gp in mouse epileptic brain tissues via activation of TLR4/RAGE receptors and the downstream transcription factor NF-kappa B in brain microvascular endothelial cells.	[Chen, Yan; Huang, Xian-Jing; Yu, Nian; Xie, Yuan; Zhang, Kang; Wen, Fang; Di, Qing] Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Liu, Hao] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA	Nanjing Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Di, Q (corresponding author), Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	diqing@medmail.com.cn		Yu, Nian/0000-0003-2988-4658	National Natural Science Foundation of China [81171222]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the National Natural Science Foundation of China (grant number: 81171222; URLs: http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; [Anonymous], 2011, GUIDE CARE USE LAB A; Aronica E, 2004, EPILEPSIA, V45, P441, DOI 10.1111/j.0013-9580.2004.57703.x; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Bauer B, 2008, MOL PHARMACOL, V73, P1444, DOI 10.1124/mol.107.041210; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Comerford KM, 2002, CANCER RES, V62, P3387; D'Acquisto F, 2006, CURR OPIN PHARMACOL, V6, P387, DOI 10.1016/j.coph.2006.02.009; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Hartz AMS, 2009, DRUG NEWS PERSPECT, V22, P393, DOI 10.1358/dnp.2009.22.7.1401354; Hayashi K, 2005, J NEUROCHEM, V93, P1231, DOI 10.1111/j.1471-4159.2005.03114.x; Heemskerk S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525180; Holtman L, 2010, EPILEPSY RES, V91, P49, DOI 10.1016/j.eplepsyres.2010.06.011; Iori V, 2013, NEUROBIOL DIS, V58, P102, DOI 10.1016/j.nbd.2013.03.006; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Krikun G, 2012, AM J REPROD IMMUNOL, V68, P233, DOI 10.1111/j.1600-0897.2012.01164.x; Lazarowski Alberto, 2011, Drug Metabolism and Drug Interactions, V26, P21, DOI 10.1515/DMDI.2011.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubin FD, 2007, J NEUROCHEM, V103, P1381, DOI 10.1111/j.1471-4159.2007.04863.x; Magna M, 2014, MOL MED, V20, P138, DOI 10.2119/molmed.2013.00164; Maroso M, 2011, J INTERN MED, V270, P319, DOI 10.1111/j.1365-2796.2011.02431.x; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; Paxinos K.B.F., 2007, MOUSE BRAIN STEREOTA; Perucca E, 2007, LANCET NEUROL, V6, P793, DOI 10.1016/S1474-4422(07)70215-6; Potschka H, 2010, EPILEPSIA, V51, P1333, DOI 10.1111/j.1528-1167.2010.02585.x; Rizzi M, 2002, J NEUROSCI, V22, P5833, DOI 10.1523/jneurosci.22-14-05833.2002; Seegers U, 2002, EPILEPSY RES, V51, P257, DOI 10.1016/S0920-1211(02)00156-0; Shen HL, 2011, EXP HEMATOL, V39, P558, DOI 10.1016/j.exphem.2011.01.013; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Volk H, 2005, J HISTOCHEM CYTOCHEM, V53, P517, DOI 10.1369/jhc.4A6451.2005; Volk HA, 2004, NEUROSCIENCE, V123, P751, DOI 10.1016/j.neuroscience.2003.10.012; Walker L, 2012, EPILEPSY CURR, V12, P8, DOI 10.5698/1535-7511-12.1.8; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7; Xie JL, 2013, CELL SIGNAL, V25, P2185, DOI 10.1016/j.cellsig.2013.06.013; Yang J, 2010, MOL CELL BIOCHEM, V345, P189, DOI 10.1007/s11010-010-0572-9; Yin YP, 2014, MOL MED REP, V9, P1439, DOI 10.3892/mmr.2014.1961; Yoder EJ, 2002, GLIA, V38, P137, DOI 10.1002/glia.10016; Yu CH, 2008, CELL PHYSIOL BIOCHEM, V22, P745, DOI 10.1159/000185558; Yu N, 2014, CNS NEUROL DISORD-DR, V13, P661, DOI 10.2174/18715273113129990106; Yu NA, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/670613; Zhang L, 1999, EXP BRAIN RES, V126, P509, DOI 10.1007/s002210050759; Zhou HG, 2013, CNS NEUROSCI THER, V19, P252, DOI 10.1111/cns.12068	46	28	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140918	10.1371/journal.pone.0140918	http://dx.doi.org/10.1371/journal.pone.0140918			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485677	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000363028100089
J	Courtney, J; Woods, E; Scholz, D; Hall, WW; Gautier, VW				Courtney, Jane; Woods, Elena; Scholz, Dimitri; Hall, William W.; Gautier, Virginie W.			MATtrack: A MATLAB-Based Quantitative Image Analysis Platform for Investigating Real-Time Photo-Converted Fluorescent Signals in Live Cells	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MICROSCOPY; TRACKING; SYSTEMS; DENDRA2; COLOCALIZATION; MOVEMENT; RECOVERY; REVEALS; BIOLOGY	We introduce here MATtrack, an open source MATLAB-based computational platform developed to process multi-Tiff files produced by a photo-conversion time lapse protocol for live cell fluorescent microscopy. MATtrack automatically performs a series of steps required for image processing, including extraction and import of numerical values from Multi-Tiff files, red/green image classification using gating parameters, noise filtering, background extraction, contrast stretching and temporal smoothing. MATtrack also integrates a series of algorithms for quantitative image analysis enabling the construction of mean and standard deviation images, clustering and classification of subcellular regions and injection point approximation. In addition, MATtrack features a simple user interface, which enables monitoring of Fluorescent Signal Intensity in multiple Regions of Interest, over time. The latter encapsulates a region growing method to automatically delineate the contours of Regions of Interest selected by the user, and performs background and regional Average Fluorescence Tracking, and automatic plotting. Finally, MATtrack computes convenient visualization and exploration tools including a migration map, which provides an overview of the protein intracellular trajectories and accumulation areas. In conclusion, MATtrack is an open source MATLAB-based software package tailored to facilitate the analysis and visualization of large data files derived from real-time live cell fluorescent microscopy using photoconvertible proteins. It is flexible, user friendly, compatible with Windows, Mac, and Linux, and a wide range of data acquisition software. MATtrack is freely available for download at eleceng.dit.ie/courtney/MATtrack.zip.	[Courtney, Jane] Dublin Inst Technol, Dublin, Ireland; [Woods, Elena; Hall, William W.; Gautier, Virginie W.] Univ Coll Dublin, Ctr Res Infect Dis, Sch Med & Med Sci, Dublin 2, Ireland; [Scholz, Dimitri] Univ Coll Dublin, Sch Med & Biomed Sci, Conway Inst Biomol & Biomed Res, Dublin, Ireland	Technological University Dublin; University College Dublin; University College Dublin	Courtney, J (corresponding author), Dublin Inst Technol, Kevin St, Dublin, Ireland.	jane.courtney@dit.ie	Gautier, virginie/K-4057-2012; Courtney, Jane/M-2558-2019	Gautier, virginie/0000-0003-1862-2644; Courtney, Jane/0000-0002-9175-7855	National Virus Reference Laboratory (NVRL), University College Dublin, Dublin, Ireland; DIT's School of Electrical & Electronic Engineering	National Virus Reference Laboratory (NVRL), University College Dublin, Dublin, Ireland; DIT's School of Electrical & Electronic Engineering	This work was supported by the National Virus Reference Laboratory (NVRL), University College Dublin, Dublin, Ireland and the DIT's School of Electrical & Electronic Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Amersham Biosciences, 2002, FLUOR IM PRINC METH; Arias-Castro E, 2009, ANN STAT, V37, P1172, DOI 10.1214/08-AOS604; Artmann W, 2008, J ELECTRON IMAGING, V6817; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Belin BJ, 2013, MOL BIOL CELL, V24, P982, DOI 10.1091/mbc.E12-09-0685; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Chudakov DM, 2007, BIOTECHNIQUES, V42, P553, DOI 10.2144/000112470; Chudakov DM, 2006, TRAFFIC, V7, P1304, DOI 10.1111/j.1600-0854.2006.00468.x; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Conrad C, 2011, NAT METHODS, V8, P246, DOI [10.1038/nmeth.1558, 10.1038/NMETH.1558]; Cowan AE, 2009, MICROSC MICROANAL, V15, P1522, DOI 10.1017/S1431927609094835; Dovas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016485; Gonzalez R C, 1992, DIGITAL IMAGE PROCES; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Hamilton NA, 2012, METHOD ENZYMOL, V504, P393, DOI 10.1016/B978-0-12-391857-4.00020-3; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V126, P135, DOI 10.1007/s00418-006-0212-3; Houtsmuller AB, 2005, ADV BIOCHEM ENG BIOT, V95, P177, DOI 10.1007/b102214; Kuzmenko A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00195; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Misselwitz B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-30; Miura K, IMAGE PROCESSING ANA; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Scarselli M, 2012, J BIOL CHEM, V287, P16768, DOI 10.1074/jbc.M111.329912; Shimozono S, 2009, BIOPHYS J, V97, P1288, DOI 10.1016/j.bpj.2009.06.024; Thapar R, 2014, WIRES RNA, V5, P49, DOI 10.1002/wrna.1196; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Villagra N, 2000, NEUROBIOL DIS, V21, P189; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Woodcroft BJ, 2009, CYTOM PART A, V75A, P941, DOI 10.1002/cyto.a.20786; Woods E, 2014, J MICROSC-OXFORD, V256, P197, DOI 10.1111/jmi.12172	39	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140209	10.1371/journal.pone.0140209	http://dx.doi.org/10.1371/journal.pone.0140209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485569	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100022
J	Daly, C; Smith, JI; Olson, KV				Daly, Christopher; Smith, Joseph I.; Olson, Keith V.			Mapping Atmospheric Moisture Climatologies across the Conterminous United States	PLOS ONE			English	Article							HYDROLOGICALLY BASED DATASET; LAND-SURFACE FLUXES; METEOROLOGICAL DATA; CLIMATE; PRECIPITATION; TEMPERATURE; HUMIDITY	Spatial climate datasets of 1981-2010 long-term mean monthly average dew point and minimum and maximum vapor pressure deficit were developed for the conterminous United States at 30-arcsec (similar to 800m) resolution. Interpolation of long-term averages (twelve monthly values per variable) was performed using PRISM (Parameter-elevation Relationships on Independent Slopes Model). Surface stations available for analysis numbered only 4,000 for dew point and 3,500 for vapor pressure deficit, compared to 16,000 for previously-developed grids of 1981-2010 long-term mean monthly minimum and maximum temperature. Therefore, a form of Climatologically-Aided Interpolation (CAI) was used, in which the 1981-2010 temperature grids were used as predictor grids. For each grid cell, PRISM calculated a local regression function between the interpolated climate variable and the predictor grid. Nearby stations entering the regression were assigned weights based on the physiographic similarity of the station to the grid cell that included the effects of distance, elevation, coastal proximity, vertical atmospheric layer, and topographic position. Interpolation uncertainties were estimated using cross-validation exercises. Given that CAI interpolation was used, a new method was developed to allow uncertainties in predictor grids to be accounted for in estimating the total interpolation error. Local land use/land cover properties had noticeable effects on the spatial patterns of atmospheric moisture content and deficit. An example of this was relatively high dew points and low vapor pressure deficits at stations located in or near irrigated fields. The new grids, in combination with existing temperature grids, enable the user to derive a full suite of atmospheric moisture variables, such as minimum and maximum relative humidity, vapor pressure, and dew point depression, with accompanying assumptions. All of these grids are available online at http://prism.oregonstate.edu, and include 800-m and 4-km resolution data, images, metadata, pedigree information, and station inventory files.	[Daly, Christopher; Smith, Joseph I.; Olson, Keith V.] Oregon State Univ, PRISM Climate Grp, Northwest Alliance Computat Sci & Engn, Corvallis, OR 97331 USA	Oregon State University	Daly, C (corresponding author), Oregon State Univ, PRISM Climate Grp, Northwest Alliance Computat Sci & Engn, Corvallis, OR 97331 USA.	Chris.Daly@oregonstate.edu			USDA Department of Agriculture Risk Management Agency [4500054499]	USDA Department of Agriculture Risk Management Agency	This study was funded by the USDA Department of Agriculture Risk Management Agency grant number 4500054499. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou JT, 2013, INT J CLIMATOL, V33, P121, DOI 10.1002/joc.3413; Alduchov OA, 1996, J APPL METEOROL, V35, P601, DOI 10.1175/1520-0450(1996)035<0601:IMFAOS>2.0.CO;2; Anderson DB, 1936, ECOLOGY, V17, P277, DOI 10.2307/1931468; Ashcroft MB, 2013, AGR FOREST METEOROL, V176, P77, DOI 10.1016/j.agrformet.2013.03.008; Bunce JA, 1997, PLANT CELL ENVIRON, V20, P131, DOI 10.1046/j.1365-3040.1997.d01-3.x; Daly C, 2003, INT J CLIMATOL, V23, P1359, DOI 10.1002/joc.937; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Daly C., 2004, P 14 AMS C APPL CLIM; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Daly C, 2007, J APPL METEOROL CLIM, V46, P1565, DOI 10.1175/JAM2548.1; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; Daly C, 2012, J APPL METEOROL CLIM, V51, P242, DOI 10.1175/2010JAMC2536.1; Funk C, 2000, INT J CLIMATOLOGY, V1, P47, DOI DOI 10.1002/J0C.866; Hamlet AF, 2005, J HYDROMETEOROL, V6, P330, DOI 10.1175/JHM420.1; Hinckley T. M., 1978, FOREST SCI MONOGRAPH, V20; JOHNSON JD, 1983, PLANT CELL ENVIRON, V6, P451, DOI 10.1111/j.1365-3040.1983.tb01548.x; Kimball JS, 1997, AGR FOREST METEOROL, V85, P87, DOI 10.1016/S0168-1923(96)02366-0; Littell JS, 2010, CLIMATIC CHANGE, V102, P129, DOI 10.1007/s10584-010-9858-x; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Livneh B, 2013, J CLIMATE, V26, P9384, DOI 10.1175/JCLI-D-12-00508.1; Lundquist JD, 2015, J HYDROMETEOROL, V16, P1773, DOI 10.1175/JHM-D-15-0019.1; Maurer EP, 2002, J CLIMATE, V15, P3237, DOI [10.1175/1520-0442(2002)015<3237:ALTHBD>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3237:ALTHBD&gt;2.0.CO;2]; McEvoy DJ, 2014, J HYDROMETEOROL, V15, P1913, DOI 10.1175/JHM-D-14-0015.1; National Oceanic and Atmospheric Administration, WET BULB TEMP DEWP T; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; NOAA-National Climatic Data Center, 2003, DAT DOC DAT SET 3220; Plantico M.S., 2000, P 12 AMS C APPL CLIM, P247; PRISM Climate Group OSU, DESCR PRISM SPAT CLI; RUNNING SW, 1987, CAN J FOREST RES, V17, P472, DOI 10.1139/x87-081; RUNNING SW, 1980, CAN J FOREST RES, V10, P82, DOI 10.1139/x80-014; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Williams AP, 2014, J APPL METEOROL CLIM, V53, P2671, DOI 10.1175/JAMC-D-14-0053.1; WILLMOTT CJ, 1995, INT J CLIMATOL, V15, P221, DOI 10.1002/joc.3370150207; World Meteorological Organization, 1989, CALC MONTHL ANN 30 Y; Zeppel MJB, 2014, TREE PHYSIOL, V34, P1047, DOI 10.1093/treephys/tpu089	36	66	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141140	10.1371/journal.pone.0141140	http://dx.doi.org/10.1371/journal.pone.0141140			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485026	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100117
J	Fadel, SA; Ram, U; Morris, SK; Begum, R; Shet, A; Jotkar, R; Jha, P				Fadel, Shaza A.; Ram, Usha; Morris, Shaun K.; Begum, Rehana; Shet, Anita; Jotkar, Raju; Jha, Prabhat			Facility Delivery, Postnatal Care and Neonatal Deaths in India: Nationally-Representative Case-Control Studies	PLOS ONE			English	Article							MATERNAL MORTALITY; NEWBORN BABIES; UTTAR-PRADESH; HEALTH; INTERVENTIONS; METAANALYSIS; MANAGEMENT; PROGRAM	Objective Clinical studies demonstrate the efficacy of interventions to reduce neonatal deaths, but there are fewer studies of their real-life effectiveness. In India, women often seek facility delivery after complications arise, rather than to avoid complications. Our objective was to quantify the association of facility delivery and postnatal checkups with neonatal mortality while examining the "reverse causality" in which the mothers deliver at a health facility due to adverse perinatal events. Methods We conducted nationally representative case-control studies of about 300,000 live births and 4,000 neonatal deaths to examine the effect of, place of delivery and postnatal checkup on neonatal mortality. We compared neonatal deaths to all live births and to a subset of live births reporting excessive bleeding or obstructed labour that were more comparable to cases in seeking care. Findings In the larger study of 2004-8 births, facility delivery without postnatal checkup was associated with an increased odds of neonatal death (Odds ratio = 2.5; 99% CI 2.2-2.9), especially for early versus late neonatal deaths. However, use of more comparable controls showed marked attenuation (Odds ratio = 0.5; 0.4-0.5). Facility delivery with postnatal checkup was associated with reduced odds of neonatal death. Excess risks were attenuated in the earlier study of 2001-4 births. Conclusion The combined effect of facility deliveries with postnatal checks ups is substantially higher than just facility delivery alone. Evaluation of the real-life effectiveness of interventions to reduce child and maternal deaths need to consider reverse causality. If these associations are causal, facility delivery with postnatal check up could avoid about 1/3 of all neonatal deaths in India (similar to 100,000/year).	[Fadel, Shaza A.; Ram, Usha; Begum, Rehana; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON, Canada; [Fadel, Shaza A.; Ram, Usha; Begum, Rehana; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Ram, Usha] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Bombay, Maharashtra, India; [Morris, Shaun K.] Hosp Sick Children, Div Infect Dis, Toronto, ON M5G 1X8, Canada; [Morris, Shaun K.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Morris, Shaun K.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Shet, Anita] St Johns Med Coll Hosp, Dept Pediat, Bangalore, Karnataka, India; [Jotkar, Raju] Govt Maharashtra, Natl Hlth Mission, Bombay, Maharashtra, India	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; International Institute for Population Sciences; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; St. John's National Academy of Health Sciences; St. John's Medical College	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON, Canada.	Prabhat.jha@utoronto.ca	Ram, Usha/AAS-4140-2020	Ram, Usha/0000-0001-6722-7347; Jha, Prabhat/0000-0001-7067-8341; Shet, Anita/0000-0002-7204-8164; Fadel, Shaza/0000-0002-2336-6254	US National Institutes of Health [R01-TW05991-01, TW007939-01]; Canadian Institutes of Health Research, CGHR; University of Toronto; CIHR-Hope Fellowship; Endowed Chair at the University of Toronto; Canada Research Chairs program; FOGARTY INTERNATIONAL CENTER [R01TW007939, R01TW005991] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research, CGHR(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); CIHR-Hope Fellowship; Endowed Chair at the University of Toronto; Canada Research Chairs program(Canada Research Chairs); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study is supported by the grants from the US National Institutes of Health (R01-TW05991-01 and TW007939-01), Canadian Institutes of Health Research, CGHR and the University of Toronto to PJ. UR is a recipient of the CIHR-Hope Fellowship. PJ receives support from an Endowed Chair at the University of Toronto and the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed in this article are those of the authors and do not necessarily represent those of the institutions with which they are affiliated or of the Government of India.	Agrawal PK, 2012, J EPIDEMIOL COMMUN H, V66, P755, DOI 10.1136/jech-2011-200362; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS72, DOI 10.1038/sj.jp.7211276; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhandari N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1634; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Chaturvedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096773; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ghosh R, 2010, J BIOSOC SCI, V42, P511, DOI 10.1017/S0021932010000040; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Goudar SS, 2013, PEDIATRICS, V131, pE344, DOI 10.1542/peds.2012-2112; Gulmezoglu AM, REPROD MATERNAL NEWB, V2; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS), 2006, DISTR LEV HOUS SURV; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1136/bmjopen-2015-008188; Koueta Fla, 2011, Sante, V21, P209, DOI 10.1684/san.2011.0271; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Malhotra C, 2014, ASIA-PAC J PUBLIC HE, V26, P401, DOI 10.1177/1010539511420418; Matthews M., 2010, WHO TECHNICAL CONSUL; Mbaruku G, 2009, INT J GYNECOL OBSTET, V106, P85, DOI 10.1016/j.ijgo.2009.04.008; Montgomery AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095696; National Rural Health Mission Ministry of Health & Family Welfare, 2013, STRAT APPR REPR MAT; Office of the Registrar General & Census Commissioner, 2013, SAMPLE REGISTRATION; Pasha O, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-215; Ram U, 2013, LANCET GLOB HEALTH, V1, pE219, DOI 10.1016/S2214-109X(13)70073-1; Rammohan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057244; Requejo J, 2014, INT J EPIDEMIOL, V43, P586, DOI 10.1093/ije/dyu034; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037037; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; UNICEF, 2010, COV EV SURV 2009 ALL; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; WHO, 2009, WHO UNICEF JOINT STA	37	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140448	10.1371/journal.pone.0140448	http://dx.doi.org/10.1371/journal.pone.0140448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479476	Green Published, Green Submitted, gold			2022-12-27	WOS:000363026600011
J	Konkle, JJ; Goodwill, PW; Hensley, DW; Orendorff, RD; Lustig, M; Conolly, SM				Konkle, Justin J.; Goodwill, Patrick W.; Hensley, Daniel W.; Orendorff, Ryan D.; Lustig, Michael; Conolly, Steven M.			A Convex Formulation for Magnetic Particle Imaging X-Space Reconstruction	PLOS ONE			English	Article							ITERATIVE RECONSTRUCTION; MRI; ALGORITHM; MPI; RESOLUTION; GRAPPA	Magnetic Particle Imaging (MPI) is an emerging imaging modality with exceptional promise for clinical applications in rapid angiography, cell therapy tracking, cancer imaging, and inflammation imaging. Recent publications have demonstrated quantitative MPI across rat sized fields of view with x-space reconstruction methods. Critical to any medical imaging technology is the reliability and accuracy of image reconstruction. Because the average value of the MPI signal is lost during direct-feedthrough signal filtering, MPI reconstruction algorithms must recover this zero-frequency value. Prior x-space MPI recovery techniques were limited to 1D approaches which could introduce artifacts when reconstructing a 3D image. In this paper, we formulate x-space reconstruction as a 3D convex optimization problem and apply robust a priori knowledge of image smoothness and non-negativity to reduce non-physical banding and haze artifacts. We conclude with a discussion of the powerful extensibility of the presented formulation for future applications.	[Konkle, Justin J.; Goodwill, Patrick W.; Hensley, Daniel W.; Orendorff, Ryan D.; Lustig, Michael; Conolly, Steven M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Lustig, Michael; Conolly, Steven M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Conolly, SM (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	sconolly@berkeley.edu	Goodwill, Patrick/AAB-8825-2022; Lustig, Michael/G-7081-2012	Goodwill, Patrick/0000-0003-4240-1956; Conolly, Steven/0000-0002-3310-6085	National Science Foundation Graduate Research Fellowship Program [DGE 1106400]; California Institute of Regenerative Medicine [RT2-01893]; University of California; National Institute of Health [NIBIB 1R01EB013689]; William M. Keck Foundation [034317]; Sloan Research Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013689, R01EB019458] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); University of California(University of California System); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William M. Keck Foundation(W.M. Keck Foundation); Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Science Foundation Graduate Research Fellowship Program-DGE 1106400-http://www.nsfgrfp.org (JJK), the California Institute of Regenerative Medicine-RT2-01893-https://www.cirm.ca.gov (SMC), the University of California Discovery Grant-http://ucop.edu/research-initiatives/programs/innovation-opportunities/discovery-grant.html (SMC), the National Institute of Health-NIBIB 1R01EB013689-http://www.nibib.nih.gov (SMC), the William M. Keck Foundation-034317-http://www.wmkeck.org (SMC), and the Sloan Research Fellowship-http://www.sloan.org (ML). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, CIRM, UC Discovery or any other agency of the State of California. JK, DWH, PWG are employed/consult at Magnetic Insight, Inc. JJK, PWG, DWH, and SMC own stock in Magnetic Insight, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Boyd S., 2004, CONVEX OPTIMIZATION; Chen GH, 2008, MED PHYS, V35, P660, DOI 10.1118/1.2836423; Claerbout J. F., 1992, EARTH SOUNDINGS ANAL; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Goodwill PW, 2011, IEEE T MED IMAGING, V30, P1581, DOI 10.1109/TMI.2011.2125982; Goodwill PW, 2010, IEEE T MED IMAGING, V29, P1851, DOI 10.1109/TMI.2010.2052284; Goodwill PW, 2012, ADV MATER, V24, P3870, DOI 10.1002/adma.201200221; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Han XA, 2011, IEEE T MED IMAGING, V30, P606, DOI 10.1109/TMI.2010.2089695; Knopp T, 2010, PHYS MED BIOL, V55, P1577, DOI 10.1088/0031-9155/55/6/003; Knopp T, 2013, IEEE T MED IMAGING, V32, P1473, DOI 10.1109/TMI.2013.2258029; Knopp T, 2010, MED PHYS, V37, P485, DOI 10.1118/1.3271258; Konkle JJ, 2013, BIOMED ENG-BIOMED TE, V58, P565, DOI 10.1515/bmt-2012-0062; Konkle JJ, 2013, IEEE T MED IMAGING, V32, P338, DOI 10.1109/TMI.2012.2227121; Lampe J, 2012, PHYS MED BIOL, V57, P1113, DOI 10.1088/0031-9155/57/4/1113; Li MH, 2002, PHYS MED BIOL, V47, P2599, DOI 10.1088/0031-9155/47/15/303; Lu K, 2013, IEEE T MED IMAGING, V32, P1565, DOI 10.1109/TMI.2013.2257177; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Lustig M, 2010, MAGN RESON MED, V64, P457, DOI 10.1002/mrm.22428; Man BD, 2004, PHYS MED BIOL, V49, P2463, DOI DOI 10.1088/0031-9155/49/11/024; NIENABER CA, 1993, NEW ENGL J MED, V328, P1, DOI 10.1056/NEJM199301073280101; Noone TC, 2004, MAGN RESON IMAGING, V22, P19, DOI 10.1016/j.mri.2003.01.001; Parikh Neal, 2014, Foundations and Trends in Optimization, V1, P127, DOI 10.1561/2400000003; Rahmer J, 2013, PHYS MED BIOL, V58, P3965, DOI 10.1088/0031-9155/58/12/3965; Rahmer J, 2012, IEEE T MED IMAGING, V31, P1289, DOI 10.1109/TMI.2012.2188639; Rahmer Jurgen, 2009, BMC Med Imaging, V9, P4, DOI 10.1186/1471-2342-9-4; Saritas EU, 2013, IEEE T MED IMAGING, V32, P1600, DOI 10.1109/TMI.2013.2260764; Saritas EU, 2013, J MAGN RESON, V229, P116, DOI 10.1016/j.jmr.2012.11.029; Tang J, 2009, PHYS MED BIOL, V54, P5781, DOI 10.1088/0031-9155/54/19/008; Uecker M, 2014, MAGN RESON MED, V71, P990, DOI 10.1002/mrm.24751; Weaver JB, 2009, MED PHYS, V36, P1822, DOI 10.1118/1.3106342; Weizenecker J, 2007, PHYS MED BIOL, V52, P6363, DOI 10.1088/0031-9155/52/21/001; Weizenecker J, 2009, PHYS MED BIOL, V54, pL1, DOI 10.1088/0031-9155/54/5/L01	36	22	23	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140137	10.1371/journal.pone.0140137	http://dx.doi.org/10.1371/journal.pone.0140137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495839	gold, Green Published, Green Submitted			2022-12-27	WOS:000363309200013
J	Lobo, D; Godinho, R; Alvares, F; Lopez-Bao, JV; Rodriguez, A				Lobo, Diana; Godinho, Raquel; Alvares, Francisco; Lopez-Bao, Jose V.; Rodriguez, Alejandro			A New Method for Noninvasive Genetic Sampling of Saliva in Ecological Research	PLOS ONE			English	Article							POPULATION-SIZE; MICROSATELLITE GENOTYPES; ALLELIC DROPOUT; BUCCAL SWABS; NUCLEAR-DNA; WOLF; PCR; IDENTIFICATION; SUCCESS; URINE	Noninvasive samples for genetic analyses have become essential to address ecological questions. Popular noninvasive samples such as faeces contain degraded DNA which may compromise genotyping success. Saliva is an excellent alternative DNA source but scarcity of suitable collection methods makes its use anecdotal in field ecological studies. We develop a noninvasive method of collection that combines baits and porous materials able to capture saliva. We report its potential in optimal conditions, using confined dogs and collecting saliva early after deposition. DNA concentration in saliva extracts was generally high (mean 14 ng mu l(-1)). We correctly identified individuals in 78% of samples conservatively using ten microsatellite loci, and 90% of samples using only eight loci. Consensus genotypes closely matched reference genotypes obtained from hair DNA (99% of identification successes and 91% of failures). Mean genotyping effort needed for identification using ten loci was 2.2 replicates. Genotyping errors occurred at a very low frequency (allelic dropout: 2.3%; false alleles: 1.5%). Individual identification success increased with duration of substrate handling inside dog's mouth and the volume of saliva collected. Low identification success was associated with baits rich in DNA-oxidant polyphenols and DNA concentrations <1 ng mu l(-1). The procedure performed at least as well as other noninvasive methods, and could advantageously allow detection of socially low-ranked individuals underrepresented in sources of DNA that are involved in marking behaviour (faeces or urine). Once adapted and refined, there is promise for this technique to allow potentially high rates of individual identification in ecological field studies requiring noninvasive sampling of wild vertebrates.	[Lobo, Diana; Godinho, Raquel; Alvares, Francisco] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Lobo, Diana; Godinho, Raquel] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Porto, Portugal; [Lopez-Bao, Jose V.] Univ Oviedo, Res Unit Biodivers UO CSIC PA, Mieres, Spain; [Lopez-Bao, Jose V.] Swedish Univ Agr Sci SLU, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Rodriguez, Alejandro] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain	Universidade do Porto; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Swedish University of Agricultural Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Rodriguez, A (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	rgodinho@cibio.up.pt; alrodri@ebd.csic.es	Godinho, Raquel/L-6804-2013; Rodríguez, Alejandro/E-7709-2011; Alvares, Francisco/K-6353-2013; Lobo, Diana/E-8764-2015	Godinho, Raquel/0000-0002-4260-4799; Rodríguez, Alejandro/0000-0001-9367-3420; Lopez-Bao, Jose Vicente/0000-0001-9213-998X; Alvares, Francisco/0000-0002-4033-6989; Lobo, Diana/0000-0001-6988-9993	North Portugal Regional Operational Programme; European Regional Development Fund; Spanish Ministry of Economy and Competitiveness [CGL2011-27469, SEV-2012-0262]; Fundacao para a Ciencia e a Tecnologia [IF/00564/2012]	North Portugal Regional Operational Programme; European Regional Development Fund(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Funded by North Portugal Regional Operational Programme 2007/2013 (http://www.novonorte.qren.pt/pt/menu-topo/english-version/), European Regional Development Fund (http://ec.europa.eu/regional_policy/index.cfm/en/funding/erdf/), Grants CGL2011-27469 and SEV-2012-0262, Spanish Ministry of Economy and Competitiveness, formerly Spanish Ministry of Science and Innovation, (http://www.mineco.gob.es/portal/site/mineco/idi), and Grant IF/00564/2012, Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algar D, 2008, WILDLIFE RES, V35, P471, DOI 10.1071/WR07167; Ball MC, 2007, CONSERV GENET, V8, P577, DOI 10.1007/s10592-006-9193-y; Banks SC, 2010, OECOLOGIA, V162, P359, DOI 10.1007/s00442-009-1464-0; Bellemain E, 2004, MOL ECOL NOTES, V4, P519, DOI 10.1111/j.1471-8286.2004.00711.x; Bennett A, 2010, DOMEST ANIM ENDOCRIN, V39, P171, DOI 10.1016/j.domaniend.2010.04.003; Blacket MJ, 2012, MOL ECOL RESOUR, V12, P456, DOI 10.1111/j.1755-0998.2011.03104.x; Blejwas KM, 2006, J WILDLIFE MANAGE, V70, P1087, DOI 10.2193/0022-541X(2006)70[1087:SDECBM]2.0.CO;2; Bohling JH, 2011, MOL ECOL, V20, P2142, DOI 10.1111/j.1365-294X.2011.05084.x; Brashares JS, 1999, ANIM BEHAV, V57, P11, DOI 10.1006/anbe.1998.0942; Broquet T, 2007, CONSERV GENET, V8, P249, DOI 10.1007/s10592-006-9146-5; Cahan SH, 2006, ECOLOGY, V87, P2160, DOI 10.1890/0012-9658(2006)87[2160:RIBPRA]2.0.CO;2; Caniglia R, 2013, FORENSIC SCI INT-GEN, V7, P397, DOI 10.1016/j.fsigen.2012.11.001; Conde E, 1997, J AGR FOOD CHEM, V45, P2695, DOI 10.1021/jf960486w; CRAWLEY MJ, 2002, STAT COMPUTING; Croft DP, 2012, OECOLOGIA, V170, P955, DOI 10.1007/s00442-012-2379-8; Dawes C, 2003, ARCH ORAL BIOL, V48, P329, DOI 10.1016/S0003-9969(03)00014-1; Dempsey SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105873; Dreschel NA, 2009, HORM BEHAV, V55, P163, DOI 10.1016/j.yhbeh.2008.09.010; Ebert C, 2010, WILDLIFE BIOL, V16, P225, DOI 10.2981/09-108; Elliott DR, 2005, J CLIN MICROBIOL, V43, P5470, DOI 10.1128/JCM.43.11.5470-5476.2005; Fickel J, 2006, EUR J WILDLIFE RES, V52, P28, DOI 10.1007/s10344-005-0003-5; Floyd CH, 2005, ECOLOGY, V86, P2145, DOI 10.1890/04-1227; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Godinho R, 2015, MOL ECOL RESOUR, V15, P317, DOI 10.1111/1755-0998.12313; Goossens B, 2006, MOL ECOL, V15, P2577, DOI 10.1111/j.1365-294X.2006.02952.x; Hadi SM, 2007, SEMIN CANCER BIOL, V17, P370, DOI 10.1016/j.semcancer.2007.04.002; Hausknecht R, 2007, MOL ECOL NOTES, V7, P208, DOI 10.1111/j.1471-8286.2006.01622.x; Hausknecht R, 2009, ACTA THERIOL, V54, P277, DOI 10.4098/j.at.0001-7051.072.2008; Hebert L, 2011, CONSERV GENET RESOUR, V3, P41, DOI 10.1007/s12686-010-9280-8; Heffernan DJ, 2007, J WILDLIFE MANAGE, V71, P587, DOI 10.2193/2005-505; Inoue E, 2007, PRIMATES, V48, P156, DOI 10.1007/s10329-006-0017-y; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Jordan NR, 2007, ANIM BEHAV, V73, P613, DOI 10.1016/j.anbehav.2006.06.010; Kobelt AJ, 2003, RES VET SCI, V75, P157, DOI 10.1016/S0034-5288(03)00080-8; Kohn MH, 1999, P ROY SOC B-BIOL SCI, V266, P657, DOI 10.1098/rspb.1999.0686; Lima DP, 2010, INT J INFECT DIS, V14, pE184, DOI 10.1016/j.ijid.2009.04.022; Looi ML, 2012, CLIN LAB, V58, P307; Lopez-Bao JV, 2008, BIOL CONSERV, V141, P1857, DOI 10.1016/j.biocon.2008.05.002; Lucchini V, 2002, MOL ECOL, V11, P857, DOI 10.1046/j.1365-294X.2002.01489.x; Martin-Galvez D, 2011, MOL ECOL RESOUR, V11, P481, DOI 10.1111/j.1755-0998.2010.02953.x; Medina I, 1998, J AGR FOOD CHEM, V46, P1150, DOI 10.1021/jf970587+; Meek PD, 2012, WILDLIFE RES, V39, P649, DOI 10.1071/WR12138; Miller CR, 2002, GENETICS, V160, P357; Miller HC, 2006, CONSERV GENET, V7, P1001, DOI 10.1007/s10592-006-9120-2; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Murphy MA, 2007, CONSERV GENET, V8, P1219, DOI 10.1007/s10592-006-9264-0; NAVIDI W, 1992, AM J HUM GENET, V50, P347; Nichols RV, 2012, MOL ECOL RESOUR, V12, P983, DOI 10.1111/j.1755-0998.2012.03172.x; Niitepold K, 2011, OECOLOGIA, V165, P847, DOI 10.1007/s00442-010-1886-8; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Obbard ME, 2008, URSUS, V19, P33, DOI 10.2192/1537-6176(2008)19[33:SBCTHH]2.0.CO;2; Oliveira R, 2010, CONSERV GENET, V11, P1023, DOI 10.1007/s10592-009-9947-4; Pichlmuller F, 2013, AMPHIBIA-REPTILIA, V34, P517, DOI 10.1163/15685381-00002909; Pooe OJ, 2011, AFR J MICROBIOL RES, V5, P5120, DOI 10.5897/AJMR11.1090; Poschadel JR, 2004, CONSERV GENET, V5, P865, DOI 10.1007/s10592-004-1974-6; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Rogers SO., 1994, PLANT MOL BIOL, V1, P183, DOI 10.1007/978-94-011-0511-8_12; Ruell EW, 2007, J WILDLIFE MANAGE, V71, P1690, DOI 10.2193/2006-061; Santin R, 2013, BRAZ J MICROBIOL, V44, P139, DOI 10.1590/S1517-83822013005000018; Santini A, 2007, MOL ECOL NOTES, V7, P955, DOI 10.1111/j.1471-8286.2007.01829.x; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID, P2078; SCALBERT A, 1992, BASIC LIFE SCI, V59, P935; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Schwartz Michael K., 2008, P238; Shafer ABA, 2012, ECOLOGY, V93, P1317; Simons ND, 2012, AM J PRIMATOL, V74, P1064, DOI 10.1002/ajp.22062; Sindicic M, 2013, CONSERV GENET, V14, P1009, DOI 10.1007/s10592-013-0491-x; Smith DA, 2006, MOL ECOL, V15, P387, DOI 10.1111/j.1365-294X.2005.02841.x; Spiering PA, 2009, CONSERV GENET, V10, P2005, DOI 10.1007/s10592-009-9880-6; Sugimoto T, 2012, J MAMMAL, V93, P93, DOI 10.1644/10-MAMM-A-368.1; Sundqvist AK, 2008, CONSERV GENET, V9, P1275, DOI 10.1007/s10592-007-9454-4; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Thomson PC, 2002, WILDLIFE RES, V29, P371, DOI 10.1071/WR01098; Travaini A, 2013, BEHAV PROCESS, V92, P79, DOI 10.1016/j.beproc.2012.10.008; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Valiere N, 2003, ANIM CONSERV, V6, P83, DOI 10.1017/S1367943003003111; Valiere N, 2002, MOL ECOL NOTES, V2, P83, DOI 10.1046/j.1471-8278 .2001.00134.x; Valiere N, 2000, MOL ECOL, V9, P2150, DOI 10.1046/j.1365-294X.2000.11142.x; Vargas ML, 2009, MOL ECOL RESOUR, V9, P505, DOI 10.1111/j.1755-0998.2008.02498.x; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Woodruff SP, 2015, MOL ECOL RESOUR, V15, P843, DOI 10.1111/1755-0998.12362; Yannic G, 2011, MOL ECOL RESOUR, V11, P877, DOI 10.1111/j.1755-0998.2011.03015.x; Zhu LF, 2013, ECOLOGY, V94, P2346, DOI 10.1890/12-1451.1	85	8	10	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0139765	10.1371/journal.pone.0139765	http://dx.doi.org/10.1371/journal.pone.0139765			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496352	Green Published, gold, Green Accepted			2022-12-27	WOS:000363309200008
J	Srinivasan, VB; Venkataramaiah, M; Mondal, A; Rajamohan, G				Srinivasan, Vijaya Bharathi; Venkataramaiah, Manjunath; Mondal, Amitabha; Rajamohan, Govindan			Functional Characterization of AbeD, an RND-Type Membrane Transporter in Antimicrobial Resistance in Acinetobacter baumannii	PLOS ONE			English	Article							EFFLUX PUMP; MULTIDRUG-RESISTANCE; ESCHERICHIA-COLI; MERR FAMILY; ANTIBIOTICS; EXPRESSION; TOLERANCE; CONFERS; ADEIJK; ACRD	Background Acinetobacter baumannii is becoming an increasing menace in health care settings especially in the intensive care units due to its ability to withstand adverse environmental conditions and exhibit innate resistance to different classes of antibiotics. Here we describe the biological contributions of abeD, a novel membrane transporter in bacterial stress response and antimicrobial resistance in A. baumannii. Results The abeD mutant displayed similar to 3.37 fold decreased survival and >5-fold reduced growth in hostile osmotic (0.25 M; NaCl) and oxidative (2.631 mu M-6.574 mu M; H2O2) stress conditions respectively. The abeD inactivated cells displayed increased susceptibility to ceftriaxone, gentamicin, rifampicin and tobramycin (similar to 4.0 fold). The mutant displayed increased sensitivity to the hospital-based disinfectant benzalkonium chloride (similar to 3.18-fold). In Caenorhabditis elegans model, the abeD mutant exhibited (P<0.01) lower virulence capability. Binding of SoxR on the regulatory fragments of abeD provide strong evidence for the involvement of SoxR system in regulating the expression of abeD in A. baumannii. Conclusion This study demonstrates the contributions of membrane transporter AbeD in bacterial physiology, stress response and antimicrobial resistance in A. baumannii for the first time.	[Srinivasan, Vijaya Bharathi; Venkataramaiah, Manjunath; Mondal, Amitabha; Rajamohan, Govindan] Inst Microbial Technol, CSIR, Sect 39 A, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Rajamohan, G (corresponding author), Inst Microbial Technol, CSIR, Sect 39 A, Chandigarh 160036, India.	rmohan@imtech.res.in		Govindan, Rajamohan/0000-0002-0208-3546	CSIR [BSC0210H, OLP0061]; DBT [BT/PR14304/BRB/10/822/2010, BT/HRD/NBA/34/01/2012]	CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India)	Funding from CSIR (BSC0210H, OLP0061) and DBT (BT/PR14304/BRB/10/822/2010, BT/HRD/NBA/34/01/2012) is highly acknowledged, however they had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Coudeyras S, 2008, INFECT IMMUN, V76, P4633, DOI 10.1128/IAI.00356-08; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Durante-Mangoni E, 2011, FUTURE MICROBIOL, V6, P407, DOI [10.2217/FMB.11.23, 10.2217/fmb.11.23]; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Fraud S, 2008, ANTIMICROB AGENTS CH, V52, P4478, DOI 10.1128/AAC.01072-08; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; Hidalgo E, 1997, CELL, V88, P121, DOI 10.1016/S0092-8674(00)81864-4; Hobman JL, 2005, BIOMETALS, V18, P429, DOI 10.1007/s10534-005-3717-7; Hood MI, 2010, ANTIMICROB AGENTS CH, V54, P1029, DOI 10.1128/AAC.00963-09; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Marchand I, 2004, ANTIMICROB AGENTS CH, V48, P3298, DOI 10.1128/AAC.48.9.3298-3304.2004; McEwan AG, 2011, ADV MICROB PHYSIOL, V58, P1, DOI 10.1016/B978-0-12-381043-4.00001-5; Nachimuthu R, 2015, J CHEMOTHER; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Pletzer D, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-13; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P1919, DOI 10.1093/jac/dkq195; Rosenberg EY, 2000, J BACTERIOL, V182, P1754, DOI 10.1128/JB.182.6.1754-1756.2000; Rosenfeld N, 2012, ANTIMICROB AGENTS CH, V56, P2504, DOI 10.1128/AAC.06422-11; Rynga D, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0101-5; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Srinivasan VB, 2015, ANTIMICROB AGENTS CH, V59, P1236, DOI 10.1128/AAC.03626-14; Srinivasan VB, 2013, ANTIMICROB AGENTS CH, V57, P4449, DOI 10.1128/AAC.02284-12; Srinivasan VB, 2009, ANTIMICROB AGENTS CH, V53, P5312, DOI 10.1128/AAC.00748-09; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Trainor EA, 2011, INFECT IMMUN, V79, P88, DOI 10.1128/IAI.00974-09; Yoon EJ, 2015, MBIO, V6, DOI 10.1128/mBio.00309-15	35	11	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141314	10.1371/journal.pone.0141314	http://dx.doi.org/10.1371/journal.pone.0141314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496475	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200091
J	Raut, MP; Karunakaran, E; Mukherjee, J; Biggs, CA; Wright, PC				Raut, Mahendra P.; Karunakaran, Esther; Mukherjee, Joy; Biggs, Catherine A.; Wright, Phillip C.			Influence of Substrates on the Surface Characteristics and Membrane Proteome of Fibrobacter succinogenes S85	PLOS ONE			English	Article							RUMINOCOCCUS-ALBUS; ELECTROPHORETIC MOBILITY; CELLULOSE; BACTERIA; ADHESION; BIOFILM; GLUCOSE; PROTEINS; GROWTH; DEGRADATION	Although Fibrobacter succinogenes S85 is one of the most proficient cellulose degrading bacteria among all mesophilic organisms in the rumen of herbivores, the molecular mechanism behind cellulose degradation by this bacterium is not fully elucidated. Previous studies have indicated that cell surface proteins might play a role in adhesion to and subsequent degradation of cellulose in this bacterium. It has also been suggested that cellulose degradation machinery on the surface may be selectively expressed in response to the presence of cellulose. Based on the genome sequence, several models of cellulose degradation have been suggested. The aim of this study is to evaluate the role of the cell envelope proteins in adhesion to cellulose and to gain a better understanding of the subsequent cellulose degradation mechanism in this bacterium. Comparative analysis of the surface (exposed outer membrane) chemistry of the cells grown in glucose, acid-swollen cellulose and microcrystalline cellulose using physico-chemical characterisation techniques such as electrophoretic mobility analysis, microbial adhesion to hydrocarbons assay and Fourier transform infra-red spectroscopy, suggest that adhesion to cellulose is a consequence of an increase in protein display and a concomitant reduction in the cell surface polysaccharides in the presence of cellulose. In order to gain further understanding of the molecular mechanism of cellulose degradation in this bacterium, the cell envelope-associated proteins were enriched using affinity purification and identified by tandem mass spectrometry. In total, 185 cell envelope-associated proteins were confidently identified. Of these, 25 proteins are predicted to be involved in cellulose adhesion and degradation, and 43 proteins are involved in solute transport and energy generation. Our results supports the model that cellulose degradation in F. succinogenes occurs at the outer membrane with active transport of cellodextrins across for further metabolism of cellodextrins to glucose in the periplasmic space and inner cytoplasmic membrane.	[Raut, Mahendra P.; Karunakaran, Esther; Mukherjee, Joy; Biggs, Catherine A.; Wright, Phillip C.] Univ Sheffield, ChELSI Inst, Dept Chem & Biol Engn, Sheffield S1 3JD, S Yorkshire, England	University of Sheffield	Wright, PC (corresponding author), Univ Sheffield, ChELSI Inst, Dept Chem & Biol Engn, Mappin St, Sheffield S1 3JD, S Yorkshire, England.	p.c.wright@sheffield.ac.uk		Karunakaran, Esther/0000-0003-1913-4319; Raut, Mahendra/0000-0002-6919-3467; Wright, Phillip/0000-0002-8834-0426	Ministry of Social Justice and Empowerment Govt. of India [11015/22/2008-SCD-V]; Engineering and Physical Science Research Council (EPSRC) [EP/E036252/1, EP/E053556/1]; European Union [251132, FP7-ENERGY-2009-BRAZIL]; EPSRC [EP/E036252/1, EP/I031812/1, EP/E053556/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E053556/1, EP/I031812/1, EP/E036252/1] Funding Source: researchfish	Ministry of Social Justice and Empowerment Govt. of India; Engineering and Physical Science Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors wish to acknowledge the Ministry of Social Justice and Empowerment Govt. of India for providing financial support under the National Overseas Fellowship (Grant No. 11015/22/2008-SCD-V) (MPR). The Engineering and Physical Science Research Council (EPSRC; www.epsrc.ac.uk) (EP/E036252/1, EP/E053556/1) (PCW) and European Union Framework VII SUNLIBB (SUNLIBB =Sustainable Liquid Biofuels from Biomass Biorefining, Project 251132, FP7-ENERGY-2009-BRAZIL; www.sunlibb.eu) programme are also acknowledged (PCW).	Badieyan S, 2012, BIOTECHNOL BIOENG, V109, P31, DOI 10.1002/bit.23280; Ben Slama R., 2012, African Journal of Biotechnology, V11, P12475; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bosch A, 2006, APPL MICROBIOL BIOT, V71, P736, DOI 10.1007/s00253-005-0202-8; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ge Y, 2007, INFECT IMMUN, V75, P3833, DOI 10.1128/IAI.00188-07; Ge Y, 2006, CELL MICROBIOL, V8, P1406, DOI 10.1111/j.1462-5822.2006.00720.x; Harvey J.R., 1972, United States Patent, Patent No. [3:658, 588., 3658588]; Hayashi H, 2003, J COLLOID INTERF SCI, V264, P565, DOI 10.1016/S0021-9797(03)00418-1; Hong Y, 2008, LANGMUIR, V24, P5003, DOI 10.1021/la703564q; Jun HS, 2007, J BACTERIOL, V189, P6806, DOI 10.1128/JB.00560-07; Karunakaran E, 2011, APPL MICROBIOL BIOT, V89, P1161, DOI 10.1007/s00253-010-2919-2; Kim C, 2006, COLLOID SURFACE B, V47, P153, DOI 10.1016/j.colsurfb.2005.12.009; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; KUDO H, 1987, CAN J MICROBIOL, V33, P267, DOI 10.1139/m87-045; Kwaszewska AK, 2006, POL J MICROBIOL, V55, P189; Lasch P., 2015, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A0117.PUB2; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Malburg LM, 1996, APPL ENVIRON MICROB, V62, P898, DOI 10.1128/AEM.62.3.898-906.1996; Malburg SRC, 1997, APPL ENVIRON MICROB, V63, P2449, DOI 10.1128/AEM.63.6.2449-2453.1997; Marshall KC., 1977, SOIL SCI, V123, P344, DOI [10.1097/00010694-197705000-00012, DOI 10.1097/00010694-197705000-00012]; Matheron C, 1996, CAN J MICROBIOL, V42, P1091, DOI 10.1139/m96-140; MCGAVIN MJ, 1989, J BACTERIOL, V171, P5587, DOI 10.1128/jb.171.10.5587-5595.1989; MORRIS EJ, 1987, J GEN MICROBIOL, V133, P1023; Morrison M, 2000, FEMS MICROBIOL LETT, V185, P109; Mukherjee J, 2012, BIOFOULING, V28, P1, DOI 10.1080/08927014.2011.639067; Nunomura K, 2005, MOL CELL PROTEOMICS, V4, P1968, DOI 10.1074/mcp.M500216-MCP200; Olsen MA, 2011, RANGIFER, V18, P55; Qi M, 2007, APPL ENVIRON MICROB, V73, P6098, DOI 10.1128/AEM.01037-07; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871; RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P191, DOI 10.1016/0927-7765(94)01164-Z; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Rosenberg M, 2006, FEMS MICROBIOL LETT, V262, P129, DOI 10.1111/j.1574-6968.2006.00291.x; Russell JB, 2009, FEMS MICROBIOL ECOL, V67, P183, DOI 10.1111/j.1574-6941.2008.00633.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sawano T, 2013, FEBS J, V280, P4463, DOI 10.1111/febs.12408; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; Shintate K, 2003, CARBOHYD RES, V338, P1981, DOI 10.1016/S0008-6215(03)00314-8; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; SONOHARA R, 1995, BIOPHYS CHEM, V55, P273, DOI 10.1016/0301-4622(95)00004-H; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Taherzadeh MJ, 2008, INT J MOL SCI, V9, P1621, DOI 10.3390/ijms9091621; Tahmourespour A, 2008, IRAN J BASIC MED SCI, V10, P251; Thomas S, 2004, CURR MICROBIOL, V48, P219, DOI 10.1007/s00284-003-4151-0; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Weimann A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-24; Weimer PJ, 2009, BIORESOURCE TECHNOL, V100, P5323, DOI 10.1016/j.biortech.2009.04.075; WEIMER PJ, 1991, APPL MICROBIOL BIOT, V36, P178, DOI 10.1007/BF00164416; Wells JE, 1996, J DAIRY SCI, V79, P1487, DOI 10.3168/jds.S0022-0302(96)76508-6; Wilson DB, 2009, CELLULOSE, V16, P723, DOI 10.1007/s10570-009-9326-9; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang LB, 2007, J IMMUNOL METHODS, V321, P80, DOI 10.1016/j.jim.2007.01.009	56	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141197	10.1371/journal.pone.0141197	http://dx.doi.org/10.1371/journal.pone.0141197			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492413	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000363249300034
J	Boelema, SR; Harakeh, Z; van Zandvoort, MJE; Reijneveld, SA; Verhulst, FC; Ormel, J; Vollebergh, WAM				Boelema, Sarai R.; Harakeh, Zeena; van Zandvoort, Martine J. E.; Reijneveld, Sijmen A.; Verhulst, Frank C.; Ormel, Johan; Vollebergh, Wilma A. M.			Adolescent Heavy Drinking Does Not Affect Maturation of Basic Executive Functioning: Longitudinal Findings from the TRAILS Study	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; ALCOHOL-USE DISORDERS; BRAIN-DEVELOPMENT; PREADOLESCENTS; BEHAVIOR; CHILDHOOD; ATTENTION; CHILDREN; GENDER; SAMPLE	Background and Aims Excessive alcohol use is assumed to affect maturation of cognitive functioning in adolescence. However, most existing studies that have tested this hypothesis are seriously flawed due to the use of selective groups and/or cross-sectional designs, which limits the ability to draw firm conclusions. This longitudinal study investigated whether patterns of alcohol use predicted differences in maturation of executive functioning in adolescence. Additionally, gender was tested as a possible moderator. Methods We used data from the Tracking Adolescents' Individual Lives Survey (TRAILS), which comprises a cohort of 2,230 Dutch adolescents. Maturation of executive functioning was measured by assessing the standardized improvement on each of four basic executive functions (i.e., inhibition, working memory, and shift-and sustained attention) between ages 11 and 19. Participants were assigned to one of six (heavy) drinking groups (i.e., non-drinkers, light drinkers, infrequent heavy drinkers, increased heavy drinkers, decreased heavy drinkers, and chronic heavy drinkers). We conducted linear regression analyses, and adjusted for relevant confounders. Results The six drinking groups did not reveal significant differences in maturation between drinking groups. E.g., maturation executive functioning of chronic heavy drinkers in comparison to non-drinkers; inhibition: B = -0.14, 95% CI [-0.41 to 0.14], working memory: B = -0.03, 95% CI [-0.26 to 0.21], shift attention: B = 0.13, 95% CI [-0.17 to 0.41], sustained attention: B = 0.12, 95% CI [-0.60 to 0.36]. Furthermore, gender was not found to be a significant moderator. Conclusions Four years of weekly heavy drinking (i.e., chronic heavy drinkers) did not result in measurable impairments in four basic executive functions. Thus, regular heavy drinking in adolescence does not seem to affect these basic behavioural measures of executive functioning.	[Boelema, Sarai R.; Harakeh, Zeena; Vollebergh, Wilma A. M.] Univ Utrecht, Fac Social & Behav Sci, Utrecht, Netherlands; [van Zandvoort, Martine J. E.] Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands; [Reijneveld, Sijmen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands; [Verhulst, Frank C.] Erasmus Univ, Med Ctr, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Ormel, Johan] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands	Utrecht University; Utrecht University; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Boelema, SR (corresponding author), Univ Utrecht, Fac Social & Behav Sci, Utrecht, Netherlands.	s.r.boelema@uu.nl	Vollebergh, Wilma A M/C-2323-2012; ormel, johan/AAC-5584-2019; Ormel, Johan/C-6094-2013	Vollebergh, Wilma A M/0000-0003-3532-3072; ormel, johan/0000-0002-5463-037X; Reijneveld, Sijmen/0000-0002-1206-7523	Netherlands Organization for Scientific Research NWO (Medical Research Council) [GB-MW 940-38-011]; Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant) [100-001-004]; Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants) [60-60600-97-118]; Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant) [261-98-710]; Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants) [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Netherlands Organization for Scientific Research NWO (Social Sciences Council) [GB-MaGW 452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant) [175.010.2003.005]; Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding) [481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]; Accare Center for Child and Adolescent Psychiatry	Netherlands Organization for Scientific Research NWO (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant); Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants); Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant); Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants); Netherlands Organization for Scientific Research NWO (Social Sciences Council)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant); Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding); Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL; Accare Center for Child and Adolescent Psychiatry	TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), the participating universities, and Accare Center for Child and Adolescent Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; Altink ME, 2009, EUR CHILD ADOLES PSY, V18, P465, DOI 10.1007/s00787-009-0001-3; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Best JR, 2009, DEV REV, V29, P180, DOI 10.1016/j.dr.2009.05.002; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Blankers M, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1448; Boelema SR, 2014, NEUROPSYCHOLOGY, V28, P177, DOI 10.1037/neu0000049; Brown SA, 2000, ALCOHOL CLIN EXP RES, V24, P164, DOI 10.1111/j.1530-0277.2000.tb04586.x; Brunnekreef JA, 2007, J CHILD PSYCHOL PSYC, V48, P185, DOI 10.1111/j.1469-7610.2006.01695.x; Caldwell LC, 2005, ALCOHOL ALCOHOLISM, V40, P194, DOI 10.1093/alcalc/agh134; Clark DB, 2008, ALCOHOL CLIN EXP RES, V32, P375, DOI 10.1111/j.1530-0277.2007.00601.x; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P825, DOI 10.1111/j.1467-7687.2009.00918.x; De Sonneville LMJ, 2002, J CLIN EXP NEUROPSYC, V24, P200, DOI 10.1076/jcen.24.2.200.989; de Sonneville LMJ, 1999, COMP PSYCH, V6, P187; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Ganzeboom HBG, 1996, SOC SCI RES, V25, P201, DOI 10.1006/ssre.1996.0010; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Hermens DF, 2013, CORTEX, V49, P3, DOI 10.1016/j.cortex.2012.05.021; Hingson RW, 2009, PEDIATRICS, V123, P1477, DOI 10.1542/peds.2008-2176; Huijbregts SCJ, 2003, NEUROPSYCHOLOGY, V17, P369, DOI 10.1037/0894-4105.17.3.369; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Koning IM, 2013, ADDICT BEHAV, V38, P2032, DOI 10.1016/j.addbeh.2012.12.013; Koning IM, 2010, J SUBST USE, V15, P166, DOI 10.3109/14659890903013091; Maurage P, 2012, CLIN NEUROPHYSIOL, V123, P892, DOI 10.1016/j.clinph.2011.09.018; Medina KL, 2007, NEUROTOXICOL TERATOL, V29, P141, DOI 10.1016/j.ntt.2006.10.010; MOSS HB, 1994, ALCOHOL CLIN EXP RES, V18, P159, DOI 10.1111/j.1530-0277.1994.tb00897.x; Ormel J, 2012, J AM ACAD CHILD PSY, V51, P1020, DOI 10.1016/j.jaac.2012.08.004; Rowbotham I, 2009, NEUROPSYCHOLOGY, V23, P50, DOI 10.1037/a0013927; Schweinsburg AD, 2010, ALCOHOL, V44, P111, DOI 10.1016/j.alcohol.2009.09.032; Squeglia LM, 2012, J STUD ALCOHOL DRUGS, V73, P749, DOI 10.15288/jsad.2012.73.749; Squeglia LM, 2011, ALCOHOL CLIN EXP RES, V35, P1831, DOI 10.1111/j.1530-0277.2011.01527.x; Squeglia LM, 2009, PSYCHOL ADDICT BEHAV, V23, P715, DOI 10.1037/a0016516; Stins JF, 2005, BEHAV GENET, V35, P407, DOI 10.1007/s10519-004-3875-3; Tapert SF, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00007; TARTER RE, 1995, DRUG ALCOHOL DEPEN, V39, P15, DOI 10.1016/0376-8716(95)01129-M; Tarter RE, 2003, AM J PSYCHIAT, V160, P1078, DOI 10.1176/appi.ajp.160.6.1078; Tsuchida A, 2013, CORTEX, V49, P1790, DOI 10.1016/j.cortex.2012.10.014; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Van Rijn S, 2009, SCHIZOPHR RES, V112, P91, DOI 10.1016/j.schres.2009.04.017; Veenstra R, 2005, DEV PSYCHOL, V41, P672, DOI 10.1037/0012-1649.41.4.672; Verdurmen J. E. E., 2012, JEUGD RISKANT GEDRAG; Weingardt KR, 1998, PSYCHOL ADDICT BEHAV, V12, P155, DOI 10.1037/0893-164X.12.3.155; Wetherill RR, 2013, PSYCHOPHARMACOLOGY, V230, P663, DOI 10.1007/s00213-013-3198-2; Wiers Reinout W, 2015, Curr Addict Rep, V2, P141	45	31	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139186	10.1371/journal.pone.0139186	http://dx.doi.org/10.1371/journal.pone.0139186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26489080	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400022
J	Cai, R; Wang, ZL; Yuan, YH; Liu, B; Wang, L; Yue, TL				Cai, Rui; Wang, Zhouli; Yuan, Yahong; Liu, Bin; Wang, Ling; Yue, Tianli			Detection of Alicyclobacillus spp. in Fruit Juice by Combination of Immunomagnetic Separation and a SYBR Green I Real-Time PCR Assay	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; APPLE JUICE; RAPID DETECTION; PROCESSING ENVIRONMENT; POULTRY MEAT; ACIDOTERRESTRIS; PRODUCTS; SAMPLES; QUANTIFICATION; IDENTIFICATION	An approach based on immunomagnetic separation (IMS) and SYBR Green I real-time PCR (real-time PCR) with species-specific primers and melting curve analysis was proposed as a rapid and effective method for detecting Alicyclobacillus spp. in fruit juices. Specific primers targeting the 16S rDNA sequences of Alicyclobacillus spp. were designed and then confirmed by the amplification of DNA extracted from standard strains and isolates. Spiked samples containing known amounts of target bacteria were used to obtain standard curves; the correlation coefficient was greater than 0.986 and the real-time PCR amplification efficiencies were 98.9%-101.8%. The detection limit of the testing system was 2.8x10(1) CFU/mL. The coefficient of variation for intra-assay and inter-assay variability were all within the acceptable limit of 5%. Besides, the performance of the IMS-real-time PCR assay was further investigated by detecting naturally contaminated kiwi fruit juice; the sensitivity, specificity and accuracy were 91.7%, 95.9% and 95.3%, respectively. The established IMS-real-time PCR procedure provides a new method for identification and quantitative detection of Alicyclobacillus spp. in fruit juice.	[Cai, Rui; Wang, Zhouli; Yuan, Yahong; Liu, Bin; Wang, Ling; Yue, Tianli] Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Wang, ZL (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China.	wzl1014@nwsuaf.edu.cn; yuetl305@nwsuaf.edu.cn	Cai, Rui/GRO-1869-2022; yue, tianli/AEY-3384-2022	yue, tianli/0000-0002-4768-5831	Science and Technology Research and Development Program of Shaanxi Province, China [2015SF278, 2014K13-15]; Northwest AF University [Z109021503, A213021401]; National Natural Science Foundation of China [31501499]; Basic Research Program of Science and Technology [2013FY113400]	Science and Technology Research and Development Program of Shaanxi Province, China; Northwest AF University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Program of Science and Technology	The research was supported by Science and Technology Research and Development Program of Shaanxi Province, China (2015SF278, 2014K13-15); Scientific research start-up funding of Northwest A&F University (Z109021503, A213021401); National Natural Science Foundation of China (31501499); Basic Research Program of Science and Technology (2013FY113400).	Agrimonti C, 2013, FOOD ANAL METHOD, V6, P1004, DOI 10.1007/s12161-013-9583-y; Bahceci KS, 2003, EUR FOOD RES TECHNOL, V217, P249, DOI 10.1007/s00217-003-0750-z; Bennett AR, 1996, LETT APPL MICROBIOL, V22, P237, DOI 10.1111/j.1472-765X.1996.tb01151.x; Bustin S., 2005, ENCY DIAGNOSTIC GENO, V10, P1117; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Concina I, 2010, FOOD RES INT, V43, P2108, DOI 10.1016/j.foodres.2010.07.012; Connor CJ, 2005, INT J FOOD MICROBIOL, V99, P229, DOI 10.1016/j.ijfoodmicro.2004.08.016; Danyluk MD, 2011, FOOD MICROBIOL, V28, P472, DOI 10.1016/j.fm.2010.10.008; Durak MZ, 2010, INT J FOOD MICROBIOL, V142, P286, DOI 10.1016/j.ijfoodmicro.2010.07.003; Fontaine M, 2003, J MICROBIOL METH, V54, P29, DOI 10.1016/S0167-7012(03)00005-8; Grasso EM, 2009, J AGR FOOD CHEM, V57, P10670, DOI 10.1021/jf902371j; Groenewald WH, 2009, FOOD MICROBIOL, V26, P71, DOI 10.1016/j.fm.2008.07.008; Henczka M, 2013, J MICROBIOL METH, V92, P1, DOI 10.1016/j.mimet.2012.10.007; Islam A, 2004, J VIROL METHODS, V119, P103, DOI 10.1016/j.jviromet.2004.03.006; Kumar JS, 2014, MOL CELL PROBE, V28, P221, DOI 10.1016/j.mcp.2014.03.005; Li JK, 2013, FOOD CONTROL, V30, P251, DOI 10.1016/j.foodcont.2012.07.009; McKnight IC, 2010, FOOD MICROBIOL, V27, P1016, DOI 10.1016/j.fm.2010.06.010; Nam HM, 2005, FOODBORNE PATHOG DIS, V2, P160, DOI 10.1089/fpd.2005.2.160; Patel P, 2000, J RAPID METH AUT MIC, V8, P227, DOI 10.1111/j.1745-4581.2000.tb00326.x; Santhosh SR, 2007, J VIROL METHODS, V143, P73, DOI 10.1016/j.jviromet.2007.02.011; Shields MJ, 2012, J FOOD PROTECT, V75, P1243, DOI 10.4315/0362-028X.JFP-12-048; Smit Y, 2011, FOOD MICROBIOL, V28, P331, DOI 10.1016/j.fm.2010.11.008; Soares S, 2013, MEAT SCI, V94, P115, DOI 10.1016/j.meatsci.2012.12.012; Spanova A, 2003, J CHROMATOGR A, V1009, P215, DOI 10.1016/S0021-9673(03)00431-X; Steyn CE, 2011, INT J FOOD MICROBIOL, V147, P1, DOI 10.1016/j.ijfoodmicro.2011.03.004; Wang Y, 2010, J FOOD PROTECT, V73, P390, DOI 10.4315/0362-028X-73.2.390; Wang ZL, 2014, INT J FOOD MICROBIOL, V175, P30, DOI 10.1016/j.ijfoodmicro.2014.01.015; Wang ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082376; Wang ZL, 2013, FOOD RES INT, V54, P302, DOI 10.1016/j.foodres.2013.07.021; Wang ZL, 2013, INT J FOOD MICROBIOL, V166, P28, DOI 10.1016/j.ijfoodmicro.2013.06.015; Yang H, 2007, INT J FOOD MICROBIOL, V118, P132, DOI 10.1016/j.ijfoodmicro.2007.06.019; Yang ZY, 2010, J AGR FOOD CHEM, V58, P7135, DOI 10.1021/jf1009654; Yao L, 2009, LETT APPL MICROBIOL, V49, P173, DOI 10.1111/j.1472-765X.2009.02638.x; Yue TL, 2014, COMPR REV FOOD SCI F, V13, P771, DOI 10.1111/1541-4337.12093; Yue TianLi, 2013, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V44, P187; Zhang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067704	36	8	8	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141049	10.1371/journal.pone.0141049	http://dx.doi.org/10.1371/journal.pone.0141049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488469	gold, Green Submitted, Green Published			2022-12-27	WOS:000363248400098
J	Granic, A; Davies, K; Adamson, A; Kirkwood, T; Hill, TR; Siervo, M; Mathers, JC; Jagger, C				Granic, Antoneta; Davies, Karen; Adamson, Ashley; Kirkwood, Thomas; Hill, Tom R.; Siervo, Mario; Mathers, John C.; Jagger, Carol			Dietary Patterns and Socioeconomic Status in the Very Old: The Newcastle 85+Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CLUSTER-ANALYSIS; CARDIOVASCULAR-DISEASE; BRITISH ADULTS; HEALTHY DIET; LIFE-STYLE; QUALITY; RISK; DETERMINANTS; COHORT	Background Dietary patterns (DP) are associated with health outcomes in younger adults but there is a lack of evidence in the very old (aged 85+) on DP and their association with sociodemographic factors, lifestyle, health and functioning measures. Higher socioeconomic status (SES) has been linked with healthier DP but it is not known whether these associations are sustained in the very old. Objective We aimed to (a) characterise DP in the very old and (b) assess the relationships between three SES indicators (education, occupational class and area-deprivation index [IMD]) and DP. Methods Complete dietary data at baseline (2006/07) for 793 participants in the Newcastle 85+ Study were established through 24-hr multiple pass recall. We used Two-Step clustering and 30 food groups to derive DP, and multinomial logistic regression models to assess the association with SES. Results We identified three distinct DP (characterised as 'High Red Meat', 'Low Meat', and 'High Butter') that varied with key sociodemographic, health and functioning measures. 'Low Meat' participants were more advantaged (i.e. higher education and occupational class, and lived in more affluent areas in owned homes), were least disabled, cognitively impaired, and depressed, and were more physically active than those in the other DP. After adjusting for other lifestyle factors, cognitive status and BMI, lower educational attainment remained a significant predictor of 'High Red Meat' and 'High Butter' membership compared with 'Low Meat' ('High Red Meat': OR [95% CI] for 0-9 and 10-11 years of education vs. >= 12 years: 5.28 [2.85-9.79], p<0.001 and 3.27 [1.65-6.51], p = 0.001, respectively; 'High Butter': 3.32 [1.89-5.82], p<0.001 and 2.83 [1.52-5.28], p = 0.001). Conclusions In this cohort of very old adults, we detected a favourable DP ('Low Meat'), which was associated with better health and functioning and higher SES.	[Granic, Antoneta; Davies, Karen; Adamson, Ashley; Kirkwood, Thomas; Siervo, Mario; Mathers, John C.; Jagger, Carol] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Granic, Antoneta; Davies, Karen; Adamson, Ashley; Jagger, Carol] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adamson, Ashley; Hill, Tom R.; Siervo, Mario; Mathers, John C.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kirkwood, Thomas] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hill, Tom R.] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Siervo, Mario; Mathers, John C.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Granic, A (corresponding author), Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	antoneta.granic@newcastle.ac.uk	Siervo, Mario/AAB-9302-2019	Granic, Antoneta/0000-0001-9247-899X; Davies, Karen/0000-0002-2820-9397; Siervo, Mario/0000-0001-5515-0944; Mathers, John/0000-0003-3406-3002; Jagger, Carol/0000-0002-6377-9926; Adamson, Ashley/0000-0003-3735-2846	National Institute for Health Research Newcastle Biomedical Research Centre based at Newcastle Hospitals Foundation Trust and Newcastle University; AXA Carol Jagger Chair of Epidemiology of Ageing; Medical Research Council; Biotechnology and Biological Sciences Research Council; Dunhill Medical Trust; British Heart Foundation; Unilever Corporate Research; Newcastle University; North of England Commissioning Support Unit; National Institute for Health Research Newcastle Biomedical Research Centre, based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University; Medical Research Council [G0500997, MR/K006312/1, MR/K02325X/1B, MR/J50001X/1, MR/L016354/1, G0700718, G0700718B] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-001] Funding Source: researchfish; MRC [G0700718, G0500997, MR/L016354/1, MR/K006312/1, MR/J50001X/1] Funding Source: UKRI	National Institute for Health Research Newcastle Biomedical Research Centre based at Newcastle Hospitals Foundation Trust and Newcastle University; AXA Carol Jagger Chair of Epidemiology of Ageing(AXA Research Fund); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dunhill Medical Trust(Dunhill Medical Trust); British Heart Foundation(British Heart Foundation); Unilever Corporate Research(Unilever); Newcastle University; North of England Commissioning Support Unit; National Institute for Health Research Newcastle Biomedical Research Centre, based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study has been funded by the National Institute for Health Research Newcastle Biomedical Research Centre based at Newcastle Hospitals Foundation Trust and Newcastle University and AXA Carol Jagger Chair of Epidemiology of Ageing (AG). The Newcastle 85+ Study has been funded by the Medical Research Council, Biotechnology and Biological Sciences Research Council and the Dunhill Medical Trust. Parts of the work have also been funded by the British Heart Foundation, Unilever Corporate Research, Newcastle University and the North of England Commissioning Support Unit (formerly NHS North of Tyne). The research was also supported by the National Institute for Health Research Newcastle Biomedical Research Centre, based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The views expressed are those of the authors and not necessarily those of the National Health Service, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AJ, 2009, EUR J CLIN NUTR, V63, pS6, DOI 10.1038/ejcn.2008.60; Anderson AL, 2011, J AM DIET ASSOC, V111, P84, DOI 10.1016/j.jada.2010.10.012; Atkins JL, 2014, J NUTR, V144, P673, DOI 10.3945/jn.113.186486; Bacher J., 2004, LEHRSTUHL SOZIOLOGIE, P3; Bamia C, 2005, BRIT J NUTR, V94, P100, DOI 10.1079/BJN20051456; Beckmann M, 2013, P NUTR SOC, V72, P352, DOI 10.1017/S0029665113001237; Celis-Morales C, 2015, P NUTR SOC, V74, P130, DOI 10.1017/S0029665114001633; Chandola T, 2000, J PUBLIC HEALTH MED, V22, P182, DOI 10.1093/pubmed/22.2.182; Chiu T., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P263, DOI 10.1145/502512.502549; Collerton Joanna, 2007, BMC Geriatr, V7, P14, DOI 10.1186/1471-2318-7-14; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Conklin AI, 2014, SOC SCI MED, V100, P167, DOI 10.1016/j.socscimed.2013.08.018; Deierlein AL, 2014, J ACAD NUTR DIET, V114, P279, DOI 10.1016/j.jand.2013.09.002; Devlin UM, 2012, P NUTR SOC, V71, P599, DOI 10.1017/S0029665112000729; Dupre ME, 2007, J HEALTH SOC BEHAV, V48, P1, DOI 10.1177/002214650704800101; Dynesen AW, 2003, EUR J CLIN NUTR, V57, P1586, DOI 10.1038/sj.ejcn.1601728; Everitt B, 2001, CLUSTERING ANAL; Finger JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078390; Food Standards Agency, 2002, MCCANCE WIDD COMP FO; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Gu Y, 2011, CURR ALZHEIMER RES, V8, P510, DOI 10.2174/156720511796391836; Hiza HAB, 2013, J ACAD NUTR DIET, V113, P297, DOI 10.1016/j.jand.2012.08.011; Hsiao PY, 2013, J NUTR HEALTH AGING, V17, P19, DOI 10.1007/s12603-012-0082-4; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Jankovic N, 2014, AM J EPIDEMIOL, V180, P978, DOI 10.1093/aje/kwu229; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Lallukka T, 2007, EUR J CLIN NUTR, V61, P701, DOI 10.1038/sj.ejcn.1602583; Lara J, 2014, MATURITAS, V79, P292, DOI 10.1016/j.maturitas.2014.07.003; Larrieu S, 2014, J NUTR HEALTH AGING, V8, P497; Larsson SC, 2014, NEUROLOGY, V83, P1699, DOI 10.1212/WNL.0000000000000954; Leite MLC, 2003, EUR J CLIN NUTR, V57, P1514, DOI 10.1038/sj.ejcn.1601719; Lloyd, 2004, ENGLISH INDICES DEPR; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; Mirowsky J, 1998, RES AGING, V20, P415, DOI 10.1177/0164027598204003; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Mullie P, 2010, EUR J CLIN NUTR, V64, P231, DOI 10.1038/ejcn.2009.145; Nelson M, 1997, PHOTOGRAPHIC ATLAS F; Nelson M, 2007, LOW INCOME DIET NUTR, V3, P38; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Payette H, 2005, CAN J PUBLIC HEALTH, V96, pS27, DOI 10.1007/BF03405198; Penn L, 2010, GENES NUTR, V5, P205, DOI 10.1007/s12263-010-0175-9; Pryer JA, 2001, PUBLIC HEALTH NUTR, V4, P787, DOI 10.1079/PHN200098; Reedy J, 2014, J NUTR, V144, P881, DOI 10.3945/jn.113.189407; Reynolds JR, 1998, SOC PROBL, V45, P221, DOI 10.1525/sp.1998.45.2.03x0167k; Romesburg HC, 2004, CLUSTERING ANAL RES; Shahar D, 2005, NUTRITION, V21, P559, DOI 10.1016/j.nut.2004.09.018; Shatenstein B, 2013, J NUTR HEALTH AGING, V17, P419, DOI 10.1007/s12603-012-0436-y; Siervo M, 2015, BRIT J NUTR, V113, P1, DOI 10.1017/S0007114514003341; Slattery ML, 2010, APPL PHYSIOL NUTR ME, V35, P207, DOI 10.1139/H10-006; Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169; Tangney CC, 2014, NEUROLOGY, V83, P1410, DOI 10.1212/WNL.0000000000000884; Turrell G, 2001, PUBLIC HEALTH NUTR, V6, P191; Willcox DC, 2014, MECH AGEING DEV, V136, P148, DOI 10.1016/j.mad.2014.01.002	54	17	18	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139713	10.1371/journal.pone.0139713	http://dx.doi.org/10.1371/journal.pone.0139713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488497	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400035
J	Hammerstrom, TG; Beabout, K; Clements, TP; Saxer, G; Shamoo, Y				Hammerstrom, Troy G.; Beabout, Kathryn; Clements, Thomas P.; Saxer, Gerda; Shamoo, Yousif			Acinetobacter baumannii Repeatedly Evolves a Hypermutator Phenotype in Response to Tigecycline That Effectively Surveys Evolutionary Trajectories to Resistance	PLOS ONE			English	Article							RIBOSOMAL S10 PROTEIN; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; EFFLUX PUMP; DECREASED SUSCEPTIBILITY; ADAPTIVE EVOLUTION; CYSTIC-FIBROSIS; MUTATION-RATES; ADEABC; GENE	The evolution of hypermutators in response to antibiotic treatment in both clinical and laboratory settings provides a unique context for the study of adaptive evolution. With increased mutation rates, the number of hitchhiker mutations within an evolving hypermutator population is remarkably high and presents substantial challenges in determining which mutations are adaptive. Intriguingly however, hypermutators also provide an opportunity to explore deeply the accessible evolutionary trajectories that lead to increased organism fitness, in this case the evolution of antibiotic resistance to the clinically relevant antibiotic tigecycline by the hospital pathogen Acinetobacter baumannii. Using a continuous culture system, AB210M, a clinically derived strain of A. baumannii, was evolved to tigecycline resistance. Analysis of the adapted populations showed that nearly all the successful lineages became hypermutators via movement of a mobile element to inactivate mutS. In addition, metagenomic analysis of population samples revealed another 896 mutations that occurred at a frequency greater than 5% in the population, while 38 phenotypically distinct individual colonies harbored a total of 1712 mutations. These mutations were scattered throughout the genome and affected similar to 40% of the coding sequences. The most highly mutated gene was adeS, a known tigecycline-resistance gene; however, adeS was not solely responsible for the high level of TGC resistance. Sixteen other genes stood out as potentially relevant to increased resistance. The five most prominent candidate genes (adeS, rpsJ, rrf, msbA, and gna) consistently re-emerged in subsequent replicate population studies suggesting they are likely to play a role in adaptation to tigecycline. Interestingly, the repeated evolution of a hypermutator phenotype in response to antibiotic stress illustrates not only a highly adaptive strategy to resistance, but also a remarkably efficient survey of successful evolutionary trajectories.	[Hammerstrom, Troy G.; Beabout, Kathryn; Clements, Thomas P.; Saxer, Gerda; Shamoo, Yousif] Rice Univ, Dept Biosci, Houston, TX 77005 USA	Rice University	Shamoo, Y (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77005 USA.	shamoo@rice.edu	Clements, Thomas/AAP-5818-2020; Beabout, Kathryn/J-9175-2015; Hegde, Nagendra/J-5920-2014	Clements, Thomas/0000-0003-3480-9214; Beabout, Kathryn/0000-0003-2353-9685; Hegde, Nagendra/0000-0001-5260-2159; Shamoo, Yousif/0000-0001-9241-8962	Defense Threat Reduction Agency [HDTRA-1-10-1-0069]; National Institutes of Health [R01AI080714]; National Institute of General Medical Sciences of the National Institutes of Health [F31GM108402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM108402] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the Defense Threat Reduction Agency (HDTRA-1-10-1-0069) to YS and the National Institutes of Health (R01AI080714) to YS. KRB was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number F31GM108402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin IM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-158; Aranda J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-279; Baquero MR, 2004, J BACTERIOL, V186, P5538, DOI 10.1128/JB.186.16.5538-5542.2004; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beabout K, 2015, MOL BIOL EVOL, V32, P2585, DOI 10.1093/molbev/msv133; Beabout K, 2015, ANTIMICROB AGENTS CH, V59, P5561, DOI 10.1128/AAC.00547-15; Cattoir V, 2015, ANTIMICROB AGENTS CH, V59, P239, DOI 10.1128/AAC.04174-14; CDC, 2013, ANTIBIOTIC RESISTANC; Chen CC, 2011, J BACTERIOL, V193, P2361, DOI 10.1128/JB.00244-11; Chen Q, 2014, J ANTIMICROB CHEMOTH, V69, P72, DOI 10.1093/jac/dkt319; Chopra I, 2003, DRUG RESIST UPDATE, V6, P137, DOI 10.1016/S1368-7646(03)00041-4; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Deatherage DE, 2014, METHODS MOL BIOL, V1151, P165, DOI 10.1007/978-1-4939-0554-6_12; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Geisinger E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004691; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Hornsey M, 2011, J ANTIMICROB CHEMOTH, V66, P1499, DOI 10.1093/jac/dkr168; Hornsey M, 2010, J ANTIMICROB CHEMOTH, V65, P1589, DOI 10.1093/jac/dkq218; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hu M, 2005, ANTIMICROB AGENTS CH, V49, P4327, DOI 10.1128/AAC.49.10.4327-4334.2005; Ishino T, 2000, GENES CELLS, V5, P953, DOI 10.1046/j.1365-2443.2000.00382.x; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; Kenyon JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062160; King G, 2012, CRIT REV BIOCHEM MOL, V47, P75, DOI 10.3109/10409238.2011.636505; LABIGNEROUSSEL A, 1983, MOL GEN GENET, V189, P102, DOI 10.1007/BF00326061; Lang GI, 2014, GENOMICS, V104, P412, DOI 10.1016/j.ygeno.2014.09.011; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Marchand I, 2004, ANTIMICROB AGENTS CH, V48, P3298, DOI 10.1128/AAC.48.9.3298-3304.2004; Marvig RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003741; Miller C, 2013, ANTIMICROB AGENTS CH, V57, P5373, DOI 10.1128/AAC.01473-13; Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625; Navon-Venezia S, 2007, J ANTIMICROB CHEMOTH, V59, P772, DOI 10.1093/jac/dkm018; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oliver A, 2010, CLIN MICROBIOL INFEC, V16, P798, DOI 10.1111/j.1469-0691.2010.03250.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Rosenfeld N, 2012, ANTIMICROB AGENTS CH, V56, P2504, DOI 10.1128/AAC.06422-11; Ruzin A, 2007, J ANTIMICROB CHEMOTH, V59, P1001, DOI 10.1093/jac/dkm058; Saxer G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004872; Saxer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014184; Shilling RA, 2006, TRENDS PHARMACOL SCI, V27, P195, DOI 10.1016/j.tips.2006.02.008; Sun JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049534; Sun JR, 2010, ANTIMICROB AGENTS CH, V54, P4934, DOI 10.1128/AAC.00414-10; Villa L, 2014, ANTIMICROB AGENTS CH, V58, P1707, DOI 10.1128/AAC.01803-13; Vivanco-Dominguez S, 2012, J MOL BIOL, V417, P425, DOI 10.1016/j.jmb.2012.02.008; Walkiewicz K, 2012, P NATL ACAD SCI USA, V109, P21408, DOI 10.1073/pnas.1209335110; Weigand MR, 2012, P NATL ACAD SCI USA, V109, P13680, DOI 10.1073/pnas.1205357109; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Yoon E-J, 2015, MBIO, P6, DOI [10.1128/rnBic.G030S-15, DOI 10.1128/RNBIC.G030S-15]; Yoon EJ, 2013, ANTIMICROB AGENTS CH, V57, P2989, DOI 10.1128/AAC.02556-12	60	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140489	10.1371/journal.pone.0140489	http://dx.doi.org/10.1371/journal.pone.0140489			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488727	Green Published, gold			2022-12-27	WOS:000363248400055
J	Southwell, C; Emmerson, L; McKinlay, J; Newbery, K; Takahashi, A; Kato, A; Barbraud, C; DeLord, K; Weimerskirch, H				Southwell, Colin; Emmerson, Louise; McKinlay, John; Newbery, Kym; Takahashi, Akinori; Kato, Akiko; Barbraud, Christophe; DeLord, Karine; Weimerskirch, Henri			Spatially Extensive Standardized Surveys Reveal Widespread, Multi-Decadal Increase in East Antarctic Adelie Penguin Populations	PLOS ONE			English	Article							SEA-ICE EXTENT; SOUTHERN-OCEAN; PYGOSCELIS PENGUINS; AD,LIE PENGUINS; WHALING RECORDS; PACIFIC SECTOR; HOLM BAY; CLIMATE; TRENDS; VARIABILITY	Seabirds are considered to be useful and practical indicators of the state of marine ecosystems because they integrate across changes in the lower trophic levels and the physical environment. Signals from this key group of species can indicate broad scale impacts or response to environmental change. Recent studies of penguin populations, the most commonly abundant Antarctic seabirds in the west Antarctic Peninsula and western Ross Sea, have demonstrated that physical changes in Antarctic marine environments have profound effects on biota at high trophic levels. Large populations of the circumpolar-breeding Adelie penguin occur in East Antarctica, but direct, standardized population data across much of this vast coastline have been more limited than in other Antarctic regions. We combine extensive new population survey data, new population estimation methods, and re-interpreted historical survey data to assess decadal-scale change in East Antarctic Adelie penguin breeding populations. We show that, in contrast to the west Antarctic Peninsula and western Ross Sea where breeding populations have decreased or shown variable trends over the last 30 years, East Antarctic regional populations have almost doubled in abundance since the 1980's and have been increasing since the earliest counts in the 1960's. The population changes are associated with five-year lagged changes in the physical environment, suggesting that the changing environment impacts primarily on the pre-breeding age classes. East Antarctic marine ecosystems have been subject to a number of changes over the last 50 years which may have influenced Adelie penguin population growth, including decadal-scale climate variation, an inferred mid-20th century sea-ice contraction, and early-to-mid 20th century exploitation of fish and whale populations.	[Southwell, Colin; Emmerson, Louise; McKinlay, John; Newbery, Kym] Australian Antarctic Div, Dept Environm, Kingston, Tas, Australia; [Takahashi, Akinori; Kato, Akiko] Natl Inst Polar Res, Tachikawa, Tokyo, Japan; [Barbraud, Christophe; DeLord, Karine; Weimerskirch, Henri] Univ La Rochelle, CNRS, UMR7372, Ctr Etud Biol Chize, Villiers En Bois, France	Australian Antarctic Division; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Southwell, C (corresponding author), Australian Antarctic Div, Dept Environm, Kingston, Tas, Australia.	colin.southwell@aad.gov.au	Weimerskirch, Henri/F-5562-2013; Barbraud, Christophe/A-5870-2012; Weimerskirch, Henri/K-7306-2019; Kato, Akiko/W-2447-2019	Barbraud, Christophe/0000-0003-0146-212X; Weimerskirch, Henri/0000-0002-0457-586X; Kato, Akiko/0000-0002-8947-3634; McKinlay, John/0000-0003-4858-2604	Australian Antarctic Science projects [2722, 4087, 4088]; Japanese Antarctic Research Expeditions programs [AMB1, AP12]; Institut Paul Emile Victor (IPEV); Zone Atelier Antarctique (CNRS-INEE); Terres Australes et Antarctiques Francaises	Australian Antarctic Science projects; Japanese Antarctic Research Expeditions programs; Institut Paul Emile Victor (IPEV); Zone Atelier Antarctique (CNRS-INEE); Terres Australes et Antarctiques Francaises	The work was carried out under funding to (i) Australian Antarctic Science projects 2722, 4087 and 4088, (ii) Japanese Antarctic Research Expeditions programs AMB1 and AP12, and (iii) Institut Paul Emile Victor (IPEV), Zone Atelier Antarctique (CNRS-INEE), and Terres Australes et Antarctiques Francaises. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley S, 2003, POLAR RES, V22, P19, DOI 10.1111/j.1751-8369.2003.tb00091.x; Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Ainley DG, 2009, FISH FISH, V10, P13, DOI 10.1111/j.1467-2979.2008.00293.x; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001739; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Barbraud C, 2011, ANTARCT SCI, V23, P461, DOI 10.1017/S0954102011000356; Branch T. A., 2011, Journal of Cetacean Research and Management, P53; Bricher PK, 2008, POLAR BIOL, V31, P1397, DOI 10.1007/s00300-008-0479-z; CHAPPELL MA, 1990, OECOLOGIA, V83, P420, DOI 10.1007/BF00317570; Cotte C, 2007, DEEP-SEA RES PT I, V54, P243, DOI 10.1016/j.dsr.2006.11.001; Curran MAJ, 2003, SCIENCE, V302, P1203, DOI 10.1126/science.1087888; de la Mare WK, 2009, CLIMATIC CHANGE, V92, P461, DOI 10.1007/s10584-008-9473-2; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Dugger KM, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00068; Dugger KM, 2010, P NATL ACAD SCI USA, V107, P12375, DOI 10.1073/pnas.1000623107; Emmerson L, 2008, ECOLOGY, V89, P2096, DOI 10.1890/08-0011.1; Emmerson L, 2011, OECOLOGIA, V167, P951, DOI 10.1007/s00442-011-2044-7; Forcada J, 2005, ECOLOGY, V86, P2408, DOI 10.1890/04-1153; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Fretwell PT, 2009, GLOBAL ECOL BIOGEOGR, V18, P543, DOI 10.1111/j.1466-8238.2009.00467.x; Hinke JT, 2007, OECOLOGIA, V153, P845, DOI 10.1007/s00442-007-0781-4; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Jenouvrier S, 2006, POLAR BIOL, V29, P413, DOI 10.1007/s00300-005-0073-6; Kato A, 2002, POLAR BIOL, V25, P934, DOI 10.1007/s00300-002-0434-3; Kato A, 2009, POLAR BIOL, V32, P181, DOI 10.1007/s00300-008-0518-9; Kato Akiko, 2006, Polar Bioscience, P55; Kock KH, 2007, ANTARCT SCI, V19, P231, DOI 10.1017/S0954102007000302; LaRue MA, 2014, POLAR BIOL, V37, P507, DOI 10.1007/s00300-014-1451-8; LaRue MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060568; LaRue MA, 2011, POLAR BIOL, V34, P1727, DOI 10.1007/s00300-011-1023-0; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Lynch HJ, 2014, AUK, V131, P457, DOI 10.1642/AUK-14-31.1; Lynch HJ, 2009, CCAMLR SCI, V16, P149; Lynch HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113301; Lynch HJ, 2012, ECOLOGY, V93, P1367; Lyver PO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091188; Massom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064756; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; McKinlay J, 2010, CCAMLR SCI, V17, P213; Millar CD, 2012, INTEGR ZOOL, V7, P113, DOI 10.1111/j.1749-4877.2012.00288.x; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Murphy EJ, 2007, P ROY SOC B-BIOL SCI, V274, P3057, DOI 10.1098/rspb.2007.1180; Parkinson CL, 2004, ANTARCT SCI, V16, P387, DOI 10.1017/S0954102004002214; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; Robertson G, 2014, POLAR BIOL, V37, P251, DOI 10.1007/s00300-013-1428-z; Sailley SF, 2013, MAR ECOL PROG SER, V492, P253, DOI 10.3354/meps10534; Schwaller MR, 2013, REMOTE SENS ENVIRON, V139, P353, DOI 10.1016/j.rse.2013.08.009; Sinclair KE, 2014, GEOPHYS RES LETT, V41, P3510, DOI 10.1002/2014GL059821; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Southwell C, 2010, CCAMLR SCI, V17, P229; Southwell C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123540; Southwell C, 2015, J NAT CONSERV, V23, P1, DOI 10.1016/j.jnc.2014.11.002; Southwell C, 2013, POLAR BIOL, V36, P843, DOI 10.1007/s00300-013-1310-z; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Stonehouse B, 1965, NEW SCIENTIST, V29, P273; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Vaughan Stephen, 2000, Polar Record, V36, P345; Weimerskirch H, 2003, ANTARCT SCI, V15, P249, DOI 10.1017/S0954102003001202; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301; Woehler E., 2001, STAT ASSESSMENT STAT	64	36	36	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139877	10.1371/journal.pone.0139877	http://dx.doi.org/10.1371/journal.pone.0139877			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488299	Green Published, gold			2022-12-27	WOS:000363248400042
J	Bevilacqua, A; Mischitelli, M; Pietropaolo, V; Ciuffreda, E; Sinigaglia, M; Corbo, MR				Bevilacqua, Antonio; Mischitelli, Monica; Pietropaolo, Valeria; Ciuffreda, Emanuela; Sinigaglia, Milena; Corbo, Maria Rosaria			Genotypic and Phenotypic Heterogeneity in Alicyclobacillus acidoterrestris: A Contribution to Species Characterization	PLOS ONE			English	Article							FRUIT PROCESSING ENVIRONMENT; SP-NOV.; BACILLUS-ACIDOTERRESTRIS; GENUS ALICYCLOBACILLUS; RAPID IDENTIFICATION; ACIDIC BEVERAGES; JUICE; SOIL; GENOMOVAR; SEQUENCE	Alicyclobacillus acidoterrestris is the main cause of most spoilage problems in fruit juices and acidic products. Since soil borne species often contaminate fruit juices and do not need strict extreme requirements for survival, it is a great concern to investigate whether and how soil species could evolve from their ecological niches in microbial community to new environments as fruit juices. In this study, 23 isolates of thermo-acidophilic, spore-forming bacteria from soil were characterized by cultural and molecular methods. In addition, 2 strains isolated from a spoilage incident in pear juice were typed. Strains phenotyping showed that they could be grouped into 3 different clusters, and some isolates showed identical or quite similar patterns. Analyzing pH and temperature ranges for growth, the majority of strains were able to grow at values described for many species of Alicyclobacillus. Qualitative utilization of lysine, arginine and indole production from tryptophan revealed, for the first time, deamination of lysine and decarboxylation of arginine. Resistance to 5% NaCl as well as the ability to hydrolyze starch and gelatin, nitrate reduction, catalase and oxidase activities confirmed literature evidences. Examining of 16S rRNA, showed that isolates were divided into three blocks represented by effectively soil species and strains that are moving from soil to other possible growing source characterized by parameters that could strongly influence bacterial survival. RAPD PCR technique evidenced a great variability in banding patterns and, although it was not possible to obtain genotypically well-distinguished groups, it was feasible to appreciate genetic similarity between some strains. In conclusion, the investigation of a microbial community entails a combination of metagenomic and classic culturedependent approaches to expand our knowledge about Alicyclobacillus and to look for new subspecies.	[Bevilacqua, Antonio; Ciuffreda, Emanuela; Sinigaglia, Milena; Corbo, Maria Rosaria] Univ Foggia, Dept Sci Agr Food & Environm SAFE, I-71122 Foggia, Italy; [Mischitelli, Monica; Pietropaolo, Valeria] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy	University of Foggia; Sapienza University Rome	Corbo, MR (corresponding author), Univ Foggia, Dept Sci Agr Food & Environm SAFE, Via Napoli 25, I-71122 Foggia, Italy.	mariarosaria.corbo@unifg.it	Pietropaolo, Valeria/J-8339-2018	Pietropaolo, Valeria/0000-0001-5723-8886; Bevilacqua, Antonio/0000-0002-2118-9186				Albuquerque L, 2000, INT J SYST EVOL MICR, V50, P451, DOI 10.1099/00207713-50-2-451; Baumgart J., 1997, Fluessiges Obst, V64, P178; Bevilacqua A, 2008, INT J FOOD MICROBIOL, V125, P103, DOI 10.1016/j.ijfoodmicro.2008.02.030; Bevilacqua A, 2012, STRESS RESPONSE FOOD, P175; Bevilacqua A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00195; Bevilacqua A, 2011, J FOOD SCI, V76, pM130, DOI 10.1111/j.1750-3841.2010.02032.x; CERNY G, 1984, Z LEBENSM UNTERS FOR, V179, P224, DOI 10.1007/BF01041898; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; DEINHARD G, 1987, SYST APPL MICROBIOL, V10, P47, DOI 10.1016/S0723-2020(87)80009-7; Funes-Huacca M, 2004, ELECTROPHORESIS, V25, P3860, DOI 10.1002/elps.200406105; Goto K, 2008, LETT APPL MICROBIOL, V46, P289, DOI 10.1111/j.1472-765X.2007.02307.x; Goto K, 2002, J GEN APPL MICROBIOL, V48, P243, DOI 10.2323/jgam.48.243; Goto K., 2007, ALICYCLOBACILLUS THE, P9, DOI [10.1007/978-4-431-69850-0_3, DOI 10.1007/978-4-431-69850-0_3]; Goto K, 2007, INT J SYST EVOL MICR, V57, P1276, DOI 10.1099/ijs.0.64692-0; Groenewald WH, 2009, FOOD MICROBIOL, V26, P71, DOI 10.1016/j.fm.2008.07.008; Guo X, 2009, INT J SYST EVOL MICR, V59, P2415, DOI 10.1099/ijs.0.008870-0; Imperio T, 2008, INT J SYST EVOL MICR, V58, P221, DOI 10.1099/ijs.0.65092-0; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Karavaiko GI, 2005, INT J SYST EVOL MICR, V55, P941, DOI 10.1099/ijs.0.63300-0; Kawase KYF, 2013, J APPL MICROBIOL, V115, P466, DOI 10.1111/jam.12227; Khan A, 2013, WORLD J MICROB BIOT, V29, P2033, DOI 10.1007/s11274-013-1366-5; Kim MG, 2014, J MICROBIOL, V52, P884, DOI 10.1007/s12275-014-3625-z; Manachini PL, 1998, SYST APPL MICROBIOL, V21, P520, DOI 10.1016/S0723-2020(98)80064-7; Oteiza JM, 2014, INT J FOOD MICROBIOL, V172, P119, DOI 10.1016/j.ijfoodmicro.2013.12.007; Matsubara H, 2002, INT J SYST EVOL MICR, V52, P1681, DOI [10.1099/ijs.0.02169-0, 10.1099/00207713-52-5-1681]; Mbwana J, 2006, J CLIN MICROBIOL, V44, P132, DOI 10.1128/JCM.44.1.132-137.2006; Mulet M, 2008, INT J SYST EVOL MICR, V58, P2309, DOI 10.1099/ijs.0.65797-0; Novichkov PS, 2004, J BACTERIOL, V186, P6575, DOI 10.1128/JB.186.19.6575-6585.2004; Splittstoesser D. F., 1998, Dairy, Food and Environmental Sanitation, V18, P585; Steyn CE, 2011, INT J FOOD MICROBIOL, V147, P1, DOI 10.1016/j.ijfoodmicro.2011.03.004; Tiecco G., 2001, MICROBIOLOGIA ALIMEN; Trantas EA, 2013, EUR J PLANT PATHOL, V137, P477, DOI 10.1007/s10658-013-0258-8; Tsuruoka N, 2003, INT J SYST EVOL MICR, V53, P1081, DOI 10.1099/ijs.0.02409-0; Walker M, 2008, INT J FOOD SCI TECH, V43, P250, DOI 10.1111/j.1365-2621.2006.01427.x; Walls I., 1998, Dairy, Food and Environmental Sanitation, V18, P499; Walls I., 1994, SPORE FORMERS CAN GR; Wang ZL, 2012, J FOOD SCI, V77, pM643, DOI 10.1111/j.1750-3841.2012.02961.x; WISOTZKEY JD, 1992, INT J SYST BACTERIOL, V42, P263, DOI 10.1099/00207713-42-2-263; Yamazaki K, 1997, BIOSCI BIOTECH BIOCH, V61, P1016, DOI 10.1271/bbb.61.1016; Zhang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067704; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	41	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141228	10.1371/journal.pone.0141228	http://dx.doi.org/10.1371/journal.pone.0141228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484547	Green Published, gold			2022-12-27	WOS:000363028100124
J	Kamikawa, A; Sugimoto, S; Ichii, O; Kondoh, D				Kamikawa, Akihiro; Sugimoto, Shota; Ichii, Osamu; Kondoh, Daisuke			Decrease in an Inwardly Rectifying Potassium Conductance in Mouse Mammary Secretory Cells after Forced Weaning	PLOS ONE			English	Article							GLAND INVOLUTION; MILK SECRETION; EPITHELIAL-CELLS; GENE-EXPRESSION; KIR2.1 CHANNELS; APOPTOSIS; TRANSPORT; REMOVAL; DEATH; STAT3	Mammary glands are physiologically active in female mammals only during nursing. Immediately after weaning, most lactation-related genes are downregulated and milk production ceases. In our previous study, we have detected an inwardly rectifying potassium channel (Kir) 2.1-like current in mammary secretory (MS) cells freshly isolated from lactating mice. This current is highly sensitive to external Ba2+. The potassium permeability of the Kir channels may contribute to the secretion and/or preservation of ions in milk. We hypothesized that the functions of the Kir channels in MS cells are regulated after weaning. To test this hypothesis, we examined the effect of forced weaning on the Ba2+-sensitive Kir current and Kir2.1 expression in the mouse mammary glands. Twenty-four hours after weaning, the lumina of mammary acini were histologically enlarged by milk accumulation. The whole-cell patch-clamp analyses showed that the Ba2+-sensitive Kir current in the post-weaning MS cells was smaller than in the lactating MS cells. The inward conductances of the current in the lactating and post-weaning cells were 4.25 +/- 0.77 and 0.93 +/- 0.34 nS, respectively. Furthermore, real-time PCR and Western blot analyses showed that Kir2.1 mRNA and protein expression decreased in the post-weaning mammary gland (mRNA, 90% reduction; protein, 47% reduction). Moreover, the local milk accumulation caused by teat sealing decreased Kir conductance in MS cells (2.74 +/- 0.45 and 0.36 +/- 0.27 nS for control and sealed mammary glands, respectively). This was concomitant with the reduction in the Kir2.1 mRNA expression. Our results suggest that milk stasis after weaning immediately decreases the Kir conductance in MS cells. This decrease in the Kir conductance may be partly caused by the reduction in the Kir2.1 mRNA and protein expression. These alterations during the post-weaning period may be involved in the cessation of ion secretion and/or preservation in the milk.	[Kamikawa, Akihiro; Sugimoto, Shota; Kondoh, Daisuke] Obihiro Univ Agr & Vet Med, Div Biomed Sci, Dept Basic Vet Med, Obihiro, Hokkaido 080, Japan; [Ichii, Osamu] Hokkaido Univ, Dept Biomed Sci, Anat Lab, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	Obihiro University of Agriculture & Veterinary Medicine; Hokkaido University	Kamikawa, A (corresponding author), Obihiro Univ Agr & Vet Med, Div Biomed Sci, Dept Basic Vet Med, Obihiro, Hokkaido 080, Japan.	akami@obihiro.ac.jp	Kondoh, Daisuke/D-6312-2017; Kamikawa, Akihiro/L-3654-2019	Kondoh, Daisuke/0000-0002-3015-5156; Kamikawa, Akihiro/0000-0001-8530-6049	President's Discretionary Budget of Obihiro University of Agriculture and Veterinary Medicine [221]	President's Discretionary Budget of Obihiro University of Agriculture and Veterinary Medicine	This work was supported by the President's Discretionary Budget of Obihiro University of Agriculture and Veterinary Medicine, No. 221(AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaug S, 2001, AM J PHYSIOL-CELL PH, V281, pC633, DOI 10.1152/ajpcell.2001.281.2.C633; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Clarkson RWE, 2000, J BIOL CHEM, V275, P12737, DOI 10.1074/jbc.275.17.12737; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Humphreys RC, 1999, CELL GROWTH DIFFER, V10, P685; Ichii O, 2008, HISTOL HISTOPATHOL, V23, P411, DOI 10.14670/HH-23.411; Kamikawa A, 2014, AM J PHYSIOL-CELL PH, V306, pC230, DOI 10.1152/ajpcell.00219.2013; Kim JY, 1997, MOL CELL ENDOCRINOL, V131, P31, DOI 10.1016/S0303-7207(97)00086-5; Kolb AR, 2014, MOL BIOL CELL, V25, P276, DOI 10.1091/mbc.E13-07-0394; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Kuraishi T, 2000, BIOCHEM J, V347, P579, DOI 10.1042/0264-6021:3470579; Lee SY, 2007, AM J PHYSIOL-CELL PH, V293, pC1472, DOI 10.1152/ajpcell.00068.2007; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Li ML, 1997, P NATL ACAD SCI USA, V94, P3425, DOI 10.1073/pnas.94.7.3425; LINZELL JL, 1971, PHYSIOL REV, V51, P564, DOI 10.1152/physrev.1971.51.3.564; Marti A, 1999, J MAMMARY GLAND BIOL, V4, P145, DOI 10.1023/A:1018721107061; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Palmer ML, 2011, J PHYSIOL-LONDON, V589, P3483, DOI 10.1113/jphysiol.2011.207548; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Sargeant TJ, 2014, NAT CELL BIOL, V16, P1057, DOI 10.1038/ncb3043; Schere-Levy C, 2003, EXP CELL RES, V282, P35, DOI 10.1006/excr.2002.5666; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Tolkunov YA, 1997, J DAIRY RES, V64, P39, DOI 10.1017/S0022029996001859; Uejyo T, 2015, CELL TISSUE RES, V359, P643, DOI 10.1007/s00441-014-2013-7; Wilde CJ, 1999, J MAMMARY GLAND BIOL, V4, P129, DOI 10.1023/A:1018717006152; Xie LH, 2008, J PHYSIOL-LONDON, V586, P1833, DOI 10.1113/jphysiol.2007.147868	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141131	10.1371/journal.pone.0141131	http://dx.doi.org/10.1371/journal.pone.0141131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484867	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100116
J	Kelemen, Z; Sebastian, A; Xu, WJ; Grain, D; Salsac, F; Avon, A; Berger, N; Tran, J; Dubreucq, B; Lurin, C; Lepiniec, L; Contreras-Moreira, B; Dubos, C				Kelemen, Zsolt; Sebastian, Alvaro; Xu, Wenjia; Grain, Damaris; Salsac, Fabien; Avon, Alexandra; Berger, Nathalie; Tran, Joseph; Dubreucq, Bertrand; Lurin, Claire; Lepiniec, Loic; Contreras-Moreira, Bruno; Dubos, Christian			Analysis of the DNA-Binding Activities of the Arabidopsis R2R3-MYB Transcription Factor Family by One-Hybrid Experiments in Yeast	PLOS ONE			English	Article							CELL-WALL BIOSYNTHESIS; GENOME-WIDE; ROOT EPIDERMIS; STRUCTURAL-ANALYSIS; ACID BIOSYNTHESIS; GENE-EXPRESSION; FACTOR MYB.PH3; DIRECT TARGET; MYB PROTEINS; PLANT	The control of growth and development of all living organisms is a complex and dynamic process that requires the harmonious expression of numerous genes. Gene expression is mainly controlled by the activity of sequence-specific DNA binding proteins called transcription factors (TFs). Amongst the various classes of eukaryotic TFs, the MYB superfamily is one of the largest and most diverse, and it has considerably expanded in the plant kingdom. R2R3-MYBs have been extensively studied over the last 15 years. However, DNA-binding specificity has been characterized for only a small subset of these proteins. Therefore, one of the remaining challenges is the exhaustive characterization of the DNA-binding specificity of all R2R3-MYB proteins. In this study, we have developed a library of Arabidopsis thaliana R2R3-MYB open reading frames, whose DNA-binding activities were assayed in vivo (yeast one-hybrid experiments) with a pool of selected cis-regulatory elements. Altogether 1904 interactions were assayed leading to the discovery of specific patterns of interactions between the various R2R3-MYB subgroups and their DNA target sequences and to the identification of key features that govern these interactions. The present work provides a comprehensive in vivo analysis of R2R3-MYB binding activities that should help in predicting new DNA motifs and identifying new putative target genes for each member of this very large family of TFs. In a broader perspective, the generated data will help to better understand how TF interact with their target DNA sequences.	[Kelemen, Zsolt; Xu, Wenjia; Grain, Damaris; Salsac, Fabien; Berger, Nathalie; Tran, Joseph; Dubreucq, Bertrand; Lepiniec, Loic; Dubos, Christian] Univ Paris Saclay, IJPB, Saclay Plant Sci, INRA,AgroParisTech,CNRS, Versailles, France; [Sebastian, Alvaro; Contreras-Moreira, Bruno] CSIC, Estn Expt Aula Dei, Zaragoza, Spain; [Sebastian, Alvaro; Contreras-Moreira, Bruno] Fdn ARAID, Zaragoza, Spain; [Avon, Alexandra; Lurin, Claire] Saclay Plant Sci, Paris Saclay Inst Plant Sci IPS2, UMR INRA, CNRS,P11,P7,UEVE 1403, Evry, France; [Berger, Nathalie; Dubos, Christian] UM, Biochim & Physiol Mol Plantes, UMR 5004, INRA,CNRS,SupAgro M, Montpellier, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD); Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Dubos, C (corresponding author), Univ Paris Saclay, IJPB, Saclay Plant Sci, INRA,AgroParisTech,CNRS, Versailles, France.	christian.dubos@supagro.inra.fr	DUBREUCQ, Bertrand/AAY-9948-2020; /AAD-1735-2020; Dubos, Christian/D-8712-2019; Lepiniec, Loic/G-5808-2012; Contreras-Moreira, Bruno/G-4334-2011	DUBREUCQ, Bertrand/0000-0003-2661-5479; /0000-0003-3516-4438; Dubos, Christian/0000-0001-5486-3643; Lepiniec, Loic/0000-0002-5845-3323; Contreras Moreira, Bruno/0000-0002-5462-907X; Berger, Nathalie/0000-0003-0477-4903; Tran, Joseph/0000-0002-4624-0363; XU, Wenjia/0000-0003-1945-4451	French National Research Agency (CERES) [ANR-BLAN-1238]; PLANT-KBBE Initiative (STREG) [ANR-08-KBBE-011-01]; STREG project; China Scholarship Council (CSC)	French National Research Agency (CERES)(French National Research Agency (ANR)); PLANT-KBBE Initiative (STREG); STREG project; China Scholarship Council (CSC)(China Scholarship Council)	Part of this work was supported by the French National Research Agency (CERES, Grant ANR-BLAN-1238) and the PLANT-KBBE Initiative (STREG, ANR-08-KBBE-011-01). http://www.agencenationale-recherche.fr/. The work of ZK, FS and AS was supported by the STREG project. WX was supported by a fellowship from the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Barthole G, 2014, PLANT CELL, V26, P3519, DOI 10.1105/tpc.114.130021; Berckmans B, 2009, CURR OPIN PLANT BIOL, V12, P599, DOI 10.1016/j.pbi.2009.07.005; Charoensawan V, 2010, TRENDS GENET, V26, P388, DOI 10.1016/j.tig.2010.06.004; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Contreras-Moreira B, 2010, NUCLEIC ACIDS RES, V38, pD91, DOI 10.1093/nar/gkp781; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Du H, 2013, DNA RES, V20, P437, DOI 10.1093/dnares/dst021; Dubos C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-317; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Frerigmann H, 2014, PLANT PHYSIOL, V166, P349, DOI 10.1104/pp.114.240887; Guo MJ, 2008, PLANT CELL, V20, P48, DOI 10.1105/tpc.107.056127; HATTON D, 1995, PLANT J, V7, P859, DOI 10.1046/j.1365-313X.1995.07060859.x; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Heine GF, 2004, J BIOL CHEM, V279, P37878, DOI 10.1074/jbc.M405166200; Heppel SC, 2013, PLANT MOL BIOL, V82, P457, DOI 10.1007/s11103-013-0074-8; Hoeren FU, 1998, GENETICS, V149, P479; Kang YH, 2009, PLANT CELL, V21, P1080, DOI 10.1105/tpc.108.063180; Kapushesky M, 2003, ANAL GENE EXPRESSION, P142; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Lee MM, 2001, DEVELOPMENT, V128, P1539; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Li L, 2009, PLANT J, V58, P275, DOI 10.1111/j.1365-313X.2008.03778.x; Li SF, 2009, PLANT CELL, V21, P72, DOI 10.1105/tpc.108.063503; Liang G, 2014, J EXP BOT, V65, P3215, DOI 10.1093/jxb/eru179; Lipsick JS, 2010, P NATL ACAD SCI USA, V107, P17067, DOI 10.1073/pnas.1012402107; Lipsick JS, 1996, ONCOGENE, V13, P223; Lou YC, 2009, NUCLEIC ACIDS RES, V37, P2381, DOI 10.1093/nar/gkp097; Marino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2479; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Morohashi K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000396; Morse AM, 2009, NEW PHYTOL, V183, P1001, DOI 10.1111/j.1469-8137.2009.02900.x; Oda M, 1999, BIOCHEM BIOPH RES CO, V262, P94, DOI 10.1006/bbrc.1999.1159; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ohman D, 2013, PLANT J, V73, P63, DOI 10.1111/tpj.12018; Patzlaff A, 2003, PLANT MOL BIOL, V53, P597, DOI 10.1023/B:PLAN.0000019066.07933.d6; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Prouse MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065132; Prouse MB, 2012, BBA-GENE REGUL MECH, V1819, P67, DOI 10.1016/j.bbagrm.2011.10.010; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Romano JM, 2012, NEW PHYTOL, V195, P774, DOI 10.1111/j.1469-8137.2012.04201.x; Romero I, 1998, PLANT J, V14, P273, DOI 10.1046/j.1365-313X.1998.00113.x; Sebastian A, 2014, BIOINFORMATICS, V30, P258, DOI 10.1093/bioinformatics/btt663; Sebastian A, 2013, NUCLEIC ACIDS RES, V41, P1438, DOI 10.1093/nar/gks1301; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solano R, 1997, J BIOL CHEM, V272, P2889, DOI 10.1074/jbc.272.5.2889; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Soler M, 2015, NEW PHYTOL, V206, P1364, DOI 10.1111/nph.13039; Song SK, 2011, PLANT PHYSIOL, V157, P1196, DOI 10.1104/pp.111.185785; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Stracke R, 2010, NEW PHYTOL, V188, P985, DOI 10.1111/j.1469-8137.2010.03421.x; TANIKAWA J, 1993, P NATL ACAD SCI USA, V90, P9320, DOI 10.1073/pnas.90.20.9320; Tavares CP, 2014, BBA-PROTEINS PROTEOM, V1844, P810, DOI 10.1016/j.bbapap.2014.02.015; Thevenin J, 2012, NEW PHYTOL, V193, P504, DOI 10.1111/j.1469-8137.2011.03936.x; Tominaga-Wada R, 2012, PLANT SCI, V183, P37, DOI 10.1016/j.plantsci.2011.11.001; Vilarrasa-Blasi J, 2014, DEV CELL, V30, P36, DOI 10.1016/j.devcel.2014.05.020; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Williams CE, 1997, J BIOL CHEM, V272, P563, DOI 10.1074/jbc.272.1.563; Xie ZD, 2010, PLANT J, V64, P731, DOI 10.1111/j.1365-313X.2010.04364.x; Xie ZD, 2010, PLANT CELL, V22, P2306, DOI 10.1105/tpc.110.074609; Xu WJ, 2015, TRENDS PLANT SCI, V20, P176, DOI 10.1016/j.tplants.2014.12.001; Xu WJ, 2014, NEW PHYTOL, V202, P132, DOI 10.1111/nph.12620; Xu WJ, 2013, NEW PHYTOL, V198, P59, DOI 10.1111/nph.12142; Yao HY, 2013, PLANT CELL, V25, P5030, DOI 10.1105/tpc.113.120162; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P12822, DOI 10.1073/pnas.1202630109; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	79	50	52	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141044	10.1371/journal.pone.0141044	http://dx.doi.org/10.1371/journal.pone.0141044			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484765	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100104
J	Luo, JG; Ault, JS; Shay, LK; Hoolihan, JP; Prince, ED; Brown, CA; Rooker, JR				Luo, Jiangang; Ault, Jerald S.; Shay, Lynn K.; Hoolihan, John P.; Prince, Eric D.; Brown, Craig A.; Rooker, Jay R.			Ocean Heat Content Reveals Secrets of Fish Migrations	PLOS ONE			English	Article							ATLANTIC BLUEFIN TUNA; VERTICAL HABITAT USE; SAILFISH ISTIOPHORUS-PLATYPTERUS; MARINE PREDATOR MOVEMENTS; MARLIN MAKAIRA-NIGRICANS; SEA-SURFACE-TEMPERATURE; NORTH PACIFIC-OCEAN; THUNNUS-THYNNUS; HORIZONTAL MOVEMENTS; SPAWNING HABITATS	For centuries, the mechanisms surrounding spatially complex animal migrations have intrigued scientists and the public. We present a new methodology using ocean heat content (OHC), a habitat metric that is normally a fundamental part of hurricane intensity forecasting, to estimate movements and migration of satellite-tagged marine fishes. Previous satellite-tagging research of fishes using archival depth, temperature and light data for geolocations have been too coarse to resolve detailed ocean habitat utilization. We combined tag data with OHC estimated from ocean circulation and transport models in an optimization framework that substantially improved geolocation accuracy over SST-based tracks. The OHC-based movement track provided the first quantitative evidence that many of the tagged highly migratory fishes displayed affinities for ocean fronts and eddies. The OHC method provides a new quantitative tool for studying dynamic use of ocean habitats, migration processes and responses to environmental changes by fishes, and further, improves ocean animal tracking and extends satellite-based animal tracking data for other potential physical, ecological, and fisheries applications.	[Luo, Jiangang; Ault, Jerald S.; Shay, Lynn K.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Hoolihan, John P.] Univ Miami, Cooperat Inst Marine & Atmospher Studies, Miami, FL USA; [Prince, Eric D.; Brown, Craig A.] NOAA Fisheries, Southeast Fisheries Sci Ctr, Sustainable Fisheries Div, Highly Migratory Species Branch, Miami, FL USA; [Rooker, Jay R.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	University of Miami; University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Texas A&M University System	Ault, JS (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	jault@rsmas.miami.edu	Ault, Jerald S/A-5241-2008	Ault, Jerald S/0000-0001-9657-8007	Robertson Foundation; National Science Foundation [EAR-1204752]; NOAA Fisheries Southeast Fisheries Science Center CRP; McDaniel Charitable Foundation; Billfish Foundation; Adopt-A-Billfish Program; Bonefish; Tarpon Trust; NOAA Pacific Islands Fisheries Science Center [WE-133F-12SE-2099]; NOAA MARFIN Grant [NA11NMF4330129]; Cooperative Institute for Marine and Atmospheric Studies; Cooperative Institute of the University of Miami; NOAA [NA1RJ1266]; Directorate For Geosciences [1204752] Funding Source: National Science Foundation	Robertson Foundation; National Science Foundation(National Science Foundation (NSF)); NOAA Fisheries Southeast Fisheries Science Center CRP; McDaniel Charitable Foundation; Billfish Foundation; Adopt-A-Billfish Program; Bonefish; Tarpon Trust; NOAA Pacific Islands Fisheries Science Center; NOAA MARFIN Grant; Cooperative Institute for Marine and Atmospheric Studies; Cooperative Institute of the University of Miami; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The Tarpon & Bonefish Research Center at the University of Miami provided support for JL and JSA. Support for satellite tagging of tarpon was provided by the Robertson Foundation, and the National Science Foundation under Grant No. EAR-1204752 (JSA and JL). Support for tagging of marlin and tuna was provided through the NOAA Fisheries Southeast Fisheries Science Center CRP, McDaniel Charitable Foundation, The Billfish Foundation and Adopt-A-Billfish Program (JPH, EDP, and JRR). Additional support for JSA and JL was provided by Bonefish and Tarpon Trust, NOAA Pacific Islands Fisheries Science Center Contract No. WE-133F-12SE-2099, and NOAA MARFIN Grant No. NA11NMF4330129 (JSA and JL). Other support for JPH and JL was provided by the Cooperative Institute for Marine and Atmospheric Studies, a Cooperative Institute of the University of Miami and the NOAA (Cooperative Agreement Number NA1RJ1266).	[Anonymous], 2006, 2 MINUTE GRIDDED GLO; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Belkin IM, 2014, DEEP-SEA RES PT II, V107, P1, DOI 10.1016/j.dsr2.2014.07.009; Belkin IM, 2009, J MARINE SYST, V78, P319, DOI 10.1016/j.jmarsys.2008.11.018; Bestley S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2262; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; Dagorn L, 1997, BIOSYSTEMS, V44, P167, DOI 10.1016/S0303-2647(97)00051-8; Domeier ML, 2005, FISH B-NOAA, V103, P292; Druon JN, 2011, MAR ECOL PROG SER, V439, P223, DOI 10.3354/meps09321; Farneti R, 2010, J PHYS OCEANOGR, V40, P1539, DOI 10.1175/2010JPO4353.1; Goodyear CP, 2008, MAR ECOL PROG SER, V365, P233, DOI 10.3354/meps07505; Hallberg R, 2013, OCEAN MODEL, V72, P92, DOI 10.1016/j.ocemod.2013.08.007; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Haupt R.L., 2004, PRACTICAL GENETIC AL, VSecond, DOI DOI 10.1002/0471671746; Hill RD, 2001, P S TAGG TRACK MAR F; Holdsworth JC, 2009, MAR BIOL, V156, P505, DOI 10.1007/s00227-008-1104-y; Hoolihan JP, 2014, MAR COAST FISH, V6, P211, DOI 10.1080/19425120.2014.935900; Hoolihan JP, 2007, ICES J MAR SCI, V64, P1791, DOI 10.1093/icesjms/fsm148; Hoolihan JP, 2015, ICES J MAR SCI, V72, P2364, DOI 10.1093/icesjms/fsv082; Hoolihan JP, 2011, ICES J MAR SCI, V68, P880, DOI 10.1093/icesjms/fsr024; Hoolihan JP, 2011, FISH OCEANOGR, V20, P192, DOI 10.1111/j.1365-2419.2011.00577.x; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Kraus RT, 2011, MAR BIOL, V158, P699, DOI 10.1007/s00227-010-1593-3; Kraus Richard T., 2007, Gulf and Caribbean Research, V19, P89; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; LEGGETT WC, 1977, ANNU REV ECOL SYST, V8, P285, DOI 10.1146/annurev.es.08.110177.001441; Leipper D. F., 1972, Journal of Physical Oceanography, V2, P218, DOI 10.1175/1520-0485(1972)002<0218:HHPOTG>2.0.CO;2; Luo JG, 2008, MAR ECOL PROG SER, V357, P101, DOI 10.3354/meps07288; Luo JG, 2012, MAR ECOL PROG SER, V467, P167, DOI 10.3354/meps09957; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Mansfield KL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3039; MAUL GA, 1984, OCEANOL ACTA, V7, P469; Meyers PC, 2014, J ATMOS OCEAN TECH, V31, P131, DOI 10.1175/JTECH-D-13-00100.1; Michaels AF, 2007, SCIENCE, V316, P992, DOI 10.1126/science.1140059; Muhling BA, 2011, ICES J MAR SCI, V68, P1051, DOI 10.1093/icesjms/fsr008; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; O'Hem Julia E., 2009, Aquatic Mammals, V35, P358, DOI 10.1578/AM.35.3.2009.358; Olson Donald B., 2002, P187; Owen R.W., 1981, ANAL MAR ECOSYST, P197, DOI DOI 10.1371/JOURNAL.PONE; Palmen E., 1948, GEOPHYSICA, V3, P26; Prince ED, 2002, AM FISH S S, V30, P155; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; Sabarros PS, 2014, DEEP-SEA RES PT II, V107, P77, DOI 10.1016/j.dsr2.2013.06.023; Shay LK, 2010, MON WEATHER REV, V138, P2110, DOI 10.1175/2010MWR3189.1; Shillinger GL, 2012, P ROY SOC B-BIOL SCI, V279, P2391, DOI 10.1098/rspb.2011.2348; Sibert JR, 2003, FISH OCEANOGR, V12, P141, DOI 10.1046/j.1365-2419.2003.00228.x; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Solanki HU, 2005, CONT SHELF RES, V25, P2163, DOI 10.1016/j.csr.2005.08.025; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; Twatwa NM, 2005, AFR J MAR SCI, V27, P487, DOI 10.2989/18142320509504107; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Zainuddin M, 2008, FISH OCEANOGR, V17, P61, DOI 10.1111/j.1365-2419.2008.00461.x	60	14	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141101	10.1371/journal.pone.0141101	http://dx.doi.org/10.1371/journal.pone.0141101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484541	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100113
J	Ma, YC; Lin, CC; Yang, SY; Chen, HJ; Li, TC; Lin, JG				Ma, Yi-Chun; Lin, Cheng-Chieh; Yang, Sing-Yu; Chen, Hsuan-Ju; Li, Tsai-Chung; Lin, Jaung-Geng			Time Trend Analysis of the Prevalence and Incidence of Diagnosed Asthma and Traditional Chinese Medicine Use among Adults in Taiwan from 2000 to 2011: A Population-Based Study	PLOS ONE			English	Article							SOUTHERN TAIWAN; RISK-FACTORS; MORTALITY; TAIPEI	Background The aim of this study was to determine the annual trends of traditional Chinese medicine (TCM) use for prevalent and incident asthmatic adults in Taiwan from 2000 to 2011. The annual prevalence and incidence of asthma in adults among subgroups of sociodemographic factors were also investigated. Methods A population-based study was conducted using a random sample with one million beneficiaries of all residents aged >= 18 years enrolled in the National Health Insurance program. Adults diagnosed with asthma were identified from the National Health Insurance Research Database. The annual prevalence and incidence of asthma in the adult population were estimated by using International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic codes to identify relevant cases from 2000 to 2011. Results The number of annual prevalent cases of diagnosed asthma increased from 56,885 in 2000 to 101,535 in 2011. The prevalence increased significantly on annual basis, whereas the incidence rate fluctuated over time. The prevalence of TCM use by adults with asthma decreased significantly (p<0.05), from 38.58% in 2000 to 29.26% in 2011. The number of annual incident cases of diagnosed asthma decreased from 3,896 in 2000 to 2,684 in 2011. TCM use rates in asthma incident adults decreased significantly (p<0.05), from 54.24% in 2000 to 38.19% in 2011. Conclusion The prevalence of TCM utilization is high among adults with asthma in Taiwan. However, our study demonstrated a substantial decrease in the annual prevalence of TCM use by prevalent and incident asthmatic adults in Taiwan from 2000 to 2011. In addition, the prevalence of TCM use was higher among incident cases, compared with those with prevalent cases.	[Ma, Yi-Chun; Lin, Jaung-Geng] China Med Univ, Coll Chinese Med, Grad Inst Chinese Med, Taichung, Taiwan; [Ma, Yi-Chun] Tai An Hosp, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yang, Sing-Yu; Li, Tsai-Chung] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Li, TC (corresponding author), China Med Univ, Grad Inst Biostat, Taichung, Taiwan.	tcli@mail.cmu.edu.tw; jglin@mail.cmu.edu.tw	Lin, Cheng-Chieh/P-2564-2015; Li, Tsai-Chung/P-2052-2015	Lin, Cheng-Chieh/0000-0002-9625-6216; Li, Tsai-Chung/0000-0002-3346-7462	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW 104-TDU-B-212-113002]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW 104-TDU-B-212-113002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Boffetta P, 2010, CRIT REV FOOD SCI, V50, P13, DOI 10.1080/10408398.2010.526842; CHANG LTL, 2006, FU JEN J MED, V4, P61; Chen FP, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-26; Eagan TML, 2005, INT J TUBERC LUNG D, V9, P603; Hsiao HJ, 2013, PEDIATR NEONATOL, V54, P254, DOI 10.1016/j.pedneo.2013.01.017; HSIEH KH, 1988, J ASTHMA, V25, P73, DOI 10.3109/02770908809071357; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Jan IS, 2004, J FORMOS MED ASSOC, V103, P259; Kuo LC, 2003, J FORMOS MED ASSOC, V102, P534; Lee YL, 2006, CHEST, V129, P300, DOI 10.1378/chest.129.2.300; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Pan HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096190; Seage GR., 2013, ESSENTIALS EPIDEMIOL; Song WJ, 2014, ASIA PAC ALLERGY, V4, P3, DOI [10.5415/apallergy.2014.4.1.3, 10.5415/apallergy.2014.4.2.75]; Sun HL, 2008, ALLERGY ASTHMA PROC, V29, P177, DOI 10.2500/aap.2008.29.3095; TANG RB, 1990, CLIN EXP ALLERGY, V20, P33, DOI 10.1111/j.1365-2222.1990.tb02772.x; Wang HM, 2014, ANN ALLERG ASTHMA IM, V112, P465, DOI 10.1016/j.anai.2014.02.012; Wang Wen-Cheng, 1998, Acta Paediatrica Sinica, V39, P314; Wu JH, 1998, CHIN J PUBLIC HLTH T, V17, P214; Wu TJ, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0135-9; Yanez A, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-8; Zhang XY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1156	24	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140318	10.1371/journal.pone.0140318	http://dx.doi.org/10.1371/journal.pone.0140318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484761	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100027
J	Akilimali, PZ; Kashala-Abotnes, E; Musumari, PM; Kayembe, PK; Tylleskar, T; Mapatano, MA				Akilimali, Pierre Zalagile; Kashala-Abotnes, Esperance; Musumari, Patou Masika; Kayembe, Patrick Kalambayi; Tylleskar, Thorkild; Mapatano, Mala Ali			Predictors of Persistent Anaemia in the First Year of Antiretroviral Therapy: A Retrospective Cohort Study from Goma, the Democratic Republic of Congo	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; SCALE-UP; PREVALENCE; ZIDOVUDINE; MORTALITY; PROGNOSIS; DISEASE; COMPLEX; RISK	Background Anaemia is associated with adverse outcomes including early death in the first year of anti-retroviral therapy (ART). This study reports on the factors associated with persistent anaemia among HIV-infected patients initiating ART in the Democratic Republic of Congo (DR Congo). Methods We conducted a retrospective cohort study and analyzed data from patients receiving HIV care between January 2004 and December 2012 at two major hospitals in Goma, DR Congo. Haemoglobin concentrations of all patients on ART regimen were obtained prior to and within one year of ART initiation. A logistic regression model was used to identify the predictors of persistent anaemia after 12 months of ART. Results Of 756 patients, 69% of patients were anaemic (IC95%: 65.7-72.3) at baseline. After 12 months of follow up, there was a 1.2 g/dl average increase of haemoglobin concentration (P < 0.001) with differences depending on the therapeutic regimen. Patients who received zidovudine (AZT) gained less than those who did not receive AZT (0.99 g/dl vs 1.33 g/dl; p < 0.001). Among 445 patient who had anaemia at the beginning, 33% (147/445) had the condition resolved. Among patients with anaemia at ART initiation, those who did not receive cotrimoxazole prophylaxis before starting ART(AOR 3.89; 95% CI 2.09-7.25; P < 0.001) and a AZT initial regimen (AOR 2.19; 95% CI 1.36-3.52; P < 0.001) were significantly at risk of persistent anaemia. Conclusions More than two thirds of patients had anaemia at baseline. The AZT-containing regimen and absence of cotrimoxazole prophylaxis before starting ART were associated with persistent anaemia 12 months, after initiation of treatment. Considering the large proportion of patients with persistence of anaemia at 12 months, we suggest that it is necessary to conduct a large study to assess anaemia among HIV-infected patients in Goma.	[Akilimali, Pierre Zalagile; Kayembe, Patrick Kalambayi; Mapatano, Mala Ali] Univ Kinshasa, Kinshasa Univ Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Kashala-Abotnes, Esperance; Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Musumari, Patou Masika] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan	Universite de Kinshasa; University of Bergen; Kyoto University	Akilimali, PZ (corresponding author), Univ Kinshasa, Kinshasa Univ Sch Publ Hlth, Kinshasa, DEM REP CONGO.	pierretulanefp@gmail.com	Akilimali, Pierre Z/D-2564-2018; Tylleskär, Thorkild/S-5529-2017	Akilimali, Pierre Z/0000-0002-3828-6214; Tylleskär, Thorkild/0000-0003-4801-4324				Adane Asfaw, 2012, Ethiop Med J, V50, P13; Akilimali PZ, 2014, REV EPIDEMIOL SANTE, V62, P201, DOI 10.1016/j.respe.2014.03.004; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; DOUKAS MA, 1992, MED CLIN N AM, V76, P699, DOI 10.1016/S0025-7125(16)30348-0; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Forna Fatu, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P128, DOI 10.1177/1545109709333081; FRASER I, 1994, CLIN INFECT DIS, V19, P211, DOI 10.1093/clinids/19.1.211; GELMON K, 1989, AIDS, V3, P555, DOI 10.1097/00002030-198909000-00001; GROOPMAN JE, 1990, REV INFECT DIS, V12, P931; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Johannessen A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-190; KEISU M, 1990, J INTERN MED, V228, P353, DOI 10.1111/j.1365-2796.1990.tb00245.x; Kerkhoff AD, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0702-1; Kiragga AN, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-42; Laurent C, 2008, AIDS RES HUM RETROV, V24, P393, DOI 10.1089/aid.2007.0219; Levine AM, 2001, J ACQ IMMUN DEF SYND, V26, P28, DOI 10.1097/00126334-200101010-00004; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Ministere du Plan, 2014, ENQ DEM SANT 2013 20; MIR N, 1989, EUR J HAEMATOL, V42, P339; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moore RD, 2002, J ACQ IMMUN DEF SYND, V29, P54, DOI 10.1097/00042560-200201010-00007; Mugisha JO, 2008, TROP MED INT HEALTH, V13, P788, DOI 10.1111/j.1365-3156.2008.02069.x; Obirikorang C, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-102; [Republique Democratique du Congo Ministere de la Sante], 2005, PROGR NAT LUTT VIH G; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; Russell EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-433; Semba RD, 2001, AIDS PATIENT CARE ST, V15, P473, DOI 10.1089/108729101753145466; Semba RD, 2002, CLIN INFECT DIS, V34, P260, DOI 10.1086/338151; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Subbaraman R, 2007, CLIN INFECT DIS, V45, P1093, DOI 10.1086/521150; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; WHO, 2010, ANT THER HIV INF AD; Wills Todd S, 2004, AIDS Read, V14, P305; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2006, ANT THER HIV INF AD; Zhou JL, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-5	36	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140240	10.1371/journal.pone.0140240	http://dx.doi.org/10.1371/journal.pone.0140240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474481	Green Published, Green Submitted, gold			2022-12-27	WOS:000363185500033
J	Virine, B; Osiowy, C; Gao, S; Wang, T; Castillo, E; Martin, SR; Lee, SS; Simmonds, K; van Marle, G; Coffin, CS				Virine, Boris; Osiowy, Carla; Gao, Shan; Wang, Tong; Castillo, Eliana; Martin, Steven R.; Lee, Samuel S.; Simmonds, Kimberley; van Marle, Guido; Coffin, Carla S.			Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up	PLOS ONE			English	Article							TO-INFANT TRANSMISSION; SURFACE-ANTIGEN; ANTIVIRAL THERAPY; EXTENDING THERAPY; NATURAL-HISTORY; DRUG-RESISTANT; IMMUNIZATION; DETERMINANT; INFECTION; PREVENTION	Background Chronic hepatitis B (CHB) is a dynamic disease that may be affected by immune changes in pregnancy. Guidelines suggest consideration of nucleos/tide analogs (NA), i. e., tenofovir, (TDF) in highly viremic mothers to reduce vertical transmission risk. HBV variability affects CHB outcome, but little is known about HBV genetic changes in pregnancy due to immune or NA selection. Objectives To evaluate HBV diversity in NA treated or untreated pregnant vs. post-partum CHB carriers. Study Design In plasma collected from 21 mothers (7 matching pre/post-partum), HBV serological tests, genotype and viral load were assayed. The HBV pre-surface (S) /S overlapping polymerase (P) (N = 20), pre-core (C) /C (N = 11) and/or full genome PCR amplicons (N = 3) underwent clonal sequence analysis. Results The median age was 31 y, 71% Asian, 68% genotype B or C, 33% HBV eAg+, 5 received TDF (median HBV DNA 8.5 log IU/ml). In untreated mothers, median antepartum vs. postpartum ALT was 21 vs. 24 U/L and HBV DNA was 2.7 vs. 2.4 log(10) IU/ml. ALT and/or HBV DNA flares occurred during pregnant and/or post-partum period in 47% (10/21). Clonal sequencing antepartum showed the presence of minor "a determinant" and/or vaccine escape mutants (VEM) but drug resistant variants were infrequent. Analysis of pregnant vs. post-partum samples showed different HBV variants and viral diversity. Conclusions Differences in immune and/or by NA selective pressures during pregnancy may affect HBV evolution during pregnancy. The presence of minor VEM warrant infant follow-up.	[Virine, Boris; Gao, Shan; Wang, Tong; Lee, Samuel S.; Coffin, Carla S.] Univ Calgary, Cumming Sch Med, Div Gastroenterol & Hepatol, Liver Unit, Calgary, AB, Canada; [Virine, Boris; Gao, Shan; van Marle, Guido; Coffin, Carla S.] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Osiowy, Carla] Natl Microbiol Lab, Bloodborne Pathogens & Hepatitis Lab, Winnipeg, MB, Canada; [Gao, Shan] Capital Med Univ, Beijing YouAn Hosp, Artif Liver Ctr, Beijing, Peoples R China; [Castillo, Eliana] Univ Calgary, Cumming Sch Med, Sect Internal Med, Maternal Disorders Pregnancy,Dept Med, Calgary, AB, Canada; [Martin, Steven R.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Cumming Sch Med, Calgary, AB T2N 1N4, Canada; [Simmonds, Kimberley] Govt Alberta, Alberta, Edmonton, AB, Canada	University of Calgary; University of Calgary; Capital Medical University; University of Calgary; Alberta Childrens Hospital; University of Calgary	Coffin, CS (corresponding author), Univ Calgary, Cumming Sch Med, Div Gastroenterol & Hepatol, Liver Unit, Calgary, AB, Canada.	cscoffin@ucalgary.ca	Osiowy, Carla/L-5692-2019	Osiowy, Carla/0000-0002-5429-7220; Wang, Tong/0000-0001-9359-9750; van Marle, Guido/0000-0002-5148-6229	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors received no specific funding for this work. CSC was supported by a salary support award from the Canadian Institutes of Health Research.	Adar T, 2015, DIGEST DIS SCI, V60, P2581, DOI 10.1007/s10620-015-3683-z; Ayres A, 2014, J VIRAL HEPATITIS, V21, P809, DOI 10.1111/jvh.12212; Baz EMK, 2001, TRANSFUSION MED, V11, P355, DOI 10.1046/j.1365-3148.2001.00323.x; Beale MA, 2010, J GEN VIROL, V91, P68, DOI 10.1099/vir.0.013078-0; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Bian T, 2013, J VIROL, V87, P12196, DOI 10.1128/JVI.02127-13; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Chen HL, 2012, GASTROENTEROLOGY, V142, P773, DOI 10.1053/j.gastro.2011.12.035; Cheng H, 2009, VIROLOGY, V387, P168, DOI 10.1016/j.virol.2009.02.015; Chiou HL, 1997, J GEN VIROL, V78, P2639, DOI 10.1099/0022-1317-78-10-2639; Coffin CS, 2015, J VIRAL HEPATITIS, V22, P416, DOI 10.1111/jvh.12308; Coffin CS, 2014, ALIMENT PHARM THER, V40, P115, DOI 10.1111/apt.12793; Coffin CS, 2012, CAN J GASTROENTEROL, V26, P917, DOI 10.1155/2012/506819; Ferrari C, 2015, LIVER INT, V35, P121, DOI 10.1111/liv.12749; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gunther S, 2006, J CLIN VIROL, V36, pS3, DOI 10.1016/S1386-6532(06)80002-8; Kochaksaraei GS, 2016, J VIRAL HEPATITIS, V23, P15, DOI 10.1111/jvh.12436; Lai MW, 2012, GASTROENTEROLOGY, V143, P400, DOI 10.1053/j.gastro.2012.05.002; Lee HW, 2014, J CLIN VIROL, V60, P313, DOI 10.1016/j.jcv.2014.03.018; Locarnini S, 2014, J VIROL, V88, P6532, DOI 10.1128/JVI.00234-14; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Mackie CO, 2009, CAN MED ASSOC J, V180, P196, DOI 10.1503/cmaj.081112; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nguyen V, 2014, ALIMENT PHARM THER, V39, P1225, DOI 10.1111/apt.12726; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Osiowy C, 2011, J VIRAL HEPATITIS, V18, pe11, DOI 10.1111/j.1365-2893.2010.01356.x; Pande C, 2013, J VIRAL HEPATITIS, V20, P801, DOI 10.1111/jvh.12102; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Pollicino T, 2012, HEPATOLOGY, V56, P434, DOI 10.1002/hep.25592; Raimondo G, 2010, PATHOL BIOL, V58, P254, DOI 10.1016/j.patbio.2010.02.003; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Samadi Kochaksaraei G, 2015, J VIRAL HEP IN PRESS; Su HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070768; Szpakowski JL, 2013, HEPATOLOGY, V58, P21, DOI 10.1002/hep.26110; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teo CG, 2010, ANTIVIR THER, V15, P445, DOI 10.3851/IMP1556; WATERS JA, 1992, J CLIN INVEST, V90, P2543, DOI 10.1172/JCI116148; Wen WH, 2013, J HEPATOL, V59, P24, DOI 10.1016/j.jhep.2013.02.015; WHO, 2014, HEP B WHO FACT SHEET; Zhang H, 2014, HEPATOLOGY, V60, P468, DOI 10.1002/hep.27034	41	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140070	10.1371/journal.pone.0140070	http://dx.doi.org/10.1371/journal.pone.0140070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474400	gold, Green Published, Green Submitted			2022-12-27	WOS:000363185500022
J	Xie, DX; Zeng, C; Wang, YL; Li, YS; Wei, J; Li, H; Yang, T; Yang, TB; Lei, GH				Xie, Dong-xing; Zeng, Chao; Wang, Yi-lun; Li, Yu-sheng; Wei, Jie; Li, Hui; Yang, Tuo; Yang, Tu-bao; Lei, Guang-hua			A Single-Dose Intra-Articular Morphine plus Bupivacaine versus Morphine Alone following Knee Arthroscopy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							LOCAL-ANESTHETICS; PAIN-CONTROL; POSTARTHROSCOPY ANALGESIA; ARTICULAR-CARTILAGE; SURGERY; PLACEBO; RELIEF; CHONDROTOXICITY; MANAGEMENT; INJECTION	Objectives The purpose of this study was to compare the efficacy and safety of a single-dose intra-articular morphine plus bupivacaine versus morphine alone in patients undergoing arthroscopic knee surgery. Methods Randomized controlled trials comparing a combination of morphine and bupivacaine with morphine alone injected intra-articularly in the management of pain after knee arthrocopic surgery were retrieved (up to August 10, 2014) from MEDLINE, the Cochrane Library and Embase databases. The weighted mean difference (WMD), relative risk (RR) and their corresponding 95% confidence intervals (CIs) were calculated using RevMan statistical software. Results Thirteen randomized controlled trials were included. Statistically significant differences were observed with regard to the VAS values during the immediate period (0-2h) (WMD -1.16; 95% CI -2.01 to -0.31; p = 0.007) and the time to first request for rescue analgesia (WMD = 2.05; 95% CI 0.19 to 3.92; p = 0.03). However, there was no significant difference in the VAS pain score during the early period (2-6h) (WMD -0.36; 95% CI -1.13 to 0.41; p = 0.35), the late period (6-48h) (WMD 0.11; 95% CI -0.40 to 0.63; p = 0.67), and the number of patients requiring supplementary analgesia (RR = 0.78; 95% CI 0.57 to 1.05; p = 0.10). In addition, systematic review showed that intra-articular morphine plus bupivacaine would not increase the incidence of adverse effects compared with morphine alone. Conclusion The present study suggested that the administration of single-dose intra-articular morphine plus bupivacaine provided better pain relief during the immediate period (0-2h), and lengthened the time interval before the first request for analgesic rescue without increasing the short-term side effects when compared with morphine alone.	[Xie, Dong-xing; Zeng, Chao; Wang, Yi-lun; Li, Yu-sheng; Li, Hui; Yang, Tuo; Lei, Guang-hua] Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China; [Wei, Jie; Yang, Tu-bao] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China	Central South University; Central South University	Lei, GH (corresponding author), Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China.	lgh9640@sina.cn	Wei, Jie/ACR-8087-2022; Wang, Yilun/W-6530-2019	Wei, Jie/0000-0003-3510-8241; 	National Natural Science Foundation of China [81272034, 81472130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81272034, 81472130).	Aasbo V, 1996, ACTA ANAESTH SCAND, V40, P585, DOI 10.1111/j.1399-6576.1996.tb04492.x; Alagol A, 2005, KNEE SURG SPORT TR A, V13, P658, DOI 10.1007/s00167-004-0612-7; ALLEN GC, 1993, ANESTHESIOLOGY, V79, P475, DOI 10.1097/00000542-199309000-00010; Anz A, 2009, ARTHROSCOPY, V25, P225, DOI 10.1016/j.arthro.2008.12.003; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BJORNSSON A, 1994, REGION ANESTH, V19, P104; Breu A, 2013, ANESTH ANALG, V117, P514, DOI 10.1213/ANE.0b013e31829481ed; Calmet J, 2004, KNEE SURG SPORT TR A, V12, P552, DOI 10.1007/s00167-003-0483-3; Chan S. T., 1995, Singapore Medical Journal, V36, P35; Chirwa SS, 1998, ARTHROSCOPY, V5, P33; Chu CR, 2010, J BONE JOINT SURG AM, V92A, P599, DOI 10.2106/JBJS.I.00425; De Andres J, 1998, EUR J ANAESTH, V15, P10, DOI 10.1097/00003643-199801000-00003; Denti M, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P206, DOI 10.1007/s001670050051; Dragoo JL, 2008, AM J SPORT MED, V36, P1484, DOI 10.1177/0363546508318190; Dragoo JL, 2012, AM J SPORT MED, V40, P794, DOI 10.1177/0363546511434571; Dragoo JL, 2010, AM J SPORT MED, V38, P1154, DOI 10.1177/0363546509359680; Drosos Gl, 2000, KNEE, V9, P335; Eroglu A, 2010, KNEE SURG SPORT TR A, V18, P1487, DOI 10.1007/s00167-010-1061-0; Foley NC, 2006, PHYS THER, V86, P817, DOI 10.1093/ptj/86.6.817; Goodwin RC, 2005, ARTHROSCOPY, V21, P307, DOI 10.1016/j.arthro.2004.11.015; HENDERSON RC, 1990, AM J SPORT MED, V18, P614, DOI 10.1177/036354659001800610; Hosseini H, 2012, KNEE SURG SPORT TR A, V20, P1839, DOI 10.1007/s00167-011-1791-7; Ickert I, 2015, KNEE SURG SPORT TR A, V23, P2674, DOI 10.1007/s00167-014-2989-2; JOSHI GP, 1993, ANESTH ANALG, V76, P333; KAEDING C C, 1990, Arthroscopy, V6, P33, DOI 10.1016/0749-8063(90)90094-T; Kalso E, 1997, PAIN, V71, P127, DOI 10.1016/S0304-3959(97)03344-7; Kalso E, 2002, PAIN, V98, P269, DOI 10.1016/S0304-3959(02)00019-2; Karlsson J, 1995, Knee Surg Sports Traumatol Arthrosc, V3, P55, DOI 10.1007/BF01553527; KATZ JA, 1988, ANESTH ANALG, V67, P872; KHOURY GF, 1992, ANESTHESIOLOGY, V77, P263, DOI 10.1097/00000542-199208000-00007; MCSWINEY MM, 1993, ANAESTH INTENS CARE, V21, P201, DOI 10.1177/0310057X9302100212; Piper SL, 2011, AM J SPORT MED, V39, P2245, DOI 10.1177/0363546511402780; Reuben SS, 2000, J BONE JOINT SURG AM, V82A, P1754, DOI 10.2106/00004623-200012000-00010; Reuben SS, 1998, ANESTH ANALG, V86, P374, DOI 10.1097/00000539-199802000-00029; Rosseland LA, 2003, ACTA ANAESTH SCAND, V47, P732, DOI 10.1034/j.1399-6576.2003.00155.x; RUWE PA, 1995, AM J SPORT MED, V23, P59, DOI 10.1177/036354659502300110; Solheim N, 2006, REGION ANESTH PAIN M, V31, P506, DOI 10.1016/j.rapm.2006.06.206; STEIN C, 1991, NEW ENGL J MED, V325, P1123, DOI 10.1056/NEJM199110173251602; STPIERRE DMM, 1995, SPORTS MED, V20, P338, DOI 10.2165/00007256-199520050-00005; STUBHAUG A, 1995, BAILLIERE CLIN ANAES, V9, P555, DOI 10.1016/S0950-3501(95)80022-0; Tetzlaff JE, 1999, REGION ANESTH PAIN M, V24, P220, DOI 10.1016/S1098-7339(99)90131-1; Wang YL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006815; Wei J, 2014, KNEE SURG SPORT TR A, V22, P1517, DOI 10.1007/s00167-013-2543-7; Yang Y., 2015, KNEE SURG SPORTS TRA; Zeng C, 2013, ARTHROSCOPY, V29, P1450, DOI 10.1016/j.arthro.2013.04.005	45	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140512	10.1371/journal.pone.0140512	http://dx.doi.org/10.1371/journal.pone.0140512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474401	Green Published, Green Submitted, gold			2022-12-27	WOS:000363185500062
J	Ye, XJ; Kohtz, A; Pollonini, G; Riccio, A; Alberini, CM				Ye, Xiaojing; Kohtz, Amy; Pollonini, Gabriella; Riccio, Andrea; Alberini, Cristina M.			Insulin Like Growth Factor 2 Expression in the Rat Brain Both in Basal Condition and following Learning Predominantly Derives from the Maternal Allele	PLOS ONE			English	Article							FACTOR-II GENE; IGF-II; CTCF; METHYLATION; H19; CHROMATIN; TRANSCRIPTION; PROMOTERS; MAINTAINS; PARENT	Insulin like growth factor 2 (Igf2) is known as a maternally imprinted gene involved in growth and development. Recently, Igf2 was found to also be regulated and required in the adult rat hippocampus for long-term memory formation, raising the question of its allelic regulation in adult brain regions following experience and in cognitive processes. We show that, in adult rats, Igf2 is abundantly expressed in brain regions involved in cognitive functions, like hippocampus and prefrontal cortex, compared to the peripheral tissues. In contrast to its maternal imprinting in peripheral tissues, Igf2 is mainly expressed from the maternal allele in these brain regions. The training-dependent increase in Igf2 expression derives proportionally from both parental alleles, and, hence, is mostly maternal. Thus, Igf2 parental expression in the adult rat brain does not follow the imprinting rules found in peripheral tissues, suggesting differential expression regulation and functions of imprinted genes in the brain.	[Ye, Xiaojing; Kohtz, Amy; Pollonini, Gabriella; Alberini, Cristina M.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Kohtz, Amy] SUNY Albany, Grad Program Psychol, Albany, NY 12222 USA; [Riccio, Andrea] Univ Naples 2, DiSTABiF, I-81100 Caserta, Italy; [Riccio, Andrea] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80131 Naples, Italy	New York University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Alberini, CM (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	ca60@nyu.edu	Cerrato, Flavia/O-8315-2015; Riccio, Andrea/AAY-7571-2020; Riccio, Andrea/A-4991-2015	Cerrato, Flavia/0000-0003-3794-3021; Riccio, Andrea/0000-0001-7990-3576; Riccio, Andrea/0000-0001-7990-3576; Kohtz, Amy/0000-0002-7625-6534; Ye, Xiaojing/0000-0003-4673-3763	US National Institutes of Mental Health [MH065635]; Brain & Behavior Research Foundation (NARSAD Young Investigator Grant); Telethon-Italia grants [GGP15131, GGP11122]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065635, R37MH065635] Funding Source: NIH RePORTER	US National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain & Behavior Research Foundation (NARSAD Young Investigator Grant); Telethon-Italia grants(Fondazione Telethon); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the US National Institutes of Mental Health (MH065635 to C.M.A.), the Brain & Behavior Research Foundation (NARSAD Young Investigator Grant to X.Y.), and Telethon-Italia grants (N. GGP15131 and N. GGP11122 to A.R.).	Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; BECK F, 1988, DEVELOPMENT, V104, P29; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Caraguel CGB, 2011, J VET DIAGN INVEST, V23, P2, DOI 10.1177/104063871102300102; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GRAY A, 1987, DNA-J MOLEC CELL BIO, V6, P283, DOI 10.1089/dna.1987.6.283; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Han L, 2008, MOL CELL BIOL, V28, P1124, DOI 10.1128/MCB.01361-07; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Harper KM, 2014, PSYCHONEUROENDOCRINO, V45, P187, DOI 10.1016/j.psyneuen.2014.04.002; Hetts SW, 1997, J NEUROSCI RES, V50, P958, DOI 10.1002/(SICI)1097-4547(19971215)50:6<958::AID-JNR6>3.0.CO;2-C; HU JF, 1995, MOL ENDOCRINOL, V9, P628, DOI 10.1210/me.9.5.628; Jones BK, 2001, HUM MOL GENET, V10, P807, DOI 10.1093/hmg/10.8.807; Jouvenot Y, 1999, CURR BIOL, V9, P1199, DOI 10.1016/S0960-9822(00)80026-3; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; LUND PK, 1986, J BIOL CHEM, V261, P4539; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Mellott TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094287; Milekic MH, 2007, LEARN MEMORY, V14, P504, DOI 10.1101/lm.598307; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Ohlsson R, 1995, INT J DEV BIOL, V39, P869; Pascual-Lucas M, 2014, EMBO MOL MED, V6, P1246, DOI 10.15252/emmm.201404228; PEDONE PV, 1994, J BIOL CHEM, V269, P23970; Pham NV, 1998, BRAIN RES, V810, P1, DOI 10.1016/S0006-8993(98)00783-5; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Singh Purnima, 2012, Frontiers in Genetics, V3, P214, DOI 10.3389/fgene.2012.00214; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Stern SA, 2014, NEUROPSYCHOPHARMACOL, V39, P2179, DOI 10.1038/npp.2014.69; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wilkins JF, 2011, PROG MOL BIOL TRANSL, V101, P401, DOI 10.1016/B978-0-12-387685-0.00013-5	41	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141078	10.1371/journal.pone.0141078	http://dx.doi.org/10.1371/journal.pone.0141078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495851	gold, Green Submitted, Green Published			2022-12-27	WOS:000363309200058
J	D'Souza, E; Patankar, V; Arthur, R; Marba, N; Alcoverro, T				D'Souza, Elrika; Patankar, Vardhan; Arthur, Rohan; Marba, Nuria; Alcoverro, Teresa			Seagrass Herbivory Levels Sustain Site-Fidelity in a Remnant Dugong Population	PLOS ONE			English	Article							ISLANDS; CONSERVATION; ABUNDANCE; MOVEMENT; BEHAVIOR; MULLER; FORAGE	Herds of dugong, a largely tropical marine megaherbivore, are known to undertake long-distance movements, sequentially overgrazing seagrass meadows in their path. Given their drastic declines in many regions, it is unclear whether at lower densities, their grazing is less intense, reducing their need to travel between meadows. We studied the effect of the feeding behaviour of a small dugong population in the Andaman and Nicobar archipelago, India to understand how small isolated populations graze seagrasses. In the seven years of our observation, all recorded dugongs travelled either solitarily or in pairs, and their use of seagrasses was limited to 8 meadows, some of which were persistently grazed. These meadows were relatively large, contiguous and dominated by short-lived seagrasses species. Dugongs consumed approximately 15% of meadow primary production, but there was a large variation (3-40% of total meadow production) in consumption patterns between meadows. The impact of herbivory was relatively high, with shoot densities c. 50% higher inside herbivore exclosures than in areas exposed to repeated grazing. Our results indicate that dugongs in the study area repeatedly graze the same meadows probably because the proportion of primary production consumed reduces shoot density to levels that are still above values that can trigger meadow abandonment. This ability of seagrasses to cope perhaps explains the long-term site fidelity shown by individual dugongs in these meadows. The fact that seagrass meadows in the archipelago are able to support dugong foraging requirements allows us to clearly identify locations where this remnant population persists, and where urgent management efforts can be directed.	[D'Souza, Elrika; Patankar, Vardhan; Arthur, Rohan; Marba, Nuria; Alcoverro, Teresa] Nat Conservat Fdn, Oceans & Coasts Program, Mysore, Karnataka, India; [Patankar, Vardhan] Ctr Wildlife Studies, Bengaluru, Karnataka, India; [Patankar, Vardhan] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Marba, Nuria] Inst Mediterrani Estudis Avancats, Dept Global Change Res, IMEDEA CSIC UIB, Illes Balears, Spain; [Alcoverro, Teresa] Ctr Estudis Avancats Blanes CSIC, Blanes, Girona, Spain	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	D'Souza, E (corresponding author), Nat Conservat Fdn, Oceans & Coasts Program, Mysore, Karnataka, India.	elrika@ncf-india.org	Alcoverro, Teresa/J-9258-2012; Marba, Nuria/H-8136-2015	Alcoverro, Teresa/0000-0002-3910-9594; Marba, Nuria/0000-0002-8048-6789; Arthur, Rohan/0000-0003-4267-9720	Ravi Sankaran Inlaks Fellowship Program; Mohammed Bin Zayed Species Conservation Fund; Ministry of Environment and Forests, CSIC under the PIE programme [201330E062]	Ravi Sankaran Inlaks Fellowship Program; Mohammed Bin Zayed Species Conservation Fund; Ministry of Environment and Forests, CSIC under the PIE programme	This work was supported byRavi Sankaran Inlaks Fellowship Program, to ED; Mohammed Bin Zayed Species Conservation Fund, to ED; Ministry of Environment and Forests, CSIC under the PIE programme (Ref: 201330E062), to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PK, 1981, B MAR SCI, V31, P640; Andrews H., 2005, ECOLOGICAL IMPACT AS, V2, P78; Aragones Lemnuel, 2000, Pacific Conservation Biology, V5, P277; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Census Directorate, 2011, PROV POP TOT RUR URB; Chilvers BL, 2004, J EXP MAR BIOL ECOL, V304, P203, DOI 10.1016/j.jembe.2003.12.010; D'Souza E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076181; D'Souza Elrika, 2010, P443; Das HS, 1996, STATUS SEAGRASS HABI; De Iongh HH, 2007, HYDROBIOLOGIA, V591, P73, DOI 10.1007/s10750-007-0785-4; De Iongh HH, 1998, MAR ECOL-P S Z N I, V19, P179; Gera A, 2013, J ECOL, V101, P1053, DOI 10.1111/1365-2745.12109; Henriksen Snorre, 2003, Rangifer, V23, P25; Hines EM, 2005, MAR MAMMAL SCI, V21, P536, DOI 10.1111/j.1748-7692.2005.tb01247.x; Jackson JBC, 2001, SCIENCE, V293, P2401, DOI 10.1126/science.1063789; JAGTAP TG, 1991, AQUAT BOT, V40, P379, DOI 10.1016/0304-3770(91)90082-G; Kelkar N, 2013, MAR ECOL PROG SER, V485, P235, DOI 10.3354/meps10406; KENWORTHY WJ, 1989, MAR ECOL PROG SER, V51, P277, DOI 10.3354/meps051277; Lanyon JM, 2003, WILDLIFE RES, V30, P397, DOI 10.1071/WR98082; Malik JN, 2005, CURR SCI INDIA, V88, P1384; Marsh H., 2002, EARLY WARNING ASSESS; Nakaoka M, 1999, MAR ECOL PROG SER, V184, P97, DOI 10.3354/meps184097; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Planes S, 2011, MAR ECOL PROG SER, V431, P205, DOI 10.3354/meps09089; Prado P, 2007, J EXP MAR BIOL ECOL, V350, P130, DOI 10.1016/j.jembe.2007.05.033; PREEN A, 1995, MAR ECOL PROG SER, V124, P201, DOI 10.3354/meps124201; PREEN A, 1995, J MAMMAL, V76, P163, DOI 10.2307/1382325; Preen A., 1992, INTERACTIONS DUGONGS; Ramachandran S, 2005, CURR SCI INDIA, V89, P195; SANKARAN R., 2005, GROUND WAVES POSTTSU, VII, P10; SEAGLE SW, 1992, LANDSCAPE ECOL, V7, P229, DOI 10.1007/BF00131254; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sheppard JK, 2010, MAR MAMMAL SCI, V26, P855, DOI 10.1111/j.1748-7692.2010.00374.x; Shirakihara M, 2007, MAR MAMMAL SCI, V23, P694, DOI 10.1111/j.1748-7692.2007.00123.x; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; Wirsing AJ, 2008, MAR MAMMAL SCI, V24, P1, DOI 10.1111/j.1748-7692.2007.00167.x; Wirsing AJ, 2007, ANIM BEHAV, V74, P1085, DOI 10.1016/j.anbehav.2007.02.009; Wirsing AJ, 2007, ANIM BEHAV, V74, P93, DOI 10.1016/j.anbehav.2006.11.016	38	19	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141224	10.1371/journal.pone.0141224	http://dx.doi.org/10.1371/journal.pone.0141224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492558	gold, Green Published, Green Submitted			2022-12-27	WOS:000363249300036
J	Rakshit, T; Senapati, S; Sinha, S; Whited, AM; Park, PSH				Rakshit, Tatini; Senapati, Subhadip; Sinha, Satyabrata; Whited, A. M.; Park, Paul S. -H.			Rhodopsin Forms Nanodomains in Rod Outer Segment Disc Membranes of the Cold-Blooded Xenopus laevis	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; RETINAL RODS; MOLECULAR-INTERACTIONS; FROG; PROTEIN; ORGANIZATION; PHOTORECEPTORS; BOVINE; ULTRASTRUCTURE; ARCHITECTURE	Rhodopsin forms nanoscale domains (i.e., nanodomains) in rod outer segment disc membranes from mammalian species. It is unclear whether rhodopsin arranges in a similar manner in amphibian species, which are often used as a model system to investigate the function of rhodopsin and the structure of photoreceptor cells. Moreover, since samples are routinely prepared at low temperatures, it is unclear whether lipid phase separation effects in the membrane promote the observed nanodomain organization of rhodopsin from mammalian species. Rod outer segment disc membranes prepared from the cold-blooded frog Xenopus laevis were investigated by atomic force microscopy to visualize the organization of rhodopsin in the absence of lipid phase separation effects. Atomic force microscopy revealed that rhodopsin nanodomains form similarly as that observed previously in mammalian membranes. Formation of nanodomains in ROS disc membranes is independent of lipid phase separation and conserved among vertebrates.	[Rakshit, Tatini; Senapati, Subhadip; Sinha, Satyabrata; Whited, A. M.; Park, Paul S. -H.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Case Western Reserve University	Park, PSH (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.	paul.park@case.edu	Sinha, Satyabrata/K-9095-2016	Sinha, Satyabrata/0000-0003-0514-8613; Whited, Allison/0000-0001-5655-7332; Rakshit, Tatini/0000-0002-4182-9240; Senapati, Subhadip/0000-0001-9071-1911	National Institutes of Health [R01EY021731, P30EY011373]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY011373, R01EY021731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by grants from the National Institutes of Health (R01EY021731 and P30EY011373) and Research to Prevent Blindness (Unrestricted Grant).	BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BOWNDS D, 1975, J GEN PHYSIOL, V66, P407, DOI 10.1085/jgp.66.4.407; Buzhynskyy N, 2011, J MOL RECOGNIT, V24, P483, DOI 10.1002/jmr.1086; Chabre M, 2003, NATURE, V426, P30, DOI 10.1038/426030b; CHABRE M, 1975, BIOCHIM BIOPHYS ACTA, V382, P322, DOI 10.1016/0005-2736(75)90274-6; Dell'Orco D, 2013, FEBS LETT, V587, P2060, DOI 10.1016/j.febslet.2013.05.017; Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; Gunkel M, 2015, STRUCTURE, V23, P628, DOI 10.1016/j.str.2015.01.015; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; HAMM HE, 1986, BIOCHEMISTRY-US, V25, P4512, DOI 10.1021/bi00364a010; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; Kawamura S, 2010, BIOCHEMISTRY-US, V49, P10412, DOI 10.1021/bi101345x; Kirchhoff H, 2014, BBA-BIOENERGETICS, V1837, P495, DOI 10.1016/j.bbabio.2013.11.003; KORENBROT JI, 1972, J GEN PHYSIOL, V60, P20, DOI 10.1085/jgp.60.1.20; LAMBA OP, 1994, BIOCHEMISTRY-US, V33, P1704, DOI 10.1021/bi00173a012; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; LIEBMAN PA, 1968, VISION RES, V8, P761, DOI 10.1016/0042-6989(68)90128-4; Lodowski KH, 2013, J NEUROSCI, V33, P13621, DOI 10.1523/JNEUROSCI.1520-13.2013; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Muller DJ, 2008, BIOCHEMISTRY-US, V47, P7986, DOI 10.1021/bi800753x; Najafi M, 2012, J GEN PHYSIOL, V140, P249, DOI 10.1085/jgp.201210818; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; NILSSON SEG, 1965, J ULTRA MOL STRUCT R, V12, P207, DOI 10.1016/S0022-5320(65)80016-8; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; PAPERMASTER DS, 1978, J CELL BIOL, V78, P415, DOI 10.1083/jcb.78.2.415; Park Paul S-H, 2015, Methods Mol Biol, V1271, P173, DOI 10.1007/978-1-4939-2330-4_12; Rakshit T, 2015, BIOCHEMISTRY-US, V54, P2885, DOI 10.1021/acs.biochem.5b00003; Rosenkranz J, 1977, Int Rev Cytol, V50, P25; Sapra KT, 2006, J MOL BIOL, V358, P255, DOI 10.1016/j.jmb.2006.02.008; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091; TSUKAMOTO Y, 1987, EXP EYE RES, V45, P105, DOI 10.1016/S0014-4835(87)80082-9; Whited AM, 2015, BBA-BIOMEMBRANES, V1848, P26, DOI 10.1016/j.bbamem.2014.10.007; Whited AM, 2014, BBA-BIOMEMBRANES, V1838, P56, DOI 10.1016/j.bbamem.2013.04.011	41	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141114	10.1371/journal.pone.0141114	http://dx.doi.org/10.1371/journal.pone.0141114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492040	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300030
J	Goto-Yamamoto, N; Sawler, J; Myles, S				Goto-Yamamoto, Nami; Sawler, Jason; Myles, Sean			Genetic Analysis of East Asian Grape Cultivars Suggests Hybridization with Wild Vitis	PLOS ONE			English	Article							ORIENTAL CULTIVARS; SEQUENCE; VINIFERA; WINES; CHINA; KOSHU	Koshu is a grape cultivar native to Japan and is one of the country's most important cultivars for wine making. Koshu and other oriental grape cultivars are widely believed to belong to the European domesticated grape species Vitis vinifera. To verify the domesticated origin of Koshu and four other cultivars widely grown in China and Japan, we genotyped 48 ancestry informative single nucleotide polymorphisms (SNPs) and estimated wild and domesticated ancestry proportions. Our principal components analysis (PCA) based ancestry estimation revealed that Koshu is 70% V. vinifera, and that the remaining 30% of its ancestry is most likely derived from wild East Asian Vitis species. Partial sequencing of chloroplast DNA suggests that Koshu's maternal line is derived from the Chinese wild species V. davidii or a closely related species. Our results suggest that many traditional East Asian grape cultivars such as Koshu were generated from hybridization events with wild grape species.	[Goto-Yamamoto, Nami] Natl Res Inst Brewing, Higashihiroshima, Japan; [Sawler, Jason; Myles, Sean] Dalhousie Univ, Fac Agr, Truro, NS, Canada; [Sawler, Jason] Anandia Labs, Vancouver, BC, Canada	Dalhousie University	Goto-Yamamoto, N (corresponding author), Natl Res Inst Brewing, Higashihiroshima, Japan.	gotoh_n@nrib.go.jp; sean.myles@dal.ca		Myles, Sean/0000-0001-9754-5987	Japan Society for the Promotion of Science [24580063]; Anandia Labs	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Anandia Labs	This work was funded by a Grant-in Aid for Scientific Research (C) No. 24580063 from Japan Society for the Promotion of Science to NG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Jason Sawler is employed by Anandia Labs. Anandia Labs provided support in the form of salaries for author JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Goto-Yamamoto N, 2006, AM J ENOL VITICULT, V57, P105; Goto-Yamamoto N, 2000, BREEDING SCI, V50, P53, DOI 10.1270/jsbbs.50.53; Goto-Yamamoto N, 2013, J JPN SOC HORTIC SCI, V82, P125, DOI 10.2503/jjshs1.82.125; Goto-Yamamoto N, 2009, J JPN SOC HORTIC SCI, V78, P175, DOI 10.2503/jjshs1.78.175; Hancock J, 2008, BREEDING TEMPERATE F, P197; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kobayashi H, 2010, AM J ENOL VITICULT, V61, P176; Kobayashi H, 2009, AM J ENOL VITICULT, V60, P362; Liang NN, 2013, J AGR FOOD CHEM, V61, P6016, DOI 10.1021/jf3052658; McGovern PE, 2003, ANCIENT WINE SEARCH; Miller AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078680; Morinaga K., 2001, GRAPE PRODUCTION JAP; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Sawler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080791; Tabidze V, 2014, J INT SCI VIGNE VIN, V48, P99; Tamura K., 2013, MEGA6 MOL EVOLUTIONA; Wan YZ, 2008, VITIS, V47, P77; YOKOTSUKA K, 1984, J FERMENT TECHNOL, V62, P477; Zecca G, 2012, MOL PHYLOGENET EVOL, V62, P736, DOI 10.1016/j.ympev.2011.11.015	21	14	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140841	10.1371/journal.pone.0140841	http://dx.doi.org/10.1371/journal.pone.0140841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488600	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400072
J	Guimaraes, PM; Guimaraes, LA; Morgante, CV; Silva, OB; Araujo, ACG; Martins, ACQ; Saraiva, MAP; Oliveira, TN; Togawa, RC; Leal-Bertioli, SCM; Bertioli, DJ; Brasileiro, ACM				Guimaraes, Patricia M.; Guimaraes, Larissa A.; Morgante, Carolina V.; Silva, Orzenil B., Jr.; Araujo, Ana Claudia G.; Martins, Andressa C. Q.; Saraiva, Mario A. P.; Oliveira, Thais N.; Togawa, Roberto C.; Leal-Bertioli, Soraya C. M.; Bertioli, David J.; Brasileiro, Ana Cristina M.			Root Transcriptome Analysis of Wild Peanut Reveals Candidate Genes for Nematode Resistance	PLOS ONE			English	Article							ALLENE-OXIDE-CYCLASE; PLANT-CELL DEATH; KNOT NEMATODE; SALICYLIC-ACID; MELOIDOGYNE-ARENARIA; EXPRESSION ANALYSIS; DISEASE RESISTANCE; CYST-NEMATODE; ARACHIS; DEFENSE	Wild peanut relatives (Arachis spp.) are genetically diverse and were adapted to a range of environments during the evolution course, constituting an important source of allele diversity for resistance to biotic and abiotic stresses. The wild diploid A. stenosperma harbors high levels of resistance to a variety of pathogens, including the root-knot nematode (RKN) Meloidogyne arenaria, through the onset of the Hypersensitive Response (HR). In order to identify genes and regulators triggering this defense response, a comprehensive root transcriptome analysis during the first stages of this incompatible interaction was conducted using Illumina Hi-Seq. Overall, eight cDNA libraries were produced generating 28.2 GB, which were de novo assembled into 44,132 contigs and 37,882 loci. Differentially expressed genes (DEGs) were identified and clustered according to their expression profile, with the majority being downregulated at 6 DAI, which coincides with the onset of the HR. Amongst these DEGs, 27 were selected for further qRT-PCR validation allowing the identification of nematode-responsive candidate genes that are putatively related to the resistance response. Those candidates are engaged in the salycilic (NBS-LRR, lipocalins, resveratrol synthase) and jasmonic (patatin, allene oxidase cyclase) acids pathways, and also related to hormonal balance (auxin responsive protein, GH3) and cellular plasticity and signaling (tetraspanin, integrin, expansin), with some of them showing contrasting expression behavior between Arachis RKN-resistant and susceptible genotypes. As these candidate genes activate different defensive signaling systems, the genetic (HR) and the induced resistance (IR), their pyramidding in one genotype via molecular breeding or transgenic strategy might contribute to a more durable resistance, thus improving the long-term control of RKN in peanut.	[Guimaraes, Patricia M.; Guimaraes, Larissa A.; Silva, Orzenil B., Jr.; Araujo, Ana Claudia G.; Saraiva, Mario A. P.; Togawa, Roberto C.; Leal-Bertioli, Soraya C. M.; Brasileiro, Ana Cristina M.] EMBRAPA Genet Resources & Biotechnol, Brasilia, DF, Brazil; [Morgante, Carolina V.] EMBRAPA Semiarid, Petrolina, PE, Brazil; [Martins, Andressa C. Q.; Oliveira, Thais N.; Bertioli, David J.] Univ Brasilia, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia	Guimaraes, PM (corresponding author), EMBRAPA Genet Resources & Biotechnol, Brasilia, DF, Brazil.	patricia.guimaraes@embrapa.br	Silva-Junior, Orzenil/B-3488-2013; Brasileiro, Ana Cristina Miranda/AAN-2187-2021; Guimaraes, Patricia messenberg/G-1824-2012	Silva-Junior, Orzenil/0000-0002-2104-2010; Brasileiro, Ana Cristina Miranda/0000-0003-0530-062X; Guimaraes, patricia/0000-0001-9799-3042; BERTIOLI, SORAYA/0000-0002-9683-5357; Togawa, Roberto/0000-0001-7179-3210	EMBRAPA; CNPq-PRONEX	EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CNPq-PRONEX(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	EMBRAPA (www.embrapa.br) and CNPq-PRONEX (http://www.cnpq.br/) contributed to funding this work with financial support and sponsorships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2010, ADV BOT RES, V53, P147, DOI 10.1016/S0065-2296(10)53005-2; [Anonymous], 2011, SUST AGR NEW BIOT, V1st ed., P341; Bendezu IF, 2003, J NEMATOL, V35, P115; Branch C, 2004, MOL PLANT MICROBE IN, V17, P351, DOI 10.1094/MPMI.2004.17.4.351; Brasileiro ACM, 2015, PLANT MOL BIOL REP, V33, P1876, DOI 10.1007/s11105-015-0882-x; Burow MD, 2014, MOL BREEDING, V34, P393, DOI 10.1007/s11032-014-0042-2; Chang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026405; Charron JBF, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-86; Chen N, 2014, GENE, V533, P332, DOI 10.1016/j.gene.2013.08.092; Chen XP, 2013, PLANT BIOTECHNOL J, V11, P115, DOI 10.1111/pbi.12018; Chu Y, 2014, PLANT DIS, V98, P1292, DOI 10.1094/PDIS-12-13-1241-RE; Danchin EGJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003745; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-480; Davies KG, 2011, ANNU REV PHYTOPATHOL, V49, P135, DOI 10.1146/annurev-phyto-121310-111406; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Djian-Caporalino C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-53; Doyle EA, 2003, MOL PLANT MICROBE IN, V16, P123, DOI 10.1094/MPMI.2003.16.2.123; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Fuller VL, 2008, NEW PHYTOL, V180, P27, DOI 10.1111/j.1469-8137.2008.02508.x; Gan ZW, 2007, APPL MICROBIOL BIOT, V76, P1309, DOI 10.1007/s00253-007-1111-9; Guimaraes P, 2010, TROPICAL PLANT BIOL, P1; Guimaraes P. M., 2010, Tropical Plant Biology, V3, P183, DOI 10.1007/s12042-010-9056-z; Guimaraes PM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-387; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Holbrook CC, 2002, PL BRED RE, V22, P297; Hong L, 2013, BIOL PLANTARUM, V57, P56, DOI 10.1007/s10535-012-0236-6; Hwang IS, 2014, NEW PHYTOL, V201, P518, DOI 10.1111/nph.12521; Isayenkov S, 2005, PLANT PHYSIOL, V139, P1401, DOI 10.1104/pp.105.069054; Jammes F, 2005, PLANT J, V44, P447, DOI 10.1111/j.1365-313X.2005.02532.x; Kalavacharla V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-135; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Kiselev KV, 2010, RUSS J PLANT PHYSL+, V57, P415, DOI 10.1134/S1021443710030143; Klink VP, 2007, PLANTA, V226, P1389, DOI 10.1007/s00425-007-0581-4; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; La Camera S, 2009, MOL PLANT MICROBE IN, V22, P469, DOI 10.1094/MPMI-22-4-0469; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Lopes RM, 2013, GENET RESOUR CROP EV, V60, P2219, DOI 10.1007/s10722-013-9987-y; Melillo MT, 2006, NEW PHYTOL, V170, P501, DOI 10.1111/j.1469-8137.2006.001724.x; Morgante CV, 2013, FUNCT PLANT BIOL, V40, P1298, DOI 10.1071/FP13096; Morgante Carolina V, 2011, BMC Res Notes, V4, P339, DOI 10.1186/1756-0500-4-339; Nagy ED, 2010, MOL BREEDING, V26, P357, DOI 10.1007/s11032-010-9430-4; Nandi B, 2003, NEMATOLOGY, V5, P747, DOI 10.1163/156854103322746922; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Portillo M, 2013, NEW PHYTOL, V197, P1276, DOI 10.1111/nph.12121; Proite K, 2008, PLANT PATHOL, V57, P974, DOI 10.1111/j.1365-3059.2008.01861.x; Proite K, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-7; Riemann M, 2013, PLANT J, V74, P226, DOI 10.1111/tpj.12115; Schaff JE, 2007, PLANT PHYSIOL, V144, P1079, DOI 10.1104/pp.106.090241; Schroder R, 2009, ANN BOT-LONDON, V104, P197, DOI 10.1093/aob/mcp120; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Soriano IR, 2004, J CHEM ECOL, V30, P1885, DOI 10.1023/B:JOEC.0000045584.56515.11; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tillman B, 2010, OIL CROPS, P287; Tirumalaraju SV, 2011, J PLANT PHYSIOL, V168, P481, DOI 10.1016/j.jplph.2010.08.006; Udvardi MK, 2007, PLANT PHYSIOL, V144, P538, DOI 10.1104/pp.107.098061; Uehara T, 2010, PLANT CELL PHYSIOL, V51, P1524, DOI 10.1093/pcp/pcq109; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Wang F, 2012, PLANT SCI, V190, P9, DOI 10.1016/j.plantsci.2012.03.005; Williamson VM, 2006, TRENDS GENET, V22, P396, DOI 10.1016/j.tig.2006.05.003; Wu N, 2013, THEOR APPL GENET, V126, P1145, DOI 10.1007/s00122-013-2042-8; Xu XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056146; Yin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073767; Zambounis AG, 2012, PLANT MOL BIOL REP, V30, P225, DOI 10.1007/s11105-011-0335-0; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhu WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053901; Zinovieva SV, 2013, BIOL BULL+, V40, P297, DOI 10.1134/S1062359013030126; Zinovieva SV, 2011, BIOL BULL+, V38, P453, DOI 10.1134/S1062359011050177	72	39	40	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140937	10.1371/journal.pone.0140937	http://dx.doi.org/10.1371/journal.pone.0140937			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488731	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400082
J	Hussain, S; Davanger, S				Hussain, Suleman; Davanger, Svend			Postsynaptic VAMP/Synaptobrevin Facilitates Differential Vesicle Trafficking of GluA1 and GluA2 AMPA Receptor Subunits	PLOS ONE			English	Article							LONG-TERM POTENTIATION; HOMEOSTATIC SYNAPTIC PLASTICITY; MEMBRANE-FUSION; HIPPOCAMPAL-NEURONS; PLASMA-MEMBRANE; RECYCLING ENDOSOMES; TETANUS TOXIN; GLUTAMATE; PROTEIN; LTP	Vertebrate organisms adapt to a continuously changing environment by regulating the strength of synaptic connections between brain cells. Excitatory synapses are believed to increase their strength by vesicular insertion of transmitter glutamate receptors into the postsynaptic plasma membrane. These vesicles, however, have never been demonstrated or characterized. For the first time, we show the presence of small vesicles in postsynaptic spines, often closely adjacent to the plasma membrane and PSD (postsynaptic density). We demonstrate that they harbor vesicle-associated membrane protein 2 (VAMP2/synaptobrevin-2) and glutamate receptor subunit 1 (GluA1). Disrupting VAMP2 by tetanus toxin treatment reduces the concentration of GluA1 in the postsynaptic plasma membrane. GluA1/VAMP2-containing vesicles, but not GluA2/VAMP2-vesicles, are concentrated in postsynaptic spines relative to dendrites. Our results indicate that small postsynaptic vesicles containing GluA1 are inserted directly into the spine plasma membrane through a VAMP2-dependent mechanism.	[Hussain, Suleman; Davanger, Svend] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Lab Synapt Plast,Div Anat, N-0317 Oslo, Norway	University of Oslo	Davanger, S (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Lab Synapt Plast,Div Anat, POB 1105 Blindern, N-0317 Oslo, Norway.	svend.davanger@medisin.uio.no	Davanger, Svend/AAN-8754-2020		University of Oslo; European Union [QLG3-CT-2001-02089, LSCHM-CT-2005-005320]	University of Oslo; European Union(European Commission)	The University of Oslo, and the European Union Projects QLG3-CT-2001-02089 (KARTRAP) and LSCHM-CT-2005-005320 (GRIPANNT) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Araki Y, 2010, P NATL ACAD SCI USA, V107, P11080, DOI 10.1073/pnas.1006584107; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bowers MS, 2010, NEURON, V67, P11, DOI 10.1016/j.neuron.2010.06.004; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; de ROBERTIS E., 1963, JOUR NEUROCHEM, V10, P225; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Gammelsaeter R, 2004, J CELL SCI, V117, P3749, DOI 10.1242/jcs.01209; Gan Q, 2015, J PHYSIOL-LONDON, V593, P39, DOI 10.1113/jphysiol.2014.273755; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Groth RD, 2011, P NATL ACAD SCI USA, V108, P828, DOI 10.1073/pnas.1018022108; Haglerod C, 2009, NEUROSCIENCE, V158, P242, DOI 10.1016/j.neuroscience.2008.11.029; Hanley JG, 2008, CELL ADHES MIGR, V2, P276, DOI 10.4161/cam.2.4.6510; Hummelshoj JS, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3148892; Hussain S, 2011, NEUROSCIENCE, V190, P12, DOI 10.1016/j.neuroscience.2011.05.057; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Kliachkin L M, 1989, Voen Med Zh, P41; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Mathiisen TM, 2006, NEUROANATOMICAL TRACT-TRACING 3: MOLECULES, NEURONS, AND SYSTEMS, P72; Morimoto T, 2010, NEUROSCIENCE, V165, P1284, DOI 10.1016/j.neuroscience.2009.11.059; Nakagawa T, 2010, MOL NEUROBIOL, V42, P161, DOI 10.1007/s12035-010-8149-x; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Oltedal L, 2008, EXP BRAIN RES, V184, P479, DOI 10.1007/s00221-007-1118-6; Ormel L, 2012, GLIA, V60, P229, DOI 10.1002/glia.21258; PAGANETTI P, 1994, BRAIN RES, V633, P53, DOI 10.1016/0006-8993(94)91521-0; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Patterson MA, 2010, P NATL ACAD SCI USA, V107, P15951, DOI 10.1073/pnas.0913875107; PELLEGRINI LL, 1994, FEBS LETT, V353, P319, DOI 10.1016/0014-5793(94)01070-6; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Roberg B, 2000, AM J PHYSIOL-CELL PH, V279, pC648, DOI 10.1152/ajpcell.2000.279.3.C648; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Santos MS, 2009, NEUROSCIENCE, V158, P189, DOI 10.1016/j.neuroscience.2008.03.029; SCHIAVO G, 1992, EMBO J, V11, P3577, DOI 10.1002/j.1460-2075.1992.tb05441.x; Schmetsdorf S, 2007, CEREB CORTEX, V17, P1821, DOI 10.1093/cercor/bhl091; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Soares C, 2013, J NEUROSCI, V33, P13547, DOI 10.1523/JNEUROSCI.1873-13.2013; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tarusawa E, 2009, J NEUROSCI, V29, P12896, DOI 10.1523/JNEUROSCI.6160-08.2009; TRIMBLE WS, 1990, J NEUROSCI, V10, P1380; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Utvik JK, 2009, NEUROSCIENCE, V158, P96, DOI 10.1016/j.neuroscience.2008.11.030; Vik-Mo EO, 2003, NEUROSCIENCE, V119, P73, DOI 10.1016/S0306-4522(03)00065-4; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WHITTAKER VP, 1964, BIOCHEM J, V90, P293, DOI 10.1042/bj0900293; WREDMARK T, 1991, FOOT ANKLE, V11, P404, DOI 10.1177/107110079101100613; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Zander JF, 2010, J NEUROSCI, V30, P7634, DOI 10.1523/JNEUROSCI.0141-10.2010	66	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140868	10.1371/journal.pone.0140868	http://dx.doi.org/10.1371/journal.pone.0140868			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488171	gold, Green Published			2022-12-27	WOS:000363248400077
J	Gonalons, C; Farina, WM				Mengoni Gonalons, Carolina; Marcelo Farina, Walter			Effects of Sublethal Doses of Imidacloprid on Young Adult Honeybee Behaviour	PLOS ONE			English	Article							SUCROSE RESPONSIVENESS; RESPONSE THRESHOLDS; RECEIVING NECTAR; INCOMING NECTAR; INSECT; BEES; MEMORY; FORAGERS; TOXICITY; ODORS	Imidacloprid (IMI), a neonicotinoid used for its high selective toxicity to insects, is one of the most commonly used pesticides. However, its effect on beneficial insects such as the honeybee Apis mellifera L is still controversial. As young adult workers perform in-hive duties that are crucial for colony maintenance and survival, we aimed to assess the effect of sublethal IMI doses on honeybee behaviour during this period. Also, because this insecticide acts as a cholinergic-nicotinic agonist and these pathways take part in insect learning and memory processes; we used IMI to assess their role and the changes they suffer along early adulthood. We focused on appetitive behaviours based on the proboscis extension response. Laboratory reared adults of 2 to 10 days of age were exposed to sublethal IMI doses (0.25 or 0.50ng) administered orally or topically prior to behavioural assessment. Modification of gustatory responsiveness and impairment of learning and memory were found as a result of IMI exposure. These outcomes differed depending on age of evaluation, type of exposure and IMI dose, being the youngest bees more sensitive and the highest oral dose more toxic. Altogether, these results imply that IMI administered at levels found in agroecosystems can reduce sensitivity to reward and impair associative learning in young honeybees. Therefore, once a nectar inflow with IMI traces is distributed within the hive, it could impair in-door duties with negative consequences on colony performance.	[Mengoni Gonalons, Carolina; Marcelo Farina, Walter] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Insectos Sociales, Dept Biodiversidad & Biol Expt,IFIBYNE CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Farina, WM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Insectos Sociales, Dept Biodiversidad & Biol Expt,IFIBYNE CONICET, Ciudad Univ, Buenos Aires, DF, Argentina.	walter@fbmc.fcen.uba.ar		Farina, Walter/0000-0001-6411-489X	CONICET (The National Scientific and Technical Research Council (Spanish: Consejo Nacional de Investigaciones Cientificas y Tecnicas)); ANPCYT (Agencia Nacional de Promocion Cientifica y Tecnologica); University of Buenos Aires	CONICET (The National Scientific and Technical Research Council (Spanish: Consejo Nacional de Investigaciones Cientificas y Tecnicas)); ANPCYT (Agencia Nacional de Promocion Cientifica y Tecnologica)(ANPCyT); University of Buenos Aires(University of Buenos Aires)	This work was supported by CONICET (The National Scientific and Technical Research Council (Spanish: Consejo Nacional de Investigaciones Cientificas y Tecnicas)), ANPCYT (Agencia Nacional de Promocion Cientifica y Tecnologica), and the University of Buenos Aires for financial support.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Arenas A, 2012, EUR J NEUROSCI, V35, P682, DOI 10.1111/j.1460-9568.2012.07999.x; Arenas A, 2008, J COMP PHYSIOL A, V194, P629, DOI 10.1007/s00359-008-0337-z; Arenas A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00041; Arenas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008046; Behrends A, 2009, ANIM COGN, V12, P249, DOI 10.1007/s10071-008-0187-7; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; DeGrandi-Hoffman G, 2000, INSECT SOC, V47, P302, DOI 10.1007/PL00001720; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Farina WM, 2007, NATURWISSENSCHAFTEN, V94, P55, DOI 10.1007/s00114-006-0157-3; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; FREE JB, 1969, NATURE, V222, P778, DOI 10.1038/222778a0; Frings H, 1944, J EXP ZOOL, V97, P123, DOI 10.1002/jez.1400970203; Gauthier M, 2010, ADV EXP MED BIOL, V683, P97; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Goyret J, 2005, NATURWISSENSCHAFTEN, V92, P440, DOI 10.1007/s00114-005-0016-7; Gruter C, 2006, BEHAV ECOL SOCIOBIOL, V60, P707, DOI 10.1007/s00265-006-0214-0; Guez D, 2003, PHARMACOL BIOCHEM BE, V75, P217, DOI 10.1016/S0091-3057(03)00070-4; Guez D, 2001, NEUROBIOL LEARN MEM, V76, P183, DOI 10.1006/nlme.2000.3995; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Martinez A, 2008, BEHAV ECOL SOCIOBIOL, V62, P529, DOI 10.1007/s00265-007-0477-0; Masson C., 1987, P280; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; McQuillan HJ, 2012, J COMP PHYSIOL A, V198, P753, DOI 10.1007/s00359-012-0745-y; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Morgan SM, 1998, BEHAV BRAIN RES, V91, P115, DOI 10.1016/S0166-4328(97)00118-6; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; NIXON HL, 1952, PROC R SOC SER B-BIO, V140, P43, DOI 10.1098/rspb.1952.0042; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Pankiw T, 2004, BEHAV ECOL SOCIOBIOL, V55, P286, DOI 10.1007/s00265-003-0714-0; Rarmrez GP, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013498, DOI 10.1371/J0URNAL.P0NE.0013498]; Rohlf FJ, 1987, INTRODUCTION TO BIOS; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Seeley T, 1995, THE WISDOM OF THE HI; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Balbuena MS, 2012, ANIM BEHAV, V84, P77, DOI 10.1016/j.anbehav.2012.04.008; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Thany SH, 2010, ADV EXP MED BIOL, V683, P75; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Von Frisch K, 1967, THE DANCE LANGUAGE A; Williamson SM, 2013, INVERTEBR NEUROSCI, V13, P63, DOI 10.1007/s10158-012-0144-7; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Winston ML, 1987, THE BIOLOGY OF THE H; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Zhang WenJun, 2011, Proceedings of the International Academy of Ecology and Environmental Sciences, V1, P125	61	39	43	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140814	10.1371/journal.pone.0140814	http://dx.doi.org/10.1371/journal.pone.0140814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488410	Green Published, gold			2022-12-27	WOS:000363248400070
J	Sheppard, DP; Kretschmer, A; Knispel, E; Vollert, B; Altgassen, M				Sheppard, Daniel Patrick; Kretschmer, Anett; Knispel, Elisa; Vollert, Bianka; Altgassen, Mareike			The Role of Extrinsic Rewards and Cue-Intention Association in Prospective Memory in Young Children	PLOS ONE			English	Article							SEMANTIC RELATEDNESS; PERFORMANCE; AGE; PRESCHOOLERS; RETRIEVAL; SALIENCE; REMEMBER; IMPACT; ADULTS	The current study examined, for the first time, the effect of cue-intention association, as well as the effects of promised extrinsic rewards, on prospective memory in young children, aged 5-years-old (n = 39) and 7-years-old (n = 40). Children were asked to name pictures for a toy mole, whilst also having to remember to respond differently to certain target pictures (prospective memory task). The level to which the target picture was associated with the intention was manipulated across two conditions (low-or high-association) for all participants, whilst half of the participants were promised a reward for good prospective memory performance. Results showed a main effect of age, with the 7-year-olds outperforming the 5-year-olds. Furthermore, there was a main effect of reward, with those promised a reward performing better than those who were not. No effect was found for cue-association, with the participants of both age groups performing equally well in both association conditions. No significant interactions were found between any of the variables. The potentially important role of reward in young children's everyday prospective memory tasks, and possible reasons for the lack of a reflexive-associative effect, are discussed.	[Sheppard, Daniel Patrick; Altgassen, Mareike] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Kretschmer, Anett; Knispel, Elisa; Vollert, Bianka; Altgassen, Mareike] Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany	Radboud University Nijmegen; Technische Universitat Dresden	Sheppard, DP (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	d.sheppard@donders.ru.nl	Altgassen, Mareike/J-3048-2012; Kretschmer-Trendowicz, Anett/L-9513-2016; Altgassen, Mareike/AAN-1767-2020	Altgassen, Mareike/0000-0002-2644-8298	 [SFB 940/1 2012]		The study was supported by SFB 940/1 2012.	Altgassen M, 2007, J INT NEUROPSYCH SOC, V13, P888, DOI 10.1017/S1355617707071068; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Arthur-Kelly M., 2003, CLASSROOM MANAGEMENT; Bartsch L, 2013, THESIS; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Causey KB, 2014, J EXP CHILD PSYCHOL, V127, P36, DOI 10.1016/j.jecp.2014.01.020; Cherner M, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200401001-00005; Clunies-Ross P, 2008, EDUC PSYCHOL-UK, V28, P693, DOI 10.1080/01443410802206700; Cook GI, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00278; Einstein GO, 2003, J EXP PSYCHOL-APPL, V9, P147, DOI 10.1037/1076-898X.9.3.147; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Einstein GO, 2000, PSYCHOL AGING, V15, P671, DOI 10.1037//0882-7974.15.4.671; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Ford RM, 2012, J EXP CHILD PSYCHOL, V111, P468, DOI 10.1016/j.jecp.2011.10.006; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Guajardo NR, 2000, COGNITIVE DEV, V15, P75, DOI 10.1016/S0885-2014(00)00016-2; Hering A, 2014, GERONTOLOGY, V60, P73, DOI 10.1159/000355057; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kliegel M, 2004, MEMORY, V12, P553, DOI 10.1080/09658210344000099; Kliegel M, 2003, INT J PSYCHOL, V38, P207, DOI 10.1080/00207590344000132; Kliegel M, 2008, DEV PSYCHOL, V44, P612, DOI 10.1037/0012-1649.44.2.612; Kliegel M, 2007, COGNITIVE DEV, V22, P33, DOI 10.1016/j.cogdev.2006.08.003; Kliegel M, 2006, DEV NEUROPSYCHOL, V30, P819, DOI 10.1207/s15326942dn3003_4; Kliegel M, 2013, J EXP CHILD PSYCHOL, V116, P792, DOI 10.1016/j.jecp.2013.07.012; Kliegel M, 2010, EUR J DEV PSYCHOL, V7, P223, DOI 10.1080/17405620802025643; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Lee K, 2013, CHILD DEV, V84, P1933, DOI 10.1111/cdev.12096; Mahy CEV, 2014, DEV REV, V34, P305, DOI 10.1016/j.dr.2014.08.001; Mahy CEV, 2014, J EXP CHILD PSYCHOL, V127, P52, DOI 10.1016/j.jecp.2014.01.006; Mahy CEV, 2011, COGNITIVE DEV, V26, P269, DOI 10.1016/j.cogdev.2011.06.002; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McCauley SR, 2011, J CLIN EXP NEUROPSYC, V33, P639, DOI 10.1080/13803395.2010.547844; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McDaniel MA, 2004, APPL COGNITIVE PSYCH, V18, P533, DOI 10.1002/acp.1002; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA, 2003, PSYCHOL AGING, V18, P823, DOI 10.1037/0882-7974.18.4.823; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Meacham J. A., 1982, MEMORY OBSERVED REME, P327; Munakata Y, 2012, CURR DIR PSYCHOL SCI, V21, P71, DOI 10.1177/0963721412436807; Penningroth S.L., 2007, PSYCHOL MOTIVATION, p(pp. 115; Pereira A, 2012, AGING NEUROPSYCHOL C, V19, P549, DOI 10.1080/13825585.2011.638977; Pereira A, 2012, CONSCIOUS COGN, V21, P1257, DOI 10.1016/j.concog.2012.04.012; Petermann F, 2008, KINDH ENTWICKL, V17, P71, DOI 10.1026/0942-5403.17.2.71; Rendell PG, 2009, COGNITIVE DEV, V24, P156, DOI 10.1016/j.cogdev.2008.12.002; Ricken G., 2007, HANNOVER WECHSLER IN; Sacktor N, 2007, J NEUROVIROL, V13, P203, DOI 10.1080/13550280701258423; SCHNEIDER W, 1992, CHILD DEV, V63, P461, DOI 10.2307/1131492; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P190, DOI 10.1037/a0017732; Slusarczyk E, 2013, COGNITIVE DEV, V28, P179, DOI 10.1016/j.cogdev.2012.10.004; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SOMERVILLE SC, 1983, J GENET PSYCHOL, V143, P87, DOI 10.1080/00221325.1983.10533537; Suddendorf T, 2011, COGNITIVE DEV, V26, P295, DOI 10.1016/j.cogdev.2011.09.001; Walsh SJ, 2014, J EXP CHILD PSYCHOL, V127, P8, DOI 10.1016/j.jecp.2013.10.003; Ward H, 2005, CHILD NEUROPSYCHOL, V11, P527, DOI 10.1080/09297040490920186; Woods SP, 2014, J INT NEUROPSYCH SOC, V20, P652, DOI 10.1017/S1355617714000435; Woods SP, 2010, J CLIN EXP NEUROPSYC, V32, P398, DOI 10.1080/13803390903130737; Zelato P. D., 2008, HDB DEV COGNITIVE NE, P553, DOI DOI 10.1002/9780470996652.CH20; Zelazo P. D., 2003, MONOGRAPHS SOC RES C, pi	59	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140987	10.1371/journal.pone.0140987	http://dx.doi.org/10.1371/journal.pone.0140987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26489046	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400093
J	Tiwari, P; Kumar, A; Das, RN; Malhotra, V; VijayRaghavan, K				Tiwari, Prabhat; Kumar, Arun; Das, Rudra Nayan; Malhotra, Vivek; VijayRaghavan, K.			A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction	PLOS ONE			English	Article							INDIRECT FLIGHT MUSCLES; MYOTENDINOUS JUNCTION; DROSOPHILA REQUIRES; COLLAGEN SECRETION; MEDIATED ADHESION; BINDING PROTEIN; MYOBLAST FUSION; PS INTEGRINS; ATTACHMENT; GENE	Tendons are fibrous connective tissue which connect muscles to the skeletal elements thus acting as passive transmitters of force during locomotion and provide appropriate body posture. Tendon-derived cues, albeit poorly understood, are necessary for proper muscle guidance and attachment during development. In the present study, we used dorsal longitudinal muscles of Drosophila and their tendon attachment sites to unravel the molecular nature of interactions between muscles and tendons. We performed a genetic screen using RNAi-mediated knockdown in tendon cells to find out molecular players involved in the formation and maintenance of myotendinous junction and found 21 candidates out of 2507 RNAi lines screened. Of these, 19 were novel molecules in context of myotendinous system. Integrin-beta PS and Talin, picked as candidates in this screen, are known to play important role in the cell-cell interaction and myotendinous junction formation validating our screen. We have found candidates with enzymatic function, transcription activity, cell adhesion, protein folding and intracellular transport function. Tango1, an ER exit protein involved in collagen secretion was identified as a candidate molecule involved in the formation of myotendinous junction. Tango1 knockdown was found to affect development of muscle attachment sites and formation of myotendinous junction. Tango1 was also found to be involved in secretion of Viking (Collagen type IV) and BM-40 from hemocytes and fat cells.	[Tiwari, Prabhat; Kumar, Arun; Das, Rudra Nayan; VijayRaghavan, K.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Malhotra, Vivek] Ctr Genom Regulat, Barcelona, Spain	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	VijayRaghavan, K (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	vijay@ncbs.res.in	Kumar, Arun/Y-7925-2018; Malhotra, Vivek/O-9811-2014; Tiwari, Prabhat/HCI-5318-2022	Kumar, Arun/0000-0003-1105-3530; Malhotra, Vivek/0000-0001-6198-7943; Tiwari, Prabhat/0000-0001-9229-4592	National Center for Biological Sciences [6192]	National Center for Biological Sciences	This work was supported by National Center for Biological Sciences 6192.	Asha H, 2003, GENETICS, V163, P203; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; BROWN NH, 1994, DEVELOPMENT, V120, P1221; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Chanana B, 2007, MECH DEVELOP, V124, P463, DOI 10.1016/j.mod.2007.03.005; Charvet B, 2013, DEVELOPMENT, V140, P4602, DOI 10.1242/dev.096024; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; Chen XC, 2010, MOL CELL BIOL, V30, P4022, DOI 10.1128/MCB.00124-10; Crossley AC, 1978, GENETICS BIOL DROSOP; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dorfman R, 2002, DEV BIOL, V252, P119, DOI 10.1006/dbio.2002.0836; FERNANDES J, 1991, DEVELOPMENT, V113, P67; Fernandes JJ, 1996, DEV BIOL, V176, P166, DOI 10.1006/dbio.1996.0125; Fernandes JJ, 1996, DEVELOPMENT, V122, P3755; FESSLER JH, 1989, ANNU REV CELL BIOL, V5, P309, DOI 10.1146/annurev.cb.05.110189.001521; FESSLER LI, 1994, METHOD ENZYMOL, V245, P271; FOGERTY FJ, 1994, DEVELOPMENT, V120, P1747; Frommer G, 1996, EMBO J, V15, P1642, DOI 10.1002/j.1460-2075.1996.tb00509.x; Ghazi A, 2003, MECH DEVELOP, V120, P519, DOI 10.1016/S0925-4773(03)00042-X; Ghazi A, 2000, DEVELOPMENT, V127, P5309; Gilsohn E, 2010, FLY, V4, P149, DOI 10.4161/fly.4.2.11231; Gilsohn E, 2010, DEVELOPMENT, V137, P785, DOI 10.1242/dev.043703; Gomez MR, 1997, DEVELOPMENT, V124, P4857; GOTWALS PJ, 1994, P NATL ACAD SCI USA, V91, P11447, DOI 10.1073/pnas.91.24.11447; Guerquin MJ, 2013, J CLIN INVEST, V123, P3564, DOI 10.1172/JCI67521; Gunage RD, 2014, ELIFE, V3, DOI 10.7554/eLife.03126; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Herold N, 2009, MOL CELL BIOL, V29, P281, DOI 10.1128/MCB.01415-08; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Iyadurai SJP, 2008, J CELL SCI, V121, P2643, DOI 10.1242/jcs.027144; James BP, 2007, MOL BIOL CELL, V18, P4190, DOI 10.1091/mbc.E06-07-0659; Kardon G, 1998, DEVELOPMENT, V125, P4019; Klapholz B, 2009, CHROMOSOMA, V118, P235, DOI 10.1007/s00412-008-0192-2; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Kulkarni V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027667; LEE JC, 1995, P NATL ACAD SCI USA, V92, P10344, DOI 10.1073/pnas.92.22.10344; Lei EP, 2002, DEV CELL, V2, P261, DOI 10.1016/S1534-5807(02)00134-X; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; Lerner DW, 2013, DEV CELL, V24, P159, DOI 10.1016/j.devcel.2012.12.005; Liu Z, 2012, CELL ADHES MIGR, V6, P4, DOI 10.4161/cam.19774; Liu Z, 2011, DEV BIOL, V359, P176, DOI 10.1016/j.ydbio.2011.08.028; Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22; Martinek N, 2002, DEV GENES EVOL, V212, P124, DOI 10.1007/s00427-002-0220-9; Martinek N, 2008, J CELL SCI, V121, P1671, DOI 10.1242/jcs.021931; Mishra RK, 2010, NAT CELL BIOL, V12, P164, DOI 10.1038/ncb2016; Moller A, 2005, J MOL BIOL, V352, P329, DOI 10.1016/j.jmb.2005.07.009; Mukherjee P, 2011, DEVELOPMENT, V138, P2347, DOI 10.1242/dev.055012; Nabel-Rosen H, 1999, MOL CELL, V4, P573, DOI 10.1016/S1097-2765(00)80208-7; NEWMAN SM, 1981, DEV BIOL, V86, P393, DOI 10.1016/0012-1606(81)90197-4; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Rodriguez-Guzman M, 2007, DEV BIOL, V302, P267, DOI 10.1016/j.ydbio.2006.09.034; Roy S, 1999, BIOESSAYS, V21, P486, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;486::AID-BIES5&gt;3.0.CO;2-M; Roy S, 1998, J CELL BIOL, V141, P1135, DOI 10.1083/jcb.141.5.1135; Saito K, 2011, MOL BIOL CELL, V22, P2301, DOI 10.1091/mbc.E11-02-0143; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Sandstrom DJ, 1999, J CELL SCI, V112, P4051; Sandstrom DJ, 1997, DEV BIOL, V181, P168, DOI 10.1006/dbio.1996.8469; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Sink H., 2006, MUSCLE DEV DROSOPHIL; Subramanian A, 2007, DEVELOPMENT, V134, P1269, DOI 10.1242/dev.000406; Subramanian A, 2014, ELIFE, V3, DOI 10.7554/eLife.02372; TAYLOR MV, 1995, CURR BIOL, V5, P740, DOI 10.1016/S0960-9822(95)00149-7; Toba G, 1999, GENETICS, V151, P725; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Weitkunat M, 2014, METHODS, V68, P2, DOI 10.1016/j.ymeth.2014.02.037; Weitkunat M, 2014, CURR BIOL, V24, P705, DOI 10.1016/j.cub.2014.02.032; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yarnitzky T, 1997, GENE DEV, V11, P2691, DOI 10.1101/gad.11.20.2691; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Yuan L, 2010, J CELL SCI, V123, P939, DOI 10.1242/jcs.063040; Zirin J, 2013, DEV BIOL, V383, P275, DOI 10.1016/j.ydbio.2013.08.029; Zraly CB, 2006, J BIOL CHEM, V281, P35305, DOI 10.1074/jbc.M607806200	82	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140976	10.1371/journal.pone.0140976	http://dx.doi.org/10.1371/journal.pone.0140976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488612	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400090
J	Garau, G; Palma, A; Lauro, GP; Mele, E; Senette, C; Manunza, B; Deiana, S				Garau, Giovanni; Palma, Amedeo; Lauro, Gian Paolo; Mele, Elena; Senette, Caterina; Manunza, Bruno; Deiana, Salvatore			Detoxification Processes from Vanadate at the Root Apoplasm Activated by Caffeic and Polygalacturonic Acids	PLOS ONE			English	Article							CA-POLYGALACTURONATE; VANADIUM; OXIDATION; REDUCTION; ACCUMULATION; CATECHOL; RHIZOPLANE; COMPLEXES; CHEMISTRY; MECHANISM	In the root apoplasm, V(V) and V(IV) toxicity can be alleviated through redox and complexation reactions involving phenolic substances and the polyuronic components. In such context we report the role of polygalacturonic acid (PGA) on the reducing activity of caffeic acid (CAF) towards V(V). The redox reaction was particularly effective at pH 2.8 leading to the formation of oxidation products with redox activity towards V(V). An o-quinone was identified as the first product of the reaction which is further involved in the formation of CAF dimers. At pH >= 3.6 the redox activity decreased and a yield in V(IV) equal to 38, 31, 21 and 14% was found at pH 3.6, 4.0. 5.0 and 6.0 respectively compared with that obtained at pH 2.8. The redox reaction was faster in the presence of PGA and a higher yield of V(IV) was found in the 4.0-6.0 pH range with respect to the CAF-V(V) binary system. The higher efficiency of the redox reaction in the presence of PGA was related with the ability of PGA to bind V(IV). The biological significance of the redox reaction between CAF and V(V), as well as the role of PGA in such reaction, was established "in vivo" using triticale plants. Results showed that PGA reduced significantly the phytotoxic effects of the V(V)-CAF system.	[Garau, Giovanni; Lauro, Gian Paolo; Mele, Elena; Senette, Caterina; Manunza, Bruno; Deiana, Salvatore] Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy; [Palma, Amedeo] CNR, Ist Sci Prod Alimentari, Sassari, Italy	University of Sassari; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR)	Garau, G (corresponding author), Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy.	ggarau@uniss.it; sadeiana@uniss.it	Garau, Giovanni/J-5362-2014; Palma, Amedeo/P-8616-2015	Garau, Giovanni/0000-0001-8292-8336; Palma, Amedeo/0000-0002-7263-4868	Sardinian Region; Ministero dell'Istruzione, dell'Universita e della Ricerca PRIN	Sardinian Region(Regione Sardegna); Ministero dell'Istruzione, dell'Universita e della Ricerca PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The authors acknowledge the support of the Sardinian Region (P.O.R. Sardegna F.S.E. 2007-2013 - Obiettivo competitivita regionale e occupazione, Asse IV Capitale umano, Linea di Attivita l.3.1.) which funded the research position of Dr. G. Garau. The support from the Ministero dell'Istruzione, dell'Universita e della Ricerca PRIN 2010-2011 is also gratefully acknowledged.	Andrezalova L, 2013, J TRACE ELEM MED BIO, V27, P21, DOI 10.1016/j.jtemb.2012.04.007; Baran EJ, 2001, J COORD CHEM, V54, P215, DOI 10.1080/00958970108022636; Borraccino R, 2001, WATER RES, V35, P3729, DOI 10.1016/S0043-1354(01)00097-5; Brimecombe MJ, 2001, RHIZOSPHERE BIOCH OR, P73; Castaldi P, 2012, J INORG BIOCHEM, V108, P30, DOI 10.1016/j.jinorgbio.2011.10.015; Castaldi P, 2010, PLANT PHYSIOL BIOCH, V48, P1008, DOI 10.1016/j.plaphy.2010.09.017; Chasteen ND, 1983, BIOCH VANADIUM STRUC, P105; CHEYNIER V, 1992, J AGR FOOD CHEM, V40, P2038, DOI 10.1021/jf00023a002; Crans DC, 2004, CHEM REV, V104, P849, DOI 10.1021/cr020607t; Crowley DE, 2001, RHIZOSPHERE BIOCH OR, P173; Deiana S, 2003, J PLANT NUTR, V26, P1909, DOI 10.1081/PLN-120024253; Deiana S, 2001, TRACE ELEMENTS IN THE RHIZOSPHERE, P127; DEIANA S, 1995, SOIL SCI SOC AM J, V59, P1301, DOI 10.2136/sssaj1995.03615995005900050014x; Deiana S, 2008, PLANT PHYSIOL BIOCH, V46, P435, DOI 10.1016/j.plaphy.2008.02.003; Deiana S, 2007, CHEMOSPHERE, V67, P1919, DOI 10.1016/j.chemosphere.2006.12.003; Dhakal RP, 2005, SEP PURIF TECHNOL, V42, P219, DOI 10.1016/j.seppur.2004.07.016; Evans L. J., 2010, Trace elements in soils, P515; FLOYD RA, 1970, PLANT SOIL, V33, P331, DOI 10.1007/BF01378226; FOSTER RC, 1986, ANNU REV PHYTOPATHOL, V24, P211; FULCRAND H, 1994, PHYTOCHEMISTRY, V35, P499, DOI 10.1016/S0031-9422(00)94790-3; Garau G, 2015, BIOL FERTILITY SOILS; GESSA C, 1992, PLANT SOIL, V140, P1, DOI 10.1007/BF00012801; Gharib F, 2008, J MOL LIQ, V138, P9, DOI 10.1016/j.molliq.2007.06.009; Greenwood N.N., 1997, CHEM ELEMENTS; Hotta H, 2002, BBA-GEN SUBJECTS, V1572, P123, DOI 10.1016/S0304-4165(02)00285-4; Hotta H, 2001, BBA-GEN SUBJECTS, V1526, P159, DOI 10.1016/S0304-4165(01)00123-4; Islam MK, 2007, BBA-GEN SUBJECTS, V1770, P1212, DOI 10.1016/j.bbagen.2007.05.003; KABATA-PENDIAS A., 2011, TRACE ELEMENTS SOILS, V4th, DOI DOI 10.1016/j.gexplo.2015.12.013; Kanamori K, 1999, J INORG BIOCHEM, V77, P157, DOI 10.1016/S0162-0134(99)00186-5; KAPLAN DI, 1990, WATER AIR SOIL POLL, V49, P81, DOI 10.1007/BF00279512; KARPISHIN TB, 1993, J AM CHEM SOC, V115, P182, DOI 10.1021/ja00054a025; KARPISHIN TB, 1993, J AM CHEM SOC, V115, P1842, DOI 10.1021/ja00058a032; Lapouge C, 2007, CHEMPHYSCHEM, V8, P473, DOI 10.1002/cphc.200600620; Leopoldini M, 2004, J PHYS CHEM A, V108, P4916, DOI 10.1021/jp037247d; Leopoldini M, 2011, FOOD CHEM, V125, P288, DOI 10.1016/j.foodchem.2010.08.012; LEPPARD GG, 1974, SCIENCE, V185, P1066, DOI 10.1126/science.185.4156.1066; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; McBride MB, 2001, COMMUN SOIL SCI PLAN, V32, P139, DOI 10.1081/CSS-100102999; Nakamoto K., 2009, INFRARED RAMAN SPECT, V6th; Olness A, 2005, IND CROP PROD, V21, P165, DOI 10.1016/j.indcrop.2004.02.005; Pettersson L, 2003, COORDIN CHEM REV, V237, P77, DOI 10.1016/S0010-8545(02)00223-0; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Saco D, 2013, BIOL PLANTARUM, V57, P128, DOI 10.1007/s10535-012-0133-z; Tazaki H, 2001, BIOSCI BIOTECH BIOCH, V65, P2613, DOI 10.1271/bbb.65.2613; Thoma V, 2008, BIOINORG CHEM APPL, V2008, DOI 10.1155/2008/624583; Tracey A. S., 2007, VANADIUM CHEM BIOCH; ULLRICHEBERIUS CI, 1989, J EXP BOT, V40, P119, DOI 10.1093/jxb/40.1.119; Vachirapatama N., 2011, Songklanakarin Journal of Science and Technology, V33, P255; Vachirapatama N, 2002, J CHROMATOGR A, V956, P221, DOI 10.1016/S0021-9673(02)00039-0; VARA F, 1982, J BIOL CHEM, V257, P2826; Williams PAM, 2002, POLYHEDRON, V21, P1979, DOI 10.1016/S0277-5387(02)01097-5; Yaul AR, 2010, RUSS J COORD CHEM+, V36, P254, DOI 10.1134/S1070328410040032	52	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141041	10.1371/journal.pone.0141041	http://dx.doi.org/10.1371/journal.pone.0141041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484667	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100103
J	Oueslati, A; Lovisa, B; Perrin, J; Wagnieres, G; van den Bergh, H; Tardy, Y; Lashuel, HA				Oueslati, Abid; Lovisa, Blaise; Perrin, John; Wagnieres, Georges; van den Bergh, Hubert; Tardy, Yanik; Lashuel, Hilal A.			Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson's Disease	PLOS ONE			English	Article							LOW-LEVEL LASER; MITOCHONDRIAL DYSFUNCTION; PHOSPHORYLATION; MECHANISMS; PREVENT; MICE	Converging lines of evidence indicate that near-infrared light treatment, also known as photobiomodulation (PBM), may exert beneficial effects and protect against cellular toxicity and degeneration in several animal models of human pathologies, including neurodegenerative disorders. In the present study, we report that chronic PMB treatment mitigates dopaminergic loss induced by unilateral overexpression of human alpha-synuclein (alpha-syn) in the substantia nigra of an AAV-based rat genetic model of Parkinson's disease (PD). In this model, daily exposure of both sides of the rat's head to 808-nm near-infrared light for 28 consecutive days alleviated alpha-syn-induced motor impairment, as assessed using the cylinder test. This treatment also significantly reduced dopaminergic neuronal loss in the injected substantia nigra and preserved dopaminergic fibers in the ipsilateral striatum. These beneficial effects were sustained for at least 6 weeks after discontinuing the treatment. Together, our data point to PBM as a possible therapeutic strategy for the treatment of PD and other related synucleinopathies.	[Oueslati, Abid; Perrin, John; Lashuel, Hilal A.] Swiss Fed Inst Technol EPFL, Brain Mind Inst, Lab Mol & Chem Biol Neurodegenerat, CH-1015 Lausanne, Switzerland; [Oueslati, Abid] Univ Laval, Ctr Rech, Ctr Hosp Quebec, Axe Neurosci, Quebec City, PQ G1V 4G2, Canada; [Oueslati, Abid] Univ Laval, Dept Med Mol, Quebec City, PQ G1V 4G2, Canada; [Lovisa, Blaise; Wagnieres, Georges; van den Bergh, Hubert] Swiss Fed Inst Technol EPFL, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Lovisa, Blaise; Tardy, Yanik] Medos Int Sarl, CH-2400 Le Locle, Switzerland; [Lashuel, Hilal A.] Hamad Bin Khalifa Univ, Qatar Fdn, Qatar Biomed Res Inst, Doha, Qatar	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Laval University; Laval University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI)	Oueslati, A (corresponding author), Swiss Fed Inst Technol EPFL, Brain Mind Inst, Lab Mol & Chem Biol Neurodegenerat, CH-1015 Lausanne, Switzerland.	Abid.Oueslati@crchudequebec.ulaval.ca; hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Oueslati, Abid/ABG-8116-2020	Oueslati, Abid/0000-0003-1122-7086; Wagnieres, Georges/0000-0002-9082-3099	Medos International Sarl, a JohnsonJohnson company; Ecole Polytechnique Federal de Lausanne; Commission for Technology and Innovation (CTI); CTI projects [13758.1, 14660.1]; Swiss National Science Foundation (SNSF) [205320_147141, CR32I3_159746]	Medos International Sarl, a JohnsonJohnson company; Ecole Polytechnique Federal de Lausanne; Commission for Technology and Innovation (CTI); CTI projects; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was in part supported by Medos International Sarl, a Johnson&Johnson company. The funder provided support in the form of salaries for authors [BL, YT], but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. HAL, GW, HvdB and AO were supported by the Ecole Polytechnique Federal de Lausanne and JP and BL were supported by the Commission for Technology and Innovation (CTI). Additional supports were provided by the CTI projects 13758.1 and 14660.1, and the Swiss National Science Foundation (SNSF) projects No 205320_147141 and CR32I3_159746.	Avci P, 2013, SEMIN CUTAN MED SURG, V32, P41; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Decressac M, 2012, EXP NEUROL, V235, P306, DOI 10.1016/j.expneurol.2012.02.012; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Gupta A, 2014, LASER MED SCI, V29, P257, DOI 10.1007/s10103-013-1319-0; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Jankovic Joseph, 2008, Neuropsychiatr Dis Treat, V4, P743; Karu T, 2010, PHOTOMED LASER SURG, V28, P159, DOI 10.1089/pho.2010.2789; Kirik D, 2002, P NATL ACAD SCI USA, V99, P4708, DOI 10.1073/pnas.062047599; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; McCormack AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012122; Mullin S, 2013, MOL NEUROBIOL, V47, P587, DOI 10.1007/s12035-013-8394-x; Nash KR, 2015, MOL THER, V23, P17, DOI 10.1038/mt.2014.175; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Olanow CW, 2013, ANN NEUROL, V74, P337, DOI 10.1002/ana.24011; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Oueslati A, 2012, J NEUROSCI, V32, P1536, DOI 10.1523/JNEUROSCI.3784-11.2012; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Peoples Cassandra, 2012, ISRN Neurol, V2012, P850150, DOI 10.5402/2012/850150; Peoples C, 2012, PARKINSONISM RELAT D, V18, P469, DOI 10.1016/j.parkreldis.2012.01.005; Purushothuman S, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt232; Purushothuman S, 2013, BRAIN RES, V1535, P61, DOI 10.1016/j.brainres.2013.08.047; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shaw VE, 2010, J COMP NEUROL, V518, P25, DOI 10.1002/cne.22207; Spatola Marianna, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS35, DOI 10.1016/S1353-8020(13)70011-7; Trancikova A, 2012, ANTIOXID REDOX SIGN, V16, P896, DOI 10.1089/ars.2011.4200; Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132; Ulusoy Ayse, 2010, Prog Brain Res, V184, P89, DOI 10.1016/S0079-6123(10)84005-1; Vos M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078562; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wilden L, 1998, J CLIN LASER MED SUR, V16, P159, DOI 10.1089/clm.1998.16.159; Wong-Riley MTT, 2001, NEUROREPORT, V12, P3033, DOI 10.1097/00001756-200110080-00011	38	32	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140880	10.1371/journal.pone.0140880	http://dx.doi.org/10.1371/journal.pone.0140880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484876	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100083
J	Panda, A; Khalil, S; Mirdha, BR; Singh, Y; Kaushik, S				Panda, Ashutosh; Khalil, Shehla; Mirdha, Bijay Ranjan; Singh, Yogita; Kaushik, Samander			Prevalence of Naegleria fowleri in Environmental Samples from Northern Part of India	PLOS ONE			English	Article							FREE-LIVING AMEBAS; INTERNAL TRANSCRIBED SPACERS; MENINGOENCEPHALITIS; WATER; IDENTIFICATION; ACANTHAMOEBA; MENINGITIS; DIAGNOSIS; SURVIVAL; STRAINS	Naegleria fowleri the causative agent of Primary Amoebic Meningoencephalitis, is ubiquitously distributed worldwide in various warm aquatic environments and soil habitats. The present study reports on the presence of Naegleria spp. in various water bodies present in Rohtak and Jhajjar district, of state Haryana, India. A total of 107 water reservoirs were screened from summer till autumn (2012 and 2013). In order to isolate Naegleria spp. from the collected water samples, the water samples were filtered and the trapped debris after processing were transferred to non-nutrient agar plates already seeded with lawn culture of Escherichia coli. Out of total 107 water samples, 43 (40%) samples were positive by culture for free living amoeba after incubation for 14 days at 37 degrees C. To identify the isolates, the ITS1, 5.8SrDNA and ITS2 regions were targeted for PCR assay. Out of total 43 positive samples, 37 isolates were positive for Naegleria spp. using genus specific primers and the most frequently isolated species was Naegleria australiensis. Out of 37 Naegleria spp. positive isolates, 1 isolate was positive for Naegleria fowleri. The sequence analysis revealed that the Naegleria fowleri strain belonged to Type 2.	[Panda, Ashutosh; Khalil, Shehla; Mirdha, Bijay Ranjan; Singh, Yogita] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India; [Kaushik, Samander] Maharshi Dayanand Univ, Ctr Biotechnol, Rohtak, Haryana, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Maharshi Dayanand University	Mirdha, BR (corresponding author), All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India.	mirdhabr2078@gmail.com	Panda, Ashutosh/AAK-7851-2020	Kaushik, Samander/0000-0003-4835-6383	Defence Research and Development Organization (DRDO) [DLS/81/48222/LSRB-219/BTB/2010]	Defence Research and Development Organization (DRDO)(Defence Research & Development Organisation (DRDO))	Defence Research and Development Organization (DRDO) has provided the funds to carry out this research work (Grant No. DLS/81/48222/LSRB-219/BTB/2010).	Angrup A., 2010, J I MED NEPAL, V32, P56; Barnett NDP, 1996, PEDIATR NEUROL, V15, P230, DOI 10.1016/S0887-8994(96)00173-7; Behets J, 2007, PARASITOL RES, V100, P1249, DOI 10.1007/s00436-006-0399-1; BOSE K, 1990, BRAZ J MED BIOL RES, V23, P1271; Carraway M, 1996, APPL ENVIRON MICROB, V62, P712, DOI 10.1128/AEM.62.2.712-716.1996; De Jonckheere JF, 2004, PROTIST, V155, P89, DOI 10.1078/1434461000167; De Jonckheere JF, 2002, ACTA PROTOZOOL, V41, P309; De Jonckheere JF, 1998, PROTIST, V149, P221, DOI 10.1016/S1434-4610(98)70030-6; De Jonckheere JF, 2011, INFECT GENET EVOL, V11, P1520, DOI 10.1016/j.meegid.2011.07.023; Ettinger MR, 2003, PARASITOL RES, V89, P6, DOI 10.1007/s00436-002-0707-3; Garstecki T, 2005, EUR J PROTISTOL, V41, P119, DOI 10.1016/j.ejop.2005.01.003; Gautam PL, 2012, INDIAN J CRIT CARE M, V16, P34, DOI 10.4103/0972-5229.94432; Gianinazzi C, 2010, EXP PARASITOL, V126, P45, DOI 10.1016/j.exppara.2009.12.008; Gianinazzi C, 2009, RES MICROBIOL, V160, P367, DOI 10.1016/j.resmic.2009.06.007; GOGATE A, 1985, T ROY SOC TROP MED H, V79, P134, DOI 10.1016/0035-9203(85)90258-5; Gornik K, 2004, ANN AGR ENV MED, V11, P233; Gupta N, 2009, BRAZ J INFECT DIS, V13, P236, DOI 10.1590/S1413-86702009000300016; GUPTA S, 1992, T ROY SOC TROP MED H, V86, P46, DOI 10.1016/0035-9203(92)90436-G; Hebbar S, 2005, ANN TROP PAEDIATR, V25, P223, DOI 10.1179/146532805X58166; Huang SW, 2011, ACTA TROP, V119, P114, DOI 10.1016/j.actatropica.2011.04.016; Ithoi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024327; Jain R, 2002, NEUROL INDIA, V50, P470; JOHN DT, 1995, PARASITOL RES, V81, P193; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Kaushal V, 2008, J Assoc Physicians India, V56, P459; Khanna V, 2011, CASE REP NEUROL MED, V2011, DOI 10.1155/2011/782539; Kilvington S, 2004, INVEST OPHTH VIS SCI, V45, P165, DOI 10.1167/iovs.03-0559; Lorenzo-Morales J, 2005, ANN TROP MED PARASIT, V99, P751, DOI 10.1179/136485905X65215; Lorenzo-Morales J, 2006, ACTA TROP, V100, P63, DOI 10.1016/j.actatropica.2006.09.008; MALHOTRA KK, 1978, J TROP MED HYG, V81, P113; Marciano-Cabral F, 2009, J INFECT DIS, V199, P1104, DOI 10.1086/597474; MARCIANOCABRAL F, 1988, MICROBIOL REV, V52, P114, DOI 10.1128/MMBR.52.1.114-133.1988; Moussa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054414; Pelandakis M, 2000, J EUKARYOT MICROBIOL, V47, P116, DOI 10.1111/j.1550-7408.2000.tb00020.x; Rai R, 2008, INDIAN PEDIATR, V45, P1004; SCAGLIA M, 1983, APPL ENVIRON MICROB, V46, P1282, DOI 10.1128/AEM.46.6.1282-1285.1983; Schild M, 2007, J CLIN MICROBIOL, V45, P564, DOI 10.1128/JCM.01357-06; Schuster FL, 2004, INT J PARASITOL, V34, P1001, DOI 10.1016/j.ijpara.2004.06.004; Sheehan KB, 2003, APPL ENVIRON MICROB, V69, P5914, DOI 10.1128/AEM.69.10.5914-5918.2003; Shenoy S, 2002, J CLIN MICROBIOL, V40, P309, DOI 10.1128/JCM.40.1.309-310.2002; Shoff ME, 2008, J WATER HEALTH, V6, P99, DOI 10.2166/wh.2007.014; Singh P, 2006, AM J NEURORADIOL, V27, P1217; Singh S N, 1998, Indian Pediatr, V35, P1012; Sood A, 2014, INDIAN J MED MICROBI, V32, P193, DOI 10.4103/0255-0857.129834; Tilak R., 2008, INDIAN J PREVENTIVE, V39, P178; Tsvetkova N, 2004, PARASITOL RES, V92, P405, DOI 10.1007/s00436-003-1052-x; Tungikar S L, 2006, J Assoc Physicians India, V54, P327; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; Wang W, 2014, IRAN J PARASITOL, V9, P254; Yadav D, 2013, INDIAN J PEDIATR, V80, P253, DOI 10.1007/s12098-012-0756-2	50	25	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0137736	10.1371/journal.pone.0137736	http://dx.doi.org/10.1371/journal.pone.0137736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484533	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100003
J	Chen, Y; Wang, XM; Zhou, L; He, Y; Wang, D; Qi, YH; Jiang, DA				Chen, Yue; Wang, Xiao-Man; Zhou, Li; He, Yi; Wang, Dun; Qi, Yan-Hua; Jiang, De-An			Rubisco Activase Is Also a Multiple Responder to Abiotic Stresses in Rice	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE OXYGENASE; GIBBERELLIN-BINDING PHOSPHOPROTEIN; HEAT-STRESS; DROUGHT STRESS; 2 ISOFORMS; PROTEIN; EXPRESSION; SPINACH; PHOTOSYNTHESIS; ACCLIMATION	Ribulose-1,5-bisphosphate carboxylase/oxygenase activase (RCA) is a nuclear gene that encodes a chloroplast protein that plays an important role in photosynthesis. Some reports have indicated that it may play a role in acclimation to different abiotic stresses. In this paper, we analyzed the stress-responsive elements in the 2.0 kb 5'-upstream regions of the RCA gene promoter and the primary, secondary and tertiary structure of the protein. We identified some cis-elements of multiple stress-related components in the RCA promoter. Amino acid and evolution analyses showed that the RCA protein had conserved regions between different species; however, the size and type varied. The secondary structures, binding sites and tertiary structures of the RCA proteins were also different. This might reflect the differences in the transcription and translation levels of the two RCA isoforms during adaptation to different abiotic stresses. Although both the transcription and translation levels of RCA isoforms in the rice leaves increased under various stresses, the large isoform was increased more significantly in the chloroplast stroma and thylakoid. It can be concluded that RCA, especially RCA(L), is also a multiple responder to abiotic stresses in rice, which provides new insights into RCA functions.	[Chen, Yue; Wang, Xiao-Man; Zhou, Li; He, Yi; Wang, Dun; Qi, Yan-Hua; Jiang, De-An] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Jiang, DA (corresponding author), Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310058, Zhejiang, Peoples R China.	dajiang@zju.edu.cn	wang, xiaoman/GQH-0836-2022; He, Yi/Z-4347-2019	He, Yi/0000-0003-0465-7352				ANDREWS TJ, 1995, J EXP BOT, V46, P1293, DOI 10.1093/jxb/46.special_issue.1293; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; DEJIMENEZ ES, 1995, BIOCHEMISTRY-US, V34, P2826, DOI 10.1021/bi00009a012; Guha A, 2013, J PHOTOCH PHOTOBIO B, V119, P71, DOI 10.1016/j.jphotobiol.2012.12.006; Ji KX, 2012, J PLANT PHYSIOL, V169, P336, DOI 10.1016/j.jplph.2011.10.010; Kallis RP, 2000, PLANT PHYSIOL, V123, P1077, DOI 10.1104/pp.123.3.1077; Kaur C, 2014, PHYSIOL PLANTARUM, V152, P1, DOI 10.1111/ppl.12147; Komatsu S, 1996, FEBS LETT, V384, P167, DOI 10.1016/0014-5793(96)00275-X; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; Law RD, 1999, PLANT PHYSIOL, V120, P173, DOI 10.1104/pp.120.1.173; Law RD, 2001, PLANTA, V214, P117, DOI 10.1007/s004250100592; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu B, 2012, PLANT CELL REP, V31, P1021, DOI 10.1007/s00299-011-1220-x; Nakamura R, 2014, J PROTEOME RES, V13, P489, DOI 10.1021/pr4006487; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; QIAN J, 1993, PLANT PHYSIOL, V102, P683, DOI 10.1104/pp.102.2.683; ROBINSON SP, 1989, PLANT PHYSIOL, V90, P968, DOI 10.1104/pp.90.3.968; Rokka A, 2001, PLANT J, V25, P463, DOI 10.1046/j.1365-313x.2001.00981.x; Rollins JA, 2013, J EXP BOT, V64, P3201, DOI 10.1093/jxb/ert158; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RUNDLE SJ, 1991, J BIOL CHEM, V266, P14802; Sage RF, 2008, J EXP BOT, V59, P1581, DOI 10.1093/jxb/ern053; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Salvucci ME, 2003, PLANTA, V216, P736, DOI 10.1007/s00425-002-0923-1; Sharma A, 2002, BIOCHEM BIOPH RES CO, V290, P690, DOI 10.1006/bbrc.2001.6269; SHEN JB, 1991, J BIOL CHEM, V266, P8963; Son JA, 2014, SAUDI J BIOL SCI, V21, P89, DOI 10.1016/j.sjbs.2013.06.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; To KY, 1999, PLANTA, V209, P66, DOI 10.1007/s004250050607; Wang D, 2010, PHYSIOL PLANTARUM, V139, P55, DOI 10.1111/j.1399-3054.2009.01344.x; Way DA, 2008, PLANT CELL ENVIRON, V31, P1250, DOI 10.1111/j.1365-3040.2008.01842.x; WERNEKE JM, 1989, PLANT CELL, V1, P815, DOI 10.1105/tpc.1.8.815; WERNEKE JM, 1988, P NATL ACAD SCI USA, V85, P787, DOI 10.1073/pnas.85.3.787; Yamori W, 2006, PLANT CELL ENVIRON, V29, P1659, DOI 10.1111/j.1365-3040.2006.01550.x; Yang ZP, 2012, BIOCHEM BIOPH RES CO, V418, P565, DOI 10.1016/j.bbrc.2012.01.073; Yin ZT, 2010, PLANT PHYSIOL, V152, P1625, DOI 10.1104/pp.109.148312; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang N, 1999, P NATL ACAD SCI USA, V96, P9438, DOI 10.1073/pnas.96.16.9438; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999; Zhang N, 2001, PHOTOSYNTH RES, V68, P29, DOI 10.1023/A:1011845506196	44	37	41	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140934	10.1371/journal.pone.0140934	http://dx.doi.org/10.1371/journal.pone.0140934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479064	gold, Green Submitted, Green Published			2022-12-27	WOS:000363026600026
J	Liu, QL; Krishnasamy, Y; Rehman, H; Lemasters, JJ; Schnellmann, RG; Zhong, Z				Liu, Qinlong; Krishnasamy, Yasodha; Rehman, Hasibur; Lemasters, John J.; Schnellmann, Rick G.; Zhong, Zhi			Disrupted Renal Mitochondrial Homeostasis after Liver Transplantation in Rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; PROLIFERATOR-ACTIVATED RECEPTOR; ACUTE TUBULAR-NECROSIS; CRITICAL ILLNESS; ISCHEMIA-REPERFUSION; HEPATORENAL-SYNDROME; MAMMALIAN-CELLS; PROTEIN-KINASE; RISK-FACTORS; BIOGENESIS	Background Suppressed mitochondrial biogenesis (MB) contributes to acute kidney injury (AKI) after many insults. AKI occurs frequently after liver transplantation (LT) and increases mortality. This study investigated whether disrupted mitochondrial homeostasis plays a role in AKI after LT. Methods Livers were explanted from Lewis rats and implanted after 18 h cold storage. Kidney and blood were collected 18 h after LT. Results In the kidney, oxidative phosphorylation (OXPHOS) proteins ATP synthase-beta and NADH dehydrogenase-3 decreased 44% and 81%, respectively, with marked reduction in associated mRNAs. Renal PGC-1 alpha, the major regulator of MB, decreased 57% with lower mRNA and increased acetylation, indicating inhibited synthesis and suppressed activation. Mitochondrial transcription factor-A, which controls mtDNA replication and transcription, protein and mRNA decreased 66% and 68%, respectively, which was associated with 64% decreases in mtDNA. Mitochondrial fission proteins Drp-1 and Fis-1 and mitochondrial fusion protein mitofusin-1 all decreased markedly. In contrast, PTEN-induced putative kinase 1 and microtubule-associated protein 1A/1B-light chain 3 increased markedly after LT, indicating enhanced mitophagy. Concurrently, 18- and 13-fold increases in neutrophil gelatinase-associated lipocalin and cleaved caspase-3 occurred in renal tissue. Both serum creatinine and blood urea nitrogen increased >= 2 fold. Mild to moderate histological changes were observed in the kidney, including loss of brush border, vacuolization of tubular cells in the cortex, cast formation and necrosis in some proximal tubular cells. Finally, myeloperoxidase and ED-1 also increased, indicating inflammation. Conclusion Suppression of MB, inhibition of mitochondrial fission/fusion and enhancement of mitophagy occur in the kidneys of recipients of liver grafts after long cold storage, which may contribute to the occurrence of AKI and increased mortality after LT.	[Liu, Qinlong; Krishnasamy, Yasodha; Rehman, Hasibur; Lemasters, John J.; Schnellmann, Rick G.; Zhong, Zhi] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Liu, Qinlong] Dalian Med Univ, Affiliated Hosp 2, Dalian, Liaoning Provin, Peoples R China; [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Schnellmann, Rick G.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; Dalian Medical University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Zhong, Z (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	zhong@musc.edu	Rehman, Hasibur/K-5224-2019	Rehman, Hasibur/0000-0003-1551-6520	National Institutes of Health [DK70844, DK073336, DK037034]; Chinese National Natural Foundation [81470878]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037034, R56DK037034, R01DK037034, R01DK073336, R01DK070844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R41ES023767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Natural Foundation(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by grants DK70844, DK073336 and DK037034 from the National Institutes of Health and grant #81470878 from Chinese National Natural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqahtani SA, 2012, CURR OPIN GASTROEN, V28, P230, DOI 10.1097/MOG.0b013e3283527f16; Altamirano J, 2012, CLIN GASTROENTEROL H, V10, P65, DOI 10.1016/j.cgh.2011.09.011; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Bagshaw SM, 2010, CAN J ANESTH, V57, P985, DOI 10.1007/s12630-010-9375-4; Bagshaw SM, 2010, CAN J ANESTH, V57, P999, DOI 10.1007/s12630-010-9376-3; Bahirwani R, 2011, TRANSPLANTATION, V92, P952, DOI 10.1097/TP.0b013e31822e6eda; Barri YM, 2009, LIVER TRANSPLANT, V15, P475, DOI 10.1002/lt.21682; Biancofiorea G, 2008, CURR OPIN ORGAN TRAN, V13, P291, DOI 10.1097/MOT.0b013e328300a058; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cabezuelo JB, 2006, KIDNEY INT, V69, P1073, DOI 10.1038/sj.ki.5000216; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Choi HK, 2011, J CLIN VIROL, V52, P192, DOI 10.1016/j.jcv.2011.07.013; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; Dikov D, 2011, EMBO J, V30, P2751, DOI 10.1038/emboj.2011.219; FOX IJ, 1993, AM J GASTROENTEROL, V88, P1876; Fraley DS, 1998, KIDNEY INT, V54, P518, DOI 10.1046/j.1523-1755.1998.00004.x; Francoz C, 2012, CRIT CARE, V16, DOI 10.1186/cc11207; Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Garrett SM, 2014, J PHARMACOL EXP THER, V350, P257, DOI 10.1124/jpet.114.214700; Gonwa TA, 2006, AM J TRANSPLANT, V6, P2651, DOI 10.1111/j.1600-6143.2006.01526.x; Gunst J, 2013, CRIT CARE MED, V41, P182, DOI 10.1097/CCM.0b013e3182676657; Harland RC, 1996, J HEPATOL, V25, P248, DOI 10.1016/S0168-8278(96)80082-1; Herrmann JM, 2012, ADV EXP MED BIOL, V748, P41, DOI 10.1007/978-1-4614-3573-0_3; Holt S, 1999, KIDNEY INT, V55, P271, DOI 10.1046/j.1523-1755.1999.00252.x; Hoppins S, 2014, CURR OPIN CELL BIOL, V29, P46, DOI 10.1016/j.ceb.2014.03.005; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Iglesias JI, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-30; Ishihara M, 2013, AM J PHYSIOL-RENAL, V305, pF495, DOI 10.1152/ajprenal.00642.2012; Jesinkey SR, 2014, J AM SOC NEPHROL, V25, P1157, DOI 10.1681/ASN.2013090952; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Korrapati MC, 2012, J PHARMACOL EXP THER, V341, P126, DOI 10.1124/jpet.111.190249; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lee HT, 2009, LAB INVEST, V89, P196, DOI 10.1038/labinvest.2008.124; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041834; MANDAL AK, 1982, AM J KIDNEY DIS, V2, P363, DOI 10.1016/S0272-6386(82)80096-6; MANNY J, 1980, ISRAEL J MED SCI, V16, P153; MCCAULEY J, 1990, NEPHRON, V55, P121, DOI 10.1159/000185938; Mehta RL, 2003, J AM SOC NEPHROL, V14, P2178, DOI 10.1097/01.ASN.0000079042.13465.1A; Mehta RL, 2003, SEMIN NEPHROL, V23, P283, DOI 10.1016/S0270-9295(03)00064-0; Nadim MK, 2012, LIVER TRANSPLANT, V18, P539, DOI 10.1002/lt.23384; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; O'Riordan A, 2009, NEPHROL DIAL TRANSPL, V24, P2276, DOI 10.1093/ndt/gfp112; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Parikh SM, 2015, SEMIN NEPHROL, V35, P108, DOI 10.1016/j.semnephrol.2015.01.011; Pham PTT, 2009, ADV CHRONIC KIDNEY D, V16, P256, DOI 10.1053/j.ackd.2009.04.002; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Pirola L, 2012, MOL CELL ENDOCRINOL, V362, P1, DOI 10.1016/j.mce.2012.05.011; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Redmann M, 2014, INT J BIOCHEM CELL B, V53, P127, DOI 10.1016/j.biocel.2014.05.010; Rehman H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065029; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Sampaio MS, 2014, CLIN LIVER DIS, V18, P543, DOI 10.1016/j.cld.2014.05.003; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Smith JA, 2015, J PHARMACOL EXP THER, V352, P346, DOI 10.1124/jpet.114.221085; Stallons L Jay, 2013, Curr Pathobiol Rep, V1, DOI 10.1007/s40139-013-0023-x; Stallons LJ, 2014, TOXICOL LETT, V224, P326, DOI 10.1016/j.toxlet.2013.11.014; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wadei HM, 2013, J INTENSIVE CARE MED, V28, P79, DOI 10.1177/0885066611408692; Warner NS, 2011, J INVEST MED, V59, P1244, DOI 10.2130/JIM.0b013e3182321471; Weber ML, 2012, LIVER TRANSPLANT, V18, P1290, DOI 10.1002/lt.23522; Wertheim JA, 2012, CURR OPIN ORGAN TRAN, V17, P235, DOI 10.1097/MOT.0b013e3283534ec9; Winder WW, 2006, MED SCI SPORT EXER, V38, P1945, DOI 10.1249/01.mss.0000233798.62153.50; Zhong Z, 2008, AM J PHYSIOL-GASTR L, V295, pG823, DOI 10.1152/ajpgi.90287.2008; Zhu M, 2010, TRANSPL P, V42, P3634, DOI 10.1016/j.transproceed.2010.08.059; Zsengeller ZK, 2012, J HISTOCHEM CYTOCHEM, V60, P521, DOI 10.1369/0022155412446227	77	4	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140906	10.1371/journal.pone.0140906	http://dx.doi.org/10.1371/journal.pone.0140906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480480	Green Published, gold, Green Submitted			2022-12-27	WOS:000363026600025
J	Torkashvand, F; Vaziri, B; Maleknia, S; Heydari, A; Vossoughi, M; Davami, F; Mahboudi, F				Torkashvand, Fatemeh; Vaziri, Behrouz; Maleknia, Shayan; Heydari, Amir; Vossoughi, Manouchehr; Davami, Fatemeh; Mahboudi, Fereidoun			Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; SERUM-FREE MEDIUM; CHO-CELLS; OPTIMIZATION; MEDIA; GLYCOSYLATION; METABOLISM; COMPONENTS; HYBRIDOMA	Cell culture feeds optimization is a critical step in process development of pharmaceutical recombinant protein production. Amino acids are the basic supplements of mammalian cell culture feeds with known effect on their growth promotion and productivity. In this study, we reported the implementation of the Plackett-Burman (PB) multifactorial design to screen the effects of amino acids on the growth promotion and productivity of a Chinese hamster ovary DG-44 (CHO-DG44) cell line producing bevacizumab. After this screening, the amino acid combinations were optimized by the response surface methodology (RSM) to determine the most effective concentration in feeds. Through this strategy, the final monoclonal antibody (mAb) titre was enhanced by 70%, compared to the control group. For this particular cell line, aspartic acid, glutamic acid, arginine and glycine had the highest positive effects on the final mAb titre. Simultaneously, the impact of the designed amino acid feed on some critical quality attributes of bevacizumab was examined in the group with highest productivity. The product was analysed for N-glycan profiles, charge variant distribution, and low molecular weight forms. The results showed that the target product quality has been improved using this feeding strategy. It was shown how this strategy could significantly diminish the time and number of experiments in identifying the most effective amino acids and related concentrations in target product enhancement. This model could be successfully applied to other components of culture media and feeds.	[Torkashvand, Fatemeh; Vaziri, Behrouz; Davami, Fatemeh; Mahboudi, Fereidoun] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran; [Maleknia, Shayan] Aryogen Biopharma Inc, Proc Dev Dept, Alborz, Iran; [Heydari, Amir; Vossoughi, Manouchehr] Sharif Univ Technol, Dept Chem & Petr Engn, Biochem & Bioenvironm Res Ctr, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Sharif University of Technology	Vaziri, B (corresponding author), Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran.	behrouz-vaziri@pasteur.ac.ir; mahboudi@pasteur.ac.ir	Heydari, Amir/W-6408-2019; Davami, Fatemeh/L-8916-2017; Mahboudi, Fereidoun/L-5057-2017; Vaziri, Behrouz/B-4619-2009; Torkashvand, Fatemeh/K-4247-2018	Heydari, Amir/0000-0001-8357-6694; Davami, Fatemeh/0000-0002-7693-2926; Mahboudi, Fereidoun/0000-0002-3380-5257; Torkashvand, Fatemeh/0000-0003-3066-1144	Aryogen Biopharma Inc.	Aryogen Biopharma Inc.	This work was funded by Aryogen Biopharma Inc. The funder provided support in the form of salaries for S. A., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Ahuja SK, 2004, BIOTECHNOL BIOENG, V85, P666, DOI 10.1002/bit.10880; Altamirano C, 2004, J BIOTECHNOL, V110, P171, DOI 10.1016/j.jbiotec.2004.02.004; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Carrillo-Cocom LM, 2015, CYTOTECHNOLOGY, V67, P809, DOI 10.1007/s10616-014-9720-5; Chen PF, 2005, J BIOTECHNOL, V117, P277, DOI 10.1016/j.jbiotec.2005.02.003; Chong WPK, 2010, J BIOTECHNOL, V147, P116, DOI 10.1016/j.jbiotec.2010.03.018; Chong WPK, 2012, BIOTECHNOL BIOENG, V109, P3103, DOI 10.1002/bit.24580; Costa AR, 2010, EUR J PHARM BIOPHARM, V74, P127, DOI 10.1016/j.ejpb.2009.10.002; del Val IJ, 2010, BIOTECHNOL PROGR, V26, P1505, DOI 10.1002/btpr.470; deZengotita VM, 2002, BIOTECHNOL BIOENG, V78, P741, DOI 10.1002/bit.10255; DUVAL D, 1991, BIOTECHNOL BIOENG, V38, P561, DOI 10.1002/bit.260380602; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Gheshlaghi R, 2005, BIOTECHNOL BIOENG, V90, P754, DOI 10.1002/bit.20474; Ghorbaniaghdam A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090832; Gonzalez-Leal IJ, 2011, BIOTECHNOL PROGR, V27, P1709, DOI 10.1002/btpr.674; Gramer MJ, 2011, BIOTECHNOL BIOENG, V108, P1591, DOI 10.1002/bit.23075; Hanczko R, 2007, J CHROMATOGR A, V1163, P25, DOI 10.1016/j.chroma.2007.06.013; HANSEN HA, 1994, APPL MICROBIOL BIOT, V41, P560, DOI 10.1007/BF00178489; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Jordan M, 2013, CYTOTECHNOLOGY, V65, P31, DOI 10.1007/s10616-012-9462-1; Kim EJ, 1998, IN VITRO CELL DEV-AN, V34, P757, DOI 10.1007/s11626-998-0029-6; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Kishishita S, 2015, J BIOSCI BIOENG, V120, P78, DOI 10.1016/j.jbiosc.2014.11.022; Li F, 2010, MABS-AUSTIN, V2, P466, DOI 10.4161/mabs.2.5.12720; Parampalli A, 2007, CYTOTECHNOLOGY, V54, P57, DOI 10.1007/s10616-007-9074-3; Quek LE, 2010, METAB ENG, V12, P161, DOI 10.1016/j.ymben.2009.09.002; Read EK, 2013, BIOTECHNOL PROGR, V29, P745, DOI 10.1002/btpr.1728; Rispoli F, 2009, BIOTECHNOL PROGR, V25, P980, DOI 10.1002/btpr.225; Rouiller Y, 2014, BIOTECHNOL PROGR, V30, P571, DOI 10.1002/btpr.1921; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445; Sen S, 2013, CYTOTECHNOLOGY, V65, P233, DOI 10.1007/s10616-012-9480-z; Stockert R J, 1991, Targeted Diagn Ther, V4, P41; Tao YX, 2006, MOL IMMUNOL, V43, P335, DOI 10.1016/j.molimm.2005.02.018; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Zhang HF, 2013, CYTOTECHNOLOGY, V65, P363, DOI 10.1007/s10616-012-9488-4; Zhang YX, 2009, ADV BIOCHEM ENG BIOT, V113, P177, DOI 10.1007/10_2008_19	40	36	39	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140597	10.1371/journal.pone.0140597	http://dx.doi.org/10.1371/journal.pone.0140597			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480023	Green Published, Green Submitted, gold			2022-12-27	WOS:000363026600014
J	Ding, H; Guo, MH; Vidhyasagar, V; Talwar, T; Wu, YL				Ding, Hao; Guo, Manhong; Vidhyasagar, Venkatasubramanian; Talwar, Tanu; Wu, Yuliang			The Q Motif Is Involved in DNA Binding but Not ATP Binding in ChlR1 Helicase	PLOS ONE			English	Article							WARSAW BREAKAGE SYNDROME; SINGLE-STRANDED-DNA; BOX RNA HELICASES; CRYSTAL-STRUCTURE; IN-VITRO; BIOCHEMICAL-CHARACTERIZATION; STRUCTURAL BASIS; REPAIR; PROTEIN; DOMAIN	Helicases are molecular motors that couple the energy of ATP hydrolysis to the unwinding of structured DNA or RNA and chromatin remodeling. The conversion of energy derived from ATP hydrolysis into unwinding and remodeling is coordinated by seven sequence motifs (I, Ia, II, III, IV, V, and VI). The Q motif, consisting of nine amino acids (GFXXPXPIQ) with an invariant glutamine (Q) residue, has been identified in some, but not all helicases. Compared to the seven well-recognized conserved helicase motifs, the role of the Q motif is less acknowledged. Mutations in the human ChlR1 (DDX11) gene are associated with a unique genetic disorder known as Warsaw Breakage Syndrome, which is characterized by cellular defects in genome maintenance. To examine the roles of the Q motif in ChlR1 helicase, we performed site directed mutagenesis of glutamine to alanine at residue 23 in the Q motif of ChlR1. ChlR1 recombinant protein was overexpressed and purified from HEK293T cells. ChlR1-Q23A mutant abolished the helicase activity of ChlR1 and displayed reduced DNA binding ability. The mutant showed impaired ATPase activity but normal ATP binding. A thermal shift assay revealed that ChlR1-Q23A has a melting point value similar to ChlR1-WT. Partial proteolysis mapping demonstrated that ChlR1-WT and Q23A have a similar globular structure, although some subtle conformational differences in these two proteins are evident. Finally, we found ChlR1 exists and functions as a monomer in solution, which is different from FANCJ, in which the Q motif is involved in protein dimerization. Taken together, our results suggest that the Q motif is involved in DNA binding but not ATP binding in ChlR1 helicase.	[Ding, Hao; Guo, Manhong; Vidhyasagar, Venkatasubramanian; Talwar, Tanu; Wu, Yuliang] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Wu, YL (corresponding author), Univ Saskatchewan, Dept Biochem, Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 0W0, Canada.	yuliang.wu@usask.ca	Vidhyasagar, Venkatasubramanian/M-9442-2013	Vidhyasagar, Venkatasubramanian/0000-0001-8679-4021	Natural Sciences and Engineering Research Council of Canada (NSERC) [418480]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by The Natural Sciences and Engineering Research Council of Canada (NSERC) to YW (No. 418480). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2012, INT J MULTIDISCIP SC, V3, P7, DOI DOI 10.1371/J0URNAL.P0NE.0049385; Andreou AZ, 2014, J MOL BIOL, V426, P51, DOI 10.1016/j.jmb.2013.09.027; Bailey C, 2015, EUR J MED GENET, V58, P235, DOI 10.1016/j.ejmg.2015.02.001; Banroques J, 2011, J MOL BIOL, V413, P451, DOI 10.1016/j.jmb.2011.08.032; Bernstein DA, 2003, NUCLEIC ACIDS RES, V31, P2778, DOI 10.1093/nar/gkg376; Bharti SK, 2014, CELL MOL LIFE SCI, V71, P2625, DOI 10.1007/s00018-014-1569-4; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bouthier dIT, 2008, J BIOL CHEM, V283, P27395, DOI [10.1074/jbc.M800567200, DOI 10.1074/JBC.M800867200]; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Capo-Chichi JM, 2013, HUM MUTAT, V34, P103, DOI 10.1002/humu.22226; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; Gallivan JP, 2003, FEBS LETT, V554, P485, DOI 10.1016/S0014-5793(03)01229-8; Gilhooly NS, 2014, NUCLEIC ACIDS RES, V42, P5633, DOI 10.1093/nar/gku188; Guo MH, 2015, J BIOL CHEM, V290, P5174, DOI 10.1074/jbc.M114.634923; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hajer BH, 2014, J BIOTECHNOL, V173, P1, DOI 10.1016/j.jbiotec.2014.01.005; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P1497, DOI 10.1093/nar/21.6.1497; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031; Mackeldanz P, 2013, BIOCHIMIE, V95, P817, DOI 10.1016/j.biochi.2012.11.014; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Mehta J, 2011, MOL BIOCHEM PARASIT, V176, P58, DOI 10.1016/j.molbiopara.2010.12.003; Nongkhlaw M, 2012, BIOCHEMISTRY-US, V51, P3711, DOI 10.1021/bi2014757; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Robert F, 2013, WIRES RNA, V4, P333, DOI 10.1002/wrna.1163; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065; Rudra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075435; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Sainsbury S, 2011, J MOL BIOL, V405, P173, DOI 10.1016/j.jmb.2010.10.024; Schutz P, 2010, J MOL BIOL, V400, P768, DOI 10.1016/j.jmb.2010.05.046; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Sinha KM, 2009, BIOCHEMISTRY-US, V48, P4019, DOI 10.1021/bi900103d; Strohmeier J, 2011, BIOL CHEM, V392, P357, DOI 10.1515/BC.2011.034; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Tsay JM, 2009, P NATL ACAD SCI USA, V106, P14355, DOI 10.1073/pnas.0904364106; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, J BIOL CHEM, V287, P21699, DOI 10.1074/jbc.M112.351338; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Zegeye ED, 2014, MICROBIOL-SGM, V160, P217, DOI 10.1099/mic.0.072140-0	69	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140755	10.1371/journal.pone.0140755	http://dx.doi.org/10.1371/journal.pone.0140755			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474416	Green Submitted, gold, Green Published			2022-12-27	WOS:000363185500102
J	Ginsburg, AS; Delarosa, J; Brunette, W; Levari, S; Sundt, M; Larson, C; Agyemang, CT; Newton, S; Borriello, G; Anderson, R				Ginsburg, Amy Sarah; Delarosa, Jaclyn; Brunette, Waylon; Levari, Shahar; Sundt, Mitch; Larson, Clarice; Agyemang, Charlotte Tawiah; Newton, Sam; Borriello, Gaetano; Anderson, Richard			mPneumonia: Development of an Innovative mHealth Application for Diagnosing and Treating Childhood Pneumonia and Other Childhood Illnesses in Low-Resource Settings	PLOS ONE			English	Article							INTEGRATED MANAGEMENT; PULSE OXIMETRY; HEALTH-WORKERS; SOUTH-AFRICA; CARE; CHILDREN; IMPLEMENTATION; TECHNOLOGY; IMCI; EXPERIENCES	Pneumonia is the leading infectious cause of death in children worldwide. Each year, pneumonia kills an estimated 935,000 children under five years of age, with most of these deaths occurring in developing countries. The current approach for pneumonia diagnosis in low-resource settings-using the World Health Organization Integrated Management of Childhood Illness (IMCI) paper-based protocols and relying on a health care provider's ability to manually count respiratory rate-has proven inadequate. Furthermore, hypoxemia-a diagnostic indicator of the presence and severity of pneumonia often associated with an increased risk of death-is not assessed because pulse oximetry is frequently not available in low-resource settings. In an effort to address childhood pneumonia mortality and improve frontline health care providers' ability to diagnose, classify, and manage pneumonia and other childhood illnesses, PATH collaborated with the University of Washington to develop "mPneumonia," an innovative mobile health application using an Android tablet. mPneumonia integrates a digital version of the IMCI algorithm with a software-based breath counter and a pediatric pulse oximeter. We conducted a design-stage usability field test of mPneumonia in Ghana, with the goal of creating a user-friendly diagnostic and management tool for childhood pneumonia and other childhood illnesses that would improve diagnostic accuracy and facilitate adherence by health care providers to established guidelines in low-resource settings. The results of the field test provided valuable information for understanding the usability and acceptability of mPneumonia among health care providers, and identifying approaches to iterate and improve. This critical feedback helped ascertain the common failure modes related to the user interface design, navigation, and accessibility of mPneumonia and the modifications required to improve user experience and create a tool aimed at decreasing mortality from pneumonia and other childhood illnesses in low-resource settings.	[Ginsburg, Amy Sarah; Delarosa, Jaclyn] PATH, Seattle, WA 98109 USA; [Brunette, Waylon; Levari, Shahar; Sundt, Mitch; Larson, Clarice; Borriello, Gaetano; Anderson, Richard] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Agyemang, Charlotte Tawiah; Newton, Sam] Kintampo Hlth Res Ctr, Kintampo, Ghana	University of Washington; University of Washington Seattle; Kintampo Health Research Centre	Ginsburg, AS (corresponding author), PATH, Seattle, WA 98109 USA.	aginsburg@path.org	Brunette, Waylon/ABC-8255-2020	Brunette, Waylon/0000-0001-8254-9440	United States National Institutes of Health; National Science Foundation Research Grant [IIS-111143]; United Nations Children's Fund	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Research Grant(National Science Foundation (NSF)); United Nations Children's Fund	The development of mPneumonia was funded by United States National Institutes of Health (ASG, JD, WB, RA) and National Science Foundation Research Grant No. IIS-111143 (WB, SL, MS, CL, GB, RA). The field testing in Ghana was funded by the United Nations Children's Fund (ASG, JD, CTA, SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2005, B WORLD HEALTH ORGAN, V83, P369; Ahmed HM, 2010, HEALTH POLICY, V96, P128, DOI 10.1016/j.healthpol.2010.01.013; [Anonymous], 2013, PO DAT KIT 2 0 EXP R; Black J, 2015, INT J NURS STUD, V52, P963, DOI 10.1016/j.ijnurstu.2015.01.016; DeRenzi B, 2008, IMPROVING PEDIAT HLT; Duke T, 2010, INT J TUBERC LUNG D, V14, P1362; Duke T, 2009, ANN TROP PAEDIATR, V29, P165, DOI 10.1179/027249309X12467994190011; Ginsburg AS, 2012, J TROP PEDIATRICS, V58, P389, DOI 10.1093/tropej/fmr103; Horwood C, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-62; Kallander K, 2006, T ROY SOC TROP MED H, V100, P956, DOI 10.1016/j.trstmh.2005.11.004; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mitchell M, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-95; Mitchell M, 2012, J HEALTH COMMUN, V17, P118, DOI 10.1080/10810730.2011.649105; Mitchell M, 2012, INT J MED INFORM, V81, P166, DOI 10.1016/j.ijmedinf.2011.11.003; Mitchell M, 2009, INT J HEALTHC TECHNO, V10, P156, DOI 10.1504/IJHTM.2009.025819; Mukanga D, 2011, TROP MED INT HEALTH, V16, P1234, DOI 10.1111/j.1365-3156.2011.02831.x; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; Shao AF, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0805-4; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNICEF, 2011, SYN ARI TIM RES REP; UNICEF, 2013, STRENGTH PNEUM DIAGN; United Nations Children's Fund (UNICEF), 2013, PNEUM DIAGN CURR OUT; Victora CG, 2006, B WORLD HEALTH ORGAN, V84, P792, DOI 10.2471/BLT.06.030502; Walter ND, 2009, B WORLD HEALTH ORGAN, V87, P99, DOI 10.2471/BLT.08.050740; World Health Organization, 2014, INTEGRATED MANAGEMEN; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE	27	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0139625	10.1371/journal.pone.0139625	http://dx.doi.org/10.1371/journal.pone.0139625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474321	Green Published, gold, Green Submitted			2022-12-27	WOS:000363185500011
J	Kramer, G; Woolerton, Y; van Straalen, JP; Vissers, JPC; Dekker, N; Langridge, JI; Beynon, RJ; Speijer, D; Sturk, A; Aerts, JMFG				Kramer, Gertjan; Woolerton, Yvonne; van Straalen, Jan P.; Vissers, Johannes P. C.; Dekker, Nick; Langridge, James I.; Beynon, Robert J.; Speijer, Dave; Sturk, Auguste; Aerts, Johannes M. F. G.			Accuracy and Reproducibility in Quantification of Plasma Protein Concentrations by Mass Spectrometry without the Use of Isotopic Standards	PLOS ONE			English	Article							ABSOLUTE QUANTIFICATION; DIGESTION EFFICIENCY; SAMPLE PREPARATION; ABUNDANCE; EXPRESSION; PROTEOMICS; QUANTITATION; ASSAYS; BIOMARKERS; ENRICHMENT	Background Quantitative proteomic analysis with mass spectrometry holds great promise for simultaneously quantifying proteins in various biosamples, such as human plasma. Thus far, studies addressing the reproducible measurement of endogenous protein concentrations in human plasma have focussed on targeted analyses employing isotopically labelled standards. Non-targeted proteomics, on the other hand, has been less employed to this end, even though it has been instrumental in discovery proteomics, generating large datasets in multiple fields of research. Results Using a non-targeted mass spectrometric assay (LCMSE), we quantified abundant plasma proteins (43 mg/mL-40 ug/mL range) in human blood plasma specimens from 30 healthy volunteers and one blood serum sample (ProteomeXchange: PXD000347). Quantitative results were obtained by label-free mass spectrometry using a single internal standard to estimate protein concentrations. This approach resulted in quantitative results for 59 proteins (cut off >= 11 samples quantified) of which 41 proteins were quantified in all 31 samples and 23 of these with an inter-assay variability of <= 20%. Results for 7 apolipoproteins were compared with those obtained using isotope-labelled standards, while 12 proteins were compared to routine immunoassays. Comparison of quantitative data obtained by LCMSE and immunoassays showed good to excellent correlations in relative protein abundance (r = 0.72-0.96) and comparable median concentrations for 8 out of 12 proteins tested. Plasma concentrations of 56 proteins determined by LCMSE were of similar accuracy as those reported by targeted studies and 7 apolipoproteins quantified by isotope-labelled standards, when compared to reference concentrations from literature. Conclusions This study shows that LCMSE offers good quantification of relative abundance as well as reasonable estimations of concentrations of abundant plasma proteins.	[Kramer, Gertjan; Dekker, Nick; Speijer, Dave; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [van Straalen, Jan P.; Sturk, Auguste] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; [Woolerton, Yvonne; Beynon, Robert J.] Univ Liverpool, Inst Integrat Biol, Ctr Proteome Res, Liverpool L69 3BX, Merseyside, England; [Vissers, Johannes P. C.; Langridge, James I.] Waters Corp, MS Technol Ctr, Manchester, Lancs, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool; Waters UK	Kramer, G (corresponding author), European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany.	gertjan.kramer@embl.de	Speijer, Dave/AAE-4613-2019; Aerts, Johannes/A-1028-2009; Beynon, Robert/K-1408-2014	Speijer, Dave/0000-0002-2340-2753; Aerts, Johannes/0000-0001-8168-2565; Beynon, Robert/0000-0003-0857-495X; Kramer, Gertjan/0000-0002-8541-0337	Academic Medical Center, University of Amsterdam; Waters Corporation; Alexander von Humboldt Stiftung; BBSRC [BB/M018725/1, BB/M025756/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M025756/1, BB/M018725/1] Funding Source: researchfish	Academic Medical Center, University of Amsterdam; Waters Corporation; Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was funded by the Academic Medical Center, University of Amsterdam. Coauthor JPCV and JIL are employed by Waters Corporation (MS Technologies Center, Manchester, United Kingdom). Waters Corporation provided support in the form of salary for authors JPCV and JIL. The Alexander von Humboldt Stiftung provided support in the form of salary for author GK. The specific role of these authors is articulated in the 'author contributions' section. All funders, Academic Medical Center, Waters Corporation and the Alexander von Humboldt Stiftung, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Agger SA, 2010, CLIN CHEM, V56, P1804, DOI 10.1373/clinchem.2010.152264; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Arike L, 2012, J PROTEOMICS, V75, P5437, DOI 10.1016/j.jprot.2012.06.020; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Brownridge P, 2011, METHODS, V54, P351, DOI 10.1016/j.ymeth.2011.05.005; Brownridge Philip J, 2012, Methods Mol Biol, V893, P267, DOI 10.1007/978-1-61779-885-6_18; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; Distler U, 2014, NAT METHODS, V11, P167, DOI [10.1038/NMETH.2767, 10.1038/nmeth.2767]; Domanski D, 2012, PROTEOMICS, V12, P1222, DOI 10.1002/pmic.201100568; Ellington AA, 2010, CLIN CHEM, V56, P186, DOI 10.1373/clinchem.2009.127514; Fonslow BR, 2014, NAT METHODS, V11, P347, DOI 10.1038/nmeth0314-347; Fonslow BR, 2013, NAT METHODS, V10, P54, DOI [10.1038/NMETH.2250, 10.1038/nmeth.2250]; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Grossmann J, 2010, J PROTEOMICS, V73, P1740, DOI 10.1016/j.jprot.2010.05.011; Hoofnagle AN, 2008, CLIN CHEM, V54, P1796, DOI 10.1373/clinchem.2008.109652; Hoofnagle AN, 2012, CLIN CHEM, V58, P777, DOI 10.1373/clinchem.2011.173856; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Huttenhain R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003989; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Keshishian H, 2009, MOL CELL PROTEOMICS, V8, P2339, DOI 10.1074/mcp.M900140-MCP200; Kuhn E, 2009, CLIN CHEM, V55, P1108, DOI 10.1373/clinchem.2009.123935; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lassman ME, 2012, RAPID COMMUN MASS SP, V26, P101, DOI 10.1002/rcm.5296; Leon IR, 2013, MOL CELL PROTEOMICS, V12, P2992, DOI 10.1074/mcp.M112.025585; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; Martens L, 2005, BIOINFORMATICS, V21, P3584, DOI 10.1093/bioinformatics/bti588; Mertens BJA, 2006, J COMPUT BIOL, V13, P1591, DOI 10.1089/cmb.2006.13.1591; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nicol GR, 2008, MOL CELL PROTEOMICS, V7, P1974, DOI 10.1074/mcp.M700476-MCP200; Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x; Pagel O, 2015, EXPERT REV PROTEOMIC, V12, P235, DOI 10.1586/14789450.2015.1042867; Parker CE, 2014, MOL ONCOL, V8, P840, DOI 10.1016/j.molonc.2014.03.006; Parker CE, 2010, ANALYST, V135, P1830, DOI 10.1039/c0an00105h; Percy AJ, 2014, BBA-PROTEINS PROTEOM, V1844, P917, DOI 10.1016/j.bbapap.2013.06.008; Percy AJ, 2013, PROTEOMICS, V13, P2202, DOI 10.1002/pmic.201200316; Proc JL, 2010, J PROTEOME RES, V9, P5422, DOI 10.1021/pr100656u; Rivers J, 2007, MOL CELL PROTEOMICS, V6, P1416, DOI 10.1074/mcp.M600456-MCP200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Valentine SJ, 2006, J PROTEOME RES, V5, P2977, DOI 10.1021/pr060232i; van Breemen MJ, 2008, CLIN CHIM ACTA, V396, P26, DOI 10.1016/j.cca.2008.06.018; Vissers JPC, 2007, MOL CELL PROTEOMICS, V6, P755, DOI 10.1074/mcp.M600303-MCP200; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Williams DK, 2009, J PROTEOME RES, V8, P1085, DOI 10.1021/pr800922p; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhang H, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.005678, 10.1074/mcp.M111.009936, 10.1186/1476-4598-10-108]	50	18	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140097	10.1371/journal.pone.0140097	http://dx.doi.org/10.1371/journal.pone.0140097			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474480	gold, Green Published, Green Submitted			2022-12-27	WOS:000363185500023
J	Rzezak, P; Squarzoni, P; Duran, FL; Alves, TDF; Tamashiro-Duran, J; Bottino, CM; Ribeiz, S; Lotufo, PA; Menezes, PR; Scazufca, M; Busatto, GF				Rzezak, Patricia; Squarzoni, Paula; Duran, Fabio L.; Ferraz Alves, Tania de Toledo; Tamashiro-Duran, Jaqueline; Bottino, Cassio M.; Ribeiz, Salma; Lotufo, Paulo A.; Menezes, Paulo R.; Scazufca, Marcia; Busatto, Geraldo F.			Relationship between Brain Age-Related Reduction in Gray Matter and Educational Attainment	PLOS ONE			English	Article							VOXEL-BASED-MORPHOMETRY; PRECLINICAL ALZHEIMERS-DISEASE; MENTAL-STATE-EXAMINATION; SAO-PAULO; COGNITIVE RESERVE; BRAZILIAN POPULATION; WORKING-MEMORY; STRUCTURAL MRI; OLDER-ADULTS; RISK-FACTORS	Inter-subject variability in age-related brain changes may relate to educational attainment, as suggested by cognitive reserve theories. This voxel-based morphometry study investigated the impact of very low educational level on the relationship between regional gray matter (rGM) volumes and age in healthy elders. Magnetic resonance imaging data were acquired in elders with low educational attainment (less than 4 years) (n = 122) and high educational level (n = 66), pulling together individuals examined using either of three MRI scanners/acquisition protocols. Voxelwise group comparisons showed no rGM differences (p<0.05, family-wise error corrected for multiple comparisons). When within-group voxel-wise patterns of linear correlation were compared between high and low education groups, there was one cluster of greater rGM loss with aging in low versus high education elders in the left anterior cingulate cortex (p<0.05, FWE-corrected), as well as a trend in the left dorsomedial prefrontal cortex (p<0.10). These results provide preliminary indication that education might exert subtle protective effects against age-related brain changes in healthy subjects. The anterior cingulate cortex, critical to inhibitory control processes, may be particularly sensitive to such effects, possibly given its involvement in cognitive stimulating activities at school or later throughout life.	[Rzezak, Patricia; Squarzoni, Paula; Duran, Fabio L.; Ferraz Alves, Tania de Toledo; Tamashiro-Duran, Jaqueline; Busatto, Geraldo F.] Univ Sao Paulo, Lab Psychiat Neuroimaging, Dept & Inst Psychiat, Fac Med, Sao Paulo, SP, Brazil; [Rzezak, Patricia; Squarzoni, Paula; Duran, Fabio L.; Ferraz Alves, Tania de Toledo; Tamashiro-Duran, Jaqueline; Busatto, Geraldo F.] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci, Sao Paulo, SP, Brazil; [Bottino, Cassio M.; Ribeiz, Salma] Univ Sao Paulo, Old Age Res Grp PROTER, Dept & Inst Psychiat, Fac Med, Sao Paulo, SP, Brazil; [Lotufo, Paulo A.] Univ Sao Paulo, Ctr Clin & Epidemiol Res, Univ Hosp, Sao Paulo, SP, Brazil; [Lotufo, Paulo A.] Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil; [Menezes, Paulo R.] Univ Sao Paulo, Dept Prevent Med, Fac Med, Sao Paulo, SP, Brazil; [Scazufca, Marcia] Univ Sao Paulo, Lab Psychopharmacol & Clin Psychophysiol LIM 23, Fac Med, Inst Psychiat, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Rzezak, P (corresponding author), Univ Sao Paulo, Lab Psychiat Neuroimaging, Dept & Inst Psychiat, Fac Med, Sao Paulo, SP, Brazil.	patriciarzezak@gmail.com	Busatto, Geraldo F/D-4431-2009; Souza-Duran, Fabio Luis/L-1371-2013; Rzezak, Patricia/P-5274-2017; Menezes, Paulo/AAM-3529-2021; Menezes, Paulo R/C-9985-2010; Squarzoni, Paula S/M-6155-2014; Tamashiro-Duran, Jaqueline Hatsuko/B-1023-2013; Alves, Tania/ABF-5712-2020; Scazufca, Marcia/K-7418-2012; Lotufo, Paulo/A-9843-2008; Alves, Tania CTF/B-6571-2008	Busatto, Geraldo F/0000-0003-4749-4602; Souza-Duran, Fabio Luis/0000-0002-7603-6152; Rzezak, Patricia/0000-0001-9023-9733; Menezes, Paulo/0000-0001-6330-3314; Menezes, Paulo R/0000-0001-6330-3314; Squarzoni, Paula S/0000-0002-5483-759X; Tamashiro-Duran, Jaqueline Hatsuko/0000-0002-5448-8158; Alves, Tania/0000-0003-3402-9656; Lotufo, Paulo/0000-0002-4856-8450; Alves, Tania CTF/0000-0003-3402-9656; Scazufca, Marcia/0000-0002-4545-006X	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/50329-6, 2004/09586-9, 2012/13065-0, 2013/03231-3]; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Project Grant number 2012/50329-6, 2004/09586-9, and scholarship to Patricia Rzezak, number 2012/13065-0; Paula Squarzoni, number 2013/03231-3) and CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Tania CTF Alves, Paulo A Lotufo, Geraldo Busatto Filho, Paulo R Menezes, Cassio MC Bottino, and Marcia Scazufca).	Allegri Ricardo F., 2010, Dement. neuropsychol., V4, P28, DOI 10.1590/S1980-57642010DN40100005; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bottino CMC, 2008, DEMENT GERIATR COGN, V26, P291, DOI 10.1159/000161053; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Busatto GF, 2003, NEUROBIOL AGING, V24, P221, DOI 10.1016/S0197-4580(02)00084-2; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Copeland JRM, 2002, INT J GERIATR PSYCH, V17, P729, DOI 10.1002/gps.667; Curiati PK, 2009, AM J NEURORADIOL, V30, P1850, DOI 10.3174/ajnr.A1727; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Alves TCDF, 2011, J ALZHEIMERS DIS, V27, P575, DOI 10.3233/JAD-2011-110827; Ferrari C, 2014, NEURODEGENER DIS, V13, P157, DOI 10.1159/000353690; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Foubert-Samier A, 2012, NEUROBIOL AGING, V33, pe15, DOI [10.1016/j.neurobiolaging.2010.09.023, DOI 10.1016/j.neurobiolaging.2010.09.023]; FULD PA, 1990, J CLIN EXP NEUROPSYC, V12, P520, DOI 10.1080/01688639008400998; Galluzzi S, 2008, NEUROL SCI, V29, pS296, DOI 10.1007/s10072-008-1002-6; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grieve SM, 2005, HUM BRAIN MAPP, V25, P391, DOI 10.1002/hbm.20115; Groves AR, 2012, NEUROIMAGE, V63, P365, DOI 10.1016/j.neuroimage.2012.06.038; Gutchess AH, 2005, J COGNITIVE NEUROSCI, V17, P84, DOI 10.1162/0898929052880048; Hall KS, 2000, INT J GERIATR PSYCH, V15, P521, DOI 10.1002/1099-1166(200006)15:6<521::AID-GPS182>3.0.CO;2-F; Harrison TM, 2012, J INT NEUROPSYCH SOC, V18, P1081, DOI 10.1017/S1355617712000847; Herrera E, 2002, ALZ DIS ASSOC DIS, V16, P103, DOI 10.1097/00002093-200204000-00007; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Kim J, 2015, NEUROSCI RES, V94, P50, DOI 10.1016/j.neures.2014.12.009; Lazarczyk MJ, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-127; Liu YW, 2012, NEURORADIOLOGY, V54, P929, DOI 10.1007/s00234-012-1005-0; Marstaller L, 2015, NEUROSCIENCE, V290, P369, DOI 10.1016/j.neuroscience.2015.01.049; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Miller MI, 2013, NEUROIMAGE-CLIN, V3, P352, DOI 10.1016/j.nicl.2013.09.001; MONSCH AU, 1992, ARCH NEUROL-CHICAGO, V49, P1253, DOI 10.1001/archneur.1992.00530360051017; Nitrini R, 2012, LANCET, V380, P1470, DOI 10.1016/S0140-6736(12)61838-8; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Perneczky R, 2009, J ALZHEIMERS DIS, V17, P855, DOI 10.3233/JAD-2009-1117; Persson N, 2014, NEUROIMAGE, V103, P334, DOI 10.1016/j.neuroimage.2014.09.042; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Resnick SM, 2003, J NEUROSCI, V23, P3295; Ribeiz SRI, 2013, CROSS SECTIONAL PROS, V8, P1, DOI [10.1371/journal.pone.0080049, DOI 10.1371/J0URNAL.P0NE.0080049]; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Scazufca M, 2008, INT J EPIDEMIOL, V37, P879, DOI 10.1093/ije/dyn125; Scazufca M, 2008, INT J EPIDEMIOL, V37, P721, DOI 10.1093/ije/dym154; Scazufca M, 2008, INT PSYCHOGERIATR, V20, P394, DOI 10.1017/S1041610207005625; Seo SW, 2011, NEUROBIOL AGING, V32, P200, DOI 10.1016/j.neurobiolaging.2009.02.004; Shum FWF, 2007, LEARN MEMORY, V14, P304, DOI 10.1101/lm.530607; Squarzoni P, 2012, J ALZHEIMERS DIS, V31, P45, DOI 10.3233/JAD-2012-111124; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Streitburger DP, 2014, NEUROIMAGE, V87, P170, DOI 10.1016/j.neuroimage.2013.10.051; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Teipel SJ, 2007, NEUROIMAGE, V34, P985, DOI 10.1016/j.neuroimage.2006.07.047; Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008; Tournoux P., 1988, COPLANAR STEREOTAXIC; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Younes L, 2014, NEUROIMAGE-CLIN, V5, P178, DOI 10.1016/j.nicl.2014.04.009; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	62	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140945	10.1371/journal.pone.0140945	http://dx.doi.org/10.1371/journal.pone.0140945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0DF	26474472	Green Submitted, Green Published, gold			2022-12-27	WOS:000363185500133
J	Singh, VK; Dwivedi, P; Chaudhary, BR; Singh, R				Singh, Vineet Kumar; Dwivedi, Padmanabh; Chaudhary, B. R.; Singh, Ramesh			Immunomodulatory Effect of Gymnema sylvestre (R.Br.) Leaf Extract: An In Vitro Study in Rat Model	PLOS ONE			English	Article							VISCUM-ALBUM EXTRACTS; STIMULATES INSULIN-SECRETION; AQUEOUS EXTRACT; DIABETES-MELLITUS; PERITONEAL-MACROPHAGES; SEXUAL-DIMORPHISM; HUMAN ISLETS; VIVO; GLUCOSE; CELLS	Gymnema sylvestre Wild R.Br (family: Asclepidaceae) is a valuable medicinal plant used in folk medicine to treat diabetes, obesity, asthma etc. in India for antiquity. Diabetes mellitus is a syndrome characterized immunologically by lymphocyte apoptosis and reduced cell-mediated and humoral immunity. Modulation of immune responses to alleviate diseases has been of interest, and traditional herbal medicines may play an important role in this regard. In this study, we aim to evaluate the immunomodulatory potential of methanolic extract of G. sylvestre leaf using rat model. HPLC analysis of leaf extract was carried out for gymnemic acid. The method involves the initial hydrolysis of gymnemic acids, the active ingredients, to a common aglycone followed by the quantitative estimation of gymnemagenin, using gymnemagenin as reference standard. Gymnemic acid content was 2.40% (w/w) in G. sylvestre leaf extract. In vitro immunomodulatory activity of the methanolic extract of G. sylvestre leaf (1-200 mu g/ml) was evaluated by gauging its effects on nitroblue tetrazolium reduction and nitrite release in rat peritoneal macrophages and on mitogen (ConA, PHA and LPS) induced splenic lymphocyte proliferation. G. sylvestre leaf extract showed significant (<0.05) enhancement in NO and ROS generation in macrophages and in proliferation of lymphocytes in dose dependent manner. EC50 value was 3.10, 3.75 and 2.68 mu g/ml for NBT reduction, nitrite release and lymphoproliferation, respectively. Potential effect was observed at 100 mu g/ml in NO and ROS generation in macrophages and 20 mu g/ml in lymphocyte proliferation. G. sylvestre leaf extract stimulates macrophage reactivity, increasing the level of activity even higher when combined with PMA or LPS. These findings suggest the presence of active compounds, gymnemic acid, in methanolic extract of G. sylvestre leaf that stimulates both myeloid and lymphoid components of immune system, and therefore can restore the innate immune function. Through this study, the traditional knowledge of anti-diabetic property of G. sylvestre is scientifically supplemented with its immunomodulatory properties.	[Singh, Vineet Kumar; Chaudhary, B. R.] Banaras Hindu Univ, Ctr Adv Study Bot, Varanasi 221005, UP, India; [Dwivedi, Padmanabh] Banaras Hindu Univ, Inst Agr Sci, Dept Plant Physiol, Varanasi 221005, UP, India; [Singh, Ramesh] Udai Pratap Autonomous Coll, Dept Zool, Varanasi, UP, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Udai Pratap College, Varanasi	Singh, R (corresponding author), Udai Pratap Autonomous Coll, Dept Zool, Varanasi, UP, India.	upcrsingh@yahoo.com	Dwivedi, Padmanabh/L-5307-2019; Dwivedi, Padmanabh/AAJ-8808-2020					Al-Romaiyan A, 2013, PHYTOTHER RES, V27, P1006, DOI 10.1002/ptr.4815; Al-Romaiyan A, 2010, PHYTOTHER RES, V24, P1370, DOI 10.1002/ptr.3125; BABIOR BM, 1984, J CLIN INVEST, V73, P599, DOI 10.1172/JCI111249; BASKARAN K, 1990, J ETHNOPHARMACOL, V30, P295, DOI 10.1016/0378-8741(90)90108-6; Berger J., 2003, COMP CLIN PATHOL, V12, P84, DOI [10.1007/s00580-003-0478-y, DOI 10.1007/S00580-003-0478-Y]; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bishayi Biswadev, 2002, J Toxicol Sci, V27, P139, DOI 10.2131/jts.27.139; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cruz GVB, 2007, J ETHNOPHARMACOL, V111, P148, DOI 10.1016/j.jep.2006.11.006; DING AH, 1988, J IMMUNOL, V141, P2407; Diwanay S, 2004, J ETHNOPHARMACOL, V90, P49, DOI 10.1016/j.jep.2003.09.023; ELIASHIV A, 1978, ARCH SURG-CHICAGO, V113, P1180; Elluru SR, 2015, TRANSL RES BIOMED, V4, P67, DOI 10.1159/000375427; Elluru SR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-161; Elluru SR, 2009, ANTICANCER RES, V29, P2945; Elluru S, 2007, MEDICINA-BUENOS AIRE, V67, P85; Elluru S, 2006, ARZNEIMITTEL-FORSCH, V56, P461; Flanagan KL, 2014, T ROY SOC TROP MED H, V108, P385, DOI 10.1093/trstmh/tru079; FUSHIKI T, 1992, J NUTR, V122, P2367, DOI 10.1093/jn/122.12.2367; Gautam M, 2009, J ETHNOPHARMACOL, V121, P41, DOI 10.1016/j.jep.2008.10.028; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; GIENI RS, 1995, J IMMUNOL METHODS, V187, P85, DOI 10.1016/0022-1759(95)00170-F; Hegde P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026312; Jayathirtha MG, 2004, PHYTOMEDICINE, V11, P361, DOI 10.1078/0944711041495236; Jeong SC, 2006, J MED FOOD, V9, P175, DOI 10.1089/jmf.2006.9.175; Khanna V, 2009, INT J GREEN PHARM, V3, P227, DOI DOI 10.4103/0973-8258.56280; Leach MJ, 2007, J ALTERN COMPLEM MED, V13, P977, DOI 10.1089/acm.2006.6387; Liu B, 2009, CELL PHYSIOL BIOCHEM, V23, P125, DOI 10.1159/000204101; Mandal S.C., 2007, BIODIVERSITY ENV BIO, P177; Manosroi A, 2005, J ETHNOPHARMACOL, V102, P5, DOI 10.1016/j.jep.2005.04.033; Manosroi A, 2005, J ETHNOPHARMACOL, V101, P90, DOI 10.1016/j.jep.2005.03.031; Manosroi A, 2004, FITOTERAPIA, V75, P302, DOI 10.1016/j.fitote.2004.01.009; Manosroi A, 2003, J ETHNOPHARMACOL, V89, P155, DOI 10.1016/S0378-8741(03)00278-2; Manosroi A, 2006, FITOTERAPIA, V77, P189, DOI 10.1016/j.fitote.2006.01.003; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Otton R, 2004, J ENDOCRINOL, V182, P145, DOI 10.1677/joe.0.1820145; Persaud SJ, 1999, J ENDOCRINOL, V163, P207, DOI 10.1677/joe.0.1630207; Porchezhian E, 2003, PHARMAZIE, V58, P5; Sabu MC, 2002, J ETHNOPHARMACOL, V81, P155, DOI 10.1016/S0378-8741(02)00034-X; Saha C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114965; Saravanan S, 2012, J ETHNOPHARMACOL, V140, P239, DOI 10.1016/j.jep.2012.01.010; Sengupta M, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-102; Sengupta Mahuya, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P193, DOI 10.1016/S2221-1691(11)60026-9; SHANMUGASUNDARAM ERB, 1990, J ETHNOPHARMACOL, V30, P281, DOI 10.1016/0378-8741(90)90107-5; SHANMUGASUNDARAM ERB, 1990, J ETHNOPHARMACOL, V30, P265, DOI 10.1016/0378-8741(90)90106-4; Sharma U, 2012, J ETHNOPHARMACOL, V141, P918, DOI 10.1016/j.jep.2012.03.027; Toffoli-Kadri MC, 2014, J ETHNOPHARMACOL, V153, P461, DOI 10.1016/j.jep.2014.03.008; Tripathi MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116588; Tripathi MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104431; Van Huyen JPD, 2003, CHEMOTHERAPY, V49, P298, DOI 10.1159/000074530; Van Huyen JPD, 2002, MOL MED, V8, P600, DOI 10.1007/BF03402170; Van Huyen JPD, 2001, CHEMOTHERAPY, V47, P366, DOI 10.1159/000048545; VANDERNAT JM, 1987, J ETHNOPHARMACOL, V19, P125, DOI 10.1016/0378-8741(87)90036-5; Weissenstein U, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-6; WHO, 2011, QUAL CONTR METH HERB, P1; Wu XY, 2012, FOOD RES INT, V48, P935, DOI [10.1016/j.foodres.2011.01.031, 10.1016/j.foodres.2012.02.006]	57	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0139631	10.1371/journal.pone.0139631	http://dx.doi.org/10.1371/journal.pone.0139631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474420	Green Submitted, Green Published, gold			2022-12-27	WOS:000363185500012
J	George, AS; Mehra, V; Scott, K; Sriram, V				George, Asha S.; Mehra, Vrinda; Scott, Kerry; Sriram, Veena			Community Participation in Health Systems Research: A Systematic Review Assessing the State of Research, the Nature of Interventions Involved and the Features of Engagement with Communities	PLOS ONE			English	Article							DIRECTED TREATMENT; ONCHOCERCIASIS CONTROL; ALMA-ATA; SOCIAL REPRESENTATIONS; FACILITY COMMITTEES; RUKUNGIRI DISTRICT; TREATMENT PROGRAMS; INCOME COUNTRIES; AFRICAN PROGRAM; IVERMECTIN CDTI	Background Community participation is a major principle of people centered health systems, with considerable research highlighting its intrinsic value and strategic importance. Existing reviews largely focus on the effectiveness of community participation with less attention to how community participation is supported in health systems intervention research. Objective To explore the extent, nature and quality of community participation in health systems intervention research in low- and middle-income countries. Methodology We searched for peer-reviewed, English language literature published between January 2000 and May 2012 through four electronic databases. Search terms combined the concepts of community, capability/participation, health systems research and low- and middle-income countries. The initial search yielded 3,092 articles, of which 260 articles with more than nominal community participation were identified and included. We further excluded 104 articles due to lower levels of community participation across the research cycle and poor description of the process of community participation. Out of the remaining 160 articles with rich community participation, we further examined 64 articles focused on service delivery and governance within health systems research. Results Most articles were led by authors in high income countries and many did not consistently list critical aspects of study quality. Articles were most likely to describe community participation in health promotion interventions (78%, 202/260), even though they were less participatory than other health systems areas. Community involvement in governance and supply chain management was less common (12%, 30/260 and 9%, 24/260 respectively), but more participatory. Articles cut across all health conditions and varied by scale and duration, with those that were implemented at national scale or over more than five years being mainstreamed by government. Most articles detailed improvements in service availability, accessibility and acceptability, with fewer efforts focused on quality, and few designs able to measure impact on health outcomes. With regards to participation, most articles supported community's in implementing interventions (95%, n = 247/260), in contrast to involving communities in identifying and defining problems (18%, n = 46/260). Many articles did not discuss who in communities participated, with just over a half of the articles disaggregating any information by sex. Articles were largely under theorized, and only five mentioned power or control. Majority of the articles (57/64) described community participation processes as being collaborative with fewer describing either community mobilization or community empowerment. Intrinsic individual motivations, community-level trust, strong external linkages, and supportive institutional processes facilitated community participation, while lack of training, interest and information, along with weak financial sustainability were challenges. Supportive contextual factors included decentralization reforms and engagement with social movements. Conclusion Despite positive examples, community participation in health systems interventions was variable, with few being truly community directed. Future research should more thoroughly engage with community participation theory, recognize the power relations inherent in community participation, and be more realistic as to how much communities can participate and cognizant of who decides that.	[George, Asha S.; Mehra, Vrinda; Scott, Kerry; Sriram, Veena] Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	George, AS (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	ageorg22@jhu.edu		George, Asha/0000-0002-5968-1424	Future Health Systems Consortium; UK Department for International Development (DFID); Department for International Development (DFID) [201888] Funding Source: researchfish	Future Health Systems Consortium; UK Department for International Development (DFID); Department for International Development (DFID)	This work is supported by the Future Health Systems Consortium (http://www.futurehealthsystems.org). This document is an output funded by the UK Aid from the UK Department for International Development (DFID) for the benefit of low and middle income countries. However, the views expressed and information contained in it are not necessarily those of or endorsed by DFID, which can accept no responsibility for such views or information or for any reliance placed on them.	Ackumey MM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001187; Ahluwalia IB, 2003, INT J GYNECOL OBSTET, V82, P231, DOI 10.1016/S0020-7292(03)00081-X; Ahluwalia IB, 2010, GLOB HEALTH PROMOT, V17, P39, DOI 10.1177/1757975909356627; Ali M, 2006, PUBLIC HEALTH, V120, P50, DOI 10.1016/j.puhe.2005.03.009; Amazigo UV, 2002, ANN TROP MED PARASIT, V96, P75, DOI 10.1179/00349802125000664; Andersson Neil, 2004, J Interprof Care, V18, P381, DOI 10.1080/13561820400012758; Anselmi M, 2003, TROP MED INT HEALTH, V8, P634, DOI 10.1046/j.1365-3156.2003.01073.x; ARNSTEIN SR, 1969, J AM I PLANNERS, V35, P216, DOI 10.1080/01944366908977225; Atkinson J, 2011, MALARIA J, V10; Bennett S., 2010, WHAT MUST BE DONE EN; Campbell C, 2000, J COMMUNITY APPL SOC, V10, P255, DOI 10.1002/1099-1298(200007/08)10:4<255::AID-CASP582>3.0.CO;2-M; Chaiken MS, 2006, FOOD NUTR BULL, V27, P95, DOI 10.1177/156482650602700201; Clemmons L, 2002, ANN TROP MED PARASIT, V96, P59, DOI 10.1179/000349802125000655; Critical Appraisal Skills Programme (CASP), 2013, 10 QUEST HELP YOU MA; de Souza R, 2011, HEALTH COMMUN, V26, P25, DOI 10.1080/10410236.2011.527619; Dennis R, B WHO, V82, P764; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Dongre AR, 2011, FOOD NUTR BULL, V32, P315, DOI 10.1177/156482651103200402; Du Mortier S, 2005, INT J QUAL HEALTH C, V17, P293, DOI 10.1093/intqhc/mzi042; Eisenbruch M, 2004, J TRAUMA STRESS, V17, P123, DOI 10.1023/B:JOTS.0000022618.65406.e8; El Ansari W, 2005, PUBLIC HEALTH, V119, P758, DOI 10.1016/j.puhe.2005.01.014; el Ansari W, 2001, J Interprof Care, V15, P351; El Ansari W, 2002, PUBLIC HEALTH, V116, P151, DOI 10.1038/sj.ph.1900839; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Farnsworth SK, 2014, J HEALTH COMMUN, V19, P67, DOI 10.1080/10810730.2014.941519; Few R, 2003, HEALTH PLACE, V9, P45, DOI 10.1016/S1353-8292(02)00029-1; Fiedler JL, 2000, INT J HEALTH PLAN M, V15, P319, DOI 10.1002/hpm.598; Ghaffar A, 2008, CHANGING MINDSETS RE; Gilson L, 2011, BUILDING FIELD HLTH, P1549; Goodman C, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-229; Gyapong M, 2001, ANN TROP MED PARASIT, V95, P77, DOI 10.1080/00034980020035942; Harman S, 2009, J HEALTH MANAG, V11, P297, DOI 10.1177/097206340901100203; Harpham T, 2002, J PUBLIC HEALTH MED, V24, P112, DOI 10.1093/pubmed/24.2.112; Hayashi K, 2012, SUBST USE MISUSE, V47, P502, DOI 10.3109/10826084.2012.644110; Hayward R, 2007, COMMUNITY MENT HLT J, V43, P517, DOI 10.1007/s10597-007-9086-7; Heinonen T, 2000, HEALTH POLICY PLANN, V15, P194, DOI 10.1093/heapol/15.2.194; Houeto D, 2008, INT Q COMMUNITY HEAL, V28, P51, DOI 10.2190/IQ.28.1.e; Howarth C, 2004, J HEALTH PSYCHOL, V9, P229, DOI 10.1177/1359105304040889; Howarth CS, 2001, J THEOR SOC BEHAV, V31, P223, DOI 10.1111/1468-5914.00155; Hoy D, 2008, Glob Public Health, V3, P47, DOI 10.1080/17441690701192022; Israr SM, 2006, INT J HEALTH PLAN M, V21, P313, DOI 10.1002/hpm.852; Iwami M, 2002, J PUBLIC HEALTH MED, V24, P246, DOI 10.1093/pubmed/24.4.246; Jacobs B, 2003, HEALTH POLICY PLANN, V18, P399, DOI 10.1093/heapol/czg048; Jacobs B, 2006, HEALTH POLICY PLANN, V21, P27, DOI 10.1093/heapol/czj001; Jacobs B, 2007, INT J HEALTH PLAN M, V22, P183, DOI 10.1002/hpm.890; Joffe H, 2003, BRIT J SOC PSYCHOL, V42, P55, DOI 10.1348/014466603763276126; Joffe H, 1993, INT C AIDS, V9; Jones S., 2011, Water Alternatives, V4, P54; Kapiriri L, 2003, HEALTH POLICY PLANN, V18, P205, DOI 10.1093/heapol/czg025; Katabarwa MN, 2002, ANN TROP MED PARASIT, V96, P61, DOI 10.1179/000349802125000529; Katabarwa MN, 2002, HEALTH SOC CARE COMM, V10, P382, DOI 10.1046/j.1365-2524.2002.00378.x; Katabarwa MN, 2001, ANN TROP MED PARASIT, V95, P485, DOI 10.1080/00034980120072260; Katabarwa M, 2010, TROP MED INT HEALTH, V15, P216, DOI 10.1111/j.1365-3156.2009.02442.x; Katabarwa MN, 2010, T ROY SOC TROP MED H, V104, P265, DOI 10.1016/j.trstmh.2009.10.012; Katabarwa NM, 2000, ANN TROP MED PARASIT, V94, P343, DOI 10.1080/00034980050034590; Kenny A, 2014, HLTH EXPECT; Kenny A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-64; Kilonzo A, 2001, AM J PUBLIC HEALTH, V91, P1636, DOI 10.2105/AJPH.91.10.1636; Leonard KL, 2010, HEALTH ECON, V19, P1461, DOI 10.1002/hec.1564; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Li VC, 2001, SOC SCI MED, V52, P279, DOI 10.1016/S0277-9536(00)00132-5; Liberato SC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-850; Lucas PJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-4; MacPhail C, 2006, SOC DYNAMICS, V32, P170, DOI 10.1080/02533950608628731; Marston C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055012; Massa K, 2009, J BIOSOC SCI, V41, P89, DOI 10.1017/S0021932008002964; McCoy DC, 2012, HEALTH POLICY PLANN, V27, P449, DOI 10.1093/heapol/czr077; Meheux K, 2010, DISASTERS, V34, P1102, DOI 10.1111/j.1467-7717.2010.01185.x; Mijnarends D., 2011, DISABIL CBR INCLUSIV, V22, P3, DOI [10.5463/dcid.v22i2.54, DOI 10.5463/DCID.V22I2.54]; Molyneux S, 2012, HEALTH POLICY PLANN, V27, P541, DOI 10.1093/heapol/czr083; Morrison J, 2010, INT HEALTH, V2, P25, DOI 10.1016/j.inhe.2009.11.004; Morrison Joanna, 2005, BMC Pregnancy Childbirth, V5, P6, DOI 10.1186/1471-2393-5-6; Mosquera M, 2001, HEALTH POLICY PLANN, V16, P52, DOI 10.1093/heapol/16.suppl_2.52; Mushi D, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-14; Mutalemwa P, 2009, Tanzan J Health Res, V11, P116; Nahar T, 2012, BMC PREGNANCY CHILDB, P12; NAVARRO V, 1984, INT J HEALTH SERV, V14, P159, DOI 10.2190/9A9A-3ECR-M3N5-YJHH; Neupane D, 2014, LANCET GLOB HEALTH, V2, pE567, DOI 10.1016/S2214-109X(14)70303-1; O'Meara WP, 2011, HEALTH POLICY, V99, P234, DOI 10.1016/j.healthpol.2010.08.027; O'Rourke K, 1998, Rev Panam Salud Publica, V3, P9; Paxman JM, 2005, STUD FAMILY PLANN, V36, P203, DOI 10.1111/j.1728-4465.2005.00062.x; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Prata N, 2012, SOC SCI MED, V74, P1288, DOI 10.1016/j.socscimed.2011.11.035; Preston R, 2010, AUST J PRIM HEALTH, V16, P4, DOI 10.1071/PY09053; Pronyk PM, 2008, SOC SCI MED, V67, P1559, DOI 10.1016/j.socscimed.2008.07.022; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Ramiro LS, 2001, HEALTH POLICY PLANN, V16, P61, DOI 10.1093/heapol/16.suppl_2.61; Rath S, 2010, BMC INT HEALTH HUM R, V10; Remme JHF, 2010, B WORLD HEALTH ORGAN, V88, P509, DOI 10.2471/BLT.09.069203; Rifkin S, 1986, HLTH POLICY PLANNING, V1986, P3; Rifkin SB, 2003, J HEALTH POPUL NUTR, V21, P168; Rifkin SB, 1996, ACTA TROP, V61, P79, DOI 10.1016/0001-706X(95)00105-N; Rifkin SB, 1991, COMMUNITY PARTICIPAT; Rifkin SB, 2014, HEALTH POLICY PLANN, V29, P98, DOI 10.1093/heapol/czu076; Rifkin SB, 2009, INT HEALTH, V1, P31, DOI 10.1016/j.inhe.2009.02.001; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Schmid T, 2001, AM J PUBLIC HEALTH, V91, P1589, DOI 10.2105/AJPH.91.10.1589; Schneider SD, 2009, MED ANTHROPOL Q, V23, P235, DOI 10.1111/j.1548-1387.2009.01058.x; Schueth Tobias, 2005, Food and Nutrition Bulletin, V26, P366; Sennun Panida, 2006, Rural Remote Health, V6, P440; Shayo EH, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-30; Shiffman J, 2002, SOC SCI MED, V54, P1199, DOI 10.1016/S0277-9536(01)00090-9; Shrestha S, 2002, J HEALTH POPUL NUTR, V20, P156; Sloand E, 2012, QUAL HEALTH RES, V22, P488, DOI 10.1177/1049732311425054; Solomon Yodit, 2008, Promot Educ, V15, P32, DOI 10.1177/1025382308097696; Standing H, 2004, HLTH SYSTEMS RESOURC; Suh S, 2007, HUMAN RESOURCES HLTH, P5; Tanaka Y, 2004, PUBLIC HEALTH, V118, P50, DOI 10.1016/S0033-3506(03)00137-9; UGALDE A, 1985, SOC SCI MED, V21, P41, DOI 10.1016/0277-9536(85)90286-2; UNESCO, 2010, UNESCO SCI REP 2010; Volmink J, 2005, BMJ-BRIT MED J, V331, P705, DOI 10.1136/bmj.331.7519.705; Wallerstein N, 1992, Am J Health Promot, V6, P197; WHO, 2013, WORLD  HLTH REP 2013; WHO Europe, 1978, DECL ALM AT; World Health Organization, 2014, WHO REC COMM MOB FAC; Zachariah R, 2006, T ROY SOC TROP MED H, V100, P167, DOI 10.1016/j.trstmh.2005.07.008; Zakus JDL, 1998, HEALTH POLICY PLANN, V13, P1, DOI 10.1093/heapol/13.1.1	117	125	125	13	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141091	10.1371/journal.pone.0141091	http://dx.doi.org/10.1371/journal.pone.0141091			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU1VG	26496124	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200060
J	Podobnik, B; Vukovic, V; Stanley, HE				Podobnik, Boris; Vukovic, Vuk; Stanley, H. Eugene			Does the Wage Gap between Private and Public Sectors Encourage Political Corruption?	PLOS ONE			English	Article							GROWTH	We present a dynamic network model of corrupt and noncorrupt employees representing two states in the public and private sector. Corrupt employees are more connected to one another and are less willing to change their attitudes regarding corruption than noncorrupt employees. This behavior enables them to prevail and become the majority in the workforce through a first-order phase transition even though they initially represented a minority. In the model, democracy-understood as the principle of majority rule-does not create corruption, but it serves as a mechanism that preserves corruption in the long run. The motivation for our network model is a paradox that exists on the labor market. Although economic theory indicates that higher risk investments should lead to larger rewards, in many developed and developing countries workers in lower-risk public sector jobs are paid more than workers in higher-risk private sector jobs. To determine the long-run sustainability of this economic paradox, we study data from 28 EU countries and find that the public sector wage premium increases with the level of corruption.	[Podobnik, Boris; Stanley, H. Eugene] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Podobnik, Boris; Stanley, H. Eugene] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Podobnik, Boris] Univ Rijeka, Fac Civil Engn, Rijeka 51000, Croatia; [Podobnik, Boris] Univ Ljubljana, Fac Econ, Ljubljana 1000, Slovenia; [Podobnik, Boris; Vukovic, Vuk] Zagreb Sch Econ & Management, Zagreb 10000, Croatia; [Podobnik, Boris; Vukovic, Vuk] Adriat Econ Assoc, Zagreb 10000, Croatia; [Podobnik, Boris] Luxembourg Sch Business, Luxembourg, Luxembourg; [Vukovic, Vuk] Adam Smith Inst, London, England	Boston University; Boston University; University of Rijeka; University of Ljubljana	Podobnik, B (corresponding author), Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA.	bp@phy.hr	Podobnik, Boris/S-4583-2018	Podobnik, Boris/0000-0003-4270-1756; Stanley, H./0000-0003-2800-4495	University of Rijeka; Zagreb School of Economics and Management; Adriatic Economic Association	University of Rijeka; Zagreb School of Economics and Management; Adriatic Economic Association	This paper was supported by the University of Rijeka, the Zagreb School of Economics and Management, and the Adriatic Economic Association.	Acemoglu D, 2000, AM ECON REV, V90, P194, DOI 10.1257/aer.90.1.194; Acemoglu D, 2012, WHY NATIONS FAIL; [Anonymous], 2014, WORLD BANK DATABASE; Bardhan P, 1997, J ECON LIT, V35, P1320; BELLANTE D, 1981, IND LABOR RELAT REV, V34, P408, DOI 10.2307/2522787; BESLEY T, 1993, ECON J, V103, P119, DOI 10.2307/2234340; Bueno de Mesquita Bruce., 2005, LOGIC POLITICAL SURV; Congressional BudgetOffice, 2012, C US; de Castro F, 2013, EC PAPERS EUROPEAN C, V508; Djankov S, 2002, Q J ECON, V117, P1, DOI 10.1162/003355302753399436; Franicevic V, 2013, PUBLIC SECTOR SHOCK: THE IMPACT OF POLICY RETRENCHMENT IN EUROPE, P134; Glaeser E, 2003, J MONETARY ECON, V50, P199, DOI 10.1016/S0304-3932(02)00204-0; Hamilton JD, 2000, TIME SERIES ANAL; International Labor Organization, 2014, LABORSTA DAT OCC WAG; Johnston M, 1989, CORRUPTION INEQUALIT; La Porta R, 1998, J POLIT ECON, V106, P1113, DOI 10.1086/250042; Majdandzic A, 2014, NAT PHYS, V10, P34, DOI [10.1038/nphys2819, 10.1038/NPHYS2819]; MAURO P, 1995, Q J ECON, V110, P681, DOI 10.2307/2946696; Olson M., 2000, POWER PROSPERITY OUT; Podobnik B, 2014, PHYS REV E, V89, DOI [10.1103/PhysRevE.89.042807, DOI 10.1103/PHYSREVE.89.042807]; Podobnik B, 2008, EUR PHYS J B, V63, P547, DOI 10.1140/epjb/e2008-00210-2; Podobnik B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00678; Rock MT, 2009, J DEV STUD, V45, P55, DOI 10.1080/00220380802468579; Rose-Ackerman Bonnie J., 2016, CORRUPTION GOVT CAUS, DOI 10.1017/CBO9781139175098; Rose-Ackerman S., 1975, J PUBLIC ECON, V4, P187, DOI [10.1016/0047-2727(75)90017-1, DOI 10.1016/0047-2727(75)90017-1]; Rose-Ackerman Susan., 1978, CORRUPTION STUDY POL, P1, DOI [10.1016/B978-0-12-596350-3.50005-3, DOI 10.1016/B978-0-12-596350-3.50005-3]; SHARPE WF, 1966, J BUS, V39, P119, DOI 10.1086/294846; SHLEIFER A, 1993, Q J ECON, V108, P599, DOI 10.2307/2118402; Shleifer A., 1998, THE GRABBING HAND; Svensson J, 2005, J ECON PERSPECT, V19, P19, DOI 10.1257/089533005774357860; Transparency International, 2014, CORRUPTION PERCEPTIO; Treisman D, 2000, J PUBLIC ECON, V76, P399, DOI 10.1016/S0047-2727(99)00092-4; Treisman D, 2007, ANNU REV POLIT SCI, V10, P211, DOI 10.1146/annurev.polisci.10.081205.095418; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	34	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141211	10.1371/journal.pone.0141211	http://dx.doi.org/10.1371/journal.pone.0141211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU1VG	26495847	gold, Green Published			2022-12-27	WOS:000363309200076
J	Deng, LJ; Huang, TZ; Zhao, XL				Deng, Liang-Jian; Huang, Ting-Zhu; Zhao, Xi-Le			Exemplar-Based Image Inpainting Using a Modified Priority Definition	PLOS ONE			English	Article							TEXTURE SYNTHESIS; OBJECT REMOVAL; FIELDS	Exemplar-based algorithms are a popular technique for image inpainting. They mainly have two important phases: deciding the filling-in order and selecting good exemplars. Traditional exemplar-based algorithms are to search suitable patches from source regions to fill in the missing parts, but they have to face a problem: improper selection of exemplars. To improve the problem, we introduce an independent strategy through investigating the process of patches propagation in this paper. We first define a new separated priority definition to propagate geometry and then synthesize image textures, aiming to well recover image geometry and textures. In addition, an automatic algorithm is designed to estimate steps for the new separated priority definition. Comparing with some competitive approaches, the new priority definition can recover image geometry and textures well.	[Deng, Liang-Jian; Huang, Ting-Zhu; Zhao, Xi-Le] Univ Elect Sci & Technol China, Sch Math Sci, Res Ctr Image & Vis Comp, Chengdu 610054, Sichuan, Peoples R China	University of Electronic Science & Technology of China	Huang, TZ (corresponding author), Univ Elect Sci & Technol China, Sch Math Sci, Res Ctr Image & Vis Comp, Chengdu 610054, Sichuan, Peoples R China.	tingzhuhuang@126.com		Zhao, Xi-Le/0000-0002-6540-946X	973 Program [2013CB329404]; NSFC [61370147, 61402082]; Fundamental Research Funds for the Central Universities [ZYGX2013Z005, ZYGX2013J106]; Outstanding Doctoral Students Academic Support Program of UESTC [A1098524023901001044]	973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Outstanding Doctoral Students Academic Support Program of UESTC	All authors are supported by 973 Program (2013CB329404), NSFC (61370147), the Fundamental Research Funds for the Central Universities (ZYGX2013Z005). The first author is also supported by Outstanding Doctoral Students Academic Support Program of UESTC (A1098524023901001044). The work of X. -L. Zhao is supported by NSFC (61402082), and in part by the Fundamental Research Funds for the Central Universities (ZYGX2013J106).	Ashikhmin M., 2001, P ACM S INT 3D GRAPH, P217; Aujol JF, 2010, SIAM J MATH ANAL, V42, P1246, DOI 10.1137/080743883; Ballester C, 2001, IEEE T IMAGE PROCESS, V10, P1200, DOI 10.1109/83.935036; Barnes C, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1531326.1531330; Bertalmio M, 2000, COMP GRAPH, P417, DOI 10.1145/344779.344972; Chan TF, 2001, J VIS COMMUN IMAGE R, V12, P436, DOI 10.1006/jvci.2001.0487; Chan TF, 2002, SIAM J APPL MATH, V62, P1019, DOI 10.1137/S0036139900368844; Criminisi A, 2004, IEEE T IMAGE PROCESS, V13, P1200, DOI 10.1109/TIP.2004.833105; Criminisi A, 2003, PROC CVPR IEEE, P721; De Benet J. S., 1997, Computer Graphics Proceedings, SIGGRAPH 97, P361, DOI 10.1145/258734.258882; Deledalle CA, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.25; Efros A. A., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1033, DOI 10.1109/ICCV.1999.790383; Elad M, 2005, APPL COMPUT HARMON A, V19, P340, DOI 10.1016/j.acha.2005.03.005; Freeman WT, 2000, INT J COMPUT VISION, V40, P25, DOI 10.1023/A:1026501619075; Freeman WT, 2002, IEEE COMPUT GRAPH, V22, P56, DOI 10.1109/38.988747; Garber D, 1981, THESIS U S CALIFORNI; He KM, 2012, PROC CVPR IEEE, P111, DOI 10.1109/CVPR.2012.6247665; Heeger D. J., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P229, DOI 10.1145/218380.218446; Hesabi S., 2012, 2012 16th CSI International Symposium on Artificial Intelligence and Signal Processing (AISP), P43, DOI 10.1109/AISP.2012.6313715; Igehy H, 1997, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING - PROCEEDINGS, VOL III, P186, DOI 10.1109/ICIP.1997.632049; Korman S, 2011, IEEE I CONF COMP VIS, P1607, DOI 10.1109/ICCV.2011.6126421; Levina E, 2006, ANN STAT, V34, P1751, DOI 10.1214/009053606000000588; Liang L, 2001, ACM T GRAPHIC, V20, P127, DOI 10.1145/501786.501787; Liu YQ, 2013, IEEE T IMAGE PROCESS, V22, P1699, DOI 10.1109/TIP.2012.2218828; Newson A, 2014, SIAM J IMAGING SCI, V7, P1993, DOI 10.1137/140954933; Wei LY, 2000, COMP GRAPH, P479, DOI 10.1145/344779.345009; Wohlberg B, 2011, IEEE SIGNAL PROC LET, V18, P75, DOI 10.1109/LSP.2010.2095842; Xu ZB, 2010, IEEE T IMAGE PROCESS, V19, P1153, DOI 10.1109/TIP.2010.2042098	31	27	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141199	10.1371/journal.pone.0141199	http://dx.doi.org/10.1371/journal.pone.0141199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492491	Green Submitted, gold, Green Published			2022-12-27	WOS:000363249300035
J	Allen, ML; Wittmer, HU; Houghtaling, P; Smith, J; Elbroch, LM; Wilmers, CC				Allen, Maximilian L.; Wittmer, Heiko U.; Houghtaling, Paul; Smith, Justine; Elbroch, L. Mark; Wilmers, Christopher C.			The Role of Scent Marking in Mate Selection by Female Pumas (Puma concolor)	PLOS ONE			English	Article							EVOLUTION	Mate selection influences individual fitness, is often based on complex cues and behaviours, and can be difficult to study in solitary species including carnivores. We used motion-triggered cameras at 29 community scrapes (i.e. scent marking locations used by multiple individuals) and home range data from 39 GPS-collared pumas (Puma concolor) to assess the relevance of communication behaviours for mate selection by female pumas in California. Female pumas visited community scrapes irregularly and visitation bouts appeared to be correlated with oestrus. Female pumas on average selected from 1.7 collared males, and selection was based on multiple cues that varied among the different time periods measured (i.e. the female's visitation bout and in 90 days previous to the consorting event). Female mate selection over the course of a visitation bout was based on frequency of the male visitation, mass, and age. In the 90 days previous to consorting, the number of scrapes a male created was the most important contributor to selection, which was likely related to his residency status. We also found that at least 14% of females mated with multiple males, thus possibly confusing paternity. Our findings provide a mechanistic understanding of how female pumas use scent and auditory communication at community scrapes to select dominant resident males to mate with.	[Allen, Maximilian L.; Houghtaling, Paul; Smith, Justine; Wilmers, Christopher C.] Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Allen, Maximilian L.; Wittmer, Heiko U.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Elbroch, L. Mark] Panthera, New York, NY USA	University of California System; University of California Santa Cruz; Victoria University Wellington	Allen, ML (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA.	maxallen@ucsc.edu	Wittmer, Heiko U/D-4172-2015; Smith, Justine A/AAY-2879-2021; Allen, Maximilian/ABG-9307-2020	Wittmer, Heiko U/0000-0002-8861-188X; Smith, Justine A/0000-0001-8753-4061; Allen, Maximilian/0000-0001-8976-889X	NSF [0963022, 1255913]; Gordon and Betty Moore Foundation; California Department of Fish and Wildlife; University of California at Santa Cruz; University of California at Davis; Victoria University of Wellington tuition scholarship	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); California Department of Fish and Wildlife; University of California at Santa Cruz; University of California at Davis(University of California System); Victoria University of Wellington tuition scholarship	This work was supported by NSF grants 0963022 and 1255913, the Gordon and Betty Moore Foundation, the California Department of Fish and Wildlife, the University of California at Santa Cruz, and the University of California at Davis. M. Allen was supported by a Victoria University of Wellington tuition scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2014, BEHAVIOUR, V151, P819, DOI 10.1163/1568539X-00003173; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; [Anonymous], 2014, R LANG ENV STAT COMP; Ashman D, 1983, W4815 NEV GAM FISH D; BAILEY TN, 1974, J WILDLIFE MANAGE, V38, P435, DOI 10.2307/3800874; Balme GA, 2013, ANIM BEHAV, V86, P791, DOI 10.1016/j.anbehav.2013.07.019; Balme GA, 2013, MAMMAL REV, V43, P221, DOI 10.1111/j.1365-2907.2012.00219.x; Bothma J.duP, 1993, J ARID ENVIRON, V29, P511; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Clapham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035404; CURRIER M J P, 1983, Mammalian Species, P1, DOI 10.2307/3503951; Darwin C, 1859, ORIGIN SPECIES MEANS; ENQUIST M, 1990, ANIM BEHAV, V39, P1, DOI 10.1016/S0003-3472(05)80721-3; Gehrt SD, 1998, ANIM BEHAV, V55, P1211, DOI 10.1006/anbe.1997.0657; George SL, 2006, BIOL CONSERV, V133, P107, DOI 10.1016/j.biocon.2006.05.024; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; Gorman M.L., 1989, P57; Guthlin D, 2014, WILDLIFE SOC B, V38, P205, DOI 10.1002/wsb.377; Harmsen BJ, 2010, J MAMMAL, V91, P1225, DOI 10.1644/09-MAMM-A-416.1; Hoogland JL, 2013, J MAMMAL, V94, P731, DOI 10.1644/12-MAMM-A-291.1; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Jansen BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044625; Kelly MJ, 2008, J MAMMAL, V89, P408, DOI 10.1644/06-MAMM-A-424R.1; Laundre JW, 2007, J MAMMAL, V88, P1300, DOI 10.1644/06-MAMM-A-296R.1; Laundre JW, 2000, WILDLIFE SOC B, V28, P963; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Logan Kenneth A., 2010, P105; Mattisson J, 2013, MAMM BIOL, V78, P304, DOI 10.1016/j.mambio.2012.11.006; McBride R, 2015, SOUTHEAST NAT, V14, P351, DOI 10.1656/058.014.0215; Pinheiro J, 2020, R PACKAGE VERSION 31; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Seidensticker JC, 1973, WILDLIFE MONOGR, V35, P3; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; SMITH JLD, 1989, ANIM BEHAV, V37, P1; Stein Andrew B., 2013, Mammalian Species, P30, DOI 10.1644/900.1; Stenstrom D, 2000, WILDLIFE BIOL, V6, P23, DOI 10.2981/wlb.2000.034; Venables WN., 2002, MODERN APPL STAT S 4; Wang YW, 2015, BIOL CONSERV, V190, P23, DOI 10.1016/j.biocon.2015.05.007; Wilmers CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060590	41	25	26	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139087	10.1371/journal.pone.0139087	http://dx.doi.org/10.1371/journal.pone.0139087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489008	Green Submitted, gold, Green Published			2022-12-27	WOS:000363248400021
J	Shafer, SL; Bartlein, PJ; Gray, EM; Pelltier, RT				Shafer, Sarah L.; Bartlein, Patrick J.; Gray, Elizabeth M.; Pelltier, Richard T.			Projected Future Vegetation Changes for the Northwest United States and Southwest Canada at a Fine Spatial Resolution Using a Dynamic Global Vegetation Model	PLOS ONE			English	Article							INCORPORATING CLIMATE-CHANGE; SPECIES DISTRIBUTION; WILLAMETTE VALLEY; ECOSYSTEM; FIRE; HISTORY; OREGON; IMPACT; SHIFTS; RISK	Future climate change may significantly alter the distributions of many plant taxa. The effects of climate change may be particularly large in mountainous regions where climate can vary significantly with elevation. Understanding potential future vegetation changes in these regions requires methods that can resolve vegetation responses to climate change at fine spatial resolutions. We used LPJ, a dynamic global vegetation model, to assess potential future vegetation changes for a large topographically complex area of the northwest United States and southwest Canada (38.0-58.0 degrees N latitude by 136.6-103.0 degrees W longitude). LPJ is a process-based vegetation model that mechanistically simulates the effect of changing climate and atmospheric CO2 concentrations on vegetation. It was developed and has been mostly applied at spatial resolutions of 10-minutes or coarser. In this study, we used LPJ at a 30-second (similar to 1-km) spatial resolution to simulate potential vegetation changes for 2070-2099. LPJ was run using downscaled future climate simulations from five coupled atmosphere-ocean general circulation models (CCSM3, CGCM3.1(T47), GISS-ER, MIROC3.2(medres), UKMO-HadCM3) produced using the A2 greenhouse gases emissions scenario. Under projected future climate and atmospheric CO2 concentrations, the simulated vegetation changes result in the contraction of alpine, shrub-steppe, and xeric shrub vegetation across the study area and the expansion of woodland and forest vegetation. Large areas of maritime cool forest and cold forest are simulated to persist under projected future conditions. The fine spatial-scale vegetation simulations resolve patterns of vegetation change that are not visible at coarser resolutions and these fine-scale patterns are particularly important for understanding potential future vegetation changes in topographically complex areas.	[Shafer, Sarah L.] US Geol Survey, Corvallis, OR USA; [Bartlein, Patrick J.] Univ Oregon, Dept Geog, Eugene, OR 97403 USA; [Gray, Elizabeth M.] Nature Conservancy, Maryland DC, Bethesda, MD USA; [Pelltier, Richard T.] US Geol Survey, Denver, CO 80225 USA	United States Department of the Interior; United States Geological Survey; University of Oregon; Nature Conservancy; United States Department of the Interior; United States Geological Survey	Shafer, SL (corresponding author), US Geol Survey, Corvallis, OR USA.	sshafer@usgs.gov	Bartlein, Patrick J./E-4643-2011	Bartlein, Patrick J./0000-0001-7657-5685	U.S. Geological Survey National Climate Change and Wildlife Science Center; U.S. Geological Survey Climate and Land Use Change Research and Development Program	U.S. Geological Survey National Climate Change and Wildlife Science Center; U.S. Geological Survey Climate and Land Use Change Research and Development Program	Funding for this research was provided by the U.S. Geological Survey National Climate Change and Wildlife Science Center (https://nccwsc.usgs.gov/). SLS and RTP were supported by the U.S. Geological Survey Climate and Land Use Change Research and Development Program (http://www.usgs.gov/climate_landuse/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1973, PNW8 USDA FOR SERV; [Anonymous], 2001, GEN TECH REP PNW GTR; [Anonymous], 2007, TERRESTRIAL ECOSYSTE, DOI [10.1007/978-3-540-32730-1, DOI 10.1007/978-3-540-32730-1_15]; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; Bachelet D, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001508; Bartlein PJ, 2015, US GEOLOGICAL SURVEY, DOI [10.5066/F73X84PH, DOI 10.5066/F73X84PH]; Bartlein PJ, 2015, US GEOLOGICAL SURVEY, DOI [10.5066/F7H70CWW, DOI 10.5066/F7H70CWW]; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Christy JA, 2011, NORTHWEST SCI, V85, P93, DOI 10.3955/046.085.0202; Cleveland WS., 1993, VISUALIZING DATA; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Conservation Biology Institute, 2012, US POT NAT VEG OR KU; Coops NC, 2011, ECOL MODEL, V222, P2119, DOI 10.1016/j.ecolmodel.2011.03.033; Cross MS, 2012, ENVIRON MANAGE, V50, P341, DOI 10.1007/s00267-012-9893-7; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Doherty RM, 2010, GLOBAL CHANGE BIOL, V16, P617, DOI 10.1111/j.1365-2486.2009.01997.x; Doorenbos J., 1977, FAO IRRIGATION DRAIN; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Gerber S, 2004, GLOBAL CHANGE BIOL, V10, P1223, DOI 10.1111/j.1529-8817.2003.00807.x; Gerten D, 2004, J HYDROL, V286, P249, DOI 10.1016/j.jhydrol.2003.09.029; Giorgi F, 2005, CLIMATIC CHANGE, V73, P239, DOI 10.1007/a10584-005-6857-4; Global Soil Data Task, 2000, GLOB SOIL DAT PROD C; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Hasumi H., 2004, K 1 MODEL DEV K 1 CO; Hessburg PF, 2003, FOREST ECOL MANAG, V178, P23, DOI 10.1016/S0378-1127(03)00052-5; Hickler T, 2006, GLOBAL ECOL BIOGEOGR, V15, P567, DOI 10.1111/j.1466-8238.2006.00254.x; Hickler T, 2012, GLOBAL ECOL BIOGEOGR, V21, P50, DOI 10.1111/j.1466-8238.2010.00613.x; Hickler T, 2009, GLOBAL ECOL BIOGEOGR, V18, P304, DOI 10.1111/j.1466-8238.2009.00455.x; Hulme M, 1995, INT J CLIMATOL, V15, P1333, DOI 10.1002/joc.3370151204; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jiang XY, 2013, J CLIMATE, V26, P3671, DOI 10.1175/JCLI-D-12-00430.1; Kuchler AW, 1964, AM GEOGRAPHICAL SOC; Leuzinger S, 2013, GLOBAL ECOL BIOGEOGR, V22, P924, DOI 10.1111/geb.12047; Liu ZY, 2006, J CLIMATE, V19, P787, DOI 10.1175/JCLI3658.1; Miller DA, 1998, EARTH INTERACT, V2, P2, DOI DOI 10.1175/1087-3562(1998)002<0001:ACUSMS>2.3.C0;2; Miller RF, 1999, J RANGE MANAGE, V52, P550, DOI 10.2307/4003623; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Nakicenovic N., 2000, SPECIAL REPORT EMISS; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Notaro M, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001382; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pfeiffer M, 2013, GEOSCI MODEL DEV, V6, P643, DOI 10.5194/gmd-6-643-2013; Polley HW, 2013, RANGELAND ECOL MANAG, V66, P493, DOI 10.2111/REM-D-12-00068.1; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Prentice IC, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003906; Prentice IC, 2011, NEW PHYTOL, V189, P988, DOI 10.1111/j.1469-8137.2010.03620.x; Prentice IC, 2009, CLIM PAST, V5, P297, DOI 10.5194/cp-5-297-2009; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Rogelj J, 2012, NAT CLIM CHANGE; Rogers BM, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001695; SAXTON KE, 1986, SOIL SCI SOC AM J, V50, P1031, DOI 10.2136/sssaj1986.03615995005000040039x; Schmidt GA, 2006, J CLIMATE, V19, P153, DOI 10.1175/JCLI3612.1; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Scinocca JF, 2008, ATMOS CHEM PHYS, V8, P7055, DOI 10.5194/acp-8-7055-2008; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Smith WK, 2009, BOT REV, V75, P163, DOI 10.1007/s12229-009-9030-3; Thompson R.S., 1999, 1650B US GEOL SURV, V1650-B; Thompson RS, 1999, 1650A US GEOL SURV; Thonicke K, 2010, BIOGEOSCIENCES, V7, P1991, DOI 10.5194/bg-7-1991-2010; Thonicke K, 2001, GLOBAL ECOL BIOGEOGR, V10, P661, DOI 10.1046/j.1466-822X.2001.00175.x; [U. S. Geological Survey National Center for Earth Resources Observation and Science], 2002, N AM LANC COV CHAR 1; U. S. Geological Survey, 2002, GRAYSC N AM SHAD REL; Walsh MK, 2010, PALAEOGEOGR PALAEOCL, V297, P273, DOI 10.1016/j.palaeo.2010.08.007; Wania R, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003412; Warszawski L, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044018; Wuebbles D, 2014, B AM METEOROL SOC, V95, P571, DOI 10.1175/BAMS-D-12-00172.1; Zaehle S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002395; Zhao DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060849	77	23	25	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0138759	10.1371/journal.pone.0138759	http://dx.doi.org/10.1371/journal.pone.0138759			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488750	Green Submitted, gold, Green Published			2022-12-27	WOS:000363248400010
J	Coenen, C; Liedtke, S; Kogler, G				Coenen, Carolin; Liedtke, Stefanie; Kogler, Gesine			RNA Amplification Protocol Leads to Biased Polymerase Chain Reaction Results Especially for Low-Copy Transcripts of Human Bone Marrow-Derived Stromal Cells	PLOS ONE			English	Article							PHI-29 DNA-POLYMERASE; GENOME AMPLIFICATION; GENE-EXPRESSION; HOX GENES; PCR; TECHNOLOGY; ORGANS	The amplification of RNA is becoming increasingly important, as often only limited amounts of cells are available for gene expression analysis. In this study, the gene expression profile of the 39 human homeobox (HOX) genes was analyzed in bone marrow-derived multipotent stromal cells (BM-MSCs) by reverse transcription (RT-) and quantitative polymerase chain reaction (qPCR). For further unlimited gene expression analysis, Whole Transcriptome Amplification (WTA) was used to amplify RNA from human BM-MSCs. However, WTA led to biased RT- and qPCR results, and even non-detectability of HOX transcripts compared to non-amplified BM-MSC samples which instead revealed transcription. It is important to note that the same RNA of the respective human BM-MSC line was used for normal cDNA synthesis by standard reverse transcription (non-amplified RT samples) and for cDNA synthesis by WTA (amplified WTA samples). On this account, the different RT-and qPCR results were unexpected applying WTA. The significantly reduced detection of HOX transcripts after WTA has been demonstrated for numerous BM-MSC lines (n = 26) by RT-PCR analysis. Furthermore, undetectable HOX transcripts meaning HOX transcripts of human BMMSCs that were detected after normal cDNA synthesis, but were no longer detectable after WTA, were consistently observed by qPCR analysis. Finally, qPCR experiments revealed a possible explanation for the differences between amplified and non-amplified BM-MSC samples: an inverse correlation between the biased qPCR results and the low expression level of the respective HOX gene. The PCR analysis of high-copy transcripts like GAPDH or RPL13A revealed unchanged qPCR results after WTA compared to corresponding nonamplified BM-MSC samples. In contrast, WTA led to biased qPCR results for medium-copy HOX transcripts, and even non-detectability of low-copy HOX transcripts of human BM-MSCs resulting in false negative RT- and qPCR data applying WTA.	[Coenen, Carolin; Liedtke, Stefanie; Kogler, Gesine] Univ Dusseldorf, Med Ctr, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Coenen, C (corresponding author), Univ Dusseldorf, Med Ctr, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany.	Carolin.Coenen@med.uni-duesseldorf.de						Ackema KB, 2008, STEM CELLS DEV, V17, P979, DOI 10.1089/scd.2007.0220; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Eckert K A, 1991, PCR Methods Appl, V1, P17; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Hwang Y, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.94; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Liedtke S, 2013, STEM CELL RES, V11, P634, DOI 10.1016/j.scr.2013.04.001; Liedtke S, 2010, STEM CELL RES, V5, P40, DOI 10.1016/j.scr.2010.03.004; Reinart N, 2013, BLOOD, V121, P812, DOI 10.1182/blood-2012-05-431452; Takahashi Y, 2004, EXP CELL RES, V293, P144, DOI 10.1016/j.yexcr.2003.09.024; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wu JY, 2011, J MICROBIOL METH, V84, P88, DOI 10.1016/j.mimet.2010.10.018; Xiang CC, 2000, BIOTECHNOL ADV, V18, P35, DOI 10.1016/S0734-9750(99)00035-X; Yamamoto M, 2003, GENE EXPRESSION, V11, P199, DOI 10.3727/000000003108749071	19	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141070	10.1371/journal.pone.0141070	http://dx.doi.org/10.1371/journal.pone.0141070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485654	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100111
J	Fan, GQ; Niu, SY; Xu, T; Deng, MJ; Zhao, ZL; Wang, YL; Cao, L; Wang, Z				Fan, Guoqiang; Niu, Suyan; Xu, Tong; Deng, Minjie; Zhao, Zhenli; Wang, Yuanlong; Cao, Lin; Wang, Zhe			Plant-Pathogen Interaction-Related MicroRNAs and Their Targets Provide Indicators of Phytoplasma Infection in Paulownia tomentosa x Paulownia fortunei	PLOS ONE			English	Article							STRESS-RESPONSIVE MICRORNAS; TRANSCRIPTION FACTOR; DNA METHYLATION; EXPRESSION; IDENTIFICATION; MIRNA; RNA; PCR; IMMUNITY; LEAD	Paulownia witches' broom (PaWB) caused by a phytoplasma, has caused extensive losses in the yields of paulownia timber and resulted in significant economic losses. However, the molecular mechanisms in Paulownia that underlie the phytoplasma stress are poorly characterized. In this study, we use an Illumina platform to sequence four small RNA libraries and four degradome sequencing libraries derived from healthy, PaWB-infected, and PaWB-infected 15 mg.L-1 and 30 mg.L-1 methyl methane sulfonate (MMS)-treated plants. In total, 125 conserved and 118 novel microRNAs (miRNAs) were identified and 33 miRNAs responsive to PaWB disease were discovered. Furthermore, 166 target genes for 18 PaWB disease-related miRNAs were obtained, and found to be involved in plant-pathogen interaction and plant hormone signal transduction metabolic pathways. Eleven miRNAs and target genes responsive to PaWB disease were examined by a quantitative real-time PCR approach. Our findings will contribute to studies on miRNAs and their targets in Paulownia, and provide new insights to further understand plant-phytoplasma interactions.	[Fan, Guoqiang; Niu, Suyan; Deng, Minjie; Zhao, Zhenli; Wang, Yuanlong; Cao, Lin; Wang, Zhe] Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China; [Xu, Tong] Beijing Genom Inst, Shenzhen, Guangdong, Peoples R China	Henan Agricultural University; Beijing Genomics Institute (BGI)	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China.	zlxx64@126.com		Wang, Zhe/0000-0001-6671-694X	National Natural Science Foundation of China [30271082, 30571496, U1204309]; Outstanding Talents Project of Henan Province [122101110700]; Transformation Project of the National Agricultural Scientific and Technological Achievement of China [2012GB2D000271]; Science and Technology Innovation Team Project of Zhengzhou City [121PCXTD515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Talents Project of Henan Province; Transformation Project of the National Agricultural Scientific and Technological Achievement of China; Science and Technology Innovation Team Project of Zhengzhou City	Funding was provided to GQF by National Natural Science Foundation of China (Grant no. 30271082, 30571496, U1204309), http://www.nsfc.gov.cn/; Outstanding Talents Project of Henan Province (Grant no. 122101110700); Transformation Project of the National Agricultural Scientific and Technological Achievement of China (Grant no. 2012GB2D000271), and Science and Technology Innovation Team Project of Zhengzhou City (Grant no. 121PCXTD515).	Abreu PMV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103401; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Leyva-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048138; Baric S, 2006, PLANT MOL BIOL REP, V24, P169, DOI 10.1007/BF02914056; Bayliss KL, 2005, AUSTRALAS PLANT PATH, V34, P123, DOI 10.1071/AP04089; Boccara M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003883; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dickinson Matt, 2013, Methods Mol Biol, V938, P1, DOI 10.1007/978-1-62703-089-2_1; Doi M, 1967, ANN PHYTOPATHOL SOC, V33, P259, DOI DOI 10.3186/JJPHYT0PATH.33.259; Ehya F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066372; Eldem V, 2012, GENOME WIDE IDENTIFI; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Ellendorff U, 2009, J EXP BOT, V60, P591, DOI 10.1093/jxb/ern306; Fan GQ, 2014, INT J MOL SCI, V15, P23141, DOI 10.3390/ijms151223141; Fan GQ, 2014, BIOCHIMIE, V102, P68, DOI 10.1016/j.biochi.2014.02.008; Finnegan EJ, 1998, P NATL ACAD SCI USA, V95, P5824, DOI 10.1073/pnas.95.10.5824; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Firrao G, 2004, INT J SYST EVOL MICR, V54, P1243, DOI 10.1099/ijs.0.02854-0; Gai YP, 2014, SCI REP-UK, V4, DOI 10.1038/srep05378; Goettel W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086153; Gupta OP, 2014, PHYSIOL MOL PLANT P, V85, P1, DOI 10.1016/j.pmpp.2013.10.002; He QL, 2014, FUNCT INTEGR GENOMIC, V14, P507, DOI 10.1007/s10142-014-0378-z; Heinrich M, 2001, PLANT MOL BIOL REP, V19, P169, DOI 10.1007/BF02772160; Hiruki C, 1999, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.1999.496.6; Inal B, 2014, PLANTA, V240, P1287, DOI 10.1007/s00425-014-2153-8; Kaja E, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0812-3; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080238; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Gomollon S, 2012, PLANTA, V236, P1875, DOI 10.1007/s00425-012-1734-7; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mou HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077217; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Niu SY, 2014, PLANT CELL TISS ORG, V119, P457, DOI 10.1007/s11240-014-0546-9; Niu SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106736; Perilla-Henao LM, 2012, PLANT DIS, V96, P1372, DOI 10.1094/PDIS-03-12-0290-PDN; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Shen D, 2014, NEW PHYTOL, V204, P577, DOI 10.1111/nph.12934; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Wei MM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-66; Xu L, 2013, J EXP BOT, V64, P4271, DOI 10.1093/jxb/ert240; Zeng QY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-182; Zhai XiaoQiao, 2010, Scientia Silvae Sinicae, V46, P176; Zhao YP, 2013, ANN BOT-LONDON, V112, P633, DOI 10.1093/aob/mct133; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	58	10	10	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140590	10.1371/journal.pone.0140590	http://dx.doi.org/10.1371/journal.pone.0140590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484670	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100048
J	Liem, GS; Mo, FKF; Pang, E; Suen, JJS; Tang, NLS; Lee, KM; Yip, CHW; Tam, WH; Ng, R; Koh, J; Yip, CCH; Kong, GWS; Yeo, W				Liem, Giok S.; Mo, Frankie K. F.; Pang, Elizabeth; Suen, Joyce J. S.; Tang, Nelson L. S.; Lee, Kun M.; Yip, Claudia H. W.; Tam, Wing H.; Ng, Rita; Koh, Jane; Yip, Christopher C. H.; Kong, Grace W. S.; Yeo, Winnie			Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles	PLOS ONE			English	Article							PREMENOPAUSAL WOMEN; ADJUVANT CHEMOTHERAPY; VASOMOTOR SYMPTOMS; OVARIAN-FUNCTION; AGE; SMOKING; TAMOXIFEN; THERAPY; DETERMINANTS; PREVALENCE	Purpose In this prospective cross-sectional study on young premenopausal breast cancer patients, the objectives were to: determine the incidences of chemotherapy-related amenorrhea (CRA) and menopause (CRM); identify associated factors; and assess plasma levels of estradiol (E2) and follicular stimulating hormone (FSH) among patients who developed menopause. Methods Eligibility criteria include Chinese stage I-III breast cancer patients, premenopausal, age <= 45 at breast cancer diagnosis, having received adjuvant chemotherapy, within 3-10 years after breast cancer diagnosis. Detailed menstrual history prior to and after adjuvant treatment was taken at study entry. Patients' background demographics, tumor characteristics and anti-cancer treatments were collected. The rates of CRA and CRM were determined. Analysis was conducted to identify factors associated with CRM. For postmenopausal patients, levels of E2 and FSH were analyzed. Results 286 patients were recruited; the median time from breast cancer diagnosis to study entry was 5.0 years. 255 patients (91.1%) developed CRA. Of these, 66.7% regained menstruation. At the time of study entry, 137 (48.9%) had developed CRM, amongst whom 84 were age <= 45. On multivariate analysis, age was the only associated factor. Among patients with CRM, the median FSH was 41.0 IU/L; this was significantly lower in those who were taking tamoxifen compared to those who were not (20.1 vs. 59.7 IU/L, p<0.0001). The E2 level was <40 pmol/L; there was no difference between those who were still on tamoxifen or not. Conclusion After adjuvant chemotherapy, the majority of young Chinese breast cancer patients developed CRA; similar to 50% developed CRM, with 61% at age <= 45. Age at diagnosis is the only factor associated with CRM. FSH level may be affected by tamoxifen intake.	[Liem, Giok S.; Mo, Frankie K. F.; Pang, Elizabeth; Suen, Joyce J. S.; Lee, Kun M.; Yip, Claudia H. W.; Ng, Rita; Koh, Jane; Yip, Christopher C. H.; Yeo, Winnie] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China; [Liem, Giok S.; Mo, Frankie K. F.; Pang, Elizabeth; Suen, Joyce J. S.; Lee, Kun M.; Yip, Claudia H. W.; Ng, Rita; Koh, Jane; Yip, Christopher C. H.; Yeo, Winnie] Chinese Univ Hong Kong, Prince Wales Hosp, Comprehens Canc Trials Unit, Shatin, Hong Kong, Peoples R China; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Tang, Nelson L. S.; Tam, Wing H.; Kong, Grace W. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Yeo, W (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China.	winnieyeo@cuhk.edu.hk	Yeo, Winnie/R-4792-2018; Mo, Frankie/AAC-9230-2022; Mo, Frankie/AAG-8079-2021; Tang, Nelson L/P-5018-2017; Tam, Hung/AAE-3628-2020	Yeo, Winnie/0000-0002-0863-8469; Mo, Frankie/0000-0002-0566-3212; Tang, Nelson L/0000-0002-3607-5819; Tam, Hung/0000-0003-1189-740X	Hong Kong Cancer Fund	Hong Kong Cancer Fund	The study is supported by Hong Kong Cancer Fund.	Abusief ME, 2012, FERTIL STERIL, V97, P154, DOI 10.1016/j.fertnstert.2011.10.005; Anderson RA, 2006, HUM REPROD, V21, P2583, DOI 10.1093/humrep/del201; [Anonymous], 2015, BREAST CANC GUID; Avis NE, 2005, J CLIN ONCOL, V23, P3322, DOI 10.1200/JCO.2005.05.130; BAILEY A, 1977, LANCET, V2, P722; Berliere M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066616; BESER E, 1994, GYNECOL OBSTET INVES, V37, P40; Bromberger JT, 1997, AM J EPIDEMIOL, V145, P124; Cella D, 2001, J CLIN ONCOL, V19, P3385, DOI 10.1200/JCO.2001.19.14.3385; Colleoni M, 2006, J CLIN ONCOL, V24, P1332, DOI 10.1200/JCO.2005.03.0783; DANIELL HW, 1978, LANCET, V2, P373; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Di Cosimo S, 2004, ANN ONCOL, V15, P1065, DOI 10.1093/annonc/mdh266; Dorjgochoo T, 2009, MENOPAUSE, V16, P1205, DOI 10.1097/gme.0b013e3181aac32b; Fornier MN, 2005, CANCER-AM CANCER SOC, V104, P1575, DOI 10.1002/cncr.21385; Ganz PA, 2003, J CLIN ONCOL, V21, P4184, DOI 10.1200/JCO.2003.04.196; Kluthcovsky ACGC, 2012, SUPPORT CARE CANCER, V20, P1901, DOI 10.1007/s00520-011-1293-7; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; JORDAN VC, 1991, J NATL CANCER I, V83, P1488, DOI 10.1093/jnci/83.20.1488; Jung M, 2010, ANN SURG ONCOL, V17, P3259, DOI 10.1245/s10434-010-1172-3; Larsen EC, 2003, J CLIN ENDOCR METAB, V88, P5307, DOI 10.1210/jc.2003-030352; Leining MG, 2006, ANN ONCOL, V17, P1777, DOI 10.1093/annonc/mdl299; Li Hui-ping, 2006, Zhonghua Zhongliu Zazhi, V28, P848; MATTISON DR, 1978, LANCET, V1, P187; Meng KX, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-101; NICOSIA SV, 1985, CANCER, V55, P2364, DOI 10.1002/1097-0142(19850515)55:10<2364::AID-CNCR2820551011>3.0.CO;2-E; Ortmann O, 2011, CANCER TREAT REV, V37, P97, DOI 10.1016/j.ctrv.2010.05.005; Pandey Manoj, 2005, World J Surg Oncol, V3, P63, DOI 10.1186/1477-7819-3-63; Parulekar WR, 2005, J CLIN ONCOL, V23, P6002, DOI 10.1200/JCO.2005.07.096; Powis G, CANC CHEMOTHER PHARM, V20, P219; Rossi E, 2009, J CLIN ONCOL, V27, P3192, DOI 10.1200/JCO.2008.18.6213; Schover LR, 2008, J CLIN ONCOL, V26, P753, DOI 10.1200/JCO.2007.14.1655; Shobeiri F, 2014, INT J FERTIL STERIL, V8, P267; Singh KL, 2005, HUM REPROD UPDATE, V11, P69, DOI 10.1093/humupd/dmh052; Smith IE, 2006, J CLIN ONCOL, V24, P2444, DOI 10.1200/JCO.2005.05.3694; Stearns V, 2006, NAT REV CANCER, V6, P886, DOI 10.1038/nrc1992; Stovall DW, 2009, CURR OPIN INVEST DR, V10, P365; Su HI, 2010, CANCER-AM CANCER SOC, V116, P592, DOI 10.1002/cncr.24746; Swain SM, 2009, BREAST CANCER RES TR, V113, P315, DOI 10.1007/s10549-008-9937-0; Torino F, 2014, CRIT REV ONCOL HEMAT, V89, P27, DOI 10.1016/j.critrevonc.2013.07.007; Walshe JM, 2006, J CLIN ONCOL, V24, P5769, DOI 10.1200/JCO.2006.07.2793; Wang SP, 2005, J CLIN ENDOCR METAB, V90, P1407, DOI 10.1210/jc.2004-0766; WARNE GL, 1973, NEW ENGL J MED, V289, P1159, DOI 10.1056/NEJM197311292892202; *WHO, 1981, WHO TECHN REP SER, V670; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Wu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103673; Yeo WN, 2014, WORLD J CLIN ONCOL, V5, P1097, DOI 10.5306/wjco.v5.i5.1097	48	21	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140842	10.1371/journal.pone.0140842	http://dx.doi.org/10.1371/journal.pone.0140842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485568	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100077
J	Yomosa, M; Mizuguchi, T; Vasarhelyi, G; Nagy, M				Yomosa, Makoto; Mizuguchi, Tsuyoshi; Vasarhelyi, Gabor; Nagy, Mate			Coordinated Behaviour in Pigeon Flocks	PLOS ONE			English	Article							COLUMBA-LIVIA; ORGANIZATION; LEADERSHIP; DYNAMICS; FIDELITY; SCHOOLS; FLIGHT; SHAPE; FISH	We analysed pigeon flock flights using GPS trajectory data to reveal the most important kinematic aspects of flocking behaviour. We quantitatively investigated the internal motion of the flock based on pairwise statistics and found the following general relationships in all datasets: i) the temporal order of decisions characterised by the delay between directional changes is strictly related to the spatial order characterised by the longitudinal relative position within the flock; ii) during circling motion, pigeons use a mixture of two idealised and fundamentally different turning strategies, namely, parallel-path and equal-radius type turning. While pigeons tend to maintain their relative position within the flock on average, as in the parallel-path approximation, those who turn later also get behind as in the equal-radius case. Equal-radius type turning also tends to be expressed more during smaller radius turns.	[Yomosa, Makoto; Mizuguchi, Tsuyoshi] Osaka Prefecture Univ, Dept Math Sci, Osaka, Japan; [Vasarhelyi, Gabor; Nagy, Mate] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Vasarhelyi, Gabor; Nagy, Mate] Hungarian Acad Sci, MTA ELTE Stat & Biol Phys Res Grp, Budapest, Hungary; [Nagy, Mate] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Nagy, Mate] Max Planck Inst Ornithol, Dept Collect Behav, Constance, Germany	Osaka Metropolitan University; Eotvos Lorand University; Hungarian Academy of Sciences; University of Oxford; Max Planck Society	Yomosa, M (corresponding author), Osaka Prefecture Univ, Dept Math Sci, Osaka, Japan.	yomosa@ms.osakafu-u.ac.jp	Nagy, Máté/B-3180-2011; Vasarhelyi, Gabor/A-5632-2013	Nagy, Máté/0000-0001-8817-087X; Vasarhelyi, Gabor/0000-0002-5797-2340	JST PRESTO program; FI program of Osaka Prefecture University; European Union; European Social Fund through project FuturICT.hu [TAMOP-4.2.2.C-11/1/KONV-2012-0013]	JST PRESTO program; FI program of Osaka Prefecture University; European Union(European Commission); European Social Fund through project FuturICT.hu	This work was supported by the JST PRESTO program and the FI program of Osaka Prefecture University. This work was also partially supported by the European Union and the European Social Fund through project FuturICT.hu (grant no.: TAMOP-4.2.2.C-11/1/KONV-2012-0013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; BREDER CM, 1976, FISH B-NOAA, V74, P471; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Freeman R, 2011, BIOL LETTERS, V7, P63, DOI 10.1098/rsbl.2010.0627; Hayakawa Y, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/48004; Hemelrijk CK, 2012, INTERFACE FOCUS, V2, P726, DOI 10.1098/rsfs.2012.0025; Hemelrijk CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022479; Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734; MAJOR PF, 1978, BEHAV ECOL SOCIOBIOL, V4, P111, DOI 10.1007/BF00354974; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Nagy M, 2013, P NATL ACAD SCI USA, V110, P13049, DOI 10.1073/pnas.1305552110; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Pettit B, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0529; POMEROY H, 1992, AUK, V109, P256; Portugal SJ, 2014, NATURE, V505, P399, DOI 10.1038/nature12939; SHAW E, 1978, AM SCI, V66, P166; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; Usherwood JR, 2011, NATURE, V474, P494, DOI 10.1038/nature10164; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Yomosa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081754	24	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140558	10.1371/journal.pone.0140558	http://dx.doi.org/10.1371/journal.pone.0140558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485662	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100045
J	Warschburger, P; Calvano, C; Richter, EM; Engbert, R				Warschburger, Petra; Calvano, Claudia; Richter, Eike M.; Engbert, Ralf			Analysis of Attentional Bias towards Attractive and Unattractive Body Regions among Overweight Males and Females: An Eye-Movement Study	PLOS ONE			English	Article							EATING-DISORDERS; CHECKING QUESTIONNAIRE; SELECTIVE ATTENTION; COGNITIVE BIAS; WEIGHT-LOSS; OWN BODY; DISSATISFACTION; SELF; AVOIDANCE; WOMEN	Background Body image distortion is highly prevalent among overweight individuals. Whilst there is evidence that body-dissatisfied women and those suffering from disordered eating show a negative attentional bias towards their own unattractive body parts and others' attractive body parts, little is known about visual attention patterns in the area of obesity and with respect to males. Since eating disorders and obesity share common features in terms of distorted body image and body dissatisfaction, the aim of this study was to examine whether overweight men and women show a similar attentional bias. Methods/Design We analyzed eye movements in 30 overweight individuals (18 females) and 28 normal-weight individuals (16 females) with respect to the participants' own pictures as well as gender- and BMI-matched control pictures (front and back view). Additionally, we assessed body image and disordered eating using validated questionnaires. Discussion The overweight sample rated their own body as less attractive and showed a more disturbed body image. Contrary to our assumptions, they focused significantly longer on attractive compared to unattractive regions of both their own and the control body. For one's own body, this was more pronounced for women. A higher weight status and more frequent body checking predicted attentional bias towards attractive body parts. We found that overweight adults exhibit an unexpected and stable pattern of selective attention, with a distinctive focus on their own attractive body regions despite higher levels of body dissatisfaction. This positive attentional bias may either be an indicator of a more pronounced pattern of attentional avoidance or a self-enhancing strategy. Further research is warranted to clarify these results.	[Warschburger, Petra; Calvano, Claudia] Univ Potsdam, Div Counseling Psychol, Dept Psychol, Potsdam, Germany; [Richter, Eike M.; Engbert, Ralf] Univ Potsdam, Div Expt & Biol Psychol, Dept Psychol, Potsdam, Germany	University of Potsdam; University of Potsdam	Warschburger, P (corresponding author), Univ Potsdam, Div Counseling Psychol, Dept Psychol, Potsdam, Germany.	warschb@uni-potsdam.de	Engbert, Ralf/AAC-4860-2020	Engbert, Ralf/0000-0002-2909-5811; Warschburger, Petra/0000-0001-7979-7451				[Anonymous], 1995, PHYS STAT US INT ANT; Berger U, 2011, PSYCHOTHER PSYCH MED, V61, P311, DOI 10.1055/s-0031-1271786; Blechert J, 2009, PSYCHOSOM MED, V71, P907, DOI 10.1097/PSY.0b013e3181b4434d; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brooks S, 2011, CLIN PSYCHOL REV, V31, P37, DOI 10.1016/j.cpr.2010.09.006; Cho A, 2013, BODY IMAGE, V10, P95, DOI 10.1016/j.bodyim.2012.09.005; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; CROCKER J, 1989, PSYCHOL REV, V96, P608, DOI 10.1037/0033-295X.96.4.608; Dobson KS, 2004, CLIN PSYCHOL REV, V23, P1001, DOI 10.1016/j.cpr.2003.09.004; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Faulconbridge LF, 2014, CURR OBES REP, V3, P127, DOI 10.1007/s13679-013-0080-9; Forman EM, 2015, CURR OPIN PSYCHOL, V2, P87, DOI 10.1016/j.copsyc.2014.12.020; Forrester-Knauss C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-809; Frederick David A, 2006, Body Image, V3, P413, DOI 10.1016/j.bodyim.2006.08.002; FREEMAN R, 1991, INT J EAT DISORDER, V10, P709, DOI 10.1002/1098-108X(199111)10:6&lt;709::AID-EAT2260100609&gt;3.0.CO;2-N; Gao X, 2013, BODY IMAGE, V10, P191, DOI 10.1016/j.bodyim.2012.12.005; GARDNER RM, 1990, INT J EAT DISORDER, V9, P537, DOI 10.1002/1098-108X(199009)9:5&lt;537::AID-EAT2260090509&gt;3.0.CO;2-A; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Glauert R, 2010, INT J EAT DISORDER, V43, P42, DOI 10.1002/eat.20663; Grilo CM, 2005, BEHAV RES THER, V43, P629, DOI 10.1016/j.brat.2004.05.003; Hansson LM, 2014, BODY IMAGE, V11, P43, DOI 10.1016/j.bodyim.2013.10.004; Hewig J, 2008, PSYCHOSOM MED, V70, P729, DOI 10.1097/PSY.0b013e31817e41d3; Hilbert A, 2002, J PSYCHOSOM RES, V52, P137, DOI 10.1016/S0022-3999(01)00314-2; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; Horndasch S, 2012, PSYCHIAT RES, V198, P321, DOI 10.1016/j.psychres.2011.12.029; Janelle C M, 2003, Eat Weight Disord, V8, P138; Janelle CM, 2009, PSYCHOL HEALTH, V24, P351, DOI 10.1080/08870440701697367; Jansen A, 2005, BEHAV RES THER, V43, P183, DOI 10.1016/j.brat.2004.01.003; Jansen A, 2008, APPETITE, V51, P214, DOI 10.1016/j.appet.2008.01.011; Latner J.D., 2012, ENCY BODY IMAGE HUMA, V1, P264; Latner JD, 2008, BODY IMAGE, V5, P91, DOI 10.1016/j.bodyim.2007.08.001; Legenbauer T., 2010, KORPERBILDTHERAPIE B; Legenbauer T, 2011, BEHAV MODIF, V35, P162, DOI 10.1177/0145445510393478; Lykins AD, 2014, BODY IMAGE, V11, P404, DOI 10.1016/j.bodyim.2014.05.003; Martijn C, 2013, HEALTH PSYCHOL, V32, P433, DOI 10.1037/a0028592; Meermann R, 1987, THERAPIE DER MAGERSU; Mele S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081378; Menzel JE, 2010, BODY IMAGE, V7, P261, DOI 10.1016/j.bodyim.2010.05.004; Meyer C, 2011, BEHAV COGN PSYCHOTH, V39, P591, DOI 10.1017/S1352465811000270; Mountford V, 2006, INT J EAT DISORDER, V39, P708, DOI 10.1002/eat.20279; Nissen NK, 2015, OBES REV, V16, P150, DOI 10.1111/obr.12231; Olson KL, 2015, PSYCHOSOM MED, V77, P59, DOI 10.1097/PSY.0000000000000127; Powell PA, 2015, BODY IMAGE, V12, P98, DOI 10.1016/j.bodyim.2014.10.006; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Reas DL, 2005, INT J EAT DISORDER, V37, P342, DOI 10.1002/eat.20092; Reas DL, 2002, INT J EAT DISORDER, V31, P324, DOI 10.1002/eat.10012; Roefs A, 2008, APPETITE, V51, P552, DOI 10.1016/j.appet.2008.04.008; Rosen J., 1991, PSYCHOL ASSESSMENT J, V3, P32, DOI [https://doi.org/10.1037/1040-3590.3.1.32, DOI 10.1037/1040-3590.3.1.32]; Schwartz Marlene B, 2004, Body Image, V1, P43, DOI 10.1016/S1740-1445(03)00007-X; Seifert A L, 2008, Eat Weight Disord, V13, pe84; Shafran R, 2004, INT J EAT DISORDER, V35, P93, DOI 10.1002/eat.10228; Smeets E, 2011, HEALTH PSYCHOL, V30, P360, DOI 10.1037/a0022095; Smeets E, 2011, INT J EAT DISORDER, V44, P50, DOI 10.1002/eat.20776; Smith E, 2010, INT J EAT DISORDER, V43, P358, DOI 10.1002/eat.20703; Striegel-Moore RH, 2003, INT J EAT DISORDER, V34, pS19, DOI 10.1002/eat.10202; Svaldi J, 2012, PSYCHOTHER PSYCHOSOM, V81, P52, DOI 10.1159/000329110; Svaldi J, 2011, PSYCHOTHER PSYCHOSOM, V80, P186, DOI 10.1159/000317538; Thompson J Kevin, 2004, Body Image, V1, P7, DOI 10.1016/S1740-1445(03)00004-4; Thompson JK, 1995, HDB ASSESSMENT METHO, P119; THOMPSON MA, 1995, J PERS ASSESS, V64, P258, DOI 10.1207/s15327752jpa6402_6; Tsai SA, 2016, AM J MENS HEALTH, V10, P389, DOI 10.1177/1557988314567223; Vocks S, 2008, Z KL PSYCH PSYCHOTH, V37, P131, DOI 10.1026/1616-3443.37.2.131; Vocks S, 2007, J PSYCHOSOM RES, V62, P231, DOI 10.1016/j.jpsychores.2006.08.007; von Wietersheim J, 2012, PSYCHOSOM MED, V74, P107, DOI 10.1097/PSY.0b013e31823ba787; Wadlinger HA, 2011, PERS SOC PSYCHOL REV, V15, P75, DOI 10.1177/1088868310365565; Walker D. C., 2012, ENCY BODY IMAGE HUMA, V1, P166, DOI DOI 10.1016/B978-0-12-384925-0.00025-0; Williamson DA, 1999, BEHAV MODIF, V23, P556, DOI 10.1177/0145445599234003	69	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140813	10.1371/journal.pone.0140813	http://dx.doi.org/10.1371/journal.pone.0140813			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7WW	26479500	Green Submitted, Green Published, gold			2022-12-27	WOS:000363026600020
J	Costa, FO; Cota, LOM; Cortelli, JR; Cortelli, SC; Cyrino, RM; Lages, EJP; Oliveira, APL				Costa, Fernando Oliveira; Miranda Cota, Luis Otavio; Cortelli, Jose Roberto; Cortelli, Sheila Cavalca; Cyrino, Renata Magalhaes; Pereira Lages, Eugenio Jose; Lima Oliveira, Ana Paula			Surgical and Non-Surgical Procedures Associated with Recurrence of Periodontitis in Periodontal Maintenance Therapy: 5-Year Prospective Study	PLOS ONE			English	Article							DISEASE PROGRESSION; RISK-ASSESSMENT; TOOTH LOSS; GLYCEMIC CONTROL; PLAQUE CONTROL; FOLLOW-UP; INDIVIDUALS; POPULATION; SMOKING; CARE	Background and Objective Prospective studies that investigated the influence of surgical and nonsurgical procedures in the recurrence of periodontitis and tooth loss in periodontal maintenance therapy (PMT) programs have not been previously reported. The objective of this study was to evaluate longitudinally the recurrence of periodontitis in regular compliers (RC) and irregular compliers (IC) individuals undergoing surgical and non-surgical procedures over 5 years in a program of PMT. Materials and Methods A total of 212 individuals participated in this study. Full-mouth periodontal examination including bleeding on probing, probing depth, and clinical attachment level were determined at all PMT visits over 5 years. The recurrence of periodontitis was evaluated in RC and IC individuals undergoing surgical and non-surgical procedures in PMT. The influences of risk variables of interest were tested through univariate analysis and multivariate logistic regression. Results Recurrence of periodontitis was significantly lower among RC when compared to IC. Individuals with recurrence of periodontitis and undergoing surgical procedures showed higher probing depth and clinical attachment loss than those who received non-surgical procedures. Recurrence of periodontitis was higher in individual undergoing surgical procedures and irregular compliance during PMT. Conclusions Irregular compliance and surgical procedures in individuals undergoing PMT presented higher rates of recurrence of periodontitis when compared to regular compliant patients undergoing non-surgical procedures.	[Costa, Fernando Oliveira; Miranda Cota, Luis Otavio; Cyrino, Renata Magalhaes; Pereira Lages, Eugenio Jose] Univ Fed Minas Gerais, Sch Dent, Dept Periodontol, Belo Horizonte, MG, Brazil; [Cortelli, Jose Roberto; Cortelli, Sheila Cavalca] Univ Taubate, Ctr Periodontal Res, Sao Paulo, Brazil; [Lima Oliveira, Ana Paula] Univ Fed Uberlandia, Dept Periodontol, Sch Dent, BR-38400 Uberlandia, MG, Brazil	Universidade Federal de Minas Gerais; Universidade de Taubate; Universidade Federal de Uberlandia	Costa, FO (corresponding author), Univ Fed Minas Gerais, Sch Dent, Dept Periodontol, Belo Horizonte, MG, Brazil.	focperio@uol.com.br; aplimaoliveira@yahoo.com.br	cortelli, jose/AGP-8091-2022; de Lima Oliveira, Ana Paula/M-6700-2013; Cota, Luís O. M./H-9702-2012; Cortelli, Jose R/D-1771-2011	de Lima Oliveira, Ana Paula/0000-0001-6532-1700; Cota, Luís O. M./0000-0003-1517-5842; Cortelli, Jose R/0000-0001-5147-0705; COSTA, FERNANDO/0000-0002-7687-1238	Minas Gerais State Foundation (FAPEMIG/Brazil) [10137]; National Counsel of Technological and Scientific Development (CNPq/Brazil) [471616, 301493]	Minas Gerais State Foundation (FAPEMIG/Brazil); National Counsel of Technological and Scientific Development (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from the Minas Gerais State Foundation (FAPEMIG/Brazil) (PROJECT #10137) and from the National Counsel of Technological and Scientific Development (CNPq/Brazil) (project #471616 and #301493).	[Anonymous], 2005, J PERIODONTOL, V76, P1406, DOI 10.1902/jop.2005.76.8.1406; Apatzidou Danae A, 2010, Dent Clin North Am, V54, P1, DOI 10.1016/j.cden.2009.08.006; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; BADERSTEN A, 1990, J CLIN PERIODONTOL, V17, P102, DOI 10.1111/j.1600-051X.1990.tb01070.x; Bandyopadhyay D, 2010, J CLIN PERIODONTOL, V37, P501, DOI 10.1111/j.1600-051X.2010.01564.x; Becker W, 2001, J PERIODONTOL, V72, P1675, DOI 10.1902/jop.2001.72.12.1675; BECKER W, 1979, J PERIODONTOL, V50, P234, DOI 10.1902/jop.1979.50.5.234; Cattabriga M, 2001, J PERIODONTOL, V72, P767, DOI 10.1902/jop.2001.72.6.767; Checchi L, 2002, J CLIN PERIODONTOL, V29, P651, DOI 10.1034/j.1600-051X.2002.290710.x; Claffey N, 2004, PERIODONTOL 2000, V36, P35, DOI 10.1111/j.1600-0757.2004.00073.x; Costa FO, 2014, J PERIODONTAL RES, V49, P121, DOI 10.1111/jre.12087; Costa FO, 2007, J PERIODONTOL, V78, P198, DOI 10.1902/jop.2007.060150; Costa FO, 2012, J PERIODONTOL, V83, P292, DOI 10.1902/jop.2011.110187; Costa FO, 2011, J PERIODONTOL, V82, P1279, DOI 10.1902/jop.2011.100664; De Marchi RJ, 2012, COMMUNITY DENT ORAL, V40, P396, DOI 10.1111/j.1600-0528.2012.00689.x; Famili P., 2010, GEN DENT, V58, P42; Fisher S, 2008, J PERIODONTOL, V79, P461, DOI [10.1902/jop.2008.070296, 10.1902/jop.2008.070296 ]; Gavin JR, 1999, DIABETES CARE, V22, pS5; Harrel SK, 2001, J PERIODONTOL, V72, P1509, DOI 10.1902/jop.2001.72.11.1509; Heasman L, 2006, J CLIN PERIODONTOL, V33, P241, DOI 10.1111/j.1600-051X.2006.00902.x; Heitz-Mayfield LJA, 2005, PERIODONTOL 2000, V37, P72, DOI 10.1111/j.1600-0757.2004.03797.x; Ishikawa I, 2004, PERIODONTOL 2000, V36, P9, DOI 10.1111/j.1600-0757.2004.03670.x; ISIDOR F, 1986, J PERIODONTAL RES, V21, P462, DOI 10.1111/j.1600-0765.1986.tb01482.x; Kaldahl WB, 1996, J PERIODONTOL, V67, P93, DOI 10.1902/jop.1996.67.2.93; KALDAHL WB, 1993, J PERIODONTOL, V64, P243, DOI 10.1902/jop.1993.64.4.243; Kim SY, 2014, J PERIODONTAL IMPLAN, V44, P65, DOI 10.5051/jpis.2014.44.2.65; Konig J, 2001, J CLIN PERIODONTOL, V28, P227, DOI 10.1034/j.1600-051x.2001.028003227.x; Leininger M, 2010, J CLIN PERIODONTOL, V37, P427, DOI 10.1111/j.1600-051X.2010.01553.x; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; Matuliene G, 2010, J CLIN PERIODONTOL, V37, P191, DOI 10.1111/j.1600-051X.2009.01508.x; McLeod DE, 1998, QUINTESSENCE INT, V29, P631; Lorentz TCM, 2009, J CLIN PERIODONTOL, V36, P58, DOI 10.1111/j.1600-051X.2008.01342.x; Meinberg T A, 2001, J Dent Hyg, V75, P15; Miyamoto T, 2010, J PERIODONTOL, V81, P1280, DOI 10.1902/jop.2010.100039; NORDLAND P, 1987, J CLIN PERIODONTOL, V14, P231, DOI 10.1111/j.1600-051X.1987.tb00972.x; Papantonopoulos GH, 2004, J PERIODONTOL, V75, P839, DOI 10.1902/jop.2004.75.6.839; Ramberg P, 2001, J CLIN PERIODONTOL, V28, P446, DOI 10.1034/j.1600-051x.2001.028005446.x; Renvert S, 2004, PERIODONTOL 2000, V36, P179, DOI 10.1111/j.1600-0757.2004.03680.x; RENVERT S, 1990, J CLIN PERIODONTOL, V17, P356, DOI 10.1111/j.1600-051X.1990.tb00031.x; Rosling B, 1997, J CLIN PERIODONTOL, V24, P881, DOI 10.1111/j.1600-051X.1997.tb01206.x; Rosling B, 2001, J CLIN PERIODONTOL, V28, P241, DOI 10.1034/j.1600-051x.2001.028003241.x; Scott DA, 2001, J CLIN PERIODONTOL, V28, P715, DOI 10.1034/j.1600-051X.2001.280801.x; Svardstrom G, 2000, J PERIODONTOL, V71, P579, DOI 10.1902/jop.2000.71.4.579; Taylor GW, 2008, ORAL DIS, V14, P191, DOI 10.1111/j.1601-0825.2008.01442.x; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; Tonetti MS, 2000, J CLIN PERIODONTOL, V27, P824, DOI 10.1034/j.1600-051x.2000.027011824.x; TURESKY S, 1970, J PERIODONTOL, V41, P41, DOI 10.1902/jop.1970.41.1.41; Umaki TM, 2012, J PERIODONTOL, V83, P395, DOI 10.1902/jop.2011.110344; WILSON TG, 1993, J PERIODONTOL, V64, P311, DOI 10.1902/jop.1993.64.4.311	51	25	26	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140847	10.1371/journal.pone.0140847	http://dx.doi.org/10.1371/journal.pone.0140847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496187	gold, Green Submitted, Green Published			2022-12-27	WOS:000363309200034
J	Silva, NCD; Vidal, R; Costa, FM; Vaio, M; Ogliari, JB				de Almeida Silva, Natalia Carolina; Vidal, Rafael; Costa, Flaviane Malaquias; Vaio, Magdalena; Ogliari, Juliana Bernardi			Presence of Zea luxurians (Durieu and Ascherson) Bird in Southern Brazil: Implications for the Conservation of Wild Relatives of Maize	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC DIVERSITY; TEOSINTE; NICARAGUENSIS; ETHNOBOTANY; GRAMINEAE; TAXONOMY; POACEAE	Records of the occurrence of wild relatives of maize in South American lowlands are unprecedented, especially in sympatric coexistence with landraces. This fact is relevant, because regions of occurrence of wild relatives of cultivated plants should be a priority for conservation, even if they do not correspond to the center of origin of the species. The aim of this study was to identify and characterize the wild relatives of maize in the Far West of Santa Catarina, southern Brazil. Therefore, phenotypic characterization was performed for five populations, based on 22 morphological traits deemed as fundamental for classifying the species of the genus Zea, and validated through the characterization of chromosomal knobs of two populations. The occurrence and distribution of teosinte populations were described through semi-structured interviews applied to a sample of 305 farmers. A total of 136 teosinte populations were identified; 75% of them occur spontaneously, 17% are cultivated populations, and 8% occur both ways, for the same farm. Populations that were characterized morphologically had trapezoidal fruits mostly, upright tassel branch (4-18), non-prominent main branch and glabrous glumes, with two protruding outer ribs and 8 inner ribs, on average. Cytogenetic analysis identified 10 pairs of homologous chromosomes (2n = 20) with 26 knobs, located in the terminal region of all chromosomes. The similarity of these results with the information reported in the literature indicates that the five populations of wild relatives of maize in this region of Santa Catarina belong to the botanical species Zea luxurians.	[de Almeida Silva, Natalia Carolina; Vidal, Rafael; Costa, Flaviane Malaquias; Ogliari, Juliana Bernardi] Univ Fed Santa Catarina, Dept Fitotecnia, Ctr Ciencias Agr CCA, Florianopolis, SC, Brazil; [Vidal, Rafael; Vaio, Magdalena] Univ Republica, Fac Agron, Dept Biol Vegetal, Montevideo, Uruguay	Universidade Federal de Santa Catarina (UFSC); Universidad de la Republica, Uruguay	Ogliari, JB (corresponding author), Univ Fed Santa Catarina, Dept Fitotecnia, Ctr Ciencias Agr CCA, Florianopolis, SC, Brazil.	juliana.bernardi@ufsc.br	Almeida, Natália/S-3152-2019; Vaio, Magdalena/AHC-3976-2022	Vidal, Rafael/0000-0001-6162-6355; Vaio, Magdalena/0000-0001-8377-6485	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (National Council for Scientific and Technological Development) [564497/2010-0]; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina - FAPESC (Research Support Foundation of the Santa Catarina) [3463/2012]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (Coordination of Personal Perfectioning of Superior Level)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina - FAPESC (Research Support Foundation of the Santa Catarina); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (Coordination of Personal Perfectioning of Superior Level)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (National Council for Scientific and Technological Development): Processo CNPq n. 564497/2010-0: JBO; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina - FAPESC (Research Support Foundation of the Santa Catarina): Processo FAPESC n. 3463/2012: JBO. The scholarship was granted to the authors FMC, NCAS and RV by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (Coordination of Personal Perfectioning of Superior Level). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, but they gave the financial support to perform the research and translate the manuscript.	Alves PA, 2006, MIGRACOES OESTE CATA; [Anonymous], 1993, ISTA INT RULES SEED; Araujo AA, 1972, FORRAGEIRAS CEIFA CA, P79; Aylor DE, 2003, AGR FOREST METEOROL, V119, P111, DOI 10.1016/S0168-1923(03)00159-X; Bellon MR, 2003, GENET RESOUR CROP EV, V50, P401, DOI 10.1023/A:1023967611495; BENZ BF, 1990, MAYDICA, V35, P85; Bioversity and The Christensen Fund, 2009, DESCR FARM KNOWL PLA; BIRD RM, 1978, TAXON, V27, P361, DOI 10.2307/1220377; Blancas L., 2001, THESIS U CALIFORNIA; Brieger F.G., 1958, RACES MAIZE BRAZIL O; Buckler ES, 2006, MAYDICA, V51, P123; Cabral JS, 2006, GENET MOL BIOL, V29, P659, DOI 10.1590/S1415-47572006000400015; Cadima X, 2014, J NAT CONSERV, V22, P113, DOI 10.1016/j.jnc.2013.09.007; Collins GN, 1921, J HERED, V7, P339; Dejean S., 2014, MIXOMICS OMICS DATA; DOEBLEY J, 1990, MAYDICA, V35, P143; Doebley J., 1983, P INT MAIZ VIR DIS C, P15; DOEBLEY JF, 1980, AM J BOT, V67, P982, DOI 10.2307/2442441; Ellneskog-Staam P, 2007, HEREDITAS, V144, P96, DOI 10.1111/j.2007.0018-0661.01989.x; Gonzalez GE, 2013, REV FITOTEC MEX, V36, P127; Fukunaga K, 2005, GENETICS, V169, P2241, DOI 10.1534/genetics.104.031393; Gonzalez GE, 2011, GENOME, V54, P26, DOI 10.1139/G10-089; Gonzalez-Sanchez M, 2003, HEREDITY, V90, P122, DOI 10.1038/sj.hdy.6800185; Heywood V, 2007, AGR ECOSYST ENVIRON, V121, P245, DOI 10.1016/j.agee.2006.12.014; Hijmans R.J., 2001, DIVA GIS VERSION 1 4; Hufford MB, 2012, TRENDS GENET, V28, P606, DOI 10.1016/j.tig.2012.08.004; Iltis HH, 2000, NOVON, V10, P382, DOI 10.2307/3392992; ILTIS HH, 1980, AM J BOT, V67, P994, DOI 10.2307/2442442; Jarvis A, 2008, AGR ECOSYST ENVIRON, V126, P13, DOI 10.1016/j.agee.2008.01.013; Kato YTA., 1976, MASS AGR EXP STN B, V635, P1; Kovacs MIP, 1998, J CEREAL SCI, V27, P47, DOI 10.1006/jcrs.1997.0144; Loaisiga CH, 2012, J MED RES SCI, V2, P29; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Maxted N, 2006, BIODIVERS CONSERV, V15, P2673, DOI 10.1007/s10531-005-5409-6; McClintock B, 1981, CHROMOSOME CONSTITUT; Meilleur BA, 2004, BIODIVERS CONSERV, V13, P663, DOI 10.1023/B:BIOC.0000011719.03230.17; Miranda MR., 2000, THESIS U GUADALAJARA; Molina MD, 2013, BIOL PLANTARUM, V57, P449, DOI 10.1007/s10535-012-0299-4; Mondragon-Pichardo J, 2005, MAYDICA, V50, P123; Pan QL, 2000, GENETICS, V155, P309; Paterniani E, 1977, RACES OF MAIZE IN BR; Pio-Correa M, 1984, DICIONARIO PLANTAS U; Poggio L, 1998, ANN BOT-LONDON, V82, P107, DOI 10.1006/anbo.1998.0757; RELWANI L. L., 1968, Indian Dairyman, V20, P61; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; Sanchez JJ, 2011, AM J BOT, V98, P1537, DOI 10.3732/ajb.1100193; Spillman A, 2003, AGR RES, P18; Tsegaye B, 2007, AGR HUM VALUES, V24, P219, DOI 10.1007/s10460-006-9055-8; Vibrans H, 1998, MAYDICA, V43, P45; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wang LZ, 2008, EUPHYTICA, V164, P789, DOI 10.1007/s10681-008-9730-5; Warburton ML, 2011, GENET RESOUR CROP EV, V58, P1243, DOI 10.1007/s10722-010-9658-1; Wilkes H.G., 1967, TEOSINTE CLOSEST REL; WILKES HG, 1977, ECON BOT, V31, P254, DOI 10.1007/BF02866877; Woloszyn N., 2008, BUSCA TERRA COLONIZA; [No title captured]	56	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139034	10.1371/journal.pone.0139034	http://dx.doi.org/10.1371/journal.pone.0139034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488577	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400018
J	Gong, HY; Li, Y; Fang, G; Hu, DH; Bin Jin, W; Wang, ZH; Li, YS				Gong, Han Yu; Li, Yang; Fang, Gen; Hu, Dao Heng; Bin Jin, Wen; Wang, Zhao Hai; Li, Yang Sheng			Transgenic Rice Expressing Ictb and FBP/Sbpase Derived from Cyanobacteria Exhibits Enhanced Photosynthesis and Mesophyll Conductance to CO2	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ORYZA-SATIVA L.; DIFFUSION CONDUCTANCE; TEMPERATURE RESPONSE; CARBOHYDRATE-METABOLISM; ISOTOPE DISCRIMINATION; C-4 PHOTOSYNTHESIS; FUNCTIONAL-ANATOMY; NITRATE NUTRITION; LEAVES	To find a way to promote the rate of carbon flux and further improve the photosynthetic rate in rice, two CO2-transporting and fixing relevant genes, Ictb and FBP/Sbpase, which were derived from cyanobacteria with the 35SCaMV promotor in the respective constructs, were transformed into rice. Three homologous transgenic groups with Ictb, FBP/Sbpase and the two genes combined were constructed in parallel, and the functional effects of these two genes were investigated by physiological, biochemical and leaf anatomy analyses. The results indicated that the mesophyll conductance and net photosynthetic rate were higher at approximately 10.5-36.8% and 13.5-34.6%, respectively, in the three groups but without any changes in leaf anatomy structure compared with wild type. Other physiological and biochemical parameters increased with the same trend in the three groups, which showed that the effect of FBP/SBPase on improving photosynthetic capacity was better than that of ICTB and that there was an additive effect in ICTB+FBP/SBPase. ICTB localized in the cytoplasm, whereas FBP/SBPase was successfully transported to the chloroplast. The two genes might show a synergistic interaction to promote carbon flow and the assimilation rate as a whole. The multigene transformation engineering and its potential utility for improving the photosynthetic capacity and yield in rice were discussed.	[Gong, Han Yu; Li, Yang; Fang, Gen; Hu, Dao Heng; Bin Jin, Wen; Wang, Zhao Hai; Li, Yang Sheng] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Gong, Han Yu] South Cent Univ Nationalities, Engn Res Ctr Protect & Utilizat Bioresource Ethn, Wuhan, Peoples R China	Wuhan University; South Central Minzu University	Li, YS (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	lysh2001@whu.edu.cn	Li, Yang/GWM-7879-2022; li, yong/HDN-3885-2022; Li, Yuan/GXV-1310-2022		National Natural Science Foundation of China [31271699, 30971741]; National Program of Transgenic Variety Development of China [2011ZX08001-001, 2011ZX08001-004]; Chinese Ministry of Education [313039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of Transgenic Variety Development of China; Chinese Ministry of Education(Ministry of Education, China)	http://www.nsfc.gov.cn/, National Natural Science Foundation of China. (31271699) Han Yu Gong; http://www.nsfc.gov.cn/, National Natural Science Foundation of China. (30971741) Yang Sheng Li. The National Program of Transgenic Variety Development of China (Grant No. 2011ZX08001-001 and 2011ZX08001-004); and Key Grant Project of Chinese Ministry of Education (Grant No. 313039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Albertsson PA, 2001, TRENDS PLANT SCI, V6, P349, DOI 10.1016/S1360-1385(01)02021-0; [Anonymous], 2005, PLANT TISSUE CULT LE; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Assuero SG, 2002, AUST J AGR RES, V53, P29, DOI 10.1071/AR01023; Bassel GW, 2012, PLANT CELL, V24, P3859, DOI 10.1105/tpc.112.100776; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1111/j.1365-3040.2001.00668.x; Bonfil DJ, 1998, FEBS LETT, V430, P236, DOI 10.1016/S0014-5793(98)00662-0; Bouman B.A.M., 2007, WATER MANAGEMENT IRR, P53; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; Busch FA, 2013, PLANT CELL ENVIRON, V36, P200, DOI 10.1111/j.1365-3040.2012.02567.x; Callaway E, 2014, NATURE, V514, pS58, DOI 10.1038/514S58a; Chen WF, 2000, ACTA AGRON SIN, V26, P623; Cinelli RAG, 2000, PHOTOCHEM PHOTOBIOL, V71, P771, DOI 10.1562/0031-8655(2000)071<0771:TEGFPA>2.0.CO;2; Damour G, 2010, PLANT CELL ENVIRON, V33, P1419, DOI 10.1111/j.1365-3040.2010.02181.x; Dawe D., 2007, CHARTING NEW PATHWAY, P37; EHLERINGER J, 1983, PLANT PHYSIOL, V73, P555, DOI 10.1104/pp.73.3.555; EPRON D, 1995, PLANT CELL ENVIRON, V18, P43, DOI 10.1111/j.1365-3040.1995.tb00542.x; Escobara NM, 2003, PLANT CELL, V15, P1507, DOI 10.1105/tpc.013284; Evans JR, 2013, PLANT CELL ENVIRON, V36, P745, DOI 10.1111/j.1365-3040.2012.02591.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Feild TS, 2011, P NATL ACAD SCI USA, V108, P8363, DOI 10.1073/pnas.1014456108; Feng LL, 2007, FUNCT PLANT BIOL, V34, P822, DOI 10.1071/FP07074; Feng LL, 2007, PLANT CELL REP, V26, P1635, DOI 10.1007/s00299-006-0299-y; Flexas J, 2006, PLANT J, V48, P427, DOI 10.1111/j.1365-313X.2006.02879.x; Flexas J, 2012, PLANT SCI, V193, P70, DOI 10.1016/j.plantsci.2012.05.009; Fukuzawa H, 2012, ADV PHOTOSYNTH RESP, V34, P625, DOI 10.1007/978-94-007-1579-0_25; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gomez-Del-Campo M, 2003, J INT SCI VIGNE VIN, V37, P131; Guo S, 2007, PLANT BIOLOGY, V9, P21, DOI 10.1055/s-2006-924541; Guo S, 2005, PHYSIOL PLANTARUM, V123, P288, DOI 10.1111/j.1399-3054.2005.00467.x; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Harrison EP, 1998, PLANTA, V204, P27, DOI 10.1007/s004250050226; Hassiotou F, 2009, J EXP BOT, V60, P2303, DOI 10.1093/jxb/erp021; Hibberd JM, 2008, CURR OPIN PLANT BIOL, V11, P228, DOI 10.1016/j.pbi.2007.11.002; James SA, 2001, AUST J BOT, V49, P259, DOI 10.1071/BT99044; Peguero-Pina JJ, 2012, PLANT CELL ENVIRON, V35, P2121, DOI 10.1111/j.1365-3040.2012.02540.x; Serrato AJ, 2009, J EXP BOT, V60, P2923, DOI 10.1093/jxb/erp066; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Kodama N, 2011, PLANT CELL ENVIRON, V34, P1548, DOI 10.1111/j.1365-3040.2011.02352.x; Ku MSB, 1999, NAT BIOTECHNOL, V17, P76, DOI 10.1038/5256; Li XM, 2011, J EXP BOT, V62, P4763, DOI 10.1093/jxb/err084; Li Y, 2012, PLANT CELL PHYSIOL, V53, P892, DOI 10.1093/pcp/pcs032; Li Y, 2009, J EXP BOT, V60, P2351, DOI 10.1093/jxb/erp127; Lieman-Hurwitz J, 2003, PLANT BIOTECHNOL J, V1, P43, DOI 10.1046/j.1467-7652.2003.00003.x; Lin YJ, 2005, PLANT CELL REP, V23, P540, DOI 10.1007/s00299-004-0843-6; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Maire V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038345; Makino A, 2011, PLANT PHYSIOL, V155, P125, DOI 10.1104/pp.110.165076; Manter DK, 2004, J EXP BOT, V55, P2581, DOI 10.1093/jxb/erh260; Mitchell PL, 2006, NEW PHYTOL, V171, P688, DOI 10.1111/j.1469-8137.2006.01855.x; Miyagawa Y, 2001, NAT BIOTECHNOL, V19, P965, DOI 10.1038/nbt1001-965; Niinemets U, 2009, J EXP BOT, V60, P2249, DOI 10.1093/jxb/erp036; OGREN E, 1993, PLANTA, V189, P182, DOI 10.1007/BF00195075; Park YI, 2009, PLANT BIOTECHNOL REP, V3, P267, DOI 10.1007/s11816-009-0100-0; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Price GD, 2013, J EXP BOT, V64, P753, DOI 10.1093/jxb/ers257; Price GD, 1998, CAN J BOT, V76, P973, DOI 10.1139/b98-081; Raines CA, 2003, PHOTOSYNTH RES, V75, P1, DOI 10.1023/A:1022421515027; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Sage TL, 2009, PLANT CELL PHYSIOL, V50, P756, DOI 10.1093/pcp/pcp033; SAGE TL, 1995, SEX PLANT REPROD, V8, P257; Scafaro AP, 2011, PLANT CELL ENVIRON, V34, P1999, DOI 10.1111/j.1365-3040.2011.02398.x; Sheehy JE, 2008, PHOTOSYNTHESIS ENERG, P1243; Simkin AJ, 2015, J EXP BOT, V66, P4075, DOI 10.1093/jxb/erv204; Sinclair TR, 2004, TRENDS PLANT SCI, V9, P70, DOI 10.1016/j.tplants.2003.12.008; Tamoi M, 1996, ARCH BIOCHEM BIOPHYS, V334, P27, DOI 10.1006/abbi.1996.0425; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; THAIN JF, 1983, J EXP BOT, V34, P87, DOI 10.1093/jxb/34.1.87; Toki S, 1997, PLANT MOL BIOL REP, V15, P16, DOI 10.1007/BF02772109; Tomas M, 2013, J EXP BOT, V64, P2269, DOI 10.1093/jxb/ert086; Tosens T, 2012, J EXP BOT, V63, P5105, DOI 10.1093/jxb/ers171; Tripathi AK, 2012, RICE, V5, DOI 10.1186/1939-8433-5-37; Uehlein N, 2008, PLANT CELL, V20, P648, DOI 10.1105/tpc.107.054023; Urade R, 2009, BIOFACTORS, V35, P326, DOI 10.1002/biof.45; VALENTINI R, 1995, PLANT CELL ENVIRON, V18, P631, DOI 10.1111/j.1365-3040.1995.tb00564.x; Vrabl D, 2009, J EXP BOT, V60, P2315, DOI 10.1093/jxb/erp115; Warren C, 2006, FUNCT PLANT BIOL, V33, P431, DOI 10.1071/FP05298; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037914; Xue GP, 2008, PLANT MOL BIOL, V67, P197, DOI 10.1007/s11103-008-9311-y; Xue GP, 2008, PLANT PHYSIOL, V146, P441, DOI 10.1104/pp.107.113076; Yang S-M., 2008, PHOTOSYNTHESIS ENERG, P1243, DOI 10.1007/978-1-4020-6709-9_268; Yu HT, 2012, J PROTEOME RES, V11, P359, DOI 10.1021/pr200779p; Yu JJ, 2011, J PROTEOME RES, V10, P3852, DOI 10.1021/pr101102p; Zhu GH, 2010, ADV PHOTOSYNTH RESP, V31, P307; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206; Zurbriggen M.D., 2009, RECENT ADV PLANT BIO, P65	91	32	33	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140928	10.1371/journal.pone.0140928	http://dx.doi.org/10.1371/journal.pone.0140928			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488581	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400081
J	Koo, JH; Choi, SH; Lee, SA; Wang, JH				Koo, Ji Hyun; Choi, Sang-Hee; Lee, Seung Ah; Wang, Joon Ho			Comparison of Medial and Lateral Meniscus Root Tears	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; KNEE MRI; EXTRUSION; ARTHROSCOPY	The meniscus root plays an essential role in maintaining the circumferential hoop tension and preventing meniscal displacement. Studies on meniscus root tears have investigated the relationship of osteoarthritis and an anterior cruciate ligament tear. However, few studies have directly compared the medial and lateral root tears. To assess the prevalence of meniscal extrusion and its relationship with clinical features in medial and lateral meniscus root tears, we performed a retrospective review of the magnetic resonance imaging (MRI) results of 42 knee patients who had meniscus posterior horn root tears and who had undergone arthroscopic operations. The presence of meniscal extrusion was evaluated and the exact extent was measured from the tibial margin. The results were correlated with arthroscopic findings. Clinical features including patients' ages, joint abnormalities, and previous trauma histories were evaluated. Twenty-two patients had medial meniscus root tears (MMRTs) and twenty patients had lateral meniscus root tears (LMRTs). Meniscal extrusion was present in 18 MMRT patients and one LMRT patient. The mean extent of extrusion was 4.2mm (range, 0.6 to 7.8) in the MMRT group and 0.9mm (range, -1.9 to 3.4) in the LMRT group. Five patients with MMRT had a history of trauma, while 19 patients with LMRT had a history of trauma. Three patients with MMRT had anterior cruciate ligament (ACL) tears, while 19 patients with LMRT had ACL tears. The mean age of the patients was 52 years (range: 29-71 years) and 30 years (range: 14-62 years) in the MMRT and LMRT group, respectively. There was a significant correlation between a MMRT and meniscal extrusion (p<0.0001), and between an ACL tear and LMRT (p<0.0001). A history of trauma was significantly common in LMRT (p<0.0001). LMRT patients were significantly younger than MMRT patients (p<0.0001). Kellgren-Lawrence (K-L) grade differed significantly between MMRT and LMRT group (p<0.0001). Meniscal extrusion is common in patients with MMRTs. However, it is rare in patients with LMRTs, which are more commonly associated with a history of trauma and ACL tears.	[Koo, Ji Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol,Hlth Promot Ctr, Seoul, South Korea; [Choi, Sang-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Lee, Seung Ah] Kyung Hee Univ, Coll Med, Dept Phys Med & Rehabil, Seoul, South Korea; [Wang, Joon Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthoped Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University; Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.	shchoimd@skku.edu						BESSETTE GC, 1992, ORTHOPEDICS, V15, P35; Brody JM, 2007, AM J ROENTGENOL, V188, pW446, DOI 10.2214/AJR.06.0509; Brody JM, 2006, RADIOLOGY, V239, P805, DOI 10.1148/radiol.2393050559; BYLSKIAUSTROW DI, 1994, J BIOMECH, V27, P421, DOI 10.1016/0021-9290(94)90018-3; Choi CJ, 2010, ARTHROSCOPY, V26, P1602, DOI 10.1016/j.arthro.2010.05.004; Choi SH, 2012, KNEE SURG SPORT TR A, V20, P2094, DOI 10.1007/s00167-011-1794-4; Costa CR, 2004, AM J ROENTGENOL, V183, P17, DOI 10.2214/ajr.183.1.1830017; De Smet AA, 2008, AM J ROENTGENOL, V190, P22, DOI 10.2214/AJR.07.2611; De Smet AA, 2009, AM J ROENTGENOL, V192, P480, DOI 10.2214/AJR.08.1300; DESMET AA, 1994, AM J ROENTGENOL, V162, P905, DOI 10.2214/ajr.162.4.8141016; Jones RS, 1996, CLIN BIOMECH, V11, P295, DOI 10.1016/0268-0033(96)00003-4; Kim YJ, 2010, KNEE, V17, P324, DOI 10.1016/j.knee.2009.10.001; Lee DH, 2011, KNEE SURG SPORT TR A, V19, P222, DOI 10.1007/s00167-010-1274-2; Lerer DB, 2004, SKELETAL RADIOL, V33, P569, DOI 10.1007/s00256-004-0791-2; Magee T, 2008, J MAGN RESON IMAGING, V28, P466, DOI 10.1002/jmri.21460; Miller TT, 1997, SKELETAL RADIOL, V26, P424, DOI 10.1007/s002560050259; Ozkoc G, 2008, KNEE SURG SPORT TR A, V16, P849, DOI 10.1007/s00167-008-0569-z; TUNG GA, 1993, RADIOLOGY, V188, P661, DOI 10.1148/radiology.188.3.8351329	18	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141021	10.1371/journal.pone.0141021	http://dx.doi.org/10.1371/journal.pone.0141021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488288	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400096
J	Lei, WW; Ravoninjohary, A; Li, X; Margolskee, RF; Reed, DR; Beauchamp, GK; Jiang, PH				Lei, Weiwei; Ravoninjohary, Aurore; Li, Xia; Margolskee, Robert F.; Reed, Danielle R.; Beauchamp, Gary K.; Jiang, Peihua			Functional Analyses of Bitter Taste Receptors in Domestic Cats (Felis catus)	PLOS ONE			English	Article							GENES; EVOLUTION; DIET	Cats are obligate carnivores and under most circumstances eat only animal products. Owing to the pseudogenization of one of two subunits of the sweet receptor gene, they are indifferent to sweeteners, presumably having no need to detect plant-based sugars in their diet. Following this reasoning and a recent report of a positive correlation between the proportion of dietary plants and the number of Tas2r (bitter receptor) genes in vertebrate species, we tested the hypothesis that if bitter perception exists primarily to protect animals from poisonous plant compounds, the genome of the domestic cat (Felis catus) should have lost functional bitter receptors and they should also have reduced bitter receptor function. To test functionality of cat bitter receptors, we expressed cat Tas2R receptors in cell-based assays. We found that they have at least 7 functional receptors with distinct receptive ranges, showing many similarities, along with some differences, with human bitter receptors. To provide a comparative perspective, we compared the cat repertoire of intact receptors with those of a restricted number of members of the order Carnivora, with a range of dietary habits as reported in the literature. The numbers of functional bitter receptors in the terrestrial Carnivora we examined, including omnivorous and herbivorous species, were roughly comparable to that of cats thereby providing no strong support for the hypothesis that a strict meat diet influences bitter receptor number or function. Maintenance of bitter receptor function in terrestrial obligate carnivores may be due to the presence of bitter compounds in vertebrate and invertebrate prey, to the necessary role these receptors play in non-oral perception, or to other unknown factors. We also found that the two aquatic Carnivora species examined had fewer intact bitter receptors. Further comparative studies of factors driving numbers and functions of bitter taste receptors will aid in understanding the forces shaping their repertoire.	[Lei, Weiwei; Ravoninjohary, Aurore; Margolskee, Robert F.; Reed, Danielle R.; Beauchamp, Gary K.; Jiang, Peihua] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Li, Xia] Cincinnati Childrens Hosp, Cincinnati, OH 45229 USA	Monell Chemical Senses Center; Cincinnati Children's Hospital Medical Center	Jiang, PH (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	pjiang@monell.org		Margolskee, Robert/0000-0002-9572-2887	National Institute on Deafness and other communication disorders at the National Institutes of Health [R01DC010842, 1P30DC011735]; Monell Chemical Senses Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC011735, R01DC010842] Funding Source: NIH RePORTER	National Institute on Deafness and other communication disorders at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Monell Chemical Senses Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by the National Institute on Deafness and other communication disorders at the National Institutes of Health (R01DC010842 to PJ) and institutional funds from the Monell Chemical Senses Center; DNA analysis and calcium mobilization assays were performed at the Monell Genotyping and DNA/RNA Analysis Core and the Chemosensory Receptor Signaling Core, respectively, which was supported in part by funding from the National Institute on Deafness and Other Communication Disorders at the National Institutes of Health (1P30DC011735 to RFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Baldwin MW, 2014, SCIENCE, V345, P929, DOI 10.1126/science.1255097; Behrens M, 2014, MOL BIOL EVOL, V31, P3216, DOI 10.1093/molbev/msu254; Boitani L, 2003, WOLVES BEHAV ECOLOGY, Vxvii; Bradshaw JWS, 1996, COMP BIOCHEM PHYS A, V114, P205, DOI 10.1016/0300-9629(95)02133-7; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; BURN DM, 1986, COMP BIOCHEM PHYS A, V85, P139, DOI 10.1016/0300-9629(86)90475-5; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Doherty TS, 2015, J BIOGEOGR, V42, P964, DOI 10.1111/jbi.12469; Eizirik E, 2010, MOL PHYLOGENET EVOL, V56, P49, DOI 10.1016/j.ympev.2010.01.033; Fay FH, 1982, N AM FAUNA, DOI DOI 10.3996/NAFA.74.0001; Feng P, 2014, GENOME BIOL EVOL, V6, P1254, DOI 10.1093/gbe/evu095; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Go Y, 2005, GENETICS, V170, P313, DOI 10.1534/genetics.104.037523; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Johnson-Delaney Cathy A., 2014, Veterinary Clinics of North America Exotic Animal Practice, V17, P449, DOI 10.1016/j.cvex.2014.05.008; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; LEGRANDDEFRETIN V, 1994, P NUTR SOC, V53, P15, DOI 10.1079/PNS19940004; Li DY, 2014, MOL BIOL EVOL, V31, P303, DOI 10.1093/molbev/mst219; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Liman ER, 2014, NEURON, V81, P984, DOI 10.1016/j.neuron.2014.02.022; LYDERSEN C, 1991, HOLARCTIC ECOL, V14, P219; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Riedman M, 1991, PINNIPEDS SEALS SEA; Sandau MM, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0170-6; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P231, DOI 10.1017/S0025315407055233; Schaller G.B., 1985, GIANT PANDAS WOLONG; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Stupans I, 2001, COMP BIOCHEM PHYS C, V128, P367, DOI 10.1016/S1532-0456(00)00211-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Zhu KL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0218-8	37	28	29	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139670	10.1371/journal.pone.0139670	http://dx.doi.org/10.1371/journal.pone.0139670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488302	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400033
J	Ngangbam, AK; Baten, A; Waters, DLE; Whalan, S; Benkendorff, K				Ngangbam, Ajit Kumar; Baten, Abdul; Waters, Daniel L. E.; Whalan, Steve; Benkendorff, Kirsten			Characterization of Bacterial Communities Associated with the Tyrian Purple Producing Gland in a Marine Gastropod	PLOS ONE			English	Article							DICATHAIS-ORBITA GMELIN; 1791 NEOGASTROPODA MURICIDAE; TUBEWORM RIFTIA-PACHYPTILA; EGG MASSES; METAGENOMIC ANALYSIS; HYPOBRANCHIAL GLAND; PSEUDOMONAS-AUREOFACIENS; VANADIUM BROMOPEROXIDASE; NONHEME BROMOPEROXIDASE; INDOLE-DERIVATIVES	Dicathais orbita is a marine mollusc recognised for the production of anticancer compounds that are precursors to Tyrian purple. This study aimed to assess the diversity and identity of bacteria associated with the Tyrian purple producing hypobranchial gland, in comparison with foot tissue, using a high-throughput sequencing approach. Taxonomic and phylogenetic analysis of variable region V1-V3 of 16S rRNA bacterial gene amplicons in QIIME and MEGAN were carried out. This analysis revealed a highly diverse bacterial assemblage associated with the hypobranchial gland and foot tissues of D. orbita. The dominant bacterial phylum in the 16S rRNA bacterial profiling data set was Proteobacteria followed by Bacteroidetes, Tenericutes and Spirochaetes. In comparison to the foot, the hypobranchial gland had significantly lower bacterial diversity and a different community composition, based on taxonomic assignment at the genus level. A higher abundance of indole producing Vibrio spp. and the presence of bacteria with brominating capabilities in the hypobranchial gland suggest bacteria have a potential role in biosynthesis of Tyrian purple in D. orbita.	[Ngangbam, Ajit Kumar; Whalan, Steve; Benkendorff, Kirsten] So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia; [Baten, Abdul; Waters, Daniel L. E.] So Cross Univ, Southern Cross Plant Sci, Lismore, NSW 2480, Australia	Southern Cross University; Southern Cross University	Benkendorff, K (corresponding author), So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia.	kirsten.benkendorff@scu.edu.au	Benkendorff, Kirsten/Q-4200-2017	Benkendorff, Kirsten/0000-0003-4052-3888; Baten, Abdul/0000-0003-4673-0685; Whalan, Steve/0000-0001-6786-8945; Waters, Daniel/0000-0002-8622-3162				Agarwal V, 2014, NAT CHEM BIOL, V10, P640, DOI 10.1038/nchembio.1564; AJISAKA M, 1969, AGR BIOL CHEM TOKYO, V33, P294, DOI 10.1080/00021369.1969.10859317; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; BAKER JT, 1968, TETRAHEDRON LETT, P43; Bechtold T, 2002, BIORESOURCE TECHNOL, V81, P171, DOI 10.1016/S0960-8524(01)00146-8; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Benkendorff K, 2004, NAT PROD RES, V18, P427, DOI 10.1080/1478641031000620682; Benkendorff K, 2001, MOLECULES, V6, P70, DOI 10.3390/60100070; Benkendorff K, 2000, J CHEM ECOL, V26, P1037, DOI 10.1023/A:1005441116095; Benkendorff K., 2014, NEUROECOLOGY NEUROET, P13; Benkendorff K, 2013, MAR DRUGS, V11, P1370, DOI 10.3390/md11041370; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Butler A, 2004, NAT PROD REP, V21, P180, DOI 10.1039/b302337k; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen T, 2015, FISH SHELLFISH IMMUN, V42, P114, DOI 10.1016/j.fsi.2014.10.042; CHENG CA, 1995, FOOD CHEM TOXICOL, V33, P929, DOI 10.1016/0278-6915(95)00061-6; Chimetto LA, 2011, INT J SYST EVOL MICR, V61, P362, DOI 10.1099/ijs.0.019729-0; Cleary DF, 2015, ANTON LEEUW INT J G, P1; Cooksey CJ, 2001, MOLECULES, V6, P736, DOI 10.3390/60900736; Curson ARJ, 2012, BIOGEOCHEMISTRY, V110, P109, DOI 10.1007/s10533-011-9663-2; Davis J, 2013, APPL ENVIRON MICROB, V79, P7073, DOI 10.1128/AEM.01568-13; Devine SP, 2012, BIOL BULL-US, V223, P138, DOI 10.1086/BBLv223n1p138; Dudek M, 2014, INT J MOL SCI, V15, P18819, DOI 10.3390/ijms151018819; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards V, 2012, MAR DRUGS, V10, P64, DOI 10.3390/md10010064; ELYAKOV GB, 1991, EXPERIENTIA, V47, P632, DOI 10.1007/BF01949894; Esmaeelian B, 2014, MAR DRUGS, V12, P17, DOI 10.3390/md12010017; Esmaeelian B, 2013, MAR DRUGS, V11, P3802, DOI 10.3390/md11103802; Fagervold SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096248; Feher D, 2010, J NAT PROD, V73, P1963, DOI 10.1021/np100506z; Felbeck H, 1998, PHYSIOL ZOOL, V71, P294, DOI 10.1086/515931; Freidlander P., 1909, CHEM BER, V42, P765; Garren M, 2014, ISME J, V8, P999, DOI 10.1038/ismej.2013.210; GIEBEL J, 1991, INT J SYST BACTERIOL, V41, P39, DOI 10.1099/00207713-41-1-39; Gribble GW, 2004, AM SCI, V92, P342, DOI 10.1511/2004.4.342; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; Ito T, 2007, BIOSCI BIOTECH BIOCH, V71, P366, DOI 10.1271/bbb.60295; ITOH N, 1994, BBA-PROTEIN STRUCT M, V1207, P208, DOI 10.1016/0167-4838(94)00053-0; JANNUN R, 1987, COMP BIOCHEM PHYS B, V88, P917, DOI 10.1016/0305-0491(87)90264-1; JANSSEN PH, 1995, ARCH MICROBIOL, V164, P29; Johnson TL, 2011, J PHYCOL, V47, P792, DOI 10.1111/j.1529-8817.2011.01007.x; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; Kimbell JR, 2003, INTEGR COMP BIOL, V43, P254, DOI 10.1093/icb/43.2.254; KNOCH M, 1989, J GEN MICROBIOL, V135, P2493; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Laffy PW, 2013, COMP BIOCHEM PHYS D, V8, P111, DOI 10.1016/j.cbd.2013.01.001; LAUE BE, 1994, J BACTERIOL, V176, P3723, DOI 10.1128/JB.176.12.3723-3729.1994; Lim HK, 2005, APPL ENVIRON MICROB, V71, P7768, DOI 10.1128/AEM.71.12.7768-7777.2005; Maniloff J., 1992, MYCOPLASMAS MOLECULA; Mansson M, 2011, MAR DRUGS, V9, P1440, DOI 10.3390/md9091440; Martinez JS, 2001, J AM CHEM SOC, V123, P3289, DOI 10.1021/ja004176c; Maugard T, 2001, PHYTOCHEMISTRY, V58, P897, DOI 10.1016/S0031-9422(01)00335-1; Naim MA, 2014, FEMS MICROBIOL ECOL, V90, P390, DOI 10.1111/1574-6941.12400; Ngangbam AK, 2015, J SHELLFISH RES, V34, P443, DOI 10.2983/035.034.0228; Nikfarjam L, 2012, CELL J, V13, P203; Nishiguchi MK, 2004, EVOL DEV, V6, P41, DOI 10.1111/j.1525-142X.2004.04009.x; Ozturk B, 2013, SCI REP-UK, V3, DOI 10.1038/srep02780; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Pimentel-Elardo SM, 2012, MAR DRUGS, V10, P1192, DOI 10.3390/md10061192; Pratheepa VK, 2014, CURR MICROBIOL, V68, P140, DOI 10.1007/s00284-013-0450-2; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pukall R, 1999, INT J SYST BACTERIOL, V49, P513, DOI 10.1099/00207713-49-2-513; Qu YY, 2012, BIOTECHNOL LETT, V34, P353, DOI 10.1007/s10529-011-0778-2; Qu YY, 2010, BIORESOURCE TECHNOL, V101, P4527, DOI 10.1016/j.biortech.2010.01.033; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Ruby EG, 1996, ANNU REV MICROBIOL, V50, P591, DOI 10.1146/annurev.micro.50.1.591; Rudd D, 2015, SCI REP-UK, V5, DOI 10.1038/srep13408; Schirmer A, 2005, APPL ENVIRON MICROB, V71, P4840, DOI 10.1128/AEM.71.8.4840-4849.2005; Small AL, 1999, J CELL BIOCHEM, V72, P445, DOI 10.1002/(SICI)1097-4644(19990315)72:4<445::AID-JCB1>3.0.CO;2-P; Sugumar G, 1998, DIS AQUAT ORGAN, V33, P111, DOI 10.3354/dao033111; SUTTON DC, 1993, DIS AQUAT ORGAN, V16, P47, DOI 10.3354/dao016047; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Fernandez NT, 2014, FEMS MICROBIOL ECOL, V88, P69, DOI 10.1111/1574-6941.12270; VANPEE KH, 1985, J BACTERIOL, V161, P1171; VANPEE KH, 1983, J ANTIBIOT, V36, P1735; VANPEE KH, 1987, BIOL CHEM H-S, V368, P1225, DOI 10.1515/bchm3.1987.368.2.1225; VANPEE KH, 1985, J GEN MICROBIOL, V131, P1911; Wang GY, 2006, J IND MICROBIOL BIOT, V33, P545, DOI 10.1007/s10295-006-0123-2; Wang LP, 2015, AQUAC RES, V46, P395, DOI 10.1111/are.12191; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Westley C, 2006, FRANCE LIFE IN PROGR, P31; Westley C., 2008, THE DISTRIBUTION BIO, P237; Westley CB, 2010, J MOLLUS STUD, V76, P186, DOI 10.1093/mollus/eyp056; Westley C, 2008, J CHEM ECOL, V34, P44, DOI 10.1007/s10886-007-9402-2; Westley C, 2009, NAUTILUS, V123, P148; Westley CB, 2010, CANCER BIOL THER, V9, P371, DOI 10.4161/cbt.9.5.10887; WIESNER W, 1985, BIOL CHEM H-S, V366, P1085, DOI 10.1515/bchm3.1985.366.2.1085; Wynands I, 2004, FEMS MICROBIOL LETT, V237, P363, DOI 10.1016/j.femsle.2004.06.053; ZEINER R, 1988, J GEN MICROBIOL, V134, P3141; Zeng J, 2011, BIOTECHNOL LETT, V33, P1607, DOI 10.1007/s10529-011-0595-7; Zhang Z, 2015, AQUAC RES, V46, P462, DOI 10.1111/are.12194	96	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140725	10.1371/journal.pone.0140725	http://dx.doi.org/10.1371/journal.pone.0140725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488885	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400065
J	Smittenaar, P; Rutledge, RB; Zeidman, P; Adams, RA; Brown, H; Lewis, G; Dolan, RJ				Smittenaar, Peter; Rutledge, Robb B.; Zeidman, Peter; Adams, Rick A.; Brown, Harriet; Lewis, Glyn; Dolan, Raymond J.			Proactive and Reactive Response Inhibition across the Lifespan	PLOS ONE			English	Article							STOP SIGNAL INTENSITY; SEX-DIFFERENCES; BASAL GANGLIA; SELECTIVE-INHIBITION; GENDER-DIFFERENCES; REACTION-TIME; AGE; ABILITY; MODEL; INFORMATION	One expression of executive control involves proactive preparation for future events, and this contrasts with stimulus driven reactive control exerted in response to events. Here we describe findings from a response inhibition task, delivered using a smartphone-based platform, that allowed us to index proactive and reactive inhibitory self-control in a large community sample (n = 12,496). Change in stop-signal reaction time (SSRT) when participants are provided with advance information about an upcoming trial, compared to when they are not, provides a measure of proactive control while SSRT in the absence of advance information provides a measure of reactive control. Both forms of control rely on overlapping frontostriatal pathways known to deteriorate in healthy aging, an age-related decline that occurs at an accelerated rate in men compared to women. Here we ask whether these patterns of agerelated decline are reflected in similar changes in proactive and reactive inhibitory control across the lifespan. As predicted, we observed a decline in reactive control with natural aging, with a greater rate of decline in men compared to women (similar to 10 ms versus similar to 8 ms per decade of adult life). Surprisingly, the benefit of preparation, i.e. proactive control, did not change over the lifespan and women showed superior proactive control at all ages compared to men. Our results suggest that reactive and proactive inhibitory control partially rely on distinct neural substrates that are differentially sensitive to age-related change.	[Smittenaar, Peter; Rutledge, Robb B.; Zeidman, Peter; Adams, Rick A.; Brown, Harriet; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Adams, Rick A.; Lewis, Glyn] UCL, Div Psychiat, London W1W 7EJ, England; [Adams, Rick A.] UCL, Inst Cognit Neurosci, London WC1N 3BG, England; [Rutledge, Robb B.; Dolan, Raymond J.] Max Planck Univ Coll London, Ctr Computat Psychiat & Ageing Res, London WC1B 5EH, England	University of London; University College London; University of London; University College London; University of London; University College London	Smittenaar, P (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England.	peter@petersmittenaar.com	Adams, Rick/M-7640-2015; Lewis, Glyn/E-9944-2012	Adams, Rick/0000-0002-7661-8881; Lewis, Glyn/0000-0001-5205-8245; Rutledge, Robb/0000-0001-7337-5039; Zeidman, Peter/0000-0003-3610-6619; Feldman, Harriet/0000-0002-2365-1805	Wellcome Trust [092859/Z/10/Z, 098362/Z/12/Z, 091593/Z/10/Z, 101252/Z/13/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust, 092859/Z/10/Z, (www.wellcome.ac.uk) to PS, Wellcome Trust, 098362/Z/12/Z, 091593/Z/10/Z, (www.wellcome.ac.uk) to RJD and Wellcome Trust, 101252/Z/13/Z, (www.wellcome.ac.uk) to PS RBR PZ RAA HB RJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2008, PSYCHOL SCI, V19, P1146, DOI 10.1111/j.1467-9280.2008.02216.x; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bedard AC, 2002, DEV NEUROPSYCHOL, V21, P93, DOI 10.1207/S15326942DN2101_5; Bicheno S., 2012, STRATEGY ANAL; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Brown HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100662; Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Coffey CE, 1998, ARCH NEUROL-CHICAGO, V55, P169, DOI 10.1001/archneur.55.2.169; Congdon E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00037; COWELL PE, 1994, J NEUROSCI, V14, P4748; Coxon JP, 2007, J NEUROPHYSIOL, V97, P2480, DOI 10.1152/jn.01284.2006; Coxon JP, 2012, J NEUROSCI, V32, P8401, DOI 10.1523/JNEUROSCI.6360-11.2012; Coxon JP, 2009, J COGNITIVE NEUROSCI, V21, P1193, DOI 10.1162/jocn.2009.21081; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Driscoll I, 2005, HORM BEHAV, V47, P326, DOI 10.1016/j.yhbeh.2004.11.013; Dufau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024974; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Good C.D., 2002, BIOM IM 2002 5 IEEE; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Hojsgaard S., 2006, NEWSL R PROJ, V6, P47; Jahfari S, 2012, J NEUROSCI, V32, P10870, DOI 10.1523/JNEUROSCI.0902-12.2012; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Kline R.B., 2013, SIGNIFICANCE TESTING; Lau MA, 2007, PSYCHOL MED, V37, P1249, DOI 10.1017/S0033291707000530; Lavallee CF, 2014, FRONT HUM NEUROSCI, P8; LINDENBERGER U, 2014, SCI ENG ETHICS, V18, P7, DOI DOI 10.1016/J.TICS.2013.10.006; Lipszyc J, 2010, J INT NEUROPSYCH SOC, V16, P1064, DOI 10.1017/S1355617710000895; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Logan GD, 1994, INHIBITORY PROCESSES, Vxiv, P461; Majid DSA, 2013, J NEUROSCI, V33, P13259, DOI 10.1523/JNEUROSCI.5651-12.2013; Maylor EA, 2007, ARCH SEX BEHAV, V36, P235, DOI 10.1007/s10508-006-9155-y; Mayse JD, 2014, FRONTIERS IN NEUROSC, P8, DOI [10.3389/fnins.2014.00408, DOI 10.3389/FNINS.2014.00408]; Monterosso JR, 2005, DRUG ALCOHOL DEPEN, V79, P273, DOI 10.1016/j.drugalcdep.2005.02.002; Morein-Zamir S, 2006, EXP BRAIN RES, V175, P453, DOI 10.1007/s00221-006-0564-x; Murphy DGM, 1996, ARCH GEN PSYCHIAT, V53, P585; R Core Team, 2012, R LANG ENV STAT COMP; Ridderinkhof KR, 1999, ACTA PSYCHOL, V101, P315; Rucklidge JJ, 2002, J CHILD PSYCHOL PSYC, V43, P988, DOI 10.1111/1469-7610.00227; Rutledge RB, 2014, P NATL ACAD SCI USA, V111, P12252, DOI 10.1073/pnas.1407535111; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schall JD, 2012, CURR OPIN NEUROBIOL, V22, P1012, DOI 10.1016/j.conb.2012.06.002; Schmidt R, 2013, NAT NEUROSCI, V16, P1118, DOI 10.1038/nn.3456; Sjoerds Z, 2014, PSYCHOL MED, V44, P1713, DOI 10.1017/S0033291713002274; Smittenaar P, 2013, J NEUROSCI, V33, P18087, DOI 10.1523/JNEUROSCI.2167-13.2013; The R Development Core Team, 2008, R LANGUAGE ENV STAT, P1; Van der Schoot M, 2005, SCAND J PSYCHOL, V46, P331, DOI 10.1111/j.1467-9450.2005.00463.x; van Gaal S, 2009, J EXP PSYCHOL HUMAN, V35, P1129, DOI 10.1037/a0013551; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2013, PSYCHOL SCI, V24, P352, DOI 10.1177/0956797612457390; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; WILLIS SL, 1988, SEX ROLES, V18, P189, DOI 10.1007/BF00287789; Zandbelt BB, 2013, HUM BRAIN MAPP, V34, P2015, DOI 10.1002/hbm.22047; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	61	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140383	10.1371/journal.pone.0140383	http://dx.doi.org/10.1371/journal.pone.0140383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488166	gold, Green Submitted, Green Published			2022-12-27	WOS:000363248400050
J	Steen, R; Wheeler, T; Gorgens, M; Mziray, E; Dallabetta, G				Steen, Richard; Wheeler, Tisha; Gorgens, Marelize; Mziray, Elizabeth; Dallabetta, Gina			Feasible, Efficient and Necessary, without Exception - Working with Sex Workers Interrupts HIV/STI Transmission and Brings Treatment to Many in Need	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; SUB-SAHARAN AFRICA; HIV TRANSMISSION; STRUCTURAL INTERVENTIONS; COMMUNITY MOBILIZATION; PREVENTION PROGRAM; FEMALE; INFECTION; PREVALENCE; EPIDEMICS	Background and Overview High rates of partner change in sex work-whether in professional, 'transactional' or other context-disproportionately drive transmission of HIV and other sexually transmitted infections. Several countries in Asia have demonstrated that reducing transmission in sex work can reverse established epidemics among sex workers, their clients and the general population. Experience and emerging research from Africa reaffirms unprotected sex work to be a key driver of sexual transmission in different contexts and regardless of stage or classification of HIV epidemic. This validation of the epidemiology behind sexual transmission carries an urgent imperative to realign prevention resources and scale up effective targeted interventions in sex work settings, and, given declining HIV resources, to do so efficiently. Eighteen articles in this issue highlight the importance and feasibility of such interventions under four themes: 1) epidemiology, data needs and modelling of sex work in generalised epidemics; 2) implementation science addressing practical aspects of intervention scale-up; 3) community mobilisation and 4) the treatment cascade for sex workers living with HIV. Conclusion Decades of empirical evidence, extended by analyses in this collection, argue that protecting sex work is, without exception, feasible and necessary for controlling HIV/STI epidemics. In addition, the disproportionate burden of HIV borne by sex workers calls for facilitated access to ART, care and support. The imperative for Africa is rapid scale-up of targeted prevention and treatment, facilitated by policies and action to improve conditions where sex work takes place. The opportunity is a wealth of accumulated experience working with sex workers in diverse settings, which can be tapped to make up for lost time. Elsewhere, even in countries with strong interventions and services for sex workers, an emerging challenge is to find ways to sustain them in the face of declining global resources.	[Steen, Richard] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Wheeler, Tisha] US Agcy Int Dev, Off HIV AIDS, Washington, DC 20523 USA; [Gorgens, Marelize; Mziray, Elizabeth] World Bank, Washington, DC 20433 USA; [Dallabetta, Gina] Bill & Melinda Gates Fdn, Washington, DC USA	Erasmus University Rotterdam; Erasmus MC; United States Agency for International Development (USAID); The World Bank; Bill & Melinda Gates Foundation	Steen, R (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	steenr7@gmail.com						Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Baral S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115465; Baral S, 2012, SAHARA J-J SOC ASP H, V9, P127, DOI 10.1080/17290376.2012.743787; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Blankenship KM, 2000, AIDS, V14, pS11, DOI 10.1097/00002030-200006001-00003; BRUNHAM RC, 1990, MED CLIN N AM, V74, P1339, DOI 10.1016/S0025-7125(16)30484-9; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Cianci F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100107; Dallabetta G, 2014, SEX HEALTH, V11, P207, DOI 10.1071/SH14064; Donastorg Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088157; Ikpeazu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103619; Jana S, 2006, LANCET, V367, P814, DOI 10.1016/S0140-6736(06)68331-1; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan D, 2015, LANCET, V385, P172, DOI 10.1016/S0140-6736(14)60973-9; Kimani J, 2008, AIDS, V22, P131, DOI 10.1097/QAD.0b013e3282f27035; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Langa J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094838; Meda N, 1999, AIDS, V13, P1397, DOI 10.1097/00002030-199907300-00018; Mishra S, 2014, PLOS ONE IN PRESS; Mishra S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101690; Mishra S, 2014, SEX TRANSM INFECT, V90, P19, DOI 10.1136/sextrans-2013-051250; Moore L, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-47; Morales-Miranda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103455; Moses S, 2002, SEX TRANSM INFECT, V78, pI114, DOI 10.1136/sti.78.suppl_1.i114; Mountain E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105645; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Panovska-Griffiths J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107066; Pickles M, 2013, LANCET GLOB HEALTH, V1, pE289, DOI 10.1016/S2214-109X(13)70083-4; Prudden HJ, 2013, AIDS, V27, P2623, DOI 10.1097/01.aids.0000432476.22616.2f; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Reza-Paul S, 2012, INDIAN J MED RES, V135, P98, DOI 10.4103/0971-5916.93431; Rojanapithayalkorn W, 2006, REPROD HEALTH MATTER, V14, P41, DOI 10.1016/S0968-8080(06)28270-3; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Sadhu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090592; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Steen R, 2000, SEX TRANSM DIS, V27, P1, DOI 10.1097/00007435-200001000-00001; Steen R, 2014, AIDS, V28, P891, DOI 10.1097/QAD.0000000000000176; Steen R, 2013, EXPERT REV ANTI-INFE, V11, P999, DOI 10.1586/14787210.2013.824717; Thomson N, 2014, PLOS ONE IN PRESS; [United Nations Population Fund The World Bank Joint United Nations Programme on HIV/AIDS Global Network of Sex Work Projects World Health Organization], 2013, IMPM COMPR HIV STI P; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vassall A, 2014, PLOS ONE IN PRESS; Vun MC, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18905; Vuylsteke B, 2009, HIV PREVENTION: A COMPREHENSIVE APPROACH, P376, DOI 10.1016/B978-0-12-374235-3.00014-5; Wheeler T, 2012, J EPIDEMIOL COMMUN H, V66, pII16, DOI 10.1136/jech-2012-201081; Williams JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102643; Wirtz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088047; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7	55	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0121145	10.1371/journal.pone.0121145	http://dx.doi.org/10.1371/journal.pone.0121145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488796	Green Published, gold			2022-12-27	WOS:000363248400001
J	Bosch, PJ; Peng, LF; Kivell, BM				Bosch, Peter J.; Peng, Lifeng; Kivell, Bronwyn M.			Proteomics Analysis of Dorsal Striatum Reveals Changes in Synaptosomal Proteins following Methamphetamine Self-Administration in Rats	PLOS ONE			English	Article							INDUCED BEHAVIORAL SENSITIZATION; SHOTGUN PROTEOMICS; EXPRESSION PROFILE; PREFRONTAL CORTEX; STATISTICAL-MODEL; NUCLEUS-ACCUMBENS; MASS-SPECTROMETRY; COCAINE; NEUROTRANSMITTERS; NEUROTOXICITY	Methamphetamine is a widely abused, highly addictive drug. Regulation of synaptic proteins within the brain's reward pathway modulates addiction behaviours, the progression of drug addiction and long-term changes in brain structure and function that result from drug use. Therefore, using large scale proteomics studies we aim to identify global protein expression changes within the dorsal striatum, a key brain region involved in the modulation of addiction. We performed LC-MS/MS analyses on rat striatal synaptosomes following 30 days of methamphetamine self-administration (2 hours/day) and 14 days abstinence. We identified a total of 84 differentially-expressed proteins with known roles in neuroprotection, neuroplasticity, cell cytoskeleton, energy regulation and synaptic vesicles. We identify significant expression changes in stress-induced phosphoprotein and tubulin polymerisation-promoting protein, which have not previously been associated with addiction. In addition, we confirm the role of amphiphysin and phosphatidylethanolamine binding protein in addiction. This approach has provided new insight into the effects of methamphetamine self-administration on synaptic protein expression in a key brain region associated with addiction, showing a large set of differentially-expressed proteins that persist into abstinence. The mass spectrometry proteomics data are available via ProteomeXchange with identifier PXD001443.	[Bosch, Peter J.; Peng, Lifeng; Kivell, Bronwyn M.] Victoria Univ Wellington, Sch Biol Sci, Ctr Biodiscovery, Wellington, New Zealand	Victoria University Wellington	Peng, LF (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Ctr Biodiscovery, Wellington, New Zealand.	lifeng.peng@vuw.ac.nz; bronwyn.kivell@vuw.ac.nz	; Kivell, Bronwyn/P-3140-2014	Bosch, Peter/0000-0002-0480-3439; Kivell, Bronwyn/0000-0001-9699-553X; Peng, Lifeng/0000-0002-2043-5912	Victoria University of Wellington	Victoria University of Wellington	This work was supported by Victoria University of Wellington. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Fengju, 2007, V43, P77, DOI 10.1007/978-1-4020-5943-8_6; Bai JH, 2010, CELL, V143, P430, DOI 10.1016/j.cell.2010.09.024; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Brennan KA, 2010, BRAIN RES, V1317, P137, DOI 10.1016/j.brainres.2009.11.069; Breukel A I, 1997, Methods Mol Biol, V72, P33; Charntikov S, 2015, DRUG ALCOHOL DEPEN, V152, P15, DOI 10.1016/j.drugalcdep.2015.04.012; Costain WJ, 2010, PROTEOMICS, V10, P3272, DOI 10.1002/pmic.200900447; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Faure JJ, 2009, METAB BRAIN DIS, V24, P685, DOI 10.1007/s11011-009-9167-0; Flynn JM, 2012, FREE RADICAL BIO MED, V53, P1048, DOI 10.1016/j.freeradbiomed.2012.07.004; Freeman WM, 2005, PHARMACOGENOMICS J, V5, P203, DOI 10.1038/sj.tpj.6500309; Friedman SD, 1998, PHARMACOL BIOCHEM BE, V61, P35, DOI 10.1016/S0091-3057(98)00066-5; Hamamura M, 2013, J NEURAL TRANSM, V120, P1039, DOI 10.1007/s00702-012-0931-7; Hartmann CA, 2013, FEBS LETT, V587, P238, DOI 10.1016/j.febslet.2012.11.032; Hengst U, 2001, J BIOL CHEM, V276, P535, DOI 10.1074/jbc.M002524200; Iwazaki T, 2007, PROTEOMICS, V7, P1131, DOI 10.1002/pmic.200600595; Iwazaki T, 2006, BRAIN RES, V1097, P19, DOI 10.1016/j.brainres.2006.04.052; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kobeissy FH, 2010, METHODS MOL BIOL, V662, P303, DOI 10.1007/978-1-60761-800-3_15; Krasnova IN, 2010, PLOS ONE, V5, pe8790; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Li XF, 2008, NEUROCHEM INT, V52, P256, DOI 10.1016/j.neuint.2007.06.014; Luscher C, 2013, J NEUROSCI, V33, P17641, DOI 10.1523/JNEUROSCI.3406-13.2013; Lull ME, 2009, PROTEOM CLIN APPL, V3, P462, DOI 10.1002/prca.200800055; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nordahl TE, 2003, J NEUROPSYCH CLIN N, V15, P317, DOI 10.1176/appi.neuropsych.15.3.317; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Peng LF, 2011, PROTEOMICS, V11, P4376, DOI 10.1002/pmic.201100169; Petit A., 2012, J ADDICTION RES THER, V1, P006, DOI [10.4172/2155-6105.S1-006, DOI 10.4172/2155-6105.S1-006]; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107; Schrimpf SP, 2005, PROTEOMICS, V5, P2531, DOI 10.1002/pmic.200401198; Schwendt M, 2009, J PHARMACOL EXP THER, V331, P555, DOI 10.1124/jpet.109.155770; Stefanski R, 2004, PSYCHOPHARMACOLOGY, V175, P68, DOI 10.1007/s00213-004-1779-9; United Nations Office on Drugs and Crime, 2013, WORLD DRUG REP 2013; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Wang J, 2011, MOL NEUROBIOL, V44, P269, DOI 10.1007/s12035-011-8202-4; Wang SJ, 2003, NEUROPHARMACOLOGY, V44, P686, DOI 10.1016/S0028-3908(03)00045-5; Yang MH, 2008, ADDICT BIOL, V13, P287, DOI 10.1111/j.1369-1600.2007.00090.x; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; ZHANG L, 1994, J CELL BIOL, V127, P1871, DOI 10.1083/jcb.127.6.1871; Zhu J, 2012, J NEUROSCI RES, V90, P895, DOI 10.1002/jnr.22821	46	12	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139829	10.1371/journal.pone.0139829	http://dx.doi.org/10.1371/journal.pone.0139829			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484527	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100014
J	Ciceri, D; Allanore, A				Ciceri, Davide; Allanore, Antoine			Microfluidic Leaching of Soil Minerals: Release of K+ from K Feldspar	PLOS ONE			English	Article							POTASSIUM; TEMPERATURE; DISSOLUTION; RATES	The rate of K+ leaching from soil minerals such as K-feldspar is believed to be too slow to provide agronomic benefit. Currently, theories and methods available to interpret kinetics of mineral processes in soil fail to consider its microfluidic nature. In this study, we measure the leaching rate of K+ ions from a K-feldspar-bearing rock (syenite) in a microfluidic environment, and demonstrate that at the spatial and temporal scales experienced by crop roots, K+ is available at a faster rate than that measured with conventional apparatuses. We present a device to investigate kinetics of mineral leaching at an unprecedented simultaneous resolution of space (similar to 10(1)-10(2) mu m), time (similar to 10(1)-10(2) min) and fluid volume (similar to 10(0)-10(1) mL). Results obtained from such a device challenge the notion that silicate minerals cannot be used as alternative fertilizers for tropical soils.	[Ciceri, Davide; Allanore, Antoine] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Allanore, A (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	allanore@mit.edu	Ciceri, Davide/I-1381-2019; Ciceri, Davide/AFA-8820-2022	Ciceri, Davide/0000-0002-9075-8768; Ciceri, Davide/0000-0002-9075-8768; Allanore, Antoine/0000-0002-2594-0264	Terrativa Minerals; Office of Sponsored Programs at MIT	Terrativa Minerals; Office of Sponsored Programs at MIT	Terrativa Minerals, a commercial company, provided funding for this research in the form of salaries for the authors, equipment, and materials. This funding was subject to the terms set forth by the Office of Sponsored Programs at MIT (http://osp.mit.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya S, 2005, J MICROELECTROMECH S, V14, P590, DOI 10.1109/JMEMS.2005.844746; Blum AE, 1995, REV MINERALOGY GEOCH, V31, P291; CHOU L, 1984, GEOCHIM COSMOCHIM AC, V48, P2205, DOI 10.1016/0016-7037(84)90217-5; Ciceri D, 2015, SCI TOTAL ENVIRON, V502, P590, DOI 10.1016/j.scitotenv.2014.09.013; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Gin S, 2013, MATER TODAY, V16, P243, DOI 10.1016/j.mattod.2013.06.008; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Guidry MW, 2003, GEOCHIM COSMOCHIM AC, V67, P2949, DOI 10.1016/S0016-7037(03)00265-5; Huang P. M., 2005, Chemical processes in soils, P227; Huang P. M., 1989, Minerals in Soil Environments, SSSA Book Series, no. 1., P975; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2010, J PLANT NUTR SOIL SC, V173, P4, DOI 10.1002/jpln.200900290; Li L, 2008, GEOCHIM COSMOCHIM AC, V72, P360, DOI 10.1016/j.gca.2007.10.027; Lis D, 2014, SCIENCE, V344, P1138, DOI 10.1126/science.1253793; Maher K, 2010, EARTH PLANET SC LETT, V294, P101, DOI 10.1016/j.epsl.2010.03.010; Manning DAC, 2010, AGRON SUSTAIN DEV, V30, P281, DOI 10.1051/agro/2009023; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Mirsal IA, 2008, ORIGIN MONITORING RE, DOI [10.3389/fmicb.2015.00940, DOI 10.3389/FMICB.2015.00940]; O'Donnell AG, 2007, NAT REV MICROBIOL, V5, P689, DOI 10.1038/nrmicro1714; Pagliai M, 2008, NEW TRENDS SOIL MICR, P5, DOI DOI 10.1007/978-3-540-79134-8_2; Palm C, 2007, ANNU REV ENV RESOUR, V32, P99, DOI 10.1146/annurev.energy.31.020105.100307; Skorina T, 2015, AQUEOUS ALTERATION P; Sparks D.L., 2003, ENV SOIL CHEM; SPARKS DL, 1984, SOIL SCI, V138, P115, DOI 10.1097/00010694-198408000-00004; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Stephens JC, 2008, CLIMATIC CHANGE, V90, P217, DOI 10.1007/s10584-008-9440-y; Van Straaten P, 2011, INNOVATIONS KEY GREE, P31, DOI DOI 10.1007/978-90-481-2543-2_3; White AF, 2003, CHEM GEOL, V202, P479, DOI 10.1016/j.chemgeo.2003.03.001; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wilson MJ, 2004, CLAY MINER, V39, P233, DOI 10.1180/0009855043930133; Zhu C, 2009, REV MINERAL GEOCHEM, V70, P533, DOI 10.2138/rmg.2009.70.12	32	20	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139979	10.1371/journal.pone.0139979	http://dx.doi.org/10.1371/journal.pone.0139979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485160	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100019
J	Jones, RT; Borchert, J; Eisen, R; MacMillan, K; Boegler, K; Gage, KL				Jones, Ryan Thomas; Borchert, Jeff; Eisen, Rebecca; MacMillan, Katherine; Boegler, Karen; Gage, Kenneth L.			Flea-Associated Bacterial Communities across an Environmental Transect in a Plague-Endemic Region of Uganda	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; RICKETTSIA-FELIS; WOLBACHIA ENDOSYMBIONTS; YERSINIA-PESTIS; UNITED-STATES; NEW-MEXICO; CAT FLEAS; DIVERSITY; TRANSMISSION; SIPHONAPTERA	The vast majority of human plague cases currently occur in sub-Saharan Africa. The primary route of transmission of Yersinia pestis, the causative agent of plague, is via flea bites. Non-pathogenic flea-associated bacteria may interact with Y. pestis within fleas and it is important to understand what factors govern flea-associated bacterial assemblages. Six species of fleas were collected from nine rodent species from ten Ugandan villages between October 2010 and March 2011. A total of 660,345 16S rRNA gene DNA sequences were used to characterize bacterial communities of 332 individual fleas. The DNA sequences were binned into 421 Operational Taxonomic Units (OTUs) based on 97% sequence similarity. We used beta diversity metrics to assess the effects of flea species, flea sex, rodent host species, site (i.e. village), collection date, elevation, mean annual precipitation, average monthly precipitation, and average monthly temperature on bacterial community structure. Flea species had the greatest effect on bacterial community structure with each flea species harboring unique bacterial lineages. The site (i.e. village), rodent host, flea sex, elevation, precipitation, and temperature also significantly affected bacterial community composition. Some bacterial lineages were widespread among flea species (e.g. Bartonella spp. and Wolbachia spp.), but each flea species also harbored unique bacterial lineages. Some of these lineages are not closely related to known bacterial diversity and likely represent newly discovered lineages of insect symbionts. Our finding that flea species has the greatest effect on bacterial community composition may help future investigations between Yersinia pestis and non-pathogenic flea-associated bacteria. Characterizing bacterial communities of fleas during a plague epizootic event in the future would be helpful.	[Jones, Ryan Thomas] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Jones, Ryan Thomas] Montana State Univ, Montana Inst Ecosyst, Bozeman, MT 59717 USA; [Borchert, Jeff; Eisen, Rebecca; MacMillan, Katherine; Boegler, Karen; Gage, Kenneth L.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Centers for Disease Control & Prevention - USA	Jones, RT (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	DrRyanJones@gmail.com	Borchert, Jeff/GSD-7753-2022		Centers for Disease Control and Prevention; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding was provided by the Centers for Disease Control and Prevention.	Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Ari TB, 2010, AM J TROP MED HYG, V83, P624, DOI 10.4269/ajtmh.2010.09-0775; Bell CW, 2009, MICROB ECOL, V58, P827, DOI 10.1007/s00248-009-9529-5; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brown HE, 2010, AM J TROP MED HYG, V82, P95, DOI 10.4269/ajtmh.2010.09-0247; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996; Collinge Sharon K., 2005, EcoHealth, V2, P102, DOI 10.1007/s10393-005-3877-5; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Dittmar K, 2004, J PARASITOL, V90, P953, DOI 10.1645/GE-186R; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisen RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035598; Eisen RJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008039; Enscore RE, 2002, AM J TROP MED HYG, V66, P186, DOI 10.4269/ajtmh.2002.66.186; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Ghiglione JF, 2005, AQUAT MICROB ECOL, V40, P229, DOI 10.3354/ame040229; Ghyselinck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071360; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Gonzalez A, 2012, CURR OPIN BIOTECH, V23, P431, DOI 10.1016/j.copbio.2011.11.017; Gorham CH, 2003, J PARASITOL, V89, P283, DOI 10.1645/0022-3395(2003)089[0283:WEIFS]2.0.CO;2; Haack SK, 2004, ENVIRON MICROBIOL, V6, P438, DOI 10.1111/j.1462-2920.2003.00563.x; Hawlena H, 2013, ISME J, V7, P221, DOI 10.1038/ismej.2012.71; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hornok S, 2010, VET MICROBIOL, V140, P98, DOI 10.1016/j.vetmic.2009.07.013; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Jones RT, 2013, AM J TROP MED HYG, V89, P784, DOI 10.4269/ajtmh.13-0138; Jones RT, 2013, ISME J, V7, P224, DOI 10.1038/ismej.2012.95; Jones RT, 2012, J MED ENTOMOL, V49, P492, DOI 10.1603/ME11244; Jones RT, 2010, ISME J, V4, P223, DOI 10.1038/ismej.2009.111; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; MacMillan K, 2011, AM J TROP MED HYG, V84, P435, DOI 10.4269/ajtmh.2011.10-0571; Matsuura Y, 2012, APPL ENVIRON MICROB, V78, P4149, DOI 10.1128/AEM.00673-12; Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146; Moore SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044431; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Parmenter RR, 1999, AM J TROP MED HYG, V61, P814, DOI 10.4269/ajtmh.1999.61.814; Pornwiroon W, 2007, ISME J, V1, P394, DOI 10.1038/ismej.2007.38; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rolain JM, 2003, EMERG INFECT DIS, V9, P338, DOI 10.3201/eid0903.020278; Sackal C, 2008, EMERG INFECT DIS, V14, P1972, DOI 10.3201/eid1412.080610; Schabereiter-Gurtner C, 2003, J MICROBIOL METH, V52, P251, DOI 10.1016/S0167-7012(02)00186-0; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; *WHO, 2010, WKLY EPIDEMIOL REC, V85, P40; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14	55	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141057	10.1371/journal.pone.0141057	http://dx.doi.org/10.1371/journal.pone.0141057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485147	Green Published, gold			2022-12-27	WOS:000363028100107
J	Vatner, DF; Snikeris, J; Popov, V; Perry, RJ; Rahimi, Y; Samuel, VT				Vatner, Daniel F.; Snikeris, Jaclyn; Popov, Violeta; Perry, Rachel J.; Rahimi, Yasmeen; Samuel, Varman T.			3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats	PLOS ONE			English	Article							RECEPTOR-BETA AGONISTS; PROTEIN-KINASE-C; THYROID-HORMONE; LIVER-DISEASE; METABOLIC-REGULATION; REDUCES CHOLESTEROL; 3,5-DIIODO-L-THYRONINE; ACTIVATION; EXPRESSION; TRIIODOTHYRONINE	Thyroid hormone mimetics are alluring potential therapies for diseases like dyslipidemia, nonalcoholic fatty liver disease (NAFLD), and insulin resistance. Though diiodothyronines are thought inactive, pharmacologic treatment with 3,5-Diiodo-L-Thyronine (T2) reportedly reduces hepatic lipid content and improves glucose tolerance in fat-fed male rats. To test this, male Sprague Dawley rats fed a safflower-oil based high-fat diet were treated with T2 (0.25 mg/kg-d) or vehicle. Neither 10 nor 30 days of T2 treatment had an effect on weight, adiposity, plasma fatty acids, or hepatic steatosis. Insulin action was quantified in vivo by a hyperinsulinemic-euglycemic clamp. T2 did not alter fasting plasma glucose or insulin concentration. Basal endogenous glucose production (EGP) rate was unchanged. During the clamp, there was no difference in insulin stimulated whole body glucose disposal. Insulin suppressed EGP by 60% +/- 10 in T2-treated rats as compared with 47% +/- 4 suppression in the vehicle group (p = 0.32). This was associated with an improvement in hepatic insulin signaling; insulin stimulated Akt phosphorylation was similar to 2.5 fold greater in the T2-treated group as compared with the vehicle-treated group (p = 0.003). There was no change in expression of genes thought to mediate the effect of T2 on hepatic metabolism, including genes that regulate hepatic lipid oxidation (ppara, carnitine palmitoyltransferase 1a), genes that regulate hepatic fatty acid synthesis (srebp1c, acetyl coa carboxylase, fatty acid synthase), and genes involved in glycolysis and gluconeogenesis (L-pyruvate kinase, glucose 6 phosphatase). Therefore, in contrast with previous reports, in Sprague Dawley rats fed an unsaturated fat diet, T2 administration failed to improve NAFLD or whole body insulin sensitivity. Though there was a modest improvement in hepatic insulin signaling, this was not associated with significant differences in hepatic insulin action. Further study will be necessary before diiodothyronines can be considered an effective treatment for NAFLD and dyslipidemia.	[Vatner, Daniel F.; Snikeris, Jaclyn; Popov, Violeta; Rahimi, Yasmeen; Samuel, Varman T.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Perry, Rachel J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Samuel, Varman T.] West Haven VAMC, West Haven, CT USA	Yale University; Yale University	Samuel, VT (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	varman.samuel@yale.edu		Perry, Rachel/0000-0003-0748-8064	Veterans Affairs Merit Grant [I01 BX000901]; US Public Health Service [R24 DK-085638, T32 DK-007058, P30 DK-079310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK102874, T32DK101019, T32DK007058, R24DK085638, P30DK079310] Funding Source: NIH RePORTER	Veterans Affairs Merit Grant(US Department of Veterans Affairs); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by Veterans Affairs Merit Grant I01 BX000901 (VTS), http://www.research.va.gov; and US Public Health Service Grants R24 DK-085638 (VTS), T32 DK-007058 (DFV), and P30 DK-079310 (VTS), https://grants.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005; Ball SG, 1997, J MOL ENDOCRINOL, V19, P137, DOI 10.1677/jme.0.0190137; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Bromati CR, 2011, AM J PHYSIOL-REG I, V300, pR92, DOI 10.1152/ajpregu.00169.2010; de Lange P, 2011, DIABETES, V60, P2730, DOI 10.2337/db11-0207; Deldicque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020993; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Erion MD, 2007, P NATL ACAD SCI USA, V104, P15490, DOI 10.1073/pnas.0702759104; GALAN X, 1993, BIOL NEONATE, V64, P295; Gnocchi D, 2014, HORM METAB RES, V46, P333, DOI 10.1055/s-0034-1371858; Goldberg IJ, 2012, ENDOCRINOLOGY, V153, P5143, DOI 10.1210/en.2012-1572; Grasselli E, 2012, J ENDOCRINOL, V212, P149, DOI 10.1530/JOE-11-0288; Hashimoto K, 2006, ENDOCRINOLOGY, V147, P4292, DOI 10.1210/en.2006-0116; Johansson L, 2005, P NATL ACAD SCI USA, V102, P10297, DOI 10.1073/pnas.0504379102; Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266; KUHN ER, 1983, HORM METAB RES, V15, P491, DOI 10.1055/s-2007-1018767; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lanni A, 2005, FASEB J, V19, DOI 10.1096/fj.05.3977fje; Liang XM, 2011, ANTIOXID REDOX SIGN, V15, P425, DOI 10.1089/ars.2010.3780; Liu YY, 2010, TRENDS ENDOCRIN MET, V21, P166, DOI 10.1016/j.tem.2009.11.004; Lopez D, 2007, BBA-MOL CELL BIOL L, V1771, P1216, DOI 10.1016/j.bbalip.2007.05.001; MCCLURE J, 1961, J ENDOCRINOL, V22, P87, DOI 10.1677/joe.0.0220087; Mendoza A, 2013, ENDOCRINOLOGY, V154, P2948, DOI 10.1210/en.2013-1030; Mollica MP, 2009, J HEPATOL, V51, P363, DOI 10.1016/j.jhep.2009.03.023; Moreno M, 1997, J PHYSIOL-LONDON, V505, P529, DOI 10.1111/j.1469-7793.1997.529bb.x; OMARA BA, 1993, ENDOCRINOLOGY, V133, P1715, DOI 10.1210/en.133.4.1715; Padron AS, 2014, J ENDOCRINOL, V221, P415, DOI 10.1530/JOE-13-0502; PETERSEN KF, 1994, AM J PHYSIOL, V267, pE273, DOI 10.1152/ajpendo.1994.267.2.E273; PETERSEN KF, 1995, METABOLISM, V44, P1380, DOI 10.1016/0026-0495(95)90133-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shin DJ, 2003, J BIOL CHEM, V278, P34114, DOI 10.1074/jbc.M305417200; SHULMAN GI, 1985, J CLIN INVEST, V76, P757, DOI 10.1172/JCI112032; Thompson CC, 1996, J NEUROSCI, V16, P7832; Vatner DF, 2013, AM J PHYSIOL-ENDOC M, V305, pE89, DOI 10.1152/ajpendo.00573.2012; Vernia S, 2014, CELL METAB, V20, P512, DOI 10.1016/j.cmet.2014.06.010; Webb P, 2004, EXPERT OPIN INV DRUG, V13, P489, DOI 10.1517/13543784.13.5.489; You M, 2008, J NUTR, V138, P497, DOI 10.1093/jn/138.3.497	41	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140837	10.1371/journal.pone.0140837	http://dx.doi.org/10.1371/journal.pone.0140837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485433	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100076
J	Nakanishi, M; Wang, YJ; Wang, YT; Jung, TP				Nakanishi, Masaki; Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping			A Comparison Study of Canonical Correlation Analysis Based Methods for Detecting Steady-State Visual Evoked Potentials	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; FREQUENCY RECOGNITION; DESIGN	Canonical correlation analysis (CCA) has been widely used in the detection of the steady-state visual evoked potentials (SSVEPs) in brain-computer interfaces (BCIs). The standard CCA method, which uses sinusoidal signals as reference signals, was first proposed for SSVEP detection without calibration. However, the detection performance can be deteriorated by the interference from the spontaneous EEG activities. Recently, various extended methods have been developed to incorporate individual EEG calibration data in CCA to improve the detection performance. Although advantages of the extended CCA methods have been demonstrated in separate studies, a comprehensive comparison between these methods is still missing. This study performed a comparison of the existing CCA-based SSVEP detection methods using a 12-class SSVEP dataset recorded from 10 subjects in a simulated online BCI experiment. Classification accuracy and information transfer rate (ITR) were used for performance evaluation. The results suggest that individual calibration data can significantly improve the detection performance. Furthermore, the results showed that the combination method based on the standard CCA and the individual template based CCA (IT-CCA) achieved the highest performance.	[Nakanishi, Masaki; Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping] Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA; [Nakanishi, Masaki; Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping] Univ Calif San Diego, Inst Engn Med, Ctr Adv Neurol Engn, La Jolla, CA 92093 USA; [Wang, Yijun] Chinese Acad Sci, Inst Semicond, State Key Lab Integrated Optoelect, Beijing 100083, Peoples R China	University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese Academy of Sciences; Institute of Semiconductors, CAS	Wang, YJ (corresponding author), Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA.	wangyj@semi.ac.cn	Nakanishi, Masaki/S-9251-2019; Wang, Yijun/GXW-1763-2022	Jung, Tzyy-Ping/0000-0002-8377-2166	Swartz Foundation; U.S. Office of Naval Research [N00014-08-1215]; Army Research Office [W911NF-09-1-0510]; Army Research Laboratory [W911NF-10-2-0022]; DARPA [USDI D11PC20183]; UC Proof of Concept Grant [269228]; NIH [1R21EY025056-01]; Recruitment Program for Young Professionals; NATIONAL EYE INSTITUTE [R21EY025056] Funding Source: NIH RePORTER	Swartz Foundation; U.S. Office of Naval Research(Office of Naval Research); Army Research Office; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); UC Proof of Concept Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Recruitment Program for Young Professionals; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported in part by a gift fund from Swartz Foundation, U.S. Office of Naval Research (N00014-08-1215), Army Research Office (W911NF-09-1-0510), Army Research Laboratory (W911NF-10-2-0022), DARPA (USDI D11PC20183), UC Proof of Concept Grant Award (269228), and NIH Grant (1R21EY025056-01). YW is also supported by the Recruitment Program for Young Professionals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cao L, 2015, J NEUROSCI METH, V253, P10, DOI 10.1016/j.jneumeth.2015.05.014; Chen XG, 2014, BRAIN-COMPUT INTERFA, V1, P181, DOI 10.1080/2326263X.2014.944469; Chen XG, 2014, IEEE ENG MED BIO, P3993, DOI 10.1109/EMBC.2014.6944499; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Gao SK, 2014, IEEE T BIO-MED ENG, V61, P1436, DOI 10.1109/TBME.2014.2300164; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Kimura Y, 2013, IEEE T BIO-MED ENG, V60, P2831, DOI 10.1109/TBME.2013.2265260; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Nakanishi M, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500191; Nakanishi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099235; Nan WY, 2011, I IEEE EMBS C NEUR E, P469, DOI 10.1109/NER.2011.5910588; Pan J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036027; Parini Sergio, 2009, Comput Intell Neurosci, P864564, DOI 10.1155/2009/864564; Poryzala P, 2014, BIOMED SIGNAL PROCES, V10, P201, DOI 10.1016/j.bspc.2013.11.003; Tello RMG, 2014, ISSNIP BIOSIG BIOROB, P7; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang Y, 2010, ELECTRON LETT, V46, P1057, DOI 10.1049/el.2010.0923; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576; Wang YJ, 2014, IEEE ENG MED BIO, P3037, DOI 10.1109/EMBC.2014.6944263; Wang YJ, 2008, IEEE ENG MED BIOL, V27, P64, DOI 10.1109/MEMB.2008.923958; Wang YT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025018; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zhang YS, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/908719; Zhang YS, 2014, J NEUROSCI METH, V221, P32, DOI 10.1016/j.jneumeth.2013.07.018; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038603; Zhang Y, 2015, J NEUROSCI METH, V244, P8, DOI 10.1016/j.jneumeth.2014.03.012; Zhang Y, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500130; Zhang Y, 2013, IEEE T NEUR SYS REH, V21, P887, DOI 10.1109/TNSRE.2013.2279680; Zhang Y, 2011, LECT NOTES COMPUT SC, V7062, P287, DOI 10.1007/978-3-642-24955-6_35; Zhu Danhua, 2010, Comput Intell Neurosci, P702357, DOI 10.1155/2010/702357	35	188	190	11	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140703	10.1371/journal.pone.0140703	http://dx.doi.org/10.1371/journal.pone.0140703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479067	Green Submitted, gold, Green Published			2022-12-27	WOS:000363026600017
J	Chen, S; Lei, J; Fu, KY; Wang, X; Yi, B				Chen, Shuo; Lei, Jie; Fu, Kai-Yuan; Wang, Xing; Yi, Biao			Cephalometric Analysis of the Facial Skeletal Morphology of Female Patients Exhibiting Skeletal Class II Deformity with and without Temporomandibular Joint Osteoarthrosis	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; INTERNAL DERANGEMENT; ORTHOGNATHIC SURGERY; DISORDERS; RELIABILITY; PREVALENCE; RADIOLOGY; WOMEN	Purpose This study evaluated the differences in the facial morphological characteristics of female patients exhibiting skeletal class II deformity with and without temporomandibular joint osteoarthrosis. Methods Eighty-three female patients with skeletal class II deformity were included in this study; these patients were classified into three groups on the basis of the condylar features shown in cone-beam computed tomography scans: normal group, indeterminate for osteoarthrosis group, and osteoarthrosis group. The cephalometric differences among the three groups were evaluated through one-way ANOVA. Results Of the 83 patients, 52.4% were diagnosed with osteoarthrosis, as indicated by the changes in the condylar osseous component. The cephalometric measurements that represented skeletal characteristics, including mandibular position relative to the cranial base, mandibular plane angle (MP-SN), posterior facial height (S-Go), and facial height ratio, were significantly different among the three groups (p < 0.05). The patients in the osteoarthrosis group yielded the smallest S-Go, the highest MP-SN, and the most retruded mandible. Conclusions Temporomandibular joint osteoarthrosis is commonly observed in female patients with skeletal class II deformity. The morphological characteristics of the facial skeleton in patients with bilateral condylar osteoarthrosis may be altered.	[Chen, Shuo; Wang, Xing; Yi, Biao] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China; [Lei, Jie; Fu, Kai-Yuan] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Radiol, Beijing 100871, Peoples R China	Peking University; Peking University	Yi, B (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China.	yibiaopku@163.com		Fu, Kai-Yuan/0000-0001-7049-9888	Capital Featured Clinical Application Research Project [Z13110700220000]	Capital Featured Clinical Application Research Project	This study was funded by The Capital Featured Clinical Application Research Project (Z13110700220000) [http://mis.bjkw.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2009, ORAL SURG ORAL MED O, V107, P844, DOI 10.1016/j.tripleo.2009.02.023; Ahn SJ, 2004, AM J ORTHOD DENTOFAC, V126, P486, DOI 10.1016/j.ajodo.2003.08.029; Alexiou KE, 2009, DENTOMAXILLOFAC RAD, V38, P141, DOI 10.1259/dmfr/59263880; BJORK A, 1983, EUR J ORTHODONT, V5, P1; Burke G, 1998, AM J ORTHOD DENTOFAC, V114, P328, DOI 10.1016/S0889-5406(98)70216-1; BURSTONE CJ, 1978, J ORAL SURG, V36, P269; Byun ES, 2005, AM J ORTHOD DENTOFAC, V128, P87, DOI 10.1016/j.ajodo.2004.01.028; COPRAY JCVM, 1988, ANGLE ORTHOD, V58, P369; Dahlberg G, 1940, STAT METHODS MED BIO; Daniele M., 2010, CURRENT CONCEPTS TEM; Pontual MLD, 2012, DENTOMAXILLOFAC RAD, V41, P24, DOI 10.1259/dmfr/17815139; Fu Kai-Yuan, 2007, Zhonghua Kou Qiang Yi Xue Za Zhi, V42, P417; Fu Kai-Yuan, 2004, Zhonghua Kou Qiang Yi Xue Za Zhi, V39, P471; Honda K, 2006, DENTOMAXILLOFAC RAD, V35, P152, DOI 10.1259/dmfr/15831361; Honey OB, 2007, AM J ORTHOD DENTOFAC, V132, P429, DOI 10.1016/j.ajodo.2005.10.032; Krisjane Z, 2012, INT J ORAL MAX SURG, V41, P690, DOI 10.1016/j.ijom.2012.03.006; Ludlow JB, 2006, DENTOMAXILLOFAC RAD, V35, P219, DOI 10.1259/dmfr/14340323; Ma X., 2011, CLIN APPL ORAL MAXIL; Maglione HO, 2013, CRANIO, V31, P276, DOI 10.1179/crn.2013.31.4.005; Nebbe B, 2000, ANGLE ORTHOD, V70, P454; Sanroman JF, 1998, J CRANIO MAXILL SURG, V26, P35; SCHELLHAS KP, 1992, PLAST RECONSTR SURG, V90, P218, DOI 10.1097/00006534-199290020-00009; Sun Zhi-Peng, 2008, Beijing Da Xue Xue Bao Yi Xue Ban, V40, P47; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; Tsiklakis K, 2004, DENTOMAXILLOFAC RAD, V33, P196, DOI 10.1259/dmfr/27403192; Wiberg B, 1998, ORAL SURG ORAL MED O, V86, P158, DOI 10.1016/S1079-2104(98)90118-4; Zarb GA, 1999, J OROFAC PAIN, V13, P295; Zhao YP, 2011, ORAL SURG ORAL MED O, V111, pE27, DOI 10.1016/j.tripleo.2010.09.076	28	10	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0139743	10.1371/journal.pone.0139743	http://dx.doi.org/10.1371/journal.pone.0139743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474490	gold, Green Submitted, Green Published			2022-12-27	WOS:000363185500013
J	Humphrey, S; Lacharme-Lora, L; Chaloner, G; Gibbs, K; Humphrey, T; Williams, N; Wigley, P				Humphrey, Suzanne; Lacharme-Lora, Lizeth; Chaloner, Gemma; Gibbs, Kirsty; Humphrey, Tom; Williams, Nicola; Wigley, Paul			Heterogeneity in the Infection Biology of Campylobacter jejuni Isolates in Three Infection Models Reveals an Invasive and Virulent Phenotype in a ST21 Isolate from Poultry	PLOS ONE			English	Article							CHICKENS; COLONIZATION; SPP.; SALMONELLA; CARCASSES; STRAINS; SURFACE; ORGANS	Although Campylobacter is the leading cause of bacterial foodborne gastroenteritis in the world and the importance of poultry as a source of infection is well understood we know relatively little about its infection biology in the broiler chicken. Much of what we know about the biology of Campylobacter jejuni is based on infection of inbred or SPF laboratory lines of chickens with a small number of isolates used in most laboratory studies. Recently we have shown that both the host response and microbial ecology of C. jejuni in the broiler chicken varies with both the host-type and significantly between C. jejuni isolates. Here we describe heterogeneity in infection within a panel of C. jejuni isolates in two broiler chicken breeds, human intestinal epithelial cells and the Galleria insect model of virulence. All C. jejuni isolates colonised the chicken caeca, though colonisation of other parts of the gastrointestinal tract varied between isolates. Extra-intestinal spread to the liver varied between isolates and bird breed but a poultry isolate 13126 (sequence type 21) showed the greatest levels of extra-intestinal spread to the liver in both broiler breeds with over 70% of birds of the fast growing breed and 50% of the slower growing breed having C. jejuni in their livers. Crucially 13126 is significantly more invasive than other isolates in human intestinal epithelial cells and gave the highest mortality in the Galleria infection model. Taken together our findings suggest that not only is there considerable heterogeneity in the infection biology of C. jejuni in avian, mammalian and alternative models, but that some isolates have an invasive and virulent phenotype. Isolates with an invasive phenotype would pose a significant risk and increased difficulty in control in chicken production and coupled with the virulent phenotype seen in 13126 could be an increased risk to public health.	[Humphrey, Suzanne; Lacharme-Lora, Lizeth; Chaloner, Gemma; Gibbs, Kirsty; Humphrey, Tom; Wigley, Paul] Univ Liverpool, Inst Infect & Global Hlth, Dept Infect Biol, Neston, England; [Williams, Nicola] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Neston, England; [Wigley, Paul] Univ Liverpool, Sch Vet Sci, Neston, England	University of Liverpool; University of Liverpool; University of Liverpool	Wigley, P (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Infect Biol, Leahurst Campus, Neston, England.	paul.wigley@liv.ac.uk	Chaloner, Gemma/AAE-1102-2022	Chaloner, Gemma/0000-0001-8497-1370; Williams, Nicola/0000-0003-4709-4190; Humphrey, Suzanne/0000-0002-9893-3209; Wigley, Paul/0000-0001-6563-0773; Humphrey, Tom/0000-0001-7965-8988	Biotechnology and Biological Sciences Research Council [BB/J071353/1]; BBSRC [BB/K000055/1, BB/J017353/1, BB/I024674/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K000055/1, BB/J017353/1, BB/I024674/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) Grant Number BB/J071353/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad WA, 2015, INNATE IMMUN-LONDON, V21, P151, DOI 10.1177/1753425914521648; BERNDTSON E, 1992, INT J FOOD MICROBIOL, V15, P45, DOI 10.1016/0168-1605(92)90134-O; Boyd Y, 2005, IMMUNOGENETICS, V57, P248, DOI 10.1007/s00251-005-0790-6; Bull SA, 2008, APPL ENVIRON MICROB, V74, P5408, DOI 10.1128/AEM.00462-08; Cencic A, 2010, INT J FOOD MICROBIOL, V141, pS4, DOI 10.1016/j.ijfoodmicro.2010.03.026; Chaloner G, 2014, APPL ENVIRON MICROB, V80, P6366, DOI 10.1128/AEM.01901-14; Champion OL, 2010, J INFECT DIS, V201, P776, DOI 10.1086/650494; Cox NA, 2007, J APPL POULTRY RES, V16, P477, DOI 10.3382/japr.2006-00123; Cox NA, 2006, AVIAN DIS, V50, P450, DOI 10.1637/7481-120205R.1; Cox NA, 2005, AVIAN DIS, V49, P155, DOI 10.1637/7234-070704R; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Gundogdu O, 2011, J BACTERIOL, V193, P4238, DOI 10.1128/JB.05189-11; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Humphrey T. J., 1991, Veterinary Annual, V31, P32; Jones MA, 2004, INFECT IMMUN, V72, P3769, DOI 10.1128/IAI.72.7.3769-3776.2004; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Knudsen KN, 2006, AVIAN DIS, V50, P10, DOI 10.1637/7376-051005R.1; Loretz M, 2010, FOOD CONTROL, V21, P791, DOI 10.1016/j.foodcont.2009.11.007; Luber P, 2007, J APPL MICROBIOL, V102, P313, DOI 10.1111/j.1365-2672.2006.03105.x; Nagel GM, 2013, INT J FOOD MICROBIOL, V165, P281, DOI 10.1016/j.ijfoodmicro.2013.05.016; Rees LE, 2008, INFLAMM BOWEL DIS, V14, P303, DOI 10.1002/ibd.20325; Scherer K, 2006, J FOOD PROTECT, V69, P757, DOI 10.4315/0362-028X-69.4.757; Senior NJ, 2011, J MED MICROBIOL, V60, P661, DOI 10.1099/jmm.0.026658-0; Smith CK, 2008, FEMS IMMUNOL MED MIC, V54, P114, DOI 10.1111/j.1574-695X.2008.00458.x; SMITH HW, 1975, J HYG-CAMBRIDGE, V75, P275, DOI 10.1017/S0022172400047306; Williams LK, 2013, AVIAN DIS, V57, P238, DOI 10.1637/10442-110212-Reg.1; MBIO	28	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141182	10.1371/journal.pone.0141182	http://dx.doi.org/10.1371/journal.pone.0141182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496441	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200072
J	Jolley, CJ; Bell, J; Rafferty, GF; Moxham, J; Strang, J				Jolley, Caroline J.; Bell, James; Rafferty, Gerrard F.; Moxham, John; Strang, John			Understanding Heroin Overdose: A Study of the Acute Respiratory Depressant Effects of Injected Pharmaceutical Heroin	PLOS ONE			English	Article							MAINTENANCE TREATMENT; SYMPTOMATIC THERAPY; DRIVE; ADDICTS; VENTILATION; METHADONE; TRIAL; HYPERCAPNIA; PREVALENCE; ACTIVATION	Opioids are respiratory depressants and heroin/opioid overdose is a major contributor to the excess mortality of heroin addicts. The individual and situational variability of respiratory depression caused by intravenous heroin is poorly understood. This study used advanced respiratory monitoring to follow the time course and severity of acute opioid-induced respiratory depression. 10 patients (9/10 with chronic airflow obstruction) undergoing supervised injectable opioid treatment for heroin addiction received their usual prescribed dose of injectable opioid (diamorphine or methadone) (IOT), and their usual prescribed dose of oral opioid (methadone or sustained release oral morphine) after 30 minutes. The main outcome measures were pulse oximetry (SpO(2)%), end-tidal CO2% (ETCO2%) and neural respiratory drive (NRD) (quantified using parasternal intercostal muscle electromyography). Significant respiratory depression was defined as absence of inspiratory airflow > 10s, SpO(2)% < 90% for > 10s and ETCO2% per breath > 6.5%. Increases in ETCO2% indicated significant respiratory depression following IOT in 8/10 patients at 30 minutes. In contrast, SpO(2)% indicated significant respiratory depression in only 4/10 patients, with small absolute changes in SpO(2)% at 30 minutes. A decline in NRD from baseline to 30 minutes post IOT was also observed, but was not statistically significant. Baseline NRD and opioid-induced drop in SpO(2)% were inversely related. We conclude that significant acute respiratory depression is commonly induced by opioid drugs prescribed to treat opioid addiction. Hypoventilation is reliably detected by capnography, but not by SpO(2)% alone. Chronic suppression of NRD in the presence of underlying lung disease may be a risk factor for acute opioid-induced respiratory depression.	[Jolley, Caroline J.; Rafferty, Gerrard F.; Moxham, John] Kings Coll London, Kings Hlth Partners, Fac Life Sci & Med, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England; [Bell, James; Strang, John] Kings Coll London, Inst Psychiat Psychol & Neurosci, Natl Addict Ctr, Kings Hlth Partners, London WC2R 2LS, England; [Bell, James; Strang, John] South London & Maudsley NHS Fdn Trust, Kings Hlth Partners, Addict Serv, London, England	University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London	Jolley, CJ (corresponding author), Kings Coll London, Kings Hlth Partners, Fac Life Sci & Med, Div Asthma Allergy & Lung Biol, Denmark Hill, London WC2R 2LS, England.	caroline.jolley@kcl.ac.uk	Rafferty, Gerrard F/B-2826-2011; Strang, John/H-5460-2011	Rafferty, Gerrard F/0000-0001-9520-6500; Strang, John/0000-0002-5413-2725; Jolley, Caroline/0000-0003-3538-2451	Kings Health Partners Biomedical Research Centre; NIHR Academic Clinical Lectureship in Respiratory Medicine; National Institute for Health Research [CL-2012-17-007] Funding Source: researchfish	Kings Health Partners Biomedical Research Centre; NIHR Academic Clinical Lectureship in Respiratory Medicine; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by a grant from Kings Health Partners Biomedical Research Centre. Dr. Caroline Jolley is supported by a NIHR Academic Clinical Lectureship in Respiratory Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clemens KE, 2008, J PALLIAT MED, V11, P204, DOI 10.1089/jpm.2007.0131; Clemens KE, 2007, J PAIN SYMPTOM MANAG, V33, P473, DOI 10.1016/j.jpainsymman.2006.09.015; Conti G, 2002, ANAESTHESIA, V57, P540, DOI 10.1046/j.1365-2044.2002.02573.x; Cornish R, 2010, RISK DEATH OPIATE SU, V23; Cronin AJ, 2003, BRIT J ANAESTH, V91, P805, DOI 10.1093/bja/aeg273; Dalchow S, 2013, INT J OBSTET ANESTH, V22, P217, DOI 10.1016/j.ijoa.2013.04.003; Darke S, 1996, ADDICTION, V91, P1765, DOI 10.1111/j.1360-0443.1996.tb03800.x; Duiverman ML, 2004, J APPL PHYSIOL, V96, P1723, DOI 10.1152/japplphysiol.00914.2003; Dursteler-Mac Farland KM, 2000, ADDICTION, V95, P285; Fugelstad A, 2003, ADDICTION, V98, P463, DOI 10.1046/j.1360-0443.2003.00330.x; GILBERT R, 1972, J APPL PHYSIOL, V33, P252, DOI 10.1152/jappl.1972.33.2.252; Guydish J, 2011, NICOTINE TOB RES, V13, P401, DOI 10.1093/ntr/ntr048; Haasen C, 2007, BRIT J PSYCHIAT, V191, P55, DOI 10.1192/bjp.bp.106.026112; Hall W, 1998, DRUG ALCOHOL DEPEN, V52, P71, DOI 10.1016/S0376-8716(98)00044-1; Herman NL, 1999, ANESTH ANALG, V89, P378, DOI 10.1097/00000539-199908000-00024; Jolley CJ, 2009, EUR RESPIR J, V33, P289, DOI 10.1183/09031936.00093408; Jolley CJ, 2015, EUR RESPIR J, V45, P355, DOI 10.1183/09031936.00063014; Kopka A, 2007, BRIT J ANAESTH, V99, P567, DOI 10.1093/bja/aem206; Maarsingh EJW, 2002, RESP PHYSIOL NEUROBI, V133, P89, DOI 10.1016/S1569-9048(02)00130-1; MacBean V, 2014, THORAX, V69, pA170, DOI 10.1136/thoraxjnl-2014-206260.341; Madadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060600; March JC, 2006, J SUBST ABUSE TREAT, V31, P203, DOI 10.1016/j.jsat.2006.04.007; Murphy PB, 2011, THORAX, V66, P602, DOI 10.1136/thx.2010.151332; Office for National Statistics, 2015, STAT B; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P777, DOI 10.1056/NEJMoa0810635; Palmer F, 2012, PRIM CARE RESP J, V21, P377, DOI 10.4104/pcrj.2012.00069; Passarino G, 2005, AM J FOREN MED PATH, V26, P106, DOI 10.1097/01.paf.0000159990.54730.4b; Perneger TV, 1998, BMJ-BRIT MED J, V317, P13, DOI 10.1136/bmj.317.7150.13; Pierdominici S, 1997, Acta Anaesthesiol Belg, V48, P85; Reilly CC, 2012, EUR RESPIR J, V40, P977, DOI 10.1183/09031936.00163111; Reilly CC, 2011, THORAX, V66, P240, DOI 10.1136/thx.2010.142646; Reimer J, 2011, ADDICTION, V106, P1647, DOI 10.1111/j.1360-0443.2011.03463.x; Rook EJ, 2006, BASIC CLIN PHARM TOX, V98, P00; Sinderby C, 2001, AM J RESP CRIT CARE, V163, P1637, DOI 10.1164/ajrccm.163.7.2007033; Sinderby C, 1998, J APPL PHYSIOL, V85, P2146, DOI 10.1152/jappl.1998.85.6.2146; Steier J, 2011, THORAX, V66, P609, DOI 10.1136/thx.2010.152462; Stoermer R, 2003, BIOL PSYCHIAT, V54, P854, DOI 10.1016/S0006-3223(03)00290-7; Strang J, 2015, BRIT J PSYCHIAT, V207, P5, DOI 10.1192/bjp.bp.114.149195; Strang J, 2010, LANCET, V375, P1885, DOI 10.1016/S0140-6736(10)60349-2; TABATABAI M, 1989, ANESTHESIOLOGY, V70, P489, DOI 10.1097/00000542-198903000-00020; Teichtahl H, 2005, CHEST, V128, P1339, DOI 10.1378/chest.128.3.1339; van den Brink W, 2003, BRIT MED J, V327, P310, DOI 10.1136/bmj.327.7410.310; Warner-Smith M, 2001, ADDICTION, V96, P1113, DOI 10.1046/j.1360-0443.2001.96811135.x; WEIL JV, 1975, NEW ENGL J MED, V292, P1103, DOI 10.1056/NEJM197505222922106; WHO, 2014, COMM MAN OP OV	45	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140995	10.1371/journal.pone.0140995	http://dx.doi.org/10.1371/journal.pone.0140995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495843	Green Published, gold			2022-12-27	WOS:000363309200049
J	Li, JJ; Niu, SZ; Huang, J; Bian, ZY; Feng, QJ; Yu, GH; Liang, ZR; Chen, WF; Ma, JH				Li, Jiaojiao; Niu, Shanzhou; Huang, Jing; Bian, Zhaoying; Feng, Qianjin; Yu, Gaohang; Liang, Zhengrong; Chen, Wufan; Ma, Jianhua			An Efficient Augmented Lagrangian Method for Statistical X-Ray CT Image Reconstruction	PLOS ONE			English	Article							ITERATIVE RECONSTRUCTION; COMPUTED-TOMOGRAPHY; NOISE-REDUCTION; ALGORITHMS; COMPRESSION; QUALITY	Statistical iterative reconstruction (SIR) for X-ray computed tomography (CT) under the penalized weighted least-squares criteria can yield significant gains over conventional analytical reconstruction from the noisy measurement. However, due to the nonlinear expression of the objective function, most exiting algorithms related to the SIR unavoidably suffer from heavy computation load and slow convergence rate, especially when an edge-preserving or sparsity-based penalty or regularization is incorporated. In this work, to address abovementioned issues of the general algorithms related to the SIR, we propose an adaptive nonmonotone alternating direction algorithm in the framework of augmented Lagrangian multiplier method, which is termed as "ALM-ANAD". The algorithm effectively combines an alternating direction technique with an adaptive nonmonotone line search to minimize the augmented Lagrangian function at each iteration. To evaluate the present ALM-ANAD algorithm, both qualitative and quantitative studies were conducted by using digital and physical phantoms. Experimental results show that the present ALM-ANAD algorithm can achieve noticeable gains over the classical nonlinear conjugate gradient algorithm and state-of-the-art split Bregman algorithm in terms of noise reduction, contrast-to-noise ratio, convergence rate, and universal quality index metrics.	[Li, Jiaojiao; Huang, Jing; Bian, Zhaoying; Feng, Qianjin; Chen, Wufan; Ma, Jianhua] Southern Med Univ, Sch Biomed Engn, Guangzhou 510515, Guangdong, Peoples R China; [Niu, Shanzhou; Yu, Gaohang] Gannan Normal Univ, Sch Math & Comp Sci, Ganzhou 341000, Peoples R China; [Liang, Zhengrong] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA	Southern Medical University - China; Gannan Normal University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Huang, J (corresponding author), Southern Med Univ, Sch Biomed Engn, Guangzhou 510515, Guangdong, Peoples R China.	hjing@smu.edu.cn	Yu, Gaohang/F-2329-2011; feng, qianjin/GNM-7856-2022	feng, qianjin/0000-0002-3830-5120	National Natural Science Foundation of China [81101046, 81371544, 61262026]; Science and Technology Program of Guangdong Province of China [2011A030300005]; Natural Science Foundation of Jiangxi Province [20132BAB201026]; JGZX programme of Jiangxi Province [20112BCB23027]; 973 Program of China [2010CB732504]; NIH/NCI [CA143111, CA082402]; NATIONAL CANCER INSTITUTE [R01CA082402, R01CA143111] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong Province of China; Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); JGZX programme of Jiangxi Province; 973 Program of China(National Basic Research Program of China); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under grants No. 81101046, No. 81371544 and No. 61262026; the Science and Technology Program of Guangdong Province of China (http://www.gdstc.gov.cn/) under grant No. 2011A030300005; the Natural Science Foundation of Jiangxi Province (http://www.jxstc.gov.cn) under grant No. 20132BAB201026; the JGZX programme of Jiangxi Province (http://www.jxstc.gov.cn) under grant No. 20112BCB23027; and the 973 Program of China (http://www.973.gov.cn/) under grant No. 2010CB732504. Z. L was partially supported by the NIH/NCI (https://madb.nci.nih.gov/) under grants \#CA143111 and \#CA082402.	BARZILAI J, 1988, IMA J NUMER ANAL, V8, P141, DOI 10.1093/imanum/8.1.141; Benson TM, 2010, IEEE NUCL SCI CONF R, P2856, DOI 10.1109/NSSMIC.2010.5874316; CALAMAI PH, 1987, MATH PROGRAM, V39, P93, DOI 10.1007/BF02592073; Chambolle A, 1998, IEEE T IMAGE PROCESS, V7, P319, DOI 10.1109/83.661182; Dai YH, 2005, NUMER MATH, V100, P21, DOI 10.1007/s00211-004-0569-y; De Man B., 2002, NUCL SCI S 2002 IEEE, V3, P1477; Fessler JA, 1999, IEEE T IMAGE PROCESS, V8, P688, DOI 10.1109/83.760336; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Hager W.W., 2006, PACIFIC J OPTIM, V2, P335; Han GP, 1999, IEEE NUCL SCI CONF R, P1515, DOI 10.1109/NSSMIC.1999.842846; Hestenes M. R., 1969, Journal of Optimization Theory and Applications, V4, P303, DOI 10.1007/BF00927673; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Li C., 2011, THESIS RICE U; Ma JH, 2012, PHYS MED BIOL, V57, P7519, DOI 10.1088/0031-9155/57/22/7519; Ma JH, 2012, MED PHYS, V39, P4051, DOI 10.1118/1.4722751; Ma JH, 2010, COMPUT BIOL MED, V40, P565, DOI 10.1016/j.compbiomed.2010.03.012; Mercier B, 1984, DUAL ALGORITHM SOLUT; Ng MK, 2011, SIAM J SCI COMPUT, V33, P1643, DOI 10.1137/100807697; Nikolova M, 2005, SIAM J SCI COMPUT, V27, P937, DOI 10.1137/030600862; Niu SZ, 2014, PHYS MED BIOL, V59, P2997, DOI 10.1088/0031-9155/59/12/2997; Powell M.J., 1969, OPTIMIZATION, P283; Ramani S, 2012, IEEE T MED IMAGING, V31, P677, DOI 10.1109/TMI.2011.2175233; Ramani S, 2011, IEEE T MED IMAGING, V30, P694, DOI 10.1109/TMI.2010.2093536; SAUER K, 1993, IEEE T SIGNAL PROCES, V41, P534, DOI 10.1109/78.193196; Segars WP, 2010, MED PHYS, V37, P4902, DOI 10.1118/1.3480985; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Tang J, 2009, PHYS MED BIOL, V54, P5781, DOI 10.1088/0031-9155/54/19/008; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; Wang J, 2006, IEEE T MED IMAGING, V25, P1272, DOI 10.1109/TMI.2006.882141; Wang J, 2011, MED PHYS, V38, P4066, DOI 10.1118/1.3600696; Wang J, 2009, MED PHYS, V36, P252, DOI 10.1118/1.3036112; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Wolf PA, 2013, PHYS MED BIOL, V58, P5629, DOI 10.1088/0031-9155/58/16/5629; Xiao YH, 2012, J MATH IMAGING VIS, V44, P114, DOI 10.1007/s10851-011-0314-y; Xiao YH, 2012, INVERSE PROBL IMAG, V6, P547, DOI 10.3934/ipi.2012.6.547; Yang JF, 2011, SIAM J SCI COMPUT, V33, P250, DOI 10.1137/090777761; Yin WT, 2008, SIAM J IMAGING SCI, V1, P143, DOI 10.1137/070703983; Yu GH, 2009, J MATH IMAGING VIS, V35, P143, DOI 10.1007/s10851-009-0160-3; Zhang H, 2013, IEEE T BIOMED ENG; Zhang H, 2014, MED PHYS, V41, DOI 10.1118/1.4865782	43	3	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140579	10.1371/journal.pone.0140579	http://dx.doi.org/10.1371/journal.pone.0140579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495975	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200023
J	Reina, A; Valentini, G; Fernandez-Oto, C; Dorigo, M; Trianni, V				Reina, Andreagiovanni; Valentini, Gabriele; Fernandez-Oto, Cristian; Dorigo, Marco; Trianni, Vito			A Design Pattern for Decentralised Decision Making	PLOS ONE			English	Article							DIVISION-OF-LABOR; SCOUTING BEHAVIOR; HONEYBEE SWARMS; SPEED; NETWORKS; REINFORCEMENT; SELECTION; COLONIES; ROBOTS; ANTS	The engineering of large-scale decentralised systems requires sound methodologies to guarantee the attainment of the desired macroscopic system-level behaviour given the microscopic individual-level implementation. While a general-purpose methodology is currently out of reach, specific solutions can be given to broad classes of problems by means of well-conceived design patterns. We propose a design pattern for collective decision making grounded on experimental/theoretical studies of the nest-site selection behaviour observed in honeybee swarms (Apis mellifera). The way in which honeybee swarms arrive at consensus is fairly well-understood at the macroscopic level. We provide formal guidelines for the microscopic implementation of collective decisions to quantitatively match the macroscopic predictions. We discuss implementation strategies based on both homogeneous and heterogeneous multiagent systems, and we provide means to deal with spatial and topological factors that have a bearing on the micro-macro link. Finally, we exploit the design pattern in two case studies that showcase the viability of the approach. Besides engineering, such a design pattern can prove useful for a deeper understanding of decision making in natural systems thanks to the inclusion of individual heterogeneities and spatial factors, which are often disregarded in theoretical modelling.	[Reina, Andreagiovanni; Valentini, Gabriele; Dorigo, Marco] Univ Libre Bruxelles, IRIDIA, Brussels, Belgium; [Fernandez-Oto, Cristian] Univ Libre Bruxelles, Fac Sci, Brussels, Belgium; [Trianni, Vito] CNR, ISTC, Rome, Italy	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Trianni, V (corresponding author), CNR, ISTC, Rome, Italy.	vito.trianni@istc.cnr.it	Trianni, Vito/B-8332-2015; Reina, Andreagiovanni/ABA-3754-2021	Trianni, Vito/0000-0002-9114-8486; Reina, Andreagiovanni/0000-0003-4745-992X; Valentini, Gabriele/0000-0002-8961-3211	European Research Council (ERC) Advanced Grant "E-SWARM: Engineering Swarm Intelligence Systems" [246939]; Marie Sklodowska-Curie Career Integration Grant "DICE: Distributed Cognition Engineering" [631297]; Belgian "Fonds de la Recherche Scientifique - FNRS"; Becas Chile	European Research Council (ERC) Advanced Grant "E-SWARM: Engineering Swarm Intelligence Systems"; Marie Sklodowska-Curie Career Integration Grant "DICE: Distributed Cognition Engineering"; Belgian "Fonds de la Recherche Scientifique - FNRS"(Fonds de la Recherche Scientifique - FNRS); Becas Chile	The research presented in this paper has been supported by the European Research Council (ERC) Advanced Grant "E-SWARM: Engineering Swarm Intelligence Systems" awarded to MD (contract 246939, http://www.e-swarm.org) and by the Marie Sklodowska-Curie Career Integration Grant "DICE: Distributed Cognition Engineering" awarded to VT (contract 631297, http://laral.istc.cnr.it/dice-project). MD acknowledges support from the Belgian "Fonds de la Recherche Scientifique - FNRS" (http://www.frs-fnrs.be/). CFO acknowledges support from Becas Chile (http://www.mineduc.cl/index.php?id_portal=60).	Akyildiz IF, 2011, PHYS COMMUN-AMST, V4, P40, DOI 10.1016/j.phycom.2010.12.003; Babaoglu O, 2006, ACM T AUTON ADAP SYS, V1, P26, DOI 10.1145/1152934.1152937; Baronchelli A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.015102; Baronchelli A, 2013, TRENDS COGN SCI, V17, P348, DOI 10.1016/j.tics.2013.04.010; Berman Spring, 2011, IEEE International Conference on Robotics and Automation, P378; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Burns James G., 2005, Animal Behaviour, V70, pe1, DOI 10.1016/j.anbehav.2005.06.002; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Crespi V, 2008, AUTON ROBOT, V24, P303, DOI 10.1007/s10514-007-9080-5; De Martino A, 2006, J PHYS A-MATH GEN, V39, pR465, DOI 10.1088/0305-4470/39/43/R01; Derler P, 2012, P IEEE, V100, P13, DOI 10.1109/JPROC.2011.2160929; Duarte A, 2012, BEHAV ECOL SOCIOBIOL, V66, P947, DOI 10.1007/s00265-012-1343-2; Dussutour A, 2008, ANIM BEHAV, V76, P5, DOI 10.1016/j.anbehav.2007.12.009; Franklin EL, 2012, J EXP BIOL, V215, P1287, DOI 10.1242/jeb.064618; Franks NR, 2013, ANIM BEHAV, V85, P1233, DOI 10.1016/j.anbehav.2013.03.010; Gamma E., 1994, DESIGN PATTERNS ELEM; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Gutierrez A, 2010, NEURAL COMPUT APPL, V19, P807, DOI 10.1007/s00521-010-0380-x; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Hamann Heiko, 2008, Swarm Intelligence, V2, P209, DOI 10.1007/s11721-008-0015-3; Helbing D., 2012, SOCIAL SELF ORGANIZA; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Huang KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120317; Jandt JM, 2014, BIOL REV, V89, P48, DOI 10.1111/brv.12042; Janson S, 2007, BEHAV ECOL, V18, P384, DOI 10.1093/beheco/arl095; JEANSON R, 2013, BIOL REV CAMBRIDGE P, V89, P671, DOI DOI 10.1111/BRV.12074; Laomettachit T, 2015, J THEOR BIOL, V364, P21, DOI 10.1016/j.jtbi.2014.09.005; Lee EA, 2014, IEEE DES TEST, V31, P8, DOI 10.1109/MDAT.2014.2314600; Liang ZZS, 2012, SCIENCE, V335, P1225, DOI 10.1126/science.1213962; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Fernandez-Marquez JL, 2013, NAT COMPUT, V12, P43, DOI 10.1007/s11047-012-9324-y; Mailleux AC, 2006, J EXP BIOL, V209, P4224, DOI 10.1242/jeb.02461; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Michael N, 2009, INT J ROBOT RES, V28, P962, DOI 10.1177/0278364909340280; Moretti P, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-20501-1; Nelson W., 1969, J QUAL TECHNOL, V1, P27; Pais D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073216; Passino KM, 2006, BEHAV ECOL SOCIOBIOL, V59, P427, DOI 10.1007/s00265-005-0067-y; Planas-Sitja I, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2515; Reina A, 2015, SWARM INTELL-US, V9, P75, DOI 10.1007/s11721-015-0105-y; Robinson EJH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019981; Sartoretti G, 2014, SWARM INTELL-US, V8, P329, DOI 10.1007/s11721-014-0101-7; Schaerf TM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0533; Seeley TD, 2012, SCIENCE, V335, P108, DOI 10.1126/science.1210361; Sood V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.178701; Srivastava V, 2014, IEEE TRANS CONTROL N, V1, P121, DOI 10.1109/TCNS.2014.2310271; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; Valentini G, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS (AAMAS'15), P1305; Vigelius M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111542; Weidenmuller A, 2004, BEHAV ECOL, V15, P120, DOI 10.1093/beheco/arg101; Westhus C, 2013, ANIM BEHAV, V85, P27, DOI 10.1016/j.anbehav.2012.10.003; Wray MK, 2011, BEHAV ECOL SOCIOBIOL, V65, P2061, DOI 10.1007/s00265-011-1215-1	56	69	69	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140950	10.1371/journal.pone.0140950	http://dx.doi.org/10.1371/journal.pone.0140950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496359	Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200044
J	Sharma, SK; Kohli, M; Yadav, RN; Chaubey, J; Bhasin, D; Sreenivas, V; Sharma, R; Singh, BK				Sharma, Surendra K.; Kohli, Mikashmi; Yadav, Raj Narayan; Chaubey, Jigyasa; Bhasin, Dinkar; Sreenivas, Vishnubhatla; Sharma, Rohini; Singh, Binit K.			Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis	PLOS ONE			English	Article							RIFAMPIN RESISTANCE; EXTRAPULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; GENEXPERT MTB/RIF; CHILDREN; CULTURE; SMEAR	Pulmonary tuberculosis still remains a major communicable disease worldwide. In 2013, 9 million people developed TB and 1.5 million people died from the disease. India constitutes 24% of the total TB burden. Early detection of TB cases is the key to successful treatment and reduction of disease transmission. Xpert MTB/RIF, an automated cartridge-based molecular technique detects Mycobacterium tuberculosis and rifampicin resistance within two hours has been endorsed by WHO for rapid diagnosis of TB. Our study is the first study from India with a large sample size to evaluate the performance of Xpert MTB/RIF assay in PTB samples. The test showed an overall sensitivity and specificity of 95.7% (430/449) and 99.3% (984/990) respectively. In smear negative-culture positive cases, the test had a sensitivity of 77.7%. The sensitivity and specificity for detecting rifampicin resistance was 94.5% and 97.7% respectively with respect to culture as reference standard. However, after resolving the discrepant samples with gene sequencing, the sensitivity and specificity rose to 99.0% and 99.3% respectively. Hence, while solid culture still forms the foundation of TB diagnosis, Xpert MTB/RIF proposes to be a strong first line diagnostic tool for pulmonary TB cases.	[Sharma, Surendra K.; Kohli, Mikashmi; Yadav, Raj Narayan; Chaubey, Jigyasa; Bhasin, Dinkar; Sharma, Rohini; Singh, Binit K.] All India Inst Med Sci, Dept Internal Med, New Delhi, India; [Sreenivas, Vishnubhatla] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Sharma, SK (corresponding author), All India Inst Med Sci, Dept Internal Med, New Delhi, India.	sksharma.aiims@gmail.com			Ministry of Science and Technology, Government of India [SB/S2/JCB-04/2013]; AIIMS administration	Ministry of Science and Technology, Government of India(Ministry of Science and Technology, Government of India); AIIMS administration	The study was supported by J.C. Bose National Fellowship awarded to Prof. SK Sharma (SB/S2/JCB-04/2013), from the Ministry of Science and Technology, Government of India. We are also thankful to the AIIMS administration for providing financial-aid.	[Anonymous], 2005, REV NAT TUB CONTR PR; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Calligaro GL, 2015, LANCET RESP MED; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P4357, DOI 10.1128/JCM.43.9.4357-4362.2005; Foundation for Innovative New Diagnostics, 2011, FIND REP PERF XPERT; Lee HR, 2013, J CELL MOL MED, V17, P1, DOI 10.1111/j.1582-4934.2012.01649.x; Moore DF, 2005, DIAGN MICR INFEC DIS, V52, P247, DOI 10.1016/j.diagmicrobio.2005.02.014; Morgan M, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-62; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Revised National Tuberculosis Programme, REV NAT TUB PROGR CU; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Sekadde MP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-133; Sharma SK, 2014, EUR RESPIR J, V44, P1090, DOI 10.1183/09031936.00059014; Shenoi SV, 2010, CLIN INFECT DIS, V50, pS231, DOI 10.1086/651496; Siddiqi SH, 2006, MGIT PROCEDURE MANUA; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; Vadwai V, 2012, INDIAN J MED RES, V135, P560; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; Walters E, 2014, PEDIATR PULM, V49, P1133, DOI 10.1002/ppul.22970; WHO, 2014, GLOB TUB REP 2014; WILLIAMS DL, 1994, ANTIMICROB AGENTS CH, V38, P2380, DOI 10.1128/AAC.38.10.2380; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11	23	72	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141011	10.1371/journal.pone.0141011	http://dx.doi.org/10.1371/journal.pone.0141011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496123	gold, Green Published, Green Submitted			2022-12-27	WOS:000363309200051
J	Anagnostopoulos, A; Ledergerber, B; Jaccard, R; Shaw, SA; Stoeckle, M; Bernasconi, E; Barth, J; Calmy, A; Berney, A; Jenewein, J; Weber, R				Anagnostopoulos, Alexia; Ledergerber, Bruno; Jaccard, Rene; Shaw, Susy Ann; Stoeckle, Marcel; Bernasconi, Enos; Barth, Juergen; Calmy, Alexandra; Berney, Alexandre; Jenewein, Josef; Weber, Rainer		Swiss HIV Cohort Study	Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS)	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; LONGITUDINAL ANALYSIS; DISORDERS; ADHERENCE; SYMPTOMS; AIDS; METAANALYSIS; PROGRESSION; MORTALITY; SEVERITY	Objectives We studied the incidence and prevalence of, and co-factors for depression in the Swiss HIV Cohort Study. Methods Depression-specific items were introduced in 2010 and prospectively collected at semiannual cohort visits. Clinical, laboratory and behavioral co-factors of incident depression among participants free of depression at the first two visits in 2010 or thereafter were analyzed with Poisson regression. Cumulative prevalence of depression at the last visit was analyzed with logistic regression. Results Among 4,422 participants without a history of psychiatric disorders or depression at baseline, 360 developed depression during 9,348 person-years (PY) of follow-up, resulting in an incidence rate of 3.9 per 100 PY (95% confidence interval (CI) 3.5-4.3). Cumulative prevalence of depression during follow-up was recorded for 1,937/6,756 (28.7%) participants. Incidence and cumulative prevalence were higher in injection drug users (IDU) and women. Older age, preserved work ability and higher physical activity were associated with less depression episodes. Mortality (0.96 per 100 PY, 95% CI 0.83-1.11) based upon 193 deaths over 20,102 PY was higher among male IDU (2.34, 1.78-3.09), female IDU (2.33, 1.59-3.39) and white heterosexual men (1.32, 0.94-1.84) compared to white heterosexual women and homosexual men (0.53, 0.29-0.95; and 0.71, 0.55-0.92). Compared to participants free of depression, mortality was slightly elevated among participants with a history of depression (1.17, 0.94-1.45 vs. 0.86, 0.71-1.03, P = 0.033). Suicides (n = 18) did not differ between HIV transmission groups (P = 0.50), but were more frequent among participants with a prior diagnosis of depression (0.18 per 100 PY, 95% CI 0.10-0.31; vs. 0.04, 0.02-0.10; P = 0.003). Conclusions Depression is a frequent co-morbidity among HIV-infected persons, and thus an important focus of care.	[Anagnostopoulos, Alexia; Ledergerber, Bruno; Weber, Rainer] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Zurich Hosp, Zurich, Switzerland; [Shaw, Susy Ann] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [Stoeckle, Marcel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Bernasconi, Enos] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland; [Barth, Juergen] Univ Bern, ISPM, Bern, Switzerland; [Calmy, Alexandra] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Berney, Alexandre] Univ Lausanne Hosp, Psychiat Liaison Serv, Lausanne, Switzerland; [Jenewein, Josef] Univ Zurich Hosp, Dept Psychiat & Psychotherapy, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Basel; University of Bern; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University Zurich Hospital	Ledergerber, B (corresponding author), Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Zurich Hosp, Zurich, Switzerland.	infled@usz.uzh.ch	Jenewein, Josef/AAN-4666-2021; Pantaleo, Giuseppe/K-6163-2016; Jenewein, Josef/B-2390-2016; Anagnostopoulos, Alexia/D-3687-2018; Weber, Rainer/D-5175-2012; Ledergerber, Bruno/B-5656-2009	Jenewein, Josef/0000-0003-4271-918X; Anagnostopoulos, Alexia/0000-0001-6197-3023; Ledergerber, Bruno/0000-0002-6881-4401; Berney, Alexandre/0000-0001-9535-1222	Swiss National Science Foundation [148522]; SHCS project [711]; SHCS research foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SHCS project; SHCS research foundation	This study has been financed within the framework of the Swiss HIV Cohort Study (www.shcs.ch), supported by the Swiss National Science Foundation (www.snf.ch, grant #148522), by SHCS project #711 and by the SHCS research foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljassem K, 2014, J INT ASS PROVIDERS; Barth J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001454; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Boarts JM, 2006, AIDS BEHAV, V10, P253, DOI 10.1007/s10461-006-9069-7; Caldwell JZK, 2014, J NEUROVIROL, V20, P398, DOI 10.1007/s13365-014-0257-3; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Cook JA, 2004, AM J PUBLIC HEALTH, V94, P1133, DOI 10.2105/AJPH.94.7.1133; Del Guerra FB, 2013, J NEUROVIROL, V19, P314, DOI 10.1007/s13365-013-0177-7; Dew MA, 1997, PSYCHOL MED, V27, P395, DOI 10.1017/S0033291796004552; Franke Leonora, 2014, Depress Res Treat, V2014, P821381, DOI 10.1155/2014/821381; Glassman Alexander H, 2007, Dialogues Clin Neurosci, V9, P9; Golub ET, 2003, JAIDS-J ACQ IMM DEF, V32, P429, DOI 10.1097/00126334-200304010-00013; Goodwin RD, 2003, PREV MED, V36, P698, DOI 10.1016/S0091-7435(03)00042-2; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; Gutierrez F, 2014, HIV MED, V15, P213, DOI 10.1111/hiv.12104; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Journot V, 2006, CLIN INFECT DIS, V42, P1790, DOI 10.1086/504323; Kacanek D, 2010, JAIDS-J ACQ IMM DEF, V53, P266, DOI 10.1097/QAI.0b013e3181b720e7; Keiser O, 2010, AM J PSYCHIAT, V167, P143, DOI 10.1176/appi.ajp.2009.09050651; KELLY JA, 1992, AM J PSYCHIAT, V149, P886; KELLY JA, 1993, HEALTH PSYCHOL, V12, P215, DOI 10.1037/0278-6133.12.3.215; Leserman J, 2003, BIOL PSYCHIAT, V54, P295, DOI 10.1016/S0006-3223(03)00323-8; McManus H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089089; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Schumacher JE, 2013, AIDS BEHAV, V17, P2781, DOI 10.1007/s10461-012-0342-7; Sheridan DA, 2014, METABOLIC BRAIN DIS; Sin NL, 2014, ANN BEHAV MED, V47, P259, DOI 10.1007/s12160-013-9559-6; Taniguchi T, 2014, AIDS CARE, V26, P1004, DOI 10.1080/09540121.2014.880399; Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004; Weber R, 2009, HIV MED, V10, P407, DOI 10.1111/j.1468-1293.2009.00701.x; Weber R, 2014, HIV MED IN PRESS; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x	34	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140943	10.1371/journal.pone.0140943	http://dx.doi.org/10.1371/journal.pone.0140943			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZU	26492488	Green Published, Green Accepted, gold			2022-12-27	WOS:000363249300017
J	Hartwig, H; Silvestre-Roig, C; Hendrikse, J; Beckers, L; Paulin, N; Van der Heiden, K; Braster, Q; Drechsler, M; Daemen, MJ; Lutgens, E; Soehnlein, O				Hartwig, Helene; Silvestre-Roig, Carlos; Hendrikse, Jeffrey; Beckers, Linda; Paulin, Nicole; Van der Heiden, Kim; Braster, Quinte; Drechsler, Maik; Daemen, Mat J.; Lutgens, Esther; Soehnlein, Oliver			Atherosclerotic Plaque Destabilization in Mice: A Comparative Study	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; E-KNOCKOUT MOUSE; E-DEFICIENT MICE; SHEAR-STRESS; RUPTURE; STRATEGIES; MECHANISMS; STABILITY; DISEASES; THERAPY	Atherosclerosis-associated diseases are the main cause of mortality and morbidity in western societies. The progression of atherosclerosis is a dynamic process evolving from early to advanced lesions that may become rupture-prone vulnerable plaques. Acute coronary syndromes are the clinical manifestation of life-threatening thrombotic events associated with high-risk vulnerable plaques. Hyperlipidemic mouse models have been extensively used in studying the mechanisms controlling initiation and progression of atherosclerosis. However, the understanding of mechanisms leading to atherosclerotic plaque destabilization has been hampered by the lack of proper animal models mimicking this process. Although various mouse models generate atherosclerotic plaques with histological features of human advanced lesions, a consensus model to study atherosclerotic plaque destabilization is still lacking. Hence, we studied the degree and features of plaque vulnerability in different mouse models of atherosclerotic plaque destabilization and find that the model based on the placement of a shear stress modifier in combination with hypercholesterolemia represent with high incidence the most human like lesions compared to the other models.	[Hartwig, Helene; Silvestre-Roig, Carlos; Hendrikse, Jeffrey; Braster, Quinte; Drechsler, Maik; Daemen, Mat J.; Soehnlein, Oliver] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Silvestre-Roig, Carlos; Paulin, Nicole; Drechsler, Maik; Lutgens, Esther] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany; [Beckers, Linda; Lutgens, Esther] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Van der Heiden, Kim] Erasmus MC, Dept Cardiol, Biomed Engn, Rotterdam, Netherlands; [Soehnlein, Oliver] Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Munich, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Munich; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; German Centre for Cardiovascular Research; Munich Heart Alliance	Soehnlein, O (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	oliver.soehnlein@gmail.com	Drechsler, Maik/C-3829-2008; Silvestre-Roig, Carlos/ABF-9769-2020; van der Heiden, Kim/AAJ-7844-2021	Silvestre-Roig, Carlos/0000-0003-1169-7475; Daemen, Mat/0000-0003-1076-199X; van der Heiden, Kim/0000-0002-6537-5992	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VIDI project) [91712303]; Deutsche Forschungsgemeinschaft (DFG) [SO876/6-1, SFB1123 TP A06, SFB1123 TP B05]; LMU excellent program	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VIDI project); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); LMU excellent program	The research was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VIDI project 91712303), the Deutsche Forschungsgemeinschaft (DFG) (SO876/6-1, SFB1123 TP A06 and B05), and the LMU excellent program.	Bentzon JF, 2010, CURR OPIN LIPIDOL, V21, P434, DOI 10.1097/MOL.0b013e32833ded6a; Chen YC, 2013, CIRC RES, V113, P252, DOI 10.1161/CIRCRESAHA.113.301562; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Goodpaster T, 2014, J HISTOCHEM CYTOCHEM, V62, P197, DOI 10.1369/0022155413511620; Hellings WE, 2010, CIRCULATION, V121, P1941, DOI 10.1161/CIRCULATIONAHA.109.887497; Jackson CL, 2007, ARTERIOSCL THROM VAS, V27, P714, DOI 10.1161/01.ATV.0000261873.86623.e1; Jin SX, 2012, ARTERIOSCL THROM VAS, V32, P2372, DOI 10.1161/ATVBAHA.111.236158; Johnson J, 2005, CIRCULATION, V111, P1422, DOI 10.1161/01.CIR.0000158435.98035.8D; Johnson JL, 2001, ATHEROSCLEROSIS, V154, P399, DOI 10.1016/S0021-9150(00)00515-3; Koboziev I, 2015, INFLAMM BOWEL DIS, V21, P1652, DOI 10.1097/MIB.0000000000000446; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Newby AC, 2012, VASC PHARMACOL, V56, P232, DOI 10.1016/j.vph.2012.01.007; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Sasaki T, 2006, ARTERIOSCL THROM VAS, V26, P1304, DOI 10.1161/01.ATV.0000219687.71607.f7; Schwartz SM, 2007, ARTERIOSCL THROM VAS, V27, P705, DOI 10.1161/01.ATV.0000261709.34878.20; Shiomi M, 2001, ATHEROSCLEROSIS, V157, P75, DOI 10.1016/S0021-9150(00)00708-5; Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355; Sullivan CJ, 2002, ARTERIOSCL THROM VAS, V22, P1100, DOI 10.1161/01.ATV.0000023230.17493.E3; Turnbull F, 2003, LANCET, V362, P1527; Yang JM, 2013, ARTERIOSCL THROM VAS, V33, P1978, DOI 10.1161/ATVBAHA.113.301320	22	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141019	10.1371/journal.pone.0141019	http://dx.doi.org/10.1371/journal.pone.0141019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492161	Green Published, gold			2022-12-27	WOS:000363249300022
J	Mikacenic, C; Hahn, WO; Price, BL; Harju-Baker, S; Katz, R; Kain, KC; Himmelfarb, J; Liles, WC; Wurfel, MM				Mikacenic, Carmen; Hahn, William O.; Price, Brenda L.; Harju-Baker, Susanna; Katz, Ronit; Kain, Kevin C.; Himmelfarb, Jonathan; Liles, W. Conrad; Wurfel, Mark M.			Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness	PLOS ONE			English	Article							MULTIPLE-ORGAN DYSFUNCTION; ACUTE KIDNEY INJURY; ACUTE LUNG INJURY; SEPTIC SHOCK; PLASMA ANGIOPOIETIN-2; EMERGENCY-DEPARTMENT; DISEASE SEVERITY; PROGNOSTIC VALUE; CYTOKINE LEVELS; SEVERE SEPSIS	Background Endothelial activation plays a role in organ dysfunction in the systemic inflammatory response syndrome (SIRS). Angiopoietin-1 (Ang-1) promotes vascular quiescence while angiopoietin-2 (Ang-2) mediates microvascular leak. Circulating levels of Ang-1 and Ang-2 in patients with SIRS could provide insight on risks for organ dysfunction and death distinct from inflammatory proteins. In this study, we determined if biomarkers of endothelial activation and inflammation exhibit independent associations with poor outcomes in SIRS. Methods We studied 943 critically ill patients with SIRS admitted to an Intensive Care Unit (ICU) of an academic medical center. We measured plasma levels of endothelial markers (Ang-1, Ang-2, soluble vascular cell adhesion molecule-1 (sVCAM-1)) and inflammatory markers (interleukin-6 (IL-6), interleukin-8 (IL-8), granulocyte-colony stimulating factor (G-CSF), soluble tumor necrosis factor receptor-1 (sTNFR-1)) within 24 hours of enrollment. We tested for associations between each marker and 28 day mortality, shock, and day 3 sequential organ failure assessment (SOFA) score. For 28 day mortality, we performed sensitivity analysis for those subjects with sepsis and those with sterile inflammation. We used multivariate models to adjust for clinical covariates and determine if associations identified with endothelial activation markers were independent of those observed with inflammatory markers. Results Higher levels of all biomarkers were associated with increased 28 day mortality except levels of Ang-1 which were associated with lower mortality. After adjustment for comorbidities and sTNFR-1 concentration, a doubling of Ang-1 concentration was associated with lower 28 day mortality (Odds ratio (OR) = 0.81; p<0.01), shock (OR = 0.82; p<0.001), and SOFA score (beta = -0.50; p<0.001), while Ang-2 concentration was associated with increased mortality (OR = 1.55; p<0.001), shock (OR = 1.51; p<0.001), and SOFA score (beta = +0.63; p<0.001). sVCAM-1 was not independently associated with SIRS outcomes. Conclusions In critically ill patients with SIRS, early measurements of Ang-1 and Ang-2 are associated with death and organ dysfunction independently of simultaneously-measured markers of inflammation.	[Mikacenic, Carmen; Harju-Baker, Susanna; Wurfel, Mark M.] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Hahn, William O.; Liles, W. Conrad] Univ Washington, Dept Med, Div Infect Dis, Seattle, WA USA; [Price, Brenda L.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Katz, Ronit; Himmelfarb, Jonathan] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [Kain, Kevin C.] Univ Toronto, Toronto Gen Hosp, Dept Med, Sandra Rotman Ctr Global Hlth,Univ Hlth Network, Toronto, ON M5G 1L7, Canada; [Kain, Kevin C.] Univ Toronto, Trop Dis Unit, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Mikacenic, C (corresponding author), Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA.	cmikacen@uw.edu	Katz, Ronit/ABA-1880-2021	Hahn, William/0000-0002-4613-0586; Kosamo, Susanna/0000-0001-5151-9361; Kain, Kevin/0000-0001-6068-1272	Parker B Francis Fellowship; University of Washington Department of Medicine;  [NIH K23HL120896];  [NIH T32AI007044-39]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL120896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007044] Funding Source: NIH RePORTER	Parker B Francis Fellowship; University of Washington Department of Medicine; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by NIH K23HL120896 and Parker B Francis Fellowship (to CM); NIH T32AI007044-39 (to WOH); and research funding from the University of Washington Department of Medicine (to WCL and MMW). For all sources of funding, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2013, AM J RESP CRIT CARE, V187, P736, DOI 10.1164/rccm.201208-1460OC; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Alfieri A, 2012, CRIT CARE, V16, DOI 10.1186/cc11666; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Calfee CS, 2012, CRIT CARE MED, V40, P1731, DOI 10.1097/CCM.0b013e3182451c87; Claeys R, 2002, CRIT CARE MED, V30, P757, DOI 10.1097/00003246-200204000-00006; Damas P, 1997, CRIT CARE MED, V25, P405, DOI 10.1097/00003246-199703000-00006; Darwish I, 2013, VIRULENCE, V4, P572, DOI 10.4161/viru.25740; David S, 2012, CRIT CARE MED, V40, P3034, DOI 10.1097/CCM.0b013e31825fdc31; David S, 2011, CYTOKINE, V55, P251, DOI 10.1016/j.cyto.2011.04.005; de Pablo R, 2013, EUR J INTERN MED, V24, P132, DOI 10.1016/j.ejim.2012.10.009; de Pablo Raul, 2011, J Intensive Care Med, V26, P125, DOI 10.1177/0885066610384465; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; HACK CE, 1989, BLOOD, V74, P1704; Herrmann W, 2000, CLIN CHEM LAB MED, V38, P41, DOI 10.1515/CCLM.2000.007; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Ko DC, 2009, AM J HUM GENET, V85, P214, DOI 10.1016/j.ajhg.2009.07.012; Kornblit B, 2013, IMMUNOBIOLOGY, V218, P1227, DOI 10.1016/j.imbio.2013.04.010; Kumpers P, 2011, CRIT CARE, V15, DOI 10.1186/cc10523; Kumpers P, 2010, INTENS CARE MED, V36, P462, DOI 10.1007/s00134-009-1726-7; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Fiusa MML, 2013, CRIT CARE, V17, DOI 10.1186/cc12848; Marti L, 2007, GERONTOLOGY, V53, P239, DOI 10.1159/000101436; MARTY C, 1994, CRIT CARE MED, V22, P673, DOI 10.1097/00003246-199404000-00025; Mehta D, 2014, AM J PHYSIOL-LUNG C, V307, pL924, DOI 10.1152/ajplung.00318.2014; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Opal SM, 2015, J INTERN MED, V277, P277, DOI 10.1111/joim.12331; Parikh SM, 2013, VIRULENCE, V4, P517, DOI 10.4161/viru.24906; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Park DW, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.05.003; Pettila V, 2002, INTENS CARE MED, V28, P1220, DOI 10.1007/s00134-002-1416-1; Presneill JJ, 2000, CRIT CARE MED, V28, P2344, DOI 10.1097/00003246-200007000-00028; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ricciuto DR, 2011, CRIT CARE MED, V39, P702, DOI 10.1097/CCM.0b013e318206d285; Schuetz P, 2011, SHOCK, V36, P104, DOI 10.1097/SHK.0b013e31821e4e04; Shapiro NI, 2010, CRIT CARE, V14, DOI 10.1186/cc9290; Shehabi Y, 2014, AM J RESP CRIT CARE, V190, P1102, DOI 10.1164/rccm.201408-1483OC; Simmons EM, 2004, KIDNEY INT, V65, P1357, DOI 10.1111/j.1523-1755.2004.00512.x; Siner JM, 2009, SHOCK, V31, P348, DOI 10.1097/SHK.0b013e318188bd06; Stiehl T, 2014, CRIT CARE MED, V42, pE654, DOI 10.1097/CCM.0000000000000524; Suarez-Santamaria M, 2010, EUR CYTOKINE NETW, V21, P19, DOI 10.1684/ecn.2009.0185; THIJS LG, 1995, INTENS CARE MED, V21, pS258, DOI 10.1007/BF01740764; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Ulla M, 2013, CRIT CARE, V17, DOI 10.1186/cc12847; Vassiliou AG, 2014, CYTOKINE, V69, P240, DOI 10.1016/j.cyto.2014.06.010; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wanner GA, 2000, CRIT CARE MED, V28, P950, DOI 10.1097/00003246-200004000-00007; Whalen MJ, 2000, CRIT CARE MED, V28, P2600, DOI 10.1097/00003246-200007000-00070; Zeni F, 1997, CRIT CARE MED, V25, P1095, DOI 10.1097/00003246-199707000-00001; Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549	56	65	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141251	10.1371/journal.pone.0141251	http://dx.doi.org/10.1371/journal.pone.0141251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492036	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300039
J	Rodriguez-Martinez, LM; Marquez-Ipina, AR; Lopez-Pacheco, F; Perez-Chavarria, R; Gonzalez-Vazquez, JC; Gonzalez-Gonzalez, E; Trujillo-de Santiago, G; de Leon, CAPP; Zhang, YS; Dokmeci, MR; Khademhosseini, A; Alvarez, MM				Mario Rodriguez-Martinez, Luis; Roberto Marquez-Ipina, Alan; Lopez-Pacheco, Felipe; Perez-Chavarria, Roberto; Carlos Gonzalez-Vazquez, Juan; Gonzalez-Gonzalez, Everardo; Trujillo-de Santiago, Grissel; Ponce-Ponce de Leon, Cesar Alejandro; Zhang, Yu Shrike; Dokmeci, Mehmet Remzi; Khademhosseini, Ali; Moises Alvarez, Mario			Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; ESCHERICHIA-COLI; MONOCLONAL-ANTIBODY; HEMORRHAGIC-FEVER; RAPID DIAGNOSIS; ELISA; SCFV; NUCLEOPROTEIN; PURIFICATION; FRAGMENTS	Background Current Ebola virus (EBOV) detection methods are costly and impractical for epidemic scenarios. Different immune-based assays have been reported for the detection and quantification of Ebola virus (EBOV) proteins. In particular, several monoclonal antibodies (mAbs) have been described that bind the capsid glycoprotein (GP) of EBOV GP. However, the currently available platforms for the design and production of full-length mAbs are cumbersome and costly. The use of antibody fragments, rather than full-length antibodies, might represent a cost-effective alternative for the development of diagnostic and possibly even therapeutic alternatives for EBOV. Methods/Principal Findings We report the design and expression of three recombinant anti-GP mAb fragments in Escherichia coli cultures. These fragments contained the heavy and light variable portions of the three well-studied anti-GP full-length mAbs 13C6, 13F6, and KZ52, and are consequently named scFv-13C6, scFv-13F6, and Fab-KZ52, respectively. All three fragments exhibited specific anti-GP binding activity in ELISA experiments comparable to that of full-length anti-GP antibodies (i.e., the same order of magnitude) and they are easily and economically produced in bacterial cultures. Conclusion/Significance Antibody fragments might represent a useful, effective, and low cost alternative to full-length antibodies in Ebola related capture and diagnostics applications.	[Mario Rodriguez-Martinez, Luis; Roberto Marquez-Ipina, Alan; Lopez-Pacheco, Felipe; Perez-Chavarria, Roberto; Carlos Gonzalez-Vazquez, Juan; Gonzalez-Gonzalez, Everardo; Trujillo-de Santiago, Grissel; Ponce-Ponce de Leon, Cesar Alejandro; Moises Alvarez, Mario] Ctr Biotecnol FEMSA, Tecnol Monterrey Monterrey, Monterrey, Nuevo Leon, Mexico; [Trujillo-de Santiago, Grissel; Zhang, Yu Shrike; Dokmeci, Mehmet Remzi; Khademhosseini, Ali; Moises Alvarez, Mario] Harvard Univ, Brigham & Womens Hosp, Sch Med, Biomat Innovat Res Ctr, Boston, MA 02115 USA; [Trujillo-de Santiago, Grissel; Zhang, Yu Shrike; Dokmeci, Mehmet Remzi; Khademhosseini, Ali; Moises Alvarez, Mario] MIT, Div Hlth Sci & Technol, Harvard Massachusetts Inst Technol, Cambridge, MA 02139 USA; [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Khademhosseini, Ali] King Abdulaziz Univ, Dept Phys, Jeddah 21413, Saudi Arabia	Tecnologico de Monterrey; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; King Abdulaziz University	Khademhosseini, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Biomat Innovat Res Ctr, Boston, MA 02115 USA.	alik@mit.edu; mario.alvarez@itesm.mx	Dokmeci, Mehmet/GRS-5590-2022; González, Everardo González/X-3440-2019; Zhang, Yu Shrike/H-4885-2013; Khademhosseini, Ali/A-9435-2010; Rodriguez-Martinez, Luis Mario/F-1220-2019	Dokmeci, Mehmet/0000-0003-2226-9441; González, Everardo González/0000-0001-6588-5856; Zhang, Yu Shrike/0000-0002-0045-0808; Khademhosseini, Ali/0000-0002-2692-1524; Marquez-Ipina, Alan Roberto/0000-0002-6278-5398; Rodriguez-Martinez, Luis Mario/0000-0002-1612-6631; Alvarez, Mario Moises/0000-0002-9131-5344; Khademhosseini, Ali/0000-0001-6322-8852; Trujillo de Santiago, Grissel/0000-0001-9230-4607	Tecnologico de Monterrey; CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico); MIT International Science and Technology Initiatives (MISTI); Fundacion Mexico en Harvard; National Science Foundation [EFRI-1240443]; IMMODGEL [602694]; National Institutes of Health [EB012597, AR057837, DE021468, HL099073, AI105024, AR063745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL099073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI105024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR063745, R01AR057837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021468] Funding Source: NIH RePORTER	Tecnologico de Monterrey; CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); MIT International Science and Technology Initiatives (MISTI); Fundacion Mexico en Harvard; National Science Foundation(National Science Foundation (NSF)); IMMODGEL; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	MMA gratefully acknowledges the institutional funding received from Tecnologico de Monterrey (seed funding to Strategic Research Groups, 2015) and funding provided from CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) in the form of Scholarships to GT-dS, ARM-I, EG-G, and RP-C. MMA, GT-dS and AK acknowledge funding from MIT International Science and Technology Initiatives (MISTI). GT-dS acknowledges funding form Fundacion Mexico en Harvard. AK, YSZ, and MRD acknowledge funding from the National Science Foundation (EFRI-1240443), IMMODGEL (602694), and the National Institutes of Health (EB012597, AR057837, DE021468, HL099073, AI105024, AR063745). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Yanes JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011694; Alvarez MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010176; Baig F, 2014, BIOTECHNOL BIOENG, V111, P980, DOI 10.1002/bit.25169; Batra SK, 2002, CURR OPIN BIOTECH, V13, P603, DOI 10.1016/S0958-1669(02)00352-X; Braize S, 2014, NEW ENGL J MED, V371, P1418; Conroy PJ, 2009, SEMIN CELL DEV BIOL, V20, P10, DOI 10.1016/j.semcdb.2009.01.010; DuBois RM, 2011, J VIROL, V85, P865, DOI 10.1128/JVI.01412-10; Enserink M, 2014, SCIENCE, V345, P364, DOI 10.1126/science.345.6195.364; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Gonzalez-Gonzalez E, 2015, CRITICAL RE IN PRESS; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Huang TK, 2009, BIOCHEM ENG J, V45, P168, DOI 10.1016/j.bej.2009.02.008; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; Jones S, 2013, United States patent, Patent No. [US 8,513,391, 8513391]; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56; Leroy EM, 2000, J MED VIROL, V60, P463, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;463::AID-JMV15&gt;3.0.CO;2-M; Lucht A, 2007, J INFECT DIS, V196, pS184, DOI 10.1086/520593; Moricoli D, 2014, J IMMUNOL METHODS, V408, P35, DOI 10.1016/j.jim.2014.04.012; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Niikura M, 2001, J CLIN MICROBIOL, V39, P3267, DOI 10.1128/JCM.39.9.3267-3271.2001; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Omasa T, 2010, CURR PHARM BIOTECHNO, V11, P233, DOI 10.2174/138920110791111960; Pang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095635; Patterson JT, 2014, BIOCONJUGATE CHEM, V25, P1402, DOI 10.1021/bc500276m; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605; Sengupta D, 2014, J VIROL METHODS, V208, P129, DOI 10.1016/j.jviromet.2014.08.009; Sharma GK, 2014, BIOLOGICALS, V42, P339, DOI 10.1016/j.biologicals.2014.08.005; Shen ZH, 2008, ANAL CHEM, V80, P1910, DOI 10.1021/ac7018624; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Thakkar S, 2014, SCI REP, V4; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Varadaraju H, 2011, BIOTECHNOL PROGR, V27, P1297, DOI 10.1002/btpr.639; WHO, 2015, GLOB AL RESP; Wilson J, 2005, United States patent, Patent No. [US 875,433,5, 68754335]; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Yu JS, 2006, J VIROL METHODS, V137, P219, DOI 10.1016/j.jviromet.2006.06.014; Yuan RS, 2014, APPL MICROBIOL BIOT, V98, P1547, DOI 10.1007/s00253-013-5351-6	41	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0135859	10.1371/journal.pone.0135859	http://dx.doi.org/10.1371/journal.pone.0135859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489048	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400003
J	Mohammed, A; Chiruvella, KK; Rao, YK; Geethangili, M; Raghavan, SC; Ghanta, RG				Mohammed, Arifullah; Chiruvella, Kishore K.; Rao, Yerra Koteswara; Geethangili, Madamanchi; Raghavan, Sathees C.; Ghanta, Rama Gopal			In Vitro Production of Echioidinin, 7-O-Methywogonin from Callus Cultures of Andrographis lineata and Their Cytotoxicity on Cancer Cells	PLOS ONE			English	Article							HAIRY ROOT; SUSPENSION CULTURES; FLAVONOIDS; PANICULATA; INHIBITION; APOPTOSIS; GROWTH; NEES	Andrographis lineata is an herbal medicinal plant used in traditional medicine as a substitute for Andrographis paniculata. Here, using mature leaf explants of A. lineata we demonstrate for the first time the callus induction established on MS medium containing 1.0 mg l(-1) IAA. Dried callus was subjected to solvent extraction with acetone. Further the acetone residue was separated by silica gel column chromatography, crystallized and characterized on the basis of nuclear magnetic resonance (proton and c13) and liquid chromatographic mass spectroscopy. This analysis revealed the occurrence of two known flavones namely, 7-O-methylwogonin (MW) and Echioidinin (ED). Furthermore, these compounds were tested for their cytotoxicity against leukemic cell line, CEM. We identify that ED and MW induced cytotoxicity in a time-and concentration-dependent manner. Further increase in the LDH release upon treatment with ED and MW further confirmed our cytotoxicity results against leukemic cell line. Strikingly, MW was more potent than ED when compared by trypan blue and MTT assays. Our results recapitulate the utility of callus cultures for the production of plant specific bioactive secondary metabolites instead of using wild plants. Together, our in vitro studies provide new insights of A. lineata callus cultures serving as a source for cancer chemotherapeutic agents.	[Mohammed, Arifullah] Univ Malaysia Kelantan, Fac Agrobased Ind, Jeli 17600, Kelantan, Malaysia; [Chiruvella, Kishore K.; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Mohammed, Arifullah; Chiruvella, Kishore K.; Ghanta, Rama Gopal] Sri Venkateswara Univ, Dept Bot, Div Plant Tissue Culture, Tirupati 517502, Andhra Pradesh, India; [Rao, Yerra Koteswara; Geethangili, Madamanchi] Chaoyang Univ Technol, Dept Appl Chem, Taichung, Taiwan	Universiti Malaysia Kelantan; Indian Institute of Science (IISC) - Bangalore; Sri Venkateswara University; Chaoyang University of Technology	Mohammed, A (corresponding author), Univ Malaysia Kelantan, Fac Agrobased Ind, Jeli Campus,Locked Bag 100, Jeli 17600, Kelantan, Malaysia.	arifullahmd@gmail.com	Chiruvella, Kishore Kumar/AAH-3131-2022; Yerra, Rao Koteswara/D-1954-2011; Madamanchi, Geethangili/W-6088-2019; Chiruvella, Kishore Kumar/AEU-8773-2022	Yerra, Rao Koteswara/0000-0001-6063-904X; Chiruvella, Kishore Kumar/0000-0002-4997-5875; Mohammed, Arifullah/0000-0001-7793-8134				Abdullah MA, 1998, PLANT CELL TISS ORG, V54, P173, DOI 10.1023/A:1006108717255; Akbar S, 2011, ALTERN MED REV, V16, P66; Alagesaboopathi C., 2012, INT J RECENT SCI RES, V3, P71; Bieker R, 2003, ONCOL REP, V10, P915; Cheng SY, 2014, NOT BOT HORTI AGROBO, V42, P88; Chiruvella KK, 2011, INVEST NEW DRUG, V29, P583, DOI 10.1007/s10637-010-9393-7; Chiruvella Kishore K, 2007, Int J Biomed Sci, V3, P269; Chiruvella KK, 2008, FEBS LETT, V582, P4066, DOI 10.1016/j.febslet.2008.11.001; D'Angiolillo F, 2014, NAT PROD COMMUN, V9, P477; Nicasio-Torres MD, 2012, ACTA PHYSIOL PLANT, V34, P307, DOI 10.1007/s11738-011-0830-9; Dias ACP, 1998, PHYTOCHEMISTRY, V48, P1165, DOI 10.1016/S0031-9422(97)00963-1; Dias ACP, 2000, PLANT SCI, V150, P93, DOI 10.1016/S0168-9452(99)00178-8; Enaksha RMW, 1993, PLANT CELL TISSUE OR, V35, P181; Filova A., 2014, Research Journal of Agricultural Science, V46, P236; Goleniowski ME, 2000, BIOCELL, V24, P139; GUPTA KK, 1983, PHYTOCHEMISTRY, V22, P314, DOI 10.1016/S0031-9422(00)80122-3; Hagendoorn MJM, 1997, J PLANT PHYSIOL, V150, P325, DOI 10.1016/S0176-1617(97)80128-9; Hussain MS, 2012, J PHARM BIOALLIED SC, V4, P10, DOI 10.4103/0975-7406.92725; IINUMA M, 1989, PHYTOCHEMISTRY, V28, P681, DOI 10.1016/0031-9422(89)80094-9; JALAL MAF, 1979, PHYTOCHEMISTRY, V18, P149, DOI 10.1016/S0031-9422(00)90934-8; Januario AH, 2005, CHEM PHARM BULL, V53, P740, DOI 10.1248/cpb.53.740; Jayaprakasam B, 1999, PHYTOCHEMISTRY, V52, P935, DOI 10.1016/S0031-9422(99)00295-2; KAMADA H, 1986, PLANT CELL REP, V5, P239, DOI 10.1007/BF00269811; Kavitha CV, 2009, BIOCHEM PHARMACOL, V77, P348, DOI 10.1016/j.bcp.2008.10.018; Kishore PH, 2003, PHYTOCHEMISTRY, V63, P457, DOI 10.1016/S031-9422(02)00702-1; Kittipongpatana N, 1998, PLANT CELL TISS ORG, V52, P133, DOI 10.1023/A:1005974611043; Kumar A, 2008, INVEST NEW DRUG, V26, P425, DOI 10.1007/s10637-008-9116-5; Kumar M, 2016, CYTOTECHNOLOGY, V68, P531, DOI 10.1007/s10616-015-9897-2; KUROYANAGI M, 1987, CHEM PHARM BULL, V35, P4429; Li W, 2002, PHYTOCHEMISTRY, V60, P351, DOI 10.1016/S0031-9422(02)00093-6; Luczkiewicz M, 2014, PLANT CELL TISS ORG, V118, P419, DOI 10.1007/s11240-014-0494-4; Maneechai S, 2012, PHYTOCHEMISTRY, V81, P42, DOI 10.1016/j.phytochem.2012.05.031; Matkowski A, 2004, J PLANT PHYSIOL, V161, P343, DOI 10.1078/0176-1617-01145; NIKAIDO T, 1988, CHEM PHARM BULL, V36, P654; Parixit B, 2012, INT J PHARM SCI, V4, P1835; Piovan A, 2014, NAT PROD COMMUN, V9, P489; Rech SB, 1998, PLANT CELL TISS ORG, V54, P61, DOI 10.1023/A:1006118220785; Renugadevi G, 2013, ASIAN PAC J TROP MED, V6, P176, DOI 10.1016/S1995-7645(13)60019-X; Roy HK, 2001, FEBS LETT, V496, P143, DOI 10.1016/S0014-5793(01)02420-6; Sangameswaran B., 2007, Nigerian Journal of Natural Products and Medicine, V11, P61; Sangameswaran B, 2008, PHYTOTHER RES, V22, P124, DOI 10.1002/ptr.2250; Santhi R., 2006, Advances in Plant Sciences, V19, P371; Sareer O, 2014, NAT PROD RES, V28, P2081, DOI 10.1080/14786419.2014.924004; Somasagara RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047021; Srivastava M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06147; Tarbeeva DV, 2013, NAT PROD COMMUN, V8, P1419; Varma A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep135; Wewetzer A, 1998, PHYTOPARASITICA, V26, P47, DOI 10.1007/BF02981265; Yamamoto H, 2002, PHYTOCHEMISTRY, V60, P263, DOI 10.1016/S0031-9422(02)00111-5; YAMAMOTO O, 1986, PLANT CELL REP, V5, P50, DOI 10.1007/BF00269717	50	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141154	10.1371/journal.pone.0141154	http://dx.doi.org/10.1371/journal.pone.0141154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488879	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400110
J	Pan, ML; Chen, LR; Tsao, HM; Chen, KH				Pan, Mei-Lien; Chen, Li-Ru; Tsao, Hsiao-Mei; Chen, Kuo-Hu			Relationship between Polycystic Ovarian Syndrome and Subsequent Gestational Diabetes Mellitus: A Nationwide Population-Based Study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; PREGNANCY OUTCOMES; INSULIN-RESISTANCE; METABOLIC FEATURES; WOMEN; PREVALENCE; ENDOCRINE; METFORMIN; HISTORY; PCOS	Objective This nationwide population-based study aims to explore the relationship between polycystic ovarian syndrome (PCOS) and subsequent gestational diabetes mellitus (GDM). Methods Data from 1998-2012 Taiwan National Health Insurance Research Database were used for this study. ICD9-CM codes 256.4X and 648. X were used separately for the diagnoses of PCOS and GDM, which were further confirmed by records of blood tests or ultrasonography to ensure the accuracy of the diagnoses. Women diagnosed at < 15 or > 45 years of age, and those diagnosed with overt diabetes mellitus or GDM prior to PCOS were excluded. During pregnancy, each woman with a previous diagnosis of PCOS was age-matched to 10 women without PCOS. Odds ratios (ORs) for risk of GDM were calculated by logistic regression analysis with adjustment for economic status and co-morbidities. Results Among 7,629 eligible women with a valid PCOS diagnosis, 3,109 (42.87%) had subsequent pregnancies. GDM occurred frequently among women with a history of PCOS as compared to those without PCOS (20.46% vs. 10.54%, p< 0.0001). Logistic regression analysis revealed that PCOS was associated with GDM (adjusted OR = 2.15; 95% CI: 1.96-2.37). Among 3,109 affected patients, 1,160 (37.31%) had used medications for PCOS and 261 (8.39%) were treated with an oral hypoglycemic agent (OHA). There was no significant difference in development of GDM between the medication and no medication sub-groups (p> 0.05). If not used after conception, OHAs did not reduce the risk of GDM (adjusted OR = 1.20; 95% CI: 0.88-1.62). Conclusions A history of PCOS is a significant and independent risk factor for development of GDM. Medication for PCOS or pre-pregnancy use of OHAs does not reduce the risk of GDM. When at-risk women become pregnant, they require closer surveillance for maternal and fetal well-being, and should follow a strict diet and adhere to weight gain control to avoid obstetric complications due to GDM.	[Pan, Mei-Lien] Acad Sinica, Inst Informat Sci, Taipei 115, Taiwan; [Chen, Li-Ru] Mackay Mem Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Li-Ru] Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan; [Tsao, Hsiao-Mei] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Kuo-Hu] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Kuo-Hu] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Academia Sinica - Taiwan; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tzu Chi University	Chen, KH (corresponding author), Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	alexgfctw@yahoo.com.tw			Ministry of Science and Technology, Taiwan [NSC 104-0210-01-08-04]; Taipei Tzu-Chi Hospital, Taiwan [TCRD-TPE-103-40]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Tzu-Chi Hospital, Taiwan	This work was supported by 1) MLP: the Ministry of Science and Technology, Taiwan (http://www.most.gov.tw/mp.aspx?mp=7) (NSC 104-0210-01-08-04), and 2) KHC: Taipei Tzu-Chi Hospital, Taiwan (https://www.tzuchi.com.tw/tzuchi_en/About_TP_Center/Default.htm) (TCRD-TPE-103-40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila L, 1998, OBSTET GYNECOL, V92, P13, DOI 10.1016/S0029-7844(98)00133-1; Begum MR, 2009, J OBSTET GYNAECOL RE, V35, P282, DOI 10.1111/j.1447-0756.2008.00876.x; Bjercke S, 2002, GYNECOL OBSTET INVES, V54, P94, DOI 10.1159/000067719; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Cunningham FG, 2005, WILLIAMS OBSTET, P1172; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Eroglu D, 2006, J OBSTET GYNAECOL RE, V32, P408, DOI 10.1111/j.1447-0756.2006.00418.x; Glintborg D, 2004, FERTIL STERIL, V82, P1570, DOI 10.1016/j.fertnstert.2004.06.040; Haakova L, 2003, HUM REPROD, V18, P1438, DOI 10.1093/humrep/deg289; Hart R, 2007, CURR OPIN OBSTET GYN, V19, P529, DOI 10.1097/GCO.0b013e3282f10e22; Holte J, 1998, J CLIN ENDOCR METAB, V83, P1143, DOI 10.1210/jc.83.4.1143; Kashanian M, 2008, DIABETES RES CLIN PR, V80, P289, DOI 10.1016/j.diabres.2007.12.022; Kousta E, 2000, CLIN ENDOCRINOL, V53, P501, DOI 10.1046/j.1365-2265.2000.01123.x; Legro RS, 1996, ENDOCRINOLOGIST, V6, P307, DOI 10.1097/00019616-199607000-00007; Lo JC, 2006, DIABETES CARE, V29, P1915, DOI 10.2337/dc06-0877; Miehle K, 2012, CLIN ENDOCRINOL, V76, P2, DOI 10.1111/j.1365-2265.2011.04234.x; Mikola M, 2001, HUM REPROD, V16, P226, DOI 10.1093/humrep/16.2.226; Nawaz FH, 2008, J OBSTET GYNAECOL RE, V34, P832, DOI 10.1111/j.1447-0756.2008.00856.x; Paradisi G, 1998, HUM REPROD, V13, P542, DOI 10.1093/humrep/13.3.542; Radon PA, 1999, OBSTET GYNECOL, V94, P194, DOI 10.1016/S0029-7844(99)00252-5; Turhan NO, 2003, INT J GYNECOL OBSTET, V81, P163, DOI 10.1016/S0020-7292(03)00003-1; Vollenhoven B, 2000, AUST NZ J OBSTET GYN, V40, P54, DOI 10.1111/j.1479-828X.2000.tb03167.x; Weerakiet S, 2004, GYNECOL ENDOCRINOL, V19, P134, DOI 10.1080/09513590400007242	25	41	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140544	10.1371/journal.pone.0140544	http://dx.doi.org/10.1371/journal.pone.0140544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488176	gold, Green Submitted, Green Published			2022-12-27	WOS:000363248400059
J	Ramachandran, SD; Schirmer, K; Munst, B; Heinz, S; Ghafoory, S; Wolfl, S; Simon-Keller, K; Marx, A; Oie, CI; Ebert, MP; Walles, H; Braspenning, J; Breitkopf-Heinlein, K				Ramachandran, Sarada Devi; Schirmer, Katharina; Muenst, Bernhard; Heinz, Stefan; Ghafoory, Shahrouz; Woelfl, Stefan; Simon-Keller, Katja; Marx, Alexander; Oie, Cristina Ionica; Ebert, Matthias P.; Walles, Heike; Braspenning, Joris; Breitkopf-Heinlein, Katja			In Vitro Generation of Functional Liver Organoid-Like Structures Using Adult Human Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN HEPATOCYTES; EXPRESSION; INDUCTION	In this study we used differentiated adult human upcyte (R) cells for the in vitro generation of liver organoids. Upcyte (R) cells are genetically engineered cell strains derived from primary human cells by lenti-viral transduction of genes or gene combinations inducing transient proliferation capacity (upcyte (R) process). Proliferating upcyte (R) cells undergo a finite number of cell divisions, i.e., 20 to 40 population doublings, but upon withdrawal of proliferation stimulating factors, they regain most of the cell specific characteristics of primary cells. When a defined mixture of differentiated human upcyte (R) cells (hepatocytes, liver sinusoidal endothelial cells (LSECs) and mesenchymal stem cells (MSCs)) was cultured in vitro on a thick layer of Matrigel T, they self-organized to form liver organoid-like structures within 24 hours. When further cultured for 10 days in a bioreactor, these liver organoids show typical functional characteristics of liver parenchyma including activity of cytochromes P450, CYP3A4, CYP2B6 and CYP2C9 as well as mRNA expression of several marker genes and other enzymes. In summary, we hereby describe that 3D functional hepatic structures composed of primary human cell strains can be generated in vitro. They can be cultured for a prolonged period of time and are potentially useful ex vivo models to study liver functions.	[Ramachandran, Sarada Devi; Muenst, Bernhard; Heinz, Stefan; Braspenning, Joris] Medicyte GmbH, D-69120 Heidelberg, Germany; [Schirmer, Katharina; Ebert, Matthias P.; Breitkopf-Heinlein, Katja] Heidelberg Univ, Fac Med Mannheim, Dept Med 2, Mannheim, Germany; [Heinz, Stefan] Upcyte Technol GmbH, D-22529 Hamburg, Germany; [Ghafoory, Shahrouz; Woelfl, Stefan] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Simon-Keller, Katja; Marx, Alexander] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany; [Oie, Cristina Ionica] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Vasc Biol Res Grp, N-9037 Tromso, Norway; [Walles, Heike] Univ Wurzburg, Tissue Engn & Regenerat Med, D-97070 Wurzburg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; UiT The Arctic University of Tromso; University of Wurzburg	Breitkopf-Heinlein, K (corresponding author), Heidelberg Univ, Fac Med Mannheim, Dept Med 2, Mannheim, Germany.	katja.breitkopf@medma.uni-heidelberg.de	Walles, Heike/M-1289-2015	Walles, Heike/0000-0002-1512-7448; Simon-Keller, Katja/0000-0003-2340-8765	European Union [304961]; HeMiBio consortium [HEALTH-F5-2010-266777]; Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg; Medicyte GmbH; upcyte technologies GmbH	European Union(European Commission); HeMiBio consortium; Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg; Medicyte GmbH; upcyte technologies GmbH	The work leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 304961, the HeMiBio consortium (grant agreement no. HEALTH-F5-2010-266777) and from the "Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg", funding program "Entwicklung von Alternativmethoden zur Vermeidung von Tierversuchen" (KB-H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Medicyte GmbH and upcyte technologies GmbH provided support in the form of salaries for authors [SDR, BM, SH, JB] and [SH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Burkard A, 2012, XENOBIOTICA, V42, P939, DOI 10.3109/00498254.2012.675093; Cienfuegos Javier A., 2014, Rev. esp. enferm. dig., V106, P171; Ghafoory S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078262; Ghafoory S, 2012, HISTOPATHOLOGY, V61, P306, DOI 10.1111/j.1365-2559.2012.04237.x; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Kurinna S, 2011, INT J BIOCHEM CELL B, V43, P189, DOI 10.1016/j.biocel.2010.03.013; Lange C, 2005, WORLD J GASTROENTERO, V11, P4497, DOI 10.3748/wjg.v11.i29.4497; Levy G, 2015, NATURE BIOTECHNOLOGY; Luk JM, 2005, J IMMUNOL METHODS, V305, P39, DOI 10.1016/j.jim.2005.07.006; Matsusaki M, 2014, ADV DRUG DELIVER REV, V74, P95, DOI 10.1016/j.addr.2014.01.003; Mendieta-Wejebe JE, 2011, CURR DRUG METAB; Norenberg A, 2013, MUTAT RES-GEN TOX EN, V758, P69, DOI 10.1016/j.mrgentox.2013.09.008; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Rai R, 2013, INDIAN J SURG, V75, P185, DOI 10.1007/s12262-012-0643-0; Ramachandran SD, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.161; Schanz S, 2012, ARCH DERMATOL, V148, P17, DOI 10.1001/archdermatol.2011.341; Shu SN, 2004, WORLD J GASTROENTERO, V10, P2818; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Volarevic V, 2014, STEM CELLS; Xagorari A, 2013, INT J CLIN EXP PATHO, V6, P831; Zanger Ulrich M., 2013, Frontiers in Genetics, V4, P24, DOI 10.3389/fgene.2013.00024; Zeitler P, 2004, HISTOPATHOLOGY, V44, P360, DOI 10.1111/j.1365-2559.2004.01854.x	23	65	67	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139345	10.1371/journal.pone.0139345	http://dx.doi.org/10.1371/journal.pone.0139345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488607	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400027
J	Ruiz, JI; Nuhu, K; McDaniel, JT; Popoff, F; Izcovich, A; Criniti, JM				Ruiz, Juan Ignacio; Nuhu, Kaamel; McDaniel, Justin Tyler; Popoff, Federico; Izcovich, Ariel; Martin Criniti, Juan			Inequality as a Powerful Predictor of Infant and Maternal Mortality around the World	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; CHILDHOOD MORTALITY; DETERMINANTS	Background Maternal and infant mortality are highly devastating, yet, in many cases, preventable events for a community. The human development of a country is a strong predictor of maternal and infant mortality, reflecting the importance of socioeconomic factors in determinants of health. Previous research has shown that the Human Development Index (HDI) predicts infant mortality rate (IMR) and the maternal mortality ratio (MMR). Inequality has also been shown to be associated with worse health in certain populations. The main purpose of the present study was to determine the correlation and predictive power of the Inequality Adjusted Human Development Index (IHDI) as a measure of inequality with the Infant Mortality Rate (IMR), Maternal Mortality Rate (MMR), Early Neonatal Mortality Rate (ENMR), Late Neonatal Mortality Rate (LNMR), and the Post Neonatal Mortality Rate (PNMR). Methods and Findings Data for the present study were downloaded from two sources: infant and maternal mortality data were downloaded from the Global Burden of Disease 2013 Cause of Death Database and the Human Development Index (HDI) and Inequality-Adjusted Human Development Index (IHDI) data were downloaded from the United Nations Development Program (UNDP). Pearson correlation coefficients were estimated, following logarithmic transformations to the data, to examine the relationship between HDI and IHDI with MMR, IMR, ENMR, LNMR, and PNMR. Steiger's Z test for the equality of two dependent correlations was utilized in order to determine whether the HDI or IHDI was more strongly associated with the outcome variables. Lastly, we constructed OLS regression models in order to determine the predictive power of the HDI and IHDI in terms of the MMR, IMR, ENMR, LNMR, and PNMR. Maternal and infant mortality were both strongly and negatively correlated with both HDI and IHDI; however, Steiger's Z test for the equality of two dependent correlations revealed that IHDI was more strongly correlated than HDI with MMR (Z = 4.897, p < 0.001), IMR (Z = 2.524, p = 0.012), ENMR (Z = 2.936, p = 0.003), LNMR (Z = 2.272, p = 0.023), and PNMR (Z = 2.277, p = 0.023). Furthermore, side-by-side OLS regression models revealed that, when IHDI was used as the predictor variable instead of HDI, the R-2 value was 0.053 higher for MMR, 0.025 higher for IMR, 0.038 higher for ENMR, 0.029 higher for LNMR, and 0.026 higher for PNMR. Conclusions Even when both the HDI and the IHDI correlate with the infant and maternal mortality rates, the IHDI is a better predictor for these two health indicators. Therefore, these results add more evidence that inequality is playing an important role in determining the health status of various populations in the world and more efforts should be put into programs to fight inequality.	[Ruiz, Juan Ignacio; Nuhu, Kaamel; McDaniel, Justin Tyler] So Illinois Univ, Coll Educ & Human Serv, Dept Hlth Educ & Recreat, Carbondale, IL 62901 USA; [Popoff, Federico; Izcovich, Ariel; Martin Criniti, Juan] Hosp Aleman, Serv Clin Med, Buenos Aires, DF, Argentina	Southern Illinois University System; Southern Illinois University; Hospital Aleman; University of Buenos Aires	Ruiz, JI (corresponding author), So Illinois Univ, Coll Educ & Human Serv, Dept Hlth Educ & Recreat, Carbondale, IL 62901 USA.	juaniruiz@siu.edu	Nuhu, Kaamel/AAS-2233-2021	Nuhu, Kaamel/0000-0002-3812-7969; Izcovich, Ariel/0000-0001-9053-4396				Centers for Disease Control and Prevention, 2015, HLTH DISP 2015; Elgar FJ, 2010, AM J PUBLIC HEALTH, V100, P2311, DOI 10.2105/AJPH.2009.189134; ESRI, 2011, ARCGIS DESKT REL 10; Hicks DA, 1997, WORLD DEV, V25, P1283, DOI 10.1016/S0305-750X(97)00034-X; Houweling TAJ, 2010, BRIT MED BULL, V93, P7, DOI 10.1093/bmb/ldp048; Inequality. org, 2011, IN HLTH 2011; International Pathfinder, 2009, REF ACC MAT MORT 200; Kanmiki EW, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-24; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kim D, 2013, INT J ENV RES PUB HE, V10, P2296, DOI 10.3390/ijerph10062296; Lee K, 1997, J PEDIATR-US, V131, P3; Alvarez JL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-462; Owoseni JS, 2014, STAND RES J MED MED, V2, P1; Sokal R, 2014, LANCET, V384, P73; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Surgeon General, EL HLTH DISP; UCL Institute of Health Equity, 2015, SOC IN LEAD CAUS EAR; ul Haq M., 1990, HUM DEV REP 1990; United Nations Development Programme, 2014, HUM DEV REP 2014 HUM; United Nations Development Programme, 2013, HUM DEV REP 2013 IN; van Deurzen I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115109; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9	23	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140796	10.1371/journal.pone.0140796	http://dx.doi.org/10.1371/journal.pone.0140796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488170	gold, Green Submitted, Green Published			2022-12-27	WOS:000363248400068
J	Balloy, V; Varet, H; Dillies, MA; Proux, C; Jagla, B; Coppee, JY; Tabary, O; Corvol, H; Chignard, M; Guillot, L				Balloy, Viviane; Varet, Hugo; Dillies, Marie-Agnes; Proux, Caroline; Jagla, Bernd; Coppee, Jean-Yves; Tabary, Olivier; Corvol, Harriet; Chignard, Michel; Guillot, Loiec			Normal and Cystic Fibrosis Human Bronchial Epithelial Cells Infected with Pseudomonas aeruginosa Exhibit Distinct Gene Activation Patterns	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; AIRWAY INFLAMMATION; GM-CSF; EXPRESSION; SPUTUM; METALLOPROTEINASES; IDENTIFICATION; EVOLUTION; CHILDREN; SURVIVAL	Background and Aims In cystic fibrosis (CF), Pseudomonas aeruginosa is not eradicated from the lower respiratory tract and is associated with epithelial inflammation that eventually causes tissue damage. To identify the molecular determinants of an effective response to P. aeruginosa infection, we performed a transcriptomic analysis of primary human bronchial epithelial cells from healthy donors (CTRL) 2, 4, and 6 h after induced P. aeruginosa infection. Compared to noninfected cells, infected cells showed changes in gene activity, which were most marked 6 h postinfection and usually consisted in upregulation. Results By comparing for each time point of infection, the transcriptomic response of epithelial cells from CF patients and healthy donors, we identified 851, 638, 667, and 980 differentially expressed genes 0, 2, 4, and 6 h postinfection, respectively. Gene selection followed by bioinformatic analysis showed that most of the differentially expressed genes, either up- or downregulated, were in the protein-binding and catalytic gene-ontology categories. Finally, we established that the protein products of the genes exhibiting the greatest differential upregulation (CSF2, CCL2, TNF, CSF3, MMP1, and MMP10) between CF patients and CTRL were produced in higher amounts by infected cells from CF patients versus CTRL. Conclusions The differentially expressed genes in CF patients may constitute a signature for a detrimental inflammatory response and for an inefficient P. aeruginosa host-cell response.	[Balloy, Viviane; Tabary, Olivier; Corvol, Harriet; Chignard, Michel; Guillot, Loiec] CDR St Antoine, INSERM, UMR S 938, Paris, France; [Balloy, Viviane; Tabary, Olivier; Corvol, Harriet; Chignard, Michel; Guillot, Loiec] Univ Paris 06, Sorbonne Univ, UMR S 938, CDR St Antoine, Paris, France; [Varet, Hugo; Dillies, Marie-Agnes; Proux, Caroline; Jagla, Bernd; Coppee, Jean-Yves] Inst Pasteur, Plate Forme Transcriptome Epigenome, Ctr Innovat & Rech Technol, Paris, France; [Corvol, Harriet] Hop Trousseau, AP HP, Pneumol Pediat, F-75571 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Guillot, L (corresponding author), CDR St Antoine, INSERM, UMR S 938, Paris, France.	loic.guillot@inserm.fr	Guillot, Loic/D-8893-2011; Tabary, Olivier/J-5931-2017; Corvol, Harriet/N-5922-2018; Balloy, Viviane/B-8551-2014	Guillot, Loic/0000-0001-6853-7945; Tabary, Olivier/0000-0003-1997-2400; Corvol, Harriet/0000-0002-7026-7523; Balloy, Viviane/0000-0001-9093-9676	Vaincre la mucoviscidose; Association Gregory Lemarchal	Vaincre la mucoviscidose; Association Gregory Lemarchal	This work was supported by a grant from two French non-profit cystic-fibrosis organizations, Vaincre la mucoviscidose and Association Gregory Lemarchal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2013, R LANG ENV STAT COMP; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Ballinger MN, 2006, AM J RESP CELL MOL, V34, P766, DOI 10.1165/rcmb.2005-0246OC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BenMohamed F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090466; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; DEAN TP, 1993, PEDIATR RES, V34, P159, DOI 10.1203/00006450-199308000-00010; Epling-Burnette PK, 2001, J IMMUNOL, V166, P7486, DOI 10.4049/jimmunol.166.12.7486; Faveeuw C, 2001, BLOOD, V98, P688, DOI 10.1182/blood.V98.3.688; Goss CH, 2013, AM J RESP CRIT CARE, V187, P915, DOI 10.1164/rccm.201301-0184UP; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Ichikawa JK, 2000, P NATL ACAD SCI USA, V97, P9659, DOI 10.1073/pnas.160140297; Kassim SY, 2007, INFECT IMMUN, V75, P5640, DOI 10.1128/IAI.00799-07; Kim EY, 2011, FEBS LETT, V585, P779, DOI 10.1016/j.febslet.2011.01.044; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Korner C, 2014, PEPTIDES, V62, P49, DOI 10.1016/j.peptides.2014.09.022; Koyama S, 2000, AM J PHYSIOL-LUNG C, V278, pL658, DOI 10.1152/ajplung.2000.278.4.L658; LEPPERT D, 1995, J IMMUNOL, V154, P4379; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065278; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Muller-Redetzky HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035832; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; O'Grady EP, 2006, INFECT IMMUN, V74, P5893, DOI 10.1128/IAI.00489-06; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Pressler T, 2011, J CYST FIBROS, V10, pS75, DOI 10.1016/S1569-1993(11)60011-8; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Reiniger N, 2005, INFECT IMMUN, V73, P6822, DOI 10.1128/IAI.73.10.6822-6830.2005; Saba S, 2002, AM J RESP CELL MOL, V27, P561, DOI 10.1165/rcmb.2002-0019OC; Sagel Scott D, 2007, Proc Am Thorac Soc, V4, P406, DOI 10.1513/pats.200703-044BR; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; Saunders WB, 2005, J CELL SCI, V118, P2325, DOI 10.1242/jcs.02360; Sbarbati A, 2009, ANAT REC, V292, P439, DOI 10.1002/ar.20866; Stuart B, 2010, PAEDIATR RESPIR REV, V11, P177, DOI 10.1016/j.prrv.2010.05.003; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Virella-Lowell I, 2004, MOL THER, V10, P562, DOI 10.1016/j.ymthe.2004.06.215; Vliagoftis H, 2001, J ALLERGY CLIN IMMUN, V107, P679, DOI 10.1067/mai.2001.114245; Vos JB, 2005, PHYSIOL GENOMICS, V21, P324, DOI 10.1152/physiolgenomics.00289.2004; Warner RL, 2001, AM J RESP CELL MOL, V24, P537, DOI 10.1165/ajrcmb.24.5.4160; Yaniw D, 2005, CELL RES, V15, P423, DOI 10.1038/sj.cr.7290310	47	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140979	10.1371/journal.pone.0140979	http://dx.doi.org/10.1371/journal.pone.0140979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485688	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100100
J	Banerjee, A; Abdelmegeed, MA; Jang, S; Song, BJ				Banerjee, Atrayee; Abdelmegeed, Mohamed A.; Jang, Sehwan; Song, Byoung-Joon			Increased Sensitivity to Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NONALCOHOLIC STEATOHEPATITIS; PHARMACOLOGICAL INHIBITION; MITOCHONDRIAL DYSFUNCTION; MICROBIAL TRANSLOCATION; MACROPHAGE INFILTRATION; BARRIER DYSFUNCTION; INFECTED PATIENTS; HEPATIC-FIBROSIS; ENVELOPE PROTEIN	The mechanisms of alcohol-mediated advanced liver injury in HIV-infected individuals are poorly understood. Thus, this study was aimed to investigate the effect of binge alcohol on the inflammatory liver disease in HIV transgenic rats as a model for simulating human conditions. Female wild-type (WT) or HIV transgenic rats were treated with three consecutive doses of binge ethanol (EtOH) (3.5 g/kg/dose oral gavages at 12-h intervals) or dextrose (Control). Blood and liver tissues were collected at 1 or 6-h following the last dose of ethanol or dextrose for the measurements of serum endotoxin and liver pathology, respectively. Compared to the WT, the HIV rats showed increased sensitivity to alcohol-mediated gut leakiness, hepatic steatosis and inflammation, as evidenced with the significantly elevated levels of serum endotoxin, hepatic triglycerides, histological fat accumulation and F4/80 staining. Real-time PCR analysis revealed that hepatic levels of toll-like receptor-4 (TLR4), leptin and the downstream target monocyte chemoattractant protein-1 (MCP-1) were significantly up-regulated in the HIV-EtOH rats, compared to all other groups. Subsequent experiments with primary cultured cells showed that both hepatocytes and hepatic Kupffer cells were the sources of the elevated MCP-1 in HIV-EtOH rats. Further, TLR4 and MCP-1 were found to be upregulated by leptin. Collectively, these results show that HIV rats, similar to HIV-infected people being treated with the highly active anti-retroviral therapy (HAART), are more susceptible to binge alcohol-induced gut leakiness and inflammatory liver disease than the corresponding WT, possibly due to additive or synergistic interaction between binge alcohol exposure and HIV infection. Based on these results, HIV transgenic rats can be used as a surrogate model to study the molecular mechanisms of many disease states caused by heavy alcohol intake in HIV-infected people on HAART.	[Banerjee, Atrayee; Abdelmegeed, Mohamed A.; Jang, Sehwan; Song, Byoung-Joon] NIAAA, Lab Membrane Biochem & Biophys, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Song, BJ (corresponding author), NIAAA, Lab Membrane Biochem & Biophys, Bethesda, MD 20892 USA.	bj.song@nih.gov			Intramural Program fund of the National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000036] Funding Source: NIH RePORTER	Intramural Program fund of the National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	All of the research for this work was supported by the Intramural Program fund of the National Institute on Alcohol Abuse and Alcoholism.	Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V65, P1238, DOI 10.1016/j.freeradbiomed.2013.09.009; Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V60, P211, DOI 10.1016/j.freeradbiomed.2013.02.018; Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019; Afford SC, 1998, J PATHOL, V186, P82, DOI 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D; An L, 2012, ARCH TOXICOL, V86, P1337, DOI 10.1007/s00204-012-0814-6; Baeck C, 2014, HEPATOLOGY, V59, P1060, DOI 10.1002/hep.26783; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864; Banerjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076850; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Bautista AP, 2002, FRONT BIOSCI-LANDMRK, V7, pA117; Bautista AP, 2000, J GASTROEN HEPATOL, V15, P349, DOI 10.1046/j.1440-1746.2000.02174.x; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Brailoiu E, 2006, J NEUROVIROL, V12, P17, DOI 10.1080/13550280500516427; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Centers for Disease Control and Prevention (CDC), 2011, HIV US; Chang SL, 2014, INT REV NEUROBIOL, V118, P403, DOI 10.1016/B978-0-12-801284-0.00013-0; Chen JX, 2008, LAB INVEST, V88, P1316, DOI 10.1038/labinvest.2008.92; Clary CR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-30; Conigliaro J, 2003, JAIDS-J ACQ IMM DEF, V33, P521, DOI 10.1097/00126334-200308010-00014; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Dallasta LM, 1999, AM J PATHOL, V155, P1915, DOI 10.1016/S0002-9440(10)65511-3; Das S, 2013, TOXICOL APPL PHARM, V269, P297, DOI 10.1016/j.taap.2013.02.003; Fan X, 2011, ALCOHOL CLIN EXP RES, V35, P1866, DOI 10.1111/j.1530-0277.2011.01531.x; Fantuzzi G, 2005, CLIN EXP IMMUNOL, V142, P31, DOI 10.1111/j.1365-2249.2005.02898.X; Fisher NC, 1999, GUT, V45, P416, DOI 10.1136/gut.45.3.416; Flora G, 2005, EXP NEUROL, V191, P2, DOI 10.1016/j.expneurol.2004.06.007; Galvan FH, 2002, J STUD ALCOHOL, V63, P179, DOI 10.15288/jsa.2002.63.179; Hadigan C, 2007, JAIDS-J ACQ IMM DEF, V46, P312, DOI 10.1097/QAI.0b013e3181568cc2; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Kwon HJ, 2014, HEPATOLOGY, V60, P146, DOI 10.1002/hep.27036; Ledesma JC, 2014, NEUROPHARMACOLOGY, V85, P36, DOI 10.1016/j.neuropharm.2014.05.018; Lippai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070945; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; Marra F, 2002, GASTROENTEROLOGY, V122, P1529, DOI 10.1053/gast.2002.33369; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Moon KH, 2008, PROTEOMICS, V8, P3906, DOI 10.1002/pmic.200800215; Moon KH, 2008, GASTROENTEROLOGY, V135, P1344, DOI 10.1053/j.gastro.2008.06.048; Moon KH, 2006, HEPATOLOGY, V44, P1218, DOI 10.1002/hep.21372; Nagano J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073404; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Peng JS, 2010, J NEUROIMMUNOL, V218, P94, DOI 10.1016/j.jneuroim.2009.09.014; Persidsky Y, 2011, BRAIN BEHAV IMMUN, V25, pS61, DOI 10.1016/j.bbi.2011.03.001; Petry NM, 1999, INT J STD AIDS, V10, P561, DOI 10.1258/0956462991914654; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Samet JH, 2004, AIDS RES HUM RETROV, V20, P151, DOI 10.1089/088922204773004860; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sarkar S, 2013, ALCOHOL CLIN EXP RES, V37, P1082, DOI 10.1111/acer.12077; Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Singh AK, 2008, J NEUROCHEM, V104, P1478, DOI 10.1111/j.1471-4159.2007.05094.x; Singh AK, 2007, ALCOHOL, V41, P591, DOI 10.1016/j.alcohol.2007.08.003; Stickel F, 2010, BEST PRACT RES CL GA, V24, P683, DOI 10.1016/j.bpg.2010.07.003; Sun R, 2006, HEPATOLOGY, V44, P955, DOI 10.1002/hep.21344; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Szabo G, 2011, WORLD J GASTROENTERO, V17, P2500, DOI 10.3748/wjg.v17.i20.2500; Thakur V, 2007, J GASTROEN HEPATOL, V22, pS53, DOI 10.1111/j.1440-1746.2006.04650.x; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, pG625, DOI 10.1152/ajpgi.00350.2009; Zhou Z, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-109	70	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140498	10.1371/journal.pone.0140498	http://dx.doi.org/10.1371/journal.pone.0140498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484872	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100039
J	Harskamp-van Ginkel, MW; London, SJ; Magnus, MC; Gademan, MG; Vrijkotte, TG				Harskamp-van Ginkel, Margreet W.; London, Stephanie J.; Magnus, Maria C.; Gademan, Maaike G.; Vrijkotte, Tanja G.			A Study on Mediation by Offspring BMI in the Association between Maternal Obesity and Child Respiratory Outcomes in the Amsterdam Born and Their Development Study Cohort	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; PREPREGNANCY OBESITY; PREGNANCY; ASTHMA; RISK; OVERWEIGHT; DISEASES; ORIGINS; PROFILE; WHEEZE	Background A causal relationship between maternal obesity and offspring asthma is hypothesized to begin during early development, but no underlying mechanism for the found association is identified. We quantitatively examined mediation by offspring body mass index (BMI) in the association of maternal pre-pregnancy BMI on risk of asthma and wheezing during the first 7-8 years of life in a large Amsterdam born birth cohort. Methods For 3185 mother-child pairs, mothers reported maternal pre-pregnancy BMI and offspring outcomes "ever being diagnosed with asthma" and "wheezing in the past 12 months" on questionnaires. We measured offspring height and weight at age 5-6 years. We performed a multivariate log linear regression comparing outcomes in offspring of mothers with different BMI categories. For each category we quantified and tested mediation by offspring BMI and also investigated interaction by parental asthma. Results At the age of 7-8 years, 8% of the offspring ever had asthma and 7% had current wheezing. Maternal pre-pregnancy obesity was associated with higher risks of asthma (adjusted RR 2.32 (95% CI: 1.49-3.61) and wheezing (adjusted RR 2.16 (95% CI: 1.28-3.64). Offspring BMI was a mediator in the association between maternal BMI and offspring wheezing, but not for asthma. There was no interaction by parental asthma. Conclusions Maternal pre-pregnancy obesity was associated with higher risks of offspring asthma and wheezing. The association between maternal obesity and offspring wheezing was both direct and indirect (mediated) through the child's own BMI.	[Harskamp-van Ginkel, Margreet W.; Gademan, Maaike G.; Vrijkotte, Tanja G.] Acad Med Ctr, Dept Publ Hlth, NL-1100 DD Amsterdam, Netherlands; [London, Stephanie J.] NIEHS, Epidemiol Branch, NIH, Dept Hlth & Human Serv, Durham, NC USA; [London, Stephanie J.] NIEHS, Lab Resp Biol, NIH, Dept Hlth & Human Serv, Durham, NC USA; [Magnus, Maria C.] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Chron Dis, Oslo, Norway	University of Amsterdam; Academic Medical Center Amsterdam; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Norwegian Institute of Public Health (NIPH)	Vrijkotte, TG (corresponding author), Acad Med Ctr, Dept Publ Hlth, POB 22660, NL-1100 DD Amsterdam, Netherlands.	t.vrijkotte@amc.uva.nl	London, Stephanie/C-3734-2019	London, Stephanie/0000-0003-4911-5290; Vrijkotte, Tanja/0000-0003-3641-4048; Harskamp-van Ginkel, Margreet/0000-0001-8792-6663	Netherlands Organization for Health Research and Development (ZonMW) [40-00812-98-11010]; Academic Medical Center, Amsterdam; Public Health Service Amsterdam, Amsterdam; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [ZO1 ES49019]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049019] Funding Source: NIH RePORTER	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Academic Medical Center, Amsterdam; Public Health Service Amsterdam, Amsterdam; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Netherlands Organization for Health Research and Development (ZonMW, TOPgrant: 40-00812-98-11010), the Academic Medical Center, Amsterdam and the Public Health Service Amsterdam, Amsterdam. Dr. London is supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (ZO1 ES49019).	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Caudri D, 2013, CLIN EXP ALLERGY, V43, P1395, DOI 10.1111/cea.12173; Chen YC, 2013, OBES REV, V14, P222, DOI 10.1111/j.1467-789X.2012.01055.x; de Vries A, 2014, J DEV ORIG HLTH DIS, V25, P1; Dekkers JC, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-69; Duijts L, 2014, EUR J EPIDEMIOL, V29, P871, DOI 10.1007/s10654-014-9981-5; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Forno E, 2014, PEDIATRICS, V134, pE535, DOI 10.1542/peds.2014-0439; Granell R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001669; Guerra S, 2013, PAEDIATR PERINAT EP, V27, P100, DOI 10.1111/ppe.12013; Haberg SE, 2009, PAEDIATR PERINAT EP, V23, P352, DOI 10.1111/j.1365-3016.2009.01034.x; Harpsoe MC, 2013, J ALLERGY CLIN IMMUN, V131, P1033, DOI 10.1016/j.jaci.2012.09.008; Hayes A. F., 2013, BRIT J MATH STAT PSY; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hersoug LG, 2007, ALLERGY, V62, P1205, DOI 10.1111/j.1398-9995.2007.01506.x; Kumar R, 2010, PEDIAT ALLER IMM PUL, V23, P183, DOI 10.1089/ped.2010.0032; Leermakers ETM, 2013, EUR RESPIR J, V42, P1234, DOI 10.1183/09031936.00148212; Lowe A, 2011, J ALLERGY CLIN IMMUN, V128, P1107, DOI 10.1016/j.jaci.2011.08.025; Moller LM, 2012, BR J NUTR, P1; Papachatzi E, 2013, J Neonatal Perinatal Med, V6, P203, DOI 10.3233/NPM-1370313; Papoutsakis C, 2013, J ACAD NUTR DIET, V113, P77, DOI 10.1016/j.jand.2012.08.025; PARKER DJP, 1992, J EPIDEMIOL COMMUN H, V46, P8, DOI 10.1136/jech.46.1.8; Patel SP, 2012, J EPIDEMIOL COMMUN H, V66, P809, DOI 10.1136/jech.2011.133777; Pike KC, 2013, THORAX, V68, P372, DOI 10.1136/thoraxjnl-2012-202556; Reichman NE, 2008, MATERN CHILD HLTH J, V12, P725, DOI 10.1007/s10995-007-0292-2; Scholtens S, 2010, INT J OBESITY, V34, P606, DOI 10.1038/ijo.2009.194; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Tromp M, 2009, PAEDIATR PERINAT EP, V23, P264, DOI 10.1111/j.1365-3016.2009.01030.x; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Vidmar S, 2004, STATA J, V4, P50, DOI 10.1177/1536867X0100400104; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; Weiss ST, 2005, NAT IMMUNOL, V6, P537, DOI 10.1038/ni0605-537; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Willeboordse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077574; World Health Organization, 2014, BMI CLASSIFICATION; Wright RJ, 2013, AM J RESP CRIT CARE, V187, P1186, DOI 10.1164/rccm.201208-1530OC	39	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140641	10.1371/journal.pone.0140641	http://dx.doi.org/10.1371/journal.pone.0140641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485533	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100055
J	Li, K; Gesang, LB; Dan, Z; Gusang, LM; Dawa, C; Nie, YQ				Li, Kang; Gesang, Luobu; Dan, Zeng; Gusang, Lamu; Dawa, Ciren; Nie, Yuqiang			Transcriptome Reveals 1400-Fold Upregulation of APOA4-APOC3 and 1100-Fold Downregulation of GIF in the Patients with Polycythemia-Induced Gastric Injury	PLOS ONE			English	Article							APOLIPOPROTEIN-A-IV; ACID-SECRETION; POLYMORPHISM; RATS; LIPOPROTEIN; CONSENSUS; PROFILES; BEDSIDE; DISEASE; MUCOSA	High-altitude polycythemia (HAPC) inducing gastric mucosal lesion (GML) is still out of control and molecular mechanisms remain widely unknown. To address the issues, endoscopy and histopathological analyses were performed. Meanwhile, microarray-based transcriptome profiling was conducted in the gastric mucosa from 3 pairs of healthy subjects and HAPC-induced GML patients. HAPC caused morphological changes and pathological damages of the gastric mucosa of GML patients. A total of 10304 differentially expressed genes (DEGs) were identified, including 4941 up-regulated and 5363 down-regulated DEGs in gastric mucosa of GML patients compared with healthy controls (fold change >= 2, P< 0.01 and FDR < 0.01). Particularly, apolipoprotein genes APOA4 and APOC3 were 1473-fold and 1468-fold up-regulated in GML patients compared with the controls. In contrast, gastric intrinsic factor (GIF) was 1102-fold down-regulated in GML patients compared with the controls. APOA4 (chr11:116691770-116691711), APOC3 (chr11:116703530-116703589) and GIF (chr11:59603362-59603303) genes are all located on chromosome 11. APOA4 and APOC3 act as an inhibitor of gastric acid secretion while gastric acid promotes ulceration. GIF deficiency activates a program of acute anemia, which may antagonize polycythemia while polycythemia raises the risk of GML. Therefore, the present findings reveal that HAPC-induced GML inspires the protection responses by up-regulating APOA4 and APOC3, and down-regulating GIF. These results may offer the basic information for the treatment of HAPC-induced gastric lesion in the future.	[Li, Kang; Gesang, Luobu] Peoples Hosp Tibet Autonomous Reg, High Altitude Med Res Inst, Lhasa 850000, Peoples R China; [Li, Kang; Dan, Zeng] Peoples Hosp Tibet Autonomous Reg, Dept Gastroenterol, Lhasa 850000, Peoples R China; [Gesang, Luobu; Gusang, Lamu; Dawa, Ciren] Peoples Hosp Tibet Autonomous Reg, Dept Cardiol, Lhasa 850000, Peoples R China; [Nie, Yuqiang] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Gastroenterol, Guangzhou 510180, Guangdong, Peoples R China	Guangzhou Medical University	Li, K (corresponding author), Peoples Hosp Tibet Autonomous Reg, High Altitude Med Res Inst, Lhasa 850000, Peoples R China.	likang820@aliyun.com; nieyqiang@sina.com			National "Twelfth Five-Year" Plan for Science & Technology Support of China [2013BAI05B04]; Key project for Natural Science Foundation in Tibet Autonomous Region, China	National "Twelfth Five-Year" Plan for Science & Technology Support of China; Key project for Natural Science Foundation in Tibet Autonomous Region, China	This study was supported by a grant from the National "Twelfth Five-Year" Plan for Science & Technology Support of China (2013BAI05B04) and the Key project for Natural Science Foundation in Tibet Autonomous Region, China (2012).	Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; ANTONARAKIS SE, 1988, HUM GENET, V80, P265, DOI 10.1007/BF01790095; Chu XQ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031505; D'Argenio G, 2008, BRIT J NUTR, V100, P1228, DOI 10.1017/S0007114508988747; DVORIN E, 1986, J BIOL CHEM, V261, P5714; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; Fang JY, 2007, J DIGEST DIS, V8, P107, DOI 10.1111/j.1443-9573.2007.00295.x; GUTH PH, 1992, YALE J BIOL MED, V65, P677; Hosseini-Esfahani F, 2014, J NUTRIGENET NUTRIGE, V7, P105, DOI 10.1159/000365445; Jiang CH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-701; Kamiya A, 2015, CURR OPIN GASTROEN, V31, P233, DOI 10.1097/MOG.0000000000000180; KURATA JH, 1989, GASTROENTEROLOGY, V96, P569, DOI 10.1016/S0016-5085(89)80052-6; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Leon-Velarde F, 2005, HIGH ALT MED BIOL, V6, P147, DOI 10.1089/ham.2005.6.147; LLOYD KCK, 1993, AM J PHYSIOL, V264, pG659, DOI 10.1152/ajpgi.1993.264.4.G659; Lo CMC, 2012, ENDOCRINOLOGY, V153, P5857, DOI 10.1210/en.2012-1427; Manninen P, 2015, SCAND J GASTROENTERO, V50, P423, DOI 10.3109/00365521.2014.946085; MARCUARD SP, 1989, DIGEST DIS SCI, V34, P1238, DOI 10.1007/BF01537272; Martin D, 2008, POSTGRAD MED J, V84, P622, DOI 10.1136/pgmj.2008.068296; Mendivil CO, 2010, ARTERIOSCL THROM VAS, V30, P239, DOI 10.1161/ATVBAHA.109.197830; OKUMURA T, 1995, GASTROENTEROLOGY, V109, P1583, DOI 10.1016/0016-5085(95)90647-9; Recalde D, 2004, ARTERIOSCL THROM VAS, V24, P756, DOI 10.1161/01.ATV.0000119353.03690.22; Russo GT, 2001, ATHEROSCLEROSIS, V158, P173, DOI 10.1016/S0021-9150(01)00409-9; SACHS G, 1976, J BIOL CHEM, V251, P7690; Singh Namrata, 2008, Trop Gastroenterol, V29, P26; Syam Ari F, 2011, Acta Med Indones, V43, P243; Toptas B, 2011, IN VIVO, V25, P425; Vador N, 2012, INDIAN J PHARM SCI, V74, P387, DOI 10.4103/0250-474X.108413; VARNER AA, 1980, GASTROENTEROLOGY, V79, P873; Yoshida Masashi, 2002, Keio J Med, V51, P193; Zhao G B, 1991, Zhonghua Nei Ke Za Zhi, V30, P492; Zhao G B, 1989, Zhonghua Nei Ke Za Zhi, V28, P529; Zhao GB, 1989, ZHONGHUA NEI KE ZA Z, V28, P71; Zhao GB, 1991, ZHONGHUA NEI KE ZA Z, V30, P521	34	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140534	10.1371/journal.pone.0140534	http://dx.doi.org/10.1371/journal.pone.0140534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485402	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100043
J	Wang, WJ; Cheng, W; Luo, M; Yan, QY; Yu, HM; Li, Q; Cao, DD; Huang, SF; Xu, AL; Mariuzza, RA; Chen, YX; Zhou, CZ				Wang, Wen-Jie; Cheng, Wang; Luo, Ming; Yan, Qingyu; Yu, Hong-Mei; Li, Qiong; Cao, Dong-Dong; Huang, Shengfeng; Xu, Anlong; Mariuzza, Roy A.; Chen, Yuxing; Zhou, Cong-Zhao			Activity Augmentation of Amphioxus Peptidoglycan Recognition Protein BbtPGRP3 via Fusion with a Chitin Binding Domain	PLOS ONE			English	Article							URTICA-DIOICA AGGLUTININ; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENOMIC ANALYSIS; CLASS-I; PATTERN; RECEPTOR; PHAGOCYTOSIS; COMPLEXITY; SIMILARITY	Peptidoglycan recognition proteins (PGRPs), which have been identified in most animals, are pattern recognition molecules that involve antimicrobial defense. Resulting from extraordinary expansion of innate immune genes, the amphioxus encodes many PGRPs of diverse functions. For instance, three isoforms of PGRP encoded by Branchiostoma belcheri tsingtauense, termed BbtPGRP1 similar to 3, are fused with a chitin binding domain (CBD) at the N-terminus. Here we report the 2.7 angstrom crystal structure of BbtPGRP3, revealing an overall structure of an N-terminal hevein-like CBD followed by a catalytic PGRP domain. Activity assays combined with site-directed mutagenesis indicated that the individual PGRP domain exhibits amidase activity towards both DAP-type and Lys-type peptidoglycans (PGNs), the former of which is favored. The N-terminal CBD not only has the chitin-binding activity, but also enables BbtPGRP3 to gain a five-fold increase of amidase activity towards the Lys-type PGNs, leading to a significantly broadened substrate spectrum. Together, we propose that modular evolution via domain shuffling combined with gene horizontal transfer makes BbtPGRP1 similar to 3 novel PGRPs of augmented catalytic activity and broad recognition spectrum.	[Wang, Wen-Jie; Cheng, Wang; Luo, Ming; Yu, Hong-Mei; Li, Qiong; Cao, Dong-Dong; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Wang, Wen-Jie; Cheng, Wang; Luo, Ming; Yu, Hong-Mei; Li, Qiong; Cao, Dong-Dong; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Innovat Ctr Cell Signaling Network, Hefei 230026, Anhui, Peoples R China; [Yan, Qingyu; Huang, Shengfeng; Xu, Anlong] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD USA; [Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University; University System of Maryland; University of Maryland College Park	Chen, YX (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	cyxing@ustc.edu.cn; zcz@ustc.edu.cn	Chen, Yuxing/P-4156-2014; Zhou, Cong-Zhao/E-9174-2011; yan, qing/GZN-2287-2022	Chen, Yuxing/0000-0002-7560-1922; Zhou, Cong-Zhao/0000-0002-6881-7151; Cao, Dongdong/0000-0002-2031-9321	Ministry of Science and Technology of China [2013CB835300, 2014CB910100]; Hefei Science Center of CAS [2015SRG-HSC045, 2015SRG-HSC046]; Program for Changjiang Scholars and Innovative Research Team in University	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Hefei Science Center of CAS; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was funded by the project 2013CB835300 and 2014CB910100 from the Ministry of Science and Technology of China (http://www.most.gov.cn/), the Scientific Research Grants 2015SRG-HSC045 and 2015SRG-HSC046 from Hefei Science Center of CAS (http://www.cas.cn/), and the Program for Changjiang Scholars and Innovative Research Team in University [http://www.moe.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Destoumieux D, 2000, J CELL SCI, V113, P461; Dishaw LJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-78; DOOLITTLE RF, 1993, SCI AM, V269, P50, DOI 10.1038/scientificamerican1093-50; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii T, 2004, ACTA CRYSTALLOGR D, V60, P665, DOI 10.1107/S090744490400232X; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guan RJ, 2006, PROTEIN SCI, V15, P1199, DOI 10.1110/ps.062077606; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Harata K, 2001, ACTA CRYSTALLOGR D, V57, P1513, DOI 10.1107/S090744490101232X; HAWKINS AR, 1995, EUR J BIOCHEM, V232, P7, DOI 10.1111/j.1432-1033.1995.tb20775.x; Hayashida M, 2003, J MOL BIOL, V334, P551, DOI 10.1016/j.jmb.2003.09.076; Hemmi H, 2003, J BIOL CHEM, V278, P22820, DOI 10.1074/jbc.M301025200; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Huang SF, 2011, J IMMUNOL, V186, P2042, DOI 10.4049/jimmunol.1001824; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jimenez-Barbero J, 2006, ADV CARBOHYD CHEM BI, V60, P303, DOI 10.1016/S0065-2318(06)60007-3; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253; Kezuka Y, 2010, PROTEINS, V78, P2295, DOI 10.1002/prot.22742; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; LLC S, 2010, PYMOL MOL GRAPHICS S; Martinez-Caballero S, 2014, FEBS J, V281, P4535, DOI 10.1111/febs.12962; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mellroth P, 2006, BIOCHEM BIOPH RES CO, V350, P994, DOI 10.1016/j.bbrc.2006.09.139; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osaki T, 1999, J BIOL CHEM, V274, P26172, DOI 10.1074/jbc.274.37.26172; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JW, 2006, J BIOL CHEM, V281, P7747, DOI 10.1074/jbc.M510058200; Patthy L, 1996, MATRIX BIOL, V15, P301, DOI 10.1016/S0945-053X(96)90131-6; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Saul FA, 2000, STRUCTURE, V8, P593, DOI 10.1016/S0969-2126(00)00142-8; Schwefel D, 2010, J AM CHEM SOC, V132, P8704, DOI 10.1021/ja101646k; Shen ZC, 1999, J MOL EVOL, V48, P341, DOI 10.1007/PL00006478; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Sumathipala N, 2010, INSECT BIOCHEM MOLEC, V40, P487, DOI 10.1016/j.ibmb.2010.04.008; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Velikovsky CA, 2009, NAT STRUCT MOL BIOL, V16, P725, DOI 10.1038/nsmb.1619; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; WRIGHT CS, 1990, J MOL BIOL, V215, P635, DOI 10.1016/S0022-2836(05)80174-3; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; ZHOU RQ, 1988, ANAL BIOCHEM, V171, P141, DOI 10.1016/0003-2697(88)90134-0	65	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140953	10.1371/journal.pone.0140953	http://dx.doi.org/10.1371/journal.pone.0140953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479246	Green Submitted, Green Published, gold			2022-12-27	WOS:000363026600027
J	Ramirez-Velez, R; Rodrigues-Bezerra, D; Correa-Bautista, JE; Izquierdo, M; Lobelo, F				Ramirez-Velez, Robinson; Rodrigues-Bezerra, Diogo; Enrique Correa-Bautista, Jorge; Izquierdo, Mikel; Lobelo, Felipe			Reliability of Health-Related Physical Fitness Tests among Colombian Children and Adolescents: The FUPRECOL Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; ANTHROPOMETRIC MEASUREMENTS; CARDIORESPIRATORY FITNESS; METABOLIC RISK; SHUTTLE RUN; JUMP; HARMONIZATION; MULTICENTER; CHILDHOOD; STRENGTH	Substantial evidence indicates that youth physical fitness levels are an important marker of lifestyle and cardio-metabolic health profiles and predict future risk of chronic diseases. The reliability physical fitness tests have not been explored in Latino-American youth population. This study's aim was to examine the reliability of health-related physical fitness tests that were used in the Colombian health promotion "Fuprecol study". Participants were 229 Colombian youth (boys n = 124 and girls n = 105) aged 9 to 17.9 years old. Five components of health-related physical fitness were measured: 1) morphological component: height, weight, body mass index (BMI), waist circumference, triceps skinfold, subscapular skinfold, and body fat (%) via impedance; 2) musculoskeletal component: handgrip and standing long jump test; 3) motor component: speed/agility test (4x10 m shuttle run); 4) flexibility component (hamstring and lumbar extensibility, sit-and-reach test); 5) cardiorespiratory component: 20-meter shuttle-run test (SRT) to estimate maximal oxygen consumption. The tests were performed two times, 1 week apart on the same day of the week, except for the SRT which was performed only once. Intra-observer technical errors of measurement (TEMs) and inter-rater (reliability) were assessed in the morphological component. Reliability for the Musculoskeletal, motor and cardiorespiratory fitness components was examined using Bland-Altman tests. For the morphological component, TEMs were small and reliability was greater than 95% of all cases. For the musculoskeletal, motor, flexibility and cardiorespiratory components, we found adequate reliability patterns in terms of systematic errors (bias) and random error (95% limits of agreement). When the fitness assessments were performed twice, the systematic error was nearly 0 for all tests, except for the sit and reach (mean difference: -1.03% [95% CI = -4.35% to -2.28%]. The results from this study indicate that the "Fuprecol study" health-related physical fitness battery, administered by physical education teachers, was reliable for measuring health-related components of fitness in children and adolescents aged 9-17.9 years old in a school setting in Colombia.	[Ramirez-Velez, Robinson; Rodrigues-Bezerra, Diogo; Enrique Correa-Bautista, Jorge] Univ Rosario, Escuela Med & Ciencias Salud, Ctr Estudios Med Actividad Fis CEMA, Bogota, DC, Colombia; [Ramirez-Velez, Robinson; Izquierdo, Mikel] Univ Santo Tomas, Fac Cultura Fis Deporte & Recreac, Grp GICAEDS, Bogota, DC, Colombia; [Izquierdo, Mikel] Univ Publ Navarra, Dept Hlth Sci, Pamplona, Spain; [Lobelo, Felipe] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Universidad del Rosario; Universidad Santo Tomas USTA; Universidad Publica de Navarra; Emory University; Rollins School Public Health	Ramirez-Velez, R (corresponding author), Univ Rosario, Escuela Med & Ciencias Salud, Ctr Estudios Med Actividad Fis CEMA, Bogota, DC, Colombia.	robin640@hotmail.com	Lobelo, R.L Felipe/AAB-2264-2021; Ramírez-Vélez, Robinson/D-5311-2016; Izquierdo, Mikel/O-8049-2019; Correa-Bautista, Jorge Enrique/N-2741-2015; Izquierdo, Mikel/A-4894-2010	Lobelo, R.L Felipe/0000-0003-4185-7193; Ramírez-Vélez, Robinson/0000-0003-3075-6960; Correa-Bautista, Jorge Enrique/0000-0002-0646-2316; Izquierdo, Mikel/0000-0002-1506-4272; Castro-Reina, Andres/0000-0002-0607-5076	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" COLCIENCIAS [671-2014, 122265743978]	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	The "Fuprecol Study" was carried out with the financial support of Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" COLCIENCIAS (Contract No 671-2014 Code 122265743978). The authors are grateful to the Bogota District Education Secretary for the data used in this study. The authors also thank the participating Bogota District students, teachers, schools, and staff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artero EG, 2011, INT J SPORTS MED, V32, P159, DOI 10.1055/s-0030-1268488; Australian Council for Health Physical Education and Recreation (ACHPER), 1996, HDB AUSTR FITN ED AW; Beets M. W., 2006, J PHYS ACTIVITY H S2, V3, pS21; Bianco A, 2015, INT J OCCUP MED ENV, V28, P445, DOI 10.13075/ijomeh.1896.00393; Buchan DS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-498; Canadian Society for Exercise Physiology, 2003, CAN PHYS ACT FITN LI; Caprio S, 2008, DIABETES CARE, V31, P2211, DOI 10.2337/dc08-9024; Castro-Pinero J, 2009, INT J SPORTS MED, V30, P366, DOI 10.1055/s-0028-1105934; Castro-Pinero J, 2010, J STRENGTH COND RES, V24, P1810, DOI 10.1519/JSC.0b013e3181ddb03d; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cooper Institute for Aerobics Research, 2004, PRUD FITN TEST ADM M; Council of Europe Committee forthe Development of Sport, 1993, EUROFIT HDB EUROFIT; De Miguel-Etayo P, 2014, OBES REV, V15, P67, DOI 10.1111/obr.12181; Departamento Administrative Nacional de Estadfstica (DANE), 2007, LOS GRUP ETN COL CEN; Dumith SC, 2012, J SPORT MED PHYS FIT, V52, P181; Eisenmann JC, 2007, ACTA PAEDIATR, V96, P1723, DOI 10.1111/j.1651-2227.2007.00534.x; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Espana-Romero V, 2010, INT J SPORTS MED, V31, P490, DOI 10.1055/s-0030-1251990; Garcia S, 2012, PUBLIC HEALTH NUTR, V13, P1; Gomez-Cabello A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041752; Gonzalez SA, 2014, J PHYS ACT HEALTH, V11, pS33, DOI 10.1123/jpah.2014-0170; Grontved A, 2015, BRIT J SPORT MED, V49, P90, DOI 10.1136/bjsports-2012-091907; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; HARTMAN J. G., 2003, MEASUREMENT IN PHYSI, V7, P71, DOI DOI 10.1207/S15327841MPEE0702_2; Hurtig-Wennlof A, 2007, EUR J CARDIOV PREV R, V14, P575, DOI 10.1097/HJR.0b013e32808c67e3; Kaminsky LA, 2013, CIRCULATION, V127, P652, DOI 10.1161/CIR.0b013e31827ee100; Kelishadi R, 2007, INT J CARDIOL, V117, P340, DOI 10.1016/j.ijcard.2006.06.012; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; LIU NYS, 1992, RES Q EXERCISE SPORT, V63, P360, DOI 10.1080/02701367.1992.10608757; Lopez AD, 2006, GLOBAL BURDEN DIS RI; Moir G, 2008, J STRENGTH COND RES, V22, P1779, DOI 10.1519/JSC.0b013e318185f0df; Moreno LA, 2003, NUTRITION, V19, P481, DOI 10.1016/S0899-9007(03)00040-6; Nagy E, 2008, INT J OBESITY, V32, pS58, DOI 10.1038/ijo.2008.184; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Nuzzo JL, 2011, J STRENGTH COND RES, V25, P2580, DOI 10.1519/JSC.0b013e3181fee650; Ortega FB, 2008, INT J OBESITY, V32, pS49, DOI 10.1038/ijo.2008.183; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2011, MED SCI SPORT EXER, V43, P1891, DOI 10.1249/MSS.0b013e3182190d71; Parra DC, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-014-0057-5; Pitetti KH, 2002, PEDIATR EXERC SCI, V14, P125, DOI 10.1123/pes.14.2.125; Pratt M, 2014, BRIT J SPORT MED, V48, P171, DOI 10.1136/bjsports-2012-091810; ROBERTSON DGE, 1987, CAN J SPORT SCI, V12, P19; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341; Santos EJAM, 2012, J STRENGTH COND RES, V26, P2641, DOI 10.1519/JSC.0b013e31823f8dd4; Steene-Johannessen J, 2009, MED SCI SPORT EXER, V41, P1361, DOI 10.1249/MSS.0b013e31819aaae5; Stomfai S, 2011, INT J OBESITY, V35, pS45, DOI 10.1038/ijo.2011.34; Ulijaszek S. J., 1994, ANTHROPOMETRY INDIVI, P30, DOI DOI 10.1017/CBO9780511600500.004; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Vanhelst J, 2016, CLIN PHYSIOL FUNCT I, V36, P106, DOI 10.1111/cpf.12202	51	84	87	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140875	10.1371/journal.pone.0140875	http://dx.doi.org/10.1371/journal.pone.0140875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474474	gold, Green Submitted, Green Published			2022-12-27	WOS:000363185500123
J	Flegr, J; Hoffmann, R; Dammann, M				Flegr, Jaroslav; Hoffmann, Rudolf; Dammann, Mike			Worse Health Status and Higher Incidence of Health Disorders in Rhesus Negative Subjects	PLOS ONE			English	Article							RHD MOLECULE; TOXOPLASMA; POLYMORPHISM; PROTEINS; WOMEN	Rhesus-positive and Rhesus-negative persons differ in the presence-absence of highly immunogenic RhD protein on the erythrocyte membrane. The biological function of the RhD molecule is unknown. Its structure suggests that the molecular complex with RhD protein transports NH3 or CO2 molecules across the erythrocyte cell membrane. Some data indicate that RhD positive and RhD negative subjects differ in their tolerance to certain biological factors, including, Toxoplasma infection, aging and fatique. Present cross sectional study performed on 3,130 subjects) showed that Rhesus negative subjects differed in many indices of their health status, including incidences of many disorders. Rhesus negative subjects reported to have more frequent allergic, digestive, heart, hematological, immunity, mental health, and neurological problems. On the population level, a Rhesus-negativity-associated burden could be compensated for, for example, by the heterozygote advantage, but for Rhesus negative subjects this burden represents a serious problem.	[Flegr, Jaroslav; Dammann, Mike] Charles Univ Prague, Fac Sci, Div Biol, Prague, Czech Republic; [Hoffmann, Rudolf] Homolce Hosp, Dept Hematol, Prague, Czech Republic	Charles University Prague; Na Homolce Hospital	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Div Biol, Prague, Czech Republic.	flegr@cesnet.cz	Flegr, Jaroslav/AAG-7568-2021; Flegr, Jaroslav/A-1564-2008	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126	Czech Science Foundation [P303/11/1398]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by Czech Science Foundation (project No. P303/11/1398). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1954, T ROY SOC TROP MED H, V48, P312, DOI 10.1016/0035-9203(54)90101-7; Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; FELDMAN MW, 1969, AM J HUM GENET, V21, P171; Fisher RA, 1944, NATURE, V153, P106, DOI 10.1038/153106b0; Flegel WA, 2011, TRANSFUS APHER SCI, V44, P81, DOI 10.1016/j.transci.2010.12.013; Flegr J, 2013, PLOS ONE, P8; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049478; Flegr J, 2010, FOLIA PARASIT, V57, P143, DOI 10.14411/fp.2010.018; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Guthrie KA, 2001, J ROY STAT SOC A STA, V164, P141, DOI 10.1111/1467-985X.00193; Haldane JBS, 1942, EUGENICS, V11, P333; Hogben L, 1943, NATURE, V152, P721, DOI 10.1038/152721c0; Kankova S, 2010, PARASITOLOGY, V137, P1773, DOI 10.1017/S0031182010000661; Kankova S, 2015, FOLIA PARASIT, P62; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Kustu S, 2006, TRANSFUS CLIN BIOL, V13, P103, DOI 10.1016/j.tracli.2006.03.001; Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002; LI CC, 1953, AM NAT, V87, P257, DOI 10.1086/281782; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Prandota J., 2012, NEUROINFLAMMATION PA, P423; Siegel S, 1988, NONPARAMETRIC STAT B, Vxxiii; Wagner FF, 2000, BLOOD, V95, P3662; Wakefield J, 2001, J R STAT SOC A STAT, V164, P119, DOI 10.1111/1467-985X.00191	24	17	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141362	10.1371/journal.pone.0141362	http://dx.doi.org/10.1371/journal.pone.0141362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495842	gold, Green Submitted, Green Published			2022-12-27	WOS:000363309200103
J	Liu, PF; Cai, JL; Dong, DL; Chen, YY; Liu, XB; Wang, Y; Zhou, YL				Liu, Pengfei; Cai, Jinglei; Dong, Delu; Chen, Yaoyu; Liu, Xiaobo; Wang, Yi; Zhou, Yulai			Effects of SOX2 on Proliferation, Migration and Adhesion of Human Dental Pulp Stem Cells	PLOS ONE			English	Article							CANCER CELLS; DIFFERENTIATION; OVEREXPRESSION; EXPRESSION; PLURIPOTENCY; INDUCTION; PROMOTES; INVASION; IMPROVES; PATHWAY	As a key factor for cell pluripotent and self-renewing phenotypes, SOX2 has attracted scientists' attention gradually in recent years. However, its exact effects in dental pulp stem cells (DPSCs) are still unclear. In this study, we mainly investigated whether SOX2 could affect some biological functions of DPSCs. DPSCs were isolated from the dental pulp of human impacted third molar. SOX2 overexpressing DPSCs (DPSCs-SOX2) were established through retroviral infection. The effect of SOX2 on cell proliferation, migration and adhesion ability was evaluated with CCK-8, trans-well system and fibronectin-induced cell attachment experiment respectively. Whole genome expression of DPSCs-SOX2 was analyzed with RNA microarray. Furthermore, a rescue experiment was performed with SOX2-siRNA in DPSC-SOX2 to confirm the effect of SOX2 overexpression in DPSCs. We found that SOX2 overexpression could result in the enhancement of cell proliferation, migration, and adhesion in DPSCs obviously. RNA microarray analysis indicated that some key genes in the signal pathways associated with cell cycle, migration and adhesion were upregulated in different degree, and the results were further confirmed with qPCR and western-blot. Finally, DPSC-SOX2 transfected with SOX2-siRNA showed a decrease of cell proliferation, migration and adhesion ability, which further confirmed the biological effect of SOX2 in human DPSCs. This study indicated that SOX2 could improve the cell proliferation, migration and adhesion ability of DPSCs through regulating gene expression about cell cycle, migration and adhesion, and provided a novel strategy to develop seed cells with strong proliferation, migration and adhesion ability for tissue engineering.	[Liu, Pengfei; Dong, Delu; Chen, Yaoyu; Liu, Xiaobo; Wang, Yi; Zhou, Yulai] Jilin Univ, Sch Pharmaceut Sci, Dept Regenerat Med, Changchun 130023, Peoples R China; [Liu, Pengfei; Cai, Jinglei; Chen, Yaoyu; Liu, Xiaobo] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China	Jilin University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Zhou, YL (corresponding author), Jilin Univ, Sch Pharmaceut Sci, Dept Regenerat Med, Changchun 130023, Peoples R China.	zhouyl@jlu.edu.cn			National Natural Science Foundation of China [81570944]; Graduate Innovation Fund of Jilin University [2015009]; Guangzhou science and technology program [201505011555341]; Science and Technology Development Project of Jilin Province [20120955]; Scientific Research of Health Department of Jilin Province [2009Z043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Innovation Fund of Jilin University(Jilin University); Guangzhou science and technology program; Science and Technology Development Project of Jilin Province; Scientific Research of Health Department of Jilin Province	This study was supported by the grants from the National Natural Science Foundation of China (81570944), Project (No. 2015009) supported by Graduate Innovation Fund of Jilin University, Guangzhou science and technology program project (201505011555341), Science and Technology Development Project of Jilin Province (No. 20120955), and Scientific Research of Health Department of Jilin Province (No. 2009Z043).	Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Cheng K, 2013, EXP MOL PATHOL, V94, P466, DOI 10.1016/j.yexmp.2013.03.002; Conde MCM, 2012, INT ENDOD J, V45, P266, DOI 10.1111/j.1365-2591.2011.01971.x; d'Aquino R, 2009, J EXP ZOOL PART B, V312B, P408, DOI 10.1002/jez.b.21263; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fan YX, 2013, GENET MOL RES, V12, P6067, DOI 10.4238/2013.December.2.5; Galler KM, 2016, INT ENDOD J, V49, P581, DOI 10.1111/iej.12492; Gao F, 2015, CELL BIOCHEM BIOPHYS, V71, P481, DOI 10.1007/s12013-014-0228-6; Go MJ, 2008, EXP CELL RES, V314, P1147, DOI 10.1016/j.yexcr.2007.11.021; Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13, DOI 10.1177/154411130401500103; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Han SM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.28; Hendriks S, 2015, HUM REPROD UPDATE, V21, P285, DOI 10.1093/humupd/dmv001; Hutz K, 2014, CARCINOGENESIS, V35, P942, DOI 10.1093/carcin/bgt410; Jayaraman P, 2015, CLIN ORAL INVEST, DOI [10.l007/s00784-015-1497-1, DOI 10.L007/S00784-015-1497-1]; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; La Noce M, 2014, J DENT, V42, P761, DOI 10.1016/j.jdent.2014.02.018; Lewis S, 2013, NAT REV NEUROSCI, V14, P78, DOI [DOI 10:1038/NRN3432, 10.1038/nrn3432]; Lin F, 2012, CELL PROLIFERAT, V45, P207, DOI 10.1111/j.1365-2184.2012.00812.x; Liu JJ, 2015, STEM CELLS, V33, P627, DOI 10.1002/stem.1909; Liu L, 2015, STEM CELLS DEV, V24, P962, DOI 10.1089/scd.2014.0388; Liu L, 2011, J ENDODONT, V37, P466, DOI 10.1016/j.joen.2010.12.012; Liu NM, 2013, J CELL BIOCHEM, V114, P2677, DOI 10.1002/jcb.24615; Liu PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097123; Liu PF, 2013, LIFE SCI, V92, P829, DOI 10.1016/j.lfs.2013.02.016; Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335; Majchrzak K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076789; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuzawa M, 2015, J PERIODONTAL RES, V50, P855, DOI 10.1111/jre.12277; Paino F, 2014, STEM CELLS, V32, P279, DOI 10.1002/stem.1544; Pisciotta A, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0065-x; Qin YR, 2015, CELL REPROGRAM, V17, P221, DOI 10.1089/cell.2015.0001; Qin ZJ, 2015, J ENDODONT, V41, P1066, DOI 10.1016/j.joen.2015.02.020; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Tatullo M, 2015, J TISSUE ENG REGEN M, V9, P1205, DOI 10.1002/term.1899; Tirino V, 2011, STEM CELL REV REP, V7, P608, DOI 10.1007/s12015-011-9235-9; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099594; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yang N, 2014, TUMOR BIOL, V35, P7965, DOI 10.1007/s13277-014-2045-3; Yang N, 2014, ONCOL REP, V31, P2651, DOI 10.3892/or.2014.3120; Yoon DS, 2011, CELL PROLIFERAT, V44, P428, DOI 10.1111/j.1365-2184.2011.00770.x; Zhang W, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0189-x	46	29	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141346	10.1371/journal.pone.0141346	http://dx.doi.org/10.1371/journal.pone.0141346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496354	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200098
J	Ruderman, MA; Wilson, DF; Reid, S				Ruderman, Michael A.; Wilson, Deirdra F.; Reid, Savanna			Does Prison Crowding Predict Higher Rates of Substance Use Related Parole Violations? A Recurrent Events Multi-Level Survival Analysis	PLOS ONE			English	Article							DRUG-USE; INCARCERATION; VICTIMIZATION; DETERMINANTS; STRESS; CARE	Objective This administrative data-linkage cohort study examines the association between prison crowding and the rate of post-release parole violations in a random sample of prisoners released with parole conditions in California, for an observation period of two years (January 2003 through December 2004). Background Crowding overextends prison resources needed to adequately protect inmates and provide drug rehabilitation services. Violence and lack of access to treatment are known risk factors for drug use and substance use disorders. These and other psychosocial effects of crowding may lead to higher rates of recidivism in California parolees. Methods Rates of parole violation for parolees exposed to high and medium levels of prison crowding were compared to parolees with low prison crowding exposure. Hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated using a Cox model for recurrent events. Our dataset included 13070 parolees in California, combining individual level parolee data with aggregate level crowding data for multilevel analysis. Results Comparing parolees exposed to high crowding with those exposed to low crowding, the effect sizes from greatest to least were absconding violations (HR 3.56 95% CI: 3.05-4.17), drug violations (HR 2.44 95% CI: 2.00-2.98), non-violent violations (HR 2.14 95% CI: 1.73-2.64), violent and serious violations (HR 1.88 95% CI: 1.45-2.43), and technical violations (HR 1.86 95% CI: 1.37-2.53). Conclusions Prison crowding predicted higher rates of parole violations after release from prison. The effect was magnitude-dependent and particularly strong for drug charges. Further research into whether adverse prison experiences, such as crowding, are associated with recidivism and drug use in particular may be warranted.	[Ruderman, Michael A.] Touro Univ Calif, Coll Osteopath Med, Vallejo, CA USA; [Ruderman, Michael A.; Wilson, Deirdra F.] Touro Univ Calif, Publ Hlth Program, Vallejo, CA USA; [Reid, Savanna] Univ Nevada, Dept Epidemiol, Las Vegas, NV 89154 USA	Touro University California; Touro University California; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Ruderman, MA (corresponding author), Touro Univ Calif, Coll Osteopath Med, Vallejo, CA USA.	mikeruderman@gmail.com	Ruderman, Michael/GWC-2211-2022	Ruderman, Michael/0000-0003-1169-3597				AIELLO JR, 1981, PERS SOC PSYCHOL B, V7, P643, DOI 10.1177/014616728174021; AIELLO JR, 1979, CHILD DEV, V50, P195, DOI 10.1111/j.1467-8624.1979.tb02994.x; Aiello JR, 1985, HABITATS CHILDREN IM, P97; Appelbaum PS, 2011, PSYCHIAT SERV, V62, P1121, DOI 10.1176/ps.62.10.pss6210_1121; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Awofeso N, 2012, PUB HLTH REPORTS S4, V125, P25; Baillargeon J, 2010, ADM POLICY MENT HLTH, V37, P367, DOI 10.1007/s10488-009-0252-9; Baillargeon J, 2009, PSYCHIAT SERV, V60, P1516, DOI 10.1176/appi.ps.60.11.1516; BAUM A, 1978, J PERS SOC PSYCHOL, V36, P1000, DOI 10.1037/0022-3514.36.9.1000; Baum A, 1981, COGNITION SOC BEHAV, P513; Blair C, 2011, CHILD DEV, V82, P1970, DOI 10.1111/j.1467-8624.2011.01643.x; Borucka J., 2013, SP07 PHUSE PAREXEL; Box-Steffensmeier JM, 2006, STAT MED, V25, P3518, DOI 10.1002/sim.2434; Brinkley-Rubinstein L., 2013, HEAL JUSTICE, V1, P1, DOI [10.1186/2194-7899-1-3, DOI 10.1186/2194-7899-1-3]; Bronstein N, 2015, COLUMBIA J IN PRESS, V48; California Department of Corrections and Rehabilitation (CDCR), 2010, CAL PRIS PAR; California Department of Corrections and Rehabilitation (CDCR), 2011, CORR YEAR GLANC; California State Sheriffs' Association, 2006, DO CRIM DO TIM MAYB; Chen M.K., 2007, AM LAW ECON REV, V9, P1, DOI [DOI 10.1093/ALER/AHM006, 10.1093/aler/ahm006]; CLAYTON O, 1987, J CRIM JUST, V15, P201, DOI 10.1016/0047-2352(87)90044-4; Davis LM., 2009, UNDERSTANDING PUBLIC; Deater-Deckard K, 2012, J FAM PSYCHOL, V26, P391, DOI 10.1037/a0028331; Drago F, 2011, AM LAW ECON REV, V13, P103, DOI 10.1093/aler/ahq024; Drucker E., 2013, PLAGUE PRISONS EPIDE; Edelman Marian Wright, 2007, Prev Chronic Dis, V4, pA43; Farrington DP, 1980, J CRIM JUST, V8, P221; Friedman SR, 2011, AM J PUBLIC HEALTH, V101, P344, DOI 10.2105/AJPH.2010.191759; Gaes GG, 2009, J EXP CRIMINOL, V5, P139, DOI 10.1007/s11292-009-9070-z; GAES GG, 1985, CRIME JUSTICE, V6, P95, DOI 10.1086/449105; GAES GG, 1985, J RES CRIME DELINQ, V22, P41, DOI 10.1177/0022427885022001003; Grattet R., 2009, FED PROBAT, V73, P2; Grattet R, 2010, MULTILEVAL POLICY FO; Grattet R, 2008, PAROLE VIOLATIONS RE; Grolemond G, 2011, J STAT SOFTW, V40, P1; Guo Z, 2008, METHOD INFORM MED, V47, P107, DOI 10.3414/ME0478; Hopper Allen, 2012, PUBLIC SAFETY REALIG; Horne C, 2015, J AM ACAD PSYCHIATRY, V43, P87; Iacus S, 2006, UNIMI RES PAPERS EC; Iacus Stefano M., 2012, RRP RANDOM RECURSIVE; Justice Policy Institute, 2010, SHIFT PROBL CAL PROP; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; KRUEGER DW, 1981, J HUM STRESS, V7, P3, DOI 10.1080/0097840X.1981.9936820; Kulkarni SP, 2010, J COMMUN HEALTH, V35, P268, DOI 10.1007/s10900-010-9234-9; Lahm KF, 2008, CRIM JUSTICE BEHAV, V35, P120, DOI 10.1177/0093854807308730; Lawrence S, 2012, CALIFORNIA CONTEXT D CALIFORNIA CONTEXT D; Lo CC, 2008, SUBST USE MISUSE, V43, P1340, DOI 10.1080/10826080801922157; Mallik-Kane K, 2008, HLTH PRISONER REENTR; Massoglia M, 2008, J HEALTH SOC BEHAV, V49, P56, DOI 10.1177/002214650804900105; Mayzer R, 2004, J CRIM JUST, V32, P137, DOI 10.1016/j.jcrimjus.2003.12.004; Peterson B, FACTORS RELATED PARO; Petteruti A, 2008, SUBSTANCE ABUSE TREA; Physician Leadership on National Drug Policy, 2000, PHYS LEAD NAT DRUG P; Pritikin MH, 2008, WISC LAW REV, P1049; RCore Team, 2020, R LANG ENV STAT COMP; Restum ZG, 2005, AM J PUBLIC HEALTH, V95, P1689, DOI 10.2105/AJPH.2004.055053; Rich JD, 2008, NEW ENGL J MED, V364, P2081; Seale L, 2011, 2011 ADULT I OUTCOME; Siegel L., 1992, CRIMINOLOGY; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Sinha Rajita, 2007, Curr Psychiatry Rep, V9, P388, DOI 10.1007/s11920-007-0050-6; Spector D, 2010, FEDERAL SENTENCING R, V22, P194; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SER H, VSMA 10-4609; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Ullah S, 2014, BRIT J SPORT MED, V48, P1287, DOI 10.1136/bjsports-2011-090803; United States Government Accountability Office, 2012, GAO12743; Vaughn MG, 2010, ANN EPIDEMIOL, V20, P281, DOI 10.1016/j.annepidem.2009.11.011; Visher C., 2004, RETURNING HOME UNDER; Wakefield J, 2009, INT J EPIDEMIOL, V38, P330, DOI 10.1093/ije/dyp179; Williams F. P., 2000, PRISON J, V80, P24, DOI DOI 10.1177/0032885500080001002; Wolff N, 2009, JUSTICE Q, V26, P445, DOI 10.1080/07418820802427858; Yang C, 2011, J URBAN HEALTH, V88, P1044, DOI 10.1007/s11524-011-9610-5; Young AMW, 2006, AM J PUBLIC HEALTH, V96, P589, DOI 10.2105/AJPH.2005.083691	72	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141328	10.1371/journal.pone.0141328	http://dx.doi.org/10.1371/journal.pone.0141328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZU	26492490	gold, Green Published, Green Submitted			2022-12-27	WOS:000363249300044
J	Balsamo, M; Carlucci, L; Sergi, MR; Murdock, KK; Saggino, A				Balsamo, Michela; Carlucci, Leonardo; Sergi, Maria Rita; Murdock, Karla Klein; Saggino, Aristide			The Mediating Role of Early Maladaptive Schemas in the Relation between Co-Rumination and Depression in Young Adults	PLOS ONE			English	Article							GENDER-DIFFERENCES; PSYCHOMETRIC PROPERTIES; INTERNALIZING SYMPTOMS; INTERPERSONAL STRESS; QUESTIONNAIRE; ASSOCIATIONS; ADOLESCENTS; DIFFERENCE; DISORDERS; EXPLAIN	Research on co-rumination has investigated its relationship with internalizing symptoms, but few studies have addressed underlying maladaptive cognitive-affective processes that may play an important role in the maintenance of this relation. This study examines if Young's schema domains mediate the relation between co-rumination and depression in a community sample of non-clinical young adults. Participants completed the Co-Rumination Questionnaire, Young Schema Questionnaire-L3, and Teate Depression Inventory. Correlations and path analysis were calculated for the full sample and separately by gender. The schema domains of Overvigilance/Inhibition and Other-Directedness fully mediated the relation between co-rumination and depression. When analyses were performed separately for males and females, mediation persisted only for females. Findings suggest that among young women, co-rumination with a friend may be associated with depressive symptoms because of its activation of specific maladaptive cognitive schemas. Better understanding of the content and processes underpinning co-rumination may have important implications for the prevention and treatment of depression.	[Balsamo, Michela; Carlucci, Leonardo; Sergi, Maria Rita; Saggino, Aristide] Univ G DAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy; [Murdock, Karla Klein] Washington & Lee Univ, Dept Psychol, Lexington, VA 24450 USA	G d'Annunzio University of Chieti-Pescara; Washington & Lee University	Balsamo, M (corresponding author), Univ G DAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy.	michela.balsamo@libero.it	Carlucci, Leonardo/T-7915-2018; Balsamo, Michela/AAP-1182-2020	Carlucci, Leonardo/0000-0002-9853-5606; Balsamo, Michela/0000-0001-5396-3853; SERGI, MARIA RITA/0000-0002-8821-3304				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; ANDRICH D, 1995, PSYCHOMETRIKA, V60, P37, DOI 10.1007/BF02294428; Balsamo M., 2013, TDI TEATE DEPRESSION; Balsamo M, 2016, ITAL J COGN BEHAV TE, P1; Balsamo M, 2015, J PERS ASSESS, V97, P81, DOI 10.1080/00223891.2014.947650; Balsamo M, 2014, NEUROPSYCH DIS TREAT, V10, P987, DOI 10.2147/NDT.S55706; Balsamo M, 2014, NEUROPSYCH DIS TREAT, V10, P153, DOI 10.2147/NDT.S53425; Balsamo M, 2013, J PSYCHOPATHOL BEHAV, V35, P475, DOI 10.1007/s10862-013-9354-5; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barstead MG, 2013, J SOC CLIN PSYCHOL, V32, P791, DOI 10.1521/jscp.2013.32.7.791; BECK AT, 1964, ARCH GEN PSYCHIAT, V10, P561; Byrd-Craven J, 2008, HORM BEHAV, V53, P489, DOI 10.1016/j.yhbeh.2007.12.002; Calmes CA, 2008, COGNITIVE THER RES, V32, P577, DOI 10.1007/s10608-008-9200-3; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Ciesla JA, 2011, COGNITIVE THER RES, V35, P142, DOI 10.1007/s10608-011-9355-1; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Davidson CL, 2014, PERS INDIV DIFFER, V70, P171, DOI 10.1016/j.paid.2014.07.002; Gladstone TRG, 1997, J ABNORM CHILD PSYCH, V25, P297, DOI 10.1023/A:1025712419436; Hankin BL, 2010, DEV PSYCHOPATHOL, V22, P217, DOI 10.1017/S0954579409990368; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Hoffart A, 2005, COGNITIVE THER RES, V29, P627, DOI 10.1007/s10608-005-9630-0; Hyde JS, 2008, PSYCHOL REV, V115, P291, DOI 10.1037/0033-295X.115.2.291; Innamorati M, 2013, DEPRESS RES TREAT; Jose PE, 2012, J CLIN CHILD ADOLESC, V41, P86, DOI 10.1080/15374416.2012.632346; Kenny DA, 2011, SPSS MACRO MEDTEXT; Kilduff M, 2010, ACAD MANAG ANN, V4, P317, DOI 10.1080/19416520.2010.494827; Klein KJ, 2004, ACAD MANAGE J, V47, P952, DOI 10.2307/20159634; Kline P, 2000, HDB PSYCHOMETRIC TES; Lee CW, 1999, COGNITIVE THER RES, V23, P441, DOI 10.1023/A:1018712202933; Little T. D., 2007, MODELING CONTEXTUAL; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Morrison A.P., 2007, COGNITIVE SCHEMAS CO, P177; Murdock KK, 2015, J ADOLESCENCE, V38, P27, DOI 10.1016/j.adolescence.2014.10.010; Nicolai KA, 2013, J YOUTH ADOLESCENCE, V42, P1183, DOI 10.1007/s10964-012-9866-4; Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037/0022-3514.77.5.1061; Nordahl HM, 2005, CLIN PSYCHOL PSYCHOT, V12, P142, DOI 10.1002/cpp.430; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preddy T, 2012, CAMPUS, V17, P18, DOI DOI 10.1002/ABC.21082; Rafaeli E, 2011, CBT DISTINCT FEATURE, P1; Rose AJ, 2002, CHILD DEV, V73, P1830, DOI 10.1111/1467-8624.00509; Rose AJ, 2007, DEV PSYCHOL, V43, P1019, DOI 10.1037/0012-1649.43.4.1019; Rudiger JA, 2013, BODY IMAGE, V10, P462, DOI 10.1016/j.bodyim.2013.07.010; Saggino A, 2007, ITAL J COGN BEHAV TE; Schwartz-Mette RA, 2012, DEV PSYCHOL, V48, P1355, DOI 10.1037/a0027484; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI 10.2307/270723; Starr LR, 2009, J ADOLESCENCE, V32, P19, DOI 10.1016/j.adolescence.2007.12.005; Stone LB, 2015, J ADOLESCENCE, V38, P1, DOI 10.1016/j.adolescence.2014.10.008; Stone LB, 2011, J ABNORM PSYCHOL, V120, P752, DOI 10.1037/a0023384; van Asselt ADI, 2008, BRIT J PSYCHIAT, V192, P450, DOI 10.1192/bjp.bp.106.033597; Van Vlierberghe L, 2010, COGNITIVE THER RES, V34, P316, DOI 10.1007/s10608-009-9283-5; Waller G, 2001, COGNITIVE THER RES, V25, P137, DOI 10.1023/A:1026487018110; Waller JM, 2014, J AM ACAD CHILD PSY, V53, P869, DOI 10.1016/j.jaac.2014.05.004; Welburn K, 2002, COGNITIVE THER RES, V26, P519, DOI 10.1023/A:1016231902020; White ME, 2012, J CLIN CHILD ADOLESC, V41, P598, DOI 10.1080/15374416.2012.706518; Young J., 2003, YOUNG SCHEMA QUESTIO; Young J. E., 2003, SCHEMA THERAPY PRACT; Young Jeremy R., 1994, P63; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257	60	39	39	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140177	10.1371/journal.pone.0140177	http://dx.doi.org/10.1371/journal.pone.0140177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488748	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400046
J	Leung, LC; Harris, WA; Holt, CE; Piper, M				Leung, Louis C.; Harris, William A.; Holt, Christine E.; Piper, Michael			NF-Protocadherin Regulates Retinal Ganglion Cell Axon Behaviour in the Developing Visual System	PLOS ONE			English	Article							GROWTH CONES; IN-VIVO; CHEMOTROPIC RESPONSES; CADHERIN SUPERFAMILY; GAMMA-PROTOCADHERINS; PROTEIN-SYNTHESIS; TIME-LAPSE; GUIDANCE; XENOPUS; NETRIN-1	Cell adhesion molecules play a central role in mediating axonal tract development within the nascent nervous system. NF-protocadherin (NFPC), a member of the non-clustered protocadherin family, has been shown to regulate retinal ganglion cell (RGC) axon and dendrite initiation, as well as influencing axonal navigation within the mid-optic tract. However, whether NFPC mediates RGC axonal behaviour at other positions within the optic pathway remains unclear. Here we report that NFPC plays an important role in RGC axonogenesis, but not in intraretinal guidance. Moreover, axons with reduced NFPC levels exhibit insensitivity to Netrin-1, an attractive guidance cue expressed at the optic nerve head. Netrin-1 induces rapid turnover of NFPC localized to RGC growth cones, suggesting that the regulation of NFPC protein levels may underlie Netrin-1-mediated entry of RGC axons into the optic nerve head. At the tectum, we further reveal a function for NFPC in controlling RGC axonal entry into the final target area. Collectively, our results expand our understanding of the role of NFPC in RGC guidance and illustrate that this adhesion molecule contributes to axon behaviour at multiple points in the optic pathway.	[Leung, Louis C.; Harris, William A.; Holt, Christine E.; Piper, Michael] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Piper, Michael] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Piper, Michael] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Cambridge; University of Queensland; University of Queensland	Holt, CE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England.	ceh33@cam.ac.uk; m.piper@uq.edu.au	Piper, Michael J/B-2805-2010	Piper, Michael J/0000-0002-6759-2560; Holt, Christine Elizabeth/0000-0003-2829-121X	Wellcome Trust [085314/Z/08/Z]; National Health and Medical Research Council [1003462, 1057751, 1022308]; Australian Research Council [FT120100170]; Medical Research Council	Wellcome Trust(Wellcome Trust); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Wellcome Trust Programme Grant (CEH, 085314/Z/08/Z), and by National Health and Medical Research Council project grants (MP, grant numbers 1003462, 1057751 and 1022308). MP was supported by a fellowship (Australian Research Council Future Fellowship; FT120100170). LCL was supported by a Medical Research Council doctoral training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekirov IH, 2008, HIPPOCAMPUS, V18, P349, DOI 10.1002/hipo.20395; Brackenbury WJ, 2008, J NEUROSCI, V28, P3246, DOI 10.1523/JNEUROSCI.5446-07.2008; Bradley RS, 1998, CURR BIOL, V8, P325, DOI 10.1016/S0960-9822(98)70132-0; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P413, DOI 10.1006/mcne.1995.1031; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P433, DOI 10.1006/mcne.1995.1032; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Emond MR, 2008, DEV BIOL, V321, P175, DOI 10.1016/j.ydbio.2008.06.011; Falk J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-107; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Johnson K G, 2000, Results Probl Cell Differ, V31, P157; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Leung LC, 2013, NAT NEUROSCI, V16, P166, DOI 10.1038/nn.3290; LOHOF AM, 1992, J NEUROSCI, V12, P1253; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; McFarlane S, 2012, DEV NEUROBIOL, V72, P520, DOI 10.1002/dneu.20928; Nieuwkoop FJ, 1967, NORMAL TABLES XENOPU; Nishiyama M, 2008, NAT NEUROSCI, V11, P762, DOI 10.1038/nn.2130; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Piper M, 2008, J NEUROSCI, V28, P100, DOI 10.1523/JNEUROSCI.4490-07.2008; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Reines A, 2012, J NEUROSCI, V32, P6323, DOI 10.1523/JNEUROSCI.0916-12.2012; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; STIER H, 1995, DEVELOPMENT, V121, P1443; Stuermer CAO, 2000, PROG NEUROBIOL, V62, P197, DOI 10.1016/S0301-0082(00)00012-5; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Thompson H, 2006, J NEUROSCI, V26, P8082, DOI 10.1523/JNEUROSCI.1342-06.2006; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Walz A, 2002, J NEUROBIOL, V53, P330, DOI 10.1002/neu.10113; Walz A, 1997, DEVELOPMENT, V124, P2421; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141290	10.1371/journal.pone.0141290	http://dx.doi.org/10.1371/journal.pone.0141290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489017	Green Submitted, gold, Green Published			2022-12-27	WOS:000363248400120
J	Tissot, A; Jaffre, S; Gagnadoux, F; Levaillant, M; Corne, F; Chollet, S; Blanc, FX; Goupil, F; Priou, P; Trzepizur, W; Magnan, A				Tissot, Adrien; Jaffre, Sandrine; Gagnadoux, Frederic; Levaillant, Marc; Corne, Frederic; Chollet, Sylvaine; Blanc, Francois-Xavier; Goupil, Franois; Priou, Pascaline; Trzepizur, Wojciech; Magnan, Antoine		IRSR NIV Cohort Grp	Home Non-Invasive Ventilation Fails to Improve Quality of Life in the Elderly: Results from a Multicenter Cohort Study	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; OBESITY HYPOVENTILATION SYNDROME; STABLE HYPERCAPNIC COPD; MECHANICAL VENTILATION; RESPIRATORY INSUFFICIENCY; TRIAL; AGE	Background Home non-invasive ventilation (NIV) is a widely used treatment for chronic hypoventilation but little is known on its impact in the elderly. In a multicenter prospective cohort study, we studied tolerance and efficacy of domiciliary NIV in patients aged 75 or more compared to younger ones. Methods and Results 264 patients with at least a six-month follow-up were analyzed. Among them, 82 were elderly. In the elderly and the younger, we found an improvement of arterial blood gas, the Epworth sleepiness scale and the Pittsburgh sleep quality index at 6 months. Mean daily use of NIV at 6 months was 7 hours and the rate of non-adherent patients was similar in both group. Health-related quality of life (HRQL) assessed by SF-36 questionnaires did not change significantly after NIV initiation in the elderly whereas HRQL improved in the less than 75. On univariate analysis, we found that diabetes was a predictive factor for non-adherence in the elderly (Odds ratio: 3.95% confidence interval: 1.06-8.52). Conclusion NIV was efficient in the elderly while evaluation at 6 months showed a good adherence but failed to improve HRQL.	[Tissot, Adrien; Jaffre, Sandrine; Corne, Frederic; Chollet, Sylvaine; Blanc, Francois-Xavier; Magnan, Antoine] CHU Nantes, Inst Thorax, Serv Pneumol, F-44035 Nantes 01, France; [Gagnadoux, Frederic; Priou, Pascaline; Trzepizur, Wojciech] CHU Angers, Dept Pneumol, Angers, France; [Levaillant, Marc] CERMES, CNRS UMR8211, Inserm U988, EHESS, Villejuif, France; [Goupil, Franois] Ctr Hosp Mans, Serv Pneumol, Le Mans, France	Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Le Mans	Tissot, A (corresponding author), CHU Nantes, Inst Thorax, Serv Pneumol, F-44035 Nantes 01, France.	adrientissot@hotmail.com	Blanc, François-Xavier/D-7425-2015; MAGNAN, ANTOINE/GVT-4308-2022	Blanc, François-Xavier/0000-0001-7644-2188; 	Institut de Recherche en Sante Respiratoire des Pays de Loire	Institut de Recherche en Sante Respiratoire des Pays de Loire	The study was funded by the Institut de Recherche en Sante Respiratoire des Pays de Loire. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen-Ranberg K, 1999, AGE AGEING, V28, P373, DOI 10.1093/ageing/28.4.373; [Anonymous], 1999, CHEST, V116, P521; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Dreher M, 2010, THORAX, V65, P303, DOI 10.1136/thx.2009.124263; Farrero E, 2007, RESP MED, V101, P1068, DOI 10.1016/j.rmed.2006.10.005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Heinemann F, 2007, RESP MED, V101, P1229, DOI 10.1016/j.rmed.2006.10.027; Hung WW, 2012, MED CARE, V50, P501, DOI 10.1097/MLR.0b013e318245a0e0; Janssens JP, 1998, RESP MED, V92, P1311, DOI 10.1016/S0954-6111(98)90135-4; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Klein BEK, 2005, ARCH GERONTOL GERIAT, V41, P141, DOI 10.1016/j.archger.2005.01.002; LEGER P, 1994, CHEST, V105, P100, DOI 10.1378/chest.105.1.100; Lloyd-Owen SJ, 2005, EUR RESPIR J, V25, P1025, DOI 10.1183/09031936.05.00066704; Marti S, 2010, RESP MED, V104, P1843, DOI 10.1016/j.rmed.2010.08.013; McEvoy RD, 2009, THORAX, V64, P561, DOI 10.1136/thx.2008.108274; McKim DA, 2011, CAN RESPIR J, V18, P197, DOI 10.1155/2011/139769; Olson AL, 2005, AM J MED, V118, P948, DOI 10.1016/j.amjmed.2005.03.042; Priou P, 2010, CHEST, V138, P84, DOI 10.1378/chest.09-2472; SIMONDS AK, 1995, THORAX, V50, P604, DOI 10.1136/thx.50.6.604; Tsuboi T, 2010, RESP MED, V104, P1850, DOI 10.1016/j.rmed.2010.04.027; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Windisch W, 2003, J CLIN EPIDEMIOL, V56, P752, DOI 10.1016/S0895-4356(03)00088-X	22	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141156	10.1371/journal.pone.0141156	http://dx.doi.org/10.1371/journal.pone.0141156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489014	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400111
J	Chen, L; Yang, L; Qiao, F; Hu, X; Li, S; Yao, L; Yang, XL; Shao, ZM				Chen, Li; Yang, Liu; Qiao, Feng; Hu, Xin; Li, Shan; Yao, Ling; Yang, Xue-Li; Shao, Zhi-Ming			High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer	PLOS ONE			English	Article							SUBTYPES; NUSAP; IDENTIFICATION; RISK	Purpose Nucleolar spindle-associated protein (NuSAP1) is an important mitosis-related protein, and aberrant NuSAP1 expression is associated with abnormal spindles and mitosis. This study investigated the prognostic value of NuSAP1 in breast cancer. Methods Two sets of tissue microarrays (TMAs) that included samples from 450 breast cancer patients were constructed, of which 250 patients were training set and the other 200 patients were validation set. Immunohistochemical staining was performed to determine the NuSAP1 levels. A Kaplan-Meier analysis was used to estimate the prognostic value of NuSAP1 in breast cancer. A stepwise Cox analysis was performed to construct a risk-prediction model for triple-negative breast cancer (TNBC). All statistical analysis was performed with SPSS software. Results There were 108 (43.5%) and 88 (44.0%) patients expressed NuSAP1 in the training set and validation set respectively. High levels of NuSAP1 expression were related to poor diseasefree survival (DFS) in both training (P = 0.028) and validation (P = 0.006) cohorts, particularly in TNBC. With combination of two cohorts, both NuSAP1 (HR = 4.136, 95% CI: 1.9568.747, P < 0.001) and BRCA1 (HR = 0.383, 95% CI: 0.160-0.915, P = 0.031) were independent prognostic indicators of DFS in TNBC. A receiver operating characteristic (ROC) analysis revealed that the combination of NuSAP1 and BRCA1 significantly improved the prognostic power compared with the traditional model (0.778 versus 0.612, P < 0.001). Conclusions Our study confirms the prognostic value of NuSAP1 in breast cancer. The combination of NuSAP1 and BRCA1 could improve the DFS prediction accuracy in TNBC.	[Chen, Li; Yang, Liu; Qiao, Feng; Hu, Xin; Li, Shan; Yao, Ling; Shao, Zhi-Ming] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200032, Peoples R China; [Chen, Li; Yang, Liu; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Yang, Xue-Li] Dalian Med Univ, Dept Canc Stem Cell, Dalian, Peoples R China	Fudan University; Fudan University; Dalian Medical University	Yao, L (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200032, Peoples R China.	yaoling19852@126.com; zhimingshao@yahoo.com			National Natural Science Foundation of China [81201531]; Shanghai Committee of Science and Technology Funds [12ZR1406200, 12DZ2260100, 12140901502]; Shanghai Committee of Science and Technology Fund for the Qimingxing Project [13QA1400900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee); Shanghai Committee of Science and Technology Fund for the Qimingxing Project	This work was supported by grants from the National Natural Science Foundation of China (81201531), the 2012 Shanghai Committee of Science and Technology Funds (12ZR1406200, 12DZ2260100 and 12140901502) and the Shanghai Committee of Science and Technology Fund for the 2013 Qimingxing Project (13QA1400900 to X. Hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidkhori G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067552; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Guler G, 2011, BREAST CANCER RES TR, V129, P421, DOI 10.1007/s10549-010-1248-6; Gulzar ZG, 2013, ONCOGENE, V32, P70, DOI 10.1038/onc.2012.27; Hassan MSU, 2010, ONCOL REP, V24, P1121, DOI 10.3892/or_00000963; Hill SJ, 2014, MOL CELL BIOL, V34, P3828, DOI 10.1128/MCB.01646-13; Iyer J, 2011, CELL SIGNAL, V23, P991, DOI 10.1016/j.cellsig.2010.11.006; Khoshnaw SM, 2012, BREAST CANCER RES TR, V135, P403, DOI 10.1007/s10549-012-2169-3; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Espinosa AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055975; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Rebbeck TR, 2015, JAMA-J AM MED ASSOC, V313, P1347, DOI 10.1001/jama.2014.5985; Ribbeck K, 2006, MOL BIOL CELL, V17, P2646, DOI 10.1091/mbc.E05-12-1178; Ricciardi GRR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128368; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Severson TM, 2015, MOL ONCOL, V9, P1528, DOI 10.1016/j.molonc.2015.04.011; Stuart JE, 2011, J NEUROPATH EXP NEUR, V70, P1, DOI 10.1097/NEN.0b013e3182018f1c; Thompson ME, 2005, J BIOL CHEM, V280, P21854, DOI 10.1074/jbc.M502676200; Timms KM, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0475-x; Verbakel W, 2011, BIOCHEM BIOPH RES CO, V411, P732, DOI 10.1016/j.bbrc.2011.07.015; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Zhang L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/357485	27	31	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140572	10.1371/journal.pone.0140572	http://dx.doi.org/10.1371/journal.pone.0140572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485712	gold, Green Submitted, Green Published			2022-12-27	WOS:000363028100046
J	Lanata, A; Guidi, A; Baragli, P; Valenza, G; Scilingo, EP				Lanata, Antonio; Guidi, Andrea; Baragli, Paolo; Valenza, Gaetano; Scilingo, Enzo Pasquale			A Novel Algorithm for Movement Artifact Removal in ECG Signals Acquired from Wearable Systems Applied to Horses	PLOS ONE			English	Article							MOTION-ARTIFACT; CARDIAC-ARRHYTHMIAS; ELECTROCARDIOGRAPHIC SIGNALS; COMPONENT ANALYSIS; ADAPTIVE REMOVAL; NOISE; EXERCISE; DECOMPOSITION; ENHANCEMENT; PERFORMANCE	This study reports on a novel method to detect and reduce the contribution of movement artifact (MA) in electrocardiogram (ECG) recordings gathered from horses in free movement conditions. We propose a model that integrates cardiovascular and movement information to estimate the MA contribution. Specifically, ECG and physical activity are continuously acquired from seven horses through a wearable system. Such a system employs completely integrated textile electrodes to monitor ECG and is also equipped with a triaxial accelerometer for movement monitoring. In the literature, the most used technique to remove movement artifacts, when noise bandwidth overlaps the primary source bandwidth, is the adaptive filter. In this study we propose a new algorithm, hereinafter called Stationary Wavelet Movement Artifact Reduction (SWMAR), where the Stationary Wavelet Transform (SWT) decomposition algorithm is employed to identify and remove movement artifacts from ECG signals in horses. A comparative analysis with the Normalized Least Mean Square Adaptive Filter technique (NLMSAF) is performed as well. Results achieved on seven hours of recordings showed a reduction greater than 40% of MA percentage (between before- and after- the application of the proposed algorithm). Moreover, the comparative analysis with the NLMSAF, applied to the same ECG recordings, showed a greater reduction of MA percentage in favour of SWMAR with a statistical significant difference (p-value < 0.0.5).	[Lanata, Antonio; Guidi, Andrea; Valenza, Gaetano; Scilingo, Enzo Pasquale] Univ Pisa, Sch Engn, Res Ctr E Piaggio, Pisa, Italy; [Baragli, Paolo] Univ Pisa, Dept Vet Sci, Pisa, Italy	University of Pisa; University of Pisa	Lanata, A (corresponding author), Univ Pisa, Sch Engn, Res Ctr E Piaggio, Pisa, Italy.	a.lanata@centropiaggio.unipi.it	Baragli, Paolo/AAZ-1020-2021	Baragli, Paolo/0000-0001-5221-5714; Guidi, Andrea/0000-0003-2978-5705; Lanata, Antonio/0000-0002-6540-5952; Valenza, Gaetano/0000-0001-6574-1879				Aase SO, 2000, IEEE T BIO-MED ENG, V47, P1440, DOI 10.1109/10.880095; Anapagamini SA, 2013, 2013 INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND SIGNAL PROCESSING (ICCSP), P288, DOI 10.1109/iccsp.2013.6577061; Barros AK, 1998, NEUROCOMPUTING, V22, P173, DOI 10.1016/S0925-2312(98)00056-3; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buhl R, 2013, VET J, V196, P483, DOI 10.1016/j.tvjl.2012.11.016; Buhl R, 2010, EQUINE VET J, V42, P196, DOI 10.1111/j.2042-3306.2010.00185.x; Buhl R, 2010, VET J, V183, P117, DOI 10.1016/j.tvjl.2009.06.018; BURBANK DP, 1978, MED BIOL ENG COMPUT, V16, P31, DOI 10.1007/BF02442929; Chang KM, 2010, SENSORS-BASEL, V10, P6063, DOI 10.3390/s100606063; Chawla MPS, 2011, APPL SOFT COMPUT, V11, P2216, DOI 10.1016/j.asoc.2010.08.001; Cottin F, 2006, Equine Vet J Suppl, P204; Deepu C. J., 2010, Proceedings of the Fifth IEEE International Workshop on Electronic Design, Test and Application (DELTA 2010), P225, DOI 10.1109/DELTA.2010.43; deTalhouet H, 1996, PHYSIOL MEAS, V17, P81, DOI 10.1088/0967-3334/17/2/003; Devlin PH., 1984, Computers in Cardiology (Cat. No. 84CH2078-4), P51; Ercelebi E, 2004, COMPUT BIOL MED, V34, P479, DOI 10.1016/S0010-4825(03)00090-8; FERRARA ER, 1982, IEEE T BIO-MED ENG, V29, P458, DOI 10.1109/TBME.1982.324973; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Greco A, 2012, IEEE ENG MED BIO, P6691, DOI 10.1109/EMBC.2012.6347529; Hamilton PS, 1997, P ANN INT IEEE EMBS, V19, P297; Hamilton PS, 2000, COMPUT CARDIOL, V27, P383, DOI 10.1109/CIC.2000.898537; Hamilton PS, 1999, BIOMEDICAL INSTRUMEN, V34, P197; HEDLEY M, 1992, MAGN RESON IMAGING, V10, P627, DOI 10.1016/0730-725X(92)90014-Q; Holschneider M, 1990, WAVELETS, P286; Khan A, 1974, PHYSL ELECTRODES MEC, P1073; LAGUNA P, 1994, COMPUT BIOMED RES, V27, P45, DOI 10.1006/cbmr.1994.1006; Lanata A, 2015, IEEE T INTELL TRANSP, V16, P1505, DOI 10.1109/TITS.2014.2365681; Lanata A, 2010, IEEE T INF TECHNOL B, V14, P817, DOI 10.1109/TITB.2009.2024414; Lanata A, 2010, IEEE T INF TECHNOL B, V14, P378, DOI 10.1109/TITB.2009.2037614; Lee J, 2012, IEEE T BIO-MED ENG, V59, P1499, DOI 10.1109/TBME.2011.2175729; Lim YG, 2007, IEEE T BIO-MED ENG, V54, P718, DOI 10.1109/TBME.2006.889194; Liu Yan, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P6045; Luo S, 1995, COMPUT CARDIOL, P33, DOI 10.1109/CIC.1995.482564; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Maronna R.A., 2006, ROBUST STAT; Marr C., 2011, CARDIOLOGY HORSE, V2nd ed.; Martin BB, 2000, J AM VET MED ASSOC, V216, P554, DOI 10.2460/javma.2000.216.554; Martinez JP, 2004, IEEE T BIO-MED ENG, V51, P570, DOI 10.1109/TBME.2003.821031; Milanesi M, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3391; Milanesi M, 2008, MED BIOL ENG COMPUT, V46, P251, DOI 10.1007/s11517-007-0293-8; ODMAN S, 1982, MED BIOL ENG COMPUT, V20, P159, DOI 10.1007/BF02441351; Pesquet JC, 1996, IEEE T SIGNAL PROCES, V44, P1964, DOI 10.1109/78.533717; Petersen E, 2008, P BEVA C LIV UK SEPT, P138; Rahman Mohammad Zia Ur, 2009, 2009 2nd International Conference on Adaptive Science & Technology (ICAST 2009), P380, DOI 10.1109/ICASTECH.2009.5409698; Raya MAD, 2002, P ANN INT IEEE EMBS, P1756, DOI 10.1109/IEMBS.2002.1106637; Reef VB, 2014, J VET INTERN MED, V28, P749, DOI 10.1111/jvim.12340; Ryan N, 2005, EQUINE VET J, V37, P265, DOI 10.2746/0425164054530713; Sameni R, 2008, IEEE T BIO-MED ENG, V55, P1935, DOI 10.1109/TBME.2008.919714; Sameni Reza, 2010, Open Pacing Electrophysiol Ther J, V3, P4; Scheffer CJW, 1996, VET QUART, V18, P2, DOI 10.1080/01652176.1996.9694601; Serteyn A, 2013, IEEE ENG MED BIO, P4795, DOI 10.1109/EMBC.2013.6610620; Shah AP, 2007, J ELECTROCARDIOL, V40, P385, DOI 10.1016/j.jelectrocard.2007.03.008; Shoker L, 2005, IEEE SIGNAL PROC LET, V12, P721, DOI 10.1109/LSP.2005.855539; Strasser F, 2012, EUR SIGNAL PR CONF, P899; Suyi Li, 2009, 2009 WRI World Congress on Computer Science and Information Engineering, CSIE, P469, DOI 10.1109/CSIE.2009.999; TAM HW, 1977, IEEE T BIO-MED ENG, V24, P134, DOI 10.1109/TBME.1977.326117; Thakor N., 1978, P ANN C ENG BIOL MED, V20, P212; THAKOR NV, 1991, IEEE T BIO-MED ENG, V38, P785, DOI 10.1109/10.83591; Tong DA, 2002, P ANN INT IEEE EMBS, P1403, DOI 10.1109/IEMBS.2002.1106451; Trachsel DS, 2010, EQUINE VET J, V42, P208, DOI 10.1111/j.2042-3306.2010.00172.x; van Loon G., 2013, EQUINE SPORTS MED SU, P695; Velazquez R, 2002, 2002 6TH INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING PROCEEDINGS, VOLS I AND II, P1504, DOI 10.1109/ICOSP.2002.1180080; Verheyen T, 2010, VLAAMS DIERGEN TIJDS, V79, P331; VETTERLI M, 1987, IEEE T ACOUST SPEECH, V35, P356, DOI 10.1109/TASSP.1987.1165137; Vitale V, 2013, J VET BEHAV, V8, P400, DOI 10.1016/j.jveb.2013.02.003; Vullings R, 2011, IEEE T BIO-MED ENG, V58, P1094, DOI 10.1109/TBME.2010.2099229; Webster J.G., 2009, MED INSTRUM; WEBSTER JG, 1984, IEEE T BIO-MED ENG, V31, P823, DOI 10.1109/TBME.1984.325244; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Wu YF, 2007, CAN CON EL COMP EN, P864; YELDERMAN M, 1983, IEEE T BIO-MED ENG, V30, P392, DOI 10.1109/TBME.1983.325039; Zito D, 2008, INT J TELEMED APPL, V2008, DOI 10.1155/2008/328597	73	27	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140783	10.1371/journal.pone.0140783	http://dx.doi.org/10.1371/journal.pone.0140783			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484686	gold, Green Submitted, Green Published			2022-12-27	WOS:000363028100070
J	Ostberg, CO; Chase, DM; Hauser, L				Ostberg, Carl O.; Chase, Dorothy M.; Hauser, Lorenz			Hybridization between Yellowstone Cutthroat Trout and Rainbow Trout Alters the Expression of Muscle Growth-Related Genes and Their Relationships with Growth Patterns	PLOS ONE			English	Article							ONCORHYNCHUS-CLARKII-LEWISI; SKELETAL-MUSCLE; LIFE-HISTORY; MYOSTATIN; INSULIN; MYKISS; INTROGRESSION; CONSEQUENCES; DIVERGENCE; MORPHOLOGY	Hybridization creates novel gene combinations that may generate important evolutionary novelty, but may also reduce existing adaptation by interrupting inherent biological processes, such as genotype-environment interactions. Hybridization often causes substantial change in patterns of gene expression, which, in turn, may cause phenotypic change. Rainbow trout (Oncorhynchus mykiss) and cutthroat trout (O. clarkii) produce viable hybrids in the wild, and introgressive hybridization with introduced rainbow trout is a major conservation concern for native cutthroat trout. The two species differ in body shape, which is likely an evolutionary adaptation to their native environments, and their hybrids tend to show intermediate morphology. The characterization of gene expression patterns may provide insights on the genetic basis of hybrid and parental morphologies, as well as on the ecological performance of hybrids in the wild. Here, we evaluated the expression of eight growth-related genes (MSTN-1a, MSTN-1b, MyoD1a, MyoD1b, MRF-4, IGF-1, IGF-2, and CAST-L) and the relationship of these genes with growth traits (length, weight, and condition factor) in six line crosses: both parental species, both reciprocal F1 hybrids, and both first-generation backcrosses (F1 x rainbow trout and F1 x cutthroat trout). Four of these genes were differentially expressed among rainbow, cutthroat, and their hybrids. Transcript abundance was significantly correlated with growth traits across the parent species, but not across hybrids. Our findings suggest that rainbow and cutthroat trout exhibit differences in muscle growth regulation, that transcriptional networks may be modified by hybridization, and that hybridization disrupts intrinsic relationships between gene expression and growth patterns that may be functionally important for phenotypic adaptations.	[Ostberg, Carl O.; Chase, Dorothy M.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA 98104 USA; [Hauser, Lorenz] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle	Ostberg, CO (corresponding author), US Geol Survey, Western Fisheries Res Ctr, Seattle, WA 98104 USA.	costberg@usgs.gov	Hauser, Lorenz/E-4365-2010		Recruitment, Admissions, and Scholarship Committee, School of Aquatic and Fishery Sciences, University of Washington; U.S. Geological Survey	Recruitment, Admissions, and Scholarship Committee, School of Aquatic and Fishery Sciences, University of Washington; U.S. Geological Survey(United States Geological Survey)	This work was funded in part by an award granted to COO from the Recruitment, Admissions, and Scholarship Committee, School of Aquatic and Fishery Sciences, University of Washington. All other project funding was provided by the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ALLENDORF F W, 1988, Conservation Biology, V2, P170, DOI 10.1111/j.1523-1739.1988.tb00168.x; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Behnke R.J., 1992, AM FISHERIES SOC MON, V6, pi; Benjamini Y, 2001, ANN STAT, V29, P1165; Bougas B, 2010, GENETICS, V186, P97, DOI 10.1534/genetics.110.118158; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Busacker G.P., 1990, P363; Clarke KR, 2015, PRIMER V7 USER MANUA; Corsi MP, 2013, CAN J FISH AQUAT SCI, V70, P895, DOI 10.1139/cjfas-2012-0312; Fay JC, 2008, HEREDITY, V100, P191, DOI 10.1038/sj.hdy.6801000; Fuentes EN, 2013, GEN COMP ENDOCR, V192, P136, DOI 10.1016/j.ygcen.2013.06.009; Garikipati DK, 2006, J ENDOCRINOL, V190, P879, DOI 10.1677/joe.1.06866; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Gibson G, 2008, NAT REV GENET, V9, P575, DOI 10.1038/nrg2383; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Hawkins DK, 1996, CAN J FISH AQUAT SCI, V53, P1487, DOI 10.1139/cjfas-53-7-1487; Huang CW, 2012, J ANIM SCI, V90, P4266, DOI 10.2527/jas.2012-5142; Johansen KA, 2005, MAR BIOTECHNOL, V7, P576, DOI 10.1007/s10126-004-5133-3; Johnston IA, 2011, J EXP BIOL, V214, P1617, DOI 10.1242/jeb.038620; Kovach RP, 2015, P ROYAL SOC LONDON B, V282; Landry CR, 2007, HEREDITY, V99, P483, DOI 10.1038/sj.hdy.6801045; Lee CY, 2009, BIOCHEM BIOPH RES CO, V387, P766, DOI 10.1016/j.bbrc.2009.07.110; Macqueen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001567; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mommsen Thomas W., 2001, Fish Physiology, V18, P251; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Normandeau E, 2009, EVOL APPL, V2, P489, DOI 10.1111/j.1752-4571.2009.00074.x; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Ortiz-Barrientos D, 2007, GENETICA, V129, P71, DOI 10.1007/s10709-006-0034-1; Ostberg CO, 2011, T AM FISH SOC, V140, P334, DOI 10.1080/00028487.2011.567866; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rasmussen JB, 2012, BIOL J LINN SOC, V105, P56, DOI 10.1111/j.1095-8312.2011.01768.x; Rasmussen JB, 2010, CAN J FISH AQUAT SCI, V67, P357, DOI 10.1139/F09-191; Renaut S, 2009, MOL BIOL EVOL, V26, P925, DOI 10.1093/molbev/msp017; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rieseberg LH, 2000, PLANT MOL BIOL, V42, P205, DOI 10.1023/A:1006340407546; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Roberge C, 2008, MOL ECOL, V17, P314, DOI 10.1111/j.1365-294X.2007.03438.x; Roberts SB, 2004, J EXP BIOL, V207, P3741, DOI 10.1242/jeb.01210; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rottscheidt R, 2007, GENETICS, V177, P1553, DOI 10.1534/genetics.107.076190; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seiler SM, 2007, ANIM BEHAV, V74, P1805, DOI 10.1016/j.anbehav.2007.03.025; Seiler SM, 2007, CAN J FISH AQUAT SCI, V64, P127, DOI 10.1139/F06-175; Seiler SM, 2009, CAN J FISH AQUAT SCI, V66, P133, DOI 10.1139/F08-194; Valente LMP, 1999, J FISH BIOL, V55, P675, DOI 10.1111/j.1095-8649.1999.tb00710.x; Valente LMP, 1998, FISH PHYSIOL BIOCHEM, V18, P213, DOI 10.1023/A:1007774929535; Venables WN., 2002, MODERN APPL STAT S 4; Wang YH, 2008, DEV DYNAM, V237, P1043, DOI 10.1002/dvdy.21478; Watabe S., 2001, FISH PHYSIOL, P19, DOI DOI 10.1016/S1546-5098(01)18003-9; Westers H, 2001, FISH HATCHERY MANAGEMENT, SECOND EDITION, P31; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Wilson WD, 2009, MOL PHYLOGENET EVOL, V52, P406, DOI 10.1016/j.ympev.2009.03.018; Yau MM, 2013, CONSERV GENET, V14, P885, DOI 10.1007/s10592-013-0485-8	56	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141373	10.1371/journal.pone.0141373	http://dx.doi.org/10.1371/journal.pone.0141373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485525	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100132
J	Zou, FF; Chen, C; Zhong, DB; Shen, B; Zhang, DH; Guo, Q; Wang, WJ; Yu, J; Lv, Y; Lei, ZT; Ma, K; Ma, L; Zhu, CL; Yan, GY				Zou, Feifei; Chen, Chen; Zhong, Daibin; Shen, Bo; Zhang, Donghui; Guo, Qin; Wang, Weijie; Yu, Jing; Lv, Yuan; Lei, Zhentao; Ma, Kai; Ma, Lei; Zhu, Changliang; Yan, Guiyun			Identification of QTLs Conferring Resistance to Deltamethrin in Culex pipiens pallens	PLOS ONE			English	Article							MOSQUITO AEDES-AEGYPTI; QUANTITATIVE TRAIT LOCI; VECTOR ANOPHELES-FUNESTUS; INSECTICIDE RESISTANCE; MALARIA VECTOR; LINKAGE MAP; PERMETHRIN RESISTANCE; PYRETHROID RESISTANCE; GENETIC-LINKAGE; GENOME	Culex pipiens pallens is the most abundant Culex mosquito species in northern China and is an important vector of bancroftian filariasis and West Nile virus. Deltamethrin is an insecticide that is widely used for mosquito control, however resistance to this and other insecticides has become a major challenge in the control of vector-borne diseases that appear to be inherited quantitatively. Furthermore, the genetic basis of insecticide resistance remains poorly understood. In this study, quantitative trait loci (QTL) mapping of resistance to deltamethrin was conducted in F-2 intercross segregation populations using bulked segregation analysis (BSA) and amplified fragment length polymorphism markers (AFLP) in Culex pipiens pallens. A genetic linkage map covering 381 cM was constructed and a total of seven QTL responsible for resistance to deltamethrin were detected by composite interval mapping (CIM), which explained 95% of the phenotypic variance. The major QTL in linkage group 2 accounted for 62% of the variance and is worthy of further study. 12 AFLP markers in the map were cloned and the genomic locations of these marker sequences were determined by applying the Basic Local Alignment Search Tool (BLAST) tool to the genome sequence of the closely related Culex quinquefasciatus. Our results suggest that resistance to deltamethrin is a quantitative trait under the control of a major QTL in Culex pipiens pallens. Cloning of related AFLP markers confirm the potential utility for anchoring the genetic map to the physical map. The results provide insight into the genetic architecture of the trait.	[Zou, Feifei; Chen, Chen; Shen, Bo; Zhang, Donghui; Guo, Qin; Wang, Weijie; Yu, Jing; Lv, Yuan; Lei, Zhentao; Ma, Kai; Ma, Lei; Zhu, Changliang] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Zhong, Daibin; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA	Nanjing Medical University; University of California System; University of California Irvine	Zhu, CL (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China.	clzhu@njmu.edu.cn	Zhong, Daibin/GRF-0564-2022		National Institutes of Health of US (NIH) [2R01AI0757460]; National Natural Science Foundation of China [81171610, 81101279, 81301458]; National S & T Major Program [2012ZX10004-219, 2012ZX10004-220]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20113234120007]; Natural Science Foundation of Jiangsu Province [81101279]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075746] Funding Source: NIH RePORTER	National Institutes of Health of US (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S & T Major Program; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health of US (NIH)(Grant No. 2R01AI0757460, http://www.nih.gov/; the National Natural Science Foundation of China (Grant No. 81171610, 81101279 and 81301458), http://www.nsfc.gov.cn/nsfc/cen/00/download.html; the National S & T Major Program (Grant No. 2012ZX10004-219 and 2012ZX10004-220), http://english.cas.cn/; Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20113234120007), http://en.moe.gov.cn/; Natural Science Foundation of Jiangsu Province (Grant No. 81101279), http://www.jstd.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Brown SE, 2001, GENETICS, V157, P1299; Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011681; Cornel AJ, 2003, J MED ENTOMOL, V40, P36, DOI 10.1603/0022-2585-40.1.36; Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288; DARVASI A, 1993, GENETICS, V134, P943; DARVASI A, 1994, GENETICS, V138, P1365; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Fulton RE, 2001, GENETICS, V158, P715; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hickner PV, 2013, J HERED, V104, P649, DOI 10.1093/jhered/est040; Hu ZN, 2011, INSECT BIOCHEM MOLEC, V41, P9, DOI 10.1016/j.ibmb.2010.09.005; Kim SC, 2007, J HERED, V98, P293, DOI 10.1093/jhered/esm052; Liu J, 2014, G3-GENES GENOM GENET, V4, P595, DOI 10.1534/g3.114.010389; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Midamegbe A, 2011, MOL ECOL, V20, P1414, DOI 10.1111/j.1365-294X.2011.05035.x; Mori A, 1999, J HERED, V90, P160, DOI 10.1093/jhered/90.1.160; Mori A, 2001, INSECT MOL BIOL, V10, P197, DOI 10.1046/j.1365-2583.2001.00255.x; Paris M, 2012, MOL ECOL, V21, P1672, DOI 10.1111/j.1365-294X.2012.05499.x; Ranson H, 2000, INSECT MOL BIOL, V9, P499, DOI 10.1046/j.1365-2583.2000.00214.x; Ranson H, 2004, INSECT MOL BIOL, V13, P379, DOI 10.1111/j.0962-1075.2004.00495.x; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x; Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924; Severson DW, 2002, INSECT MOL BIOL, V11, P371, DOI 10.1046/j.1365-2583.2002.00347.x; Severson DW, 1997, J HERED, V88, P520, DOI 10.1093/oxfordjournals.jhered.a023148; Sun Y, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-134; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; Tan WB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-215; Tollenaere C, 2013, MOL ECOL, V22, P354, DOI 10.1111/mec.12115; van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340; Venkatesan M, 2009, INSECT MOL BIOL, V18, P453, DOI 10.1111/j.1365-2583.2009.00885.x; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang WJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0709-5; Witzig C, 2013, PARASITOLOGY, V140, P1468, DOI 10.1017/S0031182013000024; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-34; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-5; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Wondji CS, 2005, GENETICS, V171, P1779, DOI 10.1534/genetics.105.044800; Xiulan Li LM, 2002, APPL ENTOMOL ZOOL, V37, P305; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng LB, 1996, GENETICS, V143, P941; Zhong DB, 2006, GENETICS, V173, P1337, DOI 10.1534/genetics.105.055178	48	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140923	10.1371/journal.pone.0140923	http://dx.doi.org/10.1371/journal.pone.0140923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484540	gold, Green Published			2022-12-27	WOS:000363028100091
J	Zou, W; Fang, C; Ji, XF; Liang, XF; Liu, Y; Han, C; Huang, L; Zhang, QQ; Li, HY; Zhang, YJ; Liu, JQ; Liu, J				Zou, Wei; Fang, Chen; Ji, Xiaofei; Liang, Xiaofeng; Liu, Yang; Han, Chao; Huang, Liang; Zhang, Qiqi; Li, Hongyan; Zhang, Yejun; Liu, Jinqiu; Liu, Jing			Estrogen Receptor (ER)-alpha 36 Is Involved in Estrogen- and Tamoxifen-Induced Neuroprotective Effects in Ischemic Stroke Models	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEGATIVE BREAST-CANCER; ER-ALPHA; AGONIST ACTION; ER-ALPHA-36; VARIANT; BRAIN; RECEPTOR-ALPHA-36; EXPRESSION; ESTRADIOL	The neuroprotection by estrogen (E2) and tamoxifen is well documented in experimental stroke models; however, the exact mechanism is unclear. A membrane-based estrogen receptor, ER-alpha 36, has been identified. Postmenopausal-levels of E2 act through ER-alpha 36 to induce osteoclast apoptosis due to a prolonged activation of the mitogen-activated protein kinase (MAPK)/extracellular signal-related kinase (ERK) signaling. We hypothesized that ER-alpha 36 may play a role in the neuroprotective activities of estrogen and tamoxifen. Here, we studied ER-alpha 36 expression in the brain, as well as its neuroprotective effects against oxygen and glucose deprivation (OGD) in PC12 cells. We found that ER-alpha 36 was expressed in both rat and human brain. In addition, OGD-induced cell death was prevented by l nmol/L 17 beta-estradiol (E2 beta). E2 beta activates the MAPK/ERK signaling pathway in PC12 cells under basal and OGD conditions by interacting with ER-alpha 36 and also induces ER-alpha 36 expression. Low-dose of tamoxifen up-regulated ER-alpha 36 expression and enhanced neuronal survival in an ovariectomized ischemic stroke model. Furthermore, low-dose of tamoxifen enhanced neuroprotective effects by modulating activates or suppress ER-alpha 36. Our results thus demonstrated that ER-alpha 36 is involved in neuroprotective activities mediated by both estrogen and tamoxifen.	[Ji, Xiaofei; Han, Chao; Liu, Jing] Dalian Med Univ, Affiliated Hosp 1, Regenerat Med Ctr, Dalian 116011, Peoples R China; [Zou, Wei; Fang, Chen; Liang, Xiaofeng; Liu, Yang; Han, Chao; Huang, Liang; Zhang, Qiqi; Li, Hongyan; Zhang, Yejun] Liaoning Normal Univ, Coll Life Sci, Dalian 116081, Peoples R China; [Zou, Wei; Li, Hongyan; Zhang, Yejun] Liaoning Key Labs Biotechnol & Mol Drug Res & Dev, Dalian 116081, Peoples R China; [Liu, Jinqiu] Dalian Med Univ, Affiliated Hosp 1, Dept Cardiol, Dalian 116011, Peoples R China	Dalian Medical University; Liaoning Normal University; Dalian Medical University	Zou, W (corresponding author), Liaoning Normal Univ, Coll Life Sci, Dalian 116081, Peoples R China.	Weizou60@126.com; liujing.dlrmc@hotmail.com	Liu, Jing/O-8529-2019	Liu, Jing/0000-0002-0493-296X; Fang, Chen/0000-0003-2441-4470	National Natural Science foundation of China [30570225, 30970353, 81071009, 1271412]; International S&T Cooperation Project of the Ministry of ST of China [2010DFR30850]; People's Livelihood S&T Project, Bureau of ST of Dalian [2010E11SF008, 2011E12SF030]; Scientific Research Foundation for Returned Overseas Chinese Scholars; State Education Ministry; Science and Technology Development Plan Project of Jilin Province, China	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Project of the Ministry of ST of China; People's Livelihood S&T Project, Bureau of ST of Dalian; Scientific Research Foundation for Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry; Science and Technology Development Plan Project of Jilin Province, China	This work was supported by the National Natural Science foundation of China (No. 30570225, No. 30970353, No. 81071009 and No. 1271412), International S&T Cooperation Project of the Ministry of S&T of China (No. 2010DFR30850), The People's Livelihood S&T Project, Bureau of S&T of Dalian (No. 2010E11SF008, 2011E12SF030), the Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry, and the Science and Technology Development Plan Project of Jilin Province, China.	BERGMAN MD, 1992, ENDOCRINOLOGY, V130, P1923, DOI 10.1210/en.130.4.1923; Boulos AS, 2011, J NEUROSURG, V114, P1117, DOI 10.3171/2010.8.JNS09352; Bushnell CD, 2004, NEUROLOGY, V63, P1230, DOI 10.1212/01.WNL.0000140491.54664.50; Culmsee C, 1999, J CEREBR BLOOD F MET, V19, P1263, DOI 10.1097/00004647-199911000-00011; Dubal DB, 2006, ENDOCRINOLOGY, V147, P3076, DOI 10.1210/en.2005-1177; Gibson CL, 2006, J CEREBR BLOOD F MET, V26, P1103, DOI 10.1038/sj.jcbfm.9600270; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; Liu Yang, 2013, Shengli Xuebao, V65, P263; Nakamura T, 2006, ACTA NEUROCHIR SUPPL, V96, P218; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; Sampei K, 2000, STROKE, V31, P738, DOI 10.1161/01.STR.31.3.738; Shin JA, 2011, BBA-MOL BASIS DIS, V1812, P1154, DOI 10.1016/j.bbadis.2011.05.004; Wakade C, 2008, ENDOCRINOLOGY, V149, P367, DOI 10.1210/en.2007-0899; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Xie H, 2011, J BONE MINER RES, V26, P156, DOI 10.1002/jbmr.169; Zhang J, 2012, STEROIDS, V77, P666, DOI 10.1016/j.steroids.2012.02.013; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zhang XT, 2012, ONCOL REP, V27, P2057, DOI 10.3892/or.2012.1722; Zhang XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030174; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015	22	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140660	10.1371/journal.pone.0140660	http://dx.doi.org/10.1371/journal.pone.0140660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484775	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100060
J	Esber, N; Le Billan, F; Resche-Rigon, M; Loosfelt, H; Lombes, M; Chabbert-Buffet, N				Esber, Nathalie; Le Billan, Florian; Resche-Rigon, Michele; Loosfelt, Hugues; Lombes, Marc; Chabbert-Buffet, Nathalie			Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L-1 Expression	PLOS ONE			English	Article							CELL-LINE; TGF-BETA; UTERINE; HORMONE; BINDING; KINASE; GROWTH; TRANSACTIVATION; RESPONSIVENESS; TRANSCRIPTION	The progesterone receptor (PR) with its isoforms and ligands are involved in breast tumorigenesis and prognosis. We aimed at analyzing the respective contribution of PR isoforms, PRA and PRB, in breast cancer cell proliferation in a new estrogen-independent cell based-model, allowing independent PR isoforms analysis. We used the bi-inducible human breast cancer cell system MDA-iPRAB. We studied the effects and molecular mechanisms of action of progesterone (P4) and ulipristal acetate (UPA), a new selective progesterone receptor modulator, alone or in combination. P4 significantly stimulated MDA-iPRA expressing cells proliferation. This was associated with P4-stimulated expression of the anti-apoptotic factor BCL2-L1 and enhanced recruitment of PRA, SRC-1 and RNA Pol II onto the +58 kb PR binding motif of the BCL2-L-1 gene. UPA decreased cell proliferation and repressed BCL2-L-1 expression in the presence of PRA, correlating with PRA and SRC1 but not RNA Pol II recruitment. These results bring new information on the mechanism of action of PR ligands in controlling breast cancer cell proliferation through PRA in an estrogen independent model. Evaluation of PR isoforms ratio, as well as molecular signature studies based on PRA target genes could be proposed to facilitate personalized breast cancer therapy. In this context, UPA could be of interest in endocrine therapy. Further confirmation in the clinical setting is required.	[Esber, Nathalie; Le Billan, Florian; Loosfelt, Hugues; Lombes, Marc] Fac Med Paris Sud, INSERM, Unite Mixte Rech Sci 1185, Le Kremlin Bicetre, France; [Esber, Nathalie; Le Billan, Florian; Loosfelt, Hugues; Lombes, Marc] Univ Paris 11, Fac Med Paris Sud, Unite Mixte Rech Sci 1185, Le Kremlin Bicetre, France; [Esber, Nathalie; Resche-Rigon, Michele] HRA Pharma, Paris, France; [Lombes, Marc] Hop Bicetre, Assistance Publ Hop Paris, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Chabbert-Buffet, Nathalie] Hop Univ Est Parisien Site Tenon, AP HP, Serv Gynecol Obstet Med Reprod, Paris, France; [Chabbert-Buffet, Nathalie] Univ Paris 06, INSERM, Unite Mixte Rech Sci 938, Ctr Rech St Antoine, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Chabbert-Buffet, N (corresponding author), Hop Univ Est Parisien Site Tenon, AP HP, Serv Gynecol Obstet Med Reprod, Paris, France.	nathalie.chabbert-buffet@tnn.aphp.fr	Lombes, Marc/L-5933-2018	Lombes, Marc/0000-0003-3189-023X; Le Billan, Florian/0000-0002-3400-9295	HRA Pharma; national agency for Research (ANRT/HRA pharma CIFRE i.e. Conventions Industrielles de Formation par la Recherche, in English Research Training Industrial Grant Contract)	HRA Pharma; national agency for Research (ANRT/HRA pharma CIFRE i.e. Conventions Industrielles de Formation par la Recherche, in English Research Training Industrial Grant Contract)	The funder HRA Pharma provided support in the form of salary for one author [MRR], joint grant together with the national agency for Research (ANRT/HRA pharma CIFRE i.e. Conventions Industrielles de Formation par la Recherche, in English Research Training Industrial Grant Contract) [NE] but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. Data from the paper have been discussed twice a year with MRR, as required in the joint ANRT /HRAPharma CIFRE. The final MS has been approved by all coauthors before submission. The specific roles of these authors are articulated in the 'author contributions' section	Alvarez LD, 2011, BIOORGAN MED CHEM, V19, P1683, DOI 10.1016/j.bmc.2011.01.033; Attardi BJ, 2002, MOL CELL ENDOCRINOL, V188, P111, DOI 10.1016/S0303-7207(01)00743-2; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bellance C, 2013, MOL BIOL CELL, V24, P1363, DOI 10.1091/mbc.E12-11-0807; Bertucci PY, 2013, NUCLEIC ACIDS RES, V41, P6072, DOI 10.1093/nar/gkt327; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Chabbert-Buffet N, 2005, HUM REPROD UPDATE, V11, P293, DOI 10.1093/humupd/dmi002; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Clarke CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035859; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Communal L, 2012, HUM REPROD, V27, P2785, DOI 10.1093/humrep/des221; Comsa S, 2015, ANTICANCER RES, V35, P3147; DARBRE PD, 1990, J STEROID BIOCHEM, V37, P753, DOI 10.1016/0960-0760(90)90416-I; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Diep CH, 2015, J MOL ENDOCRINOL, V54, pR31, DOI 10.1530/JME-14-0252; Donnez J, 2014, FERTIL STERIL, V101, P1565, DOI 10.1016/j.fertnstert.2014.02.008; Donnez J, 2012, NEW ENGL J MED, V366, P421, DOI 10.1056/NEJMoa1103180; Engman M, 2008, HUM REPROD, V23, P2072, DOI 10.1093/humrep/den228; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Giulianelli S, 2013, VITAM HORM, V93, P161, DOI 10.1016/B978-0-12-416673-8.00009-5; Glasier AF, 2010, LANCET, V375, P555, DOI 10.1016/S0140-6736(10)60101-8; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; Hagan CR, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-32; Hagan CR, 2013, NUCLEIC ACIDS RES, V41, P8926, DOI 10.1093/nar/gkt706; Horwitz KB, 2008, J CLIN ENDOCR METAB, V93, P3295, DOI 10.1210/jc.2008-0938; Jackson SE, 2015, INT J CANCER, V137, P262, DOI 10.1002/ijc.28940; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Khan JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045993; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Knutson TP, 2014, PHARMACOL THERAPEUT, V142, P114, DOI 10.1016/j.pharmthera.2013.11.010; Le Billan F, 2015, FASEB J; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Leo JCL, 2008, INT J CANCER, V122, P230, DOI 10.1002/ijc.23081; Lindet C, 2012, INT J BIOL MARKER, V27, pE111, DOI 10.5301/JBM.2012.9198; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McGowan EM, 1999, MOL ENDOCRINOL, V13, P1657, DOI 10.1210/me.13.10.1657; McGowan EM, 2003, J MOL ENDOCRINOL, V31, P241, DOI 10.1677/jme.0.0310241; Moore MR, 2000, BIOCHEM BIOPH RES CO, V277, P650, DOI 10.1006/bbrc.2000.3728; Mote PA, 2008, ERNST SCHERING FOUND, V1, P77, DOI 10.1007/2789_2008_076; Mote PA, 2002, BREAST CANCER RES TR, V72, P163, DOI 10.1023/A:1014820500738; Mote PA, 2004, GENE CHROMOSOME CANC, V39, P236, DOI 10.1002/gcc.10321; Mote PA, 2015, BREAST CANCER RES TR, V151, P309, DOI 10.1007/s10549-015-3397-0; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; SARTORIUS CA, 1994, MOL ENDOCRINOL, V8, P1347, DOI 10.1210/me.8.10.1347; Shah R, 2014, WORLD J CLIN ONCOL, V5, P283, DOI 10.5306/wjco.v5.i3.283; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tung L, 2006, MOL ENDOCRINOL, V20, P2656, DOI 10.1210/me.2006-0105; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Wargon V, 2015, INT J CANCER, V136, P2680, DOI 10.1002/ijc.29304; Wargon V, 2009, BREAST CANCER RES TR, V116, P449, DOI 10.1007/s10549-008-0150-y; Whittle JR, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0523-1; Xu Q, 2005, J CLIN ENDOCR METAB, V90, P953, DOI 10.1210/jc.2004-1569; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021; Yun BS, 2015, EUR J OBSTET GYN R B, V191, P62, DOI 10.1016/j.ejogrb.2015.05.022	57	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140795	10.1371/journal.pone.0140795	http://dx.doi.org/10.1371/journal.pone.0140795			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474308	Green Published, gold, Green Submitted			2022-12-27	WOS:000363185500111
J	Raveh, O; David, N; Rilov, G; Rahav, E				Raveh, Ofrat; David, Niv; Rilov, Gil; Rahav, Eyal			The Temporal Dynamics of Coastal Phytoplankton and Bacterioplankton in the Eastern Mediterranean Sea	PLOS ONE			English	Article							MICROBIAL FOOD-WEB; DINITROGEN FIXATION; LEVANTINE BASIN; BACTERIAL PRODUCTION; PRIMARY PRODUCTIVITY; CRETAN SEA; COMMUNITY STRUCTURE; SEASONAL DYNAMICS; STANDING STOCKS; P-LIMITATION	This study considers variability in phytoplankton and heterotrophic bacterial abundances and production rates, in one of the most oligotrophic marine regions in the world-the Levantine Basin. The temporal dynamics of these planktonic groups were studied in the coastal waters of the southeastern Mediterranean Sea approximately every two weeks for a total of two years. Heterotrophic bacteria were abundant mostly during late summer and midwinter, and were positively correlated with bacterial production and with N-2 fixation. Based on size fractionating, picophytoplankton was abundant during the summer, whereas nano-microphytoplankton predominated during the winter and early spring, which were also evident in the size-fractionated primary production rates. Autotrophic abundance and production correlated negatively with temperature, but did not correlate with inorganic nutrients. Furthermore, a comparison of our results with results from the open Levantine Basin demonstrates that autotrophic and heterotrophic production, as well as N-2 fixation rates, are considerably higher in the coastal habitat than in the open sea, while nutrient levels or cell abundance are not different. These findings have important ecological implications for food web dynamics and for biological carbon sequestration in this understudied region.	[Raveh, Ofrat; David, Niv; Rilov, Gil; Rahav, Eyal] Natl Inst Oceanog, Israel Oceanog & Limnol Res, IL-31080 Haifa, Israel	Israel Oceanographic & Limnological Research Institute	Rahav, E (corresponding author), Natl Inst Oceanog, Israel Oceanog & Limnol Res, IL-31080 Haifa, Israel.	eyal.rahav@ocean.org.il		Rilov, Gil/0000-0002-1334-4887	Ministry of National Infrastructures, Energy and Water Resources [3-11519]	Ministry of National Infrastructures, Energy and Water Resources	This work was supported by the Ministry of National Infrastructures, Energy and Water Resources (grant number 3-11519) to E.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HE, 2010, ENVIRON MICROBIOL, V12, P1319, DOI 10.1111/j.1462-2920.2010.02176.x; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; AZOV Y, 1986, J PLANKTON RES, V8, P41, DOI 10.1093/plankt/8.1.41; Bar-Zeev E, 2011, MAR ECOL PROG SER, V431, P107, DOI 10.3354/meps09110; Bar-Zeev E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00403; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; BERMAN T, 1984, OCEANOL ACTA, V7, P367; Berman-Frank I., 2012, LIFE MEDITERRANEAN S, P199; BILLEN G, 1990, HYDROBIOLOGIA, V207, P37, DOI 10.1007/BF00041438; Bonnet S, 2011, BIOGEOSCIENCES, V8, P2257, DOI 10.5194/bg-8-2257-2011; Bosc E, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002034; CEDERWALL H, 1990, AMBIO, V19, P109; Chen BZ, 2010, MAR ECOL PROG SER, V407, P43, DOI 10.3354/meps08572; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; Christaki U, 2011, BIOGEOSCIENCES, V8, P1839, DOI 10.5194/bg-8-1839-2011; Christaki U, 1999, MAR ECOL PROG SER, V181, P297, DOI 10.3354/meps181297; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Denis M, 2010, BIOGEOSCIENCES, V7, P2227, DOI 10.5194/bg-7-2227-2010; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Efrati S, 2013, BIOGEOSCIENCES, V10, P3349, DOI 10.5194/bg-10-3349-2013; Foster RA, 2009, LIMNOL OCEANOGR, V54, P219, DOI 10.4319/lo.2009.54.1.0219; Fussel HM, 2009, CLIMATIC CHANGE, V97, P469, DOI 10.1007/s10584-009-9648-5; Garneau ME, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004281; Gertman I., 2013, RAPP CONGRESS CIESM, V40, P211; Gotsis-Skretas O, 1999, PROG OCEANOGR, V44, P625, DOI 10.1016/S0079-6611(99)00048-8; Groom S, 2005, DEEP-SEA RES PT II, V52, P2990, DOI 10.1016/j.dsr2.2005.08.019; Grover JP, 2006, J PLANKTON RES, V28, P1, DOI 10.1093/plankt/fbi095; HARRIS GP, 1991, J PLANKTON RES, V13, pS109; Herut B, 2005, DEEP-SEA RES PT II, V52, P3024, DOI 10.1016/j.dsr2.2005.09.003; Herut B, 2002, FRESEN ENVIRON BULL, V11, P782; Herut B, 2000, OCEANOL ACTA, V23, P771, DOI 10.1016/S0399-1784(00)01118-X; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Hoshiai G, 2003, FISHERIES SCI, V69, P1303, DOI 10.1111/j.0919-9268.2003.00760.x; Ibello V, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041635; Ignatiades L, 2002, J MARINE SYST, V36, P11, DOI 10.1016/S0924-7963(02)00132-X; Ignatiades L, 2009, J PLANKTON RES, V31, P411, DOI 10.1093/plankt/fbn124; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Kirchman DL, 1997, MICROBIAL ECOL, V33, P11, DOI 10.1007/s002489900003; Kirchman DL, 1992, MICROBIAL ECOLOGY OC, P85; Kostadinov TS, 2010, BIOGEOSCIENCES, V7, P3239, DOI 10.5194/bg-7-3239-2010; Kress N, 2005, DEEP-SEA RES PT II, V52, P3054, DOI 10.1016/j.dsr2.2005.08.013; Kress N, 2001, DEEP-SEA RES PT I, V48, P2347, DOI 10.1016/S0967-0637(01)00022-X; Kress N, 2014, J MARINE SYST, V135, P6, DOI 10.1016/j.jmarsys.2013.11.016; Krom MD, 2010, PROG OCEANOGR, V85, P236, DOI 10.1016/j.pocean.2010.03.003; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Li WKW, 1998, CAN DATA REP FISH AQ, V0, P1; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Lomas MW, 2013, DEEP-SEA RES PT II, V93, P16, DOI 10.1016/j.dsr2.2013.01.008; Luna GM, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004168; MAGAZZU G, 1995, AQUAT MICROB ECOL, V9, P97, DOI 10.3354/ame009097; Marty JC, 2002, DEEP-SEA RES PT II, V49, P1965, DOI 10.1016/S0967-0645(02)00022-X; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Moran XAG, 2010, AQUAT MICROB ECOL, V58, P229, DOI 10.3354/ame01374; Moutin T, 2002, J MARINE SYST, V33, P273, DOI 10.1016/S0924-7963(02)00062-3; Moutin T, 2002, LIMNOL OCEANOGR, V47, P1562, DOI 10.4319/lo.2002.47.5.1562; Oviatt C, 2002, ESTUAR COAST SHELF S, V54, P1013, DOI 10.1006/ecss.2001.0872; Paytan A, 2009, P NATL ACAD SCI USA, V106, P4601, DOI 10.1073/pnas.0811486106; Pinhassi J, 2000, AQUAT MICROB ECOL, V21, P245, DOI 10.3354/ame021245; Psarra S, 2000, PROG OCEANOGR, V46, P187, DOI 10.1016/S0079-6611(00)00018-5; Pulido-Villena E., 2012, LIFE MEDITERRANEAN S, P227; Rahav E, 2013, OCEAN SCI, V9, P489, DOI 10.5194/os-9-489-2013; Rahav E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00227; Rahav E, 2013, J GEOPHYS RES-BIOGEO, V118, P195, DOI 10.1002/jgrg.20023; ress N., 2012, LIFE MEDITERRANEAN S, P157; Reynolds C, 2000, HYDROBIOLOGIA, V424, P147, DOI 10.1023/A:1003973532706; Robertson BR, 1998, APPL ENVIRON MICROB, V64, P3900; SHIAH FK, 1994, LIMNOL OCEANOGR, V39, P1243, DOI 10.4319/lo.1994.39.6.1243; SIMON M, 1990, MAR ECOL PROG SER, V65, P205, DOI 10.3354/meps065205; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; SIMON N, 1994, J PHYCOL, V30, P922, DOI 10.1111/j.0022-3646.1994.00922.x; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Stambler N, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003373; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Tait LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074413; TAKAHASHI M, 1984, MAR BIOL, V79, P177, DOI 10.1007/BF00951826; Tanaka T, 2011, BIOGEOSCIENCES, V8, P525, DOI 10.5194/bg-8-525-2011; Tanaka T, 2003, LIMNOL OCEANOGR, V48, P1150, DOI 10.4319/lo.2003.48.3.1150; Tanaka T, 2007, DEEP-SEA RES PT I, V54, P1721, DOI 10.1016/j.dsr.2007.06.008; TOWNSEND DW, 1994, DEEP-SEA RES PT I, V41, P747, DOI 10.1016/0967-0637(94)90075-2; Turley CM, 2000, MAR ECOL PROG SER, V193, P11, DOI 10.3354/meps193011; Van Wambeke F, 2000, PROG OCEANOGR, V46, P205, DOI 10.1016/S0079-6611(00)00019-7; Van Wambeke F, 2011, BIOGEOSCIENCES, V8, P1853, DOI 10.5194/bg-8-1853-2011; Van Wambeke F, 2002, MICROB ECOL, V43, P119, DOI 10.1007/s00248-001-0038-4; Vaulot D, 1999, J GEOPHYS RES-OCEANS, V104, P3297, DOI 10.1029/98JC01333; YACOBI YZ, 1995, J MARINE SYST, V6, P179, DOI 10.1016/0924-7963(94)00028-A; Yogev T, 2011, ENVIRON MICROBIOL, V13, P854, DOI 10.1111/j.1462-2920.2010.02402.x; Zohary T, 2005, DEEP-SEA RES PT II, V52, P3011, DOI 10.1016/j.dsr2.2005.08.011; Zohary T, 1998, LIMNOL OCEANOGR, V43, P387, DOI 10.4319/lo.1998.43.3.0387; Zohary T, 1998, MAR ECOL PROG SER, V167, P47, DOI 10.3354/meps167047	93	47	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140690	10.1371/journal.pone.0140690	http://dx.doi.org/10.1371/journal.pone.0140690			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474399	gold, Green Submitted, Green Published			2022-12-27	WOS:000363185500082
J	Koslicki, D; Chatterjee, S; Shahrivar, D; Walker, AW; Francis, SC; Fraser, LJ; Vehkapera, M; Lan, YH; Corander, J				Koslicki, David; Chatterjee, Saikat; Shahrivar, Damon; Walker, Alan W.; Francis, Suzanna C.; Fraser, Louise J.; Vehkaperae, Mikko; Lan, Yueheng; Corander, Jukka			ARK: Aggregation of Reads by K-Means for Estimation of Bacterial Community Composition	PLOS ONE			English	Article							SPLIT VECTOR QUANTIZATION; SEQUENCES	Motivation Estimation of bacterial community composition from high-throughput sequenced 16S rRNA gene amplicons is a key task in microbial ecology. Since the sequence data from each sample typically consist of a large number of reads and are adversely impacted by different levels of biological and technical noise, accurate analysis of such large datasets is challenging. Results There has been a recent surge of interest in using compressed sensing inspired and convex-optimization based methods to solve the estimation problem for bacterial community composition. These methods typically rely on summarizing the sequence data by frequencies of low-order k-mers and matching this information statistically with a taxonomically structured database. Here we show that the accuracy of the resulting community composition estimates can be substantially improved by aggregating the reads from a sample with an unsupervised machine learning approach prior to the estimation phase. The aggregation of reads is a pre-processing approach where we use a standard K-means clustering algorithm that partitions a large set of reads into subsets with reasonable computational cost to provide several vectors of first order statistics instead of only single statistical summarization in terms of k-mer frequencies. The output of the clustering is then processed further to obtain the final estimate for each sample. The resulting method is called Aggregation of Reads by K-means (ARK), and it is based on a statistical argument via mixture density formulation. ARK is found to improve the fidelity and robustness of several recently introduced methods, with only a modest increase in computational complexity. Availability An open source, platform-independent implementation of the method in the Julia programming language is freely available at https://github.com/dkoslicki/ARK. A Matlab implementation is available at http://www.ee.kth.se/ctsoftware.	[Koslicki, David] Oregon State Univ, Dept Math, Corvallis, OR 97331 USA; [Chatterjee, Saikat; Shahrivar, Damon] KTH Royal Inst Technol, Dept Commun Theory, Stockholm, Sweden; [Walker, Alan W.] Univ Aberdeen, Microbiol Grp, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Francis, Suzanna C.] Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1E 7HT, England; [Fraser, Louise J.] Illumina Cambridge Ltd, Cambridge, Essex, England; [Vehkaperae, Mikko] Univ Sheffield, Dept Elect & Elect Engn, Sheffield S1 3JD, S Yorkshire, England; [Lan, Yueheng] Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China; [Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland	Oregon State University; Royal Institute of Technology; University of Aberdeen; University of London; London School of Hygiene & Tropical Medicine; Illumina; University of Sheffield; Tsinghua University; University of Helsinki	Chatterjee, S (corresponding author), KTH Royal Inst Technol, Dept Commun Theory, Stockholm, Sweden.	sach@kth.se	Lan, Yue-heng/AAI-4419-2020; Walker, Alan W./AAE-8102-2019; Vehkapera, Mikko/L-3697-2014; Vehkapera, Mikko/AAG-7464-2020	Walker, Alan W./0000-0001-5099-8495; Vehkapera, Mikko/0000-0002-3085-538X; Francis, Suzanna Carter/0000-0002-3724-4813	Swedish Research Council Linnaeus Centre ACCESS; ERC grant [239784]; Academy of Finland Center of Excellence COIN; Academy of Finland; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); UK MRC/DFID grant [G1002369]; Illumina Cambridge Ltd.; MRC [G1002369, G0701039] Funding Source: UKRI; Medical Research Council [G1002369, G0701039, MR/K012126/1] Funding Source: researchfish	Swedish Research Council Linnaeus Centre ACCESS; ERC grant; Academy of Finland Center of Excellence COIN(Academy of Finland); Academy of Finland(Academy of Finland); Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); UK MRC/DFID grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Illumina Cambridge Ltd.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Swedish Research Council Linnaeus Centre ACCESS (S.C.), ERC grant 239784 (J.C.), the Academy of Finland Center of Excellence COIN (J.C.), the Academy of Finland (M.V.), the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS) (A.W.W), and the UK MRC/DFID grant G1002369 (S.C.F). L.J.F. received funding in the form of salary from Illumina Cambridge Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambat SK, 2013, IEEE T SIGNAL PROCES, V61, P3699, DOI 10.1109/TSP.2013.2259821; Angly FE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks251; Balzer S, 2010, BIOINFORMATICS, V26, pi420, DOI 10.1093/bioinformatics/btq365; Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Chatterjee S, 2008, SIGNAL PROCESS, V88, P1528, DOI 10.1016/j.sigpro.2008.01.001; Chatterjee S, 2007, IEEE SIGNAL PROC LET, V14, P641, DOI 10.1109/LSP.2007.894960; Chatterjee S, 2014, BIOINFORMATICS, V30, P2423, DOI 10.1093/bioinformatics/btu320; Cheng L, 2012, NUCLEIC ACIDS RES, V40, P5240, DOI 10.1093/nar/gks227; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Droge J, 2015, BIOINFORMATICS, V31, P817, DOI 10.1093/bioinformatics/btu745; Duda R. O., 2010, PATTERN CLASSIFICATI; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Koslicki D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091784; Koslicki D, 2013, BIOINFORMATICS, V29, P2096, DOI 10.1093/bioinformatics/btt336; LINDE Y, 1980, IEEE T COMMUN, V28, P84, DOI 10.1109/TCOM.1980.1094577; Meinicke P, 2011, BIOINFORMATICS, V27, P1618, DOI 10.1093/bioinformatics/btr266; Mitra S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S17; Ong SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060811; Otu HH, 2003, BIOINFORMATICS, V19, P22, DOI 10.1093/bioinformatics/19.1.22; Rosen Gail, 2008, Advances in Bioinformatics, V2008, P205969, DOI 10.1155/2008/205969; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	24	3	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0140644	10.1371/journal.pone.0140644	http://dx.doi.org/10.1371/journal.pone.0140644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496191	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000363309200025
J	Mellander, C; Lobo, J; Stolarick, K; Matheson, Z				Mellander, Charlotta; Lobo, Jose; Stolarick, Kevin; Matheson, Zara			Night-Time Light Data: A Good Proxy Measure for Economic Activity?	PLOS ONE			English	Article							POPULATION; EMISSIONS; IMAGERY	Much research has suggested that night-time light (NTL) can be used as a proxy for a number of variables, including urbanization, density, and economic growth. As governments around the world either collect census data infrequently or are scaling back the amount of detail collected, alternate sources of population and economic information like NTL are being considered. But, just how close is the statistical relationship between NTL and economic activity at a fine-grained geographical level? This paper uses a combination of correlation analysis and geographically weighted regressions in order to examine if light can function as a proxy for economic activities at a finer level. We use a fine-grained geo-coded residential and industrial full sample micro-data set for Sweden, and match it with both radiance and saturated light emissions. We find that the correlation between NTL and economic activity is strong enough to make it a relatively good proxy for population and establishment density, but the correlation is weaker in relation to wages. In general, we find a stronger relation between light and density values, than with light and total values. We also find a closer connection between radiance light and economic activity, than with saturated light. Further, we find the link between light and economic activity, especially estimated by wages, to be slightly overestimated in large urban areas and underestimated in rural areas.	[Mellander, Charlotta] Jonkoping Univ, Jonkoping Int Business Sch, Jonkoping, Sweden; [Lobo, Jose] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Stolarick, Kevin] OCAD Univ, Inclus Design Res Ctr, Toronto, ON, Canada; [Matheson, Zara] Univ Toronto, Rotman Sch Management, Former Martin Prosper Inst, Toronto, ON, Canada	Jonkoping University; Arizona State University; Arizona State University-Tempe; University of Toronto	Mellander, C (corresponding author), Jonkoping Univ, Jonkoping Int Business Sch, Jonkoping, Sweden.	charlotta.mellander@ju.se						Angel S, 2012, PLANET OF CITIES; Angel S., 2011, POLICY FOCUS REPORT, DOI 10.4337/9781849808057.00023; [Anonymous], 2013, WORLD FACT BOOK; Brunsdon C., 2002, J ROYAL STAT SOC D, V47, P431; Chen X, 2011, P NATL ACAD SCI USA, V108, P8589, DOI 10.1073/pnas.1017031108; Doll CNH, 2000, AMBIO, V29, P157, DOI 10.1639/0044-7447(2000)029[0157:NTIAAT]2.0.CO;2; Elvidge CD, 1997, INT J REMOTE SENS, V18, P1373, DOI 10.1080/014311697218485; Elvidge CD, 1997, GLOBAL CHANGE BIOL, V3, P387, DOI 10.1046/j.1365-2486.1997.00115.x; Elvidge CD, 1997, PHOTOGRAMM ENG REM S, V63, P727; Elvidge CD, 1999, REMOTE SENS ENVIRON, V68, P77, DOI 10.1016/S0034-4257(98)00098-4; Elvidge CD, 2009, COMPUT GEOSCI-UK, V35, P1652, DOI 10.1016/j.cageo.2009.01.009; Florida R, 2012, PROF GEOGR, V64, P178, DOI 10.1080/00330124.2011.583590; Florida R, 2008, CAMB J REG ECON SOC, V1, P459, DOI 10.1093/cjres/rsn018; Ghosh T, 2012, SOCIAL GEOGRAPHY, V7, P23, DOI [10.5194/sg-7-23-2012, DOI 10.5194/SG-7-23-2012]; Henderson V, 2011, AM ECON REV, V101, P194, DOI 10.1257/aer.101.3.194; Imhoff ML, 1997, REMOTE SENS ENVIRON, V61, P361; Letu H, 2012, IEEE T GEOSCI REMOTE, V50, P389, DOI 10.1109/TGRS.2011.2178031; Leung Y, 2000, ENVIRON PLANN A, V32, P871, DOI 10.1068/a32117; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Small C, 2011, REMOTE SENS ENVIRON, V115, P269, DOI 10.1016/j.rse.2010.08.021; Sutton P., 2007, INT J ECOL EC STAT, V8, P5; Townsend AC, 2010, INT J REMOTE SENS, V31, P4459, DOI 10.1080/01431160903261005; Zhang QL, 2011, REMOTE SENS ENVIRON, V115, P2320, DOI 10.1016/j.rse.2011.04.032; Zhuo L, 2009, INT J REMOTE SENS, V30, P1003, DOI 10.1080/01431160802430693; Ziskin D, 2010, P 30 M AS PAC ADV NE, V30, P131, DOI DOI 10.7125/APAN.30.18	25	181	186	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0139779	10.1371/journal.pone.0139779	http://dx.doi.org/10.1371/journal.pone.0139779			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU1VG	26496428	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000363309200009
J	Kaiser, M; Kirsch, B; Hauser, H; Schneider, D; Seuss-Baum, I; Goycoolea, FM				Kaiser, Mathias; Kirsch, Benedikt; Hauser, Hannah; Schneider, Desiree; Seuss-Baum, Ingrid; Goycoolea, Francisco M.			In Vitro and Sensory Evaluation of Capsaicin-Loaded Nanoformulations	PLOS ONE			English	Article							ALPHA-AMYLASE; CHITOSAN; MECHANISMS	Capsaicin has known health beneficial and therapeutic properties. It is also able to enhance the permeability of drugs across epithelial tissues. Unfortunately, due to its pungency the oral administration of capsaicin is limited. To this end, we assessed the effect of nanoencapsulation of capsaicin, under the hypothesis that this would reduce its pungency. Core-shell nanocapsules with an oily core and stabilized with phospholipids were used. This system was used with or without chitosan coating. In this work, we investigated the in vitro release behavior of capsaicin-loaded formulations in different physiological media (including simulated saliva fluid). We also evaluated the influence of encapsulation of capsaicin on the cell viability of buccal cells (TR146). To study the changes in pungency after encapsulation we carried out a sensory analysis with a trained panel of 24 students. The in vitro release study showed that the systems discharged capsaicin slowly in a monotonic manner and that the chitosan coating had an effect on the release profile. The cytotoxic response of TR146 cells to capsaicin at a concentration of 500 mu M, which was evident for the free compound, was reduced following its encapsulation. The sensory study revealed that a chitosan coating results in a lower threshold of perception of the formulation. The nanoencapsulation of capsaicin resulted in attenuation of the sensation of pungency significantly. However, the presence of a chitosan shell around the nanoformulations did not mask the pungency, when compared with uncoated systems.	[Kaiser, Mathias; Goycoolea, Francisco M.] Univ Munster, IBBP, D-48149 Munster, North Rhine Wes, Germany; [Kirsch, Benedikt; Hauser, Hannah; Schneider, Desiree; Seuss-Baum, Ingrid] Univ Appl Sci Fulda, Dept Food Technol, Fulda, Hesse, Germany	University of Munster	Goycoolea, FM (corresponding author), Univ Munster, IBBP, D-48149 Munster, North Rhine Wes, Germany.	goycoole@uni-muenster.de	Goycoolea, Francisco M./Q-5841-2017; Goycoolea, Francisco M. M/G-5755-2017	Goycoolea, Francisco M./0000-0001-7949-5429; Goycoolea, Francisco M. M/0000-0001-7949-5429	DFG, Germany [GRK 1549]; Danish Agency for Science, Technology and Innovation, Denmark (FENAMI project) [10-093456]; European Union [613931]	DFG, Germany(German Research Foundation (DFG)); Danish Agency for Science, Technology and Innovation, Denmark (FENAMI project); European Union(European Commission)	The authors acknowledge support from DFG, Germany (Project GRK 1549 International Research Training Group 'Molecular and Cellular GlycoSciences'), and from The Danish Agency for Science, Technology and Innovation, Denmark (FENAMI project 10-093456). The research leading to these results has also received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 613931.	[Anonymous], 13301200209 ISO; [Anonymous], 10970200209 DIN; [Anonymous], 10962199710 DIN; Arhakis A, 2013, OPEN DENT J, V7, P7, DOI 10.2174/1874210601307010007; Calvo P, 1997, INT J PHARM, V153, P41, DOI 10.1016/S0378-5173(97)00083-5; Chien PJ, 2007, J FOOD ENG, V78, P225, DOI 10.1016/j.jfoodeng.2005.09.022; Choi AJ, 2011, FOOD BIOPROCESS TECH, V4, P1119, DOI 10.1007/s11947-011-0568-9; Choi AY, 2013, J AGR FOOD CHEM, V61, P2096, DOI 10.1021/jf3052708; Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1; Davidov-Pardo G., 2008, American Journal of Food Technology, V3, P384; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DIN-EN-ISO, 2014, 8586201405 DIN EN IS; GOVINDARAJAN VS, 1991, CRIT REV FOOD SCI, V29, P435, DOI 10.1080/10408399109527536; Goycoolea FM, 2012, COLLOID POLYM SCI, V290, P1423, DOI 10.1007/s00396-012-2669-z; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kaiser M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10048; Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004; Kim JH, 2014, J AGR FOOD CHEM, V62, P725, DOI 10.1021/jf404220n; Korel F, 2002, J AGR FOOD CHEM, V50, P3257, DOI 10.1021/jf010537b; KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9; KRAJEWSKA AM, 1988, J FOOD SCI, V53, P902, DOI 10.1111/j.1365-2621.1988.tb08981.x; Kurita S, 2002, BIOSCI BIOTECH BIOCH, V66, P532, DOI 10.1271/bbb.66.532; Meghvansi MK, 2010, J ETHNOPHARMACOL, V132, P1, DOI 10.1016/j.jep.2010.08.034; Menchicchi B, 2014, BIOMACROMOLECULES, V15, P3550, DOI 10.1021/bm5007954; Nascimento PLA, 2014, MOLECULES, V19, P5434, DOI 10.3390/molecules19045434; Peh KK, 1999, J PHARM PHARM SCI, V2, P53; RINAUDO M, 1993, INT J BIOL MACROMOL, V15, P281, DOI 10.1016/0141-8130(93)90027-J; Rodriguez MS, 2003, J FOOD SCI, V68, P665, DOI 10.1111/j.1365-2621.2003.tb05728.x; Schneider D., 2014, ADV J FOOD SCI TECHN, V6, P36; Schneider DJ, 2014, FOOD QUAL PREFER, V38, P98, DOI 10.1016/j.foodqual.2014.05.017; Schneider DJ, 2011, 6 DLG LEB DARMST; Shiobara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079954; SIZER F, 1985, CHEM SENSES, V10, P279, DOI 10.1093/chemse/10.3.279; Tsukura Y, 2007, BIOL PHARM BULL, V30, P1982, DOI 10.1248/bpb.30.1982; Turgut C, 2004, ENVIRON SCI POLLUT R, V11, P7, DOI 10.1065/espr2003.12.180; Wang JC, 2010, J APPL POLYM SCI, V116, P2234, DOI 10.1002/app.31684; Wu SJ, 2011, FOOD CHEM, V128, P769, DOI 10.1016/j.foodchem.2011.03.111; Xing FB, 2004, J APPL POLYM SCI, V91, P2669, DOI 10.1002/app.13449; Xing FB, 2006, J APPL POLYM SCI, V102, P1318, DOI 10.1002/app.23766; Yeh TH, 2011, BIOMATERIALS, V32, P6164, DOI 10.1016/j.biomaterials.2011.03.056; Yi EJ, 2014, INT J PHARMACEUT, V466, P286, DOI 10.1016/j.ijpharm.2014.03.001; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b; Zhu Y, 2014, J FUNCT FOODS, V8, P358, DOI 10.1016/j.jff.2014.04.001	43	19	19	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141017	10.1371/journal.pone.0141017	http://dx.doi.org/10.1371/journal.pone.0141017			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492045	Green Published, Green Submitted, gold			2022-12-27	WOS:000363249300021
J	Morton, B; Nagaraja, S; Collins, A; Pennington, SH; Blakey, JD				Morton, Ben; Nagaraja, Shankara; Collins, Andrea; Pennington, Shaun H.; Blakey, John D.			A Retrospective Evaluation of Critical Care Blood Culture Yield - Do Support Services Contribute to the "Weekend Effect"?	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; MORTALITY; BACTEREMIA; DIAGNOSIS; PATIENT; TIME	Background The "weekend effect" describes an increase in adverse outcomes for patients admitted at the weekend. Critical care units have moved to higher intensity working patterns to address this with some improved outcomes. However, support services have persisted with traditional working patterns. Blood cultures are an essential diagnostic tool for patients with sepsis but yield is dependent on sampling technique and processing. We therefore used blood culture yield as a surrogate for the quality of support service provision. We hypothesized that blood culture yields would be lower over the weekend as a consequence of reduced support services. Methods We performed a retrospective observational study examining 1575 blood culture samples in a university hospital critical care unit over a one-year period. Results Patients with positive cultures had, on average, higher APACHE II scores (p = 0.015), longer durations of stay (p = 0.03), required more renal replacement therapy (p<0.001) and had higher mortality (p = 0.024). Blood culture yield decreased with repeated sampling with an increased proportion of contaminants. Blood cultures were 26.7% less likely to be positive if taken at the weekend (p = 0.0402). This effect size is the equivalent to the impact of sampling before and after antibiotic administration. Conclusions Our study demonstrates that blood culture yield is lower at the weekend. This is likely caused by delays or errors in incubation and processing, reflecting the reduced provision of support services at the weekend. Reorganization of services to address the "weekend effect" should acknowledge the interdependent nature of healthcare service delivery.	[Morton, Ben; Collins, Andrea; Pennington, Shaun H.; Blakey, John D.] Univ Liverpool Liverpool Sch Trop Med, Resp Infect Grp, Dept Clin Sci, Liverpoool, England; [Morton, Ben; Nagaraja, Shankara; Blakey, John D.] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Collins, Andrea] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine; Aintree University Hospitals NHS Foundation Trust; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Morton, B (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Resp Infect Grp, Dept Clin Sci, Liverpoool, England.	ben.morton@lstmed.ac.uk	Pennington, Shaun/CAF-3518-2022	Pennington, Shaun/0000-0002-7160-6275; collins, andrea/0000-0002-4094-1572; Morton, Ben/0000-0002-6164-2854				Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Aylin P, 2010, QUAL SAF HEALTH CARE, V19, P213, DOI 10.1136/qshc.2008.028639; BATES DW, 1990, ANN INTERN MED, V113, P495, DOI 10.7326/0003-4819-113-7-495; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Bell CM, 2004, AM J MED, V117, P175, DOI 10.1016/j.amjmed.2004.02.047; Bloos F, 2010, INTENS CARE MED, V36, P241, DOI 10.1007/s00134-009-1705-z; Campbell SG, 2003, CHEST, V123, P1142, DOI 10.1378/chest.123.4.1142; Cavallazzi R, 2010, CHEST, V138, P68, DOI 10.1378/chest.09-3018; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Deshmukh A, 2012, AM J CARDIOL, V110, P208, DOI 10.1016/j.amjcard.2012.03.011; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Hauptfleisch J, 2013, CLIN RADIOL, V68, pE245, DOI 10.1016/j.crad.2012.12.007; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Magadia RR, 2001, INFECT DIS CLIN N AM, V15, P1009, DOI 10.1016/S0891-5520(05)70184-7; Mohammed MA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-87; Muscedere J, 2008, J CRIT CARE, V23, P138, DOI 10.1016/j.jcrc.2007.12.008; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Roth A, 2010, J CLIN MICROBIOL, V48, P4552, DOI 10.1128/JCM.00877-10; Schwetz I, 2007, J CLIN MICROBIOL, V45, P2691, DOI 10.1128/JCM.00085-07; Shafazand S, 2002, CHEST, V122, P1727, DOI 10.1378/chest.122.5.1727; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Tokars JI, 2004, CLIN INFECT DIS, V39, P333, DOI 10.1086/421941; Varnava AM, 2002, HEART, V87, P216, DOI 10.1136/heart.87.3.216; Waterer GW, 2001, RESP MED, V95, P78, DOI 10.1053/rmed.2000.0977; Wilcox ME, 2013, CRIT CARE MED, V41, P2253, DOI 10.1097/CCM.0b013e318292313a	27	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141361	10.1371/journal.pone.0141361	http://dx.doi.org/10.1371/journal.pone.0141361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492559	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000363249300045
J	Stelfox, HT; Niven, DJ; Clement, FM; Bagshaw, SM; Cook, DJ; McKenzie, E; Potestio, ML; Doig, CJ; O'Neill, B; ZygunDavid				Stelfox, Henry T.; Niven, Daniel J.; Clement, Fiona M.; Bagshaw, Sean M.; Cook, Deborah J.; McKenzie, Emily; Potestio, Melissa L.; Doig, Christopher J.; O'Neill, Barbara; ZygunDavid		Critical Care Strategic Clinical N; Alberta Hlth Serv	Stakeholder Engagement to Identify Priorities for Improving the Quality and Value of Critical Care	PLOS ONE			English	Article							LONGITUDINAL DATA-ANALYSIS; TOP 5 LIST; ILL PATIENTS; VENOUS THROMBOEMBOLISM; KNOWLEDGE TRANSLATION; HEALTH; TRIAL; IMPROVEMENT; MEDICINE; OUTCOMES	Background Large amounts of scientific evidence are generated, but not implemented into patient care (the 'knowledge-to-care' gap). We identified and prioritized knowledge-to-care gaps in critical care as opportunities to improve the quality and value of healthcare. Methods We used a multi-method community-based participatory research approach to engage a Network of all adult (n = 14) and pediatric (n = 2) medical-surgical intensive care units (ICUs) in a fully integrated geographically defined healthcare system serving 4 million residents. Participants included Network oversight committee members (n = 38) and frontline providers (n = 1,790). Network committee members used a modified RAND/University of California Appropriateness Methodology, to serially propose, rate (validated 9 point scale) and revise potential knowledge-to-care gaps as priorities for improvement. The priorities were sent to frontline providers for evaluation. Results were relayed back to all frontline providers for feedback. Results Initially, 68 knowledge-to-care gaps were proposed, rated and revised by the committee (n = 32 participants) over 3 rounds of review and resulted in 13 proposed priorities for improvement. Then, 1,103 providers (62% response rate) evaluated the priorities, and rated 9 as 'necessary' (median score 7-9). Several factors were associated with rating priorities as necessary in multivariable logistic regression, related to the provider (experience, teaching status of ICU) and topic (strength of supporting evidence, potential to benefit the patient, potential to improve patient/family experience, potential to decrease costs). Conclusions A community-based participatory research approach engaged a diverse group of stakeholders to identify 9 priorities for improving the quality and value of critical care. The approach was time and cost efficient and could serve as a model to prioritize areas for research quality improvement across other settings.	[Stelfox, Henry T.; Niven, Daniel J.; Doig, Christopher J.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Stelfox, Henry T.; Niven, Daniel J.; Clement, Fiona M.; McKenzie, Emily; Potestio, Melissa L.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Stelfox, Henry T.; Niven, Daniel J.; Bagshaw, Sean M.; Potestio, Melissa L.; Doig, Christopher J.; O'Neill, Barbara; ZygunDavid] Alberta Hlth Serv, Calgary, AB, Canada; [Bagshaw, Sean M.; ZygunDavid] Univ Alberta, Fac Med & Dent, Div Crit Care Med, Edmonton, AB, Canada; [Cook, Deborah J.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Cook, Deborah J.] McMaster Univ, Dept Crit Care, Hamilton, ON, Canada; [Cook, Deborah J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Cook, Deborah J.] St Josephs Healthcare, Hamilton, ON, Canada; [Clement, Fiona M.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Alberta; McMaster University; McMaster University; McMaster University; University of Calgary	Stelfox, HT (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	tstelfox@ucalgary.ca	Zuege, Danny J./L-5368-2017; Doig, Christopher/AAC-7949-2020	Zuege, Danny J./0000-0003-2033-5847; Doig, Christopher/0000-0002-8576-9139; Stelfox, Henry/0000-0003-1231-1490; Yipp, Bryan/0000-0002-5887-9551	Partnerships for Research and Innovation in Health System Improvement Grant from Alberta Innovates Health Solutions [201309 AIHS PRIHS]; Alberta Innovates [201300477] Funding Source: researchfish	Partnerships for Research and Innovation in Health System Improvement Grant from Alberta Innovates Health Solutions; Alberta Innovates	The project was supported by a Partnerships for Research and Innovation in Health System Improvement Grant ( 201309 AIHS PRIHS, www.aihealthsolutions.ca) from Alberta Innovates Health Solutions. Funding sources had no role in the design, conduct, or reporting of this study.	Alberta Health Services, 2014, CRIT CAR STRAT CLIN; Alberta Innovates Health Solutions, 2013, PARTN RES INN HLTH S; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Atkinson AA, 1997, SLOAN MANAGE REV, V38, P25; Bartlett Susan J, 2014, Ann Am Thorac Soc, V11 Suppl 2, pS112, DOI 10.1513/AnnalsATS.201309-327RM; Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Carlin J B, 2001, Biostatistics, V2, P397, DOI 10.1093/biostatistics/2.4.397; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Davis D, 2003, BMJ-BRIT MED J, V327, P33, DOI 10.1136/bmj.327.7405.33; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Fitch K., 2001, RAND UCLA APPROPRIAT; Fowler RA, 2014, JAMA-J AM MED ASSOC, V312, P2135, DOI 10.1001/jama.2014.15101; Gill M, 2015, PATIENT FAMILY UNPUB; Grady D, 2014, JAMA INTERN MED, V174, P498, DOI 10.1001/jamainternmed.2013.8272; Graham Ian D, 2004, Can J Nurs Res, V36, P89; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Halpern SD, 2014, AM J RESP CRIT CARE, V190, P818, DOI 10.1164/rccm.201407-1317ST; Horowitz CR, 2009, CIRCULATION, V119, P2633, DOI 10.1161/CIRCULATIONAHA.107.729863; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Kahn JM, 2009, CRIT CARE MED, V37, pS147, DOI 10.1097/CCM.0b013e3181920fa3; Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871; Kitson AL, 2013, KNOWLEDGE TRANSLATION IN HEALTH CARE: MOVING FROM EVIDENCE TO PRACTICE, 2ND EDITION, P97; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; Lauzier F, 2014, CRIT CARE, V18, DOI 10.1186/cc13844; LEVINSKY NG, 1984, NEW ENGL J MED, V311, P1573, DOI 10.1056/NEJM198412133112412; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Niven DJ, 2015, JAMA INTERN MED, V175, P801, DOI 10.1001/jamainternmed.2015.0157; Ovretveit J, 2014, J HEALTH ORGAN MANAG, V28, P115, DOI 10.1108/JHOM-08-2013-0164; Scales DC, 2011, JAMA-J AM MED ASSOC, V305, P363, DOI 10.1001/jama.2010.2000; Schuur JD, 2014, JAMA INTERN MED, V174, P509, DOI 10.1001/jamainternmed.2013.12688; Shekelle PG, 1998, NEW ENGL J MED, V338, P1888, DOI 10.1056/NEJM199806253382607; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Tilburt JC, 2013, JAMA-J AM MED ASSOC, V310, P380, DOI 10.1001/jama.2013.8278; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	40	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140141	10.1371/journal.pone.0140141	http://dx.doi.org/10.1371/journal.pone.0140141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492196	gold, Green Submitted, Green Published			2022-12-27	WOS:000363249300005
J	Maniscalco, JM; Springer, AM; Adkison, MD; Parker, P				Maniscalco, John M.; Springer, Alan M.; Adkison, Milo D.; Parker, Pamela			Population Trend and Elasticities of Vital Rates for Steller Sea Lions (Eumetopias jubatus) in the Eastern Gulf of Alaska: A New Life-History Table Analysis	PLOS ONE			English	Article							REGIME SHIFT; DYNAMICS; FITNESS; GROWTH; PATTERNS; RECOVERY; DECLINE; REPRODUCTION; HYPOTHESIS; MORTALITY	Steller sea lion (Eumetopias jubatus) numbers are beginning to recover across most of the western distinct population segment following catastrophic declines that began in the 1970s and ended around the turn of the century. This study makes use of contemporary vital rate estimates from a trend-site rookery in the eastern Gulf of Alaska (a sub-region of the western population) in a matrix population model to estimate the trend and strength of the recovery across this region between 2003 and 2013. The modeled population trend was projected into the future based on observed variation in vital rates and a prospective elasticity analysis was conducted to determine future trends and which vital rates pose the greatest threats to recovery. The modeled population grew at a mean rate of 3.5% per yr between 2003 and 2013 and was correlated with census count data from the local rookery and throughout the eastern Gulf of Alaska. If recent vital rate estimates continue with little change, the eastern Gulf of Alaska population could be fully recovered to pre-decline levels within 23 years. With density dependent growth, the population would need another 45 years to fully recover. Elasticity analysis showed that, as expected, population growth rate (lambda) was most sensitive to changes in adult survival, less sensitive to changes in juvenile survival, and least sensitive to changes in fecundity. A population decline could be expected with only a 6% decrease in adult survival, whereas a 32% decrease in fecundity would be necessary to bring about a population decline. These results have important implications for population management and suggest current research priorities should be shifted to a greater emphasis on survival rates and causes of mortality.	[Maniscalco, John M.; Parker, Pamela] Alaska SeaLife Ctr, Dept Sci, Seward, AK 99664 USA; [Maniscalco, John M.; Springer, Alan M.; Adkison, Milo D.] Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks	Maniscalco, JM (corresponding author), Alaska SeaLife Ctr, Dept Sci, Seward, AK 99664 USA.	johnm@alaskasealife.org			National Oceanic and Atmospheric Administration / National Marine Fisheries Service [NA12NMF4390066]	National Oceanic and Atmospheric Administration / National Marine Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by the National Oceanic and Atmospheric Administration / National Marine Fisheries Service Grant No. NA12NMF4390066 (http://www.nmfs.noaa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altukhov AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127292; [Anonymous], 1995, MAR FISH REV; Atkinson S, 2008, MAR MAMMAL SCI, V24, P276, DOI 10.1111/j.1748-7692.2008.00188.x; Atkinson S, 2008, MAMMAL REV, V38, P1, DOI 10.1111/j.1365-2907.2008.00128.x; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Bowen WD, 2003, ICES J MAR SCI, V60, P1265, DOI 10.1016/S1054-3139(03)00147-4; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Calkins Donald G., 1994, P119; Calkins DG, 2013, J EXP MAR BIOL ECOL, V441, P55, DOI 10.1016/j.jembe.2013.01.011; Caswell H, 2000, ECOLOGY, V81, P619, DOI 10.2307/177364; CASWELL H, 1989, ECOL MODEL, V46, P221, DOI 10.1016/0304-3800(89)90019-7; Caswell H, 2000, MATRIX POPULATION MO, V2nd; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Crone EE, 2001, EVOLUTION, V55, P2611; Dans SL, 2004, CAN J FISH AQUAT SCI, V61, P1681, DOI 10.1139/F04-105; DeMaster D., 2009, AERIAL SURVEY STELLE; DeMaster D, 2011, RESULTS STELLER SEA; Doak DF, 2005, AM NAT, V166, pE14, DOI 10.1086/430642; Fritz L, 2013, NMFSAFSC251 NOAA US; Fritz LW, 2014, ENDANGER SPECIES RES, V26, P13, DOI 10.3354/esr00634; Fritz LW, 2005, MAR MAMMAL SCI, V21, P476, DOI 10.1111/j.1748-7692.2005.tb01245.x; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gales NJ, 2000, WILDLIFE RES, V27, P165, DOI 10.1071/WR99027; Gerber LR, 2004, BIOL CONSERV, V120, P121, DOI 10.1016/j.biocon.2004.01.029; Gerber LR, 2001, MAMMAL REV, V31, P131, DOI 10.1046/j.1365-2907.2001.00081.x; Guenette S, 2006, CAN J FISH AQUAT SCI, V63, P2495, DOI 10.1139/F06-136; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Hatch SA, 2013, MAR ECOL PROG SER, V477, P271, DOI 10.3354/meps10161; Hennen D, 2006, ECOL APPL, V16, P704, DOI 10.1890/1051-0761(2006)016[0704:ABTASS]2.0.CO;2; Holmes EE, 2007, ECOL APPL, V17, P2214, DOI 10.1890/07-0508.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Horning M, 2014, FISH B-NOAA, V112, P297, DOI 10.7755/FB.112.4.6; Horning M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030173; Jemison LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070167; Johnson DS, 2014, METHODS ECOL EVOL, V5, P1110, DOI 10.1111/2041-210X.12231; KASTELEIN R A, 1991, Aquatic Mammals, V17, P91; Knape J, 2013, ECOLOGY, V94, P2097, DOI 10.1890/12-0712.1; LESLIE PH, 1948, BIOMETRIKA, V35, P213, DOI 10.2307/2332342; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; LOUGHLIN TR, 1986, MAR MAMMAL SCI, V2, P14, DOI 10.1111/j.1748-7692.1986.tb00025.x; Loughlin TR., 1998, BIOSPH CONSER NAT WI, V1, P91, DOI [10.20798/biospherecons.1.2_91, DOI 10.20798/BIOSPHERECONS.1.2_91]; Maniscalco JM, 2006, J MAMMAL, V87, P304, DOI 10.1644/05-MAMM-A-163R2.1; Maniscalco JM, 2007, MAR MAMMAL SCI, V23, P306, DOI 10.1111/j.1748-7692.2007.00103.x; Maniscalco JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111523; Maniscalco JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096328; Maniscalco JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010076; Maniscalco John M., 2008, Aquatic Mammals, V34, P277, DOI 10.1578/AM.34.3.2008.277; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; National Research Council, 2003, DECL STELL SEA LION; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; PITCHER KW, 1981, J MAMMAL, V62, P599, DOI 10.2307/1380406; Pitcher KW, 1998, CAN J ZOOL, V76, P2075, DOI 10.1139/cjz-76-11-2075; Rotella JJ, 2012, J ANIM ECOL, V81, P162, DOI 10.1111/j.1365-2656.2011.01902.x; Saether BE, 2013, AM NAT, V182, P743, DOI 10.1086/673497; Sandvik H, 2012, MAR ECOL PROG SER, V454, P273, DOI 10.3354/meps09558; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; Stewart Brent S., 1994, P29; Trites Andrew W., 2006, Aquatic Mammals, V32, P85, DOI 10.1578/AM.32.1.2006.85; Verhulst, 1845, NOUVEAUX MEMOIRES AC, V18, P1; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	68	11	11	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140982	10.1371/journal.pone.0140982	http://dx.doi.org/10.1371/journal.pone.0140982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488901	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400092
J	Prats, E; Tejero, E; Pardo, P; Gavilan, A; Galera, R; Donado, JR; Racionero, MA; Casitas, R; Zapatero, A; Garcia-Rio, F				Prats, Eva; Tejero, Elena; Pardo, Paloma; Gavilan, Adelaida; Galera, Raul; Ramon Donado, Jose; Angel Racionero, Miguel; Casitas, Raquel; Zapatero, Antonio; Garcia-Rio, Francisco			Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study	PLOS ONE			English	Article							AIR-FLOW OBSTRUCTION; LUNG-FUNCTION; FEV1/FEV6; MORTALITY; EXACERBATION; DIAGNOSIS; DECLINE; INDEXES; CANCER; VOLUME	Background The six-second spirometry has been proposed as an alternative to diagnose airflow limitation, although its prognostic value in patients with chronic obstructive pulmonary disease (COPD) remains unknown. The purpose of this study was to determine the prognostic value of the postbronchodilator forced expiratory volume in 1 second (FEV1)/forced expiratory volume in 6 seconds (FEV6) ratio and FEV6 in COPD patients. Methods and Findings The study population consisted of 2,614 consecutive stable patients with COPD. The patients were monitored for an average period of 4.3 years regarding mortality, hospitalizations by COPD exacerbations, diagnosis of lung cancer, and annual lung function decline. The overall rate of death was 10.7 (95% CI: 8.7-12.7) per 1000 person-years. In addition to male gender, age and comorbidity, FEV6 (hazard ratio [HR]: 0.981, 95% CI: 0.968-0.003) and FEV1/FEV6 quartiles (lowest quartile (< 74% pred.): HR 3.558, 95% CI: 1.752-7.224; and second quartile (74-84% pred.): HR 2.599, 95% CI: 1.215-5.561; versus best quartile (> 0.89% pred.)) were independently associated with mortality, whereas FEV1 was not retained in the model. 809 patients (30.9%) had at least one hospital admission due to COPD exacerbation. In addition to sex, age, smoking and comorbidity, FEV1 and FEV1/FEV6 quartiles were independent risk factors of hospitalization. FEV6 was the only spirometric parameter independently related with lung function annual decline, while the FEV6 and FEV1/FEV6 quartiles were independent risk factors for lung cancer. Conclusions In a general COPD outpatient population, airflow obstruction assessed by the FEV1/FEV6 is an independent risk factor for both death and hospitalization.	[Prats, Eva; Ramon Donado, Jose; Angel Racionero, Miguel] Hosp Univ Fuenlabrada, Unidad Neumol, Madrid, Spain; [Tejero, Elena; Pardo, Paloma; Gavilan, Adelaida] Hosp Univ Fuenlabrada, Serv Urgencias, Madrid, Spain; [Galera, Raul; Casitas, Raquel; Garcia-Rio, Francisco] IdiPAZ, Hosp Univ La Paz, Serv Neumol, Madrid, Spain; [Zapatero, Antonio] Hosp Univ Fuenlabrada, Med Interna Serv, Madrid, Spain; [Galera, Raul; Casitas, Raquel; Garcia-Rio, Francisco] CIBERES, Madrid, Spain; [Garcia-Rio, Francisco] Univ Autonoma Madrid, Madrid, Spain	Hospital Universitario Fuenlabrada; Hospital Universitario Fuenlabrada; Hospital Universitario La Paz; Hospital Universitario Fuenlabrada; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Madrid	Garcia-Rio, F (corresponding author), IdiPAZ, Hosp Univ La Paz, Serv Neumol, Madrid, Spain.	fgr01m@gmail.com	Garcia-Rio, Francisco/AAC-9981-2020	Racionero Casero, Miguel Angel/0000-0002-2306-8046; Garcia-Rio, Francisco/0000-0002-7227-2238	Instituto de Salud Carlos III, Spain [PI10-00642, PI13-01512]; Comunidad de Madrid, Spain [S2010/BMD-2542]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Comunidad de Madrid, Spain(Comunidad de Madrid)	This study is supported by grants from the Instituto de Salud Carlos III, Spain (PI10-00642 and PI13-01512) and from the Comunidad de Madrid, Spain (S2010/BMD-2542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellia V, 2008, THORAX, V63, P60, DOI 10.1136/thx.2007.080572; Bhatt Surya P, 2014, Ann Am Thorac Soc, V11, P335, DOI 10.1513/AnnalsATS.201308-251OC; Boutou AK, 2013, EUR RESPIR J, V42, P616, DOI 10.1183/09031936.00146012; Brusasco V, 1997, EUR RESPIR J, V10, P1316, DOI 10.1183/09031936.97.10061316; Casanova C, 2005, AM J RESP CRIT CARE, V171, P591, DOI 10.1164/rccm.200407-867OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Clini EM, 2013, AM J RESP CRIT CARE, V187, P668, DOI 10.1164/rccm.201302-0230ED; de Marco R, 2009, AM J RESP CRIT CARE, V180, P956, DOI 10.1164/rccm.200904-0543OC; DiSantostefano RL, 2014, INT J CHRONIC OBSTR, V9, P457, DOI 10.2147/COPD.S60498; Enright PL, 2002, RESP MED, V96, P444, DOI 10.1053/rmed.2001.1270; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Fry JS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-498; Garcia-Rio F, 2013, COPD, V10, P436, DOI 10.3109/15412555.2012.761959; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jing JY, 2009, CHEST, V135, P991, DOI 10.1378/chest.08-0723; Johnson LSB, 2014, EUROPACE, V16, P182, DOI 10.1093/europace/eut255; Lamprecht B, 2007, AM J RESP CRIT CARE, V176, P460, DOI 10.1164/rccm.200702-337OC; Menezes AMB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109732; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miravitlles M, 2009, THORAX, V64, P863, DOI 10.1136/thx.2009.115725; Morris ZQ, 2012, COPD, V9, P22, DOI 10.3109/15412555.2012.630701; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pedone C, 2010, J AM MED DIR ASSOC, V11, P598, DOI 10.1016/j.jamda.2009.12.003; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Soderholm M, 2012, STROKE, V43, P2598, DOI 10.1161/STROKEAHA.112.658427; Sorino C, 2011, CLIN PHYSIOL FUNCT I, V31, P101, DOI 10.1111/j.1475-097X.2010.00984.x; Swanney MP, 2000, AM J RESP CRIT CARE, V162, P917, DOI 10.1164/ajrccm.162.3.9907115; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wouters EFM, 2005, THORAX, V60, P480, DOI 10.1136/thx.2004.034280; Yu D, 2014, DIABETIC MED, V31, P595, DOI 10.1111/dme.12346	35	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140855	10.1371/journal.pone.0140855	http://dx.doi.org/10.1371/journal.pone.0140855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26489023	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400075
J	Ruzich, E; Allison, C; Chakrabarti, B; Smith, P; Musto, H; Ring, H; Baron-Cohen, S				Ruzich, Emily; Allison, Carrie; Chakrabarti, Bhismadev; Smith, Paula; Musto, Henry; Ring, Howard; Baron-Cohen, Simon			Sex and STEM Occupation Predict Autism-Spectrum Quotient (AQ) Scores in Half a Million People	PLOS ONE			English	Article							BIG DATA; ASPERGER SYNDROME; TRAITS; EMPATHY; STATISTICS; TALENT; BRAIN	This study assesses Autism-Spectrum Quotient (AQ) scores in a 'big data' sample collected through the UK Channel 4 television website, following the broadcasting of a medical education program. We examine correlations between the AQ and age, sex, occupation, and UK geographic region in 450,394 individuals. We predicted that age and geography would not be correlated with AQ, whilst sex and occupation would have a correlation. Mean AQ for the total sample score was m = 19.83 (SD = 8.71), slightly higher than a previous systematic review of 6,900 individuals in a non-clinical sample (mean of means = 16.94) This likely reflects that this big-data sample includes individuals with autism who in the systematic review score much higher (mean of means = 35.19). As predicted, sex and occupation differences were observed: on average, males (m = 21.55, SD = 8.82) scored higher than females (m = 18.95; SD = 8.52), and individuals working in a STEM career (m = 21.92, SD = 8.92) scored higher than individuals non-STEM careers (m = 18.92, SD = 8.48). Also as predicted, age and geographic region were not meaningfully correlated with AQ. These results support previous findings relating to sex and STEM careers in the largest set of individuals for which AQ scores have been reported and suggest the AQ is a useful self-report measure of autistic traits.	[Ruzich, Emily; Allison, Carrie; Chakrabarti, Bhismadev; Smith, Paula; Musto, Henry; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Ruzich, Emily; Ring, Howard] Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Cambridge, England; [Allison, Carrie; Ring, Howard; Baron-Cohen, Simon] Cambridgeshire & Peterborough NHS Fdn Trust, NIHR CLAHRC EoE, Cambridge, England; [Chakrabarti, Bhismadev] Univ Reading, Sch Psychol & Clin Language Sci, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England; [Baron-Cohen, Simon] Cambridgeshire & Peterborough NHS Fdn Trust, CLASS Clin, Cambridge, England	University of Cambridge; University of Cambridge; University of Reading	Ruzich, E (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.	emr37@cam.ac.uk		Baron-Cohen, Simon/0000-0001-9217-2544; Chakrabarti, Bhismadev/0000-0002-6649-7895; Ruzich, Emily/0000-0001-6612-7600	UK Medical Research Council (MRC); Wellcome Trust; National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care (NIHR CLAHRC) East of England; Autism Research Trust; MRC [G0600977] Funding Source: UKRI; Medical Research Council [G0600977] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care (NIHR CLAHRC) East of England; Autism Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors of this work were supported by grants from the UK Medical Research Council (MRC), the Wellcome Trust, the National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care (NIHR CLAHRC) East of England and the Autism Research Trust during the period of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102251; Baron-Cohen S, 2012, SCI AM, V307, P72, DOI 10.1038/scientificamerican1112-72; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Baron-Cohen Simon, 1997, AUTISM, V1, P101, DOI [10.1177/1362361397011010, DOI 10.1177/1362361397011010]; Beacher FD, 2012, AM J NEURORADIOL, V33, P83, DOI 10.3174/ajnr.A2880; Billington J, 2007, LEARN INDIVID DIFFER, V17, P260, DOI 10.1016/j.lindif.2007.02.004; Bourne PE, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004073; Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Chen CLP, 2014, INFORM SCIENCES, V275, P314, DOI 10.1016/j.ins.2014.01.015; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Cohen J, 1993, THE EARTH IS ROUND, P997; Cukier K, 2010, DATA DATA EVERYWHERE; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Freeth M, 2013, J AUTISM DEV DISORD, V43, P2569, DOI 10.1007/s10803-013-1808-9; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Harford T, 2014, FINANC TIMES MAG; Harris N, 2014, EMBARRASSING BODIES, V4; Hashem IAT, 2015, INFORM SYST, V47, P98, DOI 10.1016/j.is.2014.07.006; Hey T, 2009, THE FOURTH PARADIGM; Kambatla K, 2014, J PARALLEL DISTR COM, V74, P2561, DOI 10.1016/j.jpdc.2014.01.003; Magoulas R, 2009, INTRODUCTION TO BIG; Marcus G., 2014, NY TIMES; Morsanyi K, 2012, BRIT J PSYCHOL, V103, P472, DOI 10.1111/j.2044-8295.2011.02089.x; R Core Team, 2014, R A LANGUAGE AND ENV; Roelfsema MT, 2012, J AUTISM DEV DISORD, V42, P734, DOI 10.1007/s10803-011-1302-1; Ruzich E, 2015, MOL AUTISM, V6, DOI [10.1186/s13229-015-0038-8, 10.1186/2040-2392-6-2]; Vayena E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003904; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; Woodbury-Smith MR, 2005, J AUTISM DEV DISORD, V35, P331, DOI 10.1007/s10803-005-3300-7; Yang M, 2015, J BIOMED INFORM, V54, P230, DOI 10.1016/j.jbi.2015.01.011	39	39	39	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141229	10.1371/journal.pone.0141229	http://dx.doi.org/10.1371/journal.pone.0141229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488477	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400116
J	Akiyama, J; Kato, S; Tsubokura, M; Mori, J; Tanimoto, T; Abe, K; Sakai, S; Hayano, R; Tokiwa, M; Shimmura, H				Akiyama, Junichi; Kato, Shigeaki; Tsubokura, Masaharu; Mori, Jinichi; Tanimoto, Tetsuya; Abe, Koichiro; Sakai, Shuji; Hayano, Ryugo; Tokiwa, Michio; Shimmura, Hiroaki			Minimal Internal Radiation Exposure in Residents Living South of the Fukushima Daiichi Nuclear Power Plant Disaster	PLOS ONE			English	Article							IONIZING-RADIATION; MINAMISOMA CITY; NPP ACCIDENT; CONTAMINATION; HEALTH; CANCER; JAPAN; EARTHQUAKE; CHILDREN; IMPACT	Following the Fukushima nuclear power plant disaster, assessment of internal radiation exposure was indispensable to predict radiation-related health threats to residents of neighboring areas. Although many evaluations of internal radiation in residents living north and west of the crippled Fukushima nuclear power plant are available, there is little information on residents living in areas south of the plant, which were similarly affected by radio-contamination from the disaster. To assess the internal radio-contamination in residents living in affected areas to the south of the plant or who were evacuated into Iwaki city, a whole body counter (WBC) screening program of internal radio-contamination was performed on visitors to the Jyoban hospital in Iwaki city, which experienced less contamination than southern areas adjacent to the nuclear plant. The study included 9,206 volunteer subjects, of whom 6,446 were schoolchildren aged 4-15 years. Measurements began one year after the incident and were carried out over the course of two years. Early in the screening period only two schoolchildren showed Cs-137 levels that were over the detection limit (250 Bq/body), although their Cs-134 levels were below the detection limit (220 Bq/body). Among the 2,760 adults tested, 35 (1.3%) had detectable internal radio-contamination, but only for Cs-137 (range: 250 Bq/body to 859 Bq/body), and not Cs-134. Of these 35 subjects, nearly all (34/35) showed elevated Cs-137 levels only during the first year of the screening. With the exception of potassium 40, no other radionuclides were detected during the screening period. The maximum annual effective dose calculated from the detected Cs-137 levels was 0.029 and 0.028 mSv/year for the schoolchildren and adults, respectively, which is far below the 1 mSv/year limit set by the government of Japan. Although the data for radiation exposure during the most critical first year after the incident are unavailable due to a lack of systemic measurements, the present results suggest that internal radio-contamination levels more than one year after the incident were minimal for residents living south of the crippled Fukushima nuclear plant, and that the annual additional effective doses derived from internal Cs contamination were negligible. Thus, internal radio-contamination of residents living in southern radio-contaminated areas appears to be generally well controlled.	[Akiyama, Junichi; Kato, Shigeaki; Mori, Jinichi; Tanimoto, Tetsuya; Tokiwa, Michio; Shimmura, Hiroaki] Tokiwa Fdn, Jyoban Hosp, Iwaki, Fukushima, Japan; [Kato, Shigeaki; Tsubokura, Masaharu] Soma Cent Hosp, Dept Radiat Protect, Soma, Fukushima, Japan; [Tsubokura, Masaharu] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo, Japan; [Tsubokura, Masaharu] Minamisoma Municipal Gen Hosp, Dept Radiat Protect, Fukushima, Japan; [Abe, Koichiro; Sakai, Shuji] Tokyo Womens Med Univ, Dept Diagnost Imaging & Nucl Med, Shinjuku Ku, Tokyo, Japan; [Hayano, Ryugo] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; Tokyo Women's Medical University; University of Tokyo	Kato, S (corresponding author), Tokiwa Fdn, Jyoban Hosp, Iwaki, Fukushima, Japan.	uskato0525@gmail.com; shimmura@tokiwa.or.jp	Tsubokura, Masaharu/D-7300-2017; Tsubokura, Masaharu/AAV-4364-2021; Hayano, Ryugo/F-7889-2012	Tsubokura, Masaharu/0000-0001-8027-202X; Tsubokura, Masaharu/0000-0001-8027-202X; Hayano, Ryugo/0000-0002-1214-7806	Japan Health Foundation [145100000258]	Japan Health Foundation(Japan Health Foundation)	This work was supported by a Japan Health Foundation Grant to M. Tsubokura (#145100000258), which is for his broad research activity and not limited to this study.	Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Goto A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0443-8; Hasegawa J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122631; Hayano RS, 2014, J RADIOL PROT, V34, P787, DOI 10.1088/0952-4746/34/4/787; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; ICRP, 1992, ICRP PUBL, V67; ICRP, 2009, ICRP PUBL, V111; Ishii T, 2013, J BONE MINER METAB, V31, P613, DOI 10.1007/s00774-013-0482-5; Kodama Y, 2014, DISASTER MED PUBLIC, V8, P471, DOI 10.1017/dmp.2014.112; Likhtarev IA, 1996, HEALTH PHYS, V70, P297, DOI 10.1097/00004032-199603000-00001; Moysich KB, 2002, LANCET ONCOL, V3, P269, DOI 10.1016/S1470-2045(02)00727-1; Nomura S, 2015, ENVIRON SCI TECHNOL, V49, P1009, DOI 10.1021/es503504y; Orita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114407; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Ruhm W, 1999, HEALTH PHYS, V77, P373, DOI 10.1097/00004032-199910000-00004; Sakai A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1318; Sugimoto A, 2014, ENVIRON HEALTH PERSP, V122, P587, DOI 10.1289/ehp.1306848; Thielen H, 2012, HEALTH PHYS, V103, P169, DOI 10.1097/HP.0b013e31825b57ec; Tsubokura M, 2015, HEALTH PHYS, V108, P39, DOI 10.1097/HP.0000000000000167; Tsubokura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100302; Tsubokura M, 2013, JAMA PEDIATR, V167, P1169, DOI 10.1001/jamapediatrics.2013.2311; Tsubokura M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-267; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; Tsubokura M, 2012, HEMODIAL INT, V16, P320, DOI 10.1111/j.1542-4758.2011.00655.x; UNSCEAR, 2014, UNSCEAR 2013 REP SOU; World Health Organization, 2012, PREL DOS EST NUCL AC	27	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140482	10.1371/journal.pone.0140482	http://dx.doi.org/10.1371/journal.pone.0140482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484532	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100036
J	Bazzoli, A; Kelow, SP; Karanicolas, J				Bazzoli, Andrea; Kelow, Simon P.; Karanicolas, John			Enhancements to the Rosetta Energy Function Enable Improved Identification of Small Molecules that Inhibit Protein-Protein Interactions	PLOS ONE			English	Article							CONFORMER GENERATION; STRUCTURE PREDICTION; DRUGGABLE GENOME; DRUG DISCOVERY; DATABASE; DESIGN; INTERFACES; ALGORITHM; ACCURACY; DOCKING	Protein-protein interactions are among today's most exciting and promising targets for therapeutic intervention. To date, identifying small-molecules that selectively disrupt these interactions has proven particularly challenging for virtual screening tools, since these have typically been optimized to perform well on more "traditional" drug discovery targets. Here, we test the performance of the Rosetta energy function for identifying compounds that inhibit protein interactions, when these active compounds have been hidden amongst pools of "decoys." Through this virtual screening benchmark, we gauge the effect of two recent enhancements to the functional form of the Rosetta energy function: the new "Talaris" update and the "pwSHO" solvation model. Finally, we conclude by developing and validating a new weight set that maximizes Rosetta's ability to pick out the active compounds in this test set. Looking collectively over the course of these enhancements, we find a marked improvement in Rosetta's ability to identify small-molecule inhibitors of protein-protein interactions.	[Bazzoli, Andrea; Kelow, Simon P.; Karanicolas, John] Univ Kansas, Ctr Computat Biol, Lawrence, KS 66045 USA; [Karanicolas, John] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Karanicolas, J (corresponding author), Univ Kansas, Ctr Computat Biol, 2030 Becker Dr, Lawrence, KS 66045 USA.	johnk@ku.edu			National Institute of General Medical Sciences of the National Institutes of Health [R01GM099959]; National Science Foundation through XSEDE allocation [MCB130049]; Post Baccalaureate Research Education grant from National Institutes of General Medical Sciences of the National Institutes of Health [2R25GM078441]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099959, R25GM078441] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation through XSEDE allocation; Post Baccalaureate Research Education grant from National Institutes of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Sciences of the National Institutes of Health (R01GM099959), and by the National Science Foundation through XSEDE allocation MCB130049. Simon Kelow was supported by a Post Baccalaureate Research Education grant (2R25GM078441) from the National Institutes of General Medical Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], QUACPAC VERS 1 5 0; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], OMEGA VERS 2 4 3; [Anonymous], FRED VERS 3 0 0; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Bazzoli A, FAST PAIRWISE UNPUB; Bietz S, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-12; Bourgeas R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009598; Cierpicki T, 2015, IMMUNOL REV, V263, P279, DOI 10.1111/imr.12244; Cummings CG, 2010, CURR OPIN CHEM BIOL, V14, P341, DOI 10.1016/j.cbpa.2010.04.001; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Drew K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067051; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Gowthaman R, 2013, J CHEM INF MODEL, V53, P2073, DOI 10.1021/ci4002316; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Higueruelo AP, 2009, CHEM BIOL DRUG DES, V74, P457, DOI 10.1111/j.1747-0285.2009.00889.x; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Lill Markus, 2013, Methods Mol Biol, V993, P1, DOI 10.1007/978-1-62703-342-8_1; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pacella MS, 2013, METHOD ENZYMOL, V532, P343, DOI 10.1016/B978-0-12-416617-2.00016-3; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Simons KT, 1999, PROTEINS, P171; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Smith CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020451; Song YF, 2011, PROTEINS, V79, P1898, DOI 10.1002/prot.23013; Talele TT, 2010, CURR TOP MED CHEM, V10, P127, DOI 10.2174/156802610790232251; Whitby LR, 2012, ACCOUNTS CHEM RES, V45, P1698, DOI 10.1021/ar300025n; Willett P, 2003, BIOCHEM SOC T, V31, P603, DOI 10.1042/bst0310603; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	47	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140359	10.1371/journal.pone.0140359	http://dx.doi.org/10.1371/journal.pone.0140359			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484863	Green Published, gold, Green Submitted			2022-12-27	WOS:000363028100028
J	Hermans, MCE; Hoeijmakers, JGJ; Faber, CG; Merkies, ISJ				Hermans, Mieke C. E.; Hoeijmakers, Janneke G. J.; Faber, Catharina G.; Merkies, Ingemar S. J.			Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale	PLOS ONE			English	Article							DAYTIME SLEEPINESS; MEASUREMENT MODEL; EXAMPLE	Introduction A previously published Rasch-built activity and participation scale specifically designed for patients with myotonic dystrophy type 1 (DM1) was criticized for having been constructed in a relatively small cohort of patients and containing items too broadly phrased for DM1 patients, thus hampering its clinical use. Methods We report the results of the reconstructed Rasch-built DM1 activity and participation scale for clinical use (DM1-Activ(C)) through Rasch analyses using an expanded questionnaire containing 146 more simply phrased activity and participation inquiries completed by 340 patients with DM1. Results Through stepwise investigation including data quality control, model fit, response category ordering, local dependency and item bias, we succeeded in reconstructing the DM1-Activ(C) consisting of 25 items that showed good Rasch model fit, including construct convergent validity, items' weights and persons' locations reliability, and unidimensionality. Conclusion The DM1-Activ(C) scale has been reconstructed and fulfills all modern clinimetric requirements. Its use is recommended in future longitudinal trials in patients with DM1 to determine its responsiveness.	[Hermans, Mieke C. E.; Hoeijmakers, Janneke G. J.; Faber, Catharina G.; Merkies, Ingemar S. J.] Maastricht Univ, Med Ctr, Dept Neurol, NL-6200 MD Maastricht, Netherlands; [Merkies, Ingemar S. J.] Spaarne Hosp, Dept Neurol, Hoofddorp, Netherlands	Maastricht University; Spaarne Hospital	Faber, CG (corresponding author), Maastricht Univ, Med Ctr, Dept Neurol, NL-6200 MD Maastricht, Netherlands.	c.faber@mumc.nl	Hoeijmakers, Janneke/AAI-7260-2020		Talecris company; Talecris Talents program for PeriNomS Study; European Union [602273]; GBS/CIDP foundation international; Prinses Beatrix Spierfonds [W.OR12-01]	Talecris company; Talecris Talents program for PeriNomS Study; European Union(European Commission); GBS/CIDP foundation international; Prinses Beatrix Spierfonds	Dr. Merkies' competing interests: Scientific Advisory Boards: Participation in steering committees of the Talecris ICE Study, CSL Behring, LFB, Novartis and Octapharma (a research foundation at the University of Maastricht received the honoraria on behalf of Dr. Merkies); Funding for travel or speaker honoraria: Talecris company, travel funding for presentations on the ICE trial at EFNS meetings (2009, 2010); Research Support, Commercial Entities: Talecris Talents program for PeriNomS Study; Research Support, Government Entities: European Union 7th Framework Programme, grant no602273, 2013; Research Support, Foundations and Societies: GBS/CIDP foundation international, grant for PeriNomS study. Dr. Faber: European Union 7th Framework Programme (grant no602273); Prinses Beatrix Spierfonds (W.OR12-01); Grifols Lamepro. Dr. Hermans and Dr. Hoeijmakers have declared that no competing interests exist.	Arnould C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001807; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Draak THP, 2014, NEUROLOGY, V83, P2124, DOI 10.1212/WNL.0000000000001044; Fisher WP., 1992, RASCH MEASURE T, V6, P238; Grimby G, 2012, J REHABIL MED, V44, P97, DOI 10.2340/16501977-0938; Hermans MCE, 2013, MUSCLE NERVE, V47, P89, DOI 10.1002/mus.23478; Hermans MCE, 2010, NEUROMUSCULAR DISORD, V20, P310, DOI 10.1016/j.nmd.2010.03.010; Hobart J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13120; Kucukdeveci AA, 2004, ARTHRIT RHEUM-ARTHR, V51, P14, DOI 10.1002/art.20091; Laberge L, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0340-9; Linacre JM, 1994, RASCH MEASURE T, V7, P28; Magana JJ, 2011, J NEUROSCI RES, V89, P275, DOI 10.1002/jnr.22551; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; Meola G, 2015, BBA-MOL BASIS DIS, V1852, P594, DOI 10.1016/j.bbadis.2014.05.019; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Rasch G., 1980, PROBABILISTIC MODELS; Sloan Jeff A, 2005, COPD, V2, P57; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; van der Beek NAME, 2013, NEUROMUSCULAR DISORD, V23, P256, DOI 10.1016/j.nmd.2012.10.024; van Nes SI, 2011, NEUROLOGY, V76, P337, DOI 10.1212/WNL.0b013e318208824b; Vandervelde L, 2007, NEUROMUSCULAR DISORD, V17, P459, DOI 10.1016/j.nmd.2007.02.013; WHO, 2001, WHO INT CLASS FUNCT; Wright B., 1999, MEASUREMENT ESSENTIA, V2nd	26	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0139944	10.1371/journal.pone.0139944	http://dx.doi.org/10.1371/journal.pone.0139944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484877	Green Submitted, gold, Green Published			2022-12-27	WOS:000363028100017
J	Ma, SS; Kang, ZQ; Lu, P; Yang, YH; Yao, Q; Xia, HC; Chen, KP				Ma, Shangshang; Kang, Zhiqiong; Lu, Peng; Yang, Yanhua; Yao, Qin; Xia, Hengchuan; Chen, Keping			Molecular and Physiological Characterization of Two Novel Multirepeat beta-Thymosins from Silkworm, Bombyx mori	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITIES; REPEAT PROTEIN; ACTIN; NUCLEOPOLYHEDROVIRUS; INVASION; CELLS; GENE; IDENTIFICATION; MIGRATION; DOMAIN	beta-thymosin plays important roles in the development of the lymphatic system and the central nervous system in vertebrates. However, its role and function in invertebrates remain much less explored. Here, we firstly isolated a gene encoding beta-thymosin in silkworm (Bombyx mori L.). Interestingly, this gene encodes two polypeptides, named as BmTHY1 and BmTHY2, via two different modes of RNA splicing. The recombinant proteins fused with an N-term GST tag were over-expressed in Escherichia coli (E. coli) and further purified to near homogenity to prepare mouse antibodies. The Western blot analysis showed that these proteins were expressed in various tissues and organs, as well as in different developmental stages. Amazingly, the expression of BmTHY2 was hugely increased during the pupae stage, indicating a specialized role in this period. The expression of these proteins was gradually decreased in BmN cells infected by BmNPV, suggesting they may play different roles in the virus infection. In addition, both BmTHY1 and BmTHY2 can interact with 14-3-3 of silkworm and Ubiquitin of BmNPV as shown by GST pull down and Co-IP assays, consistent with their roles in the regulation of the development of nervous system.	[Ma, Shangshang; Kang, Zhiqiong; Lu, Peng; Yang, Yanhua; Yao, Qin; Xia, Hengchuan; Chen, Keping] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Xia, HC (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	hchxia@mail.ujs.edu.cn; kpchen@ujs.edu.cn	Xia, Hengchuan/AAB-1301-2020; Xia, hengchuan/GQB-2955-2022	Xia, hengchuan/0000-0002-5701-6092	Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China [31572467, 31372259]; National Basic Research Program of China "973" [2012CB114604]	Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China "973"(National Basic Research Program of China)	Funded by Priority Academic Program Development of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn), National Natural Science Foundation of China (31572467, 31372259) (http://www.nsfc.gov.cn/), and National Basic Research Program of China "973" (2012CB114604) (http://program.most.gov.cn/).	Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boquet I, 2000, CELL, V102, P797, DOI 10.1016/S0092-8674(00)00068-4; Cavasin MA, 2004, HYPERTENSION, V43, P1140, DOI 10.1161/01.HYP.0000126172.01673.84; Chen HQ, 2007, FEBS LETT, V581, P5836, DOI 10.1016/j.febslet.2007.11.059; Crow T, 2004, BIOCHEM BIOPH RES CO, V323, P395, DOI 10.1016/j.bbrc.2004.08.103; Crow T, 2007, NEUROSCI LETT, V424, P6, DOI 10.1016/j.neulet.2007.07.013; Domanski M, 2004, J BIOL CHEM, V279, P23637, DOI 10.1074/jbc.M311413200; Eccles SA, 2005, BIOTECHNOL ANN REV, V11, P391, DOI 10.1016/S1387-2656(05)11013-8; Freeman KW, 2011, FASEB J, V25, P907, DOI 10.1096/fj.10-169417; Gai YC, 2009, DEV COMP IMMUNOL, V33, P867, DOI 10.1016/j.dci.2009.02.003; GOLDSCHMIDTCLERMONT PJ, 1992, MOL BIOL CELL, V3, P1015, DOI 10.1091/mbc.3.9.1015; GOLDSTEI.AL, 1966, P NATL ACAD SCI USA, V56, P1010, DOI 10.1073/pnas.56.3.1010; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; GOLDSTEIN AL, 1972, P NATL ACAD SCI USA, V69, P1800, DOI 10.1073/pnas.69.7.1800; Herrmann D, 2005, MECH DEVELOP, V122, P1183, DOI 10.1016/j.mod.2005.07.003; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Kasman LM, 2000, J GEN VIROL, V81, P1881, DOI 10.1099/0022-1317-81-7-1881; KOKKINOPOULOS D, 1985, BLUT, V50, P341, DOI 10.1007/BF00320927; Kong LY, 2007, BBA-GEN SUBJECTS, V1770, P1598, DOI 10.1016/j.bbagen.2007.08.005; Koshikawa S, 2005, FEBS LETT, V579, P1365, DOI 10.1016/j.febslet.2005.01.031; Koshikawa S, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-63; Liu HP, 2011, DEV COMP IMMUNOL, V35, P716, DOI 10.1016/j.dci.2011.02.015; LOW TLK, 1979, J BIOL CHEM, V254, P981; Lu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064962; Luo L, 2014, PROTEOMICS, V14, P19, DOI 10.1002/pmic.201300315; Manuel M, 2000, J MOL EVOL, V51, P378, DOI 10.1007/s002390010100; Marleen VT, 2007, ACTIN MONOMER BINDIN, P71; Netnapa S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060974PMID, DOI 10.1371/J0URNAL.P0NE.0060974]; Ohkawa T, 2002, J VIROL, V76, P12281, DOI 10.1128/JVI.76.23.12281-12289.2002; Piao Z, 2014, BIOCHEM BIOPH RES CO, V452, P858, DOI 10.1016/j.bbrc.2014.09.012; Ramirez GF, 2007, IMMUNOGENETICS, V60, P57; Sosne G, 2010, FASEB J, V24, P2144, DOI 10.1096/fj.09-142307; Telford MJ, 2004, EVOL DEV, V6, P90, DOI 10.1111/j.1525-142X.2004.04013.x; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Wang Q, 2007, VIRUS RES, V127, P81, DOI 10.1016/j.virusres.2007.03.021; Wang WS, 2004, ONCOGENE, V23, P6666, DOI 10.1038/sj.onc.1207888; Wu LJ, 2009, FISH SHELLFISH IMMUN, V27, P379, DOI 10.1016/j.fsi.2009.05.019; Yang H, 2008, NEUROCHEM RES, V33, P2269, DOI 10.1007/s11064-008-9712-y; [姚勤 Yao Qin], 2002, [生命科学研究, Life science research], V6, P322; Zhang FX, 2011, INSECT MOL BIOL, V20, P519, DOI 10.1111/j.1365-2583.2011.01082.x; Zhang WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031040	41	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140182	10.1371/journal.pone.0140182	http://dx.doi.org/10.1371/journal.pone.0140182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474303	Green Submitted, gold, Green Published			2022-12-27	WOS:000363185500031
J	Zhu, SM; Wang, JG; Xie, BK; Luo, ZG; Lin, XK; Liao, DJ				Zhu, Shengming; Wang, Jiangang; Xie, Bingkun; Luo, Zhiguo; Lin, Xiukun; Liao, D. Joshua			Culture at a Higher Temperature Mildly Inhibits Cancer Cell Growth but Enhances Chemotherapeutic Effects by Inhibiting Cell-Cell Collaboration	PLOS ONE			English	Article							CLOVE SYZYGIUM-AROMATICUM; BREAST-CANCER; MAINTENANCE IMMUNOTHERAPY; HISTORICAL-PERSPECTIVE; CISPLATIN RESISTANCE; HYPERTHERMIA; THERAPY; FEVER; APOPTOSIS; BIOLOGY	Acute febrile infections have historically been used to treat cancer. To explore the underlying mechanism, we studied chronic effects of fever on cancer cell growth and chemotherapeutic efficacy in cell culture. We found that culturing cancer cells at 39 degrees C mildly inhibited cell growth by arresting the cells at the G1 phase of the cell cycle. When cells were seeded in culture dishes at a lower density, e.g. about 1000-2000 cells per 35-mm dish, the growth inhibition was much greater, manifested as many fewer cell colonies in the 39 degrees C dishes, compared with the results at a higher density seeding, e.g. 20,000 cells per dish, suggesting that cell-cell collaboration as the Allee effect in cell culture is inhibited at 39 degrees C. Withdrawal of cells from serum enhanced the G1 arrest at 39 degrees C and, for some cell lines such as A549 lung cancer cells, serum replenishment failed to quickly drive the cells from the G1 into the S and G2-M phases. Therapeutic effects of several chemotherapeutic agents, including clove bud extracts, on several cancer cell lines were more potent at 39 degrees C than at 37 degrees C, especially when the cells were seeded at a low density. For some cell lines and some agents, this enhancement is long-lasting, i.e. continuing after the cessation of the treatment. Collectively these results suggest that hyperthermia may inhibit cancer cell growth by G1 arrest and by inhibition of cell-cell collaboration, and may enhance the efficacy of several chemotherapeutic agents, an effect which may persist beyond the termination of chemotherapy.	[Zhu, Shengming; Wang, Jiangang; Xie, Bingkun; Liao, D. Joshua] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Zhu, Shengming; Luo, Zhiguo] Hubei Univ Med, Taihe Hosp, Dept Oncol, Shiyan 442000, Hubei Province, Peoples R China; [Luo, Zhiguo; Lin, Xiukun] Capital Med Univ, Dept Pharmacol, Beijing 100069, Peoples R China	University of Minnesota System; Hubei University of Medicine; Capital Medical University	Luo, ZG (corresponding author), Hubei Univ Med, Taihe Hosp, Dept Oncol, Shiyan 442000, Hubei Province, Peoples R China.	camelwhite@163.com; xiukunlin@126.com; djliao@hi.umn.edu	wang, jian/GVS-0711-2022	Lin, Xiukun/0000-0002-0306-4953				Ahmed M, 2011, SURG ONCOL CLIN N AM, V20, P237, DOI 10.1016/j.soc.2010.11.011; Alvarez-Berrios MP, 2013, INT J NANOMED, V8, P1003, DOI 10.2147/IJN.S38842; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Bergs JWJ, 2007, INT J HYPERTHER, V23, P329, DOI 10.1080/02656730701378684; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bickels J, 2002, ISRAEL MED ASSOC J, V4, P471; BRUNS P, 1887, BEITR KLIN CHIR, V3, P443; BULL JMC, 1982, CA-CANCER J CLIN, V32, P123, DOI 10.3322/canjclin.32.2.123; Busch W., 1866, VERHANDLUNGEN NATURH, V23, P28; Busch W., 1868, BERL KLIN WOCHENSCHR, V5, P137; Cann SAH, 2003, POSTGRAD MED J, V79, P672; Cann SAH, 2002, MED HYPOTHESES, V58, P115, DOI 10.1054/mehy.2001.1469; Coffey DS, 2006, JAMA-J AM MED ASSOC, V296, P445, DOI 10.1001/jama.296.4.445; Dewey WC, 2009, INT J HYPERTHER, V25, P3, DOI 10.1080/02656730902747919; Dewhirst MW, 2005, INT J HYPERTHER, V21, P779, DOI 10.1080/02656730500271668; Dwivedi V, 2011, ASIAN PAC J CANCER P, V12, P1989; Fehleisen F., 1882, DEUT MED WOCHENSCHR, V8, P553, DOI DOI 10.1055/S-0029-1196806; FIELD S B, 1983, Radiotherapy and Oncology, V1, P179, DOI 10.1016/S0167-8140(83)80020-6; Gabano E, 2008, J INORG BIOCHEM, V102, P629, DOI 10.1016/j.jinorgbio.2007.10.006; Genet SC, 2013, J CELL PHYSIOL, V228, P1473, DOI 10.1002/jcp.24302; Gibb RK, 1997, GYNECOL ONCOL, V65, P13, DOI 10.1006/gyno.1997.4637; Giuseppe M, 2013, CANCER EPIDEMIOL, V37, P528, DOI 10.1016/j.canep.2013.04.008; Guo Y, 2015, J CELL MOL MED, V19, P340, DOI 10.1111/jcmm.12444; Hasday JD, 2014, COMPR PHYSIOL, V4, P109, DOI 10.1002/cphy.c130019; Hassan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/150845; Hobohm U, 2001, CANCER IMMUNOL IMMUN, V50, P391; Hobohm U, 2009, BIOESSAYS, V31, P1071, DOI 10.1002/bies.200900025; Hoption SA, 2006, CANCER DETECT PREV, V30, P83, DOI 10.1016/j.cdp.2005.11.001; Horibe S, 2015, LIFE SCI, V124, P31, DOI 10.1016/j.lfs.2015.01.011; Isobe I, 1999, NEUROSCI LETT, V266, P129, DOI 10.1016/S0304-3940(99)00282-7; Jacobsen C, 2015, ANDROLOGY-US, V3, P111, DOI 10.1111/andr.299; Jessy Thomas, 2011, J Nat Sci Biol Med, V2, P43, DOI 10.4103/0976-9668.82318; Kaufman HL, 2014, J PERS MED, V4, P52, DOI 10.3390/jpm4010052; Kleef R, 2001, NEUROIMMUNOMODULAT, V9, P55, DOI 10.1159/000049008; Kokolus KM, 2010, INT J HYPERTHER, V26, P662, DOI 10.3109/02656736.2010.507235; Korolev KS, 2014, NAT REV CANCER, V14, P371, DOI 10.1038/nrc3712; Liao J, 2005, MED HYPOTHESES, V65, P23, DOI 10.1016/j.mehy.2005.01.028; Liu HZ, 2013, ONCOL RES, V21, P247, DOI 10.3727/096504014X13946388748910; Lundin JI, 2010, CIENC SAUDE COLETIVA, V15, P2787, DOI 10.1590/S1413-81232010000600016; Massabuau JC, 2001, RESP PHYSIOL, V128, P249, DOI 10.1016/S0034-5687(01)00305-X; Muenyi CS, 2014, TOXICOL SCI, V139, P74, DOI 10.1093/toxsci/kfu029; Nauts H C, 1990, Adv Exp Med Biol, V267, P483; Prashar A, 2006, CELL PROLIFERAT, V39, P241, DOI 10.1111/j.1365-2184.2006.00384.x; Recchia F, 2008, ONCOL REP, V20, P1173, DOI 10.3892/or_00000126; Recchia F, 2008, J IMMUNOTHER, V31, P413, DOI 10.1097/CJI.0b013e31816d1d8e; Recchia F, 2007, ANTI-CANCER DRUG, V18, P597, DOI 10.1097/CAD.0b013e3280262447; Recchia F, 2007, CANCER IMMUNOL IMMUN, V56, P699, DOI 10.1007/s00262-006-0224-9; Recchia F, 2010, GYNECOL ONCOL, V116, P202, DOI 10.1016/j.ygyno.2009.09.042; Repasky EA, 2013, CANCER IMMUNOL RES, V1, P210, DOI 10.1158/2326-6066.CIR-13-0118; Richardson MA, 1999, ALTERN THER HEALTH M, V5, P42; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; Skitzki JJ, 2009, CURR OPIN INVEST DR, V10, P550; Stevens JB, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.60; Sun Y, 2013, ONCOGENE, V32, P1794, DOI 10.1038/onc.2012.200; Sun Y, 2013, CELL CYCLE, V12, P3512, DOI 10.4161/cc.26510; Sun Yuan, 2012, J Carcinog, V11, P12, DOI 10.4103/1477-3163.100401; Sun Y, 2011, J CANCER, V2, P36, DOI 10.7150/jca.2.36; Vega-Avila Elisa, 2011, Proc West Pharmacol Soc, V54, P10; WEIL TM, 1973, J ORAL SURG, V31, P201; Weyermann J, 2005, INT J PHARMACEUT, V288, P369, DOI 10.1016/j.ijpharm.2004.09.018; WIEMANN B, 1994, PHARMACOL THERAPEUT, V64, P529, DOI 10.1016/0163-7258(94)90023-X; Zhang Ju, 2014, Oncoscience, V1, P407	63	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0137042	10.1371/journal.pone.0137042	http://dx.doi.org/10.1371/journal.pone.0137042			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495849	Green Submitted, gold, Green Published			2022-12-27	WOS:000363309200004
J	Chang, CF; Ke, CY; Wu, YC; Chuang, TH				Chang, Chi-Fen; Ke, Ci-Yi; Wu, Yang-Chang; Chuang, Ta-Hsien			Structure-Activity Relationship of Synthetic 2-Phenylnaphthalenes with Hydroxyl Groups that Inhibit Proliferation and Induce Apoptosis of MCF-7 Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; CYCLE ARREST; PATHWAYS; COMPLEX; FAMILY; DEATH	In this study, six 2-phenylnaphthalenes with hydroxyl groups were synthesized in high yields by the demethylation of the corresponding methoxy-2-phenylnaphthalenes, and one 2-phenylnaphthalene with an amino group was obtained by hydrogenation. All of the 2-phenylnaphthalene derivatives were evaluated for cytotoxicity, and the structure-activity relationship (SAR) against human breast cancer (MCF-7) cells was also determined. The SAR results revealed that cytotoxicity was markedly promoted by the hydroxyl group at the C-7 position of the naphthalene ring. The introduction of hydroxyl groups at the C-6 position of the naphthalene ring and the C-4' position of the phenyl ring fairly enhanced cytotoxicity, but the introduction of a hydroxyl group at the C-3' position of the phenyl ring slightly decreased cytotoxicity. Overall, 6,7-dihydroxy-2-(4'-hydroxyphenyl) naphthalene (PNAP-6h) exhibited the best cytotoxicity, with an IC50 value of 4.8 mu M against the MCF-7 cell line, and showed low toxicity toward normal human mammary epithelial cells (MCF-10A). PNAP-6h led to cell arrest at the S phase, most likely due to increasing levels of p21 and p27 and decreasing levels of cyclin D1, CDK4, cyclin E, and CDK2. In addition, PNAP-6h decreased CDK1 and cyclin B1 expression, most likely leading to G(2)/M arrest, and induced morphological changes, such as nuclear shrinkage, nuclear fragmentation, and nuclear hypercondensation, as observed by Hoechst 33342 staining. PNAP-6h induced apoptosis, most likely by the promotion of Fas expression, increased PARP activity, caspase-7, caspase-8, and caspase-9 expression, the Bax/Bcl-2 ratio, and the phosphorylation of p38, and decreased the phosphorylation of ERK. This study provides the first demonstration of the cytotoxicity of PNAPs against MCF-7 cells and elucidates the mechanism underlying PNAP-induced cytotoxicity.	[Chang, Chi-Fen] China Med Univ, Dept Anat, Sch Med, Taichung, Taiwan; [Ke, Ci-Yi] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Wu, Yang-Chang; Chuang, Ta-Hsien] China Med Univ, Sch Pharm, Taichung, Taiwan; [Wu, Yang-Chang; Chuang, Ta-Hsien] China Med Univ, Res Ctr Chinese Herbal Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Chang, CF (corresponding author), China Med Univ, Dept Anat, Sch Med, Taichung, Taiwan.	cfchang@mail.cmu.edu.tw; thchuang@mail.cmu.edu.tw	Wu, Yang-Chang/C-5682-2009	Wu, Yang-Chang/0000-0001-7815-2686	Ministry of Science and Technology, Taiwan [MOST 103-2320-B-039-027-, MOST 103-2113-M-039-003-, MOST 103-2738-M-039-001-]; China Medical University [CMU103-N-05]; Chinese Medicine Research Center, China Medical University (the Ministry of Education, the Aim for the Top University Plan)	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Chinese Medicine Research Center, China Medical University (the Ministry of Education, the Aim for the Top University Plan)	The authors would like to thank the Ministry of Science and Technology, Taiwan (MOST 103-2320-B-039-027-; MOST 103-2113-M-039-003- and MOST 103-2738-M-039-001-), China Medical University (CMU103-N-05), and in part, the grant from the Chinese Medicine Research Center, China Medical University (the Ministry of Education, the Aim for the Top University Plan) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; CHENG CC, 1986, MED HYPOTHESES, V20, P157, DOI 10.1016/0306-9877(86)90122-2; Chuang TH, 2011, J ORG CHEM, V76, P9678, DOI 10.1021/jo2017247; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Elsayed YA, 2001, ONCOLOGIST, V6, P517, DOI 10.1634/theoncologist.6-6-517; Ghiani CA, 2001, J NEUROSCI, V21, P1274; Gildor T, 2005, EUKARYOT CELL, V4, P310, DOI 10.1128/EC.4.2.310-318.2005; Gu Q, 2005, CARCINOGENESIS, V26, P541, DOI 10.1093/carcin/bgh345; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Hu YW, 2009, J ETHNOPHARMACOL, V123, P293, DOI 10.1016/j.jep.2009.03.016; Imahori T, 2012, ORG LETT, V14, P1172, DOI 10.1021/ol300145g; Kalimuthu S, 2013, INT J MOL SCI, V14, P2334, DOI 10.3390/ijms14022334; Korzelius J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002362; Li Z, 2008, CELL BIOL TOXICOL, V24, P401, DOI 10.1007/s10565-008-9054-1; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mewshaw RE, 2005, J MED CHEM, V48, P3953, DOI 10.1021/jm058173s; Miyake Y, 2003, J BIOL CHEM, V278, P11213, DOI 10.1074/jbc.M209610200; Mongiat M, 2007, MOL CELL BIOL, V27, P7176, DOI 10.1128/MCB.00696-07; Ontiveros SJ, 2010, VIROLOGY, V401, P165, DOI 10.1016/j.virol.2010.02.018; Ouyang GL, 2009, CELL BIOL INT, V33, P1237, DOI 10.1016/j.cellbi.2009.08.011; Polkowski K, 2000, Acta Pol Pharm, V57, P135; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Samraj AK, 2007, MOL BIOL CELL, V18, P84, DOI 10.1091/mbc.E06-04-0263; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Shim HY, 2007, ANTI-CANCER DRUG, V18, P649, DOI 10.1097/CAD.0b013e3280825573; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Su CC, 2006, ANTICANCER RES, V26, P1281; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wailer PC, 1956, AUST J CHEM, V9, P373; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wang X, 2006, CELL DEATH DIFFER, V13, P2099, DOI 10.1038/sj.cdd.4401969; Wang Y, 2014, FOOD CHEM TOXICOL, V67, P17, DOI 10.1016/j.fct.2014.02.007; Waxman DJ, 2003, CANCER RES, V63, P8563; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; Yang JS, 2010, J PHARMACOL EXP THER, V334, P477, DOI 10.1124/jpet.109.165415; Yang PM, 2012, INT J ONCOL, V40, P469, DOI 10.3892/ijo.2011.1203; Yuan JW, 2014, BIOORG MED CHEM LETT, V24, P2324, DOI 10.1016/j.bmcl.2014.03.072; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	39	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141184	10.1371/journal.pone.0141184	http://dx.doi.org/10.1371/journal.pone.0141184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492346	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300033
J	Marchini-Alves, CMM; Lorenzi, VCB; da Silva, EZM; Mazucato, VM; Jamur, MC; Oliver, C				Meirelles Marchini-Alves, Claudia Maria; Barbosa Lorenzi, Valeria Cintra; Marcelino da Silva, Elaine Zayas; Mazucato, Vivian Marino; Jamur, Maria Celia; Oliver, Constance			Phospholipase D2 Modulates the Secretory Pathway in RBL-2H3 Mast Cells	PLOS ONE			English	Article							ADP-RIBOSYLATION-FACTOR; PROTEIN-KINASE-C; TRANS-GOLGI NETWORK; PHOSPHATIDIC-ACID; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; RECEPTOR ENDOCYTOSIS; MEMBRANE CURVATURE; TERMINAL ALKYNES; PLASMA-MEMBRANE; APPARATUS	Phospholipase D (PLD) hydrolyses phosphatidylcholine to produce phosphatidic acid (PA) and choline. It has two isoforms, PLD1 and PLD2, which are differentially expressed depending on the cell type. In mast cells it plays an important role in signal transduction. The aim of the present study was to clarify the role of PLD2 in the secretory pathway. RBL-2H3 cells, a mast cell line, transfected to overexpress catalytically active (PLD2CA) and inactive (PLD2CI) forms of PLD2 were used. Previous observations showed that the Golgi complex was well organized in CA cells, but was disorganized and dispersed in CI cells. Furthermore, in CI cells, the microtubule organizing center was difficult to identify and the microtubules were disorganized. These previous observations demonstrated that PLD2 is important for maintaining the morphology and organization of the Golgi complex. To further understand the role of PLD2 in secretory and vesicular trafficking, the role of PLD2 in the secretory process was investigated. Incorporation of sialic acid was used to follow the synthesis and transport of glycoconjugates in the cell lines. The modified sialic acid was subsequently detected by labeling with a fluorophore or biotin to visualize the localization of the molecule after a pulse-chase for various times. Glycoconjugate trafficking was slower in the CI cells and labeled glycans took longer to reach the plasma membrane. Furthermore, in CI cells sialic acid glycans remained at the plasma membrane for longer periods of time compared to RBL-2H3 cells. These results suggest that PLD2 activity plays an important role in regulating glycoconjugate trafficking in mast cells.	[Meirelles Marchini-Alves, Claudia Maria; Barbosa Lorenzi, Valeria Cintra; Marcelino da Silva, Elaine Zayas; Mazucato, Vivian Marino; Jamur, Maria Celia; Oliver, Constance] Univ Sao Paulo, Dept Cell & Mol Biol & Pathogen Bioagents, Ribeirao Preto Med Sch, Sao Paulo, Brazil	Universidade de Sao Paulo	Oliver, C (corresponding author), Univ Sao Paulo, Dept Cell & Mol Biol & Pathogen Bioagents, Ribeirao Preto Med Sch, Sao Paulo, Brazil.	coliver@fmrp.usp.br	Jamur, Maria Celia/L-5520-2016; Da Silva, Elaine Z/O-5535-2015; LARIJANI, Professor Banafshe/H-3909-2015	Jamur, Maria Celia/0000-0001-7065-8543; Da Silva, Elaine Z/0000-0002-2749-6275; LARIJANI, Professor Banafshe/0000-0003-4735-1169	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/52768-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior /Fulbright [BEX 9168/12-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior /Fulbright	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/; Pre-doctoral Fellowship 2009/52768-4), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior /Fulbright (http://www.capes.gov.br/; Pre-doctoral Fellowship BEX 9168/12-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Bhattacharya M, 2004, J NEUROSCI, V24, P8752, DOI 10.1523/JNEUROSCI.3155-04.2004; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; Boisgard R, 2000, BBA-MOL CELL RES, V1495, P281, DOI 10.1016/S0167-4889(99)00167-6; Chen JS, 2004, J BIOL CHEM, V279, P22076, DOI 10.1074/jbc.M311033200; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Choi WS, 2002, J IMMUNOL, V168, P5682, DOI 10.4049/jimmunol.168.11.5682; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; de Souza LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091868; Denmat-Ouisse LA, 2001, J BIOL CHEM, V276, P48840, DOI 10.1074/jbc.M104276200; Divecha N, 2000, EMBO J, V19, P5440, DOI 10.1093/emboj/19.20.5440; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Farquhar MG, 1998, TRENDS CELL BIOL, V8, P2, DOI 10.1016/S0962-8924(97)01187-2; FARQUHAR MG, 1981, J CELL BIOL, V91, P77; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Glick BS, 2000, CURR OPIN CELL BIOL, V12, P450, DOI 10.1016/S0955-0674(00)00116-2; Gomez-Cambronero Julian, 2014, Advances in Biological Regulation, V54, P197, DOI 10.1016/j.jbior.2013.08.006; Gomez-Cambronero J, 2011, CELL SIGNAL, V23, P1885, DOI 10.1016/j.cellsig.2011.06.017; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; GUO N, 1989, J BIOL CHEM, V264, P13267; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Hitomi T, 2004, BLOOD, V104, P4122, DOI 10.1182/blood-2004-06-2091; Hong V, 2010, BIOCONJUGATE CHEM, V21, P1912, DOI 10.1021/bc100272z; Karabasheva D, 2014, J BIOL CHEM, V289, P19477, DOI 10.1074/jbc.M114.564666; Koch T, 2004, J NEUROCHEM, V88, P680, DOI 10.1046/j.1471-4159.2003.02189.x; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Marchini-Alves CMM, 2012, J HISTOCHEM CYTOCHEM, V60, P386, DOI 10.1369/0022155412438886; Morgan CP, 1997, BIOCHEM J, V325, P581, DOI 10.1042/bj3250581; Polishchuk RS, 2004, CELL MOL LIFE SCI, V61, P146, DOI 10.1007/s00018-003-3353-8; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; Siddhanta A, 2000, J BIOL CHEM, V275, P12023, DOI 10.1074/jbc.275.16.12023; Singer WD, 1996, J BIOL CHEM, V271, P4504; STUTCHFIELD J, 1993, BIOCHEM J, V293, P649, DOI 10.1042/bj2930649; Sweeney DA, 2002, J BIOL CHEM, V277, P3030, DOI 10.1074/jbc.M104639200; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; van Vliet C, 2003, PROG BIOPHYS MOL BIO, V83, P1, DOI 10.1016/S0079-6107(03)00019-1; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	47	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0139888	10.1371/journal.pone.0139888	http://dx.doi.org/10.1371/journal.pone.0139888			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492088	Green Published, Green Submitted, gold			2022-12-27	WOS:000363249300004
J	Aubry, A; Hausswirth, C; Louis, J; Coutts, AJ; Buchheit, M; Le Meur, Y				Aubry, Anael; Hausswirth, Christophe; Louis, Julien; Coutts, Aaron J.; Buchheit, Martin; Le Meur, Yann			The Development of Functional Overreaching Is Associated with a Faster Heart Rate Recovery in Endurance Athletes	PLOS ONE			English	Article							PERFORMANCE; EXERCISE	Purpose The aim of the study was to investigate whether heart rate recovery (HRR) may represent an effective marker of functional overreaching (f-OR) in endurance athletes. Methods and Results Thirty-one experienced male triathletes were tested (10 control and 21 overload subjects) before (Pre), and immediately after an overload training period (Mid) and after a 2-week taper (Post). Physiological responses were assessed during an incremental cycling protocol to exhaustion, including heart rate, catecholamine release and blood lactate concentration. Ten participants from the overload group developed signs of f-OR at Mid (i.e. -2.1 +/- 0.8% change in performance associated with concomitant high perceived fatigue). Additionally, only the f-OR group demonstrated a 99% chance of increase in HRR during the overload period (+8 +/- 5 bpm, large effect size). Concomitantly, this group also revealed a >80% chance of decreasing blood lactate (-11 +/- 14%, large), plasma norepinephrine (-12 +/- 37%, small) and plasma epinephrine peak concentrations (-51 +/- 22%, moderate). These blood measures returned to baseline levels at Post. HRR change was negatively correlated to changes in performance, peak HR and peak blood metabolites concentrations. Conclusion These findings suggest that i) a faster HRR is not systematically associated with improved physical performance, ii) changes in HRR should be interpreted in the context of the specific training phase, the athletes perceived level of fatigue and the performance response; and, iii) the faster HRR associated with f-OR may be induced by a decreased central command and by a lower chemoreflex activity.	[Aubry, Anael; Hausswirth, Christophe; Louis, Julien; Buchheit, Martin; Le Meur, Yann] Natl Inst Sport Expertise & Performance, Lab Sport Expertise & Performance INSEP, EA 7370, Paris, France; [Louis, Julien] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 3AF, Merseyside, England; [Coutts, Aaron J.] Univ Technol Sydney, Fac Hlth, Sport & Exercise Discipline Grp, Sydney, NSW 2007, Australia; [Buchheit, Martin] Victoria Univ, Sch Sport & Exercise Sci, Inst Sport Exercise & Active Living ISEAL, Melbourne, Vic 8001, Australia	Liverpool John Moores University; University of Technology Sydney; Victoria University	Le Meur, Y (corresponding author), Natl Inst Sport Expertise & Performance, Lab Sport Expertise & Performance INSEP, EA 7370, Paris, France.	yann.le-meur@insep.fr	Louis, Julien/AAI-4392-2021; Coutts, Aaron J/E-5261-2011	Louis, Julien/0000-0002-9109-0958; Coutts, Aaron J/0000-0002-1782-7691	French Institute of Sport, Expertise and Performance (INSEP, Paris, France); French Ministry of Sport Grant [11-I-0036]; French Anti-Doping Agency grant (AFLD, Paris, France)	French Institute of Sport, Expertise and Performance (INSEP, Paris, France); French Ministry of Sport Grant; French Anti-Doping Agency grant (AFLD, Paris, France)	The authors received funding for research on which this article is based from the French Institute of Sport, Expertise and Performance (INSEP, Paris, France), the French Ministry of Sport Grant No. 11-I-0036, and a French Anti-Doping Agency grant (AFLD, Paris, France).	Aubry A, 2014, MED SCI SPORT EXER, V46, P1769, DOI 10.1249/MSS.0000000000000301; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Borresen J, 2007, EUR J APPL PHYSIOL, V101, P503, DOI 10.1007/s00421-007-0516-6; Bosquet L, 2001, EUR J APPL PHYSIOL, V84, P107, DOI 10.1007/s004210000343; Bosquet L, 2007, MED SCI SPORT EXER, V39, P1358, DOI 10.1249/mss.0b013e31806010e0; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH8, DOI 10.1152/ajpheart.00335.2007; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; Charloux A, 2000, EUR J APPL PHYSIOL, V82, P313, DOI 10.1007/s004210000226; Daanen HAM, 2012, INT J SPORT PHYSIOL, V7, P251, DOI 10.1123/ijspp.7.3.251; Dupuy O, 2014, SCAND J MED SCI SPOR, V24, P234, DOI 10.1111/j.1600-0838.2012.01465.x; Dupuy O, 2013, APPL PHYSIOL NUTR ME, V38, P200, DOI 10.1139/apnm-2012-0203; Dupuy O, 2012, CLIN PHYSIOL FUNCT I, V32, P296, DOI 10.1111/j.1475-097X.2012.01125.x; Halson SL, 2004, SPORTS MED, V34, P967, DOI 10.2165/00007256-200434140-00003; Hedelin R, 2000, MED SCI SPORT EXER, V32, P1531, DOI 10.1097/00005768-200009000-00001; Hedelin R, 2000, MED SCI SPORT EXER, V32, P1480, DOI 10.1097/00005768-200008000-00017; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Hug B, 2014, INT J SPORTS MED, V35, P676, DOI 10.1055/s-0033-1361184; Lamberts RP, 2010, EUR J APPL PHYSIOL, V108, P183, DOI 10.1007/s00421-009-1291-3; Le Meur Y, 2014, J APPL PHYSIOL, V117, P214, DOI 10.1152/japplphysiol.00191.2014; Le Meur Y, 2013, MED SCI SPORT EXER, V45, P2061, DOI 10.1249/MSS.0b013e3182980125; Le Meur Y, 2013, J APPL PHYSIOL, V114, P411, DOI 10.1152/japplphysiol.01254.2012; LEHMANN M, 1991, INT J SPORTS MED, V12, P444, DOI 10.1055/s-2007-1024711; Mac Nair D, 1971, PROFILE MOOD STATES, P27; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Pyne DB, 2000, EUR J APPL PHYSIOL, V82, P112, DOI 10.1007/s004210050659; Thomson RL, 2016, J SCI MED SPORT, V19, P255, DOI 10.1016/j.jsams.2015.02.010; Urhausen A, 1998, INT J SPORTS MED, V19, P114, DOI 10.1055/s-2007-971892; White DW, 2014, J PHYSIOL-LONDON, V592, P2491, DOI 10.1113/jphysiol.2014.271858	30	38	38	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139754	10.1371/journal.pone.0139754	http://dx.doi.org/10.1371/journal.pone.0139754			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488766	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000363248400037
J	Clote, P; Bayegan, A				Clote, Peter; Bayegan, Amir			Network Properties of the Ensemble of RNA Structures	PLOS ONE			English	Article							SECONDARY STRUCTURE; WEB SERVER; KINETICS; SEQUENCES; CLASSIFICATION; COMPILATION; COMPUTATION; PREDICTION; STABILITY; ALGORITHM	We describe the first dynamic programming algorithm that computes the expected degree for the network, or graph G = (V, E) of all secondary structures of a given RNA sequence a = a(1), ... , a(n). Here, the nodes V correspond to all secondary structures of a, while an edge exists between nodes s, t if the secondary structure t can be obtained from s by adding, removing or shifting a base pair. Since secondary structure kinetics programs implement the Gillespie algorithm, which simulates a random walk on the network of secondary structures, the expected network degree may provide a better understanding of kinetics of RNA folding when allowing defect diffusion, helix zippering, and related conformation transformations. We determine the correlation between expected network degree, contact order, conformational entropy, and expected number of native contacts for a benchmarking dataset of RNAs. Source code is available at http://bioinformatics.bc.edu/clotelab/RNAexpNumNbors.	[Clote, Peter; Bayegan, Amir] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA	Boston College	Clote, P (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA.	clote@bc.edu			National Science Foundation [DBI-1262439]	National Science Foundation(National Science Foundation (NSF))	PC received funding from the National Science Foundation under grant DBI-1262439 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JWJ, 2013, BIOINFORMATICS, V29, P704, DOI 10.1093/bioinformatics/btt050; Antczak M, 2014, NUCLEIC ACIDS RES, V42, pW368, DOI 10.1093/nar/gku330; Aviram I, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-24; Best RB, 2013, P NATL ACAD SCI USA, V110, P17874, DOI 10.1073/pnas.1311599110; Bogatyreva NS, 2009, NUCLEIC ACIDS RES, V37, pD342, DOI 10.1093/nar/gkn696; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Clote P., 2015, 150803815 ARXIV; Clote P, 2015, J COMPUT CHEM, V36, P103, DOI 10.1002/jcc.23776; Danilova Ludmlla V., 2006, Journal of Bioinformatics and Computational Biology, V4, P589, DOI 10.1142/S0219720006001904; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Dotu I, 2010, NUCLEIC ACIDS RES, V38, P1711, DOI 10.1093/nar/gkp1054; Dykeman EC, 2015, NUCLEIC ACIDS RES, V43, P5708, DOI 10.1093/nar/gkv480; Flamm C, 2000, RNA, V6, P325, DOI 10.1017/S1355838200992161; Flamm C, 2002, Z PHYS CHEM, V216, P155, DOI 10.1524/zpch.2002.216.2.155; Flamm C, 2001, RNA, V7, P254, DOI 10.1017/S1355838201000863; Flamm C, 1998, KINETIC FOLDING OF R; Galzitskaya OV, 2010, ENTROPY-SWITZ, V12, P961, DOI 10.3390/e12040961; Garcia-Martin JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137859; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Geis M, 2008, J MOL BIOL, V379, P160, DOI 10.1016/j.jmb.2008.02.064; Gerdes K, 1997, ANNU REV GENET, V31, P1, DOI 10.1146/annurev.genet.31.1.1; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Heine C, 2006, IEEE T VIS COMPUT GR, V12, P781, DOI 10.1109/TVCG.2006.196; Ivankov DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006476; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kemena C, 2013, BIOINFORMATICS, V29, P1112, DOI 10.1093/bioinformatics/btt096; Kucharik M, 2014, BIOINFORMATICS, V30, P2009, DOI 10.1093/bioinformatics/btu156; LECUYER KA, 1993, BIOCHEMISTRY-US, V32, P5301, DOI 10.1021/bi00071a004; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Makarov DE, 2002, P NATL ACAD SCI USA, V99, P3535, DOI 10.1073/pnas.052713599; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Morgan SR, 1998, J PHYS A-MATH GEN, V31, P3153, DOI 10.1088/0305-4470/31/14/005; Nawrocki EP, 2014, NUCL ACIDS RES; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Ponty Y, 2006, MODELISATION SEQUENC, VXI; PORSCHKE D, 1974, BIOPHYS CHEM, V2, P83, DOI 10.1016/0301-4622(74)80028-1; Reinisch KM, 2007, CURR OPIN STRUC BIOL, V17, P209, DOI 10.1016/j.sbi.2007.03.012; Senter E, 2015, J COMPUT BIOL, V22, P124, DOI 10.1089/cmb.2014.0193; SHAKHNOVICH E, 1991, PHYS REV LETT, V67, P1665, DOI 10.1103/PhysRevLett.67.1665; Shapiro BA, 2001, J MOL BIOL, V312, P27, DOI 10.1006/jmbi.2001.4931; Smit S, 2008, RNA, V14, P410, DOI 10.1261/rna.881308; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; STEIN PR, 1979, DISCRETE MATH, V26, P261, DOI 10.1016/0012-365X(79)90033-5; Tang XY, 2005, J COMPUT BIOL, V12, P862, DOI 10.1089/cmb.2005.12.862; Thachuk C, 2010, BIOCOMPUT-PAC SYM, P108; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Wiese KC, 2005, IEEE T NANOBIOSCI, V4, P212, DOI 10.1109/TNB.2005.853646; Wolfinger MT, 2004, J PHYS A-MATH GEN, V37, P4731, DOI 10.1088/0305-4470/37/17/005; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; Wuchty S, 2003, NUCLEIC ACIDS RES, V31, P1108, DOI 10.1093/nar/gkg162; Xayaphoummine A, 2005, NUCLEIC ACIDS RES, V33, pW605, DOI 10.1093/nar/gki447; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; Zhang AT, 2011, J CELL SCI, V124, P2058, DOI 10.1242/jcs.086561; Zhang WB, 2002, P NATL ACAD SCI USA, V99, P1931, DOI 10.1073/pnas.032443099; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	58	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139476	10.1371/journal.pone.0139476	http://dx.doi.org/10.1371/journal.pone.0139476			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488894	Green Submitted, Green Published, gold			2022-12-27	WOS:000363248400029
J	Schmid, M; Dufner, B; Durk, J; Bedal, K; Stricker, K; Prokoph, LA; Koch, C; Wege, AK; Zirpel, H; van Zandbergen, G; Ecker, R; Boghiu, B; Ritter, U				Schmid, Maximilian; Dufner, Bianca; Duerk, Julius; Bedal, Konstanze; Stricker, Kristina; Prokoph, Lukas Ali; Koch, Christoph; Wege, Anja K.; Zirpel, Henner; van Zandbergen, Ger; Ecker, Rupert; Boghiu, Bogdan; Ritter, Uwe			An Emerging Approach for Parallel Quantification of Intracellular Protozoan Parasites and Host Cell Characterization Using TissueFAXS Cytometry	PLOS ONE			English	Article							EXPERIMENTAL CUTANEOUS LEISHMANIASIS; REAL-TIME PCR; DENDRITIC CELLS; BALB/C MICE; IN-VIVO; MACROPHAGES; MICROSCOPY; GAMMA	Characterization of host-pathogen interactions is a fundamental approach in microbiological and immunological oriented disciplines. It is commonly accepted that host cells start to change their phenotype after engulfing pathogens. Techniques such as real time PCR or ELISA were used to characterize the genes encoding proteins that are associated either with pathogen elimination or immune escape mechanisms. Most of such studies were performed in vitro using primary host cells or cell lines. Consequently, the data generated with such approaches reflect the global RNA expression or protein amount recovered from all cells in culture. This is justified when all host cells harbor an equal amount of pathogens under experimental conditions. However, the uptake of pathogens by phagocytic cells is not synchronized. Consequently, there are host cells incorporating different amounts of pathogens that might result in distinct pathogen-induced protein biosynthesis. Therefore, we established a technique able to detect and quantify the number of pathogens in the corresponding host cells using immunofluorescence-based high throughput analysis. Paired with multicolor staining of molecules of interest it is now possible to analyze the infection profile of host cell populations and the corresponding phenotype of the host cells as a result of parasite load.	[Schmid, Maximilian; Dufner, Bianca; Duerk, Julius; Bedal, Konstanze; Stricker, Kristina; Prokoph, Lukas Ali; Koch, Christoph; Ritter, Uwe] Univ Regensburg, Inst Immunol, D-93053 Regensburg, Germany; [Wege, Anja K.; van Zandbergen, Ger] Univ Regensburg, Dept Gynecol & Obstet, D-93053 Regensburg, Germany; [Zirpel, Henner] Paul Ehrlich Inst, Div Immunol, Langen, Germany; [van Zandbergen, Ger] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, D-55122 Mainz, Germany; [Ecker, Rupert; Boghiu, Bogdan] TissueGnostics GmbH, Vienna, Austria	University of Regensburg; University of Regensburg; Paul Ehrlich Institute; Johannes Gutenberg University of Mainz	Ritter, U (corresponding author), Univ Regensburg, Inst Immunol, D-93053 Regensburg, Germany.	Uwe.Ritter@klinik.uni-regensburg.de		Zirpel, Henner/0000-0003-0053-4312; Ecker, Rupert Christian/0000-0002-1095-8592	DFG Priority Program of the German Research Foundation [RI 1849/2-1]; Major Research Instrumentation Programme INST [INST 89/341-1 FUGG]; TissueGnostics GmbH, a commercial company	DFG Priority Program of the German Research Foundation; Major Research Instrumentation Programme INST; TissueGnostics GmbH, a commercial company	This work was supported by the DFG Priority Program of the German Research Foundation (RI 1849/2-1) and the Major Research Instrumentation Programme INST (INST 89/341-1 FUGG). TissueGnostics GmbH, a commercial company, provided support in the form of salaries for authors Rupert Ecker and Bogdan Boghiu and provided research materials (antibodies and reagents), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Arif M, 2011, J BIOTECHNOL, DOI [10.1016/j.ibiotec.2011.03.008, DOI 10.1016/J.JBI0TEC.2011.03.008]; BLANK C, 1993, J INFECT DIS, V167, P418, DOI 10.1093/infdis/167.2.418; Bogdan C, 1999, PARASITOL TODAY, V15, P22, DOI 10.1016/S0169-4758(98)01362-3; Bogdan C, 1996, CURR OPIN IMMUNOL, V8, P517, DOI 10.1016/S0952-7915(96)80040-9; Castro R, 2006, J PARASITOL, V92, P1162, DOI 10.1645/GE-841R.1; Crauwels P, 2015, AUTOPHAGY, V11, P285, DOI 10.1080/15548627.2014.998904; Eckert RC, 2004, CYTOM PART A, V59A, P182, DOI 10.1002/cyto.a.20052; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Pahl A, 1999, J CLIN MICROBIOL, V37, P1958, DOI 10.1128/JCM.37.6.1958-1963.1999; Parihar SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075490; PEARSON RD, 1983, REV INFECT DIS, V5, P907; Ritter U, 2004, MICROBES INFECT, V6, P559, DOI 10.1016/j.micinf.2004.02.008; Schlederer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100822; Schmid M, 2014, EUR J IMMUNOL, V44, P3295, DOI 10.1002/eji.201344335; Schonlau F, 2000, EUR J IMMUNOL, V30, P2729, DOI 10.1002/1521-4141(200009)30:9&lt;2729::AID-IMMU2729&gt;3.0.CO;2-3; Schulz A, 2003, J CLIN MICROBIOL, V41, P1529, DOI 10.1128/JCM.41.4.1529-1535.2003; SOLBACH W, 1986, J IMMUNOL, V137, P702; Steiner GE, 2000, J IMMUNOL METHODS, V237, P39, DOI 10.1016/S0022-1759(99)00240-9; STENGER S, 1991, EUR J IMMUNOL, V21, P1669, DOI 10.1002/eji.1830210713; VODOVOTZ Y, 1993, J EXP MED, V178, P605, DOI 10.1084/jem.178.2.605; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Yazdanparast E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002850; Zink D, 2003, METHODS, V29, P42, DOI 10.1016/S1046-2023(02)00289-X	25	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139866	10.1371/journal.pone.0139866	http://dx.doi.org/10.1371/journal.pone.0139866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488169	gold, Green Published, Green Submitted			2022-12-27	WOS:000363248400041
J	Tenni, B; Carpenter, J; Thomson, N				Tenni, Brigitte; Carpenter, Jenae; Thomson, Nicholas			Arresting HIV: Fostering Partnerships between Sex Workers and Police to Reduce HIV Risk and Promote Professionalization within Policing Institutions: A Realist Review	PLOS ONE			English	Review							VIOLENCE; FEMALE; NEGOTIATION; INDIA	In many countries around the world sex work is criminalised and its regulatory control is therefore often in the hands of the police. In addition to the impact of this criminalised legal environment, much literature describes the negative impact that certain police practices can have on the ability of sex workers and the programs that work with sex workers to access essential HIV prevention, treatment, care and support services. This situation has resulted in persistent concentrated HIV epidemics among sex workers in many countries of the world. The need for multi-sector partnerships between police and HIV programs is increasingly recognised in various UN declarations and resolutions yet descriptions of the process or key ingredients required to actually establish and sustain these necessary partnerships between police and sex workers [or the programs that provide essential services to sex workers] are sparse. The paper seeks to establish key considerations and critical processes that are required to foster partnerships that if further investigated and scaled up, could result in an enhanced enabling environment for the provision of essential HIV services for sex workers around the globe. This paper is based on a realist review that investigated isolated examples of partnership formation between law enforcement and HIV programs working with sex workers. This methodology research is designed to work with complex social interventions and is based on the emerging 'realist' approach to evaluation. A realist review methodology was chosen given the paucity of relevant literature in this vein and the authors' familiarity with the grey literature and relationships with experts who work in this sphere. The review found that political and police leadership, civil society strengthening and police reform in relation to HIV, are critical factors and key ingredients in changing the enabling environment in which sex work takes place to ensure that HIV prevention, individual and public health as well as HIV prevention and the promotion of human rights are the number one priority. Further research into this relationship is needed to provide evidence for effective HIV programming with police.	[Tenni, Brigitte; Carpenter, Jenae; Thomson, Nicholas] Univ Melbourne, Nossal Inst Global Hlth, Carlton, Vic 3010, Australia; [Thomson, Nicholas] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	University of Melbourne; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Thomson, N (corresponding author), Univ Melbourne, Nossal Inst Global Hlth, Level 4,Alan Gilbert Bldg,161 Barry St, Carlton, Vic 3010, Australia.	nicholast@unimelb.edu.au						Abel G, 2010, TAKING THE CRIME OUT OF SEX WORK: NEW ZEALAND SEX WORKERS' FIGHT FOR DECRIMINALISATION, P1, DOI 10.1332/policypress/9781847423344.001.0001; Ahmad K, 2001, LANCET, V358, P643, DOI 10.1016/S0140-6736(01)05819-6; Ajmera VM, 2004, INT C AIDS 15 BANGK; Aral SO, 2003, SEX TRANSM DIS, V30, P39, DOI 10.1097/00007435-200301000-00009; Ardayfio R., 2012, GHANA POLICE SERVICE; Australian Government Department of Health and Ageing (DoHA), 2010, 6 NAT HIV STRAT 2010; Bandyopadhyay N, 2006, IDS BULL-I DEV STUD, V37, P102, DOI 10.1111/j.1759-5436.2006.tb00292.x; Beletsky L, 2013, DRUG ALCOHOL DEPEN, V132, pS48, DOI 10.1016/j.drugalcdep.2013.06.027; Biradavolu MR, 2009, SOC SCI MED, V68, P1541, DOI 10.1016/j.socscimed.2009.01.040; Crofts N., 2011, ARRESTING HIV LAW EN; Decker M. R., 2012, SEXUALLY TRANSMITTED; Donovan Basil, 2010, N S W Public Health Bull, V21, P74, DOI 10.1071/NB10013; Erausquin JT, 2011, J INFECT DIS, V204, pS1223, DOI 10.1093/infdis/jir539; Harcourt Christine, 2005, Sex Health, V2, P121, DOI 10.1071/SH04042; Human Rights Watch, 2010, STREETS ARB DET OTH; Human Rights Watch, 2003, FANN FLAM HUM RIGHTS, V15; International HIV/AIDS Alliance, 2008, SEX WORK VIOL HIV GU; International HIV/AIDS Alliance, 2008, FRONT PREV PROJ SEX; Jeffreys E, 2010, REPROD HEALTH MATTER, V18, P129, DOI 10.1016/S0968-8080(10)35496-6; Jenkins C., 2000, UNAIDS BEST PRACTICE; McMillan K, 2010, HIV MATTERS DISCUSSI, V2, P4; Nair P. M., 2003, REPORT TRAFFICKING W, VI; Nepal Police, 2015, HUM RIGHTS UN; Odhiambo T., REMAKING LAW ENFORCE; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Rao Sandhya, 2009, WHO STOLE TARTS SEX; Reid R, 2010, EJOURNAL AUSTR A APR; Rhodes T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a811; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Stachowiak JA, 2005, SIECUS REPORT, V22, P18; Strathdee SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019048; UNDP, 2012, SEX WORK LAW AS PAC; UNDP, SEX WORK LAW AS PAC; UNODC, 2013, MIN INT DRUG ENF UN; WHO, 2012, CONS GUID US ANT DRU	37	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0134900	10.1371/journal.pone.0134900	http://dx.doi.org/10.1371/journal.pone.0134900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZM	26488904	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400002
J	Huang, YB; Hu, CR; Zhang, L; Yin, W; Hu, B				Huang, Yu-Bin; Hu, Chun-Rui; Zhang, Li; Yin, Wu; Hu, Bing			In Vivo Study of Dynamics and Stability of Dendritic Spines on Olfactory Bulb Interneurons in Xenopus laevis Tadpoles	PLOS ONE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; NMDA RECEPTOR SUBUNITS; POSTSYNAPTIC DENSITIES; SYNAPTIC PLASTICITY; STRUCTURAL DYNAMICS; NEURONS; GROWTH; SYNAPTOGENESIS; ZEBRAFISH; CELL	Dendritic spines undergo continuous remodeling during development of the nervous system. Their stability is essential for maintaining a functional neuronal circuit. Spine dynamics and stability of cortical excitatory pyramidal neurons have been explored extensively in mammalian animal models. However, little is known about spiny interneurons in non-mammalian vertebrate models. In the present study, neuronal morphology was visualized by single-cell electroporation. Spiny neurons were surveyed in the Xenopus tadpole brain and observed to be widely distributed in the olfactory bulb and telencephalon. DsRed-or PSD95-GFP-expressing spiny interneurons in the olfactory bulb were selected for in vivo time-lapse imaging. Dendritic protrusions were classified as filopodia, thin, stubby, or mushroom spines based on morphology. Dendritic spines on the interneurons were highly dynamic, especially the filopodia and thin spines. The stubby and mushroom spines were relatively more stable, although their stability significantly decreased with longer observation intervals. The 4 spine types exhibited diverse preferences during morphological transitions from one spine type to others. Sensory deprivation induced by severing the olfactory nerve to block the input of mitral/tufted cells had no significant effects on interneuron spine stability. Hence, a new model was established in Xenopus laevis tadpoles to explore dendritic spine dynamics in vivo.	[Hu, Bing] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Brain Funct & Dis, Hefei, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Hu, B (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Key Lab Brain Funct & Dis, Hefei, Anhui, Peoples R China.	bhu@ustc.edu.cn	hu, bing/B-1030-2010	hu, bing/0000-0001-8627-5272	National Natural Science Foundation of China [91132724, 30870833, U1332136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China, grant numbers: 91132724, 30870833, and U1332136, http://www.nsfc.gov.cn/. BH received the funding. The funders supported the study design, data collection, analysis, and decision to publish.	Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Bestman JE, 2006, NAT PROTOC, V1, P1267, DOI 10.1038/nprot.2006.186; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; BYRD CA, 1991, J COMP NEUROL, V314, P79, DOI 10.1002/cne.903140108; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cohen-Cory Susana, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4782; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ebihara T, 2003, J NEUROSCI, V23, P2170; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Gahtan E, 2003, J COMP NEUROL, V459, P186, DOI 10.1002/cne.10621; Haas K, 2006, P NATL ACAD SCI USA, V103, P12127, DOI 10.1073/pnas.0602670103; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hofer SB, 2010, CURR BIOL, V20, pR157, DOI 10.1016/j.cub.2009.12.040; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hu B, 2005, DEVELOPMENT, V132, P4285, DOI 10.1242/dev.02017; Hutson LD, 2002, CURR OPIN NEUROBIOL, V12, P87, DOI 10.1016/S0959-4388(02)00294-5; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kalueff AV, 2014, TRENDS PHARMACOL SCI, V35, P63, DOI 10.1016/j.tips.2013.12.002; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; KIMMEL CB, 1990, NEURON, V4, P535, DOI 10.1016/0896-6273(90)90111-R; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lin BJ, 2007, J PHYSIOL-LONDON, V582, P163, DOI 10.1113/jphysiol.2006.125963; Livneh Y, 2009, J NEUROSCI, V29, P86, DOI 10.1523/JNEUROSCI.4105-08.2009; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Manzini I, 2003, J PHYSIOL-LONDON, V551, P115, DOI 10.1113/jphysiol.2003.043059; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; McFarlane S, 2012, DEV NEUROBIOL, V72, P520, DOI 10.1002/dneu.20928; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Mizrahi A, 2007, NAT NEUROSCI, V10, P444, DOI 10.1038/nn1875; Nevian T, 2007, PFLUG ARCH EUR J PHY, V454, P675, DOI 10.1007/s00424-007-0234-2; Nezlin LP, 2000, CELL TISSUE RES, V302, P21, DOI 10.1007/s004410000208; Nezlin LP, 2003, J COMP NEUROL, V464, P257, DOI 10.1002/cne.10709; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Niethammer M, 1996, J NEUROSCI, V16, P2157; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Pratt KG, 2013, DIS MODEL MECH, V6, P1057, DOI 10.1242/dmm.012138; Ruthazer Edward S, 2013, Cold Spring Harb Protoc, V2013, P804, DOI 10.1101/pdb.top077156; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409; Scheidweiler U, 2001, CHEM SENSES, V26, P399, DOI 10.1093/chemse/26.4.399; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tropea D, 2010, J NEUROSCI, V30, P11086, DOI 10.1523/JNEUROSCI.1661-10.2010; Wu GY, 2003, J COMP NEUROL, V459, P392, DOI 10.1002/cne.10618; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	64	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140752	10.1371/journal.pone.0140752	http://dx.doi.org/10.1371/journal.pone.0140752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485435	Green Published, gold			2022-12-27	WOS:000363028100065
J	Kumar, R; Kaur, R; Auffarth, B; Bhondekar, AP				Kumar, Ritesh; Kaur, Rishemjit; Auffarth, Benjamin; Bhondekar, Amol P.			Understanding the Odour Spaces: A Step towards Solving Olfactory Stimulus-Percept Problem	PLOS ONE			English	Article							POWER LAWS; DISTRIBUTIONS; THRESHOLDS; TETRALIN; BEHAVIOR; DATABASE	Odours are highly complex, relying on hundreds of receptors, and people are known to disagree in their linguistic descriptions of smells. It is partly due to these facts that, it is very hard to map the domain of odour molecules or their structure to that of perceptual representations, a problem that has been referred to as the Structure-Odour-Relationship. We collected a number of diverse open domain databases of odour molecules having unorganised perceptual descriptors, and developed a graphical method to find the similarity between perceptual descriptors; which is intuitive and can be used to identify perceptual classes. We then separately projected the physico-chemical and perceptual features of these molecules in a non-linear dimension and clustered the similar molecules. We found a significant overlap between the spatial positioning of the clustered molecules in the physico-chemical and perceptual spaces. We also developed a statistical method of predicting the perceptual qualities of a novel molecule using its physico-chemical properties with high receiver operating characteristics(ROC).	[Kumar, Ritesh; Kaur, Rishemjit; Bhondekar, Amol P.] CSIR Cent Sci Instruments Org, Chandigarh, India; [Kumar, Ritesh; Kaur, Rishemjit; Bhondekar, Amol P.] Acad Sci & Innovat Res, New Delhi, India; [Kaur, Rishemjit] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Auffarth, Benjamin] Free Univ Berlin, Neuroinformat, Dept Neurobiol, Berlin, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Scientific Instruments Organisation (CSIO); Academy of Scientific & Innovative Research (AcSIR); Nagoya University; Free University of Berlin	Kumar, R (corresponding author), CSIR Cent Sci Instruments Org, Chandigarh, India.	riteshkr@csio.res.in	Kumar, Ritesh/E-5466-2012; Kaur, Rishemjit/E-5462-2012	Kumar, Ritesh/0000-0003-4284-5311; Kaur, Rishemjit/0000-0002-9424-0907	Council of Scientific and Industrial Research (CSIR) [SUPRA Institutional Project]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by the Council of Scientific and Industrial Research (CSIR) Grant Number: SUPRA Institutional Project- OMEGA Website: http://www.csir.res.in/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1990, ANAL CHIM ACTA, V239, P73, DOI 10.1016/S0003-2670(00)83837-4; Acree T., 2004, FLAVORNET; Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a; Adamic L, 2011, NATURE, V474, P164, DOI 10.1038/474164a; Aggarwal CC, SUPRISING BEHAV DIST; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; AMOORE JE, 1977, CHEM SENS FLAV, V2, P267, DOI 10.1093/chemse/2.3.267; Auffarth B, 2013, NEUROSCI BIOBEHAV R, V37, P1667, DOI 10.1016/j.neubiorev.2013.06.009; Bak P., 1997, NATURE WORKS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Burroughs SM, 2001, PURE APPL GEOPHYS, V158, P741, DOI 10.1007/PL00001202; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Castro JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073289; Chastrette M, 1997, SAR QSAR Environ Res, V6, P215, DOI 10.1080/10629369708033253; Chastrette M, 1996, J CHEM INF COMP SCI, V36, P108, DOI 10.1021/ci950154b; Cherqaoui D, 1998, NEW J CHEM, V22, P839, DOI 10.1039/a709269e; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Czerny M, 2011, CHEM SENSES, V36, P539, DOI 10.1093/chemse/bjr009; Dielenberg RA, 2001, NEUROSCI BIOBEHAV R, V25, P597, DOI 10.1016/S0149-7634(01)00044-6; DUBES RC, 1987, PATTERN RECOGN, V20, P645, DOI 10.1016/0031-3203(87)90034-3; Dunkel M, 2009, NUCLEIC ACIDS RES, V37, pD291, DOI 10.1093/nar/gkn695; ERDOS P, 1960, B INT STATIST INST, V38, P343; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gerkin RC, 2015, ELIFE, V4, DOI 10.7554/eLife.08127; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Haddad R, 2010, J NEUROSCI, V30, P9017, DOI 10.1523/JNEUROSCI.0398-10.2010; Johnson S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108702; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Koulakov A, 2009, ARXIV09073964, P1; Koutra D., 2011, P EC INF C, V17; Lavine BK, 2012, CHEM SENSES, V37, P723, DOI 10.1093/chemse/bjs058; Leon M., 2008, GLOMERULAR RESPONSE; Loper E., 2002, P COLING ACL INT PRE, V1, P63, DOI DOI 10.3115/1225403.1225421; Luebke W., 1980, GOOD SCENTS CO; Majid A, 2014, COGNITION, V130, P266, DOI 10.1016/j.cognition.2013.11.004; Mamlouk AM, 2003, NEUROCOMPUTING, V52-4, P591, DOI 10.1016/S0925-2312(02)00805-6; Meister M, 2015, ELIFE, V4, DOI 10.7554/eLife.07865; Muller J., 1992, H R BOOK PERFUME UND; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Raman B, 2011, ACS CHEM NEUROSCI, V2, P487, DOI 10.1021/cn200027r; Rossiter KJ, 1996, CHEM REV, V96, P3201, DOI 10.1021/cr950068a; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Schmuker M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-11; Schmuker M, 2007, P NATL ACAD SCI USA, V104, P20285, DOI 10.1073/pnas.0705683104; Snitz K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003184; Stevens K., 2012, P 2012 JOINT C EMPIR, P952, DOI DOI 10.5555/2390948.2391052; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Yeshurun Y, 2010, ANNU REV PSYCHOL, V61, P219, DOI 10.1146/annurev.psych.60.110707.163639; Zarzo M, 2006, CHEM SENSES, V31, P713, DOI 10.1093/chemse/bjl013; Zarzo M, 2011, SENSORS-BASEL, V11, P3667, DOI 10.3390/s110403667; Zipf GK, 1950, J CLIN PSYCHOL, V6, P306	54	18	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0141263	10.1371/journal.pone.0141263	http://dx.doi.org/10.1371/journal.pone.0141263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484763	gold, Green Submitted, Green Published			2022-12-27	WOS:000363028100126
J	Nishioji, K; Mochizuki, N; Kobayashi, M; Kamaguchi, M; Sumida, Y; Nishimura, T; Yamaguchi, K; Kadotani, H; Itoh, Y				Nishioji, Kenichi; Mochizuki, Naomi; Kobayashi, Masao; Kamaguchi, Mai; Sumida, Yoshio; Nishimura, Takeshi; Yamaguchi, Kanji; Kadotani, Hiroshi; Itoh, Yoshito			The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain >= 10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; RISK-FACTORS; INSULIN-RESISTANCE; CHINESE POPULATION; I148M VARIANT; FOLLOW-UP; ASSOCIATION; PREVALENCE; SUSCEPTIBILITY	Non-alcoholic fatty liver disease (NAFLD) in non-obese individuals is inadequately elucidated. We aim to investigate the impact of known genetic polymorphisms on NAFLD and the interaction between genetic risks and weight gain on NAFLD in obese and non-obese Japanese individuals. A total of 1164 participants who received health checkups were included. Participants with excessive alcohol consumption, with viral hepatitis or other inappropriate cases were excluded. Fatty liver was diagnosed by ultrasonography. Participants with a body mass index (BMI) of < 18.5 kg/m(2), 18.5-22.9 kg/m(2), 23.0-24.9 kg/m(2) and >= 25 kg/m2 were classified underweight, normal weight, overweight and obese, respectively. Self-administered questionnaire for lifestyle was assessed and a total of 8 previously reported genetic polymorphisms were chosen and examined. In all, 824 subjects were enrolled. The overall prevalence of NAFLD was 33.0%: 0% in underweight, 15.3% in normal weight, 41.1% in overweight and 71.7% in obese individuals. The prevalence of NAFLD is more affected by the G allele of patatin-like phospholipase domain-containing protein 3 (PNPLA3) rs738409 in normal weight (odds ratio (OR) 3.52; 95%-CI: 1.42-8.71; P = 0.0063) and in overweight individuals (OR 2.60; 95%-CI: 1.14-5.91; P = 0.0225) than in obese individuals (not significant). Moreover, the G allele of PNPLA3 rs738409 and weight gain >= 10 kg after age 20 had a joint effect on the risk of NAFLD in the normal weight (OR 12.00; 95% CI: 3.71-38.79; P = 3.3x10(-5)) and the overweight individuals (OR 13.40; 95% CI: 2.92-61.36; P = 0.0008). The G allele of PNPLA3 rs738409 is a prominent risk factor for NAFLD and the interaction between the PNPLA3 rs738409 and weight gain >= 10 kg after age 20 plays a crucial role in the pathogenesis of NAFLD, especially in non-obese Japanese individuals.	[Nishioji, Kenichi; Mochizuki, Naomi; Kobayashi, Masao; Kamaguchi, Mai] Kyoto Second Red Cross Hosp, Div Hlth Care, Kyoto, Kyoto, Japan; [Sumida, Yoshio; Nishimura, Takeshi; Yamaguchi, Kanji; Itoh, Yoshito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Mol Gastroenterol & Hepatol, Kyoto, Kyoto, Japan; [Kadotani, Hiroshi] Shiga Univ Med Sci, Dept Psychiat, Otsu, Shiga 52021, Japan	Kyoto Prefectural University of Medicine; Shiga University of Medical Science	Itoh, Y (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Mol Gastroenterol & Hepatol, Kyoto, Kyoto, Japan.	yitoh@koto.kpu-m.ac.jp	Sumida, Yoshio/AAL-6723-2020; Kadotani, Hiroshi/A-7908-2015	Kadotani, Hiroshi/0000-0001-7474-3315				[Anonymous], 2007, STAND HLTH CHECK HLT; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; De la Cruz AC, 2014, DIGESTIVE DIS WEEK; Eguchi Y, 2006, J GASTROENTEROL, V41, P462, DOI 10.1007/s00535-006-1790-5; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; FRIEDMAN GD, 1986, J CHRON DIS, V39, P453, DOI 10.1016/0021-9681(86)90112-8; Hernaez R, 2013, CLIN GASTROENTEROL H, V11, P1183, DOI 10.1016/j.cgh.2013.02.011; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hotta K, 2012, J HUM GENET, V57, P46, DOI 10.1038/jhg.2011.127; Hotta K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-172; Hyysalo J, 2014, DIABETES, V63, P312, DOI 10.2337/db13-0774; International Obesity Task Force, 2000, AS PAC PERSP RED OB; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Kimura T, 2015, J GASTROEN HEPATOL, V30, P909, DOI 10.1111/jgh.12861; Kitamoto A, 2014, ENDOCR J, V61, P683, DOI 10.1507/endocrj.EJ14-0052; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Korenblat KM, 2008, GASTROENTEROLOGY, V134, P1369, DOI 10.1053/j.gastro.2008.01.075; Kwon YM, 2012, AM J GASTROENTEROL, V107, P1852, DOI 10.1038/ajg.2012.314; Lee SS, 2014, DIGEST DIS SCI, V59, P2967, DOI 10.1007/s10620-014-3279-z; Li YL, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-113; Lin YC, 2014, AM J CLIN NUTR, V99, P869, DOI 10.3945/ajcn.113.079749; Liu CJ, 2012, J GASTROEN HEPATOL, V27, P1555, DOI 10.1111/j.1440-1746.2012.07222.x; McCarthy EM, 2012, J ACAD NUTR DIET, V112, P401, DOI 10.1016/j.jada.2011.10.007; Nishioji K, 2015, J GASTROENTEROL, V50, P95, DOI 10.1007/s00535-014-0948-9; Okanoue T, 2005, J HEPATOL, V43, P599, DOI 10.1016/j.jhep.2005.04.008; Pagadala MR, 2012, AM J GASTROENTEROL, V107, P1859, DOI 10.1038/ajg.2012.320; Palmer ND, 2013, HEPATOLOGY, V58, P966, DOI 10.1002/hep.26440; Pirazzi C, 2014, HUM MOL GENET, V23, P4077, DOI 10.1093/hmg/ddu121; Pirazzi C, 2012, J HEPATOL, V57, P1276, DOI 10.1016/j.jhep.2012.07.030; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Ruhanen H, 2014, J LIPID RES, V55, P739, DOI 10.1194/jlr.M046607; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Shen J, 2014, ALIMENT PHARM THER, V39, P532, DOI 10.1111/apt.12609; Shen JY, 2015, J GASTROEN HEPATOL, V30, P139, DOI 10.1111/jgh.12656; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Tan HL, 2014, J GASTROENTEROL, V49, P1056, DOI 10.1007/s00535-013-0850-x; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wang CW, 2011, LIVER INT, V31, P1326, DOI 10.1111/j.1478-3231.2011.02526.x; Xu CF, 2013, AM J GASTROENTEROL, V108, P1299, DOI 10.1038/ajg.2013.104; Yang Z, 2011, MOL BIOL REP, V38, P1145, DOI 10.1007/s11033-010-0212-1; Yasutake K, 2009, SCAND J GASTROENTERO, V44, P471, DOI 10.1080/00365520802588133; Zain SM, 2015, J GASTROEN HEPATOL, V30, P21, DOI 10.1111/jgh.12714; Zhang YC, 2014, IEEE INT CONF ELECTR, P9	45	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140427	10.1371/journal.pone.0140427	http://dx.doi.org/10.1371/journal.pone.0140427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485523	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100033
J	Visscher, AM; Belfield, EJ; Vlad, D; Irani, N; Moore, I; Harberd, NP				Visscher, Anne M.; Belfield, Eric J.; Vlad, Daniela; Irani, Niloufer; Moore, Ian; Harberd, Nicholas P.			Overexpressing the Multiple-Stress Responsive Gene At1g74450 Reduces Plant Height and Male Fertility in Arabidopsis thaliana	PLOS ONE			English	Article							POLLEN DEVELOPMENT; MALE-STERILITY; VECTOR SET; ANTHER; GROWTH; ACCUMULATION; INTEGRATION; PROTEINS; PATHWAY; IDENTIFICATION	A subset of genes in Arabidopsis thaliana is known to be up-regulated in response to a wide range of different environmental stress factors. However, not all of these genes are characterized as yet with respect to their functions. In this study, we used transgenic knockout, overexpression and reporter gene approaches to try to elucidate the biological roles of five unknown multiple-stress responsive genes in Arabidopsis. The selected genes have the following locus identifiers: At1g18740, At1g74450, At4g27652, At4g29780 and At5g12010. Firstly, T-DNA insertion knockout lines were identified for each locus and screened for altered phenotypes. None of the lines were found to be visually different from wildtype Col-0. Secondly, 35S-driven overexpression lines were generated for each open reading frame. Analysis of these transgenic lines showed altered phenotypes for lines overexpressing the At1g74450 ORF. Plants overexpressing the multiple-stress responsive gene At1g74450 are stunted in height and have reduced male fertility. Alexander staining of anthers from flowers at developmental stage 12-13 showed either an absence or a reduction in viable pollen compared to wildtype Col-0 and At1g74450 knockout lines. Interestingly, the effects of stress on crop productivity are most severe at developmental stages such as male gametophyte development. However, the molecular factors and regulatory networks underlying environmental stress-induced male gametophytic alterations are still largely unknown. Our results indicate that the At1g74450 gene provides a potential link between multiple environmental stresses, plant height and pollen development. In addition, ruthenium red staining analysis showed that At1g74450 may affect the composition of the inner seed coat mucilage layer. Finally, C-terminal GFP fusion proteins for At1g74450 were shown to localise to the cytosol.	[Visscher, Anne M.; Belfield, Eric J.; Vlad, Daniela; Irani, Niloufer; Moore, Ian; Harberd, Nicholas P.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, Oxon, England	University of Oxford	Visscher, AM (corresponding author), Kew, Royal Bot Gardens, Dept Comparat Plant & Fungal Biol, Ardingly RH17 6TN, W Sussex, England.	a.visscher@kew.org; nicholas.harberd@plants.ox.ac.uk		Belfield, Eric/0000-0003-0892-100X; Irani, Niloufer/0000-0003-3252-4493	King Abdullah University of Science and Technology [KUK-I1-002-03]; Biotechnology and Biological Sciences Research Council [BB/F020759/1]; Biotechnology and Biological Sciences Research Council [REI20537, BB/I022996/1] Funding Source: researchfish; BBSRC [BB/I022996/1, BB/F020759/1] Funding Source: UKRI	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by King Abdullah University of Science and Technology [Award No. KUK-I1-002-03] and a Biotechnology and Biological Sciences Research Council grant [BB/F020759/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colebrook EH, 2014, J EXP BIOL, V217, P67, DOI 10.1242/jeb.089938; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; de Ribou SD, 2013, PLANT SCI, V210, P159, DOI 10.1016/j.plantsci.2013.05.010; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; Dolferus R, 2014, PLANT SCI, V229, P247, DOI 10.1016/j.plantsci.2014.10.002; Dorion S, 1996, PLANT PHYSIOL, V111, P137, DOI 10.1104/pp.111.1.137; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fan XP, 2014, PLANT PHYSIOL, V164, P1338, DOI 10.1104/pp.113.227769; Fei HM, 1999, SEX PLANT REPROD, V12, P188, DOI 10.1007/s004970050191; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Garcia-Molina A, 2014, PLANT PHYSIOL, V164, P828, DOI 10.1104/pp.113.228239; Gaspar T, 2002, PLANT GROWTH REGUL, V37, P263, DOI 10.1023/A:1020835304842; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Gendre D, 2013, PLANT CELL, V25, P2633, DOI 10.1105/tpc.113.112482; Gendre D, 2011, P NATL ACAD SCI USA, V108, P8048, DOI 10.1073/pnas.1018371108; Gonzalez-Perez S, 2011, PLANT PHYSIOL, V156, P1439, DOI 10.1104/pp.111.177766; Gothandam KM, 2007, J PLANT BIOL, V50, P396, DOI 10.1007/BF03030674; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Griffiths JS, 2014, PLANT PHYSIOL, V165, P991, DOI 10.1104/pp.114.239400; Guan YF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004384; Haughn GW, 2012, FRONT PLANT SCI, V3; Heyndrickx KS, 2012, PLANT PHYSIOL, V159, P884, DOI 10.1104/pp.112.196725; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu LF, 2011, PLANT CELL, V23, P515, DOI 10.1105/tpc.110.074369; Jain M, 2007, PLANTA, V227, P67, DOI 10.1007/s00425-007-0595-y; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Klopffleisch K, 2011, MOL SYSTEMS BIOL, V7; Koonjul PK, 2005, J EXP BOT, V56, P179, DOI 10.1093/jxb/eri018; Kranner I, 2010, NEW PHYTOL, V188, P655, DOI 10.1111/j.1469-8137.2010.03461.x; Kulich I, 2010, NEW PHYTOL, V188, P615, DOI 10.1111/j.1469-8137.2010.03372.x; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Mandaokar A, 2009, PLANT PHYSIOL, V149, P851, DOI 10.1104/pp.108.132597; Marmagne A, 2004, MOL CELL PROTEOMICS, V3, P675, DOI 10.1074/mcp.M400001-MCP200; McFarlane H.E., 2014, BIOPROTOCOL, V4, P1096, DOI DOI 10.21769/BioProtoc.1096; Mitra SK, 2007, J PROTEOME RES, V6, P1933, DOI 10.1021/pr060525b; Mudgil Y, 2009, PLANT CELL, V21, P3591, DOI 10.1105/tpc.109.065557; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Narusaka Y, 2012, TRANSGENIC PLANTS AD; Oliver SN, 2005, PLANT CELL ENVIRON, V28, P1534, DOI 10.1111/j.1365-3040.2005.01390.x; Peterson R., 2010, International Journal of Plant Biology, V1, P66; Pitzschke A, 2009, MOL PLANT, V2, P120, DOI 10.1093/mp/ssn079; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Renak D, 2014, PLANT CELL ENVIRON, V37, P670, DOI 10.1111/pce.12186; Rhee SY, 2014, TRENDS PLANT SCI, V19, P212, DOI 10.1016/j.tplants.2013.10.006; Sakata T, 2010, P NATL ACAD SCI USA, V107, P8569, DOI 10.1073/pnas.1000869107; Sato S, 2006, ANN BOT-LONDON, V97, P731, DOI 10.1093/aob/mcl037; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Suzuki K, 2001, SEX PLANT REPROD, V13, P293, DOI 10.1007/s004970100071; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Thevenin J, 2011, MOL PLANT, V4, P70, DOI 10.1093/mp/ssq045; Van Norman JM, 2011, PLANT CELL, V23, P855, DOI 10.1105/tpc.111.082982; Visscher AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012348; Voiniciuc C, 2015, INT J MOL SCI, V16, P3452, DOI 10.3390/ijms16023452; Vriet C, 2012, PLANT CELL, V24, P842, DOI 10.1105/tpc.111.094912; Weigel D, 2006, PLANTA TRANSFORMATIO, V2006; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xie B, 2011, PLANT J, V65, P1, DOI 10.1111/j.1365-313X.2010.04399.x; Xing S, 2008, PLANT J, V53, P790, DOI 10.1111/j.1365-313X.2007.03375.x; Ye QQ, 2010, P NATL ACAD SCI USA, V107, P6100, DOI 10.1073/pnas.0912333107; Yoshimoto N, 2002, PLANT J, V29, P465, DOI 10.1046/j.0960-7412.2001.01231.x; Zanor MI, 2009, PLANT PHYSIOL, V150, P1204, DOI 10.1104/pp.109.136598; Zou CS, 2010, J EXP BOT, V61, P3901, DOI 10.1093/jxb/erq204	70	11	11	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140368	10.1371/journal.pone.0140368	http://dx.doi.org/10.1371/journal.pone.0140368			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485022	Green Submitted, Green Published, gold			2022-12-27	WOS:000363028100029
J	Zhong, J; Narsinh, K; Morel, PA; Xu, HY; Ahrens, ET				Zhong, Jia; Narsinh, Kazim; Morel, Penelope A.; Xu, Hongyan; Ahrens, Eric T.			In Vivo Quantification of Inflammation in Experimental Autoimmune Encephalomyelitis Rats Using Fluorine-19 Magnetic Resonance Imaging Reveals Immune Cell Recruitment outside the Nervous System	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; SPINAL-CORD; IRON-OXIDE; MRI; MACROPHAGES; BLOOD; NEURODEGENERATION; SUBSTITUTES; GADOLINIUM	Progress in identifying new therapies for multiple sclerosis (MS) can be accelerated by using imaging biomarkers of disease progression or abatement in model systems. In this study, we evaluate the ability to noninvasively image and quantitate disease pathology using emerging "hot-spot" F-19 MRI methods in an experimental autoimmune encephalomyelitis (EAE) rat, a model of MS. Rats with clinical symptoms of EAE were compared to control rats without EAE, as well as to EAE rats that received daily prophylactic treatments with cyclophosphamide. Perfluorocarbon (PFC) nanoemulsion was injected intravenously, which labels predominately monocytes and macrophages in situ. Analysis of the spin-density weighted F-19 MRI data enabled quantification of the apparent macrophage burden in the central nervous system and other tissues. The in vivo MRI results were confirmed by extremely high-resolution F-19/H-1 magnetic resonance microscopy in excised tissue samples and histopathologic analyses. Additionally, F-19 nuclear magnetic resonance spectroscopy of intact tissue samples was used to assay the PFC biodistribution in EAE and control rats. In vivo hot-spot F-19 signals were detected predominantly in the EAE spinal cord, consistent with the presence of inflammatory infiltrates. Surprising, prominent F-19 hot-spots were observed in bone-marrow cavities adjacent to spinal cord lesions; these were not observed in control animals. Quantitative evaluation of cohorts receiving cyclophosphamide treatment displayed significant reduction in F-19 signal within the spinal cord and bone marrow of EAE rats. Overall, F-19 MRI can be used to quantitatively monitored EAE disease burden, discover unexpected sites of inflammatory activity, and may serve as a sensitive biomarker for the discovery and preclinical assessment of novel MS therapeutic interventions.	[Zhong, Jia; Narsinh, Kazim; Xu, Hongyan; Ahrens, Eric T.] Univ Calif San Diego, Sch Med, Dept Radiol, La Jolla, CA 92093 USA; [Morel, Penelope A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA	University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahrens, ET (corresponding author), Univ Calif San Diego, Sch Med, Dept Radiol, La Jolla, CA 92093 USA.	eahrens@ucsd.edu	Morel, Penelope Anne/AAI-6239-2020	Morel, Penelope Anne/0000-0002-1743-3676	National Institutes of Health [R01-CA134633]; California Institute for Regenerative Medicine [LA1-C12-06919, TG2-01154]; Radiological Society of North America [RR1452]; NATIONAL CANCER INSTITUTE [R01CA134633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Radiological Society of North America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	EA is funded by National Institutes of Health R01-CA134633 (http://www.nih.gov/) and California Institute for Regenerative Medicine LA1-C12-06919 (http://www.cirm.ca.gov/). KN is funded by California Institute for Regenerative Medicine TG2-01154 (http://www.cirm.ca.gov/) and Radiological Society of North America RR1452 (http://www.rsna.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2013, NMR BIOMED, V26, P860, DOI 10.1002/nbm.2948; Ahrens ET, 2011, BIOTECHNIQUES, V50, P229, DOI 10.2144/000113652; Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Balducci A, 2012, J INFLAMM, V9, P1, DOI DOI 10.1186/1476-9255-9-24; Bauer J, 1995, GLIA, V15, P437, DOI 10.1002/glia.440150407; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Buck D, 2012, J NUCL MED, V53, P1269, DOI 10.2967/jnumed.111.102608; Costa GL, 2001, J IMMUNOL, V167, P2379, DOI 10.4049/jimmunol.167.4.2379; Dousset V, 1999, AM J NEURORADIOL, V20, P223; Dousset V, 2006, AM J NEURORADIOL, V27, P1000; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; FLAIM SF, 1994, ARTIF CELL BLOOD SUB, V22, P1043, DOI 10.3109/10731199409138801; Flogel U, 2011, AM J TRANSPLANT, V11, P235, DOI 10.1111/j.1600-6143.2010.03372.x; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Hendriks JJA, 2005, BRAIN RES REV, V48, P185, DOI 10.1016/j.brainresrev.2004.12.008; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Hitchens TK, 2011, MAGN RESON MED, V65, P1145, DOI 10.1002/mrm.22702; Kadayakkara DK, 2012, LAB INVEST, V92, P636, DOI 10.1038/labinvest.2012.7; Ladewig G, 2009, EXP NEUROL, V220, P207, DOI 10.1016/j.expneurol.2009.08.027; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; LONGMAID HE, 1985, INVEST RADIOL, V20, P141, DOI 10.1097/00004424-198503000-00009; Lorentzen JC, 1995, J NEUROIMMUNOL, V63, P193, DOI 10.1016/0165-5728(95)00153-0; Lowe KC, 2003, TISSUE ENG, V9, P389, DOI 10.1089/107632703322066570; Luo J, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-6; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; Noth U, 1997, ARTIF CELL BLOOD SUB, V25, P243, DOI 10.3109/10731199709118914; Polfliet MMJ, 2002, J NEUROIMMUNOL, V122, P1, DOI 10.1016/S0165-5728(01)00445-3; Radu CG, 2007, P NATL ACAD SCI USA, V104, P1937, DOI 10.1073/pnas.0610544104; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RATNER AV, 1988, INVEST RADIOL, V23, P361, DOI 10.1097/00004424-198805000-00006; RATNER AV, 1988, AM J ROENTGENOL, V151, P477, DOI 10.2214/ajr.151.3.477; Rausch M, 2003, MAGNET RESON MED, V50, P309, DOI 10.1002/mrm.10541; Riess JG, 2005, ARTIF CELL BLOOD SUB, V33, P47, DOI 10.1081/BIO-200046659; Trapp BD, 1999, NEUROSCIENTIST, V5, P48, DOI 10.1177/107385849900500107; Weise G, 2011, EXP NEUROL, V229, P494, DOI 10.1016/j.expneurol.2011.03.020; Xu S, 1998, J NEUROSCI RES, V52, P549, DOI 10.1002/(SICI)1097-4547(19980601)52:5<549::AID-JNR7>3.3.CO;2-6	40	23	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140238	10.1371/journal.pone.0140238	http://dx.doi.org/10.1371/journal.pone.0140238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485716	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000363028100024
J	Wood, SA; Depree, C; Brown, L; McAllister, T; Hawes, I				Wood, Susanna A.; Depree, Craig; Brown, Logan; McAllister, Tara; Hawes, Ian			Entrapped Sediments as a Source of Phosphorus in Epilithic Cyanobacterial Proliferations in Low Nutrient Rivers	PLOS ONE			English	Article							HOMOANATOXIN-A; ANATOXIN-A; BENTHIC CYANOBACTERIA; DOG NEUROTOXICOSIS; 1ST REPORT; LAKE; MATS; RELEASE; RATES; PHOTOINHIBITION	Proliferations of the benthic mat-forming cyanobacteria Phormidium have been reported in rivers worldwide. Phormidium commonly produces natural toxins which pose a health risk to animal and humans. Recent field studies in New Zealand identified that sites with Phormidium proliferations consistently have low concentrations of water column dissolved reactive phosphorus (DRP). Unlike other river periphyton, Phormidium mats are thick and cohesive, with water and fine sediment trapped in a mucilaginous matrix. We hypothesized that daytime photosynthetic activity would elevate pH inside the mats, and/or night time respiration would reduce dissolved oxygen. Either condition could be sufficient to facilitate desorption of phosphates from sediment incorporated within mats, thus allowing Phormidium to utilize it for growth. Using microelectrodes, optodes and pulse amplitude modulation fluorometry we demonstrated that photosynthetic activity results in elevated pH (>9) during daytime, and that night-time respiration causes oxygen depletion (<4 mg L-1) within mats. Water trapped within the mucilaginous Phormidium mat matrix had on average 320-fold higher DRP concentrations than bulk river water and this, together with elevated concentrations of elements, including iron, suggest phosphorus release from entrapped sediment. Sequential extraction of phosphorus from trapped sediment was used to investigate the role of sediment at sites on the Mangatainoka River (New Zealand) with and without Phormidium proliferations. Deposition of fine sediment (<63 mu m) was significantly higher at the site with the most extensive proliferations and concentrations of biological available phosphorus were two-to four-fold higher. Collectively these results provide evidence that fine sediment can provide a source of phosphorus to support Phormidium growth and proliferation.	[Wood, Susanna A.] Cawthron Inst, Nelson, New Zealand; [Wood, Susanna A.] Univ Waikato, Environm Res Inst, Hamilton, New Zealand; [Depree, Craig] NIWA, Hamilton, New Zealand; [Brown, Logan] Horizons Reg Council, Palmerston North, New Zealand; [McAllister, Tara; Hawes, Ian] Univ Canterbury, Waterways Ctr Freshwater Management, Christchurch 1, New Zealand	Cawthron Institute; University of Waikato; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Canterbury	Wood, SA (corresponding author), Cawthron Inst, Nelson, New Zealand.	Susie.wood@cawthron.org.nz		Hawes, Ian/0000-0003-2471-6903	Horizons Regional Council; New Zealand Ministry for Business, Innovation and Employment Cumulative Effects programme [CO1X0803]	Horizons Regional Council; New Zealand Ministry for Business, Innovation and Employment Cumulative Effects programme(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This project was funded by the Horizons Regional Council and the New Zealand Ministry for Business, Innovation and Employment Cumulative Effects programme (CO1X0803).	Aboal M, 2002, J APPL PHYCOL, V14, P49, DOI 10.1023/A:1015298905510; Aboal M, 2000, INT VER THEOR ANGEW, V27, P555; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; ANDERSEN JM, 1975, ARCH HYDROBIOL, V76, P411; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2014, R LANG ENV STAT COMP; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Beer S, 2004, EUR J PHYCOL, V39, P1, DOI 10.1080/0967026032000157138; Beuzenberg V, 2014, NEW ZEAL J BOT, V52, P136, DOI 10.1080/0028825X.2013.859627; BIGGS BJF, 1990, NEW ZEAL J MAR FRESH, V24, P9, DOI 10.1080/00288330.1990.9516398; BOTHWELL ML, 1989, CAN J FISH AQUAT SCI, V46, P1293, DOI 10.1139/f89-166; Brady AL, 2010, CHEM GEOL, V274, P56, DOI 10.1016/j.chemgeo.2010.03.016; Brasell KA, 2015, MICROB ECOL, V69, P254, DOI 10.1007/s00248-014-0538-7; Bridge B., 2014, 2537 CAWTHR NELS CIT, V16; Denis L, 2012, J SOIL SEDIMENT, V12, P1517, DOI 10.1007/s11368-012-0588-8; Des Marais D., 2010, MICROBIAL MATS, V14, P401; Dodds WK, 2003, J PHYCOL, V39, P840, DOI 10.1046/j.1529-8817.2003.02081.x; Eckert W, 1997, WATER AIR SOIL POLL, V99, P401, DOI 10.1007/BF02406880; Faassen EJ, 2012, TOXICON, V60, P378, DOI 10.1016/j.toxicon.2012.04.335; Frantz CM, 2015, GEOBIOLOGY, V13, P409, DOI 10.1111/gbi.12145; Gugger M, 2005, TOXICON, V45, P919, DOI 10.1016/j.toxicon.2005.02.031; Hall K., 2008, THESIS TRINITY COLL; Heath MW, 2015, RIVER RES APPL, V31, P98, DOI 10.1002/rra.2722; Heath MW, 2011, AQUAT MICROB ECOL, V64, P69, DOI 10.3354/ame01516; HICKEY CW, 1988, J ENVIRON ENG-ASCE, V114, P828, DOI 10.1061/(ASCE)0733-9372(1988)114:4(828); HOFSTRAAT JW, 1994, MAR ECOL PROG SER, V103, P187, DOI 10.3354/meps103187; Hoiczyk E, 1998, J BACTERIOL, V180, P3923, DOI 10.1128/JB.180.15.3923-3932.1998; House WA, 2003, APPL GEOCHEM, V18, P739, DOI 10.1016/S0883-2927(02)00158-0; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; JORGENSEN BB, 1990, LIMNOL OCEANOGR, V35, P1343, DOI 10.4319/lo.1990.35.6.1343; Kozerski HP, 2002, WATER RES, V36, P2983, DOI 10.1016/S0043-1354(01)00533-4; Krienitz L, 2003, FEMS MICROBIOL ECOL, V43, P141, DOI 10.1111/j.1574-6941.2003.tb01053.x; Li HL, 2009, LIMNOLOGICA, V39, P255, DOI 10.1016/j.limno.2008.08.002; Lukkari K, 2007, LIMNOL OCEANOGR-METH, V5, P433, DOI 10.4319/lom.2007.5.433; Mohamed ZA, 2006, TOXICON, V47, P584, DOI 10.1016/j.toxicon.2006.01.029; Pajdak-Stos A, 2001, AQUAT MICROB ECOL, V23, P237, DOI 10.3354/ame023237; Pearl HW, 1989, MICROBIAL MATS PHYSL, P326; PETTERSSON K, 1988, HYDROBIOLOGIA, V170, P91, DOI 10.1007/BF00024900; Psenner R., 1988, ADV LIMNOLOGY, V30, P43; Quiblier C, 2013, WATER RES, V47, P5464, DOI 10.1016/j.watres.2013.06.042; REVSBECH NP, 1983, POLAROGRAPHIC OXYGEN, P265; Romani AM, 2000, MICROB ECOL, V40, P16, DOI 10.1007/s002480000041; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Stal LJ, 2012, ECOLOGY CYANOBACTERI, P65, DOI [DOI 10.1007/978-94-007-3855-3_4, 10.1007/978-94-007-3855-3_4]; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; STORCH TA, 1990, APPL ENVIRON MICROB, V56, P466, DOI 10.1128/AEM.56.2.466-471.1990; Stumm W, 1995, AQUATIC CHEM CHEM EQ, V3rd, DOI [DOI 10.1094/ASBCMOA-BEER-13, 10.1094/asbcmoa-beer-13]; Tyystjarvi E, 2013, INT REV CEL MOL BIO, V300, P243, DOI 10.1016/B978-0-12-405210-9.00007-2; Wang SR, 2008, COLLOID SURFACE A, V316, P245, DOI 10.1016/j.colsurfa.2007.09.007; Withers PJA, 2008, SCI TOTAL ENVIRON, V400, P379, DOI 10.1016/j.scitotenv.2008.08.002; Wood SA, 2010, J APPL MICROBIOL, V109, P2011, DOI 10.1111/j.1365-2672.2010.04831.x; Wood SA, 2014, 2624 CAWTHR; Wood SA, 2014, 2575 CAWTHR; Wood SA, 2007, TOXICON, V50, P292, DOI 10.1016/j.toxicon.2007.03.025; Wood SA, 2010, TOXICON, V55, P897, DOI 10.1016/j.toxicon.2009.12.019; Xu D, 2013, J ENVIRON SCI-CHINA, V25, P637, DOI 10.1016/S1001-0742(12)60136-3; Zhou QX, 2001, CHEMOSPHERE, V42, P221, DOI 10.1016/S0045-6535(00)00129-6	57	49	51	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0141063	10.1371/journal.pone.0141063	http://dx.doi.org/10.1371/journal.pone.0141063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479491	Green Submitted, Green Published, gold			2022-12-27	WOS:000363026600029
J	Lin, P; Lu, JM; Wang, YF; Gu, W; Yu, J; Zhao, RH				Lin, Pei; Lu, Jianmei; Wang, Yanfang; Gu, Wen; Yu, Jie; Zhao, Ronghua			Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TETRAHYDROXYSTILBENE GLUCOSIDE; METABOLIC-SYNDROME; CONTROLLED-TRIAL; VITAMIN-E; IN-VITRO; HEALTH; DIET; PIOGLITAZONE; ACTIVATION	The gut-liver axis is largely involved in the development of non-alcoholic fatty liver disease (NAFLD). We investigated whether 2, 3, 5, 4'-tetrahydroxy-stilbene-2-O-beta-D-glucoside (TSG) could reverse NAFLD induced by a high-fat diet (HFD) and whether it did so via the gut-liver axis. Results showed that TSG could reduce the accumulation of FFA and it did so by reducing the expression of L-FABP and FATP4. TSG regulated gut microbiota balanced and increased the protein expression of ZO-1 and occludin, which could improve the function of the intestinal mucosal barrier and reduce serum LPS content by about 25%. TSG reduced TL4 levels by 56% and NF-kappa B expression by 23% relative to the NAFLD model group. This suggests that prevention of NAFLD by TSG in HFD-fed rats is mediated by modulation of the gut microbiota and TLR4/NF-kappa B pathway, which may alleviate chronic low-grade inflammation by reducing the exogenous antigen load on the host.	[Lin, Pei; Lu, Jianmei; Wang, Yanfang; Gu, Wen; Yu, Jie; Zhao, Ronghua] Yunnan Univ Tradit Chinese Med, Dept Pharm, Kunming, Yunnan, Peoples R China	Yunnan University of Chinese Medicine	Yu, J (corresponding author), Yunnan Univ Tradit Chinese Med, Dept Pharm, Kunming, Yunnan, Peoples R China.	cz.yujie@gmail.com; kmzhaoronghua@hotmail.com			National Natural Science Foundation of China [81060337, 81260553, 81460623]; Natural Science Foundation of Yunnan Province [2014FA035, 2012FD043]; Southern Medicine Collaborative And Innovation Center [30270100500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Southern Medicine Collaborative And Innovation Center	This research was financially supported by the National Natural Science Foundation of China (Grant no. 81060337, Grant no. 81260553, and Grant no. 81460623), the Natural Science Foundation of Yunnan Province (Grant no. 2014FA035 and Grant no. 2012FD043) and the Southern Medicine Collaborative And Innovation Center (30270100500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Broering R, 2011, CLIN SCI, V121, P415, DOI 10.1042/CS20110065; Bugianesi E, 2005, AM J GASTROENTEROL, V100, P1082, DOI 10.1111/j.1572-0241.2005.41583.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chassaing B, 2014, HEPATOLOGY, V59, P328, DOI 10.1002/hep.26494; Dai X, 2014, HEPATO-GASTROENTEROL, V61, P136, DOI 10.5754/hge12760; Fan JG, 2003, WORLD J GASTROENTERO, V9, P2045, DOI 10.3748/wjg.v9.i9.2045; Feng Ai-juan, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P776; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Goldsmith JR, 2014, J GASTROENTEROL, V49, P785, DOI 10.1007/s00535-014-0953-z; Heinrichsdorff J, 2012, NAT MED, V18, P1182, DOI 10.1038/nm.2869; Ito-Nagahata T, 2013, BIOSCI BIOTECH BIOCH, V77, P1229, DOI 10.1271/bbb.121000; Jiang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08096; Machado MV, 2012, ANN HEPATOL, V11, P440, DOI 10.1016/S1665-2681(19)31457-7; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Mehal WZ, 2013, NAT REV GASTRO HEPAT, V10, P637, DOI 10.1038/nrgastro.2013.146; Miura K, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/362847; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Sun FL, 2011, EUR J PHARMACOL, V660, P283, DOI 10.1016/j.ejphar.2011.03.046; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tilg H, 2011, J HEPATOL, V55, P960, DOI 10.1016/j.jhep.2011.04.007; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang WE, 2014, J ETHNOPHARMACOL, V153, P763, DOI 10.1016/j.jep.2014.03.042; Wattacheril J, 2012, HEPATOLOGY, V56, P1580, DOI 10.1002/hep.26031; Yu J, 2014, CHIN PHARM J, V23, P2077; Zhang SH, 2009, ACTA PHARMACOL SIN, V30, P1479, DOI 10.1038/aps.2009.144; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhong L, 2000, J CHIN PRAC MED, V2, P3; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	39	35	36	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140346	10.1371/journal.pone.0140346	http://dx.doi.org/10.1371/journal.pone.0140346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474417	gold, Green Published, Green Submitted			2022-12-27	WOS:000363185500042
J	Bossers, SM; Schwarte, LA; Loer, SA; Twisk, JWR; Boer, C; Schober, P				Bossers, Sebastiaan M.; Schwarte, Lothar A.; Loer, Stephan A.; Twisk, Jos W. R.; Boer, Christa; Schober, Patrick			Experience in Prehospital Endotracheal Intubation Significantly Influences Mortality of Patients with Severe Traumatic Brain Injury: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RAPID-SEQUENCE INTUBATION; GLASGOW COMA SCALE; HEAD-INJURY; YOUNG-PEOPLE; FOLLOW-UP; IMPACT; MANAGEMENT; MODERATE; OUTCOMES; FIELD	Background Patients with severe traumatic brain injury (TBI) are at high risk for airway obstruction and hypoxia at the accident scene, and routine prehospital endotracheal intubation has been widely advocated. However, the effects on outcome are unclear. We therefore aim to determine effects of prehospital intubation on mortality and hypothesize that such effects may depend on the emergency medical service providers' skill and experience in performing this intervention. Methods and Findings PubMed, Embase and Web of Science were searched without restrictions up to July 2015. Studies comparing effects of prehospital intubation versus non-invasive airway management on mortality in non-paediatric patients with severe TBI were selected for the systematic review. Results were pooled across a subset of studies that met predefined quality criteria. Random effects meta-analysis, stratified by experience, was used to obtain pooled estimates of the effect of prehospital intubation on mortality. Meta-regression was used to formally assess differences between experience groups. Mortality was the main outcome measure, and odds ratios refer to the odds of mortality in patients undergoing prehospital intubation versus odds of mortality in patients who are not intubated in the field. The study was registered at the International Prospective Register of Systematic Reviews (PROSPERO) with number CRD42014015506. The search provided 733 studies, of which 6 studies including data from 4772 patients met inclusion and quality criteria for the meta-analysis. Prehospital intubation by providers with limited experience was associated with an approximately twofold increase in the odds of mortality (OR 2.33, 95% CI 1.61 to 3.38, p<0.001). In contrast, there was no evidence for higher mortality in patients who were intubated by providers with extended level of training (OR 0.75, 95% CI 0.52 to 1.08, p = 0.126). Metaregression confirmed that experience is a significant predictor of mortality (p = 0.009). Conclusions Effects of prehospital endotracheal intubation depend on the experience of prehospital healthcare providers. Intubation by paramedics who are not well skilled to do so markedly increases mortality, suggesting that routine prehospital intubation of TBI patients should be abandoned in emergency medical services in which providers do not have ample training, skill and experience in performing this intervention.	[Bossers, Sebastiaan M.; Schwarte, Lothar A.; Loer, Stephan A.; Boer, Christa; Schober, Patrick] Vrije Univ Amsterdam, Med Ctr, Dept Anaesthesiol, Amsterdam, Netherlands; [Schwarte, Lothar A.; Schober, Patrick] Vrije Univ Amsterdam, Med Ctr, Helicopter Emergency Med Serv Lifeliner 1, Amsterdam, Netherlands; [Twisk, Jos W. R.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Boer, Christa] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Schober, P (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Anaesthesiol, Amsterdam, Netherlands.	p.schober@vumc.nl	Schober, Patrick/G-7400-2012; Bossers, Sebastiaan/AAE-1085-2020	Schober, Patrick/0000-0003-0814-081X; Bossers, Sebastiaan/0000-0002-2396-2777; Boer, Christa/0000-0002-7781-6951	Dutch Brain Foundation [F2010(1)-14]	Dutch Brain Foundation	This article was funded by the Dutch Brain Foundation, project number F2010(1)-14 (https://www.hersenstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Surgeons Committee on Trauma, 2012, ADV TRAUM LIF SUPP; Atkinson JLD, 2000, MAYO CLIN PROC, V75, P37, DOI 10.4065/75.1.37; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Blyth A, 2014, BMJ-BRIT MED J, P348; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; BOIDIN MP, 1985, BRIT J ANAESTH, V57, P306, DOI 10.1093/bja/57.3.306; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bukur M, 2011, J SURG RES, V170, pE117, DOI 10.1016/j.jss.2011.04.005; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Hammell CL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1683; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Humphries RL, 2008, CURRENT DIAGNOSIS TR, P313; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Irvin CB, 2010, PREHOSP DISASTER MED, V25, P541, DOI 10.1017/S1049023X00008736; Karamanos E, 2014, PREHOSP DISASTER MED, V29, P32, DOI 10.1017/S1049023X13008947; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lockey DJ, 1999, ANAESTHESIA, V54, P1097, DOI 10.1046/j.1365-2044.1999.00754.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; MOULTON C, 1991, BRIT MED J, V303, P1240, DOI 10.1136/bmj.303.6812.1240; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Poste Jennifer C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.04.006; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; SAFAR P, 1959, J APPL PHYSIOL, V14, P760, DOI 10.1152/jappl.1959.14.5.760; Salomone JP, 2008, TRAUMA, P121; SINGBARTL G, 1985, ANASTH INTENSIV NOTF, V20, P251, DOI 10.1055/s-2007-1003119; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tuma M, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/135986; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; Vandromme MJ, 2011, J TRAUMA, V71, P1615, DOI 10.1097/TA.0b013e31822a30a1; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2014, EMERG MED J, V31, P186, DOI 10.1136/emermed-2012-202101; Wells G.A., NEWCASTLE OTTAWA SCA; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	59	68	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141034	10.1371/journal.pone.0141034	http://dx.doi.org/10.1371/journal.pone.0141034			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496440	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200054
J	Strong, RA; Hester, PY; Eicher, SD; Hu, JY; Cheng, HW				Strong, Rebecca A.; Hester, Patricia Y.; Eicher, Susan D.; Hu, Jiaying; Cheng, Heng-Wei			The Effect of Cooled Perches on Immunological Parameters of Caged White Leghorn Hens during the Hot Summer Months	PLOS ONE			English	Article							HIGH ENVIRONMENTAL-TEMPERATURE; HETEROPHIL-LYMPHOCYTE RATIO; HEAT-STRESS; LAYING HENS; BROILER-CHICKENS; T-CELLS; IMMUNE-RESPONSES; NITRIC-OXIDE; PHYSIOLOGICAL-RESPONSES; GROWTH-PERFORMANCE	The objective of this study was to determine if thermally cooled perches improve hen immunity during hot summer. White Leghorn pullets at 16 week of age were randomly assigned to 18 cages of 3 banks at 9 hens per cage. Each bank was assigned to 1 of the 3 treatments up to 32 week of age: 1) thermally cooled perches, 2) perches with ambient air, and 3) cages without perches. Hens were exposed to natural ambient temperatures from June through September 2013 in Indiana with a 4 h acute heat episode at 27.6 week of age. The packed cell volume, heterophil to lymphocyte (H/L) ratio, plasma concentrations of total IgG, and cytokines of interleukin-1 beta and interleukin-6, plus lipopolysaccharide-induced tumor necrosis factor-alpha factor were measured at both 27.6 and 32 week of age. The mRNA expressions of these cytokines, toll-like receptor-4, and inducible nitric oxide synthase were also examined in the spleen of 32 week-old hens. Except for H/L ratio, thermally cooled perches did not significantly improve currently measured immunological indicators. These results indicated that the ambient temperature of 2013 summer in Indiana (24 degrees C, 17.1 to 33.1 degrees C) was not high enough and the 4 h heat episode at 33.3 degrees C (32 to 34.6 degrees C) was insufficient in length to evoke severe heat stress in hens. However, cooled perch hens had a lower H/L ratio than both air perch hens and control hens at 27.6 week of age and it was still lower compared to control hens (P < 0.05, respectively) at 32 week of age. The lowered H/L ratio of cooled perch hens may suggest that they were able to cope with acute heat stress more effectively than control hens. Further studies are needed to evaluate the effectiveness of thermally cooled perches on hen health under higher ambient temperatures.	[Strong, Rebecca A.; Hester, Patricia Y.; Hu, Jiaying] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Eicher, Susan D.; Cheng, Heng-Wei] USDA, Livestock Behav Res Unit, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA)	Cheng, HW (corresponding author), USDA, Livestock Behav Res Unit, W Lafayette, IN 47907 USA.	Heng-Wei.Cheng@ars.usda.gov		Hu, Jiaying/0000-0003-2718-2783	National Institute of Food and Agriculture, United States Department of Agriculture Award [2013-67021-21094]; ARS [ARS-0425202] Funding Source: Federal RePORTER	National Institute of Food and Agriculture, United States Department of Agriculture Award; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the National Institute of Food and Agriculture, United States Department of Agriculture Award No. 2013-67021-21094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademola S. G., 2013, Online Journal of Animal and Feed Research (OJAFR), V3, P159; Appleby MC, 2002, BRIT POULTRY SCI, V43, P489, DOI 10.1080/0007166022000004390; APPLEBY MC, 1990, WORLD POULTRY SCI J, V46, P38, DOI 10.1079/WPS19900007; ARAD Z, 1982, BRIT POULTRY SCI, V23, P333, DOI 10.1080/00071688208447966; ASHMAN RB, 1995, MICROBIOL REV, V59, P646, DOI 10.1128/MMBR.59.4.646-672.1995; Attia YA, 2011, J ANIM PHYSIOL AN N, V95, P744, DOI 10.1111/j.1439-0396.2010.01104.x; Bao Y, 2014, J AUTOIMMUN, V55, P10, DOI 10.1016/j.jaut.2014.04.001; Barnett JL, 1997, AUST J EXP AGR, V37, P523, DOI 10.1071/EA97024; Biggs PM, 1957, AM J PATHOL, V53, P735; BILLIPS LG, 1990, BLOOD, V75, P611; Bizeray D, 2002, APPL ANIM BEHAV SCI, V79, P27, DOI 10.1016/S0168-1591(02)00083-7; BLAZSEK I, 1983, BIOMED PHARMACOTHER, V37, P258; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Campo JL, 2005, POULTRY SCI, V84, P1004, DOI 10.1093/ps/84.7.1004; Cheng HW, 2004, POULTRY SCI, V83, P707, DOI 10.1093/ps/83.5.707; Cheng HW, 2001, POULTRY SCI, V80, P1079, DOI 10.1093/ps/80.8.1079; Cheng HW, 2014, POULTRY SCI S1, V93, P92; Cowan T, 2014, TABLE EGG PRODUCTION; Curtis SE, 1983, POULTRY SCI, V68, P522; Deng W, 2012, POULTRY SCI, V91, P575, DOI 10.3382/ps.2010-01293; DINARELLO CA, 1988, DIGEST DIS SCI, V33, pS25, DOI 10.1007/BF01538128; DUNCAN ET, 1992, BRIT POULTRY SCI, V33, P25, DOI 10.1080/00071669208417441; Ebeid TA, 2012, POULTRY SCI, V91, P2282, DOI 10.3382/ps.2011-01898; Enneking SA, 2012, POULTRY SCI, V91, P2114, DOI 10.3382/ps.2012-02328; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Felver-Gant JN, 2012, POULTRY SCI, V91, P1542, DOI 10.3382/ps.2011-01988; Franco-Jimenez DJ, 2007, J APPL POULTRY RES, V16, P628, DOI 10.3382/japr.2005-00088; Fujio K, 2010, ADV IMMUNOL, V105, P99, DOI 10.1016/S0065-2776(10)05004-2; Gates RS, 2014, DESIGN PERFORMANCE C; Ghazi SH, 2002, BIOL TRACE ELEM RES, V146, P309; GREEN SJ, 1990, IMMUNOL LETT, V25, P15, DOI 10.1016/0165-2478(90)90083-3; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; GROSS WB, 1980, AVIAN DIS, V24, P569, DOI 10.2307/1589792; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Habib T, 2003, J ALLERGY CLIN IMMUN, V112, P1033, DOI 10.1016/j.jaci.2003.08.039; Hammac GK, 2013, VACCINE, V31, P3617, DOI 10.1016/j.vaccine.2013.04.069; Harrison PC, 1993, POULTRY SCI, V70, P2253; Hegeman R., 2011, HUFFINGTON POST 0912; HENKEN AM, 1983, POULTRY SCI, V62, P51, DOI 10.3382/ps.0620051; Hester PY, 2014, WORLD POULTRY SCI J, V70, P247, DOI 10.1017/S0043933914000270; Hester PY, 2013, POULTRY SCI, V92, P310, DOI 10.3382/ps.2012-02744; Hester PY, 2014, POULTRY SCI S1, V93, P93; HILLMAN PE, 1989, J THERM BIOL, V14, P205, DOI 10.1016/0306-4565(89)90007-7; JEURISSEN SHM, 1993, IMMUNOLOGY, V80, P29; Jiang S, 2013, POULTRY SCI, V92, P1951, DOI 10.3382/ps.2012-02909; Kang SY, 2011, ASIAN AUSTRAL J ANIM, V24, P414, DOI 10.5713/ajas.2011.10315; Kared H, 2014, CURR OPIN IMMUNOL, V29, P79, DOI 10.1016/j.coi.2014.05.003; KELLEY KW, 1983, T ASAE, V26, P834; KINDLER V, 1991, Behring Institute Mitteilungen, P120; Kita K, 2014, POULTRY SCI, V93, P429, DOI 10.3382/ps.2013-03576; Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552; Lara Lucas J, 2013, Animals (Basel), V3, P356, DOI 10.3390/ani3020356; Li W, 2009, EUR J IMMUNOL, V39, P1019, DOI 10.1002/eji.200838885; Liedtke EA, 2014, P 12 INT SOC APPL ET, P50; Lustick S.I., 1983, P265; Mahmoud KZ, 1996, POULTRY SCI, V75, P1555, DOI 10.3382/ps.0751555; Makagon MM, 2014, P 48 C INT SOC APPL, P181; MANETTI R, 1994, RES IMMUNOL, V145, P93, DOI 10.1016/S0923-2494(94)80019-7; Marcotty T, 2008, PREV VET MED, V87, P288, DOI 10.1016/j.prevetmed.2008.05.002; MARSDEN A, 1987, BRIT POULTRY SCI, V28, P693, DOI 10.1080/00071668708417005; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; Maxwell MH, 1983, WORLDS POULT SCI, V49, P34; MUIRURI HK, 1991, APPL ANIM BEHAV SCI, V28, P333, DOI 10.1016/0168-1591(91)90165-T; Niu ZY, 2009, POULTRY SCI, V88, P2101, DOI 10.3382/ps.2009-00220; Olab I, 2008, AVIAN IMMUNOLOGY, P13; Olsson IAS, 2000, APPL ANIM BEHAV SCI, V68, P243, DOI 10.1016/S0168-1591(00)00097-6; Osborne LC, 2010, CYTOKINE, V50, P105, DOI 10.1016/j.cyto.2009.09.008; Panaro M. A., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P210, DOI 10.2174/1568008033340216; Perle D., 2012, PETA CALLS CRUELTY C; Plaut M., 1997, ANNU REV IMMUNOL, V5, P621; POPE CR, 1991, VET IMMUNOL IMMUNOP, V30, P31, DOI 10.1016/0165-2427(91)90006-X; Quinteiro WM, 2010, POULTRY SCI, V89, P1905, DOI 10.3382/ps.2010-00812; RAO DSV, 1970, P SOC EXP BIOL MED, V133, P445, DOI 10.3181/00379727-133-34493; REGNIER JA, 1980, POULTRY SCI, V59, P985, DOI 10.3382/ps.0590985; REILLY WM, 1991, POULTRY SCI, V70, P1699, DOI 10.3382/ps.0701699; Sahin K, 2009, POULTRY SCI, V88, P2176, DOI 10.3382/ps.2008-00560; Saleh MA, 2011, VET RES COMMUN, V35, P35, DOI 10.1007/s11259-010-9450-x; Salvemini D, 2013, AM J PHYSIOL-REG I, V304, pR473, DOI 10.1152/ajpregu.00355.2012; SAS Institute Inc, 2008, SAS PROPR SOFTW VERS; SCOTT TA, 1988, BRIT POULTRY SCI, V29, P613, DOI 10.1080/00071668808417088; SIEGEL HS, 1995, BRIT POULTRY SCI, V36, P3, DOI 10.1080/00071669508417748; Siegel HS, 1982, POULTRY SCI, V51, P1519; SIEGEL PB, 1982, ANIM BLOOD GROUPS BI, V13, P291; SIEGEL PB, 1980, POULTRY SCI, V59, P1, DOI 10.3382/ps.0590001; Soleimani AF, 2011, POULTRY SCI, V90, P1435, DOI 10.3382/ps.2011-01381; Spencer H., 2001, HEAT ABATEMENT PROGR; St Paul M, 2013, VET IMMUNOL IMMUNOP, V152, P191, DOI 10.1016/j.vetimm.2012.10.013; Steel R., 1997, PRINCIPLES PROCEDURE; Sun Y, 2013, POULTRY SCI, V92, P2024, DOI 10.3382/ps.2013-03144; Sundaresan NR, 2007, ANIM REPROD SCI, V102, P335, DOI 10.1016/j.anireprosci.2007.01.022; Tecchio C, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00508; THAXTON P, 1968, POULTRY SCI, V47, P264, DOI 10.3382/ps.0470264; Thomas HE, 2013, ANN NY ACAD SCI, V1283, P81, DOI 10.1111/j.1749-6632.2012.06797.x; Torki M, 2015, INT J BIOMETEOROL, V59, P575, DOI 10.1007/s00484-014-0870-0; United Egg Producers, 2010, UN EGG PROD AN HUSB; VANDERZIJPP AJ, 1983, POULTRY SCI, V62, P565, DOI 10.3382/ps.0620565; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Walberg J, 2001, SEMIN AVIAN EXOT PET, V10, P72, DOI 10.1053/saep.2001.22051; Whitehead CC, 1998, BRIT POULTRY SCI, V39, pS44; WINER B. J, 1997, STAT PRINCIPLES EXPT; Wondmeneh E, 2015, POULTRY SCI, V94, P1493, DOI 10.3382/ps/pev107; Wurtman RJ, 2002, METABOLISM, V51, P11, DOI 10.1053/meta.2002.33185; Yahav S, 2009, WORLD POULTRY SCI J, V65, P719, DOI 10.1017/S004393390900049X; Yan FF, 2014, POULTRY SCI, V93, P1318, DOI 10.3382/ps.2013-03572; Yan FF, 2013, POULTRY SCI, V92, P2853, DOI 10.3382/ps.2013-03271; Yuan C, 2015, MOL CELL BIOCHEM, V399, P229, DOI 10.1007/s11010-014-2249-2; Zhao JP, 2013, POULTRY SCI, V92, P1962, DOI 10.3382/ps.2012-02933; Zhao JP, 2012, POULTRY SCI, V91, P1775, DOI 10.3382/ps.2011-02058	108	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141215	10.1371/journal.pone.0141215	http://dx.doi.org/10.1371/journal.pone.0141215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26495988	Green Published, gold, Green Submitted			2022-12-27	WOS:000363309200077
J	Yang, S; Shi, SX; Hu, XB; Wang, MJ				Yang, Su; Shi, Shixiong; Hu, Xiaobing; Wang, Minjie			Spatiotemporal Context Awareness for Urban Traffic Modeling and Prediction: Sparse Representation Based Variable Selection	PLOS ONE			English	Article							FLOW PREDICTION; CONGESTION PREDICTION; NEURAL-NETWORK; MULTIVARIATE	Spatial-temporal correlations among the data play an important role in traffic flow prediction. Correspondingly, traffic modeling and prediction based on big data analytics emerges due to the city-scale interactions among traffic flows. A new methodology based on sparse representation is proposed to reveal the spatial-temporal dependencies among traffic flows so as to simplify the correlations among traffic data for the prediction task at a given sensor. Three important findings are observed in the experiments: (1) Only traffic flows immediately prior to the present time affect the formation of current traffic flows, which implies the possibility to reduce the traditional high-order predictors into an 1-order model. (2) The spatial context relevant to a given prediction task is more complex than what is assumed to exist locally and can spread out to the whole city. (3) The spatial context varies with the target sensor undergoing prediction and enlarges with the increment of time lag for prediction. Because the scope of human mobility is subject to travel time, identifying the varying spatial context against time lag is crucial for prediction. Since sparse representation can capture the varying spatial context to adapt to the prediction task, it outperforms the traditional methods the inputs of which are confined as the data from a fixed number of nearby sensors. As the spatial-temporal context for any prediction task is fully detected from the traffic data in an automated manner, where no additional information regarding network topology is needed, it has good scalability to be applicable to large-scale networks.	[Yang, Su; Shi, Shixiong; Hu, Xiaobing; Wang, Minjie] Fudan Univ, Sch Comp Sci, Shanghai Key Lab Intelligent Informat Proc, Shanghai 200433, Peoples R China	Fudan University	Yang, S (corresponding author), Fudan Univ, Sch Comp Sci, Shanghai Key Lab Intelligent Informat Proc, Shanghai 200433, Peoples R China.	suyang@fudan.edu.cn			National Natural Science Foundation of China [61472087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	SY was supported by National Natural Science Foundation of China under grant 61472087 (isis.nsfc.gov.cn).	Castro Pablo Samuel, 2012, Pervasive Computing. Proceedings of the 10th International Conference, Pervasive 2012, P57, DOI 10.1007/978-3-642-31205-2_4; Castro-Neto M, 2009, EXPERT SYST APPL, V36, P6164, DOI 10.1016/j.eswa.2008.07.069; Chan KY, 2012, IEEE T IND INFORM, V8, P255, DOI 10.1109/TII.2011.2179052; Chandra SR, 2009, J INTELL TRANSPORT S, V13, P53, DOI 10.1080/15472450902858368; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Elad M, 2010, SPARSE AND REDUNDANT REPRESENTATIONS, P3, DOI 10.1007/978-1-4419-7011-4_1; Ghosh B, 2009, IEEE T INTELL TRANSP, V10, P246, DOI 10.1109/TITS.2009.2021448; Hodge VJ, 2014, NEURAL COMPUT APPL, V25, P1639, DOI 10.1007/s00521-014-1646-5; Hu J, 2009, IET INTELL TRANSP SY, V3, P159, DOI 10.1049/iet-its:20070062; Huang WH, 2014, IEEE T INTELL TRANSP, V15, P2191, DOI 10.1109/TITS.2014.2311123; Kamarianakis Y, 2012, APPL STOCH MODEL BUS, V28, P297, DOI 10.1002/asmb.1937; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Mairal J, 2013, J MACH LEARN RES, V14, P2449; Min WL, 2011, TRANSPORT RES C-EMER, V19, P606, DOI 10.1016/j.trc.2010.10.002; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Peng CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034487; Petri G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01798; Smith BL, 2002, TRANSPORT RES C-EMER, V10, P303, DOI 10.1016/S0968-090X(02)00009-8; Sun SL, 2007, IEEE T INTELL TRANSP, V8, P367, DOI 10.1109/TITS.2006.888603; Vlahogianni EI, 2005, TRANSPORT RES C-EMER, V13, P211, DOI 10.1016/j.trc.2005.04.007; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01001; Whittaker J, 1997, INT J FORECASTING, V13, P51, DOI 10.1016/S0169-2070(96)00700-5; Yang S, 2015, DISCOVERING SPATIAL, P364; Yang S, 2013, TRANSPORT RES C-EMER, V26, P160, DOI 10.1016/j.trc.2012.08.005; Zhang X, 2014, TRANSPORT RES C-EMER, V43, P127, DOI 10.1016/j.trc.2014.02.013; Zheng WZ, 2006, J TRANSP ENG, V132, P114, DOI 10.1061/(ASCE)0733-947X(2006)132:2(114); Zheng Y, 2011, UBICOMP'11: PROCEEDINGS OF THE 2011 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P89, DOI 10.1145/2030112.2030126	31	22	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2015	10	10							e0141223	10.1371/journal.pone.0141223	http://dx.doi.org/10.1371/journal.pone.0141223			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU1VG	26496370	Green Submitted, Green Published, gold			2022-12-27	WOS:000363309200080
J	Huang, YC; Chin, CC; Chen, CS; Shindel, AW; Ho, DR; Lin, CS; Shi, CS				Huang, Yun-Ching; Chin, Chih-Chien; Chen, Chih-Shou; Shindel, Alan. W.; Ho, Dong-Ru; Lin, Ching-Shwun; Shi, Chung-Sheng			Chronic Cigarette Smoking Impairs Erectile Function through Increased Oxidative Stress and Apoptosis, Decreased nNOS, Endothelial and Smooth Muscle Contents in a Rat Model	PLOS ONE			English	Article							DYSFUNCTION; EXPRESSION; EXPOSURE; BLADDER; PLASMA; TISSUE; MEN	Cigarette use is an independent risk factor for the development of erectile dysfunction (ED). While the association between chronic smoking and ED is well established, the fundamental mechanism(s) of cigarette-related ED are incompletely understood, partly due to no reliable animal model of smoking-induced ED. The present study was designed to validate an in vivo rat model of chronic cigarette-induced ED. Forty 12-week old male Sprague-Dawley rats were divided into 4 groups. Ten rats served as control group and were exposed only to room air. The remaining 30 rats were passively exposed to cigarette smoke (CS) for 4 weeks (n = 10), 12 weeks (n = 10), and 24 weeks (n = 10). At the 24-week time point all rats were assessed with intracavernous pressure (ICP) during cavernous nerve electrostimulation. Blood and urine were collected to measure serum testosterone and oxidative stress, respectively. Corporal tissue was assessed by Western blot for neuronal nitric oxide synthase (nNOS). Penile tissues were subjected to immunohistochemistry for endothelial, smooth muscle, and apoptotic content. Mean arterial pressure (MAP) was significantly higher in 24-week cigarette exposed animals compared to the control animals. Mean ICP/MAP ratio and cavernosal smooth muscle/endothelial contents were significantly lower in the 12- and 24-week rats compared to control animals. Oxidative stress was significantly higher in the 24-week cigarette exposed group compared to control animals. Mean nNOS expression was significantly lower, and apoptotic index significantly higher, in CS-exposed animals compared to control animals. These findings indicate that the rat model exposure to CS increases apoptosis and oxidative stress and decreases nNOS, endothelial and smooth muscle contents, and ICP in a dose dependent fashion. The rat model is a useful tool for further study of the molecular and cellular mechanisms of CS-related ED.	[Huang, Yun-Ching; Chen, Chih-Shou; Ho, Dong-Ru] Chang Gung Mem Hosp, Div Urol, Dept Surg, Chiayi, Taiwan; [Huang, Yun-Ching; Shi, Chung-Sheng] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Chin, Chih-Chien] Chang Gung Mem Hosp, Div Colon & Rectal Surg, Dept Surg, Chiayi, Taiwan; [Shindel, Alan. W.] Univ Calif Davis, Dept Urol, Davis, CA 95616 USA; [Lin, Ching-Shwun] Univ Calif San Francisco, Dept Urol, Knuppe Mol Urol Lab, San Francisco, CA USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; University of California System; University of California Davis; University of California System; University of California San Francisco	Shi, CS (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan.	csshi@mail.cgu.edu.tw		Chen, Chih-Shou/0000-0002-5785-2373; Chin, Chih-Chien/0000-0003-1535-3530; Ho, Dong-Ru/0000-0002-1805-0538; Shi, Chung-Sheng/0000-0002-5548-7675	National Science Council, Taiwan [NSC 102-2314-B-182A-092]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by a grant from the National Science Council, Taiwan (NSC 102-2314-B-182A-092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBER JC, 1987, J UROLOGY, V137, P1039, DOI 10.1016/S0022-5347(17)44355-2; Bernhard D, 2007, CURR MED CHEM, V14, P1703; Bivalacqua TJ, 2009, J UROLOGY, V181, P899, DOI 10.1016/j.juro.2008.10.062; Chiou CC, 2003, CLIN CHIM ACTA, V334, P87, DOI 10.1016/S0009-8981(03)00191-8; Chung E, 2011, J SEX MED, V8, P3291, DOI 10.1111/j.1743-6109.2011.02505.x; Csiszar A, 2009, FRONT BIOSCI-LANDMRK, V14, P3128, DOI 10.2741/3440; Doruk S, 2011, CLIN CHEM LAB MED, V49, P2007, DOI 10.1515/CCLM.2011.698; Duke T, 2013, CAN VET J, V54, P276; Erdelmeier I, 1998, CHEM RES TOXICOL, V11, P1184, DOI 10.1021/tx970180z; Feldman HA, 2000, PREV MED, V30, P328, DOI 10.1006/pmed.2000.0643; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; GRASSI G, 1994, CIRCULATION, V90, P248, DOI 10.1161/01.CIR.90.1.248; He J, 2007, AM J EPIDEMIOL, V166, P803, DOI 10.1093/aje/kwm154; Huang YC, 2010, J SEX MED, V7, P1391, DOI 10.1111/j.1743-6109.2009.01697.x; Huang YC, 2010, J UROLOGY, V183, P1232, DOI 10.1016/j.juro.2009.11.012; Imamura M, 2007, AM J PHYSIOL-REG I, V293, pR2081, DOI 10.1152/ajpregu.00406.2007; JUENEMANN KP, 1987, J UROLOGY, V138, P438, DOI 10.1016/S0022-5347(17)43181-8; Karatzi K, 2007, INT J CARDIOL, V120, P404, DOI 10.1016/j.ijcard.2006.07.200; Lee IN, 2012, METAB BRAIN DIS, V27, P197, DOI 10.1007/s11011-012-9294-x; Lin WY, 2011, BJU INT, V107, P1839, DOI 10.1111/j.1464-410X.2010.09597.x; McVary KT, 2001, J UROLOGY, V166, P1624, DOI 10.1016/S0022-5347(05)65641-8; Montorsi F, 2010, J SEX MED, V7, P3572, DOI 10.1111/j.1743-6109.2010.02062.x; Orth SR, 2004, J AM SOC NEPHROL, V15, pS58, DOI 10.1097/01.ASN.0000093461.36097.D5; Park MG, 2012, J SEX MED, V9, P472, DOI 10.1111/j.1743-6109.2011.02555.x; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Wang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118951; Xie YN, 1997, J UROLOGY, V157, P1121, DOI 10.1016/S0022-5347(01)65153-X	27	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140728	10.1371/journal.pone.0140728	http://dx.doi.org/10.1371/journal.pone.0140728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26491965	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300011
J	Larson, MJ; Clayson, PE; Primosch, M; Leyton, M; Steffensen, SC				Larson, Michael J.; Clayson, Peter E.; Primosch, Mark; Leyton, Marco; Steffensen, Scott C.			The Effects of Acute Dopamine Precursor Depletion on the Cognitive Control Functions of Performance Monitoring and Conflict Processing: An Event-Related Potential (ERP) Study	PLOS ONE			English	Article							ERROR-RELATED-NEGATIVITY; ACUTE PHENYLALANINE/TYROSINE DEPLETION; SPATIAL WORKING-MEMORY; ANTERIOR CINGULATE; TYROSINE DEPLETION; SEX-DIFFERENCES; ELECTROPHYSIOLOGICAL INDEXES; ATTENTIONAL CONTROL; HEALTHY-VOLUNTEERS; STROOP TASK	Studies using medications and psychiatric populations implicate dopamine in cognitive control and performance monitoring processes. However, side effects associated with medication or studying psychiatric groups may confound the relationship between dopamine and cognitive control. To circumvent such possibilities, we utilized a randomized, double-blind, placebo-controlled, within-subjects design wherein participants were administered a nutritionally-balanced amino acid mixture (BAL) and an amino acid mixture deficient in the dopamine precursors tyrosine (TYR) and phenylalanine (PHE) on two separate occasions. Order of sessions was randomly assigned. Cognitive control and performance monitoring were assessed using response times (RT), error rates, the N450, an event-related potential (ERP) index of conflict monitoring, the conflict slow potential (conflict SP), an ERP index of conflict resolution, and the error-related negativity (ERN) and error positivity (Pe), ERPs associated with performance monitoring. Participants were twelve males who completed a Stroop color-word task while ERPs were collected four hours following acute PHE and TYR depletion (APTD) or balanced (BAL) mixture ingestion in two separate sessions. N450 and conflict SP ERP amplitudes significantly differentiated congruent from incongruent trials, but did not differ as a function of APTD or BAL mixture ingestion. Similarly, ERN and Pe amplitudes showed significant differences between error and correct trials that were not different between APTD and BAL conditions. Findings indicate that acute dopamine precursor depletion does not significantly alter cognitive control and performance monitoring ERPs. Current results do not preclude the role of dopamine in these processes, but suggest that multiple methods for dopamine-related hypothesis testing are needed.	[Larson, Michael J.; Clayson, Peter E.; Primosch, Mark; Steffensen, Scott C.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.; Steffensen, Scott C.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Clayson, Peter E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Leyton, Marco] McGill Univ, Dept Psychiat, Montreal, PQ H3A 1A1, Canada	Brigham Young University; Brigham Young University; University of California System; University of California Los Angeles; McGill University	Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.	michael_larson@byu.edu	Larson, Michael J/C-8543-2012; Leyton, Marco/AAY-7557-2020; Clayson, Peter E/F-5438-2011; Clayson, Peter E/AAC-9207-2019	Larson, Michael J/0000-0002-8199-8065; Leyton, Marco/0000-0002-1243-2252; Clayson, Peter E/0000-0003-4437-6598; Clayson, Peter E/0000-0003-4437-6598	Brigham Young University College of Family, Home, and Social Sciences; Canadian Institutes of Health Research [MOP-36429]; National Institute of Health (NIH) grants [AA020919, DA035958]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035958] Funding Source: NIH RePORTER	Brigham Young University College of Family, Home, and Social Sciences; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health (NIH) grants; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for the study was provided by the Brigham Young University College of Family, Home, and Social Sciences, and the Canadian Institutes of Health Research (MOP-36429). Additional funding was provided by National Institute of Health (NIH) grants AA020919 and DA035958 to SCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AA-B B, 2007, INT C SERIES, V1304, P159; Barnes JJM, 2014, PSYCHOPHARMACOLOGY, V231, P379, DOI 10.1007/s00213-013-3246-y; Barrett SP, 2008, EUR NEUROPSYCHOPHARM, V18, P439, DOI 10.1016/j.euroneuro.2008.01.008; Bates AT, 2002, CLIN NEUROPHYSIOL, V113, P1454, DOI 10.1016/S1388-2457(02)00154-2; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; Brazdil M, 2005, J PSYCHOPHYSIOL, V19, P244, DOI 10.1027/0269-8803.19.4.244; Carter CS, 1997, AM J PSYCHIAT, V154, P1670, DOI 10.1176/ajp.154.12.1670; Cawley EI, 2013, J PSYCHIATR NEUROSCI, V38, P388, DOI 10.1503/jpn.120181; CHECKLEY SA, 1980, PSYCHOL MED, V10, P35, DOI 10.1017/S0033291700039593; Chouiter L, 2014, BRAIN TOPOGR, V27, P279, DOI 10.1007/s10548-013-0303-0; Clark J.H., 1924, AM J PHYSL OPTICS, V5, P269; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P174, DOI 10.1111/psyp.12001; Clayson PE, 2011, BIOL PSYCHOL, V87, P282, DOI 10.1016/j.biopsycho.2011.03.011; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; de Bruijn ERA, 2006, BRAIN RES, V1105, P122, DOI 10.1016/j.brainres.2006.01.006; de Bruijn ERA, 2004, PSYCHOPHARMACOLOGY, V177, P151, DOI 10.1007/s00213-004-1915-6; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dien J., 2005, EVENT RELATED POTENT; Dien J, 2010, BRAIN RES, V1355, P126, DOI 10.1016/j.brainres.2010.07.099; Dien J, 2010, J NEUROSCI METH, V187, P138, DOI 10.1016/j.jneumeth.2009.12.009; Djamshidian A, 2011, PARKINSONISM RELAT D, V17, P212, DOI 10.1016/j.parkreldis.2010.12.014; Ellenbogen MA, 1996, NEUROPSYCHOPHARMACOL, V15, P465, DOI 10.1016/S0893-133X(96)00056-5; Ellis KA, 2007, HUM BRAIN MAPP, V28, P1136, DOI 10.1002/hbm.20339; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P1583, DOI 10.1038/sj.npp.1301278; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gajewski PD, 2008, BRAIN RES, V1189, P127, DOI 10.1016/j.brainres.2007.10.076; Gajewski PD, 2012, NEUROPSYCHOLOGIA, V50, P3554, DOI 10.1016/j.neuropsychologia.2012.09.042; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gijsman HJ, 2002, PSYCHOPHARMACOLOGY, V160, P192, DOI 10.1007/s00213-001-0970-5; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Harmer CJ, 2001, PSYCHOPHARMACOLOGY, V154, P105, DOI 10.1007/s002130000613; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2008, CORTEX, V44, P548, DOI 10.1016/j.cortex.2007.08.013; Hughes G, 2011, NEUROPSYCHOLOGIA, V49, P405, DOI 10.1016/j.neuropsychologia.2010.11.036; Jocham G, 2009, NEUROSCI BIOBEHAV R, V33, P48, DOI 10.1016/j.neubiorev.2008.08.011; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Keselman HJ, 2003, PSYCHOPHYSIOLOGY, V40, P586, DOI 10.1111/1469-8986.00060; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Larson MJ, 2012, DEV NEUROPSYCHOL, V37, P343, DOI 10.1080/87565641.2011.650337; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2012, NEUROPSYCHOLOGIA, V50, P426, DOI 10.1016/j.neuropsychologia.2011.12.021; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2011, NEUROREPORT, V22, P44, DOI 10.1097/WNR.0b013e3283427403; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Laurens KR, 2010, BIOL PSYCHIAT, V67, P238, DOI 10.1016/j.biopsych.2009.07.030; Le Masurier M, 2014, J PSYCHOPHARMACOL, V28, P561, DOI 10.1177/0269881113507642; Leyton M, 2004, NEUROPSYCHOPHARMACOL, V29, P427, DOI 10.1038/sj.npp.1300328; Leyton M, 2000, NEUROPSYCHOPHARMACOL, V22, P52, DOI 10.1016/S0893-133X(99)00086-X; Leyton M, 2010, ENCY PSYCHOPHARMACOL; Leyton M, 2007, J PSYCHIATR NEUROSCI, V32, P129; Li SC, 2013, NEUROPSYCHOLOGIA, V51, P1649, DOI 10.1016/j.neuropsychologia.2013.04.005; Linssen AMW, 2011, J PSYCHOPHARMACOL, V25, P230, DOI 10.1177/0269881109348160; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Lythe KE, 2005, J PSYCHOPHARMACOL, V19, P5, DOI 10.1177/0269881105048886; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Masaki H., 2004, JPN J PHYSL PSYCHOL, V22, P3; MCDERMOTT JL, 1994, HORM BEHAV, V28, P16, DOI 10.1006/hbeh.1994.1002; McTavish SFB, 2001, BRIT J PSYCHIAT, V179, P356, DOI 10.1192/bjp.179.4.356; McTavish SFB, 1999, J PSYCHOPHARMACOL, V13, P379, DOI 10.1177/026988119901300408; McTavish SFB, 1999, PSYCHOPHARMACOLOGY, V141, P182, DOI 10.1007/s002130050823; Mehta MA, 2005, PSYCHOPHARMACOLOGY, V180, P654, DOI 10.1007/s00213-004-2128-8; Montgomery AJ, 2003, AM J PSYCHIAT, V160, P1887, DOI 10.1176/appi.ajp.160.10.1887; Moran TP, 2012, INT J PSYCHOPHYSIOL, V85, P188, DOI 10.1016/j.ijpsycho.2012.05.005; Nagano-Saito A, 2008, J NEUROSCI, V28, P3697, DOI 10.1523/JNEUROSCI.3921-07.2008; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; OLDENDORF WH, 1976, AM J PHYSIOL, V230, P94, DOI 10.1152/ajplegacy.1976.230.1.94; Orr C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00177; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; SCHIMMEL H, 1967, SCIENCE, V157, P92, DOI 10.1126/science.157.3784.92; Scholes KE, 2007, NEUROPSYCHOPHARMACOL, V32, P1600, DOI 10.1038/sj.npp.1301262; Shalgi S, 2009, EUR J NEUROSCI, V29, P1522, DOI 10.1111/j.1460-9568.2009.06690.x; Sheehan BD, 1996, J PSYCHOPHARMACOL, V10, P231, DOI 10.1177/026988119601000309; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; Stough C, 2002, INT J NEUROPSYCHOPH, V5, pS191; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; van Meel CS, 2005, NEUROPSYCHOLOGIA, V43, P1946, DOI 10.1016/j.neuropsychologia.2005.03.018; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Venugopalan VV, 2011, NEUROPSYCHOPHARMACOL, V36, P2469, DOI 10.1038/npp.2011.135; Vocat R, 2008, NEUROPSYCHOLOGIA, V46, P2545, DOI 10.1016/j.neuropsychologia.2008.04.006; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Wei DT, 2010, NEUROSCI LETT, V474, P121, DOI 10.1016/j.neulet.2010.03.005; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2005, EXP BRAIN RES, V167, P38, DOI 10.1007/s00221-005-2366-y; West R, 2004, J COGNITIVE NEUROSCI, V16, P103, DOI 10.1162/089892904322755593; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; Wiersema JR, 2009, J NEURAL TRANSM, V116, P371, DOI 10.1007/s00702-008-0165-x; Wiersema JR, 2005, J NEURAL TRANSM, V112, P1417, DOI 10.1007/s00702-005-0276-6; Willemssen R, 2008, J NEURAL TRANSM, V115, P461, DOI 10.1007/s00702-007-0842-1; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Zirnheld PJ, 2004, J COGNITIVE NEUROSCI, V16, P1098, DOI 10.1162/0898929041502779; Zurron M, 2013, J PSYCHOPHYSIOL, V27, P149, DOI 10.1027/0269-8803/a000100; Zurron M, 2009, INT J PSYCHOPHYSIOL, V72, P246, DOI 10.1016/j.ijpsycho.2009.01.002	102	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140770	10.1371/journal.pone.0140770	http://dx.doi.org/10.1371/journal.pone.0140770			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0ZU	26492082	Green Published, gold, Green Submitted			2022-12-27	WOS:000363249300013
J	Lu, HF; Hung, KS; Hsu, YW; Tai, YT; Huang, LS; Wang, YJ; Wong, HSC; Hsu, YH; Chang, WC				Lu, Hsing-Fang; Hung, Kuo-Sheng; Hsu, Yu-Wen; Tai, Yu-Ting; Huang, Lin-Shan; Wang, Yu-Jia; Wong, Henry Sung-Ching; Hsu, Yi-Hsiang; Chang, Wei-Chiao			Association Study between the FTCDNL1 (FONG) and Susceptibility to Osteoporosis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; GENOME-WIDE ASSOCIATION; GENETIC-FACTORS; FRACTURES; MASS; DIAGNOSIS; GEOMETRY; CANADA; RISK; LOCI	Osteoporosis is a systemic skeletal disease characterized by a decreased bone mineral density that results in an increased risk of fragility fractures. Previous studies indicated that genetic factors are involved in the pathogenesis of osteoporosis. Polymorphisms of the FONG (FTCDNL1) gene (rs7605378) were reported to be associated with the risk of osteoporosis in a Japanese population. To assess whether polymorphisms of the FTCDNL1 gene contribute to the susceptibility and severity of osteoporosis in a Taiwanese population, 326 osteoporosis patients and 595 controls of a Taiwanese population were included in this study. Our results indicated that rs10203122 was significantly associated with osteoporosis susceptibility among female. Our findings provide evidence that rs10203122 in FTCDNL1 is associated with a susceptibility to osteoporosis.	[Lu, Hsing-Fang; Hsu, Yu-Wen; Huang, Lin-Shan; Wang, Yu-Jia; Chang, Wei-Chiao] Taipei Med Univ, Dept Clin Pharm, Taipei, Taiwan; [Lu, Hsing-Fang] Taipei Med Univ, Dept Pharm, Shuang Ho Hosp, Taipei, Taiwan; [Hung, Kuo-Sheng] Taipei Med Univ, Dept Neurosurg, Wan Fang Hosp, Taipei, Taiwan; [Hung, Kuo-Sheng; Wong, Henry Sung-Ching; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Tai, Yu-Ting] Taipei Med Univ, Dept Anesthesiol, Taipei, Taiwan; [Hsu, Yi-Hsiang] Broad Inst MIT & Harvard, Cambridge, MA USA; [Hsu, Yi-Hsiang] Harvard Univ, Sch Med, Hebrew SeniorLife Inst Aging Res, Boston, MA USA	Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Hebrew SeniorLife	Chang, WC (corresponding author), Taipei Med Univ, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw		Chang, Wei-Chiao/0000-0002-8573-5924	Comprehensive Cancer Center of Taipei Medical University/Health and welfare surcharge of tobacco products [MOHW103-TD-B-111-01]	Comprehensive Cancer Center of Taipei Medical University/Health and welfare surcharge of tobacco products	Funded by Comprehensive Cancer Center of Taipei Medical University/Health and welfare surcharge of tobacco products (MOHW103-TD-B-111-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagha OME, 2006, RHEUM DIS CLIN N AM, V32, P659, DOI 10.1016/j.rdc.2006.08.001; Arden NK, 1996, J BONE MINER RES, V11, P530; Boronova I, 2014, J APPL GENETICS; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Kanis JA, 1997, OSTEOPOROSIS INT, V7, P108, DOI 10.1007/BF03194355; Karasik D, 2008, ANN HUM GENET, V72, P696, DOI 10.1111/j.1469-1809.2008.00447.x; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Kou I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019641; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Liu YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003160; Morimoto R, 2006, EMBO J, V25, P4175, DOI 10.1038/sj.emboj.7601317; MURLEY LL, 1995, BIOCHEMISTRY-US, V34, P10358, DOI 10.1021/bi00033a006; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Slemenda CW, 1996, OSTEOPOROSIS INT, V6, P178, DOI 10.1007/BF01623944; SMITH DM, 1973, J CLIN INVEST, V52, P2800, DOI 10.1172/JCI107476; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Wiktorowicz ME, 2001, OSTEOPOROSIS INT, V12, P271, DOI 10.1007/s001980170116; Yang KD, 2010, ALLERGY, V65, P731, DOI 10.1111/j.1398-9995.2009.02260.x; Yang NP, 2006, HEALTH POLICY, V75, P329, DOI 10.1016/j.healthpol.2005.04.009	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0140549	10.1371/journal.pone.0140549	http://dx.doi.org/10.1371/journal.pone.0140549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492493	gold, Green Submitted, Green Published			2022-12-27	WOS:000363249300008
J	Xing, LD; Lockley, MG; Marty, D; Zhang, JP; Wang, Y; Klein, H; McCrea, RT; Buckley, LG; Belvedere, M; Mateus, O; Gierlinski, GD; Pinuela, L; Persons, WS; Wang, FP; Ran, H; Dai, H; Xie, XM				Xing, Lida; Lockley, Martin G.; Marty, Daniel; Zhang, Jianping; Wang, Yan; Klein, Hendrik; McCrea, Richard T.; Buckley, Lisa G.; Belvedere, Matteo; Mateus, Octavio; Gierlinski, Gerard D.; Pinuela, Laura; Persons, W. Scott; Wang, Fengping; Ran, Hao; Dai, Hui; Xie, Xianming			An Ornithopod-Dominated Tracksite from the Lower Cretaceous Jiaguan Formation (Barremian-Albian) of Qijiang, South-Central China: New Discoveries, Ichnotaxonomy, Preservation and Palaeoecology	PLOS ONE			English	Article							DINOSAUR FOOTPRINTS; JINDONG FORMATION; SAUROPOD TRACKWAYS; SHANDONG PROVINCE; DIVERSE SAUROPOD; SICHUAN PROVINCE; PTEROSAUR-TRACK; GANSU PROVINCE; HEKOU GROUP; EAST-ASIA	The historically-famous Lotus Fortress site, a deep 1.5-3.0-meter-high, 200-meter-long horizonal notch high up in near-vertical sandstone cliffs comprising the Cretaceous Jiaguan Formation, has been known since the 13th Century as an impregnable defensive position. The site is also extraordinary for having multiple tetrapod track-bearing levels, of which the lower two form the floor of part of the notch, and yield very well preserved asseamblages of ornithopod, bird (avian theropod) and pterosaur tracks. Trackway counts indicate that ornithopods dominate (69%) accounting for at least 165 trackmakers, followed by bird (18%), sauropod (10%), and pterosaur (3%). Previous studies designated Lotus Fortress as the type locality of Caririchnium lotus and Wupus agilis both of which are recognized here as valid ichnotaxa. On the basis of multiple parallel trackways both are interpreted as representing the trackways of gregarious species. C. lotus is redescribed here in detail and interpreted to indicate two age cohorts representing subadults that were sometimes bipedal and larger quadrupedal adults. Two other previously described dinosaurian ichnospecies, are here reinterpreted as underprints and considered nomina dubia. Like a growing number of significant tetrapod tracksites in China the Lotus Fortress site reveals new information about the composition of tetrapod faunas from formations in which the skeletal record is sparse. In particular, the site shows the relatively high abundance of Caririchium in a region where saurischian ichnofaunas are often dominant. It is also the only site known to have yielded Wupus agilis. In combination with information from other tracksites from the Jiaguan formation and other Cretaceous formations in the region, the track record is proving increasingly impotant as a major source of information on the vertebrate faunas of the region. The Lotus Fortress site has been developed as a spectacular, geologically-, paleontologically- and a culturally-significant destination within Qijiang National Geological Park.	[Xing, Lida; Zhang, Jianping] China Univ Geosci, Sch Earth Sci Resources, Beijing 100083, Peoples R China; [Lockley, Martin G.] Univ Colorado, Dinosaur Trackers Res Grp, Denver, CO 80202 USA; [Marty, Daniel] Nat Hist Museum Basel, CH-4001 Basel, Switzerland; [Wang, Yan] Linyi Univ, Inst Geol & Paleontol, Linyi 276000, Shandong, Peoples R China; [Klein, Hendrik] Saurierwelt Palaontol Museum, D-92318 Neumarkt, Germany; [McCrea, Richard T.; Buckley, Lisa G.] Peace Reg Palaeontol Res Ctr, Tumbler Ridge, BC V0C 2W0, Canada; [Belvedere, Matteo] Museum Nat Kunde, D-10115 Berlin, Germany; [Mateus, Octavio] Univ Nova Lisboa, Dept Ciencias Terra CICEGe FCT, P-2530157 Lisbon, Portugal; [Gierlinski, Gerard D.] Moab Giants Tracks Museum, Moab, UT USA; [Pinuela, Laura] Jurass Museum Asturias, Museo Juras Asturias MUJA, E-33328 Colunga, Spain; [Persons, W. Scott] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Wang, Fengping; Xie, Xianming] Qijiang Dist Bur Land Resources, Chongqing 401420, Peoples R China; [Ran, Hao] Minist Educ, Key Lab Ecol Rare & Endangered Species & Environm, Guilin 541004, Peoples R China; [Dai, Hui] Chongqing Bur Geol & Mineral Resource Explorat &, Hydrogeol & Engn Geol Team 208, Chongqing 400700, Peoples R China	China University of Geosciences; University of Colorado System; University of Colorado Denver; Linyi University; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Universidade Nova de Lisboa; University of Alberta	Xing, LD (corresponding author), China Univ Geosci, Sch Earth Sci Resources, Beijing 100083, Peoples R China.	xinglida@gmail.com	Mateus, Octávio/F-2910-2010; Belvedere, Matteo/D-2880-2017; Piñuela, Laura/ABB-9908-2020	Mateus, Octávio/0000-0003-1253-3616; Belvedere, Matteo/0000-0002-0135-4455; Ran, Hao/0000-0001-5462-3615; Gierlinski, Gerard/0000-0001-7038-3738	Qijiang District Bureau of Land Resources, Chongqing [QDBLR-2007-2015]; Research of Paleoenvironment in Early Cretaceous Qijiang Dinosaur Assemblage [CQGT-KJ-2014057]; National Natural Science Foundation of China [41402017]	Qijiang District Bureau of Land Resources, Chongqing; Research of Paleoenvironment in Early Cretaceous Qijiang Dinosaur Assemblage; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a special project grant of the Qijiang District Bureau of Land Resources, Chongqing (No. QDBLR-2007-2015) (LX); the Research of Paleoenvironment in Early Cretaceous Qijiang Dinosaur Assemblage (No. CQGT-KJ-2014057) (HD, LX) and the National Natural Science Foundation of China (No. 41402017) (YW).	ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; Anfinson OA, 2009, CRETACEOUS RES, V30, P885, DOI 10.1016/j.cretres.2009.02.001; Buatois LA, 2002, PALAEOGEOGR PALAEOCL, V183, P71, DOI 10.1016/S0031-0182(01)00459-X; Buatois Luis A., 1993, Ichnos, V2, P237; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081830; Chen HX, 2009, THESIS CHENGDU U TEC; Chen L, 2014, THESIS SW PETROLEUM; Currie Philip J., 2003, Ichnos, V10, P1, DOI 10.1080/10420940390235071; CURRIE PJ, 1991, CAN J EARTH SCI, V28, P102, DOI 10.1139/e91-009; Dai H, 2015, CRETACEOUS RES, V53, P98, DOI 10.1016/j.cretres.2014.10.012; Farlow J.O., 1989, P371; Farlow James O., 1992, Zubia, V10, P89; FREY RW, 1984, J PALEONTOL, V58, P511; Fujita M, 2012, PALAIOS, V27, P560, DOI 10.2110/palo.2012.p12-015r; Garcia-Ramos J.C., 2002, DINOSAURIOS RUTAS JU; Gou Z.H., 2001, J STRATIGRAPHY, V25, P28; GRAHAM JR, 1982, PALAEOGEOGR PALAEOCL, V38, P257, DOI 10.1016/0031-0182(82)90006-2; He Q, 2013, ACTA GEOL SIN-ENGL, V87, P1477, DOI 10.1111/1755-6724.12151; Hu Bin, 1993, Acta Palaeontologica Sinica, V32, P478; Hu Bin, 1991, Acta Sedimentologica Sinica, V9, P128; Huh M, 2003, ISL ARC, V12, P132, DOI 10.1046/j.1440-1738.2003.00386.x; Hunt AP, 1996, REEVALUATION VERTEBR, V18, P57; Kappus Eric, 2003, Palaeontologia Electronica, V6, P1; Lee YN, 1997, CRETACEOUS RES, V18, P849, DOI 10.1006/cres.1997.0091; Leonardi G., 1989, P165; Leonardi G., 1984, ORME DINOSAURI, P165; Li Daqing, 2006, Journal of the Paleontological Society of Korea, V22, P29; Li DQ, 2015, SCI BULL, V60, P264, DOI 10.1007/s11434-014-0681-z; Li J., 2011, DINOSAUR TRACKS LOWE; Li RH, 2015, CRETACEOUS RES, V52, P83, DOI 10.1016/j.cretres.2014.08.004; Li Y L., 1995, J CHENGDU U TECHNOLO, V22, P11; Li YW, 1983, P CHIN ACAD GEOL SCI, V6, P107; Lim JD, 2012, ICHNOS, V19, P101, DOI 10.1080/10420940.2012.664059; Liu Y, 2010, STRUCT CHEM, V21, P21, DOI 10.1007/s11224-009-9519-8; Lockley M, 2002, CRETACEOUS RES, V23, P363, DOI 10.1006/cres.2002.1005; LOCKLEY M, 1995, DINOSAUR TRACKS OTHE; Lockley M.G., 1987, Mountain Geologist, V24, P107; Lockley M.G, 2010, TRENDS ORNITHOLOGICA; Lockley Martin, 2008, Zitteliana Reihe B, V28, P185; Lockley Martin G., 1994, Gaia, V10, P135; Lockley MG, 2014, BIOL J LINN SOC, V113, P721, DOI 10.1111/bij.12294; Lockley MG, 2013, ACTA GEOL SIN-ENGL, V87, P1, DOI 10.1111/1755-6724.12026; Lockley MG, 2012, ICHNOS, V19, P17, DOI 10.1080/10420940.2012.660409; Lockley MG, 2009, GEOL Q, V53, P415; Lockley Martin G., 2004, Ichnos, V11, P261, DOI 10.1080/10420940490428805; Lockley Martin G., 1994, P347; Lockley MG, 2006, CRETACEOUS RES, V27, P70, DOI 10.1016/j.cretres.2005.10.010; LOCKLEY MG, 1992, PHILOS T ROY SOC B, V336, P113, DOI 10.1098/rstb.1992.0051; Lockley MG, 2001, MOUNTAIN GEOL, V38, P87; Lockley MG, 1992, ASPECTS NONMARINE CR, P269; Lu Ting-qing, 2013, Acta Palaeontologica Sinica, V52, P518; Lull R. S., 1904, Memoirs of the Boston Society, Vv, P461; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Marty D, 2008, GEOFOCUS, V21, P1; Marty D, 2010, HIST BIOL, V22, P109, DOI 10.1080/08912960903503345; Matsukawa M, 2006, CRETACEOUS RES, V27, P3, DOI 10.1016/j.cretres.2005.10.009; Matsukawa M, 1999, PALAEOGEOGR PALAEOCL, V147, P39, DOI 10.1016/S0031-0182(98)00154-0; MATSUKAWA M, 1995, PALAIOS, V10, P3, DOI 10.2307/3515004; Matsukawa Masaki, 2005, Ichnos, V12, P201, DOI 10.1080/10420940591009231; McCrea Richard T., 2014, Bulletin of the New Mexico Museum of Natural History and Science, P5; Milan J, 2006, PALAEOGEOGR PALAEOCL, V231, P253, DOI 10.1016/j.palaeo.2004.12.022; Norman D., 1988, ILLUSTRATED ENCY DIN; OSTROM JH, 1972, PALAEOGEOGR PALAEOCL, V11, P287, DOI 10.1016/0031-0182(72)90049-1; Paik IS, 2001, CRETACEOUS RES, V22, P79, DOI 10.1006/cres.2000.0241; Peng G.-Z., 2005, JURASSIC DINOSAUR FA; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Shipman P., 1986, DISCOVER MAG, V10, P94; The No.2 Territorial Survey Team of Sichuan Geological Bureau, 1971, REP SURV GEOL MIN RE; Thulborn RA., 1990, DINOSAUR TRACKS; [王长征 Wang Changzheng], 2014, [沉积学报, Acta Sedimentologica Sinica], V32, P1007; Weems RE, 2004, DINOSAUR DOMINATED I, P116; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Xing L. D., 2015, NEW MEXICO MUSEUM NA, V68, P319; Xing LD, HIST BIOL IN PRESS; Xing LD, 2013, PALAEOWORLD, V22, P42, DOI 10.1016/j.palwor.2013.03.001; Xing Li-Da, 2012, Palaeoworld, V21, P50, DOI 10.1016/j.palwor.2012.02.004; Xing Li-da, 2010, Acta Palaeontologica Sinica, V49, P448; Xing Li-Da, 2011, Palaeoworld, V20, P308, DOI 10.1016/j.palwor.2011.01.001; Xing LD, 2015, CRETACEOUS RES, V56, P345, DOI 10.1016/j.cretres.2015.05.008; Xing LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124039; Xing LD, 2015, CRETACEOUS RES, V52, P194, DOI 10.1016/j.cretres.2014.10.001; Xing LD, 2015, CRETACEOUS RES, V52, P138, DOI 10.1016/j.cretres.2014.09.010; Xing LD, 2014, PALAEOGEOGR PALAEOCL, V414, P79, DOI 10.1016/j.palaeo.2014.08.011; Xing LD, 2014, ICHNOS, V21, P213, DOI 10.1080/10420940.2014.951998; Xing LD, 2013, PALAEOGEOGR PALAEOCL, V392, P177, DOI 10.1016/j.palaeo.2013.09.003; Xing LD, 2013, CHINESE SCI BULL, V58, P2370, DOI 10.1007/s11434-013-5802-6; Xing LD, 2013, CRETACEOUS RES, V42, P55, DOI 10.1016/j.cretres.2013.01.006; Xing LD, 2012, ACTA GEOL SIN-ENGL, V86, P304, DOI 10.1111/j.1755-6724.2012.00660.x; Xing LD, 2011, ICHNOS, V18, P213, DOI 10.1080/10420940.2011.634038; [邢立达 XING Lida], 2011, [地质通报, Geological Bulletin of China], V30, P1530; Xing Lida, 2007, Dizhi Xuebao, V81, P1591; Yang Shipu., 2004, TRACE FOSSILS CHINA; Yang XL, 1987, DINOSAUR FOOTPRINTS; You H, 1995, 6 S MES TERR EC BIOT; Zhang JP, 2006, CRETACEOUS RES, V27, P44, DOI 10.1016/j.cretres.2005.10.006; Zhen Shuonan, 1995, Memoirs of Beijing Natural History Museum, V54, P105; Zhou ZH, 2010, J EARTH SCI-CHINA, V21, P228, DOI 10.1007/s12583-010-0220-z	97	28	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2015	10	10							e0141059	10.1371/journal.pone.0141059	http://dx.doi.org/10.1371/journal.pone.0141059			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZU	26492525	gold, Green Published, Green Submitted			2022-12-27	WOS:000363249300026
J	Andreotti, G; Monti, MC; Citro, V; Cubellis, MV				Andreotti, Giuseppina; Monti, Maria Chiara; Citro, Valentina; Cubellis, Maria Vittoria			Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2	PLOS ONE			English	Article							TYPE-1 GAUCHER-DISEASE; SYNDROME TYPE 1A; PHARMACOLOGICAL CHAPERONE; CONGENITAL DISORDERS; PMM2; MUTATIONS; GLYCOSYLATION; EXPRESSION; PROTEIN; SAFETY	The most frequent disorder of glycosylation is due to mutations in the gene encoding phosphomannomutase2 (PMM2-CDG). For this disease, which is autosomal and recessive, there is no cure at present. Most patients are composite heterozygous and carry one allele encoding an inactive mutant, R141H, and one encoding a hypomorphic mutant. Phosphomannomutase2 is a dimer. We reproduced composite heterozygosity in vitro by mixing R141H either with the wild type protein or the most common hypomorphic mutant F119L and compared the quaternary structure, the activity and the stability of the heterodimeric enzymes. We demonstrated that the activity of R141H/F119L heterodimers in vitro, which reproduces the protein found in patients, has the same activity of wild type/R141H, which reproduces the protein found in healthy carriers. On the other hand the stability of R141H/F119L appears to be reduced both in vitro and in vivo. These findings suggest that a therapy designed to enhance protein stability such as those based on pharmacological chaperones or modulation of proteostasis could be beneficial for PMM2-CDG patients carrying R141H/F119L genotype as well as for other genotypes where protein stability rather than specific activity is affected by mutations.	[Andreotti, Giuseppina] CNR, Ist Chim Biomol, Pozzuoli, Italy; [Monti, Maria Chiara] Univ Salerno, Dipartimento Farm, Fisciano, Italy; [Citro, Valentina; Cubellis, Maria Vittoria] Univ Naples Federico II, Dipartimento Biol, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); University of Salerno; University of Naples Federico II	Cubellis, MV (corresponding author), Univ Naples Federico II, Dipartimento Biol, Naples, Italy.	cubellis@unina.it	ANDREOTTI, GIUSEPPINA/AAX-8952-2020	ANDREOTTI, GIUSEPPINA/0000-0002-1594-0156; cubellis, maria vittoria/0000-0001-6147-6553; Citro, Valentina/0000-0002-0289-404X	Telethon - Italy [GGP12108]; project CREME, P.O. R. Campania FSE, Progetto CREMe [CUP B25B09000050007]	Telethon - Italy(Fondazione Telethon); project CREME, P.O. R. Campania FSE, Progetto CREMe	Funding was provided by Telethon - Italy (Grant no. GGP12108) and the project CREME, P.O. R. Campania FSE 2007-2013, Progetto CREMe, CUP B25B09000050007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti G, 2015, DRUG TEST ANAL, V7, P831, DOI 10.1002/dta.1798; Andreotti G, 2014, J BIOL CHEM, V289, P34900, DOI 10.1074/jbc.M114.586362; Andreotti G, 2013, MOL GENET GENOM MED, V1, P32, DOI 10.1002/mgg3.3; ARNONE MI, 1992, EUR J BIOCHEM, V204, P1183, DOI 10.1111/j.1432-1033.1992.tb16745.x; Bjursell C, 1998, EUR J HUM GENET, V6, P603, DOI 10.1038/sj.ejhg.5200234; Chakraborty S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102572; Germain DP, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-91; Vega AI, 2011, J INHERIT METAB DIS, V34, P929, DOI 10.1007/s10545-011-9328-2; Kjaergaard S, 1998, EUR J HUM GENET, V6, P331, DOI 10.1038/sj.ejhg.5200194; Kjaergaard S, 1999, EUR J HUM GENET, V7, P884, DOI 10.1038/sj.ejhg.5200398; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuter DJ, 2013, BLOOD CELL MOL DIS, V51, P116, DOI 10.1016/j.bcmd.2013.04.005; Le Bizec Christiane, 2005, Hum Mutat, V25, P504, DOI 10.1002/humu.9336; Matthijs G, 2000, TRENDS BIOCHEM SCI, V25, P428, DOI 10.1016/S0968-0004(00)01629-7; Matthijs G, 1998, AM J HUM GENET, V62, P542, DOI 10.1086/301763; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; Pirard M, 1999, FEBS LETT, V452, P319, DOI 10.1016/S0014-5793(99)00673-0; Pirard M, 1999, BIOCHEM J, V339, P201, DOI 10.1042/0264-6021:3390201; Pirard M, 1997, FEBS LETT, V411, P251, DOI 10.1016/S0014-5793(97)00704-7; Schollen E, 2000, EUR J HUM GENET, V8, P367, DOI 10.1038/sj.ejhg.5200470; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Song Y, 2012, BIOTECHNOL BIOENG, V109, P2875, DOI 10.1002/bit.24564; Yuste-Checa P, 2015, HUM MUTAT, V36, P851, DOI 10.1002/humu.22817; Zimran A, 2013, BLOOD CELL MOL DIS, V50, P134, DOI 10.1016/j.bcmd.2012.09.006	24	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0139882	10.1371/journal.pone.0139882	http://dx.doi.org/10.1371/journal.pone.0139882			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488408	Green Published, gold			2022-12-27	WOS:000363248400043
J	Paszti-Gere, E; McManus, S; Meggyeshazi, N; Balla, P; Galfi, P; Steinmetzer, T				Paszti-Gere, E.; McManus, S.; Meggyeshazi, N.; Balla, P.; Galfi, P.; Steinmetzer, T.			Inhibition of Matriptase Activity Results in Decreased Intestinal Epithelial Monolayer Integrity In Vitro	PLOS ONE			English	Article							TRANSMEMBRANE SERINE-PROTEASE; FLUORESCENT-PROBES; REACTIVE OXYGEN; CELL LINE; IPEC-J2; BARRIER; PERMEABILITY; EXPRESSION; CHALLENGES; NITROGEN	Barrier dysfunction in inflammatory bowel diseases implies enhanced paracellular flux and lowered transepithelial electrical resistance (TER) causing effective invasion of enteropathogens or altered intestinal absorption of toxins and drug compounds. To elucidate the role of matriptase-driven cell surface proteolysis in the maintenance of intestinal barrier function, the 3-amidinophenylalanine-derived matriptase inhibitor, MI-432 was used on porcine IPEC-J2 cell monolayer. Studies with two fluorescent probes revealed that short (2 h) treatment with MI-432 caused an altered distribution of oxidative species between intracellular and extracellular spaces in IPEC-J2 cells. This perturbation was partially compensated when administration of inhibitor continued for up to 48 h. Significant decrease in TER between apical and basolateral compartments of MI-432-treated IPEC-J2 cell monolayers proved that matriptase is one of the key effectors in the maintenance of barrier integrity. Changes in staining pattern of matriptase and in localization of the junctional protein occludin were observed suggesting that inhibition of matriptase by MI-432 can also exert an effect on paracellular gate opening via modulation of tight junctional protein assembly. This study confirms that non-tumorigenic IPEC-J2 cells can be used as an appropriate small intestinal model for the in vitro characterization of matriptase-related effects on intestinal epithelium. These findings demonstrate indirectly that matriptase plays a pivotal role in the development of barrier integrity; thus matriptase dysfunction can facilitate the occurence of leaky gut syndrome observed in intestinal inflammatory diseases.	[Paszti-Gere, E.; McManus, S.; Galfi, P.] Szent Istvan Univ, Dept Pharmacol & Toxicol, Fac Vet Sci, Budapest, Hungary; [Meggyeshazi, N.; Balla, P.] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Steinmetzer, T.] Univ Marburg, Fac Pharm, Inst Pharmaceut Chem, Marburg, Germany	Hungarian University of Agriculture & Life Sciences; Semmelweis University; Philipps University Marburg	Paszti-Gere, E (corresponding author), Szent Istvan Univ, Dept Pharmacol & Toxicol, Fac Vet Sci, Budapest, Hungary.	Gere.Erzsebet@aotk.szie.hu			Hungarian Scientific Research Fund [115685]; Szent Istvan University, Faculty of Veterinary Science; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Szent Istvan University, Faculty of Veterinary Science; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This research was supported by the Hungarian Scientific Research Fund [grant number: 115685] and by the Research Faculty Grant 2015 of the Szent Istvan University, Faculty of Veterinary Science. This project was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences.	Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Brosnahan AJ, 2012, VET MICROBIOL, V156, P229, DOI 10.1016/j.vetmic.2011.10.017; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Colombo E, 2012, ACS MED CHEM LETT, V3, P530, DOI 10.1021/ml3000534; Galkin AV, 2004, PROSTATE, V61, P228, DOI 10.1002/pros.20094; Geens MM, 2011, CYTOTECHNOLOGY, V63, P415, DOI 10.1007/s10616-011-9362-9; Hammami M, 2012, MEDCHEMCOMM, V3, P807, DOI 10.1039/c2md20074k; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kosa P, 2012, ONCOGENE, V31, P3679, DOI 10.1038/onc.2011.545; Laukoetter MG, 2008, WORLD J GASTROENTERO, V14, P401, DOI 10.3748/wjg.14.401; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; MacNaughton W, 2014, FASEB J, V28; Meyer D, 2013, BIOCHEM J, V452, P331, DOI 10.1042/BJ20130101; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Netzel-Arnett S, 2012, INFLAMM BOWEL DIS, V18, P1303, DOI 10.1002/ibd.21930; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Paszti-Gere E, 2016, J ENZYM INHIB MED CH, V31, P736, DOI 10.3109/14756366.2015.1060483; Paszti-Gere E, 2015, INFLAMMATION, V38, P775, DOI 10.1007/s10753-014-9988-9; Paszti-Gere E, 2014, INFLAMMATION, V37, P247, DOI 10.1007/s10753-013-9735-7; Paszti-Gere E, 2012, INFLAMMATION, V35, P994, DOI 10.1007/s10753-011-9403-8; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Ronaghan N, 2015, FASEB J, V29; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Tarpey MM, 2004, AM J PHYSIOL-REG I, V286, pR431, DOI 10.1152/ajpregu.00361.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Winterbourn CC, 2014, BBA-GEN SUBJECTS, V1840, P730, DOI 10.1016/j.bbagen.2013.05.004; Zakrzewski SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079643	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0141077	10.1371/journal.pone.0141077	http://dx.doi.org/10.1371/journal.pone.0141077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488575	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000363248400099
J	Ruiz-Ramos, DV; Saunders, M; Fisher, CR; Baums, IB				Ruiz-Ramos, Dannise V.; Saunders, Miles; Fisher, Charles R.; Baums, Iliana B.			Home Bodies and Wanderers: Sympatric Lineages of the Deep-Sea Black Coral Leiopathes glaberrima	PLOS ONE			English	Article							MIXED MATING SYSTEMS; POPULATION-STRUCTURE; SCLERACTINIAN CORALS; NULL ALLELES; GENE FLOW; INFERENCE; DIVERGENCE; MORPHOLOGY; SOFTWARE; PATTERNS	Colonial corals occur in a wide range of marine benthic habitats from the shallows to the deep ocean, often defining the structure of their local community. The black coral Leiopathes glaberrima is a long-lived foundation species occurring on carbonate outcrops in the Northern Gulf of Mexico (GoM). Multiple color morphs of L. glaberrima grow sympatrically in the region. Morphological, mitochondrial and nuclear ribosomal markers supported the hypothesis that color morphs constituted a single biological species and that colonies, regardless of color, were somewhat genetically differentiated east and west of the Mississippi Canyon. Ten microsatellite loci were used to determine finer-scale population genetic structure and reproductive characteristics. Gene flow was disrupted between and within two nearby (distance = 36.4 km) hardground sites and two sympatric microsatellite lineages, which might constitute cryptic species, were recovered. Lineage one was outbred and found in all sampled locations (N = 5) across 765.6 km in the Northern Gulf of Mexico. Lineage two was inbred, reproducing predominantly by fragmentation, and restricted to sites around Viosca Knoll. In these sites the lineages and the color phenotypes occurred in different microhabitats, and models of maximum entropy suggested that depth and slope influence the distribution of the color phenotypes within the Vioska Knolls. We conclude that L. glaberrima is phenotypically plastic with a mixed reproductive strategy in the Northern GoM. Such strategy might enable this long-lived species to balance local recruitment with occasional long-distance dispersal to colonize new sites in an environment where habitat is limited.	[Ruiz-Ramos, Dannise V.; Saunders, Miles; Fisher, Charles R.; Baums, Iliana B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ruiz-Ramos, DV (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	dannise821@gmail.com	Baums, Iliana Brigitta/G-6435-2010	Baums, Iliana Brigitta/0000-0001-6463-7308; Ruiz-Ramos, Dannise/0000-0001-7282-0380	Bureau of Ocean Energy Management [M08PC20038]; National Science Foundation [OCE - 0825979]; Gulf of Mexico Research Initiative; NOAA Deep-sea Coral Research and Technology Program; Florida Atlantic University (Harbor Branch Oceanographic Institute) as part of the Cooperative Institute for Ocean Exploration, Research and Technology;  [05HQAG0099]	Bureau of Ocean Energy Management; National Science Foundation(National Science Foundation (NSF)); Gulf of Mexico Research Initiative; NOAA Deep-sea Coral Research and Technology Program; Florida Atlantic University (Harbor Branch Oceanographic Institute) as part of the Cooperative Institute for Ocean Exploration, Research and Technology; 	This work was supported by the Bureau of Ocean Energy Management contract M08PC20038 to TDI Brooks with vessel and submergence facilities support provided by National Oceanic and Atmospheric Administration's Office of Ocean Exploration and Research, and the National Science Foundation (OCE - 0825979) to IB. Funding was also provided by the Gulf of Mexico Research Initiative funding to support the Ecosystem Impacts of Oil and Gas Inputs to the Gulf (ECOGIG) consortium administered by the University of Mississippi. R/V Seward Johnson was funded by NOAA Deep-sea Coral Research and Technology Program awarded to S. Ross. Use of Johnson-Sea-Link II funded by Florida Atlantic University (Harbor Branch Oceanographic Institute) as part of the Cooperative Institute for Ocean Exploration, Research and Technology. Support for R/V Hatteras missions funded by Cooperative Agreement No. 05HQAG0099, Cooperative Project Award to University of North Carolina Wilmington, to S. Ross.	Aguayo J, 2013, PHYTOPATHOLOGY, V103, P190, DOI 10.1094/PHYTO-05-12-0116-R; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boulay JN, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1580; BRAZEAU DA, 1988, CORAL REEFS, V7, P139, DOI 10.1007/BF00300973; Brugler MR, 2007, MOL PHYLOGENET EVOL, V42, P776, DOI 10.1016/j.ympev.2006.08.016; Brugler MR, 2011, MOL EVOLUTION BLACK; Bruvo R, 2007, OIKOS, V116, P313, DOI 10.1111/j.2006.0030-1299.15388.x; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; Cairns Stephen D., 1993, Northeast Gulf Science, V13, P1; Carlon DB, 1999, TRENDS ECOL EVOL, V14, P491, DOI 10.1016/S0169-5347(99)01709-7; Carlon DB, 2002, EVOLUTION, V56, P2227; Carney SL, 2006, DEEP-SEA RES PT I, V53, P1061, DOI 10.1016/j.dsr.2006.03.002; Chybicki IJ, 2010, MOL ECOL, V19, P2137, DOI 10.1111/j.1365-294X.2010.04632.x; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Coates DJ, 2007, AUST J BOT, V55, P239, DOI 10.1071/BT06142; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Cowart DA, 2013, MOL ECOL, V22, P4147, DOI 10.1111/mec.12379; Dart SR, 2012, ANN BOT-LONDON, V109, P599, DOI 10.1093/aob/mcr266; Dart SR, 2013, EVOLUTION FLORAL MAT; David P, 2007, MOL ECOL, V16, P2474, DOI 10.1111/j.1365-294X.2007.03330.x; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Doughty CL, 2014, DEEP-SEA RES PT II, V99, P71, DOI 10.1016/j.dsr2.2013.05.023; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Glynn PW, 1996, MAR BIOL, V125, P579; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Guest JR, 2012, CORAL REEFS, V31, P705, DOI 10.1007/s00338-012-0881-4; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Harder LD, 2008, EVOLUTION, V62, P157, DOI 10.1111/j.1558-5646.2007.00272.x; Hardner CM, 1997, EVOLUTION, V51, P103, DOI 10.1111/j.1558-5646.1997.tb02392.x; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Herrera S, 2012, MOL ECOL, V21, P6053, DOI 10.1111/mec.12074; Hill GE, 2002, P ROY SOC B-BIOL SCI, V269, P1119, DOI 10.1098/rspb.2002.1980; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Johnson SB, 2008, J SHELLFISH RES, V27, P43, DOI 10.2983/0730-8000(2008)27[43:DBOLLR]2.0.CO;2; Kamvar ZN, 2013, PEERJ PREPRINTS, P1; Kim K, 1997, J EXP MAR BIOL ECOL, V215, P49, DOI 10.1016/S0022-0981(97)00015-4; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Loya Y, 2008, P ROY SOC B-BIOL SCI, V275, P2335, DOI 10.1098/rspb.2008.0675; Mackiewicz M, 2006, P ROY SOC B-BIOL SCI, V273, P2449, DOI 10.1098/rspb.2006.3594; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; Miller KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019004; Miller KJ, 1998, MAR ECOL PROG SER, V163, P225, DOI 10.3354/meps163225; Morrison CL, 2011, CONSERV GENET, V12, P713, DOI 10.1007/s10592-010-0178-5; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Opresko D. M., 2003, Zoologische Mededelingen (Leiden), V77, P495; Opresko Dennis M., 1998, Records of the South Australian Museum (Adelaide), V31, P99; Opresko DM., 2009, ANTIPATHARIA CNIDARI; Palumbi SR, 2003, ECOL APPL, V13, pS146; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez G, 2010, MOL ECOL, V19, P1801, DOI 10.1111/j.1365-294X.2010.04584.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinzon JH, 2012, CORAL REEFS, V31, P765, DOI 10.1007/s00338-012-0887-y; Pinzon JH, 2013, J BIOGEOGR, V40, P1595, DOI 10.1111/jbi.12110; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Prada C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-47; Pritchard JK, 2000, GENETICS, V155, P945; Quattrini AM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0008; Quattrini AM, 2013, MOL ECOL, V22, P4123, DOI 10.1111/mec.12370; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Raymond M, 2000, GENEPOP WEB POPULATI; Rogers AD, 2000, DEEP-SEA RES PT II, V47, P119, DOI 10.1016/S0967-0645(99)00107-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinniger F, 2009, J COR REEF STU, V11, P21, DOI DOI 10.3755/GALAXEA.11.21; Takabayashi M, 1998, MOL ECOL, V7, P928; Team R. D. C., 2008, R LANG ENV STAT COMP; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Vallejo-Marin M, 2010, ANNU REV ECOL EVOL S, V41, P193, DOI 10.1146/annurev.ecolsys.110308.120258; VRIJENHOEK RC, 1994, DEEP-SEA RES PT I, V41, P1171, DOI 10.1016/0967-0637(94)90039-6; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; Wagner D, 2011, INVERTEBR BIOL, V130, P211, DOI 10.1111/j.1744-7410.2011.00233.x; Warner PA, 2015, MOL ECOLOGY	83	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0138989	10.1371/journal.pone.0138989	http://dx.doi.org/10.1371/journal.pone.0138989			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488161	Green Published, gold, Green Submitted			2022-12-27	WOS:000363248400014
J	Woo, EJ; Lee, WJ; Hu, KS; Hwang, JJ				Woo, Eun Jin; Lee, Won-Joon; Hu, Kyung-Seok; Hwang, Jae Joon			Paleopathological Study of Dwarfism-Related Skeletal Dysplasia in a Late Joseon Dynasty (South Korean) Population	PLOS ONE			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; LYSOSOMAL STORAGE DISORDERS; HUMERUS VARUS; CHONDRODYSTROPHIC DWARFISM; GENETIC-HETEROGENEITY; ACHONDROPLASIA; THALASSEMIA; FEATURES; MANIFESTATIONS; TUBERCULOSIS	Skeletal dysplasias related to genetic etiologies have rarely been reported for past populations. This report presents the skeletal characteristics of an individual with dwarfism-related skeletal dysplasia from South Korea. To assess abnormal deformities, morphological features, metric data, and computed tomography scans are analyzed. Differential diagnoses include achondroplasia or hypochondroplasia, chondrodysplasia, multiple epiphyseal dysplasia, thalassemia-related hemolytic anemia, and lysosomal storage disease. The diffused deformities in the upper-limb bones and several coarsened features of the craniofacial bones indicate the most likely diagnosis to have been a certain type of lysosomal storage disease. The skeletal remains of EP-III-4-No. 107 from the Eunpyeong site, although incomplete and fragmented, provide important clues to the paleopathological diagnosis of skeletal dysplasias.	[Woo, Eun Jin] Yonsei Univ, Coll Dent, Div Anat & Dev Biol, Dept Oral Biol,PLUS Project BK21, Seoul 120749, South Korea; [Lee, Won-Joon] Yonsei Univ, Coll Med, Inst Forens Sci, Seoul, South Korea; [Hu, Kyung-Seok] Yonsei Univ, Coll Dent, Human Identificat Res Inst, Dept Oral Biol,Div Anat & Dev Biol, Seoul 120749, South Korea; [Hwang, Jae Joon] Yonsei Univ, Coll Dent, Dent Hosp, Dept Oral & Maxillofacial Radiol, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Woo, EJ (corresponding author), Yonsei Univ, Coll Dent, Div Anat & Dev Biol, Dept Oral Biol,PLUS Project BK21, Seoul 120749, South Korea.	redqin@yuhs.ac		Hu, Kyung-Seok/0000-0002-9048-3805	National Research Foundation of Korea - Korean Government	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenhoven M, 2009, ANN RHEUM DIS, V68, P1659, DOI 10.1136/ard.2008.095315; Baujat G, 2008, BEST PRACT RES CL RH, V22, P3, DOI 10.1016/j.berh.2007.12.008; Buikstra J.E., 1994, STANDARDS DATA COLLE; Castriota-Scanderbeg A, 2005, ABNORMAL SKELETAL PH; Central Institute of Cultural Heritage, 2009, EUNP JINGW DONG BUR; DEERE M, 1995, AM J HUM GENET, V56, P698; ELLEFSEN BK, 1994, J PEDIATR ORTHOPED, V14, P479, DOI 10.1097/01241398-199407000-00011; FIELD RE, 1994, J BONE JOINT SURG BR, V76B, P975, DOI 10.1302/0301-620X.76B6.7983131; FRAYER DW, 1988, AM J PHYS ANTHROPOL, V75, P549, DOI 10.1002/ajpa.1330750412; GAMBOA I, 1974, CLIN GENET, V6, P15; Garel C, 1998, SKELETAL RADIOL, V27, P43, DOI 10.1007/s002560050335; Gill TJ, 1997, J SHOULDER ELB SURG, V6, P306, DOI 10.1016/S1058-2746(97)90021-5; Gtadykowska-Rzeczycka J, 1980, OSSA, V7, P71; Hendriksz C, 2014, JIMD REPORTS; HERSHKOVITZ I, 1991, AM J PHYS ANTHROPOL, V85, P7, DOI 10.1002/ajpa.1330850103; Hong CR, 2013, J KOREAN MED SCI, V28, P1645, DOI 10.3346/jkms.2013.28.11.1645; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; INGRAM RR, 1991, J BONE JOINT SURG BR, V73, P277, DOI 10.1302/0301-620X.73B2.2005154; ISHIDA H, 1990, HUM BIOL, V62, P389; Kacki S, 2013, INT J OSTEOARCHAEOL, V23, P119, DOI 10.1002/oa.1249; KOIDE T, 1983, PEDIATR RADIOL, V13, P102, DOI 10.1007/BF02390112; Kozieradzka-Ogunmakin I, 2011, INT J PALEOPATHOL, V1, P200, DOI 10.1016/j.ijpp.2011.10.002; Kozma C, 2006, AM J MED GENET A, V140A, P303, DOI 10.1002/ajmg.a.31068; KVAAL SI, 1995, FORENSIC SCI INT, V74, P175, DOI 10.1016/0379-0738(95)01760-G; Lachman R, 2015, J PEDIAT REHABIL MED, V3, P109; LANGER LO, 1977, AM J MED GENET, V1, P87, DOI 10.1002/ajmg.1320010110; LANGER LO, 1980, RADIOLOGY, V137, P349, DOI 10.1148/radiology.137.2.7433666; LAWSON JP, 1983, AM J ROENTGENOL, V140, P239, DOI 10.2214/ajr.140.2.239; Lee MY, 2008, FIELD ARCHAEOLOGY, V5, P79; Malm D, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-21; MANN RW, 1987, J FORENSIC SCI, V32, P148; Mays S, 2002, AM J PHYS ANTHROPOL, V119, P27, DOI 10.1002/ajpa.10099; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Metcalf JA, 2009, MOL GENET METAB, V97, P202, DOI 10.1016/j.ymgme.2009.03.005; Miura H, 2000, CLIN ORTHOP RELAT R, P184; Molto JE, 2000, AM J PHYS ANTHROPOL, V113, P103, DOI 10.1002/1096-8644(200009)113:1<103::AID-AJPA9>3.0.CO;2-A; Monsell, 2012, ORTHOP TRAUMA, V26, P60; Mortier GR, 2001, EUR J RADIOL, V40, P161, DOI 10.1016/S0720-048X(01)00397-7; Nelson M A, 1970, Ann R Coll Surg Engl, V47, P185; OGDEN JA, 1976, CLIN ORTHOP RELAT R, P158; Ortner D. J., 2003, IDENTIFICATION PATHO, P545; Palmucci S, 2013, INSIGHTS IMAGING, V4, P443, DOI 10.1007/s13244-013-0246-8; Pan J, 2013, INT J RHEUM DIS, V16, P361, DOI 10.1111/j.1756-185X.2012.01749.x; Pastores GM, 2008, BEST PRACT RES CL RH, V22, P937, DOI 10.1016/j.berh.2008.09.005; PAZZAGLIA UE, 1988, PEDIATR RADIOL, V19, P41, DOI 10.1007/BF02388409; Pinto R, 2004, EUR J HUM GENET, V12, P87, DOI 10.1038/sj.ejhg.5201044; Post M, 1988, SHOULDER, P92; RIMOIN DL, 1975, ADV HUM GENET, V5, P1; ROBERTS C, 1994, AM J PHYS ANTHROPOL, V95, P169, DOI 10.1002/ajpa.1330950205; Rodriguez-Martin C, 1998, CAMBRIDGE ENCY HUMAN, P347; Sables A, 2010, INT J OSTEOARCHAEOL, V20, P47, DOI 10.1002/oa.1006; SJOGREN P, 1986, ACTA ANAESTH SCAND, V30, P484, DOI 10.1111/j.1399-6576.1986.tb02459.x; Slon V, 2013, INT J OSTEOARCHAEOL, V23, P573, DOI 10.1002/oa.1285; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Snow CE, 1943, ALABAMA MUSEUM NATUR, V21, P1; SPRANGER J, 1977, AM J MED GENET, V1, P21, DOI 10.1002/ajmg.1320010104; SPRANGER J, 1974, BONE DYSPLASIA ATLAS; Stevenson DA, 2013, PEDIATR ENDOCR REV P, V10, P406; Tunaci M, 1999, EUR RADIOL, V9, P1804, DOI 10.1007/s003300050926; Ubelaker D., 1999, HUMAN SKELETAL REMAI, V3rd; Unger S, 2008, BEST PRACT RES CL RH, V22, P19, DOI 10.1016/j.berh.2007.11.009; Valayannopoulos V, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-5; VANDEKAMP JJP, 1981, CLIN GENET, V20, P152; Waters-Rist AL, 2013, INT J PALEOPATHOL, V3, P243, DOI 10.1016/j.ijpp.2013.08.004; White KK, 2011, RHEUMATOLOGY, V50, pV26, DOI 10.1093/rheumatology/ker393; Wynne-Davies R, 1985, ATLAS SKELETON DYSPL	66	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2015	10	10							e0140901	10.1371/journal.pone.0140901	http://dx.doi.org/10.1371/journal.pone.0140901			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0ZM	26488291	Green Published, Green Submitted, gold			2022-12-27	WOS:000363248400078
J	Coulibaly, ST; Rossolillo, P; Winter, F; Kretzschmar, FK; Braye, M; Martin, DP; Lener, D; Negroni, M				Coulibaly, Safiatou T.; Rossolillo, Paola; Winter, Flore; Kretzschmar, Franziska K.; Braye, Melanie; Martin, Darren P.; Lener, Daniela; Negroni, Matteo			Potent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine Kinase	PLOS ONE			English	Article							SUICIDE GENE-THERAPY; PHASE-II TRIAL; IN-VIVO; CYTOSINE-ARABINOSIDE; NUCLEOSIDE ANALOGS; LUNG-CANCER; GEMCITABINE; RESISTANCE; 2',2'-DIFLUORODEOXYCYTIDINE; LEUKEMIA	Identifying enzymes that, once introduced in cancer cells, lead to an increased efficiency of treatment constitutes an important goal for biomedical applications. Using an original procedure whereby mutant genes are generated based on the use of conditional lentivector genome mobilisation, we recently described, for the first time, the identification of a human deoxycytidine kinase (dCK) mutant (G12) that sensitises a panel of cancer cell lines to treatment with the dCK analogue gemcitabine. Here, starting from the G12 variant itself, we generated a new library and identified a mutant (M36) that triggers even greater sensitisation to gemcitabine than G12. With respect to G12, M36 presents an additional mutation located in the region that constitutes the interface of the dCK dimer. The simple presence of this mutation halves both the IC50 and the proportion of residual cells resistant to the treatment. Furthermore, the use of vectors with self-inactivating LTRs leads to an increased sensitivity to treatment, a result compatible with a relief of the transcriptional interference exerted by the U3 promoter on the internal promoter that drives the expression of M36. Importantly, a remarkable effect is also observed in treatments with the anticancer compound cytarabine (AraC), for which a 10,000 fold decrease in IC50 occurred. By triggering the sensitisation of various cancer cell types with poor prognosis to two commonly used anticancer compounds M36 is a promising candidate for suicide gene approaches.	[Coulibaly, Safiatou T.; Rossolillo, Paola; Winter, Flore; Kretzschmar, Franziska K.; Braye, Melanie; Lener, Daniela; Negroni, Matteo] Univ Strasbourg, CNRS, IBMC, Architecture & React ARN, F-67084 Strasbourg, France; [Martin, Darren P.] Ctr High Performance Comp, Cape Town, South Africa; [Martin, Darren P.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Cape Town	Negroni, M (corresponding author), Univ Strasbourg, CNRS, IBMC, Architecture & React ARN, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	m.negroni@ibmc-cnrs.unistra.fr	COULIBALY, Tata Gniré Safiatou/AAU-9157-2021; Martin, Darren P/C-4599-2008; Martin, Darren/ABE-3614-2021; coulibaly, safiatou/GYJ-7557-2022	Negroni, Matteo/0000-0003-3005-8871; Lener, Daniela/0000-0001-8266-8810; COULIBALY, Tata Gnire Safiatou/0000-0001-9398-9556	Ligue Contre le Cancer; Appel d'offre Conference de Coordination InterRegionale du Grand Est; French "Ministere de l'Enseignement Superieur et de la Recherche"	Ligue Contre le Cancer(Ligue nationale contre le cancer); Appel d'offre Conference de Coordination InterRegionale du Grand Est; French "Ministere de l'Enseignement Superieur et de la Recherche"	This work was supported by funding from the Ligue Contre le Cancer (http://www.ligue-cancer.net), Appel d'offre Conference de Coordination InterRegionale du Grand Est 2012 to MN. S. Coulibaly is recipient of a fellowship from the French "Ministere de l'Enseignement Superieur et de la Recherche".	ABRATT RP, 1994, J CLIN ONCOL, V12, P1535, DOI 10.1200/JCO.1994.12.8.1535; Agarwal K C, 1978, Methods Enzymol, V51, P483; ANDERSON H, 1994, J CLIN ONCOL, V12, P1821, DOI 10.1200/JCO.1994.12.9.1821; Baker AM, 2007, J BIOL CHEM, V282, P35163, DOI 10.1074/jbc.M705617200; Beausejour CM, 2002, BIOCHEM BIOPH RES CO, V293, P1478, DOI 10.1016/S0006-291X(02)00413-8; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Bergman AM, 2000, EUR J CANCER, V36, P1974, DOI 10.1016/S0959-8049(00)00246-X; Bergman AM, 2002, DRUG RESIST UPDATE, V5, P19, DOI 10.1016/S1368-7646(02)00002-X; BHALLA K, 1984, CANCER RES, V44, P5029; Blackstock AW, 2001, CLIN CANCER RES, V7, P3263; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Bonini C, 2007, MOL THER, V15, P1248, DOI 10.1038/sj.mt.6300190; CARMICHAEL J, 1995, J CLIN ONCOL, V13, P2731, DOI 10.1200/JCO.1995.13.11.2731; CASPER ES, 1994, INVEST NEW DRUG, V12, P29, DOI 10.1007/BF00873232; COHEN A, 1983, BLOOD, V61, P660; Duarte S, 2012, CANCER LETT, V324, P160, DOI 10.1016/j.canlet.2012.05.023; FLASSHOVE M, 1994, LEUKEMIA, V8, P780; Galmarini Carlos Maria, 2004, BMC Pharmacology, V4, P8, DOI 10.1186/1471-2210-4-8; Geutjes EJ, 2012, BREAST CANCER RES TR, V131, P809, DOI 10.1007/s10549-011-1477-3; Hamoudi M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-114; Hapke DM, 1996, CANCER RES, V56, P2343; Hazra S, 2011, BIOCHEMISTRY-US, V50, P2870, DOI 10.1021/bi2001032; Immonen A, 2004, MOL THER, V10, P967, DOI 10.1016/j.ymthe.2004.08.002; Jordheim LP, 2006, CANCER CHEMOTH PHARM, V58, P547, DOI 10.1007/s00280-006-0195-8; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; KAWASAKI H, 1993, BLOOD, V81, P597; Kroep JR, 2002, MOL CANCER THER, V1, P371; Lee MW, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-223; LUND B, 1994, J NATL CANCER I, V86, P1530, DOI 10.1093/jnci/86.20.1530; Manome Y, 1996, NAT MED, V2, P567, DOI 10.1038/nm0596-567; McSorley T, 2008, FEBS LETT, V582, P720, DOI 10.1016/j.febslet.2008.01.048; MOMPARLER RL, 1968, BIOCHIM BIOPHYS ACTA, V161, P481, DOI 10.1016/0005-2787(68)90124-X; MOMPARLER RL, 1989, CANCER CHEMOTH PHARM, V25, P51, DOI 10.1007/BF00694338; Moore M, 1996, CANCER, V78, P633; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; Preuss E, 2011, J MOL MED, V89, P1113, DOI 10.1007/s00109-011-0777-8; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rossolillo P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002904; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; Shalev M, 2000, J UROLOGY, V163, P1747, DOI 10.1016/S0022-5347(05)67534-9; Simon-Loriere E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000418; Smal C, 2006, J BIOL CHEM, V281, P4887, DOI 10.1074/jbc.M512129200; Van Rompay AR, 2003, PHARMACOL THERAPEUT, V100, P119, DOI 10.1016/j.pharmthera.2003.07.001; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140741	10.1371/journal.pone.0140741	http://dx.doi.org/10.1371/journal.pone.0140741			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26485161	gold, Green Published, Green Submitted			2022-12-27	WOS:000363028100063
J	Wei, LM; Zhu, YQ; Liu, F; Zhang, PL; Li, XC; Zhao, JG; Lu, HT				Wei, Li-Ming; Zhu, Yue-Qi; Liu, Fang; Zhang, Pei-Lei; Li, Xiao-Cong; Zhao, Jun-Gong; Lu, Hai-Tao			RETRACTED: Percutaneous Aspiration Thrombectomy for Arterial Thromboembolism during Infrainguinal Endovascular Recanalization (Retracted article. See vol. 13, artn. e019676, 2018)	PLOS ONE			English	Article; Retracted Publication							EMBOLIC PROTECTION; REVASCULARIZATION; ANGIOPLASTY; COMPLICATIONS; DISEASE	Objectives To evaluate the efficacy of percutaneous aspiration thrombectomy (PAT) for infrainguinal arterial thromboembolism in patients undergoing endovascular recanalization (EVR) and to investigate the predictors for thromboembolic complications. Materials and Methods In total, 23 patients (23 limbs) who underwent PAT for thromboembolism (PAT group, PG) during EVR and 237 patients (302 limbs) who underwent successful EVR without thromboembolic complications (control group, CG) were enrolled. Immediate post-operation and follow-up outcomes were compared between the two groups. Multivariate analysis was performed to identify the predictors of thromboembolic complications. Technical success of PAT was defined as achievement of <30% residual stenosis and restoration of mTIMI grade 3. Results The technical success rate was 95.7% in PG. After intervention, the ankle-brachial index (ABI), restoration of blood flow and improvement in dorsal/plantar arterial pulse score showed no significant differences between PG and CG. During follow-up in PG, a sustained ABI improvement was observed in 63.6% (70.9% in CG), an improvement in walking distance in 68.8%(79.9% in CG,), ulcer healing in 75.0%(71.7% in CG) and restenosis/occlusion in 31.8% (25.2% in CG). The limb salvage rate was 100% in PG (96.0% in CG), and pain relief was observed in 66.7% patients with critical limb ischaemia (81.6% in CG). Superficial femoral artery involvement [0.233; 95% confidence interval (CI), 0.108-0.461; P < 0.001], de-novo lesion occlusion (683.8; 95% CI, 36.5-12804.6; P < 0.001) and intraluminal angioplasty (118.4; 95% CI, 8.0-1758.0; P = 0.001) was associated with high incidence of thromboembolism. Conclusion PAT is a safe and effective treatment for thromboembolism during infrainguinal arterial EVR. SFA involvement, de-novo lesion occlusion and intraluminal angioplasty may be predictors of thromboembolic complications.	[Wei, Li-Ming; Zhu, Yue-Qi; Zhang, Pei-Lei; Li, Xiao-Cong; Zhao, Jun-Gong; Lu, Hai-Tao] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Diagnost & Intervent Radiol, Shanghai 200030, Peoples R China; [Liu, Fang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhao, JG (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Diagnost & Intervent Radiol, Shanghai 200030, Peoples R China.	zhaojungong6th@hotmail.com	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022		National Natural Science Foundation of China [81000652, 81370041, 81271683]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study received funding from the National Natural Science Foundation of China (Nos. 81000652; 81370041, 81271683).	CLEVELAND TJ, 1994, CLIN RADIOL, V49, P549, DOI 10.1016/S0009-9260(05)82935-6; FOGARTY TJ, 1963, SURG GYNECOL OBSTET, V116, P241; Gray WA, 2006, J VASC SURG, V44, P258, DOI 10.1016/j.jvs.2006.03.044; Horvath L II, 1978, PERCUTANEOUS VASCULA, P126; Karnabatidis D, 2006, J ENDOVASC THER, V13, P269, DOI 10.1583/05-1771.1; Ko YG, 2007, J ENDOVASC THER, V14, P374, DOI 10.1583/06-1983.1; Li J, 2011, ACAD RADIOL, V18, P755, DOI 10.1016/j.acra.2011.01.013; Lookstein RA, 2010, TECH VASC INTERV RAD, V13, P54, DOI 10.1053/j.tvir.2009.10.007; Mendes BC, 2014, J VASC SURG, V59, P359, DOI 10.1016/j.jvs.2013.07.119; Schleder S, 2015, CARDIOVASC INTER RAD, V38, P60, DOI 10.1007/s00270-014-0857-6; Sianos G, 2007, J AM COLL CARDIOL, V50, P573, DOI 10.1016/j.jacc.2007.04.059; Spiliopoulos S, 2014, J ENDOVASC THER, V21, P474, DOI 10.1583/14-4703.1; Spiliopoulos S, 2012, J VASC SURG, V56, P1308, DOI 10.1016/j.jvs.2012.04.036; Sumitsuji S, 2011, JACC-CARDIOVASC INTE, V4, P941, DOI 10.1016/j.jcin.2011.06.011; Vorwerk D, 2006, CARDIOVASC INTER RAD, V29, P7, DOI 10.1007/s00270-005-8888-7; Ward TJ, 2014, J VASC INTERV RADIOL, V25, P1533, DOI 10.1016/j.jvir.2014.07.016; Wei LM, 2014, ACAD RADIOL, V21, P1475, DOI 10.1016/j.acra.2014.05.023; Zafar N, 2008, CATHETER CARDIO INTE, V71, P972, DOI 10.1002/ccd.21561; Zhang FX, 2014, ANN VASC SURG, V28, P590, DOI 10.1016/j.avsg.2013.05.015	19	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140494	10.1371/journal.pone.0140494	http://dx.doi.org/10.1371/journal.pone.0140494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484672	gold, Green Published			2022-12-27	WOS:000363028100037
J	Wu, LW; Yen, SH; Lees, DC; Lu, CC; Yang, PS; Hsu, YF				Wu, Li-Wei; Yen, Shen-Horn; Lees, David C.; Lu, Chih-Chien; Yang, Ping-Shih; Hsu, Yu-Feng			Phylogeny and Historical Biogeography of Asian Pterourus Butterflies (Lepidoptera: Papilionidae): A Case of Intercontinental Dispersal from North America to East Asia	PLOS ONE			English	Article							RIODINIDAE LEPIDOPTERA; MOLECULAR PHYLOGENY; VICARIANCE ANALYSIS; DIVERSIFICATION; SWALLOWTAIL; EVOLUTION; DIVERGENCE; DISJUNCT; MODELS; ORIGIN	The phylogenetic status of the well-known Asian butterflies often known as Agehana (a species group, often treated as a genus or a subgenus, within Papilio sensu lato) has long remained unresolved. Only two species are included, and one of them especially, Papilio maraho, is not only rare but near-threatened, being monophagous on its vulnerable hostplant, Sassafras randaiense (Lauraceae). Although the natural history and population conservation of "Agehana" has received much attention, the biogeographic origin of this group still remains enigmatic. To clarify these two questions, a total of 86 species representatives within Papilionidae were sampled, and four genes (concatenated length 3842 bp) were used to reconstruct their phylogenetic relationships and historical scenarios. Surprisingly, "Agehana" fell within the American Papilio subgenus Pterourus and not as previously suggested, phylogenetically close to the Asian Papilio subgenus Chilasa. We therefore formally synonymize Agehana with Pterourus. Dating and biogeographic analysis allow us to infer an intercontinental dispersal of an American ancestor of Asian Pterourus in the early Miocene, which was coincident with historical paleo-land bridge connections, resulting in the present "East Asia-America" disjunction distribution. We emphasize that species exchange between East Asia and America seems to be a quite frequent occurrence in butterflies during the Oligocene to Miocene climatic optima.	[Wu, Li-Wei] Natl Taiwan Univ, Coll Bioresources & Agr, Expt Forest, Nantou, Taiwan; [Yen, Shen-Horn] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Lees, David C.] Univ Cambridge, Dept Zool, Cambridge, England; [Lu, Chih-Chien; Hsu, Yu-Feng] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Yang, Ping-Shih] Natl Taiwan Univ, Dept & Grad Inst Entomol, Taipei 10764, Taiwan	National Taiwan University; National Sun Yat Sen University; University of Cambridge; National Taiwan Normal University; National Taiwan University	Wu, LW (corresponding author), Natl Taiwan Univ, Coll Bioresources & Agr, Expt Forest, Nantou, Taiwan.	chiladessp@gmail.com; t43018@ntnu.edu.tw	Lees, David/AAD-7382-2021		National Science Council (NSC) [101-2621-B-003-001-, 102-2621-B-003 -004-MY2]; Council of Agriculture (COA) [91AS-2.1.4-FC-R1, 92AS-4.1.4-FC-R1, 93AS-4.1.1-FB-e2, 94AS-9.1.7-FB-e1]; Institut National de Recherche Agronomique (INRA); European Research Council (ERC) [250325]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Council of Agriculture (COA); Institut National de Recherche Agronomique (INRA); European Research Council (ERC)(European Research Council (ERC)European Commission)	This study was financially supported by National Science Council (NSC) grands of Taiwan (101-2621-B-003-001-, and 102-2621-B-003 -004-MY2) and Council of Agriculture (COA) grants of Taiwan (91AS-2.1.4-FC-R1, 92AS-4.1.4-FC-R1, 93AS-4.1.1-FB-e2, and 94AS-9.1.7-FB-e1). DCL was funded by Institut National de Recherche Agronomique (INRA) and European Research Council (ERC) #250325 during the writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Braby MF, 2005, INVERTEBR SYST, V19, P113, DOI 10.1071/IS04020; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Campbell DL, 2000, MOL BIOL EVOL, V17, P684, DOI 10.1093/oxfordjournals.molbev.a026347; Caterino MS, 1999, MOL PHYLOGENET EVOL, V11, P122, DOI 10.1006/mpev.1998.0549; Condamine FL, 2013, CLADISTICS, V29, P88, DOI 10.1111/j.1096-0031.2012.00412.x; Condamine FL, 2013, J BIOGEOGR, V40, P9, DOI 10.1111/j.1365-2699.2012.02787.x; Condamine FL, 2012, ECOL LETT, V15, P267, DOI 10.1111/j.1461-0248.2011.01737.x; CONEY PJ, 1982, ANN MO BOT GARD, V69, P432, DOI 10.2307/2399080; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durden CJ, 1978, BUTTERFLIES MIDDLE E; Emmel T. C., 1992, FLORISSANT BUTTERFLI; Espeland M, 2015, MOL PHYLOGENET EVOL, V93, P296, DOI 10.1016/j.ympev.2015.08.006; Evanoff Emmett, 2001, Proceedings of the Denver Museum of Nature & Science, V4, P1; Hancock David L., 2009, Australian Entomologist, V36, P7; HANCOCK DL, 1983, SMITHERSIA, V2, P1; HAUSER CL, 2005, PAPILIONIDAE REVISED; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; HERNANDEZ L. M., 2002, HOSTPLANTS MOTH BUTT; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Igarashi S., 1984, Tyo To Ga, V34, P41; Kandul NP, 2004, SYST BIOL, V53, P278, DOI 10.1080/10635150490423692; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kawahara AY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0970; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lu C-C, 1998, IUCN 2011 IUCN RED L; Lu CC, 2009, ZOOL STUD, V48, P270; MARSHALL LG, 1982, SCIENCE, V215, P1351, DOI 10.1126/science.215.4538.1351; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; MILLER JS, 1987, B AM MUS NAT HIST, V186, P365; Morris M. G., 1985, THREATENED SWALLOWTA; Mullen SP, 2006, MOL PHYLOGENET EVOL, V39, P747, DOI 10.1016/j.ympev.2006.01.021; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nazari V, 2007, MOL PHYLOGENET EVOL, V42, P131, DOI 10.1016/j.ympev.2006.06.022; Nie ZL, 2007, PLANT SYST EVOL, V267, P191, DOI 10.1007/s00606-007-0550-1; Nie ZL, 2008, MOL PHYLOGENET EVOL, V48, P1027, DOI 10.1016/j.ympev.2008.06.004; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Ott M, 2007, P 2007 ACM IEEE C SU; Pena C, 2010, ZOOL SCR, V39, P243, DOI 10.1111/j.1463-6409.2010.00421.x; PINDELL JL, 1988, TECTONOPHYSICS, V155, P121, DOI 10.1016/0040-1951(88)90262-4; Rambaut A., 2014, TRACER V1 6; Robinson G.S., 2010, HOSTS A DATABASE WOR; Robinson GS, 2001, HOSTPLANTS MOTH BUTT; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Scott J. A., 1986, BUTTERFLIES N AM NAT; Simonsen TJ, 2011, CLADISTICS, V27, P113, DOI 10.1111/j.1096-0031.2010.00326.x; SMITH AB, 1994, BIOL J LINN SOC, V51, P279, DOI 10.1111/j.1095-8312.1994.tb00962.x; Sota T, 2008, MOL PHYLOGENET EVOL, V46, P183, DOI 10.1016/j.ympev.2007.10.016; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsukada E, 1982, BUTTERFLIES S E ASIA, VI; TYLER HA, 1994, SWALLOWTAIL BUTTERFL; Vila R, 2011, P ROY SOC B-BIOL SCI, V278, P2737, DOI 10.1098/rspb.2010.2213; von Dohlen CD, 2002, MOL PHYLOGENET EVOL, V23, P257, DOI 10.1016/S1055-7903(02)00025-8; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Wahlberg N, 2009, P ROY SOC B-BIOL SCI, V276, P4295, DOI 10.1098/rspb.2009.1303; Wang LH, 2008, STUDY ECOLOGICAL REQ; Warren A.D., INTERACTIVE LISTING; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wolfe J.A., 1985, CARBON CYCLE ATMOSPH, V32, pPP. 357, DOI 10.1029/GM032p0357; Wu LW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-468; Wu LW, 2010, ENTOMOL NEWS, V121, P267; Yen S. H., 2001, ILLUSTRATED IDENTIFI, P176; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403	72	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2015	10	10							e0140933	10.1371/journal.pone.0140933	http://dx.doi.org/10.1371/journal.pone.0140933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7XI	26484776	Green Published, Green Submitted, gold			2022-12-27	WOS:000363028100093
J	Arighi, A; Rango, M; Bozzali, M; Pietroboni, AM; Fumagalli, G; Ghezzi, L; Fenoglio, C; Biondetti, PR; Bresolin, N; Galimberti, D; Scarpini, E				Arighi, Andrea; Rango, Mario; Bozzali, Marco; Pietroboni, Anna M.; Fumagalli, Giorgio; Ghezzi, Laura; Fenoglio, Chiara; Biondetti, Pietro R.; Bresolin, Nereo; Galimberti, Daniela; Scarpini, Elio			Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; NORMATIVE DATA; CSF-TAU; PET; PRESENTATIONS; SPECTROSCOPY; MORPHOMETRY; DEMENTIAS; MARKERS	Background Posterior Cortical Atrophy (PCA) is a neurodegenerative disease characterized by a progressive decline in selective cognitive functions anatomically referred to occipital, parietal and temporal brain regions, whose diagnosis is rather challenging for clinicians. The aim of this study was to assess, using quantitative Magnetic Resonance Imaging techniques, the pattern of regional grey matter loss and metabolism in individuals with PCA to improve pathophysiological comprehension and diagnostic confidence. Methods We enrolled 5 patients with PCA and 5 matched controls who all underwent magnetic resonance imaging (MRI) and spectroscopy (MRS). Patients also underwent neuropsychological and cerebrospinal fluid (CSF) assessments. MRI data were used for unbiased assessment of regional grey matter loss in PCA patients compared to controls. MRS data were obtained from a set of brain regions, including the occipital lobe and the centrum semiovale bilaterally, and the posterior and anterior cingulate. Results VBM analysis documented the presence of focal brain atrophy in the occipital lobes and in the posterior parietal and temporal lobes bilaterally but more pronounced on the right hemisphere. MRS revealed, in the occipital lobes and in the posterior cingulate cortex of PCA patients, reduced levels of N-Acetyl Aspartate (NAA, a marker of neurodegeneration) and increased levels of Myo-Inositol (Ins, a glial marker), with no hemispheric lateralization. Conclusion The bilateral but asymmetric pattern of regional grey matter loss is consistent with patients' clinical and neuropsychological features and with previous literature. The MRS findings reveal different stages of neurodegeneration (neuronal loss; gliosis), which coexist and likely precede the occurrence of brain tissue loss, and might represent early biomarkers. In conclusion, this study indicates the potential usefulness of a multi-parametric MRI approach for an early diagnosis and staging of patients with PCA.	[Arighi, Andrea; Rango, Mario; Pietroboni, Anna M.; Fumagalli, Giorgio; Ghezzi, Laura; Fenoglio, Chiara; Bresolin, Nereo; Galimberti, Daniela; Scarpini, Elio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neurol Unit, I-20121 Milan, Italy; [Rango, Mario; Bresolin, Nereo] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Magnet Resonance Spect Ctr, I-20121 Milan, Italy; [Bozzali, Marco] IRCCS Santa Lucia Fdn, Neuorimaging Lab, Rome, Italy; [Biondetti, Pietro R.] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Radiol, I-20121 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Santa Lucia; IRCCS Ca Granda Ospedale Maggiore Policlinico	Arighi, A (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neurol Unit, Via Francesco Sforza 35, I-20121 Milan, Italy.	andrea.arighi@yahoo.it	Pietroboni, Anna Margherita/L-2970-2015; Bozzali, Marco/AAC-1031-2022; Arighi, Andrea/J-6010-2015; Ghezzi, Laura/V-5280-2019; Ghezzi, Laura/J-2284-2018; Fumagalli, Giorgio/L-8306-2013; Galimberti, Daniela/N-7209-2019; rango, mario/AIA-9372-2022; Scarpini, Elio/K-6547-2016	Pietroboni, Anna Margherita/0000-0003-1538-1830; Arighi, Andrea/0000-0003-2865-3970; Ghezzi, Laura/0000-0001-8180-9730; Fumagalli, Giorgio/0000-0003-0687-7199; Galimberti, Daniela/0000-0002-9284-5953; Scarpini, Elio/0000-0002-6395-2119; Bozzali, Marco/0000-0002-0568-2026; Bresolin, Nereo/0000-0001-6694-3595				Aharon-Peretz J, 1999, DEMENT GERIATR COGN, V10, P483, DOI 10.1159/000017194; Alladi S, 2007, BRAIN, V130, P2636, DOI 10.1093/brain/awm213; Alves J, 2013, BRAIN IMAGING BEHAV, V7, P353, DOI 10.1007/s11682-013-9236-1; Andreasen N, 2003, WORLD J BIOL PSYCHIA, V4, P147, DOI 10.1080/15622970310029912; Andreasen N, 2001, ARCH NEUROL-CHICAGO, V58, P373, DOI 10.1001/archneur.58.3.373; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Baumann TP, 2010, DEMENT GERIATR COGN, V29, P530, DOI 10.1159/000314679; BENSON DF, 1988, ARCH NEUROL-CHICAGO, V45, P789, DOI 10.1001/archneur.1988.00520310107024; Borroni B, 2012, NEUROBIOL AGING, V33, P2506, DOI 10.1016/j.neurobiolaging.2011.10.031; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Croisile B, 1999, DEMENT GERIATR COGN, V10, P226, DOI 10.1159/000017124; Crutch SJ, 2013, ALZHEIMERS DEMENT, V9, P463, DOI 10.1016/j.jalz.2012.11.004; Crutch SJ, 2012, LANCET NEUROL, V11, P170, DOI 10.1016/S1474-4422(11)70289-7; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Ernst T, 1997, RADIOLOGY, V203, P829, DOI 10.1148/radiology.203.3.9169712; Galton CJ, 2000, BRAIN, V123, P484, DOI 10.1093/brain/123.3.484; Giannakopoulos P, 1999, NEUROLOGY, V52, P71, DOI 10.1212/WNL.52.1.71; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Goethals M, 2001, CLIN NEUROL NEUROSUR, V103, P115, DOI 10.1016/S0303-8467(01)00114-7; Goodglass H., 1983, BOSTON NAMING TEST; HOF PR, 1989, BRAIN RES, V493, P368, DOI 10.1016/0006-8993(89)91173-6; Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210; Kantarci K, 2004, NEUROLOGY, V63, P1393; Kas A, 2011, BRAIN, V134, P1464, DOI 10.1093/brain/awr055; Kim EH, 2005, CLIN NEUROL NEUROSUR, V108, P97, DOI 10.1016/j.clineuro.2004.11.022; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Mendez MF, 2002, DEMENT GERIATR COGN, V14, P33, DOI 10.1159/000058331; Nestor PJ, 2003, J NEUROL NEUROSUR PS, V74, P1521, DOI 10.1136/jnnp.74.11.1521; Novelli G, 1986, TRE TEST CLIN RICERC; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Renner JA, 2004, NEUROLOGY, V63, P1175, DOI 10.1212/01.WNL.0000140290.80962.BF; Schmidtke K, 2005, J NEUROL, V252, P27, DOI 10.1007/s00415-005-0594-5; Seguin J, 2011, NEUROLOGY, V76, P1782, DOI 10.1212/WNL.0b013e31821ccc98; Serra L, 2010, J ALZHEIMERS DIS, V21, P627, DOI 10.3233/JAD-2010-100048; Shames H, 2015, J NEUROL, V262, P1751, DOI 10.1007/s00415-015-7774-8; Spinnler H., 1987, ITAL J NEUROL SCI, VS8, P6; Tang-Wai DF, 2004, NEUROLOGY, V63, P1168, DOI 10.1212/01.WNL.0000140289.18472.15; TEIXEIRA F, 1995, J PSYCHIATR NEUROSCI, V20, P276; WAKAI M, 1994, ACTA NEUROL SCAND, V89, P458; Warren JD, 2012, NAT REV NEUROL, V8, P451, DOI 10.1038/nrneurol.2012.135; Warrington EK., 1991, VISUAL OBJECT SPACE; Whitwell JL, 2007, NEUROBIOL AGING, V28, P1051, DOI 10.1016/j.neurobiolaging.2006.05.026	44	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140639	10.1371/journal.pone.0140639	http://dx.doi.org/10.1371/journal.pone.0140639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480294	Green Published, gold, Green Submitted			2022-12-27	WOS:000363026600015
J	Dehmer, M; Emmert-Streib, F; Shi, YT; Stefu, M; Tripathi, S				Dehmer, Matthias; Emmert-Streib, Frank; Shi, Yongtang; Stefu, Monica; Tripathi, Shailesh			Discrimination Power of Polynomial-Based Descriptors for Graphs by Using Functional Matrices	PLOS ONE			English	Article							ENTROPY	In this paper, we study the discrimination power of graph measures that are based on graph-theoretical matrices. The paper generalizes the work of [M. Dehmer, M. Moosbrugger. Y. Shi, Encoding structural information uniquely with polynomial-based descriptors by employing the Randic matrix, Applied Mathematics and Computation, 268(2015), 164-168]. We demonstrate that by using the new functional matrix approach, exhaustively generated graphs can be discriminated more uniquely than shown in the mentioned previous work.	[Dehmer, Matthias] Univ Bundeswehr Munchen, Dept Comp Sci, D-85577 Neubiberg, Germany; [Dehmer, Matthias; Stefu, Monica] UMIT, Dept Mechatron & Biomed Comp Sci, Eduard Wallnoefer Zentrum 1, A-6060 Hall In Tirol, Austria; [Emmert-Streib, Frank] Tampere Univ Technol, Dept Signal Proc, Computat Med & Stat Learning Lab, FI-33720 Tampere, Finland; [Shi, Yongtang] Nankai Univ, Ctr Combinator, Tianjin 300071, Peoples R China; [Shi, Yongtang] Nankai Univ, LPMC TJKLC, Tianjin 300071, Peoples R China; [Tripathi, Shailesh] Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland	Bundeswehr University Munich; Tampere University; Nankai University; Nankai University; Queens University Belfast	Dehmer, M (corresponding author), Univ Bundeswehr Munchen, Dept Comp Sci, Werner Heisenberg Weg 39, D-85577 Neubiberg, Germany.	matthias.dehmer@umit.at; shi@nankai.edu.cn	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020; Trpathi, Shailesh/T-2123-2017	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641; 	Austrian Science Funds [P26142]; NSFC, PCSIRT, China Postdoctoral Science Foundation	Austrian Science Funds(Austrian Science Fund (FWF)); NSFC, PCSIRT, China Postdoctoral Science Foundation	Matthias Dehmer thanks the Austrian Science Funds for supporting this work (project P26142). Yongtang Shi is supported by NSFC, PCSIRT, China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban AT, 2006, SAR QSAR ENVIRON RES, V17, P429, DOI 10.1080/10629360600884421; BONCHEV D, 1981, J COMPUT CHEM, V2, P127, DOI 10.1002/jcc.540020202; Cvetkovic DM, 1980, SPECTRA OF GRAPHS TH; Das KC, 2014, MATCH-COMMUN MATH CO, V72, P227; Dehmer M, 2015, APPL MATH COMPUT, V268, P164, DOI 10.1016/j.amc.2015.04.115; Dehmer M, 2008, APPL MATH COMPUT, V201, P82, DOI 10.1016/j.amc.2007.12.010; Dehmer M, 2015, APPL MATH COMPUT, V250, P352, DOI 10.1016/j.amc.2014.10.048; Dehmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102459; Dehmer M, 2013, MATCH-COMMUN MATH CO, V69, P785; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031214; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011393; Ellis-Monaghan JA, 2011, STRUCTURAL ANALYSIS OF COMPLEX NETWORKS, P219, DOI 10.1007/978-0-8176-4789-6_9; Gomes H, 2014, MATCH-COMMUN MATH CO, V72, P249; Gutman I, 1991, CHEM GRAPH THEORY IN, P133; Harary F., 1969, GRAPH THEORY; Holzinger A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S6-I1; HOSOYA H, 1988, DISCRETE APPL MATH, V19, P239, DOI 10.1016/0166-218X(88)90017-0; HOSOYA H, 1971, B CHEM SOC JPN, V44, P2332, DOI 10.1246/bcsj.44.2332; Konstantinova EV, 1996, J CHEM INF COMP SCI, V36, P54, DOI 10.1021/ci9502461; Li XL, 2008, MATCH-COMMUN MATH CO, V59, P127; Liu BL, 2012, MATCH-COMMUN MATH CO, V68, P913; Mckay B. D., 1981, C NUMERANTIUM, V30, P45, DOI DOI 10.1016/J.JSC.2013.09.003; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; Randic M., 2001, QSPR QSAR STUDIES MO QSPR QSAR STUDIES MO, P93; Todeschini R., 2002, HDB MOL DESCRIPTORS	26	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0139265	10.1371/journal.pone.0139265	http://dx.doi.org/10.1371/journal.pone.0139265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479495	gold, Green Submitted, Green Published			2022-12-27	WOS:000363026600003
J	Huentelman, MJ; Muppana, L; Corneveaux, JJ; Dinu, V; Pruzin, JJ; Reiman, R; Borish, CN; De Both, M; Ahmed, A; Todorov, A; Cloninger, CR; Zhang, R; Ma, J; Gallitano, AL				Huentelman, Matthew J.; Muppana, Leela; Corneveaux, Jason J.; Dinu, Valentin; Pruzin, Jeremy J.; Reiman, Rebecca; Borish, Cassie N.; De Both, Matt; Ahmed, Amber; Todorov, Alexandre; Cloninger, C. Robert; Zhang, Rui; Ma, Jie; Gallitano, Amelia L.			Association of SNPs in EGR3 and ARC with Schizophrenia Supports a Biological Pathway for Schizophrenia Risk	PLOS ONE			English	Article							FAMILY-BASED ASSOCIATION; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; GENE POLYMORPHISMS; FACTOR EXPRESSION; BIPOLAR DISORDER; CELL GROWTH; LINKAGE; SUSCEPTIBILITY; METAANALYSIS	We have previously hypothesized a biological pathway of activity-dependent synaptic plasticity proteins that addresses the dual genetic and environmental contributions to schizophrenia. Accordingly, variations in the immediate early gene EGR3, and its target ARC, should influence schizophrenia susceptibility. We used a pooled Next-Generation Sequencing approach to identify variants across these genes in U.S. populations of European (EU) and African (AA) descent. Three EGR3 and one ARC SNP were selected and genotyped for validation, and three SNPs were tested for association in a replication cohort. In the EU group of 386 schizophrenia cases and 150 controls EGR3 SNP rs1877670 and ARC SNP rs35900184 showed significant associations (p = 0.0078 and p = 0.0275, respectively). In the AA group of 185 cases and 50 controls, only the ARC SNP revealed significant association (p = 0.0448). The ARC SNP did not show association in the Han Chinese (CH) population. However, combining the EU, AA, and CH groups revealed a highly significant association of ARC SNP rs35900184 (p = 2.353 x 10(-7); OR [95% CI] = 1.54 [1.310-1.820]). These findings support previously reported associations between EGR3 and schizophrenia. Moreover, this is the first report associating an ARC SNP with schizophrenia and supports recent large-scale GWAS findings implicating the ARC complex in schizophrenia risk. These results support the need for further investigation of the proposed pathway of environmentally responsive, synaptic plasticity-related, schizophrenia genes.	[Huentelman, Matthew J.; Corneveaux, Jason J.; Pruzin, Jeremy J.; Reiman, Rebecca; Borish, Cassie N.; De Both, Matt] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA; [Muppana, Leela; Ahmed, Amber; Gallitano, Amelia L.] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85004 USA; [Dinu, Valentin] Arizona State Univ, Dept Biomed Informat, Scottsdale, AZ USA; [Todorov, Alexandre; Cloninger, C. Robert] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Zhang, Rui] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp, Xian Hong Hui Hosp, Xian 710049, Shaanxi, Peoples R China; [Ma, Jie] Xi An Jiao Tong Univ, Sch Med, Dept Biochem & Mol Biol, Xian 710049, Shaanxi, Peoples R China	Translational Genomics Research Institute; University of Arizona; Arizona State University; Washington University (WUSTL); Xi'an Jiaotong University; Xi'an Jiaotong University	Gallitano, AL (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85004 USA.	amelia@email.arizona.edu	Cloninger, Claude/F-5357-2012; Gallitano, Amelia L./C-5591-2014	Cloninger, Claude/0000-0003-3096-4807; Gallitano, Amelia L./0000-0002-0544-7114; Zhang, Rui/0000-0002-8664-6915; Dinu, Valentin/0000-0001-6192-7836	NIH [U01 MH046276, R01 MH097803, R01 MH-083823, R01 MH-067921]; Pfizer Fellowship in Biological Psychiatry; National Alliance for Research on Schizophrenia and Depression/Sidney R Baer Jr. Foundation Young Investigator Award; Arizona Biomedical Research Collaborative grant; Institute of Mental Health Research award; State of Arizona Department of Health Services; Fundamental Research Funds for the Central Universities [2012JDGZ07, XJJ2012124]; Ministry of Education, PRC [20090201120062]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083823, R01MH067921, U01MH046276, R01MH097803] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Fellowship in Biological Psychiatry; National Alliance for Research on Schizophrenia and Depression/Sidney R Baer Jr. Foundation Young Investigator Award; Arizona Biomedical Research Collaborative grant; Institute of Mental Health Research award; State of Arizona Department of Health Services; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Education, PRC; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The collection of data and biomaterials for this study was supported by funding from NIH U01 MH046276 (to CRC). This work was supported by a Pfizer Fellowship in Biological Psychiatry, a National Alliance for Research on Schizophrenia and Depression/Sidney R Baer Jr. Foundation Young Investigator Award, an Arizona Biomedical Research Collaborative grant, NIH R01 MH097803 (to ALG), NIH R01 MH-083823 (to MJH), NIH R01 MH-083823 (to AT), NIH R01 MH-067921 (PI-Todd RD), an Institute of Mental Health Research award (to ALG and MJH), and the State of Arizona Department of Health Services. Additional support was from the Fundamental Research Funds for the Central Universities (No. 2012JDGZ07, No. XJJ2012124) and the Ministry of Education, PRC (No. 20090201120062) (to JM and RZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bresnahan M, 2007, INT J EPIDEMIOL, V36, P751, DOI 10.1093/ije/dym041; Cheng MC, 2012, PROG NEURO-PSYCHOPH, V39, P149, DOI 10.1016/j.pnpbp.2012.06.004; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fahmy RG, 2007, J CELL BIOCHEM, V100, P1526, DOI 10.1002/jcb.21145; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gallitano A, 2008, DYSFUNCTION IMMEDIAT; Gallitano AL, 2012, J AFFECT DISORDERS, V138, P387, DOI 10.1016/j.jad.2012.01.011; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Gallitano-Mendel A, 2008, NEUROPSYCHOPHARMACOL, V33, P1266, DOI 10.1038/sj.npp.1301505; Guo AY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-10; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; Holliday EG, 2008, AM J MED GENET B, V147B, P1080, DOI 10.1002/ajmg.b.30722; Jacobson C, 2004, P NATL ACAD SCI USA, V101, P12218, DOI 10.1073/pnas.0404240101; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.0.CO;2-W; Kim SH, 2010, AM J MED GENET B, V153B, P1355, DOI 10.1002/ajmg.b.31115; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kyogoku C, 2011, PSYCHIAT RES, V185, P16, DOI 10.1016/j.psychres.2009.11.003; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Liu BC, 2010, PROG NEURO-PSYCHOPH, V34, P506, DOI 10.1016/j.pnpbp.2010.02.005; Maier W, 2008, EUR ARCH PSY CLIN N, V258, P37, DOI 10.1007/s00406-008-2008-z; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Mexal S, 2005, MOL BRAIN RES, V139, P317, DOI 10.1016/j.molbrainres.2005.06.006; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Ning Qi-Lan, 2012, Yichuan, V34, P307, DOI 10.3724/SP.J.1005.2012.00307; Nishimura Y, 2014, NEUROIMAGE, V85, P527, DOI 10.1016/j.neuroimage.2013.08.021; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; RAO DC, 1981, HUM HERED, V31, P325, DOI 10.1159/000153233; Schrauwen I, 2013, AM J MED GENET A, V161A, P145, DOI 10.1002/ajmg.a.35737; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Takahashi S, 2005, PSYCHIAT RES, V133, P111, DOI 10.1016/j.psychres.2004.12.003; Tam GWC, 2009, BIOL PSYCHIAT, V66, P1005, DOI 10.1016/j.biopsych.2009.07.027; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Yamagata K, 1994, Learn Mem, V1, P140; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030237; Zhang WC, 2015, NEURON, V86, P490, DOI 10.1016/j.neuron.2015.03.030	59	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0135076	10.1371/journal.pone.0135076	http://dx.doi.org/10.1371/journal.pone.0135076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474411	Green Submitted, Green Published, gold			2022-12-27	WOS:000363185500002
J	Jordana-Lluch, E; Gimenez, M; Quesada, MD; Rivaya, B; Marco, C; Dominguez, MJ; Armestar, F; Martro, E; Ausina, V				Jordana-Lluch, Elena; Gimenez, Montserrat; Dolores Quesada, Ma; Rivaya, Belen; Marco, Clara; Jesus Dominguez, Ma; Armestar, Fernando; Martro, Elisa; Ausina, Vicente			Evaluation of the Broad-Range PCR/ESI-MS Technology in Blood Specimens for the Molecular Diagnosis of Bloodstream Infections	PLOS ONE			English	Article							ENTEROCOCCUS-FAECIUM; PERFORMANCE; BACTEREMIA	Background Rapid identification of the etiological agent in bloodstream infections is of vital importance for the early administration of the most appropriate antibiotic therapy. Molecular methods may offer an advantage to current culture-based microbiological diagnosis. The goal of this study was to evaluate the performance of IRIDICA, a platform based on universal genetic amplification followed by mass spectrometry (PCR/ESI-MS) for the molecular diagnosis of sepsis-related pathogens directly from the patient's blood. Methods A total of 410 whole blood specimens from patients admitted to Emergency Room (ER) and Intensive Care Unit (ICU) with clinical suspicion of sepsis were tested with the IRIDICA BAC BSI Assay (broad identification of bacteria and Candida spp.). Microorganisms grown in culture and detected by IRIDICA were compared considering blood culture as gold standard. When discrepancies were found, clinical records and results from other cultures were taken into consideration (clinical infection criterion). Results The overall positive and negative agreement of IRIDICA with blood culture in the analysis by specimen was 74.8% and 78.6%, respectively, rising to 76.9% and 87.2% respectively, when compared with the clinical infection criterion. Interestingly, IRIDICA detected 41 clinically significant microorganisms missed by culture, most of them from patients under antimicrobial treatment. Of special interest were the detections of one Mycoplasma hominis and two Mycobacterium simiae in immunocompromised patients. When ICU patients were analyzed separately, sensitivity, specificity, positive and negative predictive values compared with blood culture were 83.3%, 78.6%, 33.9% and 97.3% respectively, and 90.5%, 87.2%, 64.4% and 97.3% respectively, in comparison with the clinical infection criterion. Conclusions IRIDICA is a promising technology that offers an early and reliable identification of a wide variety of pathogens directly from the patient's blood within 6h, which brings the opportunity to improve management of septic patients, especially for those critically ill admitted to the ICU.	[Jordana-Lluch, Elena; Gimenez, Montserrat; Dolores Quesada, Ma; Rivaya, Belen; Marco, Clara; Martro, Elisa; Ausina, Vicente] Autonomous Univ Barcelona, Dept Genet & Microbiol, Germans Trias & Pujol Univ Hosp, Microbiol Serv, Badalona, Spain; [Jordana-Lluch, Elena; Gimenez, Montserrat; Ausina, Vicente] CIBER Resp Dis CIBERES, Madrid, Spain; [Jesus Dominguez, Ma] Germans Trias & Pujol Univ Hosp, Badalona, Spain; [Armestar, Fernando] Germans Trias & Pujol Univ Hosp, Intens Care Unit, Badalona, Spain; [Jordana-Lluch, Elena; Martro, Elisa; Ausina, Vicente] Hlth Sci Res Inst IGTP, Badalona, Spain; [Martro, Elisa] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Martro, E (corresponding author), Autonomous Univ Barcelona, Dept Genet & Microbiol, Germans Trias & Pujol Univ Hosp, Microbiol Serv, Badalona, Spain.	emartro.igtp.germanstrias@gencat.cat	Martró, Elisa/K-9688-2015; JORDANA-LLUCH, ELENA/L-2976-2015	Martró, Elisa/0000-0002-2867-6649; Armestar, Fernando/0000-0002-6374-1418; Rivaya Sanchez, Belen/0000-0003-2562-6248; Gimenez, Montserrat/0000-0001-8841-810X; JORDANA-LLUCH, ELENA/0000-0002-1115-2048	"Ministerio de Ciencia e Innovacion" (MICINN) [PTA2011-5619-T]; Plan Nacional de Investigacion cientifica, Desarrollo e Innovacion Tecnologica (I+D+I); "Sociedad Espanola de Enfermedades Infecciosas y de Microbiologia Clinica" (SEIMC)	"Ministerio de Ciencia e Innovacion" (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan Nacional de Investigacion cientifica, Desarrollo e Innovacion Tecnologica (I+D+I); "Sociedad Espanola de Enfermedades Infecciosas y de Microbiologia Clinica" (SEIMC)	EM holds a Miguel Servet position for researchers in the Spanish National Health System (MS09/00044, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad). This work was partially funded by grant number PTA2011-5619-T ("Personal Tecnico de Apoyo") from "Ministerio de Ciencia e Innovacion" (MICINN), "Plan Nacional de Investigacion cientifica, Desarrollo e Innovacion Tecnologica (I+D+I)" and the "Sociedad Espanola de Enfermedades Infecciosas y de Microbiologia Clinica" (SEIMC) (EJL). All reagents and materials necessary for IRIDICA testing were supplied by Ibis Biosciences. This institution had no role in study design, decision to publish, or preparation of the manuscript.	Afshari A, 2012, CRIT CARE, V16, DOI 10.1186/cc11202; Alvarez J, 2012, ANAESTH INTENS CARE, V40, P958, DOI 10.1177/0310057X1204000606; Bacconi A, 2014, J CLIN MICROBIOL, V52, P3164, DOI 10.1128/JCM.00801-14; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Chang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054564; Dean AG, OPENEPI OPEN SOURCE; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Gimenez M, 50 INT C ANT AG CHEM; Jordana-Lluch E, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062108, DOI 10.1371/J0URNAL.P0NE.0062108]; Jordana-Lluch E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/501214; Klare I, 2012, DIAGN MICR INFEC DIS, V74, P171, DOI 10.1016/j.diagmicrobio.2012.06.020; Laffler TG, 2013, J CLIN MICROBIOL, V51, P3535, DOI 10.1128/JCM.00876-13; Lehmann LE, 2010, CRIT CARE, V14, DOI 10.1186/cc9294; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; O'Brien JM, 2007, AM J MED, V120, P1012, DOI 10.1016/j.amjmed.2007.01.035; Paolucci M, 2010, INT J ANTIMICROB AG, V36, pS6, DOI 10.1016/j.ijantimicag.2010.11.010; Quesada MD, 2010, CLIN MICROBIOL INFEC, V16, P137, DOI 10.1111/j.1469-0691.2009.02907.x; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Reimer LG, 1997, CLIN MICROBIOL REV, V10, P444, DOI 10.1128/CMR.10.3.444; Szakacs TA, 2014, J CLIN MICROBIOL, V52, P1682, DOI 10.1128/JCM.03563-13; Willems E, 2012, DIAGN MICR INFEC DIS, V73, P1, DOI 10.1016/j.diagmicrobio.2012.01.009	23	40	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140865	10.1371/journal.pone.0140865	http://dx.doi.org/10.1371/journal.pone.0140865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474394	Green Submitted, Green Published, gold			2022-12-27	WOS:000363185500122
J	Kumachev, A; Yan, M; Berry, S; Ko, YJ; Martinez, MCR; Shah, K; Chan, KKW				Kumachev, Alexander; Yan, Marie; Berry, Scott; Ko, Yoo-Joung; Martinez, Maria C. R.; Shah, Keya; Chan, Kelvin K. W.			A Systematic Review and Network Meta-Analysis of Biologic Agents in the First Line Setting for Advanced Colorectal Cancer	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; WILD-TYPE KRAS; 1ST-LINE TREATMENT; MONOCLONAL-ANTIBODIES; INITIAL TREATMENT; BEVACIZUMAB; CHEMOTHERAPY; OXALIPLATIN; FLUOROURACIL; PANITUMUMAB	Background Epithelial growth factor receptor inhibitors (EGFRis) and bevacizumab (BEV) are used in combination with chemotherapy for the treatment of metastatic colorectal cancer (mCRC). However, few randomized controlled trials (RCTs) have directly compared their relative efficacy on progression-free survival (PFS) and overall survival (OS). Methods We conducted a systematic review of first-line RCTs comparing (1) EGFRis vs. BEV, with chemotherapy in both arms (2) EGFRis + chemotherapy vs. chemotherapy alone, or (3) BEV + chemotherapy vs. chemotherapy alone, using Cochrane methodology. Data on and PFS and OS were extracted using the Parmar method. Pairwise meta-analyses and Bayesian network meta-analyses (NMA) were conducted to estimate the direct, indirect and combined PFS and OS hazard ratios (HRs) comparing EGFRis to BEV. Results Seventeen RCTs contained extractable data for quantitative analysis. Combining direct and indirect data using an NMA did not show a statistical difference between EGFRis versus BEV (PFS HR = 1.11 (95% CR: 0.92-1.36) and OS HR = 0.91 (95% CR: 0.75-1.09)). Direct meta-analysis (3 RCTs), indirect (14 RCTs) and combined (17 RCTs) NMA of PFS HRs were concordant and did not show a difference between EGFRis and BEV. Meta-analysis of OS using direct evidence, largely influenced by one trial, showed an improvement with EGFRis therapy (HR = 0.79 (95% CR: 0.65-0.98)), while indirect and combined NMA of OS did not show a difference between EGFRis and BEV Successive inclusions of trials over time in the combined NMA did not show superiority of EGFRis over BEV. Conclusions Our findings did not support OS or PFS benefits of EGFRis over BEV in first-line mCRC.	[Kumachev, Alexander; Yan, Marie; Berry, Scott; Ko, Yoo-Joung; Chan, Kelvin K. W.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Berry, Scott; Ko, Yoo-Joung; Martinez, Maria C. R.; Chan, Kelvin K. W.] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Shah, Keya] Queens Univ, Fac Med, Kingston, ON, Canada; [Chan, Kelvin K. W.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Queens University - Canada; University of Toronto	Chan, KKW (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.	kelvin.chan@sunnybrook.ca	Riesco-Martinez, Maria/C-5896-2019	Riesco-Martinez, Maria/0000-0003-0626-0607				Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; [Anonymous], [No title captured]; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Caro JJ, 2012, VALUE HEALTH, V15, P796, DOI 10.1016/j.jval.2012.06.012; Chen CX, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.30_suppl.9; Cress RD, 2006, CANCER, V107, P1142, DOI 10.1002/cncr.22011; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Edwards MS, 2012, COLORECTAL DIS, V14, pe31, DOI 10.1111/j.1463-1318.2011.02765.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fuchs CS, 2007, J CLIN ONCOL, V25, P4779, DOI 10.1200/JCO.2007.11.3357; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Liao WC, 2013, LANCET ONCOL, V14, P1095, DOI 10.1016/S1470-2045(13)70388-7; Loupakis F, 2012, CANCER-AM CANCER SOC, V118, P1523, DOI 10.1002/cncr.26460; Loupakis F, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-58; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Macedo LT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-89; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nagayama A., 2014, JNCI-J NATL CANCER I, V106; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Petrelli F, 2011, INT J COLORECTAL DIS, V26, P823, DOI 10.1007/s00384-011-1149-0; Pietrantonioa F, 2015, CRIT REV ONCOL HEMAT; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sanoff HK, 2008, J CLIN ONCOL, V26, P5721, DOI 10.1200/JCO.2008.17.7147; Schwartzberg LS, 2014, J CLIN ONCOL, V32, P2240, DOI 10.1200/JCO.2013.53.2473; Skoetz N, 2013, LANCET ONCOL, V14, P943, DOI 10.1016/S1470-2045(13)70341-3; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stintzing S, 2014, ANN ONCOL, V25, DOI 10.1093/annonc/mdu438.9; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Tang PA, 2007, J CLIN ONCOL, V25, P4562, DOI 10.1200/JCO.2006.08.1935; Tol J, 2010, CLIN THER, V32, P437, DOI 10.1016/j.clinthera.2010.03.012; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Van Cutsem E, 2009, ANN ONCOL, V20, P61, DOI 10.1093/annonc/mdp130; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Venook AP, 2014, J CLIN ONCOL S, V32; Woods BS, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-54; Yoo PS, 2006, CLIN COLORECTAL CANC, V6, P202, DOI 10.3816/CCC.2006.n.036	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140187	10.1371/journal.pone.0140187	http://dx.doi.org/10.1371/journal.pone.0140187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474403	Green Submitted, Green Published, gold			2022-12-27	WOS:000363185500032
J	Nagelkerke, N; Fidler, V				Nagelkerke, Nico; Fidler, Vaclav			Estimating a Logistic Discrimination Functions When One of the Training Samples Is Subject to Misclassification: A Maximum Likelihood Approach	PLOS ONE			English	Article							TUBERCULOSIS; REGRESSION	The problem of discrimination and classification is central to much of epidemiology. Here we consider the estimation of a logistic regression/discrimination function from training samples, when one of the training samples is subject to misclassification or mislabeling, e.g. diseased individuals are incorrectly classified/labeled as healthy controls. We show that this leads to zero-inflated binomial model with a defective logistic regression or discrimination function, whose parameters can be estimated using standard statistical methods such as maximum likelihood. These parameters can be used to estimate the probability of true group membership among those, possibly erroneously, classified as controls. Two examples are analyzed and discussed. A simulation study explores properties of the maximum likelihood parameter estimates and the estimates of the number of mislabeled observations.	[Nagelkerke, Nico] Malawi Liverpool Wellcome Trust, Blantyre 3, Malawi	University of Malawi	Nagelkerke, N (corresponding author), Malawi Liverpool Wellcome Trust, Blantyre 3, Malawi.	nnagelkerke@mlw.medcol.mw						Albert PS, 2014, BIOMETRICS, V70, P175, DOI 10.1111/biom.12106; [Anonymous], 2014, R LANG ENV STAT COMP; Barandela R, 2000, LECT NOTES COMPUT SC, V1876, P621; Bootkrajang Jakramate, 2012, Machine Learning and Knowledge Discovery in Databases. Proceedings of the European Conference (ECML PKDD 2012), P143, DOI 10.1007/978-3-642-33460-3_15; Bootkrajang J., 2011, P 19 EUR S ART NEUR, P345; Bootkrajang J, 2013, LECT NOTES COMPUT SC, V8206, P569, DOI 10.1007/978-3-642-41278-3_69; Cour T, 2011, J MACH LEARN RES, V12, P1501; Euser SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047437; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; James G., 2014, INTRO STAT LEARNING; Kaul KL, 2001, CLIN CHEM, V47, P1553; LACHENBRUCH PA, 1966, TECHNOMETRICS, V8, P657, DOI 10.2307/1266637; Lawrence N. D., 2001, 18 INT C MACHINE LEA, V1, P306; Long PM, 2010, MACH LEARN, V78, P287, DOI 10.1007/s10994-009-5165-z; LUGOSI G, 1992, PATTERN RECOGN, V25, P79, DOI 10.1016/0031-3203(92)90008-7; Manevitz LM, 2002, J MACH LEARN RES, V2, P139, DOI 10.1162/15324430260185574; Nagelkerke NJD, 2001, STAT MED, V20, P1113, DOI 10.1002/sim.745; Rao C.R, 1973, LINEAR STAT INFERENC, V2; Raykar VC, 2010, J MACH LEARN RES, V11, P1297; TUYNS AJ, 1977, B CANCER, V64, P45	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140718	10.1371/journal.pone.0140718	http://dx.doi.org/10.1371/journal.pone.0140718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474313	Green Submitted, Green Published, gold			2022-12-27	WOS:000363185500091
J	Xu, YP; Li, ZQ; Ai, FL; Chen, JH; Xing, Q; Zhou, P; Wei, ZL; Shi, YY; He, XJ; Cao, YX				Xu, Yuping; Li, Zhiqiang; Ai, Fenglian; Chen, Jianhua; Xing, Qiong; Zhou, Ping; Wei, Zhaolian; Shi, Yongyong; He, Xiao-Jin; Cao, Yunxia			Systematic Evaluation of Genetic Variants for Polycystic Ovary Syndrome in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHROMOSOME 2P16.3; SUSCEPTIBILITY LOCI; WOMEN; PCOS; PREVALENCE; DENND1A; COHORT; RISK; GWAS	To date, eleven genome-wide significant (GWS) loci (P < 5x10(-8)) for polycystic ovary syndrome (PCOS) have been identified through genome-wide association studies (GWAS). Some of the risk loci have been selected for replications and validated in multiple ethnicities, however, few previous studies investigated all loci. Scanning all the GWAS variants would demonstrate a more informative profile of variance they explained. Thus, we analyzed all the 17 single nucleotide polymorphisms (SNPs) mapping to the 11 GWAS loci in an independent sample set of 800 Chinese subjects with PCOS and 1110 healthy controls systematically. Variants of rs3802457 in C9orf3 locus (P = 5.99x10(-4)) and rs13405728 in LHCGR locus (P = 3.73x10(-4)) were significantly associated with PCOS after the strict Bonferroni correction in our data set. The further haplotype analysis indicated that in the block of C9orf3 gene (rs4385527 and rs3802457), GA haplotype played a protective role in PCOS (8.7 vs 5.0, P = 9.85x10(-6), OR = 0.548, 95% CI = 0.418-0.717), while GG haplotype was found suffering from an extraordinarily increased risk of PCOS (73.6% vs79.2%, P = 3.41x10(-5), OR = 1.394, 95% CI = 1.191-1.632). Moreover, the directions of effects for all SNPs were consistent with previous GWAS reports (P = 1.53x10(-5)). Polygenic score analysis demonstrated that these 17 SNPs have a significant capacity on predicting case-control status in our samples (P = 7.17x10(-9)), meanwhile all these gathered 17 SNPs explained about 2.40% of variance. Our findings supported that C9orf3 and LHCGR loci variants were vital susceptibility of PCOS.	[Xu, Yuping; Ai, Fenglian; Xing, Qiong; Zhou, Ping; Wei, Zhaolian; He, Xiao-Jin; Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Reprod Med Ctr, Hefei 230022, Peoples R China; [Xu, Yuping; Ai, Fenglian; Xing, Qiong; Zhou, Ping; Wei, Zhaolian; He, Xiao-Jin; Cao, Yunxia] Anhui Med Univ, Inst Reprod Genet, Hefei 230022, Peoples R China; [Xu, Yuping; Ai, Fenglian; Xing, Qiong; Zhou, Ping; Wei, Zhaolian; He, Xiao-Jin; Cao, Yunxia] Anhui Prov Engn Technol Res Ctr Biopreservat & Ar, Hefei 230022, Peoples R China; [Li, Zhiqiang; Chen, Jianhua; Shi, Yongyong] Shanghai Jiao Tong Univ, Bio X Inst, Shanghai 200030, Peoples R China	Anhui Medical University; Anhui Medical University; Shanghai Jiao Tong University	Shi, YY (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, 1954 Huashan Rd, Shanghai 200030, Peoples R China.	shiyongyong@gmail.com; hxj0117@126.com; caoyunxia6@126.com	Shi, Yongyong/GSO-1627-2022; Chen, Jianhua/AAS-8417-2020; Li, Zhiqiang/AAI-4003-2021	Shi, Yongyong/0000-0003-1710-1505; Li, Zhiqiang/0000-0002-0174-9254; He, Xiao-Jin/0000-0001-5919-8478	National Basic Research Program of China [2012CB944704, 2015CB559100]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China 2012CB944704 (recipient: YC) and 2015CB559100 (recipient: YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefi S, 2013, GYNECOL ENDOCRINOL, V29, P470, DOI 10.3109/09513590.2013.769513; ATGER M, 1995, MOL CELL ENDOCRINOL, V111, P113, DOI 10.1016/0303-7207(95)03557-N; Brower MA, 2015, J CLIN ENDOCR METAB, V100, pE182, DOI 10.1210/jc.2014-2689; Carmina E, 2009, CLIMACTERIC, V12, P22, DOI 10.1080/13697130903003842; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Cui LL, 2013, HUM REPROD, V28, P538, DOI 10.1093/humrep/des424; Diaz-Perales A, 2005, J BIOL CHEM, V280, P14310, DOI 10.1074/jbc.M413222200; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; Goodarzi MO, 2012, J MED GENET, V49, P90, DOI 10.1136/jmedgenet-2011-100427; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Kandaraki E, 2009, ARQ BRAS ENDOCRINOL, V53, P227, DOI 10.1590/S0004-27302009000200014; Kerns SL, 2010, INT J RADIAT ONCOL, V78, P1292, DOI 10.1016/j.ijrobp.2010.07.036; Kubota Toshiro, 2013, Reproductive Medicine and Biology, V12, P71, DOI 10.1007/s12522-013-0145-1; LEGRO RS, 1995, AM J MED, V98, pS9, DOI 10.1016/S0002-9343(99)80053-9; Lerchbaum E, 2011, HORM METAB RES, V43, P743, DOI 10.1055/s-0031-1286279; Li R, 2013, HUM REPROD, V28, P2562, DOI 10.1093/humrep/det262; Li XC, 2006, AM J PHYSIOL-RENAL, V290, pF1024, DOI 10.1152/ajprenal.00221.2005; Lindholm A, 2008, INT J GYNECOL OBSTET, V102, P39, DOI 10.1016/j.ijgo.2008.01.023; Louwers YV, 2013, J CLIN ENDOCR METAB, V98, pE2006, DOI 10.1210/jc.2013-2495; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McAllister JM, 2015, TRENDS ENDOCRIN MET, V26, P118, DOI 10.1016/j.tem.2014.12.004; Mutharasan P, 2013, J CLIN ENDOCR METAB, V98, pE185, DOI 10.1210/jc.2012-2471; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Uncu G, 2002, GYNECOL ENDOCRINOL, V16, P447, DOI 10.1080/713603158; Welt CK, 2012, J CLIN ENDOCR METAB, V97, pE1342, DOI 10.1210/jc.2011-3478	27	13	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140695	10.1371/journal.pone.0140695	http://dx.doi.org/10.1371/journal.pone.0140695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474478	Green Submitted, Green Published, gold			2022-12-27	WOS:000363185500083
